,MOLECULE_CHEMBL_ID,MOLECULE_NAME,MOLECULE_TYPE,FIRST_APPROVAL,ATC_CODE,ATC_CODE_DESCRIPTION,USAN_STEM,MECHANISM_OF_ACTION,MECHANISM_COMMENT,SELECTIVITY_COMMENT,TARGET_CHEMBL_ID,TARGET_NAME,ACTION_TYPE,ORGANISM,TARGET_TYPE,SITE_NAME,BINDING_SITE_COMMENT,MECHANISM_REFS,CANONICAL_SMILES,chembl,hgnc_symbol
0,CHEMBL1615438,Levocabastine,Small molecule,1993.0,R01AC02; S01GX02,"R01AC02 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Antiallergic agents, excl. corticosteroids]; S01GX02 [SENSORY ORGANS: OPHTHALMOLOGICALS: DECONGESTANTS AND ANTIALLERGICS: Other antiallergics]",-astine,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=420b3f66-87f0-47d8-947c-541e84eb594a, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=420b3f66-87f0-47d8-947c-541e84eb594a",C[C@@H]1CN(CC[C@]1(C(=O)O)c2ccccc2)[C@@H]3CC[C@@](CC3)(C#N)c4ccc(F)cc4,CHEMBL231,HRH1
1,CHEMBL1200951,Fluphenazine Enanthate,Small molecule,1967.0,N05AB02,N05AB02 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Phenothiazines with piperazine structure],,Dopamine D2 receptor antagonist,,,CHEMBL217,Dopamine D2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11873706, URL:http://europepmc.org/abstract/MED/11873706|Name:PubMed, SrcID:7508675, URL:http://europepmc.org/abstract/MED/7508675|Name:Wikipedia, SrcID:Antipsychotic#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Antipsychotic#Mechanism_of_action|Name:PubMed, SrcID:7828655, URL:http://europepmc.org/abstract/MED/7828655",CCCCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1,CHEMBL217,DRD2
2,CHEMBL570,Triflupromazine,Small molecule,1957.0,N05AA05,N05AA05 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Phenothiazines with aliphatic side-chain],,Dopamine D2 receptor antagonist,,,CHEMBL217,Dopamine D2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:KEGG, SrcID:D00390, URL:http://www.kegg.jp/dbget-bin/www_bget?dr:D00390|Name:PubMed, SrcID:1678146, URL:http://europepmc.org/abstract/MED/1678146|Name:Wikipedia, SrcID:Antipsychotic#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Antipsychotic#Mechanism_of_action|Name:Other, SrcID:http://neurolex.org/wiki/Category:Triflupromazine, URL:http://neurolex.org/wiki/Category:Triflupromazine|Name:PubMed, SrcID:497523, URL:http://europepmc.org/abstract/MED/497523|Name:PubMed, SrcID:239403, URL:http://europepmc.org/abstract/MED/239403",CN(C)CCCN1c2ccccc2Sc3ccc(cc13)C(F)(F)F,CHEMBL217,DRD2
3,CHEMBL27,Propranolol,Small molecule,1967.0,C07AA05,"C07AA05 [CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, non-selective]",-olol,Beta-1 adrenergic receptor antagonist,,,CHEMBL213,Beta-1 adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=fce692df-1e68-465e-8dda-0cb01320608c, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fce692df-1e68-465e-8dda-0cb01320608c|Name:Wikipedia, SrcID:Propranolol, URL:http://en.wikipedia.org/wiki/Propranolol",CC(C)NCC(O)COc1cccc2ccccc12,,
4,CHEMBL13,Metoprolol,Small molecule,1978.0,C07AB02,"C07AB02 [CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, selective]",-olol,Beta-1 adrenergic receptor antagonist,,,CHEMBL213,Beta-1 adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=31d8610a-ab22-49e5-a762-6b08244ee93a, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=31d8610a-ab22-49e5-a762-6b08244ee93a|Name:DailyMed, SrcID:setid=f3817543-544a-4afa-ac7c-c1b48c1307c2, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f3817543-544a-4afa-ac7c-c1b48c1307c2",COCCc1ccc(OCC(O)CNC(C)C)cc1,,
5,CHEMBL1112,Aripiprazole,Small molecule,2002.0,N05AX12,N05AX12 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Other antipsychotics],-prazole,Serotonin 1a (5-HT1a) receptor partial agonist,,,CHEMBL214,Serotonin 1a (5-HT1a) receptor,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=c040bd1d-45b7-49f2-93ea-aed7220b30ac#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c040bd1d-45b7-49f2-93ea-aed7220b30ac#nlm34090-1",Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,CHEMBL214,HTR1A
6,CHEMBL1388,Monobenzone,Small molecule,1952.0,D11AX13,D11AX13 [DERMATOLOGICALS: OTHER DERMATOLOGICAL PREPARATIONS: OTHER DERMATOLOGICAL PREPARATIONS: Other dermatologicals],,Tyrosinase inhibitor,,,CHEMBL1973,Tyrosinase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19159217, URL:http://europepmc.org/abstract/MED/19159217",Oc1ccc(OCc2ccccc2)cc1,CHEMBL1973,TYR
7,CHEMBL1201635,Insulin Susp Isophane Beef/Pork,Protein,1966.0,,,,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/022472s006s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022472s006s008lbl.pdf|Name:DailyMed, SrcID:setid=457531f0-9331-47fe-90b5-b31f284044dc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=457531f0-9331-47fe-90b5-b31f284044dc",,CHEMBL1981,INSR
8,CHEMBL1201538,Insulin Lispro,Protein,1996.0,A10AC04; A10AB04,"A10AC04 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: INSULINS AND ANALOGUES: Insulins and analogues for injection, intermediate-acting]; A10AB04 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: INSULINS AND ANALOGUES: Insulins and analogues for injection, fast-acting]",,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=c8ecbd7a-0e22-4fc7-a503-faa58c1b6f3f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c8ecbd7a-0e22-4fc7-a503-faa58c1b6f3f",,CHEMBL1981,INSR
9,CHEMBL1505,Almotriptan,Small molecule,2001.0,N02CC05,N02CC05 [NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Selective serotonin (5HT1) agonists],-triptan,Serotonin 1d (5-HT1d) receptor agonist,,Selective,CHEMBL1983,Serotonin 1d (5-HT1d) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2009/021001s010s011lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021001s010s011lbl.pdf",CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12,CHEMBL1983,HTR1D
10,CHEMBL715,Olanzapine,Small molecule,1996.0,N05AH03,"N05AH03 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Diazepines, oxazepines, thiazepines and oxepines]",-pin(e),Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=4464f13c-b9b9-4464-a05e-5b2cdc091fb2#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4464f13c-b9b9-4464-a05e-5b2cdc091fb2#nlm34090-1|Name:FDA, SrcID:label/2015/020592s064,021086s042,021253s049lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020592s064,021086s042,021253s049lbl.pdf|Name:FDA, SrcID:label/2012/022173s008s010s014lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022173s008s010s014lbl.pdf",CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24,CHEMBL224,HTR2A
11,CHEMBL1201342,Methixene,Small molecule,1982.0,N04AA03,N04AA03 [NERVOUS SYSTEM: ANTI-PARKINSON DRUGS: ANTICHOLINERGIC AGENTS: Tertiary amines],,Serotonin 2c (5-HT2c) receptor antagonist,,,CHEMBL225,Serotonin 2c (5-HT2c) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 153, 162, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:3353357, URL:http://europepmc.org/abstract/MED/3353357",CN1CCCC(CC2c3ccccc3Sc4ccccc24)C1,,
12,CHEMBL1005,Remifentanil,Small molecule,1996.0,N01AH06,"N01AH06 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Opioid anesthetics]",-fentanil,Mu opioid receptor agonist,,,CHEMBL233,Mu opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=dbc63b6e-f8c5-4fd0-8ec3-4f5e19125313#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dbc63b6e-f8c5-4fd0-8ec3-4f5e19125313#nlm34090-1",CCC(=O)N(c1ccccc1)C2(CCN(CCC(=O)OC)CC2)C(=O)OC,CHEMBL233,OPRM1
13,CHEMBL181,Diazoxide,Small molecule,1973.0,C02DA01; V03AH01,"C02DA01 [CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON: Thiazide derivatives]; V03AH01 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Drugs for treatment of hypoglycemia]",,"Potassium channel, inwardly rectifying, subfamily J, member 8 opener",,,CHEMBL4770,"Potassium channel, inwardly rectifying, subfamily J, member 8",OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Diazoxide, URL:http://en.wikipedia.org/wiki/Diazoxide|Name:DailyMed, SrcID:setid=b16c7832-2fd9-49af-b923-1dc0d91fd6e2#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b16c7832-2fd9-49af-b923-1dc0d91fd6e2#nlm34090-1|Name:ISBN, SrcID:0443-059748 PP. 288, 394, URL:http://www.isbnsearch.org/isbn/0443059748",CC1=NS(=O)(=O)c2cc(Cl)ccc2N1,CHEMBL4770,KCNJ8
14,CHEMBL1433,Doxycycline,Small molecule,1967.0,J01AA02; A01AB22,J01AA02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: TETRACYCLINES: Tetracyclines]; A01AB22 [ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Antiinfectives and antiseptics for local oral treatment],-cycline,Matrix metalloproteinase-1 inhibitor,"It is an antibiotic, however, its primary action, due to the concentration reached in the human body is via metalloproteinases inhibition, which is beneficial in many pathological conditions in which MMP-mediated proteolysis of the extracellular matrix (ECM) contributes to the pathogenesis, such as heart remodeling, tumor invasion, and inflammation",,CHEMBL332,Matrix metalloproteinase-1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=3105a84b-655e-4940-9d11-4209cdb05d6b, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3105a84b-655e-4940-9d11-4209cdb05d6b|Name:PubMed, SrcID:20370419, URL:http://europepmc.org/abstract/MED/20370419|Name:PubMed, SrcID:20592239, URL:http://europepmc.org/abstract/MED/20592239|Name:PubMed, SrcID:17199549, URL:http://europepmc.org/abstract/MED/17199549",C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(=C(C(=O)N)C(=O)[C@@]3(O)C(=C2C(=O)c4c(O)cccc14)O)O,CHEMBL332,MMP1
15,CHEMBL1946170,Regorafenib,Small molecule,2012.0,L01XE21,L01XE21 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-rafenib,Tyrosine-protein kinase TIE-2 inhibitor,,,CHEMBL4128,Tyrosine-protein kinase TIE-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Expert, SrcID:REGORAFENIB, URL:http://chembl.blogspot.co.uk/search?q=REGORAFENIB",CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,CHEMBL4128,TEK
16,CHEMBL193240,Roflumilast,Small molecule,2011.0,R03DX07,R03DX07 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: Other systemic drugs for obstructive airway diseases],-ast,Phosphodiesterase 4 inhibitor,,Selective,CHEMBL2093863,Phosphodiesterase 4,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=95519b97-d0a6-4c9f-baf0-bc5da08296c7#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=95519b97-d0a6-4c9f-baf0-bc5da08296c7#nlm34090-1|Name:PubMed, SrcID:22735051, URL:http://europepmc.org/abstract/MED/22735051",FC(F)Oc1ccc(cc1OCC2CC2)C(=O)Nc3c(Cl)cncc3Cl,,
17,CHEMBL654,Mirtazapine,Small molecule,1996.0,N06AX11,N06AX11 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants],-pin(e),Adrenergic receptor alpha-2 antagonist,,,CHEMBL2095158,Adrenergic receptor alpha-2,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=f23631be-c7ae-46e9-b771-a70be17bc9f0#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f23631be-c7ae-46e9-b771-a70be17bc9f0#nlm34090-1",CN1CCN2C(C1)c3ccccc3Cc4cccnc24,,
18,CHEMBL677,Levonordefrin,Small molecule,1960.0,,,,Adrenergic receptor alpha-2 agonist,,,CHEMBL2095158,Adrenergic receptor alpha-2,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:ISBN, SrcID:0443-059748 PP. 156, URL:http://www.isbnsearch.org/isbn/0443059748|Name:Wikipedia, SrcID:Levonordefrin, URL:http://en.wikipedia.org/wiki/Levonordefrin",C[C@H](N)[C@H](O)c1ccc(O)c(O)c1,,
19,CHEMBL1169,Aminosalicylic Acid,Small molecule,1950.0,J04AA01,J04AA01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOBACTERIALS: DRUGS FOR TREATMENT OF TUBERCULOSIS: Aminosalicylic acid and derivatives],-sal-,Cyclooxygenase inhibitor,,,CHEMBL2094253,Cyclooxygenase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:12208114, URL:http://europepmc.org/abstract/MED/12208114",Nc1ccc(C(=O)O)c(O)c1,,
20,CHEMBL425,Olsalazine,Small molecule,1990.0,A07EC03,"A07EC03 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Aminosalicylic acid and similar agents]",-sal-,Cyclooxygenase inhibitor,,,CHEMBL2094253,Cyclooxygenase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:12950415, URL:http://europepmc.org/abstract/MED/12950415|Name:DailyMed, SrcID:setid=75a96561-6f52-4c11-a105-391fbbfe4827, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=75a96561-6f52-4c11-a105-391fbbfe4827|Name:PubMed, SrcID:14742690, URL:http://europepmc.org/abstract/MED/14742690|Name:PubMed, SrcID:12463455, URL:http://europepmc.org/abstract/MED/12463455",OC(=O)c1cc(ccc1O)N=Nc2ccc(O)c(c2)C(=O)O,,
21,CHEMBL1237132,Clevidipine,Small molecule,2008.0,C08CA16,C08CA16 [CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS: Dihydropyridine derivatives],-dipine,Voltage-gated L-type calcium channel blocker,,,CHEMBL2095229,Voltage-gated L-type calcium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=095081a0-1398-11dc-82e1-0002a5d5c51b#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=095081a0-1398-11dc-82e1-0002a5d5c51b#nlm34090-1",CCCC(=O)OCOC(=O)C1=C(C)NC(=C(C1c2cccc(Cl)c2Cl)C(=O)OC)C,,
22,CHEMBL6966,Verapamil,Small molecule,1981.0,C08DA51; C08DA01,C08DA51 [CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS: Phenylalkylamine derivatives]; C08DA01 [CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS: Phenylalkylamine derivatives],-pamil,Voltage-gated L-type calcium channel blocker,,,CHEMBL2095229,Voltage-gated L-type calcium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2011/018817s027lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018817s027lbl.pdf|Name:ISBN, SrcID:9780702034718 PP. 256, URL:http://www.isbnsearch.org/isbn/9780702034718",COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC,,
23,CHEMBL500,Pindolol,Small molecule,1982.0,C07AA03,"C07AA03 [CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, non-selective]",-olol,Beta-2 adrenergic receptor partial agonist,,,CHEMBL210,Beta-2 adrenergic receptor,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=07fe9cc3-1ef2-420c-b45d-7f1e894b6ef9, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=07fe9cc3-1ef2-420c-b45d-7f1e894b6ef9",CC(C)NCC(O)COc1cccc2[nH]ccc12,CHEMBL210,ADRB2
24,CHEMBL1483,Albendazole,Small molecule,1996.0,P02CA03,"P02CA03 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTHELMINTICS: ANTINEMATODAL AGENTS: Benzimidazole derivatives]",-bendazole,Tubulin inhibitor,,,CHEMBL2364704,Tubulin,INHIBITOR,Taeniidae,PROTEIN COMPLEX GROUP,Beta tubulin,Binds to beta tubulin,"Name:DailyMed, SrcID:setid=e8941166-b77d-45aa-a6e8-04f1c0afd845, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e8941166-b77d-45aa-a6e8-04f1c0afd845|Name:ISBN, SrcID:9780702034718 PP. 669, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:13678839, URL:http://europepmc.org/abstract/MED/13678839",CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1,,
25,CHEMBL1200438,Tioconazole,Small molecule,1983.0,G01AF08; D01AC07,"G01AF08 [GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Imidazole derivatives]; D01AC07 [DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Imidazole and triazole derivatives]",-conazole,Cytochrome P450 51 inhibitor,,,CHEMBL1780,Cytochrome P450 51,INHIBITOR,Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast),SINGLE PROTEIN,,,"Name:PubMed, SrcID:15314102, URL:http://europepmc.org/abstract/MED/15314102|Name:PubMed, SrcID:15625110, URL:http://europepmc.org/abstract/MED/15625110|Name:PubMed, SrcID:19934256, URL:http://europepmc.org/abstract/MED/19934256|Name:PubMed, SrcID:3202901, URL:http://europepmc.org/abstract/MED/3202901",Clc1ccc(C(Cn2ccnc2)OCc3ccsc3Cl)c(Cl)c1,,
26,CHEMBL1397,Posaconazole,Small molecule,2006.0,J02AC04,J02AC04 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: Triazole derivatives],-conazole,Cytochrome P450 51 inhibitor,,,CHEMBL1780,Cytochrome P450 51,INHIBITOR,Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast),SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=b073b082-7b57-4423-8c06-4fd4263d6f84, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b073b082-7b57-4423-8c06-4fd4263d6f84",CC[C@@H]([C@H](C)O)N1N=CN(C1=O)c2ccc(cc2)N3CCN(CC3)c4ccc(OC[C@@H]5CO[C@](Cn6cncn6)(C5)c7ccc(F)cc7F)cc4,,
27,CHEMBL1346,Darifenacin,Small molecule,2004.0,G04BD10,G04BD10 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Drugs for urinary frequency and incontinence],-fenacin,Muscarinic acetylcholine receptor M2 antagonist,"Indicated for overactive bladder, M2 likely responsible",,CHEMBL211,Muscarinic acetylcholine receptor M2,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16465186, URL:http://europepmc.org/abstract/MED/16465186|Name:DailyMed, SrcID:setid=cec47488-ebad-4a3a-904c-e916b432e2cf, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cec47488-ebad-4a3a-904c-e916b432e2cf",NC(=O)C([C@@H]1CCN(CCc2ccc3OCCc3c2)C1)(c4ccccc4)c5ccccc5,CHEMBL211,CHRM2
28,CHEMBL1308,Fomepizole,Small molecule,1997.0,V03AB34,V03AB34 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Antidotes],,Alcohol dehydrogenase class I inhibitor,Competitive inhibitor,,CHEMBL2363044,Alcohol dehydrogenase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=c045b5a8-b220-4f0a-a831-155b29c19454#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c045b5a8-b220-4f0a-a831-155b29c19454#nlm34090-1|Name:Wikipedia, SrcID:Alcohol_dehydrogenase, URL:http://en.wikipedia.org/wiki/Alcohol_dehydrogenase",Cc1cn[nH]c1,,
29,CHEMBL550348,Deferasirox,Small molecule,2005.0,V03AC03,V03AC03 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Iron chelating agents],,Iron chelating agent,,Selective,CHEMBL2363058,Iron,CHELATING AGENT,,METAL,,,"Name:DailyMed, SrcID:setid=3495a70c-870c-4968-940e-8baea152cf85#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3495a70c-870c-4968-940e-8baea152cf85#nlm34090-1",OC(=O)c1ccc(cc1)n2nc(nc2c3ccccc3O)c4ccccc4O,,
30,CHEMBL1023,Bexarotene,Small molecule,1999.0,L01XX25,L01XX25 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-arotene,Retinoid X receptor agonist,,,CHEMBL2363070,Retinoid X receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=63656f64-e240-4855-8df9-ca1655863735, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=63656f64-e240-4855-8df9-ca1655863735|Name:FDA, SrcID:label/2015/021055s010lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021055s010lbl.pdf",Cc1cc2c(cc1C(=C)c3ccc(cc3)C(=O)O)C(C)(C)CCC2(C)C,,
31,CHEMBL1200910,Sulfisoxazole Acetyl,Small molecule,1953.0,,,,Bacterial dihydropteroate synthase inhibitor,,Broad spectrum,CHEMBL2364668,Bacterial dihydropteroate synthase,INHIBITOR,Bacteria,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15673729, URL:http://europepmc.org/abstract/MED/15673729|Name:PubMed, SrcID:7486915, URL:http://europepmc.org/abstract/MED/7486915|Name:PubMed, SrcID:16000430, URL:http://europepmc.org/abstract/MED/16000430",CC(=O)N(c1onc(C)c1C)S(=O)(=O)c2ccc(N)cc2,,
32,CHEMBL148,Imipenem,Small molecule,1985.0,,,-penem,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=fe44d24d-55cd-439c-895b-00a38cd59f65, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fe44d24d-55cd-439c-895b-00a38cd59f65",C[C@@H](O)[C@@H]1[C@H]2CC(=C(N2C1=O)C(=O)O)SCCNC=N,,
33,CHEMBL2096637,Pyrethrins,Small molecule,2000.0,,,,Voltage-sensitive sodium channel alpha-subunit blocker,,,CHEMBL2362984,Voltage-sensitive sodium channel alpha-subunit,BLOCKER,Pediculus humanus,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Pyrethrin, URL:http://en.wikipedia.org/wiki/Pyrethrin|Name:PubMed, SrcID:23317040, URL:http://europepmc.org/abstract/MED/23317040|Name:PubMed, SrcID:23099312, URL:http://europepmc.org/abstract/MED/23099312|Name:FDA, SrcID:label/2000/21043lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21043lbl.pdf",COC(=O)\C(=C\[C@@H]1[C@@H](C(=O)O[C@H]2CC(=O)C(=C2C)C\C=C/C=C)C1(C)C)\C.CC(=C[C@@H]3[C@@H](C(=O)O[C@H]4CC(=O)C(=C4C)C\C=C/C=C)C3(C)C)C,,
34,CHEMBL507870,Telavancin,Small molecule,2009.0,J01XA03,J01XA03 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER ANTIBACTERIALS: Glycopeptide antibacterials],,Cell outer membrane inhibitor,,,CHEMBL2364032,Cell outer membrane,INHIBITOR,Bacteria,SUBCELLULAR,,,"Name:FDA, SrcID:label/2009/022110s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022110s000lbl.pdf",CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2Oc3c4Oc5ccc(cc5Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@H]6C(=O)N[C@H]7C(=O)N[C@@H]([C@H](O)c8ccc(Oc3cc6c4)c(Cl)c8)C(=O)N[C@H](C(=O)O)c9cc(O)c(CNCP(=O)(O)O)c(O)c9c%10cc7ccc%10O)O[C@@H](C)[C@H]1O,,
35,CHEMBL1201129,Decitabine,Small molecule,2006.0,L01BC08,L01BC08 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Pyrimidine analogues],-citabine,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13|Name:Wikipedia, SrcID:DNA_methylation, URL:http://en.wikipedia.org/wiki/DNA_methylation",NC1=NC(=O)N(C=N1)[C@H]2C[C@H](O)[C@@H](CO)O2,,
36,CHEMBL1201328,Carphenazine,Small molecule,1982.0,,,,Dopamine D2 receptor antagonist,,,CHEMBL217,Dopamine D2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:4889058, URL:http://europepmc.org/abstract/MED/4889058|Name:Wikipedia, SrcID:Carphenazine, URL:http://en.wikipedia.org/wiki/Carphenazine|Name:ISBN, SrcID:0443-059748 PP. 544, URL:http://www.isbnsearch.org/isbn/0443059748",CCC(=O)c1ccc2Sc3ccccc3N(CCCN4CCN(CCO)CC4)c2c1,CHEMBL217,DRD2
37,CHEMBL1200694,Sevoflurane,Small molecule,1995.0,N01AB08,"N01AB08 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,Potassium channel subfamily K member 9 opener,,,CHEMBL2321614,Potassium channel subfamily K member 9,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:22226507, URL:http://europepmc.org/abstract/MED/22226507|Name:PubMed, SrcID:21788314, URL:http://europepmc.org/abstract/MED/21788314",FCOC(C(F)(F)F)C(F)(F)F,CHEMBL2321614,KCNK9
38,CHEMBL697,Methsuximide,Small molecule,1957.0,N03AD03,N03AD03 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Succinimide derivatives],,Voltage-gated T-type calcium channel blocker,,,CHEMBL2362995,Voltage-gated T-type calcium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:12522170, URL:http://europepmc.org/abstract/MED/12522170|Name:PubMed, SrcID:11641441, URL:http://europepmc.org/abstract/MED/11641441",CN1C(=O)CC(C)(C1=O)c2ccccc2,,
39,CHEMBL1201603,Cryptenamine Tannates,Small molecule,1982.0,,,,Unknown,,,,,,,,,,"Name:PubMed, SrcID:7192510, URL:http://europepmc.org/abstract/MED/7192510",,,
40,CHEMBL3545049,Bay-1125976,Small molecule,,,,,Serine/threonine-protein kinase AKT inhibitor,Allosteric inhibitor.,,CHEMBL4282,Serine/threonine-protein kinase AKT,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1158/1538-7445.AM2014-3685, URL:http://cancerres.aacrjournals.org/content/74/19_Supplement/3685|Name:DOI, SrcID:10.1158/1538-7445.AM2013-2050, URL:http://cancerres.aacrjournals.org/content/73/8_Supplement/2050",,CHEMBL4282,AKT1
41,CHEMBL3545120,Ce-245677,Small molecule,,,,,Tyrosine-protein kinase TIE-2 inhibitor,Also potent inhibitor of NTRK1 and NTRK2,,CHEMBL4128,Tyrosine-protein kinase TIE-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://cancerres.aacrjournals.org/content/67/9_Supplement/3259.short, URL:http://cancerres.aacrjournals.org/content/67/9_Supplement/3259.short",,CHEMBL4128,TEK
42,CHEMBL3545003,Msc-2363318a,Small molecule,,,,,Serine/threonine-protein kinase AKT3 inhibitor,,,CHEMBL4816,Serine/threonine-protein kinase AKT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://biopharma.merckgroup.com/en/research_development/pipeline/pipeline.html, URL:http://biopharma.merckgroup.com/en/research_development/pipeline/pipeline.html",,CHEMBL4816,AKT3
43,CHEMBL3545387,Sad448,Small molecule,,,,,Cannabinoid CB1 receptor agonist,,,CHEMBL218,Cannabinoid CB1 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17630726, URL:http://europepmc.org/abstract/MED/17630726|Name:PubMed, SrcID:24121462, URL:http://europepmc.org/abstract/MED/24121462",,CHEMBL218,CNR1
44,CHEMBL2364652,Vantictumab,Antibody,,,,-mab,Frizzled-1 antagonist,mAB,,CHEMBL2346493,Frizzled-1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22753465, URL:http://europepmc.org/abstract/MED/22753465",,CHEMBL2346493,FZD1
45,CHEMBL3545290,Prs-211375,Small molecule,,,,,Cannabinoid CB2 receptor agonist,,,CHEMBL253,Cannabinoid CB2 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20207474, URL:http://europepmc.org/abstract/MED/20207474|Name:PubMed, SrcID:14638775, URL:http://europepmc.org/abstract/MED/14638775",,CHEMBL253,CNR2
46,CHEMBL41194,Pratosartan,Small molecule,,,,-sartan,Solute carrier family 22 member 8 inhibitor,,,CHEMBL1641348,Solute carrier family 22 member 8,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17674156, URL:http://europepmc.org/abstract/MED/17674156",CCCc1nc2CCCCC(=O)c2n1Cc3ccc(cc3)c4ccccc4c5nn[nH]n5,CHEMBL1641348,SLC22A8
47,CHEMBL1742428,Donitriptan,Small molecule,,,,-triptan,Serotonin 1b (5-HT1b) receptor agonist,,,CHEMBL1898,Serotonin 1b (5-HT1b) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10381763, URL:http://europepmc.org/abstract/MED/10381763",NCCc1c[nH]c2ccc(OCC(=O)N3CCN(CC3)c4ccc(cc4)C#N)cc12,CHEMBL1898,HTR1B
48,CHEMBL1688243,Incb-9471,Small molecule,,,,,C-C chemokine receptor type 5 antagonist,"HIV-1 entry inhibitor, noncompetitive CCR5 allosteric antagonist. Indication: HIV infections",,CHEMBL274,C-C chemokine receptor type 5,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24900235, URL:http://europepmc.org/abstract/MED/24900235|Name:PubMed, SrcID:21459966, URL:http://europepmc.org/abstract/MED/21459966",CCO[C@@H]1Cc2cc(ccc2[C@H]1N3CCN(C[C@@H]3C)C4(C)CCN(CC4)C(=O)c5c(C)ncnc5C)C(F)(F)F,CHEMBL274,CCR5
49,CHEMBL2146883,Cobimetinib,Small molecule,2015.0,L01XE38,L01XE38 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,Approved in Switzerland 2015 for use in combination with vemurafenib as a treatment for patients with advanced melanoma.,,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22496205, URL:http://europepmc.org/abstract/MED/22496205|Name:DailyMed, SrcID:setid=c387579e-cee0-4334-bd1e-73f93ac1bde6, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c387579e-cee0-4334-bd1e-73f93ac1bde6|Name:PubMed, SrcID:22084396, URL:http://europepmc.org/abstract/MED/22084396",OC1(CN(C1)C(=O)c2ccc(F)c(F)c2Nc3ccc(I)cc3F)[C@@H]4CCCCN4,CHEMBL3587,MAP2K1
50,CHEMBL562668,Otenabant,Small molecule,,,,-nab-,Cannabinoid CB1 receptor antagonist,Development Discontinuedbecause of potential serious side effects linked to targetting of CNR1 (http://en.wikipedia.org/wiki/Otenabant).,,CHEMBL218,Cannabinoid CB1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19102698, URL:http://europepmc.org/abstract/MED/19102698",CCNC1(CCN(CC1)c2ncnc3c2nc(c4ccccc4Cl)n3c5ccc(Cl)cc5)C(=O)N,CHEMBL218,CNR1
51,CHEMBL2336071,Siponimod,Small molecule,,,,-imod,Sphingosine 1-phosphate receptor Edg-1 agonist,,,CHEMBL4333,Sphingosine 1-phosphate receptor Edg-1,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22646698, URL:http://europepmc.org/abstract/MED/22646698|Name:PubMed, SrcID:23285242, URL:http://europepmc.org/abstract/MED/23285242",CCc1cc(ccc1CN2CC(C2)C(=O)O)\C(=N\OCc3ccc(C4CCCCC4)c(c3)C(F)(F)F)\C,CHEMBL4333,S1PR1
52,CHEMBL2108675,Dupilumab,Antibody,2017.0,,,-mab,Interleukin-4 receptor subunit alpha antagonist,,,CHEMBL3580490,Interleukin-4 receptor subunit alpha,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23688323, URL:http://europepmc.org/abstract/MED/23688323",,CHEMBL3580490,IL4R
53,CHEMBL2103839,Ridaforolimus,Small molecule,,L01XE19,L01XE19 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-imus,Serine/threonine-protein kinase mTOR inhibitor,,,CHEMBL2842,Serine/threonine-protein kinase mTOR,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18451242, URL:http://europepmc.org/abstract/MED/18451242",CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(/C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(/C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC)CC[C@H]1OP(=O)(C)C,CHEMBL2842,MTOR
54,CHEMBL2017179,Evacetrapib,Small molecule,,,,-cetrapib,Cholesteryl ester transfer protein inhibitor,Benzazepine-based CETP inhibitor,,CHEMBL3572,Cholesteryl ester transfer protein,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21957197, URL:http://europepmc.org/abstract/MED/21957197",Cc1cc(C)c2N(C[C@@H]3CC[C@H](CC3)C(=O)O)CCC[C@H](N(Cc4cc(cc(c4)C(F)(F)F)C(F)(F)F)c5nnn(C)n5)c2c1,CHEMBL3572,CETP
55,CHEMBL298734,Lonafarnib,Small molecule,,,,-farnib,Protein farnesyltransferase inhibitor,,,CHEMBL2094108,Protein farnesyltransferase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:9810004, URL:http://europepmc.org/abstract/MED/9810004",NC(=O)N1CCC(CC(=O)N2CCC(CC2)[C@H]3c4ncc(Br)cc4CCc5cc(Cl)cc(Br)c35)CC1,,
56,CHEMBL1770248,Ertugliflozin,Small molecule,,,,-gliflozin,Sodium/glucose cotransporter 2 inhibitor,,It shows >2000-fold selectivity for SGLT2 inhibition (relative to SGLT1) in vitro,CHEMBL3884,Sodium/glucose cotransporter 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21690265, URL:http://europepmc.org/abstract/MED/21690265",CCOc1ccc(Cc2cc(ccc2Cl)[C@]34OC[C@](CO)(O3)[C@@H](O)[C@H](O)[C@H]4O)cc1,CHEMBL3884,SLC5A2
57,CHEMBL3544911,Prexasertib,Small molecule,,,,-sertib,Serine/threonine-protein kinase Chk1 inhibitor,Selective ATP competitor inhibitor of Chk1 and Chk2 proteins,,CHEMBL4630,Serine/threonine-protein kinase Chk1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:27438145, URL:http://europepmc.org/abstract/MED/27438145",COc1cccc(OCCCN)c1c2cc(Nc3cnc(cn3)C#N)n[nH]2,CHEMBL4630,CHEK1
58,CHEMBL3833357,Begelomab,Antibody,,,,-mab,Dipeptidyl peptidase IV inhibitor,Inhibits the activation of T-cells reducing the immune response occurring during steroid resistant aGvHD.,,CHEMBL284,Dipeptidyl peptidase IV,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.ema.europa.eu/docs/en_GB/document_library/Application_withdrawal_assessment_report/human/004144/WC500219766.pdf, URL:http://www.ema.europa.eu/docs/en_GB/document_library/Application_withdrawal_assessment_report/human/004144/WC500219766.pdf|Name:Other, SrcID:https://www.karger.com/Article/Pdf/206319, URL:https://www.karger.com/Article/Pdf/206319",,CHEMBL284,DPP4
59,CHEMBL1742989,Bavituximab,Antibody,,,,-mab,Phosphatidylserine inhibitor,"In most tissues, the principal target of bavituximab, phosphatidylserine (PS), is restricted to the internal surface of the cell membrane. Bavituximab binds a complex of beta2 glycoprotein 1 (beta2GP1) and PS, triggering antitumor effects via a number of mechanisms. Principally, bavituximab acts as a vascular targeting agent. The bavituximab–beta2GP1–PS complex induces host effector processes such as antibody-dependent cellular cytotoxicity, resulting in vascular destruction.",,CHEMBL3833422,Phosphatidylserine,INHIBITOR,Homo sapiens,LIPID,,,"Name:PubMed, SrcID:15899833, URL:http://europepmc.org/abstract/MED/15899833|Name:Other, SrcID:http://www.peregrineinc.com/pipeline/bavituximab-oncology.html, URL:http://www.peregrineinc.com/pipeline/bavituximab-oncology.html|Name:PubMed, SrcID:21989064, URL:http://europepmc.org/abstract/MED/21989064",,,
60,CHEMBL2109339,Mln-1202,Antibody,,,,,C-C chemokine receptor type 2 antagonist,,,CHEMBL4015,C-C chemokine receptor type 2,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://www.takeda.com/research/files/pipeline_20160729_en.pdf, URL:https://www.takeda.com/research/files/pipeline_20160729_en.pdf|Name:PubMed, SrcID:18576354, URL:http://europepmc.org/abstract/MED/18576354",,CHEMBL4015,CCR2
61,CHEMBL2109346,Ame-133v,Antibody,,,,,Integrin beta-2 inhibitor,Mediates antibody-dependent cell-mediated cytotoxicity (ADCC) (10-fold increase in ADCC than rituximab).,,CHEMBL3631,Integrin beta-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26792592, URL:http://europepmc.org/abstract/MED/26792592|Name:PubMed, SrcID:22223529, URL:http://europepmc.org/abstract/MED/22223529",,,
62,CHEMBL2109582,81c6,Antibody,,,,,Tenascin binding agent,Radioimaging and radioimmunotherapeutic activities.,,CHEMBL3712856,Tenascin,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:2452014, URL:http://europepmc.org/abstract/MED/2452014",,CHEMBL3712856,TNC
63,CHEMBL2109589,L19tnfa,Antibody,,,,,Fibronectin binding agent,Immunocytokine. Immunostimulant.,,CHEMBL3810,Fibronectin,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,Directed against the extra-domain B (ED-B) of fibronectin (L19).,"Name:PubMed, SrcID:12810649, URL:http://europepmc.org/abstract/MED/12810649",,CHEMBL3810,FN1
64,CHEMBL1581,Perindopril,Small molecule,1993.0,C09AA04,"C09AA04 [CARDIOVASCULAR SYSTEM: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM: ACE INHIBITORS, PLAIN: ACE inhibitors, plain]",-pril,Angiotensin-converting enzyme inhibitor,,,CHEMBL1808,Angiotensin-converting enzyme,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/020184s022lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020184s022lbl.pdf|Name:FDA, SrcID:label/2015/205003s001lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205003s001lbl.pdf/label/2015/205003s001lbl.pdf|Name:DailyMed, SrcID:setid=c9d01204-2789-40d0-93e9-e4cf018e8226, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c9d01204-2789-40d0-93e9-e4cf018e8226",CCC[C@H](N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O)C(=O)OCC,CHEMBL1808,ACE
65,CHEMBL1201,Thiothixene,Small molecule,1967.0,N05AF04,N05AF04 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Thioxanthene derivatives],,Dopamine D2 receptor antagonist,,,CHEMBL217,Dopamine D2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11873706, URL:http://europepmc.org/abstract/MED/11873706|Name:PubMed, SrcID:15694263, URL:http://europepmc.org/abstract/MED/15694263|Name:PubMed, SrcID:11103886, URL:http://europepmc.org/abstract/MED/11103886|Name:Wikipedia, SrcID:Antipsychotic#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Antipsychotic#Mechanism_of_action|Name:PubMed, SrcID:3039860, URL:http://europepmc.org/abstract/MED/3039860",CN(C)S(=O)(=O)c1ccc2Sc3ccccc3\C(=C\CCN4CCN(C)CC4)\c2c1,CHEMBL217,DRD2
66,CHEMBL1200692,Olmesartan Medoxomil,Small molecule,2002.0,C09CA08,"C09CA08 [CARDIOVASCULAR SYSTEM: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM: ANGIOTENSIN II ANTAGONISTS, PLAIN: Angiotensin II antagonists, plain]",-sartan,Type-1 angiotensin II receptor antagonist,,,CHEMBL227,Type-1 angiotensin II receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=d4b8a490-d96f-414e-b020-9460625c40ef#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d4b8a490-d96f-414e-b020-9460625c40ef#section-14",CCCc1nc(c(C(=O)OCC2=C(C)OC(=O)O2)n1Cc3ccc(cc3)c4ccccc4c5nnn[nH]5)C(C)(C)O,CHEMBL227,AGTR1
67,CHEMBL1201629,Insulin Purified Beef,Protein,1980.0,A10AD02; A10AB02; A10AC02; A10AE02,"A10AD02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: INSULINS AND ANALOGUES: Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting]; A10AB02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: INSULINS AND ANALOGUES: Insulins and analogues for injection, fast-acting]; A10AC02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: INSULINS AND ANALOGUES: Insulins and analogues for injection, intermediate-acting]; A10AE02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: INSULINS AND ANALOGUES: Insulins and analogues for injection, long-acting]",,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/022472s006s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022472s006s008lbl.pdf|Name:DailyMed, SrcID:setid=457531f0-9331-47fe-90b5-b31f284044dc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=457531f0-9331-47fe-90b5-b31f284044dc",,CHEMBL1981,INSR
68,CHEMBL831,Loxapine,Small molecule,1975.0,N05AH01,"N05AH01 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Diazepines, oxazepines, thiazepines and oxepines]",-pin(e),Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=50e11732-7387-452d-b3e6-db3a431d5c4a#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=50e11732-7387-452d-b3e6-db3a431d5c4a#nlm34090-1|Name:FDA, SrcID:label/2012/022549s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022549s000lbl.pdf",CN1CCN(CC1)C2=Nc3ccccc3Oc4ccc(Cl)cc24,CHEMBL224,HTR2A
69,CHEMBL712,Anisindione,Small molecule,1957.0,,,,Vitamin K-dependent gamma-carboxylase inhibitor,,,CHEMBL2012,Vitamin K-dependent gamma-carboxylase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:978-8184485516 PP. 207, URL:http://www.isbnsearch.org/isbn/9788184485516|Name:PubMed, SrcID:3781349, URL:http://europepmc.org/abstract/MED/3781349",COc1ccc(cc1)C2C(=O)c3ccccc3C2=O,CHEMBL2012,GGCX
70,CHEMBL592,Levorphanol,Small molecule,1991.0,,,-orphan-,Mu opioid receptor agonist,,,CHEMBL233,Mu opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=a6120c36-30b8-491e-8555-29a60d6f9f5b, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6120c36-30b8-491e-8555-29a60d6f9f5b|Name:DailyMed, SrcID:archiveid=187035, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=187035|Name:DailyMed, SrcID:archiveid=13719, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=13719",CN1CC[C@]23CCCC[C@H]2[C@H]1Cc4ccc(O)cc34,CHEMBL233,OPRM1
71,CHEMBL1595,Dihydrocodeine,Small molecule,1983.0,N02AA58; N02AA08,N02AA58 [NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Natural opium alkaloids]; N02AA08 [NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Natural opium alkaloids],,Mu opioid receptor agonist,,,CHEMBL233,Mu opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Dihydrocodeine, URL:http://en.wikipedia.org/wiki/Dihydrocodeine|Name:PubMed, SrcID:11762966, URL:http://europepmc.org/abstract/MED/11762966",COc1ccc2C[C@@H]3[C@@H]4CC[C@H](O)[C@@H]5Oc1c2[C@]45CCN3C,CHEMBL233,OPRM1
72,CHEMBL635,Prednisone,Small molecule,1955.0,A07EA03; H02AB07,"A07EA03 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Corticosteroids acting locally]; H02AB07 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Glucocorticoids]",pred-,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22850902, URL:http://europepmc.org/abstract/MED/22850902|Name:Wikipedia, SrcID:Glucocorticoid, URL:http://en.wikipedia.org/wiki/Glucocorticoid|Name:ISBN, SrcID:978-1-889788-85-2, URL:http://www.isbnsearch.org/isbn/9781889788852",C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO,CHEMBL2034,NR3C1
73,CHEMBL1200538,Betamethasone Acetate,Small molecule,1965.0,S02BA07; D07AC01; D07XC01; R01AD06; S01CB04; H02AB01; C05AA05; A07EA04; S01BA06; S03BA03; R03BA04,"S02BA07 [SENSORY ORGANS: OTOLOGICALS: CORTICOSTEROIDS: Corticosteroids]; D07AC01 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, potent (group III)]; D07XC01 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, OTHER COMBINATIONS: Corticosteroids, potent, other combinations]; R01AD06 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Corticosteroids]; S01CB04 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION: Corticosteroids/antiinfectives/mydriatics in combination]; H02AB01 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Glucocorticoids]; C05AA05 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Corticosteroids]; A07EA04 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Corticosteroids acting locally]; S01BA06 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Corticosteroids, plain]; S03BA03 [SENSORY ORGANS: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS: CORTICOSTEROIDS: Corticosteroids]; R03BA04 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS: Glucocorticoids]",,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 401, URL:http://www.isbnsearch.org/isbn/9780702034718",C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C,CHEMBL2034,NR3C1
74,CHEMBL477772,Pazopanib,Small molecule,2009.0,L01XE11,L01XE11 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-anib,Fibroblast growth factor receptor 3 inhibitor,,,CHEMBL2742,Fibroblast growth factor receptor 3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14",CN(c1ccc2c(C)n(C)nc2c1)c3ccnc(Nc4ccc(C)c(c4)S(=O)(=O)N)n3,CHEMBL2742,FGFR3
75,CHEMBL1276308,Mifepristone,Small molecule,2000.0,G03XB01; G03XB51,G03XB01 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: Progesterone receptor modulators]; G03XB51 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: Progesterone receptor modulators],-pristone,Progesterone receptor antagonist,,Selective,CHEMBL208,Progesterone receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=542f3fae-8bc8-4f00-9228-e4b66c9ad6a9, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=542f3fae-8bc8-4f00-9228-e4b66c9ad6a9",CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c5ccc(cc5)N(C)C,CHEMBL208,PGR
76,CHEMBL1487,Atorvastatin,Small molecule,1996.0,C10AA05,"C10AA05 [CARDIOVASCULAR SYSTEM: LIPID MODIFYING AGENTS: LIPID MODIFYING AGENTS, PLAIN: HMG CoA reductase inhibitors]",-stat-,HMG-CoA reductase inhibitor,,,CHEMBL402,HMG-CoA reductase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=6ccdb6f3-22c7-5b48-46bc-ce4a4c65eb4d#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6ccdb6f3-22c7-5b48-46bc-ce4a4c65eb4d#section-13",CC(C)c1c(C(=O)Nc2ccccc2)c(c3ccccc3)c(c4ccc(F)cc4)n1CC[C@@H](O)C[C@@H](O)CC(=O)O,CHEMBL402,HMGCR
77,CHEMBL807,Memantine,Small molecule,2003.0,N06DX01,N06DX01 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTI-DEMENTIA DRUGS: Other anti-dementia drugs],-mantine,Glutamate [NMDA] receptor negative allosteric modulator,,,CHEMBL2094124,Glutamate [NMDA] receptor,NEGATIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:FDA, SrcID:label/2003/021487lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/021487lbl.pdf|Name:Wikipedia, SrcID:Memantine, URL:http://en.wikipedia.org/wiki/Memantine",CC12CC3CC(C)(C1)CC(N)(C3)C2,CHEMBL2094124,GRIN3B
78,CHEMBL420,Guanabenz,Small molecule,1982.0,,,guan-,Adrenergic receptor alpha-2 agonist,,,CHEMBL2095158,Adrenergic receptor alpha-2,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:anda/98/74517_Guanabenz%20Acetate_Prntlbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/anda/98/74517_Guanabenz%20Acetate_Prntlbl.pdf",NC(=N)N\N=C\c1c(Cl)cccc1Cl,,
79,CHEMBL409,Bicalutamide,Small molecule,1995.0,L02BB03,L02BB03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONE ANTAGONISTS AND RELATED AGENTS: Anti-androgens],-lutamide,Androgen Receptor antagonist,,,CHEMBL1871,Androgen Receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=7c295b64-ec39-42ec-9f02-da5b42e775e1#section-12, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7c295b64-ec39-42ec-9f02-da5b42e775e1#section-12",CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc2ccc(C#N)c(c2)C(F)(F)F,CHEMBL1871,AR
80,CHEMBL649,Nadolol,Small molecule,1979.0,C07AA12,"C07AA12 [CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, non-selective]",-olol,Beta-2 adrenergic receptor antagonist,,,CHEMBL210,Beta-2 adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=c2e709d2-96a2-41ea-b5e9-9ce4ccb91f59, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c2e709d2-96a2-41ea-b5e9-9ce4ccb91f59",CC(C)(C)NCC(O)COc1cccc2C[C@@H](O)[C@@H](O)Cc12,CHEMBL210,ADRB2
81,CHEMBL1282,Imiquimod,Small molecule,1997.0,D06BB10,D06BB10 [DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: CHEMOTHERAPEUTICS FOR TOPICAL USE: Antivirals],-imod,Toll-like receptor 7 agonist,,,CHEMBL5936,Toll-like receptor 7,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2010/020723s022lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020723s022lbl.pdf|Name:PubMed, SrcID:14616337, URL:http://europepmc.org/abstract/MED/14616337",CC(C)Cn1cnc2c(N)nc3ccccc3c12,CHEMBL5936,TLR7
82,CHEMBL1221,Sulconazole,Small molecule,1985.0,D01AC09,D01AC09 [DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Imidazole and triazole derivatives],-conazole,Cytochrome P450 51 inhibitor,,,CHEMBL1780,Cytochrome P450 51,INHIBITOR,Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast),SINGLE PROTEIN,,,"Name:KEGG, SrcID:D08535, URL:http://www.kegg.jp/dbget-bin/www_bget?dr:D08535",Clc1ccc(CSC(Cn2ccnc2)c3ccc(Cl)cc3Cl)cc1,,
83,CHEMBL182,Ganciclovir,Small molecule,1989.0,S01AD09; J05AB06,S01AD09 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Antivirals]; J05AB06 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleosides and nucleotides excl. reverse transcriptase inhibitors],-vir,Human herpesvirus 1 DNA polymerase inhibitor,,,CHEMBL1872,Human herpesvirus 1 DNA polymerase,INHIBITOR,Herpes simplex virus (type 1 / strain 17),SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=b47f5d1c-36b8-49b6-a410-3b3f4661dde7, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b47f5d1c-36b8-49b6-a410-3b3f4661dde7",Nc1nc(O)c2ncn(COC(CO)CO)c2n1,,
84,CHEMBL2108667,Yttrium Y 90 Ibritumomab Tiuxetan,Antibody,2002.0,,,,B-lymphocyte antigen CD20 binding agent,targets radiotherapy to cell(via tiuxetan),,CHEMBL2058,B-lymphocyte antigen CD20,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=ccf29429-bf8e-4cce-bd12-1de56853fc5b#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ccf29429-bf8e-4cce-bd12-1de56853fc5b#nlm34090-1",,CHEMBL2058,MS4A1
85,CHEMBL185073,Pancuronium,Small molecule,1972.0,M03AC01,"M03AC01 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS: Other quaternary ammonium compounds]",-ium,Muscle-type nicotinic acetylcholine receptor antagonist,non-depolarizing,,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:17525594, URL:http://europepmc.org/abstract/MED/17525594|Name:PubMed, SrcID:19417616, URL:http://europepmc.org/abstract/MED/19417616|Name:ISBN, SrcID:9780702034718 PP. 164, URL:http://www.isbnsearch.org/isbn/9780702034718",CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@@H]([C@@H]4OC(=O)C)[N+]5(C)CCCCC5)[C@@]2(C)C[C@@H]1[N+]6(C)CCCCC6,,
86,CHEMBL1257,Enflurane,Small molecule,1972.0,N01AB04,"N01AB04 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,GABA-A receptor; anion channel positive modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:PubMed, SrcID:11465594, URL:http://europepmc.org/abstract/MED/11465594|Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:16973644, URL:http://europepmc.org/abstract/MED/16973644",FC(F)OC(F)(F)C(F)Cl,CHEMBL2093872,GABRG3
87,CHEMBL1257,Enflurane,Small molecule,1972.0,N01AB04,"N01AB04 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,GABA-A receptor; anion channel positive modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:PubMed, SrcID:11465594, URL:http://europepmc.org/abstract/MED/11465594|Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:16973644, URL:http://europepmc.org/abstract/MED/16973644",FC(F)OC(F)(F)C(F)Cl,CHEMBL2093872,GABRP
88,CHEMBL1257,Enflurane,Small molecule,1972.0,N01AB04,"N01AB04 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,GABA-A receptor; anion channel positive modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:PubMed, SrcID:11465594, URL:http://europepmc.org/abstract/MED/11465594|Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:16973644, URL:http://europepmc.org/abstract/MED/16973644",FC(F)OC(F)(F)C(F)Cl,CHEMBL2093872,GABRE
89,CHEMBL1257,Enflurane,Small molecule,1972.0,N01AB04,"N01AB04 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,GABA-A receptor; anion channel positive modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:PubMed, SrcID:11465594, URL:http://europepmc.org/abstract/MED/11465594|Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:16973644, URL:http://europepmc.org/abstract/MED/16973644",FC(F)OC(F)(F)C(F)Cl,CHEMBL2093872,GABRG1
90,CHEMBL29,Benzylpenicillin,Small molecule,1947.0,S01AA14; J01CE01,"S01AA14 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Antibiotics]; J01CE01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: BETA-LACTAM ANTIBACTERIALS, PENICILLINS: Beta-lactamase sensitive penicillins]",-cillin,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:PubMed, SrcID:3245263, URL:http://europepmc.org/abstract/MED/3245263|Name:PubMed, SrcID:11353613, URL:http://europepmc.org/abstract/MED/11353613|Name:PubMed, SrcID:19528266, URL:http://europepmc.org/abstract/MED/19528266",CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,,
91,CHEMBL1200468,Malathion,Small molecule,1982.0,P03AX03,"P03AX03 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS: ECTOPARASITICIDES, INCL. SCABICIDES: Other ectoparasiticides, incl. scabicides]",,Acetylcholinesterase inhibitor,,,CHEMBL2362988,Acetylcholinesterase,INHIBITOR,Pediculus humanus capitis,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=0679f4fa-9e18-4da6-83a4-043100a42db4, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0679f4fa-9e18-4da6-83a4-043100a42db4|Name:Wikipedia, SrcID:Malathion, URL:http://en.wikipedia.org/wiki/Malathion|Name:FDA, SrcID:label/2011/018613s017lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018613s017lbl.pdf|Name:Wikipedia, SrcID:Parasympathomimetic, URL:http://en.wikipedia.org/wiki/Parasympathomimetic",CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC,,
92,CHEMBL3039471,Dirithromycin,Small molecule,1995.0,J01FA13,"J01FA13 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS: Macrolides]",-mycin,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,23S ribosomal RNA,23S RRNA,"Name:PubMed, SrcID:12762831, URL:http://europepmc.org/abstract/MED/12762831|Name:PubMed, SrcID:11324679, URL:http://europepmc.org/abstract/MED/11324679|Name:PubMed, SrcID:8478301, URL:http://europepmc.org/abstract/MED/8478301",CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]4N[C@@H](COCCOC)O[C@H]([C@H]4C)[C@]1(C)O,,
93,CHEMBL2108508,Interferon Alfa-2a,Protein,1986.0,L03AB04,L03AB04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSTIMULANTS: IMMUNOSTIMULANTS: Interferons],,Interferon alpha/beta receptor agonist,,,CHEMBL2364170,Interferon alpha/beta receptor,AGONIST,Homo sapiens,PROTEIN COMPLEX,,Alpha subunit is binding site,"Name:PubMed, SrcID:10049744, URL:http://europepmc.org/abstract/MED/10049744",,CHEMBL2364170,IFNAR2
94,CHEMBL3039590,Bleomycin,Small molecule,1973.0,L01DC01,L01DC01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES: Other cytotoxic antibiotics],-mycin,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:Wikipedia, SrcID:Bleomycin, URL:http://en.wikipedia.org/wiki/Bleomycin|Name:DailyMed, SrcID:setid=905e0984-2ce3-481c-b1a0-0ef0a616479a, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=905e0984-2ce3-481c-b1a0-0ef0a616479a",C[C@@H](O)[C@H](NC(=O)[C@@H](C)[C@H](O)[C@@H](C)NC(=O)[C@@H](NC(=O)c1nc(nc(N)c1C)[C@H](CC(=O)N)NC[C@H](N)C(=O)N)[C@@H](O[C@@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]2O[C@H]3O[C@H](CO)[C@@H](O)[C@H](OC(=O)N)[C@@H]3O)c4c[nH]cn4)C(=O)NCCc5nc(cs5)c6ncc(s6)C(=O)NCCC[S+](C)C,,
95,CHEMBL1448,Niclosamide,Small molecule,1982.0,P02DA01,"P02DA01 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTHELMINTICS: ANTICESTODALS: Salicylic acid derivatives]",,DNA inhibitor,,,CHEMBL2366044,DNA,INHIBITOR,Taenia,NUCLEIC-ACID,,,"Name:PubMed, SrcID:12392939, URL:http://europepmc.org/abstract/MED/12392939|Name:Wikipedia, SrcID:Niclosamide, URL:http://en.wikipedia.org/wiki/Niclosamide",Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-],,
96,CHEMBL79,Lidocaine,Small molecule,1948.0,N01BB02; R02AD02; C01BB01; S02DA01; N01BB52; S01HA07; C05AD01; D04AB01,"N01BB02 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Amides]; R02AD02 [RESPIRATORY SYSTEM: THROAT PREPARATIONS: THROAT PREPARATIONS: Anesthetics, local]; C01BB01 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class Ib]; S02DA01 [SENSORY ORGANS: OTOLOGICALS: OTHER OTOLOGICALS: Analgesics and anesthetics]; N01BB52 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Amides]; S01HA07 [SENSORY ORGANS: OPHTHALMOLOGICALS: LOCAL ANESTHETICS: Local anesthetics]; C05AD01 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Local anesthetics]; D04AB01 [DERMATOLOGICALS: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: Anesthetics for topical use]",-caine,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:20585544, URL:http://europepmc.org/abstract/MED/20585544|Name:PubMed, SrcID:19088384, URL:http://europepmc.org/abstract/MED/19088384",CCN(CC)CC(=O)Nc1c(C)cccc1C,,
97,CHEMBL1201303,Pyrvinium,Small molecule,1982.0,P02CX01,"P02CX01 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTHELMINTICS: ANTINEMATODAL AGENTS: Other antinematodals]",-ium; -vin-,Unknown,,,,,,,,,,"Name:PubMed, SrcID:23640456, URL:http://europepmc.org/abstract/MED/23640456",CN(C)c1ccc2c(ccc(\C=C\c3cc(C)n(c3C)c4ccccc4)[n+]2C)c1,,
98,CHEMBL2108078,Parathyroid Hormone,Protein,2015.0,H05AA03,"H05AA03 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CALCIUM HOMEOSTASIS: PARATHYROID HORMONES AND ANALOGUES: Parathyroid hormones and analogues]",,Parathyroid hormone receptor agonist,,,CHEMBL1793,Parathyroid hormone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/125511s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125511s000lbl.pdf",,CHEMBL1793,PTH1R
99,CHEMBL429910,Dapagliflozin,Small molecule,2014.0,A10BK01,"A10BK01 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Sodium-glucose co-transporter 2 (SGLT2) inhibitors]",-gliflozin,Sodium/glucose cotransporter 2 inhibitor,,,CHEMBL3884,Sodium/glucose cotransporter 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=fc6ae30e-868b-4ac9-b69d-900922503998, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fc6ae30e-868b-4ac9-b69d-900922503998",CCOc1ccc(Cc2cc(ccc2Cl)[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc1,CHEMBL3884,SLC5A2
100,CHEMBL2109540,Alirocumab,Antibody,2015.0,C10AX14,"C10AX14 [CARDIOVASCULAR SYSTEM: LIPID MODIFYING AGENTS: LIPID MODIFYING AGENTS, PLAIN: Other lipid modifying agents]",-mab,Subtilisin/kexin type 9 inhibitor,,,CHEMBL2929,Subtilisin/kexin type 9,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=446f6b5c-0dd4-44ff-9bc2-c2b41f2806b4, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=446f6b5c-0dd4-44ff-9bc2-c2b41f2806b4",,CHEMBL2929,PCSK9
101,CHEMBL2364655,Evolocumab,Antibody,2015.0,C10AX13,"C10AX13 [CARDIOVASCULAR SYSTEM: LIPID MODIFYING AGENTS: LIPID MODIFYING AGENTS, PLAIN: Other lipid modifying agents]",-mab,Subtilisin/kexin type 9 inhibitor,,,CHEMBL2929,Subtilisin/kexin type 9,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=709338ae-ab8f-44a9-b7d5-abaabec3493a, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=709338ae-ab8f-44a9-b7d5-abaabec3493a",,CHEMBL2929,PCSK9
102,CHEMBL3545097,Mln-0128,Small molecule,,,,,Serine/threonine-protein kinase mTOR inhibitor,,,CHEMBL2842,Serine/threonine-protein kinase mTOR,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25519700, URL:http://europepmc.org/abstract/MED/25519700|Name:PubMed, SrcID:23085766, URL:http://europepmc.org/abstract/MED/23085766",CC(C)n1nc(c2ccc3oc(N)nc3c2)c4c(N)ncnc14,CHEMBL2842,MTOR
103,CHEMBL598797,Cudc-101,Small molecule,,,,,Epidermal growth factor receptor erbB1 inhibitor,Inhibits class I (HDAC1 HDAC2 HDAC3 HDAC8) and II (HDAC4 HDAC5 HDAC6 HDAC7 HDAC9 HDAC10) HDACs,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20143778, URL:http://europepmc.org/abstract/MED/20143778",COc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCCCCCC(=O)NO,CHEMBL203,EGFR
104,CHEMBL3544969,Hm-71224,Small molecule,,,,,Tyrosine-protein kinase BTK inhibitor,,,CHEMBL5251,Tyrosine-protein kinase BTK,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:ClinicalTrials, SrcID:NCT01765478, URL:https://www.clinicaltrials.gov/ct2/show/NCT01765478|Name:PubMed, SrcID:23958373, URL:http://europepmc.org/abstract/MED/23958373",,CHEMBL5251,BTK
105,CHEMBL3545138,Prt-2607,Small molecule,,,,,Tyrosine-protein kinase SYK inhibitor,,,CHEMBL2599,Tyrosine-protein kinase SYK,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23220742, URL:http://europepmc.org/abstract/MED/23220742|Name:PubMed, SrcID:22040680, URL:http://europepmc.org/abstract/MED/22040680",,CHEMBL2599,SYK
106,CHEMBL3545082,Rg-7376,Small molecule,,,,,Serine/threonine-protein kinase RAF inhibitor,,,CHEMBL1906,Serine/threonine-protein kinase RAF,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21804086, URL:http://europepmc.org/abstract/MED/21804086",,CHEMBL1906,RAF1
107,CHEMBL281872,Zd-4190,Small molecule,,,,,Vascular endothelial growth factor receptor 2 inhibitor,"Also shown to inhibit EGFR, FLT4 and RET (PMID:15928657)",,CHEMBL279,Vascular endothelial growth factor receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10706112, URL:http://europepmc.org/abstract/MED/10706112",COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCn4ccnn4,CHEMBL279,KDR
108,CHEMBL3545204,Qaf805,Small molecule,,,,,Adenosine A2b receptor antagonist,,,CHEMBL255,Adenosine A2b receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15876531, URL:http://europepmc.org/abstract/MED/15876531|Name:PubMed, SrcID:16654164, URL:http://www.ncbi.nlm.nih.gov/pubmed/?term=16654164",,CHEMBL255,ADORA2B
109,CHEMBL29741,Irampanel,Small molecule,,,,-ampa,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:Wikipedia, SrcID:Irampanel, URL:https://en.wikipedia.org/wiki/Irampanel|Name:PubMed, SrcID:10336525, URL:http://europepmc.org/abstract/MED/10336525",CN(C)CCOc1ccccc1c2onc(n2)c3ccccc3,,
110,CHEMBL3545276,Cp-778875,Small molecule,,,,,Peroxisome proliferator-activated receptor alpha agonist,"Status last updated May 2009, discontinued?",,CHEMBL239,Peroxisome proliferator-activated receptor alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22301950, URL:http://europepmc.org/abstract/MED/22301950|Name:PubMed, SrcID:18678301, URL:http://europepmc.org/abstract/MED/18678301|Name:PubMed, SrcID:18971326, URL:http://europepmc.org/abstract/MED/18971326",,CHEMBL239,PPARA
111,CHEMBL181954,Naveglitazar,Small molecule,,,,-glitazar,Peroxisome proliferator-activated receptor alpha agonist,"Development stopped (PMID:20932114). There are reports of adverse events associated with PPARalfa/gamma dual agonist, for example weight gain, increased risk of bladder cancer and hyperplasia.",,CHEMBL239,Peroxisome proliferator-activated receptor alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24524207, URL:http://europepmc.org/abstract/MED/24524207|Name:KEGG, SrcID:D08949, URL:|Name:PubMed, SrcID:18474944, URL:http://europepmc.org/abstract/MED/18474944",CO[C@@H](Cc1ccc(OCCCOc2ccc(Oc3ccccc3)cc2)cc1)C(=O)O,CHEMBL239,PPARA
112,CHEMBL2105728,Crenolanib,Small molecule,,,,-anib,Platelet-derived growth factor receptor inhibitor,,,CHEMBL2095189,Platelet-derived growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:Other, SrcID:http://arogpharma.com/crenolanib, URL:http://arogpharma.com/crenolanib|Name:PubMed, SrcID:22745105, URL:http://europepmc.org/abstract/MED/22745105",CC1(COc2ccc3c(c2)ncn3c4ccc5cccc(N6CCC(N)CC6)c5n4)COC1,,
113,CHEMBL3545025,Insm-18,Small molecule,,,,,Receptor protein-tyrosine kinase erbB-2 inhibitor,,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21875414, URL:http://europepmc.org/abstract/MED/21875414|Name:PubMed, SrcID:16142439, URL:http://europepmc.org/abstract/MED/16142439",,CHEMBL1824,ERBB2
114,CHEMBL2177390,Ipatasertib,Small molecule,,,,-sertib,Serine/threonine-protein kinase AKT inhibitor,,,CHEMBL2111353,Serine/threonine-protein kinase AKT,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:22934575, URL:http://europepmc.org/abstract/MED/22934575|Name:PubMed, SrcID:23287563, URL:http://europepmc.org/abstract/MED/23287563",CC(C)NC[C@@H](C(=O)N1CCN(CC1)c2ncnc3[C@H](O)C[C@@H](C)c23)c4ccc(Cl)cc4,,
115,CHEMBL1667969,Sar-407899,Small molecule,,,,,Rho-associated protein kinase inhibitor,,,CHEMBL2111459,Rho-associated protein kinase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:19597037, URL:http://europepmc.org/abstract/MED/19597037",O=C1NC=Cc2cc(OC3CCNCC3)ccc12,,
116,CHEMBL1272307,Sb-649868,Small molecule,,,,,Orexin receptor 1 antagonist,,,CHEMBL5113,Orexin receptor 1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21045199, URL:http://europepmc.org/abstract/MED/21045199",Cc1nc(C(=O)N2CCCC[C@H]2CNC(=O)c3cccc4occc34)c(s1)c5ccc(F)cc5,CHEMBL5113,HCRTR1
117,CHEMBL2218898,Barusiban,Protein,,,,-siban,Oxytocin receptor antagonist,,,CHEMBL2049,Oxytocin receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:14592588, URL:http://europepmc.org/abstract/MED/14592588|Name:PubMed, SrcID:15740719, URL:http://europepmc.org/abstract/MED/15740719|Name:Wikipedia, SrcID:Barusiban, URL:http://en.wikipedia.org/wiki/Barusiban",CC[C@@H](C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)CCSCC[C@H](NC(=O)[C@H](CC(=O)N)NC1=O)C(=O)N(C)[C@H](CO)CCCN)[C@@H](C)CC,CHEMBL2049,OXTR
118,CHEMBL1207366,Gw468816,Small molecule,,,,,Glutamate [NMDA] receptor antagonist,Selective NMDA glycine site antagonist,,CHEMBL2094124,Glutamate [NMDA] receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:21869693, URL:http://europepmc.org/abstract/MED/21869693",OC(=O)C1C\C(=C/2\CCN(C2=O)c3ccccc3)\c4ccc(Cl)cc4N1,CHEMBL2094124,GRIN3B
119,CHEMBL3545351,Av-101,Small molecule,,,,,Glutamate [NMDA] receptor antagonist,Antagonist of the glycin-site on GRIN1-subunits.,,CHEMBL2094124,Glutamate [NMDA] receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Other, SrcID:http://www.vistagen.com/?page_id=11, URL:http://www.vistagen.com/?page_id=11|Name:PubMed, SrcID:2842779, URL:http://europepmc.org/abstract/MED/2842779|Name:Wikipedia, SrcID:4-Chlorokynurenine, URL:https://en.wikipedia.org/wiki/4-Chlorokynurenine",NC(CC(=O)c1ccc(Cl)cc1N)C(=O)O,CHEMBL2094124,GRIN3B
120,CHEMBL3545073,Ama0076,Small molecule,,,,,Rho-associated protein kinase inhibitor,,,CHEMBL2111459,Rho-associated protein kinase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:24872673, URL:http://europepmc.org/abstract/MED/24872673|Name:PubMed, SrcID:24474276, URL:http://europepmc.org/abstract/MED/24474276",,,
121,CHEMBL2103869,Dasolampanel,Small molecule,,,,-ampa,Glutamate receptor ionotropic kainate 1 antagonist,"AMPA/Kainate receptor antagonist, selective for GRIK1 subunit containing receptors. Active metabolite is NGX424.",,CHEMBL1918,Glutamate receptor ionotropic kainate 1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16470401, URL:http://europepmc.org/abstract/MED/16470401|Name:PubMed, SrcID:18793656, URL:http://europepmc.org/abstract/MED/18793656|Name:PubMed, SrcID:15033339, URL:http://europepmc.org/abstract/MED/15033339|Name:PubMed, SrcID:8609884, URL:http://europepmc.org/abstract/MED/8609884",OC(=O)[C@@H]1C[C@H]2C[C@H](CC[C@H]2CN1)Oc3cccc(Cl)c3c4nnn[nH]4,CHEMBL1918,GRIK1
122,CHEMBL415049,Barasertib,Small molecule,,,,-sertib,Serine/threonine-protein kinase Aurora-B inhibitor,,,CHEMBL2185,Serine/threonine-protein kinase Aurora-B,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17495131, URL:http://europepmc.org/abstract/MED/17495131",CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O,CHEMBL2185,AURKB
123,CHEMBL2108567,Tanezumab,Antibody,,,,-mab,Beta-nerve growth factor inhibitor,,,CHEMBL1649058,Beta-nerve growth factor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18505735, URL:http://europepmc.org/abstract/MED/18505735",,CHEMBL1649058,NGF
124,CHEMBL2103852,Crolibulin,Small molecule,,,,-bulin,Tubulin inhibitor,"Chromene analog that binds to endothelial microtubules promoting mitotic spindle destabilization, inhibition of tubulin polymerization and eventual induction of endothelial cell apoptosis.",,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Binds to the colchicine-binding site on beta-tubulin.,"Name:PubMed, SrcID:26203773, URL:http://europepmc.org/abstract/MED/26203773",COc1cc(cc(Br)c1OC)[C@H]2C(=C(N)Oc3c(N)c(N)ccc23)C#N,CHEMBL2095182,TUBB8
125,CHEMBL2103852,Crolibulin,Small molecule,,,,-bulin,Tubulin inhibitor,"Chromene analog that binds to endothelial microtubules promoting mitotic spindle destabilization, inhibition of tubulin polymerization and eventual induction of endothelial cell apoptosis.",,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Binds to the colchicine-binding site on beta-tubulin.,"Name:PubMed, SrcID:26203773, URL:http://europepmc.org/abstract/MED/26203773",COc1cc(cc(Br)c1OC)[C@H]2C(=C(N)Oc3c(N)c(N)ccc23)C#N,CHEMBL2095182,TUBA3C
126,CHEMBL2103852,Crolibulin,Small molecule,,,,-bulin,Tubulin inhibitor,"Chromene analog that binds to endothelial microtubules promoting mitotic spindle destabilization, inhibition of tubulin polymerization and eventual induction of endothelial cell apoptosis.",,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Binds to the colchicine-binding site on beta-tubulin.,"Name:PubMed, SrcID:26203773, URL:http://europepmc.org/abstract/MED/26203773",COc1cc(cc(Br)c1OC)[C@H]2C(=C(N)Oc3c(N)c(N)ccc23)C#N,CHEMBL2095182,TUBA4A
127,CHEMBL2103852,Crolibulin,Small molecule,,,,-bulin,Tubulin inhibitor,"Chromene analog that binds to endothelial microtubules promoting mitotic spindle destabilization, inhibition of tubulin polymerization and eventual induction of endothelial cell apoptosis.",,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Binds to the colchicine-binding site on beta-tubulin.,"Name:PubMed, SrcID:26203773, URL:http://europepmc.org/abstract/MED/26203773",COc1cc(cc(Br)c1OC)[C@H]2C(=C(N)Oc3c(N)c(N)ccc23)C#N,CHEMBL2095182,TUBA3E
128,CHEMBL2103852,Crolibulin,Small molecule,,,,-bulin,Tubulin inhibitor,"Chromene analog that binds to endothelial microtubules promoting mitotic spindle destabilization, inhibition of tubulin polymerization and eventual induction of endothelial cell apoptosis.",,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Binds to the colchicine-binding site on beta-tubulin.,"Name:PubMed, SrcID:26203773, URL:http://europepmc.org/abstract/MED/26203773",COc1cc(cc(Br)c1OC)[C@H]2C(=C(N)Oc3c(N)c(N)ccc23)C#N,CHEMBL2095182,TUBB6
129,CHEMBL2103852,Crolibulin,Small molecule,,,,-bulin,Tubulin inhibitor,"Chromene analog that binds to endothelial microtubules promoting mitotic spindle destabilization, inhibition of tubulin polymerization and eventual induction of endothelial cell apoptosis.",,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Binds to the colchicine-binding site on beta-tubulin.,"Name:PubMed, SrcID:26203773, URL:http://europepmc.org/abstract/MED/26203773",COc1cc(cc(Br)c1OC)[C@H]2C(=C(N)Oc3c(N)c(N)ccc23)C#N,CHEMBL2095182,TUBB2B
130,CHEMBL2103852,Crolibulin,Small molecule,,,,-bulin,Tubulin inhibitor,"Chromene analog that binds to endothelial microtubules promoting mitotic spindle destabilization, inhibition of tubulin polymerization and eventual induction of endothelial cell apoptosis.",,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Binds to the colchicine-binding site on beta-tubulin.,"Name:PubMed, SrcID:26203773, URL:http://europepmc.org/abstract/MED/26203773",COc1cc(cc(Br)c1OC)[C@H]2C(=C(N)Oc3c(N)c(N)ccc23)C#N,CHEMBL2095182,TUBA3D
131,CHEMBL506871,Veliparib,Small molecule,,,,-parib,"PARP 1, 2 and 3 inhibitor",,,CHEMBL3390820,"PARP 1, 2 and 3",INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:17473206, URL:http://europepmc.org/abstract/MED/17473206",C[C@@]1(CCCN1)c2nc3cccc(C(=O)N)c3[nH]2,,
132,CHEMBL2111100,Mifamurtide,Small molecule,,,,-tide,Nucleotide-binding oligomerization domain-containing protein 2 other,Immunostimulant,,CHEMBL1293266,Nucleotide-binding oligomerization domain-containing protein 2,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20481644, URL:http://europepmc.org/abstract/MED/20481644|Name:Other, SrcID:http://www.medicines.org.uk/emc/medicine/22763, URL:http://www.medicines.org.uk/emc/medicine/22763",CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCNC(=O)[C@H](C)NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(=O)C)C(=O)N)OC(=O)CCCCCCCCCCCCCCC,CHEMBL1293266,NOD2
133,CHEMBL190083,Tarenflurbil,Small molecule,,,,,Gamma-secretase modulator,,,CHEMBL2094135,Gamma-secretase,MODULATOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:20558395, URL:http://europepmc.org/abstract/MED/20558395",C[C@@H](C(=O)O)c1ccc(c(F)c1)c2ccccc2,CHEMBL2094135,APH1B
134,CHEMBL190083,Tarenflurbil,Small molecule,,,,,Gamma-secretase modulator,,,CHEMBL2094135,Gamma-secretase,MODULATOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:20558395, URL:http://europepmc.org/abstract/MED/20558395",C[C@@H](C(=O)O)c1ccc(c(F)c1)c2ccccc2,CHEMBL2094135,APH1A
135,CHEMBL463981,Begacestat,Small molecule,,,,-stat,Gamma-secretase inhibitor,Thiophene sulfonamide gamma-secretase inhibitor (GSI) that selectively inhibits cleavage of APP over Notch.,,CHEMBL2094135,Gamma-secretase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:19671883, URL:http://europepmc.org/abstract/MED/19671883",OC[C@@H](NS(=O)(=O)c1ccc(Cl)s1)C(C(F)(F)F)C(F)(F)F,CHEMBL2094135,APH1B
136,CHEMBL463981,Begacestat,Small molecule,,,,-stat,Gamma-secretase inhibitor,Thiophene sulfonamide gamma-secretase inhibitor (GSI) that selectively inhibits cleavage of APP over Notch.,,CHEMBL2094135,Gamma-secretase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:19671883, URL:http://europepmc.org/abstract/MED/19671883",OC[C@@H](NS(=O)(=O)c1ccc(Cl)s1)C(C(F)(F)F)C(F)(F)F,CHEMBL2094135,APH1A
137,CHEMBL142703,Vildagliptin,Small molecule,,A10BH02,"A10BH02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Dipeptidyl peptidase 4 (DPP-4) inhibitors]",-gliptin,Dipeptidyl peptidase IV inhibitor,,,CHEMBL284,Dipeptidyl peptidase IV,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15886245, URL:http://europepmc.org/abstract/MED/15886245|Name:Other, SrcID:http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000771/human_med_000803.jsp&mid=WC0b01ac058001d124, URL:http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000771/human_med_000803.jsp&mid=WC0b01ac058001d124",OC12CC3CC(C1)CC(C3)(C2)NCC(=O)N4CCC[C@H]4C#N,CHEMBL284,DPP4
138,CHEMBL2364614,Liafensine,Small molecule,,,,-fensine,Monoamine transporter inhibitor,"Selectively inhibits the reuptake of serotonin, norepinephrine, and dopamine",,CHEMBL2363064,Monoamine transporter,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:25116481, URL:http://europepmc.org/abstract/MED/25116481",CN1C[C@@H](c2ccc3ccccc3c2)c4ccc(cc4C1)c5ccc(N)nn5,,
139,CHEMBL3545042,Selurampanel,Small molecule,,,,-ampa,Glutamate receptor ionotropic kainate antagonist,,,CHEMBL2109241,Glutamate receptor ionotropic kainate,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Wikipedia, SrcID:Selurampanel, URL:https://en.wikipedia.org/wiki/Selurampanel",CC(C)c1cc2NC(=O)N(NS(=O)(=O)C)C(=O)c2cc1c3ccnn3C,CHEMBL2109241,GRIK4
140,CHEMBL2108063,Zanolimumab,Antibody,,,,-mab,T-cell surface antigen CD4 other,Induces a strong depletion of CD4-positive T cells (antibody-dependent cell-mediated cytotoxicity (ADCC)).,,CHEMBL2754,T-cell surface antigen CD4,OTHER,Homo sapiens,SINGLE PROTEIN,,,,,CHEMBL2754,CD4
141,CHEMBL1201117,Methocarbamol,Small molecule,1957.0,M03BA03; M03BA53; M03BA73,"M03BA03 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS: Carbamic acid esters]; M03BA53 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS: Carbamic acid esters]; M03BA73 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS: Carbamic acid esters]",,Carbonic anhydrase I inhibitor,,,CHEMBL261,Carbonic anhydrase I,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:1460006, URL:http://europepmc.org/abstract/MED/1460006",COc1ccccc1OCC(O)COC(=O)N,CHEMBL261,CA1
142,CHEMBL20,Acetazolamide,Small molecule,1953.0,S01EC01,S01EC01 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Carbonic anhydrase inhibitors],-zolamide,Carbonic anhydrase II inhibitor,Expressed in eye,,CHEMBL205,Carbonic anhydrase II,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20605094, URL:http://europepmc.org/abstract/MED/20605094",CC(=O)Nc1nnc(s1)S(=O)(=O)N,CHEMBL205,CA2
143,CHEMBL1106,Epinastine,Small molecule,2003.0,R06AX24; S01GX10,R06AX24 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Other antihistamines for systemic use]; S01GX10 [SENSORY ORGANS: OPHTHALMOLOGICALS: DECONGESTANTS AND ANTIALLERGICS: Other antiallergics],-astine,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2011/021565s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021565s006lbl.pdf|Name:DailyMed, SrcID:setid=6e8c8120-bdbd-f14b-2a75-40d788100c34, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6e8c8120-bdbd-f14b-2a75-40d788100c34|Name:Wikipedia, SrcID:Epinastine, URL:http://en.wikipedia.org/wiki/Epinastine",NC1=NCC2N1c3ccccc3Cc4ccccc24,CHEMBL231,HRH1
144,CHEMBL1963681,Avanafil,Small molecule,2011.0,G04BE10,G04BE10 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Drugs used in erectile dysfunction],-afil,Phosphodiesterase 5A inhibitor,,,CHEMBL1827,Phosphodiesterase 5A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2012/202276s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202276s000lbl.pdf",COc1ccc(CNc2nc(ncc2C(=O)NCc3ncccn3)N4CCC[C@H]4CO)cc1Cl,CHEMBL1827,PDE5A
145,CHEMBL1112,Aripiprazole,Small molecule,2002.0,N05AX12,N05AX12 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Other antipsychotics],-prazole,Dopamine D2 receptor partial agonist,,,CHEMBL217,Dopamine D2 receptor,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=c040bd1d-45b7-49f2-93ea-aed7220b30ac#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c040bd1d-45b7-49f2-93ea-aed7220b30ac#nlm34090-1",Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,CHEMBL217,DRD2
146,CHEMBL1201236,Carbidopa,Small molecule,1975.0,,,-dopa,DOPA decarboxylase inhibitor,,,CHEMBL1843,DOPA decarboxylase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11106255, URL:http://europepmc.org/abstract/MED/11106255|Name:DailyMed, SrcID:setid=ff8e105b-7415-42d4-bbb2-b36cfb8945a5#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ff8e105b-7415-42d4-bbb2-b36cfb8945a5#nlm34090-1",C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O,CHEMBL1843,DDC
147,CHEMBL1051,Latanoprost,Small molecule,1996.0,S01EE01,S01EE01 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Prostaglandin analogues 1)],-prost,Prostanoid FP receptor agonist,,,CHEMBL1987,Prostanoid FP receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=e2e7999b-ea0b-69d0-4ad0-c214601f97a7, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e2e7999b-ea0b-69d0-4ad0-c214601f97a7|Name:FDA, SrcID:label/2014/020597s045s048lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020597s045s048lbl.pdf",CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc2ccccc2,CHEMBL1987,PTGFR
148,CHEMBL1200542,Desoxycorticosterone Acetate,Small molecule,1939.0,H02AA03,"H02AA03 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Mineralocorticoids]",-cort-; -ster-,Mineralocorticoid receptor agonist,,,CHEMBL1994,Mineralocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17132855, URL:http://europepmc.org/abstract/MED/17132855|Name:DailyMed, SrcID:setid=5e9f71f1-09d4-4313-ad66-5cfffe428ba8, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e9f71f1-09d4-4313-ad66-5cfffe428ba8",CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,,
149,CHEMBL827,Dexmethylphenidate,Small molecule,2001.0,N06BA11,"N06BA11 [NERVOUS SYSTEM: PSYCHOANALEPTICS: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS: Centrally acting sympathomimetics]",,Dopamine transporter inhibitor,,,CHEMBL238,Dopamine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=d334e2f1-7497-4131-a5c0-7ac30d4741cb#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d334e2f1-7497-4131-a5c0-7ac30d4741cb#nlm34090-1|Name:PubMed, SrcID:18480678, URL:http://europepmc.org/abstract/MED/18480678",COC(=O)[C@@H]([C@H]1CCCCN1)c2ccccc2,CHEMBL238,SLC6A3
150,CHEMBL1200562,Hydrocortisone Valerate,Small molecule,1978.0,A07EA02; S01BA02; S01CB03; D07AA02; H02AB09; D07XA01; S02BA01; C05AA01; A01AC03,"A07EA02 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Corticosteroids acting locally]; S01BA02 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Corticosteroids, plain]; S01CB03 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION: Corticosteroids/antiinfectives/mydriatics in combination]; D07AA02 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, weak (group I)]; H02AB09 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Glucocorticoids]; D07XA01 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, OTHER COMBINATIONS: Corticosteroids, weak, other combinations]; S02BA01 [SENSORY ORGANS: OTOLOGICALS: CORTICOSTEROIDS: Corticosteroids]; C05AA01 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Corticosteroids]; A01AC03 [ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Corticosteroids for local oral treatment]",-cort-,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:6583701, URL:http://europepmc.org/abstract/MED/6583701|Name:DailyMed, SrcID:setid=7b466e08-a51f-414c-bf87-eafed577ff2d#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7b466e08-a51f-414c-bf87-eafed577ff2d#nlm34090-1",CCCCC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)CO,CHEMBL2034,NR3C1
151,CHEMBL2367706,Sucralfate,Unknown,1981.0,A02BX02,A02BX02 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)],,Pepsin A inhibitor,,,CHEMBL3295,Pepsin A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=0fb67b1c-b4c0-46f2-8a81-df1510e006aa#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0fb67b1c-b4c0-46f2-8a81-df1510e006aa#nlm34090-1|Name:ISBN, SrcID:0443-059748 PP. 376, URL:http://www.isbnsearch.org/isbn/0443059748",O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@H](O[C@]2(COS(=O)(=O)O[Al](O)O)O[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]2OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,CHEMBL3295,PGA5
152,CHEMBL1107,Halofantrine,Small molecule,1992.0,P01BX01,"P01BX01 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: ANTIMALARIALS: Other antimalarials]",,Ferriprotoporphyrin IX inhibitor,,,CHEMBL613897,Ferriprotoporphyrin IX,INHIBITOR,Plasmodium falciparum,SMALL MOLECULE,,,"Name:Wikipedia, SrcID:Halofantrine, URL:http://en.wikipedia.org/wiki/Halofantrine|Name:Wikipedia, SrcID:Quinine, URL:http://en.wikipedia.org/wiki/Quinine|Name:PubMed, SrcID:14967191, URL:http://europepmc.org/abstract/MED/14967191",CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c3cc(ccc13)C(F)(F)F,,
153,CHEMBL260538,Ulipristal Acetate,Small molecule,2010.0,,,,Progesterone receptor modulator,Mixed agonist/antagonist,,CHEMBL208,Progesterone receptor,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2012/022474s002lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022474s002lbl.pdf",CN(C)c1ccc(cc1)[C@H]2C[C@@]3(C)[C@@H](CC[C@]3(OC(=O)C)C(=O)C)[C@@H]4CCC5=CC(=O)CCC5=C24,CHEMBL208,PGR
154,CHEMBL3,Nicotine,Small molecule,1984.0,N07BA01,N07BA01 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: DRUGS USED IN ADDICTIVE DISORDERS: Drugs used in nicotine dependence],,Neuronal acetylcholine receptor; alpha4/beta2 agonist,,,CHEMBL1907589,Neuronal acetylcholine receptor; alpha4/beta2,AGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:20400469, URL:http://europepmc.org/abstract/MED/20400469|Name:PubMed, SrcID:17146052, URL:http://europepmc.org/abstract/MED/17146052|Name:PubMed, SrcID:17590520, URL:http://europepmc.org/abstract/MED/17590520|Name:PubMed, SrcID:19560048, URL:http://europepmc.org/abstract/MED/19560048|Name:PubMed, SrcID:11006350, URL:http://europepmc.org/abstract/MED/11006350|Name:PubMed, SrcID:17226798, URL:http://europepmc.org/abstract/MED/17226798|Name:PubMed, SrcID:17360707, URL:http://europepmc.org/abstract/MED/17360707|Name:PubMed, SrcID:17613539, URL:http://europepmc.org/abstract/MED/17613539|Name:PubMed, SrcID:16636791, URL:http://europepmc.org/abstract/MED/16636791|Name:PubMed, SrcID:20081230, URL:http://europepmc.org/abstract/MED/20081230|Name:PubMed, SrcID:16754836, URL:http://europepmc.org/abstract/MED/16754836",CN1CCC[C@H]1c2cccnc2,,
155,CHEMBL1752,Dyphylline,Small molecule,1951.0,R03DA51; R03DA01,R03DA51 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: Xanthines]; R03DA01 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: Xanthines],,Phosphodiesterase 4 inhibitor,,,CHEMBL2093863,Phosphodiesterase 4,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:archiveid=55650, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=55650|Name:DailyMed, SrcID:setid=6d7ed7c0-9646-11de-a404-0002a5d5c51b#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d7ed7c0-9646-11de-a404-0002a5d5c51b#nlm34090-1|Name:PubMed, SrcID:21683458, URL:http://europepmc.org/abstract/MED/21683458",CN1C(=O)N(C)c2ncn(CC(O)CO)c2C1=O,,
156,CHEMBL1617,Rifaximin,Small molecule,2004.0,A07AA11; D06AX11,"A07AA11 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFECTIVES: Antibiotics]; D06AX11 [DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: ANTIBIOTICS FOR TOPICAL USE: Other antibiotics for topical use]",rifa-,Bacterial DNA-directed RNA polymerase inhibitor,,,CHEMBL2364672,Bacterial DNA-directed RNA polymerase,INHIBITOR,Bacteria,PROTEIN COMPLEX,RNA polymerase beta/beta prime subunit,Beta subunit is binding site,"Name:DailyMed, SrcID:setid=523f0320-cc73-445a-a48d-7a181c182307, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=523f0320-cc73-445a-a48d-7a181c182307",CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(NC(=O)\C(=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(=O)C)[C@@H]1C)\C)c5c(nc6cc(C)ccn56)c4c3C2=O,,
157,CHEMBL1200453,Docosanol,Small molecule,2000.0,D06BB11,D06BB11 [DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: CHEMOTHERAPEUTICS FOR TOPICAL USE: Antivirals],,Envelope glycoprotein inhibitor,Seems to prevent the fusion between the host membrane and lipid-enveloped virus.,,CHEMBL2364696,Envelope glycoprotein,INHIBITOR,Human herpesvirus 1,PROTEIN FAMILY,,,"Name:PubMed, SrcID:15571473, URL:http://europepmc.org/abstract/MED/15571473|Name:Other, SrcID:http://libsta28.lib.cam.ac.uk:2113/protocol/10.1385/0-89603-347-3:9/fulltext.html, URL:http://libsta28.lib.cam.ac.uk:2113/protocol/10.1385/0-89603-347-3:9/fulltext.html|Name:PubMed, SrcID:9864049, URL:http://europepmc.org/abstract/MED/9864049|Name:PubMed, SrcID:20210688, URL:http://europepmc.org/abstract/MED/20210688|Name:Wikipedia, SrcID:Docosanol#Mechanism_and_history_of_antiviral_drug_usage, URL:http://en.wikipedia.org/wiki/Docosanol#Mechanism_and_history_of_antiviral_drug_usage",CCCCCCCCCCCCCCCCCCCCCCO,,
158,CHEMBL419,Mafenide,Small molecule,1969.0,D06BA03,D06BA03 [DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: CHEMOTHERAPEUTICS FOR TOPICAL USE: Sulfonamides],,Bacterial dihydropteroate synthase inhibitor,,Broad spectrum,CHEMBL2364668,Bacterial dihydropteroate synthase,INHIBITOR,Bacteria,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20542641, URL:http://europepmc.org/abstract/MED/20542641|Name:ISBN, SrcID:9780702034718 PP. 610, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:FDA, SrcID:label/1998/19832lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/19832lbl.pdf",NCc1ccc(cc1)S(=O)(=O)N,,
159,CHEMBL249837,Methacycline,Small molecule,1982.0,J01AA05,J01AA05 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: TETRACYCLINES: Tetracyclines],-cycline,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,16S ribosomal RNA,16s RRNA,"Name:PubMed, SrcID:18220943, URL:http://europepmc.org/abstract/MED/18220943|Name:PubMed, SrcID:17035842, URL:http://europepmc.org/abstract/MED/17035842|Name:PubMed, SrcID:17428623, URL:http://europepmc.org/abstract/MED/17428623|Name:PubMed, SrcID:15156014, URL:http://europepmc.org/abstract/MED/15156014",CN(C)[C@H]1[C@@H]2[C@@H](O)[C@@H]3C(=C)c4cccc(O)c4C(=O)C3=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N,,
160,CHEMBL602,Cysteamine,Small molecule,1994.0,S01XA21; A16AA04,S01XA21 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals]; A16AA04 [ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Amino acids and derivatives],,Cystine reducing agent,,,CHEMBL2364039,Cystine,REDUCING AGENT,Homo sapiens,SMALL MOLECULE,,,"Name:DailyMed, SrcID:setid=b98ee838-ed23-42a9-93b5-72579e490fba#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b98ee838-ed23-42a9-93b5-72579e490fba#nlm34090-1|Name:DailyMed, SrcID:setid=f495b76d-96c6-48e5-8fa3-30a4336628eb#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f495b76d-96c6-48e5-8fa3-30a4336628eb#nlm34090-1",NCCS,,
161,CHEMBL918,Phenacemide,Small molecule,1951.0,N03AX07,N03AX07 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:Expert, SrcID:, URL:",NC(=O)NC(=O)Cc1ccccc1,,
162,CHEMBL2108989,Asparaginase,Enzyme,1994.0,L01XX02,L01XX02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-ase,Asparagine hydrolytic enzyme,,,CHEMBL2364706,Asparagine,HYDROLYTIC ENZYME,Homo sapiens,SMALL MOLECULE,,,"Name:DailyMed, SrcID:setid=30bdf2ea-008b-4cbb-81e4-c3474f2ad286#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=30bdf2ea-008b-4cbb-81e4-c3474f2ad286#nlm34090-1",,,
163,CHEMBL49120,Pd-0166285,Small molecule,,,,,Epidermal growth factor receptor erbB1 inhibitor,Multi-targeted kinase irreversible inhibitor,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10638483, URL:http://europepmc.org/abstract/MED/10638483",CCN(CC)CCOc1ccc(Nc2ncc3C=C(C(=O)N(C)c3n2)c4c(Cl)cccc4Cl)cc1,CHEMBL203,EGFR
164,CHEMBL3545330,Msx-122,Small molecule,,,,,C-X-C chemokine receptor type 4 antagonist,,,CHEMBL2107,C-X-C chemokine receptor type 4,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19088012, URL:http://europepmc.org/abstract/MED/19088012",C(Nc1ncccn1)c2ccc(CNc3ncccn3)cc2,CHEMBL2107,CXCR4
165,CHEMBL587723,Aee-788,Small molecule,,,,,Vascular endothelial growth factor receptor 1 inhibitor,"Also potent inhibitor of SRC, ABL1 and CSF1R",,CHEMBL1868,Vascular endothelial growth factor receptor 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15256466, URL:http://europepmc.org/abstract/MED/15256466",CCN1CCN(Cc2ccc(cc2)c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)CC1,CHEMBL1868,FLT1
166,CHEMBL3545311,Brigatinib,Small molecule,,,,-tinib,ALK tyrosine kinase receptor inhibitor,Inhibits ALK and EGFR gatekeeper mutants. Does not inhibit wild type (native) EGFR.,,CHEMBL4247,ALK tyrosine kinase receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25888090, URL:http://europepmc.org/abstract/MED/25888090|Name:Other, SrcID:http://www.ariad.com/pdf/Rivera_2012_AACR_POSTER_AP26113_noQRcode.pdf, URL:http://www.ariad.com/pdf/Rivera_2012_AACR_POSTER_AP26113_noQRcode.pdf|Name:Other, SrcID:http://www.ariad.com/AP26113, URL:http://www.ariad.com/AP26113",COc1cc(ccc1Nc2ncc(Cl)c(Nc3ccccc3P(=O)(C)C)n2)N4CCC(CC4)N5CCN(C)CC5,CHEMBL4247,ALK
167,CHEMBL105442,Ci-1040,Small molecule,,,,,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,Allosteric inhibitor,,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10395327, URL:http://europepmc.org/abstract/MED/10395327|Name:PubMed, SrcID:16009947, URL:http://europepmc.org/abstract/MED/16009947",Fc1ccc(C(=O)NOCC2CC2)c(Nc3ccc(I)cc3Cl)c1F,CHEMBL2964,MAP2K2
168,CHEMBL124660,Tandutinib,Small molecule,,,,-tinib,Tyrosine-protein kinase receptor FLT3 inhibitor,,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12124172, URL:http://europepmc.org/abstract/MED/12124172|Name:PubMed, SrcID:12166950, URL:http://europepmc.org/abstract/MED/12166950|Name:Other, SrcID:http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804, URL:http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804",COc1cc2c(ncnc2cc1OCCCN3CCCCC3)N4CCN(CC4)C(=O)Nc5ccc(OC(C)C)cc5,CHEMBL1974,FLT3
169,CHEMBL3545398,Pg-760564,Small molecule,,,,,MAP kinase p38 alpha inhibitor,No assay data or further target information found,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://adisinsight.springer.com/drugs/800030315, URL:http://adisinsight.springer.com/drugs/800030315",,CHEMBL260,MAPK14
170,CHEMBL574737,(7s)-Hydroxyl-Staurosporine,Small molecule,,,,,Cyclin-dependent kinase 4 inhibitor,,,CHEMBL331,Cyclin-dependent kinase 4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7907, URL:http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7907|Name:PubMed, SrcID:12892559, URL:http://europepmc.org/abstract/MED/12892559|Name:PubMed, SrcID:19568282, URL:http://europepmc.org/abstract/MED/19568282",CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n3c4ccccc4c5c6[C@H](O)NC(=O)c6c7c8ccccc8n2c7c35,CHEMBL331,CDK4
171,CHEMBL3545401,X-82,Small molecule,,,,,Platelet-derived growth factor receptor inhibitor,,,CHEMBL2095189,Platelet-derived growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:Other, SrcID:http://www.tyrogenex.com/wordpress/wp-content/uploads/ASC0_X82_5.18.15_Rampurwala.pdf, URL:http://www.tyrogenex.com/wordpress/wp-content/uploads/ASC0_X82_5.18.15_Rampurwala.pdf|Name:Other, SrcID:http://www.tyrogenex.com/wordpress/wp-content/uploads/Oral-X-82-for-wet-AMD-ARVO-2013.pdf, URL:http://www.tyrogenex.com/wordpress/wp-content/uploads/Oral-X-82-for-wet-AMD-ARVO-2013.pdf",,,
172,CHEMBL3545285,Xl-999,Small molecule,,,,,Fibroblast growth factor receptor inhibitor,Spectrum Selective Kinase Inhibitor (SSKI),,CHEMBL2095217,Fibroblast growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://www.exelixis.com/sites/default/files/pdf/XL999_AACR-NCI-EORTCnov05.pdf, URL:http://www.exelixis.com/sites/default/files/pdf/XL999_AACR-NCI-EORTCnov05.pdf|Name:DOI, SrcID:10.1016/S1359-6349(04)80149-6, URL:http://www.sciencedirect.com/science/article/pii/S1359634904801496|Name:PubMed, SrcID:21613405, URL:http://europepmc.org/abstract/MED/21613405",,,
173,CHEMBL1272307,Sb-649868,Small molecule,,,,,Orexin receptor 2 antagonist,,,CHEMBL4792,Orexin receptor 2,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21045199, URL:http://europepmc.org/abstract/MED/21045199",Cc1nc(C(=O)N2CCCC[C@H]2CNC(=O)c3cccc4occc34)c(s1)c5ccc(F)cc5,CHEMBL4792,HCRTR2
174,CHEMBL598172,Nelotanserin,Small molecule,,,,-anserin,Serotonin 2a (5-HT2a) receptor inverse agonist,Discontinued did not meet trial endpoints.,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,INVERSE AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Nelotanserin, URL:http://en.wikipedia.org/wiki/Nelotanserin|Name:PubMed, SrcID:19841476, URL:http://europepmc.org/abstract/MED/19841476",COc1ccc(NC(=O)Nc2ccc(F)cc2F)cc1c3c(Br)cnn3C,CHEMBL224,HTR2A
175,CHEMBL377300,Brivanib,Small molecule,,,,-anib,Fibroblast growth factor receptor inhibitor,Active metabolite of Brivanib alaninate,,CHEMBL2095217,Fibroblast growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:18829493, URL:http://europepmc.org/abstract/MED/18829493|Name:PubMed, SrcID:18288793, URL:http://europepmc.org/abstract/MED/18288793",C[C@@H](O)COc1cn2ncnc(Oc3ccc4[nH]c(C)cc4c3F)c2c1C,,
176,CHEMBL2107773,Ritobegron,Small molecule,,,,-begron,Beta-3 adrenergic receptor agonist,Not in current pipeline,,CHEMBL246,Beta-3 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22552730, URL:http://europepmc.org/abstract/MED/22552730",C[C@H](NCCc1cc(C)c(OCC(=O)O)cc1C)[C@H](O)c2ccc(O)cc2,CHEMBL246,ADRB3
177,CHEMBL1743051,Onartuzumab,Antibody,,,,-mab,Hepatocyte growth factor receptor antagonist,"Binds to the extracellular domain of MET, preventing the binding of its ligand, hepatocyte growth factor (HGF).",,CHEMBL3717,Hepatocyte growth factor receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23882082, URL:http://europepmc.org/abstract/MED/23882082",,CHEMBL3717,MET
178,CHEMBL1835207,Apricoxib,Small molecule,,,,-coxib,Cyclooxygenase-2 inhibitor,,,CHEMBL230,Cyclooxygenase-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16638737, URL:http://europepmc.org/abstract/MED/16638737",CCOc1ccc(cc1)c2cc(C)cn2c3ccc(cc3)S(=O)(=O)N,CHEMBL230,PTGS2
179,CHEMBL166863,Polmacoxib,Small molecule,,,,-coxib,Cyclooxygenase-2 inhibitor,,,CHEMBL230,Cyclooxygenase-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:27475498, URL:http://europepmc.org/abstract/MED/27475498|Name:PubMed, SrcID:26095375, URL:http://europepmc.org/abstract/MED/26095375",CC1(C)OC(=C(C1=O)c2cccc(F)c2)c3ccc(cc3)S(=O)(=O)N,CHEMBL230,PTGS2
180,CHEMBL2364648,Guselkumab,Antibody,,,,-mab,Interleukin-23 subunit alpha inhibitor,,,CHEMBL3580502,Interleukin-23 subunit alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24679469, URL:http://europepmc.org/abstract/MED/24679469",,CHEMBL3580502,IL23A
181,CHEMBL2108029,Ertumaxomab,Antibody,,,,-mab,Receptor protein-tyrosine kinase erbB-2 other,"Immunomodulator. Trifunctional bispecific monoclonal antibody (mAb) has the capacity to enhance immunological effector functions such as antibody dependent cell-mediated cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP). Designed to induce the formation of tri-cell-complexes consisting of Her2-positive tumor cells, CD3+ T cells, and Fc?-receptor positive accessory cells.",,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16707606, URL:http://europepmc.org/abstract/MED/16707606",,CHEMBL1824,ERBB2
182,CHEMBL2109456,Quilizumab,Antibody,,,,-mab,Ig epsilon chain C region inhibitor,,,CHEMBL1834,Ig epsilon chain C region,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24990880, URL:http://europepmc.org/abstract/MED/24990880",,CHEMBL1834,IGHE
183,CHEMBL2108378,Edobacomab,Antibody,,,,-mab,Lipopolysaccharide (LPS) other,Inhibits priming effect of lipopolysaccharide (LPS) on the release of reactive oxygen species. Enhances classical-pathway complement fixation.,"Although endotoxins vary across gram-negative species, it has been demonstrated in vitro to react wi",CHEMBL3580508,Lipopolysaccharide (LPS),OTHER,Bacteria,MACROMOLECULE,,,,,,
184,CHEMBL2346738,Dipraglurant,Small molecule,,,,-glurant,Metabotropic glutamate receptor 5 modulator,,,CHEMBL3227,Metabotropic glutamate receptor 5,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Dipraglurant, URL:http://en.wikipedia.org/wiki/Dipraglurant",Fc1ccc2nc(CCC#Cc3ccccn3)cn2c1,CHEMBL3227,GRM5
185,CHEMBL3545106,Tm30339,Protein,,,,,Neuropeptide Y receptor type 4 agonist,Pancreatic polypeptide analogue. Phase 2 study terminated.,,CHEMBL4877,Neuropeptide Y receptor type 4,AGONIST,Homo sapiens,SINGLE PROTEIN,,,,,CHEMBL4877,NPY4R
186,CHEMBL1201764,Fesoterodine,Small molecule,2008.0,G04BD11,G04BD11 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Drugs for urinary frequency and incontinence],,Muscarinic acetylcholine receptor M3 antagonist,"Indicated for overactive bladder, M3 likely responsible",,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 160, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:16465186, URL:http://europepmc.org/abstract/MED/16465186|Name:DailyMed, SrcID:setid=5be745f0-8ae7-4c3c-9962-37d6263326f1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5be745f0-8ae7-4c3c-9962-37d6263326f1|Name:PubMed, SrcID:12076307, URL:http://europepmc.org/abstract/MED/12076307",CC(C)N(CC[C@H](c1ccccc1)c2cc(CO)ccc2OC(=O)C(C)C)C(C)C,CHEMBL245,CHRM3
187,CHEMBL1201566,Darbepoetin Alfa,Protein,2001.0,B03XA02,B03XA02 [BLOOD AND BLOOD FORMING ORGANS: ANTIANEMIC PREPARATIONS: OTHER ANTIANEMIC PREPARATIONS: Other antianemic preparations],-poetin,Erythropoietin receptor agonist,,,CHEMBL1817,Erythropoietin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10318834, URL:http://europepmc.org/abstract/MED/10318834|Name:DailyMed, SrcID:setid=37204b95-bd46-4b12-b5b7-2c4b128b7203, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=37204b95-bd46-4b12-b5b7-2c4b128b7203|Name:FDA, SrcID:label/2013/103234s5323lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/103234s5323lbl.pdf",,CHEMBL1817,EPOR
188,CHEMBL1201833,Golimumab,Antibody,2009.0,L04AB06,L04AB06 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Tumor necrosis factor alpha (TNF-&alpha;) inhibitors],-mab,TNF-alpha inhibitor,,,CHEMBL1825,TNF-alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f86cb4a7-c358-4136-ae57-b32bda9bba00, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f86cb4a7-c358-4136-ae57-b32bda9bba00",,CHEMBL1825,TNF
189,CHEMBL1201182,Temsirolimus,Small molecule,2007.0,L01XE09,L01XE09 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-imus,FK506-binding protein 1A inhibitor,,,CHEMBL1902,FK506-binding protein 1A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=95b7dc92-2180-42f1-8699-3c28f609e674#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=95b7dc92-2180-42f1-8699-3c28f609e674#section-13",CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(/C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(/C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC)CC[C@H]1OC(=O)C(C)(CO)CO,CHEMBL1902,FKBP1A
190,CHEMBL565,Clofibrate,Small molecule,1967.0,C10AB01,"C10AB01 [CARDIOVASCULAR SYSTEM: LIPID MODIFYING AGENTS: LIPID MODIFYING AGENTS, PLAIN: Fibrates]",-fibrate,Peroxisome proliferator-activated receptor alpha agonist,,,CHEMBL239,Peroxisome proliferator-activated receptor alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 290, URL:http://www.isbnsearch.org/isbn/9780702034718",CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1,CHEMBL239,PPARA
191,CHEMBL1571,Testolactone,Small molecule,1969.0,,,,Cytochrome P450 19A1 inhibitor,,,CHEMBL1978,Cytochrome P450 19A1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2003/16118slr023_teslac_lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/16118slr023_teslac_lbl.pdf",C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CCC(=O)O2,CHEMBL1978,CYP19A1
192,CHEMBL1510,Eletriptan,Small molecule,2002.0,N02CC06,N02CC06 [NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Selective serotonin (5HT1) agonists],-triptan,Serotonin 1d (5-HT1d) receptor agonist,,Selective,CHEMBL1983,Serotonin 1d (5-HT1d) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2011/021016s018lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021016s018lbl.pdf",CN1CCC[C@@H]1Cc2c[nH]c3ccc(CCS(=O)(=O)c4ccccc4)cc23,CHEMBL1983,HTR1D
193,CHEMBL1201328,Carphenazine,Small molecule,1982.0,,,,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:4889058, URL:http://europepmc.org/abstract/MED/4889058|Name:Wikipedia, SrcID:Carphenazine, URL:http://en.wikipedia.org/wiki/Carphenazine|Name:ISBN, SrcID:0443-059748 PP. 544, URL:http://www.isbnsearch.org/isbn/0443059748",CCC(=O)c1ccc2Sc3ccccc3N(CCCN4CCN(CCO)CC4)c2c1,CHEMBL224,HTR2A
194,CHEMBL708,Ziprasidone,Small molecule,2001.0,N05AE04,N05AE04 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Indole derivatives],-sidone,Serotonin 2c (5-HT2c) receptor antagonist,,,CHEMBL225,Serotonin 2c (5-HT2c) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=5c03ca62-5dd5-4cf5-abc7-b0c2873503dd#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5c03ca62-5dd5-4cf5-abc7-b0c2873503dd#nlm34090-1",Clc1cc2NC(=O)Cc2cc1CCN3CCN(CC3)c4nsc5ccccc45,,
195,CHEMBL1201129,Decitabine,Small molecule,2006.0,L01BC08,L01BC08 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Pyrimidine analogues],-citabine,DNA (cytosine-5)-methyltransferase 3A inhibitor,,,CHEMBL1992,DNA (cytosine-5)-methyltransferase 3A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13|Name:Wikipedia, SrcID:DNA_methylation, URL:http://en.wikipedia.org/wiki/DNA_methylation",NC1=NC(=O)N(C=N1)[C@H]2C[C@H](O)[C@@H](CO)O2,CHEMBL1992,DNMT3A
196,CHEMBL1201347,Anileridine,Small molecule,1982.0,N01AH05,"N01AH05 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Opioid anesthetics]",-eridine,Mu opioid receptor agonist,,,CHEMBL233,Mu opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:7541439, URL:http://europepmc.org/abstract/MED/7541439",CCOC(=O)C1(CCN(CCc2ccc(N)cc2)CC1)c3ccccc3,CHEMBL233,OPRM1
197,CHEMBL1685,Dezocine,Small molecule,1989.0,N02AX03,N02AX03 [NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Other opioids],,Mu opioid receptor partial agonist,,,CHEMBL233,Mu opioid receptor,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:0443-059748 PP. 592, URL:http://www.isbnsearch.org/isbn/0443059748|Name:PubMed, SrcID:1348168, URL:http://europepmc.org/abstract/MED/1348168",C[C@@]12CCCCC[C@@H](Cc3ccc(O)cc13)[C@@H]2N,CHEMBL233,OPRM1
198,CHEMBL220492,Topiramate,Small molecule,1996.0,N03AX11,N03AX11 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],,Glutamate receptor ionotropic AMPA antagonist,,,CHEMBL2096670,Glutamate receptor ionotropic AMPA,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=21628112-0c47-11df-95b3-498d55d89593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=21628112-0c47-11df-95b3-498d55d89593#nlm34090-1|Name:PubMed, SrcID:10768292, URL:http://europepmc.org/abstract/MED/10768292",CC1(C)O[C@@H]2CO[C@@]3(COS(=O)(=O)N)OC(C)(C)O[C@H]3[C@@H]2O1,,
199,CHEMBL1201468,"Estrogens, Esterified",Small molecule,1977.0,,,estr-,Estrogen receptor agonist,,,CHEMBL2093866,Estrogen receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=1cd07b54-f66f-4040-9058-462324267196#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1cd07b54-f66f-4040-9058-462324267196#nlm34090-1|Name:ISBN, SrcID:9780702034718 PP. 420, URL:http://www.isbnsearch.org/isbn/9780702034718",,,
200,CHEMBL1503,Omeprazole,Small molecule,1989.0,A02BC01,A02BC01 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): Proton pump inhibitors],-prazole,Potassium-transporting ATPase inhibitor,,,CHEMBL2095173,Potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,K-ATPase alpha subunit,Alpha subunit is likely binding site,"Name:PubMed, SrcID:10411559, URL:http://europepmc.org/abstract/MED/10411559|Name:FDA, SrcID:label/2012/019810s095,022056s011lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019810s095,022056s011lbl.pdf|Name:PubMed, SrcID:19120905, URL:http://europepmc.org/abstract/MED/19120905|Name:PubMed, SrcID:18925391, URL:http://europepmc.org/abstract/MED/18925391",COc1ccc2[nH]c(nc2c1)[S+]([O-])Cc3ncc(C)c(OC)c3C,CHEMBL2095173,ATP4A
201,CHEMBL1503,Omeprazole,Small molecule,1989.0,A02BC01,A02BC01 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): Proton pump inhibitors],-prazole,Potassium-transporting ATPase inhibitor,,,CHEMBL2095173,Potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,K-ATPase alpha subunit,Alpha subunit is likely binding site,"Name:PubMed, SrcID:10411559, URL:http://europepmc.org/abstract/MED/10411559|Name:FDA, SrcID:label/2012/019810s095,022056s011lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019810s095,022056s011lbl.pdf|Name:PubMed, SrcID:19120905, URL:http://europepmc.org/abstract/MED/19120905|Name:PubMed, SrcID:18925391, URL:http://europepmc.org/abstract/MED/18925391",COc1ccc2[nH]c(nc2c1)[S+]([O-])Cc3ncc(C)c(OC)c3C,CHEMBL2095173,ATP4B
202,CHEMBL836,Tamsulosin,Small molecule,1997.0,G04CA02,G04CA02 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY: Alpha-adrenoreceptor antagonists],,Adrenergic receptor alpha-1 antagonist,,,CHEMBL2094251,Adrenergic receptor alpha-1,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=6db9cdec-0833-4391-8764-079ce6f7e4d1#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6db9cdec-0833-4391-8764-079ce6f7e4d1#nlm34090-1",CCOc1ccccc1OCCN[C@H](C)Cc2ccc(OC)c(c2)S(=O)(=O)N,,
203,CHEMBL499808,Caspofungin,Small molecule,2001.0,J02AX04,J02AX04 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: Other antimycotics for systemic use],-fungin,"1,3-beta-glucan synthase inhibitor",,,CHEMBL2364673,"1,3-beta-glucan synthase",INHIBITOR,Candida,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=3bad23a6-09a6-4194-9182-093ed61bc71c#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3bad23a6-09a6-4194-9182-093ed61bc71c#nlm34090-1",CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)c4ccc(O)cc4)[C@H](O)CCN,,
204,CHEMBL114,Saquinavir,Small molecule,1995.0,J05AE01,J05AE01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Protease inhibitors],-vir,Human immunodeficiency virus type 1 protease inhibitor,,,CHEMBL243,Human immunodeficiency virus type 1 protease,INHIBITOR,Human immunodeficiency virus 1,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=c00d1607-ac36-457b-a34b-75ad74f9cf0a, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c00d1607-ac36-457b-a34b-75ad74f9cf0a",CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc3ccccc3)NC(=O)[C@H](CC(=O)N)NC(=O)c4ccc5ccccc5n4,,
205,CHEMBL646,Triazolam,Small molecule,1978.0,N05CD05,N05CD05 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:FDA, SrcID:label/2008/017892s038lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/017892s038lbl.pdf|Name:ISBN, SrcID:9780702034718 PP. 533, URL:http://www.isbnsearch.org/isbn/9780702034718",Cc1nnc2CN=C(c3ccccc3Cl)c4cc(Cl)ccc4n12,CHEMBL2093872,GABRG3
206,CHEMBL646,Triazolam,Small molecule,1978.0,N05CD05,N05CD05 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:FDA, SrcID:label/2008/017892s038lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/017892s038lbl.pdf|Name:ISBN, SrcID:9780702034718 PP. 533, URL:http://www.isbnsearch.org/isbn/9780702034718",Cc1nnc2CN=C(c3ccccc3Cl)c4cc(Cl)ccc4n12,CHEMBL2093872,GABRP
207,CHEMBL646,Triazolam,Small molecule,1978.0,N05CD05,N05CD05 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:FDA, SrcID:label/2008/017892s038lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/017892s038lbl.pdf|Name:ISBN, SrcID:9780702034718 PP. 533, URL:http://www.isbnsearch.org/isbn/9780702034718",Cc1nnc2CN=C(c3ccccc3Cl)c4cc(Cl)ccc4n12,CHEMBL2093872,GABRE
208,CHEMBL646,Triazolam,Small molecule,1978.0,N05CD05,N05CD05 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:FDA, SrcID:label/2008/017892s038lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/017892s038lbl.pdf|Name:ISBN, SrcID:9780702034718 PP. 533, URL:http://www.isbnsearch.org/isbn/9780702034718",Cc1nnc2CN=C(c3ccccc3Cl)c4cc(Cl)ccc4n12,CHEMBL2093872,GABRG1
209,CHEMBL1596,Carbenicillin Indanyl,Small molecule,1972.0,J01CA05,"J01CA05 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: BETA-LACTAM ANTIBACTERIALS, PENICILLINS: Penicillins with extended spectrum]",-cillin,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=02010995-9826-4a67-945b-f3022e6081df, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=02010995-9826-4a67-945b-f3022e6081df|Name:PubMed, SrcID:6821456, URL:http://europepmc.org/abstract/MED/6821456|Name:PubMed, SrcID:2112536, URL:http://europepmc.org/abstract/MED/2112536|Name:PubMed, SrcID:20974151, URL:http://europepmc.org/abstract/MED/20974151|Name:FDA, SrcID:label/2008/050435s009lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050435s009lbl.pdf|Name:Wikipedia, SrcID:Penicillin_binding_proteins#Function, URL:http://en.wikipedia.org/wiki/Penicillin_binding_proteins#Function",CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)Oc3ccc4CCCc4c3)c5ccccc5)C(=O)N2[C@H]1C(=O)O,,
210,CHEMBL1082,Amoxicillin,Small molecule,1974.0,J01CA04,"J01CA04 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: BETA-LACTAM ANTIBACTERIALS, PENICILLINS: Penicillins with extended spectrum]",-cillin,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:ISBN, SrcID:9780702034718 PP. 626-627, URL:http://www.isbnsearch.org/isbn/9780702034718",CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O,,
211,CHEMBL476,Dacarbazine,Small molecule,1975.0,L01AX04,L01AX04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ALKYLATING AGENTS: Other alkylating agents],,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=b6b97e41-5f15-498c-abfb-d8443ea4d216, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b6b97e41-5f15-498c-abfb-d8443ea4d216",CN(C)N=Nc1[nH]cnc1C(=O)N,,
212,CHEMBL9,Norfloxacin,Small molecule,1986.0,S01AE02; J01MA06,S01AE02 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Fluoroquinolones]; J01MA06 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolones],-oxacin,Bacterial DNA gyrase inhibitor,,,CHEMBL2311224,Bacterial DNA gyrase,INHIBITOR,Bacteria,PROTEIN COMPLEX,,,"Name:FDA, SrcID:label/2013/019384s066lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019384s066lbl.pdf|Name:DailyMed, SrcID:setid=36087c76-5da9-4fab-e88f-da1d5a579d8e, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=36087c76-5da9-4fab-e88f-da1d5a579d8e",CCN1C=C(C(=O)O)C(=O)c2cc(F)c(cc12)N3CCNCC3,,
213,CHEMBL803,Cytarabine,Small molecule,1969.0,L01BC01,L01BC01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Pyrimidine analogues],-arabine,DNA polymerase (alpha/delta/epsilon) inhibitor,,,CHEMBL2363042,DNA polymerase (alpha/delta/epsilon),INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=1315f89d-f530-4dff-98e5-27d51617d4a1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1315f89d-f530-4dff-98e5-27d51617d4a1",NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O,CHEMBL2363042,POLE
214,CHEMBL1096882,Fludarabine Phosphate,Small molecule,1991.0,L01BB05,L01BB05 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Purine analogues],-arabine,DNA polymerase (alpha/delta/epsilon) inhibitor,,,CHEMBL2363042,DNA polymerase (alpha/delta/epsilon),INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2011/022137s003lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022137s003lbl.pdf|Name:DailyMed, SrcID:setid=af05203c-16fb-44de-8f42-802fbaa03578, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=af05203c-16fb-44de-8f42-802fbaa03578",Nc1nc(F)nc2c1ncn2[C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@@H]3O,CHEMBL2363042,POLE
215,CHEMBL1179047,Chloroprocaine,Small molecule,1955.0,N01BA04,"N01BA04 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Esters of aminobenzoic acid]",-caine,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2010/009435s035s036lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/009435s035s036lbl.pdf|Name:PubMed, SrcID:15635807, URL:http://europepmc.org/abstract/MED/15635807|Name:DailyMed, SrcID:setid=db26feba-ab91-4bd0-a83c-4714829f6778#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=db26feba-ab91-4bd0-a83c-4714829f6778#nlm34090-1",CCN(CC)CCOC(=O)c1ccc(N)cc1Cl,,
216,CHEMBL479,Thioridazine,Small molecule,1962.0,N05AC02,N05AC02 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Phenothiazines with piperidine structure],,D2-like dopamine receptor antagonist,,,CHEMBL2331075,D2-like dopamine receptor,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=b8d8c29a-414d-4622-bffd-b742725b20f0#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b8d8c29a-414d-4622-bffd-b742725b20f0#nlm34090-1|Name:DailyMed, SrcID:archiveid=143101, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=143101|Name:ISBN, SrcID:0443-059748 PP. 542, URL:http://www.isbnsearch.org/isbn/0443059748",CSc1ccc2Sc3ccccc3N(CCC4CCCCN4C)c2c1,,
217,CHEMBL1200868,Phenyl Aminosalicylate,Small molecule,1982.0,,,,Unknown,,,,,,,,,,"Name:PubMed, SrcID:13301779, URL:http://europepmc.org/abstract/MED/13301779|Name:PubMed, SrcID:14790714, URL:http://europepmc.org/abstract/MED/14790714",Nc1ccc(C(=O)Oc2ccccc2)c(O)c1,,
218,CHEMBL1231723,Polidocanol,Small molecule,2010.0,C05BB02,C05BB02 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: ANTIVARICOSE THERAPY: Sclerosing agents for local injection],,Unknown,,,,,,,,,,"Name:FDA, SrcID:label/2010/021201lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021201lbl.pdf",CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,,
219,CHEMBL1201794,Riboflavin 5'-Phosphate,Small molecule,1985.0,,,,Unknown,,,,,,,,,,"Name:PubMed, SrcID:22355488, URL:http://europepmc.org/abstract/MED/22355488",Cc1cc2N=C3C(=O)NC(=O)N=C3N(C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O)c2cc1C,,
220,CHEMBL1060,Sodium Phosphate,Small molecule,1957.0,A06AD17; A06AG01; B05XA09,A06AD17 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR CONSTIPATION: DRUGS FOR CONSTIPATION: Osmotically acting laxatives]; A06AG01 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR CONSTIPATION: DRUGS FOR CONSTIPATION: Enemas]; B05XA09 [BLOOD AND BLOOD FORMING ORGANS: BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS: I.V. SOLUTION ADDITIVES: Electrolyte solutions],,Unknown,,,,,,,,,,"Name:PubMed, SrcID:428168, URL:http://europepmc.org/abstract/MED/428168",[Na+].[Na+].OP(=O)([O-])[O-],,
221,CHEMBL2107834,Riociguat,Small molecule,2013.0,C02KX05,C02KX05 [CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: OTHER ANTIHYPERTENSIVES: Antihypertensives for pulmonary arterial hypertension],-ciguat,Soluble guanylate cyclase positive allosteric modulator,"Riociguat has a dual mode of action. It sensitizes sGC to endogenous NO by stabilizing the NO-sGC binding and it also directly stimulates sGC via a different binding site, independently of NO. Recent studies have suggested that sCG stimulators bind to an allosteric nucleotide-binding site in the catalytic domains of sCG. The exact molecular mechanism of sCG stimulation remains a matter of debate.",,CHEMBL2111348,Soluble guanylate cyclase,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:16955067, URL:http://europepmc.org/abstract/MED/16955067|Name:DailyMed, SrcID:7b57509a-3d5d-41d4-8fed-1471e26372a3, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7b57509a-3d5d-41d4-8fed-1471e26372a3|Name:PubMed, SrcID:19263460, URL:http://europepmc.org/abstract/MED/19263460",COC(=O)N(C)c1c(N)nc(nc1N)c2nn(Cc3ccccc3F)c4ncccc24,CHEMBL2111348,GUCY1A2
222,CHEMBL3545077,Mk-1496,Small molecule,,,,,Serine/threonine-protein kinase PLK1 inhibitor,,,CHEMBL3024,Serine/threonine-protein kinase PLK1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://meeting.ascopubs.org/cgi/content/short/29/15_suppl/3012?rss=1, URL:http://meeting.ascopubs.org/cgi/content/short/29/15_suppl/3012?rss=1",,CHEMBL3024,PLK1
223,CHEMBL3545322,Panulisib,Small molecule,,,,-lisib,Serine/threonine-protein kinase receptor R3 inhibitor,ATP-competitive mTORC1/mTORC2 inhibitor,,CHEMBL5311,Serine/threonine-protein kinase receptor R3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25700704, URL:http://europepmc.org/abstract/MED/25700704",,CHEMBL5311,ACVRL1
224,CHEMBL3545083,Rgb-286638,Small molecule,,,,,Cyclin-dependent kinase 9 inhibitor,,,CHEMBL3116,Cyclin-dependent kinase 9,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23807770, URL:http://europepmc.org/abstract/MED/23807770",COCCN1CCN(Cc2ccc(cc2)c3n[nH]c4c5cccc(NC(=O)NN6CCOCC6)c5C(=O)c34)CC1,CHEMBL3116,CDK9
225,CHEMBL1614766,Ro-4987655,Small molecule,,,,,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,,,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19934286, URL:http://europepmc.org/abstract/MED/19934286|Name:PubMed, SrcID:23587417, URL:http://europepmc.org/abstract/MED/23587417|Name:Other, SrcID:http://cancerres.aacrjournals.org/content/69/9_Supplement/3701.abstract, URL:http://cancerres.aacrjournals.org/content/69/9_Supplement/3701.abstract",OCCONC(=O)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc3ccc(I)cc3F,CHEMBL3587,MAP2K1
226,CHEMBL1614702,Scio-323,Small molecule,,,,,MAP kinase p38 alpha inhibitor,,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18431764, URL:http://europepmc.org/abstract/MED/18431764",COc1cc2c(cc1C(=O)N3CCC(Cc4ccc(F)cc4)CC3)c(cn2C)C(=O)C(=O)N(C)C,CHEMBL260,MAPK14
227,CHEMBL1615025,Tak-733,Small molecule,,,,,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,,,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23587417, URL:http://europepmc.org/abstract/MED/23587417|Name:PubMed, SrcID:21310613, URL:http://europepmc.org/abstract/MED/21310613",CN1C(=O)C(=C(Nc2ccc(I)cc2F)C3=C1N=CN(C[C@@H](O)CO)C3=O)F,CHEMBL2964,MAP2K2
228,CHEMBL3545093,Zyh7,Small molecule,,,,,Peroxisome proliferator-activated receptor alpha agonist,,,CHEMBL239,Peroxisome proliferator-activated receptor alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://zyduscadila.com, URL:http://zyduscadila.com",,CHEMBL239,PPARA
229,CHEMBL3545334,Ave8134,Small molecule,,,,,Peroxisome proliferator-activated receptor alpha agonist,Development discontinued (http://fr.reuters.com/article/idUKL04616509200804042),,CHEMBL239,Peroxisome proliferator-activated receptor alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22212431, URL:http://europepmc.org/abstract/MED/22212431",,CHEMBL239,PPARA
230,CHEMBL565612,Sotrastaurin,Small molecule,,,,,Protein kinase C (PKC) inhibitor,,,CHEMBL2093867,Protein kinase C (PKC),INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19491325, URL:http://europepmc.org/abstract/MED/19491325",CN1CCN(CC1)c2nc(C3=C(C(=O)NC3=O)c4c[nH]c5ccccc45)c6ccccc6n2,,
231,CHEMBL587723,Aee-788,Small molecule,,,,,Epidermal growth factor receptor erbB1 inhibitor,"Also potent inhibitor of SRC, ABL1 and CSF1R",,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15256466, URL:http://europepmc.org/abstract/MED/15256466",CCN1CCN(Cc2ccc(cc2)c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)CC1,CHEMBL203,EGFR
232,CHEMBL3545150,Azm-475271,Small molecule,,,,,Tyrosine-protein kinase ABL inhibitor,,,CHEMBL1862,Tyrosine-protein kinase ABL,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.ucb.com/_up/ucb_com_rd/documents/External_poster.pdf, URL:http://www.ucb.com/_up/ucb_com_rd/documents/External_poster.pdf",,CHEMBL1862,ABL1
233,CHEMBL2110932,Elzasonan,Small molecule,,,,-sonan,Serotonin 1d (5-HT1d) receptor antagonist,,,CHEMBL1983,Serotonin 1d (5-HT1d) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Elzasonan, URL:https://en.wikipedia.org/wiki/Elzasonan|Name:PubMed, SrcID:20668248, URL:http://europepmc.org/abstract/MED/20668248",CN1CCN(CC1)c2ccccc2\C=C/3\SCCN(C3=O)c4ccc(Cl)c(Cl)c4,CHEMBL1983,HTR1D
234,CHEMBL3545405,Bay1067197,Small molecule,,,,,Adenosine A1 receptor agonist,Partial agonist,,CHEMBL226,Adenosine A1 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://clinicaltrials.gov/ct2/show/NCT02040233, URL:https://clinicaltrials.gov/ct2/show/NCT02040233",,CHEMBL226,ADORA1
235,CHEMBL3545410,Tc-6987,Small molecule,,,,,Neuronal acetylcholine receptor protein alpha-7 subunit agonist,Open channel stabilizer.,,CHEMBL2492,Neuronal acetylcholine receptor protein alpha-7 subunit,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21919481, URL:http://europepmc.org/abstract/MED/21919481|Name:Other, SrcID:http://216.139.227.101/interactive/trgt2011/pf/page_019.pdf, URL:http://216.139.227.101/interactive/trgt2011/pf/page_019.pdf",,CHEMBL2492,CHRNA7
236,CHEMBL111659,Altinicline,Small molecule,,,,-nicline,Neuronal acetylcholine receptor; alpha4/beta2 agonist,"SIB-1765F is a racemate with two isomers, SIB-1508Y and SIB-1680WD. SIB-1508Y is thought to be the active isomer.",,CHEMBL1907589,Neuronal acetylcholine receptor; alpha4/beta2,AGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:18692487, URL:http://europepmc.org/abstract/MED/18692487|Name:PubMed, SrcID:10812948, URL:http://europepmc.org/abstract/MED/10812948",CN1CCC[C@H]1c2cncc(c2)C#C,,
237,CHEMBL180022,Neratinib,Small molecule,,,,-tinib,Receptor protein-tyrosine kinase erbB-2 inhibitor,Neratinib is an irreversible pan-HER tyrosine kinase inhibitor.,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26089701, URL:http://europepmc.org/abstract/MED/26089701|Name:PubMed, SrcID:15715478, URL:http://europepmc.org/abstract/MED/15715478",CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)\C=C\CN(C)C,CHEMBL1824,ERBB2
238,CHEMBL2105759,Baricitinib,Small molecule,,L04AA37,L04AA37 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Selective immunosuppressants],-tinib,Tyrosine-protein kinase JAK1 inhibitor,,,CHEMBL2835,Tyrosine-protein kinase JAK1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20363976, URL:http://europepmc.org/abstract/MED/20363976",CCS(=O)(=O)N1CC(CC#N)(C1)n2cc(cn2)c3ncnc4[nH]ccc34,CHEMBL2835,JAK1
239,CHEMBL101253,Vatalanib,Small molecule,,,,-anib,Macrophage colony stimulating factor receptor inhibitor,,,CHEMBL1844,Macrophage colony stimulating factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10786682, URL:http://europepmc.org/abstract/MED/10786682|Name:PubMed, SrcID:16882767, URL:http://europepmc.org/abstract/MED/16882767",Clc1ccc(Nc2nnc(Cc3ccncc3)c4ccccc24)cc1,CHEMBL1844,CSF1R
240,CHEMBL274654,Orantinib,Small molecule,,,,-tinib,Fibroblast growth factor receptor inhibitor,"Ph 3 trial discontinued, compound on hold?",,CHEMBL2095217,Fibroblast growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10945623, URL:http://europepmc.org/abstract/MED/10945623",Cc1[nH]c(\C=C\2/C(=O)Nc3ccccc23)c(C)c1CCC(=O)O,,
241,CHEMBL209821,Naluzotan,Small molecule,,,,-zotan,Serotonin 1a (5-HT1a) receptor agonist,"Development stopped, not superior enough to placebo.",,CHEMBL214,Serotonin 1a (5-HT1a) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Naluzotan, URL:http://en.wikipedia.org/wiki/Naluzotan|Name:PubMed, SrcID:16722631, URL:http://europepmc.org/abstract/MED/16722631",CC(=O)Nc1cccc(c1)N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2,CHEMBL214,HTR1A
242,CHEMBL313006,Dalcetrapib,Small molecule,,,,-cetrapib,Cholesteryl ester transfer protein inhibitor,,,CHEMBL3572,Cholesteryl ester transfer protein,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15842977, URL:http://europepmc.org/abstract/MED/15842977|Name:PubMed, SrcID:11994249, URL:http://europepmc.org/abstract/MED/11994249",CCC(CC)CC1(CCCCC1)C(=O)Nc2ccccc2SC(=O)C(C)C,CHEMBL3572,CETP
243,CHEMBL48361,Dabigatran,Small molecule,,,,-gatran,Thrombin inhibitor,"Reversible direct, selective thrombin inhibitor",,CHEMBL204,Thrombin,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17721615, URL:http://europepmc.org/abstract/MED/17721615",Cn1c(CNc2ccc(cc2)C(=N)N)nc3cc(ccc13)C(=O)N(CCC(=O)O)c4ccccn4,CHEMBL204,F2
244,CHEMBL68117,Vosaroxin,Small molecule,,L01XX53,L01XX53 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-oxin,DNA topoisomerase II inhibitor,"First-in-class topoisomerase II poison and inhibitor that intercalates DNA and induces site-selective DNA DSB, G2 arrest, and apoptosis",,CHEMBL2094255,DNA topoisomerase II,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:20419121, URL:http://europepmc.org/abstract/MED/20419121",CN[C@H]1CN(C[C@@H]1OC)c2ccc3C(=O)C(=CN(c4nccs4)c3n2)C(=O)O,,
245,CHEMBL2109621,Di17e6,Antibody,,,,,Integrin alpha-V/beta-5 inhibitor,"Inhibits ligand binding to all alphav heterodimers (alphavbeta1, alphavbeta3, alphavbeta5, alphavbeta6, alphavbeta8).",Specifically directed against the alphav subunit of human integrins.,CHEMBL2096675,Integrin alpha-V/beta-5,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23791392, URL:http://europepmc.org/abstract/MED/23791392",,CHEMBL2096675,ITGB5
246,CHEMBL1742999,Carlumab,Antibody,,,,-mab,C-C motif chemokine 2 inhibitor,,,CHEMBL1649052,C-C motif chemokine 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22487721, URL:http://europepmc.org/abstract/MED/22487721",,CHEMBL1649052,CCL2
247,CHEMBL2108144,Teneliximab,Antibody,,,,-mab,Tumor necrosis factor receptor superfamily member 5 partial agonist,Blocks CD154 binding to CD40 and has partial agonist properties.,,CHEMBL1250358,Tumor necrosis factor receptor superfamily member 5,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15611281, URL:http://europepmc.org/abstract/MED/15611281",,CHEMBL1250358,CD40
248,CHEMBL2108739,Placulumab,Antibody,,,,-mab,TNF-alpha inhibitor,,,CHEMBL1825,TNF-alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20930515, URL:http://europepmc.org/abstract/MED/20930515",,CHEMBL1825,TNF
249,CHEMBL1519,Trandolapril,Small molecule,1996.0,C09AA10,"C09AA10 [CARDIOVASCULAR SYSTEM: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM: ACE INHIBITORS, PLAIN: ACE inhibitors, plain]",-pril,Angiotensin-converting enzyme inhibitor,,,CHEMBL1808,Angiotensin-converting enzyme,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=5ad67ea2-409c-4f52-a9b8-38216209609a, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ad67ea2-409c-4f52-a9b8-38216209609a",CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2[C@H]3CCCC[C@@H]3C[C@H]2C(=O)O,CHEMBL1808,ACE
250,CHEMBL946,Azatadine,Small molecule,1977.0,R06AX09,R06AX09 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Other antihistamines for systemic use],-(a)tadine,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:2568212, URL:http://europepmc.org/abstract/MED/2568212",CN1CCC(=C2c3ccccc3CCc4cccnc24)CC1,CHEMBL231,HRH1
251,CHEMBL896,Hydroxyzine,Small molecule,1956.0,N05BB01; N05BB51,N05BB01 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Diphenylmethane derivatives]; N05BB51 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Diphenylmethane derivatives],,Histamine H1 receptor antagonist,Activity against other receptors such as 5HT2A and D2 may underlie efficacy of anxiolytic and antipsychotic effects,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15627436, URL:http://europepmc.org/abstract/MED/15627436|Name:ISBN, SrcID:9780702034718 PP. 333, URL:http://www.isbnsearch.org/isbn/9780702034718",OCCOCCN1CCN(CC1)C(c2ccccc2)c3ccc(Cl)cc3,CHEMBL231,HRH1
252,CHEMBL1201580,Adalimumab,Antibody,2002.0,L04AB04,L04AB04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Tumor necrosis factor alpha (TNF-&alpha;) inhibitors],-mab,TNF-alpha inhibitor,,,CHEMBL1825,TNF-alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=608d4f0d-b19f-46d3-749a-7159aa5f933d, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=608d4f0d-b19f-46d3-749a-7159aa5f933d",,CHEMBL1825,TNF
253,CHEMBL1201250,Benzquinamide,Small molecule,1974.0,,,,Dopamine D2 receptor modulator,Antiemetic,,CHEMBL217,Dopamine D2 receptor,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:6130555, URL:http://europepmc.org/abstract/MED/6130555|Name:PubMed, SrcID:22711801, URL:http://europepmc.org/abstract/MED/22711801",CCN(CC)C(=O)C1CN2CCc3cc(OC)c(OC)cc3C2CC1OC(=O)C,CHEMBL217,DRD2
254,CHEMBL1201827,Panitumumab,Antibody,2006.0,L01XC08,L01XC08 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,Epidermal growth factor receptor erbB1 inhibitor,,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=e0fa4bca-f245-4d92-ae29-b0c630a315c2, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e0fa4bca-f245-4d92-ae29-b0c630a315c2",,CHEMBL203,EGFR
255,CHEMBL1490,Trihexyphenidyl,Small molecule,1949.0,N04AA01,N04AA01 [NERVOUS SYSTEM: ANTI-PARKINSON DRUGS: ANTICHOLINERGIC AGENTS: Tertiary amines],,Muscarinic acetylcholine receptor M1 antagonist,"Indicated for Parkinson's disease, M1 likely responsible",,CHEMBL216,Muscarinic acetylcholine receptor M1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Trihexyphenidyl, URL:http://en.wikipedia.org/wiki/Trihexyphenidyl|Name:PubMed, SrcID:2432979, URL:http://europepmc.org/abstract/MED/2432979|Name:PubMed, SrcID:9721037, URL:http://europepmc.org/abstract/MED/9721037|Name:ISBN, SrcID:9780702034718 PP. 162, 153, URL:http://www.isbnsearch.org/isbn/9780702034718",OC(CCN1CCCCC1)(C2CCCCC2)c3ccccc3,CHEMBL216,CHRM1
256,CHEMBL35,Furosemide,Small molecule,1966.0,C03CA01,"C03CA01 [CARDIOVASCULAR SYSTEM: DIURETICS: HIGH-CEILING DIURETICS: Sulfonamides, plain]",-semide,Sodium-(potassium)-chloride cotransporter 2 inhibitor,,,CHEMBL1874,Sodium-(potassium)-chloride cotransporter 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1056/NEJMra0907219, URL:http://www.nejm.org/doi/full/10.1056/NEJMra0907219|Name:DailyMed, SrcID:setid=c794c95a-654e-48fe-9596-201fc122ff75, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c794c95a-654e-48fe-9596-201fc122ff75|Name:Wikipedia, SrcID:Loop_diuretic, URL:http://en.wikipedia.org/wiki/Loop_diuretic|Name:Wikipedia, SrcID:Furosemide, URL:http://en.wikipedia.org/wiki/Furosemide",NS(=O)(=O)c1cc(C(=O)O)c(NCc2occc2)cc1Cl,CHEMBL1874,SLC12A1
257,CHEMBL128,Sumatriptan,Small molecule,1992.0,N02CC01,N02CC01 [NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Selective serotonin (5HT1) agonists],-triptan,Serotonin 1b (5-HT1b) receptor agonist,,Selective,CHEMBL1898,Serotonin 1b (5-HT1b) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2012/020080s039s040s041s045lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020080s039s040s041s045lbl.pdf",CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1,CHEMBL1898,HTR1B
258,CHEMBL1279,Frovatriptan,Small molecule,2001.0,N02CC07,N02CC07 [NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Selective serotonin (5HT1) agonists],-triptan,Serotonin 1d (5-HT1d) receptor agonist,,Selective,CHEMBL1983,Serotonin 1d (5-HT1d) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2009/021006s006s009s010lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021006s006s009s010lbl.pdf",CN[C@@H]1CCc2[nH]c3ccc(cc3c2C1)C(=O)N,CHEMBL1983,HTR1D
259,CHEMBL3187365,Asenapine,Small molecule,2009.0,N05AH05,"N05AH05 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Diazepines, oxazepines, thiazepines and oxepines]",-pin(e),Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=17209c32-56eb-4f84-954d-aed7b7a1b18d, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=17209c32-56eb-4f84-954d-aed7b7a1b18d",CN1CC2C(C1)c3cc(Cl)ccc3Oc4ccccc24,CHEMBL224,HTR2A
260,CHEMBL621,Trazodone,Small molecule,1981.0,N06AX05,N06AX05 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants],,Serotonin 2c (5-HT2c) receptor antagonist,,,CHEMBL225,Serotonin 2c (5-HT2c) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=88c45123-f475-4dd0-bbac-c261868924ef#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=88c45123-f475-4dd0-bbac-c261868924ef#nlm34090-1|Name:FDA, SrcID:label/2013/071258Orig1s040, 071196Orig1s063lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/071258Orig1s040, 071196Orig1s063lbl.pdf",Clc1cccc(c1)N2CCN(CCCN3N=C4C=CC=CN4C3=O)CC2,,
261,CHEMBL81,Raloxifene,Small molecule,1997.0,G03XC01,G03XC01 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: Selective estrogen receptor modulators],-ifene,Estrogen receptor beta modulator,Mixed agonist/antagonist,,CHEMBL242,Estrogen receptor beta,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=fcaaa6dc-74e8-4fb8-800c-5574bf0f8de9#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fcaaa6dc-74e8-4fb8-800c-5574bf0f8de9#nlm34090-1|Name:Wikipedia, SrcID:Estrogen_receptor, URL:http://en.wikipedia.org/wiki/Estrogen_receptor",Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4,CHEMBL242,ESR2
262,CHEMBL1373,Modafinil,Small molecule,1998.0,N06BA07,"N06BA07 [NERVOUS SYSTEM: PSYCHOANALEPTICS: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS: Centrally acting sympathomimetics]",,Dopamine transporter inhibitor,,,CHEMBL238,Dopamine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=2c824d4c-2309-4e2a-bc74-aa8d80a5c454#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c824d4c-2309-4e2a-bc74-aa8d80a5c454#nlm34090-1|Name:PubMed, SrcID:11222668, URL:http://europepmc.org/abstract/MED/11222668",NC(=O)C[S+]([O-])C(c1ccccc1)c2ccccc2,CHEMBL238,SLC6A3
263,CHEMBL1113,Amoxapine,Small molecule,1980.0,N06AA17,N06AA17 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Non-selective monoamine reuptake inhibitors],-pin(e),Norepinephrine transporter inhibitor,,,CHEMBL222,Norepinephrine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=261006c8-3fd0-491b-b322-42beff6f9880#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=261006c8-3fd0-491b-b322-42beff6f9880#nlm34090-1",Clc1ccc2Oc3ccccc3N=C(N4CCNCC4)c2c1,CHEMBL222,SLC6A2
264,CHEMBL1200853,Dydrogesterone,Small molecule,1982.0,G03DB01,G03DB01 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: PROGESTOGENS: Pregnadien derivatives],-gest-,Progesterone receptor agonist,,,CHEMBL208,Progesterone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16045524, URL:http://europepmc.org/abstract/MED/16045524|Name:PubMed, SrcID:6827166, URL:http://europepmc.org/abstract/MED/6827166|Name:PubMed, SrcID:15128769, URL:http://europepmc.org/abstract/MED/15128769",CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C,CHEMBL208,PGR
265,CHEMBL1743082,Trastuzumab Emtansine,Antibody,2013.0,L01XC14; L01XC03,L01XC14 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies]; L01XC03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,Tubulin inhibitor,inhibits polymerisation,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,Binds to beta tubulin,"Name:DailyMed, SrcID:setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e#nlm34090-1|Name:PubMed, SrcID:23798344, URL:http://europepmc.org/abstract/MED/23798344|Name:DailyMed, SrcID:setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e|Name:PubMed, SrcID:1241159, URL:http://europepmc.org/abstract/MED/1241159|Name:PubMed, SrcID:22044006, URL:http://europepmc.org/abstract/MED/22044006",,CHEMBL2095182,TUBB8
266,CHEMBL1743082,Trastuzumab Emtansine,Antibody,2013.0,L01XC14; L01XC03,L01XC14 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies]; L01XC03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,Tubulin inhibitor,inhibits polymerisation,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,Binds to beta tubulin,"Name:DailyMed, SrcID:setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e#nlm34090-1|Name:PubMed, SrcID:23798344, URL:http://europepmc.org/abstract/MED/23798344|Name:DailyMed, SrcID:setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e|Name:PubMed, SrcID:1241159, URL:http://europepmc.org/abstract/MED/1241159|Name:PubMed, SrcID:22044006, URL:http://europepmc.org/abstract/MED/22044006",,CHEMBL2095182,TUBA3C
267,CHEMBL1743082,Trastuzumab Emtansine,Antibody,2013.0,L01XC14; L01XC03,L01XC14 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies]; L01XC03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,Tubulin inhibitor,inhibits polymerisation,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,Binds to beta tubulin,"Name:DailyMed, SrcID:setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e#nlm34090-1|Name:PubMed, SrcID:23798344, URL:http://europepmc.org/abstract/MED/23798344|Name:DailyMed, SrcID:setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e|Name:PubMed, SrcID:1241159, URL:http://europepmc.org/abstract/MED/1241159|Name:PubMed, SrcID:22044006, URL:http://europepmc.org/abstract/MED/22044006",,CHEMBL2095182,TUBA4A
268,CHEMBL1743082,Trastuzumab Emtansine,Antibody,2013.0,L01XC14; L01XC03,L01XC14 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies]; L01XC03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,Tubulin inhibitor,inhibits polymerisation,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,Binds to beta tubulin,"Name:DailyMed, SrcID:setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e#nlm34090-1|Name:PubMed, SrcID:23798344, URL:http://europepmc.org/abstract/MED/23798344|Name:DailyMed, SrcID:setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e|Name:PubMed, SrcID:1241159, URL:http://europepmc.org/abstract/MED/1241159|Name:PubMed, SrcID:22044006, URL:http://europepmc.org/abstract/MED/22044006",,CHEMBL2095182,TUBA3E
269,CHEMBL1743082,Trastuzumab Emtansine,Antibody,2013.0,L01XC14; L01XC03,L01XC14 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies]; L01XC03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,Tubulin inhibitor,inhibits polymerisation,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,Binds to beta tubulin,"Name:DailyMed, SrcID:setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e#nlm34090-1|Name:PubMed, SrcID:23798344, URL:http://europepmc.org/abstract/MED/23798344|Name:DailyMed, SrcID:setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e|Name:PubMed, SrcID:1241159, URL:http://europepmc.org/abstract/MED/1241159|Name:PubMed, SrcID:22044006, URL:http://europepmc.org/abstract/MED/22044006",,CHEMBL2095182,TUBB6
270,CHEMBL1743082,Trastuzumab Emtansine,Antibody,2013.0,L01XC14; L01XC03,L01XC14 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies]; L01XC03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,Tubulin inhibitor,inhibits polymerisation,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,Binds to beta tubulin,"Name:DailyMed, SrcID:setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e#nlm34090-1|Name:PubMed, SrcID:23798344, URL:http://europepmc.org/abstract/MED/23798344|Name:DailyMed, SrcID:setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e|Name:PubMed, SrcID:1241159, URL:http://europepmc.org/abstract/MED/1241159|Name:PubMed, SrcID:22044006, URL:http://europepmc.org/abstract/MED/22044006",,CHEMBL2095182,TUBB2B
271,CHEMBL1743082,Trastuzumab Emtansine,Antibody,2013.0,L01XC14; L01XC03,L01XC14 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies]; L01XC03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,Tubulin inhibitor,inhibits polymerisation,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,Binds to beta tubulin,"Name:DailyMed, SrcID:setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e#nlm34090-1|Name:PubMed, SrcID:23798344, URL:http://europepmc.org/abstract/MED/23798344|Name:DailyMed, SrcID:setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e|Name:PubMed, SrcID:1241159, URL:http://europepmc.org/abstract/MED/1241159|Name:PubMed, SrcID:22044006, URL:http://europepmc.org/abstract/MED/22044006",,CHEMBL2095182,TUBA3D
272,CHEMBL477772,Pazopanib,Small molecule,2009.0,L01XE11,L01XE11 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-anib,Platelet-derived growth factor receptor inhibitor,,,CHEMBL2095189,Platelet-derived growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:DailyMed, SrcID:setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14",CN(c1ccc2c(C)n(C)nc2c1)c3ccnc(Nc4ccc(C)c(c4)S(=O)(=O)N)n3,,
273,CHEMBL1201584,Abciximab,Antibody,1993.0,B01AC13,B01AC13 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Platelet aggregation inhibitors excl. heparin],-mab,Integrin alpha-V/beta-3 inhibitor,,,CHEMBL1907598,Integrin alpha-V/beta-3,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,Integrin beta-3 subunit,Beta subunit is binding site,"Name:DailyMed, SrcID:setid=033d4c3b-4630-4256-b8f7-9ed5f15de9a3, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=033d4c3b-4630-4256-b8f7-9ed5f15de9a3|Name:PubMed, SrcID:10708709, URL:http://europepmc.org/abstract/MED/10708709",,,
274,CHEMBL822,Terbinafine,Small molecule,1992.0,D01AE15; D01BA02,D01AE15 [DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Other antifungals for topical use]; D01BA02 [DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR SYSTEMIC USE: Antifungals for systemic use],,Squalene monooxygenase inhibitor,,,CHEMBL2364679,Squalene monooxygenase,INHIBITOR,Trichophyton,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2012/020539s021lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020539s021lbl.pdf",CN(C\C=C\C#CC(C)(C)C)Cc1cccc2ccccc12,,
275,CHEMBL781,Mazindol,Small molecule,1973.0,A08AA05,"A08AA05 [ALIMENTARY TRACT AND METABOLISM: ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS: ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS: Centrally acting antiobesity products]",,Monoamine transporter inhibitor,,,CHEMBL2363064,Monoamine transporter,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:16767304, URL:http://europepmc.org/abstract/MED/16767304",OC1(N2CCN=C2c3ccccc13)c4ccc(Cl)cc4,,
276,CHEMBL661,Alprazolam,Small molecule,1981.0,N05BA12,N05BA12 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:14978513, URL:http://europepmc.org/abstract/MED/14978513|Name:PubMed, SrcID:18384456, URL:http://europepmc.org/abstract/MED/18384456|Name:Wikipedia, SrcID:Alprazolam, URL:http://en.wikipedia.org/wiki/Alprazolam",Cc1nnc2CN=C(c3ccccc3)c4cc(Cl)ccc4n12,CHEMBL2093872,GABRG3
277,CHEMBL661,Alprazolam,Small molecule,1981.0,N05BA12,N05BA12 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:14978513, URL:http://europepmc.org/abstract/MED/14978513|Name:PubMed, SrcID:18384456, URL:http://europepmc.org/abstract/MED/18384456|Name:Wikipedia, SrcID:Alprazolam, URL:http://en.wikipedia.org/wiki/Alprazolam",Cc1nnc2CN=C(c3ccccc3)c4cc(Cl)ccc4n12,CHEMBL2093872,GABRP
278,CHEMBL661,Alprazolam,Small molecule,1981.0,N05BA12,N05BA12 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:14978513, URL:http://europepmc.org/abstract/MED/14978513|Name:PubMed, SrcID:18384456, URL:http://europepmc.org/abstract/MED/18384456|Name:Wikipedia, SrcID:Alprazolam, URL:http://en.wikipedia.org/wiki/Alprazolam",Cc1nnc2CN=C(c3ccccc3)c4cc(Cl)ccc4n12,CHEMBL2093872,GABRE
279,CHEMBL661,Alprazolam,Small molecule,1981.0,N05BA12,N05BA12 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:14978513, URL:http://europepmc.org/abstract/MED/14978513|Name:PubMed, SrcID:18384456, URL:http://europepmc.org/abstract/MED/18384456|Name:Wikipedia, SrcID:Alprazolam, URL:http://en.wikipedia.org/wiki/Alprazolam",Cc1nnc2CN=C(c3ccccc3)c4cc(Cl)ccc4n12,CHEMBL2093872,GABRG1
280,CHEMBL220492,Topiramate,Small molecule,1996.0,N03AX11,N03AX11 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],,GABA-A receptor; anion channel positive modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:DailyMed, SrcID:setid=21628112-0c47-11df-95b3-498d55d89593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=21628112-0c47-11df-95b3-498d55d89593#nlm34090-1|Name:PubMed, SrcID:10768292, URL:http://europepmc.org/abstract/MED/10768292",CC1(C)O[C@@H]2CO[C@@]3(COS(=O)(=O)N)OC(C)(C)O[C@H]3[C@@H]2O1,CHEMBL2093872,GABRG3
281,CHEMBL220492,Topiramate,Small molecule,1996.0,N03AX11,N03AX11 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],,GABA-A receptor; anion channel positive modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:DailyMed, SrcID:setid=21628112-0c47-11df-95b3-498d55d89593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=21628112-0c47-11df-95b3-498d55d89593#nlm34090-1|Name:PubMed, SrcID:10768292, URL:http://europepmc.org/abstract/MED/10768292",CC1(C)O[C@@H]2CO[C@@]3(COS(=O)(=O)N)OC(C)(C)O[C@H]3[C@@H]2O1,CHEMBL2093872,GABRP
282,CHEMBL220492,Topiramate,Small molecule,1996.0,N03AX11,N03AX11 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],,GABA-A receptor; anion channel positive modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:DailyMed, SrcID:setid=21628112-0c47-11df-95b3-498d55d89593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=21628112-0c47-11df-95b3-498d55d89593#nlm34090-1|Name:PubMed, SrcID:10768292, URL:http://europepmc.org/abstract/MED/10768292",CC1(C)O[C@@H]2CO[C@@]3(COS(=O)(=O)N)OC(C)(C)O[C@H]3[C@@H]2O1,CHEMBL2093872,GABRE
283,CHEMBL220492,Topiramate,Small molecule,1996.0,N03AX11,N03AX11 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],,GABA-A receptor; anion channel positive modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:DailyMed, SrcID:setid=21628112-0c47-11df-95b3-498d55d89593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=21628112-0c47-11df-95b3-498d55d89593#nlm34090-1|Name:PubMed, SrcID:10768292, URL:http://europepmc.org/abstract/MED/10768292",CC1(C)O[C@@H]2CO[C@@]3(COS(=O)(=O)N)OC(C)(C)O[C@H]3[C@@H]2O1,CHEMBL2093872,GABRG1
284,CHEMBL1201224,Cefmenoxime,Small molecule,1987.0,J01DD05,J01DD05 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Third-generation cephalosporins],cef-,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:PubMed, SrcID:6941742, URL:http://europepmc.org/abstract/MED/6941742",CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)CSc3nnnn3C)\c4csc(N)n4,,
285,CHEMBL1359,Ertapenem,Small molecule,2001.0,J01DH03,J01DH03 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Carbapenems],-penem,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=33f3b99b-fa82-42e0-26bf-f49891ae3d22, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=33f3b99b-fa82-42e0-26bf-f49891ae3d22",C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(=C(N2C1=O)C(=O)O)S[C@@H]3CN[C@@H](C3)C(=O)Nc4cccc(c4)C(=O)O,,
286,CHEMBL3184512,Clindamycin Phosphate,Small molecule,1972.0,D10AF51,D10AF51 [DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Antiinfectives for treatment of acne],-mycin,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,23S ribosomal RNA,23S RRNA,"Name:DailyMed, SrcID:setid=b225ab20-bc7c-43af-ae93-0f07d5948e1c#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b225ab20-bc7c-43af-ae93-0f07d5948e1c#nlm34090-1|Name:Wikipedia, SrcID:Lincosamides, URL:http://en.wikipedia.org/wiki/Lincosamides|Name:Wikipedia, SrcID:Clindamycin, URL:http://en.wikipedia.org/wiki/Clindamycin|Name:PubMed, SrcID:12860123, URL:http://europepmc.org/abstract/MED/12860123",CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](OP(=O)(O)O)[C@@H](O)[C@H]2O,,
287,CHEMBL376140,Tigecycline,Small molecule,2005.0,J01AA12,J01AA12 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: TETRACYCLINES: Tetracyclines],-cycline,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,16S ribosomal RNA,16s RRNA,"Name:DailyMed, SrcID:setid=2ccdb48e-c14a-4eeb-348c-4920ccfd7465, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2ccdb48e-c14a-4eeb-348c-4920ccfd7465",CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(cc(NC(=O)CNC(C)(C)C)c(O)c4C(=O)C3=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N)N(C)C,,
288,CHEMBL1440,Tetracycline,Small molecule,1953.0,S03AA02; S02AA08; J01AA07; D06AA04; A01AB13; S01AA09,S03AA02 [SENSORY ORGANS: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS: ANTIINFECTIVES: Antiinfectives]; S02AA08 [SENSORY ORGANS: OTOLOGICALS: ANTIINFECTIVES: Antiinfectives]; J01AA07 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: TETRACYCLINES: Tetracyclines]; D06AA04 [DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: ANTIBIOTICS FOR TOPICAL USE: Tetracycline and derivatives]; A01AB13 [ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Antiinfectives and antiseptics for local oral treatment]; S01AA09 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Antibiotics],-cycline,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,16S ribosomal RNA,16s RRNA,"Name:Wikipedia, SrcID:Tetracycline#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Tetracycline#Mechanism_of_action|Name:FDA, SrcID:label/2012/050719s017s020lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050719s017s020lbl.pdf|Name:PubMed, SrcID:15141029, URL:http://europepmc.org/abstract/MED/15141029",CN(C)[C@H]1[C@@H]2C[C@H]3C(=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N)C(=O)c4c(O)cccc4[C@@]3(C)O,,
289,CHEMBL1200394,Ethanolamine Oleate,Small molecule,1988.0,,,,Calcium chelating agent,,,CHEMBL2364030,Calcium,CHELATING AGENT,null,METAL,,,"Name:PubMed, SrcID:3828735, URL:http://europepmc.org/abstract/MED/3828735|Name:DailyMed, SrcID:setid=a9c1d8c5-443e-400e-a42c-16a25fb47231#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a9c1d8c5-443e-400e-a42c-16a25fb47231#nlm34090-1",CCCCCCCC\C=C/CCCCCCC(N)(CO)C(=O)O,,
290,CHEMBL88,Cyclophosphamide,Small molecule,1959.0,,,,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=367b47d7-c4de-4b39-bd3a-69c29d80396f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=367b47d7-c4de-4b39-bd3a-69c29d80396f",ClCCN(CCCl)P1(=O)NCCCO1,,
291,CHEMBL178,Daunorubicin,Small molecule,1979.0,L01DB02,L01DB02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES: Anthracyclines and related substances],-rubicin,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:archiveid=69731, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=69731|Name:DailyMed, SrcID:setid=326cd915-5d90-46a5-9a27-af39b9ced7cc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=326cd915-5d90-46a5-9a27-af39b9ced7cc|Name:Wikipedia, SrcID:Daunorubicin, URL:http://en.wikipedia.org/wiki/Daunorubicin|Name:DailyMed, SrcID:archiveid=215669, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=215669",COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)C,,
292,CHEMBL940,Gabapentin,Small molecule,1993.0,N03AX12,N03AX12 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:PubMed, SrcID:18299583, URL:http://europepmc.org/abstract/MED/18299583|Name:Wikipedia, SrcID:Gabapentin, URL:http://en.wikipedia.org/wiki/Gabapentin|Name:FDA, SrcID:label/2012/022544s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022544s008lbl.pdf|Name:ISBN, SrcID:0-12-184453-6 PP. 124, URL:http://www.isbnsearch.org/isbn/0121844536",NCC1(CC(=O)O)CCCCC1,CHEMBL2363032,CACNB3
293,CHEMBL940,Gabapentin,Small molecule,1993.0,N03AX12,N03AX12 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:PubMed, SrcID:18299583, URL:http://europepmc.org/abstract/MED/18299583|Name:Wikipedia, SrcID:Gabapentin, URL:http://en.wikipedia.org/wiki/Gabapentin|Name:FDA, SrcID:label/2012/022544s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022544s008lbl.pdf|Name:ISBN, SrcID:0-12-184453-6 PP. 124, URL:http://www.isbnsearch.org/isbn/0121844536",NCC1(CC(=O)O)CCCCC1,CHEMBL2363032,CACNG3
294,CHEMBL940,Gabapentin,Small molecule,1993.0,N03AX12,N03AX12 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:PubMed, SrcID:18299583, URL:http://europepmc.org/abstract/MED/18299583|Name:Wikipedia, SrcID:Gabapentin, URL:http://en.wikipedia.org/wiki/Gabapentin|Name:FDA, SrcID:label/2012/022544s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022544s008lbl.pdf|Name:ISBN, SrcID:0-12-184453-6 PP. 124, URL:http://www.isbnsearch.org/isbn/0121844536",NCC1(CC(=O)O)CCCCC1,CHEMBL2363032,CACNG5
295,CHEMBL940,Gabapentin,Small molecule,1993.0,N03AX12,N03AX12 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:PubMed, SrcID:18299583, URL:http://europepmc.org/abstract/MED/18299583|Name:Wikipedia, SrcID:Gabapentin, URL:http://en.wikipedia.org/wiki/Gabapentin|Name:FDA, SrcID:label/2012/022544s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022544s008lbl.pdf|Name:ISBN, SrcID:0-12-184453-6 PP. 124, URL:http://www.isbnsearch.org/isbn/0121844536",NCC1(CC(=O)O)CCCCC1,CHEMBL2363032,CACNG4
296,CHEMBL940,Gabapentin,Small molecule,1993.0,N03AX12,N03AX12 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:PubMed, SrcID:18299583, URL:http://europepmc.org/abstract/MED/18299583|Name:Wikipedia, SrcID:Gabapentin, URL:http://en.wikipedia.org/wiki/Gabapentin|Name:FDA, SrcID:label/2012/022544s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022544s008lbl.pdf|Name:ISBN, SrcID:0-12-184453-6 PP. 124, URL:http://www.isbnsearch.org/isbn/0121844536",NCC1(CC(=O)O)CCCCC1,CHEMBL2363032,CACNG1
297,CHEMBL940,Gabapentin,Small molecule,1993.0,N03AX12,N03AX12 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:PubMed, SrcID:18299583, URL:http://europepmc.org/abstract/MED/18299583|Name:Wikipedia, SrcID:Gabapentin, URL:http://en.wikipedia.org/wiki/Gabapentin|Name:FDA, SrcID:label/2012/022544s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022544s008lbl.pdf|Name:ISBN, SrcID:0-12-184453-6 PP. 124, URL:http://www.isbnsearch.org/isbn/0121844536",NCC1(CC(=O)O)CCCCC1,CHEMBL2363032,CACNB4
298,CHEMBL940,Gabapentin,Small molecule,1993.0,N03AX12,N03AX12 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:PubMed, SrcID:18299583, URL:http://europepmc.org/abstract/MED/18299583|Name:Wikipedia, SrcID:Gabapentin, URL:http://en.wikipedia.org/wiki/Gabapentin|Name:FDA, SrcID:label/2012/022544s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022544s008lbl.pdf|Name:ISBN, SrcID:0-12-184453-6 PP. 124, URL:http://www.isbnsearch.org/isbn/0121844536",NCC1(CC(=O)O)CCCCC1,CHEMBL2363032,CACNA2D4
299,CHEMBL940,Gabapentin,Small molecule,1993.0,N03AX12,N03AX12 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:PubMed, SrcID:18299583, URL:http://europepmc.org/abstract/MED/18299583|Name:Wikipedia, SrcID:Gabapentin, URL:http://en.wikipedia.org/wiki/Gabapentin|Name:FDA, SrcID:label/2012/022544s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022544s008lbl.pdf|Name:ISBN, SrcID:0-12-184453-6 PP. 124, URL:http://www.isbnsearch.org/isbn/0121844536",NCC1(CC(=O)O)CCCCC1,CHEMBL2363032,CACNG2
300,CHEMBL940,Gabapentin,Small molecule,1993.0,N03AX12,N03AX12 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:PubMed, SrcID:18299583, URL:http://europepmc.org/abstract/MED/18299583|Name:Wikipedia, SrcID:Gabapentin, URL:http://en.wikipedia.org/wiki/Gabapentin|Name:FDA, SrcID:label/2012/022544s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022544s008lbl.pdf|Name:ISBN, SrcID:0-12-184453-6 PP. 124, URL:http://www.isbnsearch.org/isbn/0121844536",NCC1(CC(=O)O)CCCCC1,CHEMBL2363032,CACNG7
301,CHEMBL940,Gabapentin,Small molecule,1993.0,N03AX12,N03AX12 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:PubMed, SrcID:18299583, URL:http://europepmc.org/abstract/MED/18299583|Name:Wikipedia, SrcID:Gabapentin, URL:http://en.wikipedia.org/wiki/Gabapentin|Name:FDA, SrcID:label/2012/022544s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022544s008lbl.pdf|Name:ISBN, SrcID:0-12-184453-6 PP. 124, URL:http://www.isbnsearch.org/isbn/0121844536",NCC1(CC(=O)O)CCCCC1,CHEMBL2363032,CACNG8
302,CHEMBL940,Gabapentin,Small molecule,1993.0,N03AX12,N03AX12 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:PubMed, SrcID:18299583, URL:http://europepmc.org/abstract/MED/18299583|Name:Wikipedia, SrcID:Gabapentin, URL:http://en.wikipedia.org/wiki/Gabapentin|Name:FDA, SrcID:label/2012/022544s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022544s008lbl.pdf|Name:ISBN, SrcID:0-12-184453-6 PP. 124, URL:http://www.isbnsearch.org/isbn/0121844536",NCC1(CC(=O)O)CCCCC1,CHEMBL2363032,CACNG6
303,CHEMBL940,Gabapentin,Small molecule,1993.0,N03AX12,N03AX12 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:PubMed, SrcID:18299583, URL:http://europepmc.org/abstract/MED/18299583|Name:Wikipedia, SrcID:Gabapentin, URL:http://en.wikipedia.org/wiki/Gabapentin|Name:FDA, SrcID:label/2012/022544s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022544s008lbl.pdf|Name:ISBN, SrcID:0-12-184453-6 PP. 124, URL:http://www.isbnsearch.org/isbn/0121844536",NCC1(CC(=O)O)CCCCC1,CHEMBL2363032,CACNA1F
304,CHEMBL940,Gabapentin,Small molecule,1993.0,N03AX12,N03AX12 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:PubMed, SrcID:18299583, URL:http://europepmc.org/abstract/MED/18299583|Name:Wikipedia, SrcID:Gabapentin, URL:http://en.wikipedia.org/wiki/Gabapentin|Name:FDA, SrcID:label/2012/022544s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022544s008lbl.pdf|Name:ISBN, SrcID:0-12-184453-6 PP. 124, URL:http://www.isbnsearch.org/isbn/0121844536",NCC1(CC(=O)O)CCCCC1,CHEMBL2363032,CACNB1
305,CHEMBL940,Gabapentin,Small molecule,1993.0,N03AX12,N03AX12 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:PubMed, SrcID:18299583, URL:http://europepmc.org/abstract/MED/18299583|Name:Wikipedia, SrcID:Gabapentin, URL:http://en.wikipedia.org/wiki/Gabapentin|Name:FDA, SrcID:label/2012/022544s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022544s008lbl.pdf|Name:ISBN, SrcID:0-12-184453-6 PP. 124, URL:http://www.isbnsearch.org/isbn/0121844536",NCC1(CC(=O)O)CCCCC1,CHEMBL2363032,CACNA2D3
306,CHEMBL1200694,Sevoflurane,Small molecule,1995.0,N01AB08,"N01AB08 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,Potassium channel subfamily K member 18 opener,,,CHEMBL2331042,Potassium channel subfamily K member 18,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:22226507, URL:http://europepmc.org/abstract/MED/22226507|Name:PubMed, SrcID:21788314, URL:http://europepmc.org/abstract/MED/21788314",FCOC(C(F)(F)F)C(F)(F)F,CHEMBL2331042,KCNK18
307,CHEMBL2221312,Gadoxetic Acid,Small molecule,2008.0,V08CA10,V08CA10 [VARIOUS: CONTRAST MEDIA: MAGNETIC RESONANCE IMAGING CONTRAST MEDIA: Paramagnetic contrast media],gado-,Unknown,,,,,,,,,,"Name:FDA, SrcID:label/2011/022090s005lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022090s005lbl.pdf",,,
308,CHEMBL1756,Estramustine Phosphate,Small molecule,1981.0,,,estr-; -mustine,DNA inhibitor,Nitogen mustard component is DNA alkylating agent,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=a9b01bc6-95ac-46f9-befa-d845a74d53c1#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a9b01bc6-95ac-46f9-befa-d845a74d53c1#nlm34090-1|Name:PubMed, SrcID:14755680, URL:http://europepmc.org/abstract/MED/14755680",C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)[C@@H]1CC[C@@H]2OP(=O)(O)O,,
309,CHEMBL3545179,Azd-7451,Small molecule,,,,,Neurotrophic tyrosine kinase receptor type 2 inhibitor,,,CHEMBL4898,Neurotrophic tyrosine kinase receptor type 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25054037, URL:http://europepmc.org/abstract/MED/25054037|Name:PubMed, SrcID:23027130, URL:http://europepmc.org/abstract/MED/23027130",,CHEMBL4898,NTRK2
310,CHEMBL296468,Bms-387032,Small molecule,,,,,Cyclin-dependent kinase 2 inhibitor,,,CHEMBL301,Cyclin-dependent kinase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25215591, URL:http://europepmc.org/abstract/MED/25215591|Name:PubMed, SrcID:19169685, URL:http://europepmc.org/abstract/MED/19169685",CC(C)(C)c1oc(CSc2cnc(NC(=O)C3CCNCC3)s2)nc1,CHEMBL301,CDK2
311,CHEMBL3544928,Ono-4059,Small molecule,,,,,Tyrosine-protein kinase BTK inhibitor,,,CHEMBL5251,Tyrosine-protein kinase BTK,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.oncodesign.com/assets/files/posters/2012/ONCODESGIN%20Development%20of%20Bruton's%20Tyrosine%20Kinase%20iinhibitor_AACR%202012.pdf, URL:http://www.oncodesign.com/assets/files/posters/2012/ONCODESGIN%20Development%20of%20Bruton's%20Tyrosine%20Kinase%20iinhibitor_AACR%202012.pdf|Name:PubMed, SrcID:25360238, URL:http://europepmc.org/abstract/MED/25360238",,CHEMBL5251,BTK
312,CHEMBL1258517,Pki-179,Small molecule,,,,,Serine/threonine-protein kinase mTOR inhibitor,ATP-competitive PI3K/mTOR inhibitor,,CHEMBL2842,Serine/threonine-protein kinase mTOR,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20797855, URL:http://europepmc.org/abstract/MED/20797855",O=C(Nc1ccncc1)Nc2ccc(cc2)c3nc(nc(n3)N4C5CCC4COC5)N6CCOCC6,CHEMBL2842,MTOR
313,CHEMBL1944698,Tg-02,Small molecule,,,,,Cyclin-dependent kinase 1 inhibitor,,,CHEMBL308,Cyclin-dependent kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21860433, URL:http://europepmc.org/abstract/MED/21860433",CN1C\C=C\CCOc2cccc(c2)c3ccnc(Nc4cccc(C1)c4)n3,CHEMBL308,CDK1
314,CHEMBL3545145,Wx-554,Small molecule,,,,,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,,,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23587417, URL:http://europepmc.org/abstract/MED/23587417|Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=732484, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=732484",,CHEMBL2964,MAP2K2
315,CHEMBL278462,Cipralisant,Small molecule,,,,-isant,Histamine H3 receptor agonist,GT-2331 exhibits differential pharmacology at the H3 receptor depending on which receptor mediated G-protein signalling pathway is examined (functional selectivity). May indicate presence of alternative ligand bound active state receptor conformations.,,CHEMBL264,Histamine H3 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15821027, URL:http://europepmc.org/abstract/MED/15821027|Name:PubMed, SrcID:16316645, URL:http://europepmc.org/abstract/MED/16316645|Name:PubMed, SrcID:9721022, URL:http://europepmc.org/abstract/MED/9721022",CC(C)(C)CCC#C[C@@H]1C[C@H]1c2c[nH]cn2,CHEMBL264,HRH3
316,CHEMBL2107832,Pimasertib,Small molecule,,,,-sertib,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,,,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20331454, URL:http://europepmc.org/abstract/MED/20331454|Name:Other, SrcID:http://cancerres.aacrjournals.org/content/69/9_Supplement/4776.short, URL:http://cancerres.aacrjournals.org/content/69/9_Supplement/4776.short",OC[C@@H](O)CNC(=O)c1ccncc1Nc2ccc(I)cc2F,CHEMBL2964,MAP2K2
317,CHEMBL2408045,Sapitinib,Small molecule,,,,-tinib,Receptor tyrosine-protein kinase erbB-3 inhibitor,,,CHEMBL5838,Receptor tyrosine-protein kinase erbB-3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24900741, URL:http://europepmc.org/abstract/MED/24900741|Name:PubMed, SrcID:20145185, URL:http://europepmc.org/abstract/MED/20145185",CNC(=O)CN1CCC(CC1)Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC,CHEMBL5838,ERBB3
318,CHEMBL3301606,Solcitinib,Small molecule,,,,-tinib,Tyrosine-protein kinase JAK1 inhibitor,,,CHEMBL2835,Tyrosine-protein kinase JAK1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25724932, URL:http://europepmc.org/abstract/MED/25724932|Name:Other, SrcID:http://www.glpg.com/glpg-0778-555, URL:http://www.glpg.com/glpg-0778-555",CC1(C)CN(C1)C(=O)c2ccc(cc2)c3cccc4nc(NC(=O)C5CC5)nn34,CHEMBL2835,JAK1
319,CHEMBL3545156,Kw-2450,Small molecule,,,,,Insulin receptor inhibitor,,,CHEMBL1981,Insulin receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1158/1538-7445.AM2013-920, URL:http://cancerres.aacrjournals.org/content/73/8_Supplement/920",,CHEMBL1981,INSR
320,CHEMBL362558,Ly-2090314,Small molecule,,,,,Glycogen synthase kinase-3 beta inhibitor,,,CHEMBL262,Glycogen synthase kinase-3 beta,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23305709, URL:http://europepmc.org/abstract/MED/23305709|Name:PubMed, SrcID:25915038, URL:http://europepmc.org/abstract/MED/25915038",Fc1cc2CN(CCn3cc(C4=C(C(=O)NC4=O)c5cnc6ccccn56)c(c1)c23)C(=O)N7CCCCC7,CHEMBL262,GSK3B
321,CHEMBL3545283,Riviciclib,Small molecule,,,,-ciclib,Cyclin-dependent kinase 4 inhibitor,,,CHEMBL331,Cyclin-dependent kinase 4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25215591, URL:http://europepmc.org/abstract/MED/25215591|Name:PubMed, SrcID:17363486, URL:http://europepmc.org/abstract/MED/17363486",CN1CCC(C1CO)c2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccccc4Cl,CHEMBL331,CDK4
322,CHEMBL2109295,Pf-03446962,Antibody,,,,,Serine/threonine-protein kinase receptor R3 inhibitor,,,CHEMBL5311,Serine/threonine-protein kinase receptor R3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22493445, URL:http://europepmc.org/abstract/MED/22493445",,CHEMBL5311,ACVRL1
323,CHEMBL230011,Tg100-115,Small molecule,,,,,PI3-kinase p110-gamma subunit inhibitor,,,CHEMBL3267,PI3-kinase p110-gamma subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17685602, URL:http://europepmc.org/abstract/MED/17685602",Nc1nc(N)c2nc(c3cccc(O)c3)c(nc2n1)c4cccc(O)c4,CHEMBL3267,PIK3CG
324,CHEMBL1823681,Etilevodopa,Small molecule,,,,-dopa,Dopamine D3 receptor agonist,Ethyl ester prodrug of of levodopa (PMID:16476809).,,CHEMBL234,Dopamine D3 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16476809, URL:http://europepmc.org/abstract/MED/16476809",CCOC(=O)[C@@H](N)Cc1ccc(O)c(O)c1,,
325,CHEMBL2103858,Naronapride,Small molecule,,,,-pride,Serotonin 4 (5-HT4) receptor agonist,"two Ph2 studies terminated, no reason given.",,CHEMBL1875,Serotonin 4 (5-HT4) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17187586, URL:http://europepmc.org/abstract/MED/17187586",CO[C@H]1CN(CCCCCC(=O)O[C@H]2CN3CCC2CC3)CC[C@H]1NC(=O)c4cc(Cl)c(N)cc4OC,CHEMBL1875,HTR4
326,CHEMBL216981,Navarixin,Small molecule,,,,-rixin,Interleukin-8 receptor A antagonist,,,CHEMBL4029,Interleukin-8 receptor A,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17496165, URL:http://europepmc.org/abstract/MED/17496165|Name:PubMed, SrcID:17496166, URL:http://europepmc.org/abstract/MED/17496166",CC[C@@H](NC1=C(Nc2cccc(C(=O)N(C)C)c2O)C(=O)C1=O)c3oc(C)cc3,CHEMBL4029,CXCR1
327,CHEMBL2364638,Ubrogepant,Small molecule,,,,-gepant,Calcitonin gene-related peptide type 1 receptor antagonist,,,CHEMBL3798,Calcitonin gene-related peptide type 1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.allergan.com/news/news/thomson-reuters/allergan-enters-into-licensing-agreement-with-merc, URL:http://www.allergan.com/news/news/thomson-reuters/allergan-enters-into-licensing-agreement-with-merc",C[C@@H]1[C@@H](C[C@H](NC(=O)c2cnc3C[C@]4(Cc3c2)C(=O)Nc5ncccc45)C(=O)N1CC(F)(F)F)c6ccccc6,,
328,CHEMBL3092650,Gsk239512,Small molecule,,,,,Histamine H3 receptor antagonist,,,CHEMBL264,Histamine H3 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24269482, URL:http://europepmc.org/abstract/MED/24269482",O=C1CCCN1c2ccc(Oc3ccc4CCN(CCc4c3)C5CCC5)nc2,CHEMBL264,HRH3
329,CHEMBL567303,Palosuran,Small molecule,,,,-osuran,Urotensin II receptor antagonist,Discontinueddue to lack of efficacy.,,CHEMBL3764,Urotensin II receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15146030, URL:http://europepmc.org/abstract/MED/15146030",Cc1cc(NC(=O)NCCN2CCC(O)(Cc3ccccc3)CC2)c4ccccc4n1,CHEMBL3764,UTS2R
330,CHEMBL329123,Etalocib,Small molecule,,,,,Leukotriene B4 receptor 1 antagonist,,,CHEMBL3911,Leukotriene B4 receptor 1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1155/2008/827096, URL:http://www.hindawi.com/journals/ppar/2008/827096/|Name:PubMed, SrcID:9862783, URL:http://europepmc.org/abstract/MED/9862783|Name:Wikipedia, SrcID:Etalocib, URL:http://en.wikipedia.org/wiki/Etalocib",CCCc1c(OCCCOc2cc(O)c(cc2CC)c3ccc(F)cc3)cccc1Oc4ccccc4C(=O)O,CHEMBL3911,LTB4R
331,CHEMBL3545167,Fe 202767,Protein,,,,,Oxytocin receptor agonist,,,CHEMBL2049,Oxytocin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24874785, URL:http://europepmc.org/abstract/MED/24874785",,CHEMBL2049,OXTR
332,CHEMBL188462,Ispronicline,Small molecule,,,,-nicline,Neuronal acetylcholine receptor; alpha4/beta2 partial agonist,,,CHEMBL1907589,Neuronal acetylcholine receptor; alpha4/beta2,PARTIAL AGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:Wikipedia, SrcID:Ispronicline, URL:http://en.wikipedia.org/wiki/Ispronicline|Name:PubMed, SrcID:15179444, URL:http://europepmc.org/abstract/MED/15179444|Name:Other, SrcID:http://www.jefferies.com/CMSFiles/Jefferies.com/files/Conferences/060214/Presentations/Targacept.pdf, URL:http://www.jefferies.com/CMSFiles/Jefferies.com/files/Conferences/060214/Presentations/Targacept.pdf",CN[C@@H](C)C\C=C\c1cncc(OC(C)C)c1,,
333,CHEMBL2023349,R428,Small molecule,,,,,Tyrosine-protein kinase receptor UFO inhibitor,,,CHEMBL4895,Tyrosine-protein kinase receptor UFO,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20145120, URL:http://europepmc.org/abstract/MED/20145120|Name:Other, SrcID:http://www.bergenbio.com/pipeline/, URL:http://www.bergenbio.com/pipeline/",Nc1nc(Nc2ccc3CCC(CCc3c2)N4CCCC4)nn1c5cc6CCCc7ccccc7c6nn5,,
334,CHEMBL31965,Canertinib,Small molecule,,,,-tinib,Receptor protein-tyrosine kinase erbB-4 inhibitor,Canertinib is an irreversible pan-ErbB tyrosine kinase inhibitor.,,CHEMBL3009,Receptor protein-tyrosine kinase erbB-4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12648472, URL:http://europepmc.org/abstract/MED/12648472|Name:PubMed, SrcID:11706399, URL:http://europepmc.org/abstract/MED/11706399",Fc1ccc(Nc2ncnc3cc(OCCCN4CCOCC4)c(NC(=O)C=C)cc23)cc1Cl,CHEMBL3009,ERBB4
335,CHEMBL1091644,Linsitinib,Small molecule,,,,-tinib,Insulin receptor inhibitor,,,CHEMBL1981,Insulin receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25208878, URL:http://europepmc.org/abstract/MED/25208878|Name:PubMed, SrcID:21425998, URL:http://europepmc.org/abstract/MED/21425998|Name:PubMed, SrcID:17671083, URL:http://europepmc.org/abstract/MED/17671083",C[C@@]1(O)C[C@@H](C1)c2nc(c3ccc4ccc(nc4c3)c5ccccc5)c6c(N)nccn26,CHEMBL1981,INSR
336,CHEMBL2035187,Pacritinib,Small molecule,,,,-tinib,Tyrosine-protein kinase JAK2 inhibitor,,,CHEMBL2971,Tyrosine-protein kinase JAK2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22829080, URL:http://europepmc.org/abstract/MED/22829080|Name:PubMed, SrcID:22339472, URL:http://europepmc.org/abstract/MED/22339472|Name:Other, SrcID:http://www.ctibiopharma.com/pipeline/pacritinib/, URL:http://www.ctibiopharma.com/pipeline/pacritinib/|Name:PubMed, SrcID:21604762, URL:http://europepmc.org/abstract/MED/21604762",C(CN1CCCC1)Oc2ccc3Nc4nccc(n4)c5cccc(COC\C=C\COCc2c3)c5,CHEMBL2971,JAK2
337,CHEMBL405821,Senicapoc,Small molecule,,,,-capoc,Intermediate conductance calcium-activated potassium channel protein 4 blocker,,,CHEMBL4305,Intermediate conductance calcium-activated potassium channel protein 4,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18192510, URL:http://europepmc.org/abstract/MED/18192510|Name:PubMed, SrcID:23121096, URL:http://europepmc.org/abstract/MED/23121096",NC(=O)C(c1ccccc1)(c2ccc(F)cc2)c3ccc(F)cc3,CHEMBL4305,KCNN4
338,CHEMBL312443,Gaboxadol,Small molecule,,,,-adol,GABA-A receptor; agonist GABA site agonist,Potent agonist at alpha4beta3delta-containing receptors.,,CHEMBL2109244,GABA-A receptor; agonist GABA site,AGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:12706454, URL:http://europepmc.org/abstract/MED/12706454|Name:PubMed, SrcID:15451401, URL:http://europepmc.org/abstract/MED/15451401",Oc1noc2CNCCc12,,
339,CHEMBL1201341,Echothiophate,Small molecule,1960.0,S01EB03,S01EB03 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Parasympathomimetics],,Acetylcholinesterase inhibitor,Irreversible,,CHEMBL220,Acetylcholinesterase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Cholinesterase, URL:http://en.wikipedia.org/wiki/Cholinesterase|Name:FDA, SrcID:label/2006/011963s034lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/011963s034lbl.pdf|Name:DailyMed, SrcID:setid=c4adbc81-6681-4e12-f8ab-5d1cb7723aad#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4adbc81-6681-4e12-f8ab-5d1cb7723aad#nlm34090-1",CCOP(=O)(OCC)SCC[N+](C)(C)C,CHEMBL220,ACHE
340,CHEMBL2108727,Talimogene Laherparepvec,Unknown,,L01XX51,L01XX51 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],,Melanoma cells disrupting agent,Causes lysis of tumour cells.,,CHEMBL614126,Melanoma cells,DISRUPTING AGENT,Homo sapiens,CELL-LINE,,,"Name:Other, SrcID:https://www.fda.gov/downloads/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/UCM469575.pdf, URL:https://www.fda.gov/downloads/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/UCM469575.pdf",,,
341,CHEMBL2105467,Tezacitabine,Small molecule,,,,-citabine,Ribonucleoside-diphosphate reductase RR1 inhibitor,"Irreversible ribonucleotide reductase inhibitor and DNA chain terminator. Phosphorylated by cellular kinases, tezacitabine is converted into its active diphosphate and triphosphate metabolites.",,CHEMBL2095215,Ribonucleoside-diphosphate reductase RR1,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:8137252, URL:http://europepmc.org/abstract/MED/8137252|Name:PubMed, SrcID:8549673, URL:http://europepmc.org/abstract/MED/8549673",NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)/C/2=C\F,,
342,CHEMBL2304041,Sagopilone,Small molecule,,,,-opilone,Tubulin stabiliser,,,CHEMBL2095182,Tubulin,STABILISER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:21964003, URL:http://europepmc.org/abstract/MED/21964003",C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](CC=C)[C@H]1O)c3ccc4sc(C)nc4c3,CHEMBL2095182,TUBB8
343,CHEMBL2304041,Sagopilone,Small molecule,,,,-opilone,Tubulin stabiliser,,,CHEMBL2095182,Tubulin,STABILISER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:21964003, URL:http://europepmc.org/abstract/MED/21964003",C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](CC=C)[C@H]1O)c3ccc4sc(C)nc4c3,CHEMBL2095182,TUBA3C
344,CHEMBL2304041,Sagopilone,Small molecule,,,,-opilone,Tubulin stabiliser,,,CHEMBL2095182,Tubulin,STABILISER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:21964003, URL:http://europepmc.org/abstract/MED/21964003",C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](CC=C)[C@H]1O)c3ccc4sc(C)nc4c3,CHEMBL2095182,TUBA4A
345,CHEMBL2304041,Sagopilone,Small molecule,,,,-opilone,Tubulin stabiliser,,,CHEMBL2095182,Tubulin,STABILISER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:21964003, URL:http://europepmc.org/abstract/MED/21964003",C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](CC=C)[C@H]1O)c3ccc4sc(C)nc4c3,CHEMBL2095182,TUBA3E
346,CHEMBL2304041,Sagopilone,Small molecule,,,,-opilone,Tubulin stabiliser,,,CHEMBL2095182,Tubulin,STABILISER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:21964003, URL:http://europepmc.org/abstract/MED/21964003",C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](CC=C)[C@H]1O)c3ccc4sc(C)nc4c3,CHEMBL2095182,TUBB6
347,CHEMBL2304041,Sagopilone,Small molecule,,,,-opilone,Tubulin stabiliser,,,CHEMBL2095182,Tubulin,STABILISER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:21964003, URL:http://europepmc.org/abstract/MED/21964003",C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](CC=C)[C@H]1O)c3ccc4sc(C)nc4c3,CHEMBL2095182,TUBB2B
348,CHEMBL2304041,Sagopilone,Small molecule,,,,-opilone,Tubulin stabiliser,,,CHEMBL2095182,Tubulin,STABILISER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:21964003, URL:http://europepmc.org/abstract/MED/21964003",C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](CC=C)[C@H]1O)c3ccc4sc(C)nc4c3,CHEMBL2095182,TUBA3D
349,CHEMBL2364624,Pradigastat,Small molecule,,,,-stat,Diacylglycerol O-acyltransferase 1 inhibitor,,,CHEMBL6009,Diacylglycerol O-acyltransferase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25854859, URL:http://europepmc.org/abstract/MED/25854859|Name:PubMed, SrcID:2588904, URL:http://europepmc.org/abstract/MED/2588904",OC(=O)C[C@@H]1CC[C@H](CC1)c2ccc(cc2)c3ccc(Nc4ccc(nc4)C(F)(F)F)cn3,CHEMBL6009,DGAT1
350,CHEMBL484785,Crisaborole,Small molecule,2016.0,,,,Phosphodiesterase 4 inhibitor,,,CHEMBL2093863,Phosphodiesterase 4,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19303290, URL:http://europepmc.org/abstract/MED/19303290|Name:PubMed, SrcID:26461821, URL:http://europepmc.org/abstract/MED/26461821",OB1OCc2cc(Oc3ccc(cc3)C#N)ccc12,,
351,CHEMBL1742986,Atacicept,Protein,,,,-cept,Tumor necrosis factor ligand superfamily member 13B inhibitor,"It has high affinity and specificity for cytokines BLyS and APRIL, preventing receptor binding. Three receptors, TACI, BCMA (B-cell maturation antigen) and BAFF-R, have been identified that have unique binding affinities for BLyS and APRIL (PMID: 10898980).",,CHEMBL2364158,Tumor necrosis factor ligand superfamily member 13B,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21179612, URL:http://europepmc.org/abstract/MED/21179612|Name:PubMed, SrcID:18046446, URL:http://europepmc.org/abstract/MED/18046446",,CHEMBL2364158,TNFSF13B
352,CHEMBL1743076,Tadocizumab,Antibody,,,,-mab,Integrin alpha-IIb/beta-3 antagonist,,,CHEMBL2093869,Integrin alpha-IIb/beta-3,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:12919181, URL:http://europepmc.org/abstract/MED/12919181|Name:PubMed, SrcID:12186399, URL:http://europepmc.org/abstract/MED/12186399|Name:PubMed, SrcID:9600636, URL:http://europepmc.org/abstract/MED/9600636",,,
353,CHEMBL3833321,Ban2401,Antibody,,,,,Beta amyloid A4 protein inhibitor,,selectively binds soluble amyloid ? (A?) protofibrils,CHEMBL2487,Beta amyloid A4 protein,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25031633, URL:http://europepmc.org/abstract/MED/25031633",,CHEMBL2487,APP
354,CHEMBL3545087,Gsk159802,Small molecule,,,,,Beta-2 adrenergic receptor agonist,,,CHEMBL210,Beta-2 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,,,CHEMBL210,ADRB2
355,CHEMBL1200826,Lithium Carbonate,Small molecule,1970.0,N05AN01,N05AN01 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Lithium],,Inositol-1(or 4)-monophosphatase 1 inhibitor,,,CHEMBL1786,Inositol-1(or 4)-monophosphatase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=84d579dd-f12b-b727-6380-fd217ec115db#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=84d579dd-f12b-b727-6380-fd217ec115db#nlm34090-1|Name:FDA, SrcID:label/2011/018027s056lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018027s056lbl.pdf|Name:PubMed, SrcID:22707923, URL:http://europepmc.org/abstract/MED/22707923|Name:Wikipedia, SrcID:Lithium_(medication), URL:http://en.wikipedia.org/wiki/Lithium_(medication)",[Li+].[Li+].[O-]C(=O)[O-],CHEMBL1786,IMPA1
356,CHEMBL577,Enalaprilat,Small molecule,1988.0,,,-prilat,Angiotensin-converting enzyme inhibitor,,,CHEMBL1808,Angiotensin-converting enzyme,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2010/075458s007lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/075458s007lbl.pdf|Name:DailyMed, SrcID:setid=be308a70-2d5f-4e11-9cfa-66c47067540e#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=be308a70-2d5f-4e11-9cfa-66c47067540e#nlm34090-1",C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N2CCC[C@H]2C(=O)O,CHEMBL1808,ACE
357,CHEMBL431,Spirapril,Small molecule,1994.0,C09AA11,"C09AA11 [CARDIOVASCULAR SYSTEM: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM: ACE INHIBITORS, PLAIN: ACE inhibitors, plain]",-pril,Angiotensin-converting enzyme inhibitor,,,CHEMBL1808,Angiotensin-converting enzyme,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16126915, URL:http://europepmc.org/abstract/MED/16126915",CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2CC3(C[C@H]2C(=O)O)SCCS3,CHEMBL1808,ACE
358,CHEMBL813,Eprosartan,Small molecule,1997.0,C09CA02,"C09CA02 [CARDIOVASCULAR SYSTEM: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM: ANGIOTENSIN II ANTAGONISTS, PLAIN: Angiotensin II antagonists, plain]",-sartan,Type-1 angiotensin II receptor antagonist,,,CHEMBL227,Type-1 angiotensin II receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=7cde57a7-eded-4c22-b1c7-98afc5546997, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7cde57a7-eded-4c22-b1c7-98afc5546997|Name:FDA, SrcID:label/2014/020738s029lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020738s029lbl.pdf",CCCCc1ncc(\C=C(/Cc2cccs2)\C(=O)O)n1Cc3ccc(cc3)C(=O)O,CHEMBL227,AGTR1
359,CHEMBL1148,Torsemide,Small molecule,1993.0,C03CA04,"C03CA04 [CARDIOVASCULAR SYSTEM: DIURETICS: HIGH-CEILING DIURETICS: Sulfonamides, plain]",-semide,Sodium-(potassium)-chloride cotransporter 2 inhibitor,,,CHEMBL1874,Sodium-(potassium)-chloride cotransporter 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=01b388a0-7dfb-11de-bc4e-0002a5d5c51b, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=01b388a0-7dfb-11de-bc4e-0002a5d5c51b",CC(C)NC(=O)NS(=O)(=O)c1cnccc1Nc2cccc(C)c2,CHEMBL1874,SLC12A1
360,CHEMBL2368925,Dolasetron,Small molecule,1997.0,A04AA04,A04AA04 [ALIMENTARY TRACT AND METABOLISM: ANTIEMETICS AND ANTINAUSEANTS: ANTIEMETICS AND ANTINAUSEANTS: Serotonin (5HT3) antagonists],-setron,Serotonin 3a (5-HT3a) receptor antagonist,,Selective,CHEMBL1899,Serotonin 3a (5-HT3a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=6600dfea-fcf2-4f89-ab45-66282dee969f#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6600dfea-fcf2-4f89-ab45-66282dee969f#nlm34090-1",O=C(O[C@@H]1C[C@@H]2C[C@H]3C[C@H](C1)N2CC3=O)c4c[nH]c5ccccc45,CHEMBL1899,HTR3A
361,CHEMBL549,Citalopram,Small molecule,1998.0,N06AB04,N06AB04 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Selective serotonin reuptake inhibitors],,Serotonin transporter inhibitor,reuptake inhibitor,,CHEMBL228,Serotonin transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Selective_serotonin_reuptake_inhibitor, URL:http://en.wikipedia.org/wiki/Selective_serotonin_reuptake_inhibitor|Name:Wikipedia, SrcID:Citalopram, URL:http://en.wikipedia.org/wiki/Citalopram|Name:FDA, SrcID:label/2012/020822s043lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020822s043lbl.pdf",CN(C)CCCC1(OCc2cc(ccc12)C#N)c3ccc(F)cc3,CHEMBL228,SLC6A4
362,CHEMBL3039583,Pasireotide,Protein,2012.0,H01CB05,"H01CB05 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: HYPOTHALAMIC HORMONES: Somatostatin and analogues]",-tide,Somatostatin receptor 1 agonist,,Non-selective but type 5 receptor is overexpressed in Cushing's disease,CHEMBL1917,Somatostatin receptor 1,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=5504116c-d531-4d47-b160-41c6671d52aa, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5504116c-d531-4d47-b160-41c6671d52aa|Name:DailyMed, SrcID:setid=442f0d9d-5c7d-4b81-b329-d71be8cf2be2, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=442f0d9d-5c7d-4b81-b329-d71be8cf2be2|Name:PubMed, SrcID:22397653, URL:http://europepmc.org/abstract/MED/22397653|Name:PubMed, SrcID:11980628, URL:http://europepmc.org/abstract/MED/11980628",NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](NC(=O)[C@@H]4C[C@@H](CN4C(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](Cc6ccc(OCc7ccccc7)cc6)NC1=O)OC(=O)NCCN)c8ccccc8,CHEMBL1917,SSTR1
363,CHEMBL595,Pioglitazone,Small molecule,1999.0,A10BG03,"A10BG03 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Thiazolidinediones]",-glitazone,Peroxisome proliferator-activated receptor gamma agonist,,,CHEMBL235,Peroxisome proliferator-activated receptor gamma,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=d2ddc491-88a9-4063-9150-443b4fa4330c, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d2ddc491-88a9-4063-9150-443b4fa4330c",CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,CHEMBL235,PPARG
364,CHEMBL1201323,Betazole,Small molecule,1982.0,V04CG02,V04CG02 [VARIOUS: DIAGNOSTIC AGENTS: OTHER DIAGNOSTIC AGENTS: Tests for gastric secretion],,Histamine H2 receptor agonist,,,CHEMBL1941,Histamine H2 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:3661710, URL:http://europepmc.org/abstract/MED/3661710|Name:ISBN, SrcID:9780702034718 PP. 363, URL:http://www.isbnsearch.org/isbn/9780702034718",NCCc1cc[nH]n1,CHEMBL1941,HRH2
365,CHEMBL49,Buspirone,Small molecule,1986.0,N05BE01,N05BE01 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Azaspirodecanedione derivatives],-spirone,Serotonin 1a (5-HT1a) receptor partial agonist,,,CHEMBL214,Serotonin 1a (5-HT1a) receptor,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2010/018731s051lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018731s051lbl.pdf|Name:Wikipedia, SrcID:Buspirone, URL:http://en.wikipedia.org/wiki/Buspirone",O=C1CC2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)c4ncccn4,CHEMBL214,HTR1A
366,CHEMBL1201634,Insulin Zinc Susp Purified Beef/Pork,Protein,1982.0,,,,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/022472s006s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022472s006s008lbl.pdf|Name:DailyMed, SrcID:setid=457531f0-9331-47fe-90b5-b31f284044dc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=457531f0-9331-47fe-90b5-b31f284044dc",,CHEMBL1981,INSR
367,CHEMBL841,Loperamide,Small molecule,1976.0,A07DA03; A07DA53,"A07DA03 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: ANTIPROPULSIVES: Antipropulsives]; A07DA53 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: ANTIPROPULSIVES: Antipropulsives]",,Mu opioid receptor agonist,,,CHEMBL233,Mu opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23022331, URL:http://europepmc.org/abstract/MED/23022331|Name:PubMed, SrcID:10087042, URL:http://europepmc.org/abstract/MED/10087042|Name:DailyMed, SrcID:setid=72a7ae47-cdf3-4949-b9f8-f29b153f787f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=72a7ae47-cdf3-4949-b9f8-f29b153f787f",CN(C)C(=O)C(CCN1CCC(O)(CC1)c2ccc(Cl)cc2)(c3ccccc3)c4ccccc4,CHEMBL233,OPRM1
368,CHEMBL1504,Triamcinolone Acetonide,Small molecule,1960.0,,,-olone,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Corticosteroid, URL:http://en.wikipedia.org/wiki/Corticosteroid|Name:DailyMed, SrcID:setid=dbdc8273-3224-4557-b509-f3cf8ce6ccf8#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dbdc8273-3224-4557-b509-f3cf8ce6ccf8#nlm34090-1|Name:Wikipedia, SrcID:Triamcinolone_acetonide, URL:http://en.wikipedia.org/wiki/Triamcinolone_acetonide",CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,CHEMBL2034,NR3C1
369,CHEMBL1200600,Fluorometholone,Small molecule,1972.0,D07AB06; C05AA06; D07XB04; D10AA01; S01CB05; S01BA07,"D07AB06 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, moderately potent (group II)]; C05AA06 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Corticosteroids]; D07XB04 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, OTHER COMBINATIONS: Corticosteroids, moderately potent, other combinations]; D10AA01 [DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Corticosteroids, combinations for treatment of acne]; S01CB05 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION: Corticosteroids/antiinfectives/mydriatics in combination]; S01BA07 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Corticosteroids, plain]",-olone,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16895953, URL:http://europepmc.org/abstract/MED/16895953|Name:PubMed, SrcID:17038445, URL:http://europepmc.org/abstract/MED/17038445|Name:PubMed, SrcID:17086345, URL:http://europepmc.org/abstract/MED/17086345",C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)C)[C@@]3(C)C[C@H](O)[C@]2(F)[C@@]4(C)C=CC(=O)C=C14,CHEMBL2034,NR3C1
370,CHEMBL887,Rasagiline,Small molecule,2006.0,N04BD02,N04BD02 [NERVOUS SYSTEM: ANTI-PARKINSON DRUGS: DOPAMINERGIC AGENTS: Monoamine oxidase B inhibitors],-giline,Monoamine oxidase B inhibitor,Irreversible inhibitor,,CHEMBL2039,Monoamine oxidase B,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2009/021641s002s003s004s005s007s008s010lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021641s002s003s004s005s007s008s010lbl.pdf",C#CCN[C@@H]1CCc2ccccc12,CHEMBL2039,MAOB
371,CHEMBL1201477,Polyestradiol Phosphate,Small molecule,1957.0,L02AA02,L02AA02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONES AND RELATED AGENTS: Estrogens],-estr-,Estrogen receptor alpha agonist,,,CHEMBL206,Estrogen receptor alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10230677, URL:http://europepmc.org/abstract/MED/10230677",,CHEMBL206,ESR1
372,CHEMBL1201607,Natalizumab,Antibody,2004.0,L04AA23,L04AA23 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Selective immunosuppressants],-mab,Integrin alpha-4/beta-7 inhibitor,,,CHEMBL2095184,Integrin alpha-4/beta-7,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,Integrin alpha-4 subunit,Alpha subunit is binding site,"Name:DailyMed, SrcID:setid=c5fdde91-1989-4dd2-9129-4f3323ea2962, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5fdde91-1989-4dd2-9129-4f3323ea2962",,,
373,CHEMBL472,Glyburide,Small molecule,1984.0,A10BB01,"A10BB01 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Sulfonylureas]",,"Sulfonylurea receptor 1, Kir6.2 blocker",,,CHEMBL2096972,"Sulfonylurea receptor 1, Kir6.2",BLOCKER,Homo sapiens,PROTEIN COMPLEX,,,"Name:DailyMed, SrcID:setid=2d367e16-fc74-4a63-ac6d-85e038164de5, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2d367e16-fc74-4a63-ac6d-85e038164de5|Name:FDA, SrcID:label/2015/020051s021lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020051s021lbl.pdf|Name:Wikipedia, SrcID:Glyburide#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Glyburide#Mechanism_of_action",COc1ccc(Cl)cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3,,
374,CHEMBL184412,Dronedarone,Small molecule,2009.0,C01BD07,"C01BD07 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III]",-arone,Voltage-gated L-type calcium channel blocker,"Dronedarone reported to have antiarrhythmic properties belonging to all four Vaughan-Williams classes, importance of beta adrenergic receptors and calcium channels disputed in PMID: 23647933",,CHEMBL2095229,Voltage-gated L-type calcium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2013/022425s021lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022425s021lbl.pdf|Name:Wikipedia, SrcID:Dronedarone, URL:http://en.wikipedia.org/wiki/Dronedarone|Name:Expert, SrcID:DRONEDARONE, URL:http://chembl.blogspot.co.uk/search?q=DRONEDARONE|Name:PubMed, SrcID:21279331, URL:http://europepmc.org/abstract/MED/21279331",CCCCN(CCCC)CCCOc1ccc(cc1)C(=O)c2c(CCCC)oc3ccc(NS(=O)(=O)C)cc23,,
375,CHEMBL1201288,Dantrolene,Small molecule,1974.0,M03CA01,"M03CA01 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS: Dantrolene and derivatives]",,Ryanodine receptor 3 antagonist,,,CHEMBL2062,Ryanodine receptor 3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15894801, URL:http://europepmc.org/abstract/MED/15894801|Name:PubMed, SrcID:11278295, URL:http://europepmc.org/abstract/MED/11278295",[O-][N+](=O)c1ccc(cc1)c2oc(\C=N\N3CC(=O)NC3=O)cc2,CHEMBL2062,RYR3
376,CHEMBL1200842,Piperazine Citrate,Small molecule,1954.0,,,,Nematode GABA-A receptor positive modulator,,,CHEMBL2364676,Nematode GABA-A receptor,POSITIVE MODULATOR,Onchocercidae,PROTEIN COMPLEX GROUP,,,"Name:ISBN, SrcID:9780702034718 PP. 670, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:13678839, URL:http://europepmc.org/abstract/MED/13678839|Name:Wikipedia, SrcID:Anthelmintic, URL:http://en.wikipedia.org/wiki/Anthelmintic|Name:Wikipedia, SrcID:Piperazine, URL:http://en.wikipedia.org/wiki/Piperazine|Name:PubMed, SrcID:12421359, URL:http://europepmc.org/abstract/MED/12421359",OC(=O)CC(O)(CC(=O)O)C(=O)O.C1CNCCN1,,
377,CHEMBL116,Amprenavir,Small molecule,1999.0,J05AE05,J05AE05 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Protease inhibitors],-vir,Human immunodeficiency virus type 1 protease inhibitor,,,CHEMBL243,Human immunodeficiency virus type 1 protease,INHIBITOR,Human immunodeficiency virus 1,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2005/021007s017lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021007s017lbl.pdf",CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)c3ccc(N)cc3,,
378,CHEMBL1200690,Lypressin,Protein,1982.0,H01BA03,"H01BA03 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: POSTERIOR PITUITARY LOBE HORMONES: Vasopressin and analogues]",-pressin,Vasopressin receptor agonist,,,CHEMBL2363078,Vasopressin receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:ISBN, SrcID:0443-059748 PP. 416, URL:http://www.isbnsearch.org/isbn/0443059748",NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]2CSSC[C@H](N)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N2)C(=O)NCC(=O)N,,
379,CHEMBL455,Sulfacetamide,Small molecule,1945.0,D10AF06; S01AB04,D10AF06 [DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Antiinfectives for treatment of acne]; S01AB04 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Sulfonamides],sulfa-,Bacterial dihydropteroate synthase inhibitor,,Broad spectrum,CHEMBL2364668,Bacterial dihydropteroate synthase,INHIBITOR,Bacteria,SINGLE PROTEIN,,,"Name:PubMed, SrcID:14700578, URL:http://europepmc.org/abstract/MED/14700578|Name:KEGG, SrcID:D05947, URL:http://www.kegg.jp/dbget-bin/www_bget?dr:D05947|Name:PubMed, SrcID:13873645, URL:http://europepmc.org/abstract/MED/13873645",CC(=O)NS(=O)(=O)c1ccc(N)cc1,,
380,CHEMBL1599,Cephapirin,Small molecule,1974.0,J01DB08,J01DB08 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: First-generation cephalosporins],,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:ISBN, SrcID:0-86577-843-4 PP. 270, URL:http://www.isbnsearch.org/isbn/0865778434|Name:DailyMed, SrcID:setid=4e06c554-b4c3-4e83-af97-1389716213a1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4e06c554-b4c3-4e83-af97-1389716213a1",CC(=O)OCC1=C(N2[C@H](SC1)[C@H](NC(=O)CSc3ccncc3)C2=O)C(=O)O,,
381,CHEMBL130,Chloramphenicol,Small molecule,1950.0,J01BA01; D06AX02; S02AA01; S03AA08; G01AA05; S01AA01; D10AF03,"J01BA01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: AMPHENICOLS: Amphenicols]; D06AX02 [DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: ANTIBIOTICS FOR TOPICAL USE: Other antibiotics for topical use]; S02AA01 [SENSORY ORGANS: OTOLOGICALS: ANTIINFECTIVES: Antiinfectives]; S03AA08 [SENSORY ORGANS: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS: ANTIINFECTIVES: Antiinfectives]; G01AA05 [GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Antibiotics]; S01AA01 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Antibiotics]; D10AF03 [DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Antiinfectives for treatment of acne]",,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,23S ribosomal RNA,23S RRNA,"Name:Wikipedia, SrcID:Chloramphenicol, URL:http://en.wikipedia.org/wiki/Chloramphenicol|Name:PubMed, SrcID:6375931, URL:http://europepmc.org/abstract/MED/6375931|Name:PubMed, SrcID:16091044, URL:http://europepmc.org/abstract/MED/16091044",OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc(cc1)[N+](=O)[O-],,
382,CHEMBL427,Mechlorethamine,Small molecule,1949.0,L01AA05,L01AA05 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ALKYLATING AGENTS: Nitrogen mustard analogues],,DNA inhibitor,Alkylating agent,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:FDA, SrcID:label/2004/06695slr031_mustargen_lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/06695slr031_mustargen_lbl.pdf|Name:ISBN, SrcID:9780702034718 PP. 678, URL:http://www.isbnsearch.org/isbn/9780702034718",CN(CCCl)CCCl,,
383,CHEMBL1117,Idarubicin,Small molecule,1990.0,L01DB06,L01DB06 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES: Anthracyclines and related substances],-rubicin,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:Wikipedia, SrcID:Type_II_topoisomerase, URL:http://en.wikipedia.org/wiki/Type_II_topoisomerase|Name:DailyMed, SrcID:setid=0a5a6d93-cc1e-4d7f-8da1-446c134503b3, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0a5a6d93-cc1e-4d7f-8da1-446c134503b3",C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]2C[C@@](O)(Cc3c(O)c4C(=O)c5ccccc5C(=O)c4c(O)c23)C(=O)C,,
384,CHEMBL8,Ciprofloxacin,Small molecule,1987.0,S03AA07; S01AE03; J01MA02; S02AA15,S03AA07 [SENSORY ORGANS: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS: ANTIINFECTIVES: Antiinfectives]; S01AE03 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Fluoroquinolones]; J01MA02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolones]; S02AA15 [SENSORY ORGANS: OTOLOGICALS: ANTIINFECTIVES: Antiinfectives],-oxacin,Bacterial DNA gyrase inhibitor,,,CHEMBL2311224,Bacterial DNA gyrase,INHIBITOR,Bacteria,PROTEIN COMPLEX,,,"Name:FDA, SrcID:label/2009/021918lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021918lbl.pdf",OC(=O)C1=CN(C2CC2)c3cc(N4CCNCC4)c(F)cc3C1=O,,
385,CHEMBL1237021,Lurasidone,Small molecule,2010.0,N05AE05,N05AE05 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Indole derivatives],-sidone,Dopamine D2 receptor antagonist,,,CHEMBL217,Dopamine D2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=88a244d1-eddb-499c-bee2-e1f49056e78f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=88a244d1-eddb-499c-bee2-e1f49056e78f",O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1C[C@@H]4CCCC[C@H]4CN5CCN(CC5)c6nsc7ccccc67,CHEMBL217,DRD2
386,CHEMBL564085,Troleandomycin,Small molecule,1969.0,J01FA08,"J01FA08 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS: Macrolides]",-mycin,70S ribosome inhibitor,"Indicated for Streptococcus pneumoniae, Streptococcus pyogenes, Diplococcus pneumoniae",,CHEMBL2363853,70S ribosome,INHIBITOR,Streptococcus pneumoniae,PROTEIN NUCLEIC-ACID COMPLEX,23S ribosomal RNA,23S RRNA (site A),"Name:KEGG, SrcID:D01322, URL:http://www.kegg.jp/dbget-bin/www_bget?dr:D01322|Name:PubMed, SrcID:6972981, URL:http://europepmc.org/abstract/MED/6972981",CO[C@H]1C[C@H](O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(=O)C)N(C)C)[C@@H](C)C[C@@]4(CO4)C(=O)[C@H](C)[C@@H](OC(=O)C)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1OC(=O)C,,
387,CHEMBL821,Guanidine,Small molecule,1939.0,,,guan-,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:21926190, URL:http://europepmc.org/abstract/MED/21926190|Name:DailyMed, SrcID:setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1",NC(=N)N,CHEMBL2362996,KCNH6
388,CHEMBL821,Guanidine,Small molecule,1939.0,,,guan-,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:21926190, URL:http://europepmc.org/abstract/MED/21926190|Name:DailyMed, SrcID:setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1",NC(=N)N,CHEMBL2362996,KCNF1
389,CHEMBL821,Guanidine,Small molecule,1939.0,,,guan-,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:21926190, URL:http://europepmc.org/abstract/MED/21926190|Name:DailyMed, SrcID:setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1",NC(=N)N,CHEMBL2362996,KCNA7
390,CHEMBL821,Guanidine,Small molecule,1939.0,,,guan-,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:21926190, URL:http://europepmc.org/abstract/MED/21926190|Name:DailyMed, SrcID:setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1",NC(=N)N,CHEMBL2362996,KCND1
391,CHEMBL821,Guanidine,Small molecule,1939.0,,,guan-,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:21926190, URL:http://europepmc.org/abstract/MED/21926190|Name:DailyMed, SrcID:setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1",NC(=N)N,CHEMBL2362996,KCNG1
392,CHEMBL821,Guanidine,Small molecule,1939.0,,,guan-,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:21926190, URL:http://europepmc.org/abstract/MED/21926190|Name:DailyMed, SrcID:setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1",NC(=N)N,CHEMBL2362996,KCNH8
393,CHEMBL821,Guanidine,Small molecule,1939.0,,,guan-,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:21926190, URL:http://europepmc.org/abstract/MED/21926190|Name:DailyMed, SrcID:setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1",NC(=N)N,CHEMBL2362996,KCNG4
394,CHEMBL821,Guanidine,Small molecule,1939.0,,,guan-,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:21926190, URL:http://europepmc.org/abstract/MED/21926190|Name:DailyMed, SrcID:setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1",NC(=N)N,CHEMBL2362996,KCNH7
395,CHEMBL821,Guanidine,Small molecule,1939.0,,,guan-,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:21926190, URL:http://europepmc.org/abstract/MED/21926190|Name:DailyMed, SrcID:setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1",NC(=N)N,CHEMBL2362996,KCNH5
396,CHEMBL821,Guanidine,Small molecule,1939.0,,,guan-,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:21926190, URL:http://europepmc.org/abstract/MED/21926190|Name:DailyMed, SrcID:setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1",NC(=N)N,CHEMBL2362996,KCNC3
397,CHEMBL821,Guanidine,Small molecule,1939.0,,,guan-,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:21926190, URL:http://europepmc.org/abstract/MED/21926190|Name:DailyMed, SrcID:setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1",NC(=N)N,CHEMBL2362996,KCNV1
398,CHEMBL821,Guanidine,Small molecule,1939.0,,,guan-,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:21926190, URL:http://europepmc.org/abstract/MED/21926190|Name:DailyMed, SrcID:setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1",NC(=N)N,CHEMBL2362996,KCNG3
399,CHEMBL821,Guanidine,Small molecule,1939.0,,,guan-,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:21926190, URL:http://europepmc.org/abstract/MED/21926190|Name:DailyMed, SrcID:setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1",NC(=N)N,CHEMBL2362996,KCNS3
400,CHEMBL821,Guanidine,Small molecule,1939.0,,,guan-,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:21926190, URL:http://europepmc.org/abstract/MED/21926190|Name:DailyMed, SrcID:setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1",NC(=N)N,CHEMBL2362996,KCNV2
401,CHEMBL821,Guanidine,Small molecule,1939.0,,,guan-,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:21926190, URL:http://europepmc.org/abstract/MED/21926190|Name:DailyMed, SrcID:setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1",NC(=N)N,CHEMBL2362996,KCNH3
402,CHEMBL821,Guanidine,Small molecule,1939.0,,,guan-,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:21926190, URL:http://europepmc.org/abstract/MED/21926190|Name:DailyMed, SrcID:setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1",NC(=N)N,CHEMBL2362996,KCNS2
403,CHEMBL821,Guanidine,Small molecule,1939.0,,,guan-,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:21926190, URL:http://europepmc.org/abstract/MED/21926190|Name:DailyMed, SrcID:setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1",NC(=N)N,CHEMBL2362996,KCNS1
404,CHEMBL821,Guanidine,Small molecule,1939.0,,,guan-,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:21926190, URL:http://europepmc.org/abstract/MED/21926190|Name:DailyMed, SrcID:setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1",NC(=N)N,CHEMBL2362996,KCNC2
405,CHEMBL821,Guanidine,Small molecule,1939.0,,,guan-,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:21926190, URL:http://europepmc.org/abstract/MED/21926190|Name:DailyMed, SrcID:setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1",NC(=N)N,CHEMBL2362996,KCNH4
406,CHEMBL821,Guanidine,Small molecule,1939.0,,,guan-,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:21926190, URL:http://europepmc.org/abstract/MED/21926190|Name:DailyMed, SrcID:setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1",NC(=N)N,CHEMBL2362996,KCNC4
407,CHEMBL821,Guanidine,Small molecule,1939.0,,,guan-,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:21926190, URL:http://europepmc.org/abstract/MED/21926190|Name:DailyMed, SrcID:setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1",NC(=N)N,CHEMBL2362996,KCNH1
408,CHEMBL821,Guanidine,Small molecule,1939.0,,,guan-,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:21926190, URL:http://europepmc.org/abstract/MED/21926190|Name:DailyMed, SrcID:setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1",NC(=N)N,CHEMBL2362996,KCNA10
409,CHEMBL821,Guanidine,Small molecule,1939.0,,,guan-,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:21926190, URL:http://europepmc.org/abstract/MED/21926190|Name:DailyMed, SrcID:setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593#nlm34090-1",NC(=N)N,CHEMBL2362996,KCNG2
410,CHEMBL1200391,Tromethamine,Small molecule,1965.0,B05BB03; B05XX02,B05BB03 [BLOOD AND BLOOD FORMING ORGANS: BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS: I.V. SOLUTIONS: Solutions affecting the electrolyte balance]; B05XX02 [BLOOD AND BLOOD FORMING ORGANS: BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS: I.V. SOLUTION ADDITIVES: Other i.v. solution additives],,Unknown,,,,,,,,,,"Name:FDA, SrcID:label/2006/013025s040lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/013025s040lbl.pdf",NC(CO)(CO)CO,,
411,CHEMBL1238,Azelaic Acid,Small molecule,1995.0,D10AX03,D10AX03 [DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Other anti-acne preparations for topical use],,Unknown,"May act through thioredoxin reductase of acne causing bacteria (e.g., Staphylococcus epidermidis and Propionibacterium acnes)",,,,,,,,,"Name:PubMed, SrcID:2114832, URL:http://europepmc.org/abstract/MED/2114832|Name:DailyMed, SrcID:setid=b086c825-401e-48e7-a6dd-2ad7423e86a0, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b086c825-401e-48e7-a6dd-2ad7423e86a0",OC(=O)CCCCCCCC(=O)O,,
412,CHEMBL2105760,Brexpiprazole,Small molecule,2015.0,N05AX16,N05AX16 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Other antipsychotics],-prazole,Serotonin 1a (5-HT1a) receptor partial agonist,,,CHEMBL214,Serotonin 1a (5-HT1a) receptor,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/205422s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205422s000lbl.pdf",O=C1Nc2cc(OCCCCN3CCN(CC3)c4cccc5sccc45)ccc2C=C1,CHEMBL214,HTR1A
413,CHEMBL2111107,Sugammadex,Unknown,2015.0,V03AB35,V03AB35 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Antidotes],,Rocuronium sequestering agent,,,CHEMBL3559390,Rocuronium,SEQUESTERING AGENT,,SMALL MOLECULE,,,"Name:FDA, SrcID:label/2015/022225lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022225lbl.pdf",O[C@@H]1[C@@H](O)[C@@H]2O[C@H]3O[C@H](CSCCC(=O)O)[C@@H](O[C@H]4O[C@H](CSCCC(=O)O)[C@@H](O[C@H]5O[C@H](CSCCC(=O)O)[C@@H](O[C@H]6O[C@H](CSCCC(=O)O)[C@@H](O[C@H]7O[C@H](CSCCC(=O)O)[C@@H](O[C@H]8O[C@H](CSCCC(=O)O)[C@@H](O[C@H]9O[C@H](CSCCC(=O)O)[C@@H](O[C@H]1O[C@@H]2CSCCC(=O)O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)C6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O,,
414,CHEMBL103667,Doramapimod,Small molecule,,,,-imod,MAP kinase p38 alpha inhibitor,"Allosteric MAPK14 inhibitor. In addition to MAPK11, BIRB-796 has been shown to inhibit MAPK11, MAPK12 and MAPK13 (PMID:15755732).",,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11896401, URL:http://europepmc.org/abstract/MED/11896401|Name:PubMed, SrcID:14561087, URL:http://europepmc.org/abstract/MED/14561087",Cc1ccc(cc1)n2nc(cc2NC(=O)Nc3ccc(OCCN4CCOCC4)c5ccccc35)C(C)(C)C,CHEMBL260,MAPK14
415,CHEMBL3544962,Ct-1578,Small molecule,,,,,Tyrosine-protein kinase receptor FLT3 inhibitor,,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22339472, URL:http://europepmc.org/abstract/MED/22339472|Name:PubMed, SrcID:22962687, URL:http://europepmc.org/abstract/MED/22962687",,CHEMBL1974,FLT3
416,CHEMBL3544964,Gdc-0994,Small molecule,,,,,MAP kinase ERK2 inhibitor,,,CHEMBL4040,MAP kinase ERK2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://cancerres.aacrjournals.org/content/74/19_Supplement/DDT02-03, URL:http://cancerres.aacrjournals.org/content/74/19_Supplement/DDT02-03",Cn1nccc1Nc2nccc(n2)C3=CC(=O)N(C=C3)[C@H](CO)c4ccc(Cl)c(F)c4,CHEMBL4040,MAPK1
417,CHEMBL3545133,Jnj-26483327,Small molecule,,,,,Tyrosine-protein kinase FYN inhibitor,Multi-targeted tyrosine kinase inhibitor,,CHEMBL1841,Tyrosine-protein kinase FYN,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1016/S1359-6349(10)71870-X, URL:http://www.sciencedirect.com/science/article/pii/S135963491071870X|Name:PubMed, SrcID:20823884, URL:http://europepmc.org/abstract/MED/20823884",,CHEMBL1841,FYN
418,CHEMBL3545141,Rp-6530,Small molecule,,,,,PI3-kinase p110-delta subunit inhibitor,,,CHEMBL3130,PI3-kinase p110-delta subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.bloodjournal.org/content/122/21/4411?sso-checked=true, URL:http://www.bloodjournal.org/content/122/21/4411?sso-checked=true|Name:DOI, SrcID:10.1158/1538-7445.AM2015-2704, URL:http://cancerres.aacrjournals.org/content/75/15_Supplement/2704",,CHEMBL3130,PIK3CD
419,CHEMBL3545141,Rp-6530,Small molecule,,,,,PI3-kinase p110-gamma subunit inhibitor,,,CHEMBL3267,PI3-kinase p110-gamma subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.bloodjournal.org/content/122/21/4411?sso-checked=true, URL:http://www.bloodjournal.org/content/122/21/4411?sso-checked=true|Name:DOI, SrcID:10.1158/1538-7445.AM2015-2704, URL:http://cancerres.aacrjournals.org/content/75/15_Supplement/2704",,CHEMBL3267,PIK3CG
420,CHEMBL3544932,Tak-901,Small molecule,,,,,Serine/threonine-protein kinase Aurora-B inhibitor,Potently inhibits multiple kinases.,,CHEMBL2185,Serine/threonine-protein kinase Aurora-B,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23358665, URL:http://europepmc.org/abstract/MED/23358665",CCS(=O)(=O)c1cccc(c1)c2cc(C(=O)NC3CCN(C)CC3)c(C)c4[nH]c5ncc(C)cc5c24,CHEMBL2185,AURKB
421,CHEMBL3545236,Bpi-9016,Small molecule,,,,,Tyrosine-protein kinase receptor UFO inhibitor,,,CHEMBL4895,Tyrosine-protein kinase receptor UFO,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:ClinicalTrials, SrcID:NCT02478866, URL:https://www.clinicaltrials.gov/ct2/show/NCT02478866",,,
422,CHEMBL3544938,Apd334,Small molecule,,,,,Sphingosine 1-phosphate receptor Edg-1 agonist,,,CHEMBL4333,Sphingosine 1-phosphate receptor Edg-1,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.arenapharm.com/apd334, URL:http://www.arenapharm.com/apd334|Name:PubMed, SrcID:25516790, URL:http://europepmc.org/abstract/MED/25516790",,CHEMBL4333,S1PR1
423,CHEMBL3545010,Ordopidine,Small molecule,,,,-dopidine,Dopamine D2 receptor modulator,Dopidine (dopaminergic stabilizer),,CHEMBL217,Dopamine D2 receptor,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://gupea.ub.gu.se/bitstream/2077/7535/2/Thesis_Johan_Rung.pdf, URL:https://gupea.ub.gu.se/bitstream/2077/7535/2/Thesis_Johan_Rung.pdf|Name:PubMed, SrcID:24817271, URL:http://europepmc.org/abstract/MED/24817271",CCN1CCC(CC1)c2cccc(c2F)S(=O)(=O)C,CHEMBL217,DRD2
424,CHEMBL3545013,Apn1125,Small molecule,,,,,Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist,,,CHEMBL2492,Neuronal acetylcholine receptor protein alpha-7 subunit,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1016/j.jalz.2014.07.142, URL:http://www.sciencedirect.com/science/article/pii/S1552526014026405",,CHEMBL2492,CHRNA7
425,CHEMBL3545212,Amg-337,Small molecule,,,,,Hepatocyte growth factor receptor inhibitor,,,CHEMBL3717,Hepatocyte growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.amgenoncology-international.com/#/our-products/our-pipeline/, URL:http://www.amgenoncology-international.com/#/our-products/our-pipeline/|Name:PubMed, SrcID:26045669, URL:http://europepmc.org/abstract/MED/26045669|Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=690935, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=690935",,CHEMBL3717,MET
426,CHEMBL2103842,Varlitinib,Small molecule,,,,-tinib,Receptor protein-tyrosine kinase erbB-2 inhibitor,Also ERBB4 inhibitor,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://arraybiopharma.com/files/8813/9810/8032/PubAttachment460.pdf, URL:http://arraybiopharma.com/files/8813/9810/8032/PubAttachment460.pdf|Name:Other, SrcID:http://www.arraybiopharma.com/product-pipeline/other-compounds/aslan001-arry-543/, URL:http://www.arraybiopharma.com/product-pipeline/other-compounds/aslan001-arry-543/",C[C@@H]1COC(=N1)Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2,CHEMBL1824,ERBB2
427,CHEMBL1879463,Dactolisib,Small molecule,,,,-lisib,Serine/threonine-protein kinase mTOR inhibitor,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL2842,Serine/threonine-protein kinase mTOR,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18606717, URL:http://europepmc.org/abstract/MED/18606717|Name:PubMed, SrcID:24591840, URL:http://europepmc.org/abstract/MED/24591840",CN1C(=O)N(c2ccc(cc2)C(C)(C)C#N)c3c1cnc4ccc(cc34)c5cnc6ccccc6c5,CHEMBL2842,MTOR
428,CHEMBL3545396,Bms-690514,Small molecule,,,,,Receptor protein-tyrosine kinase erbB-4 inhibitor,,,CHEMBL3009,Receptor protein-tyrosine kinase erbB-4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24130056, URL:http://europepmc.org/abstract/MED/24130056|Name:PubMed, SrcID:21531814, URL:http://europepmc.org/abstract/MED/21531814",COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1,CHEMBL3009,ERBB4
429,CHEMBL14762,Seliciclib,Small molecule,,,,-ciclib,Cyclin-dependent kinase 2 inhibitor,,,CHEMBL301,Cyclin-dependent kinase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26207228, URL:http://europepmc.org/abstract/MED/26207228|Name:PubMed, SrcID:25747275, URL:http://europepmc.org/abstract/MED/25747275|Name:PubMed, SrcID:9030781, URL:http://europepmc.org/abstract/MED/9030781",CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1,CHEMBL301,CDK2
430,CHEMBL1230609,Foretinib,Small molecule,,,,-tinib,Platelet-derived growth factor receptor inhibitor,,,CHEMBL2095189,Platelet-derived growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:Other, SrcID:http://www.exelixis.com/pipeline/xl880, URL:http://www.exelixis.com/pipeline/xl880|Name:PubMed, SrcID:19808973, URL:http://europepmc.org/abstract/MED/19808973",COc1cc2c(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc5ccc(F)cc5)cc3F)ccnc2cc1OCCCN6CCOCC6,,
431,CHEMBL3544983,Tesevatinib,Small molecule,,,,-tinib,Receptor protein-tyrosine kinase erbB-2 inhibitor,,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17575237, URL:http://europepmc.org/abstract/MED/17575237|Name:Other, SrcID:http://kadmon.com/press/kadmon-corporation-presents-encouraging-nonclinical-data-on-tesevatinib-kd019-at-aacr-annual-meeting/, URL:http://kadmon.com/press/kadmon-corporation-presents-encouraging-nonclinical-data-on-tesevatinib-kd019-at-aacr-annual-meeting/|Name:PubMed, SrcID:22173702, URL:http://europepmc.org/abstract/MED/22173702",COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]4C[C@@H]5CN(C)C[C@@H]5C4,CHEMBL1824,ERBB2
432,CHEMBL3545289,Azd2207,Small molecule,,,,,Cannabinoid CB1 receptor antagonist,,,CHEMBL218,Cannabinoid CB1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://adisinsight.springer.com/drugs/800025707, URL:http://adisinsight.springer.com/drugs/800025707",C[C@@H](NC(=O)Cc1c(Cl)ccc(NCC(F)(F)c2cccc[n+]2O)[n+]1O)c3cccc(Cl)c3,CHEMBL218,CNR1
433,CHEMBL1779046,Tarafenacin,Small molecule,,,,-fenacin,Muscarinic acetylcholine receptor M3 antagonist,,,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25363415, URL:http://europepmc.org/abstract/MED/25363415|Name:PubMed, SrcID:19222482, URL:http://europepmc.org/abstract/MED/19222482",Fc1cccc(c1)N(Cc2cc(F)c(F)c(F)c2)C(=O)O[C@H]3CN4CCC3CC4,CHEMBL245,CHRM3
434,CHEMBL2108702,Imetelstat Sodium,Oligonucleotide,,,,-stat,Telomerase reverse transcriptase inhibitor,"Competitive telomerase inhibitor, which binds directly to the active site of the enzyme, thus inhibiting its activity.",,CHEMBL2916,Telomerase reverse transcriptase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,Targets the template region of the human functional telomerase RNA (hTR) subunit.,"Name:PubMed, SrcID:23545855, URL:http://europepmc.org/abstract/MED/23545855",,CHEMBL2916,TERT
435,CHEMBL218650,Delamanid,Small molecule,,J04AK06,J04AK06 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOBACTERIALS: DRUGS FOR TREATMENT OF TUBERCULOSIS: Other drugs for treatment of tuberculosis],-manid,Mycobacterium tuberculosis H37Rv inhibitor,"Inhibits the synthesis of mycobacterial cell wall components, methoxy mycolic acid and ketomycolic acid. Pro-drug activated by the enzyme deazaflavin dependent nitroreductase",,CHEMBL2111188,Mycobacterium tuberculosis H37Rv,INHIBITOR,Mycobacterium tuberculosis H37Rv,ORGANISM,,,"Name:Other, SrcID:http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002552/WC500166232.pdf, URL:http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002552/WC500166232.pdf|Name:PubMed, SrcID:17132069, URL:http://europepmc.org/abstract/MED/17132069|Name:PMC, SrcID:PMC4156838, URL:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156838",C[C@]1(COc2ccc(cc2)N3CCC(CC3)Oc4ccc(OC(F)(F)F)cc4)Cn5cc(nc5O1)[N+](=O)[O-],,
436,CHEMBL1829174,Fasiglifam,Small molecule,,,,,Free fatty acid receptor 1 positive allosteric modulator,Potentiates insulin secretion in a glucose-dependent manner by activating FFAR1 expressed in pancreatic ß cells,,CHEMBL4422,Free fatty acid receptor 1,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,SINGLE PROTEIN,,Binds to a non-canonical site created between TM helices 3–5 and the extracellular loop 2 regions,"Name:PubMed, SrcID:24130766, URL:http://europepmc.org/abstract/MED/24130766|Name:PubMed, SrcID:25043059, URL:http://europepmc.org/abstract/MED/25043059",Cc1cc(OCCCS(=O)(=O)C)cc(C)c1c2cccc(COc3ccc4[C@H](CC(=O)O)COc4c3)c2,CHEMBL4422,FFAR1
437,CHEMBL2103832,Pardoprunox,Small molecule,,,,,Serotonin 1a (5-HT1a) receptor agonist,,,CHEMBL214,Serotonin 1a (5-HT1a) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20434890, URL:http://europepmc.org/abstract/MED/20434890",CN1CCN(CC1)c2cccc3NC(=O)Oc23,CHEMBL214,HTR1A
438,CHEMBL2108313,Conbercept,Protein,,,,-cept,Vascular endothelial growth factor A inhibitor,Soluble receptor decoy which has a high binding affinity to VEGF and a long half-life in vitreous.,"All isoforms of VEGF-A, VEGF-B, VEGF-C, and PlGF.",CHEMBL1783,Vascular endothelial growth factor A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25960634, URL:http://europepmc.org/abstract/MED/25960634|Name:PubMed, SrcID:22958404, URL:http://europepmc.org/abstract/MED/22958404|Name:PubMed, SrcID:18246030, URL:http://europepmc.org/abstract/MED/18246030|Name:PubMed, SrcID:23950958, URL:http://europepmc.org/abstract/MED/23950958",,CHEMBL1783,VEGFA
439,CHEMBL2108589,Clazakizumab,Antibody,,,,-mab,Interleukin-6 inhibitor,"It binds circulating IL-6 cytokine rather than the IL-6 receptor, blocking both classic signaling and trans-signaling.",,CHEMBL1795129,Interleukin-6,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.blackwellpublishing.com/acrmeeting/abstract.asp?MeetingID=799&id=109752, URL:http://www.blackwellpublishing.com/acrmeeting/abstract.asp?MeetingID=799&id=109752|Name:PubMed, SrcID:26138593, URL:http://europepmc.org/abstract/MED/26138593",,CHEMBL1795129,IL6
440,CHEMBL2108660,Tucotuzumab Celmoleukin,Antibody,,,,-mab,Epithelial cell adhesion molecule other,"Immunomodulator. The humanized monoclonal antibody moiety of tucotuzumab celmoleukin recognizes and binds to EpCAM thereby concentrating IL2 (celmoleukin) in EpCAM-expressing tumor tissue. Subsequently, the localized IL2 moiety of this fusion protein may stimulate a cytotoxic T-cell antitumor immune response.",,CHEMBL3580493,Epithelial cell adhesion molecule,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23320927, URL:http://europepmc.org/abstract/MED/23320927",,CHEMBL3580493,EPCAM
441,CHEMBL2109332,Mlnm-2201,Antibody,,,,,Integrin beta-2 inhibitor,,,CHEMBL3631,Integrin beta-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://adisinsight.springer.com/drugs/800010178, URL:http://adisinsight.springer.com/drugs/800010178",,,
442,CHEMBL2109460,Sch-708980,Antibody,,,,,Interleukin-10 inhibitor,,,CHEMBL3712920,Interleukin-10,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PMC, SrcID:PMC3382908, URL:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382908",,CHEMBL3712920,IL10
443,CHEMBL2109498,Iph-2101,Antibody,,,,,Killer cell immunoglobulin-like receptor 2DL2 inhibitor,"Acts as a checkpoint inhibitor by blocking the interaction between KIR2DL-1,-2,-3 inhibitory receptors and their ligands.",,CHEMBL3833441,Killer cell immunoglobulin-like receptor 2DL2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19553639, URL:http://europepmc.org/abstract/MED/19553639|Name:PubMed, SrcID:22031859, URL:http://europepmc.org/abstract/MED/22031859",,CHEMBL3833441,KIR2DL2
444,CHEMBL1421,Dasatinib,Small molecule,2006.0,L01XE06,L01XE06 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Platelet-derived growth factor receptor beta inhibitor,,,CHEMBL1913,Platelet-derived growth factor receptor beta,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13",Cc1nc(Nc2ncc(s2)C(=O)Nc3c(C)cccc3Cl)cc(n1)N4CCN(CCO)CC4,CHEMBL1913,PDGFRB
445,CHEMBL1201643,Insulin Zinc Susp Prompt Purified Pork,Protein,1982.0,,,,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/022472s006s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022472s006s008lbl.pdf|Name:DailyMed, SrcID:setid=457531f0-9331-47fe-90b5-b31f284044dc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=457531f0-9331-47fe-90b5-b31f284044dc",,CHEMBL1981,INSR
446,CHEMBL1201546,Insulin Zinc Susp Purified Beef,Protein,1980.0,,,,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/022472s006s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022472s006s008lbl.pdf|Name:DailyMed, SrcID:setid=457531f0-9331-47fe-90b5-b31f284044dc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=457531f0-9331-47fe-90b5-b31f284044dc",,CHEMBL1981,INSR
447,CHEMBL14376,Iloperidone,Small molecule,2009.0,N05AX14,N05AX14 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Other antipsychotics],-peridone,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=43452bf8-76e7-47a9-a5d8-41fe84d061f0, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43452bf8-76e7-47a9-a5d8-41fe84d061f0",COc1cc(ccc1OCCCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)C,CHEMBL224,HTR2A
448,CHEMBL669,Cyclobenzaprine,Small molecule,1977.0,M03BX08,"M03BX08 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS: Other centrally acting agents]",,Serotonin 2c (5-HT2c) receptor antagonist,,,CHEMBL225,Serotonin 2c (5-HT2c) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12498911, URL:http://europepmc.org/abstract/MED/12498911|Name:Wikipedia, SrcID:Cyclobenzaprine, URL:http://en.wikipedia.org/wiki/Cyclobenzaprine",CN(C)CCC=C1c2ccccc2C=Cc3ccccc13,,
449,CHEMBL266481,Glucagon,Protein,1998.0,H04AA01,"H04AA01 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PANCREATIC HORMONES: GLYCOGENOLYTIC HORMONES: Glycogenolytic hormones]",,Glucagon receptor agonist,,,CHEMBL1985,Glucagon receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12529935, URL:http://europepmc.org/abstract/MED/12529935",CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H](NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc5ccc(O)cc5)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc6ccccc6)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc7c[nH]cn7)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O,CHEMBL1985,GCGR
450,CHEMBL1428,Nimodipine,Small molecule,1988.0,C08CA06,C08CA06 [CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS: Dihydropyridine derivatives],-dipine,Mineralocorticoid receptor antagonist,,,CHEMBL1994,Mineralocorticoid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18250364, URL:http://europepmc.org/abstract/MED/18250364",COCCOC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OC(C)C)C,,
451,CHEMBL1200545,Diflorasone Diacetate,Small molecule,1977.0,D07AC10,"D07AC10 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, potent (group III)]",,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15764038, URL:http://europepmc.org/abstract/MED/15764038",C[C@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C)C(=O)COC(=O)C,CHEMBL2034,NR3C1
452,CHEMBL1370,Budesonide,Small molecule,1994.0,R01AD05; A07EA06; R03BA02; D07AC09,"R01AD05 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Corticosteroids]; A07EA06 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Corticosteroids acting locally]; R03BA02 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS: Glucocorticoids]; D07AC09 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, potent (group III)]",-onide,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11730731, URL:http://europepmc.org/abstract/MED/11730731|Name:KEGG, SrcID:D00246, URL:http://www.kegg.jp/dbget-bin/www_bget?dr:D00246|Name:PubMed, SrcID:12920235, URL:http://europepmc.org/abstract/MED/12920235|Name:PubMed, SrcID:12601049, URL:http://europepmc.org/abstract/MED/12601049",CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,CHEMBL2034,NR3C1
453,CHEMBL924,Zoledronic Acid,Small molecule,2001.0,M05BA08,M05BA08 [MUSCULO-SKELETAL SYSTEM: DRUGS FOR TREATMENT OF BONE DISEASES: DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION: Bisphosphonates],-dronate,Farnesyl diphosphate synthase inhibitor,"Binds to the bone matrix (hydroxyapatite), and when the bone starts to be reabsorbed the compound is released and taken up by osteoclasts, inhibiting protein prenylation of the GTPases involved in the formation of the ruffled border",,CHEMBL1782,Farnesyl diphosphate synthase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16835450, URL:http://europepmc.org/abstract/MED/16835450|Name:PubMed, SrcID:15028820, URL:http://europepmc.org/abstract/MED/15028820|Name:PubMed, SrcID:11160603, URL:http://europepmc.org/abstract/MED/11160603|Name:PubMed, SrcID:16006204, URL:http://europepmc.org/abstract/MED/16006204|Name:FDA, SrcID:label/2011/021817s012lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021817s012lbl.pdf",OC(Cn1ccnc1)(P(=O)(O)O)P(=O)(O)O,CHEMBL1782,FDPS
454,CHEMBL997,Ibandronic Acid,Small molecule,2003.0,M05BA06,M05BA06 [MUSCULO-SKELETAL SYSTEM: DRUGS FOR TREATMENT OF BONE DISEASES: DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION: Bisphosphonates],-andr-,Farnesyl diphosphate synthase inhibitor,"Binds to the bone matrix (hydroxyapatite), and when the bone starts to be reabsorbed the compound is released and taken up by osteoclasts, inhibiting protein prenylation of the GTPases involved in the formation of the ruffled border",,CHEMBL1782,Farnesyl diphosphate synthase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16892359, URL:http://europepmc.org/abstract/MED/16892359|Name:DailyMed, SrcID:setid=5500be0f-8b29-450c-9857-755029965157, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5500be0f-8b29-450c-9857-755029965157|Name:PubMed, SrcID:15028820, URL:http://europepmc.org/abstract/MED/15028820|Name:PubMed, SrcID:11160603, URL:http://europepmc.org/abstract/MED/11160603",CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,CHEMBL1782,FDPS
455,CHEMBL898,Diflunisal,Small molecule,1982.0,N02BA11,N02BA11 [NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Salicylic acid and derivatives],-sal,Cyclooxygenase inhibitor,,,CHEMBL2094253,Cyclooxygenase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10825891, URL:http://europepmc.org/abstract/MED/10825891|Name:PubMed, SrcID:12852483, URL:http://europepmc.org/abstract/MED/12852483|Name:PubMed, SrcID:8737748, URL:http://europepmc.org/abstract/MED/8737748|Name:PubMed, SrcID:15755648, URL:http://europepmc.org/abstract/MED/15755648|Name:PubMed, SrcID:11315375, URL:http://europepmc.org/abstract/MED/11315375",OC(=O)c1cc(ccc1O)c2ccc(F)cc2F,,
456,CHEMBL782,Tolbutamide,Small molecule,1961.0,A10BB03; V04CA01,"A10BB03 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Sulfonylureas]; V04CA01 [VARIOUS: DIAGNOSTIC AGENTS: OTHER DIAGNOSTIC AGENTS: Tests for diabetes]",,"Sulfonylurea receptor 1, Kir6.2 blocker",,,CHEMBL2096972,"Sulfonylurea receptor 1, Kir6.2",BLOCKER,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:9647478, URL:http://europepmc.org/abstract/MED/9647478|Name:PubMed, SrcID:11226127, URL:http://europepmc.org/abstract/MED/11226127|Name:PubMed, SrcID:18220763, URL:http://europepmc.org/abstract/MED/18220763|Name:PubMed, SrcID:10455193, URL:http://europepmc.org/abstract/MED/10455193",CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1,,
457,CHEMBL1201237,Levobunolol,Small molecule,1985.0,S01ED03,S01ED03 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Beta blocking agents 1)],-olol,Beta-2 adrenergic receptor antagonist,,,CHEMBL210,Beta-2 adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=1a32c0e8-7d10-447e-a7c4-252c98b629bd, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a32c0e8-7d10-447e-a7c4-252c98b629bd",CC(C)(C)NC[C@H](O)COc1cccc2C(=O)CCCc12,CHEMBL210,ADRB2
458,CHEMBL1199324,Fosaprepitant,Small molecule,2008.0,,,fos-; -tant,Neurokinin 1 receptor antagonist,,,CHEMBL249,Neurokinin 1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=44f634f4-b794-4d55-8ab7-037fdef8ff0f#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=44f634f4-b794-4d55-8ab7-037fdef8ff0f#nlm34090-1",C[C@@H](O[C@H]1OCCN(CC2=NN(C(=O)N2)P(=O)(O)O)[C@H]1c3ccc(F)cc3)c4cc(cc(c4)C(F)(F)F)C(F)(F)F,CHEMBL249,TACR1
459,CHEMBL666,Foscarnet,Small molecule,1991.0,J05AD01,J05AD01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Phosphonic acid derivatives],fos-,Human herpesvirus 1 DNA polymerase inhibitor,,,CHEMBL1872,Human herpesvirus 1 DNA polymerase,INHIBITOR,Herpes simplex virus (type 1 / strain 17),SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=eec8727b-c98c-41a4-90b8-d49a8e01e63c, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eec8727b-c98c-41a4-90b8-d49a8e01e63c",OC(=O)P(=O)(O)O,,
460,CHEMBL1201352,Rapacuronium,Small molecule,1999.0,,,-ium,Muscle-type nicotinic acetylcholine receptor antagonist,non-depolarizing,,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:KEGG, SrcID:D05703, URL:http://www.kegg.jp/dbget-bin/www_bget?dr:D05703|Name:FDA, SrcID:label/2010/020984s003lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020984s003lbl.pdf",CCC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(=O)C)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N5CCCCC5)[N+]6(CC=C)CCCCC6,,
461,CHEMBL1341,Methoxyflurane,Small molecule,,N02BG09,N02BG09 [NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Other analgesics and antipyretics],-flurane,Glycine receptor (alpha-1/beta) agonist,,,CHEMBL2363052,Glycine receptor (alpha-1/beta),AGONIST,Homo sapiens,PROTEIN COMPLEX,Glycine receptor alpha subunit,Alpha subunit is binding site,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:18175089, URL:http://europepmc.org/abstract/MED/18175089",COC(F)(F)C(Cl)Cl,CHEMBL2363052,GLRB
462,CHEMBL32,Moxifloxacin,Small molecule,1999.0,J01MA14; S01AE07,J01MA14 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolones]; S01AE07 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Fluoroquinolones],-oxacin,Topoisomerase IV inhibitor,,Broad spectrum,CHEMBL2363076,Topoisomerase IV,INHIBITOR,Bacteria,PROTEIN COMPLEX,,,"Name:DailyMed, SrcID:setid=56b4f979-bf20-4908-9d7c-5536221d77f8, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=56b4f979-bf20-4908-9d7c-5536221d77f8",COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc4C(=O)C(=CN(C5CC5)c14)C(=O)O,,
463,CHEMBL1730,Cefotaxime,Small molecule,1981.0,J01DD01; J01DD51,J01DD01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Third-generation cephalosporins]; J01DD51 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Third-generation cephalosporins],cef-,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:PubMed, SrcID:7447421, URL:http://europepmc.org/abstract/MED/7447421",CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)COC(=O)C)\c3csc(N)n3,,
464,CHEMBL1201073,Succimer,Small molecule,1991.0,,,-mer,Lead chelating agent,,,CHEMBL2364029,Lead,CHELATING AGENT,null,METAL,,,"Name:FDA, SrcID:label/2007/019998s013lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/019998s013lbl.pdf",OC(=O)[C@H](S)[C@H](S)C(=O)O,,
465,CHEMBL671,Thiotepa,Small molecule,1959.0,L01AC01,L01AC01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ALKYLATING AGENTS: Ethylene imines],-tepa,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:FDA, SrcID:label/2015/075547Orig1s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/075547Orig1s006lbl.pdf|Name:DailyMed, SrcID:setid=b4e6b9e3-1c09-410e-a4bf-1e844887a201, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b4e6b9e3-1c09-410e-a4bf-1e844887a201",S=P(N1CC1)(N2CC2)N3CC3,,
466,CHEMBL922,Adefovir Dipivoxil,Small molecule,2002.0,J05AF08,J05AF08 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleoside and nucleotide reverse transcriptase inhibitors],-vir,DNA polymerase/reverse transcriptase inhibitor,,,CHEMBL2362994,DNA polymerase/reverse transcriptase,INHIBITOR,Hepatitis B virus,SINGLE PROTEIN,,,"Name:PubMed, SrcID:14647052, URL:http://europepmc.org/abstract/MED/14647052|Name:PubMed, SrcID:19187868, URL:http://europepmc.org/abstract/MED/19187868",CC(C)(C)C(=O)OCOP(=O)(COCCn1cnc2c(N)ncnc12)OCOC(=O)C(C)(C)C,,
467,CHEMBL558,Mexiletine,Small molecule,1985.0,C01BB02,"C01BB02 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class Ib]",,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:Wikipedia, SrcID:Mexiletine, URL:http://en.wikipedia.org/wiki/Mexiletine|Name:DailyMed, SrcID:setid=ab73778b-6794-441c-b127-610a6d0733ea, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ab73778b-6794-441c-b127-610a6d0733ea|Name:Wikipedia, SrcID:Antiarrhythmic_agent, URL:http://en.wikipedia.org/wiki/Antiarrhythmic_agent|Name:Wikipedia, SrcID:Sodium_channel, URL:http://en.wikipedia.org/wiki/Sodium_channel",CC(N)COc1c(C)cccc1C,,
468,CHEMBL71,Chlorpromazine,Small molecule,1957.0,N05AA01,N05AA01 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Phenothiazines with aliphatic side-chain],,D2-like dopamine receptor antagonist,,,CHEMBL2331075,D2-like dopamine receptor,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:Wikipedia, SrcID:Chlorpromazine, URL:http://en.wikipedia.org/wiki/Chlorpromazine|Name:ISBN, SrcID:0443059748, URL:http://www.isbnsearch.org/isbn/0443059748|Name:PubMed, SrcID:17015232, URL:http://europepmc.org/abstract/MED/17015232",CN(C)CCCN1c2ccccc2Sc3ccc(Cl)cc13,,
469,CHEMBL85,Risperidone,Small molecule,1993.0,N05AX08,N05AX08 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Other antipsychotics],-peridone,Dopamine D2 receptor antagonist,,,CHEMBL217,Dopamine D2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=b45ceaaa-1236-493a-98c1-43df2f4a08f5#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b45ceaaa-1236-493a-98c1-43df2f4a08f5#nlm34090-1|Name:FDA, SrcID:label/2014/021346s052lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021346s052lbl.pdf",CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1,CHEMBL217,DRD2
470,CHEMBL33,Levofloxacin,Small molecule,1996.0,S01AE05; J01MA12,S01AE05 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Fluoroquinolones]; J01MA12 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolones],-oxacin,Topoisomerase IV inhibitor,,,CHEMBL2363033,Topoisomerase IV,INHIBITOR,Streptococcus pneumoniae,PROTEIN COMPLEX,,,"Name:DailyMed, SrcID:setid=a1f01e8e-97e9-11de-b91d-553856d89593, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a1f01e8e-97e9-11de-b91d-553856d89593",C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc4C(=O)C(=CN1c24)C(=O)O,,
471,CHEMBL1201444,Cryptenamine Acetates,Small molecule,1982.0,,,,Unknown,,,,,,,,,,"Name:PubMed, SrcID:7192510, URL:http://europepmc.org/abstract/MED/7192510",,,
472,CHEMBL1201548,Tyloxapol,Unknown,1990.0,R05CA01,"R05CA01 [RESPIRATORY SYSTEM: COUGH AND COLD PREPARATIONS: EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS: Expectorants]",,Surfactant agent,Replaces endogenous surfactant in case of deficiency; endogenous pulmonary surfactant lower surface tension at the air-liquid of the alveolar surfaces,,,,,,,,,"Name:PubMed, SrcID:16779702, URL:http://europepmc.org/abstract/MED/16779702",,,
473,CHEMBL1201864,Dienogest,Small molecule,2010.0,G03DB08,G03DB08 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: PROGESTOGENS: Pregnadien derivatives],,Unknown,,,,,,,,,,"Name:FDA, SrcID:label/2012/022252s002lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022252s002lbl.pdf",C[C@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)CC#N,,
474,CHEMBL1628385,Procaine Benzylpenicillin,Small molecule,1948.0,J01CE09,"J01CE09 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: BETA-LACTAM ANTIBACTERIALS, PENICILLINS: Beta-lactamase sensitive penicillins]",-caine; -cillin,Unknown,,,,,,,,,,"Name:FDA, SrcID:label/2009/050138s231lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/050138s231lbl.pdf",CCN(CC)CCOC(=O)c1ccc(N)cc1.CC2(C)S[C@@H]3[C@H](NC(=O)Cc4ccccc4)C(=O)N3[C@H]2C(=O)O,,
475,CHEMBL1908370,Finafloxacin,Small molecule,2014.0,,,-oxacin,DNA gyrase inhibitor,,,CHEMBL3390828,DNA gyrase,INHIBITOR,Pseudomonas aeruginosa,PROTEIN COMPLEX,,,"Name:FDA, SrcID:label/2014/206307s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206307s000lbl.pdf",OC(=O)C1=CN(C2CC2)c3c(C#N)c(N4C[C@@H]5NCCO[C@H]5C4)c(F)cc3C1=O,,
476,CHEMBL406393,Deoxycholic Acid,Small molecule,2015.0,D11AX24,D11AX24 [DERMATOLOGICALS: OTHER DERMATOLOGICAL PREPARATIONS: OTHER DERMATOLOGICAL PREPARATIONS: Other dermatologicals],,Cell membrane disrupting agent,,,CHEMBL3390826,Cell membrane,DISRUPTING AGENT,Homo sapiens,SUBCELLULAR,,,"Name:FDA, SrcID:label/2015/206333Orig1s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206333Orig1s000lbl.pdf",C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,,
477,CHEMBL1743007,Daratumumab,Antibody,2015.0,L01XC24,L01XC24 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,Lymphocyte differentiation antigen CD38 inhibitor,,,CHEMBL4660,Lymphocyte differentiation antigen CD38,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=a4d0efe9-5e54-467e-9eb4-56fa7d53b60b, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a4d0efe9-5e54-467e-9eb4-56fa7d53b60b",,CHEMBL4660,CD38
478,CHEMBL574738,Ast-487,Small molecule,,,,,Tyrosine-protein kinase receptor RET inhibitor,"Also potent against KDR, FLT4, KIT, and ABL1. Selective inhibitor of mutant FLT3.",,CHEMBL2041,Tyrosine-protein kinase receptor RET,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17638907, URL:http://europepmc.org/abstract/MED/17638907",CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1,CHEMBL2041,RET
479,CHEMBL3545423,Azd-1208,Small molecule,,,,,Serine/threonine-protein kinase PIM inhibitor,,,CHEMBL3559682,Serine/threonine-protein kinase PIM,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:24363397, URL:http://europepmc.org/abstract/MED/24363397",NC1CCCN(C1)c2c(\C=C/3\SC(=O)NC3=O)cccc2c4ccccc4,,
480,CHEMBL3182621,Azd-8330,Small molecule,,,,,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,,,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://cancerres.aacrjournals.org/content/69/9_Supplement/3696, URL:http://cancerres.aacrjournals.org/content/69/9_Supplement/3696|Name:PubMed, SrcID:24434059, URL:http://europepmc.org/abstract/MED/24434059",CN1C(=O)C(=CC(=C1Nc2ccc(I)cc2F)C(=O)NOCCO)C,CHEMBL3587,MAP2K1
481,CHEMBL3545248,Ds-7423,Small molecule,,,,,PI3-kinase class I inhibitor,"Dual MTOR/PI3K inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:24504419, URL:http://europepmc.org/abstract/MED/24504419",,CHEMBL3559703,PIK3R2
482,CHEMBL3545248,Ds-7423,Small molecule,,,,,PI3-kinase class I inhibitor,"Dual MTOR/PI3K inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:24504419, URL:http://europepmc.org/abstract/MED/24504419",,CHEMBL3559703,PIK3R3
483,CHEMBL3545248,Ds-7423,Small molecule,,,,,PI3-kinase class I inhibitor,"Dual MTOR/PI3K inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:24504419, URL:http://europepmc.org/abstract/MED/24504419",,CHEMBL3559703,PIK3R5
484,CHEMBL3545137,Pf-00477736,Small molecule,,,,,Serine/threonine-protein kinase Chk1 inhibitor,,,CHEMBL4630,Serine/threonine-protein kinase Chk1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18723486, URL:http://europepmc.org/abstract/MED/18723486|Name:PubMed, SrcID:19568282, URL:http://europepmc.org/abstract/MED/19568282",Cn1cc(cn1)C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc5C(=O)NNC=C2c35,CHEMBL4630,CHEK1
485,CHEMBL3545326,Tas-119,Small molecule,,,,,Serine/threonine-protein kinase Aurora-A inhibitor,,,CHEMBL4722,Serine/threonine-protein kinase Aurora-A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://www.taihooncology.com/us/science/product-pipeline/, URL:https://www.taihooncology.com/us/science/product-pipeline/|Name:DOI, SrcID:10.1158/1535-7163.TARG-13-A268, URL:http://mct.aacrjournals.org/content/12/11_Supplement/A268",,,
486,CHEMBL3545086,Ly2881835,Small molecule,,,,,Free fatty acid receptor 1 agonist,Discontinueddue to toxicity,,CHEMBL4422,Free fatty acid receptor 1,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25221541, URL:http://europepmc.org/abstract/MED/25221541",,CHEMBL4422,FFAR1
487,CHEMBL3544941,Rg7185,Small molecule,,,,,G protein-coupled receptor 44 antagonist,,,CHEMBL5071,G protein-coupled receptor 44,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.roche.com/irp120608.pdf, URL:http://www.roche.com/irp120608.pdf",,CHEMBL5071,PTGDR2
488,CHEMBL2105648,Palovarotene,Small molecule,,,,-arotene,Retinoic acid receptor gamma agonist,,,CHEMBL2003,Retinoic acid receptor gamma,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22282548, URL:http://europepmc.org/abstract/MED/22282548|Name:Other, SrcID:http://clementiapharma.com/pipeline/palovarotene-faqs/, URL:http://clementiapharma.com/pipeline/palovarotene-faqs/|Name:PubMed, SrcID:19876792, URL:http://europepmc.org/abstract/MED/19876792|Name:PubMed, SrcID:17498389, URL:http://europepmc.org/abstract/MED/17498389",CC1(C)CCC(C)(C)c2cc(\C=C\c3ccc(cc3)C(=O)O)c(Cn4cccn4)cc12,CHEMBL2003,RARG
489,CHEMBL2079588,Telatinib,Small molecule,,,,-tinib,Vascular endothelial growth factor receptor 2 inhibitor,,,CHEMBL279,Vascular endothelial growth factor receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19002179, URL:http://europepmc.org/abstract/MED/19002179|Name:PubMed, SrcID:19636022, URL:http://europepmc.org/abstract/MED/19636022",CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c4ccoc24)ccn1,CHEMBL279,KDR
490,CHEMBL482968,Enmd-2076,Small molecule,,,,,Stem cell growth factor receptor inhibitor,Tartrate salt of ENMD-981693,,CHEMBL1936,Stem cell growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf, URL:http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf|Name:PubMed, SrcID:21177375, URL:http://europepmc.org/abstract/MED/21177375|Name:PubMed, SrcID:22397360, URL:http://europepmc.org/abstract/MED/22397360",CN1CCN(CC1)c2cc(Nc3cc(C)[nH]n3)nc(\C=C\c4ccccc4)n2,CHEMBL1936,KIT
491,CHEMBL254760,Mgcd-265,Small molecule,,,,,Vascular endothelial growth factor receptor inhibitor,,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://meetinglibrary.asco.org/content/96526-114, URL:http://meetinglibrary.asco.org/content/96526-114|Name:PubMed, SrcID:25806189, URL:http://europepmc.org/abstract/MED/25806189",Cn1cnc(c1)c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2,,
492,CHEMBL3545283,Riviciclib,Small molecule,,,,-ciclib,Cyclin-dependent kinase 1 inhibitor,,,CHEMBL308,Cyclin-dependent kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25215591, URL:http://europepmc.org/abstract/MED/25215591|Name:PubMed, SrcID:17363486, URL:http://europepmc.org/abstract/MED/17363486",CN1CCC(C1CO)c2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccccc4Cl,CHEMBL308,CDK1
493,CHEMBL225411,Gw842166x,Small molecule,,,,,Cannabinoid CB2 receptor agonist,,,CHEMBL253,Cannabinoid CB2 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17477516, URL:http://europepmc.org/abstract/MED/17477516",FC(F)(F)c1nc(Nc2ccc(Cl)cc2Cl)ncc1C(=O)NCC3CCOCC3,CHEMBL253,CNR2
494,CHEMBL3545224,Burixafor,Small molecule,,,,-ixafor,C-X-C chemokine receptor type 4 antagonist,,,CHEMBL2107,C-X-C chemokine receptor type 4,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24823505, URL:http://europepmc.org/abstract/MED/24823505|Name:Other, SrcID:http://www.taigenbiotech.com.tw/Product/2-2, URL:http://www.taigenbiotech.com.tw/Product/2-2",Nc1cc(nc(NCC2CCC(CNCCCNC3CCCCC3)CC2)n1)N4CCN(CCP(=O)(O)O)CC4,CHEMBL2107,CXCR4
495,CHEMBL448343,Lesogaberan,Small molecule,,,,-gab-,GABA-B receptor 1 agonist,,,CHEMBL2064,GABA-B receptor 1,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.ncats.nih.gov/files/AZD3355.pdf, URL:http://www.ncats.nih.gov/files/AZD3355.pdf|Name:PubMed, SrcID:20655487, URL:http://europepmc.org/abstract/MED/20655487",NC[C@@H](F)CP(=O)O,CHEMBL2064,GABBR1
496,CHEMBL559478,Ssr180711,Small molecule,,,,,Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist,,,CHEMBL2492,Neuronal acetylcholine receptor protein alpha-7 subunit,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21919481, URL:http://europepmc.org/abstract/MED/21919481|Name:PubMed, SrcID:17019409, URL:http://europepmc.org/abstract/MED/17019409",Brc1ccc(OC(=O)N2CCN3CCC2CC3)cc1,CHEMBL2492,CHRNA7
497,CHEMBL519504,Aleglitazar,Small molecule,,,,-glitazar,Peroxisome proliferator-activated receptor alpha agonist,Development stopped due to safety concerns and lack of efficacy (http://www.roche.com/media/media_releases/med-cor-2013-07-10.htm),,CHEMBL239,Peroxisome proliferator-activated receptor alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Aleglitazar, URL:http://en.wikipedia.org/wiki/Aleglitazar|Name:PubMed, SrcID:1486069, URL:http://europepmc.org/abstract/MED/1486069",CO[C@@H](Cc1ccc(OCCc2nc(oc2C)c3ccccc3)c4ccsc14)C(=O)O,CHEMBL239,PPARA
498,CHEMBL282686,Tesaglitazar,Small molecule,,,,-glitazar,Peroxisome proliferator-activated receptor alpha agonist,"All Ph3 trials terminated, discontinued due to safety concerns (http://en.wikipedia.org/wiki/Tesaglitazar)",,CHEMBL239,Peroxisome proliferator-activated receptor alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Tesaglitazar, URL:http://en.wikipedia.org/wiki/Tesaglitazar|Name:PubMed, SrcID:15059948, URL:http://europepmc.org/abstract/MED/15059948|Name:PubMed, SrcID:16628256, URL:http://europepmc.org/abstract/MED/16628256",CCO[C@@H](Cc1ccc(OCCc2ccc(OS(=O)(=O)C)cc2)cc1)C(=O)O,CHEMBL239,PPARA
499,CHEMBL576982,Quizartinib,Small molecule,,,,-tinib,Tyrosine-protein kinase receptor FLT3 inhibitor,,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23497317, URL:http://europepmc.org/abstract/MED/23497317|Name:PubMed, SrcID:19654408, URL:http://europepmc.org/abstract/MED/19654408",CC(C)(C)c1onc(NC(=O)Nc2ccc(cc2)c3cn4c5ccc(OCCN6CCOCC6)cc5sc4n3)c1,CHEMBL1974,FLT3
500,CHEMBL603469,Lestaurtinib,Small molecule,,,,-tinib,NT-3 growth factor receptor inhibitor,,,CHEMBL5608,NT-3 growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10473107, URL:http://europepmc.org/abstract/MED/10473107",C[C@]12O[C@H](C[C@]1(O)CO)n3c4ccccc4c5c6C(=O)NCc6c7c8ccccc8n2c7c35,CHEMBL5608,NTRK3
501,CHEMBL2110579,Anamorelin,Small molecule,,,,-relin,Ghrelin receptor agonist,,,CHEMBL4616,Ghrelin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25267366, URL:http://europepmc.org/abstract/MED/25267366",CN(C)N(C)C(=O)[C@@]1(Cc2ccccc2)CCCN(C1)C(=O)[C@@H](Cc3c[nH]c4ccccc34)NC(=O)C(C)(C)N,CHEMBL4616,GHSR
502,CHEMBL2107786,Terutroban,Small molecule,,,,-troban,Thromboxane A2 receptor antagonist,Discontinueddue to lack of clinical benefit?,,CHEMBL2069,Thromboxane A2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20050853, URL:http://europepmc.org/abstract/MED/20050853|Name:Wikipedia, SrcID:Terutroban, URL:http://en.wikipedia.org/wiki/Terutroban",Cc1ccc2C[C@@H](CCc2c1CCC(=O)O)NS(=O)(=O)c3ccc(Cl)cc3,CHEMBL2069,TBXA2R
503,CHEMBL266510,Flindokalner,Small molecule,,,,-kalner,Voltage-gated potassium channel subunit Kv7.5 activator,Indication: Stroke,,CHEMBL2925,Voltage-gated potassium channel subunit Kv7.5,ACTIVATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12481191, URL:http://europepmc.org/abstract/MED/12481191|Name:PubMed, SrcID:11890900, URL:http://europepmc.org/abstract/MED/11890900",COc1ccc(Cl)cc1[C@]2(F)C(=O)Nc3cc(ccc23)C(F)(F)F,CHEMBL2925,KCNQ5
504,CHEMBL1742996,Brodalumab,Antibody,2017.0,L04AC12,L04AC12 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Interleukin inhibitors],-mab,Interleukin-17 receptor A antagonist,,,CHEMBL3580485,Interleukin-17 receptor A,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22455412, URL:http://europepmc.org/abstract/MED/22455412",,CHEMBL3580485,IL17RA
505,CHEMBL1173055,Rucaparib,Small molecule,2016.0,,,-parib,"PARP 1, 2 and 3 inhibitor",,,CHEMBL3390820,"PARP 1, 2 and 3",INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2016/209115s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/209115s000lbl.pdf|Name:PubMed, SrcID:19047122 , URL:http://europepmc.org/abstract/MED/19047122",CNCc1ccc(cc1)c2[nH]c3cc(F)cc4C(=O)NCCc2c34,,
506,CHEMBL3137353,Bimagrumab,Antibody,,,,-mab,Activin receptor type-2B antagonist,"BYM338 prevents myostatin- or activin A-induced atrophy through inhibition of Smad2/3 phosphorylation, thus sparing the myosin heavy chain from degradation.",,CHEMBL5466,Activin receptor type-2B,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24298022, URL:http://europepmc.org/abstract/MED/24298022",,CHEMBL5466,ACVR2B
507,CHEMBL1742985,Anrukinzumab,Antibody,,,,-mab,Interleukin-13 inhibitor,"IMA-638 allows IL-13 interaction with IL-13Ralpha1 but blocks recruitment of the IL-4Ralpha–chain to form the high-affinity receptor, inhibiting downstream signal of IL-13/IL-13Ralpha1. Anrukinzumab does not block IL-13 binding to IL-13alpha1 or IL-13alpha2.",,CHEMBL3580486,Interleukin-13,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21622864, URL:http://europepmc.org/abstract/MED/21622864|Name:PubMed, SrcID:25567115, URL:http://europepmc.org/abstract/MED/25567115",,,
508,CHEMBL2108575,Aselizumab,Antibody,,,,-mab,Leukocyte adhesion molecule-1 inhibitor,,,CHEMBL3161,Leukocyte adhesion molecule-1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15483410, URL:http://europepmc.org/abstract/MED/15483410|Name:PubMed, SrcID:19889515, URL:http://europepmc.org/abstract/MED/19889515",,,
509,CHEMBL2109095,Erlizumab,Antibody,,,,-mab,Integrin beta-2 negative modulator,,,CHEMBL3631,Integrin beta-2,NEGATIVE MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11038077, URL:http://europepmc.org/abstract/MED/11038077",,,
510,CHEMBL2109412,L19sip,Antibody,,,,,Fibronectin other,Used as radiolabelled antibody radretumab.,,CHEMBL3810,Fibronectin,OTHER,Homo sapiens,SINGLE PROTEIN,,Targets the ED-B domain of Fibronectin.,"Name:PubMed, SrcID:17519905, URL:http://europepmc.org/abstract/MED/17519905",,CHEMBL3810,FN1
511,CHEMBL567597,Artemisinin,Small molecule,,P01BE01,"P01BE01 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: ANTIMALARIALS: Artemisinin and derivatives, plain]",arte-,Unknown,,,,,,,,,,,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@@]23OO4,,
512,CHEMBL2107731,Axomadol,Small molecule,,,,-adol,Kappa opioid receptor agonist,Haven't found any references that mentioned activity at targets,,CHEMBL237,Kappa opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Axomadol, URL:http://en.wikipedia.org/wiki/Axomadol",COc1cccc(c1)[C@]2(O)C[C@@H](O)CC[C@H]2CN(C)C,CHEMBL237,OPRK1
513,CHEMBL1472,Protirelin,Protein,1976.0,V04CJ02,V04CJ02 [VARIOUS: DIAGNOSTIC AGENTS: OTHER DIAGNOSTIC AGENTS: Tests for thyreoidea function],-relin,Thyrotropin-releasing hormone receptor agonist,,,CHEMBL1810,Thyrotropin-releasing hormone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=af5da799-76bf-415a-9dc7-99c7ddc62bc4#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=af5da799-76bf-415a-9dc7-99c7ddc62bc4#nlm34090-1|Name:PubMed, SrcID:23248581, URL:http://europepmc.org/abstract/MED/23248581",NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H]3CCC(=O)N3,CHEMBL1810,TRHR
514,CHEMBL855,Triprolidine,Small molecule,1983.0,R06AX07,R06AX07 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Other antihistamines for systemic use],,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22629251, URL:http://europepmc.org/abstract/MED/22629251|Name:Wikipedia, SrcID:Triprolidine, URL:http://en.wikipedia.org/wiki/Triprolidine",Cc1ccc(cc1)\C(=C/CN2CCCC2)\c3ccccn3,CHEMBL231,HRH1
515,CHEMBL1201199,Leuprolide,Protein,1985.0,L02AE02,L02AE02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONES AND RELATED AGENTS: Gonadotropin releasing hormone analogues],,Gonadotropin-releasing hormone receptor agonist,,,CHEMBL1855,Gonadotropin-releasing hormone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=fe3228a7-a5e4-40e4-9fe6-b35db60a71ce#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fe3228a7-a5e4-40e4-9fe6-b35db60a71ce#nlm34090-1|Name:FDA, SrcID:label/2016/021343s033,021379s033,021488s030,021731s029lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021343s033,021379s033,021488s030,021731s029lbl.pdf",CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CO)NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)[C@H](Cc5c[nH]cn5)NC(=O)[C@@H]6CCC(=O)N6,CHEMBL1855,GNRHR
516,CHEMBL960,Leflunomide,Small molecule,1998.0,L04AA13,L04AA13 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Selective immunosuppressants],,Dihydroorotate dehydrogenase inhibitor,,,CHEMBL1966,Dihydroorotate dehydrogenase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=320f63f2-fac3-4aee-aff8-85724e00ef52, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=320f63f2-fac3-4aee-aff8-85724e00ef52",Cc1oncc1C(=O)Nc2ccc(cc2)C(F)(F)F,CHEMBL1966,DHODH
517,CHEMBL1549,Hydrocortisone Cypionate,Small molecule,1955.0,S02BA01; C05AA01; D07AA02; H02AB09; D07XA01; S01CB03; A01AC03; A07EA02; S01BA02,"S02BA01 [SENSORY ORGANS: OTOLOGICALS: CORTICOSTEROIDS: Corticosteroids]; C05AA01 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Corticosteroids]; D07AA02 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, weak (group I)]; H02AB09 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Glucocorticoids]; D07XA01 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, OTHER COMBINATIONS: Corticosteroids, weak, other combinations]; S01CB03 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION: Corticosteroids/antiinfectives/mydriatics in combination]; A01AC03 [ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Corticosteroids for local oral treatment]; A07EA02 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Corticosteroids acting locally]; S01BA02 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Corticosteroids, plain]",-cort-,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Glucocorticoid, URL:http://en.wikipedia.org/wiki/Glucocorticoid|Name:DailyMed, SrcID:setid=b221b509-ea5c-427c-94f7-27939957ed97, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b221b509-ea5c-427c-94f7-27939957ed97",C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)COC(=O)CCC5CCCC5)[C@@]4(C)C[C@H](O)[C@H]23,CHEMBL2034,NR3C1
518,CHEMBL1091,Hydrocortisone Acetate,Small molecule,1951.0,D07AA02; D07XA01; S01CB03; A07EA02; A01AC03; H02AB09; S02BA01; S01BA02; C05AA01,"D07AA02 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, weak (group I)]; D07XA01 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, OTHER COMBINATIONS: Corticosteroids, weak, other combinations]; S01CB03 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION: Corticosteroids/antiinfectives/mydriatics in combination]; A07EA02 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Corticosteroids acting locally]; A01AC03 [ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Corticosteroids for local oral treatment]; H02AB09 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Glucocorticoids]; S02BA01 [SENSORY ORGANS: OTOLOGICALS: CORTICOSTEROIDS: Corticosteroids]; S01BA02 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Corticosteroids, plain]; C05AA01 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Corticosteroids]",-cort-,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f0f5a107-1236-8e1a-815d-dec8007c2bc9#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f0f5a107-1236-8e1a-815d-dec8007c2bc9#nlm34090-1|Name:ISBN, SrcID:0443-059748 PP. 421, URL:http://www.isbnsearch.org/isbn/0443059748",CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C,CHEMBL2034,NR3C1
519,CHEMBL1551,Ursodiol,Small molecule,1987.0,A05AA02,A05AA02 [ALIMENTARY TRACT AND METABOLISM: BILE AND LIVER THERAPY: BILE THERAPY: Bile acid preparations],,Bile acid receptor FXR agonist,,,CHEMBL2047,Bile acid receptor FXR,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22414767, URL:http://europepmc.org/abstract/MED/22414767|Name:PubMed, SrcID:22223860, URL:http://europepmc.org/abstract/MED/22223860|Name:PubMed, SrcID:23064163, URL:http://europepmc.org/abstract/MED/23064163",C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,CHEMBL2047,NR1H4
520,CHEMBL691,Ethinyl Estradiol,Small molecule,2001.0,G03CA01; L02AA03,"G03CA01 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ESTROGENS: Natural and semisynthetic estrogens, plain]; L02AA03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONES AND RELATED AGENTS: Estrogens]",,Estrogen receptor alpha agonist,,,CHEMBL206,Estrogen receptor alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:0443-059748 PP. 438, URL:http://www.isbnsearch.org/isbn/0443059748",C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C,CHEMBL206,ESR1
521,CHEMBL1200907,Trilostane,Small molecule,1984.0,H02CA01,"H02CA01 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: ANTIADRENAL PREPARATIONS: Anticorticosteroids]",,3-beta-hydroxysteroid dehydrogenase/delta 5-->4-isomerase type II inhibitor,,,CHEMBL3670,3-beta-hydroxysteroid dehydrogenase/delta 5-->4-isomerase type II,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:0443-059748 PP. 419, URL:http://www.isbnsearch.org/isbn/0443059748|Name:Wikipedia, SrcID:3-beta-HSD, URL:http://en.wikipedia.org/wiki/3-beta-HSD|Name:Wikipedia, SrcID:Cushing%27s_syndrome, URL:http://en.wikipedia.org/wiki/Cushing%27s_syndrome|Name:Wikipedia, SrcID:Trilostane, URL:http://en.wikipedia.org/wiki/Trilostane",C[C@]12CC[C@H]3[C@@H](CC[C@@]45O[C@@H]4C(=C(C[C@]35C)C#N)O)[C@@H]1CC[C@@H]2O,CHEMBL3670,HSD3B2
522,CHEMBL1171837,Ponatinib,Small molecule,2012.0,L01XE24,L01XE24 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Breakpoint cluster region protein inhibitor,,,CHEMBL5146,Breakpoint cluster region protein,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=807f988e-117b-4497-934d-73aa78baac71, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=807f988e-117b-4497-934d-73aa78baac71|Name:PubMed, SrcID:19878872, URL:http://europepmc.org/abstract/MED/19878872",CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc4cnc5cccnn45)cc2C(F)(F)F)CC1,CHEMBL5146,BCR
523,CHEMBL1643,Ribavirin,Small molecule,1985.0,J05AB04,J05AB04 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleosides and nucleotides excl. reverse transcriptase inhibitors],-vir-,Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor,,,CHEMBL5375,Hepatitis C virus NS5B RNA-dependent RNA polymerase,INHIBITOR,Hepatitis C virus,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Ribavirin#Mechanisms_of_action, URL:http://en.wikipedia.org/wiki/Ribavirin#Mechanisms_of_action|Name:PubMed, SrcID:16107837, URL:http://europepmc.org/abstract/MED/16107837",NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O,,
524,CHEMBL1742982,Aflibercept,Protein,2011.0,S01LA05; L01XX44,S01LA05 [SENSORY ORGANS: OPHTHALMOLOGICALS: OCULAR VASCULAR DISORDER AGENTS: Antineovascularisation agents]; L01XX44 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-cept,Placenta growth factor inhibitor,,,CHEMBL1697671,Placenta growth factor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f6725df6-50ee-4b0a-b900-d02ba634395d, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f6725df6-50ee-4b0a-b900-d02ba634395d|Name:DailyMed, SrcID:setid=f96cfd69-da34-41ee-90a9-610a4655cd1c, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f96cfd69-da34-41ee-90a9-610a4655cd1c",,CHEMBL1697671,PGF
525,CHEMBL190,Theophylline,Small molecule,1940.0,R03DA04; R03DA54; R03DA74,R03DA04 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: Xanthines]; R03DA54 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: Xanthines]; R03DA74 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: Xanthines],,Phosphodiesterase 3 inhibitor,,,CHEMBL2094125,Phosphodiesterase 3,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=25b2fdbe-2f18-4153-835a-7a67bff83ef8, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=25b2fdbe-2f18-4153-835a-7a67bff83ef8|Name:Wikipedia, SrcID:Theophylline#Mechanisms_of_action, URL:http://en.wikipedia.org/wiki/Theophylline#Mechanisms_of_action",CN1C(=O)N(C)c2nc[nH]c2C1=O,,
526,CHEMBL44657,Etoposide,Small molecule,1983.0,L01CB01,L01CB01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Podophyllotoxin derivatives],,DNA topoisomerase II inhibitor,,,CHEMBL2094255,DNA topoisomerase II,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:20534341, URL:http://europepmc.org/abstract/MED/20534341|Name:DailyMed, SrcID:setid=508a418e-985f-4208-9324-2230655bb5c2, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=508a418e-985f-4208-9324-2230655bb5c2",COc1cc(cc(OC)c1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)c6cc7OCOc7cc26,,
527,CHEMBL1090,Vidarabine,Small molecule,1976.0,S01AD06; J05AB03,S01AD06 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Antivirals]; J05AB03 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleosides and nucleotides excl. reverse transcriptase inhibitors],-arabine,Human herpesvirus 1 DNA polymerase inhibitor,,,CHEMBL1872,Human herpesvirus 1 DNA polymerase,INHIBITOR,Herpes simplex virus (type 1 / strain 17),SINGLE PROTEIN,,,"Name:PubMed, SrcID:16797734, URL:http://europepmc.org/abstract/MED/16797734",Nc1ncnc2c1ncn2[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3O,,
528,CHEMBL548,Dinoprostone,Small molecule,1977.0,G02AD02,G02AD02 [GENITO URINARY SYSTEM AND SEX HORMONES: OTHER GYNECOLOGICALS: UTEROTONICS: Prostaglandins],-prost-,Prostaglandin E2 receptor agonist,,,CHEMBL2363068,Prostaglandin E2 receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=f1391c7c-233e-44d8-8838-36cc12f01044#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f1391c7c-233e-44d8-8838-36cc12f01044#nlm34090-1|Name:FDA, SrcID:label/2010/019617s010lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/019617s010lbl.pdf",CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(=O)O,,
529,CHEMBL617,Cephalothin,Small molecule,1974.0,J01DB03,J01DB03 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: First-generation cephalosporins],,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:ISBN, SrcID:0-86577-843-4 PP. 270, URL:http://www.isbnsearch.org/isbn/0865778434|Name:Wikipedia, SrcID:DD-transpeptidase, URL:http://en.wikipedia.org/wiki/DD-transpeptidase|Name:PubMed, SrcID:7626623, URL:http://europepmc.org/abstract/MED/7626623",CC(=O)OCC1=C(N2[C@H](SC1)[C@H](NC(=O)Cc3cccs3)C2=O)C(=O)O,,
530,CHEMBL927,Cefdinir,Small molecule,1997.0,J01DD15,J01DD15 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Third-generation cephalosporins],cef-,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:PubMed, SrcID:16801430, URL:http://europepmc.org/abstract/MED/16801430|Name:PubMed, SrcID:17540669, URL:http://europepmc.org/abstract/MED/17540669|Name:Wikipedia, SrcID:Cefdinir#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Cefdinir#Mechanism_of_action|Name:DailyMed, SrcID:setid=a3262279-1f9e-401b-9b02-6da3ef374b46, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a3262279-1f9e-401b-9b02-6da3ef374b46|Name:Wikipedia, SrcID:Penicillin_binding_proteins#Function, URL:http://en.wikipedia.org/wiki/Penicillin_binding_proteins#Function",Nc1nc(cs1)\C(=N\O)\C(=O)N[C@H]2[C@H]3SCC(=C(N3C2=O)C(=O)O)C=C,,
531,CHEMBL1201505,"Fibrinolysin, Human",Unknown,1964.0,B01AD05,B01AD05 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Enzymes],,Fibrinogen inhibitor,,,CHEMBL2364709,Fibrinogen,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:124138, URL:http://europepmc.org/abstract/MED/124138",,CHEMBL2364709,FGA
532,CHEMBL1201505,"Fibrinolysin, Human",Unknown,1964.0,B01AD05,B01AD05 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Enzymes],,Fibrinogen inhibitor,,,CHEMBL2364709,Fibrinogen,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:124138, URL:http://europepmc.org/abstract/MED/124138",,CHEMBL2364709,FGG
533,CHEMBL1256,Isoflurane,Small molecule,1979.0,N01AB06,"N01AB06 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,Potassium channel subfamily K member 9 opener,,,CHEMBL2321614,Potassium channel subfamily K member 9,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:11605899, URL:http://europepmc.org/abstract/MED/11605899|Name:PubMed, SrcID:17227289, URL:http://europepmc.org/abstract/MED/17227289",FC(F)OC(Cl)C(F)(F)F,CHEMBL2321614,KCNK9
534,CHEMBL1255800,Fidaxomicin,Small molecule,2011.0,A07AA12,"A07AA12 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFECTIVES: Antibiotics]",-micin,DNA-directed RNA polymerase inhibitor,,,CHEMBL2363852,DNA-directed RNA polymerase,INHIBITOR,Clostridium difficile,PROTEIN COMPLEX,,,"Name:DailyMed, SrcID:setid=dd966338-c820-4270-b704-09ef75fa3ceb, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dd966338-c820-4270-b704-09ef75fa3ceb",CC[C@H]1\C=C(/C)\[C@@H](O)C\C=C\C=C(/CO[C@@H]2O[C@H](C)[C@@H](OC(=O)c3c(O)c(Cl)c(O)c(Cl)c3CC)[C@H](O)[C@@H]2OC)\C(=O)O[C@@H](C\C=C(/C)\C=C(/C)\[C@@H]1O[C@@H]4OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@@H]4O)[C@@H](C)O,,
535,CHEMBL2104993,Vortioxetine,Small molecule,2013.0,N06AX26,N06AX26 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants],-oxetine,Serotonin 3a (5-HT3a) receptor antagonist,,,CHEMBL1899,Serotonin 3a (5-HT3a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21486038, URL:http://europepmc.org/abstract/MED/21486038|Name:DailyMed, SrcID:4b0700c9-b417-4c3a-b36f-de461e125bd3, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4b0700c9-b417-4c3a-b36f-de461e125bd3",Cc1ccc(Sc2ccccc2N3CCNCC3)c(C)c1,CHEMBL1899,HTR3A
536,CHEMBL1873475,Ibrutinib,Small molecule,2013.0,L01XE27,L01XE27 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Tyrosine-protein kinase BTK inhibitor,Irreversible inhibitor,,CHEMBL5251,Tyrosine-protein kinase BTK,INHIBITOR,Homo sapiens,SINGLE PROTEIN,"Tyrosine-protein kinase BTK, Pkinase_Tyr domain",Binds to a cysteine residue in the BTK active site,"Name:FDA, SrcID:label/2013/205552lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/205552lbl.pdf",Nc1ncnc2c1c(nn2[C@@H]3CCCN(C3)C(=O)C=C)c4ccc(Oc5ccccc5)cc4,CHEMBL5251,BTK
537,CHEMBL1688530,Oritavancin,Unknown,2014.0,J01XA05,J01XA05 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER ANTIBACTERIALS: Glycopeptide antibacterials],,Peptidoglycan inhibitor,,,CHEMBL3041361,Peptidoglycan,INHIBITOR,Bacteria,MACROMOLECULE,,,"Name:FDA, SrcID:label/2014/206334s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206334s000lbl.pdf",CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)c2ccc(Oc3cc4cc(Oc5ccc(cc5Cl)[C@@H](O[C@H]6C[C@](C)(N)[C@@H](O)[C@H](C)O6)[C@@H]7NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H](CC(=O)N)NC1=O)c8ccc(O)c(c8)c9c(O)cc(O)cc9[C@H](NC7=O)C(=O)O)c3O[C@@H]%10O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%10O[C@H]%11C[C@](C)(NCc%12ccc(cc%12)c%13ccc(Cl)cc%13)[C@@H](O)[C@H](C)O%11)c(Cl)c2,,
538,CHEMBL2107830,Empagliflozin,Small molecule,2014.0,A10BK03,"A10BK03 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Sodium-glucose co-transporter 2 (SGLT2) inhibitors]",-gliflozin,Sodium/glucose cotransporter 2 inhibitor,,,CHEMBL3884,Sodium/glucose cotransporter 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2014/204629s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204629s000lbl.pdf",OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)c2ccc(Cl)c(Cc3ccc(O[C@H]4CCOC4)cc3)c2,CHEMBL3884,SLC5A2
539,CHEMBL2096647,Lanthanum Carbonate,Small molecule,2004.0,V03AE03,V03AE03 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Drugs for treatment of hyperkalemia and hyperphosphatemia],,Phosphate sequestering agent,,,CHEMBL2364184,Phosphate,SEQUESTERING AGENT,Homo sapiens,SMALL MOLECULE,,,"Name:FDA, SrcID:label/2011/021468s016lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021468s016lbl.pdf",,,
540,CHEMBL3039583,Pasireotide,Protein,2012.0,H01CB05,"H01CB05 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: HYPOTHALAMIC HORMONES: Somatostatin and analogues]",-tide,Somatostatin receptor 1 agonist,,,CHEMBL1917,Somatostatin receptor 1,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=5504116c-d531-4d47-b160-41c6671d52aa, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5504116c-d531-4d47-b160-41c6671d52aa|Name:DailyMed, SrcID:setid=442f0d9d-5c7d-4b81-b329-d71be8cf2be2, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=442f0d9d-5c7d-4b81-b329-d71be8cf2be2|Name:PubMed, SrcID:22397653, URL:http://europepmc.org/abstract/MED/22397653|Name:PubMed, SrcID:11980628, URL:http://europepmc.org/abstract/MED/11980628",NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](NC(=O)[C@@H]4C[C@@H](CN4C(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](Cc6ccc(OCc7ccccc7)cc6)NC1=O)OC(=O)NCCN)c8ccccc8,CHEMBL1917,SSTR1
541,CHEMBL2107825,Tenofovir Alafenamide,Small molecule,2015.0,J05AF13,J05AF13 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleoside and nucleotide reverse transcriptase inhibitors],-vir,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,Prodrug of tenofovir; active metabolite tenofovir diphosphate,,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,INHIBITOR,Human immunodeficiency virus 1,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=34784acf-15ed-4715-b504-eb30430518e9, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=34784acf-15ed-4715-b504-eb30430518e9",CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)Cn1cnc2c(N)ncnc12)Oc3ccccc3,,
542,CHEMBL3545052,Cudc-907,Small molecule,,,,,PI3-kinase p110-beta subunit inhibitor,Inhibits mainly class I and IIb HDACS (PMID:22693356),,CHEMBL3145,PI3-kinase p110-beta subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22693356, URL:http://europepmc.org/abstract/MED/22693356|Name:Other, SrcID:http://www.curis.com/pipeline/cudc-907, URL:http://www.curis.com/pipeline/cudc-907",,CHEMBL3145,PIK3CB
543,CHEMBL1094408,Nms-1286937,Small molecule,,,,,Serine/threonine-protein kinase PLK1 inhibitor,,,CHEMBL3024,Serine/threonine-protein kinase PLK1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22319201, URL:http://europepmc.org/abstract/MED/22319201|Name:PubMed, SrcID:21470862, URL:http://europepmc.org/abstract/MED/21470862",COc1ccc(cc1Nc2ncc3CCc4c(nn(C)c4c3n2)C(=O)N)N5CCN(C)CC5,CHEMBL3024,PLK1
544,CHEMBL3544930,Sc-80036,Small molecule,,,,,MAP kinase p38 alpha inhibitor,,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17720847, URL:http://europepmc.org/abstract/MED/17720847",,CHEMBL260,MAPK14
545,CHEMBL2326966,Sf-1126,Small molecule,,,,,PI3-kinase class I inhibitor,"Prodrug - active metabolite is LY-294002. Dual MTOR/PI3K inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor.",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:10741711, URL:http://europepmc.org/abstract/MED/10741711|Name:PubMed, SrcID:18172313, URL:http://europepmc.org/abstract/MED/18172313|Name:PubMed, SrcID:8106507, URL:http://europepmc.org/abstract/MED/8106507",NC(=N)NCCC[C@H](NC(=O)CCC(=O)OC[N+]1(CCOCC1)C2=CC(=O)c3cccc(c3O2)c4ccccc4)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)[O-],CHEMBL3559703,PIK3R2
546,CHEMBL2326966,Sf-1126,Small molecule,,,,,PI3-kinase class I inhibitor,"Prodrug - active metabolite is LY-294002. Dual MTOR/PI3K inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor.",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:10741711, URL:http://europepmc.org/abstract/MED/10741711|Name:PubMed, SrcID:18172313, URL:http://europepmc.org/abstract/MED/18172313|Name:PubMed, SrcID:8106507, URL:http://europepmc.org/abstract/MED/8106507",NC(=N)NCCC[C@H](NC(=O)CCC(=O)OC[N+]1(CCOCC1)C2=CC(=O)c3cccc(c3O2)c4ccccc4)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)[O-],CHEMBL3559703,PIK3R3
547,CHEMBL2326966,Sf-1126,Small molecule,,,,,PI3-kinase class I inhibitor,"Prodrug - active metabolite is LY-294002. Dual MTOR/PI3K inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor.",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:10741711, URL:http://europepmc.org/abstract/MED/10741711|Name:PubMed, SrcID:18172313, URL:http://europepmc.org/abstract/MED/18172313|Name:PubMed, SrcID:8106507, URL:http://europepmc.org/abstract/MED/8106507",NC(=N)NCCC[C@H](NC(=O)CCC(=O)OC[N+]1(CCOCC1)C2=CC(=O)c3cccc(c3O2)c4ccccc4)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)[O-],CHEMBL3559703,PIK3R5
548,CHEMBL2392545,Tak-960,Small molecule,,,,,Serine/threonine-protein kinase PLK1 inhibitor,,,CHEMBL3024,Serine/threonine-protein kinase PLK1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22188812, URL:http://europepmc.org/abstract/MED/22188812",COc1cc(C(=O)NC2CCN(C)CC2)c(F)cc1Nc3ncc4N(C)C(=O)C(F)(F)CN(C5CCCC5)c4n3,CHEMBL3024,PLK1
549,CHEMBL3545144,Tas-115,Small molecule,,,,,Hepatocyte growth factor receptor inhibitor,,,CHEMBL3717,Hepatocyte growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://www.taihooncology.com/us/science/product-pipeline/, URL:https://www.taihooncology.com/us/science/product-pipeline/|Name:PubMed, SrcID:24140932, URL:http://europepmc.org/abstract/MED/24140932",,CHEMBL3717,MET
550,CHEMBL398338,Abt-102,Small molecule,,,,,Vanilloid receptor antagonist,,,CHEMBL4794,Vanilloid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18515644, URL:http://europepmc.org/abstract/MED/18515644",CC(C)(C)c1ccc2[C@@H](CCc2c1)NC(=O)Nc3cccc4[nH]ncc34,CHEMBL4794,TRPV1
551,CHEMBL3545206,Gsk1482160,Small molecule,,,,,P2X purinoceptor 7 negative allosteric modulator,,,CHEMBL4805,P2X purinoceptor 7,NEGATIVE ALLOSTERIC MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22568863, URL:http://europepmc.org/abstract/MED/22568863",,CHEMBL4805,P2RX7
552,CHEMBL429317,Avl-3288,Small molecule,,,,,Neuronal acetylcholine receptor protein alpha-7 subunit positive allosteric modulator,Type I positive allosteric modulator.,,CHEMBL2492,Neuronal acetylcholine receptor protein alpha-7 subunit,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26044974, URL:http://europepmc.org/abstract/MED/26044974|Name:PubMed, SrcID:17470817, URL:http://europepmc.org/abstract/MED/17470817|Name:PubMed, SrcID:22804734, URL:http://europepmc.org/abstract/MED/22804734|Name:Other, SrcID:http://anvylllc.com/#/pipeline, URL:http://anvylllc.com/#/pipeline",Cc1cc(on1)\C(=C\Nc2ccc(Cl)cc2)\C(=O)Nc3ccc(Cl)cc3,CHEMBL2492,CHRNA7
553,CHEMBL561132,Mk-7246,Small molecule,,,,,G protein-coupled receptor 44 antagonist,,,CHEMBL5071,G protein-coupled receptor 44,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20943773, URL:http://europepmc.org/abstract/MED/20943773|Name:PubMed, SrcID:21106375, URL:http://europepmc.org/abstract/MED/21106375",CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c4ccc(F)cc4,CHEMBL5071,PTGDR2
554,CHEMBL3707399,Cx1739,Small molecule,,,,,Glutamate receptor ionotropic AMPA positive allosteric modulator,Ampakine molecule.,,CHEMBL2096670,Glutamate receptor ionotropic AMPA,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Other, SrcID:http://www.respirerx.com/development/cx1739.html, URL:http://www.respirerx.com/development/cx1739.html",,,
555,CHEMBL10041,Afimoxifene,Small molecule,,,,-ifene,Estrogen-related receptor gamma antagonist,Active metabolite of tamoxifen,,CHEMBL4245,Estrogen-related receptor gamma,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11447273, URL:http://europepmc.org/abstract/MED/11447273",CC\C(=C(/c1ccccc1)\c2ccc(OCCN(C)C)cc2)\c3ccc(O)cc3,CHEMBL4245,ESRRG
556,CHEMBL495727,At-9283,Small molecule,,,,,Serine/threonine-protein kinase Aurora-A inhibitor,,,CHEMBL4722,Serine/threonine-protein kinase Aurora-A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19143567, URL:http://europepmc.org/abstract/MED/19143567|Name:PubMed, SrcID:20507304, URL:http://europepmc.org/abstract/MED/20507304",O=C(NC1CC1)Nc2c[nH]nc2c3nc4cc(CN5CCOCC5)ccc4[nH]3,,
557,CHEMBL3545396,Bms-690514,Small molecule,,,,,Epidermal growth factor receptor erbB1 inhibitor,,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24130056, URL:http://europepmc.org/abstract/MED/24130056|Name:PubMed, SrcID:21531814, URL:http://europepmc.org/abstract/MED/21531814",COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1,CHEMBL203,EGFR
558,CHEMBL2220486,Lucitanib,Small molecule,,,,-anib,Fibroblast growth factor receptor 1 inhibitor,"E-3810 is an ambiguous research code for this compouynd, also research code for rabeprazole, a proton pump inhibitor.",,CHEMBL3650,Fibroblast growth factor receptor 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://bit.ly/1ZGqyT3, URL:http://bit.ly/1ZGqyT3|Name:PubMed, SrcID:21212416, URL:http://europepmc.org/abstract/MED/21212416|Name:PubMed, SrcID:22304225, URL:http://europepmc.org/abstract/MED/22304225",CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12,CHEMBL3650,FGFR1
559,CHEMBL3545397,Acalisib,Small molecule,,,,-lisib,PI3-kinase p110-delta subunit inhibitor,,,CHEMBL3130,PI3-kinase p110-delta subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24133210, URL:http://europepmc.org/abstract/MED/24133210",,CHEMBL3130,PIK3CD
560,CHEMBL2364611,Galunisertib,Small molecule,,,,-sertib,TGF-beta receptor type I inhibitor,,,CHEMBL4439,TGF-beta receptor type I,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.lillyoncologypipeline.com/tgfbr1-kinase-inhibitor.aspx, URL:http://www.lillyoncologypipeline.com/tgfbr1-kinase-inhibitor.aspx|Name:PubMed, SrcID:25573078, URL:http://europepmc.org/abstract/MED/25573078|Name:PubMed, SrcID:25529192, URL:http://europepmc.org/abstract/MED/25529192",Cc1cccc(n1)c2nn3CCCc3c2c4ccnc5ccc(cc45)C(=O)N,CHEMBL4439,TGFBR1
561,CHEMBL124660,Tandutinib,Small molecule,,,,-tinib,Platelet-derived growth factor receptor beta inhibitor,,,CHEMBL1913,Platelet-derived growth factor receptor beta,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12124172, URL:http://europepmc.org/abstract/MED/12124172|Name:PubMed, SrcID:12166950, URL:http://europepmc.org/abstract/MED/12166950|Name:Other, SrcID:http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804, URL:http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804",COc1cc2c(ncnc2cc1OCCCN3CCCCC3)N4CCN(CC4)C(=O)Nc5ccc(OC(C)C)cc5,CHEMBL1913,PDGFRB
562,CHEMBL253969,Osi-632,Small molecule,,,,,Vascular endothelial growth factor receptor 2 inhibitor,,,CHEMBL279,Vascular endothelial growth factor receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:14612527, URL:http://europepmc.org/abstract/MED/14612527|Name:PubMed, SrcID:17031646, URL:http://europepmc.org/abstract/MED/17031646",NC(=O)c1c(NC(=O)NCCCCN2CCCC2)snc1OCc3c(F)cc(Br)cc3F,CHEMBL279,KDR
563,CHEMBL574737,(7s)-Hydroxyl-Staurosporine,Small molecule,,,,,3-phosphoinositide dependent protein kinase-1 inhibitor,,,CHEMBL2534,3-phosphoinositide dependent protein kinase-1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7907, URL:http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7907|Name:PubMed, SrcID:12892559, URL:http://europepmc.org/abstract/MED/12892559|Name:PubMed, SrcID:19568282, URL:http://europepmc.org/abstract/MED/19568282",CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n3c4ccccc4c5c6[C@H](O)NC(=O)c6c7c8ccccc8n2c7c35,CHEMBL2534,PDPK1
564,CHEMBL3545101,Krp203,Small molecule,,,,,Sphingosine 1-phosphate receptor Edg-1 agonist,,,CHEMBL4333,Sphingosine 1-phosphate receptor Edg-1,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23545505, URL:http://europepmc.org/abstract/MED/23545505",,CHEMBL4333,S1PR1
565,CHEMBL1951914,Azd5672,Small molecule,,,,,C-C chemokine receptor type 5 antagonist,,,CHEMBL274,C-C chemokine receptor type 5,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20662070, URL:http://europepmc.org/abstract/MED/20662070|Name:PubMed, SrcID:22266038, URL:http://europepmc.org/abstract/MED/22266038",CCN(C1CCN(CC[C@H](C2CCN(CC2)S(=O)(=O)C)c3cc(F)cc(F)c3)CC1)C(=O)Cc4ccc(cc4)S(=O)(=O)C,CHEMBL274,CCR5
566,CHEMBL3545163,Amp579,Small molecule,,,,,Adenosine A1 receptor agonist,,,CHEMBL226,Adenosine A1 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16654164, URL:http://www.ncbi.nlm.nih.gov/pubmed/?term=16654164",CCNC(=O)[C@H]1CC([C@H](O)[C@@H]1O)n2ccc3c(NC(CC)Cc4sccc4Cl)ncnc23,CHEMBL226,ADORA1
567,CHEMBL303960,Rivenprost,Small molecule,,,,-prost,Prostanoid EP4 receptor agonist,,,CHEMBL1836,Prostanoid EP4 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15196475, URL:http://europepmc.org/abstract/MED/15196475|Name:PubMed, SrcID:11917107, URL:http://europepmc.org/abstract/MED/11917107",COCc1cccc(C[C@H](O)\C=C\[C@H]2[C@H](O)CC(=O)[C@@H]2CCSCCCC(=O)OC)c1,CHEMBL1836,PTGER4
568,CHEMBL281764,Tabimorelin,Small molecule,,,,-relin,Ghrelin receptor agonist,Ghrelin mimetic. Discontinued lack of efficacy and possible side effects due to CYP3A4 inhibition.,,CHEMBL4616,Ghrelin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10427162, URL:http://europepmc.org/abstract/MED/10427162|Name:Wikipedia, SrcID:Tabimorelin, URL:http://en.wikipedia.org/wiki/Tabimorelin|Name:PubMed, SrcID:11032702, URL:http://europepmc.org/abstract/MED/11032702",CNC(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@@H](Cc2ccc3ccccc3c2)N(C)C(=O)\C=C\CC(C)(C)N,CHEMBL4616,GHSR
569,CHEMBL3545104,Modimelanotide,Protein,,,,-tide,Melanocortin receptor 1 agonist,,,CHEMBL3795,Melanocortin receptor 1,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Modimelanotide, URL:https://en.wikipedia.org/wiki/Modimelanotide|Name:PubMed, SrcID:21703408, URL:http://europepmc.org/abstract/MED/21703408",,CHEMBL3795,MC1R
570,CHEMBL3545226,Acumapimod,Small molecule,,,,-imod,MAP kinase p38 alpha inhibitor,,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25599809, URL:http://europepmc.org/abstract/MED/25599809",,CHEMBL260,MAPK14
571,CHEMBL3545169,Azd1305,Small molecule,,,,,Voltage-gated L-type calcium channel blocker,"L-type calcium channel (CACNA1C, CACNA1D, CACNA1S, CACNA1F)",,CHEMBL2095229,Voltage-gated L-type calcium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:20233758, URL:http://europepmc.org/abstract/MED/20233758|Name:PubMed, SrcID:19528812, URL:http://europepmc.org/abstract/MED/19528812|Name:Wikipedia, SrcID:AZD1305, URL:http://en.wikipedia.org/wiki/AZD1305",CC(C)(C)OC(=O)NCCN1CC2CN(CCOc3ccc(cc3F)C#N)CC(C1)O2,,
572,CHEMBL3545232,Aqw051,Small molecule,,,,,Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist,Alpha-7 nicotinic receptor: consists entirely of a7 subunits (pentamere) CNS-type.,,CHEMBL2492,Neuronal acetylcholine receptor protein alpha-7 subunit,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25172125, URL:http://europepmc.org/abstract/MED/25172125|Name:PubMed, SrcID:25363835, URL:http://europepmc.org/abstract/MED/25363835",Cc1ccc(cc1)c2ccc(OC3CN4CCC3CC4)cn2,CHEMBL2492,CHRNA7
573,CHEMBL2103876,Mapracorat,Small molecule,,,,-corat,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Mapracorat, URL:http://en.wikipedia.org/wiki/Mapracorat|Name:PubMed, SrcID:22898817, URL:http://europepmc.org/abstract/MED/22898817",Cc1ccc2c(NC[C@](O)(CC(C)(C)c3cc(F)cc4CCOc34)C(F)(F)F)cccc2n1,CHEMBL2034,NR3C1
574,CHEMBL186179,Muraglitazar,Small molecule,,,,-glitazar,Peroxisome proliferator-activated receptor gamma agonist,Discontinueddue to safety concerns,,CHEMBL235,Peroxisome proliferator-activated receptor gamma,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23594962, URL:http://europepmc.org/abstract/MED/23594962|Name:PubMed, SrcID:23721199, URL:http://europepmc.org/abstract/MED/23721199|Name:Wikipedia, SrcID:Muraglitazar, URL:http://en.wikipedia.org/wiki/Muraglitazar",COc1ccc(OC(=O)N(CC(=O)O)Cc2ccc(OCCc3nc(oc3C)c4ccccc4)cc2)cc1,CHEMBL235,PPARG
575,CHEMBL603469,Lestaurtinib,Small molecule,,,,-tinib,Neurotrophic tyrosine kinase receptor type 2 inhibitor,,,CHEMBL4898,Neurotrophic tyrosine kinase receptor type 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10473107, URL:http://europepmc.org/abstract/MED/10473107",C[C@]12O[C@H](C[C@]1(O)CO)n3c4ccccc4c5c6C(=O)NCc6c7c8ccccc8n2c7c35,CHEMBL4898,NTRK2
576,CHEMBL2103840,Dinaciclib,Small molecule,,,,-ciclib,Cyclin-dependent kinase 9 inhibitor,,,CHEMBL3116,Cyclin-dependent kinase 9,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25215591, URL:http://europepmc.org/abstract/MED/25215591",CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(nc12)N4CCCC[C@H]4CCO,CHEMBL3116,CDK9
577,CHEMBL2035187,Pacritinib,Small molecule,,,,-tinib,Tyrosine-protein kinase receptor FLT3 inhibitor,,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22829080, URL:http://europepmc.org/abstract/MED/22829080|Name:PubMed, SrcID:22339472, URL:http://europepmc.org/abstract/MED/22339472|Name:PubMed, SrcID:21604762, URL:http://europepmc.org/abstract/MED/21604762",C(CN1CCCC1)Oc2ccc3Nc4nccc(n4)c5cccc(COC\C=C\COCc2c3)c5,CHEMBL1974,FLT3
578,CHEMBL596802,Pridopidine,Small molecule,,,,-dopidine,Dopamine D2 receptor modulator,Dopaminergic stabilizer,,CHEMBL217,Dopamine D2 receptor,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19919834, URL:http://europepmc.org/abstract/MED/19919834|Name:PubMed, SrcID:20667452, URL:http://europepmc.org/abstract/MED/20667452|Name:Wikipedia, SrcID:Pridopidine, URL:http://en.wikipedia.org/wiki/Pridopidine",CCCN1CCC(CC1)c2cccc(c2)S(=O)(=O)C,CHEMBL217,DRD2
579,CHEMBL2063090,Grazoprevir,Small molecule,2016.0,,,-vir,"Hepatitis C virus serine protease, NS3/NS4A inhibitor",,,CHEMBL2095231,"Hepatitis C virus serine protease, NS3/NS4A",INHIBITOR,Hepatitis C virus,PROTEIN COMPLEX,,,"Name:FDA, SrcID:label/2016/208261Orig1s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208261Orig1s000lbl.pdf",COc1ccc2nc3CCCCC[C@@H]4C[C@H]4OC(=O)N[C@H](C(=O)N5C[C@@H](C[C@H]5C(=O)N[C@@]6(C[C@H]6C=C)C(=O)NS(=O)(=O)C7CC7)Oc3nc2c1)C(C)(C)C,,
580,CHEMBL2105762,Omarigliptin,Small molecule,,,,-gliptin,Dipeptidyl peptidase IV inhibitor,,,CHEMBL284,Dipeptidyl peptidase IV,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24660890, URL:http://europepmc.org/abstract/MED/24660890",CS(=O)(=O)n1cc2CN(Cc2n1)[C@H]3CO[C@@H]([C@@H](N)C3)c4cc(F)ccc4F,CHEMBL284,DPP4
581,CHEMBL1094636,Niraparib,Small molecule,2017.0,,,-parib,Poly [ADP-ribose] polymerase-1 inhibitor,,IC(50) inhibition PARP1 (3.8 nM),CHEMBL3105,Poly [ADP-ribose] polymerase-1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19873981, URL:http://europepmc.org/abstract/MED/19873981",NC(=O)c1cccc2cn(nc12)c3ccc(cc3)[C@@H]4CCCNC4,CHEMBL3105,PARP1
582,CHEMBL1743057,Pegsunercept,Protein,,,,-cept; peg-,TNF-alpha inhibitor,,,CHEMBL1825,TNF-alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16331754, URL:http://europepmc.org/abstract/MED/16331754",,CHEMBL1825,TNF
583,CHEMBL2109364,Ar-20.5,Antibody,,,,,Mucin-1 other,Immunostimulant.,,CHEMBL3580494,Mucin-1,OTHER,Homo sapiens,SINGLE PROTEIN,,Recognises the tandem repeat peptide sequence DTRPAP.,"Name:PubMed, SrcID:11839249, URL:http://europepmc.org/abstract/MED/11839249",,,
584,CHEMBL2109458,Amg-108,Antibody,,,,,Interleukin-1 receptor antagonist,Binds the third immunoglobulin domain of the interleukin-1 receptor type 1 (IL-1R1) and nonselectively inhibits the activity of both forms of IL-1 (IL-1alpha and IL-1beta).,,CHEMBL1959,Interleukin-1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21801403, URL:http://europepmc.org/abstract/MED/21801403",,CHEMBL1959,IL1R1
585,CHEMBL3545072,Landogrozumab,Antibody,,,,-mab,Growth/differentiation factor 8 inhibitor,,,CHEMBL3407325,Growth/differentiation factor 8,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26516121, URL:http://europepmc.org/abstract/MED/26516121",,CHEMBL3407325,MSTN
586,CHEMBL3545081,Rg-7304,Small molecule,,,,,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,"Bind allosterically to MEK and prevents its phosphorylation by, and release from, RAF. This results in the formation of a stable Raf-MEK-RO5126766 complex and the inhibition of RAF kinase (PMID:23667175).",,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,,,CHEMBL2964,MAP2K2
587,CHEMBL1346,Darifenacin,Small molecule,2004.0,G04BD10,G04BD10 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Drugs for urinary frequency and incontinence],-fenacin,Muscarinic acetylcholine receptor M3 antagonist,Indicated for overactive bladder,M3 selective,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16465186, URL:http://europepmc.org/abstract/MED/16465186|Name:DailyMed, SrcID:setid=cec47488-ebad-4a3a-904c-e916b432e2cf, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cec47488-ebad-4a3a-904c-e916b432e2cf",NC(=O)C([C@@H]1CCN(CCc2ccc3OCCc3c2)C1)(c4ccccc4)c5ccccc5,CHEMBL245,CHRM3
588,CHEMBL1201619,Aprotinin,Unknown,1993.0,B02AB01,B02AB01 [BLOOD AND BLOOD FORMING ORGANS: ANTIHEMORRHAGICS: ANTIFIBRINOLYTICS: Proteinase inhibitors],,Plasminogen inhibitor,,,CHEMBL1801,Plasminogen,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=8a5982c6-825f-4d05-90f5-1519a7291d15#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8a5982c6-825f-4d05-90f5-1519a7291d15#nlm34090-1",,CHEMBL1801,PLG
589,CHEMBL3039598,Fosinopril,Small molecule,1991.0,C09AA09,"C09AA09 [CARDIOVASCULAR SYSTEM: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM: ACE INHIBITORS, PLAIN: ACE inhibitors, plain]",fos-; -pril,Angiotensin-converting enzyme inhibitor,,,CHEMBL1808,Angiotensin-converting enzyme,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2003/19915se5-037_monopril_lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/19915se5-037_monopril_lbl.pdf|Name:DailyMed, SrcID:setid=eaa753e8-9fda-af0b-9d54-bdf0d1674832, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eaa753e8-9fda-af0b-9d54-bdf0d1674832",CCC(=O)O[C@@H](O[P@](=O)(CCCCc1ccccc1)CC(=O)N2C[C@@H](C[C@H]2C(=O)O)C3CCCCC3)C(C)C,CHEMBL1808,ACE
590,CHEMBL415,Clomipramine,Small molecule,1989.0,N06AA04,N06AA04 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Non-selective monoamine reuptake inhibitors],-pramine,Serotonin transporter inhibitor,reuptake inhibitor,,CHEMBL228,Serotonin transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:9862411, URL:http://europepmc.org/abstract/MED/9862411|Name:DailyMed, SrcID:setid=4074b555-7635-41a9-809d-fae3b3610059#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4074b555-7635-41a9-809d-fae3b3610059#nlm34090-1|Name:PubMed, SrcID:11454918, URL:http://europepmc.org/abstract/MED/11454918|Name:Wikipedia, SrcID:Clomipramine, URL:http://en.wikipedia.org/wiki/Clomipramine",CN(C)CCCN1c2ccccc2CCc3ccc(Cl)cc13,CHEMBL228,SLC6A4
591,CHEMBL445,Nortriptyline,Small molecule,1964.0,N06AA10,N06AA10 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Non-selective monoamine reuptake inhibitors],-triptyline,Serotonin transporter inhibitor,,,CHEMBL228,Serotonin transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2014/018013s063lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/018013s063lbl.pdf|Name:Wikipedia, SrcID:Nortriptyline, URL:http://en.wikipedia.org/wiki/Nortriptyline|Name:DailyMed, SrcID:setid=64e8907b-a0c7-4d7a-a8a7-cbfacab24a4a#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=64e8907b-a0c7-4d7a-a8a7-cbfacab24a4a#nlm34090-1",CNCCC=C1c2ccccc2CCc3ccccc13,CHEMBL228,SLC6A4
592,CHEMBL1201346,Balsalazid,Small molecule,2000.0,A07EC04,"A07EC04 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Aminosalicylic acid and similar agents]",-sal-,Peroxisome proliferator-activated receptor gamma agonist,,,CHEMBL235,Peroxisome proliferator-activated receptor gamma,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18077625, URL:http://europepmc.org/abstract/MED/18077625|Name:PubMed, SrcID:19708827, URL:http://europepmc.org/abstract/MED/19708827|Name:PubMed, SrcID:20151072, URL:http://europepmc.org/abstract/MED/20151072",OC(=O)CCNC(=O)c1ccc(cc1)N=Nc2ccc(O)c(c2)C(=O)O,CHEMBL235,PPARG
593,CHEMBL1201620,Somatrem,Protein,1985.0,H01AC02,"H01AC02 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES: Somatropin and somatropin agonists]",som-,Growth hormone receptor agonist,It's a recombinant protein: methionyl growth hormone approved for the treatment of growth hormone deficiency,,CHEMBL1976,Growth hormone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16330223, URL:http://europepmc.org/abstract/MED/16330223",,CHEMBL1976,GHR
594,CHEMBL669,Cyclobenzaprine,Small molecule,1977.0,M03BX08,"M03BX08 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS: Other centrally acting agents]",,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12498911, URL:http://europepmc.org/abstract/MED/12498911|Name:PubMed, SrcID:8884233, URL:http://europepmc.org/abstract/MED/8884233",CN(C)CCC=C1c2ccccc2C=Cc3ccccc13,CHEMBL224,HTR2A
595,CHEMBL1286,Levetiracetam,Small molecule,1999.0,N03AX14,N03AX14 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],-racetam,Synaptic vesicle glycoprotein 2A modulator,,,CHEMBL1998,Synaptic vesicle glycoprotein 2A,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=90b553fe-4e94-4cce-b5df-ea3e6487930d#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=90b553fe-4e94-4cce-b5df-ea3e6487930d#nlm34090-1",CC[C@H](N1CCCC1=O)C(=O)N,CHEMBL1998,SV2A
596,CHEMBL614,Pyrazinamide,Small molecule,1971.0,J04AK01,J04AK01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOBACTERIALS: DRUGS FOR TREATMENT OF TUBERCULOSIS: Other drugs for treatment of tuberculosis],,Fatty acid synthase inhibitor,,,CHEMBL2011,Fatty acid synthase,INHIBITOR,Mycobacterium tuberculosis,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Pyrazinamide#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Pyrazinamide#Mechanism_of_action|Name:PubMed, SrcID:17101678, URL:http://europepmc.org/abstract/MED/17101678",NC(=O)c1cnccn1,,
597,CHEMBL1200953,Hydrocortisone Probutate,Small molecule,1997.0,D07AB11,"D07AB11 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, moderately potent (group II)]",-cort-,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16980198, URL:http://europepmc.org/abstract/MED/16980198|Name:PubMed, SrcID:16895953, URL:http://europepmc.org/abstract/MED/16895953|Name:PubMed, SrcID:17038445, URL:http://europepmc.org/abstract/MED/17038445|Name:PubMed, SrcID:17086345, URL:http://europepmc.org/abstract/MED/17086345",CCCC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)COC(=O)CC,CHEMBL2034,NR3C1
598,CHEMBL1566,Acarbose,Small molecule,1995.0,A10BF01,"A10BF01 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Alpha glucosidase inhibitors]",,Pancreatic alpha-amylase inhibitor,Competitive reversible inhibitor,,CHEMBL2045,Pancreatic alpha-amylase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=29a6f213-bc93-4dbd-bab0-744722b6f0b8, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=29a6f213-bc93-4dbd-bab0-744722b6f0b8",C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)O[C@@H]3CO)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1N[C@H]4C=C(CO)[C@@H](O)[C@H](O)[C@H]4O,CHEMBL2045,AMY2A
599,CHEMBL637,Venlafaxine,Small molecule,1993.0,N06AX16,N06AX16 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants],-faxine,Norepinephrine transporter inhibitor,,,CHEMBL222,Norepinephrine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f2f03495-12b6-457a-901f-958b9c844bfd#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f2f03495-12b6-457a-901f-958b9c844bfd#nlm34090-1",COc1ccc(cc1)C(CN(C)C)C2(O)CCCCC2,CHEMBL222,SLC6A2
600,CHEMBL1463,Flucytosine,Small molecule,1971.0,J02AX01; D01AE21,J02AX01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: Other antimycotics for systemic use]; D01AE21 [DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Other antifungals for topical use],,Thymidylate synthase inhibitor,,,CHEMBL4665,Thymidylate synthase,INHIBITOR,Cryptococcus neoformans var. neoformans B-3501A,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=820e2477-e247-4349-86fc-144c4a6a289c, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=820e2477-e247-4349-86fc-144c4a6a289c",NC1=C(F)C=NC(=O)N1,,
601,CHEMBL1162,Norethindrone,Small molecule,1962.0,G03AC01; G03DC02,G03AC01 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE: Progestogens]; G03DC02 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: PROGESTOGENS: Estren derivatives],,Progesterone receptor agonist,,,CHEMBL208,Progesterone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10494488, URL:http://europepmc.org/abstract/MED/10494488|Name:PubMed, SrcID:7711211, URL:http://europepmc.org/abstract/MED/7711211|Name:PubMed, SrcID:15261304, URL:http://europepmc.org/abstract/MED/15261304|Name:PubMed, SrcID:15189034, URL:http://europepmc.org/abstract/MED/15189034",C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C,CHEMBL208,PGR
602,CHEMBL844,Brimonidine,Small molecule,1996.0,D11AX21; S01EA05,D11AX21 [DERMATOLOGICALS: OTHER DERMATOLOGICAL PREPARATIONS: OTHER DERMATOLOGICAL PREPARATIONS: Other dermatologicals]; S01EA05 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Sympathomimetics in glaucoma therapy 1)],,Adrenergic receptor alpha-2 agonist,,,CHEMBL2095158,Adrenergic receptor alpha-2,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:11606316, URL:http://europepmc.org/abstract/MED/11606316|Name:PubMed, SrcID:10799649, URL:http://europepmc.org/abstract/MED/10799649|Name:PubMed, SrcID:12670699, URL:http://europepmc.org/abstract/MED/12670699|Name:PubMed, SrcID:11481271, URL:http://europepmc.org/abstract/MED/11481271|Name:PubMed, SrcID:14610637, URL:http://europepmc.org/abstract/MED/14610637|Name:PubMed, SrcID:8097565, URL:http://europepmc.org/abstract/MED/8097565",Brc1c(NC2=NCCN2)ccc3nccnc13,,
603,CHEMBL313833,Tranylcypromine,Small molecule,1961.0,N06AF04,"N06AF04 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Monoamine oxidase inhibitors, non-selective]",,Monoamine oxidase inhibitor,,,CHEMBL2095205,Monoamine oxidase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Wikipedia, SrcID:Monoamine_oxidase_inhibitor, URL:http://en.wikipedia.org/wiki/Monoamine_oxidase_inhibitor|Name:FDA, SrcID:label/2010/012342s063lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/012342s063lbl.pdf",NC1CC1c2ccccc2,,
604,CHEMBL1201347,Anileridine,Small molecule,1982.0,N01AH05,"N01AH05 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Opioid anesthetics]",-eridine,Kappa opioid receptor agonist,,,CHEMBL237,Kappa opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Expert, SrcID:, URL:|Name:PubMed, SrcID:7541439, URL:http://europepmc.org/abstract/MED/7541439",CCOC(=O)C1(CCN(CCc2ccc(N)cc2)CC1)c3ccccc3,CHEMBL237,OPRK1
605,CHEMBL1752,Dyphylline,Small molecule,1951.0,R03DA51; R03DA01,R03DA51 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: Xanthines]; R03DA01 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: Xanthines],,Phosphodiesterase 3A inhibitor,,,CHEMBL241,Phosphodiesterase 3A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:archiveid=55650, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=55650|Name:DailyMed, SrcID:setid=6d7ed7c0-9646-11de-a404-0002a5d5c51b#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d7ed7c0-9646-11de-a404-0002a5d5c51b#nlm34090-1|Name:PubMed, SrcID:21683458, URL:http://europepmc.org/abstract/MED/21683458",CN1C(=O)N(C)c2ncn(CC(O)CO)c2C1=O,CHEMBL241,PDE3A
606,CHEMBL1660,Rifapentine,Small molecule,1998.0,J04AB05,J04AB05 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOBACTERIALS: DRUGS FOR TREATMENT OF TUBERCULOSIS: Antibiotics],rifa-,Bacterial DNA-directed RNA polymerase inhibitor,,,CHEMBL2364672,Bacterial DNA-directed RNA polymerase,INHIBITOR,Bacteria,PROTEIN COMPLEX,RNA polymerase beta/beta prime subunit,Beta subunit is binding site,"Name:PubMed, SrcID:20185278, URL:http://europepmc.org/abstract/MED/20185278|Name:PubMed, SrcID:9661035, URL:http://europepmc.org/abstract/MED/9661035",CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(NC(=O)\C(=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(=O)C)[C@@H]1C)\C)c(\C=N\N5CCN(CC5)C6CCCC6)c(O)c4c3C2=O,,
607,CHEMBL1463,Flucytosine,Small molecule,1971.0,J02AX01; D01AE21,J02AX01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: Other antimycotics for systemic use]; D01AE21 [DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Other antifungals for topical use],,Thymidylate synthase inhibitor,,,CHEMBL2364680,Thymidylate synthase,INHIBITOR,Candida albicans,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=820e2477-e247-4349-86fc-144c4a6a289c, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=820e2477-e247-4349-86fc-144c4a6a289c",NC1=C(F)C=NC(=O)N1,,
608,CHEMBL1201201,Methamphetamine,Small molecule,1943.0,N06BA03,"N06BA03 [NERVOUS SYSTEM: PSYCHOANALEPTICS: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS: Centrally acting sympathomimetics]",,Monoamine transporter inhibitor,,,CHEMBL2363064,Monoamine transporter,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:ISBN, SrcID:0443-059748 PP. 606, URL:http://www.isbnsearch.org/isbn/0443059748|Name:Wikipedia, SrcID:Methamphetamine, URL:http://en.wikipedia.org/wiki/Methamphetamine",CN[C@@H](C)Cc1ccccc1,,
609,CHEMBL655,Midazolam,Small molecule,1985.0,N05CD08,N05CD08 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:Wikipedia, SrcID:Benzodiazepine, URL:http://en.wikipedia.org/wiki/Benzodiazepine|Name:Wikipedia, SrcID:GABAA_receptor, URL:http://en.wikipedia.org/wiki/GABAA_receptor|Name:Wikipedia, SrcID:Midazolam, URL:http://en.wikipedia.org/wiki/Midazolam|Name:ISBN, SrcID:9780702034718 PP. 497, 533, URL:http://www.isbnsearch.org/isbn/9780702034718",Cc1ncc2CN=C(c3ccccc3F)c4cc(Cl)ccc4n12,CHEMBL2093872,GABRG3
610,CHEMBL655,Midazolam,Small molecule,1985.0,N05CD08,N05CD08 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:Wikipedia, SrcID:Benzodiazepine, URL:http://en.wikipedia.org/wiki/Benzodiazepine|Name:Wikipedia, SrcID:GABAA_receptor, URL:http://en.wikipedia.org/wiki/GABAA_receptor|Name:Wikipedia, SrcID:Midazolam, URL:http://en.wikipedia.org/wiki/Midazolam|Name:ISBN, SrcID:9780702034718 PP. 497, 533, URL:http://www.isbnsearch.org/isbn/9780702034718",Cc1ncc2CN=C(c3ccccc3F)c4cc(Cl)ccc4n12,CHEMBL2093872,GABRP
611,CHEMBL655,Midazolam,Small molecule,1985.0,N05CD08,N05CD08 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:Wikipedia, SrcID:Benzodiazepine, URL:http://en.wikipedia.org/wiki/Benzodiazepine|Name:Wikipedia, SrcID:GABAA_receptor, URL:http://en.wikipedia.org/wiki/GABAA_receptor|Name:Wikipedia, SrcID:Midazolam, URL:http://en.wikipedia.org/wiki/Midazolam|Name:ISBN, SrcID:9780702034718 PP. 497, 533, URL:http://www.isbnsearch.org/isbn/9780702034718",Cc1ncc2CN=C(c3ccccc3F)c4cc(Cl)ccc4n12,CHEMBL2093872,GABRE
612,CHEMBL655,Midazolam,Small molecule,1985.0,N05CD08,N05CD08 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:Wikipedia, SrcID:Benzodiazepine, URL:http://en.wikipedia.org/wiki/Benzodiazepine|Name:Wikipedia, SrcID:GABAA_receptor, URL:http://en.wikipedia.org/wiki/GABAA_receptor|Name:Wikipedia, SrcID:Midazolam, URL:http://en.wikipedia.org/wiki/Midazolam|Name:ISBN, SrcID:9780702034718 PP. 497, 533, URL:http://www.isbnsearch.org/isbn/9780702034718",Cc1ncc2CN=C(c3ccccc3F)c4cc(Cl)ccc4n12,CHEMBL2093872,GABRG1
613,CHEMBL74632,Moxalactam,Small molecule,1982.0,J01DD06,J01DD06 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Third-generation cephalosporins],,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:ISBN, SrcID:0443-059748 PP. 694, URL:http://www.isbnsearch.org/isbn/0443059748|Name:Wikipedia, SrcID:Latamoxef, URL:http://en.wikipedia.org/wiki/Latamoxef|Name:ISBN, SrcID:0471-948470 PP. 495, URL:http://www.isbnsearch.org/isbn/0471948470",CO[C@]1(NC(=O)C(C(=O)O)c2ccc(O)cc2)[C@H]3OCC(=C(N3C1=O)C(=O)O)CSc4nnnn4C,,
614,CHEMBL1200733,Desflurane,Small molecule,1992.0,N01AB07,"N01AB07 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,Potassium channel subfamily K member 18 opener,,,CHEMBL2331042,Potassium channel subfamily K member 18,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:15562060, URL:http://europepmc.org/abstract/MED/15562060|Name:PubMed, SrcID:16192517, URL:http://europepmc.org/abstract/MED/16192517|Name:PubMed, SrcID:17227289, URL:http://europepmc.org/abstract/MED/17227289",FC(F)OC(F)C(F)(F)F,CHEMBL2331042,KCNK18
615,CHEMBL569,Procaine,Small molecule,1954.0,C05AD05; N01BA02; N01BA52; S01HA05,"C05AD05 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Local anesthetics]; N01BA02 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Esters of aminobenzoic acid]; N01BA52 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Esters of aminobenzoic acid]; S01HA05 [SENSORY ORGANS: OPHTHALMOLOGICALS: LOCAL ANESTHETICS: Local anesthetics]",-caine,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:ISBN, SrcID:9780702034718 PP. 525, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:9768788, URL:http://europepmc.org/abstract/MED/9768788|Name:Wikipedia, SrcID:Procaine, URL:http://en.wikipedia.org/wiki/Procaine|Name:PubMed, SrcID:2167458, URL:http://europepmc.org/abstract/MED/2167458|Name:PubMed, SrcID:8581044, URL:http://europepmc.org/abstract/MED/8581044",CCN(CC)CCOC(=O)c1ccc(N)cc1,,
616,CHEMBL428880,Cromolyn,Small molecule,1982.0,S01GX01; R01AC51; R03BC01; A07EB01; R01AC01; S01GX51; D11AH03,"S01GX01 [SENSORY ORGANS: OPHTHALMOLOGICALS: DECONGESTANTS AND ANTIALLERGICS: Other antiallergics]; R01AC51 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Antiallergic agents, excl. corticosteroids]; R03BC01 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS: Antiallergic agents, excl. corticosteroids]; A07EB01 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Antiallergic agents, excl. corticosteroids]; R01AC01 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Antiallergic agents, excl. corticosteroids]; S01GX51 [SENSORY ORGANS: OPHTHALMOLOGICALS: DECONGESTANTS AND ANTIALLERGICS: Other antiallergics]; D11AH03 [DERMATOLOGICALS: OTHER DERMATOLOGICAL PREPARATIONS: OTHER DERMATOLOGICAL PREPARATIONS: Agents for dermatitis, excluding corticosteroids]",,Unknown,,,,,,,,,,"Name:FDA, SrcID:anda/2000/75-271_Cromolyn%20Sodium_prntlbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/anda/2000/75-271_Cromolyn%20Sodium_prntlbl.pdf|Name:DailyMed, SrcID:setid=7179a2e5-f2e5-4b68-9ea6-92d0f680f1a7, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7179a2e5-f2e5-4b68-9ea6-92d0f680f1a7",OC(COc1cccc2OC(=CC(=O)c12)C(=O)O)COc3cccc4OC(=CC(=O)c34)C(=O)O,,
617,CHEMBL547,Isotretinoin,Small molecule,1982.0,D10AD04; D10AD54; D10BA01,D10AD04 [DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Retinoids for topical use in acne]; D10AD54 [DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Retinoids for topical use in acne]; D10BA01 [DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE: Retinoids for treatment of acne],-retin-,Retinoic acid receptor agonist,Prodrug. RARG/RXRA are predominant forms in skin,,CHEMBL2363069,Retinoic acid receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:20436884, URL:http://europepmc.org/abstract/MED/20436884",C\C(=C\C(=O)O)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C,,
618,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor,,,CHEMBL3391681,Mitochondrial glycerol-3-phosphate dehydrogenase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24847880, URL:http://europepmc.org/abstract/MED/24847880",CN(C)C(=N)NC(=N)N,CHEMBL3391681,GPD2
619,CHEMBL3039583,Pasireotide,Protein,2012.0,H01CB05,"H01CB05 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: HYPOTHALAMIC HORMONES: Somatostatin and analogues]",-tide,Somatostatin receptor 5 agonist,,,CHEMBL1792,Somatostatin receptor 5,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=5504116c-d531-4d47-b160-41c6671d52aa, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5504116c-d531-4d47-b160-41c6671d52aa|Name:PubMed, SrcID:22397653, URL:http://europepmc.org/abstract/MED/22397653|Name:DailyMed, SrcID:setid=442f0d9d-5c7d-4b81-b329-d71be8cf2be2, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=442f0d9d-5c7d-4b81-b329-d71be8cf2be2|Name:PubMed, SrcID:11980628, URL:http://europepmc.org/abstract/MED/11980628",NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](NC(=O)[C@@H]4C[C@@H](CN4C(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](Cc6ccc(OCc7ccccc7)cc6)NC1=O)OC(=O)NCCN)c8ccccc8,CHEMBL1792,SSTR5
620,CHEMBL3545160,Su-14813,Small molecule,,,,,Tyrosine-protein kinase receptor FLT3 inhibitor,,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16891463, URL:http://europepmc.org/abstract/MED/16891463",,CHEMBL1974,FLT3
621,CHEMBL272621,Hyodeoxycholic_Acid,Small molecule,,,,,LXR-beta agonist,,,CHEMBL4093,LXR-beta,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10936612, URL:http://europepmc.org/abstract/MED/10936612|Name:PubMed, SrcID:24833295, URL:http://europepmc.org/abstract/MED/24833295",C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3C[C@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,CHEMBL4093,NR1H2
622,CHEMBL3545295,Ave0847,Small molecule,,,,,Peroxisome proliferator-activated receptor gamma agonist,Development discontinued (http://fr.reuters.com/article/idUKL0461650920080404),,CHEMBL235,Peroxisome proliferator-activated receptor gamma,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://ncats.nih.gov/files/AVE0847.pdf, URL:https://ncats.nih.gov/files/AVE0847.pdf|Name:PubMed, SrcID:20932114, URL:http://europepmc.org/abstract/MED/20932114",,CHEMBL235,PPARG
623,CHEMBL129857,As-602868,Small molecule,,,,,Tyrosine-protein kinase receptor FLT3 inhibitor,,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17330097, URL:http://europepmc.org/abstract/MED/17330097",COc1cccc2nc(nc(NN3C(=O)C=C(C)C3=O)c12)c4cccs4,CHEMBL1974,FLT3
624,CHEMBL3545251,Sulfatinib,Small molecule,,,,sulfa-; -tinib,Fibroblast growth factor receptor 1 inhibitor,,,CHEMBL3650,Fibroblast growth factor receptor 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=760894, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=760894|Name:Other, SrcID:http://www.hmplglobal.com/en/sulfatinib/, URL:http://www.hmplglobal.com/en/sulfatinib/|Name:ClinicalTrials, SrcID:NCT02133157, URL:https://www.clinicaltrials.gov/ct2/show/NCT02133157",,CHEMBL3650,FGFR1
625,CHEMBL3545322,Panulisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,ATP-competitive mTORC1/mTORC2 inhibitor,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:25700704, URL:http://europepmc.org/abstract/MED/25700704",,CHEMBL3559703,PIK3R2
626,CHEMBL3545322,Panulisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,ATP-competitive mTORC1/mTORC2 inhibitor,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:25700704, URL:http://europepmc.org/abstract/MED/25700704",,CHEMBL3559703,PIK3R3
627,CHEMBL3545322,Panulisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,ATP-competitive mTORC1/mTORC2 inhibitor,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:25700704, URL:http://europepmc.org/abstract/MED/25700704",,CHEMBL3559703,PIK3R5
628,CHEMBL3545008,Sar-260301,Small molecule,,,,,PI3-kinase p110-beta subunit inhibitor,,,CHEMBL3145,PI3-kinase p110-beta subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24387221, URL:http://europepmc.org/abstract/MED/24387221",,CHEMBL3145,PIK3CB
629,CHEMBL3545202,Vx-970,Small molecule,,,,,Serine-protein kinase ATR inhibitor,,,CHEMBL5024,Serine-protein kinase ATR,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23222511, URL:http://europepmc.org/abstract/MED/23222511|Name:PubMed, SrcID:25010037, URL:http://europepmc.org/abstract/MED/25010037",,CHEMBL5024,ATR
630,CHEMBL3545328,Xl-019,Small molecule,,,,,Tyrosine-protein kinase JAK2 inhibitor,,,CHEMBL2971,Tyrosine-protein kinase JAK2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24766055, URL:http://europepmc.org/abstract/MED/24766055|Name:PubMed, SrcID:24374145, URL:http://europepmc.org/abstract/MED/24374145",O=C(Nc1ccc(cc1)c2ccnc(Nc3ccc(cc3)N4CCOCC4)n2)C5CCCN5,CHEMBL2971,JAK2
631,CHEMBL197669,St1535,Small molecule,,,,,Adenosine A2a receptor antagonist,,,CHEMBL251,Adenosine A2a receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16867213, URL:http://europepmc.org/abstract/MED/16867213|Name:PubMed, SrcID:25821194, URL:http://europepmc.org/abstract/MED/25821194",CCCCc1nc(N)c2nc(n(C)c2n1)n3nccn3,CHEMBL251,ADORA2A
632,CHEMBL3545332,Cep-2563,Small molecule,,,,,Protein kinase C (PKC) inhibitor,,,CHEMBL2093867,Protein kinase C (PKC),INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10344749, URL:http://europepmc.org/abstract/MED/10344749",,,
633,CHEMBL3707355,Azd8108,Small molecule,,,,,Glutamate [NMDA] receptor antagonist,,,CHEMBL2094124,Glutamate [NMDA] receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Other, SrcID:http://adisinsight.springer.com/drugs/800041394, URL:http://adisinsight.springer.com/drugs/800041394|Name:Other, SrcID:https://www.astrazeneca.com/our-science/pipeline.html, URL:https://www.astrazeneca.com/our-science/pipeline.html",,CHEMBL2094124,GRIN3B
634,CHEMBL1716091,Sdx-101,Small molecule,,,,,Retinoid X receptor alpha modulator,"R-enantiomer of etodolac, does not have COX inhibitory activity. Ph2 trials terminated. Received orphan product designation by FDA in 2002",,CHEMBL2061,Retinoid X receptor alpha,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25434990, URL:http://europepmc.org/abstract/MED/25434990|Name:PubMed, SrcID:15699354, URL:http://europepmc.org/abstract/MED/15699354",CCc1cccc2c3CCO[C@](CC)(CC(=O)O)c3[nH]c12,CHEMBL2061,RXRA
635,CHEMBL482968,Enmd-2076,Small molecule,,,,,Macrophage colony stimulating factor receptor inhibitor,Tartrate salt of ENMD-981693,,CHEMBL1844,Macrophage colony stimulating factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf, URL:http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf|Name:PubMed, SrcID:21177375, URL:http://europepmc.org/abstract/MED/21177375|Name:PubMed, SrcID:22397360, URL:http://europepmc.org/abstract/MED/22397360",CN1CCN(CC1)c2cc(Nc3cc(C)[nH]n3)nc(\C=C\c4ccccc4)n2,CHEMBL1844,CSF1R
636,CHEMBL3188267,Capmatinib,Small molecule,,,,-tinib,Hepatocyte growth factor receptor inhibitor,,,CHEMBL3717,Hepatocyte growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://cancerres.aacrjournals.org/content/68/9_Supplement/2577, URL:http://cancerres.aacrjournals.org/content/68/9_Supplement/2577|Name:Other, SrcID:http://www.novartisoncology.com/ct/pipelineDetails?compound=INC280&diseaseAcr=NSCLC, URL:http://www.novartisoncology.com/ct/pipelineDetails?compound=INC280&diseaseAcr=NSCLC|Name:Other, SrcID:http://clincancerres.aacrjournals.org/content/early/2011/09/14/1078-0432.CCR-11-1157.full.pdf, URL:http://clincancerres.aacrjournals.org/content/early/2011/09/14/1078-0432.CCR-11-1157.full.pdf",CNC(=O)c1ccc(cc1F)c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2,CHEMBL3717,MET
637,CHEMBL3087515,Mavoglurant,Small molecule,,,,-glurant,Metabotropic glutamate receptor 5 antagonist,,,CHEMBL3227,Metabotropic glutamate receptor 5,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25316499, URL:http://europepmc.org/abstract/MED/25316499",COC(=O)N1CC[C@@H]2[C@H]1CCC[C@@]2(O)C#Cc3cccc(C)c3,CHEMBL3227,GRM5
638,CHEMBL3545161,Ly545694,Small molecule,,,,,Metabotropic glutamate receptor 5 antagonist,,,CHEMBL3227,Metabotropic glutamate receptor 5,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24486883, URL:http://europepmc.org/abstract/MED/24486883|Name:PubMed, SrcID:24631589, URL:http://europepmc.org/abstract/MED/24631589",,CHEMBL3227,GRM5
639,CHEMBL3544948,Klh-2109,Small molecule,,,,,Gonadotropin-releasing hormone receptor antagonist,,,CHEMBL1855,Gonadotropin-releasing hormone receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.kissei.co.jp/e_contents/rd/pipeline/index.html, URL:http://www.kissei.co.jp/e_contents/rd/pipeline/index.html",,CHEMBL1855,GNRHR
640,CHEMBL2105635,Davalintide,Protein,,,,-tide,Calcitonin gene-related peptide type 1 receptor agonist,"Peptide, active fragment of ADNP",,CHEMBL3798,Calcitonin gene-related peptide type 1 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19935749, URL:http://europepmc.org/abstract/MED/19935749",CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](C)O)C(=O)N1)C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)N)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc5ccc(O)cc5)C(=O)N,,
641,CHEMBL3545233,Azd2624,Small molecule,,,,,Neurokinin 3 receptor antagonist,,,CHEMBL4429,Neurokinin 3 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://openinnovation.astrazeneca.com/what-we-offer/compound/azd2624/, URL:http://openinnovation.astrazeneca.com/what-we-offer/compound/azd2624/|Name:PubMed, SrcID:24525659, URL:http://europepmc.org/abstract/MED/24525659",CC[C@H](NC(=O)c1c(NS(=O)(=O)C)c(nc2ccccc12)c3ccccc3)c4ccccc4,CHEMBL4429,TACR3
642,CHEMBL522892,Dovitinib,Small molecule,,,,-tinib,Stem cell growth factor receptor inhibitor,,,CHEMBL1936,Stem cell growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15897558, URL:http://europepmc.org/abstract/MED/15897558",CN1CCN(CC1)c2ccc3nc([nH]c3c2)C4=C(N)c5c(F)cccc5NC4=O,CHEMBL1936,KIT
643,CHEMBL2364605,Cebranopadol,Small molecule,,,,-adol,Nociceptin receptor agonist,,,CHEMBL2014,Nociceptin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25147603, URL:http://europepmc.org/abstract/MED/25147603|Name:Wikipedia, SrcID:¿-opioid_receptor, URL:http://en.wikipedia.org/wiki/¿-opioid_receptor|Name:PubMed, SrcID:24713140, URL:http://europepmc.org/abstract/MED/24713140",CN(C)[C@@]1(CC[C@]2(CC1)OCCc3c2[nH]c4ccc(F)cc34)c5ccccc5,CHEMBL2014,OPRL1
644,CHEMBL1743078,Teplizumab,Antibody,,,,-mab,T-cell surface glycoprotein CD3 epsilon chain other,It binds to an epitope of the CD3-epsilon chain expressed on mature T cells. Modulates the T-cell receptor (TCR)–CD3 complex resulting in the cells becoming 'blind' to antigen (antigenic immunomodulation of the TCR complex).,,CHEMBL1975,T-cell surface glycoprotein CD3 epsilon chain,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17641665, URL:http://europepmc.org/abstract/MED/17641665|Name:PubMed, SrcID:10716879, URL:http://europepmc.org/abstract/MED/10716879",,CHEMBL1975,CD3E
645,CHEMBL2103778,Cilansetron,Small molecule,,A03AE03,A03AE03 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: Serotonin receptor antagonists],-setron,Serotonin 3 (5-HT3) receptor antagonist,,,CHEMBL2111332,Serotonin 3 (5-HT3) receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:10653012, URL:http://europepmc.org/abstract/MED/10653012",Cc1nccn1C[C@H]2CCc3c(C2=O)c4cccc5CCCn3c45,CHEMBL2111332,HTR3B
646,CHEMBL3833393,Emicizumab,Antibody,,,,-mab,Coagulation factor IX and X other,"Binds to and bridges activated factor IX (factor IXa) and factor X, thereby acting as a factor VIII–mimetic agent",Very weak antigen-binding affinity,CHEMBL2111424,Coagulation factor IX and X,OTHER,Homo sapiens,SELECTIVITY GROUP,,,"Name:PubMed, SrcID:27223146, URL:http://europepmc.org/abstract/MED/27223146|Name:PubMed, SrcID:24738137, URL:http://europepmc.org/abstract/MED/24738137",,,
647,CHEMBL1743032,Intetumumab,Antibody,,,,-mab,Integrin alpha-V/beta-5 antagonist,,,CHEMBL2096675,Integrin alpha-V/beta-5,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:15095296, URL:http://europepmc.org/abstract/MED/15095296",,CHEMBL2096675,ITGB5
648,CHEMBL1743050,Olokizumab,Antibody,,,,-mab,Interleukin-6 inhibitor,"Binds to IL-6 at Site 3 and neutralizes biological activity through blocking hexamer (of two molecules each of IL6, IL6R and IL6ST/gp130) formation on the IL6ST/gp130 signaling axis.",,CHEMBL1795129,Interleukin-6,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24670876, URL:http://europepmc.org/abstract/MED/24670876",,CHEMBL1795129,IL6
649,CHEMBL3833308,Biib059,Antibody,,,,,C-type lectin domain family 4 member C inhibitor,Humanized IgG1 mAb that specifically recognizes BDCA2 expressed exclusively on the surface ofplasmacytoid dendritic cells (pDCs). BIIB059 binding triggers BDCA2 internalization and potently inhibits TLR7/9-induced Type I IFN and other cytokines produced by pDCs,,CHEMBL2176855,C-type lectin domain family 4 member C,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25762615, URL:http://europepmc.org/abstract/MED/25762615",,CHEMBL2176855,CLEC4C
650,CHEMBL3545323,Pwt-33579,Small molecule,,,,,PI3-kinase p110-alpha subunit inhibitor,No references found,,CHEMBL4005,PI3-kinase p110-alpha subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,,,CHEMBL4005,PIK3CA
651,CHEMBL1900528,Tiotropium,Small molecule,2004.0,,,-ium; -trop-,Muscarinic acetylcholine receptor M3 antagonist,"Indicated for COPD, M3 likely responsible",,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=1cf82d42-5ad0-4b86-838e-9230c61cf3d4#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1cf82d42-5ad0-4b86-838e-9230c61cf3d4#nlm34090-1",C[N+]1(C)[C@@H]2C[C@H](C[C@H]1[C@@H]3O[C@H]23)OC(=O)C(O)(c4cccs4)c5cccs5,CHEMBL245,CHRM3
652,CHEMBL1201866,Liraglutide,Protein,2010.0,A10BJ02,"A10BJ02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Glucagon-like peptide-1 (GLP-1) analogues]",-tide,Glucagon-like peptide 1 receptor agonist,,,CHEMBL1784,Glucagon-like peptide 1 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=5a9ef4ea-c76a-4d34-a604-27c5b505f5a4, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5a9ef4ea-c76a-4d34-a604-27c5b505f5a4",,CHEMBL1784,GLP1R
653,CHEMBL220491,Brinzolamide,Small molecule,1998.0,S01EC04; S01EC54,S01EC04 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Carbonic anhydrase inhibitors]; S01EC54 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Carbonic anhydrase inhibitors],-zolamide,Carbonic anhydrase II inhibitor,,,CHEMBL205,Carbonic anhydrase II,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=e9ea2ae7-1b98-4034-9fba-8ce2225e0145#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e9ea2ae7-1b98-4034-9fba-8ce2225e0145#nlm34090-1",CCN[C@H]1CN(CCCOC)S(=O)(=O)c2sc(cc12)S(=O)(=O)N,CHEMBL205,CA2
654,CHEMBL178,Daunorubicin,Small molecule,1979.0,L01DB02,L01DB02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES: Anthracyclines and related substances],-rubicin,DNA topoisomerase II alpha inhibitor,,,CHEMBL1806,DNA topoisomerase II alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:archiveid=69731, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=69731|Name:DailyMed, SrcID:setid=326cd915-5d90-46a5-9a27-af39b9ced7cc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=326cd915-5d90-46a5-9a27-af39b9ced7cc|Name:Wikipedia, SrcID:Daunorubicin, URL:http://en.wikipedia.org/wiki/Daunorubicin|Name:DailyMed, SrcID:archiveid=215669, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=215669",COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)C,CHEMBL1806,TOP2A
655,CHEMBL1117,Idarubicin,Small molecule,1990.0,L01DB06,L01DB06 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES: Anthracyclines and related substances],-rubicin,DNA topoisomerase II alpha inhibitor,,,CHEMBL1806,DNA topoisomerase II alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Type_II_topoisomerase, URL:http://en.wikipedia.org/wiki/Type_II_topoisomerase|Name:DailyMed, SrcID:setid=0a5a6d93-cc1e-4d7f-8da1-446c134503b3, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0a5a6d93-cc1e-4d7f-8da1-446c134503b3",C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]2C[C@@](O)(Cc3c(O)c4C(=O)c5ccccc5C(=O)c4c(O)c23)C(=O)C,CHEMBL1806,TOP2A
656,CHEMBL1492,Diphenylpyraline,Small molecule,1982.0,R06AA07; R06AA57,R06AA07 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Aminoalkyl ethers]; R06AA57 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Aminoalkyl ethers],,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Diphenylpyraline, URL:http://en.wikipedia.org/wiki/Diphenylpyraline|Name:PubMed, SrcID:22445882, URL:http://europepmc.org/abstract/MED/22445882",CN1CCC(CC1)OC(c2ccccc2)c3ccccc3,CHEMBL231,HRH1
657,CHEMBL1252,Abarelix,Protein,2003.0,L02BX01,L02BX01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONE ANTAGONISTS AND RELATED AGENTS: Other hormone antagonists and related agents],-relix,Gonadotropin-releasing hormone receptor antagonist,,,CHEMBL1855,Gonadotropin-releasing hormone receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2003/21320_plenaxis_lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21320_plenaxis_lbl.pdf",CC(C)C[C@H](NC(=O)[C@@H](CC(=O)N)NC(=O)[C@H](Cc1ccc(O)cc1)N(C)C(=O)[C@H](CO)NC(=O)[C@@H](Cc2cccnc2)NC(=O)[C@@H](Cc3ccc(Cl)cc3)NC(=O)[C@@H](Cc4ccc5ccccc5c4)NC(=O)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N6CCC[C@H]6C(=O)N[C@H](C)C(=O)N,CHEMBL1855,GNRHR
658,CHEMBL98,Vorinostat,Small molecule,2006.0,L01XX38,L01XX38 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-stat,Histone deacetylase 6 inhibitor,,,CHEMBL1865,Histone deacetylase 6,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13",ONC(=O)CCCCCCC(=O)Nc1ccccc1,CHEMBL1865,HDAC6
659,CHEMBL456,Ethacrynic Acid,Small molecule,1967.0,C03CC01,C03CC01 [CARDIOVASCULAR SYSTEM: DIURETICS: HIGH-CEILING DIURETICS: Aryloxyacetic acid derivatives],,Sodium-(potassium)-chloride cotransporter 2 inhibitor,,,CHEMBL1874,Sodium-(potassium)-chloride cotransporter 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1056/NEJMra0907219, URL:http://www.nejm.org/doi/full/10.1056/NEJMra0907219",CCC(=C)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl,CHEMBL1874,SLC12A1
660,CHEMBL902,Famotidine,Small molecule,1986.0,A02BA03; A02BA53,A02BA03 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): H2-receptor antagonists]; A02BA53 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): H2-receptor antagonists],-tidine,Histamine H2 receptor antagonist,,,CHEMBL1941,Histamine H2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=1893ed5d-eddc-49ea-94d0-b839e0b1bfc9, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1893ed5d-eddc-49ea-94d0-b839e0b1bfc9",NC(=N)Nc1nc(CSCCC(=N)NS(=O)(=O)N)cs1,CHEMBL1941,HRH2
661,CHEMBL1201264,Methantheline,Small molecule,1951.0,A03AB07,"A03AB07 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: Synthetic anticholinergics, quaternary ammonium compounds]",,Histamine H2 receptor antagonist,,,CHEMBL1941,Histamine H2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:6116801, URL:http://europepmc.org/abstract/MED/6116801",CC[N+](C)(CC)CCOC(=O)C1c2ccccc2Oc3ccccc13,CHEMBL1941,HRH2
662,CHEMBL1444,Letrozole,Small molecule,1997.0,L02BG04,L02BG04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONE ANTAGONISTS AND RELATED AGENTS: Aromatase inhibitors],-rozole,Cytochrome P450 19A1 inhibitor,,,CHEMBL1978,Cytochrome P450 19A1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=82b77d74-085f-45ac-a7dd-1f5c038bf406#section-12, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=82b77d74-085f-45ac-a7dd-1f5c038bf406#section-12",N#Cc1ccc(cc1)C(c2ccc(cc2)C#N)n3cncn3,CHEMBL1978,CYP19A1
663,CHEMBL1201640,Insulin Zinc Susp Extended Beef,Protein,1982.0,,,,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/022472s006s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022472s006s008lbl.pdf|Name:DailyMed, SrcID:setid=457531f0-9331-47fe-90b5-b31f284044dc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=457531f0-9331-47fe-90b5-b31f284044dc",,CHEMBL1981,INSR
664,CHEMBL1112,Aripiprazole,Small molecule,2002.0,N05AX12,N05AX12 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Other antipsychotics],-prazole,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=c040bd1d-45b7-49f2-93ea-aed7220b30ac#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c040bd1d-45b7-49f2-93ea-aed7220b30ac#nlm34090-1",Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,CHEMBL224,HTR2A
665,CHEMBL1201321,Difenoxin,Small molecule,1978.0,A07DA04,"A07DA04 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: ANTIPROPULSIVES: Antipropulsives]",-oxin,Mu opioid receptor agonist,,,CHEMBL233,Mu opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Difenoxin, URL:http://en.wikipedia.org/wiki/Difenoxin|Name:PubMed, SrcID:14978639, URL:http://europepmc.org/abstract/MED/14978639|Name:Wikipedia, SrcID:Opioid_receptor, URL:http://en.wikipedia.org/wiki/Opioid_receptor",OC(=O)C1(CCN(CCC(C#N)(c2ccccc2)c3ccccc3)CC1)c4ccccc4,CHEMBL233,OPRM1
666,CHEMBL1200342,Paramethasone Acetate,Small molecule,1982.0,H02AB05,"H02AB05 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Glucocorticoids]",,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:978-1-889788-85-2, URL:http://www.isbnsearch.org/isbn/9781889788852|Name:PubMed, SrcID:4862587, URL:http://europepmc.org/abstract/MED/4862587",C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C,CHEMBL2034,NR3C1
667,CHEMBL1501,Fluocinonide,Small molecule,1971.0,C05AA11; D07AC08,"C05AA11 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Corticosteroids]; D07AC08 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, potent (group III)]",-onide,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20439738, URL:http://europepmc.org/abstract/MED/20439738",CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]23C,CHEMBL2034,NR3C1
668,CHEMBL2028850,Icatibant,Protein,2011.0,B06AC02,B06AC02 [BLOOD AND BLOOD FORMING ORGANS: OTHER HEMATOLOGICAL AGENTS: OTHER HEMATOLOGICAL AGENTS: Drugs used in hereditary angioedema],-tibant,Bradykinin B2 receptor antagonist,,,CHEMBL3157,Bradykinin B2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=ed6657ca-ab68-477a-9968-e12dc928b540#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ed6657ca-ab68-477a-9968-e12dc928b540#nlm34090-1",N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N2C[C@H](O)C[C@H]2C(=O)NCC(=O)N[C@@H](Cc3cccs3)C(=O)N[C@@H](CO)C(=O)N4Cc5ccccc5C[C@@H]4C(=O)N6[C@H]7CCCC[C@H]7C[C@H]6C(=O)N[C@@H](CCCNC(=N)N)C(=O)O,CHEMBL3157,BDKRB2
669,CHEMBL2010601,Ivacaftor,Small molecule,2012.0,R07AX02,R07AX02 [RESPIRATORY SYSTEM: OTHER RESPIRATORY SYSTEM PRODUCTS: OTHER RESPIRATORY SYSTEM PRODUCTS: Other respiratory system products],-caftor,Cystic fibrosis transmembrane conductance regulator positive modulator,,,CHEMBL4051,Cystic fibrosis transmembrane conductance regulator,POSITIVE MODULATOR,Homo sapiens,SINGLE PROTEIN,,"Mode of action is potentiator, so likely allosteric","Name:DailyMed, SrcID:setid=0ab0c9f8-3eee-4e0f-9f3f-c1e16aaffe25#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0ab0c9f8-3eee-4e0f-9f3f-c1e16aaffe25#nlm34090-1",CC(C)(C)c1cc(c(NC(=O)C2=CNc3ccccc3C2=O)cc1O)C(C)(C)C,CHEMBL4051,CFTR
670,CHEMBL1946170,Regorafenib,Small molecule,2012.0,L01XE21,L01XE21 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-rafenib,Tyrosine-protein kinase FRK inhibitor,,,CHEMBL4223,Tyrosine-protein kinase FRK,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Expert, SrcID:REGORAFENIB, URL:http://chembl.blogspot.co.uk/search?q=REGORAFENIB",CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,CHEMBL4223,FRK
671,CHEMBL1120,Bismuth Subsalicylate,Small molecule,1996.0,,,,Cyclooxygenase inhibitor,,,CHEMBL2094253,Cyclooxygenase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:15199473, URL:http://europepmc.org/abstract/MED/15199473|Name:PubMed, SrcID:15070163, URL:http://europepmc.org/abstract/MED/15070163|Name:PubMed, SrcID:15035793, URL:http://europepmc.org/abstract/MED/15035793|Name:PubMed, SrcID:15106733, URL:http://europepmc.org/abstract/MED/15106733|Name:PubMed, SrcID:15348270, URL:http://europepmc.org/abstract/MED/15348270|Name:PubMed, SrcID:15840771, URL:http://europepmc.org/abstract/MED/15840771|Name:PubMed, SrcID:15871445, URL:http://europepmc.org/abstract/MED/15871445",,,
672,CHEMBL452231,Teniposide,Small molecule,1992.0,L01CB02,L01CB02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Podophyllotoxin derivatives],,DNA topoisomerase II inhibitor,,,CHEMBL2094255,DNA topoisomerase II,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:20534341, URL:http://europepmc.org/abstract/MED/20534341|Name:DailyMed, SrcID:setid=3231dc15-5ce2-cf61-7d1f-bd86704269ae#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3231dc15-5ce2-cf61-7d1f-bd86704269ae#nlm34090-1|Name:FDA, SrcID:label/2015/020119s013lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020119s013lbl.pdf",COc1cc(cc(OC)c1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@H](O[C@H]5[C@H](O)[C@H]4O)c6cccs6)c7cc8OCOc8cc27,,
673,CHEMBL38,Tretinoin,Small molecule,1971.0,D10AD51; D10AD01; L01XX14,D10AD51 [DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Retinoids for topical use in acne]; D10AD01 [DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Retinoids for topical use in acne]; L01XX14 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-retin-,Retinoic acid receptor agonist,,,CHEMBL2363069,Retinoic acid receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=b6b45969-a64a-4ce3-b3b6-157d2568a301, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b6b45969-a64a-4ce3-b3b6-157d2568a301",C\C(=C/C=C/C(=C/C(=O)O)/C)\C=C\C1=C(C)CCCC1(C)C,,
674,CHEMBL7413,Methohexital,Small molecule,1960.0,N05CA15; N01AF01,"N05CA15 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Barbiturates, plain]; N01AF01 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Barbiturates, plain]",,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:ISBN, SrcID:0721603246 PP. 113, URL:http://www.isbnsearch.org/isbn/0721603246|Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CCC#CC(C)C1(CC=C)C(=O)NC(=O)N(C)C1=O,CHEMBL2093872,GABRG3
675,CHEMBL7413,Methohexital,Small molecule,1960.0,N05CA15; N01AF01,"N05CA15 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Barbiturates, plain]; N01AF01 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Barbiturates, plain]",,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:ISBN, SrcID:0721603246 PP. 113, URL:http://www.isbnsearch.org/isbn/0721603246|Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CCC#CC(C)C1(CC=C)C(=O)NC(=O)N(C)C1=O,CHEMBL2093872,GABRP
676,CHEMBL7413,Methohexital,Small molecule,1960.0,N05CA15; N01AF01,"N05CA15 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Barbiturates, plain]; N01AF01 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Barbiturates, plain]",,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:ISBN, SrcID:0721603246 PP. 113, URL:http://www.isbnsearch.org/isbn/0721603246|Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CCC#CC(C)C1(CC=C)C(=O)NC(=O)N(C)C1=O,CHEMBL2093872,GABRE
677,CHEMBL7413,Methohexital,Small molecule,1960.0,N05CA15; N01AF01,"N05CA15 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Barbiturates, plain]; N01AF01 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Barbiturates, plain]",,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:ISBN, SrcID:0721603246 PP. 113, URL:http://www.isbnsearch.org/isbn/0721603246|Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CCC#CC(C)C1(CC=C)C(=O)NC(=O)N(C)C1=O,CHEMBL2093872,GABRG1
678,CHEMBL1201218,Cefamandole Nafate,Small molecule,1978.0,,,cef-,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:ISBN, SrcID:0443-059748 PP. 694, URL:http://www.isbnsearch.org/isbn/0443059748|Name:Wikipedia, SrcID:Cefamandole, URL:http://en.wikipedia.org/wiki/Cefamandole|Name:ISBN, SrcID:0471-948470 PP. 494, URL:http://www.isbnsearch.org/isbn/0471948470",Cn1nnnc1SCC2=C(N3[C@H](SC2)[C@H](NC(=O)[C@H](OC=O)c4ccccc4)C3=O)C(=O)O,,
679,CHEMBL529,Azithromycin,Small molecule,1991.0,S01AA26; J01FA10,"S01AA26 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Antibiotics]; J01FA10 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS: Macrolides]",-mycin,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,23S ribosomal RNA,,"Name:PubMed, SrcID:12623020, URL:http://europepmc.org/abstract/MED/12623020|Name:PubMed, SrcID:15851032, URL:http://europepmc.org/abstract/MED/15851032|Name:PubMed, SrcID:19071138, URL:http://europepmc.org/abstract/MED/19071138",CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,
680,CHEMBL1201112,Nelarabine,Small molecule,2005.0,L01BB07,L01BB07 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Purine analogues],-arabine,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=893c95d7-d9b6-4064-db97-91dd21ce7e40#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=893c95d7-d9b6-4064-db97-91dd21ce7e40#section-13",COc1nc(N)nc2c1ncn2[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3O,,
681,CHEMBL515,Chlorambucil,Small molecule,1957.0,L01AA02,L01AA02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ALKYLATING AGENTS: Nitrogen mustard analogues],,DNA inhibitor,Alkylating agent,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:ISBN, SrcID:9780702034718 PP. 677, URL:http://www.isbnsearch.org/isbn/9780702034718",OC(=O)CCCc1ccc(cc1)N(CCCl)CCCl,,
682,CHEMBL1489,Azacitidine,Small molecule,2004.0,L01BC07,L01BC07 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Pyrimidine analogues],-tidine,RNA inhibitor,,,CHEMBL2311222,RNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:Wikipedia, SrcID:Azacitidine, URL:http://en.wikipedia.org/wiki/Azacitidine|Name:DailyMed, SrcID:setid=3495a71a-cc04-4776-851f-f185956f32af#section-12, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3495a71a-cc04-4776-851f-f185956f32af#section-12|Name:Wikipedia, SrcID:DNA_methylation, URL:http://en.wikipedia.org/wiki/DNA_methylation",NC1=NC(=O)N(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O,,
683,CHEMBL5,Nalidixic Acid,Small molecule,1964.0,J01MB02,J01MB02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Other quinolones],nal-,Bacterial DNA gyrase inhibitor,,,CHEMBL2311224,Bacterial DNA gyrase,INHIBITOR,Bacteria,PROTEIN COMPLEX,,,"Name:FDA, SrcID:label/2012/014214s060lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/014214s060lbl.pdf",CCN1C=C(C(=O)O)C(=O)c2ccc(C)nc12,,
684,CHEMBL861,Mephenytoin,Small molecule,1946.0,N03AB54; N03AB04,N03AB54 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Hydantoin derivatives]; N03AB04 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Hydantoin derivatives],-toin,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:15208697, URL:http://europepmc.org/abstract/MED/15208697|Name:PubMed, SrcID:23205958, URL:http://europepmc.org/abstract/MED/23205958|Name:DailyMed, SrcID:setid=9370d8e6-7db4-452d-9792-9093e7b4f4bd#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9370d8e6-7db4-452d-9792-9093e7b4f4bd#nlm34090-1",CCC1(NC(=O)N(C)C1=O)c2ccccc2,,
685,CHEMBL1196,Proparacaine,Small molecule,1953.0,S01HA04,S01HA04 [SENSORY ORGANS: OPHTHALMOLOGICALS: LOCAL ANESTHETICS: Local anesthetics],-caine,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:23254968, URL:http://europepmc.org/abstract/MED/23254968|Name:DailyMed, SrcID:setid=0c0fa0bf-977d-4539-b8dc-54c187c5b094#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0c0fa0bf-977d-4539-b8dc-54c187c5b094#nlm34090-1",CCCOc1ccc(cc1N)C(=O)OCCN(CC)CC,,
686,CHEMBL1201234,Mephentermine,Small molecule,1951.0,C01CA11,C01CA11 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES: Adrenergic and dopaminergic agents],,Adrenergic receptor agonist,,,CHEMBL2331074,Adrenergic receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10722, URL:http://europepmc.org/abstract/MED/10722",CNC(C)(C)Cc1ccccc1,,
687,CHEMBL2108676,Elosulfase Alfa,Enzyme,2014.0,A16AB12,A16AB12 [ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Enzymes],-ase,Keratan sulfate hydrolytic enzyme,,,CHEMBL3140341,Keratan sulfate,HYDROLYTIC ENZYME,Homo sapiens,OLIGOSACCHARIDE,,,"Name:FDA, SrcID:label/2014/125460s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125460s000lbl.pdf",,,
688,CHEMBL45816,Mibefradil,Small molecule,1997.0,C08CX01,C08CX01 [CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS: Other selective calcium channel blockers with mainly vascular effects],-dil,Voltage-gated T-type calcium channel blocker,,,CHEMBL2362995,Voltage-gated T-type calcium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:9375939, URL:http://europepmc.org/abstract/MED/9375939",COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc4cc(F)ccc4[C@@H]1C(C)C,,
689,CHEMBL3039537,Sebelipase Alfa,Enzyme,2015.0,A16AB14,A16AB14 [ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Enzymes],-ase,Cholesterol ester hydrolytic enzyme,,,CHEMBL3559388,Cholesterol ester,HYDROLYTIC ENZYME,,LIPID,,,"Name:FDA, SrcID:label/2015/125561s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125561s000lbl.pdf",,,
690,CHEMBL3545420,Ag-24322,Small molecule,,,,,Cyclin-dependent kinase 2 inhibitor,,,CHEMBL301,Cyclin-dependent kinase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://cancerres.aacrjournals.org/content/65/9_Supplement/1045.2, URL:http://cancerres.aacrjournals.org/content/65/9_Supplement/1045.2|Name:PubMed, SrcID:18509643, URL:http://europepmc.org/abstract/MED/18509643",CCNCc1cncc(c1C)c2ccc3NN\C(=C\4/N=C5C=C(F)C=C(F)C5=N4)\c3c2,CHEMBL301,CDK2
691,CHEMBL3545296,Arq-736,Small molecule,,,,,Serine/threonine-protein kinase RAF inhibitor,,,CHEMBL1906,Serine/threonine-protein kinase RAF,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=688029, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=688029|Name:DOI, SrcID:10.1158/1538-7445.AM10-2517, URL:http://cancerres.aacrjournals.org/content/70/8_Supplement/2517|Name:PubMed, SrcID:23617957, URL:http://europepmc.org/abstract/MED/23617957",,CHEMBL1906,RAF1
692,CHEMBL2010872,Cep-11981,Small molecule,,,,,Vascular endothelial growth factor receptor inhibitor,,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:22148921, URL:http://europepmc.org/abstract/MED/22148921",CC(C)Cn1c2ccc(Nc3ncccn3)cc2c4c5CNC(=O)c5c6c(CCc7nn(C)cc67)c14,,
693,CHEMBL3545074,Leo-15520,Small molecule,,,,,MAP kinase p38 alpha inhibitor,Thought to also inhibit MAPK11 and MAP2K6 but no further details available/found.,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.inflammationsocieties.org/PDF/Jago_4%20_2_.pdf, URL:http://www.inflammationsocieties.org/PDF/Jago_4%20_2_.pdf",,CHEMBL260,MAPK14
694,CHEMBL3545324,Rg-7666,Small molecule,,,,,PI3-kinase class I inhibitor,Thought to be a dual PI3K/mTOR inhibitor but no binding/selectivity/assay data found for any of the targets.,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Other, SrcID:http://www.roche.com/irp2q12e-annex.pdf, URL:http://www.roche.com/irp2q12e-annex.pdf|Name:PubMed, SrcID:4584582, URL:http://europepmc.org/abstract/MED/4584582",,CHEMBL3559703,PIK3R2
695,CHEMBL3545324,Rg-7666,Small molecule,,,,,PI3-kinase class I inhibitor,Thought to be a dual PI3K/mTOR inhibitor but no binding/selectivity/assay data found for any of the targets.,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Other, SrcID:http://www.roche.com/irp2q12e-annex.pdf, URL:http://www.roche.com/irp2q12e-annex.pdf|Name:PubMed, SrcID:4584582, URL:http://europepmc.org/abstract/MED/4584582",,CHEMBL3559703,PIK3R3
696,CHEMBL3545324,Rg-7666,Small molecule,,,,,PI3-kinase class I inhibitor,Thought to be a dual PI3K/mTOR inhibitor but no binding/selectivity/assay data found for any of the targets.,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Other, SrcID:http://www.roche.com/irp2q12e-annex.pdf, URL:http://www.roche.com/irp2q12e-annex.pdf|Name:PubMed, SrcID:4584582, URL:http://europepmc.org/abstract/MED/4584582",,CHEMBL3559703,PIK3R5
697,CHEMBL3545390,Gdc-0810,Small molecule,,,,,Estrogen receptor alpha antagonist,Selective estrogen receptor degrader (SERD),,CHEMBL206,Estrogen receptor alpha,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.gene.com/medical-professionals/pipeline, URL:http://www.gene.com/medical-professionals/pipeline",,CHEMBL206,ESR1
698,CHEMBL2219422,Afuresertib,Small molecule,,,,-sertib,Serine/threonine-protein kinase AKT inhibitor,,,CHEMBL2111353,Serine/threonine-protein kinase AKT,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:24978597, URL:http://europepmc.org/abstract/MED/24978597",Cn1ncc(Cl)c1c2cc(sc2Cl)C(=O)N[C@H](CN)Cc3cccc(F)c3,,
699,CHEMBL517140,Gsk189254,Small molecule,,,,,Histamine H3 receptor antagonist,Ph 2 trial terminated,,CHEMBL264,Histamine H3 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24269482, URL:http://europepmc.org/abstract/MED/24269482",CNC(=O)c1ccc(Oc2ccc3CCN(CCc3c2)C4CCC4)nc1,CHEMBL264,HRH3
700,CHEMBL41194,Pratosartan,Small molecule,,,,-sartan,Solute carrier family 22 member 6 inhibitor,,,CHEMBL1641347,Solute carrier family 22 member 6,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17674156, URL:http://europepmc.org/abstract/MED/17674156",CCCc1nc2CCCCC(=O)c2n1Cc3ccc(cc3)c4ccccc4c5nn[nH]n5,CHEMBL1641347,SLC22A6
701,CHEMBL3545291,Jnj-39393406,Small molecule,,,,,Neuronal acetylcholine receptor protein alpha-7 subunit positive allosteric modulator,,,CHEMBL2492,Neuronal acetylcholine receptor protein alpha-7 subunit,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26044974, URL:http://europepmc.org/abstract/MED/26044974|Name:PubMed, SrcID:22766391, URL:http://europepmc.org/abstract/MED/22766391",CN(C)C(=O)CCn1nc(Nc2ccc3OC(F)(F)Oc3c2)nc1c4ccncc4,CHEMBL2492,CHRNA7
702,CHEMBL428690,Alvocidib,Small molecule,,,,,Cyclin-dependent kinase 4 inhibitor,,,CHEMBL331,Cyclin-dependent kinase 4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25215591, URL:http://europepmc.org/abstract/MED/25215591|Name:PubMed, SrcID:15217973, URL:http://europepmc.org/abstract/MED/15217973",CN1CC[C@@H]([C@H](O)C1)c2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccccc4Cl,CHEMBL331,CDK4
703,CHEMBL300138,Enzastaurin,Small molecule,,,,,Protein kinase C beta inhibitor,,,CHEMBL3045,Protein kinase C beta,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12749884, URL:http://europepmc.org/abstract/MED/12749884|Name:PubMed, SrcID:17671157, URL:http://europepmc.org/abstract/MED/17671157",Cn1cc(C2=C(C(=O)NC2=O)c3cn(C4CCN(Cc5ccccn5)CC4)c6ccccc36)c7ccccc17,CHEMBL3045,PRKCB
704,CHEMBL3186534,Apatinib,Small molecule,,,,-tinib,Vascular endothelial growth factor receptor 2 inhibitor,,,CHEMBL279,Vascular endothelial growth factor receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&version=15.09d&ns=NCI_Thesaurus&code=C74012, URL:https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&version=15.09d&ns=NCI_Thesaurus&code=C74012|Name:PubMed, SrcID:21443688, URL:http://europepmc.org/abstract/MED/21443688|Name:PubMed, SrcID:20923544, URL:http://europepmc.org/abstract/MED/20923544",O=C(Nc1ccc(cc1)C2(CCCC2)C#N)c3cccnc3NCc4ccncc4,CHEMBL279,KDR
705,CHEMBL191413,Reparixin,Small molecule,,,,-rixin,Interleukin-8 receptor A modulator,,,CHEMBL4029,Interleukin-8 receptor A,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15302676, URL:http://europepmc.org/abstract/MED/15302676|Name:PubMed, SrcID:15282370, URL:http://europepmc.org/abstract/MED/15282370",CC(C)Cc1ccc(cc1)[C@@H](C)C(=O)NS(=O)(=O)C,CHEMBL4029,CXCR1
706,CHEMBL266510,Flindokalner,Small molecule,,,,-kalner,Voltage-gated potassium channel subunit Kv7.4 activator,Indication: Stroke,,CHEMBL3576,Voltage-gated potassium channel subunit Kv7.4,ACTIVATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12481191, URL:http://europepmc.org/abstract/MED/12481191|Name:PubMed, SrcID:11378159, URL:http://europepmc.org/abstract/MED/11378159",COc1ccc(Cl)cc1[C@]2(F)C(=O)Nc3cc(ccc23)C(F)(F)F,CHEMBL3576,KCNQ4
707,CHEMBL1743053,Otelixizumab,Antibody,,,,-mab,T-cell surface glycoprotein CD3 epsilon chain other,"Modulates the T-cell receptor (TCR)–CD3 complex resulting in the cells becoming 'blind' to antigen (a process that is also known as antigenic modulation). In addition, the monoclonal antibody preferentially induces anergy or apoptosis of activated T cells through alterations in TCR-mediated signal transduction.",,CHEMBL1975,T-cell surface glycoprotein CD3 epsilon chain,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17641665, URL:http://europepmc.org/abstract/MED/17641665",,CHEMBL1975,CD3E
708,CHEMBL2105665,Elacytarabine,Small molecule,,,,-arabine,DNA Inhibitor,Enters cells by a nucleoside transporter-independent mechanism and exhibits longer intracellular retention with accompanying longer inhibition of DNA synthesis. It also causes transient inhibition of RNA synthesis,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:PubMed, SrcID:9338077, URL:http://europepmc.org/abstract/MED/9338077|Name:PubMed, SrcID:18398748, URL:http://europepmc.org/abstract/MED/18398748",CCCCCCCC\C=C\CCCCCCCC(=O)OC[C@H]1O[C@H]([C@@H](O)[C@@H]1O)N2C=CC(=NC2=O)N,,
709,CHEMBL3545185,Selinexor,Small molecule,,,,,Exportin-1 inhibitor,,,CHEMBL5661,Exportin-1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:27893412, URL:http://europepmc.org/abstract/MED/27893412",FC(F)(F)c1cc(cc(c1)C(F)(F)F)c2ncn(\C=C/C(=O)NNc3cnccn3)n2,CHEMBL5661,XPO1
710,CHEMBL2105665,Elacytarabine,Small molecule,,,,-arabine,RNA Inhibitor,Enters cells by a nucleoside transporter-independent mechanism and exhibits longer intracellular retention with accompanying longer inhibition of DNA synthesis. It also causes transient inhibition of RNA synthesis,,CHEMBL2311222,RNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:PubMed, SrcID:9338077, URL:http://europepmc.org/abstract/MED/9338077|Name:PubMed, SrcID:18398748, URL:http://europepmc.org/abstract/MED/18398748",CCCCCCCC\C=C\CCCCCCCC(=O)OC[C@H]1O[C@H]([C@@H](O)[C@@H]1O)N2C=CC(=NC2=O)N,,
711,CHEMBL272980,Mocetinostat,Small molecule,,,,-stat,Histone deacetylase 11,,"Isotype-selective Class I (HDAC1, -2, -3, and -8) and IV (HDAC11) HDAC inhibitor.",CHEMBL3310,Histone deacetylase 11,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18413790, URL:http://europepmc.org/abstract/MED/18413790|Name:PubMed, SrcID:27551526, URL:http://europepmc.org/abstract/MED/27551526",Nc1ccccc1NC(=O)c2ccc(CNc3nccc(n3)c4cccnc4)cc2,CHEMBL3310,HDAC11
712,CHEMBL1743086,Vatelizumab,Antibody,,,,-mab,Integrin alpha-2 antagonist,,,CHEMBL4998,Integrin alpha-2,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.glenmarkpharma.com/novel-molecular-entities/research-pipeline, URL:http://www.glenmarkpharma.com/novel-molecular-entities/research-pipeline",,,
713,CHEMBL2108742,Siplizumab,Antibody,,,,-mab,T-cell surface antigen CD2 inhibitor,"The antibody tumor-killing action is a FcR?-dependent mechanism presumably mediated by effector cells, including monocytes and granulocytes that express FcR?III.",,CHEMBL2040,T-cell surface antigen CD2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10589960, URL:http://europepmc.org/abstract/MED/10589960|Name:PubMed, SrcID:12649132, URL:http://europepmc.org/abstract/MED/12649132",,CHEMBL2040,CD2
714,CHEMBL2109334,Medi-551,Antibody,,,,,B-lymphocyte antigen CD19 inhibitor,MEDI-551 binds directly to CD19 protein on the surface of the plasmablasts (produce autoantibodies called AQP4-Ab (or NMO-IgG) to the protein aquaporin-4 ) and depletes them.,,CHEMBL3390821,B-lymphocyte antigen CD19,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:27163209, URL:http://europepmc.org/abstract/MED/27163209",,CHEMBL3390821,CD19
715,CHEMBL2109402,Mm-121,Antibody,,,,,Receptor tyrosine-protein kinase erbB-3 antagonist,Blocks ligand-dependent activation (phosphorylation) of ErbB3.,,CHEMBL5838,Receptor tyrosine-protein kinase erbB-3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20215504, URL:http://europepmc.org/abstract/MED/20215504",,CHEMBL5838,ERBB3
716,CHEMBL2109544,Cdp-860,Antibody,,,,,Platelet-derived growth factor receptor beta inhibitor,,,CHEMBL1913,Platelet-derived growth factor receptor beta,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15466784, URL:http://europepmc.org/abstract/MED/15466784",,CHEMBL1913,PDGFRB
717,CHEMBL1201585,Trastuzumab,Antibody,1998.0,L01XC03,L01XC03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,Receptor protein-tyrosine kinase erbB-2 inhibitor,,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=492dbdb2-077e-4064-bff3-372d6af0a7a2, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=492dbdb2-077e-4064-bff3-372d6af0a7a2",,CHEMBL1824,ERBB2
718,CHEMBL1172,Desloratadine,Small molecule,2001.0,R06AX27,R06AX27 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Other antihistamines for systemic use],-(a)tadine,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=5b79aff4-9bed-429d-8def-a7929293387d, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5b79aff4-9bed-429d-8def-a7929293387d",Clc1ccc2C(=C3CCNCC3)c4ncccc4CCc2c1,CHEMBL231,HRH1
719,CHEMBL1004,Doxylamine,Small molecule,1948.0,R06AA59; R06AA09,R06AA59 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Aminoalkyl ethers]; R06AA09 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Aminoalkyl ethers],,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Doxylamine, URL:http://en.wikipedia.org/wiki/Doxylamine|Name:PubMed, SrcID:8099438, URL:http://europepmc.org/abstract/MED/8099438",CN(C)CCOC(C)(c1ccccc1)c2ccccn2,CHEMBL231,HRH1
720,CHEMBL61006,Phenylpropanolamine,Small molecule,1958.0,R01BA51; R01BA01,R01BA51 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: NASAL DECONGESTANTS FOR SYSTEMIC USE: Sympathomimetics]; R01BA01 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: NASAL DECONGESTANTS FOR SYSTEMIC USE: Sympathomimetics],,Alpha-1a adrenergic receptor agonist,,,CHEMBL229,Alpha-1a adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Adrenergic_receptor, URL:http://en.wikipedia.org/wiki/Adrenergic_receptor|Name:Wikipedia, SrcID:Phenylpropanolamine, URL:http://en.wikipedia.org/wiki/Phenylpropanolamine|Name:Wikipedia, SrcID:Adrenergic_agonist, URL:http://en.wikipedia.org/wiki/Adrenergic_agonist|Name:PubMed, SrcID:19948186, URL:http://europepmc.org/abstract/MED/19948186|Name:Wikipedia, SrcID:Decongestant, URL:http://en.wikipedia.org/wiki/Decongestant",CC(N)C(O)c1ccccc1,CHEMBL229,ADRA1A
721,CHEMBL1908360,Everolimus,Small molecule,2009.0,L04AA18; L01XE10,L04AA18 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Selective immunosuppressants]; L01XE10 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-imus,FK506-binding protein 1A inhibitor,,,CHEMBL1902,FK506-binding protein 1A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=2150f73a-179b-4afc-b8ce-67c85cc72f04#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04#section-13",CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(/C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(/C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC)CC[C@H]1OCCO,CHEMBL1902,FKBP1A
722,CHEMBL439849,Vilazodone,Small molecule,2011.0,N06AX24,N06AX24 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants],,Serotonin transporter inhibitor,,,CHEMBL228,Serotonin transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15740724, URL:http://europepmc.org/abstract/MED/15740724|Name:FDA, SrcID:label/2012/022567s005lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022567s005lbl.pdf",NC(=O)c1oc2ccc(cc2c1)N3CCN(CCCCc4c[nH]c5ccc(cc45)C#N)CC3,CHEMBL228,SLC6A4
723,CHEMBL1201616,Secretin Synthetic Porcine,Protein,2002.0,,,-retin,Secretin receptor agonist,,,CHEMBL1925,Secretin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=b4dfe70f-0a86-4488-9ba1-dcd8f86cbfcd, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b4dfe70f-0a86-4488-9ba1-dcd8f86cbfcd",,CHEMBL1925,SCTR
724,CHEMBL1200810,Doxercalciferol,Small molecule,1999.0,H05BX03,"H05BX03 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CALCIUM HOMEOSTASIS: ANTI-PARATHYROID AGENTS: Other anti-parathyroid agents]",-calci-,Vitamin D receptor agonist,,,CHEMBL1977,Vitamin D receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20967888, URL:http://europepmc.org/abstract/MED/20967888|Name:PubMed, SrcID:21647319, URL:http://europepmc.org/abstract/MED/21647319|Name:DailyMed, SrcID:setid=dc676bc5-f3f7-4755-92e1-1814498c1f4f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dc676bc5-f3f7-4755-92e1-1814498c1f4f|Name:PubMed, SrcID:21209008, URL:http://europepmc.org/abstract/MED/21209008",CC(C)[C@@H](C)\C=C\[C@@H](C)[C@H]1CC[C@H]2\C(=C\C=C/3\C[C@@H](O)C[C@H](O)C3=C)\CCC[C@]12C,CHEMBL1977,VDR
725,CHEMBL278020,Neostigmine,Small molecule,2013.0,N07AA51; N07AA01; S01EB06,N07AA51 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: PARASYMPATHOMIMETICS: Anticholinesterases]; N07AA01 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: PARASYMPATHOMIMETICS: Anticholinesterases]; S01EB06 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Parasympathomimetics],-stigmine,Acetylcholinesterase inhibitor,,,CHEMBL220,Acetylcholinesterase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=79ee2111-d65c-11e1-9b23-0800200c9a66#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=79ee2111-d65c-11e1-9b23-0800200c9a66#nlm34090-1",CN(C)C(=O)Oc1cccc(c1)[N+](C)(C)C,CHEMBL220,ACHE
726,CHEMBL1538,Tenofovir Disoproxil,Small molecule,2001.0,J05AF07,J05AF07 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleoside and nucleotide reverse transcriptase inhibitors],-vir,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,,,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,INHIBITOR,Human immunodeficiency virus 1,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=33fd6418-fbdc-42ca-a50d-ce2a476a5418, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=33fd6418-fbdc-42ca-a50d-ce2a476a5418",CC(C)OC(=O)OCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc12)OCOC(=O)OC(C)C,,
727,CHEMBL1561,Miglitol,Small molecule,1996.0,A10BF02,"A10BF02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Alpha glucosidase inhibitors]",,Lysosomal alpha-glucosidase inhibitor,,,CHEMBL2608,Lysosomal alpha-glucosidase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=75711d16-2d27-476e-a312-d5af448a0e25#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=75711d16-2d27-476e-a312-d5af448a0e25#nlm34090-1|Name:PubMed, SrcID:23185202, URL:http://europepmc.org/abstract/MED/23185202",OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,CHEMBL2608,GAA
728,CHEMBL1789941,Ruxolitinib,Small molecule,2011.0,L01XE18,L01XE18 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Tyrosine-protein kinase JAK2 inhibitor,,,CHEMBL2971,Tyrosine-protein kinase JAK2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2012/202192s001lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202192s001lbl.pdf",N#CC[C@H](C1CCCC1)n2cc(cn2)c3ncnc4[nH]ccc34,CHEMBL2971,JAK2
729,CHEMBL2108184,Crofelemer,Small molecule,2012.0,,,-mer,Cystic fibrosis transmembrane conductance regulator inhibitor,,,CHEMBL4051,Cystic fibrosis transmembrane conductance regulator,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=684ca8ce-2583-4c2d-a283-8a16fc63f8f8#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=684ca8ce-2583-4c2d-a283-8a16fc63f8f8#nlm34090-1",,CHEMBL4051,CFTR
730,CHEMBL1200807,Norelgestromin,Small molecule,2001.0,,,-gest-,Progesterone receptor agonist,,,CHEMBL208,Progesterone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f8e8a69e-a018-469a-af56-e20f61fe4e06#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f8e8a69e-a018-469a-af56-e20f61fe4e06#nlm34090-1",CC[C@]12CC[C@H]3[C@@H](CCC4=C\C(=N\O)\CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C,CHEMBL208,PGR
731,CHEMBL1111,Ambrisentan,Small molecule,2007.0,C02KX02,C02KX02 [CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: OTHER ANTIHYPERTENSIVES: Antihypertensives for pulmonary arterial hypertension],-entan,"Endothelin receptor, ET-A/ET-B antagonist",,,CHEMBL2096678,"Endothelin receptor, ET-A/ET-B",ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=725d4e73-6c83-477a-adc6-0ae4a133a844#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=725d4e73-6c83-477a-adc6-0ae4a133a844#section-14",COC([C@H](Oc1nc(C)cc(C)n1)C(=O)O)(c2ccccc2)c3ccccc3,,
732,CHEMBL956,Suprofen,Small molecule,1985.0,M01AE07,"M01AE07 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Propionic acid derivatives]",-profen,Cyclooxygenase inhibitor,,,CHEMBL2094253,Cyclooxygenase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10377455, URL:http://europepmc.org/abstract/MED/10377455",CC(C(=O)O)c1ccc(cc1)C(=O)c2cccs2,,
733,CHEMBL628,Pentoxifylline,Small molecule,1984.0,C04AD03,C04AD03 [CARDIOVASCULAR SYSTEM: PERIPHERAL VASODILATORS: PERIPHERAL VASODILATORS: Purine derivatives],-fylline,Adenosine A2 receptor antagonist,,,CHEMBL2094257,Adenosine A2 receptor,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19997047, URL:http://europepmc.org/abstract/MED/19997047|Name:FDA, SrcID:label/2012/018631s039lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/018631s039lbl.pdf|Name:Wikipedia, SrcID:Pentoxifylline, URL:http://en.wikipedia.org/wiki/Pentoxifylline",CN1C(=O)N(CCCCC(=O)C)C(=O)c2c1ncn2C,,
734,CHEMBL817,Tolazamide,Small molecule,1966.0,A10BB05,"A10BB05 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Sulfonylureas]",,"Sulfonylurea receptor 1, Kir6.2 blocker",,,CHEMBL2096972,"Sulfonylurea receptor 1, Kir6.2",BLOCKER,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:10354277, URL:http://europepmc.org/abstract/MED/10354277|Name:PubMed, SrcID:8799949, URL:http://europepmc.org/abstract/MED/8799949",Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2,,
735,CHEMBL1760,Terbutaline,Small molecule,1974.0,R03CC03; R03AC03; R03CC53,"R03CC03 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS FOR SYSTEMIC USE: Selective beta-2-adrenoreceptor agonists]; R03AC03 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS, INHALANTS: Selective beta-2-adrenoreceptor agonists]; R03CC53 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS FOR SYSTEMIC USE: Selective beta-2-adrenoreceptor agonists]",,Beta-2 adrenergic receptor agonist,,,CHEMBL210,Beta-2 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:archiveid=43109, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=43109|Name:DailyMed, SrcID:setid=586cbc83-85d1-cd0f-d4a2-39b20dbcc82f#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=586cbc83-85d1-cd0f-d4a2-39b20dbcc82f#nlm34090-1",CC(C)(C)NCC(O)c1cc(O)cc(O)c1,CHEMBL210,ADRB2
736,CHEMBL1138,Ezetimibe,Small molecule,2002.0,C10AX09,"C10AX09 [CARDIOVASCULAR SYSTEM: LIPID MODIFYING AGENTS: LIPID MODIFYING AGENTS, PLAIN: Other lipid modifying agents]",-imibe,Niemann-Pick C1-like protein 1 inhibitor,,,CHEMBL2027,Niemann-Pick C1-like protein 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=1396b8b6-651a-4f2f-a2c1-0165173b2eff#section-12, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1396b8b6-651a-4f2f-a2c1-0165173b2eff#section-12",O[C@@H](CC[C@@H]1[C@H](N(C1=O)c2ccc(F)cc2)c3ccc(O)cc3)c4ccc(F)cc4,CHEMBL2027,NPC1L1
737,CHEMBL374478,Rifampicin,Small molecule,1971.0,J04AB02,J04AB02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOBACTERIALS: DRUGS FOR TREATMENT OF TUBERCULOSIS: Antibiotics],rifa-,Bacterial DNA-directed RNA polymerase inhibitor,,,CHEMBL2364672,Bacterial DNA-directed RNA polymerase,INHIBITOR,Bacteria,PROTEIN COMPLEX,RNA polymerase beta/beta prime subunit,Beta subunit is binding site,"Name:PubMed, SrcID:20185278, URL:http://europepmc.org/abstract/MED/20185278|Name:PubMed, SrcID:4942761, URL:http://europepmc.org/abstract/MED/4942761|Name:PubMed, SrcID:11290327, URL:http://europepmc.org/abstract/MED/11290327|Name:Wikipedia, SrcID:Rifampin#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Rifampin#Mechanism_of_action",CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(NC(=O)\C(=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(=O)C)[C@@H]1C)\C)c(\C=N\N5CCN(C)CC5)c(O)c4c3C2=O,,
738,CHEMBL452,Clonazepam,Small molecule,1975.0,N03AE01,N03AE01 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:18384456, URL:http://europepmc.org/abstract/MED/18384456|Name:PubMed, SrcID:6135616, URL:http://europepmc.org/abstract/MED/6135616|Name:PubMed, SrcID:3034628, URL:http://europepmc.org/abstract/MED/3034628|Name:Wikipedia, SrcID:Clonazepam#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Clonazepam#Mechanism_of_action",[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1,CHEMBL2093872,GABRG3
739,CHEMBL452,Clonazepam,Small molecule,1975.0,N03AE01,N03AE01 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:18384456, URL:http://europepmc.org/abstract/MED/18384456|Name:PubMed, SrcID:6135616, URL:http://europepmc.org/abstract/MED/6135616|Name:PubMed, SrcID:3034628, URL:http://europepmc.org/abstract/MED/3034628|Name:Wikipedia, SrcID:Clonazepam#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Clonazepam#Mechanism_of_action",[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1,CHEMBL2093872,GABRP
740,CHEMBL452,Clonazepam,Small molecule,1975.0,N03AE01,N03AE01 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:18384456, URL:http://europepmc.org/abstract/MED/18384456|Name:PubMed, SrcID:6135616, URL:http://europepmc.org/abstract/MED/6135616|Name:PubMed, SrcID:3034628, URL:http://europepmc.org/abstract/MED/3034628|Name:Wikipedia, SrcID:Clonazepam#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Clonazepam#Mechanism_of_action",[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1,CHEMBL2093872,GABRE
741,CHEMBL452,Clonazepam,Small molecule,1975.0,N03AE01,N03AE01 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:18384456, URL:http://europepmc.org/abstract/MED/18384456|Name:PubMed, SrcID:6135616, URL:http://europepmc.org/abstract/MED/6135616|Name:PubMed, SrcID:3034628, URL:http://europepmc.org/abstract/MED/3034628|Name:Wikipedia, SrcID:Clonazepam#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Clonazepam#Mechanism_of_action",[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1,CHEMBL2093872,GABRG1
742,CHEMBL580,Lorazepam,Small molecule,1977.0,N05BA06; N05BA56,N05BA06 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives]; N05BA56 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:18384456, URL:http://europepmc.org/abstract/MED/18384456|Name:Wikipedia, SrcID:Lorazepam, URL:http://en.wikipedia.org/wiki/Lorazepam|Name:PubMed, SrcID:2570451, URL:http://europepmc.org/abstract/MED/2570451",OC1N=C(c2ccccc2Cl)c3cc(Cl)ccc3NC1=O,CHEMBL2093872,GABRG3
743,CHEMBL580,Lorazepam,Small molecule,1977.0,N05BA06; N05BA56,N05BA06 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives]; N05BA56 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:18384456, URL:http://europepmc.org/abstract/MED/18384456|Name:Wikipedia, SrcID:Lorazepam, URL:http://en.wikipedia.org/wiki/Lorazepam|Name:PubMed, SrcID:2570451, URL:http://europepmc.org/abstract/MED/2570451",OC1N=C(c2ccccc2Cl)c3cc(Cl)ccc3NC1=O,CHEMBL2093872,GABRP
744,CHEMBL580,Lorazepam,Small molecule,1977.0,N05BA06; N05BA56,N05BA06 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives]; N05BA56 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:18384456, URL:http://europepmc.org/abstract/MED/18384456|Name:Wikipedia, SrcID:Lorazepam, URL:http://en.wikipedia.org/wiki/Lorazepam|Name:PubMed, SrcID:2570451, URL:http://europepmc.org/abstract/MED/2570451",OC1N=C(c2ccccc2Cl)c3cc(Cl)ccc3NC1=O,CHEMBL2093872,GABRE
745,CHEMBL580,Lorazepam,Small molecule,1977.0,N05BA06; N05BA56,N05BA06 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives]; N05BA56 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:18384456, URL:http://europepmc.org/abstract/MED/18384456|Name:Wikipedia, SrcID:Lorazepam, URL:http://en.wikipedia.org/wiki/Lorazepam|Name:PubMed, SrcID:2570451, URL:http://europepmc.org/abstract/MED/2570451",OC1N=C(c2ccccc2Cl)c3cc(Cl)ccc3NC1=O,CHEMBL2093872,GABRG1
746,CHEMBL507674,Cefoperazone,Small molecule,1982.0,J01DD12; J01DD62,J01DD12 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Third-generation cephalosporins]; J01DD62 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Third-generation cephalosporins],cef-,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:PubMed, SrcID:6448021, URL:http://europepmc.org/abstract/MED/6448021",CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SCC(=C(N3C2=O)C(=O)O)CSc4nnnn4C)c5ccc(O)cc5)C(=O)C1=O,,
747,CHEMBL1201561,Peginterferon Alfa-2b,Protein,2001.0,L03AB10; L03AB60,L03AB10 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSTIMULANTS: IMMUNOSTIMULANTS: Interferons]; L03AB60 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSTIMULANTS: IMMUNOSTIMULANTS: Interferons],peg-,Interferon alpha/beta receptor agonist,,,CHEMBL2364170,Interferon alpha/beta receptor,AGONIST,Homo sapiens,PROTEIN COMPLEX,,Alpha subunit is binding site,"Name:PubMed, SrcID:17969444, URL:http://europepmc.org/abstract/MED/17969444|Name:DailyMed, SrcID:setid=de61685e-2b8c-4e22-84bb-869e13600440, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de61685e-2b8c-4e22-84bb-869e13600440",,CHEMBL2364170,IFNAR2
748,CHEMBL1289,Haloprogin,Small molecule,1982.0,D01AE11,D01AE11 [DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Other antifungals for topical use],,Cell membrane inhibitor,Disrupts cell membrane,,CHEMBL2364033,Cell membrane,INHIBITOR,Trichophyton,SUBCELLULAR,,,"Name:PubMed, SrcID:4608935, URL:http://europepmc.org/abstract/MED/4608935",Clc1cc(Cl)c(OCC#CI)cc1Cl,,
749,CHEMBL744,Riluzole,Small molecule,1995.0,N07XX02,N07XX02 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs],,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=e49d207d-8e32-4183-94ba-cd264f124090#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e49d207d-8e32-4183-94ba-cd264f124090#nlm34090-1|Name:PubMed, SrcID:9262334, URL:http://europepmc.org/abstract/MED/9262334",Nc1nc2ccc(OC(F)(F)F)cc2s1,,
750,CHEMBL856,Primidone,Small molecule,1954.0,N03AA03,N03AA03 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Barbiturates and derivatives],,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:ISBN, SrcID:9780702034718 PP. 546-548, URL:http://www.isbnsearch.org/isbn/9780702034718",CCC1(C(=O)NCNC1=O)c2ccccc2,,
751,CHEMBL42,Clozapine,Small molecule,1989.0,N05AH02,"N05AH02 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Diazepines, oxazepines, thiazepines and oxepines]",-pin(e),Dopamine D2 receptor antagonist,,,CHEMBL217,Dopamine D2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:0443059748, URL:http://www.isbnsearch.org/isbn/0443059748|Name:Wikipedia, SrcID:Clozapine, URL:http://en.wikipedia.org/wiki/Clozapine|Name:DailyMed, SrcID:setid=53bdb79c-c4cf-4818-b1f0-225e67a14536#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=53bdb79c-c4cf-4818-b1f0-225e67a14536#nlm34090-1|Name:PubMed, SrcID:17015232, URL:http://europepmc.org/abstract/MED/17015232",CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,CHEMBL217,DRD2
752,CHEMBL2021423,Magnesium Sulfate Anhydrous,Small molecule,1981.0,,,,Unknown,,,,,,,,,,"Name:FDA, SrcID:label/2012/022372s004lbledt.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022372s004lbledt.pdf",[Mg+2].[O-]S(=O)(=O)[O-],,
753,CHEMBL1201330,Mersalyl,Small molecule,,,,-sal-,Unknown,,,,,,,,,,"Name:PubMed, SrcID:1850465, URL:http://europepmc.org/abstract/MED/1850465",,,
754,CHEMBL1201313,Chlophedianol,Small molecule,1982.0,R05DB10,"R05DB10 [RESPIRATORY SYSTEM: COUGH AND COLD PREPARATIONS: COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS: Other cough suppressants]",,Unknown,Antitussive drug; probable action in the CNS cough centre,,,,,,,,,"Name:PubMed, SrcID:15491779, URL:http://europepmc.org/abstract/MED/15491779|Name:Wikipedia, SrcID:Chlophedianol, URL:http://en.wikipedia.org/wiki/Chlophedianol|Name:PubMed, SrcID:18294576, URL:http://europepmc.org/abstract/MED/18294576|Name:PubMed, SrcID:20326564, URL:http://europepmc.org/abstract/MED/20326564",CN(C)CCC(O)(c1ccccc1)c2ccccc2Cl,,
755,CHEMBL1187833,Umeclidinium,Small molecule,2013.0,,,-clidinium; -ium,Muscarinic acetylcholine receptor M3 antagonist,"Indicated for COPD, M3 responsible",,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2013/203975s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203975s000lbl.pdf",OC(c1ccccc1)(c2ccccc2)C34CC[N+](CCOCc5ccccc5)(CC3)CC4,CHEMBL245,CHRM3
756,CHEMBL2108311,Asfotase Alfa,Enzyme,2015.0,A16AB13,A16AB13 [ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Enzymes],-ase; -fo-,Pyrophosphate hydrolytic enzyme,First-in-class enzyme replacement therapy of TNSALP in case of hypophosphatasia (HPP),,CHEMBL3545435,Pyrophosphate,HYDROLYTIC ENZYME,,SMALL MOLECULE,,,"Name:PubMed, SrcID:22397652, URL:http://europepmc.org/abstract/MED/22397652|Name:DailyMed, SrcID:setid=3387574f-5eaa-4501-a71d-4cbfbd563031, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3387574f-5eaa-4501-a71d-4cbfbd563031",,,
757,CHEMBL1801204,Azd-8055,Small molecule,,,,,Serine/threonine-protein kinase mTOR inhibitor,ATP-competitive mTORC1/mTORC2 inhibitor,,CHEMBL2842,Serine/threonine-protein kinase mTOR,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20028854, URL:http://europepmc.org/abstract/MED/20028854",COc1ccc(cc1CO)c2ccc3c(nc(nc3n2)N4CCOC[C@@H]4C)N5CCOC[C@@H]5C,CHEMBL2842,MTOR
758,CHEMBL3545133,Jnj-26483327,Small molecule,,,,,Vascular endothelial growth factor receptor 3 inhibitor,Multi-targeted tyrosine kinase inhibitor,,CHEMBL1955,Vascular endothelial growth factor receptor 3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1016/S1359-6349(10)71870-X, URL:http://www.sciencedirect.com/science/article/pii/S135963491071870X|Name:PubMed, SrcID:20823884, URL:http://europepmc.org/abstract/MED/20823884",,CHEMBL1955,FLT4
759,CHEMBL3544927,L-21649,Small molecule,,,,,Vascular endothelial growth factor receptor inhibitor,No further data/studies for the compound found.,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://www.ucb.com/_up/ucb_com_rd/documents/External_poster.pdf, URL:http://www.ucb.com/_up/ucb_com_rd/documents/External_poster.pdf",,,
760,CHEMBL3348923,Mln-2480,Small molecule,,,,,RAF serine/threonine protein kinase inhibitor,,,CHEMBL3559685,RAF serine/threonine protein kinase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://www.sunesis.com/products-in-development/product/MLN2480.php, URL:http://www.sunesis.com/products-in-development/product/MLN2480.php|Name:PubMed, SrcID:5653214, URL:http://europepmc.org/abstract/MED/5653214|Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=710688, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=710688",C[C@@H](NC(=O)c1ncnc(N)c1Cl)c2ncc(s2)C(=O)Nc3cc(c(Cl)cn3)C(F)(F)F,,
761,CHEMBL3545009,Pbf-509,Small molecule,,,,,Adenosine A2a receptor antagonist,,,CHEMBL251,Adenosine A2a receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=770798, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=770798",,CHEMBL251,ADORA2A
762,CHEMBL3545272,Las190792,Small molecule,,,,,Beta-2 adrenergic receptor agonist,Dual acting MABA (beta 2 adrenergic receptor agonists; Muscarinic receptor antagonists),,CHEMBL210,Beta-2 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.almirall.com/en/about-almirall/research-and-development/pipeline, URL:http://www.almirall.com/en/about-almirall/research-and-development/pipeline|Name:Other, SrcID:http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A3767, URL:http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A3767",,CHEMBL210,ADRB2
763,CHEMBL3545088,Puquitinib,Small molecule,,,,-tinib,Vascular endothelial growth factor receptor 2 inhibitor,"Compound is most potent against PIK3CD, low potency against EGFR, KDR and PDGFRB",,CHEMBL279,Vascular endothelial growth factor receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26499488, URL:http://europepmc.org/abstract/MED/26499488|Name:DOI, SrcID:10.1158/1538-7445.AM2011-4245, URL:http://cancerres.aacrjournals.org/content/71/8_Supplement/4245|Name:PubMed, SrcID:26510909, URL:http://europepmc.org/abstract/MED/26510909",,CHEMBL279,KDR
764,CHEMBL3545332,Cep-2563,Small molecule,,,,,Platelet-derived growth factor receptor beta inhibitor,,,CHEMBL1913,Platelet-derived growth factor receptor beta,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:9259409, URL:http://europepmc.org/abstract/MED/9259409|Name:PubMed, SrcID:10344749, URL:http://europepmc.org/abstract/MED/10344749|Name:PubMed, SrcID:15292715, URL:http://europepmc.org/abstract/MED/15292715",,CHEMBL1913,PDGFRB
765,CHEMBL198877,Equol,Small molecule,,,,,Estrogen receptor beta agonist,,,CHEMBL242,Estrogen receptor beta,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.ausiopharma.com/TechPages/TechOverview.html, URL:http://www.ausiopharma.com/TechPages/TechOverview.html",Oc1ccc(cc1)[C@H]2COc3cc(O)ccc3C2,CHEMBL242,ESR2
766,CHEMBL1230609,Foretinib,Small molecule,,,,-tinib,Stem cell growth factor receptor inhibitor,,,CHEMBL1936,Stem cell growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.exelixis.com/pipeline/xl880, URL:http://www.exelixis.com/pipeline/xl880|Name:PubMed, SrcID:19808973, URL:http://europepmc.org/abstract/MED/19808973",COc1cc2c(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc5ccc(F)cc5)cc3F)ccnc2cc1OCCCN6CCOCC6,CHEMBL1936,KIT
767,CHEMBL558752,Chir-265,Small molecule,,,,,Vascular endothelial growth factor receptor 2 inhibitor,,,CHEMBL279,Vascular endothelial growth factor receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26396681, URL:http://europepmc.org/abstract/MED/26396681|Name:PubMed, SrcID:23617957, URL:http://europepmc.org/abstract/MED/23617957",Cn1c(Nc2ccc(cc2)C(F)(F)F)nc3cc(Oc4ccnc(c4)c5ncc([nH]5)C(F)(F)F)ccc13,CHEMBL279,KDR
768,CHEMBL1631540,Gsk163090,Small molecule,,,,,Serotonin transporter antagonist,,,CHEMBL228,Serotonin transporter,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21053897, URL:http://europepmc.org/abstract/MED/21053897",Cc1ccc2c(cccc2n1)N3CCN(CCc4cccc(c4)N5CCNC5=O)CC3,CHEMBL228,SLC6A4
769,CHEMBL1910936,Mk3207,Small molecule,,,,,Calcitonin gene-related peptide type 1 receptor antagonist,,,CHEMBL3798,Calcitonin gene-related peptide type 1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20065019, URL:http://europepmc.org/abstract/MED/20065019",Fc1cc(F)cc(c1)[C@@H]2CNC3(CCCC3)C(=O)N2CC(=O)Nc4ccc5C[C@]6(Cc5c4)C(=O)Nc7ncccc67,,
770,CHEMBL292376,Tecalcet,Small molecule,,,,-calcet,Calcium sensing receptor modulator,Can't find trial IDs (http://adisinsight.springer.com/drugs/800007039),,CHEMBL1878,Calcium sensing receptor,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18796518, URL:http://europepmc.org/abstract/MED/18796518|Name:PubMed, SrcID:23966241, URL:http://europepmc.org/abstract/MED/23966241|Name:PubMed, SrcID:9520489, URL:http://europepmc.org/abstract/MED/9520489",COc1cccc(c1)[C@@H](C)NCCCc2ccccc2Cl,CHEMBL1878,CASR
771,CHEMBL419667,Relcovaptan,Small molecule,,,,-vaptan,Vasopressin V1a receptor antagonist,,,CHEMBL1889,Vasopressin V1a receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10519430, URL:http://europepmc.org/abstract/MED/10519430|Name:PubMed, SrcID:21130036, URL:http://europepmc.org/abstract/MED/21130036",COc1ccc(cc1OC)S(=O)(=O)N2[C@@H](C(=O)N3CCC[C@H]3C(=O)N)[C@@](O)(c4ccccc4Cl)c5cc(Cl)ccc25,CHEMBL1889,AVPR1A
772,CHEMBL3545168,Imd-1041,Small molecule,,,,,Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor,Prodrug - active metabolite is IMD-0354,,CHEMBL1991,Inhibitor of nuclear factor kappa B kinase beta subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23042949, URL:http://europepmc.org/abstract/MED/23042949|Name:Other, SrcID:http://www.immd.co.jp/en/development.html, URL:http://www.immd.co.jp/en/development.html",,CHEMBL1991,IKBKB
773,CHEMBL220808,Sarizotan,Small molecule,,,,-zotan,Dopamine D4 receptor agonist,"Development discontunued, failed to meet primary efficacy endpoints, no difference between drug and placebo. Newron developing drug for Rett syndrome and received EMA and FDA orphan designation in July 2015. Agonist/partial agonistic/antagonsitic effect depending on dopamine receptor isoform.",,CHEMBL219,Dopamine D4 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:14767715, URL:http://europepmc.org/abstract/MED/14767715|Name:PubMed, SrcID:16844149, URL:http://europepmc.org/abstract/MED/16844149",Fc1ccc(cc1)c2cncc(CNC[C@H]3CCc4ccccc4O3)c2,,
774,CHEMBL572881,Motesanib,Small molecule,,,,-anib,Stem cell growth factor receptor inhibitor,Multi-kinase inhibitor,,CHEMBL1936,Stem cell growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16951187, URL:http://europepmc.org/abstract/MED/16951187",CC1(C)CNc2cc(NC(=O)c3cccnc3NCc4ccncc4)ccc12,CHEMBL1936,KIT
775,CHEMBL2110580,Berubicin,Small molecule,,,,-rubicin,DNA topoisomerase II inhibitor,"Intercalates into DNA and interrupts topoisomerase II activity, resulting in the inhibition of DNA replication and repair, and RNA and protein synthesis",,CHEMBL2094255,DNA topoisomerase II,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=491929, URL:https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=491929",COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](OCc6ccccc6)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO,,
776,CHEMBL2107821,Emixustat,Small molecule,,,,-stat,Retinoid isomerohydrolase inhibitor,"Nonretinoid compound with a unique mode of action in the retinal pigment epithelium, where it modulates the biosynthesis of visual chromophore through its effect on retinal pigment epithelium-specific 65 kDa protein isomerase.",,CHEMBL3831182,Retinoid isomerohydrolase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24056528 , URL:http://europepmc.org/abstract/MED/24056528 |Name:PubMed, SrcID:24056528, URL:http://europepmc.org/abstract/MED/24056528",NCC[C@@H](O)c1cccc(OCC2CCCCC2)c1,CHEMBL3831182,RPE65
777,CHEMBL1742988,Baminercept,Protein,,,,-cept,Heterotrimeric lymphotoxin LTa1b2 inhibitor,"Baminercept binds to both LTBR ligands, namely, a membrane bound heterotrimeric lymphotoxin (LT) form LTalpha1beta2 and the ligand called LIGHT (TNFSF14). It is a dual pathway inhibitor blocking signaling triggered by both membrane LT and LIGHT ligands.",,CHEMBL3833421,Heterotrimeric lymphotoxin LTa1b2,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25405351, URL:http://europepmc.org/abstract/MED/25405351",,CHEMBL3833421,LTB
778,CHEMBL1743003,Conatumumab,Antibody,,,,-mab,Tumor necrosis factor receptor superfamily member 10B agonist,"It binds to TNFRSF10B, activating intracellular caspases in vitro in the presence of a cross-linker.",,CHEMBL1075153,Tumor necrosis factor receptor superfamily member 10B,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20150762, URL:http://europepmc.org/abstract/MED/20150762",,CHEMBL1075153,TNFRSF10B
779,CHEMBL2109224,Rovelizumab,Antibody,,,,-mab,Integrin alpha-L/beta-2 (LFA-1) antagonist,Inhibits the leukocyte’s ability to adhere to the endothelial cell and transmigrate across the endothelial cell layer.,,CHEMBL2364172,Integrin alpha-L/beta-2 (LFA-1),ANTAGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:9784282, URL:http://europepmc.org/abstract/MED/9784282|Name:PubMed, SrcID:16100700, URL:http://europepmc.org/abstract/MED/16100700",,,
780,CHEMBL2109271,Mdx-210,Antibody,,,,,High affinity immunoglobulin gamma Fc receptor I other,Immunostimulant. Antibody dependent cellular phagocytosis (ADCP) and antibody-dependent cell-mediated cytotoxicity (ADCC).,,CHEMBL5349,High affinity immunoglobulin gamma Fc receptor I,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10369066, URL:http://europepmc.org/abstract/MED/10369066",,CHEMBL5349,FCGR1A
781,CHEMBL3544922,Opicinumab,Antibody,,,,-mab,Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 inhibitor,Antagonism of LINGO-1 exhibits neuroprotective effects in animal models,,CHEMBL3712965,Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_summary_pr?p_JournalId=2p_RefId=2375755p_IsPs=N, URL:https://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_summary_pr?p_JournalId=2p_RefId=2375755p_IsPs=N",,CHEMBL3712965,LINGO1
782,CHEMBL2103836,Imagabalin,Small molecule,,,,-gab-,Voltage-gated calcium channel modulator,Ligand for the voltage-gated calcium channel alpha-2-delta subunit.,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Wikipedia, SrcID:Imagabalin, URL:https://en.wikipedia.org/wiki/Imagabalin",CCC[C@@H](C)C[C@H](N)CC(=O)O,CHEMBL2363032,CACNB3
783,CHEMBL2103836,Imagabalin,Small molecule,,,,-gab-,Voltage-gated calcium channel modulator,Ligand for the voltage-gated calcium channel alpha-2-delta subunit.,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Wikipedia, SrcID:Imagabalin, URL:https://en.wikipedia.org/wiki/Imagabalin",CCC[C@@H](C)C[C@H](N)CC(=O)O,CHEMBL2363032,CACNG3
784,CHEMBL2103836,Imagabalin,Small molecule,,,,-gab-,Voltage-gated calcium channel modulator,Ligand for the voltage-gated calcium channel alpha-2-delta subunit.,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Wikipedia, SrcID:Imagabalin, URL:https://en.wikipedia.org/wiki/Imagabalin",CCC[C@@H](C)C[C@H](N)CC(=O)O,CHEMBL2363032,CACNG5
785,CHEMBL2103836,Imagabalin,Small molecule,,,,-gab-,Voltage-gated calcium channel modulator,Ligand for the voltage-gated calcium channel alpha-2-delta subunit.,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Wikipedia, SrcID:Imagabalin, URL:https://en.wikipedia.org/wiki/Imagabalin",CCC[C@@H](C)C[C@H](N)CC(=O)O,CHEMBL2363032,CACNG4
786,CHEMBL2103836,Imagabalin,Small molecule,,,,-gab-,Voltage-gated calcium channel modulator,Ligand for the voltage-gated calcium channel alpha-2-delta subunit.,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Wikipedia, SrcID:Imagabalin, URL:https://en.wikipedia.org/wiki/Imagabalin",CCC[C@@H](C)C[C@H](N)CC(=O)O,CHEMBL2363032,CACNG1
787,CHEMBL2103836,Imagabalin,Small molecule,,,,-gab-,Voltage-gated calcium channel modulator,Ligand for the voltage-gated calcium channel alpha-2-delta subunit.,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Wikipedia, SrcID:Imagabalin, URL:https://en.wikipedia.org/wiki/Imagabalin",CCC[C@@H](C)C[C@H](N)CC(=O)O,CHEMBL2363032,CACNB4
788,CHEMBL2103836,Imagabalin,Small molecule,,,,-gab-,Voltage-gated calcium channel modulator,Ligand for the voltage-gated calcium channel alpha-2-delta subunit.,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Wikipedia, SrcID:Imagabalin, URL:https://en.wikipedia.org/wiki/Imagabalin",CCC[C@@H](C)C[C@H](N)CC(=O)O,CHEMBL2363032,CACNA2D4
789,CHEMBL2103836,Imagabalin,Small molecule,,,,-gab-,Voltage-gated calcium channel modulator,Ligand for the voltage-gated calcium channel alpha-2-delta subunit.,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Wikipedia, SrcID:Imagabalin, URL:https://en.wikipedia.org/wiki/Imagabalin",CCC[C@@H](C)C[C@H](N)CC(=O)O,CHEMBL2363032,CACNG2
790,CHEMBL2103836,Imagabalin,Small molecule,,,,-gab-,Voltage-gated calcium channel modulator,Ligand for the voltage-gated calcium channel alpha-2-delta subunit.,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Wikipedia, SrcID:Imagabalin, URL:https://en.wikipedia.org/wiki/Imagabalin",CCC[C@@H](C)C[C@H](N)CC(=O)O,CHEMBL2363032,CACNG7
791,CHEMBL2103836,Imagabalin,Small molecule,,,,-gab-,Voltage-gated calcium channel modulator,Ligand for the voltage-gated calcium channel alpha-2-delta subunit.,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Wikipedia, SrcID:Imagabalin, URL:https://en.wikipedia.org/wiki/Imagabalin",CCC[C@@H](C)C[C@H](N)CC(=O)O,CHEMBL2363032,CACNG8
792,CHEMBL2103836,Imagabalin,Small molecule,,,,-gab-,Voltage-gated calcium channel modulator,Ligand for the voltage-gated calcium channel alpha-2-delta subunit.,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Wikipedia, SrcID:Imagabalin, URL:https://en.wikipedia.org/wiki/Imagabalin",CCC[C@@H](C)C[C@H](N)CC(=O)O,CHEMBL2363032,CACNG6
793,CHEMBL2103836,Imagabalin,Small molecule,,,,-gab-,Voltage-gated calcium channel modulator,Ligand for the voltage-gated calcium channel alpha-2-delta subunit.,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Wikipedia, SrcID:Imagabalin, URL:https://en.wikipedia.org/wiki/Imagabalin",CCC[C@@H](C)C[C@H](N)CC(=O)O,CHEMBL2363032,CACNA1F
794,CHEMBL2103836,Imagabalin,Small molecule,,,,-gab-,Voltage-gated calcium channel modulator,Ligand for the voltage-gated calcium channel alpha-2-delta subunit.,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Wikipedia, SrcID:Imagabalin, URL:https://en.wikipedia.org/wiki/Imagabalin",CCC[C@@H](C)C[C@H](N)CC(=O)O,CHEMBL2363032,CACNB1
795,CHEMBL2103836,Imagabalin,Small molecule,,,,-gab-,Voltage-gated calcium channel modulator,Ligand for the voltage-gated calcium channel alpha-2-delta subunit.,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Wikipedia, SrcID:Imagabalin, URL:https://en.wikipedia.org/wiki/Imagabalin",CCC[C@@H](C)C[C@H](N)CC(=O)O,CHEMBL2363032,CACNA2D3
796,CHEMBL495,Alprostadil,Small molecule,1981.0,G04BE01; C01EA01,G04BE01 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Drugs used in erectile dysfunction]; C01EA01 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: OTHER CARDIAC PREPARATIONS: Prostaglandins],-dil; -prost-,Prostanoid EP1 receptor agonist,,,CHEMBL1811,Prostanoid EP1 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=51d530fe-b283-43ea-a206-a419742b4b4b#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=51d530fe-b283-43ea-a206-a419742b4b4b#nlm34090-1|Name:FDA, SrcID:label/2015/020649s023lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020649s023lbl.pdf|Name:ISBN, SrcID:0443-059748 PP. 216, 445, URL:http://www.isbnsearch.org/isbn/0443059748",CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O,CHEMBL1811,PTGER1
797,CHEMBL704,Mesalamine,Small molecule,1987.0,A07EC02,"A07EC02 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Aminosalicylic acid and similar agents]",-sal-,Arachidonate 5-lipoxygenase inhibitor,,,CHEMBL215,Arachidonate 5-lipoxygenase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:6428914, URL:http://europepmc.org/abstract/MED/6428914|Name:PubMed, SrcID:2882965, URL:http://europepmc.org/abstract/MED/2882965|Name:PubMed, SrcID:6131674, URL:http://europepmc.org/abstract/MED/6131674",Nc1ccc(O)c(c1)C(=O)O,CHEMBL215,ALOX5
798,CHEMBL1279,Frovatriptan,Small molecule,2001.0,N02CC07,N02CC07 [NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Selective serotonin (5HT1) agonists],-triptan,Serotonin 1b (5-HT1b) receptor agonist,,Selective,CHEMBL1898,Serotonin 1b (5-HT1b) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2009/021006s006s009s010lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021006s006s009s010lbl.pdf",CN[C@@H]1CCc2[nH]c3ccc(cc3c2C1)C(=O)N,CHEMBL1898,HTR1B
799,CHEMBL623,Nefazodone,Small molecule,1994.0,N06AX06,N06AX06 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants],,Serotonin transporter inhibitor,,,CHEMBL228,Serotonin transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=b1d149db-ad43-4f3f-aef1-fb0395ba4191#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b1d149db-ad43-4f3f-aef1-fb0395ba4191#nlm34090-1",CCC1=NN(CCCN2CCN(CC2)c3cccc(Cl)c3)C(=O)N1CCOc4ccccc4,CHEMBL228,SLC6A4
800,CHEMBL973,Teriflunomide,Small molecule,2012.0,L04AA31,L04AA31 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Selective immunosuppressants],,Dihydroorotate dehydrogenase inhibitor,,,CHEMBL1966,Dihydroorotate dehydrogenase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Expert, SrcID:TERIFLUNOMIDE, URL:http://chembl.blogspot.co.uk/search?q=TERIFLUNOMIDE",C\C(=C(/C#N)\C(=O)Nc1ccc(cc1)C(F)(F)F)\O,CHEMBL1966,DHODH
801,CHEMBL1201638,Insulin Susp Protamine Zinc Purified Pork,Protein,1979.0,,,,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/022472s006s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022472s006s008lbl.pdf|Name:DailyMed, SrcID:setid=457531f0-9331-47fe-90b5-b31f284044dc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=457531f0-9331-47fe-90b5-b31f284044dc",,CHEMBL1981,INSR
802,CHEMBL1201497,Insulin Glargine,Protein,2000.0,A10AE04,"A10AE04 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: INSULINS AND ANALOGUES: Insulins and analogues for injection, long-acting]",,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=b861fdd9-e134-436e-8c0c-a60dd0006dd3, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b861fdd9-e134-436e-8c0c-a60dd0006dd3",,CHEMBL1981,INSR
803,CHEMBL1108,Droperidol,Small molecule,1970.0,N05AD08,N05AD08 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Butyrophenone derivatives],-peridol,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:0443-059748, URL:http://www.isbnsearch.org/isbn/0443059748|Name:Wikipedia, SrcID:Antipsychotics, URL:http://en.wikipedia.org/wiki/Antipsychotics|Name:Wikipedia, SrcID:Droperidol, URL:http://en.wikipedia.org/wiki/Droperidol|Name:PubMed, SrcID:20832967, URL:http://europepmc.org/abstract/MED/20832967",Fc1ccc(cc1)C(=O)CCCN2CCC(=CC2)N3C(=O)Nc4ccccc34,CHEMBL224,HTR2A
804,CHEMBL932,Dipyridamole,Small molecule,1961.0,B01AC07,B01AC07 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Platelet aggregation inhibitors excl. heparin],,Equilibrative nucleoside transporter 1 inhibitor,,,CHEMBL1997,Equilibrative nucleoside transporter 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=ae7585ec-1280-40fe-b888-613b8a0e6ef6, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ae7585ec-1280-40fe-b888-613b8a0e6ef6|Name:UniProt, SrcID:Q99808#section_comments, URL:http://www.uniprot.org/uniprot/Q99808#section_comments",OCCN(CCO)c1nc(N2CCCCC2)c3nc(nc(N4CCCCC4)c3n1)N(CCO)CCO,CHEMBL1997,SLC29A1
805,CHEMBL596,Fentanyl,Small molecule,1968.0,N01AH01; N02AB03; N01AH51,"N01AH01 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Opioid anesthetics]; N02AB03 [NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Phenylpiperidine derivatives]; N01AH51 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Opioid anesthetics]",,Mu opioid receptor agonist,,,CHEMBL233,Mu opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=4906457e-30ad-4da7-b3ac-bb9e6651a670#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4906457e-30ad-4da7-b3ac-bb9e6651a670#nlm34090-1",CCC(=O)N(C1CCN(CCc2ccccc2)CC1)c3ccccc3,CHEMBL233,OPRM1
806,CHEMBL612,Dextroamphetamine,Small molecule,1955.0,N06BA02,"N06BA02 [NERVOUS SYSTEM: PSYCHOANALEPTICS: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS: Centrally acting sympathomimetics]",,Norepinephrine transporter releasing agent,,,CHEMBL222,Norepinephrine transporter,RELEASING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17239355, URL:http://europepmc.org/abstract/MED/17239355|Name:PubMed, SrcID:19727679, URL:http://europepmc.org/abstract/MED/19727679",C[C@H](N)Cc1ccccc1,CHEMBL222,SLC6A2
807,CHEMBL1946170,Regorafenib,Small molecule,2012.0,L01XE21,L01XE21 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-rafenib,Fibroblast growth factor receptor 1 inhibitor,,,CHEMBL3650,Fibroblast growth factor receptor 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Expert, SrcID:REGORAFENIB, URL:http://chembl.blogspot.co.uk/search?q=REGORAFENIB",CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,CHEMBL3650,FGFR1
808,CHEMBL1479,Danazol,Small molecule,1976.0,G03XA01,G03XA01 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: Antigonadotropins and similar agents],,Progesterone receptor agonist,,,CHEMBL208,Progesterone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:0443-059748 PP. 447, URL:http://www.isbnsearch.org/isbn/0443059748|Name:DailyMed, SrcID:setid=d30a0bb0-d8e4-e17a-0f8b-6696a2712e98#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d30a0bb0-d8e4-e17a-0f8b-6696a2712e98#nlm34090-1|Name:FDA, SrcID:label/2011/017557s033s039s040s041s042lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/017557s033s039s040s041s042lbl.pdf|Name:PubMed, SrcID:18061638, URL:http://europepmc.org/abstract/MED/18061638",C[C@]12Cc3cnoc3C=C1CC[C@@H]4[C@@H]2CC[C@@]5(C)[C@H]4CC[C@@]5(O)C#C,CHEMBL208,PGR
809,CHEMBL1589,Acetohexamide,Small molecule,1964.0,A10BB31,"A10BB31 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Sulfonylureas]",,"Sulfonylurea receptor 1, Kir6.2 blocker",,,CHEMBL2096972,"Sulfonylurea receptor 1, Kir6.2",BLOCKER,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:10194514, URL:http://europepmc.org/abstract/MED/10194514|Name:PubMed, SrcID:22260657, URL:http://europepmc.org/abstract/MED/22260657|Name:Wikipedia, SrcID:Acetohexamide, URL:http://en.wikipedia.org/wiki/Acetohexamide",CC(=O)c1ccc(cc1)S(=O)(=O)NC(=O)NC2CCCCC2,,
810,CHEMBL1027,Tiagabine,Small molecule,1997.0,N03AG06,N03AG06 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Fatty acid derivatives],-gab-,GABA transporter 1 inhibitor,reuptake inhibitor,,CHEMBL1903,GABA transporter 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=cf97a72e-951e-a7db-a574-adac12a6b189, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cf97a72e-951e-a7db-a574-adac12a6b189|Name:PubMed, SrcID:20512624, URL:http://europepmc.org/abstract/MED/20512624|Name:Wikipedia, SrcID:Tiagabine#Pharmacology, URL:http://en.wikipedia.org/wiki/Tiagabine#Pharmacology",Cc1ccsc1C(=CCCN2CCC[C@H](C2)C(=O)O)c3sccc3C,CHEMBL1903,SLC6A1
811,CHEMBL1201587,Alemtuzumab,Antibody,2001.0,L04AA34,L04AA34 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Selective immunosuppressants],-mab,CAMPATH-1 antigen inhibitor,,,CHEMBL1912,CAMPATH-1 antigen,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=4f5f7255-7abc-4328-bd1a-ceaf139ef3e0, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4f5f7255-7abc-4328-bd1a-ceaf139ef3e0",,CHEMBL1912,CD52
812,CHEMBL1201828,Eculizumab,Antibody,2007.0,L04AA25,L04AA25 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Selective immunosuppressants],-mab,Complement C5 inhibitor,,,CHEMBL2364163,Complement C5,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=ebcd67fa-b4d1-4a22-b33d-ee8bf6b9c722, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ebcd67fa-b4d1-4a22-b33d-ee8bf6b9c722",,CHEMBL2364163,C5
813,CHEMBL562,Griseofulvin,Small molecule,1962.0,D01BA01; D01AA08,D01BA01 [DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR SYSTEMIC USE: Antifungals for systemic use]; D01AA08 [DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Antibiotics],-vin-,Tubulin inhibitor,,,CHEMBL2364703,Tubulin,INHIBITOR,Trichophyton,PROTEIN COMPLEX GROUP,Beta tubulin,Binds to beta tubulin,"Name:PubMed, SrcID:18095085, URL:http://europepmc.org/abstract/MED/18095085|Name:PubMed, SrcID:2878792, URL:http://europepmc.org/abstract/MED/2878792|Name:ISBN, SrcID:9780702034718 PP. 651, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:8651940, URL:http://europepmc.org/abstract/MED/8651940",COC1=CC(=O)C[C@@H](C)[C@]12Oc3c(Cl)c(OC)cc(OC)c3C2=O,,
814,CHEMBL638,Voriconazole,Small molecule,2002.0,J02AC03,J02AC03 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: Triazole derivatives],-conazole,Cytochrome P450 51 inhibitor,,,CHEMBL1780,Cytochrome P450 51,INHIBITOR,Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast),SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=dac26bcd-7a59-401f-9f66-a0649767cece, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dac26bcd-7a59-401f-9f66-a0649767cece",C[C@@H](c1ncncc1F)[C@](O)(Cn2cncn2)c3ccc(F)cc3F,,
815,CHEMBL612,Dextroamphetamine,Small molecule,1955.0,N06BA02,"N06BA02 [NERVOUS SYSTEM: PSYCHOANALEPTICS: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS: Centrally acting sympathomimetics]",,Synaptic vesicular amine transporter inhibitor,,,CHEMBL1893,Synaptic vesicular amine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15955613, URL:http://europepmc.org/abstract/MED/15955613|Name:PubMed, SrcID:7751968, URL:http://europepmc.org/abstract/MED/7751968",C[C@H](N)Cc1ccccc1,CHEMBL1893,SLC18A2
816,CHEMBL1336,Sorafenib,Small molecule,2005.0,L01XE05,L01XE05 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-rafenib,Tyrosine-protein kinase receptor RET inhibitor,,,CHEMBL2041,Tyrosine-protein kinase receptor RET,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2011/021923s012lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf",CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,CHEMBL2041,RET
817,CHEMBL535,Sunitinib,Small molecule,2006.0,L01XE04,L01XE04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Tyrosine-protein kinase receptor RET inhibitor,,,CHEMBL2041,Tyrosine-protein kinase receptor RET,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14",CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C\2/C(=O)Nc3ccc(F)cc23)c1C,CHEMBL2041,RET
818,CHEMBL1201604,Tositumomab,Antibody,2003.0,,,-mab,B-lymphocyte antigen CD20 inhibitor,,,CHEMBL2058,B-lymphocyte antigen CD20,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2012/125011s0126lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/125011s0126lbl.pdf|Name:DailyMed, SrcID:setid=0d706611-abab-42f1-ae8a-2097eb1be38d, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0d706611-abab-42f1-ae8a-2097eb1be38d",,CHEMBL2058,MS4A1
819,CHEMBL12,Diazepam,Small molecule,1963.0,N05BA01,N05BA01 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:Wikipedia, SrcID:Benzodiazepine, URL:http://en.wikipedia.org/wiki/Benzodiazepine|Name:Wikipedia, SrcID:Diazepam, URL:http://en.wikipedia.org/wiki/Diazepam|Name:PubMed, SrcID:15926867, URL:http://europepmc.org/abstract/MED/15926867|Name:PubMed, SrcID:2886589, URL:http://europepmc.org/abstract/MED/2886589",CN1C(=O)CN=C(c2ccccc2)c3cc(Cl)ccc13,CHEMBL2093872,GABRG3
820,CHEMBL12,Diazepam,Small molecule,1963.0,N05BA01,N05BA01 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:Wikipedia, SrcID:Benzodiazepine, URL:http://en.wikipedia.org/wiki/Benzodiazepine|Name:Wikipedia, SrcID:Diazepam, URL:http://en.wikipedia.org/wiki/Diazepam|Name:PubMed, SrcID:15926867, URL:http://europepmc.org/abstract/MED/15926867|Name:PubMed, SrcID:2886589, URL:http://europepmc.org/abstract/MED/2886589",CN1C(=O)CN=C(c2ccccc2)c3cc(Cl)ccc13,CHEMBL2093872,GABRP
821,CHEMBL12,Diazepam,Small molecule,1963.0,N05BA01,N05BA01 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:Wikipedia, SrcID:Benzodiazepine, URL:http://en.wikipedia.org/wiki/Benzodiazepine|Name:Wikipedia, SrcID:Diazepam, URL:http://en.wikipedia.org/wiki/Diazepam|Name:PubMed, SrcID:15926867, URL:http://europepmc.org/abstract/MED/15926867|Name:PubMed, SrcID:2886589, URL:http://europepmc.org/abstract/MED/2886589",CN1C(=O)CN=C(c2ccccc2)c3cc(Cl)ccc13,CHEMBL2093872,GABRE
822,CHEMBL12,Diazepam,Small molecule,1963.0,N05BA01,N05BA01 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:Wikipedia, SrcID:Benzodiazepine, URL:http://en.wikipedia.org/wiki/Benzodiazepine|Name:Wikipedia, SrcID:Diazepam, URL:http://en.wikipedia.org/wiki/Diazepam|Name:PubMed, SrcID:15926867, URL:http://europepmc.org/abstract/MED/15926867|Name:PubMed, SrcID:2886589, URL:http://europepmc.org/abstract/MED/2886589",CN1C(=O)CN=C(c2ccccc2)c3cc(Cl)ccc13,CHEMBL2093872,GABRG1
823,CHEMBL568,Oxazepam,Small molecule,1965.0,N05BA04,N05BA04 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:2570451, URL:http://europepmc.org/abstract/MED/2570451|Name:PubMed, SrcID:6135616, URL:http://europepmc.org/abstract/MED/6135616|Name:Wikipedia, SrcID:Oxazepam, URL:http://en.wikipedia.org/wiki/Oxazepam",OC1N=C(c2ccccc2)c3cc(Cl)ccc3NC1=O,CHEMBL2093872,GABRG3
824,CHEMBL568,Oxazepam,Small molecule,1965.0,N05BA04,N05BA04 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:2570451, URL:http://europepmc.org/abstract/MED/2570451|Name:PubMed, SrcID:6135616, URL:http://europepmc.org/abstract/MED/6135616|Name:Wikipedia, SrcID:Oxazepam, URL:http://en.wikipedia.org/wiki/Oxazepam",OC1N=C(c2ccccc2)c3cc(Cl)ccc3NC1=O,CHEMBL2093872,GABRP
825,CHEMBL568,Oxazepam,Small molecule,1965.0,N05BA04,N05BA04 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:2570451, URL:http://europepmc.org/abstract/MED/2570451|Name:PubMed, SrcID:6135616, URL:http://europepmc.org/abstract/MED/6135616|Name:Wikipedia, SrcID:Oxazepam, URL:http://en.wikipedia.org/wiki/Oxazepam",OC1N=C(c2ccccc2)c3cc(Cl)ccc3NC1=O,CHEMBL2093872,GABRE
826,CHEMBL568,Oxazepam,Small molecule,1965.0,N05BA04,N05BA04 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:2570451, URL:http://europepmc.org/abstract/MED/2570451|Name:PubMed, SrcID:6135616, URL:http://europepmc.org/abstract/MED/6135616|Name:Wikipedia, SrcID:Oxazepam, URL:http://en.wikipedia.org/wiki/Oxazepam",OC1N=C(c2ccccc2)c3cc(Cl)ccc3NC1=O,CHEMBL2093872,GABRG1
827,CHEMBL681,Etomidate,Small molecule,1982.0,N01AX07,"N01AX07 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Other general anesthetics]",,GABA-A receptor; anion channel positive modulator,,selectivity for beta-3 containing complexes,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:19555700, URL:http://europepmc.org/abstract/MED/19555700",CCOC(=O)c1cncn1[C@H](C)c2ccccc2,CHEMBL2093872,GABRG3
828,CHEMBL681,Etomidate,Small molecule,1982.0,N01AX07,"N01AX07 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Other general anesthetics]",,GABA-A receptor; anion channel positive modulator,,selectivity for beta-3 containing complexes,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:19555700, URL:http://europepmc.org/abstract/MED/19555700",CCOC(=O)c1cncn1[C@H](C)c2ccccc2,CHEMBL2093872,GABRP
829,CHEMBL681,Etomidate,Small molecule,1982.0,N01AX07,"N01AX07 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Other general anesthetics]",,GABA-A receptor; anion channel positive modulator,,selectivity for beta-3 containing complexes,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:19555700, URL:http://europepmc.org/abstract/MED/19555700",CCOC(=O)c1cncn1[C@H](C)c2ccccc2,CHEMBL2093872,GABRE
830,CHEMBL681,Etomidate,Small molecule,1982.0,N01AX07,"N01AX07 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Other general anesthetics]",,GABA-A receptor; anion channel positive modulator,,selectivity for beta-3 containing complexes,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:19555700, URL:http://europepmc.org/abstract/MED/19555700",CCOC(=O)c1cncn1[C@H](C)c2ccccc2,CHEMBL2093872,GABRG1
831,CHEMBL968,Flurazepam,Small molecule,1970.0,N05CD01,N05CD01 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:2863335, URL:http://europepmc.org/abstract/MED/2863335|Name:Wikipedia, SrcID:Flurazepam, URL:http://en.wikipedia.org/wiki/Flurazepam",CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c3cc(Cl)ccc13,CHEMBL2093872,GABRG3
832,CHEMBL968,Flurazepam,Small molecule,1970.0,N05CD01,N05CD01 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:2863335, URL:http://europepmc.org/abstract/MED/2863335|Name:Wikipedia, SrcID:Flurazepam, URL:http://en.wikipedia.org/wiki/Flurazepam",CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c3cc(Cl)ccc13,CHEMBL2093872,GABRP
833,CHEMBL968,Flurazepam,Small molecule,1970.0,N05CD01,N05CD01 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:2863335, URL:http://europepmc.org/abstract/MED/2863335|Name:Wikipedia, SrcID:Flurazepam, URL:http://en.wikipedia.org/wiki/Flurazepam",CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c3cc(Cl)ccc13,CHEMBL2093872,GABRE
834,CHEMBL968,Flurazepam,Small molecule,1970.0,N05CD01,N05CD01 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:2863335, URL:http://europepmc.org/abstract/MED/2863335|Name:Wikipedia, SrcID:Flurazepam, URL:http://en.wikipedia.org/wiki/Flurazepam",CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c3cc(Cl)ccc13,CHEMBL2093872,GABRG1
835,CHEMBL1201317,Triclofos,Small molecule,1982.0,N05CM07,N05CM07 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Other hypnotics and sedatives],-fo-,GABA-A receptor; anion channel positive modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Unknown binding site,"Name:PubMed, SrcID:14302355, URL:http://europepmc.org/abstract/MED/14302355",OP(=O)(O)OCC(Cl)(Cl)Cl,CHEMBL2093872,GABRG3
836,CHEMBL1201317,Triclofos,Small molecule,1982.0,N05CM07,N05CM07 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Other hypnotics and sedatives],-fo-,GABA-A receptor; anion channel positive modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Unknown binding site,"Name:PubMed, SrcID:14302355, URL:http://europepmc.org/abstract/MED/14302355",OP(=O)(O)OCC(Cl)(Cl)Cl,CHEMBL2093872,GABRP
837,CHEMBL1201317,Triclofos,Small molecule,1982.0,N05CM07,N05CM07 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Other hypnotics and sedatives],-fo-,GABA-A receptor; anion channel positive modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Unknown binding site,"Name:PubMed, SrcID:14302355, URL:http://europepmc.org/abstract/MED/14302355",OP(=O)(O)OCC(Cl)(Cl)Cl,CHEMBL2093872,GABRE
838,CHEMBL1201317,Triclofos,Small molecule,1982.0,N05CM07,N05CM07 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Other hypnotics and sedatives],-fo-,GABA-A receptor; anion channel positive modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Unknown binding site,"Name:PubMed, SrcID:14302355, URL:http://europepmc.org/abstract/MED/14302355",OP(=O)(O)OCC(Cl)(Cl)Cl,CHEMBL2093872,GABRG1
839,CHEMBL2105745,Glycerol Phenylbutyrate,Small molecule,2013.0,A16AX09,A16AX09 [ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Various alimentary tract and metabolism products],,Glutamine sequestering agent,"Removes excess nitrogen, caused by enzyme deficiency",,CHEMBL2366039,Glutamine,SEQUESTERING AGENT,Homo sapiens,SMALL MOLECULE,,,"Name:DailyMed, SrcID:setid=73bc6b83-2513-11e1-bfc2-0800200c9a66#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=73bc6b83-2513-11e1-bfc2-0800200c9a66#nlm34090-1",O=C(CCCc1ccccc1)OCC(COC(=O)CCCc2ccccc2)OC(=O)CCCc3ccccc3,,
840,CHEMBL1200971,Cephaloglycin,Small molecule,1970.0,,,,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:Wikipedia, SrcID:Cefaloglycin, URL:http://en.wikipedia.org/wiki/Cefaloglycin|Name:Wikipedia, SrcID:Penicillin_binding_proteins, URL:http://en.wikipedia.org/wiki/Penicillin_binding_proteins|Name:PubMed, SrcID:9438663, URL:http://europepmc.org/abstract/MED/9438663",CC(=O)OCC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c3ccccc3)C2=O)C(=O)O,,
841,CHEMBL1201439,Basiliximab,Antibody,1998.0,L04AC02,L04AC02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Interleukin inhibitors],-mab,Interleukin-2 receptor inhibitor,,,CHEMBL2364167,Interleukin-2 receptor,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,Interleukin-2 alpha subunit,Alpha subunit is binding site,"Name:DailyMed, SrcID:setid=1af01887-b69d-444b-91ed-ebfe12784440, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1af01887-b69d-444b-91ed-ebfe12784440",,CHEMBL2364167,IL2RG
842,CHEMBL847,Oxamniquine,Small molecule,1980.0,P02BA02,"P02BA02 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTHELMINTICS: ANTITREMATODALS: Quinoline derivatives and related substances]",,DNA inhibitor,,,CHEMBL2366043,DNA,INHIBITOR,Schistosoma mansoni,NUCLEIC-ACID,,,"Name:Wikipedia, SrcID:Oxamniquine, URL:http://en.wikipedia.org/wiki/Oxamniquine|Name:PubMed, SrcID:2617584, URL:http://europepmc.org/abstract/MED/2617584",CC(C)NCC1CCc2cc(CO)c(cc2N1)[N+](=O)[O-],,
843,CHEMBL1197,Hexylcaine,Small molecule,1982.0,,,-caine,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:ISBN, SrcID:9780702034718 PP. 525, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:Wikipedia, SrcID:Hexylcaine, URL:http://en.wikipedia.org/wiki/Hexylcaine|Name:PubMed, SrcID:13620024, URL:http://europepmc.org/abstract/MED/13620024",CC(CNC1CCCCC1)OC(=O)c2ccccc2,,
844,CHEMBL750,Zonisamide,Small molecule,2000.0,N03AX15,N03AX15 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:15511691, URL:http://europepmc.org/abstract/MED/15511691|Name:DailyMed, SrcID:setid=f94b2ba4-024f-4068-8759-da6c8d31c546#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f94b2ba4-024f-4068-8759-da6c8d31c546#nlm34090-1",OS(=N)(=O)Cc1noc2ccccc12,,
845,CHEMBL1201262,Dipivefrin,Small molecule,1980.0,S01EA02,S01EA02 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Sympathomimetics in glaucoma therapy 1)],,Adrenergic receptor agonist,,,CHEMBL2331074,Adrenergic receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2001/18239s25lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/18239s25lbl.pdf|Name:DailyMed, SrcID:setid=016fedab-9e67-4d19-9feb-239658a064e5#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=016fedab-9e67-4d19-9feb-239658a064e5#nlm34090-1",CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1,,
846,CHEMBL1201531,Veratrum Viride,Small molecule,1982.0,C02KA01,"C02KA01 [CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: OTHER ANTIHYPERTENSIVES: Alkaloids, excl. rauwolfia]",,Unknown,Hypotensive effect not fully understood,,,,,,,,,"Name:PubMed, SrcID:16958554, URL:http://europepmc.org/abstract/MED/16958554",,,
847,CHEMBL1469,Phenylbutanoic Acid,Small molecule,1996.0,,,,Glutamine sequestering agent,"Removes excess nitrogen, caused by enzyme deficiency",,CHEMBL2366039,Glutamine,SEQUESTERING AGENT,Homo sapiens,SMALL MOLECULE,,,"Name:DailyMed, SrcID:setid=6a05ace2-3d5e-48de-b158-870d404cc061#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6a05ace2-3d5e-48de-b158-870d404cc061#nlm34090-1|Name:PubMed, SrcID:11148549, URL:http://europepmc.org/abstract/MED/11148549|Name:FDA, SrcID:label/2009/020572s016,020573s015lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020572s016,020573s015lbl.pdf",OC(=O)CCCc1ccccc1,,
848,CHEMBL70927,Deferiprone,Small molecule,1999.0,V03AC02,V03AC02 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Iron chelating agents],,Unknown,,,,,,,,,,"Name:FDA, SrcID:label/2012/021825s001lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021825s001lbl.pdf",CN1C=CC(=O)C(=C1C)O,,
849,CHEMBL1173655,Afatinib,Small molecule,2013.0,L01XE13,L01XE13 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Epidermal growth factor receptor erbB1 inhibitor,"Afatinib covalently binds to the kinase domains of EGFR (ErbB1), HER2 (ErbB2), and HER4 (ErbB4) and irreversibly inhibits tyrosine kinase autophosphorylation, resulting in downregulation of ErbB signaling",,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:fd638e5e-8032-e7ca-0179-95e96ab5d387, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fd638e5e-8032-e7ca-0179-95e96ab5d387",CN(C)C\C=C\C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]4CCOC4,CHEMBL203,EGFR
850,CHEMBL1229211,Dolutegravir,Small molecule,2013.0,J05AX12,J05AX12 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Other antivirals],-vir,Human immunodeficiency virus type 1 integrase inhibitor,HIV-1 integrase strand transfer inhibitor,,CHEMBL3471,Human immunodeficiency virus type 1 integrase,INHIBITOR,Human immunodeficiency virus 1,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24052331, URL:http://europepmc.org/abstract/MED/24052331|Name:DailyMed, SrcID:63df5af3-b8ac-4e76-9830-2dbb340af922, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=63df5af3-b8ac-4e76-9830-2dbb340af922",C[C@@H]1CCO[C@H]2CN3C=C(C(=O)NCc4ccc(F)cc4F)C(=O)C(=C3C(=O)N12)O,,
851,CHEMBL2104993,Vortioxetine,Small molecule,2013.0,N06AX26,N06AX26 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants],-oxetine,Serotonin transporter inhibitor,reuptake inhibitor,,CHEMBL228,Serotonin transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21486038, URL:http://europepmc.org/abstract/MED/21486038|Name:DailyMed, SrcID:4b0700c9-b417-4c3a-b36f-de461e125bd3, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4b0700c9-b417-4c3a-b36f-de461e125bd3",Cc1ccc(Sc2ccccc2N3CCNCC3)c(C)c1,CHEMBL228,SLC6A4
852,CHEMBL2108429,Mepolizumab,Antibody,2015.0,R03DX09,R03DX09 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: Other systemic drugs for obstructive airway diseases],-mab,Interleukin-5 inhibitor,,,CHEMBL1169600,Interleukin-5,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=fefb887c-e4ac-431e-8893-e9d1a5a63fea, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fefb887c-e4ac-431e-8893-e9d1a5a63fea",,CHEMBL1169600,IL5
853,CHEMBL3545425,Bay-1161909,Small molecule,,,,,Dual specificity protein kinase TTK inhibitor,,,CHEMBL3983,Dual specificity protein kinase TTK,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1158/1538-7445.AM2015-3090, URL:http://cancerres.aacrjournals.org/content/75/15_Supplement/3090",,CHEMBL3983,TTK
854,CHEMBL258940,Falnidamol,Small molecule,,,,,Epidermal growth factor receptor erbB1 inhibitor,,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11178955, URL:http://europepmc.org/abstract/MED/11178955|Name:PubMed, SrcID:15199094, URL:http://europepmc.org/abstract/MED/15199094",CN1CCC(CC1)Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2,CHEMBL203,EGFR
855,CHEMBL598797,Cudc-101,Small molecule,,,,,Receptor protein-tyrosine kinase erbB-2 inhibitor,Inhibits class I (HDAC1 HDAC2 HDAC3 HDAC8) and II (HDAC4 HDAC5 HDAC6 HDAC7 HDAC9 HDAC10) HDACs,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20143778, URL:http://europepmc.org/abstract/MED/20143778",COc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCCCCCC(=O)NO,CHEMBL1824,ERBB2
856,CHEMBL3545133,Jnj-26483327,Small molecule,,,,,Epidermal growth factor receptor erbB1 inhibitor,Multi-targeted tyrosine kinase inhibitor,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1016/S1359-6349(10)71870-X, URL:http://www.sciencedirect.com/science/article/pii/S135963491071870X|Name:PubMed, SrcID:20823884, URL:http://europepmc.org/abstract/MED/20823884",,CHEMBL203,EGFR
857,CHEMBL3545014,Am-461,Small molecule,,,,,G protein-coupled receptor 44 antagonist,Indication: Allergic diseases,,CHEMBL5071,G protein-coupled receptor 44,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.panmira.com/pipeline.html, URL:http://www.panmira.com/pipeline.html",,CHEMBL5071,PTGDR2
858,CHEMBL513909,Bi-2536,Small molecule,,,,,Serine/threonine-protein kinase PLK1 inhibitor,Also potent inhibitor of PLK2 and PLK3.,,CHEMBL3024,Serine/threonine-protein kinase PLK1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17291761, URL:http://europepmc.org/abstract/MED/17291761|Name:PubMed, SrcID:19568282, URL:http://europepmc.org/abstract/MED/19568282|Name:PubMed, SrcID:17291758, URL:http://europepmc.org/abstract/MED/17291758",CC[C@H]1N(C2CCCC2)c3nc(Nc4ccc(cc4OC)C(=O)NC5CCN(C)CC5)ncc3N(C)C1=O,CHEMBL3024,PLK1
859,CHEMBL3545395,Bi-811283,Small molecule,,,,,Serine/threonine-protein kinase Aurora-B inhibitor,,,CHEMBL2185,Serine/threonine-protein kinase Aurora-B,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://meetinglibrary.asco.org/content/47733-74, URL:http://meetinglibrary.asco.org/content/47733-74|Name:Wikipedia, SrcID:BI811283, URL:https://en.wikipedia.org/wiki/BI811283|Name:PubMed, SrcID:25529193, URL:http://europepmc.org/abstract/MED/25529193",,CHEMBL2185,AURKB
860,CHEMBL3545216,Fx-005,Small molecule,,,,,MAP kinase p38 alpha inhibitor,,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Flexion_Therapeutics, URL:https://en.wikipedia.org/wiki/Flexion_Therapeutics|Name:Other, SrcID:http://flexiontherapeutics.com/programs-pipeline/, URL:http://flexiontherapeutics.com/programs-pipeline/",,CHEMBL260,MAPK14
861,CHEMBL3301607,Filgotinib,Small molecule,,,,-tinib,Tyrosine-protein kinase JAK1 inhibitor,,,CHEMBL2835,Tyrosine-protein kinase JAK1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24818516, URL:http://europepmc.org/abstract/MED/24818516",O=C(Nc1nc2cccc(c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C5CC5,CHEMBL2835,JAK1
862,CHEMBL3545217,Ns-018,Small molecule,,,,,Tyrosine-protein kinase JAK2 inhibitor,,,CHEMBL2971,Tyrosine-protein kinase JAK2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:2282918, URL:http://europepmc.org/abstract/MED/2282918",,CHEMBL2971,JAK2
863,CHEMBL363648,Tak-715,Small molecule,,,,,MAP kinase p38 alpha inhibitor,,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16162000, URL:http://europepmc.org/abstract/MED/16162000",CCc1nc(c2cccc(C)c2)c(s1)c3ccnc(NC(=O)c4ccccc4)c3,CHEMBL260,MAPK14
864,CHEMBL291657,Ssr125543,Small molecule,,,,,Corticotropin releasing factor receptor 1 antagonist,,,CHEMBL1800,Corticotropin releasing factor receptor 1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25446760, URL:http://europepmc.org/abstract/MED/25446760|Name:PubMed, SrcID:11907190, URL:http://europepmc.org/abstract/MED/11907190",COc1cc(Cl)c(cc1C)c2nc(sc2C)N(CC#C)[C@@H](CC3CC3)c4ccc(C)c(F)c4,CHEMBL1800,CRHR1
865,CHEMBL3545162,Pbf-680,Small molecule,,,,,Adenosine A1 receptor antagonist,,,CHEMBL226,Adenosine A1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://adisinsight.springer.com/drugs/800038189, URL:http://adisinsight.springer.com/drugs/800038189",,CHEMBL226,ADORA1
866,CHEMBL3137332,Fevipiprant,Small molecule,,,,-piprant,G protein-coupled receptor 44 antagonist,,,CHEMBL5071,G protein-coupled receptor 44,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.novartis.com/downloads/investors/reports/ar-2014-innovation-en.pdf, URL:http://www.novartis.com/downloads/investors/reports/ar-2014-innovation-en.pdf|Name:PubMed, SrcID:25881897, URL:http://europepmc.org/abstract/MED/25881897",Cc1c(CC(=O)O)c2cccnc2n1Cc3ccc(cc3C(F)(F)F)S(=O)(=O)C,CHEMBL5071,PTGDR2
867,CHEMBL539423,Sparsentan,Small molecule,,,,-entan,Endothelin receptor ET-A antagonist,,,CHEMBL252,Endothelin receptor ET-A,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:6384196, URL:http://europepmc.org/abstract/MED/6384196|Name:Other, SrcID:http://www.drugs.com/clinical_trials/pharmacopeia-announces-positive-results-initial-dara-clinical-trial-523.html, URL:http://www.drugs.com/clinical_trials/pharmacopeia-announces-positive-results-initial-dara-clinical-trial-523.html|Name:Other, SrcID:http://www.retrophin.com/content/pipeline/re021.php, URL:http://www.retrophin.com/content/pipeline/re021.php",CCCCC1=NC2(CCCC2)C(=O)N1Cc3ccc(c(COCC)c3)c4ccccc4S(=O)(=O)Nc5noc(C)c5C,CHEMBL252,EDNRA
868,CHEMBL3545346,Azd2516,Small molecule,,,,,Metabotropic glutamate receptor 5 negative allosteric modulator,,,CHEMBL3227,Metabotropic glutamate receptor 5,NEGATIVE ALLOSTERIC MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PMC, SrcID:PMC172159, URL:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC172159/",,CHEMBL3227,GRM5
869,CHEMBL3545166,Drinabant,Small molecule,,,,-nab-,Cannabinoid CB1 receptor antagonist,Discontinued possibly due to psychiatric side effects as seen with withdrawn CNR1 antagonist rimonabant.,,CHEMBL218,Cannabinoid CB1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18801827, URL:http://europepmc.org/abstract/MED/18801827|Name:PubMed, SrcID:21170298, URL:http://europepmc.org/abstract/MED/21170298|Name:Wikipedia, SrcID:Drinabant, URL:http://en.wikipedia.org/wiki/Drinabant",CS(=O)(=O)N(C1CN(C1)C(c2ccc(Cl)cc2)c3ccc(Cl)cc3)c4cc(F)cc(F)c4,CHEMBL218,CNR1
870,CHEMBL2106841,Nonabine,Small molecule,,,,-nab-,Cannabinoid CB2 receptor agonist,,,CHEMBL253,Cannabinoid CB2 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:6402096, URL:http://europepmc.org/abstract/MED/6402096|Name:Wikipedia, SrcID:Nonabine, URL:http://en.wikipedia.org/wiki/Nonabine",CCCCCC(C)C(C)c1cc(O)c2C(=CC(C)(C)Oc2c1)c3ccncc3,CHEMBL253,CNR2
871,CHEMBL1817709,Selepressin,Protein,,,,-pressin,Vasopressin V1a receptor agonist,Peptide,,CHEMBL1889,Vasopressin V1a receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23429645, URL:http://europepmc.org/abstract/MED/23429645|Name:PubMed, SrcID:24674922, URL:http://europepmc.org/abstract/MED/24674922",CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCC(=O)N)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(=O)N,CHEMBL1889,AVPR1A
872,CHEMBL3545040,Azd7009,Small molecule,,,,,HERG blocker,,,CHEMBL240,HERG,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15817095, URL:http://europepmc.org/abstract/MED/15817095",CC(C)(C)OC(=O)NCCN1CC2CN(C[C@H](O)COc3ccc(cc3)C#N)CC(C1)O2,CHEMBL240,KCNH2
873,CHEMBL3544951,Pf-04531083,Small molecule,,,,,Sodium channel protein type X alpha subunit blocker,,,CHEMBL5451,Sodium channel protein type X alpha subunit,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.sigmaaldrich.com/catalog/product/sigma/pz0273?lang=en&region=GB, URL:http://www.sigmaaldrich.com/catalog/product/sigma/pz0273?lang=en&region=GB|Name:PubMed, SrcID:25060923, URL:http://europepmc.org/abstract/MED/25060923",,CHEMBL5451,SCN10A
874,CHEMBL223360,Linifanib,Small molecule,,,,-anib,Vascular endothelial growth factor receptor inhibitor,,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:17343372, URL:http://europepmc.org/abstract/MED/17343372|Name:PubMed, SrcID:16648571, URL:http://europepmc.org/abstract/MED/16648571",Cc1ccc(F)c(NC(=O)Nc2ccc(cc2)c3cccc4[nH]nc(N)c34)c1,,
875,CHEMBL576982,Quizartinib,Small molecule,,,,-tinib,Platelet-derived growth factor receptor inhibitor,,,CHEMBL2095189,Platelet-derived growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23497317, URL:http://europepmc.org/abstract/MED/23497317|Name:PubMed, SrcID:19654408, URL:http://europepmc.org/abstract/MED/19654408",CC(C)(C)c1onc(NC(=O)Nc2ccc(cc2)c3cn4c5ccc(OCCN6CCOCC6)cc5sc4n3)c1,,
876,CHEMBL1742995,Briakinumab,Antibody,,L04AC09,L04AC09 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Interleukin inhibitors],-mab,Interleukin-12 subunit beta inhibitor,IgG1 monoclonal antibody with genetically engineered complementarity-determining regions that have high affinity for the IL-12/23 p40 subunit protein.,,CHEMBL3580484,Interleukin-12 subunit beta,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22077474, URL:http://europepmc.org/abstract/MED/22077474|Name:PubMed, SrcID:18283176, URL:http://europepmc.org/abstract/MED/18283176",,CHEMBL3580484,IL12B
877,CHEMBL1743026,Gevokizumab,Antibody,,,,-mab,Interleukin-1 beta negative allosteric modulator,"Potent anti-IL-1ß neutralizing antibody. Binds to a unique IL-1ß epitope that is proximal to, but does not overlap with the receptor/ligand interface.",,CHEMBL1909490,Interleukin-1 beta,NEGATIVE ALLOSTERIC MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21048425, URL:http://europepmc.org/abstract/MED/21048425",,CHEMBL1909490,IL1B
878,CHEMBL3039514,Elbasvir,Small molecule,2016.0,,,-vir,Nonstructural protein 5A inhibitor,,,CHEMBL3307224,Nonstructural protein 5A,INHIBITOR,Hepatitis C virus,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2016/208261Orig1s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208261Orig1s000lbl.pdf",COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1c2nc(c[nH]2)c3ccc4c(O[C@@H](c5ccccc5)n6c4cc7cc(ccc67)c8c[nH]c(n8)[C@@H]9CCCN9C(=O)[C@@H](NC(=O)OC)C(C)C)c3,,
879,CHEMBL1516,Olmesartan,Small molecule,,,,-sartan,Type-1 angiotensin II receptor antagonist,,,CHEMBL227,Type-1 angiotensin II receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:27744053, URL:http://europepmc.org/abstract/MED/27744053",CCCc1nc(c(C(=O)O)n1Cc2ccc(cc2)c3ccccc3c4nnn[nH]4)C(C)(C)O,CHEMBL227,AGTR1
880,CHEMBL395091,Esketamine,Small molecule,,N01AX14,"N01AX14 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Other general anesthetics]",,Glutamate [NMDA] receptor negative allosteric modulator,Noncompetitive binding to NMDA glutamate receptors,NMDA subtype non-selective,CHEMBL2094124,Glutamate [NMDA] receptor,NEGATIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:26707087, URL:http://europepmc.org/abstract/MED/26707087",CN[C@@]1(CCCCC1=O)c2ccccc2Cl,CHEMBL2094124,GRIN3B
881,CHEMBL2110725,Vinflunine,Small molecule,,L01CA05,L01CA05 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Vinca alkaloids and analogues],vin-,Tubulin inhibitor,VFL bound to tubulin induces structural changes favoring an inhibition of GTP hydrolysis and inhibition of microtubule assembly,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Interacts with the so-called vinca-alkaloid-binding-domain of tubulin,"Name:PubMed, SrcID:19337431, URL:http://europepmc.org/abstract/MED/19337431",CC[C@@]12C=CCN3CC[C@@]4([C@H]13)[C@@H](N(C)c5cc(OC)c(cc45)[C@]6(C[C@@H]7C[C@H](CN(C7)Cc8c6[nH]c9ccccc89)C(C)(F)F)C(=O)OC)[C@](O)([C@@H]2OC(=O)C)C(=O)OC,CHEMBL2095182,TUBB8
882,CHEMBL2110725,Vinflunine,Small molecule,,L01CA05,L01CA05 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Vinca alkaloids and analogues],vin-,Tubulin inhibitor,VFL bound to tubulin induces structural changes favoring an inhibition of GTP hydrolysis and inhibition of microtubule assembly,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Interacts with the so-called vinca-alkaloid-binding-domain of tubulin,"Name:PubMed, SrcID:19337431, URL:http://europepmc.org/abstract/MED/19337431",CC[C@@]12C=CCN3CC[C@@]4([C@H]13)[C@@H](N(C)c5cc(OC)c(cc45)[C@]6(C[C@@H]7C[C@H](CN(C7)Cc8c6[nH]c9ccccc89)C(C)(F)F)C(=O)OC)[C@](O)([C@@H]2OC(=O)C)C(=O)OC,CHEMBL2095182,TUBA3C
883,CHEMBL2110725,Vinflunine,Small molecule,,L01CA05,L01CA05 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Vinca alkaloids and analogues],vin-,Tubulin inhibitor,VFL bound to tubulin induces structural changes favoring an inhibition of GTP hydrolysis and inhibition of microtubule assembly,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Interacts with the so-called vinca-alkaloid-binding-domain of tubulin,"Name:PubMed, SrcID:19337431, URL:http://europepmc.org/abstract/MED/19337431",CC[C@@]12C=CCN3CC[C@@]4([C@H]13)[C@@H](N(C)c5cc(OC)c(cc45)[C@]6(C[C@@H]7C[C@H](CN(C7)Cc8c6[nH]c9ccccc89)C(C)(F)F)C(=O)OC)[C@](O)([C@@H]2OC(=O)C)C(=O)OC,CHEMBL2095182,TUBA4A
884,CHEMBL2110725,Vinflunine,Small molecule,,L01CA05,L01CA05 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Vinca alkaloids and analogues],vin-,Tubulin inhibitor,VFL bound to tubulin induces structural changes favoring an inhibition of GTP hydrolysis and inhibition of microtubule assembly,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Interacts with the so-called vinca-alkaloid-binding-domain of tubulin,"Name:PubMed, SrcID:19337431, URL:http://europepmc.org/abstract/MED/19337431",CC[C@@]12C=CCN3CC[C@@]4([C@H]13)[C@@H](N(C)c5cc(OC)c(cc45)[C@]6(C[C@@H]7C[C@H](CN(C7)Cc8c6[nH]c9ccccc89)C(C)(F)F)C(=O)OC)[C@](O)([C@@H]2OC(=O)C)C(=O)OC,CHEMBL2095182,TUBA3E
885,CHEMBL2110725,Vinflunine,Small molecule,,L01CA05,L01CA05 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Vinca alkaloids and analogues],vin-,Tubulin inhibitor,VFL bound to tubulin induces structural changes favoring an inhibition of GTP hydrolysis and inhibition of microtubule assembly,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Interacts with the so-called vinca-alkaloid-binding-domain of tubulin,"Name:PubMed, SrcID:19337431, URL:http://europepmc.org/abstract/MED/19337431",CC[C@@]12C=CCN3CC[C@@]4([C@H]13)[C@@H](N(C)c5cc(OC)c(cc45)[C@]6(C[C@@H]7C[C@H](CN(C7)Cc8c6[nH]c9ccccc89)C(C)(F)F)C(=O)OC)[C@](O)([C@@H]2OC(=O)C)C(=O)OC,CHEMBL2095182,TUBB6
886,CHEMBL2110725,Vinflunine,Small molecule,,L01CA05,L01CA05 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Vinca alkaloids and analogues],vin-,Tubulin inhibitor,VFL bound to tubulin induces structural changes favoring an inhibition of GTP hydrolysis and inhibition of microtubule assembly,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Interacts with the so-called vinca-alkaloid-binding-domain of tubulin,"Name:PubMed, SrcID:19337431, URL:http://europepmc.org/abstract/MED/19337431",CC[C@@]12C=CCN3CC[C@@]4([C@H]13)[C@@H](N(C)c5cc(OC)c(cc45)[C@]6(C[C@@H]7C[C@H](CN(C7)Cc8c6[nH]c9ccccc89)C(C)(F)F)C(=O)OC)[C@](O)([C@@H]2OC(=O)C)C(=O)OC,CHEMBL2095182,TUBB2B
887,CHEMBL2110725,Vinflunine,Small molecule,,L01CA05,L01CA05 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Vinca alkaloids and analogues],vin-,Tubulin inhibitor,VFL bound to tubulin induces structural changes favoring an inhibition of GTP hydrolysis and inhibition of microtubule assembly,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Interacts with the so-called vinca-alkaloid-binding-domain of tubulin,"Name:PubMed, SrcID:19337431, URL:http://europepmc.org/abstract/MED/19337431",CC[C@@]12C=CCN3CC[C@@]4([C@H]13)[C@@H](N(C)c5cc(OC)c(cc45)[C@]6(C[C@@H]7C[C@H](CN(C7)Cc8c6[nH]c9ccccc89)C(C)(F)F)C(=O)OC)[C@](O)([C@@H]2OC(=O)C)C(=O)OC,CHEMBL2095182,TUBA3D
888,CHEMBL307429,Duvoglustat,Small molecule,,,,-stat,Lysosomal alpha-glucosidase stabiliser,"Selectively and reversibly binds and stabilises the endogenous enzyme, facilitating proper protein folding and trafficking to lysosomes",,CHEMBL2608,Lysosomal alpha-glucosidase,STABILISER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22815812, URL:http://europepmc.org/abstract/MED/22815812",OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O,CHEMBL2608,GAA
889,CHEMBL1094636,Niraparib,Small molecule,2017.0,,,-parib,Poly [ADP-ribose] polymerase 2 inhibitor,,IC(50) inhibition PARP2 (2.1 nM),CHEMBL5366,Poly [ADP-ribose] polymerase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19873981, URL:http://europepmc.org/abstract/MED/19873981",NC(=O)c1cccc2cn(nc12)c3ccc(cc3)[C@@H]4CCCNC4,CHEMBL5366,PARP2
890,CHEMBL2105765,Lipegfilgrastim,Small molecule,,L03AA14,L03AA14 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSTIMULANTS: IMMUNOSTIMULANTS: Colony stimulating factors],-peg-; -stim,Granulocyte colony stimulating factor receptor agonist,,,CHEMBL1996,Granulocyte colony stimulating factor receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26858523, URL:http://europepmc.org/abstract/MED/26858523",COCCOC(=O)NCC(=O)N[C@@H]1[C@@H](O)C[C@@](OC[C@H]2O[C@H](O[C@H](C)[C@H](N)C(=O)O)[C@H](NC(=O)C)[C@@H](O)[C@H]2O)(O[C@H]1[C@H](O)[C@H](O)CO)C(=O)O,CHEMBL1996,CSF3R
891,CHEMBL3137320,Talazoparib,Small molecule,,,,-parib,Poly [ADP-ribose] polymerase 2 inhibitor,,Potent PARP1/2 inhibitor (PARP1 IC50 = 0.57 nmol/L). PARP1 Ki=1.2 nmol/L. PARP2 Ki= 0.85 nmol/L.,CHEMBL5366,Poly [ADP-ribose] polymerase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23881923, URL:http://europepmc.org/abstract/MED/23881923",Cn1ncnc1[C@@H]2[C@H](Nc3cc(F)cc4C(=O)NN=C2c34)c5ccc(F)cc5,CHEMBL5366,PARP2
892,CHEMBL2109151,Lumiliximab,Antibody,,,,-mab,Immunoglobulin epsilon Fc receptor antagonist,This mAb has been shown to block IgE synthesis in human B cells.,,CHEMBL2940,Immunoglobulin epsilon Fc receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16210051, URL:http://europepmc.org/abstract/MED/16210051",,CHEMBL2940,FCER2
893,CHEMBL2109465,Qax-576,Antibody,,,,,Interleukin-13 inhibitor,,,CHEMBL3580486,Interleukin-13,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25226850, URL:http://europepmc.org/abstract/MED/25226850",,,
894,CHEMBL2109555,Mdx-070,Antibody,,,,,Glutamate carboxypeptidase II other,"Recognizes conformational epitopes on FOLH1, mediates anti-body-dependent cellular cytotoxicity (ADCC), and is internalized.",,CHEMBL1892,Glutamate carboxypeptidase II,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://meeting.ascopubs.org/cgi/content/short/24/18_suppl/14549, URL:http://meeting.ascopubs.org/cgi/content/short/24/18_suppl/14549",,CHEMBL1892,FOLH1
895,CHEMBL2109608,L19il2,Antibody,,,,,Fibronectin binding agent,Immunocytokine. Immunostimulant.,,CHEMBL3810,Fibronectin,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23096716, URL:http://europepmc.org/abstract/MED/23096716",,CHEMBL3810,FN1
896,CHEMBL657,Diphenhydramine,Small molecule,1946.0,D04AA32; R06AA02; R06AA52,"D04AA32 [DERMATOLOGICALS: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: Antihistamines for topical use]; R06AA02 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Aminoalkyl ethers]; R06AA52 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Aminoalkyl ethers]",,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Diphenhydramine#Pharmacology, URL:http://en.wikipedia.org/wiki/Diphenhydramine#Pharmacology|Name:PubMed, SrcID:1732984, URL:http://europepmc.org/abstract/MED/1732984|Name:PubMed, SrcID:16702624, URL:http://europepmc.org/abstract/MED/16702624",CN(C)CCOC(c1ccccc1)c2ccccc2,CHEMBL231,HRH1
897,CHEMBL1421,Dasatinib,Small molecule,2006.0,L01XE06,L01XE06 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Tyrosine-protein kinase ABL inhibitor,,,CHEMBL1862,Tyrosine-protein kinase ABL,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13",Cc1nc(Nc2ncc(s2)C(=O)Nc3c(C)cccc3Cl)cc(n1)N4CCN(CCO)CC4,CHEMBL1862,ABL1
898,CHEMBL1291,Metipranolol,Small molecule,1989.0,S01ED04; S01ED54,S01ED04 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Beta blocking agents 1)]; S01ED54 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Beta blocking agents 1)],-olol,Beta-1 adrenergic receptor antagonist,,,CHEMBL213,Beta-1 adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=209a4cc3-8453-4e4c-8af5-ad059bebf046, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=209a4cc3-8453-4e4c-8af5-ad059bebf046|Name:DailyMed, SrcID:archiveid=129928, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=129928",CC(C)NCC(O)COc1cc(C)c(OC(=O)C)c(C)c1C,,
899,CHEMBL926,Dobutamine,Small molecule,1978.0,C01CA07,C01CA07 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES: Adrenergic and dopaminergic agents],,Beta-1 adrenergic receptor agonist,,,CHEMBL213,Beta-1 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2013/020255s016lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020255s016lbl.pdf|Name:DailyMed, SrcID:setid=402f24d2-5e67-4dd6-99c6-84bb7c1c29e7, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=402f24d2-5e67-4dd6-99c6-84bb7c1c29e7",CC(CCc1ccc(O)cc1)NCCc2ccc(O)c(O)c2,,
900,CHEMBL964,Disulfiram,Small molecule,1951.0,N07BB01; P03AA04; P03AA54,"N07BB01 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: DRUGS USED IN ADDICTIVE DISORDERS: Drugs used in alcohol dependence]; P03AA04 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS: ECTOPARASITICIDES, INCL. SCABICIDES: Sulfur containing products]; P03AA54 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS: ECTOPARASITICIDES, INCL. SCABICIDES: Sulfur containing products]",,Aldehyde dehydrogenase inhibitor,,,CHEMBL1935,Aldehyde dehydrogenase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=06b00003-a94f-4fe8-808c-e6e101b06ebe, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=06b00003-a94f-4fe8-808c-e6e101b06ebe|Name:DailyMed, SrcID:archiveid=146982, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=146982|Name:Wikipedia, SrcID:Disulfiram, URL:http://en.wikipedia.org/wiki/Disulfiram",CCN(CC)C(=S)SSC(=S)N(CC)CC,CHEMBL1935,ALDH2
901,CHEMBL535,Sunitinib,Small molecule,2006.0,L01XE04,L01XE04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Tyrosine-protein kinase receptor FLT3 inhibitor,,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14",CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C\2/C(=O)Nc3ccc(F)cc23)c1C,CHEMBL1974,FLT3
902,CHEMBL1201631,Insulin Human,Protein,1982.0,A10AB01; A10AD01; A10AE01; A10AF01; A10AC01,"A10AB01 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: INSULINS AND ANALOGUES: Insulins and analogues for injection, fast-acting]; A10AD01 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: INSULINS AND ANALOGUES: Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting]; A10AE01 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: INSULINS AND ANALOGUES: Insulins and analogues for injection, long-acting]; A10AF01 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: INSULINS AND ANALOGUES: Insulins and analogues for inhalation]; A10AC01 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: INSULINS AND ANALOGUES: Insulins and analogues for injection, intermediate-acting]",,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/022472s006s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022472s006s008lbl.pdf|Name:DailyMed, SrcID:setid=457531f0-9331-47fe-90b5-b31f284044dc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=457531f0-9331-47fe-90b5-b31f284044dc",,CHEMBL1981,INSR
903,CHEMBL1480,Felodipine,Small molecule,1991.0,C08CA02,C08CA02 [CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS: Dihydropyridine derivatives],-dipine,Mineralocorticoid receptor antagonist,,,CHEMBL1994,Mineralocorticoid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18250364, URL:http://europepmc.org/abstract/MED/18250364",CCOC(=O)C1=C(C)NC(=C(C1c2cccc(Cl)c2Cl)C(=O)OC)C,,
904,CHEMBL1201341,Echothiophate,Small molecule,1960.0,S01EB03,S01EB03 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Parasympathomimetics],,Acetylcholinesterase inhibitor,,,CHEMBL220,Acetylcholinesterase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Cholinesterase, URL:http://en.wikipedia.org/wiki/Cholinesterase|Name:FDA, SrcID:label/2006/011963s034lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/011963s034lbl.pdf|Name:DailyMed, SrcID:setid=c4adbc81-6681-4e12-f8ab-5d1cb7723aad#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4adbc81-6681-4e12-f8ab-5d1cb7723aad#nlm34090-1",CCOP(=O)(OCC)SCC[N+](C)(C)C,CHEMBL220,ACHE
905,CHEMBL1200386,Prednicarbate,Small molecule,1991.0,D07AC18,"D07AC18 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, potent (group III)]",pred-,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19482847, URL:http://europepmc.org/abstract/MED/19482847|Name:PubMed, SrcID:2879901, URL:http://europepmc.org/abstract/MED/2879901",CCOC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)COC(=O)CC,CHEMBL2034,NR3C1
906,CHEMBL644,Trimipramine,Small molecule,1979.0,N06AA06,N06AA06 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Non-selective monoamine reuptake inhibitors],-pramine,Norepinephrine transporter inhibitor,,,CHEMBL222,Norepinephrine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:0443-059748 PP. 555, URL:http://www.isbnsearch.org/isbn/0443059748|Name:Wikipedia, SrcID:Trimipramine, URL:http://en.wikipedia.org/wiki/Trimipramine",CC(CN(C)C)CN1c2ccccc2CCc3ccccc13,CHEMBL222,SLC6A2
907,CHEMBL222813,Zanamivir,Small molecule,1999.0,J05AH01,J05AH01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Neuraminidase inhibitors],-vir,Neuraminidase inhibitor,,,CHEMBL3377,Neuraminidase,INHIBITOR,Influenza B virus (strain B/Lee/1940),SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=12ff22f6-20b5-4fa8-9028-58f87e169ff5, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=12ff22f6-20b5-4fa8-9028-58f87e169ff5",CC(=O)N[C@@H]1[C@@H](NC(=N)N)C=C(O[C@H]1[C@H](O)[C@H](O)CO)C(=O)O,,
908,CHEMBL204656,Elvitegravir,Small molecule,2012.0,J05AX11,J05AX11 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Other antivirals],-vir,Human immunodeficiency virus type 1 integrase inhibitor,HIV-1 integrase strand transfer inhibitor,,CHEMBL3471,Human immunodeficiency virus type 1 integrase,INHIBITOR,Human immunodeficiency virus 1,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=74ae2a93-b267-444c-8f0f-a2a6522260ee, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=74ae2a93-b267-444c-8f0f-a2a6522260ee",COc1cc2N(C=C(C(=O)O)C(=O)c2cc1Cc3cccc(Cl)c3F)[C@H](CO)C(C)C,,
909,CHEMBL1214124,Perampanel,Small molecule,2012.0,N03AX22,N03AX22 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],-ampa,Glutamate receptor ionotropic AMPA antagonist,,,CHEMBL2096670,Glutamate receptor ionotropic AMPA,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Expert, SrcID:PERAMPANEL, URL:http://chembl.blogspot.co.uk/search?q=PERAMPANEL",O=C1N(C=C(C=C1c2ccccc2C#N)c3ccccn3)c4ccccc4,,
910,CHEMBL92,Docetaxel,Small molecule,1996.0,,,-taxel,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin paclitaxel binding site,Binds to beta tubulin,"Name:FDA, SrcID:label/2014/201195s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/201195s006lbl.pdf|Name:DailyMed, SrcID:setid=b35e3633-8893-4b0b-af1e-92e342557199#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b35e3633-8893-4b0b-af1e-92e342557199#section-14|Name:Wikipedia, SrcID:Microtubule, URL:http://en.wikipedia.org/wiki/Microtubule",CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)c4ccccc4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c6ccccc6)C(=C([C@@H](O)C3=O)C5(C)C)C,CHEMBL2095182,TUBB8
911,CHEMBL92,Docetaxel,Small molecule,1996.0,,,-taxel,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin paclitaxel binding site,Binds to beta tubulin,"Name:FDA, SrcID:label/2014/201195s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/201195s006lbl.pdf|Name:DailyMed, SrcID:setid=b35e3633-8893-4b0b-af1e-92e342557199#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b35e3633-8893-4b0b-af1e-92e342557199#section-14|Name:Wikipedia, SrcID:Microtubule, URL:http://en.wikipedia.org/wiki/Microtubule",CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)c4ccccc4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c6ccccc6)C(=C([C@@H](O)C3=O)C5(C)C)C,CHEMBL2095182,TUBA3C
912,CHEMBL92,Docetaxel,Small molecule,1996.0,,,-taxel,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin paclitaxel binding site,Binds to beta tubulin,"Name:FDA, SrcID:label/2014/201195s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/201195s006lbl.pdf|Name:DailyMed, SrcID:setid=b35e3633-8893-4b0b-af1e-92e342557199#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b35e3633-8893-4b0b-af1e-92e342557199#section-14|Name:Wikipedia, SrcID:Microtubule, URL:http://en.wikipedia.org/wiki/Microtubule",CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)c4ccccc4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c6ccccc6)C(=C([C@@H](O)C3=O)C5(C)C)C,CHEMBL2095182,TUBA4A
913,CHEMBL92,Docetaxel,Small molecule,1996.0,,,-taxel,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin paclitaxel binding site,Binds to beta tubulin,"Name:FDA, SrcID:label/2014/201195s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/201195s006lbl.pdf|Name:DailyMed, SrcID:setid=b35e3633-8893-4b0b-af1e-92e342557199#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b35e3633-8893-4b0b-af1e-92e342557199#section-14|Name:Wikipedia, SrcID:Microtubule, URL:http://en.wikipedia.org/wiki/Microtubule",CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)c4ccccc4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c6ccccc6)C(=C([C@@H](O)C3=O)C5(C)C)C,CHEMBL2095182,TUBA3E
914,CHEMBL92,Docetaxel,Small molecule,1996.0,,,-taxel,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin paclitaxel binding site,Binds to beta tubulin,"Name:FDA, SrcID:label/2014/201195s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/201195s006lbl.pdf|Name:DailyMed, SrcID:setid=b35e3633-8893-4b0b-af1e-92e342557199#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b35e3633-8893-4b0b-af1e-92e342557199#section-14|Name:Wikipedia, SrcID:Microtubule, URL:http://en.wikipedia.org/wiki/Microtubule",CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)c4ccccc4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c6ccccc6)C(=C([C@@H](O)C3=O)C5(C)C)C,CHEMBL2095182,TUBB6
915,CHEMBL92,Docetaxel,Small molecule,1996.0,,,-taxel,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin paclitaxel binding site,Binds to beta tubulin,"Name:FDA, SrcID:label/2014/201195s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/201195s006lbl.pdf|Name:DailyMed, SrcID:setid=b35e3633-8893-4b0b-af1e-92e342557199#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b35e3633-8893-4b0b-af1e-92e342557199#section-14|Name:Wikipedia, SrcID:Microtubule, URL:http://en.wikipedia.org/wiki/Microtubule",CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)c4ccccc4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c6ccccc6)C(=C([C@@H](O)C3=O)C5(C)C)C,CHEMBL2095182,TUBB2B
916,CHEMBL92,Docetaxel,Small molecule,1996.0,,,-taxel,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin paclitaxel binding site,Binds to beta tubulin,"Name:FDA, SrcID:label/2014/201195s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/201195s006lbl.pdf|Name:DailyMed, SrcID:setid=b35e3633-8893-4b0b-af1e-92e342557199#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b35e3633-8893-4b0b-af1e-92e342557199#section-14|Name:Wikipedia, SrcID:Microtubule, URL:http://en.wikipedia.org/wiki/Microtubule",CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)c4ccccc4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c6ccccc6)C(=C([C@@H](O)C3=O)C5(C)C)C,CHEMBL2095182,TUBA3D
917,CHEMBL1208646,Theophylline Glycinate,Small molecule,1982.0,,,,Phosphodiesterase 3 inhibitor,,,CHEMBL2094125,Phosphodiesterase 3,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=25b2fdbe-2f18-4153-835a-7a67bff83ef8, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=25b2fdbe-2f18-4153-835a-7a67bff83ef8|Name:Wikipedia, SrcID:Theophylline#Mechanisms_of_action, URL:http://en.wikipedia.org/wiki/Theophylline#Mechanisms_of_action",CN1C(=O)N(C)c2nc[nH]c2C1=O.NCC(=O)O,,
918,CHEMBL531,Pergolide,Small molecule,1988.0,N04BC02,N04BC02 [NERVOUS SYSTEM: ANTI-PARKINSON DRUGS: DOPAMINERGIC AGENTS: Dopamine agonists],-erg-,Dopamine receptor agonist,,,CHEMBL2096905,Dopamine receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=a26390e8-eb86-4623-8cdd-45b24b14df74#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a26390e8-eb86-4623-8cdd-45b24b14df74#nlm34090-1",CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc3c[nH]c4cccc2c34,,
919,CHEMBL1680,Octreotide,Protein,1988.0,H01CB02,"H01CB02 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: HYPOTHALAMIC HORMONES: Somatostatin and analogues]",-tide,Somatostatin receptor agonist,Long acting,"Selectivity for types 2, 3 and 5",CHEMBL2111436,Somatostatin receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=f278f0d8-4062-420a-97c3-3a8b88253a08#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f278f0d8-4062-420a-97c3-3a8b88253a08#nlm34090-1|Name:PubMed, SrcID:11931345, URL:http://europepmc.org/abstract/MED/11931345",C[C@@H](O)[C@@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@H](Cc4c[nH]c5ccccc45)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1,,
920,CHEMBL762,Oxymetazoline,Small molecule,1986.0,R01AB07; S01GA04; R01AA05,"R01AB07 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Sympathomimetics, combinations excl. corticosteroids]; S01GA04 [SENSORY ORGANS: OPHTHALMOLOGICALS: DECONGESTANTS AND ANTIALLERGICS: Sympathomimetics used as decongestants]; R01AA05 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Sympathomimetics, plain]",-azoline,Adrenergic receptor alpha agonist,"complex action type, partial agonist at alpha-2 receptors",,CHEMBL2095203,Adrenergic receptor alpha,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:20030735, URL:http://europepmc.org/abstract/MED/20030735|Name:PubMed, SrcID:23364786, URL:http://europepmc.org/abstract/MED/23364786|Name:ISBN, SrcID:9780702034718 PP. 186, URL:http://www.isbnsearch.org/isbn/9780702034718",Cc1cc(c(O)c(C)c1CC2=NCCN2)C(C)(C)C,,
921,CHEMBL1201168,Isocarboxazid,Small molecule,1959.0,N06AF01,"N06AF01 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Monoamine oxidase inhibitors, non-selective]",,Monoamine oxidase inhibitor,,,CHEMBL2095205,Monoamine oxidase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2007/011961s039lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/011961s039lbl.pdf|Name:Wikipedia, SrcID:Monoamine_oxidase_inhibitor, URL:http://en.wikipedia.org/wiki/Monoamine_oxidase_inhibitor",Cc1onc(c1)C(=O)NNCc2ccccc2,,
922,CHEMBL636,Rivastigmine,Small molecule,2000.0,N06DA03,N06DA03 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTI-DEMENTIA DRUGS: Anticholinesterases],-stigmine,Cholinesterases; ACHE & BCHE inhibitor,,,CHEMBL2095233,Cholinesterases; ACHE & BCHE,INHIBITOR,Homo sapiens,SELECTIVITY GROUP,,,"Name:FDA, SrcID:label/2006/020823s016,021025s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020823s016,021025s008lbl.pdf",CCN(C)C(=O)Oc1cccc(c1)[C@H](C)N(C)C,,
923,CHEMBL1201586,Palivizumab,Antibody,1998.0,J06BB16,J06BB16 [ANTIINFECTIVES FOR SYSTEMIC USE: IMMUNE SERA AND IMMUNOGLOBULINS: IMMUNOGLOBULINS: Specific immunoglobulins],-mab,Fusion glycoprotein F0 inhibitor,Pathogen target,,CHEMBL2364165,Fusion glycoprotein F0,INHIBITOR,Human respiratory syncytial virus,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=8e35c4c8-bf56-458f-a73c-8f5733829788, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e35c4c8-bf56-458f-a73c-8f5733829788",,,
924,CHEMBL1323,Darunavir,Small molecule,2006.0,J05AE10,J05AE10 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Protease inhibitors],-vir,Human immunodeficiency virus type 1 protease inhibitor,,,CHEMBL243,Human immunodeficiency virus type 1 protease,INHIBITOR,Human immunodeficiency virus 1,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=814301f9-c990-46a5-b481-2879a521a16f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=814301f9-c990-46a5-b481-2879a521a16f",CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]2CO[C@H]3OCC[C@@H]23)S(=O)(=O)c4ccc(N)cc4,,
925,CHEMBL1449,Ticarcillin,Small molecule,1976.0,J01CA13,"J01CA13 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: BETA-LACTAM ANTIBACTERIALS, PENICILLINS: Penicillins with extended spectrum]",-cillin,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:PubMed, SrcID:2387996, URL:http://europepmc.org/abstract/MED/2387996",CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](C(=O)O)c3ccsc3)C(=O)N2[C@H]1C(=O)O,,
926,CHEMBL1435,Cefazolin,Small molecule,1973.0,J01DB04,J01DB04 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: First-generation cephalosporins],cef-,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:PubMed, SrcID:2722720, URL:http://europepmc.org/abstract/MED/2722720|Name:PubMed, SrcID:3266730, URL:http://europepmc.org/abstract/MED/3266730",Cc1nnc(SCC2=C(N3[C@H](SC2)[C@H](NC(=O)Cn4cnnn4)C3=O)C(=O)O)s1,,
927,CHEMBL1201281,Chloramphenicol Succinic Acid,Small molecule,1959.0,,,,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,23S ribosomal RNA,23S RRNA,"Name:Wikipedia, SrcID:Chloramphenicol, URL:http://en.wikipedia.org/wiki/Chloramphenicol|Name:PubMed, SrcID:6375931, URL:http://europepmc.org/abstract/MED/6375931|Name:PubMed, SrcID:16091044, URL:http://europepmc.org/abstract/MED/16091044",O[C@@H]([C@@H](COC(=O)CCC(=O)O)NC(=O)C(Cl)Cl)c1ccc(cc1)[N+](=O)[O-],,
928,CHEMBL1201608,Muromonab-Cd3,Antibody,1986.0,L04AA02,L04AA02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Selective immunosuppressants],-nab-,T cell surface glycoprotein CD3 inhibitor,,,CHEMBL2364168,T cell surface glycoprotein CD3,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,CD3 epsilon subunit,Epsilon is binding site,"Name:PubMed, SrcID:15136729, URL:http://europepmc.org/abstract/MED/15136729|Name:DailyMed, SrcID:setid=2a1f1c18-fa95-45e6-bd00-ac53c73f4747, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2a1f1c18-fa95-45e6-bd00-ac53c73f4747",,CHEMBL2364168,CD3D
929,CHEMBL1201608,Muromonab-Cd3,Antibody,1986.0,L04AA02,L04AA02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Selective immunosuppressants],-nab-,T cell surface glycoprotein CD3 inhibitor,,,CHEMBL2364168,T cell surface glycoprotein CD3,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,CD3 epsilon subunit,Epsilon is binding site,"Name:PubMed, SrcID:15136729, URL:http://europepmc.org/abstract/MED/15136729|Name:DailyMed, SrcID:setid=2a1f1c18-fa95-45e6-bd00-ac53c73f4747, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2a1f1c18-fa95-45e6-bd00-ac53c73f4747",,CHEMBL2364168,CD3G
930,CHEMBL1201835,Ustekinumab,Antibody,2009.0,L04AC05,L04AC05 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Interleukin inhibitors],-mab,Interleukin-23 inhibitor,,,CHEMBL2364154,Interleukin-23,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,Interleukin-23 beta subunit,Beta subunit is binding site,"Name:DailyMed, SrcID:setid=c77a9664-e3bb-4023-b400-127aa53bca2b, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c77a9664-e3bb-4023-b400-127aa53bca2b",,,
931,CHEMBL185,Fluorouracil,Small molecule,1962.0,L01BC52; L01BC02,L01BC52 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Pyrimidine analogues]; L01BC02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Pyrimidine analogues],-uracil,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:PubMed, SrcID:12724731, URL:http://europepmc.org/abstract/MED/12724731",FC1=CNC(=O)NC1=O,,
932,CHEMBL429,Labetalol,Small molecule,1984.0,C07AG01,C07AG01 [CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Alpha and beta blocking agents],-alol,Adrenergic receptor antagonist,,,CHEMBL2331074,Adrenergic receptor,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=d8e0af49-8c2a-4ada-804f-17ce2abad15b, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d8e0af49-8c2a-4ada-804f-17ce2abad15b",CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(=O)N,,
933,CHEMBL1964120,Taliglucerase Alfa,Enzyme,2012.0,A16AB11,A16AB11 [ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Enzymes],-ase,Glucocerebroside hydrolytic enzyme,Given in cases of gaucher disease to overcome a deficiency of beta-glucocerebrosidase activity. Imiglucerase catalyses the hydrolysis of glucocerebroside to glucose and ceramide,,CHEMBL2364176,Glucocerebroside,HYDROLYTIC ENZYME,Homo sapiens,SMALL MOLECULE,,,"Name:DailyMed, SrcID:setid=fa3cbd5d-677c-4b19-9032-d9182cb69a83, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fa3cbd5d-677c-4b19-9032-d9182cb69a83",,,
934,CHEMBL493982,Vorapaxar,Small molecule,2014.0,B01AC26,B01AC26 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Platelet aggregation inhibitors excl. heparin],-paxar,Proteinase-activated receptor 1 antagonist,,,CHEMBL3974,Proteinase-activated receptor 1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2014/204886s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204886s000lbl.pdf",CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]3[C@@H]([C@@H](C)OC3=O)[C@H]2\C=C\c4ccc(cn4)c5cccc(F)c5,CHEMBL3974,F2R
935,CHEMBL2219425,Aripiprazole Lauroxil,Unknown,2015.0,,,-prazole,Dopamine D2 receptor partial agonist,Prodrug of aripiprazole,,CHEMBL217,Dopamine D2 receptor,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=17a8d11b-73b0-4833-a0b4-cf1ef85edefb, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17a8d11b-73b0-4833-a0b4-cf1ef85edefb",CCCCCCCCCCCC(=O)OCN1C(=O)CCc2ccc(OCCCCN3CCN(CC3)c4cccc(Cl)c4Cl)cc12,CHEMBL217,DRD2
936,CHEMBL1738797,Alectinib,Small molecule,2015.0,L01XE36,L01XE36 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Tyrosine-protein kinase receptor RET inhibitor,,,CHEMBL2041,Tyrosine-protein kinase receptor RET,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/208434s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/208434s000lbl.pdf",CCc1cc2C(=O)c3c([nH]c4cc(ccc34)C#N)C(C)(C)c2cc1N5CCC(CC5)N6CCOCC6,CHEMBL2041,RET
937,CHEMBL3545417,Glpg0492,Small molecule,,,,,Androgen Receptor modulator,selective androgen modulator (SARM),,CHEMBL1871,Androgen Receptor,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22957947, URL:http://europepmc.org/abstract/MED/22957947|Name:Other, SrcID:http://akashirx.com/pipeline/, URL:http://akashirx.com/pipeline/",,CHEMBL1871,AR
938,CHEMBL3545179,Azd-7451,Small molecule,,,,,Nerve growth factor receptor Trk-A inhibitor,,,CHEMBL2815,Nerve growth factor receptor Trk-A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25054037, URL:http://europepmc.org/abstract/MED/25054037|Name:PubMed, SrcID:23027130, URL:http://europepmc.org/abstract/MED/23027130",,CHEMBL2815,NTRK1
939,CHEMBL3544962,Ct-1578,Small molecule,,,,,Macrophage colony stimulating factor receptor inhibitor,,,CHEMBL1844,Macrophage colony stimulating factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22962687, URL:http://europepmc.org/abstract/MED/22962687",,CHEMBL1844,CSF1R
940,CHEMBL49120,Pd-0166285,Small molecule,,,,,Fibroblast growth factor receptor 1 inhibitor,Multi-targeted kinase irreversible inhibitor,,CHEMBL3650,Fibroblast growth factor receptor 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10638483, URL:http://europepmc.org/abstract/MED/10638483",CCN(CC)CCOc1ccc(Nc2ncc3C=C(C(=O)N(C)c3n2)c4c(Cl)cccc4Cl)cc1,CHEMBL3650,FGFR1
941,CHEMBL3545381,Plx-7486,Small molecule,,,,,NT-3 growth factor receptor inhibitor,,,CHEMBL5608,NT-3 growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.ecmcnetwork.org.uk/sites/default/files/PLX7486%20Background%20for%20CRUK%20Combinations%20Alliance%20(Non-CI)%202015-10-08%20final.pdf, URL:http://www.ecmcnetwork.org.uk/sites/default/files/PLX7486%20Background%20for%20CRUK%20Combinations%20Alliance%20(Non-CI)%202015-10-08%20final.pdf",,CHEMBL5608,NTRK3
942,CHEMBL3545311,Brigatinib,Small molecule,,,,-tinib,Epidermal growth factor receptor erbB1 inhibitor,Inhibits ALK and EGFR gatekeeper mutants. Does not inhibit wild type (native) EGFR.,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25888090, URL:http://europepmc.org/abstract/MED/25888090|Name:Other, SrcID:http://www.ariad.com/pdf/Rivera_2012_AACR_POSTER_AP26113_noQRcode.pdf, URL:http://www.ariad.com/pdf/Rivera_2012_AACR_POSTER_AP26113_noQRcode.pdf|Name:Other, SrcID:http://www.ariad.com/AP26113, URL:http://www.ariad.com/AP26113",COc1cc(ccc1Nc2ncc(Cl)c(Nc3ccccc3P(=O)(C)C)n2)N4CCC(CC4)N5CCN(C)CC5,CHEMBL203,EGFR
943,CHEMBL495727,At-9283,Small molecule,,,,,Tyrosine-protein kinase ABL inhibitor,,,CHEMBL1862,Tyrosine-protein kinase ABL,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19143567, URL:http://europepmc.org/abstract/MED/19143567",O=C(NC1CC1)Nc2c[nH]nc2c3nc4cc(CN5CCOCC5)ccc4[nH]3,CHEMBL1862,ABL1
944,CHEMBL607707,Pelitinib,Small molecule,,,,-tinib,Epidermal growth factor receptor erbB1 inhibitor,Irreversible inhibitor,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12502359, URL:http://europepmc.org/abstract/MED/12502359|Name:PubMed, SrcID:15715478, URL:http://europepmc.org/abstract/MED/15715478",CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)\C=C\CN(C)C,CHEMBL203,EGFR
945,CHEMBL3301610,Abemaciclib,Small molecule,,,,-ciclib,Cyclin-dependent kinase 4 inhibitor,,,CHEMBL331,Cyclin-dependent kinase 4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24919854, URL:http://europepmc.org/abstract/MED/24919854",CCN1CCN(Cc2ccc(Nc3ncc(F)c(n3)c4cc(F)c5nc(C)n(C(C)C)c5c4)nc2)CC1,CHEMBL331,CDK4
946,CHEMBL3545287,Ly2624803,Small molecule,,,,,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25423562, URL:http://europepmc.org/abstract/MED/25423562|Name:Other, SrcID:http://www.hra.nhs.uk/news/research-summaries/effect-of-activated-charcoal-dose-time-on-absorption-of-ly2624803/, URL:http://www.hra.nhs.uk/news/research-summaries/effect-of-activated-charcoal-dose-time-on-absorption-of-ly2624803/",,CHEMBL231,HRH1
947,CHEMBL3622820,Itacitinib,Small molecule,,,,-tinib,Tyrosine-protein kinase JAK1 inhibitor,The compound is thought to be JAK1 selective but no selectivity data available.,,CHEMBL2835,Tyrosine-protein kinase JAK1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24766055, URL:http://europepmc.org/abstract/MED/24766055|Name:PubMed, SrcID:24818516, URL:http://europepmc.org/abstract/MED/24818516",Fc1c(ccnc1C(F)(F)F)C(=O)N2CCC(CC2)N3CC(CC#N)(C3)n4cc(cn4)c5ncnc6[nH]ccc56,CHEMBL2835,JAK1
948,CHEMBL3545411,Mf101,Small molecule,,,,,Estrogen receptor beta agonist,"Herbal preparation, most active estrogenic compound in MF101 is the flavanone liquiritigenin which is a Erbeta selective agonist ( http://en.wikipedia.org/wiki/Liquiritigenin, PMC2277338)",,CHEMBL242,Estrogen receptor beta,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22616988, URL:http://europepmc.org/abstract/MED/22616988|Name:Wikipedia, SrcID:Menerba, URL:http://en.wikipedia.org/wiki/Menerba",,CHEMBL242,ESR2
949,CHEMBL566315,Obeticholic Acid,Small molecule,2016.0,A05AA04,A05AA04 [ALIMENTARY TRACT AND METABOLISM: BILE AND LIVER THERAPY: BILE THERAPY: Bile acid preparations],,Bile acid receptor FXR agonist,,,CHEMBL2047,Bile acid receptor FXR,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.interceptpharma.com/research-development/pipeline/, URL:http://www.interceptpharma.com/research-development/pipeline/|Name:PubMed, SrcID:12166927, URL:http://europepmc.org/abstract/MED/12166927",CC[C@H]1[C@@H](O)[C@H]2[C@@H]3CC[C@H]([C@H](C)CCC(=O)O)[C@@]3(C)CC[C@@H]2[C@@]4(C)CC[C@@H](O)C[C@@H]14,CHEMBL2047,NR1H4
950,CHEMBL1762621,Bardoxolone Methyl,Small molecule,,,,-olone,Peroxisome proliferator-activated receptor gamma antagonist,"Ph3 study terminated, safety and efficacy to be re-evaluated in new Ph2 study in 2014/2015. Activates KEAP1-Nrf2 pathway (http://en.wikipedia.org/wiki/Bardoxolone_methyl, http://www.kyowa-kirin.com/news_releases/2014/e20140702_01.html)",,CHEMBL235,Peroxisome proliferator-activated receptor gamma,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11043571, URL:http://europepmc.org/abstract/MED/11043571|Name:PubMed, SrcID:3542979, URL:http://europepmc.org/abstract/MED/3542979",COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]3C(=O)C=C4[C@@](C)(CC[C@H]5C(C)(C)C(=O)C(=C[C@]45C)C#N)[C@]3(C)CC2,CHEMBL235,PPARG
951,CHEMBL1743080,Tigatuzumab,Antibody,,,,-mab,Tumor necrosis factor receptor superfamily member 10B agonist,"Mimics the natural receptor ligand TRAIL and binds to TRAIL-R2 (without crosslinking), activating signal transduction pathways that may result in tumor cell apoptosis and a reduction in tumor growth.",,CHEMBL1075153,Tumor necrosis factor receptor superfamily member 10B,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18304965, URL:http://europepmc.org/abstract/MED/18304965|Name:PubMed, SrcID:20187792, URL:http://europepmc.org/abstract/MED/20187792",,CHEMBL1075153,TNFRSF10B
952,CHEMBL2028665,Remogliflozin Etabonate,Small molecule,,,,-gliflozin,Sodium/glucose cotransporter 2 inhibitor,,,CHEMBL3884,Sodium/glucose cotransporter 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18583547, URL:http://europepmc.org/abstract/MED/18583547",CCOC(=O)OC[C@H]1O[C@@H](Oc2nn(C(C)C)c(C)c2Cc3ccc(OC(C)C)cc3)[C@H](O)[C@@H](O)[C@@H]1O,CHEMBL3884,SLC5A2
953,CHEMBL3039529,Tirasemtiv,Small molecule,,,,,Fast skeletal troponin complex activator,,,CHEMBL3831282,Fast skeletal troponin complex,ACTIVATOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:22344294, URL:http://europepmc.org/abstract/MED/22344294",CCC(CC)n1c(O)nc2ncc(nc12)C#C,CHEMBL3831282,TNNC2
954,CHEMBL3039529,Tirasemtiv,Small molecule,,,,,Fast skeletal troponin complex activator,,,CHEMBL3831282,Fast skeletal troponin complex,ACTIVATOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:22344294, URL:http://europepmc.org/abstract/MED/22344294",CCC(CC)n1c(O)nc2ncc(nc12)C#C,CHEMBL3831282,TNNI2
955,CHEMBL3039529,Tirasemtiv,Small molecule,,,,,Fast skeletal troponin complex activator,,,CHEMBL3831282,Fast skeletal troponin complex,ACTIVATOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:22344294, URL:http://europepmc.org/abstract/MED/22344294",CCC(CC)n1c(O)nc2ncc(nc12)C#C,CHEMBL3831282,TNNT3
956,CHEMBL2109624,Caplacizumab,Antibody,,,,-mab,von Willebrand factor inhibitor,Inhibits the interaction between ultralarge von Willebrand factor (ULvWF) multimers and platelets by targeting the A1 domain of vWF and thus has the potential to immediately block the ULvWF mediated platelet interactions and the formation of the string-like clots in the blood of patients with acquired thrombotic thrombocytopenic purpura (TTP).,,CHEMBL2021748,von Willebrand factor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,A1 domain of vWF.,"Name:PubMed, SrcID:23307200, URL:http://europepmc.org/abstract/MED/23307200|Name:PubMed, SrcID:26863353, URL:http://europepmc.org/abstract/MED/26863353",,CHEMBL2021748,VWF
957,CHEMBL1743079,Teprotumumab,Antibody,,,,-mab,Insulin-like growth factor I receptor antagonist,Antibody binding results in endosomal degradation of IGF-1R and inhibition of receptor-mediated signaling.,,CHEMBL1957,Insulin-like growth factor I receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21127194, URL:http://europepmc.org/abstract/MED/21127194|Name:Other, SrcID:http://www.sciencedirect.com/science/article/pii/S1359634906702191, URL:http://www.sciencedirect.com/science/article/pii/S1359634906702191|Name:PubMed, SrcID:24878056, URL:http://europepmc.org/abstract/MED/24878056",,CHEMBL1957,IGF1R
958,CHEMBL1743018,Ficlatuzumab,Antibody,,,,-mab,Hepatocyte growth factor inhibitor,"Humanized IgG1 antibody that binds the HGF ligand with high affinity and specificity, thus inhibiting c-MET/HGF biological activities.",,CHEMBL5479,Hepatocyte growth factor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23493885, URL:http://europepmc.org/abstract/MED/23493885",,CHEMBL5479,HGF
959,CHEMBL3545000,Mk-2201,Small molecule,,,,,Serine/threonine-protein kinase AKT inhibitor,No references found,,CHEMBL2111353,Serine/threonine-protein kinase AKT,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,,,,
960,CHEMBL877,Tranexamic Acid,Small molecule,1986.0,B02AA02,B02AA02 [BLOOD AND BLOOD FORMING ORGANS: ANTIHEMORRHAGICS: ANTIFIBRINOLYTICS: Amino acids],,Plasminogen inhibitor,,,CHEMBL1801,Plasminogen,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=6e89a7d9-4da4-42aa-b7f8-c602c24eefe5#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6e89a7d9-4da4-42aa-b7f8-c602c24eefe5#nlm34090-1",NC[C@@H]1CC[C@H](CC1)C(=O)O,CHEMBL1801,PLG
961,CHEMBL1096885,Valrubicin,Small molecule,1998.0,L01DB09,L01DB09 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES: Anthracyclines and related substances],-rubicin,DNA topoisomerase II alpha inhibitor,,,CHEMBL1806,DNA topoisomerase II alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Type_II_topoisomerase, URL:http://en.wikipedia.org/wiki/Type_II_topoisomerase|Name:DailyMed, SrcID:setid=e96f30a0-6662-11de-8f80-0002a5d5c51b, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e96f30a0-6662-11de-8f80-0002a5d5c51b",CCCCC(=O)OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)c3c(O)c4C(=O)c5c(OC)cccc5C(=O)c4c(O)c3C1,CHEMBL1806,TOP2A
962,CHEMBL1201191,Levocetirizine,Small molecule,2007.0,R06AE09,R06AE09 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Piperazine derivatives],,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=2965ef46-18db-4615-9dce-bfb0f0b3366a, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2965ef46-18db-4615-9dce-bfb0f0b3366a",OC(=O)COCCN1CCN(CC1)[C@H](c2ccccc2)c3ccc(Cl)cc3,CHEMBL231,HRH1
963,CHEMBL554,Lapatinib,Small molecule,2007.0,L01XE07,L01XE07 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Epidermal growth factor receptor erbB1 inhibitor,,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=63319b01-cad6-4d0a-c39b-938fa951a808#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=63319b01-cad6-4d0a-c39b-938fa951a808#section-13",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2,CHEMBL203,EGFR
964,CHEMBL1201232,Isopropamide,Small molecule,1957.0,A03AB09,"A03AB09 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: Synthetic anticholinergics, quaternary ammonium compounds]",-pamide,Muscarinic acetylcholine receptor M1 antagonist,"Role in regulating gastric secretion, M1 likely involved",,CHEMBL216,Muscarinic acetylcholine receptor M1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15446040, URL:http://europepmc.org/abstract/MED/15446040|Name:PubMed, SrcID:13473394, URL:http://europepmc.org/abstract/MED/13473394|Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718",CC(C)[N+](C)(CCC(C(=O)N)(c1ccccc1)c2ccccc2)C(C)C,CHEMBL216,CHRM1
965,CHEMBL1187846,Scopolamine,Small molecule,1979.0,S01FA02; A04AD01; A04AD51; N05CM05,S01FA02 [SENSORY ORGANS: OPHTHALMOLOGICALS: MYDRIATICS AND CYCLOPLEGICS: Anticholinergics]; A04AD01 [ALIMENTARY TRACT AND METABOLISM: ANTIEMETICS AND ANTINAUSEANTS: ANTIEMETICS AND ANTINAUSEANTS: Other antiemetics]; A04AD51 [ALIMENTARY TRACT AND METABOLISM: ANTIEMETICS AND ANTINAUSEANTS: ANTIEMETICS AND ANTINAUSEANTS: Other antiemetics]; N05CM05 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Other hypnotics and sedatives],,Muscarinic acetylcholine receptor M1 antagonist,antiemetic,,CHEMBL216,Muscarinic acetylcholine receptor M1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23615033, URL:http://europepmc.org/abstract/MED/23615033|Name:ISBN, SrcID:9780702034718 PP. 153, 162, URL:http://www.isbnsearch.org/isbn/9780702034718",CN1[C@@H]2C[C@H](C[C@H]1[C@@H]3O[C@@H]23)OC(=O)[C@H](CO)c4ccccc4,CHEMBL216,CHRM1
966,CHEMBL1421,Dasatinib,Small molecule,2006.0,L01XE06,L01XE06 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Stem cell growth factor receptor inhibitor,,,CHEMBL1936,Stem cell growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13",Cc1nc(Nc2ncc(s2)C(=O)Nc3c(C)cccc3Cl)cc(n1)N4CCN(CCO)CC4,CHEMBL1936,KIT
967,CHEMBL1201414,Tinzaparin Sodium,Oligosaccharide,2000.0,B01AB10,B01AB10 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Heparin group],-parin,Antithrombin-III activator,Inhibits coagulation by activating antithrombin III; ATIII then binds to F10; It's a low-molecular-weight heparin,,CHEMBL1950,Antithrombin-III,ACTIVATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 299, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:DailyMed, SrcID:setid=d3e5fbbf-4a1f-4aa2-8e80-9729f6cf04ee, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d3e5fbbf-4a1f-4aa2-8e80-9729f6cf04ee",,CHEMBL1950,SERPINC1
968,CHEMBL1200862,Metyrosine,Small molecule,1979.0,C02KB01,C02KB01 [CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: OTHER ANTIHYPERTENSIVES: Tyrosine hydroxylase inhibitors],,Tyrosine 3-hydroxylase inhibitor,,,CHEMBL1969,Tyrosine 3-hydroxylase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=32fb2f2f-34b5-4cd5-9145-c3ab37c5ca92, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=32fb2f2f-34b5-4cd5-9145-c3ab37c5ca92",C[C@](N)(Cc1ccc(O)cc1)C(=O)O,CHEMBL1969,TH
969,CHEMBL1201653,Insulin Zinc Susp Purified Pork,Protein,1979.0,,,,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/022472s006s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022472s006s008lbl.pdf|Name:DailyMed, SrcID:setid=457531f0-9331-47fe-90b5-b31f284044dc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=457531f0-9331-47fe-90b5-b31f284044dc",,CHEMBL1981,INSR
970,CHEMBL607,Meperidine,Small molecule,1942.0,N02AB02; N02AB72; N02AB52,N02AB02 [NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Phenylpiperidine derivatives]; N02AB72 [NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Phenylpiperidine derivatives]; N02AB52 [NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Phenylpiperidine derivatives],-eridine,Mu opioid receptor agonist,,,CHEMBL233,Mu opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21215785, URL:http://europepmc.org/abstract/MED/21215785",CCOC(=O)C1(CCN(C)CC1)c2ccccc2,CHEMBL233,OPRM1
971,CHEMBL1201207,Betamethasone Phosphoric Acid,Small molecule,1965.0,,,,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 401, URL:http://www.isbnsearch.org/isbn/9780702034718",C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O,CHEMBL2034,NR3C1
972,CHEMBL2109065,Drotrecogin Alfa (Activated),Unknown,2001.0,B01AD10,B01AD10 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Enzymes],,Coagulation factor VIII inhibitor,Activated protein c cleaves clotting factors to inactivate,,CHEMBL3143,Coagulation factor VIII,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:archiveid=10210#section-12, URL:http://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=10210#section-12",,CHEMBL3143,F8
973,CHEMBL601719,Crizotinib,Small molecule,2011.0,L01XE16,L01XE16 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,ALK tyrosine kinase receptor inhibitor,,,CHEMBL4247,ALK tyrosine kinase receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2012/202570s003lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202570s003lbl.pdf",C[C@@H](Oc1cc(cnc1N)c2cnn(c2)C3CCNCC3)c4c(Cl)ccc(F)c4Cl,CHEMBL4247,ALK
974,CHEMBL916,Tirofiban,Small molecule,1998.0,B01AC17,B01AC17 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Platelet aggregation inhibitors excl. heparin],-fiban,Integrin alpha-IIb/beta-3 inhibitor,,,CHEMBL2093869,Integrin alpha-IIb/beta-3,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:DailyMed, SrcID:setid=fe0ced75-ccbf-4d2e-bd0d-b57e60ab913f#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fe0ced75-ccbf-4d2e-bd0d-b57e60ab913f#nlm34090-1",CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(=O)O,,
975,CHEMBL1271,Pentolinium,Small molecule,1982.0,,,-ium,Neuronal acetylcholine receptor; alpha3/beta4 antagonist,,,CHEMBL1907594,Neuronal acetylcholine receptor; alpha3/beta4,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:7761270, URL:http://europepmc.org/abstract/MED/7761270",C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1,,
976,CHEMBL1274,Nilutamide,Small molecule,1996.0,L02BB02,L02BB02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONE ANTAGONISTS AND RELATED AGENTS: Anti-androgens],-lutamide,Androgen Receptor antagonist,,,CHEMBL1871,Androgen Receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=6d2e5c32-3221-4605-955f-37c6bb61aef7, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d2e5c32-3221-4605-955f-37c6bb61aef7",CC1(C)NC(=O)N(C1=O)c2ccc(c(c2)C(F)(F)F)[N+](=O)[O-],CHEMBL1871,AR
977,CHEMBL264241,Anidulafungin,Small molecule,2006.0,J02AX06,J02AX06 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: Other antimycotics for systemic use],-fungin,"1,3-beta-glucan synthase inhibitor",,,CHEMBL2364673,"1,3-beta-glucan synthase",INHIBITOR,Candida,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=a88d9010-55fb-4a02-baff-042cd27688ea, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a88d9010-55fb-4a02-baff-042cd27688ea",CCCCCOc1ccc(cc1)c2ccc(cc2)c3ccc(cc3)C(=O)N[C@H]4C[C@@H](O)[C@@H](O)NC(=O)[C@@H]5[C@@H](O)[C@@H](C)CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@@H](O)CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)[C@H](O)[C@@H](O)c7ccc(O)cc7)[C@@H](C)O,,
978,CHEMBL2095208,Cobicistat,Small molecule,2012.0,V03AX03,V03AX03 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Other therapeutic products],-stat,Cytochrome P450 3A inhibitor,,,CHEMBL2364675,Cytochrome P450 3A,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=74ae2a93-b267-444c-8f0f-a2a6522260ee, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=74ae2a93-b267-444c-8f0f-a2a6522260ee|Name:DOI, SrcID:10.1021/ml1000257, URL:http://pubs.acs.org/doi/abs/10.1021/ml1000257",CC(C)c1nc(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](Cc3ccccc3)NC(=O)OCc4cncs4)Cc5ccccc5)cs1,,
979,CHEMBL1789843,Belimumab,Antibody,2011.0,L04AA26,L04AA26 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Selective immunosuppressants],-mab,Tumor necrosis factor ligand superfamily member 13B inhibitor,,,CHEMBL2364158,Tumor necrosis factor ligand superfamily member 13B,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=2fa3c528-1777-4628-8a55-a69dae2381a3, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2fa3c528-1777-4628-8a55-a69dae2381a3",,CHEMBL2364158,TNFSF13B
980,CHEMBL575,Methicillin,Small molecule,1982.0,J01CF03,"J01CF03 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: BETA-LACTAM ANTIBACTERIALS, PENICILLINS: Beta-lactamase resistant penicillins]",-cillin,Penicillin-binding protein inhibitor,,,CHEMBL2363021,Penicillin-binding protein,INHIBITOR,Staphylococcus,PROTEIN FAMILY,,,"Name:PubMed, SrcID:7447421, URL:http://europepmc.org/abstract/MED/7447421",COc1cccc(OC)c1C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(=O)O,,
981,CHEMBL163,Ritonavir,Small molecule,1996.0,J05AE03,J05AE03 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Protease inhibitors],-vir,Human immunodeficiency virus type 1 protease inhibitor,,,CHEMBL243,Human immunodeficiency virus type 1 protease,INHIBITOR,Human immunodeficiency virus 1,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=13b059c6-0c6c-49a5-b985-a4b05caf9ac9, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=13b059c6-0c6c-49a5-b985-a4b05caf9ac9",CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc3cncs3)Cc4ccccc4,,
982,CHEMBL1644,Cefadroxil,Small molecule,1978.0,J01DB05,J01DB05 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: First-generation cephalosporins],cef-,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=7bb90096-14d3-400e-94d3-048bff6b1292, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7bb90096-14d3-400e-94d3-048bff6b1292|Name:PubMed, SrcID:7447421, URL:http://europepmc.org/abstract/MED/7447421|Name:Wikipedia, SrcID:Penicillin_binding_proteins#Function, URL:http://en.wikipedia.org/wiki/Penicillin_binding_proteins#Function",CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C2=O)C(=O)O,,
983,CHEMBL53463,Doxorubicin,Small molecule,1974.0,L01DB01,L01DB01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES: Anthracyclines and related substances],-rubicin,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:Wikipedia, SrcID:Type_II_topoisomerase, URL:http://en.wikipedia.org/wiki/Type_II_topoisomerase|Name:DailyMed, SrcID:setid=5594d16e-72bf-4354-925e-c7591737ff1c, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5594d16e-72bf-4354-925e-c7591737ff1c|Name:FDA, SrcID:label/2015/050718s048lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/050718s048lbl.pdf",COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO,,
984,CHEMBL1201651,Protamine Sulfate,Protein,1969.0,V03AB14,V03AB14 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Antidotes],,Heparin inhibitor,,,CHEMBL2364712,Heparin,INHIBITOR,Homo sapiens,OLIGOSACCHARIDE,,,"Name:DailyMed, SrcID:setid=bc755638-8797-43ab-be0b-4ea3ded3f644, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bc755638-8797-43ab-be0b-4ea3ded3f644",,,
985,CHEMBL1200694,Sevoflurane,Small molecule,1995.0,N01AB08,"N01AB08 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,Potassium channel subfamily K member 2 opener,,,CHEMBL2321615,Potassium channel subfamily K member 2,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:22226507, URL:http://europepmc.org/abstract/MED/22226507|Name:PubMed, SrcID:21788314, URL:http://europepmc.org/abstract/MED/21788314",FCOC(C(F)(F)F)C(F)(F)F,CHEMBL2321615,KCNK2
986,CHEMBL1201221,Viomycin,Protein,1982.0,,,-mycin,70S ribosome inhibitor,,,CHEMBL2363965,70S ribosome,INHIBITOR,Mycobacterium tuberculosis,PROTEIN NUCLEIC-ACID COMPLEX,16S/23S ribosomal RNA interface,Binding site 23S and 16S RNA (interface),"Name:PubMed, SrcID:12936980, URL:http://europepmc.org/abstract/MED/12936980",NCCC[C@H](N)CC(=O)N[C@H]1CNC(=O)[C@H](NC(=O)\C(=C\NC(=O)N)\NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC1=O)[C@H]2C[C@H](O)NC(=N)N2,,
987,CHEMBL1747,Tobramycin,Small molecule,1975.0,S01AA12; J01GB01,S01AA12 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Antibiotics]; J01GB01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: AMINOGLYCOSIDE ANTIBACTERIALS: Other aminoglycosides],-mycin,70S ribosome inhibitor,,,CHEMBL2364022,70S ribosome,INHIBITOR,Pseudomonas aeruginosa,PROTEIN NUCLEIC-ACID COMPLEX,23S ribosomal RNA,23S RRNA (site A),"Name:FDA, SrcID:label/2013/201688s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/201688s000lbl.pdf|Name:PubMed, SrcID:20108982, URL:http://europepmc.org/abstract/MED/20108982|Name:Wikipedia, SrcID:Tobramycin#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Tobramycin#Mechanism_of_action",NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,,
988,CHEMBL1201595,Laronidase,Enzyme,2003.0,A16AB05,A16AB05 [ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Enzymes],-ase,Dermatan sulfate hydrolytic enzyme,Replacement of alpha-L-iduronidase enzyme,,CHEMBL2364179,Dermatan sulfate,HYDROLYTIC ENZYME,Homo sapiens,OLIGOSACCHARIDE,,,"Name:DailyMed, SrcID:setid=a80ac249-cae4-41f3-88bb-344088b20e60#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a80ac249-cae4-41f3-88bb-344088b20e60#nlm34090-1",,,
989,CHEMBL1243,Sulfabenzamide,Small molecule,1945.0,,,sulfa-,Unknown,,,,,,,,,,"Name:PubMed, SrcID:14700578, URL:http://europepmc.org/abstract/MED/14700578|Name:PubMed, SrcID:22214266, URL:http://europepmc.org/abstract/MED/22214266",Nc1ccc(cc1)S(=O)(=O)NC(=O)c2ccccc2,,
990,CHEMBL932,Dipyridamole,Small molecule,1961.0,B01AC07,B01AC07 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Platelet aggregation inhibitors excl. heparin],,"3',5'-cyclic phosphodiesterase inhibitor",,,CHEMBL2363066,"3',5'-cyclic phosphodiesterase",INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=ae7585ec-1280-40fe-b888-613b8a0e6ef6, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ae7585ec-1280-40fe-b888-613b8a0e6ef6|Name:Wikipedia, SrcID:Dipyridamole#Mechanism_and_effects, URL:http://en.wikipedia.org/wiki/Dipyridamole#Mechanism_and_effects|Name:PubMed, SrcID:15672122, URL:http://europepmc.org/abstract/MED/15672122",OCCN(CCO)c1nc(N2CCCCC2)c3nc(nc(N4CCCCC4)c3n1)N(CCO)CCO,CHEMBL2363066,PDE6H
991,CHEMBL932,Dipyridamole,Small molecule,1961.0,B01AC07,B01AC07 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Platelet aggregation inhibitors excl. heparin],,"3',5'-cyclic phosphodiesterase inhibitor",,,CHEMBL2363066,"3',5'-cyclic phosphodiesterase",INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=ae7585ec-1280-40fe-b888-613b8a0e6ef6, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ae7585ec-1280-40fe-b888-613b8a0e6ef6|Name:Wikipedia, SrcID:Dipyridamole#Mechanism_and_effects, URL:http://en.wikipedia.org/wiki/Dipyridamole#Mechanism_and_effects|Name:PubMed, SrcID:15672122, URL:http://europepmc.org/abstract/MED/15672122",OCCN(CCO)c1nc(N2CCCCC2)c3nc(nc(N4CCCCC4)c3n1)N(CCO)CCO,CHEMBL2363066,PDE6G
992,CHEMBL184412,Dronedarone,Small molecule,2009.0,C01BD07,"C01BD07 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III]",-arone,Inward rectifier potassium channel 2 blocker,,,CHEMBL1914276,Inward rectifier potassium channel 2,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25182566, URL:http://europepmc.org/abstract/MED/25182566|Name:PubMed, SrcID:25205296, URL:http://europepmc.org/abstract/MED/25205296",CCCCN(CCCC)CCCOc1ccc(cc1)C(=O)c2c(CCCC)oc3ccc(NS(=O)(=O)C)cc23,CHEMBL1914276,KCNJ2
993,CHEMBL3545239,Pf-05019702,Small molecule,,,,,Progesterone receptor antagonist,,,CHEMBL208,Progesterone receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://ncats.nih.gov/files/PF-05019702.pdf, URL:https://ncats.nih.gov/files/PF-05019702.pdf|Name:Other, SrcID:http://oasys2.confex.com/acs/236nm/techprogram/P1193440.HTM, URL:http://oasys2.confex.com/acs/236nm/techprogram/P1193440.HTM",,CHEMBL208,PGR
994,CHEMBL3545284,Cerdulatinib,Small molecule,,,,-tinib,Tyrosine-protein kinase JAK3 inhibitor,Dual spleen tyrosine kinase (Syk) and janus kinase (JAK) inhibitor,,CHEMBL2148,Tyrosine-protein kinase JAK3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://www.portola.com/clinical-development/cerdulatinib-dual-syk-jak-inhibitor/l-development/cerdulatinib-dual-syk-jak-inhibitor/, URL:https://www.portola.com/clinical-development/cerdulatinib-dual-syk-jak-inhibitor/l-development/cerdulatinib-dual-syk-jak-inhibitor/|Name:PubMed, SrcID:25253883, URL:http://europepmc.org/abstract/MED/25253883",,CHEMBL2148,JAK3
995,CHEMBL3545245,Bay-1082439,Small molecule,,,,,PI3-kinase p110-beta subunit inhibitor,,,CHEMBL3145,PI3-kinase p110-beta subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.pharmatest.com/files/5613/9844/3444/Suominen_BAY_1082439.pdf, URL:http://www.pharmatest.com/files/5613/9844/3444/Suominen_BAY_1082439.pdf",,CHEMBL3145,PIK3CB
996,CHEMBL3545301,Hmpl-523,Small molecule,,,,,Tyrosine-protein kinase SYK inhibitor,,,CHEMBL2599,Tyrosine-protein kinase SYK,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.chi-med.com/wp-content/uploads/2015/10/a151030.pdf, URL:http://www.chi-med.com/wp-content/uploads/2015/10/a151030.pdf|Name:Other, SrcID:http://www.hmplglobal.com/en/hmpl-523/, URL:http://www.hmplglobal.com/en/hmpl-523/",,CHEMBL2599,SYK
997,CHEMBL3128043,Pf-03758309,Small molecule,,,,,Serine/threonine-protein kinase PAK 4 inhibitor,,,CHEMBL4482,Serine/threonine-protein kinase PAK 4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20439741, URL:http://europepmc.org/abstract/MED/20439741",CN(C)C[C@@H](NC(=O)N1Cc2c(Nc3nc(C)nc4ccsc34)n[nH]c2C1(C)C)c5ccccc5,CHEMBL4482,PAK4
998,CHEMBL214268,Pha-543613,Small molecule,,,,,Neuronal acetylcholine receptor protein alpha-7 subunit agonist,,,CHEMBL2492,Neuronal acetylcholine receptor protein alpha-7 subunit,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21919481, URL:http://europepmc.org/abstract/MED/21919481|Name:Wikipedia, SrcID:PHA-543,613, URL:https://en.wikipedia.org/wiki/PHA-543,613|Name:PubMed, SrcID:16821801, URL:http://europepmc.org/abstract/MED/16821801",O=C(N[C@H]1CN2CCC1CC2)c3cc4ccoc4cn3,CHEMBL2492,CHRNA7
999,CHEMBL3545391,Org-34517,Small molecule,,,,,Glucocorticoid receptor antagonist,,,CHEMBL2034,Glucocorticoid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19120154, URL:http://europepmc.org/abstract/MED/19120154",CC#C[C@]1(O)CCC2C3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c5ccc6OCOc6c5,CHEMBL2034,NR3C1
1000,CHEMBL1614713,Cc-401,Small molecule,,,,,c-Jun N-terminal kinase 3 inhibitor,,,CHEMBL2637,c-Jun N-terminal kinase 3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17202416, URL:http://europepmc.org/abstract/MED/17202416|Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=453550, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=453550",C(CN1CCCCC1)Oc2cccc(c2)c3n[nH]c4ccc(cc34)c5nnc[nH]5,CHEMBL2637,MAPK10
1001,CHEMBL1950289,Tanzisertib,Small molecule,,,,-sertib,c-Jun N-terminal kinase 2 inhibitor,,,CHEMBL4179,c-Jun N-terminal kinase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22244937, URL:http://europepmc.org/abstract/MED/22244937",O[C@@H]1CC[C@H](CC1)Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]5CCOC5)c3n2,CHEMBL4179,MAPK9
1002,CHEMBL1097999,E-6201,Small molecule,,,,,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,,,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19684251, URL:http://europepmc.org/abstract/MED/19684251|Name:PubMed, SrcID:24448821, URL:http://europepmc.org/abstract/MED/24448821",CCNc1cc(O)c2C(=O)O[C@@H](C)[C@H](C)\C=C/C(=O)[C@@H](O)[C@@H](O)C\C=C\c2c1,CHEMBL3587,MAP2K1
1003,CHEMBL3039518,Batefenterol,Small molecule,,,,-terol,Muscarinic acetylcholine receptor M2 antagonist,,,CHEMBL211,Muscarinic acetylcholine receptor M2,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25629394, URL:http://europepmc.org/abstract/MED/25629394|Name:PubMed, SrcID:25100753, URL:http://europepmc.org/abstract/MED/25100753",COc1cc(NC(=O)CCN2CCC(CC2)OC(=O)Nc3ccccc3c4ccccc4)c(Cl)cc1CNC[C@H](O)c5ccc(O)c6NC(=O)C=Cc56,CHEMBL211,CHRM2
1004,CHEMBL3545029,Abt-288,Small molecule,,,,,Histamine H3 receptor antagonist,,,CHEMBL264,Histamine H3 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20864505, URL:http://europepmc.org/abstract/MED/20864505",CN1CC2CCN(C2C1)c3ccc(cc3)c4ccc(cc4)N5N=CC=CC5=O,CHEMBL264,HRH3
1005,CHEMBL3545100,Asp7991,Small molecule,,,,,Calcium sensing receptor positive allosteric modulator,Positive allosteric modulator,,CHEMBL1878,Calcium sensing receptor,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.abstracts2view.com/era_archive/view.php?nu=WCN09L_928, URL:http://www.abstracts2view.com/era_archive/view.php?nu=WCN09L_928",,CHEMBL1878,CASR
1006,CHEMBL3545163,Amp579,Small molecule,,,,,Adenosine A2a receptor agonist,,,CHEMBL251,Adenosine A2a receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16654164, URL:http://www.ncbi.nlm.nih.gov/pubmed/?term=16654164",CCNC(=O)[C@H]1CC([C@H](O)[C@@H]1O)n2ccc3c(NC(CC)Cc4sccc4Cl)ncnc23,CHEMBL251,ADORA2A
1007,CHEMBL3545229,Dwp05195,Small molecule,,,,,Vanilloid receptor antagonist,,,CHEMBL4794,Vanilloid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21804597, URL:http://europepmc.org/abstract/MED/21804597|Name:Other, SrcID:http://www.daewoong.com/content/content.asp?FolderName=sub02&filename=sub02_0301, URL:http://www.daewoong.com/content/content.asp?FolderName=sub02&filename=sub02_0301",,CHEMBL4794,TRPV1
1008,CHEMBL576982,Quizartinib,Small molecule,,,,-tinib,Macrophage colony stimulating factor receptor inhibitor,,,CHEMBL1844,Macrophage colony stimulating factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23497317, URL:http://europepmc.org/abstract/MED/23497317|Name:PubMed, SrcID:19654408, URL:http://europepmc.org/abstract/MED/19654408",CC(C)(C)c1onc(NC(=O)Nc2ccc(cc2)c3cn4c5ccc(OCCN6CCOCC6)cc5sc4n3)c1,CHEMBL1844,CSF1R
1009,CHEMBL109648,Clazosentan,Small molecule,,,,-entan,Endothelin receptor ET-A antagonist,Phase 3 study terminated due to lack of efficacy,,CHEMBL252,Endothelin receptor ET-A,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:9399983, URL:http://europepmc.org/abstract/MED/9399983",COc1ccccc1Oc2c(NS(=O)(=O)c3ccc(C)cn3)nc(nc2OCCO)c4ccnc(c4)c5nn[nH]n5,CHEMBL252,EDNRA
1010,CHEMBL3545045,Iti-007,Small molecule,,,,,Serotonin transporter inhibitor,"Atypical antipsychotic, shows partial agonism at the presynaptic D2 receptors and acts as an antagonist at postsynaptic D2 receptors (PMID: 25120104).",,CHEMBL228,Serotonin transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24559051, URL:http://europepmc.org/abstract/MED/24559051|Name:Other, SrcID:http://www.intracellulartherapies.com/products-technology/iti-007.html, URL:http://www.intracellulartherapies.com/products-technology/iti-007.html|Name:PubMed, SrcID:25120104, URL:http://europepmc.org/abstract/MED/25120104",CN1CCN2C3CCN(CCCC(=O)c4ccc(F)cc4)CC3c5cccc1c25,CHEMBL228,SLC6A4
1011,CHEMBL1742981,Abagovomab,Antibody,,,,-mab,Mucin-16 other,"It does not bind directly to CA-125, but it works as a ""surrogate"" antigen, enabling the immune system to identify and attack tumour cells displaying the CA-125 protein.",,CHEMBL3580482,Mucin-16,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21322756, URL:http://europepmc.org/abstract/MED/21322756|Name:PubMed, SrcID:7590775, URL:http://europepmc.org/abstract/MED/7590775",,CHEMBL3580482,MUC16
1012,CHEMBL113461,Tedisamil,Small molecule,,C01BD06,"C01BD06 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III]",,Voltage-gated potassium channel blocker,Potassium channel blocker that inhibits both transient outward (Ito) and delayed rectifier (IK) potassium currents.,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10648489, URL:http://europepmc.org/abstract/MED/10648489|Name:PubMed, SrcID:2384886, URL:http://europepmc.org/abstract/MED/2384886",C(C1CC1)N2CC3CN(CC4CC4)CC(C2)C35CCCC5,CHEMBL2362996,KCNH6
1013,CHEMBL113461,Tedisamil,Small molecule,,C01BD06,"C01BD06 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III]",,Voltage-gated potassium channel blocker,Potassium channel blocker that inhibits both transient outward (Ito) and delayed rectifier (IK) potassium currents.,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10648489, URL:http://europepmc.org/abstract/MED/10648489|Name:PubMed, SrcID:2384886, URL:http://europepmc.org/abstract/MED/2384886",C(C1CC1)N2CC3CN(CC4CC4)CC(C2)C35CCCC5,CHEMBL2362996,KCNF1
1014,CHEMBL113461,Tedisamil,Small molecule,,C01BD06,"C01BD06 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III]",,Voltage-gated potassium channel blocker,Potassium channel blocker that inhibits both transient outward (Ito) and delayed rectifier (IK) potassium currents.,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10648489, URL:http://europepmc.org/abstract/MED/10648489|Name:PubMed, SrcID:2384886, URL:http://europepmc.org/abstract/MED/2384886",C(C1CC1)N2CC3CN(CC4CC4)CC(C2)C35CCCC5,CHEMBL2362996,KCNA7
1015,CHEMBL113461,Tedisamil,Small molecule,,C01BD06,"C01BD06 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III]",,Voltage-gated potassium channel blocker,Potassium channel blocker that inhibits both transient outward (Ito) and delayed rectifier (IK) potassium currents.,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10648489, URL:http://europepmc.org/abstract/MED/10648489|Name:PubMed, SrcID:2384886, URL:http://europepmc.org/abstract/MED/2384886",C(C1CC1)N2CC3CN(CC4CC4)CC(C2)C35CCCC5,CHEMBL2362996,KCND1
1016,CHEMBL113461,Tedisamil,Small molecule,,C01BD06,"C01BD06 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III]",,Voltage-gated potassium channel blocker,Potassium channel blocker that inhibits both transient outward (Ito) and delayed rectifier (IK) potassium currents.,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10648489, URL:http://europepmc.org/abstract/MED/10648489|Name:PubMed, SrcID:2384886, URL:http://europepmc.org/abstract/MED/2384886",C(C1CC1)N2CC3CN(CC4CC4)CC(C2)C35CCCC5,CHEMBL2362996,KCNG1
1017,CHEMBL113461,Tedisamil,Small molecule,,C01BD06,"C01BD06 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III]",,Voltage-gated potassium channel blocker,Potassium channel blocker that inhibits both transient outward (Ito) and delayed rectifier (IK) potassium currents.,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10648489, URL:http://europepmc.org/abstract/MED/10648489|Name:PubMed, SrcID:2384886, URL:http://europepmc.org/abstract/MED/2384886",C(C1CC1)N2CC3CN(CC4CC4)CC(C2)C35CCCC5,CHEMBL2362996,KCNH8
1018,CHEMBL113461,Tedisamil,Small molecule,,C01BD06,"C01BD06 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III]",,Voltage-gated potassium channel blocker,Potassium channel blocker that inhibits both transient outward (Ito) and delayed rectifier (IK) potassium currents.,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10648489, URL:http://europepmc.org/abstract/MED/10648489|Name:PubMed, SrcID:2384886, URL:http://europepmc.org/abstract/MED/2384886",C(C1CC1)N2CC3CN(CC4CC4)CC(C2)C35CCCC5,CHEMBL2362996,KCNG4
1019,CHEMBL113461,Tedisamil,Small molecule,,C01BD06,"C01BD06 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III]",,Voltage-gated potassium channel blocker,Potassium channel blocker that inhibits both transient outward (Ito) and delayed rectifier (IK) potassium currents.,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10648489, URL:http://europepmc.org/abstract/MED/10648489|Name:PubMed, SrcID:2384886, URL:http://europepmc.org/abstract/MED/2384886",C(C1CC1)N2CC3CN(CC4CC4)CC(C2)C35CCCC5,CHEMBL2362996,KCNH7
1020,CHEMBL113461,Tedisamil,Small molecule,,C01BD06,"C01BD06 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III]",,Voltage-gated potassium channel blocker,Potassium channel blocker that inhibits both transient outward (Ito) and delayed rectifier (IK) potassium currents.,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10648489, URL:http://europepmc.org/abstract/MED/10648489|Name:PubMed, SrcID:2384886, URL:http://europepmc.org/abstract/MED/2384886",C(C1CC1)N2CC3CN(CC4CC4)CC(C2)C35CCCC5,CHEMBL2362996,KCNH5
1021,CHEMBL113461,Tedisamil,Small molecule,,C01BD06,"C01BD06 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III]",,Voltage-gated potassium channel blocker,Potassium channel blocker that inhibits both transient outward (Ito) and delayed rectifier (IK) potassium currents.,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10648489, URL:http://europepmc.org/abstract/MED/10648489|Name:PubMed, SrcID:2384886, URL:http://europepmc.org/abstract/MED/2384886",C(C1CC1)N2CC3CN(CC4CC4)CC(C2)C35CCCC5,CHEMBL2362996,KCNC3
1022,CHEMBL113461,Tedisamil,Small molecule,,C01BD06,"C01BD06 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III]",,Voltage-gated potassium channel blocker,Potassium channel blocker that inhibits both transient outward (Ito) and delayed rectifier (IK) potassium currents.,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10648489, URL:http://europepmc.org/abstract/MED/10648489|Name:PubMed, SrcID:2384886, URL:http://europepmc.org/abstract/MED/2384886",C(C1CC1)N2CC3CN(CC4CC4)CC(C2)C35CCCC5,CHEMBL2362996,KCNV1
1023,CHEMBL113461,Tedisamil,Small molecule,,C01BD06,"C01BD06 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III]",,Voltage-gated potassium channel blocker,Potassium channel blocker that inhibits both transient outward (Ito) and delayed rectifier (IK) potassium currents.,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10648489, URL:http://europepmc.org/abstract/MED/10648489|Name:PubMed, SrcID:2384886, URL:http://europepmc.org/abstract/MED/2384886",C(C1CC1)N2CC3CN(CC4CC4)CC(C2)C35CCCC5,CHEMBL2362996,KCNG3
1024,CHEMBL113461,Tedisamil,Small molecule,,C01BD06,"C01BD06 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III]",,Voltage-gated potassium channel blocker,Potassium channel blocker that inhibits both transient outward (Ito) and delayed rectifier (IK) potassium currents.,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10648489, URL:http://europepmc.org/abstract/MED/10648489|Name:PubMed, SrcID:2384886, URL:http://europepmc.org/abstract/MED/2384886",C(C1CC1)N2CC3CN(CC4CC4)CC(C2)C35CCCC5,CHEMBL2362996,KCNS3
1025,CHEMBL113461,Tedisamil,Small molecule,,C01BD06,"C01BD06 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III]",,Voltage-gated potassium channel blocker,Potassium channel blocker that inhibits both transient outward (Ito) and delayed rectifier (IK) potassium currents.,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10648489, URL:http://europepmc.org/abstract/MED/10648489|Name:PubMed, SrcID:2384886, URL:http://europepmc.org/abstract/MED/2384886",C(C1CC1)N2CC3CN(CC4CC4)CC(C2)C35CCCC5,CHEMBL2362996,KCNV2
1026,CHEMBL113461,Tedisamil,Small molecule,,C01BD06,"C01BD06 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III]",,Voltage-gated potassium channel blocker,Potassium channel blocker that inhibits both transient outward (Ito) and delayed rectifier (IK) potassium currents.,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10648489, URL:http://europepmc.org/abstract/MED/10648489|Name:PubMed, SrcID:2384886, URL:http://europepmc.org/abstract/MED/2384886",C(C1CC1)N2CC3CN(CC4CC4)CC(C2)C35CCCC5,CHEMBL2362996,KCNH3
1027,CHEMBL113461,Tedisamil,Small molecule,,C01BD06,"C01BD06 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III]",,Voltage-gated potassium channel blocker,Potassium channel blocker that inhibits both transient outward (Ito) and delayed rectifier (IK) potassium currents.,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10648489, URL:http://europepmc.org/abstract/MED/10648489|Name:PubMed, SrcID:2384886, URL:http://europepmc.org/abstract/MED/2384886",C(C1CC1)N2CC3CN(CC4CC4)CC(C2)C35CCCC5,CHEMBL2362996,KCNS2
1028,CHEMBL113461,Tedisamil,Small molecule,,C01BD06,"C01BD06 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III]",,Voltage-gated potassium channel blocker,Potassium channel blocker that inhibits both transient outward (Ito) and delayed rectifier (IK) potassium currents.,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10648489, URL:http://europepmc.org/abstract/MED/10648489|Name:PubMed, SrcID:2384886, URL:http://europepmc.org/abstract/MED/2384886",C(C1CC1)N2CC3CN(CC4CC4)CC(C2)C35CCCC5,CHEMBL2362996,KCNS1
1029,CHEMBL113461,Tedisamil,Small molecule,,C01BD06,"C01BD06 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III]",,Voltage-gated potassium channel blocker,Potassium channel blocker that inhibits both transient outward (Ito) and delayed rectifier (IK) potassium currents.,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10648489, URL:http://europepmc.org/abstract/MED/10648489|Name:PubMed, SrcID:2384886, URL:http://europepmc.org/abstract/MED/2384886",C(C1CC1)N2CC3CN(CC4CC4)CC(C2)C35CCCC5,CHEMBL2362996,KCNC2
1030,CHEMBL113461,Tedisamil,Small molecule,,C01BD06,"C01BD06 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III]",,Voltage-gated potassium channel blocker,Potassium channel blocker that inhibits both transient outward (Ito) and delayed rectifier (IK) potassium currents.,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10648489, URL:http://europepmc.org/abstract/MED/10648489|Name:PubMed, SrcID:2384886, URL:http://europepmc.org/abstract/MED/2384886",C(C1CC1)N2CC3CN(CC4CC4)CC(C2)C35CCCC5,CHEMBL2362996,KCNH4
1031,CHEMBL113461,Tedisamil,Small molecule,,C01BD06,"C01BD06 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III]",,Voltage-gated potassium channel blocker,Potassium channel blocker that inhibits both transient outward (Ito) and delayed rectifier (IK) potassium currents.,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10648489, URL:http://europepmc.org/abstract/MED/10648489|Name:PubMed, SrcID:2384886, URL:http://europepmc.org/abstract/MED/2384886",C(C1CC1)N2CC3CN(CC4CC4)CC(C2)C35CCCC5,CHEMBL2362996,KCNC4
1032,CHEMBL113461,Tedisamil,Small molecule,,C01BD06,"C01BD06 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III]",,Voltage-gated potassium channel blocker,Potassium channel blocker that inhibits both transient outward (Ito) and delayed rectifier (IK) potassium currents.,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10648489, URL:http://europepmc.org/abstract/MED/10648489|Name:PubMed, SrcID:2384886, URL:http://europepmc.org/abstract/MED/2384886",C(C1CC1)N2CC3CN(CC4CC4)CC(C2)C35CCCC5,CHEMBL2362996,KCNH1
1033,CHEMBL113461,Tedisamil,Small molecule,,C01BD06,"C01BD06 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III]",,Voltage-gated potassium channel blocker,Potassium channel blocker that inhibits both transient outward (Ito) and delayed rectifier (IK) potassium currents.,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10648489, URL:http://europepmc.org/abstract/MED/10648489|Name:PubMed, SrcID:2384886, URL:http://europepmc.org/abstract/MED/2384886",C(C1CC1)N2CC3CN(CC4CC4)CC(C2)C35CCCC5,CHEMBL2362996,KCNA10
1034,CHEMBL113461,Tedisamil,Small molecule,,C01BD06,"C01BD06 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III]",,Voltage-gated potassium channel blocker,Potassium channel blocker that inhibits both transient outward (Ito) and delayed rectifier (IK) potassium currents.,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10648489, URL:http://europepmc.org/abstract/MED/10648489|Name:PubMed, SrcID:2384886, URL:http://europepmc.org/abstract/MED/2384886",C(C1CC1)N2CC3CN(CC4CC4)CC(C2)C35CCCC5,CHEMBL2362996,KCNG2
1035,CHEMBL1184904,Retaspimycin,Small molecule,,,,-mycin,Heat shock protein HSP90 inhibitor,,,CHEMBL2095165,Heat shock protein HSP90,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:17090671, URL:http://europepmc.org/abstract/MED/17090671|Name:PubMed, SrcID:25542032, URL:http://europepmc.org/abstract/MED/25542032",CO[C@H]1C[C@H](C)Cc2c(O)c(NC(=O)\C(=C\C=C/[C@H](OC)[C@@H](OC(=O)N)\C(=C\[C@H](C)[C@H]1O)\C)\C)cc(O)c2NCC=C,,
1036,CHEMBL3039515,Elobixibat,Small molecule,,,,-ibat,Ileal bile acid transporter inhibitor,Inhibits ileal bile acid reuptake via the inhibition of Ileal sodium/bile acid cotransporter,,CHEMBL2778,Ileal bile acid transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26139989, URL:http://europepmc.org/abstract/MED/26139989",CCCCC1(CCCC)CN(c2ccccc2)c3cc(SC)c(OCC(=O)N[C@@H](C(=O)NCC(=O)O)c4ccccc4)cc3S(=O)(=O)C1,CHEMBL2778,SLC10A2
1037,CHEMBL1808388,Bexagliflozin,Small molecule,,,,-gliflozin,Sodium/glucose cotransporter 2 inhibitor,INHIBITOR,,CHEMBL3884,Sodium/glucose cotransporter 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.theracos.com/sglt2-inhibitors/, URL:http://www.theracos.com/sglt2-inhibitors/|Name:Other, SrcID:http://adisinsight.springer.com/drugs/800035524, URL:http://adisinsight.springer.com/drugs/800035524",OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)c2ccc(Cl)c(Cc3ccc(OCCOC4CC4)cc3)c2,CHEMBL3884,SLC5A2
1038,CHEMBL2105721,Nivocasan,Small molecule,,,,-casan,Caspase-1 inhibitor,Irreversible inhibitor,,CHEMBL4801,Caspase-1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21667042, URL:http://europepmc.org/abstract/MED/21667042",CC(C)[C@]1(CC(=NO1)c2nccc3ccccc23)C(=O)N[C@H]4CC(=O)O[C@]4(O)CF,CHEMBL4801,CASP1
1039,CHEMBL2107877,Blisibimod,Protein,,,,-imod,Tumor necrosis factor ligand superfamily member 13B inhibitor,Binds to both membrane-bound and soluble BAFF.,,CHEMBL2364158,Tumor necrosis factor ligand superfamily member 13B,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22325420, URL:http://europepmc.org/abstract/MED/22325420",,CHEMBL2364158,TNFSF13B
1040,CHEMBL1743049,Olaratumab,Antibody,2016.0,,,-mab,Platelet-derived growth factor receptor alpha antagonist,"Human immunoglobulin G subclass 1 (IgG1) monoclonal antibody that binds to PDGFRalpha and blocks the PDGF-AA, PDGF-BB, and PDGF-CC ligands from binding to the receptor.",,CHEMBL2007,Platelet-derived growth factor receptor alpha,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:27291995, URL:http://europepmc.org/abstract/MED/27291995|Name:PubMed, SrcID:15767546, URL:http://europepmc.org/abstract/MED/15767546",,CHEMBL2007,PDGFRA
1041,CHEMBL1742991,Benralizumab,Antibody,,,,-mab,Interleukin-5 receptor subunit alpha inhibitor,"Binds to an epitope on IL5RA which is in close proximity to the IL-5 binding site and thus inhibits IL-5 receptor signaling, independent of ligand.",,CHEMBL3580483,Interleukin-5 receptor subunit alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,,,CHEMBL3580483,IL5RA
1042,CHEMBL1224,Acrivastine,Small molecule,1994.0,R06AX18,R06AX18 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Other antihistamines for systemic use],-astine,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=d86c6a13-9e5f-43c2-92f5-c7ed7bfcedfc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d86c6a13-9e5f-43c2-92f5-c7ed7bfcedfc",Cc1ccc(cc1)\C(=C/CN2CCCC2)\c3cccc(\C=C\C(=O)O)n3,CHEMBL231,HRH1
1043,CHEMBL1101,Biperiden,Small molecule,1959.0,N04AA02,N04AA02 [NERVOUS SYSTEM: ANTI-PARKINSON DRUGS: ANTICHOLINERGIC AGENTS: Tertiary amines],,Muscarinic acetylcholine receptor M1 antagonist,"Indicated for Parkinson's disease, M1 likely responsible",,CHEMBL216,Muscarinic acetylcholine receptor M1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Biperiden#Pharmacology, URL:http://en.wikipedia.org/wiki/Biperiden#Pharmacology|Name:DailyMed, SrcID:archiveid=1345, URL:http://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=1345|Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718",OC(CCN1CCCCC1)(C2CC3CC2C=C3)c4ccccc4,CHEMBL216,CHRM1
1044,CHEMBL435,Hydrochlorothiazide,Small molecule,1959.0,C03AA03; C03AX01,"C03AA03 [CARDIOVASCULAR SYSTEM: DIURETICS: LOW-CEILING DIURETICS, THIAZIDES: Thiazides, plain]; C03AX01 [CARDIOVASCULAR SYSTEM: DIURETICS: LOW-CEILING DIURETICS, THIAZIDES: Thiazides, combinations with other drugs]",-thiazide,Thiazide-sensitive sodium-chloride cotransporter inhibitor,,,CHEMBL1876,Thiazide-sensitive sodium-chloride cotransporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1056/NEJMra0907219, URL:http://www.nejm.org/doi/full/10.1056/NEJMra0907219|Name:FDA, SrcID:label/2015/020125s020lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020125s020lbl.pdf|Name:DailyMed, SrcID:setid=7efb04ae-3d39-4853-9741-466c8973e8b2, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7efb04ae-3d39-4853-9741-466c8973e8b2|Name:Wikipedia, SrcID:Diuretic, URL:http://en.wikipedia.org/wiki/Diuretic|Name:Wikipedia, SrcID:Hydrochlorothiazide, URL:http://en.wikipedia.org/wiki/Hydrochlorothiazide",NS(=O)(=O)c1cc2c(NCNS2(=O)=O)cc1Cl,CHEMBL1876,SLC12A3
1045,CHEMBL1201528,Vasopressin Tannate,Protein,1982.0,,,-pressin,Vasopressin V1a receptor agonist,,,CHEMBL1889,Vasopressin V1a receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:IUPHAR, SrcID:2168, URL:http://www.iuphar-db.org/DATABASE/LigandDisplayForward?tab=biology&ligandId=2168|Name:DailyMed, SrcID:archiveid=190251, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=190251|Name:DailyMed, SrcID:setid=1b316ff5-b7f8-4509-acc4-fd263d0a1703, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1b316ff5-b7f8-4509-acc4-fd263d0a1703",,CHEMBL1889,AVPR1A
1046,CHEMBL908,Chlorprothixene,Small molecule,1967.0,N05AF03,N05AF03 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Thioxanthene derivatives],,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:2891550, URL:http://europepmc.org/abstract/MED/2891550|Name:Wikipedia, SrcID:Antipsychotic#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Antipsychotic#Mechanism_of_action|Name:Wikipedia, SrcID:Chlorprothixene#Pharmacology, URL:http://en.wikipedia.org/wiki/Chlorprothixene#Pharmacology|Name:PubMed, SrcID:3774629, URL:http://europepmc.org/abstract/MED/3774629",CN(C)CC\C=C/1\c2ccccc2Sc3ccc(Cl)cc13,CHEMBL224,HTR2A
1047,CHEMBL1201568,Pegfilgrastim,Protein,2002.0,L03AA13,L03AA13 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSTIMULANTS: IMMUNOSTIMULANTS: Colony stimulating factors],peg-; -stim,Granulocyte colony stimulating factor receptor agonist,,,CHEMBL1996,Granulocyte colony stimulating factor receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=fdfe5d72-6b80-435a-afa4-c5d74dd852ce, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fdfe5d72-6b80-435a-afa4-c5d74dd852ce|Name:PubMed, SrcID:9679526, URL:http://europepmc.org/abstract/MED/9679526|Name:PubMed, SrcID:7504384, URL:http://europepmc.org/abstract/MED/7504384",,CHEMBL1996,CSF3R
1048,CHEMBL1201229,Demecarium,Small molecule,1959.0,S01EB04,S01EB04 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Parasympathomimetics],-ium,Acetylcholinesterase inhibitor,,,CHEMBL220,Acetylcholinesterase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12641839, URL:http://europepmc.org/abstract/MED/12641839",CN(CCCCCCCCCCN(C)C(=O)Oc1cccc(c1)[N+](C)(C)C)C(=O)Oc2cccc(c2)[N+](C)(C)C,CHEMBL220,ACHE
1049,CHEMBL1641,Hydrocortisone Phosphoric Acid,Small molecule,1960.0,,,-cort-,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:0443-059748 PP. 421, URL:http://www.isbnsearch.org/isbn/0443059748",C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)COP(=O)(O)O)[C@@]4(C)C[C@H](O)[C@H]23,CHEMBL2034,NR3C1
1050,CHEMBL2028663,Dabrafenib,Small molecule,2013.0,L01XE23,L01XE23 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-rafenib,Serine/threonine-protein kinase B-raf inhibitor,,,CHEMBL5145,Serine/threonine-protein kinase B-raf,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=803beaaa-33f9-48cc-9a95-c2e887e095b4#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=803beaaa-33f9-48cc-9a95-c2e887e095b4#nlm34090-1",CC(C)(C)c1nc(c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(s1)c4ccnc(N)n4,CHEMBL5145,BRAF
1051,CHEMBL1201467,"Synthetic Conjugated Estrogens, B",Small molecule,2004.0,,,estr-,Estrogen receptor agonist,,,CHEMBL2093866,Estrogen receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=1cd07b54-f66f-4040-9058-462324267196#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1cd07b54-f66f-4040-9058-462324267196#nlm34090-1|Name:ISBN, SrcID:9780702034718 PP. 420, URL:http://www.isbnsearch.org/isbn/9780702034718",,,
1052,CHEMBL1457,Hydrocodone,Small molecule,1943.0,R05DA03,"R05DA03 [RESPIRATORY SYSTEM: COUGH AND COLD PREPARATIONS: COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS: Opium alkaloids and derivatives]",,Opioid receptors; mu/kappa/delta agonist,,,CHEMBL2095181,Opioid receptors; mu/kappa/delta,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=53ce65ab-f001-4521-862f-8ac25ec5bce1#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=53ce65ab-f001-4521-862f-8ac25ec5bce1#nlm34090-1|Name:FDA, SrcID:label/2015/202880Orig1s003lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202880Orig1s003lbl.pdf|Name:PubMed, SrcID:2849950, URL:http://europepmc.org/abstract/MED/2849950",COc1ccc2C[C@@H]3[C@@H]4CCC(=O)[C@@H]5Oc1c2[C@]45CCN3C,,
1053,CHEMBL1201752,Ixabepilone,Small molecule,2007.0,L01DC04,L01DC04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES: Other cytotoxic antibiotics],,Tubulin inhibitor,Stabilises microtubule assembly,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin paclitaxel binding site,Binds to beta tubulin,"Name:DailyMed, SrcID:setid=e7992f6b-279b-46a7-b9c3-fea4e17718dc#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e7992f6b-279b-46a7-b9c3-fea4e17718dc#nlm34090-1|Name:PubMed, SrcID:22113255, URL:http://europepmc.org/abstract/MED/22113255",C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)\C(=C\c3csc(C)n3)\C,CHEMBL2095182,TUBB8
1054,CHEMBL1201752,Ixabepilone,Small molecule,2007.0,L01DC04,L01DC04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES: Other cytotoxic antibiotics],,Tubulin inhibitor,Stabilises microtubule assembly,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin paclitaxel binding site,Binds to beta tubulin,"Name:DailyMed, SrcID:setid=e7992f6b-279b-46a7-b9c3-fea4e17718dc#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e7992f6b-279b-46a7-b9c3-fea4e17718dc#nlm34090-1|Name:PubMed, SrcID:22113255, URL:http://europepmc.org/abstract/MED/22113255",C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)\C(=C\c3csc(C)n3)\C,CHEMBL2095182,TUBA3C
1055,CHEMBL1201752,Ixabepilone,Small molecule,2007.0,L01DC04,L01DC04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES: Other cytotoxic antibiotics],,Tubulin inhibitor,Stabilises microtubule assembly,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin paclitaxel binding site,Binds to beta tubulin,"Name:DailyMed, SrcID:setid=e7992f6b-279b-46a7-b9c3-fea4e17718dc#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e7992f6b-279b-46a7-b9c3-fea4e17718dc#nlm34090-1|Name:PubMed, SrcID:22113255, URL:http://europepmc.org/abstract/MED/22113255",C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)\C(=C\c3csc(C)n3)\C,CHEMBL2095182,TUBA4A
1056,CHEMBL1201752,Ixabepilone,Small molecule,2007.0,L01DC04,L01DC04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES: Other cytotoxic antibiotics],,Tubulin inhibitor,Stabilises microtubule assembly,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin paclitaxel binding site,Binds to beta tubulin,"Name:DailyMed, SrcID:setid=e7992f6b-279b-46a7-b9c3-fea4e17718dc#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e7992f6b-279b-46a7-b9c3-fea4e17718dc#nlm34090-1|Name:PubMed, SrcID:22113255, URL:http://europepmc.org/abstract/MED/22113255",C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)\C(=C\c3csc(C)n3)\C,CHEMBL2095182,TUBA3E
1057,CHEMBL1201752,Ixabepilone,Small molecule,2007.0,L01DC04,L01DC04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES: Other cytotoxic antibiotics],,Tubulin inhibitor,Stabilises microtubule assembly,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin paclitaxel binding site,Binds to beta tubulin,"Name:DailyMed, SrcID:setid=e7992f6b-279b-46a7-b9c3-fea4e17718dc#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e7992f6b-279b-46a7-b9c3-fea4e17718dc#nlm34090-1|Name:PubMed, SrcID:22113255, URL:http://europepmc.org/abstract/MED/22113255",C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)\C(=C\c3csc(C)n3)\C,CHEMBL2095182,TUBB6
1058,CHEMBL1201752,Ixabepilone,Small molecule,2007.0,L01DC04,L01DC04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES: Other cytotoxic antibiotics],,Tubulin inhibitor,Stabilises microtubule assembly,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin paclitaxel binding site,Binds to beta tubulin,"Name:DailyMed, SrcID:setid=e7992f6b-279b-46a7-b9c3-fea4e17718dc#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e7992f6b-279b-46a7-b9c3-fea4e17718dc#nlm34090-1|Name:PubMed, SrcID:22113255, URL:http://europepmc.org/abstract/MED/22113255",C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)\C(=C\c3csc(C)n3)\C,CHEMBL2095182,TUBB2B
1059,CHEMBL1201752,Ixabepilone,Small molecule,2007.0,L01DC04,L01DC04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES: Other cytotoxic antibiotics],,Tubulin inhibitor,Stabilises microtubule assembly,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin paclitaxel binding site,Binds to beta tubulin,"Name:DailyMed, SrcID:setid=e7992f6b-279b-46a7-b9c3-fea4e17718dc#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e7992f6b-279b-46a7-b9c3-fea4e17718dc#nlm34090-1|Name:PubMed, SrcID:22113255, URL:http://europepmc.org/abstract/MED/22113255",C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)\C(=C\c3csc(C)n3)\C,CHEMBL2095182,TUBA3D
1060,CHEMBL434,Isoproterenol,Small molecule,1956.0,C01CA02; R03AB02; R03CB51; R03CB01,"C01CA02 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES: Adrenergic and dopaminergic agents]; R03AB02 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS, INHALANTS: Non-selective beta-adrenoreceptor agonists]; R03CB51 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS FOR SYSTEMIC USE: Non-selective beta-adrenoreceptor agonists]; R03CB01 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS FOR SYSTEMIC USE: Non-selective beta-adrenoreceptor agonists]",,Adrenergic receptor beta agonist,,,CHEMBL2094118,Adrenergic receptor beta,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=c4288d64-4f76-44f8-d097-4bd3955f5676#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4288d64-4f76-44f8-d097-4bd3955f5676#nlm34090-1|Name:FDA, SrcID:label/2013/010515s031lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/010515s031lbl.pdf",CC(C)NCC(O)c1ccc(O)c(O)c1,,
1061,CHEMBL134,Clonidine,Small molecule,1974.0,S01EA04; C02AC01; N02CX02,"S01EA04 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Sympathomimetics in glaucoma therapy 1)]; C02AC01 [CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ANTIADRENERGIC AGENTS, CENTRALLY ACTING: Imidazoline receptor agonists]; N02CX02 [NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Other antimigraine preparations]",,Adrenergic receptor alpha-2 agonist,,,CHEMBL2095158,Adrenergic receptor alpha-2,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=f6798f73-b5a6-434b-a627-aa102b123dd5#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f6798f73-b5a6-434b-a627-aa102b123dd5#nlm34090-1|Name:Wikipedia, SrcID:Clonidine#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Clonidine#Mechanism_of_action",Clc1cccc(Cl)c1NC2=NCCN2,,
1062,CHEMBL2103758,Pramlintide,Protein,2005.0,A10BX05,"A10BX05 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Other blood glucose lowering drugs, excl. insulins]",-tide,Amylin receptor AMY3; CALCR/RAMP3 agonist,"Is amylin analogue, calcitonin receptor is binding site",,CHEMBL2111190,Amylin receptor AMY3; CALCR/RAMP3,AGONIST,Homo sapiens,PROTEIN COMPLEX,Calcitonin receptor,Calcitonin receptor is binding site,"Name:DailyMed, SrcID:setid=d2262f20-bedb-43d9-b274-6ce275b0a69e, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d2262f20-bedb-43d9-b274-6ce275b0a69e|Name:IUPHAR, SrcID:687, URL:http://www.iuphar-db.org/DATABASE/LigandDisplayForward?tab=biology&ligandId=687",CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc3c[nH]cn3)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]5CSSC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N5)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N6CCC[C@H]6C(=O)N7CCC[C@H]7C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc8ccc(O)cc8)C(=O)N,,
1063,CHEMBL477772,Pazopanib,Small molecule,2009.0,L01XE11,L01XE11 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-anib,Vascular endothelial growth factor receptor inhibitor,,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14",CN(c1ccc2c(C)n(C)nc2c1)c3ccnc(Nc4ccc(C)c(c4)S(=O)(=O)N)n3,,
1064,CHEMBL457547,Micafungin,Small molecule,2005.0,J02AX05,J02AX05 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: Other antimycotics for systemic use],-fungin,"1,3-beta-glucan synthase inhibitor",,,CHEMBL2364673,"1,3-beta-glucan synthase",INHIBITOR,Candida,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2013/021506s014lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021506s014lbl.pdf",CCCCCOc1ccc(cc1)c2onc(c2)c3ccc(cc3)C(=O)N[C@H]4C[C@@H](O)[C@@H](O)NC(=O)[C@@H]5[C@@H](O)[C@@H](C)CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@@H](O)CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)[C@H](O)[C@@H](O)c7ccc(O)c(OS(=O)(=O)O)c7)[C@H](O)CC(=O)N,,
1065,CHEMBL833,Ticlopidine,Small molecule,1991.0,B01AC05,B01AC05 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Platelet aggregation inhibitors excl. heparin],,Purinergic receptor P2Y12 antagonist,,,CHEMBL2001,Purinergic receptor P2Y12,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15816504, URL:http://europepmc.org/abstract/MED/15816504|Name:PubMed, SrcID:15955565, URL:http://europepmc.org/abstract/MED/15955565|Name:PubMed, SrcID:11454254, URL:http://europepmc.org/abstract/MED/11454254",Clc1ccccc1CN2CCc3sccc3C2,CHEMBL2001,P2RY12
1066,CHEMBL449,Butabarbital,Small molecule,1939.0,,,-barb-,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:PubMed, SrcID:10209232, URL:http://europepmc.org/abstract/MED/10209232|Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CCC(C)C1(CC)C(=O)NC(=O)NC1=O,CHEMBL2093872,GABRG3
1067,CHEMBL449,Butabarbital,Small molecule,1939.0,,,-barb-,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:PubMed, SrcID:10209232, URL:http://europepmc.org/abstract/MED/10209232|Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CCC(C)C1(CC)C(=O)NC(=O)NC1=O,CHEMBL2093872,GABRP
1068,CHEMBL449,Butabarbital,Small molecule,1939.0,,,-barb-,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:PubMed, SrcID:10209232, URL:http://europepmc.org/abstract/MED/10209232|Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CCC(C)C1(CC)C(=O)NC(=O)NC1=O,CHEMBL2093872,GABRE
1069,CHEMBL449,Butabarbital,Small molecule,1939.0,,,-barb-,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:PubMed, SrcID:10209232, URL:http://europepmc.org/abstract/MED/10209232|Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CCC(C)C1(CC)C(=O)NC(=O)NC1=O,CHEMBL2093872,GABRG1
1070,CHEMBL372795,Streptomycin,Small molecule,1946.0,A07AA04; A07AA54; J01GA01,"A07AA04 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFECTIVES: Antibiotics]; A07AA54 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFECTIVES: Antibiotics]; J01GA01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: AMINOGLYCOSIDE ANTIBACTERIALS: Streptomycins]",-mycin,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,16S ribosomal RNA,16s RRNA,"Name:FDA, SrcID:label/2012/064210s009lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/064210s009lbl.pdf|Name:PubMed, SrcID:17967466, URL:http://europepmc.org/abstract/MED/17967466",CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](N=C(N)N)[C@@H](O)[C@@H]3N=C(N)N)O[C@@H](C)[C@]2(O)C=O,,
1071,CHEMBL1201670,Sargramostim,Protein,1991.0,L03AA09,L03AA09 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSTIMULANTS: IMMUNOSTIMULANTS: Colony stimulating factors],-stim,Granulocyte-macrophage colony-stimulating factor receptor agonist,,,CHEMBL2364169,Granulocyte-macrophage colony-stimulating factor receptor,AGONIST,Homo sapiens,PROTEIN COMPLEX,GMCSF receptor alpha subunit,Alpha subunit is binding site,"Name:PubMed, SrcID:18692472, URL:http://europepmc.org/abstract/MED/18692472|Name:DailyMed, SrcID:setid=04765fbf-f005-43aa-a628-5cc3d80f91e7, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=04765fbf-f005-43aa-a628-5cc3d80f91e7",,CHEMBL2364169,CSF2RA
1072,CHEMBL1201670,Sargramostim,Protein,1991.0,L03AA09,L03AA09 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSTIMULANTS: IMMUNOSTIMULANTS: Colony stimulating factors],-stim,Granulocyte-macrophage colony-stimulating factor receptor agonist,,,CHEMBL2364169,Granulocyte-macrophage colony-stimulating factor receptor,AGONIST,Homo sapiens,PROTEIN COMPLEX,GMCSF receptor alpha subunit,Alpha subunit is binding site,"Name:PubMed, SrcID:18692472, URL:http://europepmc.org/abstract/MED/18692472|Name:DailyMed, SrcID:setid=04765fbf-f005-43aa-a628-5cc3d80f91e7, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=04765fbf-f005-43aa-a628-5cc3d80f91e7",,CHEMBL2364169,CSF2RB
1073,CHEMBL417,Epirubicin,Small molecule,1999.0,L01DB03,L01DB03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES: Anthracyclines and related substances],-rubicin,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=0a03c798-a652-4895-b29c-3b521a89ba42#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0a03c798-a652-4895-b29c-3b521a89ba42#section-14",COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO,,
1074,CHEMBL414804,Oxaliplatin,Small molecule,2002.0,L01XA03,L01XA03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Platinum compounds],-platin,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=3c740b43-f396-4998-bc66-6964a21f7161#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3c740b43-f396-4998-bc66-6964a21f7161#section-14",,,
1075,CHEMBL826,Enoxacin,Small molecule,1991.0,J01MA04,J01MA04 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolones],-oxacin,DNA gyrase inhibitor,,,CHEMBL2311244,DNA gyrase,INHIBITOR,Neisseria gonorrhoeae,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:3282749, URL:http://europepmc.org/abstract/MED/3282749|Name:PubMed, SrcID:3542924, URL:http://europepmc.org/abstract/MED/3542924|Name:PubMed, SrcID:18471102, URL:http://europepmc.org/abstract/MED/18471102|Name:PubMed, SrcID:8388200, URL:http://europepmc.org/abstract/MED/8388200",CCN1C=C(C(=O)O)C(=O)c2cc(F)c(nc12)N3CCNCC3,,
1076,CHEMBL55,Pentamidine,Small molecule,1984.0,,,-amidine,DNA inhibitor,,,CHEMBL2366046,DNA,INHIBITOR,Pneumocystis jirovecii,NUCLEIC-ACID,,Binds minor groove of DNA,"Name:DailyMed, SrcID:setid=e2ad9d3c-b6c3-4f70-87e0-722a8ff94ccb#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e2ad9d3c-b6c3-4f70-87e0-722a8ff94ccb#nlm34090-1|Name:PubMed, SrcID:23375541, URL:http://europepmc.org/abstract/MED/23375541",NC(=N)c1ccc(OCCCCCOc2ccc(cc2)C(=N)N)cc1,,
1077,CHEMBL1200711,Omega-3-Acid Ethyl Esters,Small molecule,2004.0,C10AX06,"C10AX06 [CARDIOVASCULAR SYSTEM: LIPID MODIFYING AGENTS: LIPID MODIFYING AGENTS, PLAIN: Other lipid modifying agents]",,Unknown,"Mode of action not fully understood; it seems to increase beta-oxidation, inhibit acyl-CoA:1,2-diacylglycerol acyltransferase (EC 2.3.1.20), decreas lipogenesis in the liver, and increase plasma lipoprotein lipase activity",,,,,,,,,"Name:DailyMed, SrcID:setid=5ada82f0-a5fd-46c9-aecc-f106f614c9f0, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ada82f0-a5fd-46c9-aecc-f106f614c9f0",CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC.CCOC(=O)CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,,
1078,CHEMBL471737,Ivabradine,Small molecule,2015.0,C01EB17,C01EB17 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: OTHER CARDIAC PREPARATIONS: Other cardiac preparations],,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 blocker,,,CHEMBL1250417,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=92018a65-38f6-45f7-91d4-a34921b81d0d, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=92018a65-38f6-45f7-91d4-a34921b81d0d|Name:PubMed, SrcID:20713549, URL:http://europepmc.org/abstract/MED/20713549",COc1cc2CCN(CCCN(C)C[C@H]3Cc4cc(OC)c(OC)cc34)C(=O)Cc2cc1OC,CHEMBL1250417,HCN4
1079,CHEMBL2159122,Eluxadoline,Small molecule,2015.0,A07DA06,"A07DA06 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: ANTIPROPULSIVES: Antipropulsives]",-adol-,Mu opioid receptor agonist,,,CHEMBL233,Mu opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/206940s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206940s000lbl.pdf",COc1ccc(CN([C@@H](C)c2nc(c[nH]2)c3ccccc3)C(=O)[C@@H](N)Cc4c(C)cc(cc4C)C(=O)N)cc1C(=O)O,CHEMBL233,OPRM1
1080,CHEMBL1743010,Elotuzumab,Antibody,2015.0,L01XC23,L01XC23 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,SLAM family member 7 inhibitor,,,CHEMBL3559386,SLAM family member 7,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=80686b7e-f6f4-4154-b5c0-c846425e2d91, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=80686b7e-f6f4-4154-b5c0-c846425e2d91",,CHEMBL3559386,SLAMF7
1081,CHEMBL2165191,Azd-6482,Small molecule,,,,,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:22906130, URL:http://europepmc.org/abstract/MED/22906130",C[C@@H](Nc1ccccc1C(=O)O)C2=CC(=CN3C(=O)C=C(N=C23)N4CCOCC4)C,CHEMBL3559703,PIK3R2
1082,CHEMBL2165191,Azd-6482,Small molecule,,,,,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:22906130, URL:http://europepmc.org/abstract/MED/22906130",C[C@@H](Nc1ccccc1C(=O)O)C2=CC(=CN3C(=O)C=C(N=C23)N4CCOCC4)C,CHEMBL3559703,PIK3R3
1083,CHEMBL2165191,Azd-6482,Small molecule,,,,,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:22906130, URL:http://europepmc.org/abstract/MED/22906130",C[C@@H](Nc1ccccc1C(=O)O)C2=CC(=CN3C(=O)C=C(N=C23)N4CCOCC4)C,CHEMBL3559703,PIK3R5
1084,CHEMBL3545246,Bgb-283,Small molecule,,,,,Serine/threonine-protein kinase B-raf inhibitor,,,CHEMBL5145,Serine/threonine-protein kinase B-raf,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26208524, URL:http://europepmc.org/abstract/MED/26208524",,CHEMBL5145,BRAF
1085,CHEMBL598797,Cudc-101,Small molecule,,,,,Histone deacetylase inhibitor,Inhibits class I (HDAC1 HDAC2 HDAC3 HDAC8) and II (HDAC4 HDAC5 HDAC6 HDAC7 HDAC9 HDAC10) HDACs,,CHEMBL2093865,Histone deacetylase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:20143778, URL:http://europepmc.org/abstract/MED/20143778",COc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCCCCCC(=O)NO,,
1086,CHEMBL3545133,Jnj-26483327,Small molecule,,,,,Tyrosine-protein kinase SRC inhibitor,Multi-targeted tyrosine kinase inhibitor,,CHEMBL267,Tyrosine-protein kinase SRC,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1016/S1359-6349(10)71870-X, URL:http://www.sciencedirect.com/science/article/pii/S135963491071870X|Name:PubMed, SrcID:20823884, URL:http://europepmc.org/abstract/MED/20823884",,CHEMBL267,SRC
1087,CHEMBL3545382,R-348,Small molecule,,,,,Tyrosine-protein kinase JAK3 inhibitor,Prodrug of R333,,CHEMBL2148,Tyrosine-protein kinase JAK3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18360272, URL:http://europepmc.org/abstract/MED/18360272|Name:PubMed, SrcID:19596999, URL:http://europepmc.org/abstract/MED/19596999",,CHEMBL2148,JAK3
1088,CHEMBL3545325,Sar-125844,Small molecule,,,,,Hepatocyte growth factor receptor inhibitor,,,CHEMBL3717,Hepatocyte growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25504634, URL:http://europepmc.org/abstract/MED/25504634",,CHEMBL3717,MET
1089,CHEMBL3545201,Ta-5493,Small molecule,,,,,MAP kinase p38 alpha inhibitor,,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.mt-pharma.co.jp/e/develop/pipeline/e_pipeline1003.pdf, URL:http://www.mt-pharma.co.jp/e/develop/pipeline/e_pipeline1003.pdf",,CHEMBL260,MAPK14
1090,CHEMBL1079593,Vs-5584,Small molecule,,,,,Serine/threonine-protein kinase mTOR inhibitor,"Inhibitor of class I phosphoinositide 3-kinase (PI3K) isoforms, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL2842,Serine/threonine-protein kinase mTOR,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23270925, URL:http://europepmc.org/abstract/MED/23270925",Fc1ccc2ncn(c3ncc4NC(=O)N([C@@H]5CCOc6c(F)cccc56)c4n3)c2c1,CHEMBL2842,MTOR
1091,CHEMBL2364652,Vantictumab,Antibody,,,,-mab,Frizzled-8 antagonist,mAB,,CHEMBL3559689,Frizzled-8,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22753465, URL:http://europepmc.org/abstract/MED/22753465",,CHEMBL3559689,FZD8
1092,CHEMBL3545091,Xen403,Small molecule,,,,,Sodium channel protein type IX alpha subunit blocker,Backup to XEN402.,,CHEMBL4296,Sodium channel protein type IX alpha subunit,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25060923, URL:http://europepmc.org/abstract/MED/25060923",,CHEMBL4296,SCN9A
1093,CHEMBL3545021,Anlotinib,Small molecule,,,,-tinib,Vascular endothelial growth factor receptor 3 inhibitor,Multi-targeted receptor tyrosine kinase inhibitor,,CHEMBL1955,Vascular endothelial growth factor receptor 3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:ClinicalTrials, SrcID:NCT01924195, URL:https://www.clinicaltrials.gov/ct2/show/NCT01924195|Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=749736, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=749736",,CHEMBL1955,FLT4
1094,CHEMBL495727,At-9283,Small molecule,,,,,Tyrosine-protein kinase receptor FLT3 inhibitor,,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19143567, URL:http://europepmc.org/abstract/MED/19143567",O=C(NC1CC1)Nc2c[nH]nc2c3nc4cc(CN5CCOCC5)ccc4[nH]3,CHEMBL1974,FLT3
1095,CHEMBL1231124,Azd-1480,Small molecule,,,,,Tyrosine-protein kinase JAK2 inhibitor,Also potent inhibitor of JAK1,,CHEMBL2971,Tyrosine-protein kinase JAK2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21138246, URL:http://europepmc.org/abstract/MED/21138246|Name:PubMed, SrcID:19962667, URL:http://europepmc.org/abstract/MED/19962667",C[C@H](Nc1ncc(Cl)c(Nc2cc(C)n[nH]2)n1)c3ncc(F)cn3,CHEMBL2971,JAK2
1096,CHEMBL338604,C-1311,Small molecule,,,,,DNA topoisomerase II inhibitor,"Intercalates to DNA and following metabolic activation, covalently crosslinks DNA strands (PMID: 12007568, PMID:25896848)",,CHEMBL2094255,DNA topoisomerase II,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:8622625, URL:http://europepmc.org/abstract/MED/8622625|Name:PubMed, SrcID:25896848, URL:http://europepmc.org/abstract/MED/25896848|Name:PubMed, SrcID:23823138, URL:http://europepmc.org/abstract/MED/23823138",CCN(CC)CCNc1ccc2ncn3c4ccc(O)cc4C(=O)c1c23,,
1097,CHEMBL14762,Seliciclib,Small molecule,,,,-ciclib,Cyclin-dependent kinase 9 inhibitor,,,CHEMBL3116,Cyclin-dependent kinase 9,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26207228, URL:http://europepmc.org/abstract/MED/26207228|Name:PubMed, SrcID:25747275, URL:http://europepmc.org/abstract/MED/25747275|Name:PubMed, SrcID:9030781, URL:http://europepmc.org/abstract/MED/9030781",CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1,CHEMBL3116,CDK9
1098,CHEMBL3545338,Glpg-0259,Small molecule,,,,,MAP kinase-activated protein kinase 5 inhibitor,,,CHEMBL3094,MAP kinase-activated protein kinase 5,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22950522, URL:http://europepmc.org/abstract/MED/22950522|Name:Other, SrcID:http://www.rsc.org/images/MartinAndrews_tcm18-195242.pdf, URL:http://www.rsc.org/images/MartinAndrews_tcm18-195242.pdf",,CHEMBL3094,MAPKAPK5
1099,CHEMBL362558,Ly-2090314,Small molecule,,,,,Glycogen synthase kinase-3 alpha inhibitor,,,CHEMBL2850,Glycogen synthase kinase-3 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23305709, URL:http://europepmc.org/abstract/MED/23305709|Name:PubMed, SrcID:25915038, URL:http://europepmc.org/abstract/MED/25915038",Fc1cc2CN(CCn3cc(C4=C(C(=O)NC4=O)c5cnc6ccccn56)c(c1)c23)C(=O)N7CCCCC7,CHEMBL2850,GSK3A
1100,CHEMBL402548,Danusertib,Small molecule,,,,-sertib,Serine/threonine-protein kinase Aurora inhibitor,Pan-Aurora kinase inhibitor,,CHEMBL3430911,Serine/threonine-protein kinase Aurora,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:26345296, URL:http://europepmc.org/abstract/MED/26345296|Name:PubMed, SrcID:18089710, URL:http://europepmc.org/abstract/MED/18089710",CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(cc3)N4CCN(C)CC4)c2C1)c5ccccc5,,
1101,CHEMBL521851,Pictilisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:18754654, URL:http://europepmc.org/abstract/MED/18754654|Name:PubMed, SrcID:25370471, URL:http://europepmc.org/abstract/MED/25370471",CS(=O)(=O)N1CCN(Cc2cc3nc(nc(N4CCOCC4)c3s2)c5cccc6[nH]ncc56)CC1,CHEMBL3559703,PIK3R2
1102,CHEMBL521851,Pictilisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:18754654, URL:http://europepmc.org/abstract/MED/18754654|Name:PubMed, SrcID:25370471, URL:http://europepmc.org/abstract/MED/25370471",CS(=O)(=O)N1CCN(Cc2cc3nc(nc(N4CCOCC4)c3s2)c5cccc6[nH]ncc56)CC1,CHEMBL3559703,PIK3R3
1103,CHEMBL521851,Pictilisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:18754654, URL:http://europepmc.org/abstract/MED/18754654|Name:PubMed, SrcID:25370471, URL:http://europepmc.org/abstract/MED/25370471",CS(=O)(=O)N1CCN(Cc2cc3nc(nc(N4CCOCC4)c3s2)c5cccc6[nH]ncc56)CC1,CHEMBL3559703,PIK3R5
1104,CHEMBL1950651,Evodenoson,Small molecule,,,,-denoson,Adenosine A2a receptor agonist,,,CHEMBL251,Adenosine A2a receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20111666, URL:http://europepmc.org/abstract/MED/20111666",COC(=O)N1CCC(CC#Cc2nc(N)c3ncn([C@@H]4O[C@@H]([C@@H](O)[C@H]4O)C(=O)NC5CC5)c3n2)CC1,CHEMBL251,ADORA2A
1105,CHEMBL2012520,Ly377604,Small molecule,,,,,Beta-1 adrenergic receptor antagonist,Phase 2 study in 2011 terminated.,,CHEMBL213,Beta-1 adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24900353, URL:http://europepmc.org/abstract/MED/24900353",CC(C)(Cc1ccc(Oc2ccc(cn2)C(=O)N)cc1)NC[C@H](O)COc3cccc4[nH]c5ccccc5c34,,
1106,CHEMBL2087337,Velusetrag,Small molecule,,,,-setrag,Serotonin 4 (5-HT4) receptor agonist,,,CHEMBL1875,Serotonin 4 (5-HT4) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18415081, URL:http://europepmc.org/abstract/MED/18415081",CC(C)N1C(=O)C(=Cc2ccccc12)C(=O)N[C@H]3C[C@H]4CC[C@@H](C3)N4C[C@@H](O)CN(C)S(=O)(=O)C,CHEMBL1875,HTR4
1107,CHEMBL447955,Serlopitant,Small molecule,,,,-tant,Neurokinin 1 receptor antagonist,,,CHEMBL249,Neurokinin 1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.vpd.net/PFC/Tigercat_VPD-737_chronicpruritus.html, URL:http://www.vpd.net/PFC/Tigercat_VPD-737_chronicpruritus.html|Name:PubMed, SrcID:20639026, URL:http://europepmc.org/abstract/MED/20639026",C[C@@H](O[C@H]1CC[C@@H]2CN(C[C@H]2[C@@H]1c3ccc(F)cc3)C4=CC(=O)CC4)c5cc(cc(c5)C(F)(F)F)C(F)(F)F,CHEMBL249,TACR1
1108,CHEMBL3545099,Ccx168,Small molecule,,,,,C5a anaphylatoxin chemotactic receptor antagonist,,,CHEMBL2373,C5a anaphylatoxin chemotactic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24179165, URL:http://europepmc.org/abstract/MED/24179165",,CHEMBL2373,C5AR1
1109,CHEMBL3545042,Selurampanel,Small molecule,,,,-ampa,Glutamate receptor ionotropic AMPA antagonist,Competitive antagonist of the AMPA receptor.,,CHEMBL2096670,Glutamate receptor ionotropic AMPA,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:23963355, URL:http://europepmc.org/abstract/MED/23963355|Name:Wikipedia, SrcID:Selurampanel, URL:https://en.wikipedia.org/wiki/Selurampanel",CC(C)c1cc2NC(=O)N(NS(=O)(=O)C)C(=O)c2cc1c3ccnn3C,,
1110,CHEMBL3545293,Fgf401,Small molecule,,,,,Fibroblast growth factor receptor 4 inhibitor,,,CHEMBL3973,Fibroblast growth factor receptor 4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:ClinicalTrials, SrcID:NCT02325739, URL:https://www.clinicaltrials.gov/ct2/show/NCT02325739|Name:Other, SrcID:http://www.novartisoncology.com/ct/pipelineDetails?compound=FGF401&diseaseAcr=EST, URL:http://www.novartisoncology.com/ct/pipelineDetails?compound=FGF401&diseaseAcr=EST",,CHEMBL3973,FGFR4
1111,CHEMBL2107801,Resequinil,Small molecule,,,,-quinil,GABA-A receptor; benzodiazepine site inverse agonist,Partial inverese agonist.,,CHEMBL2109243,GABA-A receptor; benzodiazepine site,INVERSE AGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,Binds to benzodiazepine site.,"Name:PubMed, SrcID:24513525, URL:http://europepmc.org/abstract/MED/24513525|Name:Wikipedia, SrcID:Radequinil, URL:https://en.wikipedia.org/wiki/Radequinil",COc1cccc(c1)c2nccc3NC(=O)C(=Cc23)c4noc(C)n4,,
1112,CHEMBL290352,Cep-1347,Small molecule,,,,,Mitogen-activated protein kinase kinase kinase 11 inhibitor,"CEP-1347 inhibits c-Jun N-terminal kinase signaling pathway by inhibition of mixed lineage kinases (MLKs), upstreams and known activators of JNK signaling.",,CHEMBL2708,Mitogen-activated protein kinase kinase kinase 11,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15023353, URL:http://europepmc.org/abstract/MED/15023353|Name:PubMed, SrcID:11325962, URL:http://europepmc.org/abstract/MED/11325962|Name:PubMed, SrcID:18714982, URL:http://europepmc.org/abstract/MED/18714982",CCSCc1ccc2c(c1)c3c4CNC(=O)c4c5c6cc(CSCC)ccc6n7[C@H]8C[C@](O)(C(=O)OC)[C@](C)(O8)n2c3c57,CHEMBL2708,MAP3K11
1113,CHEMBL290352,Cep-1347,Small molecule,,,,,Mitogen-activated protein kinase kinase kinase 13 inhibitor,"CEP-1347 inhibits c-Jun N-terminal kinase signaling pathway by inhibition of mixed lineage kinases (MLKs), upstreams and known activators of JNK signaling.",,CHEMBL1163124,Mitogen-activated protein kinase kinase kinase 13,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11325962, URL:http://europepmc.org/abstract/MED/11325962",CCSCc1ccc2c(c1)c3c4CNC(=O)c4c5c6cc(CSCC)ccc6n7[C@H]8C[C@](O)(C(=O)OC)[C@](C)(O8)n2c3c57,CHEMBL1163124,MAP3K13
1114,CHEMBL290352,Cep-1347,Small molecule,,,,,Mitogen-activated protein kinase kinase kinase 12 inhibitor,"CEP-1347 inhibits c-Jun N-terminal kinase signaling pathway by inhibition of mixed lineage kinases (MLKs), upstreams and known activators of JNK signaling.",,CHEMBL1908389,Mitogen-activated protein kinase kinase kinase 12,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11325962, URL:http://europepmc.org/abstract/MED/11325962|Name:PubMed, SrcID:18714982, URL:http://europepmc.org/abstract/MED/18714982",CCSCc1ccc2c(c1)c3c4CNC(=O)c4c5c6cc(CSCC)ccc6n7[C@H]8C[C@](O)(C(=O)OC)[C@](C)(O8)n2c3c57,CHEMBL1908389,MAP3K12
1115,CHEMBL266510,Flindokalner,Small molecule,,,,-kalner,"Voltage-gated potassium channel, KQT; KCNQ2(Kv7.2)/KCNQ3(Kv7.3) activator",Indication: Stroke,,CHEMBL2221348,"Voltage-gated potassium channel, KQT; KCNQ2(Kv7.2)/KCNQ3(Kv7.3)",ACTIVATOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:11378159, URL:http://europepmc.org/abstract/MED/11378159",COc1ccc(Cl)cc1[C@]2(F)C(=O)Nc3cc(ccc23)C(F)(F)F,,
1116,CHEMBL266510,Flindokalner,Small molecule,,,,-kalner,Voltage-gated potassium channel KCNQ3/KCNQ4 activator,Indication: Stroke,,CHEMBL3707192,Voltage-gated potassium channel KCNQ3/KCNQ4,ACTIVATOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:11378159, URL:http://europepmc.org/abstract/MED/11378159",COc1ccc(Cl)cc1[C@]2(F)C(=O)Nc3cc(ccc23)C(F)(F)F,,
1117,CHEMBL206468,Afegostat,Small molecule,,,,-stat,Beta-glucocerebrosidase stabiliser,Specifically and reversibly binds GBA (GCase) in the ER with high affinity; this stabilizes the active form of the enzyme in the ER and increases trafficking of GBA to lysosomes,,CHEMBL2179,Beta-glucocerebrosidase,STABILISER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25037721, URL:http://europepmc.org/abstract/MED/25037721|Name:PubMed, SrcID:20148966, URL:http://europepmc.org/abstract/MED/20148966",OC[C@H]1CNC[C@@H](O)[C@@H]1O,CHEMBL2179,GBA
1118,CHEMBL2108018,Adecatumumab,Antibody,,,,-mab,Epithelial cell adhesion molecule inhibitor,Moderate affinity for EpCAM.,,CHEMBL3580493,Epithelial cell adhesion molecule,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12115595, URL:http://europepmc.org/abstract/MED/12115595",,CHEMBL3580493,EPCAM
1119,CHEMBL3833346,Biib067,Oligonucleotide,,,,,SOD1 mRNA inhibitor,Thought to reduce the production of SOD1 protein,,CHEMBL3833461,SOD1 mRNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:Other, SrcID:http://www.ionispharma.com/pipeline/, URL:http://www.ionispharma.com/pipeline/",,,
1120,CHEMBL1734,Solifenacin,Small molecule,2004.0,G04BD08,G04BD08 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Drugs for urinary frequency and incontinence],-fenacin,Muscarinic acetylcholine receptor M3 antagonist,"Indicated for overactive bladder, M3 likely responsible",,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 160, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:19446545, URL:http://europepmc.org/abstract/MED/19446545|Name:Wikipedia, SrcID:Solifenacin#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Solifenacin#Mechanism_of_action|Name:PubMed, SrcID:16465186, URL:http://europepmc.org/abstract/MED/16465186",O=C(O[C@H]1CN2CCC1CC2)N3CCc4ccccc4[C@@H]3c5ccccc5,CHEMBL245,CHRM3
1121,CHEMBL578,Enalapril,Small molecule,1985.0,C09AA02,"C09AA02 [CARDIOVASCULAR SYSTEM: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM: ACE INHIBITORS, PLAIN: ACE inhibitors, plain]",,Angiotensin-converting enzyme inhibitor,,,CHEMBL1808,Angiotensin-converting enzyme,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=2b9b72f5-ef3d-8401-bb91-9b75f80a1809, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2b9b72f5-ef3d-8401-bb91-9b75f80a1809|Name:FDA, SrcID:label/2015/018998s080lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018998s080lbl.pdf",CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O,CHEMBL1808,ACE
1122,CHEMBL900,Orphenadrine,Small molecule,1957.0,M03BC51,"M03BC51 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS: Ethers, chemically close to antihistamines]",-drine,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19217209, URL:http://europepmc.org/abstract/MED/19217209",CN(C)CCOC(c1ccccc1)c2ccccc2C,CHEMBL231,HRH1
1123,CHEMBL644,Trimipramine,Small molecule,1979.0,N06AA06,N06AA06 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Non-selective monoamine reuptake inhibitors],-pramine,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:0443-059748 PP. 555, URL:http://www.isbnsearch.org/isbn/0443059748|Name:Wikipedia, SrcID:Trimipramine, URL:http://en.wikipedia.org/wiki/Trimipramine",CC(CN(C)C)CN1c2ccccc2CCc3ccccc13,CHEMBL231,HRH1
1124,CHEMBL726,Fluphenazine,Small molecule,1959.0,N05AB02,N05AB02 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Phenothiazines with piperazine structure],,Dopamine D2 receptor antagonist,,,CHEMBL217,Dopamine D2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11873706, URL:http://europepmc.org/abstract/MED/11873706|Name:PubMed, SrcID:7508675, URL:http://europepmc.org/abstract/MED/7508675|Name:Wikipedia, SrcID:Antipsychotic#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Antipsychotic#Mechanism_of_action|Name:PubMed, SrcID:7828655, URL:http://europepmc.org/abstract/MED/7828655",OCCN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1,CHEMBL217,DRD2
1125,CHEMBL1201087,Cabergoline,Small molecule,1996.0,N04BC06; G02CB03,N04BC06 [NERVOUS SYSTEM: ANTI-PARKINSON DRUGS: DOPAMINERGIC AGENTS: Dopamine agonists]; G02CB03 [GENITO URINARY SYSTEM AND SEX HORMONES: OTHER GYNECOLOGICALS: OTHER GYNECOLOGICALS: Prolactine inhibitors],-erg-,Dopamine D2 receptor agonist,Long acting,,CHEMBL217,Dopamine D2 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=ef345c23-20a8-40d4-bf3c-5650ed81e2f1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ef345c23-20a8-40d4-bf3c-5650ed81e2f1|Name:Wikipedia, SrcID:Cabergoline, URL:http://en.wikipedia.org/wiki/Cabergoline|Name:FDA, SrcID:label/2014/020664s013lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020664s013lbl.pdf",CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(CC=C)C1,CHEMBL217,DRD2
1126,CHEMBL908,Chlorprothixene,Small molecule,1967.0,N05AF03,N05AF03 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Thioxanthene derivatives],,Dopamine D2 receptor antagonist,,,CHEMBL217,Dopamine D2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:8101879, URL:http://europepmc.org/abstract/MED/8101879|Name:Wikipedia, SrcID:Antipsychotic#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Antipsychotic#Mechanism_of_action|Name:Wikipedia, SrcID:Chlorprothixene#Pharmacology, URL:http://en.wikipedia.org/wiki/Chlorprothixene#Pharmacology|Name:PubMed, SrcID:1830565, URL:http://europepmc.org/abstract/MED/1830565",CN(C)CC\C=C/1\c2ccccc2Sc3ccc(Cl)cc13,CHEMBL217,DRD2
1127,CHEMBL1201614,Calcitonin Human,Protein,1986.0,H05BA03,"H05BA03 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CALCIUM HOMEOSTASIS: ANTI-PARATHYROID AGENTS: Calcitonin preparations]",calci-,Calcitonin receptor agonist,,,CHEMBL1832,Calcitonin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/017808s036lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/017808s036lbl.pdf|Name:IUPHAR, SrcID:685, URL:http://www.iuphar-db.org/DATABASE/LigandDisplayForward?tab=biology&ligandId=685|Name:DailyMed, SrcID:setid=f9d5a587-e2bc-4001-987d-9b04731303cb, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f9d5a587-e2bc-4001-987d-9b04731303cb",,,
1128,CHEMBL1065,Methysergide,Small molecule,1962.0,N02CA04,N02CA04 [NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Ergot alkaloids],-erg-,Serotonin 2b (5-HT2b) receptor antagonist,,,CHEMBL1833,Serotonin 2b (5-HT2b) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 199, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:8743744, URL:http://europepmc.org/abstract/MED/8743744",CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2Cc3cn(C)c4cccc(C2=C1)c34,CHEMBL1833,HTR2B
1129,CHEMBL1201697,Human Lh,Protein,1975.0,,,,Luteinizing hormone/Choriogonadotropin receptor agonist,,,CHEMBL1854,Luteinizing hormone/Choriogonadotropin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:IUPHAR, SrcID:1159, URL:http://www.iuphar-db.org/DATABASE/LigandDisplayForward?tab=biology&ligandId=1159|Name:FDA, SrcID:label/2004/21322lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21322lbl.pdf|Name:DailyMed, SrcID:setid=ae1977ed-32ea-4cbf-b51d-ce4a438215b8, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ae1977ed-32ea-4cbf-b51d-ce4a438215b8",,CHEMBL1854,LHCGR
1130,CHEMBL415606,Degarelix,Protein,2008.0,L02BX02,L02BX02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONE ANTAGONISTS AND RELATED AGENTS: Other hormone antagonists and related agents],-relix,Gonadotropin-releasing hormone receptor antagonist,,,CHEMBL1855,Gonadotropin-releasing hormone receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=5a89f93f-db62-846e-336e-ebbdb171056d#section-12, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5a89f93f-db62-846e-336e-ebbdb171056d#section-12|Name:FDA, SrcID:label/2015/022201s009lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022201s009lbl.pdf",CC(C)C[C@H](NC(=O)[C@@H](Cc1ccc(NC(=O)N)cc1)NC(=O)[C@H](Cc2ccc(NC(=O)[C@@H]3CC(=O)NC(=O)N3)cc2)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc4cccnc4)NC(=O)[C@@H](Cc5ccc(Cl)cc5)NC(=O)[C@@H](Cc6ccc7ccccc7c6)NC(=O)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N8CCC[C@H]8C(=O)N[C@H](C)C(=O)N,CHEMBL1855,GNRHR
1131,CHEMBL1201274,Levobetaxolol,Small molecule,2000.0,,,-olol,Beta-1 adrenergic receptor antagonist,,,CHEMBL213,Beta-1 adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19668496, URL:http://europepmc.org/abstract/MED/19668496",CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1,,
1132,CHEMBL1201641,Insulin Zinc Susp Extended Recombinant Human,Protein,1987.0,,,,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/022472s006s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022472s006s008lbl.pdf|Name:DailyMed, SrcID:setid=457531f0-9331-47fe-90b5-b31f284044dc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=457531f0-9331-47fe-90b5-b31f284044dc",,CHEMBL1981,INSR
1133,CHEMBL708,Ziprasidone,Small molecule,2001.0,N05AE04,N05AE04 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Indole derivatives],-sidone,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=5c03ca62-5dd5-4cf5-abc7-b0c2873503dd#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5c03ca62-5dd5-4cf5-abc7-b0c2873503dd#nlm34090-1",Clc1cc2NC(=O)Cc2cc1CCN3CCN(CC3)c4nsc5ccccc45,CHEMBL224,HTR2A
1134,CHEMBL654,Mirtazapine,Small molecule,1996.0,N06AX11,N06AX11 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants],-pin(e),Serotonin 2c (5-HT2c) receptor antagonist,,,CHEMBL225,Serotonin 2c (5-HT2c) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f23631be-c7ae-46e9-b771-a70be17bc9f0#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f23631be-c7ae-46e9-b771-a70be17bc9f0#nlm34090-1",CN1CCN2C(C1)c3ccccc3Cc4cccnc24,,
1135,CHEMBL1489,Azacitidine,Small molecule,2004.0,L01BC07,L01BC07 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Pyrimidine analogues],-tidine,DNA (cytosine-5)-methyltransferase 3A inhibitor,,,CHEMBL1992,DNA (cytosine-5)-methyltransferase 3A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Azacitidine, URL:http://en.wikipedia.org/wiki/Azacitidine|Name:DailyMed, SrcID:setid=3495a71a-cc04-4776-851f-f185956f32af#section-12, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3495a71a-cc04-4776-851f-f185956f32af#section-12|Name:Wikipedia, SrcID:DNA_methylation, URL:http://en.wikipedia.org/wiki/DNA_methylation",NC1=NC(=O)N(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O,CHEMBL1992,DNMT3A
1136,CHEMBL1201619,Aprotinin,Unknown,1993.0,B02AB01,B02AB01 [BLOOD AND BLOOD FORMING ORGANS: ANTIHEMORRHAGICS: ANTIFIBRINOLYTICS: Proteinase inhibitors],,Plasma kallikrein inhibitor,,,CHEMBL2000,Plasma kallikrein,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=8a5982c6-825f-4d05-90f5-1519a7291d15#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8a5982c6-825f-4d05-90f5-1519a7291d15#nlm34090-1",,,
1137,CHEMBL3039583,Pasireotide,Protein,2012.0,H01CB05,"H01CB05 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: HYPOTHALAMIC HORMONES: Somatostatin and analogues]",-tide,Somatostatin receptor 3 agonist,,Non-selective but type 5 receptor is overexpressed in Cushing's disease,CHEMBL2028,Somatostatin receptor 3,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=5504116c-d531-4d47-b160-41c6671d52aa, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5504116c-d531-4d47-b160-41c6671d52aa|Name:PubMed, SrcID:22397653, URL:http://europepmc.org/abstract/MED/22397653|Name:DailyMed, SrcID:setid=442f0d9d-5c7d-4b81-b329-d71be8cf2be2, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=442f0d9d-5c7d-4b81-b329-d71be8cf2be2|Name:PubMed, SrcID:11980628, URL:http://europepmc.org/abstract/MED/11980628",NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](NC(=O)[C@@H]4C[C@@H](CN4C(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](Cc6ccc(OCc7ccccc7)cc6)NC1=O)OC(=O)NCCN)c8ccccc8,CHEMBL2028,SSTR3
1138,CHEMBL1201012,Flurandrenolide,Small molecule,1965.0,D07AC07,"D07AC07 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, potent (group III)]",-andr-,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20346397, URL:http://europepmc.org/abstract/MED/20346397|Name:PubMed, SrcID:16507850, URL:http://europepmc.org/abstract/MED/16507850|Name:PubMed, SrcID:16255837, URL:http://europepmc.org/abstract/MED/16255837",CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,CHEMBL2034,NR3C1
1139,CHEMBL1200973,Estradiol Cypionate,Small molecule,1979.0,G03CA03; G03CA53,"G03CA03 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ESTROGENS: Natural and semisynthetic estrogens, plain]; G03CA53 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ESTROGENS: Natural and semisynthetic estrogens, plain]",estr-,Estrogen receptor alpha agonist,,,CHEMBL206,Estrogen receptor alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=9a4229fd-fecd-4ac1-9c4f-6d442533457f#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9a4229fd-fecd-4ac1-9c4f-6d442533457f#nlm34090-1|Name:Wikipedia, SrcID:Estrogen_receptor, URL:http://en.wikipedia.org/wiki/Estrogen_receptor",C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2OC(=O)CCC5CCCC5,CHEMBL206,ESR1
1140,CHEMBL1744,Phendimetrazine,Small molecule,1976.0,,,,Norepinephrine transporter inhibitor,,,CHEMBL222,Norepinephrine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23211394, URL:http://europepmc.org/abstract/MED/23211394|Name:FDA, SrcID:label/2012/018074s034lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/018074s034lbl.pdf|Name:DailyMed, SrcID:setid=c4adaaef-cb23-4e29-8645-347578beb60a#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4adaaef-cb23-4e29-8645-347578beb60a#nlm34090-1",CC1C(OCCN1C)c2ccccc2,CHEMBL222,SLC6A2
1141,CHEMBL1229,Oseltamivir,Small molecule,1999.0,J05AH02,J05AH02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Neuraminidase inhibitors],-vir,Neuraminidase inhibitor,,,CHEMBL3377,Neuraminidase,INHIBITOR,Influenza B virus (strain B/Lee/1940),SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=644ddc43-b2fa-44bd-aeb7-2547defb85e0, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=644ddc43-b2fa-44bd-aeb7-2547defb85e0",CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(=O)C)[C@@H](N)C1,,
1142,CHEMBL24828,Vandetanib,Small molecule,2011.0,L01XE12,L01XE12 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-anib,Tyrosine-protein kinase BRK inhibitor,,,CHEMBL4601,Tyrosine-protein kinase BRK,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13",COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC4CCN(C)CC4,CHEMBL4601,PTK6
1143,CHEMBL1389,Levonorgestrel,Small molecule,1982.0,G03AC03; G03AD01,G03AC03 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE: Progestogens]; G03AD01 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE: Emergency contraceptives],-gest-,Progesterone receptor agonist,,,CHEMBL208,Progesterone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19434887, URL:http://europepmc.org/abstract/MED/19434887|Name:Wikipedia, SrcID:Levonorgestrel, URL:http://en.wikipedia.org/wiki/Levonorgestrel",CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C,CHEMBL208,PGR
1144,CHEMBL24828,Vandetanib,Small molecule,2011.0,L01XE12,L01XE12 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-anib,Tyrosine-protein kinase TIE-2 inhibitor,,,CHEMBL4128,Tyrosine-protein kinase TIE-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13",COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC4CCN(C)CC4,CHEMBL4128,TEK
1145,CHEMBL1079,Tizanidine,Small molecule,1996.0,M03BX02,"M03BX02 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS: Other centrally acting agents]",,Adrenergic receptor alpha-2 agonist,,,CHEMBL2095158,Adrenergic receptor alpha-2,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=42097235-fa5f-4052-a558-763116afd58d#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=42097235-fa5f-4052-a558-763116afd58d#nlm34090-1",Clc1ccc2nsnc2c1NC3=NCCN3,,
1146,CHEMBL1113,Amoxapine,Small molecule,1980.0,N06AA17,N06AA17 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Non-selective monoamine reuptake inhibitors],-pin(e),Dopamine receptor antagonist,,,CHEMBL2096905,Dopamine receptor,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=261006c8-3fd0-491b-b322-42beff6f9880#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=261006c8-3fd0-491b-b322-42beff6f9880#nlm34090-1",Clc1ccc2Oc3ccccc3N=C(N4CCNCC4)c2c1,,
1147,CHEMBL421,Sulfasalazine,Small molecule,1950.0,A07EC01,"A07EC01 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Aminosalicylic acid and similar agents]",-sal-; sulfa-,Cyclooxygenase inhibitor,,,CHEMBL2094253,Cyclooxygenase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:12950415, URL:http://europepmc.org/abstract/MED/12950415|Name:PubMed, SrcID:16855178, URL:http://europepmc.org/abstract/MED/16855178|Name:PubMed, SrcID:14742690, URL:http://europepmc.org/abstract/MED/14742690|Name:PubMed, SrcID:12463455, URL:http://europepmc.org/abstract/MED/12463455",OC(=O)c1cc(ccc1O)N=Nc2ccc(cc2)S(=O)(=O)Nc3ccccn3,,
1148,CHEMBL1336,Sorafenib,Small molecule,2005.0,L01XE05,L01XE05 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-rafenib,Vascular endothelial growth factor receptor inhibitor,,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2011/021923s012lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf",CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,,
1149,CHEMBL1742994,Brentuximab Vedotin,Antibody,2011.0,L01XC12,L01XC12 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,Tumor necrosis factor receptor superfamily member 8 inhibitor,,,CHEMBL2364161,Tumor necrosis factor receptor superfamily member 8,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23515511, URL:http://europepmc.org/abstract/MED/23515511|Name:DailyMed, SrcID:setid=3904f8dd-1aef-3490-e48f-bd55f32ed67f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3904f8dd-1aef-3490-e48f-bd55f32ed67f",,CHEMBL2364161,TNFRSF8
1150,CHEMBL1201131,Piperonyl Butoxide,Small molecule,2000.0,,,,Cytochrome P450 inhibitor,,,CHEMBL2364702,Cytochrome P450,INHIBITOR,Pediculus humanus capitis,PROTEIN FAMILY,,,"Name:PubMed, SrcID:18951417, URL:http://europepmc.org/abstract/MED/18951417",CCCCOCCOCCOCc1cc2OCOc2cc1CCC,,
1151,CHEMBL2218896,Nabilone,Small molecule,1985.0,A04AD11,A04AD11 [ALIMENTARY TRACT AND METABOLISM: ANTIEMETICS AND ANTINAUSEANTS: ANTIEMETICS AND ANTINAUSEANTS: Other antiemetics],nab-,Cannabinoid CB1 receptor agonist,,,CHEMBL218,Cannabinoid CB1 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=bb582d64-0f51-11df-8a39-0800200c9a66#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bb582d64-0f51-11df-8a39-0800200c9a66#nlm34090-1",CCCCCCC(C)(C)c1cc(O)c2C3CC(=O)CCC3C(C)(C)Oc2c1,CHEMBL218,CNR1
1152,CHEMBL772,Reserpine,Small molecule,1960.0,C02AA52; C02AA02,"C02AA52 [CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ANTIADRENERGIC AGENTS, CENTRALLY ACTING: Rauwolfia alkaloids]; C02AA02 [CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ANTIADRENERGIC AGENTS, CENTRALLY ACTING: Rauwolfia alkaloids]",-serpine,Synaptic vesicular amine transporter inhibitor,,,CHEMBL1893,Synaptic vesicular amine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Reserpine, URL:http://en.wikipedia.org/wiki/Reserpine|Name:DailyMed, SrcID:setid=3a4d74d7-2e63-4789-b50e-af17ced92462, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3a4d74d7-2e63-4789-b50e-af17ced92462|Name:ISBN, SrcID:9780702034718 PP. 177, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:Wikipedia, SrcID:Vesicular_monoamine_transporter_1, URL:http://en.wikipedia.org/wiki/Vesicular_monoamine_transporter_1",CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5cc(OC)ccc45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)c6cc(OC)c(OC)c(OC)c6,CHEMBL1893,SLC18A2
1153,CHEMBL1664,Fosamprenavir,Small molecule,2003.0,J05AE07,J05AE07 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Protease inhibitors],fos-; -vir,Human immunodeficiency virus type 1 protease inhibitor,,,CHEMBL243,Human immunodeficiency virus type 1 protease,INHIBITOR,Human immunodeficiency virus 1,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/021548s035,022116s019lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021548s035,022116s019lbl.pdf|Name:DailyMed, SrcID:setid=4f5d4370-4833-412b-8699-1c66a8abeb08, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4f5d4370-4833-412b-8699-1c66a8abeb08",CC(C)CN(C[C@@H](OP(=O)(O)O)[C@H](Cc1ccccc1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)c3ccc(N)cc3,,
1154,CHEMBL1429,Desmopressin,Protein,1978.0,H01BA02,"H01BA02 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: POSTERIOR PITUITARY LOBE HORMONES: Vasopressin and analogues]",-pressin,Vasopressin receptor agonist,,,CHEMBL2363078,Vasopressin receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:Wikipedia, SrcID:Desmopressin_acetate#Mode_of_action, URL:http://en.wikipedia.org/wiki/Desmopressin_acetate#Mode_of_action|Name:PubMed, SrcID:18761325, URL:http://europepmc.org/abstract/MED/18761325|Name:PubMed, SrcID:8957254, URL:http://europepmc.org/abstract/MED/8957254|Name:PubMed, SrcID:10594321, URL:http://europepmc.org/abstract/MED/10594321|Name:PubMed, SrcID:14971638, URL:http://europepmc.org/abstract/MED/14971638|Name:PubMed, SrcID:16333859, URL:http://europepmc.org/abstract/MED/16333859|Name:PubMed, SrcID:18655906, URL:http://europepmc.org/abstract/MED/18655906|Name:PubMed, SrcID:15613460, URL:http://europepmc.org/abstract/MED/15613460",NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(=O)N)NC1=O)C(=O)N4CCC[C@H]4C(=O)N[C@H](CCCNC(=N)N)C(=O)NCC(=O)N,,
1155,CHEMBL719,Mupirocin,Small molecule,1987.0,R01AX06; D06AX09,R01AX06 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Other nasal preparations]; D06AX09 [DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: ANTIBIOTICS FOR TOPICAL USE: Other antibiotics for topical use],-rocin,Isoleucyl-tRNA synthetase inhibitor,,,CHEMBL2364671,Isoleucyl-tRNA synthetase,INHIBITOR,Streptococcus pyogenes,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=9257f9cd-abaf-4bb2-d9ac-4bc8f65ae558, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9257f9cd-abaf-4bb2-d9ac-4bc8f65ae558",C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]2CO[C@@H](C\C(=C\C(=O)OCCCCCCCCC(=O)O)\C)[C@H](O)[C@@H]2O,,
1156,CHEMBL780,Pentetic Acid,Small molecule,2004.0,,,,Radioactive metals chelating agent,Chelates radioactive contaminants to increase elimination rate.,,CHEMBL2366037,Radioactive metals,CHELATING AGENT,,METAL,,,"Name:DailyMed, SrcID:setid=9fca10ee-973e-4fe0-aaf5-a0416918a397#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9fca10ee-973e-4fe0-aaf5-a0416918a397#nlm34090-1|Name:DailyMed, SrcID:setid=6052c707-a8a3-43a7-80c2-7ad1ad9391a4#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6052c707-a8a3-43a7-80c2-7ad1ad9391a4#nlm34090-1",OC(=O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,,
1157,CHEMBL525076,Enfuvirtide,Protein,2003.0,J05AX07,J05AX07 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Other antivirals],-tide; -vir-,Transmembrane glycoprotein gp41 inhibitor,,,CHEMBL2362987,Transmembrane glycoprotein gp41,INHIBITOR,Human immunodeficiency virus,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=6935e846-d5a1-49e5-89a2-f8ebe4d5590d, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6935e846-d5a1-49e5-89a2-f8ebe4d5590d",CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)C)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc5c[nH]c6ccccc56)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc7c[nH]c8ccccc78)C(=O)N[C@@H](Cc9ccccc9)C(=O)N,,
1158,CHEMBL1201632,Imiglucerase,Enzyme,1994.0,A16AB02,A16AB02 [ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Enzymes],-ase,Glucocerebroside hydrolytic enzyme,Given in cases of gaucher disease to overcome a deficiency of beta-glucocerebrosidase activity. Imiglucerase catalyses the hydrolysis of glucocerebroside to glucose and ceramide,,CHEMBL2364176,Glucocerebroside,HYDROLYTIC ENZYME,Homo sapiens,SMALL MOLECULE,,,"Name:DailyMed, SrcID:setid=df60f030-866b-4374-a31f-8ae3f6b45c38, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=df60f030-866b-4374-a31f-8ae3f6b45c38",,,
1159,CHEMBL1863513,Ingenol Mebutate,Small molecule,2010.0,D06BX02,D06BX02 [DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: CHEMOTHERAPEUTICS FOR TOPICAL USE: Other chemotherapeutics],,Unknown,,,,,,,,,,"Name:FDA, SrcID:label/2012/202833lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202833lbl.pdf",C\C=C(\C)/C(=O)O[C@H]1C(=C[C@@]23[C@H](C)C[C@@H]4[C@H]([C@H](C=C(CO)[C@@H](O)[C@]12O)C3=O)C4(C)C)C,,
1160,CHEMBL1183349,Isavuconazonium,Small molecule,2015.0,,,-ium,Lanosterol 14-alpha demethylase inhibitor,,,CHEMBL3390825,Lanosterol 14-alpha demethylase,INHIBITOR,Mucorales,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/207500s001,207501s001lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207500s001,207501s001lbl.pdf",CNCC(=O)OCc1cccnc1N(C)C(=O)OC(C)[n+]2cnn(C[C@@](O)([C@@H](C)c3nc(cs3)c4ccc(cc4)C#N)c5cc(F)ccc5F)c2,,
1161,CHEMBL3391662,Paritaprevir,Small molecule,2014.0,,,-vir,"Hepatitis C virus serine protease, NS3/NS4A inhibitor",,,CHEMBL2095231,"Hepatitis C virus serine protease, NS3/NS4A",INHIBITOR,Hepatitis C virus,PROTEIN COMPLEX,,,"Name:FDA, SrcID:label/2015/206619s003lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206619s003lbl.pdf",Cc1cnc(cn1)C(=O)N[C@H]2CCCCC\C=C/[C@@H]3C[C@]3(NC(=O)[C@@H]4C[C@H](CN4C2=O)Oc5nc6ccccc6c7ccccc57)C(=O)NS(=O)(=O)C8CC8,,
1162,CHEMBL2105720,Lesinurad,Small molecule,2015.0,M04AB05,M04AB05 [MUSCULO-SKELETAL SYSTEM: ANTIGOUT PREPARATIONS: ANTIGOUT PREPARATIONS: Preparations increasing uric acid excretion],-urad,Solute carrier family 22 member 12 inhibitor,,,CHEMBL6120,Solute carrier family 22 member 12,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/207988lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207988lbl.pdf",OC(=O)CSc1nnc(Br)n1c2ccc(C3CC3)c4ccccc24,CHEMBL6120,SLC22A12
1163,CHEMBL2346976,Azd3514,Small molecule,,,,,Androgen Receptor modulator,"Selective androgen receptor inhibitor and down-regulator (SARD). AZD3514 binds to AR, inhibits its nuclear translocation, ligand-dependent and independent transcriptional activity and is able to induce AR down-regulation in vitro and in vivo. .Discontinued, safety/efficacy reasons.",,CHEMBL1871,Androgen Receptor,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23861347, URL:http://europepmc.org/abstract/MED/23861347|Name:PubMed, SrcID:23466225, URL:http://europepmc.org/abstract/MED/23466225",CC(=O)N1CCN(CCOc2ccc(cc2)C3CCN(CC3)C4=Nn5c(CC4)nnc5C(F)(F)F)CC1,CHEMBL1871,AR
1164,CHEMBL3544959,Arry-382,Small molecule,,,,,Macrophage colony stimulating factor receptor inhibitor,,,CHEMBL1844,Macrophage colony stimulating factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.arraybiopharma.com/product-pipeline/other-compounds/arry-382/, URL:http://www.arraybiopharma.com/product-pipeline/other-compounds/arry-382/|Name:DOI, SrcID:10.1158/1535-7163.TARG-13-A252, URL:http://mct.aacrjournals.org/content/12/11_Supplement/A252",,CHEMBL1844,CSF1R
1165,CHEMBL3544967,Gsk-2256098,Small molecule,,,,,Focal adhesion kinase 1 inhibitor,,,CHEMBL2695,Focal adhesion kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25486573, URL:http://europepmc.org/abstract/MED/25486573|Name:DOI, SrcID:10.1016/S0959-8049(12)72185-8, URL:http://www.sciencedirect.com/science/article/pii/S0959804912721858",,CHEMBL2695,PTK2
1166,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,MT-ND1
1167,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,MT-ND2
1168,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,MT-ND3
1169,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,MT-ND4L
1170,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,MT-ND5
1171,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,MT-ND6
1172,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFS3
1173,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFAF4
1174,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFS1
1175,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFB10
1176,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFA10
1177,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFS7
1178,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFA3
1179,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFV2
1180,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFA13
1181,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFB6
1182,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFA9
1183,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFA11
1184,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFA6
1185,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFAF2
1186,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFS4
1187,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFV3
1188,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFAF3
1189,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFA1
1190,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFAB1
1191,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFA5
1192,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFA7
1193,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFAF1
1194,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFA2
1195,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFB7
1196,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFS6
1197,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFA4L2
1198,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFB2
1199,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFB8
1200,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFS2
1201,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFB1
1202,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFC1
1203,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFB4
1204,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFS5
1205,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFV1
1206,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFB9
1207,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFB3
1208,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFB5
1209,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFB11
1210,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFC2
1211,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFA12
1212,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFA8
1213,CHEMBL3545320,Me-344,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFS8
1214,CHEMBL3545003,Msc-2363318a,Small molecule,,,,,Ribosomal protein S6 kinase (P70S6K) inhibitor,,,CHEMBL2111330,Ribosomal protein S6 kinase (P70S6K),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:Other, SrcID:http://biopharma.merckgroup.com/en/research_development/pipeline/pipeline.html, URL:http://biopharma.merckgroup.com/en/research_development/pipeline/pipeline.html",,,
1215,CHEMBL1738757,Rebastinib,Small molecule,,,,-tinib,Tyrosine-protein kinase ABL inhibitor,"Also potent against other kinases (Src, LYN, FGR, and HCK, KDR, FLT3 and TIE2)",,CHEMBL1862,Tyrosine-protein kinase ABL,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21481795, URL:http://europepmc.org/abstract/MED/21481795",CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(nn3c4ccc5ncccc5c4)C(C)(C)C)c(F)c2)ccn1,CHEMBL1862,ABL1
1216,CHEMBL482968,Enmd-2076,Small molecule,,,,,Serine/threonine-protein kinase Aurora-A inhibitor,Tartrate salt of ENMD-981693,,CHEMBL4722,Serine/threonine-protein kinase Aurora-A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf, URL:http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf|Name:PubMed, SrcID:21177375, URL:http://europepmc.org/abstract/MED/21177375|Name:PubMed, SrcID:22397360, URL:http://europepmc.org/abstract/MED/22397360",CN1CCN(CC1)c2cc(Nc3cc(C)[nH]n3)nc(\C=C\c4ccccc4)n2,,
1217,CHEMBL3545157,Tideglusib,Small molecule,,,,,Glycogen synthase kinase-3 beta inhibitor,,,CHEMBL262,Glycogen synthase kinase-3 beta,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22102280, URL:http://europepmc.org/abstract/MED/22102280",O=C1SN(C(=O)N1Cc2ccccc2)c3cccc4ccccc34,CHEMBL262,GSK3B
1218,CHEMBL2387080,Taselisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,Developed as an isoform-specific PI3K inhibitor with compound exhibiting high affinity for mutated PI3Ka )doi:10.1158/1538-7445.AM2013-DDT02-01).,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:23662903, URL:http://europepmc.org/abstract/MED/23662903|Name:Other, SrcID:http://www.biooncology.com/pipeline-molecules/taselisib-gdc-0032, URL:http://www.biooncology.com/pipeline-molecules/taselisib-gdc-0032|Name:DOI, SrcID:10.1158/1538-7445.AM2013-DDT02-01, URL:http://cancerres.aacrjournals.org/content/73/8_Supplement/DDT02-01",CC(C)n1nc(C)nc1c2cn3CCOc4cc(ccc4c3n2)c5cnn(c5)C(C)(C)C(=O)N,CHEMBL3559703,PIK3R2
1219,CHEMBL2387080,Taselisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,Developed as an isoform-specific PI3K inhibitor with compound exhibiting high affinity for mutated PI3Ka )doi:10.1158/1538-7445.AM2013-DDT02-01).,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:23662903, URL:http://europepmc.org/abstract/MED/23662903|Name:Other, SrcID:http://www.biooncology.com/pipeline-molecules/taselisib-gdc-0032, URL:http://www.biooncology.com/pipeline-molecules/taselisib-gdc-0032|Name:DOI, SrcID:10.1158/1538-7445.AM2013-DDT02-01, URL:http://cancerres.aacrjournals.org/content/73/8_Supplement/DDT02-01",CC(C)n1nc(C)nc1c2cn3CCOc4cc(ccc4c3n2)c5cnn(c5)C(C)(C)C(=O)N,CHEMBL3559703,PIK3R3
1220,CHEMBL2387080,Taselisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,Developed as an isoform-specific PI3K inhibitor with compound exhibiting high affinity for mutated PI3Ka )doi:10.1158/1538-7445.AM2013-DDT02-01).,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:23662903, URL:http://europepmc.org/abstract/MED/23662903|Name:Other, SrcID:http://www.biooncology.com/pipeline-molecules/taselisib-gdc-0032, URL:http://www.biooncology.com/pipeline-molecules/taselisib-gdc-0032|Name:DOI, SrcID:10.1158/1538-7445.AM2013-DDT02-01, URL:http://cancerres.aacrjournals.org/content/73/8_Supplement/DDT02-01",CC(C)n1nc(C)nc1c2cn3CCOc4cc(ccc4c3n2)c5cnn(c5)C(C)(C)C(=O)N,CHEMBL3559703,PIK3R5
1221,CHEMBL3545401,X-82,Small molecule,,,,,Vascular endothelial growth factor receptor inhibitor,,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://www.tyrogenex.com/wordpress/wp-content/uploads/ASC0_X82_5.18.15_Rampurwala.pdf, URL:http://www.tyrogenex.com/wordpress/wp-content/uploads/ASC0_X82_5.18.15_Rampurwala.pdf|Name:Other, SrcID:http://www.tyrogenex.com/wordpress/wp-content/uploads/Oral-X-82-for-wet-AMD-ARVO-2013.pdf, URL:http://www.tyrogenex.com/wordpress/wp-content/uploads/Oral-X-82-for-wet-AMD-ARVO-2013.pdf",,,
1222,CHEMBL3545027,Xl-281,Small molecule,,,,,Serine/threonine-protein kinase B-raf inhibitor,"Selectively targets RAF kinases including BRAF, RAF1 and the BRAF mutant (V600E) (http://www.exelixis.com/sites/default/files/pdf/XL281-001_ASCO-2009.pdf)",,CHEMBL5145,Serine/threonine-protein kinase B-raf,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.exelixis.com/sites/default/files/pdf/XL281-001_ASCO-2009.pdf, URL:http://www.exelixis.com/sites/default/files/pdf/XL281-001_ASCO-2009.pdf|Name:PubMed, SrcID:25476894, URL:http://europepmc.org/abstract/MED/25476894|Name:Other, SrcID:http://annonc.oxfordjournals.org/content/18/suppl_4/iv29.full.pdf, URL:http://annonc.oxfordjournals.org/content/18/suppl_4/iv29.full.pdf|Name:PubMed, SrcID:23617957, URL:http://europepmc.org/abstract/MED/23617957",COC(=O)Nc1nc2cc(ccc2[nH]1)C3(O)N(C(=O)c4ccccc34)c5cc(Cl)ccc5C,CHEMBL5145,BRAF
1223,CHEMBL3545402,Xl-820,Small molecule,,,,,Vascular endothelial growth factor receptor inhibitor,,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://www.exelixis.com/sites/default/files/pdf/XL820%20EORTC-NCI-AACRnov06.pdf, URL:http://www.exelixis.com/sites/default/files/pdf/XL820%20EORTC-NCI-AACRnov06.pdf|Name:Other, SrcID:http://www.exelixis.com/sites/default/files/pdf/AACR_NCI_EORTC2007_XL820_resist.pdf, URL:http://www.exelixis.com/sites/default/files/pdf/AACR_NCI_EORTC2007_XL820_resist.pdf",,,
1224,CHEMBL1631540,Gsk163090,Small molecule,,,,,Serotonin 1b (5-HT1b) receptor antagonist,,,CHEMBL1898,Serotonin 1b (5-HT1b) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21053897, URL:http://europepmc.org/abstract/MED/21053897",Cc1ccc2c(cccc2n1)N3CCN(CCc4cccc(c4)N5CCNC5=O)CC3,CHEMBL1898,HTR1B
1225,CHEMBL514270,Emicerfont,Small molecule,,,,-cerfont,Corticotropin releasing factor receptor 1 antagonist,,,CHEMBL1800,Corticotropin releasing factor receptor 1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23294766, URL:http://europepmc.org/abstract/MED/23294766|Name:PubMed, SrcID:18989952, URL:http://europepmc.org/abstract/MED/18989952",COc1ccc(N2CCc3c2nc(C)cc3n4ccc(n4)N5CCNC5=O)c(C)c1,CHEMBL1800,CRHR1
1226,CHEMBL3545344,Pf-05212377,Small molecule,,,,,Serotonin 6 (5-HT6) receptor antagonist,,,CHEMBL3371,Serotonin 6 (5-HT6) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.pfizer.com/research/science_and_technology/product_pipeline, URL:http://www.pfizer.com/research/science_and_technology/product_pipeline",,CHEMBL3371,HTR6
1227,CHEMBL3544947,Burapitant,Small molecule,,,,-tant,Neurokinin 1 receptor antagonist,,,CHEMBL249,Neurokinin 1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12438541, URL:http://europepmc.org/abstract/MED/12438541",CC(C)(C1CCN(CCC2(CN(CCO2)C(=O)Cc3cc(cc(c3)C(F)(F)F)C(F)(F)F)c4ccc(Cl)c(Cl)c4)CC1)C(=O)N,CHEMBL249,TACR1
1228,CHEMBL3183740,Trelanserin,Small molecule,,,,-anserin,Serotonin 1b (5-HT1b) receptor antagonist,,,CHEMBL1898,Serotonin 1b (5-HT1b) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10996601, URL:http://europepmc.org/abstract/MED/10996601|Name:PubMed, SrcID:11504649, URL:http://europepmc.org/abstract/MED/11504649",NC(=O)CN1C(=O)C=C(CCN2CCN(CC2)c3nccc4sccc34)c5ccc(F)cc15,CHEMBL1898,HTR1B
1229,CHEMBL2107725,Anatibant,Small molecule,,,,-tibant,Bradykinin B2 receptor antagonist,Possible safety concerns?,,CHEMBL3157,Bradykinin B2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10596852, URL:http://europepmc.org/abstract/MED/10596852",Cc1cc(C)c2cccc(OCc3c(Cl)ccc(c3Cl)S(=O)(=O)N4CCC[C@H]4C(=O)NCCCNC(=O)c5ccc(cc5)C(=N)N)c2n1,CHEMBL3157,BDKRB2
1230,CHEMBL3545231,Abt-126,Small molecule,,,,,Neuronal acetylcholine receptor protein alpha-7 subunit agonist,Alpha-7 nicotinic receptor: consists entirely of a7 subunits (pentamere) CNS-type.,,CHEMBL2492,Neuronal acetylcholine receptor protein alpha-7 subunit,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26044974, URL:http://europepmc.org/abstract/MED/26044974|Name:DOI, SrcID:10.1016/j.trci.2015.06.001, URL:http://www.sciencedirect.com/science/article/pii/S2352873715000104",C1C2CC3CN(C2)C[C@H]1[C@@H]3Oc4nnc(s4)c5ccccc5,CHEMBL2492,CHRNA7
1231,CHEMBL3545353,Tc-6499,Small molecule,,,,,Neuronal acetylcholine receptor; alpha3/beta4 agonist,,,CHEMBL1907594,Neuronal acetylcholine receptor; alpha3/beta4,AGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:18511441, URL:http://europepmc.org/abstract/MED/18511441|Name:Other, SrcID:http://www.jefferies.com/CMSFiles/Jefferies.com/files/Conferences/060214/Presentations/Targacept.pdf, URL:http://www.jefferies.com/CMSFiles/Jefferies.com/files/Conferences/060214/Presentations/Targacept.pdf",,,
1232,CHEMBL604710,Z160,Small molecule,,,,,Voltage-gated N-type calcium channel alpha-1B subunit blocker,"Indication: Lumbosacral Radiculopathy, Postherpetic Neuralgia",,CHEMBL4478,Voltage-gated N-type calcium channel alpha-1B subunit,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19815411, URL:http://europepmc.org/abstract/MED/19815411",O=C(CC(c1ccccc1)c2ccccc2)N3CCN(CC3)C(c4ccccc4)c5ccccc5,CHEMBL4478,CACNA1B
1233,CHEMBL2103882,Tivantinib,Small molecule,,,,-tinib,Hepatocyte growth factor receptor inhibitor,"Mechanism of action is still unclear, it is thought that Tivantinib displays cytotoxic activity via mechanisms other than only cMET inhibition (PMID:23712183)",,CHEMBL3717,Hepatocyte growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23712183, URL:http://europepmc.org/abstract/MED/23712183|Name:PubMed, SrcID:20484018, URL:http://europepmc.org/abstract/MED/20484018",O=C1NC(=O)[C@H]([C@@H]1c2c[nH]c3ccccc23)c4cn5CCCc6cccc4c56,CHEMBL3717,MET
1234,CHEMBL1078178,Momelotinib,Small molecule,,,,-tinib,Tyrosine-protein kinase JAK2 inhibitor,,,CHEMBL2971,Tyrosine-protein kinase JAK2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19295546, URL:http://europepmc.org/abstract/MED/19295546|Name:PubMed, SrcID:20385788, URL:http://europepmc.org/abstract/MED/20385788",O=C(NCC#N)c1ccc(cc1)c2ccnc(Nc3ccc(cc3)N4CCOCC4)n2,CHEMBL2971,JAK2
1235,CHEMBL3545184,Velcalcetide,Protein,2017.0,H05BX04,"H05BX04 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CALCIUM HOMEOSTASIS: ANTI-PARATHYROID AGENTS: Other anti-parathyroid agents]",-tide,Calcium sensing receptor agonist,Peptide,,CHEMBL1878,Calcium sensing receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23674604, URL:http://europepmc.org/abstract/MED/23674604",C[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](C)NC(=O)[C@@H](CSSC[C@H](N)C(=O)O)NC(=O)C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N,CHEMBL1878,CASR
1236,CHEMBL2109193,Gavilimomab,Antibody,,,,-mab,Basigin other,"Depletes activated T cells (CD4+ and CD8+) and B cells via a complement-dependent cytotoxic mechanism, while resting lymphocytes are unaffected.",,CHEMBL3580492,Basigin,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17110457, URL:http://europepmc.org/abstract/MED/17110457",,CHEMBL3580492,BSG
1237,CHEMBL1083390,Sb-742457,Small molecule,,,,,Serotonin 6 (5-HT6) receptor antagonist,,,CHEMBL3371,Serotonin 6 (5-HT6) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18625457, URL:http://europepmc.org/abstract/MED/18625457",O=S(=O)(c1ccccc1)c2cnc3c(cccc3c2)N4CCNCC4,CHEMBL3371,HTR6
1238,CHEMBL204021,Darapladib,Small molecule,,,,-pladib,LDL-associated phospholipase A2 inhibitor,Reversible oral inhibitor,,CHEMBL3514,LDL-associated phospholipase A2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24678955, URL:http://europepmc.org/abstract/MED/24678955",CCN(CC)CCN(Cc1ccc(cc1)c2ccc(cc2)C(F)(F)F)C(=O)CN3C4=C(CCC4)C(=O)N=C3SCc5ccc(F)cc5,CHEMBL3514,PLA2G7
1239,CHEMBL2109621,Di17e6,Antibody,,,,,Integrin alpha-V/beta-6 inhibitor,"Inhibits ligand binding to all alphav heterodimers (alphavbeta1, alphavbeta3, alphavbeta5, alphavbeta6, alphavbeta8).",Specifically directed against the alphav subunit of human integrins.,CHEMBL2111416,Integrin alpha-V/beta-6,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23791392, URL:http://europepmc.org/abstract/MED/23791392",,CHEMBL2111416,ITGB6
1240,CHEMBL2108167,Vepalimomab,Antibody,,,,-mab,"Amine oxidase, copper containing inhibitor",Inhibits lymphocyte binding to AOC3 (VAP-1) expressed in high endothelial venules (HEV).,,CHEMBL3437,"Amine oxidase, copper containing",INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:1529341, URL:http://europepmc.org/abstract/MED/1529341",,CHEMBL3437,AOC3
1241,CHEMBL2108248,Anatumomab Mafenatox,Antibody,,,,-mab,Trophoblast glycoprotein other,"Immunomodulator. Targets the superantigen with subsequent activation of cytotoxic T cells in tumor tissue. Targeting of superantigens towards tumours induces a strong, local cytotoxic T-cell attack, which directly kills tumour cells and leads to inflammation and the local accumulation of tumouricidal cytokines.",,CHEMBL3712934,Trophoblast glycoprotein,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17285137, URL:http://europepmc.org/abstract/MED/17285137|Name:PMC, SrcID:PMC3918406, URL:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3918406",,CHEMBL3712934,TPBG
1242,CHEMBL2109587,Az-9773,Antibody,,,,,TNF-alpha inhibitor,,,CHEMBL1825,TNF-alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22340283, URL:http://europepmc.org/abstract/MED/22340283",,CHEMBL1825,TNF
1243,CHEMBL414357,Exenatide,Protein,2005.0,A10BJ01,"A10BJ01 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Glucagon-like peptide-1 (GLP-1) analogues]",-tide,Glucagon-like peptide 1 receptor agonist,,,CHEMBL1784,Glucagon-like peptide 1 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/022200s015s016s017s018lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022200s015s016s017s018lbl.pdf|Name:DailyMed, SrcID:setid=751747da-7c1f-41ad-b1a6-a6d920f70599, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=751747da-7c1f-41ad-b1a6-a6d920f70599",CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc3cnc[nH]3)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc4c[nH]c5ccccc45)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)NCC(=O)N6CCC[C@H]6C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N7CCC[C@H]7C(=O)N8CCC[C@H]8C(=O)N9CCC[C@H]9C(=O)N[C@@H](CO)C(=O)N,CHEMBL1784,GLP1R
1244,CHEMBL1206,Ethopropazine,Small molecule,1982.0,N04AA05,N04AA05 [NERVOUS SYSTEM: ANTI-PARKINSON DRUGS: ANTICHOLINERGIC AGENTS: Tertiary amines],,Muscarinic acetylcholine receptor M1 antagonist,"Indicated for Parkinson's disease, M1 likely responsible",,CHEMBL216,Muscarinic acetylcholine receptor M1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:2236897, URL:http://europepmc.org/abstract/MED/2236897|Name:Wikipedia, SrcID:Ethopropazine, URL:http://en.wikipedia.org/wiki/Ethopropazine|Name:ISBN, SrcID:0865778434 PP. 188, URL:http://www.isbnsearch.org/isbn/0865778434|Name:Wikipedia, SrcID:Benzatropine, URL:http://en.wikipedia.org/wiki/Benzatropine",CCN(CC)C(C)CN1c2ccccc2Sc3ccccc13,CHEMBL216,CHRM1
1245,CHEMBL1201460,Dalteparin Sodium,Oligosaccharide,1994.0,B01AB04,B01AB04 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Heparin group],-parin,Antithrombin-III activator,Inhibits coagulation by activating antithrombin III; ATIII then binds to F10; It's a low-molecular-weight heparin,,CHEMBL1950,Antithrombin-III,ACTIVATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/020287s063lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020287s063lbl.pdf|Name:DailyMed, SrcID:setid=c5cd4a8e-14c0-440b-b453-9f3d3250c951#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5cd4a8e-14c0-440b-b453-9f3d3250c951#nlm34090-1",,CHEMBL1950,SERPINC1
1246,CHEMBL1336,Sorafenib,Small molecule,2005.0,L01XE05,L01XE05 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-rafenib,Tyrosine-protein kinase receptor FLT3 inhibitor,,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2011/021923s012lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf",CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,CHEMBL1974,FLT3
1247,CHEMBL1201328,Carphenazine,Small molecule,1982.0,,,,Serotonin 2c (5-HT2c) receptor antagonist,,,CHEMBL225,Serotonin 2c (5-HT2c) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:4889058, URL:http://europepmc.org/abstract/MED/4889058|Name:Wikipedia, SrcID:Carphenazine, URL:http://en.wikipedia.org/wiki/Carphenazine|Name:ISBN, SrcID:0443-059748 PP. 544, URL:http://www.isbnsearch.org/isbn/0443059748",CCC(=O)c1ccc2Sc3ccccc3N(CCCN4CCN(CCO)CC4)c2c1,,
1248,CHEMBL1201294,Diphenoxylate,Small molecule,1960.0,A07DA01,"A07DA01 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: ANTIPROPULSIVES: Antipropulsives]",,Mu opioid receptor agonist,,,CHEMBL233,Mu opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:14978639, URL:http://europepmc.org/abstract/MED/14978639|Name:Wikipedia, SrcID:Opioid_receptor, URL:http://en.wikipedia.org/wiki/Opioid_receptor",CCOC(=O)C1(CCN(CCC(C#N)(c2ccccc2)c3ccccc3)CC1)c4ccccc4,CHEMBL233,OPRM1
1249,CHEMBL389621,Hydrocortisone,Small molecule,1952.0,S01CB03; D07AA02; S01BA02; C05AA01; A07EA02; H02AB09; S02BA01; R01AD60; A01AC03; D07XA01,"S01CB03 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION: Corticosteroids/antiinfectives/mydriatics in combination]; D07AA02 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, weak (group I)]; S01BA02 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Corticosteroids, plain]; C05AA01 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Corticosteroids]; A07EA02 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Corticosteroids acting locally]; H02AB09 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Glucocorticoids]; S02BA01 [SENSORY ORGANS: OTOLOGICALS: CORTICOSTEROIDS: Corticosteroids]; R01AD60 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Corticosteroids]; A01AC03 [ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Corticosteroids for local oral treatment]; D07XA01 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, OTHER COMBINATIONS: Corticosteroids, weak, other combinations]",-cort-,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16980198, URL:http://europepmc.org/abstract/MED/16980198|Name:PubMed, SrcID:16895953, URL:http://europepmc.org/abstract/MED/16895953|Name:PubMed, SrcID:17038445, URL:http://europepmc.org/abstract/MED/17038445|Name:PubMed, SrcID:17086345, URL:http://europepmc.org/abstract/MED/17086345",C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23,CHEMBL2034,NR3C1
1250,CHEMBL1650,Cortisone Acetate,Small molecule,1950.0,S01BA03; H02AB10,"S01BA03 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Corticosteroids, plain]; H02AB10 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Glucocorticoids]",,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 401-402, URL:http://www.isbnsearch.org/isbn/9780702034718",CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C,CHEMBL2034,NR3C1
1251,CHEMBL175691,Rilpivirine,Small molecule,2011.0,J05AG05,J05AG05 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Non-nucleoside reverse transcriptase inhibitors],-virine,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,,,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,INHIBITOR,Human immunodeficiency virus 1,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=03880372-2c68-45c6-a53a-f420c49541d6, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=03880372-2c68-45c6-a53a-f420c49541d6",Cc1cc(\C=C\C#N)cc(C)c1Nc2ccnc(Nc3ccc(cc3)C#N)n2,,
1252,CHEMBL1118,Desvenlafaxine,Small molecule,2008.0,N06AX23,N06AX23 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants],-faxine,Norepinephrine transporter inhibitor,,,CHEMBL222,Norepinephrine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=d52d4043-9795-41d0-91f1-d558fe18d680#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d52d4043-9795-41d0-91f1-d558fe18d680#nlm34090-1|Name:DailyMed, SrcID:setid=91cf39c9-4d26-480a-a3a3-a3d8d4c4d222#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=91cf39c9-4d26-480a-a3a3-a3d8d4c4d222#nlm34090-1|Name:FDA, SrcID:label/2013/205208s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/205208s000lbl.pdf",CN(C)CC(c1ccc(O)cc1)C2(O)CCCCC2,CHEMBL222,SLC6A2
1253,CHEMBL256087,Menthol,Small molecule,2008.0,,,,Transient receptor potential cation channel subfamily M member 8 opener,,,CHEMBL1075319,Transient receptor potential cation channel subfamily M member 8,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23061635, URL:http://europepmc.org/abstract/MED/23061635",CC(C)C1CCC(C)CC1O,CHEMBL1075319,TRPM8
1254,CHEMBL473417,Vismodegib,Small molecule,2012.0,L01XX43,L01XX43 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-degib,Smoothened homolog inhibitor,,,CHEMBL5971,Smoothened homolog,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2012/203388lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203388lbl.pdf",CS(=O)(=O)c1ccc(C(=O)Nc2ccc(Cl)c(c2)c3ccccn3)c(Cl)c1,CHEMBL5971,SMO
1255,CHEMBL1358,Fulvestrant,Small molecule,2002.0,L02BA03,L02BA03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONE ANTAGONISTS AND RELATED AGENTS: Anti-estrogens],-estrant,Estrogen receptor antagonist,,,CHEMBL2093866,Estrogen receptor,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=83d7a440-e904-4e36-afb5-cb02b1c919f7#section-12, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=83d7a440-e904-4e36-afb5-cb02b1c919f7#section-12|Name:Wikipedia, SrcID:Estrogen_receptor, URL:http://en.wikipedia.org/wiki/Estrogen_receptor",C[C@]12CC[C@H]3[C@@H]([C@H](CCCCCCCCC[S+]([O-])CCCC(F)(F)C(F)(F)F)Cc4cc(O)ccc34)[C@@H]1CC[C@@H]2O,,
1256,CHEMBL770,Tolazoline,Small molecule,1985.0,C04AB02; M02AX02,C04AB02 [CARDIOVASCULAR SYSTEM: PERIPHERAL VASODILATORS: PERIPHERAL VASODILATORS: Imidazoline derivatives]; M02AX02 [MUSCULO-SKELETAL SYSTEM: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: Other topical products for joint and muscular pain],-azoline,Adrenergic receptor alpha antagonist,,,CHEMBL2095203,Adrenergic receptor alpha,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=0b94baa5-5af2-46e9-8111-519225206a28, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0b94baa5-5af2-46e9-8111-519225206a28|Name:PubMed, SrcID:6386273, URL:http://europepmc.org/abstract/MED/6386273|Name:DailyMed, SrcID:archiveid=232939, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=232939|Name:PubMed, SrcID:8487790, URL:http://europepmc.org/abstract/MED/8487790|Name:ISBN, SrcID:9780702034718 PP. 12, URL:http://www.isbnsearch.org/isbn/9780702034718",C(C1=NCCN1)c2ccccc2,,
1257,CHEMBL926,Dobutamine,Small molecule,1978.0,C01CA07,C01CA07 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES: Adrenergic and dopaminergic agents],,Beta-2 adrenergic receptor agonist,,,CHEMBL210,Beta-2 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2013/020255s016lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020255s016lbl.pdf|Name:DailyMed, SrcID:setid=402f24d2-5e67-4dd6-99c6-84bb7c1c29e7, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=402f24d2-5e67-4dd6-99c6-84bb7c1c29e7",CC(CCc1ccc(O)cc1)NCCc2ccc(O)c(O)c2,CHEMBL210,ADRB2
1258,CHEMBL1419,Sibutramine,Small molecule,1997.0,A08AA10,"A08AA10 [ALIMENTARY TRACT AND METABOLISM: ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS: ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS: Centrally acting antiobesity products]",,Monoamine transporter inhibitor,,,CHEMBL2363064,Monoamine transporter,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=c0333e62-bb00-4722-27b6-dca6ab4d1eb1#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c0333e62-bb00-4722-27b6-dca6ab4d1eb1#nlm34090-1|Name:FDA, SrcID:label/2010/020632s034s035lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020632s034s035lbl.pdf",CC(C)CC(N(C)C)C1(CCC1)c2ccc(Cl)cc2,,
1259,CHEMBL530,Amdinocillin,Small molecule,1984.0,J01CA11,"J01CA11 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: BETA-LACTAM ANTIBACTERIALS, PENICILLINS: Penicillins with extended spectrum]",-cillin,Bacterial penicillin-binding protein 2 inhibitor,,,CHEMBL2354313,Bacterial penicillin-binding protein 2,INHIBITOR,Bacteria,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Amdinocillin, URL:http://en.wikipedia.org/wiki/Amdinocillin|Name:PubMed, SrcID:7447421, URL:http://europepmc.org/abstract/MED/7447421",CC1(C)S[C@@H]2[C@H](\N=C\N3CCCCCC3)C(=O)N2[C@H]1C(=O)O,,
1260,CHEMBL1425,Mercaptopurine,Small molecule,1953.0,,,,DNA inhibitor,Prodrug enzyme: hypoxanthine-guanine phosphoribosyl transferase (HGPRT; ec 2.4.2.8),,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=15904472-4c32-4224-95d3-eb131a7ff9c8, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=15904472-4c32-4224-95d3-eb131a7ff9c8|Name:PubMed, SrcID:18506437, URL:http://europepmc.org/abstract/MED/18506437",Sc1ncnc2nc[nH]c12,,
1261,CHEMBL430,Gemifloxacin,Small molecule,2003.0,J01MA15,J01MA15 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolones],-oxacin,DNA gyrase inhibitor,,,CHEMBL2311225,DNA gyrase,INHIBITOR,Streptococcus pneumoniae,PROTEIN COMPLEX,,,"Name:DailyMed, SrcID:setid=54c4b48b-cad7-4889-808f-f741352a2c97, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=54c4b48b-cad7-4889-808f-f741352a2c97|Name:FDA, SrcID:label/2013/021158s022lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021158s022lbl.pdf",CO\N=C\1/CN(CC1CN)c2nc3N(C=C(C(=O)O)C(=O)c3cc2F)C4CC4,,
1262,CHEMBL1257,Enflurane,Small molecule,1972.0,N01AB04,"N01AB04 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,Potassium channel subfamily K member 10 opener,,,CHEMBL2331041,Potassium channel subfamily K member 10,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:16973644, URL:http://europepmc.org/abstract/MED/16973644|Name:PubMed, SrcID:17227289, URL:http://europepmc.org/abstract/MED/17227289",FC(F)OC(F)(F)C(F)Cl,CHEMBL2331041,KCNK10
1263,CHEMBL614,Pyrazinamide,Small molecule,1971.0,J04AK01,J04AK01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOBACTERIALS: DRUGS FOR TREATMENT OF TUBERCULOSIS: Other drugs for treatment of tuberculosis],,70S ribosome inhibitor,,,CHEMBL2363965,70S ribosome,INHIBITOR,Mycobacterium tuberculosis,PROTEIN NUCLEIC-ACID COMPLEX,30S ribosomal protein S1,30S ribosomal protein S1,"Name:PubMed, SrcID:21835980, URL:http://europepmc.org/abstract/MED/21835980|Name:Wikipedia, SrcID:Pyrazinamide#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Pyrazinamide#Mechanism_of_action",NC(=O)c1cnccn1,,
1264,CHEMBL1233,Carisoprodol,Small molecule,1959.0,M03BA72; M03BA02; M03BA52,"M03BA72 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS: Carbamic acid esters]; M03BA02 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS: Carbamic acid esters]; M03BA52 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS: Carbamic acid esters]",,Unknown,,,,,,,,,,"Name:FDA, SrcID:label/2009/011792s043lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/011792s043lbl.pdf",CCCC(C)(COC(=O)N)COC(=O)NC(C)C,,
1265,CHEMBL1200661,Unoprostone Isopropyl,Small molecule,2000.0,S01EE02,S01EE02 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Prostaglandin analogues 1)],-prost-,Unknown,,,,,,,,,,"Name:FDA, SrcID:label/2000/21214lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21214lbl.pdf",CCCCCCCC(=O)CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(=O)OC(C)C,,
1266,CHEMBL2107381,Uridine Triacetate,Small molecule,2015.0,A16AX13,A16AX13 [ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Various alimentary tract and metabolism products],,Unknown,,,,,,,,,,"Name:DailyMed, SrcID:setid=f5beed22-d71d-4c0d-8dca-2c7317d65d85, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f5beed22-d71d-4c0d-8dca-2c7317d65d85",CC(=O)OC[C@H]1O[C@H]([C@H](OC(=O)C)[C@@H]1OC(=O)C)N2C=CC(=O)NC2=O,,
1267,CHEMBL3545419,Abt-700,Small molecule,,,,,Hepatocyte growth factor receptor inhibitor,,,CHEMBL3717,Hepatocyte growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://meetinglibrary.asco.org/content/134301-144, URL:http://meetinglibrary.asco.org/content/134301-144|Name:Other, SrcID:http://www.abbvie.com/oncology/home/pipeline.html, URL:http://www.abbvie.com/oncology/home/pipeline.html",,CHEMBL3717,MET
1268,CHEMBL551064,Aew-541,Small molecule,,,,,Insulin-like growth factor I receptor inhibitor,,,CHEMBL1957,Insulin-like growth factor I receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21875414, URL:http://europepmc.org/abstract/MED/21875414|Name:PubMed, SrcID:15050915, URL:http://europepmc.org/abstract/MED/15050915",Nc1ncnc2c1c(cn2[C@@H]3C[C@H](C3)N4CCC4)c5cccc(OCc6ccccc6)c5,CHEMBL1957,IGF1R
1269,CHEMBL1908394,Gsk-461364,Small molecule,,,,,Serine/threonine-protein kinase PLK1 inhibitor,,,CHEMBL3024,Serine/threonine-protein kinase PLK1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19568282, URL:http://europepmc.org/abstract/MED/19568282|Name:PubMed, SrcID:19690138, URL:http://europepmc.org/abstract/MED/19690138",C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(CN4CCN(C)CC4)cc23)c5ccccc5C(F)(F)F,CHEMBL3024,PLK1
1270,CHEMBL3545431,Hmn-214,Small molecule,,,,,Serine/threonine-protein kinase PLK1 inhibitor,,,CHEMBL3024,Serine/threonine-protein kinase PLK1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19474163, URL:http://europepmc.org/abstract/MED/19474163|Name:PubMed, SrcID:14583495, URL:http://europepmc.org/abstract/MED/14583495",,CHEMBL3024,PLK1
1271,CHEMBL3545133,Jnj-26483327,Small molecule,,,,,Tyrosine-protein kinase Lyn inhibitor,Multi-targeted tyrosine kinase inhibitor,,CHEMBL3905,Tyrosine-protein kinase Lyn,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1016/S1359-6349(10)71870-X, URL:http://www.sciencedirect.com/science/article/pii/S135963491071870X|Name:PubMed, SrcID:20823884, URL:http://europepmc.org/abstract/MED/20823884",,CHEMBL3905,LYN
1272,CHEMBL3545083,Rgb-286638,Small molecule,,,,,Cyclin-dependent kinase 5 inhibitor,,,CHEMBL4036,Cyclin-dependent kinase 5,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23807770, URL:http://europepmc.org/abstract/MED/23807770",COCCN1CCN(Cc2ccc(cc2)c3n[nH]c4c5cccc(NC(=O)NN6CCOCC6)c5C(=O)c34)CC1,CHEMBL4036,CDK5
1273,CHEMBL2180604,Tak-593,Small molecule,,,,,Platelet-derived growth factor receptor inhibitor,,,CHEMBL2095189,Platelet-derived growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23498918, URL:http://europepmc.org/abstract/MED/23498918",Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1,,
1274,CHEMBL1980391,Rg-1530,Small molecule,,,,,Tyrosine-protein kinase receptor FLT3 inhibitor,Multi-targeted kinase inhibitor,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21553286, URL:http://europepmc.org/abstract/MED/21553286|Name:PubMed, SrcID:24900658, URL:http://europepmc.org/abstract/MED/24900658",COc1cc2Nc3n[nH]c(C)c3N=C(c4ccccc4Cl)c2cc1F,CHEMBL1974,FLT3
1275,CHEMBL29919,Elpetrigine,Small molecule,,,,,Voltage-gated P/Q-type calcium channel alpha-1A subunit blocker,,,CHEMBL4266,Voltage-gated P/Q-type calcium channel alpha-1A subunit,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18377968, URL:http://europepmc.org/abstract/MED/18377968|Name:PubMed, SrcID:19008076, URL:http://europepmc.org/abstract/MED/19008076",Nc1cnc(c(N)n1)c2cc(Cl)cc(Cl)c2Cl,,
1276,CHEMBL1614713,Cc-401,Small molecule,,,,,c-Jun N-terminal kinase 2 inhibitor,,,CHEMBL4179,c-Jun N-terminal kinase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17202416, URL:http://europepmc.org/abstract/MED/17202416|Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=453550, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=453550",C(CN1CCCCC1)Oc2cccc(c2)c3n[nH]c4ccc(cc34)c5nnc[nH]5,CHEMBL4179,MAPK9
1277,CHEMBL2107823,Gandotinib,Small molecule,,,,-tinib,Tyrosine-protein kinase JAK2 inhibitor,,,CHEMBL2971,Tyrosine-protein kinase JAK2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23584399, URL:http://europepmc.org/abstract/MED/23584399|Name:PubMed, SrcID:24766055, URL:http://europepmc.org/abstract/MED/24766055",Cc1cc(Nc2cc(CN3CCOCC3)c4nc(C)c(Cc5ccc(Cl)cc5F)n4n2)n[nH]1,CHEMBL2971,JAK2
1278,CHEMBL572878,Tozasertib,Small molecule,,,,-sertib,Serine/threonine-protein kinase Aurora inhibitor,Pan-Aurora kinase inhibitor,,CHEMBL3430911,Serine/threonine-protein kinase Aurora,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:26345296, URL:http://europepmc.org/abstract/MED/26345296|Name:PubMed, SrcID:14981513, URL:http://europepmc.org/abstract/MED/14981513",CN1CCN(CC1)c2cc(Nc3cc(C)[nH]n3)nc(Sc4ccc(NC(=O)C5CC5)cc4)n2,,
1279,CHEMBL462018,Triciribine Phosphate,Small molecule,,,,-ribine,Serine/threonine-protein kinase AKT inhibitor,,,CHEMBL2111353,Serine/threonine-protein kinase AKT,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:15231645, URL:http://europepmc.org/abstract/MED/15231645|Name:PubMed, SrcID:19422047, URL:http://europepmc.org/abstract/MED/19422047",CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c4ncnc1c24,,
1280,CHEMBL3039518,Batefenterol,Small molecule,,,,-terol,Muscarinic acetylcholine receptor M3 antagonist,,,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25629394, URL:http://europepmc.org/abstract/MED/25629394|Name:PubMed, SrcID:25100753, URL:http://europepmc.org/abstract/MED/25100753",COc1cc(NC(=O)CCN2CCC(CC2)OC(=O)Nc3ccccc3c4ccccc4)c(Cl)cc1CNC[C@H](O)c5ccc(O)c6NC(=O)C=Cc56,CHEMBL245,CHRM3
1281,CHEMBL3544953,Saf312,Small molecule,,,,,Vanilloid receptor inhibitor,"Indication: Postoperative Pain, Neurogenic Bladder Disorder. Ph2 study terminated, development halted?",,CHEMBL4794,Vanilloid receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.research-projects.uzh.ch/p16592.htm, URL:http://www.research-projects.uzh.ch/p16592.htm",,CHEMBL4794,TRPV1
1282,CHEMBL3707402,Pf-06372865,Small molecule,,,,,GABA-A receptor; anion channel agonist,,,CHEMBL2093872,GABA-A receptor; anion channel,AGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Other, SrcID:https://www.pfizer.com/sites/default/files/product-pipeline/July%2028%202015%20Pipeline%20Update.pdf, URL:https://www.pfizer.com/sites/default/files/product-pipeline/July%2028%202015%20Pipeline%20Update.pdf|Name:Other, SrcID:http://adisinsight.springer.com/drugs/800039009, URL:http://adisinsight.springer.com/drugs/800039009",,CHEMBL2093872,GABRG3
1283,CHEMBL3707402,Pf-06372865,Small molecule,,,,,GABA-A receptor; anion channel agonist,,,CHEMBL2093872,GABA-A receptor; anion channel,AGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Other, SrcID:https://www.pfizer.com/sites/default/files/product-pipeline/July%2028%202015%20Pipeline%20Update.pdf, URL:https://www.pfizer.com/sites/default/files/product-pipeline/July%2028%202015%20Pipeline%20Update.pdf|Name:Other, SrcID:http://adisinsight.springer.com/drugs/800039009, URL:http://adisinsight.springer.com/drugs/800039009",,CHEMBL2093872,GABRP
1284,CHEMBL3707402,Pf-06372865,Small molecule,,,,,GABA-A receptor; anion channel agonist,,,CHEMBL2093872,GABA-A receptor; anion channel,AGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Other, SrcID:https://www.pfizer.com/sites/default/files/product-pipeline/July%2028%202015%20Pipeline%20Update.pdf, URL:https://www.pfizer.com/sites/default/files/product-pipeline/July%2028%202015%20Pipeline%20Update.pdf|Name:Other, SrcID:http://adisinsight.springer.com/drugs/800039009, URL:http://adisinsight.springer.com/drugs/800039009",,CHEMBL2093872,GABRE
1285,CHEMBL3707402,Pf-06372865,Small molecule,,,,,GABA-A receptor; anion channel agonist,,,CHEMBL2093872,GABA-A receptor; anion channel,AGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Other, SrcID:https://www.pfizer.com/sites/default/files/product-pipeline/July%2028%202015%20Pipeline%20Update.pdf, URL:https://www.pfizer.com/sites/default/files/product-pipeline/July%2028%202015%20Pipeline%20Update.pdf|Name:Other, SrcID:http://adisinsight.springer.com/drugs/800039009, URL:http://adisinsight.springer.com/drugs/800039009",,CHEMBL2093872,GABRG1
1286,CHEMBL282686,Tesaglitazar,Small molecule,,,,-glitazar,Peroxisome proliferator-activated receptor gamma agonist,"All Ph3 trials terminated, discontinued due to safety concerns (http://en.wikipedia.org/wiki/Tesaglitazar)",,CHEMBL235,Peroxisome proliferator-activated receptor gamma,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Tesaglitazar, URL:http://en.wikipedia.org/wiki/Tesaglitazar|Name:PubMed, SrcID:15059948, URL:http://europepmc.org/abstract/MED/15059948|Name:PubMed, SrcID:16628256, URL:http://europepmc.org/abstract/MED/16628256",CCO[C@@H](Cc1ccc(OCCc2ccc(OS(=O)(=O)C)cc2)cc1)C(=O)O,CHEMBL235,PPARG
1287,CHEMBL1091644,Linsitinib,Small molecule,,,,-tinib,Insulin-like growth factor I receptor inhibitor,,,CHEMBL1957,Insulin-like growth factor I receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25208878, URL:http://europepmc.org/abstract/MED/25208878|Name:PubMed, SrcID:21425998, URL:http://europepmc.org/abstract/MED/21425998|Name:PubMed, SrcID:17671083, URL:http://europepmc.org/abstract/MED/17671083",C[C@@]1(O)C[C@@H](C1)c2nc(c3ccc4ccc(nc4c3)c5ccccc5)c6c(N)nccn26,CHEMBL1957,IGF1R
1288,CHEMBL2103830,Fostamatinib,Small molecule,,,,fos-; -tinib,Tyrosine-protein kinase SYK inhibitor,Prodrug - active metabolite is R-406,,CHEMBL2599,Tyrosine-protein kinase SYK,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19965662, URL:http://europepmc.org/abstract/MED/19965662",COc1cc(Nc2ncc(F)c(Nc3ccc4OC(C)(C)C(=O)N(COP(=O)(O)O)c4n3)n2)cc(OC)c1OC,CHEMBL2599,SYK
1289,CHEMBL3039511,Bevenopran,Small molecule,,,,-opran,Mu opioid receptor antagonist,All phase 3 studies have been terminated.,,CHEMBL233,Mu opioid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.ukmi.nhs.uk/applications/ndo/record_view_open.asp?newDrugID=5826, URL:http://www.ukmi.nhs.uk/applications/ndo/record_view_open.asp?newDrugID=5826",COc1cc(CNCCC2CCOCC2)ccc1Oc3cnc(cn3)C(=O)N,CHEMBL233,OPRM1
1290,CHEMBL572881,Motesanib,Small molecule,,,,-anib,Platelet-derived growth factor receptor inhibitor,Multi-kinase inhibitor,,CHEMBL2095189,Platelet-derived growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:16951187, URL:http://europepmc.org/abstract/MED/16951187",CC1(C)CNc2cc(NC(=O)c3cccnc3NCc4ccncc4)ccc12,,
1291,CHEMBL1743071,Sirukumab,Antibody,,,,-mab,Interleukin-6 inhibitor,It binds to soluble IL-6 and inhibits IL-6-mediated signal transducers and activation of transcription-3 phosphorylation (STAT-3).,,CHEMBL1795129,Interleukin-6,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21392075, URL:http://europepmc.org/abstract/MED/21392075",,CHEMBL1795129,IL6
1292,CHEMBL2108228,Bectumomab,Antibody,,,,-mab,CD22 other,Binds to CD22-expressing lymphocytes. It is used to determined through nuclear imaging the extent of CD22-expressing lymphomas.,,CHEMBL3218,CD22,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12537673, URL:http://europepmc.org/abstract/MED/12537673",,CHEMBL3218,CD22
1293,CHEMBL2109150,Lintuzumab,Antibody,,,,-mab,Myeloid cell surface antigen CD33 other,Antibody-dependent cell mediated cytotoxixity. Complement mediated cytotoxicity.,,CHEMBL1842,Myeloid cell surface antigen CD33,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:1458463, URL:http://europepmc.org/abstract/MED/1458463",,CHEMBL1842,CD33
1294,CHEMBL2107859,Rozrolimupab,Unknown,,,,,Rhesus D antigen inhibitor,,,CHEMBL3712996,Blood group Rh(D) polypeptide,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22915649, URL:http://europepmc.org/abstract/MED/22915649",,CHEMBL3712996,RHD
1295,CHEMBL2108557,Telbermin,Protein,,,,-ermin,Vascular endothelial growth factor receptor 1 and 2 (Flt-1 and KDR) agonist,,,CHEMBL2111480,Vascular endothelial growth factor receptor 1 and 2 (Flt-1 and KDR),AGONIST,Homo sapiens,SELECTIVITY GROUP,,,"Name:PubMed, SrcID:18210954, URL:http://europepmc.org/abstract/MED/18210954",,,
1296,CHEMBL1215923,Bimosiamose,Small molecule,,,,,Selectin inhibitor,,,CHEMBL3831288,Selectin,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:9544210, URL:http://europepmc.org/abstract/MED/9544210",OC[C@H]1O[C@H](Oc2ccc(CCCCCCc3ccc(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)c(c3)c5cccc(CC(=O)O)c5)cc2c6cccc(CC(=O)O)c6)[C@@H](O)[C@@H](O)[C@@H]1O,,
1297,CHEMBL267495,Nalfurafine,Small molecule,,V03AX02,V03AX02 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Other therapeutic products],nal-,Kappa opioid receptor agonist,,,CHEMBL237,Kappa opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:9501472, URL:http://europepmc.org/abstract/MED/9501472|Name:PubMed, SrcID:10573186, URL:http://europepmc.org/abstract/MED/10573186",CN([C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC6CC6)c45)C(=O)\C=C\c7cocc7,CHEMBL237,OPRK1
1298,CHEMBL2048028,Lifitegrast,Small molecule,2016.0,,,-ast,Integrin alpha-L/beta-2 (LFA-1) antagonist,,,CHEMBL2364172,Integrin alpha-L/beta-2 (LFA-1),ANTAGONIST,Homo sapiens,PROTEIN COMPLEX,,Binds with high-affinity to the site I domain of the aL subunit on LFA-1,"Name:PubMed, SrcID:26807723, URL:http://europepmc.org/abstract/MED/26807723",CS(=O)(=O)c1cccc(C[C@H](NC(=O)c2c(Cl)cc3CN(CCc3c2Cl)C(=O)c4ccc5ccoc5c4)C(=O)O)c1,,
1299,CHEMBL443684,Navitoclax,Small molecule,,,,-toclax,Apoptosis regulator Bcl-W inhibitor,,"High affinity for Bcl-xL, Bcl-2, and Bcl-w (Ki =1 nmol/L).",CHEMBL4677,Apoptosis regulator Bcl-W,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,"Occupies the BH3 binding groove of Bcl-xL, Bcl-2, and Bcl-w.","Name:PubMed, SrcID:18451170, URL:http://europepmc.org/abstract/MED/18451170",CC1(C)CCC(=C(CN2CCN(CC2)c3ccc(cc3)C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc6ccccc6)c(c4)S(=O)(=O)C(F)(F)F)C1)c7ccc(Cl)cc7,CHEMBL4677,BCL2L2-PABPN1
1300,CHEMBL443684,Navitoclax,Small molecule,,,,-toclax,Apoptosis regulator Bcl-W inhibitor,,"High affinity for Bcl-xL, Bcl-2, and Bcl-w (Ki =1 nmol/L).",CHEMBL4677,Apoptosis regulator Bcl-W,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,"Occupies the BH3 binding groove of Bcl-xL, Bcl-2, and Bcl-w.","Name:PubMed, SrcID:18451170, URL:http://europepmc.org/abstract/MED/18451170",CC1(C)CCC(=C(CN2CCN(CC2)c3ccc(cc3)C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc6ccccc6)c(c4)S(=O)(=O)C(F)(F)F)C1)c7ccc(Cl)cc7,CHEMBL4677,BCL2L2
1301,CHEMBL2108341,Sontuzumab,Antibody,,,,-mab,Mucin-1 other,"MUC1 is a glycoprotein overexpressed in breast and other carcinomas. When monoclonal antibody HuHMFG1 (sontuzumab) binds MUC1, it stimulates antibody-dependent cell-mediated cytotoxicity (ADCC) against tumor cells expressing MUC1, resulting in a decrease in tumor burden.",Antibody binding affinity: Kd~1 nmol/L,CHEMBL3580494,Mucin-1,OTHER,Homo sapiens,SINGLE PROTEIN,,Binds Pro-Asp-Thr-Arg sequences of tandem repeats in Mucin 1 N-terminal extracellular subunit,"Name:PubMed, SrcID:19811637, URL:http://europepmc.org/abstract/MED/19811637|Name:PubMed, SrcID:21878535, URL:http://europepmc.org/abstract/MED/21878535",,,
1302,CHEMBL1743032,Intetumumab,Antibody,,,,-mab,Integrin alpha-V/beta-1 antagonist,,,CHEMBL2111407,Integrin alpha-V/beta-1,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:15095296, URL:http://europepmc.org/abstract/MED/15095296",,,
1303,CHEMBL2109481,Icm3,Antibody,,,,,Intercellular adhesion molecule 3 inhibitor,,,CHEMBL3712862,Intercellular adhesion molecule 3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1016/S0301-472X(00)00274-5, URL:http://www.sciencedirect.com/science/article/pii/S0301472X00002745?via%3Dihub",,CHEMBL3712862,ICAM3
1304,CHEMBL2109539,Rg-7652,Antibody,,,,,Subtilisin/kexin type 9 inhibitor,"Inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9) binding to hepatic low density lipoprotein receptor (LDL-r), thereby blocking PCSK9-mediated degradation of LDL-r.",,CHEMBL2929,Subtilisin/kexin type 9,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24848798, URL:http://europepmc.org/abstract/MED/24848798|Name:PubMed, SrcID:25823668, URL:http://europepmc.org/abstract/MED/25823668",,CHEMBL2929,PCSK9
1305,CHEMBL2109591,Tol-101,Antibody,,,,,T-cell receptor inhibitor,,,CHEMBL3580506,T-cell receptor,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:24751150, URL:http://europepmc.org/abstract/MED/24751150",,CHEMBL3580506,TRGV3
1306,CHEMBL2109256,Sgn-30,Antibody,,,,,Tumor necrosis factor receptor superfamily member 8 agonist,"After binding to CD30, this agent interferes with the G1 phase of the cell cycle, thereby inducing growth arrest and apoptosis in susceptible tumor cell populations.",,CHEMBL2364161,Tumor necrosis factor receptor superfamily member 8,AGONIST,Homo sapiens,SINGLE PROTEIN,,,,,CHEMBL2364161,TNFRSF8
1307,CHEMBL1201286,Oxyphenonium,Small molecule,1982.0,A03AB03; A03AB53,"A03AB03 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: Synthetic anticholinergics, quaternary ammonium compounds]; A03AB53 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: Synthetic anticholinergics, quaternary ammonium compounds]",-ium,Muscarinic acetylcholine receptor M3 antagonist,"Indicated in mydriasis and regulating gastric secretion, M3 likely involved (main form in iris)",,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:1907331, URL:http://europepmc.org/abstract/MED/1907331|Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718",CC[N+](C)(CC)CCOC(=O)C(O)(C1CCCCC1)c2ccccc2,CHEMBL245,CHRM3
1308,CHEMBL1201593,Alteplase,Enzyme,1996.0,B01AD02; S01XA13,B01AD02 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Enzymes]; S01XA13 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-ase,Plasminogen activator,"is TPA, cleaves plasminogen to plasmin",,CHEMBL1801,Plasminogen,ACTIVATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=91ecdef2-95ff-42dd-a31c-c8a09cab3ad9, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=91ecdef2-95ff-42dd-a31c-c8a09cab3ad9",,CHEMBL1801,PLG
1309,CHEMBL511,Pyrilamine,Small molecule,1973.0,R06AC01; D04AA02,"R06AC01 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Substituted ethylene diamines]; D04AA02 [DERMATOLOGICALS: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: Antihistamines for topical use]",,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16402096, URL:http://europepmc.org/abstract/MED/16402096|Name:Wikipedia, SrcID:Pyrilamine, URL:http://en.wikipedia.org/wiki/Pyrilamine",COc1ccc(CN(CCN(C)C)c2ccccn2)cc1,CHEMBL231,HRH1
1310,CHEMBL1201271,Buclizine,Small molecule,1982.0,R06AE01; R06AE51,R06AE01 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Piperazine derivatives]; R06AE51 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Piperazine derivatives],,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20515533, URL:http://europepmc.org/abstract/MED/20515533|Name:KEGG, SrcID:D02089, URL:http://www.kegg.jp/dbget-bin/www_bget?dr:D02089",CC(C)(C)c1ccc(CN2CCN(CC2)C(c3ccccc3)c4ccc(Cl)cc4)cc1,CHEMBL231,HRH1
1311,CHEMBL499,Timolol,Small molecule,1978.0,S01ED51; C07AA06; S01ED01,"S01ED51 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Beta blocking agents 1)]; C07AA06 [CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, non-selective]; S01ED01 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Beta blocking agents 1)]",-olol,Beta-1 adrenergic receptor antagonist,,,CHEMBL213,Beta-1 adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=00f62dd1-dad2-4892-8a5d-21e5e54509ce, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=00f62dd1-dad2-4892-8a5d-21e5e54509ce",CC(C)(C)NC[C@H](O)COc1nsnc1N2CCOCC2,,
1312,CHEMBL704,Mesalamine,Small molecule,1987.0,A07EC02,"A07EC02 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Aminosalicylic acid and similar agents]",-sal-,Peroxisome proliferator-activated receptor gamma agonist,,,CHEMBL235,Peroxisome proliferator-activated receptor gamma,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15824083, URL:http://europepmc.org/abstract/MED/15824083|Name:PubMed, SrcID:18077625, URL:http://europepmc.org/abstract/MED/18077625|Name:PubMed, SrcID:18544567, URL:http://europepmc.org/abstract/MED/18544567",Nc1ccc(O)c(c1)C(=O)O,CHEMBL235,PPARG
1313,CHEMBL376359,Alogliptin,Small molecule,2013.0,A10BH04,"A10BH04 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Dipeptidyl peptidase 4 (DPP-4) inhibitors]",-gliptin,Dipeptidyl peptidase IV inhibitor,,,CHEMBL284,Dipeptidyl peptidase IV,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=a3768c7e-aa4c-44d3-bc53-43bb7346c0b0, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a3768c7e-aa4c-44d3-bc53-43bb7346c0b0",CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(Cc3ccccc3C#N)C1=O,CHEMBL284,DPP4
1314,CHEMBL1201717,Mecasermin Rinfabate,Protein,2005.0,H01AC05,"H01AC05 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES: Somatropin and somatropin agonists]",-ermin,Insulin-like growth factor I receptor agonist,,,CHEMBL1957,Insulin-like growth factor I receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=a8b27a1b-a611-4f91-ad22-76d4b390c3ae, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a8b27a1b-a611-4f91-ad22-76d4b390c3ae",,CHEMBL1957,IGF1R
1315,CHEMBL1040,25-Hydroxycholecalciferol,Small molecule,1980.0,,,calci-,Vitamin D receptor agonist,,,CHEMBL1977,Vitamin D receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15503649, URL:http://europepmc.org/abstract/MED/15503649",C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2\C(=C\C=C/3\C[C@@H](O)CCC3=C)\CCC[C@]12C,CHEMBL1977,VDR
1316,CHEMBL1324,Tolcapone,Small molecule,1998.0,N04BX01,N04BX01 [NERVOUS SYSTEM: ANTI-PARKINSON DRUGS: DOPAMINERGIC AGENTS: Other dopaminergic agents],-capone,Catechol O-methyltransferase inhibitor,,,CHEMBL2023,Catechol O-methyltransferase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=a0e47a9d-78e7-4523-983a-aa259f221736#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a0e47a9d-78e7-4523-983a-aa259f221736#nlm34090-1",Cc1ccc(cc1)C(=O)c2cc(O)c(O)c(c2)[N+](=O)[O-],CHEMBL2023,COMT
1317,CHEMBL2105717,Cabozantinib,Small molecule,2012.0,L01XE26,L01XE26 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Vascular endothelial growth factor receptor 2 inhibitor,"Multi-kinase inhibitor; Cabozantinib (XL184) is a potent inhibitor of MET and VEGFR2 that also inhibits RET, KIT, AXL, and FLT3, all of which have been implicated in tumor pathogenesis (PMID: 21926191)",,CHEMBL279,Vascular endothelial growth factor receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=1a0c3bea-c87b-4d25-bb44-5f0174da6b34, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a0c3bea-c87b-4d25-bb44-5f0174da6b34|Name:PubMed, SrcID:23104465, URL:http://europepmc.org/abstract/MED/23104465|Name:PubMed, SrcID:21926191, URL:http://europepmc.org/abstract/MED/21926191",COc1cc2nccc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc5ccc(F)cc5)cc3)c2cc1OC,CHEMBL279,KDR
1318,CHEMBL1566,Acarbose,Small molecule,1995.0,A10BF01,"A10BF01 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Alpha glucosidase inhibitors]",,Maltase-glucoamylase inhibitor,,,CHEMBL2074,Maltase-glucoamylase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=29a6f213-bc93-4dbd-bab0-744722b6f0b8, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=29a6f213-bc93-4dbd-bab0-744722b6f0b8|Name:InterPro, SrcID:IPR000322, URL:http://www.ebi.ac.uk/interpro/entry/IPR000322",C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)O[C@@H]3CO)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1N[C@H]4C=C(CO)[C@@H](O)[C@H](O)[C@H]4O,CHEMBL2074,MGAM
1319,CHEMBL1199080,Bretylium,Small molecule,1986.0,,,-ium,Norepinephrine transporter substrate,Taken up by transporter and displaces NE from vesicles,,CHEMBL222,Norepinephrine transporter,SUBSTRATE,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 190-191, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:9142404, URL:http://europepmc.org/abstract/MED/9142404|Name:PubMed, SrcID:18071295, URL:http://europepmc.org/abstract/MED/18071295",CC[N+](C)(C)Cc1ccccc1Br,CHEMBL222,SLC6A2
1320,CHEMBL220492,Topiramate,Small molecule,1996.0,N03AX11,N03AX11 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],,Carbonic anhydrase IV inhibitor,,,CHEMBL3729,Carbonic anhydrase IV,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=21628112-0c47-11df-95b3-498d55d89593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=21628112-0c47-11df-95b3-498d55d89593#nlm34090-1|Name:PubMed, SrcID:10768292, URL:http://europepmc.org/abstract/MED/10768292",CC1(C)O[C@@H]2CO[C@@]3(COS(=O)(=O)N)OC(C)(C)O[C@H]3[C@@H]2O1,CHEMBL3729,CA4
1321,CHEMBL1742994,Brentuximab Vedotin,Antibody,2011.0,L01XC12,L01XC12 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,Binds to beta tubulin,"Name:PubMed, SrcID:12714494, URL:http://europepmc.org/abstract/MED/12714494|Name:PubMed, SrcID:23515511, URL:http://europepmc.org/abstract/MED/23515511|Name:DailyMed, SrcID:setid=3904f8dd-1aef-3490-e48f-bd55f32ed67f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3904f8dd-1aef-3490-e48f-bd55f32ed67f",,CHEMBL2095182,TUBB8
1322,CHEMBL1742994,Brentuximab Vedotin,Antibody,2011.0,L01XC12,L01XC12 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,Binds to beta tubulin,"Name:PubMed, SrcID:12714494, URL:http://europepmc.org/abstract/MED/12714494|Name:PubMed, SrcID:23515511, URL:http://europepmc.org/abstract/MED/23515511|Name:DailyMed, SrcID:setid=3904f8dd-1aef-3490-e48f-bd55f32ed67f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3904f8dd-1aef-3490-e48f-bd55f32ed67f",,CHEMBL2095182,TUBA3C
1323,CHEMBL1742994,Brentuximab Vedotin,Antibody,2011.0,L01XC12,L01XC12 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,Binds to beta tubulin,"Name:PubMed, SrcID:12714494, URL:http://europepmc.org/abstract/MED/12714494|Name:PubMed, SrcID:23515511, URL:http://europepmc.org/abstract/MED/23515511|Name:DailyMed, SrcID:setid=3904f8dd-1aef-3490-e48f-bd55f32ed67f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3904f8dd-1aef-3490-e48f-bd55f32ed67f",,CHEMBL2095182,TUBA4A
1324,CHEMBL1742994,Brentuximab Vedotin,Antibody,2011.0,L01XC12,L01XC12 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,Binds to beta tubulin,"Name:PubMed, SrcID:12714494, URL:http://europepmc.org/abstract/MED/12714494|Name:PubMed, SrcID:23515511, URL:http://europepmc.org/abstract/MED/23515511|Name:DailyMed, SrcID:setid=3904f8dd-1aef-3490-e48f-bd55f32ed67f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3904f8dd-1aef-3490-e48f-bd55f32ed67f",,CHEMBL2095182,TUBA3E
1325,CHEMBL1742994,Brentuximab Vedotin,Antibody,2011.0,L01XC12,L01XC12 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,Binds to beta tubulin,"Name:PubMed, SrcID:12714494, URL:http://europepmc.org/abstract/MED/12714494|Name:PubMed, SrcID:23515511, URL:http://europepmc.org/abstract/MED/23515511|Name:DailyMed, SrcID:setid=3904f8dd-1aef-3490-e48f-bd55f32ed67f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3904f8dd-1aef-3490-e48f-bd55f32ed67f",,CHEMBL2095182,TUBB6
1326,CHEMBL1742994,Brentuximab Vedotin,Antibody,2011.0,L01XC12,L01XC12 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,Binds to beta tubulin,"Name:PubMed, SrcID:12714494, URL:http://europepmc.org/abstract/MED/12714494|Name:PubMed, SrcID:23515511, URL:http://europepmc.org/abstract/MED/23515511|Name:DailyMed, SrcID:setid=3904f8dd-1aef-3490-e48f-bd55f32ed67f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3904f8dd-1aef-3490-e48f-bd55f32ed67f",,CHEMBL2095182,TUBB2B
1327,CHEMBL1742994,Brentuximab Vedotin,Antibody,2011.0,L01XC12,L01XC12 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,Binds to beta tubulin,"Name:PubMed, SrcID:12714494, URL:http://europepmc.org/abstract/MED/12714494|Name:PubMed, SrcID:23515511, URL:http://europepmc.org/abstract/MED/23515511|Name:DailyMed, SrcID:setid=3904f8dd-1aef-3490-e48f-bd55f32ed67f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3904f8dd-1aef-3490-e48f-bd55f32ed67f",,CHEMBL2095182,TUBA3D
1328,CHEMBL760,Anagrelide,Small molecule,1997.0,L01XX35,L01XX35 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-grel-,Phosphodiesterase 3 inhibitor,,,CHEMBL2094125,Phosphodiesterase 3,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:21120194, URL:http://europepmc.org/abstract/MED/21120194|Name:Wikipedia, SrcID:PDE3, URL:http://en.wikipedia.org/wiki/PDE3|Name:FDA, SrcID:label/2015/020333s023lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020333s023lbl.pdf|Name:DailyMed, SrcID:setid=288cdfbb-c15b-4321-9ee1-9c2f2aadbb4f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=288cdfbb-c15b-4321-9ee1-9c2f2aadbb4f",Clc1ccc2N=C3NC(=O)CN3Cc2c1Cl,,
1329,CHEMBL190,Theophylline,Small molecule,1940.0,R03DA04; R03DA54; R03DA74,R03DA04 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: Xanthines]; R03DA54 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: Xanthines]; R03DA74 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: Xanthines],,Adenosine receptor antagonist,,,CHEMBL2111329,Adenosine receptor,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:15980878, URL:http://europepmc.org/abstract/MED/15980878|Name:PubMed, SrcID:12954362, URL:http://europepmc.org/abstract/MED/12954362|Name:PubMed, SrcID:3588607, URL:http://europepmc.org/abstract/MED/3588607|Name:PubMed, SrcID:14992338, URL:http://europepmc.org/abstract/MED/14992338|Name:Wikipedia, SrcID:Theophylline#Mechanisms_of_action, URL:http://en.wikipedia.org/wiki/Theophylline#Mechanisms_of_action",CN1C(=O)N(C)c2nc[nH]c2C1=O,,
1330,CHEMBL1082407,Enzalutamide,Small molecule,2012.0,L02BB04,L02BB04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONE ANTAGONISTS AND RELATED AGENTS: Anti-androgens],-lutamide,Androgen Receptor antagonist,,,CHEMBL1871,Androgen Receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Expert, SrcID:ENZALUTAMIDE, URL:http://chembl.blogspot.co.uk/search?q=ENZALUTAMIDE",CNC(=O)c1ccc(cc1F)N2C(=S)N(C(=O)C2(C)C)c3ccc(C#N)c(c3)C(F)(F)F,CHEMBL1871,AR
1331,CHEMBL1479,Danazol,Small molecule,1976.0,G03XA01,G03XA01 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: Antigonadotropins and similar agents],,Androgen Receptor agonist,,,CHEMBL1871,Androgen Receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:0443-059748 PP. 447, URL:http://www.isbnsearch.org/isbn/0443059748|Name:DailyMed, SrcID:setid=d30a0bb0-d8e4-e17a-0f8b-6696a2712e98#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d30a0bb0-d8e4-e17a-0f8b-6696a2712e98#nlm34090-1|Name:FDA, SrcID:label/2011/017557s033s039s040s041s042lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/017557s033s039s040s041s042lbl.pdf|Name:PubMed, SrcID:18061638, URL:http://europepmc.org/abstract/MED/18061638",C[C@]12Cc3cnoc3C=C1CC[C@@H]4[C@@H]2CC[C@@]5(C)[C@H]4CC[C@@]5(O)C#C,CHEMBL1871,AR
1332,CHEMBL1263,Salmeterol,Small molecule,1994.0,R03AC12,"R03AC12 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS, INHALANTS: Selective beta-2-adrenoreceptor agonists]",sal-; -terol,Beta-2 adrenergic receptor agonist,,,CHEMBL210,Beta-2 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f53cb2d5-3267-401e-9393-dff8357830dd#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f53cb2d5-3267-401e-9393-dff8357830dd#nlm34090-1",OCc1cc(ccc1O)C(O)CNCCCCCCOCCCCc2ccccc2,CHEMBL210,ADRB2
1333,CHEMBL631,Propafenone,Small molecule,1989.0,C01BC03,"C01BC03 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class Ic]",-afenone,Beta-2 adrenergic receptor antagonist,,,CHEMBL210,Beta-2 adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=d4a552ce-f215-4ec7-b5dd-aee266ba9b08, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d4a552ce-f215-4ec7-b5dd-aee266ba9b08",CCCNCC(O)COc1ccccc1C(=O)CCc2ccccc2,CHEMBL210,ADRB2
1334,CHEMBL499808,Caspofungin,Small molecule,2001.0,J02AX04,J02AX04 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: Other antimycotics for systemic use],-fungin,"1,3-beta-glucan synthase inhibitor",,,CHEMBL2364674,"1,3-beta-glucan synthase",INHIBITOR,Aspergillus,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=3bad23a6-09a6-4194-9182-093ed61bc71c#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3bad23a6-09a6-4194-9182-093ed61bc71c#nlm34090-1",CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)c4ccc(O)cc4)[C@H](O)CCN,,
1335,CHEMBL1201557,Interferon Alfacon-1,Protein,1997.0,L03AB09,L03AB09 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSTIMULANTS: IMMUNOSTIMULANTS: Interferons],,Interferon alpha/beta receptor agonist,,,CHEMBL2364170,Interferon alpha/beta receptor,AGONIST,Homo sapiens,PROTEIN COMPLEX,,Alpha subunit is binding site,"Name:PubMed, SrcID:17969444, URL:http://europepmc.org/abstract/MED/17969444|Name:DailyMed, SrcID:setid=29ad47ed-cb94-470b-b3ab-9281abf414d5, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=29ad47ed-cb94-470b-b3ab-9281abf414d5|Name:FDA, SrcID:label/2013/103663s5093lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/103663s5093lbl.pdf",,CHEMBL2364170,IFNAR2
1336,CHEMBL1321,Procarbazine,Small molecule,1969.0,L01XB01,L01XB01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Methylhydrazines],,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=de1c8271-64d8-4ea5-85e8-871faa4d7632, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de1c8271-64d8-4ea5-85e8-871faa4d7632|Name:Wikipedia, SrcID:Procarbazine, URL:http://en.wikipedia.org/wiki/Procarbazine",CNNCc1ccc(cc1)C(=O)NC(C)C,,
1337,CHEMBL141,Lamivudine,Small molecule,1995.0,J05AF05,J05AF05 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleoside and nucleotide reverse transcriptase inhibitors],-vudine,DNA polymerase/reverse transcriptase inhibitor,"When monophosporylated is incorporates into the DNA, when triphosporylated inhibits the enzymes",,CHEMBL2362994,DNA polymerase/reverse transcriptase,INHIBITOR,Hepatitis B virus,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=bc62b38c-4cc9-4e64-8852-1a0be6d36d8e, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bc62b38c-4cc9-4e64-8852-1a0be6d36d8e",NC1=NC(=O)N(C=C1)[C@@H]2CS[C@H](CO)O2,,
1338,CHEMBL1095,Ethotoin,Small molecule,1957.0,N03AB01,N03AB01 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Hydantoin derivatives],-toin,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:15208697, URL:http://europepmc.org/abstract/MED/15208697|Name:PubMed, SrcID:23205958, URL:http://europepmc.org/abstract/MED/23205958|Name:FDA, SrcID:label/2010/010841s022lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/010841s022lbl.pdf|Name:DailyMed, SrcID:setid=a9ad9c6e-bce5-4d0d-a2dd-b8fd1ef0b565#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a9ad9c6e-bce5-4d0d-a2dd-b8fd1ef0b565#nlm34090-1",CCN1C(=O)NC(C1=O)c2ccccc2,,
1339,CHEMBL3301678,Monoctanoin,Small molecule,1985.0,,,,Unknown,,,,,,,,,,"Name:PubMed, SrcID:3902430, URL:http://europepmc.org/abstract/MED/3902430|Name:PubMed, SrcID:2877061, URL:http://europepmc.org/abstract/MED/2877061",CCCCCCCCCC(=O)OCC(O)CO.CCCCCCCC(=O)OCC(O)CO.CCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCC.OCC(O)CO,,
1340,CHEMBL506,Primaquine,Small molecule,1952.0,P01BA03,"P01BA03 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: ANTIMALARIALS: Aminoquinolines]",,Unknown,Mode of action not fully understood; it seems to cause the disruption of the lipid layers in plasmodium parasites,,,,,,,,,"Name:Wikipedia, SrcID:Primaquine, URL:http://en.wikipedia.org/wiki/Primaquine|Name:Wikipedia, SrcID:Hemozoin, URL:http://en.wikipedia.org/wiki/Hemozoin|Name:PubMed, SrcID:20713019, URL:http://europepmc.org/abstract/MED/20713019",COc1cc(NC(C)CCCN)c2ncccc2c1,,
1341,CHEMBL2109931,Samarium(Ii) Lexidronam,Small molecule,1997.0,,,,Unknown,,,,,,,,,,"Name:DailyMed, SrcID:setid=89cae12d-05fc-4d53-920f-e271b2940a5d, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=89cae12d-05fc-4d53-920f-e271b2940a5d",,,
1342,CHEMBL1863514,Asparaginase Erwinia Chrysanthemi,Enzyme,2011.0,,,-ase,Asparagine hydrolytic enzyme,,,CHEMBL2364706,Asparagine,HYDROLYTIC ENZYME,Homo sapiens,SMALL MOLECULE,,,"Name:DailyMed, SrcID:setid=30bdf2ea-008b-4cbb-81e4-c3474f2ad286#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=30bdf2ea-008b-4cbb-81e4-c3474f2ad286#nlm34090-1",,,
1343,CHEMBL2374220,Ledipasvir,Small molecule,2014.0,,,-vir,Nonstructural protein 5A inhibitor,,,CHEMBL3307224,Nonstructural protein 5A,INHIBITOR,Hepatitis C virus,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2014/205834s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205834s000lbl.pdf",COC(=O)N[C@@H](C(C)C)C(=O)N1CC2(CC2)C[C@H]1c3nc(c[nH]3)c4ccc5c6ccc(cc6C(F)(F)c5c4)c7ccc8[nH]c(nc8c7)[C@@H]9[C@H]%10CC[C@H](C%10)N9C(=O)[C@@H](NC(=O)OC)C(C)C,,
1344,CHEMBL3301597,Ferric Citrate,Small molecule,2014.0,V03AE08,V03AE08 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Drugs for treatment of hyperkalemia and hyperphosphatemia],,Phosphate sequestering agent,,,CHEMBL2364184,Phosphate,SEQUESTERING AGENT,Homo sapiens,SMALL MOLECULE,,,"Name:FDA, SrcID:label/2014/205874s001lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205874s001lbl.pdf",,,
1345,CHEMBL550,Pilocarpine,Small molecule,1974.0,S01EB51; S01EB01; N07AX01,S01EB51 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Parasympathomimetics]; S01EB01 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Parasympathomimetics]; N07AX01 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: PARASYMPATHOMIMETICS: Other parasympathomimetics],-pin(e),Muscarinic acetylcholine receptor M1 agonist,"Indicated for dry mouth, M1 likely involved",,CHEMBL216,Muscarinic acetylcholine receptor M1,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11726216, URL:http://europepmc.org/abstract/MED/11726216",CC[C@H]1[C@@H](Cc2cncn2C)COC1=O,CHEMBL216,CHRM1
1346,CHEMBL2111107,Sugammadex,Unknown,2015.0,V03AB35,V03AB35 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Antidotes],,Vecuronium sequestering agent,,,CHEMBL3559391,Vecuronium,SEQUESTERING AGENT,,SMALL MOLECULE,,,"Name:FDA, SrcID:label/2015/022225lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022225lbl.pdf",O[C@@H]1[C@@H](O)[C@@H]2O[C@H]3O[C@H](CSCCC(=O)O)[C@@H](O[C@H]4O[C@H](CSCCC(=O)O)[C@@H](O[C@H]5O[C@H](CSCCC(=O)O)[C@@H](O[C@H]6O[C@H](CSCCC(=O)O)[C@@H](O[C@H]7O[C@H](CSCCC(=O)O)[C@@H](O[C@H]8O[C@H](CSCCC(=O)O)[C@@H](O[C@H]9O[C@H](CSCCC(=O)O)[C@@H](O[C@H]1O[C@@H]2CSCCC(=O)O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)C6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O,,
1347,CHEMBL3261331,Mgl-3196,Small molecule,,,,,Thyroid hormone receptor beta-1 agonist,,,CHEMBL1947,Thyroid hormone receptor beta-1,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24712661, URL:http://europepmc.org/abstract/MED/24712661|Name:Other, SrcID:http://www.madrigalpharma.com/home-page/pipeline/thr-beta-agonist/, URL:http://www.madrigalpharma.com/home-page/pipeline/thr-beta-agonist/",CC(C)C1=CC(=NNC1=O)Oc2c(Cl)cc(cc2Cl)N3N=C(C#N)C(=O)NC3=O,CHEMBL1947,THRB
1348,CHEMBL3545284,Cerdulatinib,Small molecule,,,,-tinib,Tyrosine-protein kinase TYK2 inhibitor,Dual spleen tyrosine kinase (Syk) and janus kinase (JAK) inhibitor,,CHEMBL3553,Tyrosine-protein kinase TYK2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25253883, URL:http://europepmc.org/abstract/MED/25253883",,CHEMBL3553,TYK2
1349,CHEMBL3545195,Ly-3009120,Small molecule,,,,,Serine/threonine-protein kinase B-raf inhibitor,,,CHEMBL5145,Serine/threonine-protein kinase B-raf,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25965804, URL:http://europepmc.org/abstract/MED/25965804",,CHEMBL5145,BRAF
1350,CHEMBL3545195,Ly-3009120,Small molecule,,,,,Serine/threonine-protein kinase RAF inhibitor,,,CHEMBL1906,Serine/threonine-protein kinase RAF,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25965804, URL:http://europepmc.org/abstract/MED/25965804",,CHEMBL1906,RAF1
1351,CHEMBL3545331,Rpr749,Small molecule,,,,,Adenosine A1 receptor agonist,,,CHEMBL226,Adenosine A1 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16654164, URL:http://www.ncbi.nlm.nih.gov/pubmed/?term=16654164|Name:PubMed, SrcID:15133532, URL:http://europepmc.org/abstract/MED/15133532",,CHEMBL226,ADORA1
1352,CHEMBL3545012,Dsp-2230,Small molecule,,,,,Sodium channel protein type IX alpha subunit blocker,,,CHEMBL4296,Sodium channel protein type IX alpha subunit,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.ds-pharma.com/rd/clinical/pipeline_profile.html, URL:http://www.ds-pharma.com/rd/clinical/pipeline_profile.html|Name:Wikipedia, SrcID:DSP-2230, URL:https://en.wikipedia.org/wiki/DSP-2230",,CHEMBL4296,SCN9A
1353,CHEMBL2103838,Dilmapimod,Small molecule,,,,-imod,MAP kinase p38 alpha inhibitor,,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7815, URL:http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7815|Name:PubMed, SrcID:9808629, URL:http://europepmc.org/abstract/MED/9808629|Name:PubMed, SrcID:19880675, URL:http://europepmc.org/abstract/MED/19880675",Cc1cc(F)ccc1c2nc(NC(CO)CO)nc3N(C(=O)C=Cc23)c4c(F)cccc4F,CHEMBL260,MAPK14
1354,CHEMBL3545400,Sar-103168,Small molecule,,,,,Unknown,Multi-targeted kinase inhibitor,,,,,,,,,"Name:Other, SrcID:https://ncats.nih.gov/files/SAR103168.pdf, URL:https://ncats.nih.gov/files/SAR103168.pdf",,,
1355,CHEMBL3545285,Xl-999,Small molecule,,,,,Vascular endothelial growth factor receptor inhibitor,Spectrum Selective Kinase Inhibitor (SSKI),,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://www.exelixis.com/sites/default/files/pdf/XL999_AACR-NCI-EORTCnov05.pdf, URL:http://www.exelixis.com/sites/default/files/pdf/XL999_AACR-NCI-EORTCnov05.pdf|Name:DOI, SrcID:10.1016/S1359-6349(04)80149-6, URL:http://www.sciencedirect.com/science/article/pii/S1359634904801496|Name:PubMed, SrcID:21613405, URL:http://europepmc.org/abstract/MED/21613405",,,
1356,CHEMBL2043437,Glasdegib,Small molecule,,,,-degib,Smoothened homolog antagonist,,,CHEMBL5971,Smoothened homolog,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.pfizer.com/research/science_and_technology/product_pipeline, URL:http://www.pfizer.com/research/science_and_technology/product_pipeline",CN1CC[C@H](C[C@@H]1c2nc3ccccc3[nH]2)NC(=O)Nc4ccc(cc4)C#N,CHEMBL5971,SMO
1357,CHEMBL2103828,Elinogrel,Small molecule,,,,-grel,Purinergic receptor P2Y12 antagonist,,,CHEMBL2001,Purinergic receptor P2Y12,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20608816, URL:http://europepmc.org/abstract/MED/20608816",CNc1cc2NC(=O)N(C(=O)c2cc1F)c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3,CHEMBL2001,P2RY12
1358,CHEMBL2104986,Tedatioxetine,Small molecule,,,,-oxetine,Norepinephrine transporter inhibitor,,,CHEMBL222,Norepinephrine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://www.google.com/patents/US20100144788, URL:https://www.google.com/patents/US20100144788|Name:Other, SrcID:http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false, URL:http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false|Name:Wikipedia, SrcID:Tedatioxetine, URL:http://en.wikipedia.org/wiki/Tedatioxetine",Cc1ccc(Sc2ccccc2C3CCNCC3)cc1,CHEMBL222,SLC6A2
1359,CHEMBL2104986,Tedatioxetine,Small molecule,,,,-oxetine,Serotonin 2c (5-HT2c) receptor antagonist,,,CHEMBL225,Serotonin 2c (5-HT2c) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://www.google.com/patents/US20100144788, URL:https://www.google.com/patents/US20100144788|Name:Other, SrcID:http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false, URL:http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false|Name:Wikipedia, SrcID:Tedatioxetine, URL:http://en.wikipedia.org/wiki/Tedatioxetine",Cc1ccc(Sc2ccccc2C3CCNCC3)cc1,,
1360,CHEMBL3545034,Ono-2333ms,Small molecule,,,,,Corticotropin releasing factor receptor 1 antagonist,,,CHEMBL1800,Corticotropin releasing factor receptor 1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23294766, URL:http://europepmc.org/abstract/MED/23294766",,CHEMBL1800,CRHR1
1361,CHEMBL207197,Olcegepant,Small molecule,,,,-gepant,Calcitonin gene-related peptide type 1 receptor antagonist,,,CHEMBL3798,Calcitonin gene-related peptide type 1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10711339, URL:http://europepmc.org/abstract/MED/10711339|Name:PubMed, SrcID:18808506, URL:http://europepmc.org/abstract/MED/18808506",NCCCC[C@H](NC(=O)[C@@H](Cc1cc(Br)c(O)c(Br)c1)NC(=O)N2CCC(CC2)N3Cc4ccccc4NC3=O)C(=O)N5CCN(CC5)c6ccncc6,,
1362,CHEMBL2442750,Qav680,Small molecule,,,,,G protein-coupled receptor 44 antagonist,,,CHEMBL5071,G protein-coupled receptor 44,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24021582, URL:http://europepmc.org/abstract/MED/24021582",Cc1c(CC(=O)O)c2cccnc2n1Cc3ccc(cc3)S(=O)(=O)C,CHEMBL5071,PTGDR2
1363,CHEMBL189676,Surinabant,Small molecule,,,,-nab-,Cannabinoid CB1 receptor antagonist,,,CHEMBL218,Cannabinoid CB1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15131245, URL:http://europepmc.org/abstract/MED/15131245",CCc1c(nn(c2ccc(Cl)cc2Cl)c1c3ccc(Br)cc3)C(=O)NN4CCCCC4,CHEMBL218,CNR1
1364,CHEMBL3545169,Azd1305,Small molecule,,,,,HERG blocker,"L-type calcium channel (CACNA1C, CACNA1D, CACNA1S, CACNA1F)",,CHEMBL240,HERG,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20233758, URL:http://europepmc.org/abstract/MED/20233758|Name:PubMed, SrcID:19528812, URL:http://europepmc.org/abstract/MED/19528812|Name:Wikipedia, SrcID:AZD1305, URL:http://en.wikipedia.org/wiki/AZD1305",CC(C)(C)OC(=O)NCCN1CC2CN(CCOc3ccc(cc3F)C#N)CC(C1)O2,CHEMBL240,KCNH2
1365,CHEMBL3707400,Indantadol,Small molecule,,,,-adol,Monoamine oxidase A inhibitor,,,CHEMBL1951,Monoamine oxidase A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15671203, URL:http://europepmc.org/abstract/MED/15671203",,CHEMBL1951,MAOA
1366,CHEMBL428690,Alvocidib,Small molecule,,,,,Cyclin-dependent kinase 1 inhibitor,,,CHEMBL308,Cyclin-dependent kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25215591, URL:http://europepmc.org/abstract/MED/25215591|Name:PubMed, SrcID:15217973, URL:http://europepmc.org/abstract/MED/15217973",CN1CC[C@@H]([C@H](O)C1)c2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccccc4Cl,CHEMBL308,CDK1
1367,CHEMBL220808,Sarizotan,Small molecule,,,,-zotan,Serotonin 1a (5-HT1a) receptor agonist,"Development discontunued, failed to meet primary efficacy endpoints, no difference between drug and placebo. Newron developing drug for Rett syndrome and received EMA and FDA orphan designation in July 2015. Agonist/partial agonistic/antagonsitic effect depending on dopamine receptor isoform.",,CHEMBL214,Serotonin 1a (5-HT1a) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:14767715, URL:http://europepmc.org/abstract/MED/14767715|Name:PubMed, SrcID:16844149, URL:http://europepmc.org/abstract/MED/16844149",Fc1ccc(cc1)c2cncc(CNC[C@H]3CCc4ccccc4O3)c2,CHEMBL214,HTR1A
1368,CHEMBL278623,Macimorelin,Small molecule,,V04CD06,V04CD06 [VARIOUS: DIAGNOSTIC AGENTS: OTHER DIAGNOSTIC AGENTS: Tests for pituitary function],-relin,Ghrelin receptor agonist,,,CHEMBL4616,Ghrelin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.aezsinc.com/en/page.php?p=31&prod=43, URL:http://www.aezsinc.com/en/page.php?p=31&prod=43|Name:PubMed, SrcID:23559086, URL:http://europepmc.org/abstract/MED/23559086|Name:PubMed, SrcID:12240910, URL:http://europepmc.org/abstract/MED/12240910|Name:Wikipedia, SrcID:Macimorelin, URL:http://en.wikipedia.org/wiki/Macimorelin",CC(C)(N)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc3c[nH]c4ccccc34)NC=O,CHEMBL4616,GHSR
1369,CHEMBL1743075,Tabalumab,Antibody,,,,-mab,Tumor necrosis factor ligand superfamily member 13B inhibitor,High-affinity human antibody with neutralizing activity against membrane-bound and soluble BAFF.,,CHEMBL2364158,Tumor necrosis factor ligand superfamily member 13B,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25258549, URL:http://europepmc.org/abstract/MED/25258549",,CHEMBL2364158,TNFSF13B
1370,CHEMBL1181731,Teglarinad,Small molecule,,,,,Nicotinamide phosphoribosyltransferase inhibitor,,,CHEMBL1744525,Nicotinamide phosphoribosyltransferase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25145669, URL:http://europepmc.org/abstract/MED/25145669",COCCOCCOCCOCCOC(=O)OC[n+]1ccc(N\C(=N\CCCCCCOc2ccc(Cl)cc2)\NC#N)cc1,CHEMBL1744525,NAMPT
1371,CHEMBL507282,Denufosol,Small molecule,,,,-fo-,Purinergic receptor P2Y2 agonist,Deoxycytidine-uridine dinucleotide with agonist activity at the P2Y2 receptor,,CHEMBL4398,Purinergic receptor P2Y2,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12183642, URL:http://europepmc.org/abstract/MED/12183642",NC1=NC(=O)N(C=C1)[C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)N4C=CC(=O)NC4=O)O2,CHEMBL4398,P2RY2
1372,CHEMBL3039558,Etirinotecan Pegol,Small molecule,,,,-tecan,DNA topoisomerase I inhibitor,"Its active metabolite, 7-ethyl-10-hydroxycamptothecin, binds to and stabilizes the topoisomerase I-DNA complex, leading to single- and double-stranded DNA breaks and inhibiting DNA repair.",,CHEMBL1781,DNA topoisomerase I,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23136196, URL:http://europepmc.org/abstract/MED/23136196",,CHEMBL1781,TOP1
1373,CHEMBL408194,Obatoclax,Small molecule,,,,-toclax,Apoptosis regulator Bcl-W inhibitor,,,CHEMBL4677,Apoptosis regulator Bcl-W,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18931344, URL:http://europepmc.org/abstract/MED/18931344|Name:PubMed, SrcID:16645636, URL:http://europepmc.org/abstract/MED/16645636|Name:PubMed, SrcID:18040043, URL:http://europepmc.org/abstract/MED/18040043",COC1=CC(=N/C/1=C\c2[nH]c(C)cc2C)c3cc4ccccc4[nH]3,CHEMBL4677,BCL2L2-PABPN1
1374,CHEMBL408194,Obatoclax,Small molecule,,,,-toclax,Apoptosis regulator Bcl-W inhibitor,,,CHEMBL4677,Apoptosis regulator Bcl-W,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18931344, URL:http://europepmc.org/abstract/MED/18931344|Name:PubMed, SrcID:16645636, URL:http://europepmc.org/abstract/MED/16645636|Name:PubMed, SrcID:18040043, URL:http://europepmc.org/abstract/MED/18040043",COC1=CC(=N/C/1=C\c2[nH]c(C)cc2C)c3cc4ccccc4[nH]3,CHEMBL4677,BCL2L2
1375,CHEMBL1743001,Cixutumumab,Antibody,,,,-mab,Insulin-like growth factor I receptor antagonist,"CIX binds IGF-1R with high affinity and blocks interaction between IGF-1R and its ligands, IGF-1 and -II, and induces internalization and degradation of IGF-1R.",,CHEMBL1957,Insulin-like growth factor I receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PMC, SrcID:PMC2939377, URL:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939377",,CHEMBL1957,IGF1R
1376,CHEMBL2109418,3f8,Antibody,,,,,Disialoganglioside GD2 other,Mediates cell (ADCC)- and complement (CDC)-dependent cytotoxicity of cultured human melanoma cells.,,CHEMBL3390823,Disialoganglioside GD2,OTHER,Homo sapiens,SMALL MOLECULE,,,"Name:PubMed, SrcID:26405581, URL:http://europepmc.org/abstract/MED/26405581",,,
1377,CHEMBL3545055,Ink-1117,Small molecule,,,,,PI3-kinase p110-alpha subunit inhibitor,,,CHEMBL4005,PI3-kinase p110-alpha subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,,,CHEMBL4005,PIK3CA
1378,CHEMBL1201335,Glycopyrrolate,Small molecule,1961.0,,,-ium,Muscarinic acetylcholine receptor M3 antagonist,"Role in regulating gastric secretion, M3 likely involved",,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=d200bd44-9856-4104-a29e-a4cca3db6737, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d200bd44-9856-4104-a29e-a4cca3db6737|Name:PubMed, SrcID:10385241, URL:http://europepmc.org/abstract/MED/10385241|Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718",C[N+]1(C)CCC(C1)OC(=O)C(O)(C2CCCC2)c3ccccc3,CHEMBL245,CHRM3
1379,CHEMBL1742982,Aflibercept,Protein,2011.0,S01LA05; L01XX44,S01LA05 [SENSORY ORGANS: OPHTHALMOLOGICALS: OCULAR VASCULAR DISORDER AGENTS: Antineovascularisation agents]; L01XX44 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-cept,Vascular endothelial growth factor A inhibitor,,,CHEMBL1783,Vascular endothelial growth factor A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f6725df6-50ee-4b0a-b900-d02ba634395d, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f6725df6-50ee-4b0a-b900-d02ba634395d|Name:DailyMed, SrcID:setid=f96cfd69-da34-41ee-90a9-610a4655cd1c, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f96cfd69-da34-41ee-90a9-610a4655cd1c",,CHEMBL1783,VEGFA
1380,CHEMBL1171837,Ponatinib,Small molecule,2012.0,L01XE24,L01XE24 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Tyrosine-protein kinase ABL inhibitor,,,CHEMBL1862,Tyrosine-protein kinase ABL,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=807f988e-117b-4497-934d-73aa78baac71, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=807f988e-117b-4497-934d-73aa78baac71|Name:PubMed, SrcID:19878872, URL:http://europepmc.org/abstract/MED/19878872",CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc4cnc5cccnn45)cc2C(F)(F)F)CC1,CHEMBL1862,ABL1
1381,CHEMBL1072,Bumetanide,Small molecule,1983.0,C03CA02,"C03CA02 [CARDIOVASCULAR SYSTEM: DIURETICS: HIGH-CEILING DIURETICS: Sulfonamides, plain]",-etanide,Sodium-(potassium)-chloride cotransporter 2 inhibitor,,,CHEMBL1874,Sodium-(potassium)-chloride cotransporter 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1056/NEJMra0907219, URL:http://www.nejm.org/doi/full/10.1056/NEJMra0907219|Name:FDA, SrcID:label/2010/018225s024lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018225s024lbl.pdf|Name:Wikipedia, SrcID:Bumetanide, URL:http://en.wikipedia.org/wiki/Bumetanide|Name:Wikipedia, SrcID:Loop_diuretic, URL:http://en.wikipedia.org/wiki/Loop_diuretic|Name:DailyMed, SrcID:setid=4a8f551b-9cdf-448d-94b1-df2291220aee, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4a8f551b-9cdf-448d-94b1-df2291220aee",CCCCNc1cc(cc(c1Oc2ccccc2)S(=O)(=O)N)C(=O)O,CHEMBL1874,SLC12A1
1382,CHEMBL1201513,Heparin Calcium,Oligosaccharide,1982.0,C05BA53; B01AB51; C05BA03; B01AB01; S01XA14,C05BA53 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: ANTIVARICOSE THERAPY: Heparins or heparinoids for topical use]; B01AB51 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Heparin group]; C05BA03 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: ANTIVARICOSE THERAPY: Heparins or heparinoids for topical use]; B01AB01 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Heparin group]; S01XA14 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-parin,Antithrombin-III activator,Inhibits coagulation by activating antithrombin III; ATIII then binds to F10;,,CHEMBL1950,Antithrombin-III,ACTIVATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=cbc26e3c-aee9-4c0d-bdb1-bf350308fbce#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cbc26e3c-aee9-4c0d-bdb1-bf350308fbce#nlm34090-1|Name:ISBN, SrcID:9780702034718 PP. 299, URL:http://www.isbnsearch.org/isbn/9780702034718",,CHEMBL1950,SERPINC1
1383,CHEMBL1393,Spironolactone,Small molecule,1960.0,C03DA01,C03DA01 [CARDIOVASCULAR SYSTEM: DIURETICS: POTASSIUM-SPARING AGENTS: Aldosterone antagonists],,Mineralocorticoid receptor antagonist,,,CHEMBL1994,Mineralocorticoid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=fb66327e-8261-46ae-b39a-4fa79d520844, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fb66327e-8261-46ae-b39a-4fa79d520844|Name:Wikipedia, SrcID:Spironolactone, URL:http://en.wikipedia.org/wiki/Spironolactone",CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]45CCC(=O)O5)[C@H]13,,
1384,CHEMBL70,Morphine,Small molecule,1984.0,N02AA51; A07DA52; N02AA01,"N02AA51 [NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Natural opium alkaloids]; A07DA52 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: ANTIPROPULSIVES: Antipropulsives]; N02AA01 [NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Natural opium alkaloids]",,Mu opioid receptor agonist,,,CHEMBL233,Mu opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=ca44184d-4d3b-4fda-c288-8c32527ea6ca#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ca44184d-4d3b-4fda-c288-8c32527ea6ca#nlm34090-1|Name:FDA, SrcID:label/2010/018565s020lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018565s020lbl.pdf",CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@@H]2C=C[C@@H]4O)c35,CHEMBL233,OPRM1
1385,CHEMBL270190,Alvimopan,Small molecule,2008.0,A06AH02,A06AH02 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR CONSTIPATION: DRUGS FOR CONSTIPATION: Peripheral opioid receptor antagonists],,Mu opioid receptor antagonist,,,CHEMBL233,Mu opioid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=826f647e-1c29-4f27-2db7-89d4d0f5f105, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=826f647e-1c29-4f27-2db7-89d4d0f5f105|Name:FDA, SrcID:label/2013/021775s010lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021775s010lbl.pdf",C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)NCC(=O)O)CC[C@@]1(C)c3cccc(O)c3,CHEMBL233,OPRM1
1386,CHEMBL1161,Mometasone Furoate,Small molecule,1987.0,D07AC13; R01AD09; R03BA07; D07XC03,"D07AC13 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, potent (group III)]; R01AD09 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Corticosteroids]; R03BA07 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS: Glucocorticoids]; D07XC03 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, OTHER COMBINATIONS: Corticosteroids, potent, other combinations]",,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12127907, URL:http://europepmc.org/abstract/MED/12127907|Name:PubMed, SrcID:8439518, URL:http://europepmc.org/abstract/MED/8439518|Name:PubMed, SrcID:10518812, URL:http://europepmc.org/abstract/MED/10518812|Name:PubMed, SrcID:9793625, URL:http://europepmc.org/abstract/MED/9793625",C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c5occc5)C(=O)CCl,CHEMBL2034,NR3C1
1387,CHEMBL593,Delavirdine,Small molecule,1997.0,J05AG02,J05AG02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Non-nucleoside reverse transcriptase inhibitors],-vir-,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,,,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,INHIBITOR,Human immunodeficiency virus 1,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=992306f0-c612-41dd-a4df-35d1fd360033#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=992306f0-c612-41dd-a4df-35d1fd360033#nlm34090-1",CC(C)Nc1cccnc1N2CCN(CC2)C(=O)c3cc4cc(NS(=O)(=O)C)ccc4[nH]3,,
1388,CHEMBL1201213,Isoetharine,Small molecule,1979.0,R03AC07; R03CC06,"R03AC07 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS, INHALANTS: Selective beta-2-adrenoreceptor agonists]; R03CC06 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS FOR SYSTEMIC USE: Selective beta-2-adrenoreceptor agonists]",,Beta-2 adrenergic receptor agonist,,,CHEMBL210,Beta-2 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:0471-948470 PP. 237, URL:http://www.isbnsearch.org/isbn/0471948470|Name:Wikipedia, SrcID:Isoetarine, URL:http://en.wikipedia.org/wiki/Isoetarine",CCC(NC(C)C)C(O)c1ccc(O)c(O)c1,CHEMBL210,ADRB2
1389,CHEMBL625,Thiabendazole,Small molecule,1967.0,P02CA02; D01AC06,"P02CA02 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTHELMINTICS: ANTINEMATODAL AGENTS: Benzimidazole derivatives]; D01AC06 [DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Imidazole and triazole derivatives]",-bendazole,Tubulin inhibitor,,,CHEMBL2364704,Tubulin,INHIBITOR,Taeniidae,PROTEIN COMPLEX GROUP,Beta tubulin,Binds to beta tubulin,"Name:ISBN, SrcID:0443-059748 PP. 740, URL:http://www.isbnsearch.org/isbn/0443059748|Name:PubMed, SrcID:22927795, URL:http://europepmc.org/abstract/MED/22927795|Name:ISBN, SrcID:9780702034718 PP. 669, URL:http://www.isbnsearch.org/isbn/9780702034718",c1ccc2[nH]c(nc2c1)c3cscn3,,
1390,CHEMBL339427,Tubocurarine,Small molecule,1945.0,M03AA02,"M03AA02 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS: Curare alkaloids]",,Muscle-type nicotinic acetylcholine receptor antagonist,,,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:19417616, URL:http://europepmc.org/abstract/MED/19417616|Name:PubMed, SrcID:7684066, URL:http://europepmc.org/abstract/MED/7684066|Name:PubMed, SrcID:16723497, URL:http://europepmc.org/abstract/MED/16723497|Name:PubMed, SrcID:11562442, URL:http://europepmc.org/abstract/MED/11562442|Name:PubMed, SrcID:1691468, URL:http://europepmc.org/abstract/MED/1691468|Name:Wikipedia, SrcID:Tubocurarine_chloride#Clinical_pharmacology_and_pharmacokinetics, URL:http://en.wikipedia.org/wiki/Tubocurarine_chloride#Clinical_pharmacology_and_pharmacokinetics|Name:PubMed, SrcID:10066903, URL:http://europepmc.org/abstract/MED/10066903|Name:PubMed, SrcID:18633030, URL:http://europepmc.org/abstract/MED/18633030|Name:PubMed, SrcID:12243766, URL:http://europepmc.org/abstract/MED/12243766|Name:PubMed, SrcID:20338223, URL:http://europepmc.org/abstract/MED/20338223|Name:ISBN, SrcID:9780702034718 PP. 164, URL:http://www.isbnsearch.org/isbn/9780702034718",COc1cc2CC[N+](C)(C)[C@@H]3Cc4ccc(O)c(Oc5cc6[C@H](Cc7ccc(Oc(c1O)c23)cc7)N(C)CCc6cc5OC)c4,,
1391,CHEMBL1200790,Methyprylon,Small molecule,1982.0,N05CE02,N05CE02 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Piperidinedione derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,"Likely allosteric, unclear whether benzodiazepine or barbiturate site, but is barbiturate-like","Name:PubMed, SrcID:16792, URL:http://europepmc.org/abstract/MED/16792|Name:ISBN, SrcID:9780702034718 PP. 533, URL:http://www.isbnsearch.org/isbn/9780702034718",CCC1(CC)C(=O)NCC(C)C1=O,CHEMBL2093872,GABRG3
1392,CHEMBL1200790,Methyprylon,Small molecule,1982.0,N05CE02,N05CE02 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Piperidinedione derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,"Likely allosteric, unclear whether benzodiazepine or barbiturate site, but is barbiturate-like","Name:PubMed, SrcID:16792, URL:http://europepmc.org/abstract/MED/16792|Name:ISBN, SrcID:9780702034718 PP. 533, URL:http://www.isbnsearch.org/isbn/9780702034718",CCC1(CC)C(=O)NCC(C)C1=O,CHEMBL2093872,GABRP
1393,CHEMBL1200790,Methyprylon,Small molecule,1982.0,N05CE02,N05CE02 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Piperidinedione derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,"Likely allosteric, unclear whether benzodiazepine or barbiturate site, but is barbiturate-like","Name:PubMed, SrcID:16792, URL:http://europepmc.org/abstract/MED/16792|Name:ISBN, SrcID:9780702034718 PP. 533, URL:http://www.isbnsearch.org/isbn/9780702034718",CCC1(CC)C(=O)NCC(C)C1=O,CHEMBL2093872,GABRE
1394,CHEMBL1200790,Methyprylon,Small molecule,1982.0,N05CE02,N05CE02 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Piperidinedione derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,"Likely allosteric, unclear whether benzodiazepine or barbiturate site, but is barbiturate-like","Name:PubMed, SrcID:16792, URL:http://europepmc.org/abstract/MED/16792|Name:ISBN, SrcID:9780702034718 PP. 533, URL:http://www.isbnsearch.org/isbn/9780702034718",CCC1(CC)C(=O)NCC(C)C1=O,CHEMBL2093872,GABRG1
1395,CHEMBL1095930,Cefuroxime Axetil,Small molecule,1987.0,,,cef-,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=2f439b86-59d6-4350-aeb4-c904b3781db4, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2f439b86-59d6-4350-aeb4-c904b3781db4|Name:PubMed, SrcID:9784768, URL:http://europepmc.org/abstract/MED/9784768|Name:KEGG, SrcID:D00914, URL:http://www.kegg.jp/dbget-bin/www_bget?dr:D00914",CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)OC(C)OC(=O)C)COC(=O)N)\c3occc3,,
1396,CHEMBL161,Ceftriaxone,Small molecule,1984.0,J01DD04; J01DD54,J01DD04 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Third-generation cephalosporins]; J01DD54 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Third-generation cephalosporins],cef-,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=2dd1be9e-74cc-48e8-bf02-f34a78d80fda, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2dd1be9e-74cc-48e8-bf02-f34a78d80fda|Name:PubMed, SrcID:20704258, URL:http://europepmc.org/abstract/MED/20704258|Name:Wikipedia, SrcID:Penicillin_binding_proteins#Function, URL:http://en.wikipedia.org/wiki/Penicillin_binding_proteins#Function",CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)CSC3=NC(=O)C(=NN3C)O)\c4csc(N)n4,,
1397,CHEMBL819,Oxacillin,Small molecule,1971.0,J01CF04,"J01CF04 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: BETA-LACTAM ANTIBACTERIALS, PENICILLINS: Beta-lactamase resistant penicillins]",-cillin,Penicillin-binding protein inhibitor,,,CHEMBL2362972,Penicillin-binding protein,INHIBITOR,Staphylococcus aureus,PROTEIN FAMILY,,,"Name:PubMed, SrcID:7447421, URL:http://europepmc.org/abstract/MED/7447421",Cc1onc(c2ccccc2)c1C(=O)N[C@H]3[C@H]4SC(C)(C)[C@@H](N4C3=O)C(=O)O,,
1398,CHEMBL1167,Spectinomycin,Small molecule,1971.0,J01XX04,J01XX04 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER ANTIBACTERIALS: Other antibacterials],-mycin,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,16S ribosomal RNA,16s RRNA,"Name:DailyMed, SrcID:setid=becf7b7a-508c-44ff-add0-558a60fd0067, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=becf7b7a-508c-44ff-add0-558a60fd0067|Name:PubMed, SrcID:10770780, URL:http://europepmc.org/abstract/MED/10770780|Name:FDA, SrcID:label/2012/050347s060lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050347s060lbl.pdf",CN[C@@H]1[C@H](O)[C@H](NC)[C@H]2O[C@]3(O)[C@@H](O[C@H](C)CC3=O)O[C@@H]2[C@H]1O,,
1399,CHEMBL1201469,Gramicidin,Small molecule,1968.0,R02AB30,R02AB30 [RESPIRATORY SYSTEM: THROAT PREPARATIONS: THROAT PREPARATIONS: Antibiotics],-cidin,Cell membrane inhibitor,,,CHEMBL2364031,Cell membrane,INHIBITOR,Bacteria,SUBCELLULAR,,,"Name:DailyMed, SrcID:setid=b7aa0bae-255b-4792-a963-6606370a175f#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b7aa0bae-255b-4792-a963-6606370a175f#nlm34090-1",,,
1400,CHEMBL1201283,Polymyxin B,Protein,1957.0,S03AA03; A07AA05; S01AA18; J01XB02; S02AA11,"S03AA03 [SENSORY ORGANS: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS: ANTIINFECTIVES: Antiinfectives]; A07AA05 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFECTIVES: Antibiotics]; S01AA18 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Antibiotics]; J01XB02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER ANTIBACTERIALS: Polymyxins]; S02AA11 [SENSORY ORGANS: OTOLOGICALS: ANTIINFECTIVES: Antiinfectives]",,Cell outer membrane inhibitor,,,CHEMBL2364032,Cell outer membrane,INHIBITOR,Bacteria,SUBCELLULAR,,,"Name:FDA, SrcID:label/2012/060716s018lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/060716s018lbl.pdf",CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O,,
1401,CHEMBL1201459,Desoxyribonuclease,Enzyme,1964.0,B06AA10,B06AA10 [BLOOD AND BLOOD FORMING ORGANS: OTHER HEMATOLOGICAL AGENTS: OTHER HEMATOLOGICAL AGENTS: Enzymes],-ase,DNA hydrolytic enzyme,,,CHEMBL2311221,DNA,HYDROLYTIC ENZYME,Homo sapiens,NUCLEIC-ACID,,,"Name:PubMed, SrcID:124138, URL:http://europepmc.org/abstract/MED/124138",,,
1402,CHEMBL33,Levofloxacin,Small molecule,1996.0,S01AE05; J01MA12,S01AE05 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Fluoroquinolones]; J01MA12 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolones],-oxacin,DNA gyrase inhibitor,,,CHEMBL2311225,DNA gyrase,INHIBITOR,Streptococcus pneumoniae,PROTEIN COMPLEX,,,"Name:DailyMed, SrcID:setid=a1f01e8e-97e9-11de-b91d-553856d89593, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a1f01e8e-97e9-11de-b91d-553856d89593",C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc4C(=O)C(=CN1c24)C(=O)O,,
1403,CHEMBL58323,Lacosamide,Small molecule,2008.0,N03AX18,N03AX18 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:17940193, URL:http://europepmc.org/abstract/MED/17940193|Name:Wikipedia, SrcID:Lacosamide, URL:http://en.wikipedia.org/wiki/Lacosamide|Name:FDA, SrcID:label/2013/022253s021,022254s014,022255s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022253s021,022254s014,022255s008lbl.pdf",COC[C@@H](NC(=O)C)C(=O)NCc1ccccc1,,
1404,CHEMBL1437,Norepinephrine,Small molecule,1950.0,C01CA03,C01CA03 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES: Adrenergic and dopaminergic agents],,Adrenergic receptor agonist,,,CHEMBL2331074,Adrenergic receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=8c9dc6eb-e53a-4cc0-92c3-7a53d268cf93, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8c9dc6eb-e53a-4cc0-92c3-7a53d268cf93",NC[C@H](O)c1ccc(O)c(O)c1,,
1405,CHEMBL53,Apomorphine,Small molecule,2004.0,N04BC07; G04BE07,N04BC07 [NERVOUS SYSTEM: ANTI-PARKINSON DRUGS: DOPAMINERGIC AGENTS: Dopamine agonists]; G04BE07 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Drugs used in erectile dysfunction],,D2-like dopamine receptor agonist,,,CHEMBL2331075,D2-like dopamine receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=ab5d4084-3121-4043-bc88-a77c5277bc35, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ab5d4084-3121-4043-bc88-a77c5277bc35|Name:ISBN, SrcID:0443-059748 PP. 511, URL:http://www.isbnsearch.org/isbn/0443059748",CN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34,,
1406,CHEMBL1863515,Glucarpidase,Enzyme,2012.0,V03AF09,V03AF09 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Detoxifying agents for antineoplastic treatment],-ase,Methotrexate hydrolytic enzyme,,,CHEMBL2364710,Methotrexate,HYDROLYTIC ENZYME,,SMALL MOLECULE,,,"Name:DailyMed, SrcID:setid=acaef5a6-b740-40e3-8ffe-74a75c74745c#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acaef5a6-b740-40e3-8ffe-74a75c74745c#nlm34090-1",,,
1407,CHEMBL931,Halothane,Small molecule,1958.0,N01AB01,"N01AB01 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",,Potassium channel subfamily K member 9 opener,,,CHEMBL2321614,Potassium channel subfamily K member 9,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:11886861, URL:http://europepmc.org/abstract/MED/11886861|Name:PubMed, SrcID:11605899, URL:http://europepmc.org/abstract/MED/11605899|Name:PubMed, SrcID:20519544, URL:http://europepmc.org/abstract/MED/20519544|Name:PubMed, SrcID:17227289, URL:http://europepmc.org/abstract/MED/17227289|Name:PubMed, SrcID:20217349, URL:http://europepmc.org/abstract/MED/20217349",FC(F)(F)C(Cl)Br,CHEMBL2321614,KCNK9
1408,CHEMBL1201451,Albumin Human,Protein,1997.0,B05AA01,B05AA01 [BLOOD AND BLOOD FORMING ORGANS: BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS: BLOOD AND RELATED PRODUCTS: Blood substitutes and plasma protein fractions],,Bilirubin sequestering agent,"To expand the circulating blood volume in case of shock or hemorrhage, but also used in liver failure to bind excessive plasma bilirubin",,CHEMBL2364174,Bilirubin,SEQUESTERING AGENT,Homo sapiens,SMALL MOLECULE,,,"Name:DailyMed, SrcID:setid=01d78cc3-765c-89a9-7a60-b578e5723cbb#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=01d78cc3-765c-89a9-7a60-b578e5723cbb#nlm34090-1",,,
1409,CHEMBL2108638,Raxibacumab,Antibody,2012.0,J06BB18,J06BB18 [ANTIINFECTIVES FOR SYSTEMIC USE: IMMUNE SERA AND IMMUNOGLOBULINS: IMMUNOGLOBULINS: Specific immunoglobulins],-mab,Protective antigen binding agent,"It's a monoclonal antibody that binds free PA, preventing the intracellular entry of anthrax",,CHEMBL5352,Protective antigen,BINDING AGENT,Bacillus anthracis,SINGLE PROTEIN,,,"Name:Expert, SrcID:RAXIBACUMAB, URL:http://chembl.blogspot.co.uk/search?q=RAXIBACUMAB",,,
1410,CHEMBL189963,Palbociclib,Small molecule,2015.0,L01XE33,L01XE33 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-ciclib,CDK4/cyclin D1 inhibitor,,,CHEMBL1907601,Cyclin-dependent kinase 4/cyclin D1,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:FDA, SrcID:label/2015/207103s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207103s000lbl.pdf",CC(=O)C1=C(C)c2cnc(Nc3ccc(cn3)N4CCNCC4)nc2N(C5CCCC5)C1=O,,
1411,CHEMBL1742992,Blinatumomab,Antibody,2014.0,L01XC19,L01XC19 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,B-lymphocyte antigen CD19 cross-linking agent,,,CHEMBL3390821,B-lymphocyte antigen CD19,CROSS-LINKING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2014/125557lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125557lbl.pdf",,CHEMBL3390821,CD19
1412,CHEMBL1908370,Finafloxacin,Small molecule,2014.0,,,-oxacin,Topoisomerase IV inhibitor,,,CHEMBL3390827,Topoisomerase IV,INHIBITOR,Pseudomonas aeruginosa,PROTEIN COMPLEX,,,"Name:FDA, SrcID:label/2014/206307s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206307s000lbl.pdf",OC(=O)C1=CN(C2CC2)c3c(C#N)c(N4C[C@@H]5NCCO[C@H]5C4)c(F)cc3C1=O,,
1413,CHEMBL2105737,Erismodegib,Small molecule,2015.0,L01XX48,L01XX48 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-degib,Smoothened homolog inhibitor,,,CHEMBL5971,Smoothened homolog,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=77bd079b-7168-454a-ac38-963f8ba34324, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=77bd079b-7168-454a-ac38-963f8ba34324",C[C@@H]1CN(C[C@H](C)O1)c2ccc(NC(=O)c3cccc(c3C)c4ccc(OC(F)(F)F)cc4)cn2,CHEMBL5971,SMO
1414,CHEMBL3544996,Idarucizumab,Antibody,2015.0,V03AB37,V03AB37 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Antidotes],-mab,Dabigatran sequestering agent,,,CHEMBL3545433,Dabigatran,SEQUESTERING AGENT,,SMALL MOLECULE,,,"Name:DailyMed, SrcID:setid=c7400f8a-dcf4-a6df-6d07-983081b1bf34, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c7400f8a-dcf4-a6df-6d07-983081b1bf34",,,
1415,CHEMBL3544957,Cort 125134,Small molecule,,,,,Glucocorticoid receptor antagonist,"Ph1 trial initiated in Septemebr 2014, no trial ID found.",,CHEMBL2034,Glucocorticoid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.corcept.com/news_events/view/pr_1415137296, URL:http://www.corcept.com/news_events/view/pr_1415137296",,CHEMBL2034,NR3C1
1416,CHEMBL3544962,Ct-1578,Small molecule,,,,,Tyrosine-protein kinase JAK2 inhibitor,,,CHEMBL2971,Tyrosine-protein kinase JAK2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22339472, URL:http://europepmc.org/abstract/MED/22339472|Name:PubMed, SrcID:22962687, URL:http://europepmc.org/abstract/MED/22962687",,CHEMBL2971,JAK2
1417,CHEMBL3545052,Cudc-907,Small molecule,,,,,PI3-kinase p110-alpha subunit inhibitor,Inhibits mainly class I and IIb HDACS (PMID:22693356),,CHEMBL4005,PI3-kinase p110-alpha subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22693356, URL:http://europepmc.org/abstract/MED/22693356|Name:Other, SrcID:http://www.curis.com/pipeline/cudc-907, URL:http://www.curis.com/pipeline/cudc-907",,CHEMBL4005,PIK3CA
1418,CHEMBL3545200,S-222611,Small molecule,,,,,Receptor protein-tyrosine kinase erbB-2 inhibitor,Also potent ERBB4 inhibitor,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24837299, URL:http://europepmc.org/abstract/MED/24837299|Name:PubMed, SrcID:25434923, URL:http://europepmc.org/abstract/MED/25434923",,CHEMBL1824,ERBB2
1419,CHEMBL3545271,Pbf-999,Small molecule,,,,,Adenosine A2a receptor antagonist,,,CHEMBL251,Adenosine A2a receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.palobiofarma.com, URL:http://www.palobiofarma.com",,CHEMBL251,ADORA2A
1420,CHEMBL3545146,Srx251,Small molecule,,,,,Vasopressin V1a receptor antagonist,,,CHEMBL1889,Vasopressin V1a receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16504276, URL:http://europepmc.org/abstract/MED/16504276",,CHEMBL1889,AVPR1A
1421,CHEMBL229430,Amg-517,Small molecule,,,,,Vanilloid receptor antagonist,"Discontinued, causes increased core body temperature.",,CHEMBL4794,Vanilloid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18337008, URL:http://europepmc.org/abstract/MED/18337008",CC(=O)Nc1nc2c(Oc3cc(ncn3)c4ccc(cc4)C(F)(F)F)cccc2s1,CHEMBL4794,TRPV1
1422,CHEMBL3545207,Nw-3509,Small molecule,,,,,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://www.newron.com/ENG/Default.aspx?SEZ=3&PAG=44, URL:http://www.newron.com/ENG/Default.aspx?SEZ=3&PAG=44|Name:Other, SrcID:http://www.sciencedirect.com/science/article/pii/S0924977X09709356, URL:http://www.sciencedirect.com/science/article/pii/S0924977X09709356",,,
1423,CHEMBL29741,Irampanel,Small molecule,,,,-ampa,Glutamate receptor ionotropic AMPA antagonist,Non-competitive AMPA receptor antagonist.,,CHEMBL2096670,Glutamate receptor ionotropic AMPA,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Wikipedia, SrcID:Irampanel, URL:https://en.wikipedia.org/wiki/Irampanel|Name:PubMed, SrcID:10336525, URL:http://europepmc.org/abstract/MED/10336525",CN(C)CCOc1ccccc1c2onc(n2)c3ccccc3,,
1424,CHEMBL2104984,Sodelglitazar,Small molecule,,,,-glitazar,Peroxisome proliferator-activated receptor agonist,Ph2 study terminated due to safety concerns,,CHEMBL3559683,Peroxisome proliferator-activated receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:21592078, URL:http://europepmc.org/abstract/MED/21592078|Name:Wikipedia, SrcID:Sodelglitazar, URL:http://en.wikipedia.org/wiki/Sodelglitazar",Cc1cc(SCc2sc(nc2C)c3ccc(cc3F)C(F)(F)F)ccc1OC(C)(C)C(=O)O,,
1425,CHEMBL181954,Naveglitazar,Small molecule,,,,-glitazar,Peroxisome proliferator-activated receptor gamma agonist,"Development stopped (PMID:20932114). There are reports of adverse events associated with PPARalfa/gamma dual agonist, for example weight gain, increased risk of bladder cancer and hyperplasia.",,CHEMBL235,Peroxisome proliferator-activated receptor gamma,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24524207, URL:http://europepmc.org/abstract/MED/24524207|Name:KEGG, SrcID:D08949, URL:|Name:PubMed, SrcID:18474944, URL:http://europepmc.org/abstract/MED/18474944",CO[C@@H](Cc1ccc(OCCCOc2ccc(Oc3ccccc3)cc2)cc1)C(=O)O,CHEMBL235,PPARG
1426,CHEMBL3545285,Xl-999,Small molecule,,,,,Platelet-derived growth factor receptor inhibitor,Spectrum Selective Kinase Inhibitor (SSKI),,CHEMBL2095189,Platelet-derived growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:Other, SrcID:http://www.exelixis.com/sites/default/files/pdf/XL999_AACR-NCI-EORTCnov05.pdf, URL:http://www.exelixis.com/sites/default/files/pdf/XL999_AACR-NCI-EORTCnov05.pdf|Name:DOI, SrcID:10.1016/S1359-6349(04)80149-6, URL:http://www.sciencedirect.com/science/article/pii/S1359634904801496|Name:PubMed, SrcID:21613405, URL:http://europepmc.org/abstract/MED/21613405",,,
1427,CHEMBL2107826,Vibegron,Small molecule,,,,-begron,Beta-3 adrenergic receptor agonist,,,CHEMBL246,Beta-3 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.kyorin-pharm.co.jp/en/news/docs/¿¿¿¿¿¿¿¿¿¿¿.pdf, URL:http://www.kyorin-pharm.co.jp/en/news/docs/¿¿¿¿¿¿¿¿¿¿¿.pdf|Name:Other, SrcID:http://www.ukmi.nhs.uk/applications/ndo/record_view_open.asp?newDrugID=5980, URL:http://www.ukmi.nhs.uk/applications/ndo/record_view_open.asp?newDrugID=5980",O[C@@H]([C@H]1CC[C@@H](Cc2ccc(NC(=O)[C@@H]3CCC4=NC=CC(=O)N34)cc2)N1)c5ccccc5,CHEMBL246,ADRB3
1428,CHEMBL3039520,Lasmiditan,Small molecule,,,,-ditan,Serotonin 1f (5-HT1f) receptor agonist,,,CHEMBL1805,Serotonin 1f (5-HT1f) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20855361, URL:http://europepmc.org/abstract/MED/20855361|Name:PubMed, SrcID:2928347, URL:http://europepmc.org/abstract/MED/2928347",CN1CCC(CC1)C(=O)c2cccc(NC(=O)c3c(F)cc(F)cc3F)n2,CHEMBL1805,HTR1F
1429,CHEMBL3545220,Ly2590443,Small molecule,,,,,Serotonin 7 (5-HT7) receptor antagonist,Phase 2 study in 2010 Discontinued no further studies recorded.,,CHEMBL3155,Serotonin 7 (5-HT7) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.ncats.nih.gov/files/LY2590443.pdf, URL:http://www.ncats.nih.gov/files/LY2590443.pdf",,CHEMBL3155,HTR7
1430,CHEMBL1914489,Azd1981,Small molecule,,,,,G protein-coupled receptor 44 antagonist,,,CHEMBL5071,G protein-coupled receptor 44,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.ncats.nih.gov/files/AZD1981.pdf, URL:http://www.ncats.nih.gov/files/AZD1981.pdf|Name:PubMed, SrcID:23146091, URL:http://europepmc.org/abstract/MED/23146091",CC(=O)Nc1cccc2c1c(Sc3ccc(Cl)cc3)c(C)n2CC(=O)O,CHEMBL5071,PTGDR2
1431,CHEMBL3545409,Bvt.115959,Small molecule,,,,,Adenosine A2a receptor agonist,,,CHEMBL251,Adenosine A2a receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16654164, URL:http://www.ncbi.nlm.nih.gov/pubmed/?term=16654164",,CHEMBL251,ADORA2A
1432,CHEMBL3301622,Gilteritinib,Small molecule,,,,-tinib,Tyrosine-protein kinase receptor UFO inhibitor,,,CHEMBL4895,Tyrosine-protein kinase receptor UFO,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:2073104, URL:http://europepmc.org/abstract/MED/2073104|Name:PubMed, SrcID:26555154, URL:http://europepmc.org/abstract/MED/26555154|Name:Other, SrcID:http://meetinglibrary.asco.org/content/131170-144, URL:http://meetinglibrary.asco.org/content/131170-144",CCc1nc(C(=O)N)c(Nc2ccc(N3CCC(CC3)N4CCN(C)CC4)c(OC)c2)nc1NC5CCOCC5,,
1433,CHEMBL1783282,Azd7325,Small molecule,,,,,GABA receptor alpha-3 subunit positive allosteric modulator,Discontinued by AstraZeneca but in trials by other sponsors. Compound is listed in AstaZeneca's clinical and/or preclinical compound bank and available for research projects.,"Binding affinity is high at GABAAa1, a2 and a3 (Ki of 0.5, 0.3 and 1.3 nM, respectively), but not GA",CHEMBL3026,GABA receptor alpha-3 subunit,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://openinnovation.astrazeneca.com/what-we-offer/compound/azd7325/, URL:http://openinnovation.astrazeneca.com/what-we-offer/compound/azd7325/|Name:PubMed, SrcID:24802722, URL:http://europepmc.org/abstract/MED/24802722|Name:PubMed, SrcID:22122233, URL:http://europepmc.org/abstract/MED/22122233",CCCNC(=O)c1nnc2c(cccc2c1N)c3c(F)cccc3OC,CHEMBL3026,GABRA3
1434,CHEMBL1255840,Neboglamine,Small molecule,,,,,Glutamate [NMDA] receptor positive allosteric modulator,"PAM of the glycin-site on GRIN1-subunits, binds to other allosteric site?",,CHEMBL2094124,Glutamate [NMDA] receptor,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:23009122, URL:http://europepmc.org/abstract/MED/23009122|Name:PubMed, SrcID:9294970, URL:http://europepmc.org/abstract/MED/9294970|Name:Wikipedia, SrcID:Nebostinel, URL:https://en.wikipedia.org/wiki/Nebostinel",CC1(C)CCC(CC1)NC(=O)[C@@H](N)CCC(=O)O,CHEMBL2094124,GRIN3B
1435,CHEMBL3545172,Cnv2197944,Small molecule,,,,,Voltage-gated N-type calcium channel alpha-1B subunit blocker,,,CHEMBL4478,Voltage-gated N-type calcium channel alpha-1B subunit,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.convergencepharma.com/index.asp?page_id=15, URL:http://www.convergencepharma.com/index.asp?page_id=15|Name:Other, SrcID:http://www.dddmag.com/articles/2011/05/n-type-calcium-channel-blocker-chronic-pain, URL:http://www.dddmag.com/articles/2011/05/n-type-calcium-channel-blocker-chronic-pain",,CHEMBL4478,CACNA1B
1436,CHEMBL576982,Quizartinib,Small molecule,,,,-tinib,Tyrosine-protein kinase receptor RET inhibitor,,,CHEMBL2041,Tyrosine-protein kinase receptor RET,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23497317, URL:http://europepmc.org/abstract/MED/23497317|Name:PubMed, SrcID:19654408, URL:http://europepmc.org/abstract/MED/19654408",CC(C)(C)c1onc(NC(=O)Nc2ccc(cc2)c3cn4c5ccc(OCCN6CCOCC6)cc5sc4n3)c1,CHEMBL2041,RET
1437,CHEMBL1208155,Elagolix,Small molecule,,,,-golix,Gonadotropin-releasing hormone receptor antagonist,,,CHEMBL1855,Gonadotropin-releasing hormone receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19006286, URL:http://europepmc.org/abstract/MED/19006286",COc1cccc(C2=C(C)N(Cc3c(F)cccc3C(F)(F)F)C(=O)N(C[C@H](NCCCC(=O)O)c4ccccc4)C2=O)c1F,CHEMBL1855,GNRHR
1438,CHEMBL1742995,Briakinumab,Antibody,,L04AC09,L04AC09 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Interleukin inhibitors],-mab,Interleukin-12 inhibitor,IgG1 monoclonal antibody with genetically engineered complementarity-determining regions that have high affinity for the IL-12/23 p40 subunit protein.,,CHEMBL2364153,Interleukin-12,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:22077474, URL:http://europepmc.org/abstract/MED/22077474|Name:PubMed, SrcID:18283176, URL:http://europepmc.org/abstract/MED/18283176",,,
1439,CHEMBL1743081,Tralokinumab,Antibody,,,,-mab,Interleukin-13 inhibitor,IL-13-neutralizing IgG4 monoclonal antibody.,,CHEMBL3580486,Interleukin-13,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21895629, URL:http://europepmc.org/abstract/MED/21895629",,,
1440,CHEMBL2109626,Alg-991,Antibody,,,,,Urushiol inhibitor,,,CHEMBL3580509,Urushiol,INHIBITOR,Toxicodendron,LIPID,,"Reacts with the catechol moiety of urushiol, the region of the allergen being critically important i","Name:PubMed, SrcID:10651166, URL:http://europepmc.org/abstract/MED/10651166",,,
1441,CHEMBL2103837,Tafamidis,Small molecule,,N07XX08,N07XX08 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs],-amidis,Transthyretin stabiliser,"Binds TTR with negative cooperativity and kinetically stabilizes WT-TTR and amyloidogenic mutant homotetramers under denaturing and physiologic conditions, inhibiting amyloidogenesis.",,CHEMBL3194,Transthyretin,STABILISER,Homo sapiens,SINGLE PROTEIN,,Binds with high affinity to TTR at its Thyroxine (T4)-binding sites,"Name:PubMed, SrcID:22645360, URL:http://europepmc.org/abstract/MED/22645360",OC(=O)c1ccc2nc(oc2c1)c3cc(Cl)cc(Cl)c3,CHEMBL3194,TTR
1442,CHEMBL167731,Pixantrone,Small molecule,,L01DB11,L01DB11 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES: Anthracyclines and related substances],-antrone,DNA cross-linking agent,Forms formaldehyde-mediated adducts with DNA (favours the CpG motif) and stimulates topoisomerase II-mediated DNA cleavage,,CHEMBL2311221,DNA,CROSS-LINKING AGENT,Homo sapiens,NUCLEIC-ACID,,"Binds d(TCATATGA)2, d(CCGAGAATTCCGG)2 {double bulge}, d(TACGATGAGTA) : d(TACCATCGTA) {single bulge}","Name:PubMed, SrcID:19720735, URL:http://europepmc.org/abstract/MED/19720735|Name:PubMed, SrcID:25929194, URL:http://europepmc.org/abstract/MED/25929194|Name:PubMed, SrcID:22652183, URL:http://europepmc.org/abstract/MED/22652183",NCCNc1ccc(NCCN)c2C(=O)c3cnccc3C(=O)c12,,
1443,CHEMBL2103846,Ulipristal,Small molecule,,G03AD02; G03XB02,G03AD02 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE: Emergency contraceptives]; G03XB02 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: Progesterone receptor modulators],,Progesterone receptor modulator,,,CHEMBL208,Progesterone receptor,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18216291 , URL:http://europepmc.org/abstract/MED/18216291",CN(C)c1ccc(cc1)[C@H]2C[C@@]3(C)[C@@H](CC[C@]3(O)C(=O)C)[C@@H]4CCC5=CC(=O)CCC5=C24,CHEMBL208,PGR
1444,CHEMBL2105721,Nivocasan,Small molecule,,,,-casan,Caspase-8 inhibitor,Irreversible inhibitor,,CHEMBL3776,Caspase-8,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21667042, URL:http://europepmc.org/abstract/MED/21667042",CC(C)[C@]1(CC(=NO1)c2nccc3ccccc23)C(=O)N[C@H]4CC(=O)O[C@]4(O)CF,CHEMBL3776,CASP8
1445,CHEMBL443684,Navitoclax,Small molecule,,,,-toclax,Apoptosis regulator Bcl-2 inhibitor,,"High affinity for Bcl-xL, Bcl-2, and Bcl-w (Ki =1 nmol/L).",CHEMBL4860,Apoptosis regulator Bcl-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,"Occupies the BH3 binding groove of Bcl-xL, Bcl-2, and Bcl-w.","Name:PubMed, SrcID:21094089, URL:http://europepmc.org/abstract/MED/21094089|Name:PubMed, SrcID:18451170, URL:http://europepmc.org/abstract/MED/18451170",CC1(C)CCC(=C(CN2CCN(CC2)c3ccc(cc3)C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc6ccccc6)c(c4)S(=O)(=O)C(F)(F)F)C1)c7ccc(Cl)cc7,CHEMBL4860,BCL2
1446,CHEMBL3039564,Irinotecan Sucrosofate,Small molecule,,,,-tecan,DNA topoisomerase I inhibitor,,,CHEMBL1781,DNA topoisomerase I,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25733708, URL:http://europepmc.org/abstract/MED/25733708|Name:PubMed, SrcID:14648715, URL:http://europepmc.org/abstract/MED/14648715",,CHEMBL1781,TOP1
1447,CHEMBL1241348,Faldaprevir,Small molecule,,J05AE13,J05AE13 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Protease inhibitors],-vir,"Hepatitis C virus serine protease, NS3/NS4A inhibitor",,,CHEMBL2095231,"Hepatitis C virus serine protease, NS3/NS4A",INHIBITOR,Hepatitis C virus,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:20823284, URL:http://europepmc.org/abstract/MED/20823284",COc1ccc2c(O[C@@H]3C[C@H](N(C3)C(=O)[C@@H](NC(=O)OC4CCCC4)C(C)(C)C)C(=O)N[C@@]5(C[C@H]5C=C)C(=O)O)cc(nc2c1Br)c6csc(NC(=O)C(C)C)n6,,
1448,CHEMBL1743030,Icrucumab,Antibody,,,,-mab,Vascular endothelial growth factor receptor 1 antagonist,"Human monoclonal antibody against vascular endothelial growth factor receptor-1 (VEGFR-1), potently inhibits ligand-dependent phosphorylation of VEGFR-1 and downstream signaling,",,CHEMBL1868,Vascular endothelial growth factor receptor 1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23903897, URL:http://europepmc.org/abstract/MED/23903897",,CHEMBL1868,FLT1
1449,CHEMBL2109367,Lmb-2,Antibody,,,,,Interleukin-2 receptor alpha chain binding agent,Immunotoxin.,,CHEMBL1778,Interleukin-2 receptor alpha chain,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17878392, URL:http://europepmc.org/abstract/MED/17878392",,CHEMBL1778,IL2RA
1450,CHEMBL2109387,Parsatuzumab,Antibody,,,,-mab,Epidermal growth factor-like protein 7 inhibitor,Blocks endothelial cell adhesion to the EGFL7 protein.,,CHEMBL3712972,Epidermal growth factor-like protein 7,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.roche.com/genentech_oncology_r_d.pdf, URL:http://www.roche.com/genentech_oncology_r_d.pdf",,CHEMBL3712972,EGFL7
1451,CHEMBL517712,Atropine,Small molecule,1960.0,A03BA01; S01FA01,"A03BA01 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: BELLADONNA AND DERIVATIVES, PLAIN: Belladonna alkaloids, tertiary amines]; S01FA01 [SENSORY ORGANS: OPHTHALMOLOGICALS: MYDRIATICS AND CYCLOPLEGICS: Anticholinergics]",-trop-,Muscarinic acetylcholine receptor M3 antagonist,"Indicated for mydriasis and regulating gastric secretion, M3 likely involved (main form in iris)",,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 159, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:FDA, SrcID:label/2004/17106s032lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/17106s032lbl.pdf|Name:Wikipedia, SrcID:Atropine, URL:http://en.wikipedia.org/wiki/Atropine",CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(=O)C(CO)c3ccccc3,CHEMBL245,CHRM3
1452,CHEMBL98,Vorinostat,Small molecule,2006.0,L01XX38,L01XX38 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-stat,Histone deacetylase 1 inhibitor,,,CHEMBL325,Histone deacetylase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13",ONC(=O)CCCCCCC(=O)Nc1ccccc1,CHEMBL325,HDAC1
1453,CHEMBL1200854,Fluphenazine Decanoate,Small molecule,1972.0,N05AB02,N05AB02 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Phenothiazines with piperazine structure],,Dopamine D2 receptor antagonist,,,CHEMBL217,Dopamine D2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11873706, URL:http://europepmc.org/abstract/MED/11873706|Name:PubMed, SrcID:7508675, URL:http://europepmc.org/abstract/MED/7508675|Name:Wikipedia, SrcID:Antipsychotic#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Antipsychotic#Mechanism_of_action|Name:PubMed, SrcID:7828655, URL:http://europepmc.org/abstract/MED/7828655",CCCCCCCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1,CHEMBL217,DRD2
1454,CHEMBL1201419,Lutropin Alfa,Protein,2004.0,G03GA07,G03GA07 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: GONADOTROPINS AND OTHER OVULATION STIMULANTS: Gonadotropins],,Luteinizing hormone/Choriogonadotropin receptor agonist,"It's LH, used to stimulate development of a potentially competent follicle and to indirectly prepare the reproductive tract for implantation and pregnancy",,CHEMBL1854,Luteinizing hormone/Choriogonadotropin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23798574, URL:http://europepmc.org/abstract/MED/23798574|Name:FDA, SrcID:label/2004/21322lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21322lbl.pdf|Name:DailyMed, SrcID:setid=ae1977ed-32ea-4cbf-b51d-ce4a438215b8, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ae1977ed-32ea-4cbf-b51d-ce4a438215b8",,CHEMBL1854,LHCGR
1455,CHEMBL425,Olsalazine,Small molecule,1990.0,A07EC03,"A07EC03 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Aminosalicylic acid and similar agents]",-sal-,Arachidonate 5-lipoxygenase inhibitor,,,CHEMBL215,Arachidonate 5-lipoxygenase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:6428914, URL:http://europepmc.org/abstract/MED/6428914|Name:DailyMed, SrcID:setid=75a96561-6f52-4c11-a105-391fbbfe4827, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=75a96561-6f52-4c11-a105-391fbbfe4827|Name:PubMed, SrcID:2882965, URL:http://europepmc.org/abstract/MED/2882965|Name:PubMed, SrcID:6131674, URL:http://europepmc.org/abstract/MED/6131674",OC(=O)c1cc(ccc1O)N=Nc2ccc(O)c(c2)C(=O)O,CHEMBL215,ALOX5
1456,CHEMBL1201203,Benztropine,Small molecule,1954.0,N04AC01,N04AC01 [NERVOUS SYSTEM: ANTI-PARKINSON DRUGS: ANTICHOLINERGIC AGENTS: Ethers of tropine or tropine derivatives],-trop-,Muscarinic acetylcholine receptor M1 antagonist,"Indicated for Parkinson's disease, M1 likely responsible",,CHEMBL216,Muscarinic acetylcholine receptor M1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=3a1c2de1-b692-435f-a85a-79236d1a45b1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3a1c2de1-b692-435f-a85a-79236d1a45b1|Name:FDA, SrcID:label/2013/012015s026lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/012015s026lbl.pdf|Name:ISBN, SrcID:9780702034718 PP. 162, URL:http://www.isbnsearch.org/isbn/9780702034718",CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c3ccccc3)c4ccccc4,CHEMBL216,CHRM1
1457,CHEMBL649,Nadolol,Small molecule,1979.0,C07AA12,"C07AA12 [CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, non-selective]",-olol,Beta-1 adrenergic receptor antagonist,,,CHEMBL213,Beta-1 adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=c2e709d2-96a2-41ea-b5e9-9ce4ccb91f59, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c2e709d2-96a2-41ea-b5e9-9ce4ccb91f59",CC(C)(C)NCC(O)COc1cccc2C[C@@H](O)[C@@H](O)Cc12,,
1458,CHEMBL1587,Polythiazide,Small molecule,1961.0,C03AA05,"C03AA05 [CARDIOVASCULAR SYSTEM: DIURETICS: LOW-CEILING DIURETICS, THIAZIDES: Thiazides, plain]",-thiazide,Thiazide-sensitive sodium-chloride cotransporter inhibitor,,,CHEMBL1876,Thiazide-sensitive sodium-chloride cotransporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1056/NEJMra0907219, URL:http://www.nejm.org/doi/full/10.1056/NEJMra0907219|Name:Wikipedia, SrcID:Polythiazide, URL:http://en.wikipedia.org/wiki/Polythiazide|Name:DailyMed, SrcID:setid=b503fa5e-5726-426d-867c-e8fe59ed3ead, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b503fa5e-5726-426d-867c-e8fe59ed3ead",CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(cc2S1(=O)=O)S(=O)(=O)N,CHEMBL1876,SLC12A3
1459,CHEMBL1201284,Cinacalcet,Small molecule,2004.0,H05BX01,"H05BX01 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CALCIUM HOMEOSTASIS: ANTI-PARATHYROID AGENTS: Other anti-parathyroid agents]",-calcet,Calcium sensing receptor positive allosteric modulator,,,CHEMBL1878,Calcium sensing receptor,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=45028573-13c4-4c8b-ae62-6c75bba97c81, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=45028573-13c4-4c8b-ae62-6c75bba97c81",C[C@@H](NCCCc1cccc(c1)C(F)(F)F)c2cccc3ccccc23,CHEMBL1878,CASR
1460,CHEMBL16694,Phenprocoumon,Small molecule,1957.0,B01AA04,B01AA04 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Vitamin K antagonists],,Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor,,,CHEMBL1930,Vitamin k epoxide reductase complex subunit 1 isoform 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16372822, URL:http://europepmc.org/abstract/MED/16372822|Name:Wikipedia, SrcID:Phenprocoumon, URL:http://en.wikipedia.org/wiki/Phenprocoumon",CCC(C1=C(O)Oc2ccccc2C1=O)c3ccccc3,CHEMBL1930,VKORC1
1461,CHEMBL1201532,Thyrotropin,Unknown,1953.0,V04CJ01,V04CJ01 [VARIOUS: DIAGNOSTIC AGENTS: OTHER DIAGNOSTIC AGENTS: Tests for thyreoidea function],,Thyroid stimulating hormone receptor agonist,"It's purified bovine thyroid stimulating hormone approved for diagnosis of serum thyroglobulin levels, but also is indicated as an adjunctive treatment for radioiodine ablation of thyroid tissue remnants in cancer patients",,CHEMBL1963,Thyroid stimulating hormone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10365676, URL:http://europepmc.org/abstract/MED/10365676",,,
1462,CHEMBL360328,Lorcaserin,Small molecule,2012.0,A08AA11,"A08AA11 [ALIMENTARY TRACT AND METABOLISM: ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS: ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS: Centrally acting antiobesity products]",-caserin,Serotonin 2c (5-HT2c) receptor agonist,,,CHEMBL225,Serotonin 2c (5-HT2c) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Expert, SrcID:LORCASERIN, URL:http://chembl.blogspot.co.uk/search?q=LORCASERIN",C[C@H]1CNCCc2ccc(Cl)cc12,,
1463,CHEMBL658,Sufentanil,Small molecule,1984.0,N01AH03,"N01AH03 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Opioid anesthetics]",-fentanil,Mu opioid receptor agonist,,,CHEMBL233,Mu opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21215785, URL:http://europepmc.org/abstract/MED/21215785|Name:DailyMed, SrcID:setid=95e639db-1ca3-4328-b347-7ea348f6cc72#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=95e639db-1ca3-4328-b347-7ea348f6cc72#nlm34090-1",CCC(=O)N(c1ccccc1)C2(COC)CCN(CCc3cccs3)CC2,CHEMBL233,OPRM1
1464,CHEMBL771,Cycloserine,Small molecule,1964.0,J04AB01,J04AB01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOBACTERIALS: DRUGS FOR TREATMENT OF TUBERCULOSIS: Antibiotics],,D-alanylalanine synthetase inhibitor,,,CHEMBL2030,D-alanylalanine synthetase,INHIBITOR,Mycobacterium tuberculosis,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23316042, URL:http://europepmc.org/abstract/MED/23316042|Name:ISBN, SrcID:9780702034718 PP. 635, URL:http://www.isbnsearch.org/isbn/9780702034718",N[C@@H]1CONC1=O,,
1465,CHEMBL1200878,Triamcinolone Hexacetonide,Small molecule,1969.0,R03BA06; A01AC01; S01BA05; H02AB08; D07XB02; C05AA12; R01AD11; D07AB09,"R03BA06 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS: Glucocorticoids]; A01AC01 [ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Corticosteroids for local oral treatment]; S01BA05 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Corticosteroids, plain]; H02AB08 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Glucocorticoids]; D07XB02 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, OTHER COMBINATIONS: Corticosteroids, moderately potent, other combinations]; C05AA12 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Corticosteroids]; R01AD11 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Corticosteroids]; D07AB09 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, moderately potent (group II)]",-olone,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=7094e7f5-db36-4e6a-9183-080034d5366f#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7094e7f5-db36-4e6a-9183-080034d5366f#nlm34090-1|Name:Wikipedia, SrcID:Triamcinolone, URL:http://en.wikipedia.org/wiki/Triamcinolone",CC(C)(C)CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]23C,CHEMBL2034,NR3C1
1466,CHEMBL588,Fenoldopam,Small molecule,1997.0,C01CA19,C01CA19 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES: Adrenergic and dopaminergic agents],,Dopamine D1 receptor agonist,,,CHEMBL2056,Dopamine D1 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=df4cd207-c3b8-4008-5290-02f296c2b4a6, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=df4cd207-c3b8-4008-5290-02f296c2b4a6",Oc1ccc(cc1)C2CNCCc3c(Cl)c(O)c(O)cc23,CHEMBL2056,DRD1
1467,CHEMBL259209,Milnacipran,Small molecule,2009.0,N06AX17,N06AX17 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants],,Norepinephrine transporter inhibitor,,,CHEMBL222,Norepinephrine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=16a4a314-f97e-4e91-95e9-576a3773d284#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=16a4a314-f97e-4e91-95e9-576a3773d284#nlm34090-1",CCN(CC)C(=O)C1(CC1CN)c2ccccc2,CHEMBL222,SLC6A2
1468,CHEMBL1286,Levetiracetam,Small molecule,1999.0,N03AX14,N03AX14 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],-racetam,Voltage-gated N-type calcium channel alpha-1B subunit blocker,,,CHEMBL4478,Voltage-gated N-type calcium channel alpha-1B subunit,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=90b553fe-4e94-4cce-b5df-ea3e6487930d#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=90b553fe-4e94-4cce-b5df-ea3e6487930d#nlm34090-1",CC[C@H](N1CCCC1=O)C(=O)N,CHEMBL4478,CACNA1B
1469,CHEMBL1946170,Regorafenib,Small molecule,2012.0,L01XE21,L01XE21 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-rafenib,Serine/threonine-protein kinase B-raf inhibitor,,,CHEMBL5145,Serine/threonine-protein kinase B-raf,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Expert, SrcID:REGORAFENIB, URL:http://chembl.blogspot.co.uk/search?q=REGORAFENIB",CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,CHEMBL5145,BRAF
1470,CHEMBL566534,Artemether,Small molecule,2009.0,P01BE02,"P01BE02 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: ANTIMALARIALS: Artemisinin and derivatives, plain]",arte-,Ferriprotoporphyrin IX inhibitor,prevents crystallisation,,CHEMBL613897,Ferriprotoporphyrin IX,INHIBITOR,Plasmodium falciparum,SMALL MOLECULE,,,"Name:Wikipedia, SrcID:Artemether, URL:http://en.wikipedia.org/wiki/Artemether|Name:Wikipedia, SrcID:Hemozoin, URL:http://en.wikipedia.org/wiki/Hemozoin|Name:DailyMed, SrcID:setid=7866ec19-dfac-47d4-a53f-511a12643cbf#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7866ec19-dfac-47d4-a53f-511a12643cbf#section-13",CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3,,
1471,CHEMBL1201134,Lubiprostone,Small molecule,2006.0,A06AX03,A06AX03 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR CONSTIPATION: DRUGS FOR CONSTIPATION: Other drugs for constipation],-prost-,Chloride channel protein 2 opener,,,CHEMBL1628478,Chloride channel protein 2,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=417aa15d-ac74-4fa8-a312-6e51e82ba70c#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=417aa15d-ac74-4fa8-a312-6e51e82ba70c#nlm34090-1",CCCCC(F)(F)[C@@]1(O)CC[C@@H]2[C@@H](CCCCCCC(=O)O)C(=O)C[C@H]2O1,CHEMBL1628478,CLCN2
1472,CHEMBL1174,Eptifibatide,Protein,1998.0,B01AC16,B01AC16 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Platelet aggregation inhibitors excl. heparin],-tide,Integrin alpha-IIb/beta-3 inhibitor,,,CHEMBL2093869,Integrin alpha-IIb/beta-3,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:DailyMed, SrcID:setid=5ad82e30-50d8-450c-8a2a-b4b507ed1ce2#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ad82e30-50d8-450c-8a2a-b4b507ed1ce2#nlm34090-1",NC(=N)NCCCC[C@@H]1NC(=O)CCSSC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)[C@H](CC(=O)O)NC(=O)CNC1=O)C(=O)N,,
1473,CHEMBL660,Amantadine,Small molecule,1968.0,N04BB01,N04BB01 [NERVOUS SYSTEM: ANTI-PARKINSON DRUGS: DOPAMINERGIC AGENTS: Adamantane derivatives],-mantadine,Glutamate [NMDA] receptor antagonist,Indicated for Parkinson's disease,,CHEMBL2094124,Glutamate [NMDA] receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Wikipedia, SrcID:Amantadine#Dosage_and_mechanism_of_action, URL:http://en.wikipedia.org/wiki/Amantadine#Dosage_and_mechanism_of_action|Name:DailyMed, SrcID:setid=a2caed21-e9a3-228e-70a8-de30a1b368be, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a2caed21-e9a3-228e-70a8-de30a1b368be",NC12CC3CC(CC(C3)C1)C2,CHEMBL2094124,GRIN3B
1474,CHEMBL660,Amantadine,Small molecule,1968.0,N04BB01,N04BB01 [NERVOUS SYSTEM: ANTI-PARKINSON DRUGS: DOPAMINERGIC AGENTS: Adamantane derivatives],-mantadine,Matrix protein 2 inhibitor,Antiviral activity,,CHEMBL1932894,Matrix protein 2,INHIBITOR,Influenza A virus (strain A/Puerto Rico/8/1934 H1N1),SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Amantadine#Dosage_and_mechanism_of_action, URL:http://en.wikipedia.org/wiki/Amantadine#Dosage_and_mechanism_of_action|Name:DailyMed, SrcID:setid=a2caed21-e9a3-228e-70a8-de30a1b368be, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a2caed21-e9a3-228e-70a8-de30a1b368be",NC12CC3CC(CC(C3)C1)C2,,
1475,CHEMBL1201329,Trimethaphan,Small molecule,1982.0,C02BA01,"C02BA01 [CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ANTIADRENERGIC AGENTS, GANGLION-BLOCKING: Sulfonium derivatives]",,Neuronal acetylcholine receptor; alpha3/beta4 antagonist,,,CHEMBL1907594,Neuronal acetylcholine receptor; alpha3/beta4,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:Wikipedia, SrcID:Nicotinic_acetylcholine_receptor, URL:http://en.wikipedia.org/wiki/Nicotinic_acetylcholine_receptor|Name:ISBN, SrcID:0443-059748 PP. 124, URL:http://www.isbnsearch.org/isbn/0443059748|Name:PubMed, SrcID:17160588, URL:http://europepmc.org/abstract/MED/17160588|Name:Wikipedia, SrcID:Trimetaphan, URL:http://en.wikipedia.org/wiki/Trimetaphan",O=C1N(Cc2ccccc2)C3C[S+]4CCCC4C3N1Cc5ccccc5,,
1476,CHEMBL1200436,Oxandrolone,Small molecule,1964.0,A14AA08,A14AA08 [ALIMENTARY TRACT AND METABOLISM: ANABOLIC AGENTS FOR SYSTEMIC USE: ANABOLIC STEROIDS: Androstan derivatives],-olone,Androgen Receptor agonist,,,CHEMBL1871,Androgen Receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f622616e-4c11-4149-bf00-5ea5ce97800b, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f622616e-4c11-4149-bf00-5ea5ce97800b|Name:Wikipedia, SrcID:Oxandrolone, URL:http://en.wikipedia.org/wiki/Oxandrolone",C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC(=O)OC[C@]4(C)[C@H]3CC[C@]12C,CHEMBL1871,AR
1477,CHEMBL1201222,Lisdexamfetamine,Small molecule,2007.0,N06BA12,"N06BA12 [NERVOUS SYSTEM: PSYCHOANALEPTICS: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS: Centrally acting sympathomimetics]",-fetamin(e),Synaptic vesicular amine transporter inhibitor,,,CHEMBL1893,Synaptic vesicular amine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15955613, URL:http://europepmc.org/abstract/MED/15955613|Name:DailyMed, SrcID:setid=c9eaca3d-cca7-4627-bb3e-75b1c2aec9d4#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c9eaca3d-cca7-4627-bb3e-75b1c2aec9d4#nlm34090-1|Name:PubMed, SrcID:7751968, URL:http://europepmc.org/abstract/MED/7751968",C[C@@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN,CHEMBL1893,SLC18A2
1478,CHEMBL1200733,Desflurane,Small molecule,1992.0,N01AB07,"N01AB07 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:21248852, URL:http://europepmc.org/abstract/MED/21248852",FC(F)OC(F)C(F)(F)F,CHEMBL2093872,GABRG3
1479,CHEMBL1200733,Desflurane,Small molecule,1992.0,N01AB07,"N01AB07 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:21248852, URL:http://europepmc.org/abstract/MED/21248852",FC(F)OC(F)C(F)(F)F,CHEMBL2093872,GABRP
1480,CHEMBL1200733,Desflurane,Small molecule,1992.0,N01AB07,"N01AB07 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:21248852, URL:http://europepmc.org/abstract/MED/21248852",FC(F)OC(F)C(F)(F)F,CHEMBL2093872,GABRE
1481,CHEMBL1200733,Desflurane,Small molecule,1992.0,N01AB07,"N01AB07 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:21248852, URL:http://europepmc.org/abstract/MED/21248852",FC(F)OC(F)C(F)(F)F,CHEMBL2093872,GABRG1
1482,CHEMBL931,Halothane,Small molecule,1958.0,N01AB01,"N01AB01 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:10443614, URL:http://europepmc.org/abstract/MED/10443614|Name:PubMed, SrcID:15271715, URL:http://europepmc.org/abstract/MED/15271715",FC(F)(F)C(Cl)Br,CHEMBL2093872,GABRG3
1483,CHEMBL931,Halothane,Small molecule,1958.0,N01AB01,"N01AB01 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:10443614, URL:http://europepmc.org/abstract/MED/10443614|Name:PubMed, SrcID:15271715, URL:http://europepmc.org/abstract/MED/15271715",FC(F)(F)C(Cl)Br,CHEMBL2093872,GABRP
1484,CHEMBL931,Halothane,Small molecule,1958.0,N01AB01,"N01AB01 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:10443614, URL:http://europepmc.org/abstract/MED/10443614|Name:PubMed, SrcID:15271715, URL:http://europepmc.org/abstract/MED/15271715",FC(F)(F)C(Cl)Br,CHEMBL2093872,GABRE
1485,CHEMBL931,Halothane,Small molecule,1958.0,N01AB01,"N01AB01 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:10443614, URL:http://europepmc.org/abstract/MED/10443614|Name:PubMed, SrcID:15271715, URL:http://europepmc.org/abstract/MED/15271715",FC(F)(F)C(Cl)Br,CHEMBL2093872,GABRG1
1486,CHEMBL1604,Cephradine,Small molecule,1974.0,J01DB09,J01DB09 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: First-generation cephalosporins],,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:PubMed, SrcID:7592463, URL:http://europepmc.org/abstract/MED/7592463",CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C3=CCC=CC3)C2=O)C(=O)O,,
1487,CHEMBL158,Aztreonam,Small molecule,1986.0,J01DF01,J01DF01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Monobactams],,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=d598f95b-92dd-4ef5-ae97-d68972258e44, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d598f95b-92dd-4ef5-ae97-d68972258e44",C[C@H]1[C@H](NC(=O)\C(=N/OC(C)(C)C(=O)O)\c2csc(N)n2)C(=O)N1S(=O)(=O)O,,
1488,CHEMBL996,Cefoxitin,Small molecule,1978.0,J01DC01,J01DC01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Second-generation cephalosporins],cef-,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:PubMed, SrcID:368000, URL:http://europepmc.org/abstract/MED/368000|Name:PubMed, SrcID:7447421, URL:http://europepmc.org/abstract/MED/7447421",CO[C@]1(NC(=O)Cc2cccs2)[C@H]3SCC(=C(N3C1=O)C(=O)O)COC(=O)N,,
1489,CHEMBL1200443,Merethoxylline Procaine,Small molecule,,,,-caine,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:DOI, SrcID:10.1056/NEJMra0907219, URL:http://www.nejm.org/doi/full/10.1056/NEJMra0907219|Name:Wikipedia, SrcID:Mercurial_diuretic, URL:http://en.wikipedia.org/wiki/Mercurial_diuretic|Name:PubMed, SrcID:22798951, URL:http://europepmc.org/abstract/MED/22798951|Name:PubMed, SrcID:14301996, URL:http://europepmc.org/abstract/MED/14301996|Name:PubMed, SrcID:15635807, URL:http://europepmc.org/abstract/MED/15635807|Name:Wikipedia, SrcID:Procaine, URL:http://en.wikipedia.org/wiki/Procaine|Name:PubMed, SrcID:13174657, URL:http://europepmc.org/abstract/MED/13174657|Name:PubMed, SrcID:5961353, URL:http://europepmc.org/abstract/MED/5961353",,,
1490,CHEMBL900,Orphenadrine,Small molecule,1957.0,M03BC51,"M03BC51 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS: Ethers, chemically close to antihistamines]",-drine,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19217209, URL:http://europepmc.org/abstract/MED/19217209",CN(C)CCOC(c1ccccc1)c2ccccc2C,,
1491,CHEMBL1201038,Acrisorcin,Small molecule,1982.0,,,,Unknown,,,,,,,,,,"Name:PubMed, SrcID:5952419, URL:http://europepmc.org/abstract/MED/5952419",CCCCCCc1ccc(O)cc1O.Nc2c3ccccc3nc4ccccc24,,
1492,CHEMBL2107857,Metreleptin,Protein,2014.0,A16AA07,A16AA07 [ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Amino acids and derivatives],-leptin,Leptin receptor agonist,,,CHEMBL5913,Leptin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2014/125390s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125390s000lbl.pdf",,CHEMBL5913,LEPR
1493,CHEMBL1256391,Pirfenidone,Small molecule,2011.0,L04AX05,L04AX05 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Other immunosuppressants],,Unknown,,,,,,,,,,"Name:FDA, SrcID:label/2014/022535s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022535s000lbl.pdf",CC1=CN(C(=O)C=C1)c2ccccc2,,
1494,CHEMBL139367,Peramivir,Small molecule,2014.0,,,-vir,Neuraminidase inhibitor,,,CHEMBL2051,Neuraminidase,INHIBITOR,Influenza A virus (A/Puerto Rico/8/1934(H1N1)),SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2014/206426lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206426lbl.pdf",CCC(CC)[C@H](NC(=O)C)[C@@H]1[C@H](O)[C@H](C[C@H]1NC(=N)N)C(=O)O,,
1495,CHEMBL3545047,Bms-852927,Small molecule,,,,,LXR-alpha modulator,"Ph1 study terminated in 2013, undisclosed reasons",,CHEMBL2808,LXR-alpha,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24833295, URL:http://europepmc.org/abstract/MED/24833295",,CHEMBL2808,NR1H3
1496,CHEMBL3545180,Theliatinib,Small molecule,,,,-tinib,Epidermal growth factor receptor erbB1 inhibitor,,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.hmplglobal.com/en/theliatinibhmpl-309/, URL:http://www.hmplglobal.com/en/theliatinibhmpl-309/|Name:ClinicalTrials, SrcID:NCT02601248, URL:https://www.clinicaltrials.gov/ct2/show/NCT02601248",,CHEMBL203,EGFR
1497,CHEMBL1084546,Pf-562271,Small molecule,,,,,Focal adhesion kinase 1 inhibitor,,,CHEMBL2695,Focal adhesion kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18339875, URL:http://europepmc.org/abstract/MED/18339875",CN(c1ncccc1CNc2nc(Nc3ccc4NC(=O)Cc4c3)ncc2C(F)(F)F)S(=O)(=O)C,CHEMBL2695,PTK2
1498,CHEMBL2205230,Tak-441,Small molecule,,,,,Smoothened homolog antagonist,,,CHEMBL5971,Smoothened homolog,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22898254, URL:http://europepmc.org/abstract/MED/22898254",CCC1=Cc2c(C(=O)N1CC(=O)c3ccccc3)c(OCC(F)(F)F)c(C(=O)NC4CCN(CC4)C(=O)CO)n2C,CHEMBL5971,SMO
1499,CHEMBL3545387,Sad448,Small molecule,,,,,Cannabinoid CB2 receptor agonist,,,CHEMBL253,Cannabinoid CB2 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17630726, URL:http://europepmc.org/abstract/MED/17630726|Name:PubMed, SrcID:24121462, URL:http://europepmc.org/abstract/MED/24121462",,CHEMBL253,CNR2
1500,CHEMBL2364652,Vantictumab,Antibody,,,,-mab,Frizzled-7 antagonist,mAB,,CHEMBL3559688,Frizzled-7,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22753465, URL:http://europepmc.org/abstract/MED/22753465",,CHEMBL3559688,FZD7
1501,CHEMBL3545090,Rxdx-103,Small molecule,,,,,Cell division cycle 7-related protein kinase inhibitor,,,CHEMBL5443,Cell division cycle 7-related protein kinase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://ignyta.com/technology/, URL:http://ignyta.com/technology/|Name:Other, SrcID:http://files.shareholder.com/downloads/AMDA-2CXB89/0x0x773488/f3e4833f-29aa-44df-a494-c2b8b01c175f/Ignyta-%20RXDX-103104%20investor%20presentation%20(final).pdf, URL:http://files.shareholder.com/downloads/AMDA-2CXB89/0x0x773488/f3e4833f-29aa-44df-a494-c2b8b01c175f/Ignyta-%20RXDX-103104%20investor%20presentation%20(final).pdf",,CHEMBL5443,CDC7
1502,CHEMBL2110814,Delucemine,Small molecule,,,,,Glutamate [NMDA] receptor antagonist,Non-competitive antagonist.,,CHEMBL2094124,Glutamate [NMDA] receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:10668449, URL:http://europepmc.org/abstract/MED/10668449|Name:Wikipedia, SrcID:Delucemine, URL:https://en.wikipedia.org/wiki/Delucemine",CNCCC(c1cccc(F)c1)c2cccc(F)c2,CHEMBL2094124,GRIN3B
1503,CHEMBL3137336,Uprosertib,Small molecule,,,,-sertib,Serine/threonine-protein kinase AKT inhibitor,,,CHEMBL2111353,Serine/threonine-protein kinase AKT,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:24978597, URL:http://europepmc.org/abstract/MED/24978597",Cn1ncc(Cl)c1c2cc(oc2Cl)C(=O)N[C@H](CN)Cc3ccc(F)c(F)c3,,
1504,CHEMBL2364626,Ralimetinib,Small molecule,,,,-tinib,MAP kinase p38 alpha inhibitor,Also potent inhibitor or MAPK11,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24356814, URL:http://europepmc.org/abstract/MED/24356814",CC(C)(C)Cn1c(N)nc2ccc(nc12)c3[nH]c(nc3c4ccc(F)cc4)C(C)(C)C,CHEMBL260,MAPK14
1505,CHEMBL3545026,Famitinib,Small molecule,,,,-tinib,Vascular endothelial growth factor receptor 2 inhibitor,Multi-targeted receptor tyrosine kinase inhibitor,,CHEMBL279,Vascular endothelial growth factor receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1158/1538-7445.AM2011-3604, URL:http://cancerres.aacrjournals.org/content/71/8_Supplement/3604|Name:ClinicalTrials, SrcID:NCT02390947, URL:https://www.clinicaltrials.gov/ct2/show/NCT02390947|Name:PubMed, SrcID:24043137, URL:http://europepmc.org/abstract/MED/24043137",,CHEMBL279,KDR
1506,CHEMBL403989,Tg100-801,Small molecule,,,,,Vascular endothelial growth factor receptor 2 inhibitor,Prodrug - active metabolite is TG-100-572 (HY-10184),,CHEMBL279,Vascular endothelial growth factor receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18311895, URL:http://europepmc.org/abstract/MED/18311895|Name:PubMed, SrcID:18483622, URL:http://europepmc.org/abstract/MED/18483622|Name:PubMed, SrcID:18330892, URL:http://europepmc.org/abstract/MED/18330892",Cc1cc(cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12)c5cc(OC(=O)c6ccccc6)ccc5Cl,CHEMBL279,KDR
1507,CHEMBL586701,Zstk-474,Small molecule,,,,,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:17711503, URL:http://europepmc.org/abstract/MED/17711503|Name:PubMed, SrcID:16622124, URL:http://europepmc.org/abstract/MED/16622124",Cc1ccc(cc1)C2Sc3ccccc3N=C4C2=C(O)c5ccccc45,CHEMBL3559703,PIK3R2
1508,CHEMBL586701,Zstk-474,Small molecule,,,,,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:17711503, URL:http://europepmc.org/abstract/MED/17711503|Name:PubMed, SrcID:16622124, URL:http://europepmc.org/abstract/MED/16622124",Cc1ccc(cc1)C2Sc3ccccc3N=C4C2=C(O)c5ccccc45,CHEMBL3559703,PIK3R3
1509,CHEMBL586701,Zstk-474,Small molecule,,,,,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:17711503, URL:http://europepmc.org/abstract/MED/17711503|Name:PubMed, SrcID:16622124, URL:http://europepmc.org/abstract/MED/16622124",Cc1ccc(cc1)C2Sc3ccccc3N=C4C2=C(O)c5ccccc45,CHEMBL3559703,PIK3R5
1510,CHEMBL281764,Tabimorelin,Small molecule,,,,-relin,Cytochrome P450 3A4 inhibitor,Ghrelin mimetic. Discontinued lack of efficacy and possible side effects due to CYP3A4 inhibition.,,CHEMBL340,Cytochrome P450 3A4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Tabimorelin, URL:http://en.wikipedia.org/wiki/Tabimorelin|Name:PubMed, SrcID:12610745, URL:http://europepmc.org/abstract/MED/12610745",CNC(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@@H](Cc2ccc3ccccc3c2)N(C)C(=O)\C=C\CC(C)(C)N,CHEMBL340,CYP3A4
1511,CHEMBL3545171,Pf-05089771,Small molecule,,,,,Sodium channel protein type IX alpha subunit blocker,,,CHEMBL4296,Sodium channel protein type IX alpha subunit,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25060923, URL:http://europepmc.org/abstract/MED/25060923|Name:Other, SrcID:http://www.sciencedirect.com/science/article/pii/S0006349514043495, URL:http://www.sciencedirect.com/science/article/pii/S0006349514043495",,CHEMBL4296,SCN9A
1512,CHEMBL3707317,Lorediplon,Small molecule,,,,-plon,GABA-A receptor; benzodiazepine site positive allosteric modulator,,,CHEMBL2109243,GABA-A receptor; benzodiazepine site,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Binds to benzodiazepine site.,"Name:PubMed, SrcID:22215924, URL:http://europepmc.org/abstract/MED/22215924|Name:PubMed, SrcID:24911577, URL:http://europepmc.org/abstract/MED/24911577",,,
1513,CHEMBL3545294,Odm-201,Small molecule,,,,,Androgen Receptor antagonist,,,CHEMBL1871,Androgen Receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.orion.fi/en/rd/orion-rd/pipeline/, URL:http://www.orion.fi/en/rd/orion-rd/pipeline/|Name:PubMed, SrcID:24974051, URL:http://europepmc.org/abstract/MED/24974051",,CHEMBL1871,AR
1514,CHEMBL3545235,Simotinib,Small molecule,,,,-tinib,Epidermal growth factor receptor erbB1 inhibitor,,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24440798, URL:http://europepmc.org/abstract/MED/24440798|Name:PubMed, SrcID:24522198, URL:http://europepmc.org/abstract/MED/24522198",COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCN4CC5(CC5)C6(C4)OCCO6,CHEMBL203,EGFR
1515,CHEMBL2108628,Paclitaxel Poliglumex,Unknown,,L01CD03,L01CD03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Taxanes],-taxel,Tubulin stabiliser,,,CHEMBL2095182,Tubulin,STABILISER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:17722272, URL:http://europepmc.org/abstract/MED/17722272",,CHEMBL2095182,TUBB8
1516,CHEMBL2108628,Paclitaxel Poliglumex,Unknown,,L01CD03,L01CD03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Taxanes],-taxel,Tubulin stabiliser,,,CHEMBL2095182,Tubulin,STABILISER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:17722272, URL:http://europepmc.org/abstract/MED/17722272",,CHEMBL2095182,TUBA3C
1517,CHEMBL2108628,Paclitaxel Poliglumex,Unknown,,L01CD03,L01CD03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Taxanes],-taxel,Tubulin stabiliser,,,CHEMBL2095182,Tubulin,STABILISER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:17722272, URL:http://europepmc.org/abstract/MED/17722272",,CHEMBL2095182,TUBA4A
1518,CHEMBL2108628,Paclitaxel Poliglumex,Unknown,,L01CD03,L01CD03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Taxanes],-taxel,Tubulin stabiliser,,,CHEMBL2095182,Tubulin,STABILISER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:17722272, URL:http://europepmc.org/abstract/MED/17722272",,CHEMBL2095182,TUBA3E
1519,CHEMBL2108628,Paclitaxel Poliglumex,Unknown,,L01CD03,L01CD03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Taxanes],-taxel,Tubulin stabiliser,,,CHEMBL2095182,Tubulin,STABILISER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:17722272, URL:http://europepmc.org/abstract/MED/17722272",,CHEMBL2095182,TUBB6
1520,CHEMBL2108628,Paclitaxel Poliglumex,Unknown,,L01CD03,L01CD03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Taxanes],-taxel,Tubulin stabiliser,,,CHEMBL2095182,Tubulin,STABILISER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:17722272, URL:http://europepmc.org/abstract/MED/17722272",,CHEMBL2095182,TUBB2B
1521,CHEMBL2108628,Paclitaxel Poliglumex,Unknown,,L01CD03,L01CD03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Taxanes],-taxel,Tubulin stabiliser,,,CHEMBL2095182,Tubulin,STABILISER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:17722272, URL:http://europepmc.org/abstract/MED/17722272",,CHEMBL2095182,TUBA3D
1522,CHEMBL166863,Polmacoxib,Small molecule,,,,-coxib,Carbonic anhydrase II inhibitor,,,CHEMBL205,Carbonic anhydrase II,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,One polmacoxib molecule binds the active site of CA II,"Name:PubMed, SrcID:27475498, URL:http://europepmc.org/abstract/MED/27475498|Name:PubMed, SrcID:26095375, URL:http://europepmc.org/abstract/MED/26095375",CC1(C)OC(=C(C1=O)c2cccc(F)c2)c3ccc(cc3)S(=O)(=O)N,CHEMBL205,CA2
1523,CHEMBL3833307,Sa237,Antibody,,,,,IL6Ralpha/GP130 antagonist,It blocks IL-6-mediated signal transduction by inhibiting IL-6 binding to transmembrane and soluble IL-6R.,,CHEMBL3137266,IL6Ralpha/GP130,ANTAGONIST,Homo sapiens,PROTEIN-PROTEIN INTERACTION,,It binds to IL-6 receptor multiple times.,"Name:Other, SrcID:https://myelitis.org/clinical-studies-and-trials/efficacy-and-safety-study-as-monotherapy-of-sa237-to-treat-nmo-and-nmosd/, URL:https://myelitis.org/clinical-studies-and-trials/efficacy-and-safety-study-as-monotherapy-of-sa237-to-treat-nmo-and-nmosd/|Name:PubMed, SrcID:23227116, URL:http://europepmc.org/abstract/MED/23227116",,,
1524,CHEMBL1743029,Ibalizumab,Antibody,,,,-mab,T-cell surface antigen CD4 inhibitor,"Binds CD4, the primary receptor for human immunodeficiency virus type 1 (HIV-1), and inhibits the viral entry process.",,CHEMBL2754,T-cell surface antigen CD4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19015347, URL:http://europepmc.org/abstract/MED/19015347|Name:PubMed, SrcID:21134642, URL:http://europepmc.org/abstract/MED/21134642",,CHEMBL2754,CD4
1525,CHEMBL1743044,Namilumab,Antibody,,,,-mab,Granulocyte-macrophage colony-stimulating factor inhibitor,,,CHEMBL3712955,Granulocyte-macrophage colony-stimulating factor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26633290, URL:http://europepmc.org/abstract/MED/26633290",,CHEMBL3712955,CSF2
1526,CHEMBL1743065,Roledumab,Antibody,,,,-mab,Blood group Rh(D) polypeptide inhibitor,Fully human IgG1 targeted against the human RhD antigen on RhD-positive circulating RhD-reactive B cells (RBCs).Clears of antibody-coated RhD RBCs.,,CHEMBL3712996,Blood group Rh(D) polypeptide,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22568808, URL:http://europepmc.org/abstract/MED/22568808",,CHEMBL3712996,RHD
1527,CHEMBL2108119,Pascolizumab,Antibody,,,,-mab,Interleukin-4 inhibitor,,,CHEMBL3712894,Interleukin-4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12296858, URL:http://europepmc.org/abstract/MED/12296858",,CHEMBL3712894,IL4
1528,CHEMBL1201420,Urokinase,Enzyme,2007.0,B01AD04,B01AD04 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Enzymes],-ase,Plasminogen activator,,,CHEMBL1801,Plasminogen,ACTIVATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=bfe5cfb9-591d-4df8-12a3-6555cde3185d, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bfe5cfb9-591d-4df8-12a3-6555cde3185d",,CHEMBL1801,PLG
1529,CHEMBL220492,Topiramate,Small molecule,1996.0,N03AX11,N03AX11 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],,Carbonic anhydrase II inhibitor,,,CHEMBL205,Carbonic anhydrase II,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=21628112-0c47-11df-95b3-498d55d89593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=21628112-0c47-11df-95b3-498d55d89593#nlm34090-1|Name:PubMed, SrcID:10768292, URL:http://europepmc.org/abstract/MED/10768292",CC1(C)O[C@@H]2CO[C@@]3(COS(=O)(=O)N)OC(C)(C)O[C@H]3[C@@H]2O1,CHEMBL205,CA2
1530,CHEMBL1200645,Etoposide Phosphate,Small molecule,1996.0,L01CB01,L01CB01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Podophyllotoxin derivatives],,DNA topoisomerase II alpha inhibitor,,,CHEMBL1806,DNA topoisomerase II alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Type_II_topoisomerase, URL:http://en.wikipedia.org/wiki/Type_II_topoisomerase|Name:DailyMed, SrcID:setid=e28c05f0-081f-406d-8bfb-9160a6908307#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e28c05f0-081f-406d-8bfb-9160a6908307#nlm34090-1",COc1cc(cc(OC)c1OP(=O)(O)O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)c6cc7OCOc7cc26,CHEMBL1806,TOP2A
1531,CHEMBL505,Chlorpheniramine,Small molecule,1950.0,R06AB04; R06AB54,R06AB04 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Substituted alkylamines]; R06AB54 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Substituted alkylamines],,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10511010, URL:http://europepmc.org/abstract/MED/10511010|Name:PubMed, SrcID:16413139, URL:http://europepmc.org/abstract/MED/16413139",CN(C)CCC(c1ccc(Cl)cc1)c2ccccn2,CHEMBL231,HRH1
1532,CHEMBL1088,Mesoridazine,Small molecule,1970.0,N05AC03,N05AC03 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Phenothiazines with piperidine structure],,Dopamine D2 receptor antagonist,,,CHEMBL217,Dopamine D2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Antipsychotic#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Antipsychotic#Mechanism_of_action|Name:PubMed, SrcID:10991983, URL:http://europepmc.org/abstract/MED/10991983|Name:PubMed, SrcID:11561066, URL:http://europepmc.org/abstract/MED/11561066|Name:PubMed, SrcID:15357957, URL:http://europepmc.org/abstract/MED/15357957",CN1CCCCC1CCN2c3ccccc3Sc4ccc(cc24)[S+](C)[O-],CHEMBL217,DRD2
1533,CHEMBL255863,Nilotinib,Small molecule,2007.0,L01XE08,L01XE08 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Tyrosine-protein kinase ABL inhibitor,,,CHEMBL1862,Tyrosine-protein kinase ABL,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=6093952a-5248-45cb-ad17-33716a411146#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6093952a-5248-45cb-ad17-33716a411146#section-13",Cc1cn(cn1)c2cc(NC(=O)c3ccc(C)c(Nc4nccc(n4)c5cccnc5)c3)cc(c2)C(F)(F)F,CHEMBL1862,ABL1
1534,CHEMBL181,Diazoxide,Small molecule,1973.0,C02DA01; V03AH01,"C02DA01 [CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON: Thiazide derivatives]; V03AH01 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Drugs for treatment of hypoglycemia]",,"Potassium channel, inwardly rectifying, subfamily J, member 11 opener",,,CHEMBL1886,"Potassium channel, inwardly rectifying, subfamily J, member 11",OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Diazoxide, URL:http://en.wikipedia.org/wiki/Diazoxide|Name:DailyMed, SrcID:setid=b16c7832-2fd9-49af-b923-1dc0d91fd6e2#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b16c7832-2fd9-49af-b923-1dc0d91fd6e2#nlm34090-1|Name:ISBN, SrcID:0443-059748 PP. 288, 394, URL:http://www.isbnsearch.org/isbn/0443059748",CC1=NS(=O)(=O)c2cc(Cl)ccc2N1,,
1535,CHEMBL1201528,Vasopressin Tannate,Protein,1982.0,,,-pressin,Vasopressin V1b receptor agonist,,,CHEMBL1921,Vasopressin V1b receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:IUPHAR, SrcID:2168, URL:http://www.iuphar-db.org/DATABASE/LigandDisplayForward?tab=biology&ligandId=2168|Name:DailyMed, SrcID:archiveid=190251, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=190251|Name:DailyMed, SrcID:setid=1b316ff5-b7f8-4509-acc4-fd263d0a1703, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1b316ff5-b7f8-4509-acc4-fd263d0a1703",,CHEMBL1921,AVPR1B
1536,CHEMBL1201515,Pegvisomant,Protein,2003.0,H01AX01,"H01AX01 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES: Other anterior pituitary lobe hormones and analogues]",peg-,Growth hormone receptor antagonist,It's a recombinant protein which selectively binds to growth hormone receptor,,CHEMBL1976,Growth hormone receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=222a28ca-70c3-474c-850e-fae39eaaf40f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=222a28ca-70c3-474c-850e-fae39eaaf40f",,CHEMBL1976,GHR
1537,CHEMBL1201639,Insulin Zinc Susp Beef,Protein,1982.0,,,,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/022472s006s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022472s006s008lbl.pdf|Name:DailyMed, SrcID:setid=457531f0-9331-47fe-90b5-b31f284044dc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=457531f0-9331-47fe-90b5-b31f284044dc",,CHEMBL1981,INSR
1538,CHEMBL1201,Thiothixene,Small molecule,1967.0,N05AF04,N05AF04 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Thioxanthene derivatives],,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:8593484, URL:http://europepmc.org/abstract/MED/8593484|Name:Wikipedia, SrcID:Antipsychotic#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Antipsychotic#Mechanism_of_action|Name:PubMed, SrcID:10821438, URL:http://europepmc.org/abstract/MED/10821438",CN(C)S(=O)(=O)c1ccc2Sc3ccccc3\C(=C\CCN4CCN(C)CC4)\c2c1,CHEMBL224,HTR2A
1539,CHEMBL659,Galantamine,Small molecule,2001.0,N06DA04,N06DA04 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTI-DEMENTIA DRUGS: Anticholinesterases],,Acetylcholinesterase inhibitor,,,CHEMBL220,Acetylcholinesterase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=bbdaf2f2-14e6-45c4-b807-5b22955444b0, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bbdaf2f2-14e6-45c4-b807-5b22955444b0",COc1ccc2CN(C)CC[C@@]34C=C[C@H](O)C[C@@H]3Oc1c24,CHEMBL220,ACHE
1540,CHEMBL894,Bupropion,Small molecule,1985.0,N06AX12,N06AX12 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants],,Norepinephrine transporter inhibitor,,,CHEMBL222,Norepinephrine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=5cb7fd36-ae36-409b-af79-9c432e1cf5d9#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5cb7fd36-ae36-409b-af79-9c432e1cf5d9#nlm34090-1|Name:PubMed, SrcID:19497387, URL:http://europepmc.org/abstract/MED/19497387",CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,CHEMBL222,SLC6A2
1541,CHEMBL1201776,Tapentadol,Small molecule,2008.0,N02AX06,N02AX06 [NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Other opioids],-adol,Norepinephrine transporter inhibitor,,,CHEMBL222,Norepinephrine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=e921054f-b3f1-4624-8edd-f6628c6f0fd9#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e921054f-b3f1-4624-8edd-f6628c6f0fd9#nlm34090-1",CC[C@H]([C@@H](C)CN(C)C)c1cccc(O)c1,CHEMBL222,SLC6A2
1542,CHEMBL2105395,Ospemifene,Small molecule,2013.0,G03XC05,G03XC05 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: Selective estrogen receptor modulators],-ifene,Estrogen receptor modulator,Mixed agonist/antagonist,,CHEMBL2093866,Estrogen receptor,MODULATOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=8462d6ab-e3cd-4efa-a360-75bf8f917287#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8462d6ab-e3cd-4efa-a360-75bf8f917287#nlm34090-1",OCCOc1ccc(cc1)\C(=C(\CCCl)/c2ccccc2)\c3ccccc3,,
1543,CHEMBL6622,Isosorbide Dinitrate,Small molecule,1986.0,C05AE02; C01DA08; C01DA58,C05AE02 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Muscle relaxants]; C01DA08 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: VASODILATORS USED IN CARDIAC DISEASES: Organic nitrates]; C01DA58 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: VASODILATORS USED IN CARDIAC DISEASES: Organic nitrates],,Soluble guanylate cyclase activator,,,CHEMBL2111348,Soluble guanylate cyclase,ACTIVATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Soluble guanylate cyclase beta subunit,"Heterodimer, beta (1 or 2) is binding site","Name:Wikipedia, SrcID:Soluble_guanylyl_cyclase, URL:http://en.wikipedia.org/wiki/Soluble_guanylyl_cyclase|Name:Wikipedia, SrcID:Nitrovasodilator, URL:http://en.wikipedia.org/wiki/Nitrovasodilator|Name:DailyMed, SrcID:setid=7ec5ba03-6164-4199-a333-7cd8d7c75e17, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7ec5ba03-6164-4199-a333-7cd8d7c75e17|Name:Wikipedia, SrcID:Nitric_oxide, URL:http://en.wikipedia.org/wiki/Nitric_oxide|Name:Wikipedia, SrcID:Isosorbide_dinitrate, URL:http://en.wikipedia.org/wiki/Isosorbide_dinitrate",[O-][N+](=O)O[C@H]1CO[C@@H]2[C@@H](CO[C@H]12)O[N+](=O)[O-],CHEMBL2111348,GUCY1A2
1544,CHEMBL2364968,Ergoloid,Small molecule,1953.0,,,,Adrenergic receptor alpha antagonist,,,CHEMBL2095203,Adrenergic receptor alpha,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:2869188, URL:http://europepmc.org/abstract/MED/2869188",CCC(C)[C@@H]1N2C(=O)[C@](NC(=O)[C@@H]3C[C@H]4[C@@H](Cc5c[nH]c6cccc4c56)N(C)C3)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C.CC(C)C[C@@H]8N9C(=O)[C@](NC(=O)[C@@H]%10C[C@H]%11[C@@H](Cc%12c[nH]c%13cccc%11c%12%13)N(C)C%10)(O[C@@]9(O)[C@@H]%14CCCN%14C8=O)C(C)C.CC(C)[C@@H]%15N%16C(=O)[C@](NC(=O)[C@@H]%17C[C@H]%18[C@@H](Cc%19c[nH]c%20cccc%18c%19%20)N(C)C%17)(O[C@@]%16(O)[C@@H]%21CCCN%21C%15=O)C(C)C.CC(C)[C@@]%22(NC(=O)[C@@H]%23C[C@H]%24[C@@H](Cc%25c[nH]c%26cccc%24c%25%26)N(C)C%23)O[C@@]%27(O)[C@@H]%28CCCN%28C(=O)[C@H](Cc%29ccccc%29)N%27C%22=O,,
1545,CHEMBL888,Gemcitabine,Small molecule,1996.0,L01BC05,L01BC05 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Pyrimidine analogues],-citabine,Ribonucleoside-diphosphate reductase RR1 inhibitor,,,CHEMBL2095215,Ribonucleoside-diphosphate reductase RR1,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Ribonucleoside-diphosphate reductase M1 subunit,M1 subunit is binding site,"Name:PubMed, SrcID:23115527, URL:http://europepmc.org/abstract/MED/23115527|Name:DailyMed, SrcID:setid=a625c92b-c569-4b98-8d2e-2b3f5e12b34f#section-12, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a625c92b-c569-4b98-8d2e-2b3f5e12b34f#section-12",NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)C2(F)F,,
1546,CHEMBL1200585,Oxymetholone,Small molecule,1972.0,A14AA05,A14AA05 [ALIMENTARY TRACT AND METABOLISM: ANABOLIC AGENTS FOR SYSTEMIC USE: ANABOLIC STEROIDS: Androstan derivatives],-olone,Androgen Receptor agonist,,,CHEMBL1871,Androgen Receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Oxymetholone, URL:http://en.wikipedia.org/wiki/Oxymetholone|Name:DailyMed, SrcID:setid=4b9c6c34-9cb2-4d70-b70e-c7ce2fda4212, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4b9c6c34-9cb2-4d70-b70e-c7ce2fda4212",C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC(=O)\C(=C/O)\C[C@]4(C)[C@H]3CC[C@]12C,CHEMBL1871,AR
1547,CHEMBL91,Miconazole,Small molecule,1974.0,S02AA13; A07AC01; D01AC02; A01AB09; G01AF04; D01AC52; J02AB01,"S02AA13 [SENSORY ORGANS: OTOLOGICALS: ANTIINFECTIVES: Antiinfectives]; A07AC01 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFECTIVES: Imidazole derivatives]; D01AC02 [DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Imidazole and triazole derivatives]; A01AB09 [ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Antiinfectives and antiseptics for local oral treatment]; G01AF04 [GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Imidazole derivatives]; D01AC52 [DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Imidazole and triazole derivatives]; J02AB01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: Imidazole derivatives]",-conazole,Cytochrome P450 51 inhibitor,,,CHEMBL1780,Cytochrome P450 51,INHIBITOR,Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast),SINGLE PROTEIN,,,"Name:PubMed, SrcID:12366848, URL:http://europepmc.org/abstract/MED/12366848|Name:PubMed, SrcID:8834867, URL:http://europepmc.org/abstract/MED/8834867|Name:Wikipedia, SrcID:Miconazole, URL:http://en.wikipedia.org/wiki/Miconazole|Name:PubMed, SrcID:9564569, URL:http://europepmc.org/abstract/MED/9564569|Name:PubMed, SrcID:10515900, URL:http://europepmc.org/abstract/MED/10515900",Clc1ccc(COC(Cn2ccnc2)c3ccc(Cl)cc3Cl)c(Cl)c1,,
1548,CHEMBL599,Meloxicam,Small molecule,2000.0,M01AC06; M01AC56,"M01AC06 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Oxicams]; M01AC56 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Oxicams]",-icam,Cyclooxygenase-2 inhibitor,,,CHEMBL230,Cyclooxygenase-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:8882380, URL:http://europepmc.org/abstract/MED/8882380",CN1C(=C(O)c2ccccc2S1(=O)=O)C(=O)Nc3ncc(C)s3,CHEMBL230,PTGS2
1549,CHEMBL1200983,Gallium Nitrate,Small molecule,1991.0,,,,Hydroxyapatite sequestering agent,enhances crystal formation by binding to hydroxyapatite,,CHEMBL2363055,Hydroxyapatite,SEQUESTERING AGENT,Homo sapiens,MACROMOLECULE,,,"Name:PubMed, SrcID:23666747, URL:http://europepmc.org/abstract/MED/23666747|Name:PubMed, SrcID:6715548, URL:http://europepmc.org/abstract/MED/6715548|Name:PubMed, SrcID:12776254, URL:http://europepmc.org/abstract/MED/12776254",,,
1550,CHEMBL22,Trimethoprim,Small molecule,1973.0,J01EA01,J01EA01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: SULFONAMIDES AND TRIMETHOPRIM: Trimethoprim and derivatives],-prim,Bacterial dihydrofolate reductase inhibitor,,Broad spectrum,CHEMBL2364669,Bacterial dihydrofolate reductase,INHIBITOR,Bacteria,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=a4e9183f-d0eb-4ba7-9204-760b1fd62010, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a4e9183f-d0eb-4ba7-9204-760b1fd62010",COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,,
1551,CHEMBL261772,Meclocycline Sulfosalicylate,Small molecule,1982.0,,,-cycline,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,16S ribosomal RNA,16s RRNA,"Name:PubMed, SrcID:15156014, URL:http://europepmc.org/abstract/MED/15156014",CN(C)[C@H]1[C@@H]2[C@@H](O)[C@@H]3C(=C)c4c(Cl)ccc(O)c4C(=O)C3=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N.OC(=O)c5cc(ccc5O)S(=O)(=O)O,,
1552,CHEMBL852,Melphalan,Small molecule,1964.0,L01AA03,L01AA03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ALKYLATING AGENTS: Nitrogen mustard analogues],,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=9706e9a1-96ab-46b8-8846-32ee9d756b1d, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9706e9a1-96ab-46b8-8846-32ee9d756b1d",N[C@@H](Cc1ccc(cc1)N(CCCl)CCCl)C(=O)O,,
1553,CHEMBL1201625,Cholestyramine,Unknown,1973.0,,,,Bile acids sequestering agent,Removes bile acids from the enterohepatic circulation by adsorbing and combing with the bile acids in the intestine and forming an insoluble complex which is extrected in the feces,,CHEMBL2364175,Bile acids,SEQUESTERING AGENT,Homo sapiens,SMALL MOLECULE,,,"Name:DailyMed, SrcID:setid=a7dd335a-6413-446e-8098-d4f97e935986#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a7dd335a-6413-446e-8098-d4f97e935986#nlm34090-1",,,
1554,CHEMBL1743070,Siltuximab,Antibody,2014.0,L04AC11,L04AC11 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Interleukin inhibitors],-mab,Interleukin-6 inhibitor,,,CHEMBL1795129,Interleukin-6,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2014/125496s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125496s000lbl.pdf",,CHEMBL1795129,IL6
1555,CHEMBL1908370,Finafloxacin,Small molecule,2014.0,,,-oxacin,Topoisomerase IV inhibitor,,,CHEMBL3038508,Topoisomerase IV,INHIBITOR,Staphylococcus aureus,PROTEIN COMPLEX,,,"Name:FDA, SrcID:label/2014/206307s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206307s000lbl.pdf",OC(=O)C1=CN(C2CC2)c3c(C#N)c(N4C[C@@H]5NCCO[C@H]5C4)c(F)cc3C1=O,,
1556,CHEMBL3545295,Ave0847,Small molecule,,,,,Peroxisome proliferator-activated receptor delta agonist,Development discontinued (http://fr.reuters.com/article/idUKL0461650920080404),,CHEMBL3979,Peroxisome proliferator-activated receptor delta,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://ncats.nih.gov/files/AVE0847.pdf, URL:https://ncats.nih.gov/files/AVE0847.pdf|Name:PubMed, SrcID:20932114, URL:http://europepmc.org/abstract/MED/20932114",,CHEMBL3979,PPARD
1557,CHEMBL3544961,Bi-853520,Small molecule,,,,,Focal adhesion kinase 1 inhibitor,,,CHEMBL2695,Focal adhesion kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1158/1535-7163.TARG-11-A249, URL:http://mct.aacrjournals.org/content/10/11_Supplement/A249|Name:Other, SrcID:http://www.inoncology.com/pipeline/our-compounds/ptk2-inhibitor.html, URL:http://www.inoncology.com/pipeline/our-compounds/ptk2-inhibitor.html",,CHEMBL2695,PTK2
1558,CHEMBL2029988,Cep-32496,Small molecule,,,,,Serine/threonine-protein kinase B-raf inhibitor,,,CHEMBL5145,Serine/threonine-protein kinase B-raf,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf, URL:http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf",COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(on4)C(C)(C)C(F)(F)F)c3)c2cc1OC,CHEMBL5145,BRAF
1559,CHEMBL2029988,Cep-32496,Small molecule,,,,,Tyrosine-protein kinase receptor RET inhibitor,,,CHEMBL2041,Tyrosine-protein kinase receptor RET,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://ignyta.com/wp-content/uploads/2015/11/ENA-2015-poster-RXDX-105.pdf, URL:http://ignyta.com/wp-content/uploads/2015/11/ENA-2015-poster-RXDX-105.pdf",COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(on4)C(C)(C)C(F)(F)F)c3)c2cc1OC,CHEMBL2041,RET
1560,CHEMBL3545076,Ly-2584702,Small molecule,,,,,Ribosomal protein S6 kinase 1 inhibitor,,,CHEMBL4501,Ribosomal protein S6 kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24440085, URL:http://europepmc.org/abstract/MED/24440085",Cn1cc(nc1C2CCN(CC2)c3ncnc4[nH]ncc34)c5ccc(F)c(c5)C(F)(F)F,CHEMBL4501,RPS6KB1
1561,CHEMBL2104954,Balamapimod,Small molecule,,,,-imod,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,No references found,,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://books.google.co.uk/books?id=prtObCihET4C&pg=PA7&lpg=PA7&dq=MKI-833&source=bl&ots=7p9-#v=onepage&q=MKI-833&f=false, URL:https://books.google.co.uk/books?id=prtObCihET4C&pg=PA7&lpg=PA7&dq=MKI-833&source=bl&ots=7p9-#v=onepage&q=MKI-833&f=false",COc1cc2c(Nc3ccc(Sc4nccn4C)c(Cl)c3)c(cnc2cc1N5CCC(CC5)N6CCCC6)C#N,CHEMBL3587,MAP2K1
1562,CHEMBL3545145,Wx-554,Small molecule,,,,,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,,,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23587417, URL:http://europepmc.org/abstract/MED/23587417|Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=732484, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=732484",,CHEMBL3587,MAP2K1
1563,CHEMBL2369989,Atilmotin,Protein,,,,,Motilin receptor agonist,,,CHEMBL2203,Motilin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19997977, URL:http://europepmc.org/abstract/MED/19997977",CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)[N+](C)(C)C)C(C)C)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc4ccc(O)cc4)C(=O)NCC(=O)N[C@@H](CCC(=O)[O-])C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,CHEMBL2203,MLNR
1564,CHEMBL3545214,Axp-107-11,Small molecule,,,,,Unknown,,,,,,,,,,"Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=683963, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=683963|Name:PubMed, SrcID:16204081, URL:http://europepmc.org/abstract/MED/16204081",,,
1565,CHEMBL1879463,Dactolisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:18606717, URL:http://europepmc.org/abstract/MED/18606717|Name:PubMed, SrcID:24591840, URL:http://europepmc.org/abstract/MED/24591840",CN1C(=O)N(c2ccc(cc2)C(C)(C)C#N)c3c1cnc4ccc(cc34)c5cnc6ccccc6c5,CHEMBL3559703,PIK3R2
1566,CHEMBL1879463,Dactolisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:18606717, URL:http://europepmc.org/abstract/MED/18606717|Name:PubMed, SrcID:24591840, URL:http://europepmc.org/abstract/MED/24591840",CN1C(=O)N(c2ccc(cc2)C(C)(C)C#N)c3c1cnc4ccc(cc34)c5cnc6ccccc6c5,CHEMBL3559703,PIK3R3
1567,CHEMBL1879463,Dactolisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:18606717, URL:http://europepmc.org/abstract/MED/18606717|Name:PubMed, SrcID:24591840, URL:http://europepmc.org/abstract/MED/24591840",CN1C(=O)N(c2ccc(cc2)C(C)(C)C#N)c3c1cnc4ccc(cc34)c5cnc6ccccc6c5,CHEMBL3559703,PIK3R5
1568,CHEMBL3545402,Xl-820,Small molecule,,,,,Platelet-derived growth factor receptor inhibitor,,,CHEMBL2095189,Platelet-derived growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:Other, SrcID:http://www.exelixis.com/sites/default/files/pdf/XL820%20EORTC-NCI-AACRnov06.pdf, URL:http://www.exelixis.com/sites/default/files/pdf/XL820%20EORTC-NCI-AACRnov06.pdf|Name:Other, SrcID:http://www.exelixis.com/sites/default/files/pdf/AACR_NCI_EORTC2007_XL820_resist.pdf, URL:http://www.exelixis.com/sites/default/files/pdf/AACR_NCI_EORTC2007_XL820_resist.pdf",,,
1569,CHEMBL2103862,Bavisant,Small molecule,,,,-isant,Histamine H3 receptor antagonist,,,CHEMBL264,Histamine H3 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22519922, URL:http://europepmc.org/abstract/MED/22519922",O=C(N1CCN(CC1)C2CC2)c3ccc(CN4CCOCC4)cc3,CHEMBL264,HRH3
1570,CHEMBL3301609,Toreforant,Small molecule,,,,-fo-,Histamine H4 receptor antagonist,,,CHEMBL3759,Histamine H4 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16349977, URL:http://europepmc.org/abstract/MED/16349977",CN1CCC(CCCNc2ncc(c(C)n2)c3nc4c(C)cc(C)cc4[nH]3)CC1,CHEMBL3759,HRH4
1571,CHEMBL3545348,Bkt140,Protein,,,,,C-X-C chemokine receptor type 4 antagonist,,,CHEMBL2107,C-X-C chemokine receptor type 4,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:9918823, URL:http://europepmc.org/abstract/MED/9918823|Name:PubMed, SrcID:24246358, URL:http://europepmc.org/abstract/MED/24246358|Name:PubMed, SrcID:23637121, URL:http://europepmc.org/abstract/MED/23637121",,CHEMBL2107,CXCR4
1572,CHEMBL3707249,Asm-024,Small molecule,,,,,Muscarinic acetylcholine receptor M1 antagonist,"ASM-024 displays both antagonistic and agonistic activity on CHRNA7, is thought to be a so called ""a7 silent agonist"": produce little or no CHRNA7 channel activation on its own but effectively activate the ion channel when combined with the type II positive allosteric modulator (PAM) PNU-120596. (A minimal pharmacophore for a nicotinic alpha7 silent agonist, relevance for the therapeutic development of treatments for asthma Poster#: 224.06/C24. Neuroscience Meeting Planner. New Orleans, LA: Soci",,CHEMBL216,Muscarinic acetylcholine receptor M1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24465890, URL:http://europepmc.org/abstract/MED/24465890|Name:PubMed, SrcID:25799096, URL:http://europepmc.org/abstract/MED/25799096",,CHEMBL216,CHRM1
1573,CHEMBL377300,Brivanib,Small molecule,,,,-anib,Vascular endothelial growth factor receptor inhibitor,Active metabolite of Brivanib alaninate,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:18829493, URL:http://europepmc.org/abstract/MED/18829493|Name:PubMed, SrcID:18288793, URL:http://europepmc.org/abstract/MED/18288793",C[C@@H](O)COc1cn2ncnc(Oc3ccc4[nH]c(C)cc4c3F)c2c1C,,
1574,CHEMBL3545413,Flumatinib,Small molecule,,,,-tinib,Tyrosine-protein kinase ABL inhibitor,,,CHEMBL1862,Tyrosine-protein kinase ABL,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20703259, URL:http://europepmc.org/abstract/MED/20703259|Name:PubMed, SrcID:18928591, URL:http://europepmc.org/abstract/MED/18928591",CN1CCN(Cc2ccc(cc2C(F)(F)F)C(=O)Nc3cnc(C)c(Nc4nccc(n4)c5cccnc5)c3)CC1,CHEMBL1862,ABL1
1575,CHEMBL2070241,Bremelanotide,Protein,,,,-tide,Melanocortin receptor 1 agonist,"Peptide, alpha-MSH analogue.",,CHEMBL3795,Melanocortin receptor 1,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Bremelanotide, URL:http://en.wikipedia.org/wiki/Bremelanotide|Name:PubMed, SrcID:12851303, URL:http://europepmc.org/abstract/MED/12851303|Name:PubMed, SrcID:17584130, URL:http://europepmc.org/abstract/MED/17584130",CCCC[C@H](NC(=O)C)C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc4ccccc4)NC(=O)[C@H](Cc5cnc[nH]5)NC1=O)C(=O)O,CHEMBL3795,MC1R
1576,CHEMBL1742995,Briakinumab,Antibody,,L04AC09,L04AC09 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Interleukin inhibitors],-mab,Interleukin-23 inhibitor,IgG1 monoclonal antibody with genetically engineered complementarity-determining regions that have high affinity for the IL-12/23 p40 subunit protein.,,CHEMBL2364154,Interleukin-23,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:22077474, URL:http://europepmc.org/abstract/MED/22077474|Name:PubMed, SrcID:18283176, URL:http://europepmc.org/abstract/MED/18283176",,,
1577,CHEMBL3707226,Defibrotide Sodium,Oligonucleotide,2016.0,,,-tide,Plasminogen activator,,,CHEMBL1801,Plasminogen,ACTIVATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:nda/2016/208114Orig1s000Lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/208114Orig1s000Lbl.pdf|Name:PubMed, SrcID:19809307, URL:http://europepmc.org/abstract/MED/19809307",,CHEMBL1801,PLG
1578,CHEMBL481611,Odanacatib,Small molecule,,,,-catib,Cathepsin K inhibitor,,,CHEMBL268,Cathepsin K,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18226527, URL:http://europepmc.org/abstract/MED/18226527",CC(C)(F)C[C@H](N[C@@H](c1ccc(cc1)c2ccc(cc2)S(=O)(=O)C)C(F)(F)F)C(=O)NC3(CC3)C#N,CHEMBL268,CTSK
1579,CHEMBL2105681,Sapacitabine,Small molecule,,,,-citabine,DNA inhibitor,Cytotoxic. Interferes with DNA synthesis by introducing single-strand DNA breaks leading to arrest of the cell division cycle at G2 phase and development of double-strand DNA breaks.,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:PubMed, SrcID:18483273, URL:http://europepmc.org/abstract/MED/18483273|Name:PubMed, SrcID:17637678, URL:http://europepmc.org/abstract/MED/17637678",CCCCCCCCCCCCCCCC(=O)NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2C#N,,
1580,CHEMBL3039507,Sotagliflozin,Small molecule,,,,-gliflozin,Sodium/glucose cotransporter 1 inhibitor,,"Human SGLT1 IC50=36 nmol/l, human SGLT2 IC50=1.8 nmol/l",CHEMBL4979,Sodium/glucose cotransporter 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22739142, URL:http://europepmc.org/abstract/MED/22739142",CCOc1ccc(Cc2cc(ccc2Cl)[C@@H]3O[C@H](SC)[C@@H](O)[C@H](O)[C@H]3O)cc1,CHEMBL4979,SLC5A1
1581,CHEMBL2109634,Oncolysin S,Antibody,,,,,Neural cell adhesion molecule 1 binding agent,Immunotoxin.,,CHEMBL3712938,Neural cell adhesion molecule 1,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:9053498, URL:http://europepmc.org/abstract/MED/9053498",,CHEMBL3712938,NCAM1
1582,CHEMBL2109384,Demcizumab,Antibody,,,,-mab,Delta-like protein 4 inhibitor,,,CHEMBL3712916,Delta-like protein 4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25324140, URL:http://europepmc.org/abstract/MED/25324140",,CHEMBL3712916,DLL4
1583,CHEMBL2105695,Telotristat Ethyl,Small molecule,2017.0,,,-stat,Tryptophan 5-hydroxylase inhibitor,"Prodrug, in vitro inhibitory potency of telotristat towards tryptophan hydroxylase is 29 times higher than that of telotristat ethyl",,CHEMBL3831287,Tryptophan 5-hydroxylase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2017/208794s000lbl.pdf, URL:https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208794s000lbl.pdf",CCOC(=O)[C@@H](N)Cc1ccc(cc1)c2cc(O[C@H](c3ccc(Cl)cc3n4ccc(C)n4)C(F)(F)F)nc(N)n2,,
1584,CHEMBL3545263,Lgx-806,Small molecule,,,,,Serine/threonine-protein kinase B-raf inhibitor,No references found,,CHEMBL5145,Serine/threonine-protein kinase B-raf,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,,,CHEMBL5145,BRAF
1585,CHEMBL2170582,R-343,Small molecule,,,,,Tyrosine-protein kinase SYK inhibitor,,,CHEMBL2599,Tyrosine-protein kinase SYK,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,,CNC(=O)COc1cccc(Nc2ncc(F)c(Nc3ccc4OC(F)(F)C(=O)Nc4c3)n2)c1,CHEMBL2599,SYK
1586,CHEMBL1180725,Propantheline,Small molecule,1953.0,A03AB05,"A03AB05 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: Synthetic anticholinergics, quaternary ammonium compounds]",,Muscarinic acetylcholine receptor M3 antagonist,"Role in regulating gastric secretion and overactive bladded, M3 likely involved",,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:13263156, URL:http://europepmc.org/abstract/MED/13263156|Name:PubMed, SrcID:3762265, URL:http://europepmc.org/abstract/MED/3762265|Name:PubMed, SrcID:16080359, URL:http://europepmc.org/abstract/MED/16080359|Name:PubMed, SrcID:16465186, URL:http://europepmc.org/abstract/MED/16465186|Name:PubMed, SrcID:4381291, URL:http://europepmc.org/abstract/MED/4381291|Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718",CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc3ccccc13)C(C)C,CHEMBL245,CHRM3
1587,CHEMBL1621597,Ipratropium,Small molecule,1986.0,,,-ium; -trop-,Muscarinic acetylcholine receptor M3 antagonist,"Role in regulating nasal secretion, M3 likely involved",,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=1eb2ffc4-d6d9-4efb-9f88-8434214d047e, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1eb2ffc4-d6d9-4efb-9f88-8434214d047e|Name:ISBN, SrcID:9780702034718 PP. 160, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:8873558, URL:http://europepmc.org/abstract/MED/8873558",CC(C)[N+]1(C)[C@@H]2CC[C@H]1C[C@H](C2)OC(=O)C(CO)c3ccccc3,CHEMBL245,CHRM3
1588,CHEMBL1201583,Bevacizumab,Antibody,2004.0,L01XC07,L01XC07 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,Vascular endothelial growth factor A inhibitor,,,CHEMBL1783,Vascular endothelial growth factor A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:9377574, URL:http://europepmc.org/abstract/MED/9377574|Name:DailyMed, SrcID:setid=939b5d1f-9fb2-4499-80ef-0607aa6b114e, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=939b5d1f-9fb2-4499-80ef-0607aa6b114e",,CHEMBL1783,VEGFA
1589,CHEMBL779,Tadalafil,Small molecule,2003.0,G04BE08,G04BE08 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Drugs used in erectile dysfunction],-afil,Phosphodiesterase 5A inhibitor,,Selective,CHEMBL1827,Phosphodiesterase 5A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=ff61b237-be8e-461b-8114-78c52a8ad0ae, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ff61b237-be8e-461b-8114-78c52a8ad0ae",CN1CC(=O)N2[C@H](Cc3c([nH]c4ccccc34)[C@H]2c5ccc6OCOc6c5)C1=O,CHEMBL1827,PDE5A
1590,CHEMBL1201445,Calcitonin Salmon,Protein,1978.0,,,calci-,Calcitonin receptor agonist,,,CHEMBL1832,Calcitonin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/017808s036lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/017808s036lbl.pdf|Name:IUPHAR, SrcID:685, URL:http://www.iuphar-db.org/DATABASE/LigandDisplayForward?tab=biology&ligandId=685|Name:DailyMed, SrcID:setid=f9d5a587-e2bc-4001-987d-9b04731303cb, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f9d5a587-e2bc-4001-987d-9b04731303cb",,,
1591,CHEMBL1495,Oxyphencyclimine,Small molecule,1982.0,A03AA01,"A03AA01 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: Synthetic anticholinergics, esters with tertiary amino group]",,Muscarinic acetylcholine receptor M1 antagonist,"Role in regulating gastric secretion, M1 likely involved",,CHEMBL216,Muscarinic acetylcholine receptor M1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:14492109, URL:http://europepmc.org/abstract/MED/14492109|Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:14168823, URL:http://europepmc.org/abstract/MED/14168823",CN1CCCN=C1COC(=O)C(O)(C2CCCCC2)c3ccccc3,CHEMBL216,CHRM1
1592,CHEMBL413,Sirolimus,Small molecule,1999.0,L04AA10; S01XA23,L04AA10 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Selective immunosuppressants]; S01XA23 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-imus,FK506-binding protein 1A inhibitor,,,CHEMBL1902,FK506-binding protein 1A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=3275b824-3f82-4151-2ab2-0036a9ba0acc#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3275b824-3f82-4151-2ab2-0036a9ba0acc#section-14",CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(/C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(/C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC)CC[C@H]1O,CHEMBL1902,FKBP1A
1593,CHEMBL1201488,Secretin Synthetic Human,Protein,2004.0,,,-retin,Secretin receptor agonist,,,CHEMBL1925,Secretin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=b4dfe70f-0a86-4488-9ba1-dcd8f86cbfcd, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b4dfe70f-0a86-4488-9ba1-dcd8f86cbfcd",,CHEMBL1925,SCTR
1594,CHEMBL1201630,Insulin Purified Pork,Protein,1979.0,A10AB03; A10AC03; A10AD03; A10AE03,"A10AB03 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: INSULINS AND ANALOGUES: Insulins and analogues for injection, fast-acting]; A10AC03 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: INSULINS AND ANALOGUES: Insulins and analogues for injection, intermediate-acting]; A10AD03 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: INSULINS AND ANALOGUES: Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting]; A10AE03 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: INSULINS AND ANALOGUES: Insulins and analogues for injection, long-acting]",,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/022472s006s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022472s006s008lbl.pdf|Name:DailyMed, SrcID:setid=457531f0-9331-47fe-90b5-b31f284044dc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=457531f0-9331-47fe-90b5-b31f284044dc",,CHEMBL1981,INSR
1595,CHEMBL57,Nevirapine,Small molecule,1996.0,J05AG01,J05AG01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Non-nucleoside reverse transcriptase inhibitors],-pin(e); -vir-,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,,,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,INHIBITOR,Human immunodeficiency virus 1,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=8dfe86aa-ea5d-48d2-94a8-1a5506055d70, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8dfe86aa-ea5d-48d2-94a8-1a5506055d70",Cc1ccnc2N(C3CC3)c4ncccc4C(=O)Nc12,,
1596,CHEMBL18442,Plerixafor,Small molecule,2008.0,L03AX16,L03AX16 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSTIMULANTS: IMMUNOSTIMULANTS: Other immunostimulants],-ixafor,C-X-C chemokine receptor type 4 partial agonist,,,CHEMBL2107,C-X-C chemokine receptor type 4,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=a56b1b78-0ae2-41b4-9c76-98ad9d439199#section-12, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a56b1b78-0ae2-41b4-9c76-98ad9d439199#section-12",C(N1CCCNCCNCCCNCC1)c2ccc(CN3CCCNCCNCCCNCC3)cc2,CHEMBL2107,CXCR4
1597,CHEMBL1946170,Regorafenib,Small molecule,2012.0,L01XE21,L01XE21 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-rafenib,Fibroblast growth factor receptor 2 inhibitor,,,CHEMBL4142,Fibroblast growth factor receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Expert, SrcID:REGORAFENIB, URL:http://chembl.blogspot.co.uk/search?q=REGORAFENIB",CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,CHEMBL4142,FGFR2
1598,CHEMBL957,Bosentan,Small molecule,2001.0,C02KX01,C02KX01 [CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: OTHER ANTIHYPERTENSIVES: Antihypertensives for pulmonary arterial hypertension],-entan,"Endothelin receptor, ET-A/ET-B antagonist",,,CHEMBL2096678,"Endothelin receptor, ET-A/ET-B",ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=749e42fb-2fe0-45dd-9268-b43bb3f4081c#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=749e42fb-2fe0-45dd-9268-b43bb3f4081c#section-13",COc1ccccc1Oc2c(NS(=O)(=O)c3ccc(cc3)C(C)(C)C)nc(nc2OCCO)c4ncccn4,,
1599,CHEMBL802,Minoxidil,Small molecule,1979.0,D11AX01; C02DC01,"D11AX01 [DERMATOLOGICALS: OTHER DERMATOLOGICAL PREPARATIONS: OTHER DERMATOLOGICAL PREPARATIONS: Other dermatologicals]; C02DC01 [CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON: Pyrimidine derivatives]",-dil,"Sulfonylurea receptor 2, Kir6.2 opener",,,CHEMBL2095198,"Sulfonylurea receptor 2, Kir6.2",OPENER,Homo sapiens,PROTEIN COMPLEX,Sulfonylurea receptor 2,SUR2 is binding site,"Name:PubMed, SrcID:11886528, URL:http://europepmc.org/abstract/MED/11886528",Nc1cc(nc(N)[n+]1[O-])N2CCCCC2,,
1600,CHEMBL1266,Tetrahydrozoline,Small molecule,1979.0,R01AA06; R01AB03; S01GA52; S01GA02,"R01AA06 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Sympathomimetics, plain]; R01AB03 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Sympathomimetics, combinations excl. corticosteroids]; S01GA52 [SENSORY ORGANS: OPHTHALMOLOGICALS: DECONGESTANTS AND ANTIALLERGICS: Sympathomimetics used as decongestants]; S01GA02 [SENSORY ORGANS: OPHTHALMOLOGICALS: DECONGESTANTS AND ANTIALLERGICS: Sympathomimetics used as decongestants]",,Adrenergic receptor alpha agonist,,,CHEMBL2095203,Adrenergic receptor alpha,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:18259967, URL:http://europepmc.org/abstract/MED/18259967",C1CC(C2=NCCN2)c3ccccc3C1,,
1601,CHEMBL714,Albuterol,Small molecule,1981.0,R03AC02; R03CC02,"R03AC02 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS, INHALANTS: Selective beta-2-adrenoreceptor agonists]; R03CC02 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS FOR SYSTEMIC USE: Selective beta-2-adrenoreceptor agonists]",-terol,Beta-2 adrenergic receptor agonist,,,CHEMBL210,Beta-2 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2014/020983s032lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020983s032lbl.pdf|Name:DailyMed, SrcID:setid=a3219f37-5605-4e90-ab11-45fbf1e982ee#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a3219f37-5605-4e90-ab11-45fbf1e982ee#nlm34090-1",CC(C)(C)NCC(O)c1ccc(O)c(CO)c1,CHEMBL210,ADRB2
1602,CHEMBL771,Cycloserine,Small molecule,1964.0,J04AB01,J04AB01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOBACTERIALS: DRUGS FOR TREATMENT OF TUBERCULOSIS: Antibiotics],,Alanine racemase inhibitor,,,CHEMBL2031,Alanine racemase,INHIBITOR,Mycobacterium tuberculosis,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23316042, URL:http://europepmc.org/abstract/MED/23316042|Name:ISBN, SrcID:9780702034718 PP. 635, URL:http://www.isbnsearch.org/isbn/9780702034718",N[C@@H]1CONC1=O,,
1603,CHEMBL104,Clotrimazole,Small molecule,1975.0,D01AC01; A01AB18; G01AF02,"D01AC01 [DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Imidazole and triazole derivatives]; A01AB18 [ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Antiinfectives and antiseptics for local oral treatment]; G01AF02 [GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Imidazole derivatives]",,Cytochrome P450 51 inhibitor,"Has also been implicated as a therapy for sickle cell anemia, by inhibiting the gardos channel, causing dehydration of the cells (PMID: 8636434)",,CHEMBL1780,Cytochrome P450 51,INHIBITOR,Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast),SINGLE PROTEIN,,,"Name:PubMed, SrcID:1929324, URL:http://europepmc.org/abstract/MED/1929324|Name:PubMed, SrcID:9326581, URL:http://europepmc.org/abstract/MED/9326581",Clc1ccccc1C(c2ccccc2)(c3ccccc3)n4ccnc4,,
1604,CHEMBL295698,Ketoconazole,Small molecule,1981.0,J02AB02; G01AF11; D01AC08,"J02AB02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: Imidazole derivatives]; G01AF11 [GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Imidazole derivatives]; D01AC08 [DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Imidazole and triazole derivatives]",-conazole,Cytochrome P450 51 inhibitor,,,CHEMBL1780,Cytochrome P450 51,INHIBITOR,Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast),SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 652, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:FDA, SrcID:label/2007/021738lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021738lbl.pdf",CC(=O)N1CCN(CC1)c2ccc(OC[C@@H]3CO[C@](Cn4ccnc4)(O3)c5ccc(Cl)cc5Cl)cc2,,
1605,CHEMBL141,Lamivudine,Small molecule,1995.0,J05AF05,J05AF05 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleoside and nucleotide reverse transcriptase inhibitors],-vudine,DNA inhibitor,"When monophosporylated is incorporates into the DNA, when triphosporylated inhibits the enzymes",,CHEMBL2363048,DNA,INHIBITOR,Hepatitis B virus,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=bc62b38c-4cc9-4e64-8852-1a0be6d36d8e, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bc62b38c-4cc9-4e64-8852-1a0be6d36d8e",NC1=NC(=O)N(C=C1)[C@@H]2CS[C@H](CO)O2,,
1606,CHEMBL439,Sulfadiazine,Small molecule,1941.0,J01EC02,J01EC02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: SULFONAMIDES AND TRIMETHOPRIM: Intermediate-acting sulfonamides],sulfa-,Bacterial dihydropteroate synthase inhibitor,,Broad spectrum,CHEMBL2364668,Bacterial dihydropteroate synthase,INHIBITOR,Bacteria,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15673759, URL:http://europepmc.org/abstract/MED/15673759|Name:PubMed, SrcID:9127492, URL:http://europepmc.org/abstract/MED/9127492|Name:DailyMed, SrcID:setid=b6654e2a-b901-4519-87e1-fc63eeba224a, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b6654e2a-b901-4519-87e1-fc63eeba224a",Nc1ccc(cc1)S(=O)(=O)Nc2ncccn2,,
1607,CHEMBL1605,Ceftibuten,Small molecule,1995.0,J01DD14,J01DD14 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Third-generation cephalosporins],cef-,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:PubMed, SrcID:2120175, URL:http://europepmc.org/abstract/MED/2120175",Nc1nc(cs1)\C(=C\CC(=O)O)\C(=O)N[C@H]2[C@H]3SCC=C(N3C2=O)C(=O)O,,
1608,CHEMBL454446,Cefditoren Pivoxil,Small molecule,2001.0,J01DD16,J01DD16 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Third-generation cephalosporins],cef-,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=e26a9881-a09e-41f5-8fad-6dfccbff6bf8, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e26a9881-a09e-41f5-8fad-6dfccbff6bf8|Name:FDA, SrcID:label/2012/021222s013s016lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021222s013s016lbl.pdf|Name:PubMed, SrcID:17724158, URL:http://europepmc.org/abstract/MED/17724158|Name:Wikipedia, SrcID:Penicillin_binding_proteins#Function, URL:http://en.wikipedia.org/wiki/Penicillin_binding_proteins#Function",CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)\C=C/c3scnc3C)\c4csc(N)n4,,
1609,CHEMBL1043,Dapsone,Small molecule,1979.0,J04BA02; D10AX05,J04BA02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOBACTERIALS: DRUGS FOR TREATMENT OF LEPRA: Drugs for treatment of lepra]; D10AX05 [DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Other anti-acne preparations for topical use],,Dihydropteroate synthase 1 inhibitor,,,CHEMBL2362993,Dihydropteroate synthase 1,INHIBITOR,Mycobacterium leprae (strain TN),SINGLE PROTEIN,,,"Name:ISBN, SrcID:0-86577-843-4 PP. 272, URL:http://www.isbnsearch.org/isbn/0865778434|Name:PubMed, SrcID:17134675, URL:http://europepmc.org/abstract/MED/17134675|Name:Wikipedia, SrcID:Dapsone#Mechanism, URL:http://en.wikipedia.org/wiki/Dapsone#Mechanism",Nc1ccc(cc1)S(=O)(=O)c2ccc(N)cc2,,
1610,CHEMBL2109047,Interferon Alfa-N3,Protein,1989.0,,,,Interferon alpha/beta receptor agonist,,,CHEMBL2364170,Interferon alpha/beta receptor,AGONIST,Homo sapiens,PROTEIN COMPLEX,,Alpha subunit is binding site,"Name:PubMed, SrcID:10049744, URL:http://europepmc.org/abstract/MED/10049744",,CHEMBL2364170,IFNAR2
1611,CHEMBL1475,Trioxsalen,Small molecule,1964.0,D05AD01; D05BA01,D05AD01 [DERMATOLOGICALS: ANTIPSORIATICS: ANTIPSORIATICS FOR TOPICAL USE: Psoralens for topical use]; D05BA01 [DERMATOLOGICALS: ANTIPSORIATICS: ANTIPSORIATICS FOR SYSTEMIC USE: Psoralens for systemic use],-sal-,DNA inhibitor,Photodynamic therapy,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:PubMed, SrcID:17373769, URL:http://europepmc.org/abstract/MED/17373769",CC1=CC(=O)Oc2c(C)c3oc(C)cc3cc12,,
1612,CHEMBL1301,Hydroxystilbamidine,Small molecule,1953.0,,,-amidine,RNA inhibitor,,,CHEMBL2311222,RNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:PubMed, SrcID:6897222, URL:http://europepmc.org/abstract/MED/6897222",NC(=N)c1ccc(\C=C\c2ccc(cc2O)C(=N)N)cc1,,
1613,CHEMBL1200733,Desflurane,Small molecule,1992.0,N01AB07,"N01AB07 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,Potassium channel subfamily K member 10 opener,,,CHEMBL2331041,Potassium channel subfamily K member 10,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:15562060, URL:http://europepmc.org/abstract/MED/15562060|Name:PubMed, SrcID:16192517, URL:http://europepmc.org/abstract/MED/16192517|Name:PubMed, SrcID:17227289, URL:http://europepmc.org/abstract/MED/17227289",FC(F)OC(F)C(F)(F)F,CHEMBL2331041,KCNK10
1614,CHEMBL430,Gemifloxacin,Small molecule,2003.0,J01MA15,J01MA15 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolones],-oxacin,Topoisomerase IV inhibitor,,,CHEMBL2363033,Topoisomerase IV,INHIBITOR,Streptococcus pneumoniae,PROTEIN COMPLEX,,,"Name:DailyMed, SrcID:setid=54c4b48b-cad7-4889-808f-f741352a2c97, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=54c4b48b-cad7-4889-808f-f741352a2c97|Name:FDA, SrcID:label/2013/021158s022lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021158s022lbl.pdf",CO\N=C\1/CN(CC1CN)c2nc3N(C=C(C(=O)O)C(=O)c3cc2F)C4CC4,,
1615,CHEMBL980,Guaifenesin,Small molecule,2002.0,R05CA03,"R05CA03 [RESPIRATORY SYSTEM: COUGH AND COLD PREPARATIONS: EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS: Expectorants]",,Unknown,,,,,,,,,,"Name:PubMed, SrcID:15243011, URL:http://europepmc.org/abstract/MED/15243011|Name:PubMed, SrcID:10515429, URL:http://europepmc.org/abstract/MED/10515429",COc1ccccc1OCC(O)CO,,
1616,CHEMBL1141,Potassium Iodide,Small molecule,1979.0,S01XA04; R05CA02; V03AB21,"S01XA04 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals]; R05CA02 [RESPIRATORY SYSTEM: COUGH AND COLD PREPARATIONS: EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS: Expectorants]; V03AB21 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Antidotes]",,Unknown,Iodine seems to lead to protein precipitation,,,,,,,,,"Name:ISBN, SrcID:9780702034718 PP. 410-411, URL:http://www.isbnsearch.org/isbn/9780702034718",[K+].[I-],,
1617,CHEMBL189963,Palbociclib,Small molecule,2015.0,L01XE33,L01XE33 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-ciclib,CDK6/cyclin D1 inhibitor,,,CHEMBL2111455,CDK6/cyclin D1,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:FDA, SrcID:label/2015/207103s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207103s000lbl.pdf",CC(=O)C1=C(C)c2cnc(Nc3ccc(cn3)N4CCNCC4)nc2N(C5CCCC5)C1=O,,
1618,CHEMBL3545056,Ink-128,Small molecule,,,,,Serine/threonine-protein kinase mTOR inhibitor,,,CHEMBL2842,Serine/threonine-protein kinase mTOR,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25519700, URL:http://europepmc.org/abstract/MED/25519700|Name:PubMed, SrcID:23085766, URL:http://europepmc.org/abstract/MED/23085766",,CHEMBL2842,MTOR
1619,CHEMBL3545356,Vk5211,Small molecule,,,,,Androgen Receptor modulator,SARM,,CHEMBL1871,Androgen Receptor,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24189892, URL:http://europepmc.org/abstract/MED/24189892|Name:Other, SrcID:http://www.vikingtherapeutics.com/pipeline/vk5211/, URL:http://www.vikingtherapeutics.com/pipeline/vk5211/|Name:PubMed, SrcID:22459616, URL:http://europepmc.org/abstract/MED/22459616",,CHEMBL1871,AR
1620,CHEMBL1967878,Cenisertib,Small molecule,,,,-sertib,Serine/threonine-protein kinase Aurora inhibitor,Pan-Aurora kinase inhibitor,,CHEMBL3430911,Serine/threonine-protein kinase Aurora,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:24965505, URL:http://europepmc.org/abstract/MED/24965505|Name:PubMed, SrcID:19609559, URL:http://europepmc.org/abstract/MED/19609559",CN1CCN(CC1)c2ccc(Nc3ncc(F)c(NC4C5CC(C=C5)C4C(=O)N)n3)cc2C,,
1621,CHEMBL3545427,Cm-082,Small molecule,,,,,Platelet-derived growth factor receptor beta inhibitor,,,CHEMBL1913,Platelet-derived growth factor receptor beta,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.tyrogenex.com/wordpress/wp-content/uploads/Oral-X-82-for-wet-AMD-ARVO-2013.pdf, URL:http://www.tyrogenex.com/wordpress/wp-content/uploads/Oral-X-82-for-wet-AMD-ARVO-2013.pdf",,CHEMBL1913,PDGFRB
1622,CHEMBL3545429,Gs-4997,Small molecule,,,,,Mitogen-activated protein kinase kinase kinase 5 inhibitor,,,CHEMBL5285,Mitogen-activated protein kinase kinase kinase 5,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25531162, URL:http://europepmc.org/abstract/MED/25531162",,CHEMBL5285,MAP3K5
1623,CHEMBL3188551,Gsk-2636771,Small molecule,,,,,PI3-kinase p110-beta subunit inhibitor,,,CHEMBL3145,PI3-kinase p110-beta subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:2999073, URL:http://europepmc.org/abstract/MED/2999073|Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718",Cc1c(Cn2c(C)nc3c(cc(cc23)N4CCOCC4)C(=O)O)cccc1C(F)(F)F,CHEMBL3145,PIK3CB
1624,CHEMBL3545307,Merestinib,Small molecule,,,,-tinib,Hepatocyte growth factor receptor inhibitor,,,CHEMBL3717,Hepatocyte growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25110867, URL:http://europepmc.org/abstract/MED/25110867|Name:Other, SrcID:http://www.lillyoncologypipeline.com/met-inhibitor.aspx, URL:http://www.lillyoncologypipeline.com/met-inhibitor.aspx|Name:PubMed, SrcID:23275061, URL:http://europepmc.org/abstract/MED/23275061",CC1=CC=C(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3c5cn[nH]c5)c(F)c2)C(=O)N1c6ccc(F)cc6,CHEMBL3717,MET
1625,CHEMBL258805,Indirubin Sulfate,Small molecule,,,,,Cyclin-dependent kinase 2 inhibitor,Also potent against CDK1 and CDK4,,CHEMBL301,Cyclin-dependent kinase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11507069, URL:http://europepmc.org/abstract/MED/11507069",COc1ccc2NC(=O)\C(=C/c3cnc[nH]3)\c2c1,CHEMBL301,CDK2
1626,CHEMBL405130,Whi-P131,Small molecule,,,,,Tyrosine-protein kinase JAK3 inhibitor,,,CHEMBL2148,Tyrosine-protein kinase JAK3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10389946, URL:http://europepmc.org/abstract/MED/10389946",COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC,CHEMBL2148,JAK3
1627,CHEMBL3545269,Sar425899,Small molecule,,,,,Glucagon receptor agonist,dual glucagon-like peptide-1/glucagon receptor agonist,,CHEMBL1985,Glucagon receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://adisinsight.springer.com/drugs/800041034, URL:http://adisinsight.springer.com/drugs/800041034",,CHEMBL1985,GCGR
1628,CHEMBL6318,Idoxifene,Small molecule,,,,-ifene,Estrogen receptor modulator,"SERM, development stopped as ineffective compared to tamoxifen.",,CHEMBL2093866,Estrogen receptor,MODULATOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Wikipedia, SrcID:Idoxifene, URL:http://en.wikipedia.org/wiki/Idoxifene|Name:PubMed, SrcID:9832463, URL:http://europepmc.org/abstract/MED/9832463",CC\C(=C(/c1ccc(I)cc1)\c2ccc(OCCN3CCCC3)cc2)\c4ccccc4,,
1629,CHEMBL3545213,Bentamapimod,Small molecule,,,,-imod,"c-Jun N-terminal kinase, JNK inhibitor",,,CHEMBL2096667,"c-Jun N-terminal kinase, JNK",INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:20855355, URL:http://europepmc.org/abstract/MED/20855355",N#CC(c1ccnc(OCc2ccc(CN3CCOCC3)cc2)n1)c4nc5ccccc5s4,,
1630,CHEMBL14762,Seliciclib,Small molecule,,,,-ciclib,Cyclin-dependent kinase 5 inhibitor,,,CHEMBL4036,Cyclin-dependent kinase 5,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26207228, URL:http://europepmc.org/abstract/MED/26207228|Name:PubMed, SrcID:25747275, URL:http://europepmc.org/abstract/MED/25747275|Name:PubMed, SrcID:9030781, URL:http://europepmc.org/abstract/MED/9030781",CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1,CHEMBL4036,CDK5
1631,CHEMBL1230609,Foretinib,Small molecule,,,,-tinib,Tyrosine-protein kinase receptor FLT3 inhibitor,,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.exelixis.com/pipeline/xl880, URL:http://www.exelixis.com/pipeline/xl880|Name:PubMed, SrcID:19808973, URL:http://europepmc.org/abstract/MED/19808973",COc1cc2c(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc5ccc(F)cc5)cc3F)ccnc2cc1OCCCN6CCOCC6,CHEMBL1974,FLT3
1632,CHEMBL3545026,Famitinib,Small molecule,,,,-tinib,Tyrosine-protein kinase receptor FLT3 inhibitor,Multi-targeted receptor tyrosine kinase inhibitor,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1158/1538-7445.AM2011-3604, URL:http://cancerres.aacrjournals.org/content/71/8_Supplement/3604|Name:ClinicalTrials, SrcID:NCT02390947, URL:https://www.clinicaltrials.gov/ct2/show/NCT02390947|Name:PubMed, SrcID:24043137, URL:http://europepmc.org/abstract/MED/24043137",,CHEMBL1974,FLT3
1633,CHEMBL2037511,Epelsiban,Small molecule,,,,-siban,Oxytocin receptor antagonist,,,CHEMBL2049,Oxytocin receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22239250, URL:http://europepmc.org/abstract/MED/22239250|Name:PubMed, SrcID:23530818, URL:http://europepmc.org/abstract/MED/23530818",CC[C@H](C)[C@H]1N([C@@H](C(=O)N2CCOCC2)c3ccc(C)nc3C)C(=O)[C@H](NC1=O)C4Cc5ccccc5C4,CHEMBL2049,OXTR
1634,CHEMBL3545032,Pf-04634817,Small molecule,,,,,C-C chemokine receptor type 2 antagonist,,,CHEMBL4015,C-C chemokine receptor type 2,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.pfizer.com/research/science_and_technology/product_pipeline, URL:http://www.pfizer.com/research/science_and_technology/product_pipeline",,CHEMBL4015,CCR2
1635,CHEMBL3301624,Setmelanotide,Protein,,,,-tide,Melanocortin receptor 4 agonist,Peptide,,CHEMBL259,Melanocortin receptor 4,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25652173, URL:http://europepmc.org/abstract/MED/25652173|Name:PubMed, SrcID:25675384, URL:http://europepmc.org/abstract/MED/25675384",C[C@H]1NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc4ccccc4)NC(=O)[C@H](Cc5c[nH]cn5)NC1=O)C(=O)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)C,CHEMBL259,MC4R
1636,CHEMBL3545105,Pol6326,Protein,,,,,C-X-C chemokine receptor type 4 antagonist,,,CHEMBL2107,C-X-C chemokine receptor type 4,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.polyphor.com/products/pol6326, URL:http://www.polyphor.com/products/pol6326|Name:PubMed, SrcID:15236665, URL:http://europepmc.org/abstract/MED/15236665",,CHEMBL2107,CXCR4
1637,CHEMBL238465,Sofinicline,Small molecule,,,,-nicline,Neuronal acetylcholine receptor; alpha4/beta2 agonist,selectivity for the cytisine binding site on CHRNA4,Selectivity for the cytisine binding site on CHRNA4.,CHEMBL1907589,Neuronal acetylcholine receptor; alpha4/beta2,AGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:17929796, URL:http://europepmc.org/abstract/MED/17929796|Name:PubMed, SrcID:23032073, URL:http://europepmc.org/abstract/MED/23032073",Clc1cc(cnc1Cl)N2C[C@@H]3CN[C@@H]3C2,,
1638,CHEMBL23261,Darusentan,Small molecule,,,,-entan,Endothelin receptor ET-A antagonist,Discontinued failed to meet primary endpoints in phase 3 study,,CHEMBL252,Endothelin receptor ET-A,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20660536, URL:http://europepmc.org/abstract/MED/20660536",COc1cc(OC)nc(O[C@H](C(=O)O)C(OC)(c2ccccc2)c3ccccc3)n1,CHEMBL252,EDNRA
1639,CHEMBL266510,Flindokalner,Small molecule,,,,-kalner,Voltage-gated potassium channel subunit Kv7.2 activator,Indication: Stroke,,CHEMBL2476,Voltage-gated potassium channel subunit Kv7.2,ACTIVATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11378159, URL:http://europepmc.org/abstract/MED/11378159",COc1ccc(Cl)cc1[C@]2(F)C(=O)Nc3cc(ccc23)C(F)(F)F,CHEMBL2476,KCNQ2
1640,CHEMBL572881,Motesanib,Small molecule,,,,-anib,Tyrosine-protein kinase receptor RET inhibitor,Multi-kinase inhibitor,,CHEMBL2041,Tyrosine-protein kinase receptor RET,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16951187, URL:http://europepmc.org/abstract/MED/16951187",CC1(C)CNc2cc(NC(=O)c3cccnc3NCc4ccncc4)ccc12,CHEMBL2041,RET
1641,CHEMBL3707403,Celivarone,Small molecule,,,,-arone,Unknown,,,,,,,,,,"Name:Wikipedia, SrcID:Celivarone, URL:https://en.wikipedia.org/wiki/Celivarone|Name:PubMed, SrcID:15243307, URL:http://europepmc.org/abstract/MED/15243307",CCCCN(CCCC)CCCc1ccc(cc1)C(=O)c2c(CCCC)oc3ccc(cc23)C(=O)OC(C)C,,
1642,CHEMBL348475,Tariquidar,Small molecule,,,,-dar,P-glycoprotein 1 inhibitor,,Specifically inhibitS ABCB1 among ABC transporters (KD = 5.1 nM).,CHEMBL4302,P-glycoprotein 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26658428, URL:http://europepmc.org/abstract/MED/26658428|Name:PubMed, SrcID:10510451, URL:http://europepmc.org/abstract/MED/10510451",COc1cc2CCN(CCc3ccc(NC(=O)c4cc(OC)c(OC)cc4NC(=O)c5cnc6ccccc6c5)cc3)Cc2cc1OC,CHEMBL4302,ABCB1
1643,CHEMBL501259,Eritoran,Small molecule,,,,-toran,Toll-like receptor 4/MD-2 antagonist,"Competes with LPS for binding to the TLR4 receptor complex blocking the activation of NF-kB and production of inflammatory mediators, such as TNF-a and IL6, in response to LPS",,CHEMBL3038512,Toll-like receptor 4/MD-2,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX,,Binds to the hydrophobic pocket of the MD2 portion of the TLR4 receptor complex,"Name:PubMed, SrcID:12604686, URL:http://europepmc.org/abstract/MED/12604686|Name:PubMed, SrcID:25375408, URL:http://europepmc.org/abstract/MED/25375408",CCCCCCCCCCCC(=O)CC(=O)N[C@H]1[C@@H](OP(=O)(O)O)O[C@H](CO[C@@H]2O[C@H](COC)[C@@H](OP(=O)(O)O)[C@H](OCC[C@@H](CCCCCCC)OC)[C@H]2NC(=O)CCCCCCCCC\C=C/CCCCCC)[C@@H](O)[C@@H]1OCCCCCCCCCC,,
1644,CHEMBL2108258,Atorolimumab,Antibody,,,,-mab,Blood group Rh(D) polypeptide other,Unknown,,CHEMBL3712996,Blood group Rh(D) polypeptide,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:https://en.wikipedia.org/wiki/Atorolimumab, URL:https://en.wikipedia.org/wiki/Atorolimumab|Name:Other, SrcID:http://apps.who.int/iris/bitstream/10665/57160/1/INN_1999_list42.pdf, URL:http://apps.who.int/iris/bitstream/10665/57160/1/INN_1999_list42.pdf",,CHEMBL3712996,RHD
1645,CHEMBL1742983,Alacizumab Pegol,Antibody,,,,-mab,Vascular endothelial growth factor receptor 2 antagonist,"CDP791 binds specifically to VEGFR-2, inhibiting activation by its ligands VEGF-A, VEGF-C, VEGF-D and therefore, blocking all signaling through this receptor.",,CHEMBL279,Vascular endothelial growth factor receptor 2,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.ucb.com/presscenter/News/article/Phase-II-results-for-CDP791-in-non-small-cell-lung-cancer-support-further-clinical-development, URL:http://www.ucb.com/presscenter/News/article/Phase-II-results-for-CDP791-in-non-small-cell-lung-cancer-support-further-clinical-development|Name:PubMed, SrcID:18056191, URL:http://europepmc.org/abstract/MED/18056191",,CHEMBL279,KDR
1646,CHEMBL1742986,Atacicept,Protein,,,,-cept,Tumor necrosis factor ligand superfamily member 13 inhibitor,"It has high affinity and specificity for cytokines BLyS and APRIL, preventing receptor binding. Three receptors, TACI, BCMA (B-cell maturation antigen) and BAFF-R, have been identified that have unique binding affinities for BLyS and APRIL (PMID: 10898980).",,CHEMBL3713436,Tumor necrosis factor ligand superfamily member 13,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21179612, URL:http://europepmc.org/abstract/MED/21179612|Name:PubMed, SrcID:18046446, URL:http://europepmc.org/abstract/MED/18046446",,CHEMBL3713436,TNFSF13
1647,CHEMBL2109391,Mdx-447,Antibody,,,,,High affinity immunoglobulin gamma Fc receptor I other,Binds to the EGFR and to the high-affinity immunoglobulin G (IgG) receptor CD64 both separately and simultaneously. Mediates antibody-dependent cell-mediated cytotoxicity (ADCC) with lysis of EGFR overexpressing cell lines.,,CHEMBL5349,High affinity immunoglobulin gamma Fc receptor I,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17602224, URL:http://europepmc.org/abstract/MED/17602224",,CHEMBL5349,FCGR1A
1648,CHEMBL2109500,Lirilumab,Antibody,,,,-mab,Killer cell immunoglobulin-like receptor 2DL1 inhibitor,"Blocks the interaction of the three main inhibitory KIR receptors (KIR2DL-1, -2, -3) with their ligands, the human leukocyte antigen-C (HLA-C) molecules.",,CHEMBL3712912,Killer cell immunoglobulin-like receptor 2DL1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PMC, SrcID:PMC4803142, URL:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803142|Name:PubMed, SrcID:24326534, URL:http://europepmc.org/abstract/MED/24326534",,,
1649,CHEMBL1201245,Bromodiphenhydramine,Small molecule,1954.0,R06AA01,R06AA01 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Aminoalkyl ethers],,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:1973150, URL:http://europepmc.org/abstract/MED/1973150|Name:PubMed, SrcID:22876948, URL:http://europepmc.org/abstract/MED/22876948",CN(C)CCOC(c1ccccc1)c2ccc(Br)cc2,CHEMBL231,HRH1
1650,CHEMBL1193,Pheniramine,Small molecule,1994.0,D04AA16; R06AB05,"D04AA16 [DERMATOLOGICALS: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: Antihistamines for topical use]; R06AB05 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Substituted alkylamines]",,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Pheniramine, URL:http://en.wikipedia.org/wiki/Pheniramine|Name:PubMed, SrcID:13743818, URL:http://europepmc.org/abstract/MED/13743818",CN(C)CCC(c1ccccc1)c2ccccn2,CHEMBL231,HRH1
1651,CHEMBL1621,Paliperidone,Small molecule,2006.0,N05AX13,N05AX13 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Other antipsychotics],-peridone,Dopamine D2 receptor antagonist,,,CHEMBL217,Dopamine D2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=7b8e5b26-b9e4-4704-921b-3c3c0d159916#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7b8e5b26-b9e4-4704-921b-3c3c0d159916#nlm34090-1|Name:FDA, SrcID:label/2011/022264s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022264s006lbl.pdf",CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCC(O)C5=N1,CHEMBL217,DRD2
1652,CHEMBL938,Saralasin,Protein,1982.0,,,,Type-1 angiotensin II receptor antagonist,,,CHEMBL227,Type-1 angiotensin II receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:603879, URL:http://europepmc.org/abstract/MED/603879|Name:Wikipedia, SrcID:Angiotensin_receptor, URL:http://en.wikipedia.org/wiki/Angiotensin_receptor",CNCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N3CCC[C@H]3C(=O)N[C@@H](C)C(=O)O,CHEMBL227,AGTR1
1653,CHEMBL560,Pentazocine,Small molecule,1967.0,N02AD01,N02AD01 [NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Benzomorphan derivatives],-azocine,Sigma opioid receptor modulator,Mixed agonist/antagonist,,CHEMBL287,Sigma opioid receptor,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=3107d8eb-ebe8-4114-9db0-2d278612f186#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3107d8eb-ebe8-4114-9db0-2d278612f186#nlm34090-1|Name:PubMed, SrcID:19587856, URL:http://europepmc.org/abstract/MED/19587856",C[C@H]1[C@H]2Cc3ccc(O)cc3[C@]1(C)CCN2CC=C(C)C,CHEMBL287,SIGMAR1
1654,CHEMBL1755,Conivaptan,Small molecule,2005.0,C03XA02,C03XA02 [CARDIOVASCULAR SYSTEM: DIURETICS: OTHER DIURETICS: Vasopressin antagonists],-vaptan,Vasopressin V1a receptor antagonist,,,CHEMBL1889,Vasopressin V1a receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2012/021697s003lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021697s003lbl.pdf|Name:DailyMed, SrcID:setid=87713d73-5dcc-4158-8890-60efdbd28c05#section-12, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=87713d73-5dcc-4158-8890-60efdbd28c05#section-12",Cc1nc2c(CCN(C(=O)c3ccc(NC(=O)c4ccccc4c5ccccc5)cc3)c6ccccc26)[nH]1,CHEMBL1889,AVPR1A
1655,CHEMBL1088,Mesoridazine,Small molecule,1970.0,N05AC03,N05AC03 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Phenothiazines with piperidine structure],,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16135699, URL:http://europepmc.org/abstract/MED/16135699|Name:Wikipedia, SrcID:Antipsychotic#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Antipsychotic#Mechanism_of_action|Name:PubMed, SrcID:15357957, URL:http://europepmc.org/abstract/MED/15357957",CN1CCCCC1CCN2c3ccccc3Sc4ccc(cc24)[S+](C)[O-],CHEMBL224,HTR2A
1656,CHEMBL623,Nefazodone,Small molecule,1994.0,N06AX06,N06AX06 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants],,Norepinephrine transporter inhibitor,,,CHEMBL222,Norepinephrine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=b1d149db-ad43-4f3f-aef1-fb0395ba4191#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b1d149db-ad43-4f3f-aef1-fb0395ba4191#nlm34090-1",CCC1=NN(CCCN2CCN(CC2)c3cccc(Cl)c3)C(=O)N1CCOc4ccccc4,CHEMBL222,SLC6A2
1657,CHEMBL288441,Bosutinib,Small molecule,2010.0,L01XE14,L01XE14 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Tyrosine-protein kinase HCK inhibitor,,,CHEMBL3234,Tyrosine-protein kinase HCK,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Expert, SrcID:BOSUTINIB, URL:http://chembl.blogspot.co.uk/search?q=BOSUTINIB",COc1cc(Nc2c(cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl,CHEMBL3234,HCK
1658,CHEMBL923,Risedronic Acid,Small molecule,1998.0,M05BA07,M05BA07 [MUSCULO-SKELETAL SYSTEM: DRUGS FOR TREATMENT OF BONE DISEASES: DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION: Bisphosphonates],-dronate,Farnesyl diphosphate synthase inhibitor,"Binds to the bone matrix (hydroxyapatite), and when the bone starts to be reabsorbed the compound is released and taken up by osteoclasts, inhibiting protein prenylation of the GTPases involved in the formation of the ruffled border",,CHEMBL1782,Farnesyl diphosphate synthase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=4423d70a-b120-4653-bcf3-0c5ea8b97b0e, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4423d70a-b120-4653-bcf3-0c5ea8b97b0e|Name:PubMed, SrcID:16835450, URL:http://europepmc.org/abstract/MED/16835450|Name:PubMed, SrcID:15028820, URL:http://europepmc.org/abstract/MED/15028820|Name:PubMed, SrcID:11160603, URL:http://europepmc.org/abstract/MED/11160603|Name:PubMed, SrcID:16006204, URL:http://europepmc.org/abstract/MED/16006204",OC(Cc1cccnc1)(P(=O)(O)O)P(=O)(O)O,CHEMBL1782,FDPS
1659,CHEMBL834,Pamidronic Acid,Small molecule,1991.0,M05BA03,M05BA03 [MUSCULO-SKELETAL SYSTEM: DRUGS FOR TREATMENT OF BONE DISEASES: DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION: Bisphosphonates],-dronate,Farnesyl diphosphate synthase inhibitor,"Binds to the bone matrix (hydroxyapatite), and when the bone starts to be reabsorbed the compound is released and taken up by osteoclasts, inhibiting protein prenylation of the GTPases involved in the formation of the ruffled border",,CHEMBL1782,Farnesyl diphosphate synthase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15713990, URL:http://europepmc.org/abstract/MED/15713990|Name:DailyMed, SrcID:setid=918cb226-3f1e-479e-8058-dfe60ae14fb2, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=918cb226-3f1e-479e-8058-dfe60ae14fb2|Name:PubMed, SrcID:12177810, URL:http://europepmc.org/abstract/MED/12177810|Name:PubMed, SrcID:10620343, URL:http://europepmc.org/abstract/MED/10620343|Name:PubMed, SrcID:15028820, URL:http://europepmc.org/abstract/MED/15028820|Name:PubMed, SrcID:11160603, URL:http://europepmc.org/abstract/MED/11160603|Name:FDA, SrcID:label/2014/021113s017lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021113s017lbl.pdf",NCCC(O)(P(=O)(O)O)P(=O)(O)O,CHEMBL1782,FDPS
1660,CHEMBL1208646,Theophylline Glycinate,Small molecule,1982.0,,,,Adenosine receptor antagonist,,,CHEMBL2111329,Adenosine receptor,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:15980878, URL:http://europepmc.org/abstract/MED/15980878|Name:PubMed, SrcID:12954362, URL:http://europepmc.org/abstract/MED/12954362|Name:PubMed, SrcID:3588607, URL:http://europepmc.org/abstract/MED/3588607|Name:PubMed, SrcID:14992338, URL:http://europepmc.org/abstract/MED/14992338|Name:Wikipedia, SrcID:Theophylline#Mechanisms_of_action, URL:http://en.wikipedia.org/wiki/Theophylline#Mechanisms_of_action",CN1C(=O)N(C)c2nc[nH]c2C1=O.NCC(=O)O,,
1661,CHEMBL1360,Atracurium,Small molecule,1983.0,M03AC04,"M03AC04 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS: Other quaternary ammonium compounds]",-curium,Muscle-type nicotinic acetylcholine receptor antagonist,,,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:archiveid=85008, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=85008|Name:PubMed, SrcID:16931985, URL:http://europepmc.org/abstract/MED/16931985|Name:PubMed, SrcID:19417616, URL:http://europepmc.org/abstract/MED/19417616|Name:PubMed, SrcID:11379686, URL:http://europepmc.org/abstract/MED/11379686|Name:DailyMed, SrcID:setid=51cdd8f7-e52d-4f6f-9a1b-4e9528b507cc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=51cdd8f7-e52d-4f6f-9a1b-4e9528b507cc",COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]4(C)CCc5cc(OC)c(OC)cc5C4Cc6ccc(OC)c(OC)c6)cc1OC,,
1662,CHEMBL2367706,Sucralfate,Unknown,1981.0,A02BX02,A02BX02 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)],,Glycoproteins cross-linking agent,cytoprotective barrier,,CHEMBL2363054,Glycoproteins,CROSS-LINKING AGENT,Homo sapiens,MACROMOLECULE,,,"Name:DailyMed, SrcID:setid=0fb67b1c-b4c0-46f2-8a81-df1510e006aa#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0fb67b1c-b4c0-46f2-8a81-df1510e006aa#nlm34090-1|Name:ISBN, SrcID:0443-059748 PP. 376, URL:http://www.isbnsearch.org/isbn/0443059748",O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@H](O[C@]2(COS(=O)(=O)O[Al](O)O)O[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]2OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,,
1663,CHEMBL969,Prazepam,Small molecule,1982.0,N05BA11,N05BA11 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:6114911, URL:http://europepmc.org/abstract/MED/6114911|Name:PubMed, SrcID:18384456, URL:http://europepmc.org/abstract/MED/18384456|Name:Wikipedia, SrcID:Prazepam, URL:http://en.wikipedia.org/wiki/Prazepam",Clc1ccc2N(CC3CC3)C(=O)CN=C(c4ccccc4)c2c1,CHEMBL2093872,GABRG3
1664,CHEMBL969,Prazepam,Small molecule,1982.0,N05BA11,N05BA11 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:6114911, URL:http://europepmc.org/abstract/MED/6114911|Name:PubMed, SrcID:18384456, URL:http://europepmc.org/abstract/MED/18384456|Name:Wikipedia, SrcID:Prazepam, URL:http://en.wikipedia.org/wiki/Prazepam",Clc1ccc2N(CC3CC3)C(=O)CN=C(c4ccccc4)c2c1,CHEMBL2093872,GABRP
1665,CHEMBL969,Prazepam,Small molecule,1982.0,N05BA11,N05BA11 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:6114911, URL:http://europepmc.org/abstract/MED/6114911|Name:PubMed, SrcID:18384456, URL:http://europepmc.org/abstract/MED/18384456|Name:Wikipedia, SrcID:Prazepam, URL:http://en.wikipedia.org/wiki/Prazepam",Clc1ccc2N(CC3CC3)C(=O)CN=C(c4ccccc4)c2c1,CHEMBL2093872,GABRE
1666,CHEMBL969,Prazepam,Small molecule,1982.0,N05BA11,N05BA11 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:6114911, URL:http://europepmc.org/abstract/MED/6114911|Name:PubMed, SrcID:18384456, URL:http://europepmc.org/abstract/MED/18384456|Name:Wikipedia, SrcID:Prazepam, URL:http://en.wikipedia.org/wiki/Prazepam",Clc1ccc2N(CC3CC3)C(=O)CN=C(c4ccccc4)c2c1,CHEMBL2093872,GABRG1
1667,CHEMBL446,Sulfamethazine,Small molecule,1949.0,J01EB03,J01EB03 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: SULFONAMIDES AND TRIMETHOPRIM: Short-acting sulfonamides],sulfa-,Bacterial dihydropteroate synthase inhibitor,,Broad spectrum,CHEMBL2364668,Bacterial dihydropteroate synthase,INHIBITOR,Bacteria,SINGLE PROTEIN,,,"Name:ISBN, SrcID:0-86577-843-4 PP. 272, URL:http://www.isbnsearch.org/isbn/0865778434|Name:PubMed, SrcID:23634030, URL:http://europepmc.org/abstract/MED/23634030|Name:PubMed, SrcID:21084778, URL:http://europepmc.org/abstract/MED/21084778|Name:PubMed, SrcID:7486915, URL:http://europepmc.org/abstract/MED/7486915|Name:PubMed, SrcID:4577373, URL:http://europepmc.org/abstract/MED/4577373",Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1,,
1668,CHEMBL780,Pentetic Acid,Small molecule,2004.0,,,,Radioactive metals chelating agent,,,CHEMBL2366037,Radioactive metals,CHELATING AGENT,,METAL,,,"Name:DailyMed, SrcID:setid=9fca10ee-973e-4fe0-aaf5-a0416918a397#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9fca10ee-973e-4fe0-aaf5-a0416918a397#nlm34090-1|Name:DailyMed, SrcID:setid=6052c707-a8a3-43a7-80c2-7ad1ad9391a4#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6052c707-a8a3-43a7-80c2-7ad1ad9391a4#nlm34090-1",OC(=O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,,
1669,CHEMBL137,Metronidazole,Small molecule,1963.0,A01AB17; J01XD01; D06BX01; P01AB51; P01AB01; G01AF01,"A01AB17 [ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Antiinfectives and antiseptics for local oral treatment]; J01XD01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER ANTIBACTERIALS: Imidazole derivatives]; D06BX01 [DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: CHEMOTHERAPEUTICS FOR TOPICAL USE: Other chemotherapeutics]; P01AB51 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES: Nitroimidazole derivatives]; P01AB01 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES: Nitroimidazole derivatives]; G01AF01 [GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Imidazole derivatives]",-nidazole,DNA inhibitor,Generates free radicals causing DNA damage in trichomonas + bacterial species. In H. Pylori infections the oxygen-insensitive NADPH nitroreductase enzymes responsible for metabolite generation are normally found mutated in resistant strains (PMID: 10960092),,CHEMBL2364041,DNA,INHIBITOR,Bacteria,NUCLEIC-ACID,,,"Name:Wikipedia, SrcID:Metronidazole#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Metronidazole#Mechanism_of_action|Name:FDA, SrcID:label/2011/021806s003lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021806s003lbl.pdf",Cc1ncc([N+](=O)[O-])n1CCO,,
1670,CHEMBL409542,Retapamulin,Small molecule,2007.0,D06AX13,D06AX13 [DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: ANTIBIOTICS FOR TOPICAL USE: Other antibiotics for topical use],-mulin,70S ribosome inhibitor,Indicated for staph aur and strep pyogenes.,,CHEMBL2364096,70S ribosome,INHIBITOR,Staphylococcus aureus,PROTEIN NUCLEIC-ACID COMPLEX,50S ribosomal protein L3,Binding site is 50S ribosomal protein L3,"Name:DailyMed, SrcID:setid=7acc17e7-7041-46bf-f2b2-a615cbf99da6, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7acc17e7-7041-46bf-f2b2-a615cbf99da6|Name:FDA, SrcID:label/2012/022055s002lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022055s002lbl.pdf",C[C@@H]1CC[C@@]23CCC(=O)[C@H]2[C@]1(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]3C)OC(=O)CSC4CC5CCC(C4)N5C,,
1671,CHEMBL871,Etidronic Acid,Small molecule,1977.0,M05BA01,M05BA01 [MUSCULO-SKELETAL SYSTEM: DRUGS FOR TREATMENT OF BONE DISEASES: DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION: Bisphosphonates],-dronate,ATP inhibitor,"1st generation of biphosphonates, moa: its incorporated in ATP anologues, which accumulate in osteoclasts leading to its early apoptosis (specific to osteoclast, because it binds to hydropatite, and is then slowly released when the bone is reabsorded)",,CHEMBL2366048,ATP,INHIBITOR,Homo sapiens,SMALL MOLECULE,,,"Name:DailyMed, SrcID:setid=fa07734d-b381-4f33-a555-53b6614f4b08, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fa07734d-b381-4f33-a555-53b6614f4b08|Name:PubMed, SrcID:16046206, URL:http://europepmc.org/abstract/MED/16046206|Name:ISBN, SrcID:9780702034718 PP. 437-438, URL:http://www.isbnsearch.org/isbn/9780702034718",CC(O)(P(=O)(O)O)P(=O)(O)O,,
1672,CHEMBL1200694,Sevoflurane,Small molecule,1995.0,N01AB08,"N01AB08 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,Potassium channel subfamily K member 10 opener,,,CHEMBL2331041,Potassium channel subfamily K member 10,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:22226507, URL:http://europepmc.org/abstract/MED/22226507|Name:PubMed, SrcID:21788314, URL:http://europepmc.org/abstract/MED/21788314",FCOC(C(F)(F)F)C(F)(F)F,CHEMBL2331041,KCNK10
1673,CHEMBL517,Disopyramide,Small molecule,1977.0,C01BA03,"C01BA03 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class Ia]",,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=11a68e26-d2e4-48f6-ba0f-9bdd5778f25a, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=11a68e26-d2e4-48f6-ba0f-9bdd5778f25a",CC(C)N(CCC(C(=O)N)(c1ccccc1)c2ccccn2)C(C)C,,
1674,CHEMBL1201473,Colesevelam Hydrochloride,Small molecule,2000.0,C10AC04,"C10AC04 [CARDIOVASCULAR SYSTEM: LIPID MODIFYING AGENTS: LIPID MODIFYING AGENTS, PLAIN: Bile acid sequestrants]",,Bile acids sequestering agent,,,CHEMBL2364175,Bile acids,SEQUESTERING AGENT,Homo sapiens,SMALL MOLECULE,,,"Name:DailyMed, SrcID:setid=4a06d3b2-7229-4398-baba-5d0a72f63821#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4a06d3b2-7229-4398-baba-5d0a72f63821#nlm34090-1",,,
1675,CHEMBL1201516,Pentosan Polysulfate Sodium,Small molecule,1996.0,C05BA04; G04BX15,C05BA04 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: ANTIVARICOSE THERAPY: Heparins or heparinoids for topical use]; G04BX15 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Other urologicals],,Unknown,Mode of action not fully understood; it seems to provide a protective coating to the bladder wall,,,,,,,,,"Name:DailyMed, SrcID:setid=f0ba651e-3d8a-11df-8fbe-119855d89593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f0ba651e-3d8a-11df-8fbe-119855d89593#nlm34090-1|Name:PubMed, SrcID:23294821, URL:http://europepmc.org/abstract/MED/23294821",,,
1676,CHEMBL276832,Hydralazine,Small molecule,1953.0,C02DB02,"C02DB02 [CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON: Hydrazinophthalazine derivatives]",-dralazine,Unknown,"Mode of action not fully understood; it seems to interfere with calcium release, leading to vasodilation",,,,,,,,,"Name:DailyMed, SrcID:setid=17210abc-58f6-442e-8ff2-7971333c82f6, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=17210abc-58f6-442e-8ff2-7971333c82f6|Name:Wikipedia, SrcID:Hydralazine, URL:http://en.wikipedia.org/wiki/Hydralazine",NNc1nncc2ccccc12,,
1677,CHEMBL52885,Enmd-981693,Small molecule,,,,,SRC inhibitor,,,CHEMBL2363074,SRC,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf, URL:http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf",Cn1cc(C2=C(C(=O)NC2=O)c3cn(C)c4cc(ccc34)[N+](=O)[O-])c5ccccc15,,
1678,CHEMBL3545089,Imd-0354,Small molecule,,,,,Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor,,,CHEMBL1991,Inhibitor of nuclear factor kappa B kinase beta subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20573155, URL:http://europepmc.org/abstract/MED/20573155",,CHEMBL1991,IKBKB
1679,CHEMBL3544963,Ds-3078a,Small molecule,,,,,Serine/threonine-protein kinase mTOR inhibitor,ATP-competitive mTORC1/mTORC2 inhibitor,,CHEMBL2842,Serine/threonine-protein kinase mTOR,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1158/1535-7163.TARG-13-C173, URL:http://mct.aacrjournals.org/content/12/11_Supplement/C173|Name:Other, SrcID:http://www.hra.nhs.uk/news/research-summaries/phase-1-study-of-ds-3078a-in-patients-with-advanced-cancers/, URL:http://www.hra.nhs.uk/news/research-summaries/phase-1-study-of-ds-3078a-in-patients-with-advanced-cancers/",,CHEMBL2842,MTOR
1680,CHEMBL2133806,Jnj-38877605,Small molecule,,,,,Hepatocyte growth factor receptor inhibitor,,,CHEMBL3717,Hepatocyte growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19318488, URL:http://europepmc.org/abstract/MED/19318488|Name:Other, SrcID:http://cancerres.aacrjournals.org/content/68/9_Supplement/4837, URL:http://cancerres.aacrjournals.org/content/68/9_Supplement/4837",Cn1cc(cn1)c2ccc3nnc(n3n2)C(F)(F)c4ccc5ncccc5c4,CHEMBL3717,MET
1681,CHEMBL406381,Krn-633,Small molecule,,,,,Vascular endothelial growth factor receptor inhibitor,,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:15634658, URL:http://europepmc.org/abstract/MED/15634658",CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl,,
1682,CHEMBL3545075,Loxo-101,Small molecule,,,,,Neurotrophic tyrosine kinase receptor inhibitor,,,CHEMBL3559684,Neurotrophic tyrosine kinase receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:26216294, URL:http://europepmc.org/abstract/MED/26216294|Name:Other, SrcID:http://www.arraybiopharma.com/discovery-collaborations/selected-collaborations/loxo-oncology/, URL:http://www.arraybiopharma.com/discovery-collaborations/selected-collaborations/loxo-oncology/",,,
1683,CHEMBL190333,Rwj-67657,Small molecule,,,,,MAP kinase p38 beta inhibitor,,,CHEMBL3961,MAP kinase p38 beta,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10525088, URL:http://europepmc.org/abstract/MED/10525088",OCCC#Cc1nc(c2ccc(F)cc2)c(c3ccncc3)n1CCCc4ccccc4,CHEMBL3961,MAPK11
1684,CHEMBL1980391,Rg-1530,Small molecule,,,,,Fibroblast growth factor receptor 2 inhibitor,Multi-targeted kinase inhibitor,,CHEMBL4142,Fibroblast growth factor receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21553286, URL:http://europepmc.org/abstract/MED/21553286|Name:PubMed, SrcID:24900658, URL:http://europepmc.org/abstract/MED/24900658",COc1cc2Nc3n[nH]c(C)c3N=C(c4ccccc4Cl)c2cc1F,CHEMBL4142,FGFR2
1685,CHEMBL3545148,Phe377,Small molecule,,,,,Vanilloid receptor antagonist,,,CHEMBL4794,Vanilloid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21804597, URL:http://europepmc.org/abstract/MED/21804597|Name:Other, SrcID:http://www.pharmeste.com/repository/contenuti/paragrafi/file/PharmEste_Leaflet_2012.pdf, URL:http://www.pharmeste.com/repository/contenuti/paragrafi/file/PharmEste_Leaflet_2012.pdf",,CHEMBL4794,TRPV1
1686,CHEMBL107430,Nrx195183,Small molecule,,,,,Retinoic acid receptor alpha agonist,"Not updated trial information since May 2008, discontinued?",,CHEMBL2055,Retinoic acid receptor alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17318068, URL:http://europepmc.org/abstract/MED/17318068|Name:PubMed, SrcID:23228968, URL:http://europepmc.org/abstract/MED/23228968",CC1(C)CCC(C)(C)c2c(Cl)c(O)c(cc12)C(=O)Nc3cc(F)c(C(=O)O)c(F)c3,CHEMBL2055,RARA
1687,CHEMBL2107832,Pimasertib,Small molecule,,,,-sertib,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,,,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20331454, URL:http://europepmc.org/abstract/MED/20331454|Name:Other, SrcID:http://cancerres.aacrjournals.org/content/69/9_Supplement/4776.short, URL:http://cancerres.aacrjournals.org/content/69/9_Supplement/4776.short",OC[C@@H](O)CNC(=O)c1ccncc1Nc2ccc(I)cc2F,CHEMBL3587,MAP2K1
1688,CHEMBL575448,Bms-754807,Small molecule,,,,,Insulin receptor inhibitor,,,CHEMBL1981,Insulin receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21875414, URL:http://europepmc.org/abstract/MED/21875414|Name:PubMed, SrcID:19996272, URL:http://europepmc.org/abstract/MED/19996272",C[C@]1(CCCN1c2nc(Nc3cc([nH]n3)C4CC4)c5cccn5n2)C(=O)Nc6ccc(F)nc6,CHEMBL1981,INSR
1689,CHEMBL2220486,Lucitanib,Small molecule,,,,-anib,Fibroblast growth factor receptor 2 inhibitor,"E-3810 is an ambiguous research code for this compouynd, also research code for rabeprazole, a proton pump inhibitor.",,CHEMBL4142,Fibroblast growth factor receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://bit.ly/1ZGqyT3, URL:http://bit.ly/1ZGqyT3|Name:PubMed, SrcID:21212416, URL:http://europepmc.org/abstract/MED/21212416|Name:PubMed, SrcID:22304225, URL:http://europepmc.org/abstract/MED/22304225",CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12,CHEMBL4142,FGFR2
1690,CHEMBL3545339,Fruquintinib,Small molecule,,,,-tinib,Vascular endothelial growth factor receptor inhibitor,,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:25482937, URL:http://europepmc.org/abstract/MED/25482937",,,
1691,CHEMBL3545282,Kc-706,Small molecule,,,,,MAP kinase p38 alpha inhibitor,,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://circ.ahajournals.org/cgi/content/meeting_abstract/116/16_MeetingAbstracts/II_126-c, URL:http://circ.ahajournals.org/cgi/content/meeting_abstract/116/16_MeetingAbstracts/II_126-c|Name:PubMed, SrcID:23936634, URL:http://europepmc.org/abstract/MED/23936634",,CHEMBL260,MAPK14
1692,CHEMBL2107805,Naxifylline,Small molecule,,,,-fylline,Adenosine A1 receptor antagonist,Discontinueddue to lack of oral formulation/poor solubility?,,CHEMBL226,Adenosine A1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:9191953, URL:http://europepmc.org/abstract/MED/9191953",CCCC1C(=O)N(CCC)c2[nH]c(nc2C1=O)[C@H]3C[C@H]4C[C@@H]3[C@@H]5O[C@H]45,CHEMBL226,ADORA1
1693,CHEMBL324547,Netazepide,Protein,,,,-azepide,Cholecystokinin B receptor antagonist,,,CHEMBL298,Cholecystokinin B receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:9042983, URL:http://europepmc.org/abstract/MED/9042983",CNc1cccc(NC(=O)N[C@@H]2N=C(c3ccccn3)c4ccccc4N(CC(=O)C(C)(C)C)C2=O)c1,CHEMBL298,CCKBR
1694,CHEMBL369075,Vapitadine,Small molecule,,,,-(a)tadine,Histamine H1 receptor antagonist,Binds to ADRA1B with affinity of 456nM (http://media.corporate-ir.net/media_files/irol/14/142048/scientific_pubs/113004.pdf),,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://media.corporate-ir.net/media_files/irol/14/142048/scientific_pubs/113004.pdf, URL:http://media.corporate-ir.net/media_files/irol/14/142048/scientific_pubs/113004.pdf",NC(=O)c1cnc2n1CCc3ccccc3C24CCNCC4,CHEMBL231,HRH1
1695,CHEMBL119549,Andolast,Small molecule,,,,-ast,Calcium-activated potassium channel subunit alpha-1 activator,"Indication:Bronchial asthma, COPD, Allergic rhinitis",,CHEMBL4304,Calcium-activated potassium channel subunit alpha-1,ACTIVATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:8985378, URL:http://europepmc.org/abstract/MED/8985378|Name:Other, SrcID:http://www.rottapharm.fr/rph-fr/rd.asp?pipeline, URL:http://www.rottapharm.fr/rph-fr/rd.asp?pipeline",O=C(Nc1ccc(cc1)c2nn[nH]n2)c3ccc(cc3)c4nn[nH]n4,CHEMBL4304,KCNMA1
1696,CHEMBL1908376,Seocalcitol,Small molecule,,,,-calci-,Vitamin D receptor agonist,"Ph3 trials terminated, unknown reason",,CHEMBL1977,Vitamin D receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11875725, URL:http://europepmc.org/abstract/MED/11875725|Name:PubMed, SrcID:10828309, URL:http://europepmc.org/abstract/MED/10828309",CCC(O)(CC)\C=C\C=C\[C@@H](C)[C@H]1CC[C@H]2\C(=C\C=C/3\C[C@@H](O)C[C@H](O)C3=C)\CCC[C@]12C,CHEMBL1977,VDR
1697,CHEMBL101253,Vatalanib,Small molecule,,,,-anib,Vascular endothelial growth factor receptor inhibitor,,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10786682, URL:http://europepmc.org/abstract/MED/10786682|Name:PubMed, SrcID:16882767, URL:http://europepmc.org/abstract/MED/16882767",Clc1ccc(Nc2nnc(Cc3ccncc3)c4ccccc24)cc1,,
1698,CHEMBL1366933,Esmirtazapine,Small molecule,,,,-pin(e),Serotonin 2c (5-HT2c) receptor antagonist,Discontinued(strategic reasons),,CHEMBL225,Serotonin 2c (5-HT2c) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21246188, URL:http://europepmc.org/abstract/MED/21246188|Name:PubMed, SrcID:26047892, URL:http://europepmc.org/abstract/MED/26047892",CN1CCN2[C@H](C1)c3ccccc3Cc4cccnc24,,
1699,CHEMBL3545125,Mirogabalin,Small molecule,,,,-gab-,Voltage-gated calcium channel alpha2/delta subunit 1 modulator,,,CHEMBL1919,Voltage-gated calcium channel alpha2/delta subunit 1,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25231896, URL:http://europepmc.org/abstract/MED/25231896|Name:Wikipedia, SrcID:Mirogabalin, URL:https://en.wikipedia.org/wiki/Mirogabalin",CCC1=C[C@@H]2[C@H](C1)C[C@]2(CN)CC(=O)O,CHEMBL1919,CACNA2D1
1700,CHEMBL2105646,Larazotide,Protein,,,,-tide,Neuronal acetylcholine receptor; alpha3/beta4 partial agonist,,,CHEMBL1907594,Neuronal acetylcholine receptor; alpha3/beta4,PARTIAL AGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:26162864, URL:http://europepmc.org/abstract/MED/26162864",CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)CN)C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)O,,
1701,CHEMBL218166,Bifeprunox,Small molecule,,,,,Serotonin 1a (5-HT1a) receptor partial agonist,,"High affinity: D3 and D4 receptors. Low affinity: a1, 5HT2A, 5HT2C, H1 and muscarinic receptors",CHEMBL214,Serotonin 1a (5-HT1a) receptor,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18597078, URL:http://europepmc.org/abstract/MED/18597078",O=C1Nc2cccc(N3CCN(Cc4cccc(c4)c5ccccc5)CC3)c2O1,CHEMBL214,HTR1A
1702,CHEMBL272980,Mocetinostat,Small molecule,,,,-stat,Histone deacetylase 8 inhibitor,,"Isotype-selective Class I (HDAC1, -2, -3, and -8) and IV (HDAC11) HDAC inhibitor.",CHEMBL3192,Histone deacetylase 8,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18413790, URL:http://europepmc.org/abstract/MED/18413790|Name:PubMed, SrcID:27551526, URL:http://europepmc.org/abstract/MED/27551526",Nc1ccccc1NC(=O)c2ccc(CNc3nccc(n3)c4cccnc4)cc2,CHEMBL3192,HDAC8
1703,CHEMBL3833374,Andecaliximab,Antibody,,,,-mab,Matrix metalloproteinase 9 inhibitor,"GS-5745 inhibits MMP9 by two mechanisms: 1) inhibiting the catalytic activity of MMP9 by sterically interfering with proteolysis of substrates 2) inhibiting the processing of MMP9 to an active form by sterically preventing accessibility of activating proteases. This results in an inhibition of extracellular matrix protein degradation and, potentially, the inhibition of angiogenesis, tumor growth, invasion, and metastasis.",GS-5745 binds to active-MMP9 with ~150–400 lower affinity compared to pro-MMP9 (PMID:28235803),CHEMBL321,Matrix metalloproteinase 9,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,See structure of the complex in PDBe under accession codes: 5TH6 (apo) 5TH9 (GS-5745 complex),"Name:PubMed, SrcID:28235803, URL:http://europepmc.org/abstract/MED/28235803",,CHEMBL321,MMP9
1704,CHEMBL1743037,Lorvotuzumab Mertansine,Antibody,,,,-mab,Neural cell adhesion molecule 1 binding agent,"Binding to the target tumor cell through NCAM1, the antibody-drug conjugate is internalized and then cleaved inside the cell, leading to localized and enhanced antitumor activity. The conjugated drug DM1 is a synthetic derivative of maytansine, an ansa macrolide that binds to tubulin at the vinca alkaloid-binding site leading to inhibition of microtubule assembly and cell proliferation and to cell death.",,CHEMBL3712938,Neural cell adhesion molecule 1,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24492307, URL:http://europepmc.org/abstract/MED/24492307",,CHEMBL3712938,NCAM1
1705,CHEMBL2109263,Ing-1,Antibody,,,,,Epithelial cell adhesion molecule other,Antibody-dependent cell-mediated cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC).,,CHEMBL3580493,Epithelial cell adhesion molecule,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12659687, URL:http://europepmc.org/abstract/MED/12659687",,CHEMBL3580493,EPCAM
1706,CHEMBL2109379,Ni-0801,Antibody,,,,,C-X-C motif chemokine 10 inhibitor,"Bispecific antibody that targets mesothelin, a tumor associated antigen, while neutralizing the CD47 ""don't eat me"" signal.",,CHEMBL3712964,C-X-C motif chemokine 10,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://novimmune.com/pipeline/ni-1801.html, URL:http://novimmune.com/pipeline/ni-1801.html",,CHEMBL3712964,CXCL10
1707,CHEMBL2109427,Claudiximab,Antibody,,,,-mab,Claudin-18 binding agent,"Antibody drug conjugates (ADCs), coupled to a cytotoxic agent.",Against isoform 2 of Claudin-18.,CHEMBL3712859,Claudin-18,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23900716, URL:http://europepmc.org/abstract/MED/23900716",,CHEMBL3712859,CLDN18
1708,CHEMBL2109511,Pf-00547659,Antibody,,,,,Mucosal addressin cell adhesion molecule-1 inhibitor,,,CHEMBL4467,Mucosal addressin cell adhesion molecule-1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19366349, URL:http://europepmc.org/abstract/MED/19366349",,CHEMBL4467,MADCAM1
1709,CHEMBL384304,Rg-547,Small molecule,,,,,Cyclin-dependent kinase 1 inhibitor,,,CHEMBL308,Cyclin-dependent kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,,COc1ccc(F)c(F)c1C(=O)c2cnc(NC3CCN(CC3)S(=O)(=O)C)nc2N,CHEMBL308,CDK1
1710,CHEMBL1201549,Teriparatide Acetate,Protein,1987.0,H05AA02,"H05AA02 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CALCIUM HOMEOSTASIS: PARATHYROID HORMONES AND ANALOGUES: Parathyroid hormones and analogues]",-tide,Parathyroid hormone receptor agonist,,,CHEMBL1793,Parathyroid hormone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=aae667c5-381f-4f92-93df-2ed6158d07b0, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aae667c5-381f-4f92-93df-2ed6158d07b0",,CHEMBL1793,PTH1R
1711,CHEMBL53463,Doxorubicin,Small molecule,1974.0,L01DB01,L01DB01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES: Anthracyclines and related substances],-rubicin,DNA topoisomerase II alpha inhibitor,,,CHEMBL1806,DNA topoisomerase II alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Type_II_topoisomerase, URL:http://en.wikipedia.org/wiki/Type_II_topoisomerase|Name:DailyMed, SrcID:setid=5594d16e-72bf-4354-925e-c7591737ff1c, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5594d16e-72bf-4354-925e-c7591737ff1c|Name:FDA, SrcID:label/2015/050718s048lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/050718s048lbl.pdf",COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO,CHEMBL1806,TOP2A
1712,CHEMBL192,Sildenafil,Small molecule,1998.0,G04BE03,G04BE03 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Drugs used in erectile dysfunction],-afil,Phosphodiesterase 5A inhibitor,,,CHEMBL1827,Phosphodiesterase 5A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f158fe10-d5dc-4432-b2c9-fc665401291b, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f158fe10-d5dc-4432-b2c9-fc665401291b",CCCc1nn(C)c2C(=O)NC(=Nc12)c3cc(ccc3OCC)S(=O)(=O)N4CCN(C)CC4,CHEMBL1827,PDE5A
1713,CHEMBL1201340,Diphemanil,Small molecule,1982.0,A03AB15,"A03AB15 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: Synthetic anticholinergics, quaternary ammonium compounds]",,Muscarinic acetylcholine receptor M1 antagonist,"Role in regulating gastric secretion, M1 likely involved",,CHEMBL216,Muscarinic acetylcholine receptor M1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:13478170, URL:http://europepmc.org/abstract/MED/13478170|Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718",C[N+]1(C)CCC(=C(c2ccccc2)c3ccccc3)CC1,CHEMBL216,CHRM1
1714,CHEMBL905,Rizatriptan,Small molecule,1998.0,N02CC04,N02CC04 [NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Selective serotonin (5HT1) agonists],-triptan,Serotonin 1b (5-HT1b) receptor agonist,,Selective,CHEMBL1898,Serotonin 1b (5-HT1b) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2011/020864s011s016s017s018s019,020865s012s016s018s020s021lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020864s011s016s017s018s019,020865s012s016s018s020s021lbl.pdf",CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12,CHEMBL1898,HTR1B
1715,CHEMBL1536,Ergocalciferol,Small molecule,1941.0,A11CC01,"A11CC01 [ALIMENTARY TRACT AND METABOLISM: VITAMINS: VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO: Vitamin D and analogues]",-calci-,Vitamin D receptor agonist,,,CHEMBL1977,Vitamin D receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17519354, URL:http://europepmc.org/abstract/MED/17519354|Name:PubMed, SrcID:16949927, URL:http://europepmc.org/abstract/MED/16949927|Name:PubMed, SrcID:17218095, URL:http://europepmc.org/abstract/MED/17218095",CC(C)[C@@H](C)\C=C\[C@@H](C)[C@H]1CC[C@H]2\C(=C\C=C/3\C[C@@H](O)CCC3=C)\CCC[C@]12C,CHEMBL1977,VDR
1716,CHEMBL1652,Ambenonium,Small molecule,1956.0,N07AA30,N07AA30 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: PARASYMPATHOMIMETICS: Anticholinesterases],-ium,Acetylcholinesterase inhibitor,,,CHEMBL220,Acetylcholinesterase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2014/010155s024lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/010155s024lbl.pdf|Name:DailyMed, SrcID:setid=d323d428-97c7-495d-8f65-58b5f0e8afda, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d323d428-97c7-495d-8f65-58b5f0e8afda",CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)Cc1ccccc1Cl)Cc2ccccc2Cl,CHEMBL220,ACHE
1717,CHEMBL384467,Dexamethasone,Small molecule,1958.0,S02BA06; C05AA09; R01AD03; S01CB01; H02AB02; D10AA03; D07XB05; S01BA01; A01AC02; S03BA01; D07AB19; R01AD53,"S02BA06 [SENSORY ORGANS: OTOLOGICALS: CORTICOSTEROIDS: Corticosteroids]; C05AA09 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Corticosteroids]; R01AD03 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Corticosteroids]; S01CB01 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION: Corticosteroids/antiinfectives/mydriatics in combination]; H02AB02 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Glucocorticoids]; D10AA03 [DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Corticosteroids, combinations for treatment of acne]; D07XB05 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, OTHER COMBINATIONS: Corticosteroids, moderately potent, other combinations]; S01BA01 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Corticosteroids, plain]; A01AC02 [ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Corticosteroids for local oral treatment]; S03BA01 [SENSORY ORGANS: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS: CORTICOSTEROIDS: Corticosteroids]; D07AB19 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, moderately potent (group II)]; R01AD53 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Corticosteroids]",,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16956592, URL:http://europepmc.org/abstract/MED/16956592|Name:PubMed, SrcID:16971495, URL:http://europepmc.org/abstract/MED/16971495|Name:PubMed, SrcID:16891588, URL:http://europepmc.org/abstract/MED/16891588",C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,CHEMBL2034,NR3C1
1718,CHEMBL222813,Zanamivir,Small molecule,1999.0,J05AH01,J05AH01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Neuraminidase inhibitors],-vir,Neuraminidase inhibitor,,,CHEMBL2051,Neuraminidase,INHIBITOR,Influenza A virus (A/Puerto Rico/8/1934(H1N1)),SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=12ff22f6-20b5-4fa8-9028-58f87e169ff5, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=12ff22f6-20b5-4fa8-9028-58f87e169ff5",CC(=O)N[C@@H]1[C@@H](NC(=N)N)C=C(O[C@H]1[C@H](O)[C@H](O)CO)C(=O)O,,
1719,CHEMBL2095212,Mirabegron,Small molecule,2012.0,G04BD12,G04BD12 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Drugs for urinary frequency and incontinence],-begron,Beta-3 adrenergic receptor agonist,,,CHEMBL246,Beta-3 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Expert, SrcID:MIRABEGRON, URL:http://chembl.blogspot.co.uk/search?q=MIRABEGRON",Nc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3ccccc3)cc2)cs1,CHEMBL246,ADRB3
1720,CHEMBL2364968,Ergoloid,Small molecule,1953.0,,,,Dopamine receptor agonist,,,CHEMBL2096905,Dopamine receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:2869188, URL:http://europepmc.org/abstract/MED/2869188",CCC(C)[C@@H]1N2C(=O)[C@](NC(=O)[C@@H]3C[C@H]4[C@@H](Cc5c[nH]c6cccc4c56)N(C)C3)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C.CC(C)C[C@@H]8N9C(=O)[C@](NC(=O)[C@@H]%10C[C@H]%11[C@@H](Cc%12c[nH]c%13cccc%11c%12%13)N(C)C%10)(O[C@@]9(O)[C@@H]%14CCCN%14C8=O)C(C)C.CC(C)[C@@H]%15N%16C(=O)[C@](NC(=O)[C@@H]%17C[C@H]%18[C@@H](Cc%19c[nH]c%20cccc%18c%19%20)N(C)C%17)(O[C@@]%16(O)[C@@H]%21CCCN%21C%15=O)C(C)C.CC(C)[C@@]%22(NC(=O)[C@@H]%23C[C@H]%24[C@@H](Cc%25c[nH]c%26cccc%24c%25%26)N(C)C%23)O[C@@]%27(O)[C@@H]%28CCCN%28C(=O)[C@H](Cc%29ccccc%29)N%27C%22=O,,
1721,CHEMBL1484,Nicardipine,Small molecule,1988.0,C08CA04,C08CA04 [CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS: Dihydropyridine derivatives],-dipine,Voltage-gated L-type calcium channel blocker,,,CHEMBL2095229,Voltage-gated L-type calcium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:11270579, URL:http://europepmc.org/abstract/MED/11270579|Name:FDA, SrcID:label/2011/019734s017lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019734s017lbl.pdf|Name:PubMed, SrcID:10608279, URL:http://europepmc.org/abstract/MED/10608279",COC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OCCN(C)Cc3ccccc3)C,,
1722,CHEMBL2079587,Stanozolol,Small molecule,1962.0,A14AA02,A14AA02 [ALIMENTARY TRACT AND METABOLISM: ANABOLIC AGENTS FOR SYSTEMIC USE: ANABOLIC STEROIDS: Androstan derivatives],-olol,Androgen Receptor agonist,,,CHEMBL1871,Androgen Receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18500378, URL:http://europepmc.org/abstract/MED/18500378|Name:Wikipedia, SrcID:Anabolic_steroid, URL:http://en.wikipedia.org/wiki/Anabolic_steroid",C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4Cc5n[nH]cc5C[C@]4(C)[C@H]3CC[C@]12C,CHEMBL1871,AR
1723,CHEMBL1374379,Benzonatate,Small molecule,1958.0,R05DB01,"R05DB01 [RESPIRATORY SYSTEM: COUGH AND COLD PREPARATIONS: COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS: Other cough suppressants]",,Slowly adapting pulmonary stretch receptor inhibitor,,,CHEMBL2364682,Slowly adapting pulmonary stretch receptor,INHIBITOR,Homo sapiens,UNKNOWN,,,"Name:PubMed, SrcID:15564077, URL:http://europepmc.org/abstract/MED/15564077|Name:PubMed, SrcID:12569065, URL:http://europepmc.org/abstract/MED/12569065|Name:DailyMed, SrcID:setid=abb4360a-4c52-45b6-9b80-df3c1bfc4c59#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=abb4360a-4c52-45b6-9b80-df3c1bfc4c59#nlm34090-1|Name:PubMed, SrcID:12665534, URL:http://europepmc.org/abstract/MED/12665534",CCCCNc1ccc(cc1)C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC,,
1724,CHEMBL1201569,Botulinum Toxin Type B,Unknown,2000.0,M03AX01,"M03AX01 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS: Other muscle relaxants, peripherally acting agents]",,Vesicle-associated membrane protein 2 inhibitor,Cleaves snare complex,,CHEMBL2364160,Vesicle-associated membrane protein 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=675cb354-9d13-482e-8ac2-22f709c58b4f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=675cb354-9d13-482e-8ac2-22f709c58b4f|Name:PubMed, SrcID:22510015, URL:http://europepmc.org/abstract/MED/22510015",,CHEMBL2364160,VAMP2
1725,CHEMBL1888176,Trospium,Small molecule,2004.0,G04BD09,G04BD09 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Drugs for urinary frequency and incontinence],-ium,Muscarinic acetylcholine receptor M2 antagonist,"Indicated for overactive bladder, M2 likely responsible",,CHEMBL211,Muscarinic acetylcholine receptor M2,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19029429, URL:http://europepmc.org/abstract/MED/19029429|Name:PubMed, SrcID:15723094, URL:http://europepmc.org/abstract/MED/15723094",OC(C(=O)O[C@H]1C[C@H]2CC[C@@H](C1)[N+]23CCCC3)(c4ccccc4)c5ccccc5,CHEMBL211,CHRM2
1726,CHEMBL1201016,Cefpodoxime Proxetil,Small molecule,1992.0,J01DD13,J01DD13 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Third-generation cephalosporins],cef-,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:PubMed, SrcID:12041787, URL:http://europepmc.org/abstract/MED/12041787",COCC1=C(N2[C@H](SC1)[C@H](NC(=O)\C(=N/OC)\c3csc(N)n3)C2=O)C(=O)OC(C)OC(=O)OC(C)C,,
1727,CHEMBL1136,Telithromycin,Small molecule,2004.0,J01FA15,"J01FA15 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS: Macrolides]",-mycin,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,23S ribosomal RNA,23S RRNA,"Name:DailyMed, SrcID:setid=ba1cca98-f350-4655-88e3-6ef990779fb9, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ba1cca98-f350-4655-88e3-6ef990779fb9",CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]3N(CCCCn4cnc(c4)c5cccnc5)C(=O)O[C@]13C)OC,,
1728,CHEMBL1237120,Clindamycin Palmitate,Small molecule,1986.0,,,-mycin,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,23S ribosomal RNA,23S RRNA,"Name:DailyMed, SrcID:setid=b225ab20-bc7c-43af-ae93-0f07d5948e1c#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b225ab20-bc7c-43af-ae93-0f07d5948e1c#nlm34090-1|Name:Wikipedia, SrcID:Lincosamides, URL:http://en.wikipedia.org/wiki/Lincosamides|Name:Wikipedia, SrcID:Clindamycin, URL:http://en.wikipedia.org/wiki/Clindamycin|Name:PubMed, SrcID:12860123, URL:http://europepmc.org/abstract/MED/12860123",CCCCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@@H]1SC)C(NC(=O)[C@@H]2C[C@@H](CCC)CN2C)[C@H](C)Cl,,
1729,CHEMBL108,Carbamazepine,Small molecule,1968.0,N03AF01,N03AF01 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Carboxamide derivatives],-pin(e),Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:15208697, URL:http://europepmc.org/abstract/MED/15208697|Name:PubMed, SrcID:23205958, URL:http://europepmc.org/abstract/MED/23205958",NC(=O)N1c2ccccc2C=Cc3ccccc13,,
1730,CHEMBL1201266,Lodoxamide,Small molecule,1993.0,S01GX05,S01GX05 [SENSORY ORGANS: OPHTHALMOLOGICALS: DECONGESTANTS AND ANTIALLERGICS: Other antiallergics],,Unknown,"Mode of action not fully understood; it seems to inhibit calcium influx into mast cells, stabilizing them",,,,,,,,,"Name:DailyMed, SrcID:setid=1b97597f-f2e7-4574-81a8-f35b769c957a, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1b97597f-f2e7-4574-81a8-f35b769c957a",OC(=O)C(=O)Nc1cc(cc(NC(=O)C(=O)O)c1Cl)C#N,,
1731,CHEMBL1201235,Methylhomatropine,Small molecule,1943.0,A03CB04,A03CB04 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS: Belladonna and derivatives in combination with psycholeptics],-trop-,Unknown,Antitussive drug; probable action in the CNS cough centre,,,,,,,,,"Name:PubMed, SrcID:15491779, URL:http://europepmc.org/abstract/MED/15491779|Name:FDA, SrcID:label/2009/005213s037lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/005213s037lbl.pdf",C[N+]1(C)[C@@H]2CC[C@H]1C[C@H](C2)OC(=O)C(O)c3ccccc3,,
1732,CHEMBL112,Acetaminophen,Small molecule,1968.0,N02BE51; N02BE71; N02BE01,N02BE51 [NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Anilides]; N02BE71 [NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Anilides]; N02BE01 [NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Anilides],,Anandamide amidohydrolase inhibitor,"FAAH converts acetaminophen into the active metabolite AM404, but this conversion also competes with degradation of anandamide increasing its concentration and effects",,CHEMBL2243,Anandamide amidohydrolase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Acetaminophen#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Acetaminophen#Mechanism_of_action|Name:PubMed, SrcID:15987694, URL:http://europepmc.org/abstract/MED/15987694",CC(=O)Nc1ccc(O)cc1,CHEMBL2243,FAAH
1733,CHEMBL2028019,Cariprazine,Small molecule,2015.0,N05AX15,N05AX15 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Other antipsychotics],,Dopamine D2 receptor modulator,Mixed antagonist/partial agonist,,CHEMBL217,Dopamine D2 receptor,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20093397, URL:http://europepmc.org/abstract/MED/20093397|Name:DailyMed, SrcID:setid=4b5f7c65-aa2d-452a-b3db-bc85c06ff12f, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4b5f7c65-aa2d-452a-b3db-bc85c06ff12f",CN(C)C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc(Cl)c3Cl)CC1,CHEMBL217,DRD2
1734,CHEMBL3544960,At-13148,Small molecule,,,,,Rho-associated protein kinase inhibitor,,,CHEMBL2111459,Rho-associated protein kinase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25840982, URL:http://europepmc.org/abstract/MED/25840982|Name:PubMed, SrcID:22781553, URL:http://europepmc.org/abstract/MED/22781553|Name:Other, SrcID:http://www.astx.com/pipeline/products/clinical, URL:http://www.astx.com/pipeline/products/clinical",NC[C@@](O)(c1ccc(Cl)cc1)c2ccc(cc2)c3cn[nH]c3,,
1735,CHEMBL3545247,Cal-263,Small molecule,,,,,PI3-kinase p110-delta subunit inhibitor,,,CHEMBL3130,PI3-kinase p110-delta subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25312588, URL:http://europepmc.org/abstract/MED/25312588|Name:PubMed, SrcID:15367672, URL:http://europepmc.org/abstract/MED/15367672",,CHEMBL3130,PIK3CD
1736,CHEMBL2323775,Mk-8033,Small molecule,,,,,Macrophage-stimulating protein receptor inhibitor,,,CHEMBL2689,Macrophage-stimulating protein receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23379595, URL:http://europepmc.org/abstract/MED/23379595",Cn1cc(cn1)c2cnc3C=Cc4ccc(CS(=O)(=O)NCc5ccccn5)cc4C(=O)c3c2,,
1737,CHEMBL3545078,Pf-03814735,Small molecule,,,,,Serine/threonine-protein kinase Aurora-A inhibitor,,,CHEMBL4722,Serine/threonine-protein kinase Aurora-A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19568282, URL:http://europepmc.org/abstract/MED/19568282|Name:PubMed, SrcID:20354118, URL:http://europepmc.org/abstract/MED/20354118",,,
1738,CHEMBL3545381,Plx-7486,Small molecule,,,,,Neurotrophic tyrosine kinase receptor type 2 inhibitor,,,CHEMBL4898,Neurotrophic tyrosine kinase receptor type 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.ecmcnetwork.org.uk/sites/default/files/PLX7486%20Background%20for%20CRUK%20Combinations%20Alliance%20(Non-CI)%202015-10-08%20final.pdf, URL:http://www.ecmcnetwork.org.uk/sites/default/files/PLX7486%20Background%20for%20CRUK%20Combinations%20Alliance%20(Non-CI)%202015-10-08%20final.pdf",,CHEMBL4898,NTRK2
1739,CHEMBL3545200,S-222611,Small molecule,,,,,Epidermal growth factor receptor erbB1 inhibitor,Also potent ERBB4 inhibitor,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24837299, URL:http://europepmc.org/abstract/MED/24837299|Name:PubMed, SrcID:25434923, URL:http://europepmc.org/abstract/MED/25434923",,CHEMBL203,EGFR
1740,CHEMBL3545388,Seridopidine,Small molecule,,,,-dopidine,Dopamine D2 receptor modulator,"Dopidine (dopaminergic stabilizer), have not found any reference about pharmcology for the compound.",,CHEMBL217,Dopamine D2 receptor,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://gupea.ub.gu.se/bitstream/2077/7535/2/Thesis_Johan_Rung.pdf, URL:https://gupea.ub.gu.se/bitstream/2077/7535/2/Thesis_Johan_Rung.pdf|Name:PubMed, SrcID:24817271, URL:http://europepmc.org/abstract/MED/24817271",CCN1CCC(CC1)c2cc(F)cc(c2)S(=O)(=O)C,CHEMBL217,DRD2
1741,CHEMBL3544955,Bay-1217389,Small molecule,,,,,Dual specificity protein kinase TTK inhibitor,,,CHEMBL3983,Dual specificity protein kinase TTK,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1158/1538-7445.AM2015-3090, URL:http://cancerres.aacrjournals.org/content/75/15_Supplement/3090",,CHEMBL3983,TTK
1742,CHEMBL2107341,Fispemifene,Small molecule,,,,-ifene,Estrogen receptor modulator,selective estrogen modulator (SERM),,CHEMBL2093866,Estrogen receptor,MODULATOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://www.apricusbio.com/pipeline/fispemifene/, URL:http://www.apricusbio.com/pipeline/fispemifene/|Name:PubMed, SrcID:18583549, URL:http://europepmc.org/abstract/MED/18583549",OCCOCCOc1ccc(cc1)\C(=C(\CCCl)/c2ccccc2)\c3ccccc3,,
1743,CHEMBL3545274,Mk-6913,Small molecule,,,,,Estrogen receptor agonist,"A Phase Iia was ended prematurerly, development of compound for hot flushes discontinued in 2010 (http://karobio.com/investormedia/pressreleaser/pressrelease?pid=545341)",,CHEMBL2093866,Estrogen receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://adisinsight.springer.com/drugs/800031279, URL:http://adisinsight.springer.com/drugs/800031279",CC(C)(C)n1nnc2c3C[C@]4(CCOc5ccccc5)CCC(=O)C=C4c3ccc12,,
1744,CHEMBL2105705,Lunacalcipol,Small molecule,,,,-calci-,Vitamin D receptor agonist,,,CHEMBL1977,Vitamin D receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.opkorenal.com/pipeline/product_candidates.html, URL:http://www.opkorenal.com/pipeline/product_candidates.html",C[C@H](C\C=C\S(=O)(=O)C(C)(C)C)C1=CC[C@H]2\C(=C\C=C/3\C[C@@H](O)C[C@H](O)C3=C)\CCC[C@]12C,CHEMBL1977,VDR
1745,CHEMBL3545022,Ulixertinib,Small molecule,,,,-tinib,MAP kinase ERK1 inhibitor,,,CHEMBL3385,MAP kinase ERK1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://biomed-valley.com/portfolio/bvd-523, URL:https://biomed-valley.com/portfolio/bvd-523|Name:DOI, SrcID:10.1158/1538-7445.AM2015-4693, URL:http://cancerres.aacrjournals.org/content/75/15_Supplement/4693",,CHEMBL3385,MAPK3
1746,CHEMBL3039525,Golvatinib,Small molecule,,,,-tinib,Hepatocyte growth factor receptor inhibitor,,,CHEMBL3717,Hepatocyte growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25110867, URL:http://europepmc.org/abstract/MED/25110867|Name:PubMed, SrcID:19832844, URL:http://europepmc.org/abstract/MED/19832844",CN1CCN(CC1)C2CCN(CC2)C(=O)Nc3cc(Oc4ccc(NC(=O)C5(CC5)C(=O)Nc6ccc(F)cc6)c(F)c4)ccn3,CHEMBL3717,MET
1747,CHEMBL571546,Kx2-391,Small molecule,,,,,Tyrosine-protein kinase SRC inhibitor,Targets the peptide substrate-binding site and is a non-ATP competitive inhibitor.,,CHEMBL267,Tyrosine-protein kinase SRC,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21509526, URL:http://europepmc.org/abstract/MED/21509526|Name:DOI, SrcID:10.1158/1538-7445.AM10-2487, URL:http://cancerres.aacrjournals.org/content/70/8_Supplement/2487|Name:PubMed, SrcID:23361621, URL:http://europepmc.org/abstract/MED/23361621|Name:Other, SrcID:http://www.kinexpharma.com/drug-pipeline/kx01/, URL:http://www.kinexpharma.com/drug-pipeline/kx01/",O=C(Cc1ccc(cn1)c2ccc(OCCN3CCOCC3)cc2)NCc4ccccc4,CHEMBL267,SRC
1748,CHEMBL1088751,Ph-797804,Small molecule,,,,,MAP kinase p38 alpha inhibitor,,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22174080, URL:http://europepmc.org/abstract/MED/22174080|Name:PubMed, SrcID:21641211, URL:http://europepmc.org/abstract/MED/21641211",CNC(=O)c1ccc(C)c(c1)N2C(=CC(=C(Br)C2=O)OCc3ccc(F)cc3F)C,CHEMBL260,MAPK14
1749,CHEMBL230011,Tg100-115,Small molecule,,,,,PI3-kinase p110-delta subunit inhibitor,,,CHEMBL3130,PI3-kinase p110-delta subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17685602, URL:http://europepmc.org/abstract/MED/17685602",Nc1nc(N)c2nc(c3cccc(O)c3)c(nc2n1)c4cccc(O)c4,CHEMBL3130,PIK3CD
1750,CHEMBL3545250,Gsk-2269557,Small molecule,,,,,PI3-kinase p110-delta subunit inhibitor,,,CHEMBL3130,PI3-kinase p110-delta subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26301626, URL:http://europepmc.org/abstract/MED/26301626",,CHEMBL3130,PIK3CD
1751,CHEMBL2151197,Pf-03654746,Small molecule,,,,,Histamine H3 receptor antagonist,,,CHEMBL264,Histamine H3 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21928839, URL:http://europepmc.org/abstract/MED/21928839|Name:PubMed, SrcID:22931528, URL:http://europepmc.org/abstract/MED/22931528",CCNC(=O)[C@@H]1C[C@@](F)(C1)c2ccc(CN3CCCC3)c(F)c2,CHEMBL264,HRH3
1752,CHEMBL3545165,Afacifenacin,Small molecule,,,,-fenacin,Sodium channel protein type XI alpha subunit blocker,Non-selective muscarinic receptor antagonist and sodium channel blocker.,,CHEMBL5167,Sodium channel protein type XI alpha subunit,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.jurology.com/article/S0022-5347(08)60371-7/pdf, URL:http://www.jurology.com/article/S0022-5347(08)60371-7/pdf|Name:Other, SrcID:http://www.ds-pharma.com/ir/library/financial_results_summary/pdf/ebr20130131_2.pdf, URL:http://www.ds-pharma.com/ir/library/financial_results_summary/pdf/ebr20130131_2.pdf|Name:PubMed, SrcID:21206614, URL:http://europepmc.org/abstract/MED/21206614",FC(F)(F)Oc1cccc(CN2CCC(CC2)N3C(c4ccccc4)c5ccccc5NC3=O)c1,CHEMBL5167,SCN11A
1753,CHEMBL3707319,Grc-15300,Small molecule,,,,,Transient receptor potential cation channel subfamily V member 3 antagonist,,,CHEMBL5522,Transient receptor potential cation channel subfamily V member 3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.glenmarkpharma.com/UITemplate/HtmlContainer.aspx?res=P_GLN_GDY_BNCE_FPIN_ENPG, URL:http://www.glenmarkpharma.com/UITemplate/HtmlContainer.aspx?res=P_GLN_GDY_BNCE_FPIN_ENPG",,CHEMBL5522,TRPV3
1754,CHEMBL2108724,Semaglutide,Protein,,,,-tide,Glucagon-like peptide 1 receptor agonist,"Peptide, GLP-1 analogue.",,CHEMBL1784,Glucagon-like peptide 1 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24608440, URL:http://europepmc.org/abstract/MED/24608440|Name:PubMed, SrcID:22918257, URL:http://europepmc.org/abstract/MED/22918257",,CHEMBL1784,GLP1R
1755,CHEMBL2108703,Liprotamase,Enzyme,,,,-ase,Triglyceride hydrolytic enzyme,Lipases catalyse the hydrolysis of lipids.,,CHEMBL3559389,Triglyceride,HYDROLYTIC ENZYME,,LIPID,,,"Name:PubMed, SrcID:21831726, URL:http://europepmc.org/abstract/MED/21831726",,,
1756,CHEMBL2103800,Colestilan Chloride,Small molecule,,V03AE06,V03AE06 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Drugs for treatment of hyperkalemia and hyperphosphatemia],,Phosphate sequestering agent,"Acts in the GI tract as a non-calcium, non-metallic phosphate binder",,CHEMBL2364184,Phosphate,SEQUESTERING AGENT,Homo sapiens,SMALL MOLECULE,,,"Name:Other, SrcID:http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002377/WC500139167.pdf, URL:http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002377/WC500139167.pdf",,,
1757,CHEMBL396778,Safinamide,Small molecule,2017.0,N04BD03,N04BD03 [NERVOUS SYSTEM: ANTI-PARKINSON DRUGS: DOPAMINERGIC AGENTS: Monoamine oxidase B inhibitors],,Monoamine oxidase B inhibitor,Highly selective and reversible MAO-B inhibitor,,CHEMBL2039,Monoamine oxidase B,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2017/207145lbl.pdf, URL:https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207145lbl.pdf|Name:Other, SrcID:http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002396/WC500184965.pdf, URL:http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002396/WC500184965.pdf",C[C@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(=O)N,CHEMBL2039,MAOB
1758,CHEMBL1231160,Pevonedistat,Small molecule,,,,-stat,NEDD8 activating enzyme inhibitor,Potent inhibitor of NEDD8 activating enzyme (NAE) (IC50 = 0.004uM).,,CHEMBL3831283,NEDD8 activating enzyme,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:19360080, URL:http://europepmc.org/abstract/MED/19360080",NS(=O)(=O)OC[C@@H]1C[C@H](C[C@@H]1O)n2ccc3c(N[C@H]4CCc5ccccc45)ncnc23,,
1759,CHEMBL408194,Obatoclax,Small molecule,,,,-toclax,Bcl-2-related protein A1 inhibitor,,,CHEMBL6044,Bcl-2-related protein A1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18931344, URL:http://europepmc.org/abstract/MED/18931344|Name:PubMed, SrcID:16645636, URL:http://europepmc.org/abstract/MED/16645636|Name:PubMed, SrcID:18040043, URL:http://europepmc.org/abstract/MED/18040043",COC1=CC(=N/C/1=C\c2[nH]c(C)cc2C)c3cc4ccccc4[nH]3,CHEMBL6044,BCL2A1
1760,CHEMBL2108568,Trebananib,Protein,,,,-anib,Angiopoietin-2 inhibitor,Inhibits the interaction between the ligands angiopoietin-1 and angiopoietin-2 with the Tie-2 receptor.,,CHEMBL3580489,Angiopoietin-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20677100, URL:http://europepmc.org/abstract/MED/20677100",,CHEMBL3580489,ANGPT2
1761,CHEMBL2109103,Bertilimumab,Antibody,,,,-mab,Eotaxin inhibitor,,,CHEMBL3286077,Eotaxin,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16973884, URL:http://europepmc.org/abstract/MED/16973884",,CHEMBL3286077,CCL11
1762,CHEMBL2109352,Cat-3888,Antibody,,,,,CD22 binding agent,,,CHEMBL3218,CD22,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://meeting.ascopubs.org/cgi/content/short/25/18_suppl/7095, URL:http://meeting.ascopubs.org/cgi/content/short/25/18_suppl/7095",,CHEMBL3218,CD22
1763,CHEMBL3707397,Mr-1817,Small molecule,,,,,Vanilloid receptor antagonist,,,CHEMBL4794,Vanilloid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,,,CHEMBL4794,TRPV1
1764,CHEMBL1201170,Lithium Citrate,Small molecule,1980.0,,,,Inositol-1(or 4)-monophosphatase 1 inhibitor,,,CHEMBL1786,Inositol-1(or 4)-monophosphatase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=1dadbe49-93e6-467a-a12b-2b80b811fcbb#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1dadbe49-93e6-467a-a12b-2b80b811fcbb#nlm34090-1|Name:FDA, SrcID:label/2011/017812s028,018421s027lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/017812s028,018421s027lbl.pdf|Name:PubMed, SrcID:22707923, URL:http://europepmc.org/abstract/MED/22707923|Name:Wikipedia, SrcID:Lithium_(medication), URL:http://en.wikipedia.org/wiki/Lithium_(medication)",[Li+].[Li+].[Li+].OC(CC(=O)[O-])(CC(=O)[O-])C(=O)[O-],CHEMBL1786,IMPA1
1765,CHEMBL17,Dichlorphenamide,Small molecule,1958.0,S01EC02,S01EC02 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Carbonic anhydrase inhibitors],,Carbonic anhydrase II inhibitor,,,CHEMBL205,Carbonic anhydrase II,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18336310, URL:http://europepmc.org/abstract/MED/18336310",NS(=O)(=O)c1cc(Cl)c(Cl)c(c1)S(=O)(=O)N,CHEMBL205,CA2
1766,CHEMBL1201325,Hexocyclium,Small molecule,1982.0,A03AB10,"A03AB10 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: Synthetic anticholinergics, quaternary ammonium compounds]",-ium,Muscarinic acetylcholine receptor M1 antagonist,"Role in regulating gastric secretion, M1 likely involved",,CHEMBL216,Muscarinic acetylcholine receptor M1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:8075869, URL:http://europepmc.org/abstract/MED/8075869|Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:9183081, URL:http://europepmc.org/abstract/MED/9183081",C[N+]1(C)CCN(CC(O)(C2CCCCC2)c3ccccc3)CC1,CHEMBL216,CHRM1
1767,CHEMBL1201202,Fondaparinux,Oligosaccharide,2001.0,B01AX05,B01AX05 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Other antithrombotic agents],-parinux,Antithrombin-III activator,ATIII then binds to F10,Selective,CHEMBL1950,Antithrombin-III,ACTIVATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=05bb2dd4-5fb5-4ec9-29a8-d200e62d1a8f#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=05bb2dd4-5fb5-4ec9-29a8-d200e62d1a8f#nlm34090-1|Name:FDA, SrcID:label/2014/021345s032lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021345s032lbl.pdf",CO[C@H]1O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]2O[C@H]([C@@H](O[C@H]3O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]4O[C@@H]([C@@H](O[C@H]5O[C@H](COS(=O)(=O)O)[C@@H](O)[C@H](O)[C@H]5NS(=O)(=O)O)[C@H](O)[C@H]4O)C(=O)O)[C@H](OS(=O)(=O)O)[C@H]3NS(=O)(=O)O)[C@H](O)[C@H]2OS(=O)(=O)O)C(=O)O)[C@H](O)[C@H]1NS(=O)(=O)O,CHEMBL1950,SERPINC1
1768,CHEMBL621,Trazodone,Small molecule,1981.0,N06AX05,N06AX05 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants],,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=88c45123-f475-4dd0-bbac-c261868924ef#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=88c45123-f475-4dd0-bbac-c261868924ef#nlm34090-1|Name:FDA, SrcID:label/2013/071258Orig1s040, 071196Orig1s063lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/071258Orig1s040, 071196Orig1s063lbl.pdf",Clc1cccc(c1)N2CCN(CCCN3N=C4C=CC=CN4C3=O)CC2,CHEMBL224,HTR2A
1769,CHEMBL623,Nefazodone,Small molecule,1994.0,N06AX06,N06AX06 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants],,Serotonin 2c (5-HT2c) receptor antagonist,,,CHEMBL225,Serotonin 2c (5-HT2c) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=b1d149db-ad43-4f3f-aef1-fb0395ba4191#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b1d149db-ad43-4f3f-aef1-fb0395ba4191#nlm34090-1",CCC1=NN(CCCN2CCN(CC2)c3cccc(Cl)c3)C(=O)N1CCOc4ccccc4,,
1770,CHEMBL1213351,Propoxyphene,Small molecule,1957.0,N02AC04,N02AC04 [NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Diphenylpropylamine derivatives],,Mu opioid receptor agonist,,,CHEMBL233,Mu opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=c6c48eee-240b-4425-8691-35462523652e#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c6c48eee-240b-4425-8691-35462523652e#nlm34090-1|Name:PubMed, SrcID:17122535, URL:http://europepmc.org/abstract/MED/17122535",CCC(=O)O[C@@](Cc1ccccc1)([C@H](C)CN(C)C)c2ccccc2,CHEMBL233,OPRM1
1771,CHEMBL953,Entacapone,Small molecule,1999.0,N04BX02,N04BX02 [NERVOUS SYSTEM: ANTI-PARKINSON DRUGS: DOPAMINERGIC AGENTS: Other dopaminergic agents],-capone,Catechol O-methyltransferase inhibitor,,,CHEMBL2023,Catechol O-methyltransferase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=95976f1d-1b36-4f08-a98f-36d5d7883d7b#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=95976f1d-1b36-4f08-a98f-36d5d7883d7b#nlm34090-1",CCN(CC)C(=O)\C(=C\c1cc(O)c(O)c(c1)[N+](=O)[O-])\C#N,CHEMBL2023,COMT
1772,CHEMBL1200848,Hydroxyprogesterone Caproate,Small molecule,1975.0,G03DA03,G03DA03 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: PROGESTOGENS: Pregnen (4) derivatives],-gest-,Progesterone receptor agonist,,,CHEMBL208,Progesterone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18060946, URL:http://europepmc.org/abstract/MED/18060946|Name:PubMed, SrcID:21600550, URL:http://europepmc.org/abstract/MED/21600550",CCCCCC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(=O)C,CHEMBL208,PGR
1773,CHEMBL742,Ketamine,Small molecule,1970.0,N01AX03,"N01AX03 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Other general anesthetics]",,Glutamate [NMDA] receptor negative allosteric modulator,,,CHEMBL2094124,Glutamate [NMDA] receptor,NEGATIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:19494779, URL:http://europepmc.org/abstract/MED/19494779|Name:PubMed, SrcID:8942324, URL:http://europepmc.org/abstract/MED/8942324|Name:Wikipedia, SrcID:Ketamine#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Ketamine#Mechanism_of_action|Name:PubMed, SrcID:9105235, URL:http://europepmc.org/abstract/MED/9105235|Name:DailyMed, SrcID:setid=9f675d38-d02f-455c-bc99-bac5924f5054, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9f675d38-d02f-455c-bc99-bac5924f5054",CNC1(CCCCC1=O)c2ccccc2Cl,CHEMBL2094124,GRIN3B
1774,CHEMBL477,Adenosine,Small molecule,1989.0,C01EB10,C01EB10 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: OTHER CARDIAC PREPARATIONS: Other cardiac preparations],,Adenosine receptor agonist,,,CHEMBL2111329,Adenosine receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2011/019937s026lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019937s026lbl.pdf|Name:ISBN, SrcID:9780702034718 PP. 204, URL:http://www.isbnsearch.org/isbn/9780702034718",Nc1ncnc2c1ncn2[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O,,
1775,CHEMBL2097081,Nitroprusside,Small molecule,1981.0,C02DD01,"C02DD01 [CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON: Nitroferricyanide derivatives]",-trop-,Soluble guanylate cyclase activator,,,CHEMBL2111348,Soluble guanylate cyclase,ACTIVATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Soluble guanylate cyclase beta subunit,"Heterodimer, beta (1 or 2) is binding site","Name:Wikipedia, SrcID:Soluble_guanylyl_cyclase, URL:http://en.wikipedia.org/wiki/Soluble_guanylyl_cyclase|Name:PubMed, SrcID:18307997, URL:http://europepmc.org/abstract/MED/18307997|Name:DailyMed, SrcID:setid=6a44bcac-a0e1-4069-5691-db7b83dbb4b7#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6a44bcac-a0e1-4069-5691-db7b83dbb4b7#nlm34090-1",O=N[Fe-2](C#N)(C#N)(C#N)(C#N)C#N,CHEMBL2111348,GUCY1A2
1776,CHEMBL231813,Telaprevir,Protein,2011.0,J05AE11,J05AE11 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Protease inhibitors],-vir,"Hepatitis C virus serine protease, NS3/NS4A inhibitor",,,CHEMBL2095231,"Hepatitis C virus serine protease, NS3/NS4A",INHIBITOR,Hepatitis C virus,PROTEIN COMPLEX,,,"Name:FDA, SrcID:label/2013/201917s010lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/201917s010lbl.pdf|Name:DailyMed, SrcID:setid=ed0e4f33-cf21-4fe3-918d-1d5b3a23eee4, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ed0e4f33-cf21-4fe3-918d-1d5b3a23eee4",CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)c3cnccn3)C4CCCCC4)C(C)(C)C)C(=O)C(=O)NC5CC5,,
1777,CHEMBL1337,Nitisinone,Small molecule,2002.0,A16AX04,A16AX04 [ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Various alimentary tract and metabolism products],,4-hydroxyphenylpyruvate dioxygenase inhibitor,,,CHEMBL1861,4-hydroxyphenylpyruvate dioxygenase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=1eecf439-77ff-40c8-aef8-71e024ea8b7c#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1eecf439-77ff-40c8-aef8-71e024ea8b7c#nlm34090-1|Name:FDA, SrcID:label/2014/021232s013lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021232s013lbl.pdf",[O-][N+](=O)c1cc(ccc1C(=O)C2C(=O)CCCC2=O)C(F)(F)F,,
1778,CHEMBL118,Celecoxib,Small molecule,1998.0,M01AH01; L01XX33,"M01AH01 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Coxibs]; L01XX33 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents]",-coxib,Cyclooxygenase-2 inhibitor,,,CHEMBL230,Cyclooxygenase-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=90f074fa-f205-4039-822e-d09049812237, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=90f074fa-f205-4039-822e-d09049812237",Cc1ccc(cc1)c2cc(nn2c3ccc(cc3)S(=O)(=O)N)C(F)(F)F,CHEMBL230,PTGS2
1779,CHEMBL152,Cidofovir,Small molecule,1996.0,J05AB12,J05AB12 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleosides and nucleotides excl. reverse transcriptase inhibitors],-vir,Human herpesvirus 1 DNA polymerase inhibitor,,,CHEMBL1872,Human herpesvirus 1 DNA polymerase,INHIBITOR,Herpes simplex virus (type 1 / strain 17),SINGLE PROTEIN,,,"Name:PubMed, SrcID:17913252, URL:http://europepmc.org/abstract/MED/17913252",NC1=NC(=O)N(C[C@@H](CO)OCP(=O)(O)O)C=C1,,
1780,CHEMBL1201772,Prasugrel,Small molecule,2009.0,B01AC22,B01AC22 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Platelet aggregation inhibitors excl. heparin],-grel,Purinergic receptor P2Y12 antagonist,Irreversible inhibitor,,CHEMBL2001,Purinergic receptor P2Y12,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=5fe9c118-c44b-48d7-a142-9668ae3df0c6, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5fe9c118-c44b-48d7-a142-9668ae3df0c6",CC(=O)Oc1cc2CN(CCc2s1)C(C(=O)C3CC3)c4ccccc4F,CHEMBL2001,P2RY12
1781,CHEMBL1190,Decamethonium,Small molecule,1982.0,,,-ium,Muscle-type nicotinic acetylcholine receptor partial agonist,depolarizing,,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,PARTIAL AGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:17525594, URL:http://europepmc.org/abstract/MED/17525594|Name:PubMed, SrcID:19417616, URL:http://europepmc.org/abstract/MED/19417616|Name:ISBN, SrcID:9780702034718 PP. 164, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:12067008, URL:http://europepmc.org/abstract/MED/12067008",C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C,,
1782,CHEMBL360055,Gallamine,Small molecule,1982.0,M03AC02,"M03AC02 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS: Other quaternary ammonium compounds]",,Muscle-type nicotinic acetylcholine receptor antagonist,non-depolarizing,,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:ISBN, SrcID:9780702034718 PP. 164, URL:http://www.isbnsearch.org/isbn/9780702034718",CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC,,
1783,CHEMBL1131,Acitretin,Small molecule,1996.0,D05BB02,D05BB02 [DERMATOLOGICALS: ANTIPSORIATICS: ANTIPSORIATICS FOR SYSTEMIC USE: Retinoids for treatment of psoriasis],-retin,Retinoid receptor agonist,Precise mechanism uncertain. RARG/RXRA are predominant forms in skin,,CHEMBL2363071,Retinoid receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10459139, URL:http://europepmc.org/abstract/MED/10459139|Name:PubMed, SrcID:9074840, URL:http://europepmc.org/abstract/MED/9074840|Name:PubMed, SrcID:9153406, URL:http://europepmc.org/abstract/MED/9153406",COc1cc(C)c(\C=C\C(=C\C=C\C(=C\C(=O)O)\C)\C)c(C)c1C,,
1784,CHEMBL185,Fluorouracil,Small molecule,1962.0,L01BC52; L01BC02,L01BC52 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Pyrimidine analogues]; L01BC02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Pyrimidine analogues],-uracil,RNA inhibitor,,,CHEMBL2311222,RNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:PubMed, SrcID:12724731, URL:http://europepmc.org/abstract/MED/12724731",FC1=CNC(=O)NC1=O,,
1785,CHEMBL679,Epinephrine,Small molecule,1965.0,R01AA14; R03AA01; C01CA24; R03AK01; S01EA01; B02BC09; A01AD01; S01EA51,"R01AA14 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Sympathomimetics, plain]; R03AA01 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS, INHALANTS: Alpha- and beta-adrenoreceptor agonists]; C01CA24 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES: Adrenergic and dopaminergic agents]; R03AK01 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS, INHALANTS: Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics]; S01EA01 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Sympathomimetics in glaucoma therapy 1)]; B02BC09 [BLOOD AND BLOOD FORMING ORGANS: ANTIHEMORRHAGICS: VITAMIN K AND OTHER HEMOSTATICS: Local hemostatics]; A01AD01 [ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Other agents for local oral treatment]; S01EA51 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Sympathomimetics in glaucoma therapy 1)]",,Adrenergic receptor agonist,,,CHEMBL2331074,Adrenergic receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=0d895e4c-ec4d-47ff-b624-0df457e7bfc7, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0d895e4c-ec4d-47ff-b624-0df457e7bfc7",CNC[C@H](O)c1ccc(O)c(O)c1,,
1786,CHEMBL1546,Hydroxyamphetamine,Small molecule,1969.0,,,,Adrenergic receptor agonist,,,CHEMBL2331074,Adrenergic receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:22644105, URL:http://europepmc.org/abstract/MED/22644105|Name:DailyMed, SrcID:setid=da8a8a19-ac1b-4160-aac4-c4c57598eb5d, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=da8a8a19-ac1b-4160-aac4-c4c57598eb5d|Name:PubMed, SrcID:11176985, URL:http://europepmc.org/abstract/MED/11176985|Name:PubMed, SrcID:13884064, URL:http://europepmc.org/abstract/MED/13884064|Name:PubMed, SrcID:22552730, URL:http://europepmc.org/abstract/MED/22552730",CC(N)Cc1ccc(O)cc1,,
1787,CHEMBL564,Promazine,Small molecule,1956.0,N05AA03,N05AA03 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Phenothiazines with aliphatic side-chain],,D2-like dopamine receptor antagonist,,,CHEMBL2331075,D2-like dopamine receptor,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:Wikipedia, SrcID:Chlorpromazine, URL:http://en.wikipedia.org/wiki/Chlorpromazine|Name:Wikipedia, SrcID:Promazine, URL:http://en.wikipedia.org/wiki/Promazine|Name:ISBN, SrcID:0471-948470 PP. 663, URL:http://www.isbnsearch.org/isbn/0471948470|Name:ISBN, SrcID:0443-059748 PP. 542, URL:http://www.isbnsearch.org/isbn/0443059748",CN(C)CCCN1c2ccccc2Sc3ccccc13,,
1788,CHEMBL589,Ropinirole,Small molecule,1997.0,N04BC04,N04BC04 [NERVOUS SYSTEM: ANTI-PARKINSON DRUGS: DOPAMINERGIC AGENTS: Dopamine agonists],,D2-like dopamine receptor agonist,,,CHEMBL2331075,D2-like dopamine receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=de0bb94f-4fd8-4f27-5ba6-6f392dd5160f#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de0bb94f-4fd8-4f27-5ba6-6f392dd5160f#nlm34090-1",CCCN(CCC)CCc1cccc2NC(=O)Cc12,,
1789,CHEMBL1200733,Desflurane,Small molecule,1992.0,N01AB07,"N01AB07 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,Potassium channel subfamily K member 9 opener,,,CHEMBL2321614,Potassium channel subfamily K member 9,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:15562060, URL:http://europepmc.org/abstract/MED/15562060|Name:PubMed, SrcID:16192517, URL:http://europepmc.org/abstract/MED/16192517|Name:PubMed, SrcID:17227289, URL:http://europepmc.org/abstract/MED/17227289",FC(F)OC(F)C(F)(F)F,CHEMBL2321614,KCNK9
1790,CHEMBL1201512,Fomivirsen Sodium,Oligonucleotide,1998.0,S01AD08,S01AD08 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Antivirals],-rsen,Major intermediate early region 2 mRNA antisense inhibitor,Antisense therapy; It's a phosphorothioate oligonucleotide,,CHEMBL2364186,Major intermediate early region 2 mRNA,ANTISENSE INHIBITOR,Human cytomegalovirus,NUCLEIC-ACID,,,"Name:FDA, SrcID:label/1998/20961lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20961lbl.pdf",,,
1791,CHEMBL1173655,Afatinib,Small molecule,2013.0,L01XE13,L01XE13 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Receptor protein-tyrosine kinase erbB-2 inhibitor,"Afatinib covalently binds to the kinase domains of EGFR (ErbB1), HER2 (ErbB2), and HER4 (ErbB4) and irreversibly inhibits tyrosine kinase autophosphorylation, resulting in downregulation of ErbB signaling",,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:fd638e5e-8032-e7ca-0179-95e96ab5d387, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fd638e5e-8032-e7ca-0179-95e96ab5d387",CN(C)C\C=C\C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]4CCOC4,CHEMBL1824,ERBB2
1792,CHEMBL2103822,Tasimelteon,Small molecule,2014.0,N05CH03,N05CH03 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Melatonin receptor agonists],-melteon,Melatonin receptor agonist,,,CHEMBL2094268,Melatonin receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2014/205677s000lbledt.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205677s000lbledt.pdf",CCC(=O)NC[C@@H]1C[C@H]1c2cccc3OCCc23,,
1793,CHEMBL1083659,Suvorexant,Small molecule,2014.0,,,,Orexin receptor antagonist,,,CHEMBL3307226,Orexin receptor,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2014/204569s001lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204569s001lbl.pdf",C[C@@H]1CCN(CCN1C(=O)c2cc(C)ccc2n3nccn3)c4oc5ccc(Cl)cc5n4,,
1794,CHEMBL2216870,Idelalisib,Small molecule,2014.0,L01XX47,L01XX47 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-lisib,PI3-kinase p110-delta subunit inhibitor,,,CHEMBL3130,PI3-kinase p110-delta subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2014/206545lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206545lbl.pdf",CC[C@H](Nc1ncnc2[nH]cnc12)C3=Nc4cccc(F)c4C(=O)N3c5ccccc5,CHEMBL3130,PIK3CD
1795,CHEMBL2146883,Cobimetinib,Small molecule,2015.0,L01XE38,L01XE38 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,Reversible inhibitor of mitogen-activated protein kinase (MAPK)/extracellular signal regulated kinase 1 (MEK1) and MEK2,,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22496205, URL:http://europepmc.org/abstract/MED/22496205|Name:DailyMed, SrcID:setid=c387579e-cee0-4334-bd1e-73f93ac1bde6, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c387579e-cee0-4334-bd1e-73f93ac1bde6|Name:PubMed, SrcID:22084396, URL:http://europepmc.org/abstract/MED/22084396",OC1(CN(C1)C(=O)c2ccc(F)c(F)c2Nc3ccc(I)cc3F)[C@@H]4CCCCN4,CHEMBL3587,MAP2K1
1796,CHEMBL3545047,Bms-852927,Small molecule,,,,,LXR-beta modulator,"Ph1 study terminated in 2013, undisclosed reasons",,CHEMBL4093,LXR-beta,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24833295, URL:http://europepmc.org/abstract/MED/24833295",,CHEMBL4093,NR1H2
1797,CHEMBL1980297,Ilorasertib,Small molecule,,,,-sertib,Platelet-derived growth factor receptor inhibitor,Multitargeted kinase inhibitor,,CHEMBL2095189,Platelet-derived growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:22935731, URL:http://europepmc.org/abstract/MED/22935731",Nc1ncc(c2cnn(CCO)c2)c3scc(c4ccc(NC(=O)Nc5cccc(F)c5)cc4)c13,,
1798,CHEMBL585902,Amg-548,Small molecule,,,,,MAP kinase p38 alpha inhibitor,"AMG548 has been shown to inhibit Wnt/ß-catenin signaling which is thought to be due to cross-reactivity with/inhibition of casein kinase Id/¿ (CSNK1D and CSNK1E, PMID:21513885)",,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21513885, URL:http://europepmc.org/abstract/MED/21513885",CN1C(=NC(=C(C1=O)c2ccc3ccccc3c2)c4ccncc4)NC[C@@H](N)Cc5ccccc5,CHEMBL260,MAPK14
1799,CHEMBL1650595,Ar-12,Small molecule,,,,,3-phosphoinositide dependent protein kinase-1 inhibitor,,,CHEMBL2534,3-phosphoinositide dependent protein kinase-1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15205346, URL:http://europepmc.org/abstract/MED/15205346",NCC(=O)Nc1ccc(cc1)n2nc(cc2c3ccc4c(ccc5ccccc45)c3)C(F)(F)F,CHEMBL2534,PDPK1
1800,CHEMBL3545424,Azd-8186,Small molecule,,,,,PI3-kinase p110-beta subunit inhibitor,,,CHEMBL3145,PI3-kinase p110-beta subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25514658, URL:http://europepmc.org/abstract/MED/25514658",,CHEMBL3145,PIK3CB
1801,CHEMBL3545050,Bms-817378,Small molecule,,,,,Hepatocyte growth factor receptor inhibitor,,,CHEMBL3717,Hepatocyte growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1016/S1359-6349(10)71801-2, URL:http://www.sciencedirect.com/science/article/pii/S1359634910718012",,CHEMBL3717,MET
1802,CHEMBL3545247,Cal-263,Small molecule,,,,,PI3-kinase p110-gamma subunit inhibitor,,,CHEMBL3267,PI3-kinase p110-gamma subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25312588, URL:http://europepmc.org/abstract/MED/25312588|Name:PubMed, SrcID:15367672, URL:http://europepmc.org/abstract/MED/15367672",,CHEMBL3267,PIK3CG
1803,CHEMBL1236107,Sgx-523,Small molecule,,,,,Hepatocyte growth factor receptor inhibitor,,,CHEMBL3717,Hepatocyte growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19934279, URL:http://europepmc.org/abstract/MED/19934279|Name:PubMed, SrcID:25806189, URL:http://europepmc.org/abstract/MED/25806189",Cn1cc(cn1)c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2,CHEMBL3717,MET
1804,CHEMBL3544936,Xl-844,Small molecule,,,,,Serine/threonine-protein kinase Chk1 inhibitor,,,CHEMBL4630,Serine/threonine-protein kinase Chk1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=469731, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=469731|Name:PubMed, SrcID:17245119, URL:http://europepmc.org/abstract/MED/17245119|Name:PubMed, SrcID:19568282, URL:http://europepmc.org/abstract/MED/19568282",,CHEMBL4630,CHEK1
1805,CHEMBL3545271,Pbf-999,Small molecule,,,,,Phosphodiesterase 10A inhibitor,,,CHEMBL4409,Phosphodiesterase 10A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.palobiofarma.com, URL:http://www.palobiofarma.com",,CHEMBL4409,PDE10A
1806,CHEMBL3545416,Henatinib,Small molecule,,,,-tinib,Vascular endothelial growth factor receptor 2 inhibitor,,,CHEMBL279,Vascular endothelial growth factor receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1158/1538-7445.AM2011-4259, URL:http://cancerres.aacrjournals.org/content/71/8_Supplement/4259|Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=709376, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=709376",,CHEMBL279,KDR
1807,CHEMBL3707380,Rg6029,Small molecule,,,,,Sodium channel protein type IX alpha subunit blocker,,,CHEMBL4296,Sodium channel protein type IX alpha subunit,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://adisinsight.springer.com/drugs/800043573, URL:http://adisinsight.springer.com/drugs/800043573|Name:Other, SrcID:http://www.roche.com/DE/research_and_development/who_we_are_how_we_work/pipeline.htm, URL:http://www.roche.com/DE/research_and_development/who_we_are_how_we_work/pipeline.htm",,CHEMBL4296,SCN9A
1808,CHEMBL2105738,Galeterone,Small molecule,,,,,Androgen Receptor antagonist,,,CHEMBL1871,Androgen Receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23713567, URL:http://europepmc.org/abstract/MED/23713567|Name:Other, SrcID:http://tokaipharmaceuticals.com/our-programs/about-galeterone/, URL:http://tokaipharmaceuticals.com/our-programs/about-galeterone/|Name:PubMed, SrcID:25591066, URL:http://europepmc.org/abstract/MED/25591066",C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CC=C2n5cnc6ccccc56,CHEMBL1871,AR
1809,CHEMBL3545094,Elocalcitol,Small molecule,,,,-calci-,Vitamin D receptor agonist,Development terminated due to unmet primary end points for treatment of OAB in Ph2b trial,,CHEMBL1977,Vitamin D receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19517319, URL:http://europepmc.org/abstract/MED/19517319|Name:PubMed, SrcID:16957418, URL:http://europepmc.org/abstract/MED/16957418",CCC(O)(CC)\C=C\C[C@H](C)C1=CCC2\C(=C\C=C/3\C[C@@H](O)C[C@H](O)C3=C)\CCC[C@]12C,CHEMBL1977,VDR
1810,CHEMBL3545288,V81444,Small molecule,,,,,Adenosine A2a receptor antagonist,,,CHEMBL251,Adenosine A2a receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:8113199, URL:http://europepmc.org/abstract/MED/8113199|Name:Other, SrcID:http://www.vernalis.com/development-2/nce-pipeline/2014-02-13-01-54-32/v81444, URL:http://www.vernalis.com/development-2/nce-pipeline/2014-02-13-01-54-32/v81444",,CHEMBL251,ADORA2A
1811,CHEMBL592435,Derenofylline,Small molecule,,,,-fylline,Adenosine A1 receptor antagonist,"Phase 2 study terminated early, no reason given (PMID:21641345). Company aquired by Abbott, compound not on current pipeline.",,CHEMBL226,Adenosine A1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17558436, URL:http://europepmc.org/abstract/MED/17558436|Name:PubMed, SrcID:16654164, URL:http://www.ncbi.nlm.nih.gov/pubmed/?term=16654164",OC1CCC(CC1)Nc2nc(nc3[nH]ccc23)c4ccccc4,CHEMBL226,ADORA1
1812,CHEMBL17350,Traxoprodil,Small molecule,,,,-dil,Glutamate NMDA receptor; GRIN1/GRIN2B antagonist,Development discontinued due to QT prolongation.,Selective for the NR2B subunit.,CHEMBL1907603,Glutamate NMDA receptor; GRIN1/GRIN2B,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:DOI, SrcID:10.1111/j.1527-3458.1998.tb00073.x, URL:http://onlinelibrary.wiley.com/doi/10.1111/j.1527-3458.1998.tb00073.x/abstract;jsessionid=BB969FABCAB6BFF549E3C10621012C0A.f01t01|Name:PubMed, SrcID:11897110, URL:http://europepmc.org/abstract/MED/11897110|Name:PubMed, SrcID:21699507, URL:http://europepmc.org/abstract/MED/21699507",C[C@@H]([C@@H](O)c1ccc(O)cc1)N2CCC(O)(CC2)c3ccccc3,,
1813,CHEMBL2103869,Dasolampanel,Small molecule,,,,-ampa,Glutamate receptor ionotropic AMPA antagonist,"AMPA/Kainate receptor antagonist, selective for GRIK1 subunit containing receptors. Active metabolite is NGX424.",,CHEMBL2096670,Glutamate receptor ionotropic AMPA,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:16470401, URL:http://europepmc.org/abstract/MED/16470401|Name:PubMed, SrcID:18793656, URL:http://europepmc.org/abstract/MED/18793656|Name:PubMed, SrcID:8609884, URL:http://europepmc.org/abstract/MED/8609884",OC(=O)[C@@H]1C[C@H]2C[C@H](CC[C@H]2CN1)Oc3cccc(Cl)c3c4nnn[nH]4,,
1814,CHEMBL3707293,Xen-D0501,Small molecule,,,,,Vanilloid receptor antagonist,,,CHEMBL4794,Vanilloid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.ariopharma.com/Wortley.pdf, URL:http://www.ariopharma.com/Wortley.pdf|Name:Other, SrcID:http://www.ariopharma.com/ario-pharma-partnering-TRPV1.php, URL:http://www.ariopharma.com/ario-pharma-partnering-TRPV1.php",,CHEMBL4794,TRPV1
1815,CHEMBL31965,Canertinib,Small molecule,,,,-tinib,Epidermal growth factor receptor erbB1 inhibitor,Canertinib is an irreversible pan-ErbB tyrosine kinase inhibitor.,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12648472, URL:http://europepmc.org/abstract/MED/12648472|Name:PubMed, SrcID:11706399, URL:http://europepmc.org/abstract/MED/11706399",Fc1ccc(Nc2ncnc3cc(OCCCN4CCOCC4)c(NC(=O)C=C)cc23)cc1Cl,CHEMBL203,EGFR
1816,CHEMBL2103819,Rolofylline,Small molecule,,,,-fylline,Adenosine A1 receptor antagonist,Discontinued no more effective than placebo.,,CHEMBL226,Adenosine A1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:8732272, URL:http://europepmc.org/abstract/MED/8732272|Name:PubMed, SrcID:17936154, URL:http://europepmc.org/abstract/MED/17936154",CCCN1C(=O)N(CCC)c2nc([nH]c2C1=O)[C@@]34CC5CC(C[C@H]3C5)C4,CHEMBL226,ADORA1
1817,CHEMBL2103975,Vapreotide,Protein,,H01CB04,"H01CB04 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: HYPOTHALAMIC HORMONES: Somatostatin and analogues]",-tide,Somatostatin receptor 5 agonist,"Somatostatin analogue. Not apporved by FDA, rejected by advisory panel. Not in current company pipeline and no further development reported.",,CHEMBL1792,Somatostatin receptor 5,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:7907795, URL:http://europepmc.org/abstract/MED/7907795|Name:PubMed, SrcID:7878022, URL:http://europepmc.org/abstract/MED/7878022|Name:Other, SrcID:http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2054, URL:http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2054",CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc4ccc(O)cc4)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N[C@@H](Cc5c[nH]c6ccccc56)C(=O)N)NC(=O)[C@H](N)Cc7ccccc7,CHEMBL1792,SSTR5
1818,CHEMBL3545043,Asapiprant,Small molecule,,,,-piprant,Prostanoid DP receptor antagonist,,,CHEMBL4427,Prostanoid DP receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26277322, URL:http://europepmc.org/abstract/MED/26277322",CC(C)Oc1ccc(cc1)S(=O)(=O)N2CCN(CC2)c3ccc(c(OCC(=O)O)c3)c4occn4,CHEMBL4427,PTGDR
1819,CHEMBL1743024,Ganitumab,Antibody,,,,-mab,Insulin-like growth factor I receptor antagonist,Inhibits the high-affinity binding of IGF-I and IGF-II to IGF-IR preventing the subsequent triggering of the PI3K/Akt signaling pathway.,,CHEMBL1957,Insulin-like growth factor I receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19366899, URL:http://europepmc.org/abstract/MED/19366899",,CHEMBL1957,IGF1R
1820,CHEMBL2109662,Delantercept,Protein,,,,-cept,Growth/differentiation factor 2 inhibitor,Ligand trap for BMP9 and BMP10,,CHEMBL3831181,Growth/differentiation factor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20124460, URL:http://europepmc.org/abstract/MED/20124460|Name:PubMed, SrcID:24173543, URL:http://europepmc.org/abstract/MED/24173543",,CHEMBL3831181,GDF2
1821,CHEMBL319669,Pafuramidine,Small molecule,,,,-amidine,Kinetoplast DNA inhibitor,,,CHEMBL2366047,Kinetoplast DNA,INHIBITOR,Trypanosoma brucei,NUCLEIC-ACID,,Binds to the DNA minor groove in AT sequences of at least four consecutive AT base pairs,"Name:PubMed, SrcID:19620327, URL:http://europepmc.org/abstract/MED/19620327|Name:PubMed, SrcID:18343228, URL:http://europepmc.org/abstract/MED/18343228",CONC(=N)c1ccc(cc1)c2oc(cc2)c3ccc(cc3)C(=N)NOC,,
1822,CHEMBL512351,Betrixaban,Small molecule,,,,-xaban,Coagulation factor X inhibitor,,,CHEMBL244,Coagulation factor X,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19297154, URL:http://europepmc.org/abstract/MED/19297154|Name:PubMed, SrcID:23455714, URL:http://europepmc.org/abstract/MED/23455714",COc1ccc(NC(=O)c2ccc(cc2)C(=N)N(C)C)c(c1)C(=O)Nc3ccc(Cl)cn3,CHEMBL244,F10
1823,CHEMBL2103857,Edivoxetine,Small molecule,,,,-oxetine,Norepinephrine transporter inhibitor,,,CHEMBL222,Norepinephrine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21511276, URL:http://europepmc.org/abstract/MED/21511276",COc1ccc(F)cc1C[C@@](O)(C2CCOCC2)[C@@H]3CNCCO3,CHEMBL222,SLC6A2
1824,CHEMBL1096380,Plinabulin,Small molecule,,,,-bulin; -nab-,Tubulin inhibitor,Tubulin-depolymerizing agent.,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,NPI-2358 binds to the colchicine-binding site of tubulin.,"Name:PubMed, SrcID:16317287, URL:http://europepmc.org/abstract/MED/16317287",CC(C)(C)c1[nH]cnc1\C=C\2/NC(=O)\C(=C\c3ccccc3)\NC2=O,CHEMBL2095182,TUBB8
1825,CHEMBL1096380,Plinabulin,Small molecule,,,,-bulin; -nab-,Tubulin inhibitor,Tubulin-depolymerizing agent.,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,NPI-2358 binds to the colchicine-binding site of tubulin.,"Name:PubMed, SrcID:16317287, URL:http://europepmc.org/abstract/MED/16317287",CC(C)(C)c1[nH]cnc1\C=C\2/NC(=O)\C(=C\c3ccccc3)\NC2=O,CHEMBL2095182,TUBA3C
1826,CHEMBL1096380,Plinabulin,Small molecule,,,,-bulin; -nab-,Tubulin inhibitor,Tubulin-depolymerizing agent.,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,NPI-2358 binds to the colchicine-binding site of tubulin.,"Name:PubMed, SrcID:16317287, URL:http://europepmc.org/abstract/MED/16317287",CC(C)(C)c1[nH]cnc1\C=C\2/NC(=O)\C(=C\c3ccccc3)\NC2=O,CHEMBL2095182,TUBA4A
1827,CHEMBL1096380,Plinabulin,Small molecule,,,,-bulin; -nab-,Tubulin inhibitor,Tubulin-depolymerizing agent.,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,NPI-2358 binds to the colchicine-binding site of tubulin.,"Name:PubMed, SrcID:16317287, URL:http://europepmc.org/abstract/MED/16317287",CC(C)(C)c1[nH]cnc1\C=C\2/NC(=O)\C(=C\c3ccccc3)\NC2=O,CHEMBL2095182,TUBA3E
1828,CHEMBL1096380,Plinabulin,Small molecule,,,,-bulin; -nab-,Tubulin inhibitor,Tubulin-depolymerizing agent.,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,NPI-2358 binds to the colchicine-binding site of tubulin.,"Name:PubMed, SrcID:16317287, URL:http://europepmc.org/abstract/MED/16317287",CC(C)(C)c1[nH]cnc1\C=C\2/NC(=O)\C(=C\c3ccccc3)\NC2=O,CHEMBL2095182,TUBB6
1829,CHEMBL1096380,Plinabulin,Small molecule,,,,-bulin; -nab-,Tubulin inhibitor,Tubulin-depolymerizing agent.,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,NPI-2358 binds to the colchicine-binding site of tubulin.,"Name:PubMed, SrcID:16317287, URL:http://europepmc.org/abstract/MED/16317287",CC(C)(C)c1[nH]cnc1\C=C\2/NC(=O)\C(=C\c3ccccc3)\NC2=O,CHEMBL2095182,TUBB2B
1830,CHEMBL1096380,Plinabulin,Small molecule,,,,-bulin; -nab-,Tubulin inhibitor,Tubulin-depolymerizing agent.,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,NPI-2358 binds to the colchicine-binding site of tubulin.,"Name:PubMed, SrcID:16317287, URL:http://europepmc.org/abstract/MED/16317287",CC(C)(C)c1[nH]cnc1\C=C\2/NC(=O)\C(=C\c3ccccc3)\NC2=O,CHEMBL2095182,TUBA3D
1831,CHEMBL1090771,Avagacestat,Small molecule,,,,-stat,Gamma-secretase inhibitor,,,CHEMBL2094135,Gamma-secretase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:22381714, URL:http://europepmc.org/abstract/MED/22381714",NC(=O)[C@@H](CCC(F)(F)F)N(Cc1ccc(cc1F)c2nocn2)S(=O)(=O)c3ccc(Cl)cc3,CHEMBL2094135,APH1B
1832,CHEMBL1090771,Avagacestat,Small molecule,,,,-stat,Gamma-secretase inhibitor,,,CHEMBL2094135,Gamma-secretase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:22381714, URL:http://europepmc.org/abstract/MED/22381714",NC(=O)[C@@H](CCC(F)(F)F)N(Cc1ccc(cc1F)c2nocn2)S(=O)(=O)c3ccc(Cl)cc3,CHEMBL2094135,APH1A
1833,CHEMBL1615835,Muparfostat,Oligosaccharide,,,,-fo-; -stat,Heparanase inhibitor,,,CHEMBL3921,Heparanase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10416607, URL:http://europepmc.org/abstract/MED/10416607",OP(=O)(O)OC[C@H]1O[C@H](O[C@H]2[C@H](OS(=O)(=O)O)[C@@H](COS(=O)(=O)O)O[C@H](O[C@H]3[C@H](OS(=O)(=O)O)[C@@H](COS(=O)(=O)O)O[C@H](O[C@H]4[C@H](OS(=O)(=O)O)[C@@H](COS(=O)(=O)O)O[C@H](O[C@@H]5[C@@H](OS(=O)(=O)O)O[C@H](COS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@@H]5OS(=O)(=O)O)[C@H]4OS(=O)(=O)O)[C@H]3OS(=O)(=O)O)[C@H]2OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@@H]1OS(=O)(=O)O,CHEMBL3921,HPSE
1834,CHEMBL2109650,Ro-4905417,Antibody,,,,,P-selectin inhibitor,Anti-inflammatory. Blocks monocyte and/or leukocyte penetration into intimal space.,,CHEMBL5378,P-selectin,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21532566, URL:http://europepmc.org/abstract/MED/21532566",,,
1835,CHEMBL2108354,Ublituximab,Antibody,,,,-mab,B-lymphocyte antigen CD20 other,High affinity for Fc?RIIIa (CD16) receptors and therefore greater antibody-dependent cellular cytotoxicity (ADCC) activity.,,CHEMBL2058,B-lymphocyte antigen CD20,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23958919, URL:http://europepmc.org/abstract/MED/23958919",,CHEMBL2058,MS4A1
1836,CHEMBL3833344,Mm-302,Antibody,,,,,DNA inhibitor,"Upon binding of the antibody to the receptor protein-tyrosine kinase ERBB2, the immunoliposome allows for specific delivery of doxorubicin to tumors overexpressing the ERBB2 receptor. Once inside the HER2-expressing tumor cells, doxorubicin intercalates into DNA and interferes with DNA topoisomerase II activity, thereby inhibiting DNA replication and RNA synthesis.",,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:PubMed, SrcID:21048526, URL:http://europepmc.org/abstract/MED/21048526|Name:PubMed, SrcID:26162690, URL:http://europepmc.org/abstract/MED/26162690|Name:PubMed, SrcID:27259714, URL:http://europepmc.org/abstract/MED/27259714",,,
1837,CHEMBL252518,Artenimol,Small molecule,,P01BE05,"P01BE05 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: ANTIMALARIALS: Artemisinin and derivatives, plain]",arte-,Unknown,,,,,,,,,,,C[C@@H]1CC[C@H]2[C@@H](C)[C@@H](O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@@]23OO4,,
1838,CHEMBL344159,Tolvaptan,Small molecule,2009.0,C03XA01,C03XA01 [CARDIOVASCULAR SYSTEM: DIURETICS: OTHER DIURETICS: Vasopressin antagonists],-vaptan,Vasopressin V2 receptor antagonist,,,CHEMBL1790,Vasopressin V2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=5526617c-c7b9-4556-886d-729bbabbc566, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5526617c-c7b9-4556-886d-729bbabbc566",Cc1ccccc1C(=O)Nc2ccc(C(=O)N3CCCC(O)c4cc(Cl)ccc34)c(C)c2,CHEMBL1790,AVPR2
1839,CHEMBL1237,Lisinopril,Small molecule,1987.0,,,-pril,Angiotensin-converting enzyme inhibitor,,,CHEMBL1808,Angiotensin-converting enzyme,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2016/019777s074lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019777s074lbl.pdf|Name:DailyMed, SrcID:setid=fd9c8eff-5d49-47c0-a64c-33af31722b0f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fd9c8eff-5d49-47c0-a64c-33af31722b0f",NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N2CCC[C@H]2C(=O)O,CHEMBL1808,ACE
1840,CHEMBL2007641,Pertuzumab,Antibody,2012.0,L01XC13,L01XC13 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,Receptor protein-tyrosine kinase erbB-2 inhibitor,,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=17f85d17-ab71-4f5b-9fe3-0b8c822f69ff, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=17f85d17-ab71-4f5b-9fe3-0b8c822f69ff",,CHEMBL1824,ERBB2
1841,CHEMBL594,Emedastine,Small molecule,1997.0,S01GX06,S01GX06 [SENSORY ORGANS: OPHTHALMOLOGICALS: DECONGESTANTS AND ANTIALLERGICS: Other antiallergics],-astine,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=98a010d5-4905-4abf-a9d2-c85a07daa23b, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=98a010d5-4905-4abf-a9d2-c85a07daa23b",CCOCCn1c(nc2ccccc12)N3CCCN(C)CC3,CHEMBL231,HRH1
1842,CHEMBL1180725,Propantheline,Small molecule,1953.0,A03AB05,"A03AB05 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: Synthetic anticholinergics, quaternary ammonium compounds]",,Muscarinic acetylcholine receptor M1 antagonist,"Role in regulating gastric secretion, M1 likely involved",,CHEMBL216,Muscarinic acetylcholine receptor M1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:13263156, URL:http://europepmc.org/abstract/MED/13263156|Name:PubMed, SrcID:3762265, URL:http://europepmc.org/abstract/MED/3762265|Name:PubMed, SrcID:16080359, URL:http://europepmc.org/abstract/MED/16080359|Name:PubMed, SrcID:16465186, URL:http://europepmc.org/abstract/MED/16465186|Name:PubMed, SrcID:4381291, URL:http://europepmc.org/abstract/MED/4381291|Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718",CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc3ccccc13)C(C)C,CHEMBL216,CHRM1
1843,CHEMBL878,Metolazone,Small molecule,1973.0,C03BA08,"C03BA08 [CARDIOVASCULAR SYSTEM: DIURETICS: LOW-CEILING DIURETICS, EXCL. THIAZIDES: Sulfonamides, plain]",,Thiazide-sensitive sodium-chloride cotransporter inhibitor,,,CHEMBL1876,Thiazide-sensitive sodium-chloride cotransporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1056/NEJMra0907219, URL:http://www.nejm.org/doi/full/10.1056/NEJMra0907219|Name:Wikipedia, SrcID:Metolazone, URL:http://en.wikipedia.org/wiki/Metolazone|Name:DailyMed, SrcID:setid=0b619826-2567-49d7-8972-b6da5e4467df, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0b619826-2567-49d7-8972-b6da5e4467df",CC1Nc2cc(Cl)c(cc2C(=O)N1c3ccccc3C)S(=O)(=O)N,CHEMBL1876,SLC12A3
1844,CHEMBL1201613,Insulin Glulisine,Protein,2004.0,A10AB06,"A10AB06 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: INSULINS AND ANALOGUES: Insulins and analogues for injection, fast-acting]",,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=e7af6a7a-8046-4fb4-9979-4ec4230b23aa, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e7af6a7a-8046-4fb4-9979-4ec4230b23aa",,CHEMBL1981,INSR
1845,CHEMBL1201349,Hexafluorenium,Small molecule,1982.0,M03AC05,"M03AC05 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS: Other quaternary ammonium compounds]",-ium,Acetylcholinesterase inhibitor,,,CHEMBL220,Acetylcholinesterase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:948350, URL:http://europepmc.org/abstract/MED/948350|Name:PubMed, SrcID:849069, URL:http://europepmc.org/abstract/MED/849069",C[N+](C)(CCCCCC[N+](C)(C)C1c2ccccc2c3ccccc13)C4c5ccccc5c6ccccc46,CHEMBL220,ACHE
1846,CHEMBL1201356,Methylergonovine,Small molecule,1946.0,G02AB01,G02AB01 [GENITO URINARY SYSTEM AND SEX HORMONES: OTHER GYNECOLOGICALS: UTEROTONICS: Ergot alkaloids],-erg-; -vin-,Dopamine D1 receptor antagonist,,,CHEMBL2056,Dopamine D1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10200235, URL:http://europepmc.org/abstract/MED/10200235|Name:PubMed, SrcID:15930499, URL:http://europepmc.org/abstract/MED/15930499|Name:Wikipedia, SrcID:Methylergonovine#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Methylergonovine#Mechanism_of_action",CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34,CHEMBL2056,DRD1
1847,CHEMBL1421,Dasatinib,Small molecule,2006.0,L01XE06,L01XE06 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Ephrin type-A receptor 2 inhibitor,,,CHEMBL2068,Ephrin type-A receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13",Cc1nc(Nc2ncc(s2)C(=O)Nc3c(C)cccc3Cl)cc(n1)N4CCN(CCO)CC4,CHEMBL2068,EPHA2
1848,CHEMBL827,Dexmethylphenidate,Small molecule,2001.0,N06BA11,"N06BA11 [NERVOUS SYSTEM: PSYCHOANALEPTICS: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS: Centrally acting sympathomimetics]",,Norepinephrine transporter inhibitor,,,CHEMBL222,Norepinephrine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=d334e2f1-7497-4131-a5c0-7ac30d4741cb#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d334e2f1-7497-4131-a5c0-7ac30d4741cb#nlm34090-1|Name:PubMed, SrcID:18480678, URL:http://europepmc.org/abstract/MED/18480678",COC(=O)[C@@H]([C@H]1CCCCN1)c2ccccc2,CHEMBL222,SLC6A2
1849,CHEMBL897,Probenecid,Small molecule,1951.0,M04AB01,M04AB01 [MUSCULO-SKELETAL SYSTEM: ANTIGOUT PREPARATIONS: ANTIGOUT PREPARATIONS: Preparations increasing uric acid excretion],,Solute carrier family 22 member 11 inhibitor,,,CHEMBL2073677,Solute carrier family 22 member 11,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:2962517, URL:http://europepmc.org/abstract/MED/2962517|Name:PubMed, SrcID:15377641, URL:http://europepmc.org/abstract/MED/15377641|Name:Wikipedia, SrcID:Probenecid#Pharmacology, URL:http://en.wikipedia.org/wiki/Probenecid#Pharmacology|Name:PubMed, SrcID:11426832, URL:http://europepmc.org/abstract/MED/11426832|Name:PubMed, SrcID:12130730, URL:http://europepmc.org/abstract/MED/12130730",CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)O,CHEMBL2073677,SLC22A11
1850,CHEMBL963,Oxymorphone,Small molecule,1959.0,,,,Opioid receptors; mu/kappa/delta agonist,,,CHEMBL2095181,Opioid receptors; mu/kappa/delta,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:17525040, URL:http://europepmc.org/abstract/MED/17525040|Name:DailyMed, SrcID:setid=55639e61-8757-11de-8a39-0800200c9a66#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=55639e61-8757-11de-8a39-0800200c9a66#nlm34090-1",CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@]2(O)CCC4=O)c35,,
1851,CHEMBL159,Vinblastine,Small molecule,1965.0,L01CA01,L01CA01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Vinca alkaloids and analogues],vin-,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,"Binds to beta tubulin, vinca site (PMID: 15057285)","Name:Wikipedia, SrcID:Microtubules, URL:http://en.wikipedia.org/wiki/Microtubules|Name:DailyMed, SrcID:setid=f073b58e-56d6-4c8d-a2ce-b37719402d77, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f073b58e-56d6-4c8d-a2ce-b37719402d77",CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[C@H]7[C@](O)([C@H](OC(=O)C)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1,CHEMBL2095182,TUBB8
1852,CHEMBL159,Vinblastine,Small molecule,1965.0,L01CA01,L01CA01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Vinca alkaloids and analogues],vin-,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,"Binds to beta tubulin, vinca site (PMID: 15057285)","Name:Wikipedia, SrcID:Microtubules, URL:http://en.wikipedia.org/wiki/Microtubules|Name:DailyMed, SrcID:setid=f073b58e-56d6-4c8d-a2ce-b37719402d77, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f073b58e-56d6-4c8d-a2ce-b37719402d77",CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[C@H]7[C@](O)([C@H](OC(=O)C)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1,CHEMBL2095182,TUBA3C
1853,CHEMBL159,Vinblastine,Small molecule,1965.0,L01CA01,L01CA01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Vinca alkaloids and analogues],vin-,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,"Binds to beta tubulin, vinca site (PMID: 15057285)","Name:Wikipedia, SrcID:Microtubules, URL:http://en.wikipedia.org/wiki/Microtubules|Name:DailyMed, SrcID:setid=f073b58e-56d6-4c8d-a2ce-b37719402d77, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f073b58e-56d6-4c8d-a2ce-b37719402d77",CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[C@H]7[C@](O)([C@H](OC(=O)C)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1,CHEMBL2095182,TUBA4A
1854,CHEMBL159,Vinblastine,Small molecule,1965.0,L01CA01,L01CA01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Vinca alkaloids and analogues],vin-,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,"Binds to beta tubulin, vinca site (PMID: 15057285)","Name:Wikipedia, SrcID:Microtubules, URL:http://en.wikipedia.org/wiki/Microtubules|Name:DailyMed, SrcID:setid=f073b58e-56d6-4c8d-a2ce-b37719402d77, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f073b58e-56d6-4c8d-a2ce-b37719402d77",CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[C@H]7[C@](O)([C@H](OC(=O)C)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1,CHEMBL2095182,TUBA3E
1855,CHEMBL159,Vinblastine,Small molecule,1965.0,L01CA01,L01CA01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Vinca alkaloids and analogues],vin-,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,"Binds to beta tubulin, vinca site (PMID: 15057285)","Name:Wikipedia, SrcID:Microtubules, URL:http://en.wikipedia.org/wiki/Microtubules|Name:DailyMed, SrcID:setid=f073b58e-56d6-4c8d-a2ce-b37719402d77, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f073b58e-56d6-4c8d-a2ce-b37719402d77",CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[C@H]7[C@](O)([C@H](OC(=O)C)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1,CHEMBL2095182,TUBB6
1856,CHEMBL159,Vinblastine,Small molecule,1965.0,L01CA01,L01CA01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Vinca alkaloids and analogues],vin-,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,"Binds to beta tubulin, vinca site (PMID: 15057285)","Name:Wikipedia, SrcID:Microtubules, URL:http://en.wikipedia.org/wiki/Microtubules|Name:DailyMed, SrcID:setid=f073b58e-56d6-4c8d-a2ce-b37719402d77, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f073b58e-56d6-4c8d-a2ce-b37719402d77",CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[C@H]7[C@](O)([C@H](OC(=O)C)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1,CHEMBL2095182,TUBB2B
1857,CHEMBL159,Vinblastine,Small molecule,1965.0,L01CA01,L01CA01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Vinca alkaloids and analogues],vin-,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,"Binds to beta tubulin, vinca site (PMID: 15057285)","Name:Wikipedia, SrcID:Microtubules, URL:http://en.wikipedia.org/wiki/Microtubules|Name:DailyMed, SrcID:setid=f073b58e-56d6-4c8d-a2ce-b37719402d77, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f073b58e-56d6-4c8d-a2ce-b37719402d77",CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[C@H]7[C@](O)([C@H](OC(=O)C)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1,CHEMBL2095182,TUBA3D
1858,CHEMBL509,Meclofenamic Acid,Small molecule,1980.0,M02AA18; M01AG04,"M02AA18 [MUSCULO-SKELETAL SYSTEM: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: Antiinflammatory preparations, non-steroids for topical use]; M01AG04 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Fenamates]",-fenamate,Cyclooxygenase inhibitor,,,CHEMBL2094253,Cyclooxygenase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=96f19af4-de8f-4fd7-90d8-55fe6ebdd81d, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=96f19af4-de8f-4fd7-90d8-55fe6ebdd81d|Name:PubMed, SrcID:3020588, URL:http://europepmc.org/abstract/MED/3020588",Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl,,
1859,CHEMBL1428,Nimodipine,Small molecule,1988.0,C08CA06,C08CA06 [CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS: Dihydropyridine derivatives],-dipine,Voltage-gated L-type calcium channel blocker,,,CHEMBL2095229,Voltage-gated L-type calcium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=d6a161d9-7e7a-4711-ba0e-c9040c42268d, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d6a161d9-7e7a-4711-ba0e-c9040c42268d|Name:Wikipedia, SrcID:Calcium_channel_blocker, URL:http://en.wikipedia.org/wiki/Calcium_channel_blocker|Name:Wikipedia, SrcID:L-type_calcium_channel, URL:http://en.wikipedia.org/wiki/L-type_calcium_channel|Name:Wikipedia, SrcID:Nimodipine, URL:http://en.wikipedia.org/wiki/Nimodipine|Name:Wikipedia, SrcID:Voltage-dependent_calcium_channel, URL:http://en.wikipedia.org/wiki/Voltage-dependent_calcium_channel",COCCOC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OC(C)C)C,,
1860,CHEMBL2107333,Dimethyl Fumarate,Small molecule,2013.0,N07XX09,N07XX09 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs],,Kelch-like ECH-associated protein 1 inhibitor,"Alykylates Keap1 to prevent interaction with Nrf2 (PMID: 22732183, PMID: 23709213, PMID: 18618599)",,CHEMBL2069156,Kelch-like ECH-associated protein 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=665d7e74-036c-5f68-5b67-ab84b9b49151#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=665d7e74-036c-5f68-5b67-ab84b9b49151#nlm34090-1|Name:PubMed, SrcID:23709213, URL:http://europepmc.org/abstract/MED/23709213|Name:PubMed, SrcID:18618599, URL:http://europepmc.org/abstract/MED/18618599|Name:PubMed, SrcID:22732183, URL:http://europepmc.org/abstract/MED/22732183",COC(=O)\C=C\C(=O)OC,CHEMBL2069156,KEAP1
1861,CHEMBL701,Baclofen,Small molecule,1977.0,M03BX01,"M03BX01 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS: Other centrally acting agents]",,GABA-B receptor agonist,,,CHEMBL2111463,GABA-B receptor,AGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:Wikipedia, SrcID:Baclofen, URL:http://en.wikipedia.org/wiki/Baclofen|Name:PubMed, SrcID:11168554, URL:http://europepmc.org/abstract/MED/11168554",NCC(CC(=O)O)c1ccc(Cl)cc1,,
1862,CHEMBL2108570,Abobotulinumtoxina,Unknown,2009.0,,,,Synaptosomal-associated protein 25 inhibitor,"BOTOX blocks neuromuscular transmission by binding to acceptor sites on motor or sympathetic nerve terminals, entering the nerve terminals, and inhibiting the release of acetylcholine. This inhibition occurs as the neurotoxin cleaves SNAP-25, a protein integral to the successful docking and release of acetylcholine from vesicles situated within nerve endings.",,CHEMBL2364159,Synaptosomal-associated protein 25,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2012/125274s0052lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/125274s0052lbl.pdf",,CHEMBL2364159,SNAP25
1863,CHEMBL497,Clioquinol,Small molecule,1982.0,D08AH30; G01AC02; D09AA10; S02AA05; P01AA02; P01AA52,"D08AH30 [DERMATOLOGICALS: ANTISEPTICS AND DISINFECTANTS: ANTISEPTICS AND DISINFECTANTS: Quinoline derivatives]; G01AC02 [GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Quinoline derivatives]; D09AA10 [DERMATOLOGICALS: MEDICATED DRESSINGS: MEDICATED DRESSINGS: Medicated dressings with antiinfectives]; S02AA05 [SENSORY ORGANS: OTOLOGICALS: ANTIINFECTIVES: Antiinfectives]; P01AA02 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES: Hydroxyquinoline derivatives]; P01AA52 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES: Hydroxyquinoline derivatives]",,Iron chelating agent,"Used as antibiotic against diarrhea in the 70s, but nowadays considered in cancer treatments (off-label), for its chelator and ionophore properties with capacity to inhibit proteosome",,CHEMBL2363058,Iron,CHELATING AGENT,,METAL,,,"Name:PubMed, SrcID:21247386, URL:http://europepmc.org/abstract/MED/21247386|Name:PubMed, SrcID:15833873, URL:http://europepmc.org/abstract/MED/15833873",Oc1c(I)cc(Cl)c2cccnc12,,
1864,CHEMBL404,Tazobactam,Small molecule,1993.0,J01CG02,"J01CG02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: BETA-LACTAM ANTIBACTERIALS, PENICILLINS: Beta-lactamase inhibitors]",-bactam,Bacterial beta-lactamase TEM inhibitor,,Broad spectrum,CHEMBL2364670,Bacterial beta-lactamase TEM,INHIBITOR,Bacteria,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10511459, URL:http://europepmc.org/abstract/MED/10511459",C[C@]1(Cn2ccnn2)[C@@H](N3[C@@H](CC3=O)S1(=O)=O)C(=O)O,,
1865,CHEMBL1517,Oxytetracycline,Small molecule,1964.0,J01AA06; S01AA04; D06AA03; J01AA56; G01AA07,"J01AA06 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: TETRACYCLINES: Tetracyclines]; S01AA04 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Antibiotics]; D06AA03 [DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: ANTIBIOTICS FOR TOPICAL USE: Tetracycline and derivatives]; J01AA56 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: TETRACYCLINES: Tetracyclines]; G01AA07 [GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Antibiotics]",-cycline,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,16S ribosomal RNA,16s RRNA,"Name:KEGG, SrcID:D01596, URL:http://www.kegg.jp/dbget-bin/www_bget?dr:D01596",CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N)C(=O)c4c(O)cccc4[C@@]3(C)O,,
1866,CHEMBL1024,Ifosfamide,Small molecule,1988.0,L01AA06,L01AA06 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ALKYLATING AGENTS: Nitrogen mustard analogues],-fosfamide,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=b7241707-7538-4d1a-91e7-3a25a91e0b9a#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b7241707-7538-4d1a-91e7-3a25a91e0b9a#section-13",ClCCNP1(=O)OCCCN1CCCl,,
1867,CHEMBL16,Phenytoin,Small molecule,1953.0,N03AB02; N03AB52,N03AB02 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Hydantoin derivatives]; N03AB52 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Hydantoin derivatives],-toin,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=4a4c577d-9267-40eb-9ed9-09ceb6377026#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4a4c577d-9267-40eb-9ed9-09ceb6377026#nlm34090-1|Name:PubMed, SrcID:15208697, URL:http://europepmc.org/abstract/MED/15208697|Name:PubMed, SrcID:23205958, URL:http://europepmc.org/abstract/MED/23205958|Name:FDA, SrcID:label/2016/008762s055,010151s042lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/008762s055,010151s042lbl.pdf",OC1=NC(=O)C(N1)(c2ccccc2)c3ccccc3,,
1868,CHEMBL1963685,Lucinactant,Unknown,2012.0,,,-tant,Surfactant agent,Replaces endogenous surfactant in case of deficiency; endogenous pulmonary surfactant lower surface tension at the air-liquid of the alveolar surfaces,,,,,,,,,"Name:FDA, SrcID:label/2012/021746s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021746s000lbl.pdf",,,
1869,CHEMBL1200358,Sodium Phenylacetate,Small molecule,1987.0,,,,Glutamine sequestering agent,"Removes excess nitrogen, caused by enzyme deficiency",,CHEMBL2366039,Glutamine,SEQUESTERING AGENT,Homo sapiens,SMALL MOLECULE,,,"Name:DailyMed, SrcID:setid=d564f2b1-9fc7-4201-8066-d745ac3a671f#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d564f2b1-9fc7-4201-8066-d745ac3a671f#nlm34090-1|Name:PubMed, SrcID:11148549, URL:http://europepmc.org/abstract/MED/11148549",[Na+].[O-]C(=O)Cc1ccccc1,,
1870,CHEMBL1743062,Ramucirumab,Antibody,2014.0,L01XC21,L01XC21 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,Vascular endothelial growth factor receptor 2 inhibitor,,,CHEMBL279,Vascular endothelial growth factor receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2014/125477lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125477lbl.pdf",,CHEMBL279,KDR
1871,CHEMBL502835,Nintedanib,Small molecule,2014.0,L01XE31,L01XE31 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-anib,Platelet-derived growth factor receptor inhibitor,,,CHEMBL2095189,Platelet-derived growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:FDA, SrcID:label/2014/205832s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205832s000lbl.pdf",COC(=O)c1ccc2\C(=C(\Nc3ccc(cc3)N(C)C(=O)CN4CCN(C)CC4)/c5ccccc5)\C(=O)Nc2c1,,
1872,CHEMBL2219418,Naloxegol,Small molecule,2014.0,A06AH03,A06AH03 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR CONSTIPATION: DRUGS FOR CONSTIPATION: Peripheral opioid receptor antagonists],nal-,Mu opioid receptor antagonist,,,CHEMBL233,Mu opioid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2014/204760s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204760s000lbl.pdf",COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC=C)c45,CHEMBL233,OPRM1
1873,CHEMBL296419,Astemizole,Small molecule,1988.0,R06AX11,R06AX11 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Other antihistamines for systemic use],,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:6114717, URL:http://europepmc.org/abstract/MED/6114717",COc1ccc(CCN2CCC(CC2)Nc3nc4ccccc4n3Cc5ccc(F)cc5)cc1,CHEMBL231,HRH1
1874,CHEMBL3353410,Osimertinib,Small molecule,2015.0,L01XE35,L01XE35 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Epidermal growth factor receptor inhibitor,"Binds irreversibly to certain mutant forms of EGFR (T790M, L858R, and exon 19 deletion)",,CHEMBL2363049,Epidermal growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=5e81b4a7-b971-45e1-9c31-29cea8c87ce7, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5e81b4a7-b971-45e1-9c31-29cea8c87ce7",COc1cc(N(C)CCN(C)C)c(NC(=O)C=C)cc1Nc2nccc(n2)c3cn(C)c4ccccc34,,
1875,CHEMBL1721885,Su-014813,Small molecule,,,,,Vascular endothelial growth factor receptor inhibitor,,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:16891463, URL:http://europepmc.org/abstract/MED/16891463",Cc1[nH]c(\C=C\2/C(=O)Nc3ccc(F)cc23)c(C)c1C(=O)NC[C@H](O)CN4CCOCC4,,
1876,CHEMBL216981,Navarixin,Small molecule,,,,-rixin,Interleukin-8 receptor B antagonist,,,CHEMBL2434,Interleukin-8 receptor B,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ClinicalTrials, SrcID:NCT01006616, URL:https://clinicaltrials.gov/ct2/show/NCT01006616|Name:PubMed, SrcID:17496165, URL:http://europepmc.org/abstract/MED/17496165|Name:PubMed, SrcID:17496166, URL:http://europepmc.org/abstract/MED/17496166|Name:PubMed, SrcID:17181143, URL:http://europepmc.org/abstract/MED/17181143",CC[C@@H](NC1=C(Nc2cccc(C(=O)N(C)C)c2O)C(=O)C1=O)c3oc(C)cc3,CHEMBL2434,CXCR2
1877,CHEMBL9960,Azd-7624,Small molecule,,,,,MAP kinase p38 alpha inhibitor,,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1183/13993003.congress-2015.OA483, URL:http://erj.ersjournals.com/content/46/suppl_59/OA483|Name:Other, SrcID:https://www.astrazeneca.com/our-science/pipeline.html, URL:https://www.astrazeneca.com/our-science/pipeline.html",CC[C@H](NC(=O)c1cc(nc2ccccc12)c3ccccc3)c4ccccc4,CHEMBL260,MAPK14
1878,CHEMBL296468,Bms-387032,Small molecule,,,,,Cyclin-dependent kinase 7 inhibitor,,,CHEMBL3055,Cyclin-dependent kinase 7,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25215591, URL:http://europepmc.org/abstract/MED/25215591|Name:PubMed, SrcID:19169685, URL:http://europepmc.org/abstract/MED/19169685",CC(C)(C)c1oc(CSc2cnc(NC(=O)C3CCNCC3)s2)nc1,CHEMBL3055,CDK7
1879,CHEMBL3545133,Jnj-26483327,Small molecule,,,,,Receptor protein-tyrosine kinase erbB-4 inhibitor,Multi-targeted tyrosine kinase inhibitor,,CHEMBL3009,Receptor protein-tyrosine kinase erbB-4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1016/S1359-6349(10)71870-X, URL:http://www.sciencedirect.com/science/article/pii/S135963491071870X|Name:PubMed, SrcID:20823884, URL:http://europepmc.org/abstract/MED/20823884",,CHEMBL3009,ERBB4
1880,CHEMBL3545381,Plx-7486,Small molecule,,,,,Macrophage colony stimulating factor receptor inhibitor,,,CHEMBL1844,Macrophage colony stimulating factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.ecmcnetwork.org.uk/sites/default/files/PLX7486%20Background%20for%20CRUK%20Combinations%20Alliance%20(Non-CI)%202015-10-08%20final.pdf, URL:http://www.ecmcnetwork.org.uk/sites/default/files/PLX7486%20Background%20for%20CRUK%20Combinations%20Alliance%20(Non-CI)%202015-10-08%20final.pdf",,CHEMBL1844,CSF1R
1881,CHEMBL3545382,R-348,Small molecule,,,,,Tyrosine-protein kinase SYK inhibitor,Prodrug of R333,,CHEMBL2599,Tyrosine-protein kinase SYK,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18360272, URL:http://europepmc.org/abstract/MED/18360272|Name:PubMed, SrcID:19596999, URL:http://europepmc.org/abstract/MED/19596999",,CHEMBL2599,SYK
1882,CHEMBL3545204,Qaf805,Small molecule,,,,,Adenosine A3 receptor antagonist,,,CHEMBL256,Adenosine A3 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15876531, URL:http://europepmc.org/abstract/MED/15876531|Name:PubMed, SrcID:16654164, URL:http://www.ncbi.nlm.nih.gov/pubmed/?term=16654164",,CHEMBL256,ADORA3
1883,CHEMBL1980391,Rg-1530,Small molecule,,,,,Vascular endothelial growth factor receptor inhibitor,Multi-targeted kinase inhibitor,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:21553286, URL:http://europepmc.org/abstract/MED/21553286|Name:PubMed, SrcID:24900658, URL:http://europepmc.org/abstract/MED/24900658",COc1cc2Nc3n[nH]c(C)c3N=C(c4ccccc4Cl)c2cc1F,,
1884,CHEMBL3545112,Me-401,Small molecule,,,,,PI3-kinase p110-delta subunit inhibitor,,,CHEMBL3130,PI3-kinase p110-delta subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://ash.confex.com/ash/2012/webprogram/Paper51639.html, URL:https://ash.confex.com/ash/2012/webprogram/Paper51639.html",,CHEMBL3130,PIK3CD
1885,CHEMBL3707378,Cb-189625,Small molecule,,,,,Transient receptor potential cation channel subfamily A member 1 antagonist,,,CHEMBL6007,Transient receptor potential cation channel subfamily A member 1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://adisinsight.springer.com/drugs/800031537, URL:http://adisinsight.springer.com/drugs/800031537",,CHEMBL6007,TRPA1
1886,CHEMBL1232583,Indeglitazar,Small molecule,,,,-glitazar,Peroxisome proliferator-activated receptor agonist,Ph2 study terminated due to safety concerns,,CHEMBL3559683,Peroxisome proliferator-activated receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19116277, URL:http://europepmc.org/abstract/MED/19116277",COc1ccc(cc1)S(=O)(=O)n2cc(CCC(=O)O)c3cc(OC)ccc23,,
1887,CHEMBL3545092,Cr 1447,Small molecule,,,,,Estrogen receptor beta agonist,Main metabolite is ESR2 agonist (:http://www.curadis.eu/index.php?page=cr-1447),,CHEMBL242,Estrogen receptor beta,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.curadis.eu/index.php?page=cr-1447, URL:http://www.curadis.eu/index.php?page=cr-1447",,CHEMBL242,ESR2
1888,CHEMBL1236924,Int131,Small molecule,,,,,Peroxisome proliferator-activated receptor gamma modulator,Selective PPAR gamma modulator (SPPAR?M),,CHEMBL235,Peroxisome proliferator-activated receptor gamma,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23294830, URL:http://europepmc.org/abstract/MED/23294830|Name:Other, SrcID:http://www.intekrin.com/int131.html, URL:http://www.intekrin.com/int131.html|Name:PubMed, SrcID:19452630, URL:http://europepmc.org/abstract/MED/19452630",Clc1ccc(c(Cl)c1)S(=O)(=O)Nc2cc(Cl)c(Oc3cnc4ccccc4c3)c(Cl)c2,CHEMBL235,PPARG
1889,CHEMBL2178577,Azd-5363,Small molecule,,,,,Serine/threonine-protein kinase AKT inhibitor,Part of Astra Zeneca's Open Innovation program,,CHEMBL2111353,Serine/threonine-protein kinase AKT,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:22294718, URL:http://europepmc.org/abstract/MED/22294718",CCN(C1CCN(CC[C@H](C2CCC(CC2)S(=O)(=O)C)c3cc(F)cc(F)c3)CC1)C(=O)Cc4ccc(cc4)S(=O)(=O)C,,
1890,CHEMBL2079588,Telatinib,Small molecule,,,,-tinib,Vascular endothelial growth factor receptor 3 inhibitor,,,CHEMBL1955,Vascular endothelial growth factor receptor 3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19002179, URL:http://europepmc.org/abstract/MED/19002179|Name:PubMed, SrcID:19636022, URL:http://europepmc.org/abstract/MED/19636022",CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c4ccoc24)ccn1,CHEMBL1955,FLT4
1891,CHEMBL2012520,Ly377604,Small molecule,,,,,Beta-2 adrenergic receptor antagonist,Phase 2 study in 2011 terminated.,,CHEMBL210,Beta-2 adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24900353, URL:http://europepmc.org/abstract/MED/24900353",CC(C)(Cc1ccc(Oc2ccc(cn2)C(=O)N)cc1)NC[C@H](O)COc3cccc4[nH]c5ccccc5c34,CHEMBL210,ADRB2
1892,CHEMBL2105667,Orvepitant,Small molecule,,,,-tant,Neurokinin 1 receptor antagonist,"Phase 2 study terminated, isolated seizure events to be assessed (PMC3071576)",,CHEMBL249,Neurokinin 1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23539641, URL:http://europepmc.org/abstract/MED/23539641",C[C@@H](N(C)C(=O)N1CC[C@@H](C[C@@H]1c2ccc(F)cc2C)N3CCN4[C@@H](CCC4=O)C3)c5cc(cc(c5)C(F)(F)F)C(F)(F)F,CHEMBL249,TACR1
1893,CHEMBL1254771,Safotibant,Small molecule,,,,-fo-; -tibant,Bradykinin B1 receptor antagonist,,,CHEMBL4308,Bradykinin B1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.sanofi.com/Images/31095_2012-09-12_BofA_Zerhouni.pdf, URL:http://www.sanofi.com/Images/31095_2012-09-12_BofA_Zerhouni.pdf|Name:PubMed, SrcID:24333733, URL:http://europepmc.org/abstract/MED/24333733",COc1cc(C)c(c(C)c1)S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(cc2)C3=NCCN3,CHEMBL4308,BDKRB1
1894,CHEMBL3707316,Nd0801,Small molecule,,,,,Neuronal acetylcholine receptor protein alpha-7 subunit agonist,,,CHEMBL2492,Neuronal acetylcholine receptor protein alpha-7 subunit,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://neuroderm.com/cognition-nd0801/, URL:http://neuroderm.com/cognition-nd0801/|Name:Other, SrcID:http://slideplayer.com/slide/4968214/, URL:http://slideplayer.com/slide/4968214/",,CHEMBL2492,CHRNA7
1895,CHEMBL2107762,Nerispirdine,Small molecule,,,,-pirdine,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19413590, URL:http://europepmc.org/abstract/MED/19413590|Name:Other, SrcID:http://www.google.com/patents/US20090209595, URL:http://www.google.com/patents/US20090209595",CCCN(c1ccncc1F)n2cc(C)c3ccccc23,,
1896,CHEMBL1738889,Enobosarm,Small molecule,,,,-sarm,Androgen Receptor modulator,SARM,,CHEMBL1871,Androgen Receptor,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.gtxinc.com/Pipeline/OstarineMK2866.aspx?Sid=4, URL:http://www.gtxinc.com/Pipeline/OstarineMK2866.aspx?Sid=4|Name:Wikipedia, SrcID:Enobosarm, URL:http://en.wikipedia.org/wiki/Enobosarm|Name:PubMed, SrcID:24189892, URL:http://europepmc.org/abstract/MED/24189892",C[C@](O)(COc1ccc(cc1)C#N)C(=O)Nc2ccc(C#N)c(c2)C(F)(F)F,CHEMBL1871,AR
1897,CHEMBL1908391,Masitinib,Small molecule,,L01XE22,L01XE22 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Stem cell growth factor receptor inhibitor,"Approved veterinary - 2012. Not recommended for approval (Negative opinion) in EU, phase 3 trials in US.",,CHEMBL1936,Stem cell growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19789626, URL:http://europepmc.org/abstract/MED/19789626|Name:PubMed, SrcID:19541476, URL:http://europepmc.org/abstract/MED/19541476|Name:Other, SrcID:http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/veterinary/000128/WC500064717.pdf, URL:http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/veterinary/000128/WC500064717.pdf",CN1CCN(Cc2ccc(cc2)C(=O)Nc3ccc(C)c(Nc4nc(cs4)c5cccnc5)c3)CC1,CHEMBL1936,KIT
1898,CHEMBL276711,Semaxanib,Small molecule,,,,-anib,Vascular endothelial growth factor receptor inhibitor,,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:11222388, URL:http://europepmc.org/abstract/MED/11222388|Name:PubMed, SrcID:9892193, URL:http://europepmc.org/abstract/MED/9892193",Cc1cc(C)c(\C=C\2/C(=O)Nc3ccccc23)[nH]1,,
1899,CHEMBL1672054,Casopitant,Small molecule,,A04AD13,A04AD13 [ALIMENTARY TRACT AND METABOLISM: ANTIEMETICS AND ANTINAUSEANTS: ANTIEMETICS AND ANTINAUSEANTS: Other antiemetics],-tant,Neurokinin 1 receptor antagonist,"Filing withdrawn, development halted.",,CHEMBL249,Neurokinin 1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19536319, URL:http://europepmc.org/abstract/MED/19536319|Name:PubMed, SrcID:18556439, URL:http://europepmc.org/abstract/MED/18556439",C[C@@H](N(C)C(=O)N1CC[C@@H](C[C@@H]1c2ccc(F)cc2C)N3CCN(CC3)C(=O)C)c4cc(cc(c4)C(F)(F)F)C(F)(F)F,CHEMBL249,TACR1
1900,CHEMBL1193948,Amibegron,Small molecule,,,,-begron,Beta-3 adrenergic receptor agonist,,,CHEMBL246,Beta-3 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19744528, URL:http://europepmc.org/abstract/MED/19744528",CCOC(=O)COc1ccc2CC[C@@H](Cc2c1)NC[C@H](O)c3cccc(Cl)c3,CHEMBL246,ADRB3
1901,CHEMBL2108572,Balugrastim,Protein,,L03AA15,L03AA15 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSTIMULANTS: IMMUNOSTIMULANTS: Colony stimulating factors],-stim,Granulocyte colony stimulating factor receptor agonist,Long-acting granulocyte colony-stimulating factor (G-CSF) composed of a genetic fusion between recombinant human serum albumin and G-CSF.,,CHEMBL1996,Granulocyte colony stimulating factor receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24485296, URL:http://europepmc.org/abstract/MED/24485296",,CHEMBL1996,CSF3R
1902,CHEMBL459505,Talarozole,Small molecule,,,,-rozole,Cytochrome P450 26A1 inhibitor,,,CHEMBL5141,Cytochrome P450 26A1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18951302, URL:http://europepmc.org/abstract/MED/18951302|Name:PubMed, SrcID:19016711, URL:http://europepmc.org/abstract/MED/19016711",CCC(CC)C(c1ccc(Nc2nc3ccccc3s2)cc1)n4cncn4,CHEMBL5141,CYP26A1
1903,CHEMBL3137320,Talazoparib,Small molecule,,,,-parib,Poly [ADP-ribose] polymerase 2 inhibitor,,,CHEMBL5366,Poly [ADP-ribose] polymerase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23881923, URL:http://europepmc.org/abstract/MED/23881923",Cn1ncnc1[C@@H]2[C@H](Nc3cc(F)cc4C(=O)NN=C2c34)c5ccc(F)cc5,CHEMBL5366,PARP2
1904,CHEMBL848,Lenalidomide,Small molecule,2005.0,L04AX04,L04AX04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Other immunosuppressants],,CRL4(CRBN) E3 ubiquitin ligase inhibitor,,,CHEMBL3833061,CRL4(CRBN) E3 ubiquitin ligase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,Cereblon,"Name:PubMed, SrcID:22552008, URL:http://europepmc.org/abstract/MED/22552008|Name:PubMed, SrcID:25043012, URL:http://europepmc.org/abstract/MED/25043012",Nc1cccc2C(=O)N(Cc12)C3CCC(=O)NC3=O,CHEMBL3833061,DDB1
1905,CHEMBL848,Lenalidomide,Small molecule,2005.0,L04AX04,L04AX04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Other immunosuppressants],,CRL4(CRBN) E3 ubiquitin ligase inhibitor,,,CHEMBL3833061,CRL4(CRBN) E3 ubiquitin ligase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,Cereblon,"Name:PubMed, SrcID:22552008, URL:http://europepmc.org/abstract/MED/22552008|Name:PubMed, SrcID:25043012, URL:http://europepmc.org/abstract/MED/25043012",Nc1cccc2C(=O)N(Cc12)C3CCC(=O)NC3=O,CHEMBL3833061,CUL4A
1906,CHEMBL848,Lenalidomide,Small molecule,2005.0,L04AX04,L04AX04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Other immunosuppressants],,CRL4(CRBN) E3 ubiquitin ligase inhibitor,,,CHEMBL3833061,CRL4(CRBN) E3 ubiquitin ligase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,Cereblon,"Name:PubMed, SrcID:22552008, URL:http://europepmc.org/abstract/MED/22552008|Name:PubMed, SrcID:25043012, URL:http://europepmc.org/abstract/MED/25043012",Nc1cccc2C(=O)N(Cc12)C3CCC(=O)NC3=O,CHEMBL3833061,RBX1
1907,CHEMBL2109637,Huhmfg1,Antibody,,,,,Mucin-1 other,Antibody-dependent cell-mediated cytotoxicity (ADCC).,,CHEMBL3580494,Mucin-1,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:1391628, URL:http://europepmc.org/abstract/MED/1391628|Name:PubMed, SrcID:8050089, URL:http://europepmc.org/abstract/MED/8050089",,,
1908,CHEMBL2108568,Trebananib,Protein,,,,-anib,Angiopoietin-1 inhibitor,Inhibits the interaction between the ligands angiopoietin-1 and angiopoietin-2 with the Tie-2 receptor.,,CHEMBL3217395,Angiopoietin-1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20677100, URL:http://europepmc.org/abstract/MED/20677100",,CHEMBL3217395,ANGPT1
1909,CHEMBL2107890,Taplitumomab Paptox,Antibody,,,,-mab,B-lymphocyte antigen CD19 binding agent,"CD19 is constitutively associated with P-glycoprotein (P-gp). Disruption of this association impairs the drug efflux function of P-gp. Taplitumomab (B43) is linked to the protein PAP, an antiviral from Phytolacca americana which is a ribosome inhibitory hemitoxin. Binding of B43 to CD19, disrupts the association between P-gp and CD19 and the P-gp efflux function is blocked. The PAP toxin moiety is then internalised, irreversibly inhibiting protein synthesis, leading to cellular apoptosis.",High affinity,CHEMBL3390821,B-lymphocyte antigen CD19,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:1375109, URL:http://europepmc.org/abstract/MED/1375109|Name:PubMed, SrcID:1705571, URL:http://europepmc.org/abstract/MED/1705571|Name:PubMed, SrcID:26261894, URL:http://europepmc.org/abstract/MED/26261894|Name:PubMed, SrcID:3511171, URL:http://europepmc.org/abstract/MED/3511171|Name:PubMed, SrcID:7492781, URL:http://europepmc.org/abstract/MED/7492781",,CHEMBL3390821,CD19
1910,CHEMBL2108045,Pritumumab,Antibody,,,,-mab,Vimentin other,"Antibody dependent cell-mediated cytotoxicity, Complement Dependent Cytotoxicity, Natural Killer Cell-induction.",Affinity of pritumumab for its antigen (expressed on U-251MG cell-line) is 4.5×10?7 M,CHEMBL3712854,Vimentin,OTHER,Homo sapiens,SINGLE PROTEIN,,Reactive epitope is located in the c2 (coil 2 of the central rod) domain of vimentin.,"Name:PubMed, SrcID:19996527, URL:http://europepmc.org/abstract/MED/19996527|Name:PubMed, SrcID:11673662, URL:http://europepmc.org/abstract/MED/11673662",,CHEMBL3712854,VIM
1911,CHEMBL2108679,Ozanezumab,Antibody,,,,-mab,Reticulon-4 inhibitor,,,CHEMBL3712895,Reticulon-4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24841795, URL:http://europepmc.org/abstract/MED/24841795",,CHEMBL3712895,RTN4
1912,CHEMBL2108785,Zolimomab Aritox,Antibody,,,,-mab,T-cell surface glycoprotein CD5 binding agent,Immunotoxin.,,CHEMBL3712888,T-cell surface glycoprotein CD5,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:2013915, URL:http://europepmc.org/abstract/MED/2013915",,CHEMBL3712888,CD5
1913,CHEMBL2109617,Humax-Il8,Antibody,,,,,Interleukin-8 inhibitor,,,CHEMBL2157,Interleukin-8,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=777250, URL:https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=777250",,CHEMBL2157,CXCL8
1914,CHEMBL182066,Radiprodil,Small molecule,,,,-dil,Glutamate NMDA receptor; GRIN1/GRIN2B antagonist,"Non-competitive antagonist, negative modulator.",GRIN2B selective.,CHEMBL1907603,Glutamate NMDA receptor; GRIN1/GRIN2B,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX,,Binds to ifenprodil site on N-terminal domain.,,Fc1ccc(CC2CCN(CC2)C(=O)C(=O)Nc3ccc4NC(=O)Oc4c3)cc1,,
1915,CHEMBL965,Carbachol,Small molecule,1972.0,,,,Muscarinic acetylcholine receptor M3 agonist,"Indicated for miosis, M3 likely involved (main form in iris)",,CHEMBL245,Muscarinic acetylcholine receptor M3,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:7065943, URL:http://europepmc.org/abstract/MED/7065943|Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:Wikipedia, SrcID:Carbachol, URL:http://en.wikipedia.org/wiki/Carbachol|Name:PubMed, SrcID:12628451, URL:http://europepmc.org/abstract/MED/12628451",C[N+](C)(C)CCOC(=O)N,CHEMBL245,CHRM3
1916,CHEMBL1201666,Lepirudin,Protein,1998.0,B01AE02,B01AE02 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Direct thrombin inhibitors],-irudin,Thrombin inhibitor,,,CHEMBL204,Thrombin,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=6d4819a3-b934-40a8-a967-947cc456c53c, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d4819a3-b934-40a8-a967-947cc456c53c|Name:FDA, SrcID:label/2006/020807s011lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020807s011lbl.pdf",,CHEMBL204,F2
1917,CHEMBL998,Loratadine,Small molecule,1993.0,R06AX13,R06AX13 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Other antihistamines for systemic use],-(a)tadine,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:2568212, URL:http://europepmc.org/abstract/MED/2568212",CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc4cccnc24)CC1,CHEMBL231,HRH1
1918,CHEMBL90,Histamine,Small molecule,1939.0,,,,Histamine H1 receptor agonist,Positive control for allegy test,,CHEMBL231,Histamine H1 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=1159c24c-d9ce-49a2-b0bd-dc27c710f146, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1159c24c-d9ce-49a2-b0bd-dc27c710f146",NCCc1c[nH]cn1,CHEMBL231,HRH1
1919,CHEMBL1201464,Choriogonadotropin Alfa,Protein,2000.0,G03GA08,G03GA08 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: GONADOTROPINS AND OTHER OVULATION STIMULANTS: Gonadotropins],,Luteinizing hormone/Choriogonadotropin receptor agonist,,,CHEMBL1854,Luteinizing hormone/Choriogonadotropin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=a683e58a-63ea-44b8-a326-1a99a537bcf2, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a683e58a-63ea-44b8-a326-1a99a537bcf2",,CHEMBL1854,LHCGR
1920,CHEMBL517712,Atropine,Small molecule,1960.0,A03BA01; S01FA01,"A03BA01 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: BELLADONNA AND DERIVATIVES, PLAIN: Belladonna alkaloids, tertiary amines]; S01FA01 [SENSORY ORGANS: OPHTHALMOLOGICALS: MYDRIATICS AND CYCLOPLEGICS: Anticholinergics]",-trop-,Muscarinic acetylcholine receptor M1 antagonist,"Role in regulating gastric secretion, M1 likely involved",,CHEMBL216,Muscarinic acetylcholine receptor M1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 159, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:FDA, SrcID:label/2004/17106s032lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/17106s032lbl.pdf|Name:Wikipedia, SrcID:Atropine, URL:http://en.wikipedia.org/wiki/Atropine",CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(=O)C(CO)c3ccccc3,CHEMBL216,CHRM1
1921,CHEMBL768,Esmolol,Small molecule,1986.0,C07AB09,"C07AB09 [CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, selective]",-olol,Beta-1 adrenergic receptor antagonist,,,CHEMBL213,Beta-1 adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=fdc9cea8-0eb4-4930-9e1c-d44bfa9346d2, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fdc9cea8-0eb4-4930-9e1c-d44bfa9346d2",COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1,,
1922,CHEMBL490,Paroxetine,Small molecule,1992.0,N06AB05,N06AB05 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Selective serotonin reuptake inhibitors],-oxetine,Serotonin transporter inhibitor,reuptake inhibitor,,CHEMBL228,Serotonin transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=d8a896c2-b0c2-4b44-a4e3-cb6a8ea472ee#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d8a896c2-b0c2-4b44-a4e3-cb6a8ea472ee#nlm34090-1",Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc3ccc4OCOc4c3,CHEMBL228,SLC6A4
1923,CHEMBL422,Trifluoperazine,Small molecule,1959.0,N05AB06,N05AB06 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Phenothiazines with piperazine structure],,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Trifluoperazine, URL:http://en.wikipedia.org/wiki/Trifluoperazine|Name:ISBN, SrcID:0443-059748 PP. 544, URL:http://www.isbnsearch.org/isbn/0443059748",CN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1,CHEMBL224,HTR2A
1924,CHEMBL1489,Azacitidine,Small molecule,2004.0,L01BC07,L01BC07 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Pyrimidine analogues],-tidine,DNA (cytosine-5)-methyltransferase 1 inhibitor,,,CHEMBL1993,DNA (cytosine-5)-methyltransferase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Azacitidine, URL:http://en.wikipedia.org/wiki/Azacitidine|Name:DailyMed, SrcID:setid=3495a71a-cc04-4776-851f-f185956f32af#section-12, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3495a71a-cc04-4776-851f-f185956f32af#section-12|Name:Wikipedia, SrcID:DNA_methylation, URL:http://en.wikipedia.org/wiki/DNA_methylation",NC1=NC(=O)N(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O,CHEMBL1993,DNMT1
1925,CHEMBL1200865,Loteprednol Etabonate,Small molecule,1998.0,S01BA14,"S01BA14 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Corticosteroids, plain]",-pred-,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15684812, URL:http://europepmc.org/abstract/MED/15684812|Name:PubMed, SrcID:17020532, URL:http://europepmc.org/abstract/MED/17020532|Name:PubMed, SrcID:12861354, URL:http://europepmc.org/abstract/MED/12861354",CCOC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)OCCl,CHEMBL2034,NR3C1
1926,CHEMBL1201258,Pemetrexed,Small molecule,2004.0,L01BA04,L01BA04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Folic acid analogues],-trexed,Dihydrofolate reductase inhibitor,,,CHEMBL202,Dihydrofolate reductase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f5a860f3-37ec-429c-ae04-9c88d7c55c08#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5a860f3-37ec-429c-ae04-9c88d7c55c08#section-13",NC1=Nc2[nH]cc(CCc3ccc(cc3)C(=O)N[C@H](CCC(=O)O)C(=O)O)c2C(=O)N1,CHEMBL202,DHFR
1927,CHEMBL61006,Phenylpropanolamine,Small molecule,1958.0,R01BA51; R01BA01,R01BA51 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: NASAL DECONGESTANTS FOR SYSTEMIC USE: Sympathomimetics]; R01BA01 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: NASAL DECONGESTANTS FOR SYSTEMIC USE: Sympathomimetics],,Norepinephrine transporter releasing agent,,,CHEMBL222,Norepinephrine transporter,RELEASING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Adrenergic_receptor, URL:http://en.wikipedia.org/wiki/Adrenergic_receptor|Name:Wikipedia, SrcID:Phenylpropanolamine, URL:http://en.wikipedia.org/wiki/Phenylpropanolamine|Name:Wikipedia, SrcID:Adrenergic_agonist, URL:http://en.wikipedia.org/wiki/Adrenergic_agonist|Name:PubMed, SrcID:19948186, URL:http://europepmc.org/abstract/MED/19948186|Name:Wikipedia, SrcID:Decongestant, URL:http://en.wikipedia.org/wiki/Decongestant",CC(N)C(O)c1ccccc1,CHEMBL222,SLC6A2
1928,CHEMBL254316,Raltegravir,Small molecule,2007.0,J05AX08,J05AX08 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Other antivirals],-vir,Human immunodeficiency virus type 1 integrase inhibitor,,,CHEMBL3471,Human immunodeficiency virus type 1 integrase,INHIBITOR,Human immunodeficiency virus 1,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=89a5ec53-d956-4329-8004-0f40f51c88a3, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=89a5ec53-d956-4329-8004-0f40f51c88a3",CN1C(=O)C(=C(N=C1C(C)(C)NC(=O)c2oc(C)nn2)C(=O)NCc3ccc(F)cc3)O,,
1929,CHEMBL1094,Felbamate,Small molecule,1993.0,N03AX10,N03AX10 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],-bamate,Glutamate [NMDA] receptor antagonist,,,CHEMBL2094124,Glutamate [NMDA] receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:ISBN, SrcID:0-12-184450-1, URL:http://www.isbnsearch.org/isbn/0121844501|Name:FDA, SrcID:label/2012/020189s027lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020189s027lbl.pdf|Name:PubMed, SrcID:10215667, URL:http://europepmc.org/abstract/MED/10215667",NC(=O)OCC(COC(=O)N)c1ccccc1,CHEMBL2094124,GRIN3B
1930,CHEMBL1215,Phenylephrine,Small molecule,1952.0,S01FB01; R01BA03; C01CA06; R01BA53; S01GA05; R01AA04; S01GA55; R01AB01,"S01FB01 [SENSORY ORGANS: OPHTHALMOLOGICALS: MYDRIATICS AND CYCLOPLEGICS: Sympathomimetics excl. antiglaucoma preparations]; R01BA03 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: NASAL DECONGESTANTS FOR SYSTEMIC USE: Sympathomimetics]; C01CA06 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES: Adrenergic and dopaminergic agents]; R01BA53 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: NASAL DECONGESTANTS FOR SYSTEMIC USE: Sympathomimetics]; S01GA05 [SENSORY ORGANS: OPHTHALMOLOGICALS: DECONGESTANTS AND ANTIALLERGICS: Sympathomimetics used as decongestants]; R01AA04 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Sympathomimetics, plain]; S01GA55 [SENSORY ORGANS: OPHTHALMOLOGICALS: DECONGESTANTS AND ANTIALLERGICS: Sympathomimetics used as decongestants]; R01AB01 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Sympathomimetics, combinations excl. corticosteroids]",,Adrenergic receptor alpha-1 agonist,,,CHEMBL2094251,Adrenergic receptor alpha-1,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:ISBN, SrcID:9780702034718 PP. 176, URL:http://www.isbnsearch.org/isbn/9780702034718",CNC[C@H](O)c1cccc(O)c1,,
1931,CHEMBL1481,Glimepiride,Small molecule,1995.0,A10BB12,"A10BB12 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Sulfonylureas]",gli-,"Sulfonylurea receptor 1, Kir6.2 blocker",,,CHEMBL2096972,"Sulfonylurea receptor 1, Kir6.2",BLOCKER,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:8172912, URL:http://europepmc.org/abstract/MED/8172912|Name:PubMed, SrcID:8529521, URL:http://europepmc.org/abstract/MED/8529521|Name:PubMed, SrcID:8911984, URL:http://europepmc.org/abstract/MED/8911984|Name:DailyMed, SrcID:setid=222b630b-7e09-43b4-9894-3d87f10add91, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=222b630b-7e09-43b4-9894-3d87f10add91",CCC1=C(C)CN(C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@@H]3CC[C@@H](C)CC3)C1=O,,
1932,CHEMBL891,Cloxacillin,Small molecule,1974.0,J01CF02,"J01CF02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: BETA-LACTAM ANTIBACTERIALS, PENICILLINS: Beta-lactamase resistant penicillins]",-cillin,Penicillin-binding protein inhibitor,Indicated for staphylococcal infections,,CHEMBL2363021,Penicillin-binding protein,INHIBITOR,Staphylococcus,PROTEIN FAMILY,,,"Name:ISBN, SrcID:0-86577-843-4 PP. 270, URL:http://www.isbnsearch.org/isbn/0865778434|Name:Wikipedia, SrcID:DD-transpeptidase, URL:http://en.wikipedia.org/wiki/DD-transpeptidase|Name:Wikipedia, SrcID:Cloxacillin, URL:http://en.wikipedia.org/wiki/Cloxacillin|Name:PubMed, SrcID:15631796, URL:http://europepmc.org/abstract/MED/15631796",Cc1onc(c2ccccc2Cl)c1C(=O)N[C@H]3[C@H]4SC(C)(C)[C@@H](N4C3=O)C(=O)O,,
1933,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Collagen hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364188,COL6A1
1934,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Collagen hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364188,COL6A2
1935,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Collagen hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364188,COL4A4
1936,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Collagen hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364188,COL4A3
1937,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Collagen hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364188,COL4A6
1938,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Collagen hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364188,COL11A2
1939,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Collagen hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364188,COL4A5
1940,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Collagen hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364188,COL3A1
1941,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Collagen hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364188,COL5A2
1942,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Collagen hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364188,COL27A1
1943,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Collagen hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364188,COL2A1
1944,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Collagen hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364188,COL15A1
1945,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Collagen hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364188,COL28A1
1946,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Collagen hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364188,COL5A1
1947,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Collagen hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364188,COL11A1
1948,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Collagen hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364188,COL6A5
1949,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Collagen hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364188,COL6A6
1950,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Collagen hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364188,COL24A1
1951,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Collagen hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364188,COL5A3
1952,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Collagen hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364188,COL18A1
1953,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Collagen hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364188,COL4A2
1954,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Collagen hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364188,COL6A3
1955,CHEMBL625,Thiabendazole,Small molecule,1967.0,P02CA02; D01AC06,"P02CA02 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTHELMINTICS: ANTINEMATODAL AGENTS: Benzimidazole derivatives]; D01AC06 [DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Imidazole and triazole derivatives]",-bendazole,Tubulin inhibitor,,,CHEMBL2364705,Tubulin,INHIBITOR,Nematoda,PROTEIN COMPLEX GROUP,Beta tubulin,Binds to beta tubulin,"Name:ISBN, SrcID:0443-059748 PP. 740, URL:http://www.isbnsearch.org/isbn/0443059748|Name:PubMed, SrcID:22927795, URL:http://europepmc.org/abstract/MED/22927795|Name:ISBN, SrcID:9780702034718 PP. 669, URL:http://www.isbnsearch.org/isbn/9780702034718",c1ccc2[nH]c(nc2c1)c3cscn3,,
1956,CHEMBL1727,Cephalexin,Small molecule,1971.0,J01DB01,J01DB01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: First-generation cephalosporins],,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:PubMed, SrcID:7447421, URL:http://europepmc.org/abstract/MED/7447421",CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c3ccccc3)C2=O)C(=O)O,,
1957,CHEMBL1214,Carbenicillin,Small molecule,1982.0,J01CA03,"J01CA03 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: BETA-LACTAM ANTIBACTERIALS, PENICILLINS: Penicillins with extended spectrum]",-cillin,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:PubMed, SrcID:2112536, URL:http://europepmc.org/abstract/MED/2112536",CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)O)c3ccccc3)C(=O)N2[C@H]1C(=O)O,,
1958,CHEMBL177,Amikacin,Small molecule,1981.0,J01GB06; S01AA21; D06AX12,J01GB06 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: AMINOGLYCOSIDE ANTIBACTERIALS: Other aminoglycosides]; S01AA21 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Antibiotics]; D06AX12 [DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: ANTIBIOTICS FOR TOPICAL USE: Other antibiotics for topical use],-kacin,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,16S ribosomal RNA,16s RRNA,"Name:PubMed, SrcID:17875999, URL:http://europepmc.org/abstract/MED/17875999|Name:PubMed, SrcID:10702385, URL:http://europepmc.org/abstract/MED/10702385",NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O,,
1959,CHEMBL1200647,Candicidin,Small molecule,1982.0,G01AA04,"G01AA04 [GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Antibiotics]",-cidin,Cell membrane inhibitor,"Disrupts bacterial membrane, promotes potassium outflux",,CHEMBL2364035,Cell membrane,INHIBITOR,Candida albicans,SUBCELLULAR,,,"Name:PubMed, SrcID:773298, URL:http://europepmc.org/abstract/MED/773298",CC(CC(C)C1OC(=O)CC(=O)CCCC(=O)CC(O)CC(O)CC(O)CC(=O)CC(O)C(C(O)CC(OC2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\C1C)C(=O)O)C(O)CC(=O)c3ccc(N)cc3,,
1960,CHEMBL409542,Retapamulin,Small molecule,2007.0,D06AX13,D06AX13 [DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: ANTIBIOTICS FOR TOPICAL USE: Other antibiotics for topical use],-mulin,70S ribosome inhibitor,Indicated for staph aur and strep pyogenes.,,CHEMBL2364103,70S ribosome,INHIBITOR,Streptococcus pyogenes,PROTEIN NUCLEIC-ACID COMPLEX,50S ribosomal protein L3,Binding site is 50S ribosomal protein L3,"Name:DailyMed, SrcID:setid=7acc17e7-7041-46bf-f2b2-a615cbf99da6, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7acc17e7-7041-46bf-f2b2-a615cbf99da6|Name:FDA, SrcID:label/2012/022055s002lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022055s002lbl.pdf",C[C@@H]1CC[C@@]23CCC(=O)[C@H]2[C@]1(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]3C)OC(=O)CSC4CC5CCC(C4)N5C,,
1961,CHEMBL1351,Carboplatin,Small molecule,1989.0,L01XA02,L01XA02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Platinum compounds],-platin,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=ac07712c-87c0-4351-a4f4-04064b410409, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ac07712c-87c0-4351-a4f4-04064b410409|Name:FDA, SrcID:label/2012/077139Orig1s016lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/077139Orig1s016lbl.pdf",,,
1962,CHEMBL1257,Enflurane,Small molecule,1972.0,N01AB04,"N01AB04 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,Potassium channel subfamily K member 2 opener,,,CHEMBL2321615,Potassium channel subfamily K member 2,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:16973644, URL:http://europepmc.org/abstract/MED/16973644|Name:PubMed, SrcID:17227289, URL:http://europepmc.org/abstract/MED/17227289",FC(F)OC(F)(F)C(F)Cl,CHEMBL2321615,KCNK2
1963,CHEMBL1201492,Sevelamer Hydrochloride,Small molecule,1998.0,,,-mer,Phosphate sequestering agent,It's a non-absorbed binding crosslinked polymer which binds to phosphate and removes it from circulation in case of hyperphosphatemia,,CHEMBL2364184,Phosphate,SEQUESTERING AGENT,Homo sapiens,SMALL MOLECULE,,,"Name:DailyMed, SrcID:setid=aa991f60-7c13-49ec-862b-47cca4db3c44, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aa991f60-7c13-49ec-862b-47cca4db3c44",,,
1964,CHEMBL1201507,Glatiramer Acetate,Small molecule,1996.0,L03AX13,L03AX13 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSTIMULANTS: IMMUNOSTIMULANTS: Other immunostimulants],-mer,Unknown,Contains components of myelin basic protein and may act as a decoy for the immune response,,,,,,,,,"Name:DailyMed, SrcID:setid=aa88f583-4f5f-433b-80b4-1f4c9fb28357, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aa88f583-4f5f-433b-80b4-1f4c9fb28357|Name:PubMed, SrcID:20038760, URL:http://europepmc.org/abstract/MED/20038760",,,
1965,CHEMBL373742,Vasopressin,Protein,2014.0,H01BA01,"H01BA01 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: POSTERIOR PITUITARY LOBE HORMONES: Vasopressin and analogues]",-pressin,Vasopressin receptor agonist,,,CHEMBL2363078,Vasopressin receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:IUPHAR, SrcID:2168, URL:http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2168",N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc3ccc(O)cc3)NC1=O)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N,,
1966,CHEMBL483254,Panobinostat,Small molecule,2015.0,L01XX42,L01XX42 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-stat,Histone deacetylase inhibitor,,,CHEMBL2093865,Histone deacetylase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2015/205353s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf",Cc1[nH]c2ccccc2c1CCNCc3ccc(\C=C\C(=O)NO)cc3,,
1967,CHEMBL3545173,Irx4310,Small molecule,,,,,Retinoic acid receptor antagonist,,,CHEMBL2363069,Retinoic acid receptor,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://www.nature.com/scibx/journal/v6/n47/pdf/scibx.2013.1353.pdf?WT.ec_id=SCIBX-20131212, URL:http://www.nature.com/scibx/journal/v6/n47/pdf/scibx.2013.1353.pdf?WT.ec_id=SCIBX-20131212",,,
1968,CHEMBL3545296,Arq-736,Small molecule,,,,,Serine/threonine-protein kinase B-raf inhibitor,,,CHEMBL5145,Serine/threonine-protein kinase B-raf,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=688029, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=688029|Name:DOI, SrcID:10.1158/1538-7445.AM10-2517, URL:http://cancerres.aacrjournals.org/content/70/8_Supplement/2517|Name:PubMed, SrcID:23617957, URL:http://europepmc.org/abstract/MED/23617957",,CHEMBL5145,BRAF
1969,CHEMBL3545134,Ly-2780301,Small molecule,,,,,Serine/threonine-protein kinase AKT inhibitor,,,CHEMBL2111353,Serine/threonine-protein kinase AKT,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://www.lillyoncologypipeline.com/p70s6-kinase-akt-dual-inhibitor.aspx, URL:http://www.lillyoncologypipeline.com/p70s6-kinase-akt-dual-inhibitor.aspx|Name:PubMed, SrcID:25902900, URL:http://europepmc.org/abstract/MED/25902900",,,
1970,CHEMBL3545140,Qc-12,Small molecule,,,,,Unknown,,,,,,,,,,"Name:PubMed, SrcID:26393898, URL:http://europepmc.org/abstract/MED/26393898|Name:PubMed, SrcID:11300332, URL:http://europepmc.org/abstract/MED/11300332",,,
1971,CHEMBL3545083,Rgb-286638,Small molecule,,,,,Cyclin-dependent kinase 2 inhibitor,,,CHEMBL301,Cyclin-dependent kinase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23807770, URL:http://europepmc.org/abstract/MED/23807770",COCCN1CCN(Cc2ccc(cc2)c3n[nH]c4c5cccc(NC(=O)NN6CCOCC6)c5C(=O)c34)CC1,CHEMBL301,CDK2
1972,CHEMBL2386889,Sch-900776,Small molecule,,,,,Serine/threonine-protein kinase Chk1 inhibitor,,,CHEMBL4630,Serine/threonine-protein kinase Chk1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21321066, URL:http://europepmc.org/abstract/MED/21321066",Cn1cc(cn1)c2cnn3c(N)c(Br)c(nc23)[C@@H]4CCCNC4,CHEMBL4630,CHEK1
1973,CHEMBL440115,Fk453,Small molecule,,,,,Adenosine A1 receptor antagonist,,,CHEMBL226,Adenosine A1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1111/j.1527-3466.1997.tb00323.x, URL:http://onlinelibrary.wiley.com/doi/10.1111/j.1527-3466.1997.tb00323.x/abstract;jsessionid=50C0F7C570433FE594D46A59610DA114.f01t01|Name:PubMed, SrcID:16654164, URL:http://www.ncbi.nlm.nih.gov/pubmed/?term=16654164",OCC[C@H]1CCCCN1C(=O)\C=C\c2c(nn3ccccc23)c4ccccc4,CHEMBL226,ADORA1
1974,CHEMBL3545354,Cafusertib,Small molecule,,,,-sertib,Serine/threonine-protein kinase PLK1 inhibitor,No assay data or further target information found,,CHEMBL3024,Serine/threonine-protein kinase PLK1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://adisinsight.springer.com/drugs/800040745, URL:http://adisinsight.springer.com/drugs/800040745",,CHEMBL3024,PLK1
1975,CHEMBL29919,Elpetrigine,Small molecule,,,,,Voltage-gated N-type calcium channel alpha-1B subunit blocker,,,CHEMBL4478,Voltage-gated N-type calcium channel alpha-1B subunit,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18377968, URL:http://europepmc.org/abstract/MED/18377968|Name:PubMed, SrcID:19008076, URL:http://europepmc.org/abstract/MED/19008076",Nc1cnc(c(N)n1)c2cc(Cl)cc(Cl)c2Cl,CHEMBL4478,CACNA1B
1976,CHEMBL3545021,Anlotinib,Small molecule,,,,-tinib,Stem cell growth factor receptor inhibitor,Multi-targeted receptor tyrosine kinase inhibitor,,CHEMBL1936,Stem cell growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:ClinicalTrials, SrcID:NCT01924195, URL:https://www.clinicaltrials.gov/ct2/show/NCT01924195|Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=749736, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=749736",,CHEMBL1936,KIT
1977,CHEMBL495727,At-9283,Small molecule,,,,,Serine/threonine-protein kinase Aurora-B inhibitor,,,CHEMBL2185,Serine/threonine-protein kinase Aurora-B,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19143567, URL:http://europepmc.org/abstract/MED/19143567|Name:PubMed, SrcID:20507304, URL:http://europepmc.org/abstract/MED/20507304",O=C(NC1CC1)Nc2c[nH]nc2c3nc4cc(CN5CCOCC5)ccc4[nH]3,CHEMBL2185,AURKB
1978,CHEMBL254760,Mgcd-265,Small molecule,,,,,Hepatocyte growth factor receptor inhibitor,,,CHEMBL3717,Hepatocyte growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://meetinglibrary.asco.org/content/96526-114, URL:http://meetinglibrary.asco.org/content/96526-114|Name:PubMed, SrcID:25806189, URL:http://europepmc.org/abstract/MED/25806189",Cn1cnc(c1)c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2,CHEMBL3717,MET
1979,CHEMBL574737,(7s)-Hydroxyl-Staurosporine,Small molecule,,,,,Cyclin-dependent kinase 6 inhibitor,,,CHEMBL2508,Cyclin-dependent kinase 6,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7907, URL:http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7907|Name:PubMed, SrcID:12892559, URL:http://europepmc.org/abstract/MED/12892559|Name:PubMed, SrcID:19568282, URL:http://europepmc.org/abstract/MED/19568282",CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n3c4ccccc4c5c6[C@H](O)NC(=O)c6c7c8ccccc8n2c7c35,CHEMBL2508,CDK6
1980,CHEMBL447664,Vipadenant,Small molecule,,,,-denant,Adenosine A2a receptor antagonist,"Decvelopment of compound against Parkinson's discontinued but Vernalis has outlicensed the compound to Redox Therapies for use in immuno-oncology. Also high potency at ADORA2B, ADORA1A and ADORA3",,CHEMBL251,Adenosine A2a receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19072055, URL:http://europepmc.org/abstract/MED/19072055|Name:PubMed, SrcID:9279378, URL:http://europepmc.org/abstract/MED/9279378",Cc1cc(Cn2nnc3c(nc(N)nc23)c4occc4)ccc1N,CHEMBL251,ADORA2A
1981,CHEMBL2107647,Lanicemine,Small molecule,,,,,Glutamate [NMDA] receptor blocker,"Non-selective, open-channel blocker.",,CHEMBL2094124,Glutamate [NMDA] receptor,BLOCKER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:23455590, URL:http://europepmc.org/abstract/MED/23455590|Name:Other, SrcID:http://openinnovation.astrazeneca.com/what-we-offer/compound/lanicemine-azd6765/, URL:http://openinnovation.astrazeneca.com/what-we-offer/compound/lanicemine-azd6765/|Name:Wikipedia, SrcID:Lanicemine, URL:http://en.wikipedia.org/wiki/Lanicemine",NC(Cc1ccccn1)c2ccccc2,CHEMBL2094124,GRIN3B
1982,CHEMBL426559,Laropiprant,Small molecule,,,,-piprant,Prostanoid DP receptor antagonist,"Laropiprant was in Ph4 in combination with niacin to reduce blood cholesterol but drug was withdrawn due to adverse effects out weighing benefits. Laropiprant itself has no cholesterol lowering effect, but it reduces facial flushes induced by niacin (https://en.wikipedia.org/wiki/Laropiprant). Indication: Rosacea, Seasonal Allergies",,CHEMBL4427,Prostanoid DP receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16617107, URL:http://europepmc.org/abstract/MED/16617107|Name:Other, SrcID:http://ec.europa.eu/health/documents/community-register/2008/2008070346389/anx_46389_en.pdf, URL:http://ec.europa.eu/health/documents/community-register/2008/2008070346389/anx_46389_en.pdf",CS(=O)(=O)c1cc(F)cc2c3CC[C@H](CC(=O)O)c3n(Cc4ccc(Cl)cc4)c12,CHEMBL4427,PTGDR
1983,CHEMBL576982,Quizartinib,Small molecule,,,,-tinib,Stem cell growth factor receptor inhibitor,,,CHEMBL1936,Stem cell growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23497317, URL:http://europepmc.org/abstract/MED/23497317|Name:PubMed, SrcID:19654408, URL:http://europepmc.org/abstract/MED/19654408",CC(C)(C)c1onc(NC(=O)Nc2ccc(cc2)c3cn4c5ccc(OCCN6CCOCC6)cc5sc4n3)c1,CHEMBL1936,KIT
1984,CHEMBL2110730,Pomaglumetad Methionil,Small molecule,,,,,Metabotropic glutamate receptor 2 agonist,"Inactive prodrug of LY404039. Eli Lilly Discontinueddevelopment, a Ph1 study sponsored by New York University School of Medicine is recruiting patients.",,CHEMBL5137,Metabotropic glutamate receptor 2,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17204749, URL:http://europepmc.org/abstract/MED/17204749|Name:PubMed, SrcID:20571979, URL:http://europepmc.org/abstract/MED/20571979",CSCC[C@H](N)C(=O)N[C@]1(CS(=O)(=O)[C@H]2[C@@H]([C@@H]12)C(=O)O)C(=O)O,CHEMBL5137,GRM2
1985,CHEMBL2110730,Pomaglumetad Methionil,Small molecule,,,,,Metabotropic glutamate receptor 3 agonist,"Inactive prodrug of LY404039. Eli Lilly Discontinueddevelopment, a Ph1 study sponsored by New York University School of Medicine is recruiting patients.",,CHEMBL2888,Metabotropic glutamate receptor 3,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17204749, URL:http://europepmc.org/abstract/MED/17204749|Name:PubMed, SrcID:20571979, URL:http://europepmc.org/abstract/MED/20571979",CSCC[C@H](N)C(=O)N[C@]1(CS(=O)(=O)[C@H]2[C@@H]([C@@H]12)C(=O)O)C(=O)O,CHEMBL2888,GRM3
1986,CHEMBL2105683,Naproxen Etemesil,Small molecule,,,,,Cyclooxygenase inhibitor,,,CHEMBL2094253,Cyclooxygenase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:20804454, URL:http://europepmc.org/abstract/MED/20804454",COc1ccc2cc(ccc2c1)[C@H](C)C(=O)OCCS(=O)(=O)C,,
1987,CHEMBL43452,Pomalidomide,Small molecule,2013.0,L04AX06,L04AX06 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Other immunosuppressants],-domide,CRL4(CRBN) E3 ubiquitin ligase inhibitor,,,CHEMBL3833061,CRL4(CRBN) E3 ubiquitin ligase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,Cereblon,"Name:PubMed, SrcID:22552008, URL:http://europepmc.org/abstract/MED/22552008|Name:PubMed, SrcID:25043012, URL:http://europepmc.org/abstract/MED/25043012",Nc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12,CHEMBL3833061,DDB1
1988,CHEMBL43452,Pomalidomide,Small molecule,2013.0,L04AX06,L04AX06 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Other immunosuppressants],-domide,CRL4(CRBN) E3 ubiquitin ligase inhibitor,,,CHEMBL3833061,CRL4(CRBN) E3 ubiquitin ligase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,Cereblon,"Name:PubMed, SrcID:22552008, URL:http://europepmc.org/abstract/MED/22552008|Name:PubMed, SrcID:25043012, URL:http://europepmc.org/abstract/MED/25043012",Nc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12,CHEMBL3833061,CUL4A
1989,CHEMBL43452,Pomalidomide,Small molecule,2013.0,L04AX06,L04AX06 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Other immunosuppressants],-domide,CRL4(CRBN) E3 ubiquitin ligase inhibitor,,,CHEMBL3833061,CRL4(CRBN) E3 ubiquitin ligase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,Cereblon,"Name:PubMed, SrcID:22552008, URL:http://europepmc.org/abstract/MED/22552008|Name:PubMed, SrcID:25043012, URL:http://europepmc.org/abstract/MED/25043012",Nc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12,CHEMBL3833061,RBX1
1990,CHEMBL2109334,Medi-551,Antibody,,,,,B-lymphocyte antigen CD19 other,Enhanced antibody-dependent cell-mediated cytotoxicity against B cells. Depletes mature B cells including plasmablasts and plasma cells with the added benefit of reducing serum Ab levels.,,CHEMBL3390821,B-lymphocyte antigen CD19,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:27886126, URL:http://europepmc.org/abstract/MED/27886126|Name:PubMed, SrcID:25281717, URL:http://europepmc.org/abstract/MED/25281717",,CHEMBL3390821,CD19
1991,CHEMBL2108370,Inolimomab,Antibody,,,,-mab,Interleukin-2 receptor alpha chain antagonist,,,CHEMBL1778,Interleukin-2 receptor alpha chain,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:14621910, URL:http://europepmc.org/abstract/MED/14621910",,CHEMBL1778,IL2RA
1992,CHEMBL3545263,Lgx-806,Small molecule,,,,,Serine/threonine-protein kinase RAF inhibitor,No references found,,CHEMBL1906,Serine/threonine-protein kinase RAF,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,,,CHEMBL1906,RAF1
1993,CHEMBL1520,Vardenafil,Small molecule,2003.0,G04BE09,G04BE09 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Drugs used in erectile dysfunction],-afil,Phosphodiesterase 5A inhibitor,,Selective,CHEMBL1827,Phosphodiesterase 5A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=be38b325-3a6f-4569-9ae0-a03feff8535d, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=be38b325-3a6f-4569-9ae0-a03feff8535d",CCCc1nc(C)c2C(=O)N=C(Nn12)c3cc(ccc3OCC)S(=O)(=O)N4CCN(CC)CC4,CHEMBL1827,PDE5A
1994,CHEMBL385517,Saxagliptin,Small molecule,2009.0,A10BH03,"A10BH03 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Dipeptidyl peptidase 4 (DPP-4) inhibitors]",-gliptin,Dipeptidyl peptidase IV inhibitor,,,CHEMBL284,Dipeptidyl peptidase IV,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=ba48ac4b-9503-4006-f6e2-3b8a83059c03, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ba48ac4b-9503-4006-f6e2-3b8a83059c03",N[C@H](C(=O)N1[C@@H](C[C@@H]2C[C@H]12)C#N)C34CC5CC(CC(O)(C5)C3)C4,CHEMBL284,DPP4
1995,CHEMBL905,Rizatriptan,Small molecule,1998.0,N02CC04,N02CC04 [NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Selective serotonin (5HT1) agonists],-triptan,Serotonin 1d (5-HT1d) receptor agonist,,Selective,CHEMBL1983,Serotonin 1d (5-HT1d) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2011/020864s011s016s017s018s019,020865s012s016s018s020s021lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020864s011s016s017s018s019,020865s012s016s018s020s021lbl.pdf",CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12,CHEMBL1983,HTR1D
1996,CHEMBL460,Molindone,Small molecule,1974.0,N05AE02,N05AE02 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Indole derivatives],,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Molindone, URL:http://en.wikipedia.org/wiki/Molindone|Name:Wikipedia, SrcID:Antipsychotic#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Antipsychotic#Mechanism_of_action|Name:PubMed, SrcID:2586632, URL:http://europepmc.org/abstract/MED/2586632",CCc1c(C)[nH]c2CCC(CN3CCOCC3)C(=O)c12,CHEMBL224,HTR2A
1997,CHEMBL716,Quetiapine,Small molecule,1997.0,N05AH04,"N05AH04 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Diazepines, oxazepines, thiazepines and oxepines]",-tiapine,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=a951cd63-d329-47c9-965a-582fa73a07c6#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a951cd63-d329-47c9-965a-582fa73a07c6#nlm34090-1",OCCOCCN1CCN(CC1)C2=Nc3ccccc3Sc4ccccc24,CHEMBL224,HTR2A
1998,CHEMBL54,Haloperidol,Small molecule,1967.0,N05AD01,N05AD01 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Butyrophenone derivatives],-peridol,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:0443059748, URL:http://www.isbnsearch.org/isbn/0443059748|Name:Wikipedia, SrcID:Haloperidol, URL:http://en.wikipedia.org/wiki/Haloperidol|Name:PubMed, SrcID:17015232, URL:http://europepmc.org/abstract/MED/17015232",OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,CHEMBL224,HTR2A
1999,CHEMBL831,Loxapine,Small molecule,1975.0,N05AH01,"N05AH01 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Diazepines, oxazepines, thiazepines and oxepines]",-pin(e),Serotonin 2c (5-HT2c) receptor antagonist,,,CHEMBL225,Serotonin 2c (5-HT2c) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=50e11732-7387-452d-b3e6-db3a431d5c4a#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=50e11732-7387-452d-b3e6-db3a431d5c4a#nlm34090-1|Name:FDA, SrcID:label/2012/022549s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022549s000lbl.pdf",CN1CCN(CC1)C2=Nc3ccccc3Oc4ccc(Cl)cc24,,
2000,CHEMBL1963683,Tafluprost,Small molecule,2012.0,S01EE05,S01EE05 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Prostaglandin analogues 1)],-prost,Prostanoid FP receptor agonist,,,CHEMBL1987,Prostanoid FP receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=d51cbf25-003c-4ba7-86cf-921637ef37a0, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d51cbf25-003c-4ba7-86cf-921637ef37a0|Name:FDA, SrcID:label/2015/202514s003s004lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202514s003s004lbl.pdf",CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COc2ccccc2,CHEMBL1987,PTGFR
2001,CHEMBL1029,Miglustat,Small molecule,2003.0,A16AX06,A16AX06 [ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Various alimentary tract and metabolism products],-stat,Ceramide glucosyltransferase inhibitor,,,CHEMBL2063,Ceramide glucosyltransferase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=817892d1-ee12-4632-85fc-57ccdf16d7b8#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=817892d1-ee12-4632-85fc-57ccdf16d7b8#nlm34090-1",CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,CHEMBL2063,UGCG
2002,CHEMBL135,Estradiol,Small molecule,1975.0,G03CA03; G03CA53,"G03CA03 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ESTROGENS: Natural and semisynthetic estrogens, plain]; G03CA53 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ESTROGENS: Natural and semisynthetic estrogens, plain]",estr-,Estrogen receptor alpha agonist,,,CHEMBL206,Estrogen receptor alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=0f943869-41a2-4f7e-943d-dd8c17996dd8#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0f943869-41a2-4f7e-943d-dd8c17996dd8#nlm34090-1|Name:Wikipedia, SrcID:Estrogen_receptor, URL:http://en.wikipedia.org/wiki/Estrogen_receptor",C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O,CHEMBL206,ESR1
2003,CHEMBL1655,Toremifene,Small molecule,1997.0,L02BA02,L02BA02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONE ANTAGONISTS AND RELATED AGENTS: Anti-estrogens],-ifene,Estrogen receptor modulator,Mixed agonist/antagonist,,CHEMBL2093866,Estrogen receptor,MODULATOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=a6ff9761-7442-4bff-9e50-858c03e27fd0#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6ff9761-7442-4bff-9e50-858c03e27fd0#section-14",CN(C)CCOc1ccc(cc1)\C(=C(\CCCl)/c2ccccc2)\c3ccccc3,,
2004,CHEMBL1200335,Testosterone Enanthate,Small molecule,1953.0,G03BA03,G03BA03 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ANDROGENS: 3-oxoandrosten (4) derivatives],-ster-,Androgen Receptor agonist,,,CHEMBL1871,Androgen Receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Testosterone, URL:http://en.wikipedia.org/wiki/Testosterone|Name:DailyMed, SrcID:setid=91736ab6-139c-4a1c-a81b-f9d8118b24a8#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=91736ab6-139c-4a1c-a81b-f9d8118b24a8#nlm34090-1|Name:FDA, SrcID:label/2015/009165s033lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/009165s033lbl.pdf",CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,CHEMBL1871,AR
2005,CHEMBL1198857,Vilanterol,Small molecule,2013.0,,,-terol,Beta-2 adrenergic receptor agonist,,,CHEMBL210,Beta-2 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2013/204275s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204275s000lbl.pdf",OCc1cc(ccc1O)[C@@H](O)CNCCCCCCOCCOCc2c(Cl)cccc2Cl,CHEMBL210,ADRB2
2006,CHEMBL231779,Apixaban,Small molecule,2012.0,B01AF02,B01AF02 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Direct factor Xa inhibitors],-xaban,Coagulation factor X inhibitor,,,CHEMBL244,Coagulation factor X,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=e9481622-7cc6-418a-acb6-c5450daae9b0, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e9481622-7cc6-418a-acb6-c5450daae9b0",COc1ccc(cc1)n2nc(C(=O)N)c3CCN(C(=O)c23)c4ccc(cc4)N5CCCCC5=O,CHEMBL244,F10
2007,CHEMBL849,Triclosan,Small molecule,1997.0,D09AA06; D08AE04,D09AA06 [DERMATOLOGICALS: MEDICATED DRESSINGS: MEDICATED DRESSINGS: Medicated dressings with antiinfectives]; D08AE04 [DERMATOLOGICALS: ANTISEPTICS AND DISINFECTANTS: ANTISEPTICS AND DISINFECTANTS: Phenol and derivatives],,Bacterial enoyl-[acyl-carrier-protein] reductase inhibitor,,Broad spectrum,CHEMBL2364678,Bacterial enoyl-[acyl-carrier-protein] reductase,INHIBITOR,Bacteria,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10196195, URL:http://europepmc.org/abstract/MED/10196195",Oc1cc(Cl)ccc1Oc2ccc(Cl)cc2Cl,,
2008,CHEMBL1483,Albendazole,Small molecule,1996.0,P02CA03,"P02CA03 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTHELMINTICS: ANTINEMATODAL AGENTS: Benzimidazole derivatives]",-bendazole,Tubulin inhibitor,,,CHEMBL2364705,Tubulin,INHIBITOR,Nematoda,PROTEIN COMPLEX GROUP,Beta tubulin,Binds to beta tubulin,"Name:DailyMed, SrcID:setid=e8941166-b77d-45aa-a6e8-04f1c0afd845, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e8941166-b77d-45aa-a6e8-04f1c0afd845|Name:ISBN, SrcID:9780702034718 PP. 669, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:13678839, URL:http://europepmc.org/abstract/MED/13678839",CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1,,
2009,CHEMBL122,Rofecoxib,Small molecule,1999.0,M01AH02,"M01AH02 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Coxibs]",-coxib,Cyclooxygenase-2 inhibitor,,,CHEMBL230,Cyclooxygenase-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2004/021052s026_021042s019lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/021052s026_021042s019lbl.pdf",CS(=O)(=O)c1ccc(cc1)C2=C(C(=O)OC2)c3ccccc3,CHEMBL230,PTGS2
2010,CHEMBL3545985,Benzphetamine,Small molecule,1960.0,,,,Synaptic vesicular amine transporter inhibitor,,,CHEMBL1893,Synaptic vesicular amine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10605627, URL:http://europepmc.org/abstract/MED/10605627|Name:PubMed, SrcID:7902561, URL:http://europepmc.org/abstract/MED/7902561|Name:DailyMed, SrcID:setid=e95dfb31-8365-498d-91ea-79738033f905#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e95dfb31-8365-498d-91ea-79738033f905#nlm34090-1",C[C@@H](Cc1ccccc1)N(C)Cc2ccccc2,CHEMBL1893,SLC18A2
2011,CHEMBL115,Indinavir,Small molecule,1996.0,J05AE02,J05AE02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Protease inhibitors],-vir,Human immunodeficiency virus type 1 protease inhibitor,,,CHEMBL243,Human immunodeficiency virus type 1 protease,INHIBITOR,Human immunodeficiency virus 1,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=e19405d9-d9a1-4072-5b9e-40cd3ae4bf1f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e19405d9-d9a1-4072-5b9e-40cd3ae4bf1f",CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc3ccccc3)C(=O)N[C@@H]4[C@H](O)Cc5ccccc45,,
2012,CHEMBL1382,Tolterodine,Small molecule,1998.0,G04BD07,G04BD07 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Drugs for urinary frequency and incontinence],,Muscarinic acetylcholine receptor M2 antagonist,"Indicated for overactive bladder, M2 likely responsible",,CHEMBL211,Muscarinic acetylcholine receptor M2,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Tolterodine#Pharmacology, URL:http://en.wikipedia.org/wiki/Tolterodine#Pharmacology|Name:DailyMed, SrcID:setid=5e29f133-270c-4e5a-8493-e038c163a891, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e29f133-270c-4e5a-8493-e038c163a891|Name:PubMed, SrcID:16465186, URL:http://europepmc.org/abstract/MED/16465186",CC(C)N(CC[C@H](c1ccccc1)c2cc(C)ccc2O)C(C)C,CHEMBL211,CHRM2
2013,CHEMBL1201219,Vecuronium,Small molecule,1984.0,M03AC03,"M03AC03 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS: Other quaternary ammonium compounds]",-ium,Muscle-type nicotinic acetylcholine receptor antagonist,,,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:19417616, URL:http://europepmc.org/abstract/MED/19417616|Name:Wikipedia, SrcID:Vecuronium_bromide, URL:http://en.wikipedia.org/wiki/Vecuronium_bromide|Name:PubMed, SrcID:12145052, URL:http://europepmc.org/abstract/MED/12145052|Name:PubMed, SrcID:18633030, URL:http://europepmc.org/abstract/MED/18633030|Name:ISBN, SrcID:9780702034718 PP. 164, URL:http://www.isbnsearch.org/isbn/9780702034718",CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@@H]([C@@H]4OC(=O)C)[N+]5(C)CCCCC5)[C@@]2(C)C[C@@H]1N6CCCCC6,,
2014,CHEMBL1643,Ribavirin,Small molecule,1985.0,J05AB04,J05AB04 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleosides and nucleotides excl. reverse transcriptase inhibitors],-vir-,RNA inhibitor,,,CHEMBL2363073,RNA,INHIBITOR,Hepatitis C virus,NUCLEIC-ACID,,,"Name:Wikipedia, SrcID:Ribavirin#Mechanisms_of_action, URL:http://en.wikipedia.org/wiki/Ribavirin#Mechanisms_of_action|Name:PubMed, SrcID:16107837, URL:http://europepmc.org/abstract/MED/16107837",NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O,,
2015,CHEMBL526,Propofol,Small molecule,1989.0,N01AX10,"N01AX10 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Other general anesthetics]",-fo-,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:10637364, URL:http://europepmc.org/abstract/MED/10637364",CC(C)c1cccc(C(C)C)c1O,CHEMBL2093872,GABRG3
2016,CHEMBL526,Propofol,Small molecule,1989.0,N01AX10,"N01AX10 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Other general anesthetics]",-fo-,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:10637364, URL:http://europepmc.org/abstract/MED/10637364",CC(C)c1cccc(C(C)C)c1O,CHEMBL2093872,GABRP
2017,CHEMBL526,Propofol,Small molecule,1989.0,N01AX10,"N01AX10 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Other general anesthetics]",-fo-,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:10637364, URL:http://europepmc.org/abstract/MED/10637364",CC(C)c1cccc(C(C)C)c1O,CHEMBL2093872,GABRE
2018,CHEMBL526,Propofol,Small molecule,1989.0,N01AX10,"N01AX10 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Other general anesthetics]",-fo-,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:10637364, URL:http://europepmc.org/abstract/MED/10637364",CC(C)c1cccc(C(C)C)c1O,CHEMBL2093872,GABRG1
2019,CHEMBL1583,Bacampicillin,Small molecule,1980.0,J01CA06,"J01CA06 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: BETA-LACTAM ANTIBACTERIALS, PENICILLINS: Penicillins with extended spectrum]",-cillin,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:PubMed, SrcID:6762528, URL:http://europepmc.org/abstract/MED/6762528|Name:PubMed, SrcID:7447421, URL:http://europepmc.org/abstract/MED/7447421",CCOC(=O)OC(C)OC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](NC(=O)[C@H](N)c3ccccc3)C2=O,,
2020,CHEMBL44354,Ceftazidime,Small molecule,1985.0,J01DD02; J01DD52,J01DD02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Third-generation cephalosporins]; J01DD52 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Third-generation cephalosporins],cef-,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:PubMed, SrcID:6413485, URL:http://europepmc.org/abstract/MED/6413485",CC(C)(O\N=C(/C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)[O-])C[n+]3ccccc3)\c4csc(N)n4)C(=O)O,,
2021,CHEMBL1201780,Carglumic Acid,Small molecule,2010.0,A16AA05,A16AA05 [ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Amino acids and derivatives],,"Carbamoyl-phosphate synthase [ammonia], mitochondrial positive allosteric modulator",,,CHEMBL2362990,"Carbamoyl-phosphate synthase [ammonia], mitochondrial",POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=10175e73-5172-4dde-a508-8a88b7afc0a1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10175e73-5172-4dde-a508-8a88b7afc0a1",NC(=O)N[C@@H](CCC(=O)O)C(=O)O,CHEMBL2362990,CPS1
2022,CHEMBL1201217,Dyclonine,Small molecule,1982.0,N01BX02; R02AD04,"N01BX02 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Other local anesthetics]; R02AD04 [RESPIRATORY SYSTEM: THROAT PREPARATIONS: THROAT PREPARATIONS: Anesthetics, local]",,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:8799190, URL:http://europepmc.org/abstract/MED/8799190|Name:DailyMed, SrcID:setid=6fde9446-0f8d-4bba-98dc-3e3a1f170488, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6fde9446-0f8d-4bba-98dc-3e3a1f170488|Name:PubMed, SrcID:15635807, URL:http://europepmc.org/abstract/MED/15635807",CCCCOc1ccc(cc1)C(=O)CCN2CCCCC2,,
2023,CHEMBL1401,Nitazoxanide,Small molecule,2002.0,P01AX11,"P01AX11 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES: Other agents against amoebiasis and other protozoal diseases]",-oxanide,Pyruvate:ferredoxin oxidoreductase inhibitor,,,CHEMBL2364026,Pyruvate:ferredoxin oxidoreductase,INHIBITOR,Cryptosporidium parvum,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=56b1575a-dff4-4c5a-a159-2f858e7a0cb8, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=56b1575a-dff4-4c5a-a159-2f858e7a0cb8",CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-],,
2024,CHEMBL31,Gatifloxacin,Small molecule,1999.0,S01AE06; J01MA16,S01AE06 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Fluoroquinolones]; J01MA16 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolones],-oxacin,Topoisomerase IV inhibitor,,,CHEMBL2363033,Topoisomerase IV,INHIBITOR,Streptococcus pneumoniae,PROTEIN COMPLEX,,,"Name:DailyMed, SrcID:setid=a5b0725e-9b7e-426b-ab1c-fcca3b1972fd, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a5b0725e-9b7e-426b-ab1c-fcca3b1972fd|Name:FDA, SrcID:label/2015/021493s010lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021493s010lbl.pdf",COc1c(N2CCNC(C)C2)c(F)cc3C(=O)C(=CN(C4CC4)c13)C(=O)O,,
2025,CHEMBL1257,Enflurane,Small molecule,1972.0,N01AB04,"N01AB04 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,Potassium channel subfamily K member 9 opener,,,CHEMBL2321614,Potassium channel subfamily K member 9,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:16973644, URL:http://europepmc.org/abstract/MED/16973644|Name:PubMed, SrcID:17227289, URL:http://europepmc.org/abstract/MED/17227289",FC(F)OC(F)(F)C(F)Cl,CHEMBL2321614,KCNK9
2026,CHEMBL1201487,Sacrosidase,Enzyme,1998.0,A16AB06,A16AB06 [ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Enzymes],-ase,Sucrose hydrolytic enzyme,Replaces endogenous human sucrase in case of congenital sucrase-isomaltase deficiency (CSIS),,CHEMBL2364182,Sucrose,HYDROLYTIC ENZYME,Homo sapiens,SMALL MOLECULE,,,"Name:DailyMed, SrcID:setid=d613bb7f-c3f4-462e-81a2-da2347cc4b6b, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d613bb7f-c3f4-462e-81a2-da2347cc4b6b",,,
2027,CHEMBL2110568,Chromic Phosphate,Small molecule,1974.0,,,,Unknown,,,,,,,,,,"Name:FDA, SrcID:label/2009/017084s017lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/017084s017lbl.pdf",,,
2028,CHEMBL108545,Methyl Salicylate,Small molecule,2008.0,,,,Unknown,,,,,,,,,,"Name:FDA, SrcID:label/2009/022029s003lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022029s003lbl.pdf|Name:PubMed, SrcID:22292506, URL:http://europepmc.org/abstract/MED/22292506",COC(=O)c1ccccc1O,,
2029,CHEMBL501849,Simeprevir,Small molecule,2013.0,J05AE14,J05AE14 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Protease inhibitors],-vir,"Hepatitis C virus serine protease, NS3/NS4A inhibitor",,,CHEMBL2095231,"Hepatitis C virus serine protease, NS3/NS4A",INHIBITOR,Hepatitis C virus,PROTEIN COMPLEX,,,"Name:FDA, SrcID:label/2013/205123s001lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/205123s001lbl.pdf",COc1ccc2c(O[C@@H]3C[C@@H]4[C@@H](C3)C(=O)N(C)CCCC\C=C/[C@@H]5C[C@]5(NC4=O)C(=O)NS(=O)(=O)C6CC6)cc(nc2c1C)c7nc(cs7)C(C)C,,
2030,CHEMBL3137312,Dasabuvir,Small molecule,2014.0,J05AX16,J05AX16 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Other antivirals],-vir,Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor,,,CHEMBL5375,Hepatitis C virus NS5B RNA-dependent RNA polymerase,INHIBITOR,Hepatitis C virus,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/206619s003lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206619s003lbl.pdf",COc1c(cc(cc1C(C)(C)C)N2C=CC(=O)NC2=O)c3ccc4cc(NS(=O)(=O)C)ccc4c3,,
2031,CHEMBL2023898,Daclatasvir,Small molecule,2015.0,J05AX14,J05AX14 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Other antivirals],-vir,Nonstructural protein 5A inhibitor,,,CHEMBL3307224,Nonstructural protein 5A,INHIBITOR,Hepatitis C virus,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=9803a6ff-8a3e-4c64-b3d0-7825c7123bf2, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9803a6ff-8a3e-4c64-b3d0-7825c7123bf2",COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1c2ncc([nH]2)c3ccc(cc3)c4ccc(cc4)c5cnc([nH]5)[C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C,,
2032,CHEMBL454138,Turofexorate Isopropyl,Small molecule,,,,-fexorate,Bile acid receptor FXR agonist,"A Ph1 trial was terminated in May due to pharmacokinetics issues, development stopped.",,CHEMBL2047,Bile acid receptor FXR,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19136377, URL:http://europepmc.org/abstract/MED/19136377|Name:PubMed, SrcID:19159286, URL:http://europepmc.org/abstract/MED/19159286",CC(C)OC(=O)C1=CN(CC(C)(C)c2c1[nH]c3ccccc23)C(=O)c4ccc(F)c(F)c4,CHEMBL2047,NR1H4
2033,CHEMBL3544958,Cer-002,Small molecule,,,,,Peroxisome proliferator-activated receptor delta agonist,A Ph1 trial was completed in 2008 but can't find trial ID or any further planned trials (http://www.drugs.com/clinical_trials/cerenis-therapeutics-announces-successful-completion-phase-clinical-trial-cer-002-cardiovascular-4272.html). Compound still in the company pipeline.,,CHEMBL3979,Peroxisome proliferator-activated receptor delta,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.cerenis.com/pipeline_cer002.asp, URL:http://www.cerenis.com/pipeline_cer002.asp|Name:PubMed, SrcID:25523004, URL:http://europepmc.org/abstract/MED/25523004",,CHEMBL3979,PPARD
2034,CHEMBL1645462,Ac-480,Small molecule,,,,,Epidermal growth factor receptor erbB1 inhibitor,,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19821562, URL:http://europepmc.org/abstract/MED/19821562|Name:PubMed, SrcID:17062696, URL:http://europepmc.org/abstract/MED/17062696",Cc1c(NC(=O)OC[C@@H]2COCCN2)cn3ncnc(Nc4ccc5c(cnn5Cc6cccc(F)c6)c4)c13,CHEMBL203,EGFR
2035,CHEMBL3544966,Gsk-1059615,Small molecule,,,,,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:19713247, URL:http://europepmc.org/abstract/MED/19713247",O=C1NC(=O)\C(=C\c2ccc3nccc(c4ccncc4)c3c2)\S1,CHEMBL3559703,PIK3R2
2036,CHEMBL3544966,Gsk-1059615,Small molecule,,,,,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:19713247, URL:http://europepmc.org/abstract/MED/19713247",O=C1NC(=O)\C(=C\c2ccc3nccc(c4ccncc4)c3c2)\S1,CHEMBL3559703,PIK3R3
2037,CHEMBL3544966,Gsk-1059615,Small molecule,,,,,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:19713247, URL:http://europepmc.org/abstract/MED/19713247",O=C1NC(=O)\C(=C\c2ccc3nccc(c4ccncc4)c3c2)\S1,CHEMBL3559703,PIK3R5
2038,CHEMBL1614710,Osi-930,Small molecule,,,,,Stem cell growth factor receptor inhibitor,,,CHEMBL1936,Stem cell growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16424037, URL:http://europepmc.org/abstract/MED/16424037|Name:PubMed, SrcID:23403628, URL:http://europepmc.org/abstract/MED/23403628",FC(F)(F)Oc1ccc(NC(=O)c2sccc2NCc3ccnc4ccccc34)cc1,CHEMBL1936,KIT
2039,CHEMBL3545332,Cep-2563,Small molecule,,,,,Tyrosine-protein kinase receptor FLT3 inhibitor,,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12010785, URL:http://europepmc.org/abstract/MED/12010785",,CHEMBL1974,FLT3
2040,CHEMBL3545275,Ly2623091,Small molecule,,,,,Mineralocorticoid receptor antagonist,,,CHEMBL1994,Mineralocorticoid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://adisinsight.springer.com/drugs/800033156, URL:http://adisinsight.springer.com/drugs/800033156|Name:Other, SrcID:https://www.lilly.com/research-development/approach/clinical-development-pipeline.aspx, URL:https://www.lilly.com/research-development/approach/clinical-development-pipeline.aspx",,,
2041,CHEMBL3545393,Xl550,Small molecule,,,,,Mineralocorticoid receptor antagonist,,,CHEMBL1994,Mineralocorticoid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.exelixis.com/pipeline/xl550, URL:http://www.exelixis.com/pipeline/xl550",,,
2042,CHEMBL3545150,Azm-475271,Small molecule,,,,,Tyrosine-protein kinase SRC inhibitor,,,CHEMBL267,Tyrosine-protein kinase SRC,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:14761189, URL:http://europepmc.org/abstract/MED/14761189|Name:PubMed, SrcID:15585638, URL:http://europepmc.org/abstract/MED/15585638",,CHEMBL267,SRC
2043,CHEMBL3544945,Sar-113945,Small molecule,,,,,Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor,,,CHEMBL1991,Inhibitor of nuclear factor kappa B kinase beta subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.sanofi.com/Images/23269_Pharma-Vaccines_Early-Late-Pipeline.pdf, URL:http://www.sanofi.com/Images/23269_Pharma-Vaccines_Early-Late-Pipeline.pdf",,CHEMBL1991,IKBKB
2044,CHEMBL3544983,Tesevatinib,Small molecule,,,,-tinib,Ephrin type-B receptor 4 inhibitor,,,CHEMBL5147,Ephrin type-B receptor 4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17575237, URL:http://europepmc.org/abstract/MED/17575237|Name:Other, SrcID:http://kadmon.com/press/kadmon-corporation-presents-encouraging-nonclinical-data-on-tesevatinib-kd019-at-aacr-annual-meeting/, URL:http://kadmon.com/press/kadmon-corporation-presents-encouraging-nonclinical-data-on-tesevatinib-kd019-at-aacr-annual-meeting/|Name:PubMed, SrcID:22173702, URL:http://europepmc.org/abstract/MED/22173702",COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]4C[C@@H]5CN(C)C[C@@H]5C4,CHEMBL5147,EPHB4
2045,CHEMBL3545406,Ly2940094,Small molecule,,,,,Nociceptin receptor antagonist,,,CHEMBL2014,Nociceptin receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23722336, URL:http://europepmc.org/abstract/MED/23722336",,CHEMBL2014,OPRL1
2046,CHEMBL2103878,Odelepran,Small molecule,,,,,Opioid receptors; mu/kappa/delta antagonist,,,CHEMBL2095181,Opioid receptors; mu/kappa/delta,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:24010675, URL:http://europepmc.org/abstract/MED/24010675",NC(=O)c1ccc(Oc2ccc(CNCCC3CCOCC3)cc2F)nc1,,
2047,CHEMBL45305,Befiradol,Small molecule,,,,-adol,Serotonin 1a (5-HT1a) receptor agonist,,,CHEMBL214,Serotonin 1a (5-HT1a) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22147258, URL:http://europepmc.org/abstract/MED/22147258",Cc1ccc(CNCC2(F)CCN(CC2)C(=O)c3ccc(F)c(Cl)c3)nc1,CHEMBL214,HTR1A
2048,CHEMBL2107760,Nebentan,Small molecule,,,,-entan,Endothelin receptor ET-A antagonist,,,CHEMBL252,Endothelin receptor ET-A,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18078923, URL:http://europepmc.org/abstract/MED/18078923|Name:PubMed, SrcID:15838329, URL:http://europepmc.org/abstract/MED/15838329",COc1ccccc1Oc2c(NS(=O)(=O)\C=C\c3ccccc3)nc(nc2OC)c4ncccn4,CHEMBL252,EDNRA
2049,CHEMBL3707356,Syl-1001,Small molecule,,,,,Vanilloid receptor antagonist,Small interfering RNA (siRNA).,,CHEMBL4794,Vanilloid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.sylentis.com/index.php/en/pipeline/syl1001-en, URL:http://www.sylentis.com/index.php/en/pipeline/syl1001-en",,CHEMBL4794,TRPV1
2050,CHEMBL1908391,Masitinib,Small molecule,,L01XE22,L01XE22 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Platelet-derived growth factor receptor inhibitor,"Approved veterinary - 2012. Not recommended for approval (Negative opinion) in EU, phase 3 trials in US.",,CHEMBL2095189,Platelet-derived growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:19789626, URL:http://europepmc.org/abstract/MED/19789626|Name:PubMed, SrcID:19541476, URL:http://europepmc.org/abstract/MED/19541476|Name:Other, SrcID:http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/veterinary/000128/WC500064717.pdf, URL:http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/veterinary/000128/WC500064717.pdf",CN1CCN(Cc2ccc(cc2)C(=O)Nc3ccc(C)c(Nc4nc(cs4)c5cccnc5)c3)CC1,,
2051,CHEMBL603469,Lestaurtinib,Small molecule,,,,-tinib,Tyrosine-protein kinase receptor RET inhibitor,,,CHEMBL2041,Tyrosine-protein kinase receptor RET,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:14500395, URL:http://europepmc.org/abstract/MED/14500395",C[C@]12O[C@H](C[C@]1(O)CO)n3c4ccccc4c5c6C(=O)NCc6c7c8ccccc8n2c7c35,CHEMBL2041,RET
2052,CHEMBL2103975,Vapreotide,Protein,,H01CB04,"H01CB04 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: HYPOTHALAMIC HORMONES: Somatostatin and analogues]",-tide,Somatostatin receptor 3 agonist,"Somatostatin analogue. Not apporved by FDA, rejected by advisory panel. Not in current company pipeline and no further development reported.",,CHEMBL2028,Somatostatin receptor 3,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:7907795, URL:http://europepmc.org/abstract/MED/7907795|Name:PubMed, SrcID:7878022, URL:http://europepmc.org/abstract/MED/7878022|Name:Other, SrcID:http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2054, URL:http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2054",CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc4ccc(O)cc4)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N[C@@H](Cc5c[nH]c6ccccc56)C(=O)N)NC(=O)[C@H](N)Cc7ccccc7,CHEMBL2028,SSTR3
2053,CHEMBL1743042,Motavizumab,Antibody,,J06BB17,J06BB17 [ANTIINFECTIVES FOR SYSTEMIC USE: IMMUNE SERA AND IMMUNOGLOBULINS: IMMUNOGLOBULINS: Specific immunoglobulins],-mab,Fusion glycoprotein F0 inhibitor,"Targets a highly conserved epitope in the A antigenic site of the RSV fusion (F) protein, which is important in the invasion of RSV from cell to cell.",,CHEMBL2364165,Fusion glycoprotein F0,INHIBITOR,Human respiratory syncytial virus,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19330726, URL:http://europepmc.org/abstract/MED/19330726",,,
2054,CHEMBL2109084,Desmoteplase,Enzyme,,,,-ase,Plasminogen activator,,Fibrin-selective.,CHEMBL1801,Plasminogen,ACTIVATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21627637, URL:http://europepmc.org/abstract/MED/21627637",,CHEMBL1801,PLG
2055,CHEMBL2108681,Tildrakizumab,Antibody,,,,-mab,Interleukin-23 subunit alpha inhibitor,,,CHEMBL3580502,Interleukin-23 subunit alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26042589, URL:http://europepmc.org/abstract/MED/26042589",,CHEMBL3580502,IL23A
2056,CHEMBL2109330,Ic14,Antibody,,,,,Monocyte differentiation antigen CD14 inhibitor,Diminishes inflammatory responses induced by i.v. injection of LPS.,,CHEMBL2384897,Monocyte differentiation antigen CD14,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11207321, URL:http://europepmc.org/abstract/MED/11207321",,CHEMBL2384897,CD14
2057,CHEMBL2109583,F16il2,Antibody,,,,,Tenascin other,Immunocytokine. Immunomodulator.,,CHEMBL3712856,Tenascin,OTHER,Homo sapiens,SINGLE PROTEIN,,Antibody F16 specific to the alternatively spliced A1 domain of tenascin-C,"Name:PubMed, SrcID:18927291, URL:http://europepmc.org/abstract/MED/18927291",,CHEMBL3712856,TNC
2058,CHEMBL1201015,Aluminum Acetate,Small molecule,1976.0,,,,Unknown,,,,,,,,,,,[Al+3].CC(=O)[O-].CC(=O)[O-].CC(=O)[O-],,
2059,CHEMBL1166,Argatroban,Small molecule,2000.0,B01AE03,B01AE03 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Direct thrombin inhibitors],-troban,Thrombin inhibitor,,,CHEMBL204,Thrombin,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=9c9616c0-a299-4fd5-c8ae-79e6db453595, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9c9616c0-a299-4fd5-c8ae-79e6db453595",C[C@@H]1CCN([C@H](C1)C(=O)O)C(=O)[C@H](CCCNC(=N)N)NS(=O)(=O)c2cccc3CC(C)CNc23,CHEMBL204,F2
2060,CHEMBL648,Cyclizine,Small molecule,1982.0,R06AE03; R06AE53,R06AE03 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Piperazine derivatives]; R06AE53 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Piperazine derivatives],,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20394809, URL:http://europepmc.org/abstract/MED/20394809|Name:Other, SrcID:www.medicines.org.uk/EMC/medicine/14672/SPC/Valoid+Tablets/#PHARMACOLOGICAL_PROPS, URL:www.medicines.org.uk/EMC/medicine/14672/SPC/Valoid+Tablets/#PHARMACOLOGICAL_PROPS",CN1CCN(CC1)C(c2ccccc2)c3ccccc3,CHEMBL231,HRH1
2061,CHEMBL1201747,Alcaftadine,Small molecule,2010.0,S01GX11,S01GX11 [SENSORY ORGANS: OPHTHALMOLOGICALS: DECONGESTANTS AND ANTIALLERGICS: Other antiallergics],-(a)tadine,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=17d37e8d-7825-424b-b6ca-0a85d0bf4694, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=17d37e8d-7825-424b-b6ca-0a85d0bf4694",CN1CCC(=C2c3ccccc3CCn4c(C=O)cnc24)CC1,CHEMBL231,HRH1
2062,CHEMBL1201216,Dapiprazole,Small molecule,1990.0,S01EX02,S01EX02 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Other antiglaucoma preparations],-prazole,Alpha-1a adrenergic receptor antagonist,,,CHEMBL229,Alpha-1a adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:9401944, URL:http://europepmc.org/abstract/MED/9401944",Cc1ccccc1N2CCN(CCc3nnc4CCCCn34)CC2,CHEMBL229,ADRA1A
2063,CHEMBL1201288,Dantrolene,Small molecule,1974.0,M03CA01,"M03CA01 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS: Dantrolene and derivatives]",,Ryanodine receptor 1 antagonist,,,CHEMBL1846,Ryanodine receptor 1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12167662, URL:http://europepmc.org/abstract/MED/12167662|Name:PubMed, SrcID:19460614, URL:http://europepmc.org/abstract/MED/19460614|Name:PubMed, SrcID:15023108, URL:http://europepmc.org/abstract/MED/15023108|Name:PubMed, SrcID:16945924, URL:http://europepmc.org/abstract/MED/16945924",[O-][N+](=O)c1ccc(cc1)c2oc(\C=N\N3CC(=O)NC3=O)cc2,CHEMBL1846,RYR1
2064,CHEMBL1946170,Regorafenib,Small molecule,2012.0,L01XE21,L01XE21 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-rafenib,Tyrosine-protein kinase ABL inhibitor,,,CHEMBL1862,Tyrosine-protein kinase ABL,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Expert, SrcID:REGORAFENIB, URL:http://chembl.blogspot.co.uk/search?q=REGORAFENIB",CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,CHEMBL1862,ABL1
2065,CHEMBL495,Alprostadil,Small molecule,1981.0,G04BE01; C01EA01,G04BE01 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Drugs used in erectile dysfunction]; C01EA01 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: OTHER CARDIAC PREPARATIONS: Prostaglandins],-dil; -prost-,Prostanoid EP2 receptor agonist,,,CHEMBL1881,Prostanoid EP2 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=51d530fe-b283-43ea-a206-a419742b4b4b#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=51d530fe-b283-43ea-a206-a419742b4b4b#nlm34090-1|Name:FDA, SrcID:label/2015/020649s023lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020649s023lbl.pdf|Name:ISBN, SrcID:0443-059748 PP. 216, 445, URL:http://www.isbnsearch.org/isbn/0443059748",CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O,CHEMBL1881,PTGER2
2066,CHEMBL1185,Zolmitriptan,Small molecule,1997.0,N02CC03,N02CC03 [NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Selective serotonin (5HT1) agonists],-triptan,Serotonin 1b (5-HT1b) receptor agonist,,,CHEMBL1898,Serotonin 1b (5-HT1b) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2012/020768s019s021,021231s010s011lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020768s019s021,021231s010s011lbl.pdf",CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12,CHEMBL1898,HTR1B
2067,CHEMBL1201355,Ceruletide,Protein,1982.0,V04CC04,V04CC04 [VARIOUS: DIAGNOSTIC AGENTS: OTHER DIAGNOSTIC AGENTS: Tests for bile duct patency],-tide,Cholecystokinin A receptor agonist,,,CHEMBL1901,Cholecystokinin A receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Ceruletide, URL:http://en.wikipedia.org/wiki/Ceruletide|Name:PubMed, SrcID:7491953, URL:http://europepmc.org/abstract/MED/7491953",CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc3ccc(OS(=O)(=O)O)cc3)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H]4CCC(=O)N4)[C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc5ccccc5)C(=O)N,CHEMBL1901,CCKAR
2068,CHEMBL41,Fluoxetine,Small molecule,1987.0,N06AB03,N06AB03 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Selective serotonin reuptake inhibitors],-oxetine,Serotonin transporter inhibitor,reuptake inhibitor,,CHEMBL228,Serotonin transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=59de2889-c3d3-4ebf-8826-13f30a3fa439, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=59de2889-c3d3-4ebf-8826-13f30a3fa439|Name:PubMed, SrcID:17356573, URL:http://europepmc.org/abstract/MED/17356573|Name:PubMed, SrcID:17289086, URL:http://europepmc.org/abstract/MED/17289086",CNCCC(Oc1ccc(cc1)C(F)(F)F)c2ccccc2,CHEMBL228,SLC6A4
2069,CHEMBL629,Amitriptyline,Small molecule,1961.0,N06AA09,N06AA09 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Non-selective monoamine reuptake inhibitors],-triptyline,Serotonin transporter inhibitor,,,CHEMBL228,Serotonin transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=acd53964-52dc-4534-b20f-14a7561b8a6c#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acd53964-52dc-4534-b20f-14a7561b8a6c#nlm34090-1",CN(C)CCC=C1c2ccccc2CCc3ccccc13,CHEMBL228,SLC6A4
2070,CHEMBL24828,Vandetanib,Small molecule,2011.0,L01XE12,L01XE12 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-anib,Tyrosine-protein kinase SRC inhibitor,,,CHEMBL267,Tyrosine-protein kinase SRC,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13",COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC4CCN(C)CC4,CHEMBL267,SRC
2071,CHEMBL1201222,Lisdexamfetamine,Small molecule,2007.0,N06BA12,"N06BA12 [NERVOUS SYSTEM: PSYCHOANALEPTICS: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS: Centrally acting sympathomimetics]",-fetamin(e),Dopamine transporter releasing agent,,,CHEMBL238,Dopamine transporter,RELEASING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=c9eaca3d-cca7-4627-bb3e-75b1c2aec9d4#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c9eaca3d-cca7-4627-bb3e-75b1c2aec9d4#nlm34090-1",C[C@@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN,CHEMBL238,SLC6A3
2072,CHEMBL1200500,Beclomethasone Dipropionate,Small molecule,1976.0,D07AC15; A07EA07; R01AD01; R03BA01,"D07AC15 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, potent (group III)]; A07EA07 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Corticosteroids acting locally]; R01AD01 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Corticosteroids]; R03BA01 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS: Glucocorticoids]",,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=a0d4d864-4a45-4f1e-b3e5-d6e09b59c004#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a0d4d864-4a45-4f1e-b3e5-d6e09b59c004#nlm34090-1",CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]12C,CHEMBL2034,NR3C1
2073,CHEMBL1676,Fluticasone Furoate,Small molecule,2007.0,R03BA09; R01AD12,"R03BA09 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS: Glucocorticoids]; R01AD12 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Corticosteroids]",,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=4eeb5f6a-593f-4a9e-9692-adefa2caf8fc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4eeb5f6a-593f-4a9e-9692-adefa2caf8fc",C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c5occc5)C(=O)SCF,CHEMBL2034,NR3C1
2074,CHEMBL1200989,Alclometasone Dipropionate,Small molecule,1982.0,D07AB10; S01BA10,"D07AB10 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, moderately potent (group II)]; S01BA10 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Corticosteroids, plain]",,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:999318, URL:http://europepmc.org/abstract/MED/999318|Name:PubMed, SrcID:4618210, URL:http://europepmc.org/abstract/MED/4618210",CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@H](C)C[C@H]2[C@@H]3[C@H](Cl)CC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C,CHEMBL2034,NR3C1
2075,CHEMBL629,Amitriptyline,Small molecule,1961.0,N06AA09,N06AA09 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Non-selective monoamine reuptake inhibitors],-triptyline,Norepinephrine transporter inhibitor,,,CHEMBL222,Norepinephrine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=acd53964-52dc-4534-b20f-14a7561b8a6c#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acd53964-52dc-4534-b20f-14a7561b8a6c#nlm34090-1",CN(C)CCC=C1c2ccccc2CCc3ccccc13,CHEMBL222,SLC6A2
2076,CHEMBL2103875,Trametinib,Small molecule,2013.0,L01XE25,L01XE25 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,,,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/204114s004lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204114s004lbl.pdf|Name:DailyMed, SrcID:setid=aeaf0430-f8ad-4e72-9dbf-1954503c3410#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aeaf0430-f8ad-4e72-9dbf-1954503c3410#nlm34090-1",CN1C(=O)C(=C2N(C(=O)N(C3CC3)C(=O)C2=C1Nc4ccc(I)cc4F)c5cccc(NC(=O)C)c5)C,CHEMBL2964,MAP2K2
2077,CHEMBL477772,Pazopanib,Small molecule,2009.0,L01XE11,L01XE11 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-anib,Fibroblast growth factor receptor 1 inhibitor,,,CHEMBL3650,Fibroblast growth factor receptor 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14",CN(c1ccc2c(C)n(C)nc2c1)c3ccnc(Nc4ccc(C)c(c4)S(=O)(=O)N)n3,CHEMBL3650,FGFR1
2078,CHEMBL1533,Desogestrel,Small molecule,1992.0,G03AC09,G03AC09 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE: Progestogens],-gest-,Progesterone receptor agonist,,,CHEMBL208,Progesterone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:0443-059748 PP. 447, URL:http://www.isbnsearch.org/isbn/0443059748",CC[C@]12CC(=C)[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C,CHEMBL208,PGR
2079,CHEMBL190,Theophylline,Small molecule,1940.0,R03DA04; R03DA54; R03DA74,R03DA04 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: Xanthines]; R03DA54 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: Xanthines]; R03DA74 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: Xanthines],,Phosphodiesterase 4 inhibitor,,,CHEMBL2093863,Phosphodiesterase 4,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=25b2fdbe-2f18-4153-835a-7a67bff83ef8, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=25b2fdbe-2f18-4153-835a-7a67bff83ef8|Name:Wikipedia, SrcID:Theophylline#Mechanisms_of_action, URL:http://en.wikipedia.org/wiki/Theophylline#Mechanisms_of_action",CN1C(=O)N(C)c2nc[nH]c2C1=O,,
2080,CHEMBL25,Aspirin,Small molecule,1950.0,N02BA51; N02BA71; B01AC06; A01AD05; N02BA01,N02BA51 [NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Salicylic acid and derivatives]; N02BA71 [NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Salicylic acid and derivatives]; B01AC06 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Platelet aggregation inhibitors excl. heparin]; A01AD05 [ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Other agents for local oral treatment]; N02BA01 [NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Salicylic acid and derivatives],,Cyclooxygenase inhibitor,,,CHEMBL2094253,Cyclooxygenase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Wikipedia, SrcID:Aspirin#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Aspirin#Mechanism_of_action|Name:PubMed, SrcID:17258197, URL:http://europepmc.org/abstract/MED/17258197|Name:PubMed, SrcID:17131625, URL:http://europepmc.org/abstract/MED/17131625",CC(=O)Oc1ccccc1C(=O)O,,
2081,CHEMBL6,Indomethacin,Small molecule,1965.0,M01AB01; M02AA23; C01EB03; M01AB51; S01BC01,"M01AB01 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Acetic acid derivatives and related substances]; M02AA23 [MUSCULO-SKELETAL SYSTEM: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: Antiinflammatory preparations, non-steroids for topical use]; C01EB03 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: OTHER CARDIAC PREPARATIONS: Other cardiac preparations]; M01AB51 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Acetic acid derivatives and related substances]; S01BC01 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Antiinflammatory agents, non-steroids]",,Cyclooxygenase inhibitor,,,CHEMBL2094253,Cyclooxygenase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2007/016059s097,017814s040,018332s030lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/016059s097,017814s040,018332s030lbl.pdf|Name:ISBN, SrcID:9780702034718 PP. 319-320, URL:http://www.isbnsearch.org/isbn/9780702034718",COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c3ccc(Cl)cc3,,
2082,CHEMBL1201295,Bitolterol,Small molecule,1984.0,R03AC17,"R03AC17 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS, INHALANTS: Selective beta-2-adrenoreceptor agonists]",-terol,Beta-2 adrenergic receptor agonist,,,CHEMBL210,Beta-2 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:3278878, URL:http://europepmc.org/abstract/MED/3278878",Cc1ccc(cc1)C(=O)Oc2ccc(cc2OC(=O)c3ccc(C)cc3)C(O)CNC(C)(C)C,CHEMBL210,ADRB2
2083,CHEMBL98,Vorinostat,Small molecule,2006.0,L01XX38,L01XX38 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-stat,Histone deacetylase 2 inhibitor,,,CHEMBL1937,Histone deacetylase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13",ONC(=O)CCCCCCC(=O)Nc1ccccc1,CHEMBL1937,HDAC2
2084,CHEMBL1200733,Desflurane,Small molecule,1992.0,N01AB07,"N01AB07 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,Glycine receptor (alpha-1/beta) positive modulator,alpha1/beta is main adult form,,CHEMBL2363052,Glycine receptor (alpha-1/beta),POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX,Glycine receptor alpha subunit,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123",FC(F)OC(F)C(F)(F)F,CHEMBL2363052,GLRB
2085,CHEMBL21,Sulfanilamide,Small molecule,1985.0,D06BA05; J01EB06,D06BA05 [DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: CHEMOTHERAPEUTICS FOR TOPICAL USE: Sulfonamides]; J01EB06 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: SULFONAMIDES AND TRIMETHOPRIM: Short-acting sulfonamides],sulfa-,Bacterial dihydropteroate synthase inhibitor,,Broad spectrum,CHEMBL2364668,Bacterial dihydropteroate synthase,INHIBITOR,Bacteria,SINGLE PROTEIN,,,"Name:PubMed, SrcID:9127492, URL:http://europepmc.org/abstract/MED/9127492|Name:PubMed, SrcID:16487326, URL:http://europepmc.org/abstract/MED/16487326|Name:PubMed, SrcID:16997145, URL:http://europepmc.org/abstract/MED/16997145",Nc1ccc(cc1)S(=O)(=O)N,,
2086,CHEMBL680,Cefaclor,Small molecule,1979.0,,,cef-,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:PubMed, SrcID:1622180, URL:http://europepmc.org/abstract/MED/1622180",N[C@@H](C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)Cl)c3ccccc3,,
2087,CHEMBL3301800,Cefprozil,Small molecule,1991.0,,,cef-,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:PubMed, SrcID:11959556, URL:http://europepmc.org/abstract/MED/11959556|Name:DailyMed, SrcID:setid=3ec55c0a-1456-412e-972f-352b3135c8f2, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3ec55c0a-1456-412e-972f-352b3135c8f2|Name:Wikipedia, SrcID:Penicillin_binding_proteins#Function, URL:http://en.wikipedia.org/wiki/Penicillin_binding_proteins#Function",CC=CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C2=O)C(=O)O,,
2088,CHEMBL1601,Cefonicid,Small molecule,1984.0,J01DC06,J01DC06 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Second-generation cephalosporins],cef-,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:PubMed, SrcID:6376452, URL:http://europepmc.org/abstract/MED/6376452",O[C@@H](C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)CSc3nnnn3CS(=O)(=O)O)c4ccccc4,,
2089,CHEMBL58,Mitoxantrone,Small molecule,1987.0,L01DB07,L01DB07 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES: Anthracyclines and related substances],-antrone,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=4d0f0f1a-31af-40fa-9c64-e90891fa6ce4, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4d0f0f1a-31af-40fa-9c64-e90891fa6ce4",OCCNCCNc1ccc(NCCNCCO)c2C(=O)c3c(O)ccc(O)c3C(=O)c12,,
2090,CHEMBL1129,Trifluridine,Small molecule,1980.0,L01BC59; S01AD02,L01BC59 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Pyrimidine analogues]; S01AD02 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Antivirals],-uridine,DNA inhibitor,"Virustatic antimetabolites; recent studies indicate its role as an anti-cancer (pmid: 6436227, 18600528)",,CHEMBL2366042,DNA,INHIBITOR,Human herpesvirus 1,NUCLEIC-ACID,,,"Name:PubMed, SrcID:6436227, URL:http://europepmc.org/abstract/MED/6436227|Name:PubMed, SrcID:8032338, URL:http://europepmc.org/abstract/MED/8032338|Name:ISBN, SrcID:0-86577-843-4 PP. 284, URL:http://www.isbnsearch.org/isbn/0865778434|Name:PubMed, SrcID:1377898, URL:http://europepmc.org/abstract/MED/1377898|Name:PubMed, SrcID:18600528, URL:http://europepmc.org/abstract/MED/18600528|Name:Wikipedia, SrcID:Trifluridine, URL:http://en.wikipedia.org/wiki/Trifluridine",OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(C(=O)NC2=O)C(F)(F)F,,
2091,CHEMBL54,Haloperidol,Small molecule,1967.0,N05AD01,N05AD01 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Butyrophenone derivatives],-peridol,D2-like dopamine receptor inverse agonist,,,CHEMBL2331075,D2-like dopamine receptor,INVERSE AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:ISBN, SrcID:0443059748, URL:http://www.isbnsearch.org/isbn/0443059748|Name:Wikipedia, SrcID:Haloperidol, URL:http://en.wikipedia.org/wiki/Haloperidol|Name:PubMed, SrcID:17015232, URL:http://europepmc.org/abstract/MED/17015232",OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,,
2092,CHEMBL15891,Lindane,Small molecule,1974.0,P03AB02,"P03AB02 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS: ECTOPARASITICIDES, INCL. SCABICIDES: Chlorine containing products]",,GABA-A receptor negative allosteric modulator,"mode not clear, but seems negative and likely allosteric, binds at picrotoxin site?",,CHEMBL2364024,GABA-A receptor,NEGATIVE ALLOSTERIC MODULATOR,Sarcoptes scabiei,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:14635176, URL:http://europepmc.org/abstract/MED/14635176|Name:Wikipedia, SrcID:Lindane, URL:http://en.wikipedia.org/wiki/Lindane",Cl[C@@H]1[C@@H](Cl)[C@H](Cl)[C@H](Cl)[C@@H](Cl)[C@@H]1Cl,,
2093,CHEMBL1177,Pemoline,Small molecule,1975.0,N06BA05,"N06BA05 [NERVOUS SYSTEM: PSYCHOANALEPTICS: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS: Centrally acting sympathomimetics]",,Unknown,,,,,,,,,,"Name:FDA, SrcID:label/2003/016832s022_017703s018lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/016832s022_017703s018lbl.pdf",NC1=NC(=O)C(O1)c2ccccc2,,
2094,CHEMBL125,Miltefosine,Small molecule,2014.0,L01XX09,L01XX09 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-fo-,Unknown,"The mechanism of action of miltefosine is likely to involve interaction with lipids (phospholipids and sterols), including membrane lipids, inhibition of cytochrome c oxidase (mitochondrial function), and apoptosis-like cell death.",,,,,,,,,"Name:FDA, SrcID:label/2014/204684s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204684s000lbl.pdf|Name:PubMed, SrcID:24614380, URL:http://europepmc.org/abstract/MED/24614380",CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,,
2095,CHEMBL235668,Tipiracil,Small molecule,2015.0,,,-racil,Thymidine phosphorylase inhibitor,,,CHEMBL3106,Thymidine phosphorylase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f5beed22-d71d-4c0d-8dca-2c7317d65d85, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f5beed22-d71d-4c0d-8dca-2c7317d65d85",ClC1=C(CN2CCCC2=N)NC(=O)NC1=O,CHEMBL3106,TYMP
2096,CHEMBL3545299,Bms-698769,Small molecule,,,,,Hepatocyte growth factor receptor inhibitor,,,CHEMBL3717,Hepatocyte growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://mct.aacrjournals.org/content/6/11_Supplement/B258.short, URL:http://mct.aacrjournals.org/content/6/11_Supplement/B258.short",,CHEMBL3717,MET
2097,CHEMBL3545426,Cc-115,Small molecule,,,,,DNA-dependent protein kinase inhibitor,ATP-competitive mTORC1/mTORC2 inhibitor,,CHEMBL3142,DNA-dependent protein kinase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26102506, URL:http://europepmc.org/abstract/MED/26102506",,CHEMBL3142,PRKDC
2098,CHEMBL3545051,Cep-37440,Small molecule,,,,,Focal adhesion kinase 1 inhibitor,,,CHEMBL2695,Focal adhesion kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1158/1538-7445.AM2015-3232, URL:http://cancerres.aacrjournals.org/content/75/15_Supplement/3232|Name:PubMed, SrcID:25888090, URL:http://europepmc.org/abstract/MED/25888090|Name:PubMed, SrcID:25322323, URL:http://europepmc.org/abstract/MED/25322323",,CHEMBL2695,PTK2
2099,CHEMBL3545142,Olocrolimus,Small molecule,,,,-imus,FK506-binding protein 1A inhibitor,"A rapamycin (sirolimus) derivative. Inhibits proliferation signalling probably, like rapamycin, via interaction with FK Binding Protein-12 and the mammalian target of rapamycin (mTOR) (http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3275b824-3f82-4151-2ab2-0036a9ba0acc).",,CHEMBL1902,FK506-binding protein 1A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21671437, URL:http://europepmc.org/abstract/MED/21671437",,CHEMBL1902,FKBP1A
2100,CHEMBL3544935,Xl-418,Small molecule,,,,,Serine/threonine-protein kinase AKT inhibitor,,,CHEMBL2111353,Serine/threonine-protein kinase AKT,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:13891463, URL:http://europepmc.org/abstract/MED/13891463|Name:ClinicalTrials, SrcID:NCT00460278, URL:https://www.clinicaltrials.gov/ct2/show/NCT00460278",,,
2101,CHEMBL3545386,Bi113823,Small molecule,,,,,Bradykinin B1 receptor antagonist,,,CHEMBL4308,Bradykinin B1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25088373, URL:http://europepmc.org/abstract/MED/25088373",,CHEMBL4308,BDKRB1
2102,CHEMBL3545280,Efatutazone,Small molecule,,,,,Peroxisome proliferator-activated receptor gamma agonist,"Daichii Sankyo has suspended inhouse development in jan 2013, supports external development of the compound.",,CHEMBL235,Peroxisome proliferator-activated receptor gamma,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://chem.sis.nlm.nih.gov/chemidplus/rn/223132-38-5, URL:http://chem.sis.nlm.nih.gov/chemidplus/rn/223132-38-5|Name:Other, SrcID:http://www.daiichisankyo.com/media_investors/investor_relations/ir_calendar/files/005203/Reference%20Data.pdf, URL:http://www.daiichisankyo.com/media_investors/investor_relations/ir_calendar/files/005203/Reference%20Data.pdf|Name:PubMed, SrcID:18511262, URL:http://europepmc.org/abstract/MED/18511262",Cc1cc(Oc2ccc3nc(COc4ccc(CC5SC(=O)NC5=O)cc4)n(C)c3c2)cc(C)c1N,CHEMBL235,PPARG
2103,CHEMBL1230609,Foretinib,Small molecule,,,,-tinib,Hepatocyte growth factor receptor inhibitor,,,CHEMBL3717,Hepatocyte growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.exelixis.com/pipeline/xl880, URL:http://www.exelixis.com/pipeline/xl880|Name:PubMed, SrcID:19808973, URL:http://europepmc.org/abstract/MED/19808973",COc1cc2c(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc5ccc(F)cc5)cc3F)ccnc2cc1OCCCN6CCOCC6,CHEMBL3717,MET
2104,CHEMBL206834,Bafetinib,Small molecule,,,,-tinib,Tyrosine-protein kinase ABL inhibitor,,,CHEMBL1862,Tyrosine-protein kinase ABL,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16105974, URL:http://europepmc.org/abstract/MED/16105974",CN(C)[C@H]1CCN(Cc2ccc(cc2C(F)(F)F)C(=O)Nc3ccc(C)c(Nc4nccc(n4)c5cncnc5)c3)C1,CHEMBL1862,ABL1
2105,CHEMBL403989,Tg100-801,Small molecule,,,,,Fibroblast growth factor receptor 1 inhibitor,Prodrug - active metabolite is TG-100-572 (HY-10184),,CHEMBL3650,Fibroblast growth factor receptor 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18311895, URL:http://europepmc.org/abstract/MED/18311895|Name:PubMed, SrcID:18483622, URL:http://europepmc.org/abstract/MED/18483622|Name:PubMed, SrcID:18330892, URL:http://europepmc.org/abstract/MED/18330892",Cc1cc(cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12)c5cc(OC(=O)c6ccccc6)ccc5Cl,CHEMBL3650,FGFR1
2106,CHEMBL3544999,Ly-3023414,Small molecule,,,,,Serine/threonine-protein kinase mTOR inhibitor,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL2842,Serine/threonine-protein kinase mTOR,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.lillyoncologypipeline.com/pi3kmtor-dual-inhibitor.aspx, URL:http://www.lillyoncologypipeline.com/pi3kmtor-dual-inhibitor.aspx",,CHEMBL2842,MTOR
2107,CHEMBL3545035,Revexepride,Small molecule,,,,-pride,Serotonin 4 (5-HT4) receptor agonist,,,CHEMBL1875,Serotonin 4 (5-HT4) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25767373, URL:http://europepmc.org/abstract/MED/25767373",COCCCN1CC[C@@H](CNC(=O)c2cc(Cl)c(N)c3CC(C)(C)Oc23)[C@H](O)C1,CHEMBL1875,HTR4
2108,CHEMBL218427,Fasitibant,Small molecule,,,,-tibant,Bradykinin B2 receptor antagonist,,,CHEMBL3157,Bradykinin B2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24333733, URL:http://europepmc.org/abstract/MED/24333733|Name:PubMed, SrcID:23973149, URL:http://europepmc.org/abstract/MED/23973149",Cc1cc(C)c2cccc(OCc3c(Cl)ccc(c3Cl)S(=O)(=O)NC4(CCOCC4)C(=O)N5CCN(CC5)C(=O)[C@@H](N)CCC[N+](C)(C)C)c2n1,CHEMBL3157,BDKRB2
2109,CHEMBL3545165,Afacifenacin,Small molecule,,,,-fenacin,Muscarinic acetylcholine receptor antagonist,Non-selective muscarinic receptor antagonist and sodium channel blocker.,,CHEMBL2094109,Muscarinic acetylcholine receptor,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://www.jurology.com/article/S0022-5347(08)60371-7/pdf, URL:http://www.jurology.com/article/S0022-5347(08)60371-7/pdf|Name:Other, SrcID:http://www.ds-pharma.com/ir/library/financial_results_summary/pdf/ebr20130131_2.pdf, URL:http://www.ds-pharma.com/ir/library/financial_results_summary/pdf/ebr20130131_2.pdf",FC(F)(F)Oc1cccc(CN2CCC(CC2)N3C(c4ccccc4)c5ccccc5NC3=O)c1,,
2110,CHEMBL2110618,Minopafant,Small molecule,,,,-pafant,Platelet activating factor receptor antagonist,,,CHEMBL250,Platelet activating factor receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:1663352, URL:http://europepmc.org/abstract/MED/1663352",CCCCCCCCCCCCCCCCCCNC(=O)OC1CCN(CC1)C(=O)OC[C@H](COC(=O)N(Cc2cccc[n+]2CC)C(=O)c3ccccc3OC)OC,CHEMBL250,PTAFR
2111,CHEMBL1742428,Donitriptan,Small molecule,,,,-triptan,G protein-coupled receptor 44 antagonist,,,CHEMBL5071,G protein-coupled receptor 44,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.arraybiopharma.com/product-pipeline/other-compounds/arry-502/, URL:http://www.arraybiopharma.com/product-pipeline/other-compounds/arry-502/|Name:Other, SrcID:http://erj.ersjournals.com/content/44/Suppl_58/4836, URL:http://erj.ersjournals.com/content/44/Suppl_58/4836",NCCc1c[nH]c2ccc(OCC(=O)N3CCN(CC3)c4ccc(cc4)C#N)cc12,CHEMBL5071,PTGDR2
2112,CHEMBL3545228,Jts-653,Small molecule,,,,,Vanilloid receptor antagonist,,,CHEMBL4794,Vanilloid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21804597, URL:http://europepmc.org/abstract/MED/21804597|Name:PubMed, SrcID:22588258, URL:http://europepmc.org/abstract/MED/22588258",,CHEMBL4794,TRPV1
2113,CHEMBL372205,Lecozotan,Small molecule,,,,-zotan,Serotonin 1a (5-HT1a) receptor antagonist,Not in current pipeline,,CHEMBL214,Serotonin 1a (5-HT1a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15951399, URL:http://europepmc.org/abstract/MED/15951399",C[C@H](CN(C(=O)c1ccc(cc1)C#N)c2ccccn2)N3CCN(CC3)c4cccc5OCCOc45,CHEMBL214,HTR1A
2114,CHEMBL119709,Ib-Meca,Small molecule,,,,,Adenosine A3 receptor agonist,,,CHEMBL256,Adenosine A3 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17922624, URL:http://europepmc.org/abstract/MED/17922624",CNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(NCc4cccc(I)c4)ncnc23,CHEMBL256,ADORA3
2115,CHEMBL2108569,Insulin Peglispro,Protein,,,,,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26988411, URL:http://europepmc.org/abstract/MED/26988411|Name:PubMed, SrcID:27723227, URL:http://europepmc.org/abstract/MED/27723227",,CHEMBL1981,INSR
2116,CHEMBL2103866,Forigerimod,Small molecule,,,,-imod,Heat shock cognate 71 kDa protein inhibitor,Immunomodulator. Inhibits the ability of HSC70 to refold denatured protein,,CHEMBL1275223,Heat shock cognate 71 kDa protein,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19390596, URL:http://europepmc.org/abstract/MED/19390596|Name:PubMed, SrcID:21173017, URL:http://europepmc.org/abstract/MED/21173017",CN[C@@H](COP(=O)(O)O)C(=O)C,CHEMBL1275223,HSPA8
2117,CHEMBL416146,Etoricoxib,Small molecule,,M01AH05,"M01AH05 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Coxibs]",-coxib,Cyclooxygenase-2 inhibitor,,Selectively inhibits COX-2 (IC(50) = 1.1 +/- 0.1microM) compared with COX-1 IC(50)=116 +/- 8 microM.,CHEMBL230,Cyclooxygenase-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11160644, URL:http://europepmc.org/abstract/MED/11160644",Cc1ccc(cn1)c2ncc(Cl)cc2c3ccc(cc3)S(=O)(=O)C,CHEMBL230,PTGS2
2118,CHEMBL2107821,Emixustat,Small molecule,,,,-stat,Retinoid isomerohydrolase inhibitor,,,CHEMBL3831182,Retinoid isomerohydrolase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24056528 , URL:http://europepmc.org/abstract/MED/24056528 |Name:PubMed, SrcID:24056528, URL:http://europepmc.org/abstract/MED/24056528",NCC[C@@H](O)c1cccc(OCC2CCCCC2)c1,CHEMBL3831182,RPE65
2119,CHEMBL1615835,Muparfostat,Oligosaccharide,,,,-fo-; -stat,Basic fibroblast growth factor inhibitor,PI-88 acts as a competitive inhibitor of FGF-2 binding to cell surface and matrix HSPG.,,CHEMBL3107,Basic fibroblast growth factor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:14521421, URL:http://europepmc.org/abstract/MED/14521421|Name:PubMed, SrcID:12690039, URL:http://europepmc.org/abstract/MED/12690039",OP(=O)(O)OC[C@H]1O[C@H](O[C@H]2[C@H](OS(=O)(=O)O)[C@@H](COS(=O)(=O)O)O[C@H](O[C@H]3[C@H](OS(=O)(=O)O)[C@@H](COS(=O)(=O)O)O[C@H](O[C@H]4[C@H](OS(=O)(=O)O)[C@@H](COS(=O)(=O)O)O[C@H](O[C@@H]5[C@@H](OS(=O)(=O)O)O[C@H](COS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@@H]5OS(=O)(=O)O)[C@H]4OS(=O)(=O)O)[C@H]3OS(=O)(=O)O)[C@H]2OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@@H]1OS(=O)(=O)O,CHEMBL3107,FGF2
2120,CHEMBL3301587,Durvalumab,Antibody,,,,-mab,Programmed cell death 1 ligand 1 inhibitor,Blocks PD-L1 binding to PD-1 (IC50 0.1 nM) and CD80 (IC50 0.04 nM).,,CHEMBL3580522,Programmed cell death 1 ligand 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:27265743, URL:http://europepmc.org/abstract/MED/27265743|Name:PubMed, SrcID:25943534, URL:http://europepmc.org/abstract/MED/25943534",,CHEMBL3580522,CD274
2121,CHEMBL1742997,Cantuzumab Mertansine,Antibody,,,,-mab,Mucin-1 binding agent,HuC242 binds specifically to the extracellular domain of a tumor-associated carbohydrate epitope of CanAg (a novel glycoform of MUC1).,,CHEMBL3580494,Mucin-1,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12525512, URL:http://europepmc.org/abstract/MED/12525512",,,
2122,CHEMBL1743005,Dacetuzumab,Antibody,,,,-mab,Tumor necrosis factor receptor superfamily member 5 inhibitor,Triggers antibody-dependent cell-mediated cytotoxicity. Mediates apoptosis.,,CHEMBL1250358,Tumor necrosis factor receptor superfamily member 5,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21810918, URL:http://europepmc.org/abstract/MED/21810918",,CHEMBL1250358,CD40
2123,CHEMBL1743045,Naptumomab Estafenatox,Antibody,,,,-mab,Trophoblast glycoprotein other,"The therapeutic effect is associated with activation of SAg-binding T cells. The SAg-binding T lymphocytes expand, differentiate to effector cells, and infiltrate the tumor. The therapeutic efficacy is most likely related to the dual mechanism of tumor cell killing: (1) direct lysis by cytotoxic T lymphocytes of tumor cells expressing the antigen recognized by the antibody moiety of the fusion protein and (2) secretion of cytokines eliminating antigen-negative tumor cell variants.",,CHEMBL3712934,Trophoblast glycoprotein,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24445502, URL:http://europepmc.org/abstract/MED/24445502",,CHEMBL3712934,TPBG
2124,CHEMBL1743083,Tregalizumab,Antibody,,,,-mab,T-cell surface antigen CD4 agonist,"Humanised anti-human CD4 IgG1 mAb, which selectively activates regulatory T cells (Tregs) by binding to CD4 and activatiing signalling downstream pathways. Does not induce antibody-dependent cell-mediated cytotoxicity or complement-dependent cytotoxicity.",,CHEMBL2754,T-cell surface antigen CD4,AGONIST,Homo sapiens,SINGLE PROTEIN,,Binds epitope in the IgG-like C2 type 1 domain distinct from binding region for other ligands,"Name:PubMed, SrcID:25512343, URL:http://europepmc.org/abstract/MED/25512343|Name:PMC, SrcID:PMC4724712, URL:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724712",,CHEMBL2754,CD4
2125,CHEMBL2109433,Mor-103,Antibody,,,,,Granulocyte-macrophage colony-stimulating factor inhibitor,,,CHEMBL3712955,Granulocyte-macrophage colony-stimulating factor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24534756, URL:http://europepmc.org/abstract/MED/24534756",,CHEMBL3712955,CSF2
2126,CHEMBL2109482,Bi-505,Antibody,,,,,Intercellular adhesion molecule-1 antagonist,,,CHEMBL3070,Intercellular adhesion molecule-1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23597564, URL:http://europepmc.org/abstract/MED/23597564",,CHEMBL3070,ICAM1
2127,CHEMBL2109485,Oncolysin Cd6,Antibody,,,,,T-cell differentiation antigen CD6 binding agent,Immunotoxin.,,CHEMBL3712853,T-cell differentiation antigen CD6,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://oncologyknowledgebase.com/futureoncology/pdfs/Future_Oncology.Vol.1.No.11.pdf, URL:http://oncologyknowledgebase.com/futureoncology/pdfs/Future_Oncology.Vol.1.No.11.pdf",,CHEMBL3712853,CD6
2128,CHEMBL3545020,Mbx-2044,Small molecule,,,,,Peroxisome proliferator-activated receptor gamma modulator,Selective PPAR gamma modulator (SPPAR?M),,CHEMBL235,Peroxisome proliferator-activated receptor gamma,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,,,CHEMBL235,PPARG
2129,CHEMBL3039583,Pasireotide,Protein,2012.0,H01CB05,"H01CB05 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: HYPOTHALAMIC HORMONES: Somatostatin and analogues]",-tide,Somatostatin receptor 5 agonist,,Non-selective but type 5 receptor is overexpressed in Cushing's disease,CHEMBL1792,Somatostatin receptor 5,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=5504116c-d531-4d47-b160-41c6671d52aa, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5504116c-d531-4d47-b160-41c6671d52aa|Name:PubMed, SrcID:22397653, URL:http://europepmc.org/abstract/MED/22397653|Name:DailyMed, SrcID:setid=442f0d9d-5c7d-4b81-b329-d71be8cf2be2, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=442f0d9d-5c7d-4b81-b329-d71be8cf2be2|Name:PubMed, SrcID:11980628, URL:http://europepmc.org/abstract/MED/11980628",NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](NC(=O)[C@@H]4C[C@@H](CN4C(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](Cc6ccc(OCc7ccccc7)cc6)NC1=O)OC(=O)NCCN)c8ccccc8,CHEMBL1792,SSTR5
2130,CHEMBL477772,Pazopanib,Small molecule,2009.0,L01XE11,L01XE11 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-anib,Macrophage colony stimulating factor receptor inhibitor,,,CHEMBL1844,Macrophage colony stimulating factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14",CN(c1ccc2c(C)n(C)nc2c1)c3ccnc(Nc4ccc(C)c(c4)S(=O)(=O)N)n3,CHEMBL1844,CSF1R
2131,CHEMBL1201247,Goserelin,Protein,1989.0,L02AE03,L02AE03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONES AND RELATED AGENTS: Gonadotropin releasing hormone analogues],-relin,Gonadotropin-releasing hormone receptor agonist,,,CHEMBL1855,Gonadotropin-releasing hormone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=4ff62a5a-77ba-4bf5-0497-95ccca842315#section-12, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4ff62a5a-77ba-4bf5-0497-95ccca842315#section-12",CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4cnc[nH]4)NC(=O)[C@@H]5CCC(=O)N5)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N6CCC[C@H]6C(=O)NNC(=O)N,CHEMBL1855,GNRHR
2132,CHEMBL1189679,Palonosetron,Small molecule,2003.0,A04AA05; A04AA55,A04AA05 [ALIMENTARY TRACT AND METABOLISM: ANTIEMETICS AND ANTINAUSEANTS: ANTIEMETICS AND ANTINAUSEANTS: Serotonin (5HT3) antagonists]; A04AA55 [ALIMENTARY TRACT AND METABOLISM: ANTIEMETICS AND ANTINAUSEANTS: ANTIEMETICS AND ANTINAUSEANTS: Serotonin (5HT3) antagonists],-setron,Serotonin 3a (5-HT3a) receptor antagonist,,,CHEMBL1899,Serotonin 3a (5-HT3a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=bd06f321-bb42-4748-92f3-d59626b540e0, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bd06f321-bb42-4748-92f3-d59626b540e0|Name:FDA, SrcID:label/2016/203050s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/203050s000lbl.pdf",O=C1N(C[C@H]2CCCc3cccc1c23)[C@@H]4CN5CCC4CC5,CHEMBL1899,HTR3A
2133,CHEMBL637,Venlafaxine,Small molecule,1993.0,N06AX16,N06AX16 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants],-faxine,Serotonin transporter inhibitor,,,CHEMBL228,Serotonin transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f2f03495-12b6-457a-901f-958b9c844bfd#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f2f03495-12b6-457a-901f-958b9c844bfd#nlm34090-1",COc1ccc(cc1)C(CN(C)C)C2(O)CCCCC2,CHEMBL228,SLC6A4
2134,CHEMBL941,Imatinib,Small molecule,2001.0,L01XE01,L01XE01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Stem cell growth factor receptor inhibitor,,,CHEMBL1936,Stem cell growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13|Name:Wikipedia, SrcID:Bcr-Abl_tyrosine-kinase_inhibitor, URL:http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor",CN1CCN(Cc2ccc(cc2)C(=O)Nc3ccc(C)c(Nc4nccc(n4)c5cccnc5)c3)CC1,CHEMBL1936,KIT
2135,CHEMBL908,Chlorprothixene,Small molecule,1967.0,N05AF03,N05AF03 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Thioxanthene derivatives],,Serotonin 2c (5-HT2c) receptor antagonist,,,CHEMBL225,Serotonin 2c (5-HT2c) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:2891550, URL:http://europepmc.org/abstract/MED/2891550|Name:Wikipedia, SrcID:Antipsychotic#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Antipsychotic#Mechanism_of_action|Name:Wikipedia, SrcID:Chlorprothixene#Pharmacology, URL:http://en.wikipedia.org/wiki/Chlorprothixene#Pharmacology|Name:PubMed, SrcID:3774629, URL:http://europepmc.org/abstract/MED/3774629",CN(C)CC\C=C/1\c2ccccc2Sc3ccc(Cl)cc13,,
2136,CHEMBL405,Amphetamine,Small molecule,1955.0,N06BA01,"N06BA01 [NERVOUS SYSTEM: PSYCHOANALEPTICS: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS: Centrally acting sympathomimetics]",,Dopamine transporter releasing agent,,,CHEMBL238,Dopamine transporter,RELEASING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:KEGG, SrcID:D07445, URL:http://www.kegg.jp/dbget-bin/www_bget?dr:D07445|Name:PubMed, SrcID:15602501, URL:http://europepmc.org/abstract/MED/15602501|Name:PubMed, SrcID:15795321, URL:http://europepmc.org/abstract/MED/15795321",CC(N)Cc1ccccc1,CHEMBL238,SLC6A3
2137,CHEMBL656,Oxycodone,Small molecule,1950.0,N02AA05,N02AA05 [NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Natural opium alkaloids],,Mu opioid receptor agonist,,,CHEMBL233,Mu opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=dd9f9d6d-9a59-4f74-8fe7-685e0c3c5fd4#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dd9f9d6d-9a59-4f74-8fe7-685e0c3c5fd4#nlm34090-1",COc1ccc2C[C@H]3N(C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O,CHEMBL233,OPRM1
2138,CHEMBL1237026,Tesamorelin,Protein,2010.0,H01AC06,"H01AC06 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES: Somatropin and somatropin agonists]",-relin,Growth hormone-releasing hormone receptor agonist,,,CHEMBL2032,Growth hormone-releasing hormone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=3de31cec-31dc-4ac4-9717-367a687d22f2, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3de31cec-31dc-4ac4-9717-367a687d22f2",,CHEMBL2032,GHRHR
2139,CHEMBL1200384,Betamethasone Dipropionate,Small molecule,1975.0,H02AB01; R01AD06; S01CB04; D07XC01; S03BA03; C05AA05; S01BA06; S02BA07; R03BA04; A07EA04; D07AC01,"H02AB01 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Glucocorticoids]; R01AD06 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Corticosteroids]; S01CB04 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION: Corticosteroids/antiinfectives/mydriatics in combination]; D07XC01 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, OTHER COMBINATIONS: Corticosteroids, potent, other combinations]; S03BA03 [SENSORY ORGANS: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS: CORTICOSTEROIDS: Corticosteroids]; C05AA05 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Corticosteroids]; S01BA06 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Corticosteroids, plain]; S02BA07 [SENSORY ORGANS: OTOLOGICALS: CORTICOSTEROIDS: Corticosteroids]; R03BA04 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS: Glucocorticoids]; A07EA04 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Corticosteroids acting locally]; D07AC01 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, potent (group III)]",,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12188035, URL:http://europepmc.org/abstract/MED/12188035|Name:DailyMed, SrcID:setid=892bf494-0b95-4314-a253-79350fdd7238#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=892bf494-0b95-4314-a253-79350fdd7238#nlm34090-1|Name:Wikipedia, SrcID:Betamethasone, URL:http://en.wikipedia.org/wiki/Betamethasone",CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C,CHEMBL2034,NR3C1
2140,CHEMBL1651,Dexamethasone Acetate,Small molecule,1973.0,S02BA06; D07XB05; R01AD03; H02AB02; C05AA09; A01AC02; S03BA01; D10AA03; D07AB19; R01AD53; S01BA01; S01CB01,"S02BA06 [SENSORY ORGANS: OTOLOGICALS: CORTICOSTEROIDS: Corticosteroids]; D07XB05 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, OTHER COMBINATIONS: Corticosteroids, moderately potent, other combinations]; R01AD03 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Corticosteroids]; H02AB02 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Glucocorticoids]; C05AA09 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Corticosteroids]; A01AC02 [ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Corticosteroids for local oral treatment]; S03BA01 [SENSORY ORGANS: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS: CORTICOSTEROIDS: Corticosteroids]; D10AA03 [DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Corticosteroids, combinations for treatment of acne]; D07AB19 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, moderately potent (group II)]; R01AD53 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Corticosteroids]; S01BA01 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Corticosteroids, plain]; S01CB01 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION: Corticosteroids/antiinfectives/mydriatics in combination]",,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20957171, URL:http://europepmc.org/abstract/MED/20957171|Name:ISBN, SrcID:0443-059748 PP. 421, URL:http://www.isbnsearch.org/isbn/0443059748",C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C)C(=O)CO,CHEMBL2034,NR3C1
2141,CHEMBL1276308,Mifepristone,Small molecule,2000.0,G03XB01; G03XB51,G03XB01 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: Progesterone receptor modulators]; G03XB51 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: Progesterone receptor modulators],-pristone,Glucocorticoid receptor antagonist,,Selective,CHEMBL2034,Glucocorticoid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=542f3fae-8bc8-4f00-9228-e4b66c9ad6a9, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=542f3fae-8bc8-4f00-9228-e4b66c9ad6a9|Name:PubMed, SrcID:22466348, URL:http://europepmc.org/abstract/MED/22466348",CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c5ccc(cc5)N(C)C,CHEMBL2034,NR3C1
2142,CHEMBL1405,Estrone,Small molecule,1979.0,G03CC04; G03CA07,"G03CC04 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ESTROGENS: Estrogens, combinations with other drugs]; G03CA07 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ESTROGENS: Natural and semisynthetic estrogens, plain]",estr-,Estrogen receptor alpha agonist,,,CHEMBL206,Estrogen receptor alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:6863279, URL:http://europepmc.org/abstract/MED/6863279",C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O,CHEMBL206,ESR1
2143,CHEMBL1201260,Bethanidine,Small molecule,1982.0,C02CC01,"C02CC01 [CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING: Guanidine derivatives]",,Norepinephrine transporter substrate,accumulates and displaces NE,,CHEMBL222,Norepinephrine transporter,SUBSTRATE,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:7066153, URL:http://europepmc.org/abstract/MED/7066153|Name:ISBN, SrcID:9780702034718 PP. 190-191, URL:http://www.isbnsearch.org/isbn/9780702034718",CN\C(=N/C)\NCc1ccccc1,CHEMBL222,SLC6A2
2144,CHEMBL170,Quinine,Small molecule,2005.0,M09AA72; P01BC01,"M09AA72 [MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: Quinine and derivatives]; P01BC01 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: ANTIMALARIALS: Methanolquinolines]",,Ferriprotoporphyrin IX inhibitor,,,CHEMBL613897,Ferriprotoporphyrin IX,INHIBITOR,Plasmodium falciparum,SMALL MOLECULE,,,"Name:PubMed, SrcID:14967191, URL:http://europepmc.org/abstract/MED/14967191|Name:DailyMed, SrcID:setid=1f66fba7-4026-4504-918d-4c88f2835cc0#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1f66fba7-4026-4504-918d-4c88f2835cc0#section-14",COc1ccc2nccc([C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C)c2c1,,
2145,CHEMBL2,Prazosin,Small molecule,1976.0,C02CA01,"C02CA01 [CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING: Alpha-adrenoreceptor antagonists]",-azosin,Adrenergic receptor alpha-1 antagonist,,,CHEMBL2094251,Adrenergic receptor alpha-1,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=36c4da56-502e-4da1-acf7-8e81ee453dcc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=36c4da56-502e-4da1-acf7-8e81ee453dcc|Name:Wikipedia, SrcID:Alpha-1_blocker, URL:http://en.wikipedia.org/wiki/Alpha-1_blocker",COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)c4occc4,,
2146,CHEMBL1297,Fenoprofen,Small molecule,1976.0,M01AE04,"M01AE04 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Propionic acid derivatives]",-profen,Cyclooxygenase inhibitor,,,CHEMBL2094253,Cyclooxygenase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=f90becaa-a4f3-44aa-ac8c-c69935c5ddb2, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f90becaa-a4f3-44aa-ac8c-c69935c5ddb2|Name:PubMed, SrcID:17050798, URL:http://europepmc.org/abstract/MED/17050798",CC(C(=O)O)c1cccc(Oc2ccccc2)c1,,
2147,CHEMBL597,Phentolamine,Small molecule,1952.0,C04AB01; V03AB36,C04AB01 [CARDIOVASCULAR SYSTEM: PERIPHERAL VASODILATORS: PERIPHERAL VASODILATORS: Imidazoline derivatives]; V03AB36 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Antidotes],,Adrenergic receptor alpha antagonist,,,CHEMBL2095203,Adrenergic receptor alpha,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=38be9414-87c4-4a8a-9f17-99be0d0a33fa#section-12, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=38be9414-87c4-4a8a-9f17-99be0d0a33fa#section-12",Cc1ccc(cc1)N(CC2=NCCN2)c3cccc(O)c3,,
2148,CHEMBL117785,Tetrabenazine,Small molecule,2008.0,N07XX06,N07XX06 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs],,Synaptic vesicular amine transporter inhibitor,,,CHEMBL1893,Synaptic vesicular amine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=ac768bab-8afa-4446-bc7f-caeeffec0cda, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ac768bab-8afa-4446-bc7f-caeeffec0cda",COc1cc2CCN3CC(CC(C)C)C(=O)CC3c2cc1OC,CHEMBL1893,SLC18A2
2149,CHEMBL979,Meprobamate,Small molecule,1955.0,N05BC51; N05BC01; N05CX01,"N05BC51 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Carbamates]; N05BC01 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Carbamates]; N05CX01 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Hypnotics and sedatives in combination, excl. barbiturates]",-bamate,GABA-A receptor; anion channel agonist,,,CHEMBL2093872,GABA-A receptor; anion channel,AGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,GABA A binding site,GABA site,"Name:Wikipedia, SrcID:Meprobamate, URL:http://en.wikipedia.org/wiki/Meprobamate|Name:PubMed, SrcID:9067327, URL:http://europepmc.org/abstract/MED/9067327",CCCC(C)(COC(=O)N)COC(=O)N,CHEMBL2093872,GABRG3
2150,CHEMBL979,Meprobamate,Small molecule,1955.0,N05BC51; N05BC01; N05CX01,"N05BC51 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Carbamates]; N05BC01 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Carbamates]; N05CX01 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Hypnotics and sedatives in combination, excl. barbiturates]",-bamate,GABA-A receptor; anion channel agonist,,,CHEMBL2093872,GABA-A receptor; anion channel,AGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,GABA A binding site,GABA site,"Name:Wikipedia, SrcID:Meprobamate, URL:http://en.wikipedia.org/wiki/Meprobamate|Name:PubMed, SrcID:9067327, URL:http://europepmc.org/abstract/MED/9067327",CCCC(C)(COC(=O)N)COC(=O)N,CHEMBL2093872,GABRP
2151,CHEMBL979,Meprobamate,Small molecule,1955.0,N05BC51; N05BC01; N05CX01,"N05BC51 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Carbamates]; N05BC01 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Carbamates]; N05CX01 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Hypnotics and sedatives in combination, excl. barbiturates]",-bamate,GABA-A receptor; anion channel agonist,,,CHEMBL2093872,GABA-A receptor; anion channel,AGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,GABA A binding site,GABA site,"Name:Wikipedia, SrcID:Meprobamate, URL:http://en.wikipedia.org/wiki/Meprobamate|Name:PubMed, SrcID:9067327, URL:http://europepmc.org/abstract/MED/9067327",CCCC(C)(COC(=O)N)COC(=O)N,CHEMBL2093872,GABRE
2152,CHEMBL979,Meprobamate,Small molecule,1955.0,N05BC51; N05BC01; N05CX01,"N05BC51 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Carbamates]; N05BC01 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Carbamates]; N05CX01 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Hypnotics and sedatives in combination, excl. barbiturates]",-bamate,GABA-A receptor; anion channel agonist,,,CHEMBL2093872,GABA-A receptor; anion channel,AGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,GABA A binding site,GABA site,"Name:Wikipedia, SrcID:Meprobamate, URL:http://en.wikipedia.org/wiki/Meprobamate|Name:PubMed, SrcID:9067327, URL:http://europepmc.org/abstract/MED/9067327",CCCC(C)(COC(=O)N)COC(=O)N,CHEMBL2093872,GABRG1
2153,CHEMBL1201560,Peginterferon Alfa-2a,Protein,2002.0,L03AB61; L03AB11,L03AB61 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSTIMULANTS: IMMUNOSTIMULANTS: Interferons]; L03AB11 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSTIMULANTS: IMMUNOSTIMULANTS: Interferons],peg-,Interferon alpha/beta receptor agonist,,,CHEMBL2364170,Interferon alpha/beta receptor,AGONIST,Homo sapiens,PROTEIN COMPLEX,,Alpha subunit is binding site,"Name:PubMed, SrcID:17969444, URL:http://europepmc.org/abstract/MED/17969444|Name:DailyMed, SrcID:setid=de61685e-2b8c-4e22-84bb-869e13600440, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de61685e-2b8c-4e22-84bb-869e13600440",,CHEMBL2364170,IFNAR2
2154,CHEMBL788,Idoxuridine,Small molecule,1963.0,D06BB01; S01AD01; J05AB02,D06BB01 [DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: CHEMOTHERAPEUTICS FOR TOPICAL USE: Antivirals]; S01AD01 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Antivirals]; J05AB02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleosides and nucleotides excl. reverse transcriptase inhibitors],-uridine,DNA inhibitor,Incorporation into DNA,,CHEMBL2366042,DNA,INHIBITOR,Human herpesvirus 1,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:archiveid=192294, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=192294|Name:DailyMed, SrcID:setid=3537dd95-954c-459f-97a9-54a861bed265, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3537dd95-954c-459f-97a9-54a861bed265",OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(I)C(=O)NC2=O,,
2155,CHEMBL1257,Enflurane,Small molecule,1972.0,N01AB04,"N01AB04 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,Potassium channel subfamily K member 18 opener,,,CHEMBL2331042,Potassium channel subfamily K member 18,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:16973644, URL:http://europepmc.org/abstract/MED/16973644|Name:PubMed, SrcID:17227289, URL:http://europepmc.org/abstract/MED/17227289",FC(F)OC(F)(F)C(F)Cl,CHEMBL2331042,KCNK18
2156,CHEMBL741,Lamotrigine,Small molecule,1994.0,N03AX09,N03AX09 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=d7e3572d-56fe-4727-2bb4-013ccca22678#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d7e3572d-56fe-4727-2bb4-013ccca22678#nlm34090-1|Name:PubMed, SrcID:15208697, URL:http://europepmc.org/abstract/MED/15208697|Name:PubMed, SrcID:23205958, URL:http://europepmc.org/abstract/MED/23205958|Name:PubMed, SrcID:23239147, URL:http://europepmc.org/abstract/MED/23239147",Nc1nnc(c(N)n1)c2cccc(Cl)c2Cl,,
2157,CHEMBL2103758,Pramlintide,Protein,2005.0,A10BX05,"A10BX05 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Other blood glucose lowering drugs, excl. insulins]",-tide,Amylin receptor AMY2; CALCR/RAMP2 agonist,"Is amylin analogue, calcitonin receptor is binding site",,CHEMBL2364173,Amylin receptor AMY2; CALCR/RAMP2,AGONIST,Homo sapiens,PROTEIN COMPLEX,Calcitonin receptor,Calcitonin receptor is binding site,"Name:DailyMed, SrcID:setid=d2262f20-bedb-43d9-b274-6ce275b0a69e, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d2262f20-bedb-43d9-b274-6ce275b0a69e|Name:IUPHAR, SrcID:687, URL:http://www.iuphar-db.org/DATABASE/LigandDisplayForward?tab=biology&ligandId=687",CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc3c[nH]cn3)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]5CSSC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N5)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N6CCC[C@H]6C(=O)N7CCC[C@H]7C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc8ccc(O)cc8)C(=O)N,CHEMBL2364173,RAMP2
2158,CHEMBL1201474,Colestipol Hydrochloride,Unknown,1977.0,C10AC02,"C10AC02 [CARDIOVASCULAR SYSTEM: LIPID MODIFYING AGENTS: LIPID MODIFYING AGENTS, PLAIN: Bile acid sequestrants]",,Bile acids sequestering agent,,,CHEMBL2364175,Bile acids,SEQUESTERING AGENT,Homo sapiens,SMALL MOLECULE,,,"Name:DailyMed, SrcID:setid=21b37725-fc0c-4365-a7dc-1a473d42502d#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=21b37725-fc0c-4365-a7dc-1a473d42502d#nlm34090-1",,,
2159,CHEMBL1201824,Alglucosidase Alfa,Enzyme,2006.0,A16AB07,A16AB07 [ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Enzymes],-ase,Starch hydrolytic enzyme,"1,4-alpha glucose polysaccharides (substrate)",,CHEMBL2364180,Starch,HYDROLYTIC ENZYME,Homo sapiens,OLIGOSACCHARIDE,,,"Name:DailyMed, SrcID:setid=d6bfbc45-2d34-439e-8aad-59ee2d53d4df#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d6bfbc45-2d34-439e-8aad-59ee2d53d4df#nlm34090-1",,,
2160,CHEMBL1201465,Chymotrypsin,Unknown,1959.0,B06AA04; S01KX01,B06AA04 [BLOOD AND BLOOD FORMING ORGANS: OTHER HEMATOLOGICAL AGENTS: OTHER HEMATOLOGICAL AGENTS: Enzymes]; S01KX01 [SENSORY ORGANS: OPHTHALMOLOGICALS: SURGICAL AIDS: Other surgical aids],,Polypeptides proteolytic enzyme,"To replace endogenous digestive enzyme chymotrypsin, which protects against pancreatitis, in cases where loss of function variants have been identified in the CTRC gene; preferential cleavage: leu-|-xaa, tyr-|-xaa, phe-|-xaa, met-|-xaa, trp-|-xaa, gln-|-xaa, asn-|-xaa.",,CHEMBL2364181,Polypeptides,PROTEOLYTIC ENZYME,Homo sapiens,MACROMOLECULE,,,"Name:PubMed, SrcID:22942235, URL:http://europepmc.org/abstract/MED/22942235",,,
2161,CHEMBL1908841,Levoleucovorin,Small molecule,2008.0,,,,Unknown,,,,,,,,,,"Name:FDA, SrcID:label/2011/020140s002lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020140s002lbl.pdf",NC1=NC(=O)C2=C(NC[C@H](CNc3ccc(cc3)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N2C=O)N1,,
2162,CHEMBL408513,Belinostat,Small molecule,2014.0,L01XX49,L01XX49 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-stat,Histone deacetylase inhibitor,,,CHEMBL2093865,Histone deacetylase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2014/206256lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206256lbl.pdf",ONC(=O)\C=C\c1cccc(c1)S(=O)(=O)Nc2ccccc2,,
2163,CHEMBL502835,Nintedanib,Small molecule,2014.0,L01XE31,L01XE31 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-anib,Vascular endothelial growth factor receptor inhibitor,,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2014/205832s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205832s000lbl.pdf",COC(=O)c1ccc2\C(=C(\Nc3ccc(cc3)N(C)C(=O)CN4CCN(C)CC4)/c5ccccc5)\C(=O)Nc2c1,,
2164,CHEMBL521686,Olaparib,Small molecule,2014.0,L01XX46,L01XX46 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-parib,"PARP 1, 2 & 3 inhibitor",,,CHEMBL3390820,"PARP 1, 2 and 3",INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2014/206162lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206162lbl.pdf",Fc1ccc(CC2=NNC(=O)c3ccccc23)cc1C(=O)N4CCN(CC4)C(=O)C5CC5,,
2165,CHEMBL467888,Lgd-2941,Small molecule,,,,,Androgen Receptor modulator,Selective androgen modulator (SARM). No information about further clinical development (http://www.drugs.com/clinical_trials/ligand-research-published-journal-medicinal-chemistry-lgd-2941-shows-promise-treating-muscle-bone-2222.html),,CHEMBL1871,Androgen Receptor,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17887661, URL:http://europepmc.org/abstract/MED/17887661",C[C@@H]1CC[C@H]([C@@H](O)C(F)(F)F)N1c2ccc3NC(=O)C=C(c3c2)C(F)(F)F,CHEMBL1871,AR
2166,CHEMBL3545418,Bms-779788,Small molecule,,,,,LXR-beta agonist,,,CHEMBL4093,LXR-beta,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25467132, URL:http://europepmc.org/abstract/MED/25467132|Name:Other, SrcID:http://www.exelixis.com/pipeline/xl652, URL:http://www.exelixis.com/pipeline/xl652|Name:PubMed, SrcID:24833295, URL:http://europepmc.org/abstract/MED/24833295",,CHEMBL4093,NR1H2
2167,CHEMBL3545428,Chiauranib,Small molecule,,,,-anib,Serine/threonine-protein kinase Aurora-B inhibitor,,,CHEMBL2185,Serine/threonine-protein kinase Aurora-B,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.chipscreen.com/En/ProductLine/index74.html, URL:http://www.chipscreen.com/En/ProductLine/index74.html",,CHEMBL2185,AURKB
2168,CHEMBL1908397,Kw-2449,Small molecule,,,,,Serine/threonine-protein kinase Aurora-A inhibitor,,,CHEMBL4722,Serine/threonine-protein kinase Aurora-A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19541823, URL:http://europepmc.org/abstract/MED/19541823|Name:PubMed, SrcID:21474579, URL:http://europepmc.org/abstract/MED/21474579",O=C(N1CCNCC1)c2ccc(\C=C\c3n[nH]c4ccccc34)cc2,,
2169,CHEMBL3545002,Mp-412,Small molecule,,,,,Epidermal growth factor receptor erbB1 inhibitor,,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17888033, URL:http://europepmc.org/abstract/MED/17888033|Name:PubMed, SrcID:19459856, URL:http://europepmc.org/abstract/MED/19459856",,CHEMBL203,EGFR
2170,CHEMBL1980391,Rg-1530,Small molecule,,,,,Fibroblast growth factor receptor 1 inhibitor,Multi-targeted kinase inhibitor,,CHEMBL3650,Fibroblast growth factor receptor 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21553286, URL:http://europepmc.org/abstract/MED/21553286|Name:PubMed, SrcID:24900658, URL:http://europepmc.org/abstract/MED/24900658",COc1cc2Nc3n[nH]c(C)c3N=C(c4ccccc4Cl)c2cc1F,CHEMBL3650,FGFR1
2171,CHEMBL3545012,Dsp-2230,Small molecule,,,,,Sodium channel protein type X alpha subunit blocker,,,CHEMBL5451,Sodium channel protein type X alpha subunit,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.ds-pharma.com/rd/clinical/pipeline_profile.html, URL:http://www.ds-pharma.com/rd/clinical/pipeline_profile.html|Name:Wikipedia, SrcID:DSP-2230, URL:https://en.wikipedia.org/wiki/DSP-2230",,CHEMBL5451,SCN10A
2172,CHEMBL3545333,Mk-0773,Small molecule,,,,,Androgen Receptor modulator,SARM,,CHEMBL1871,Androgen Receptor,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20356837, URL:http://europepmc.org/abstract/MED/20356837|Name:PubMed, SrcID:23732550, URL:http://europepmc.org/abstract/MED/23732550",CN1C2CCC3C4CC[C@H](C(=O)NCc5nc6ncccc6[nH]5)[C@@]4(C)CCC3[C@@]2(C)C=C(F)C1=O,CHEMBL1871,AR
2173,CHEMBL2107779,Semapimod,Small molecule,,,,-imod,MAP kinase p38 alpha inhibitor,,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:9205949, URL:http://europepmc.org/abstract/MED/9205949|Name:Wikipedia, SrcID:Semapimod, URL:https://en.wikipedia.org/wiki/Semapimod",C\C(=N/NC(=N)N)\c1cc(NC(=O)CCCCCCCCC(=O)Nc2cc(cc(c2)\C(=N\NC(=N)N)\C)\C(=N\NC(=N)N)\C)cc(c1)\C(=N\NC(=N)N)\C,CHEMBL260,MAPK14
2174,CHEMBL14762,Seliciclib,Small molecule,,,,-ciclib,Cyclin-dependent kinase 1 inhibitor,,,CHEMBL308,Cyclin-dependent kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26207228, URL:http://europepmc.org/abstract/MED/26207228|Name:PubMed, SrcID:25747275, URL:http://europepmc.org/abstract/MED/25747275|Name:PubMed, SrcID:9030781, URL:http://europepmc.org/abstract/MED/9030781",CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1,CHEMBL308,CDK1
2175,CHEMBL3545155,Ji-101,Small molecule,,,,,Platelet-derived growth factor receptor beta inhibitor,,,CHEMBL1913,Platelet-derived growth factor receptor beta,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26365907, URL:http://europepmc.org/abstract/MED/26365907|Name:DOI, SrcID:10.1158/1538-7445.AM10-17, URL:http://cancerres.aacrjournals.org/content/70/8_Supplement/17",COc1ccc(Br)cc1NC(=O)Nc2cccc3c2ccn3Cc4ccnc(N)c4,CHEMBL1913,PDGFRB
2176,CHEMBL2103856,Atopaxar,Small molecule,,,,-paxar,Proteinase-activated receptor 1 antagonist,,,CHEMBL3974,Proteinase-activated receptor 1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21300059, URL:http://europepmc.org/abstract/MED/21300059|Name:PubMed, SrcID:20050853, URL:http://europepmc.org/abstract/MED/20050853|Name:PubMed, SrcID:25135289, URL:http://europepmc.org/abstract/MED/25135289",CCOc1cc2CN(CC(=O)c3cc(N4CCOCC4)c(OC)c(c3)C(C)(C)C)C(=N)c2c(F)c1OCC,CHEMBL3974,F2R
2177,CHEMBL419667,Relcovaptan,Small molecule,,,,-vaptan,Oxytocin receptor antagonist,,,CHEMBL2049,Oxytocin receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10519430, URL:http://europepmc.org/abstract/MED/10519430|Name:PubMed, SrcID:21130036, URL:http://europepmc.org/abstract/MED/21130036",COc1ccc(cc1OC)S(=O)(=O)N2[C@@H](C(=O)N3CCC[C@H]3C(=O)N)[C@@](O)(c4ccccc4Cl)c5cc(Cl)ccc25,CHEMBL2049,OXTR
2178,CHEMBL2108318,Elsiglutide,Protein,,,,-tide,Glucagon-like peptide 2 receptor agonist,,,CHEMBL5844,Glucagon-like peptide 2 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.cancer.gov/drugdictionary?cdrid=728622, URL:http://www.cancer.gov/drugdictionary?cdrid=728622",,CHEMBL5844,GLP2R
2179,CHEMBL3545040,Azd7009,Small molecule,,,,,Sodium channel protein type V alpha subunit blocker,,,CHEMBL1980,Sodium channel protein type V alpha subunit,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15817095, URL:http://europepmc.org/abstract/MED/15817095",CC(C)(C)OC(=O)NCCN1CC2CN(C[C@H](O)COc3ccc(cc3)C#N)CC(C1)O2,CHEMBL1980,SCN5A
2180,CHEMBL3544917,Rapastinel,Protein,,,,-stinel,Glutamate [NMDA] receptor partial agonist,"NMDA glycin site partial-agonist, preferentially modulates NR2B-containing NMDAR receptor complexes","Partial agonist of the glycin-site on GRIN1-subunits, preferentially modulates NR2B-containing NMDAR",CHEMBL2094124,Glutamate [NMDA] receptor,PARTIAL AGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,Partial agonist of the glycin-site on GRIN1-subunits.,"Name:PubMed, SrcID:16051282, URL:http://europepmc.org/abstract/MED/16051282|Name:PubMed, SrcID:18796308, URL:http://europepmc.org/abstract/MED/18796308|Name:Wikipedia, SrcID:Rapastinel, URL:https://en.wikipedia.org/wiki/Rapastinel",C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N2CCC[C@H]2C(=O)N[C@@H]([C@@H](C)O)C(=O)N,CHEMBL2094124,GRIN3B
2181,CHEMBL3545352,P-1037,Small molecule,,,,,"Amiloride-sensitive sodium channel, ENaC blocker",,,CHEMBL2107836,"Amiloride-sensitive sodium channel, ENaC",BLOCKER,Homo sapiens,PROTEIN COMPLEX,,,"Name:Other, SrcID:http://www.parion.com/pipeline/p-1037-pulmonary-disease/, URL:http://www.parion.com/pipeline/p-1037-pulmonary-disease/",,CHEMBL2107836,SCNN1G
2182,CHEMBL3545352,P-1037,Small molecule,,,,,"Amiloride-sensitive sodium channel, ENaC blocker",,,CHEMBL2107836,"Amiloride-sensitive sodium channel, ENaC",BLOCKER,Homo sapiens,PROTEIN COMPLEX,,,"Name:Other, SrcID:http://www.parion.com/pipeline/p-1037-pulmonary-disease/, URL:http://www.parion.com/pipeline/p-1037-pulmonary-disease/",,CHEMBL2107836,SCNN1B
2183,CHEMBL270995,Brivanib Alaninate,Small molecule,,,,-anib,Vascular endothelial growth factor receptor inhibitor,Prodrug - active metabolite is BMS-540215,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:18829493, URL:http://europepmc.org/abstract/MED/18829493|Name:PubMed, SrcID:18288793, URL:http://europepmc.org/abstract/MED/18288793",C[C@H](COc1cn2ncnc(Oc3ccc4[nH]c(C)cc4c3F)c2c1C)OC(=O)[C@H](C)N,,
2184,CHEMBL91829,Ruboxistaurin,Small molecule,,,,,Protein kinase C beta inhibitor,,,CHEMBL3045,Protein kinase C beta,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:8614835, URL:http://europepmc.org/abstract/MED/8614835|Name:Other, SrcID:http://www.ema.europa.eu/docs/en_GB/document_library/Application_withdrawal_assessment_report/2010/01/WC500068826.pdf, URL:http://www.ema.europa.eu/docs/en_GB/document_library/Application_withdrawal_assessment_report/2010/01/WC500068826.pdf",CN(C)C[C@@H]1CCn2cc(C3=C(C(=O)NC3=O)c4cn(CCO1)c5ccccc45)c6ccccc26,CHEMBL3045,PRKCB
2185,CHEMBL522892,Dovitinib,Small molecule,,,,-tinib,Tyrosine-protein kinase receptor FLT3 inhibitor,,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15897558, URL:http://europepmc.org/abstract/MED/15897558",CN1CCN(CC1)c2ccc3nc([nH]c3c2)C4=C(N)c5c(F)cccc5NC4=O,CHEMBL1974,FLT3
2186,CHEMBL522892,Dovitinib,Small molecule,,,,-tinib,Platelet-derived growth factor receptor inhibitor,,,CHEMBL2095189,Platelet-derived growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:15897558, URL:http://europepmc.org/abstract/MED/15897558",CN1CCN(CC1)c2ccc3nc([nH]c3c2)C4=C(N)c5c(F)cccc5NC4=O,,
2187,CHEMBL1628688,Zibotentan,Small molecule,,,,-entan,Endothelin receptor ET-A antagonist,,,CHEMBL252,Endothelin receptor ET-A,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15956965, URL:http://europepmc.org/abstract/MED/15956965",COc1nc(C)cnc1NS(=O)(=O)c2cccnc2c3ccc(cc3)c4ocnn4,CHEMBL252,EDNRA
2188,CHEMBL2336071,Siponimod,Small molecule,,,,-imod,Sphingosine 1-phosphate receptor Edg-8 agonist,,,CHEMBL2274,Sphingosine 1-phosphate receptor Edg-8,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22646698, URL:http://europepmc.org/abstract/MED/22646698|Name:PubMed, SrcID:23285242, URL:http://europepmc.org/abstract/MED/23285242",CCc1cc(ccc1CN2CC(C2)C(=O)O)\C(=N\OCc3ccc(C4CCCCC4)c(c3)C(F)(F)F)\C,CHEMBL2274,S1PR5
2189,CHEMBL23261,Darusentan,Small molecule,,,,-entan,Endothelin receptor ET-B antagonist,Discontinued failed to meet primary endpoints in phase 3 study,,CHEMBL1785,Endothelin receptor ET-B,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20660536, URL:http://europepmc.org/abstract/MED/20660536",COc1cc(OC)nc(O[C@H](C(=O)O)C(OC)(c2ccccc2)c3ccccc3)n1,CHEMBL1785,EDNRB
2190,CHEMBL3545045,Iti-007,Small molecule,,,,,Dopamine D2 receptor partial agonist,"Atypical antipsychotic, shows partial agonism at the presynaptic D2 receptors and acts as an antagonist at postsynaptic D2 receptors (PMID: 25120104).",,CHEMBL217,Dopamine D2 receptor,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24559051, URL:http://europepmc.org/abstract/MED/24559051|Name:Other, SrcID:http://www.intracellulartherapies.com/products-technology/iti-007.html, URL:http://www.intracellulartherapies.com/products-technology/iti-007.html|Name:PubMed, SrcID:25120104, URL:http://europepmc.org/abstract/MED/25120104",CN1CCN2C3CCN(CCCC(=O)c4ccc(F)cc4)CC3c5cccc1c25,CHEMBL217,DRD2
2191,CHEMBL3545125,Mirogabalin,Small molecule,,,,-gab-,Voltage-gated calcium channel alpha2/delta subunit 2 modulator,,,CHEMBL3896,Voltage-gated calcium channel alpha2/delta subunit 2,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25231896, URL:http://europepmc.org/abstract/MED/25231896|Name:Wikipedia, SrcID:Mirogabalin, URL:https://en.wikipedia.org/wiki/Mirogabalin",CCC1=C[C@@H]2[C@H](C1)C[C@]2(CN)CC(=O)O,CHEMBL3896,CACNA2D2
2192,CHEMBL1743009,Efungumab,Antibody,,,,-mab,Heat shock protein 90 homolog inhibitor,"Binds to the yeast antigen heat shock protein hsp90 (rhMAB-hsp90) (present in the fungal cell wall and in extracellular material, particularly around foci of infection) preventing a conformational change needed for fungal viability.",,CHEMBL3580503,Heat shock protein 90 homolog,INHIBITOR,Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast),SINGLE PROTEIN,,,"Name:PubMed, SrcID:19773528, URL:http://europepmc.org/abstract/MED/19773528|Name:Other, SrcID:http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/000658/WC500070523.pdf, URL:http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/000658/WC500070523.pdf",,,
2193,CHEMBL2109447,Lym-1,Antibody,,,,,"HLA class II histocompatibility antigen, DRB1-10 beta chain other",Antibody-dependent cell-mediated cytotoxicity (ADCC).,,CHEMBL3580495,"HLA class II histocompatibility antigen, DRB1-10 beta chain",OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15650447, URL:http://europepmc.org/abstract/MED/15650447|Name:PubMed, SrcID:2334902, URL:http://europepmc.org/abstract/MED/2334902",,,
2194,CHEMBL2108713,Iodine I 124 Girentuximab,Antibody,,,,io-,Carbonic anhydrase IX binding agent,"The antibody binds to G250 antigen, found on over 90 % of clear cell renal cell carcinomas, and can be visualised by means of positron emission tomography (PET).",,CHEMBL3594,Carbonic anhydrase IX,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25055257, URL:http://europepmc.org/abstract/MED/25055257",,CHEMBL3594,CA9
2195,CHEMBL3707297,Cg250 177lu,Antibody,,,,,Carbonic anhydrase IX binding agent,Radioimmunotherapy. The antibody can be internalized by G250 antigen-expressing renal cell carcinoma (RCC) cells.,,CHEMBL3594,Carbonic anhydrase IX,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22159179, URL:http://europepmc.org/abstract/MED/22159179|Name:PubMed, SrcID:14960657, URL:http://europepmc.org/abstract/MED/14960657",,CHEMBL3594,CA9
2196,CHEMBL1742986,Atacicept,Protein,,,,-cept,Tumor necrosis factor ligand superfamily member 13B inhibitor,Soluble receptor. Acts as a decoy receptor for TNFSF13 (APRIL) and TNFSF13B (BAFF).,,CHEMBL2364158,Tumor necrosis factor ligand superfamily member 13B,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21179612, URL:http://europepmc.org/abstract/MED/21179612|Name:PubMed, SrcID:18046446, URL:http://europepmc.org/abstract/MED/18046446",,CHEMBL2364158,TNFSF13B
2197,CHEMBL520733,Semagacestat,Small molecule,,,,-stat,Gamma-secretase inhibitor,Decreases dose-dependently Aß production in the human central nervous system,,CHEMBL2094135,Gamma-secretase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:19360898, URL:http://europepmc.org/abstract/MED/19360898",CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@@H]1C(=O)N(C)CCc2ccccc12,CHEMBL2094135,APH1B
2198,CHEMBL520733,Semagacestat,Small molecule,,,,-stat,Gamma-secretase inhibitor,Decreases dose-dependently Aß production in the human central nervous system,,CHEMBL2094135,Gamma-secretase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:19360898, URL:http://europepmc.org/abstract/MED/19360898",CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@@H]1C(=O)N(C)CCc2ccccc12,CHEMBL2094135,APH1A
2199,CHEMBL2108703,Liprotamase,Enzyme,,,,-ase,Polypeptides proteolytic enzyme,Proteases catalyse the hydrolysis of proteins into smaller polypeptides or amino acids.,,CHEMBL2364181,Polypeptides,PROTEOLYTIC ENZYME,Homo sapiens,MACROMOLECULE,,,"Name:PubMed, SrcID:21831726, URL:http://europepmc.org/abstract/MED/21831726",,,
2200,CHEMBL1742993,Blosozumab,Antibody,,,,-mab,Sclerostin inhibitor,,,CHEMBL3580487,Sclerostin,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25954248, URL:http://europepmc.org/abstract/MED/25954248",,CHEMBL3580487,SOST
2201,CHEMBL1743004,Crenezumab,Antibody,,,,-mab,Beta amyloid A4 protein other,Binds all forms of misfolded Amyloid beta proteins to prevent Amyloid beta aggregation and promote the disaggregation of existing Amyloid beta aggregates including plaques.,,CHEMBL2487,Beta amyloid A4 protein,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15087402, URL:http://europepmc.org/abstract/MED/15087402|Name:Other, SrcID:http://www.acimmune.com/en/ad-treatment-and-prevention/, URL:http://www.acimmune.com/en/ad-treatment-and-prevention/",,CHEMBL2487,APP
2202,CHEMBL2109520,Oncolysin M,Antibody,,,,,Myeloid cell surface antigen CD33 binding agent,Immunotoxin.,,CHEMBL1842,Myeloid cell surface antigen CD33,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://oncologyknowledgebase.com/futureoncology/pdfs/Future_Oncology.Vol.1.No.11.pdf|, URL:http://oncologyknowledgebase.com/futureoncology/pdfs/Future_Oncology.Vol.1.No.11.pdf||Name:ISBN, SrcID:0203304993 PP. 6, URL:http://www.isbnsearch.org/isbn/0203304993",,CHEMBL1842,CD33
2203,CHEMBL1626,Clemastine,Small molecule,1977.0,R06AA04; D04AA14; R06AA54,"R06AA04 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Aminoalkyl ethers]; D04AA14 [DERMATOLOGICALS: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: Antihistamines for topical use]; R06AA54 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Aminoalkyl ethers]",-astine,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 333, URL:http://www.isbnsearch.org/isbn/9780702034718",CN1CCC[C@@H]1CCO[C@](C)(c2ccccc2)c3ccc(Cl)cc3,CHEMBL231,HRH1
2204,CHEMBL864,Carbinoxamine,Small molecule,2003.0,R06AA08,R06AA08 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Aminoalkyl ethers],,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2013/022556s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022556s000lbl.pdf|Name:DailyMed, SrcID:setid=040d6792-21fe-44cc-a441-b9693178b3b5, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=040d6792-21fe-44cc-a441-b9693178b3b5",CN(C)CCOC(c1ccc(Cl)cc1)c2ccccn2,CHEMBL231,HRH1
2205,CHEMBL52440,Dextromethorphan,Small molecule,1982.0,N07XX59; R05DA09,"N07XX59 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs]; R05DA09 [RESPIRATORY SYSTEM: COUGH AND COLD PREPARATIONS: COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS: Opium alkaloids and derivatives]",-orphan,Sigma opioid receptor agonist,,,CHEMBL287,Sigma opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:2897648, URL:http://europepmc.org/abstract/MED/2897648|Name:Wikipedia, SrcID:Nmda_receptor_antagonist, URL:http://en.wikipedia.org/wiki/Nmda_receptor_antagonist|Name:Wikipedia, SrcID:Dextromethorphan, URL:http://en.wikipedia.org/wiki/Dextromethorphan",COc1ccc2C[C@H]3[C@H]4CCCC[C@@]4(CCN3C)c2c1,CHEMBL287,SIGMAR1
2206,CHEMBL1577,Methyclothiazide,Small molecule,1960.0,C03AA08,"C03AA08 [CARDIOVASCULAR SYSTEM: DIURETICS: LOW-CEILING DIURETICS, THIAZIDES: Thiazides, plain]",-thiazide,Thiazide-sensitive sodium-chloride cotransporter inhibitor,,,CHEMBL1876,Thiazide-sensitive sodium-chloride cotransporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1056/NEJMra0907219, URL:http://www.nejm.org/doi/full/10.1056/NEJMra0907219|Name:DailyMed, SrcID:setid=4910dad2-c533-4232-85bf-e6b0235379c2, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4910dad2-c533-4232-85bf-e6b0235379c2",CN1C(CCl)Nc2cc(Cl)c(cc2S1(=O)=O)S(=O)(=O)N,CHEMBL1876,SLC12A3
2207,CHEMBL1200622,Paricalcitol,Small molecule,1998.0,H05BX02,"H05BX02 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CALCIUM HOMEOSTASIS: ANTI-PARATHYROID AGENTS: Other anti-parathyroid agents]",-calci-,Vitamin D receptor agonist,,,CHEMBL1977,Vitamin D receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=1b27c026-2d60-47b4-2a9c-ded1818f21b5, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1b27c026-2d60-47b4-2a9c-ded1818f21b5",C[C@H](\C=C\[C@H](C)C(C)(C)O)[C@H]1CC[C@H]2\C(=C\C=C3C[C@@H](O)C[C@H](O)C3)\CCC[C@]12C,CHEMBL1977,VDR
2208,CHEMBL1201208,Phenmetrazine,Small molecule,1982.0,,,,Dopamine transporter inhibitor,,,CHEMBL238,Dopamine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23211394, URL:http://europepmc.org/abstract/MED/23211394|Name:Wikipedia, SrcID:Phenmetrazine, URL:http://en.wikipedia.org/wiki/Phenmetrazine",CC1NCCOC1c2ccccc2,CHEMBL238,SLC6A3
2209,CHEMBL395429,Oxytocin,Protein,1980.0,H01BB02,"H01BB02 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: POSTERIOR PITUITARY LOBE HORMONES: Oxytocin and analogues]",-tocin,Oxytocin receptor agonist,,,CHEMBL2049,Oxytocin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:0443-059748 PP. 450, URL:http://www.isbnsearch.org/isbn/0443059748|Name:DailyMed, SrcID:setid=fa4fb554-cb54-4c44-9955-1c382a2daa90#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fa4fb554-cb54-4c44-9955-1c382a2daa90#nlm34090-1|Name:FDA, SrcID:label/2014/018261s031lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/018261s031lbl.pdf",CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)N)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N,CHEMBL2049,OXTR
2210,CHEMBL1201746,Pralatrexate,Small molecule,2009.0,L01BA05,L01BA05 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Folic acid analogues],-trexate,Dihydrofolate reductase inhibitor,,,CHEMBL202,Dihydrofolate reductase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=5e4cf15b-bf7b-4b83-863e-e9ef27741a51#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e4cf15b-bf7b-4b83-863e-e9ef27741a51#section-13",Nc1nc(N)c2nc(CC(CC#C)c3ccc(cc3)C(=O)N[C@@H](CCC(=O)O)C(=O)O)cnc2n1,CHEMBL202,DHFR
2211,CHEMBL271227,Abiraterone Acetate,Small molecule,2011.0,L02BX03,L02BX03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONE ANTAGONISTS AND RELATED AGENTS: Other hormone antagonists and related agents],,Cytochrome P450 17A1 inhibitor,,,CHEMBL3522,Cytochrome P450 17A1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2012/202379s003lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202379s003lbl.pdf",CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC=C4c5cccnc5)[C@@H]3CC=C2C1,CHEMBL3522,CYP17A1
2212,CHEMBL1201649,"Estrogens, Conjugated",Small molecule,1942.0,G03CA57,"G03CA57 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ESTROGENS: Natural and semisynthetic estrogens, plain]",estr-,Estrogen receptor agonist,,,CHEMBL2093866,Estrogen receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=1cd07b54-f66f-4040-9058-462324267196#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1cd07b54-f66f-4040-9058-462324267196#nlm34090-1|Name:ISBN, SrcID:9780702034718 PP. 420, URL:http://www.isbnsearch.org/isbn/9780702034718",,,
2213,CHEMBL709,Alfuzosin,Small molecule,2003.0,G04CA01,G04CA01 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY: Alpha-adrenoreceptor antagonists],,Adrenergic receptor alpha-1 agonist,,,CHEMBL2094251,Adrenergic receptor alpha-1,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=f075a897-7bef-4799-b7e2-7e051c461443#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f075a897-7bef-4799-b7e2-7e051c461443#nlm34090-1",COc1cc2nc(nc(N)c2cc1OC)N(C)CCCNC(=O)C3CCCO3,,
2214,CHEMBL95,Tacrine,Small molecule,1993.0,N06DA01,N06DA01 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTI-DEMENTIA DRUGS: Anticholinesterases],-crine,Cholinesterases; ACHE & BCHE inhibitor,,,CHEMBL2095233,Cholinesterases; ACHE & BCHE,INHIBITOR,Homo sapiens,SELECTIVITY GROUP,,,"Name:PubMed, SrcID:10375753, URL:http://europepmc.org/abstract/MED/10375753|Name:PubMed, SrcID:12871155, URL:http://europepmc.org/abstract/MED/12871155|Name:PubMed, SrcID:16860785, URL:http://europepmc.org/abstract/MED/16860785|Name:Wikipedia, SrcID:Tacrine, URL:http://en.wikipedia.org/wiki/Tacrine|Name:PubMed, SrcID:17218977, URL:http://europepmc.org/abstract/MED/17218977|Name:DailyMed, SrcID:archiveid=9851, URL:http://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=9851",Nc1c2CCCCc2nc3ccccc13,,
2215,CHEMBL1201273,Protokylol,Small molecule,1982.0,,,,Beta-2 adrenergic receptor agonist,,,CHEMBL210,Beta-2 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:216448, URL:http://europepmc.org/abstract/MED/216448",CC(Cc1ccc2OCOc2c1)NCC(O)c3ccc(O)c(O)c3,CHEMBL210,ADRB2
2216,CHEMBL1095777,Indacaterol,Small molecule,2011.0,R03AC18,"R03AC18 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS, INHALANTS: Selective beta-2-adrenoreceptor agonists]",-terol,Beta-2 adrenergic receptor agonist,Long acting,,CHEMBL210,Beta-2 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f7d013b1-5ee9-4126-8297-9efd9a5a8344, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f7d013b1-5ee9-4126-8297-9efd9a5a8344",CCc1cc2CC(Cc2cc1CC)NC[C@H](O)c3ccc(O)c4NC(=O)C=Cc34,CHEMBL210,ADRB2
2217,CHEMBL1771,Clopidogrel,Small molecule,1997.0,B01AC04,B01AC04 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Platelet aggregation inhibitors excl. heparin],-grel,Purinergic receptor P2Y12 antagonist,Irreversible inhibitor,,CHEMBL2001,Purinergic receptor P2Y12,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=0078fb3d-3595-4ae1-a059-1d5e81c879cf, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0078fb3d-3595-4ae1-a059-1d5e81c879cf",COC(=O)[C@@H](N1CCc2sccc2C1)c3ccccc3Cl,CHEMBL2001,P2RY12
2218,CHEMBL777,Clavulanic Acid,Small molecule,1984.0,,,,Bacterial beta-lactamase TEM inhibitor,,Broad spectrum,CHEMBL2364670,Bacterial beta-lactamase TEM,INHIBITOR,Bacteria,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23612724, URL:http://europepmc.org/abstract/MED/23612724|Name:ISBN, SrcID:9780702034718 PP. 627, URL:http://www.isbnsearch.org/isbn/9780702034718",OC\C=C\1/O[C@@H]2CC(=O)N2[C@H]1C(=O)O,,
2219,CHEMBL1741,Clarithromycin,Small molecule,1991.0,J01FA09,"J01FA09 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS: Macrolides]",-mycin,Bacterial 70S ribosome inhibitor,,Broad spectrum,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,23S ribosomal RNA,23S RRNA,"Name:PubMed, SrcID:9425251, URL:http://europepmc.org/abstract/MED/9425251|Name:DailyMed, SrcID:setid=aa44552c-3cfe-4111-8aa5-4251aeed9be9#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aa44552c-3cfe-4111-8aa5-4251aeed9be9#nlm34090-1|Name:PubMed, SrcID:7683018, URL:http://europepmc.org/abstract/MED/7683018",CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC,,
2220,CHEMBL931,Halothane,Small molecule,1958.0,N01AB01,"N01AB01 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",,Potassium channel subfamily K member 10 opener,,,CHEMBL2331041,Potassium channel subfamily K member 10,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:11886861, URL:http://europepmc.org/abstract/MED/11886861|Name:PubMed, SrcID:11605899, URL:http://europepmc.org/abstract/MED/11605899|Name:PubMed, SrcID:20519544, URL:http://europepmc.org/abstract/MED/20519544|Name:PubMed, SrcID:17227289, URL:http://europepmc.org/abstract/MED/17227289|Name:PubMed, SrcID:20217349, URL:http://europepmc.org/abstract/MED/20217349",FC(F)(F)C(Cl)Br,CHEMBL2331041,KCNK10
2221,CHEMBL631,Propafenone,Small molecule,1989.0,C01BC03,"C01BC03 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class Ic]",-afenone,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:Wikipedia, SrcID:Sodium_channel, URL:http://en.wikipedia.org/wiki/Sodium_channel|Name:DailyMed, SrcID:setid=d4a552ce-f215-4ec7-b5dd-aee266ba9b08, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d4a552ce-f215-4ec7-b5dd-aee266ba9b08",CCCNCC(O)COc1ccccc1C(=O)CCc2ccccc2,,
2222,CHEMBL1754,Doxapram,Small molecule,1965.0,R07AB01,R07AB01 [RESPIRATORY SYSTEM: OTHER RESPIRATORY SYSTEM PRODUCTS: OTHER RESPIRATORY SYSTEM PRODUCTS: Respiratory stimulants],,Potassium channel subfamily K member 3 blocker,,,CHEMBL2321613,Potassium channel subfamily K member 3,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=a6bebe92-c96b-4022-a78b-652f03f32ca5#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6bebe92-c96b-4022-a78b-652f03f32ca5#nlm34090-1|Name:FDA, SrcID:label/2005/14879s044lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/14879s044lbl.pdf|Name:PubMed, SrcID:17227289, URL:http://europepmc.org/abstract/MED/17227289",CCN1CC(CCN2CCOCC2)C(C1=O)(c3ccccc3)c4ccccc4,CHEMBL2321613,KCNK3
2223,CHEMBL1742992,Blinatumomab,Antibody,2014.0,L01XC19,L01XC19 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,T cell surface glycoprotein CD3 cross-linking agent,,,CHEMBL2364168,T cell surface glycoprotein CD3,CROSS-LINKING AGENT,Homo sapiens,PROTEIN COMPLEX,,,"Name:FDA, SrcID:label/2014/125557lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125557lbl.pdf",,CHEMBL2364168,CD3D
2224,CHEMBL1742992,Blinatumomab,Antibody,2014.0,L01XC19,L01XC19 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,T cell surface glycoprotein CD3 cross-linking agent,,,CHEMBL2364168,T cell surface glycoprotein CD3,CROSS-LINKING AGENT,Homo sapiens,PROTEIN COMPLEX,,,"Name:FDA, SrcID:label/2014/125557lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125557lbl.pdf",,CHEMBL2364168,CD3G
2225,CHEMBL2103870,Lumacaftor,Small molecule,2015.0,,,-caftor,Cystic fibrosis transmembrane conductance regulator stabiliser,Modulates the folding and trafficking of CFTR protein in patients with one or two copies of the F508del mutation. Acts on the membrane-spanning domain 1 of the CFTR protein.,,CHEMBL4051,Cystic fibrosis transmembrane conductance regulator,STABILISER,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/206038Orig1s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206038Orig1s000lbl.pdf",Cc1ccc(NC(=O)C2(CC2)c3ccc4OC(F)(F)Oc4c3)nc1c5cccc(c5)C(=O)O,CHEMBL4051,CFTR
2226,CHEMBL52885,Enmd-981693,Small molecule,,,,,Tyrosine-protein kinase receptor FLT3 inhibitor,,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf, URL:http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf",Cn1cc(C2=C(C(=O)NC2=O)c3cn(C)c4cc(ccc34)[N+](=O)[O-])c5ccccc15,CHEMBL1974,FLT3
2227,CHEMBL284121,Ilx23-7553,Small molecule,,,,,Vitamin D receptor agonist,,,CHEMBL1977,Vitamin D receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:14586212, URL:http://europepmc.org/abstract/MED/14586212",C[C@H](CC#CC(C)(C)O)C1=CC[C@H]2\C(=C\C=C/3\C[C@@H](O)C[C@H](O)C3=C)\CCC[C@]12C,CHEMBL1977,VDR
2228,CHEMBL3545049,Bay-1125976,Small molecule,,,,,Serine/threonine-protein kinase AKT2 inhibitor,Allosteric inhibitor.,,CHEMBL2431,Serine/threonine-protein kinase AKT2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1158/1538-7445.AM2014-3685, URL:http://cancerres.aacrjournals.org/content/74/19_Supplement/3685|Name:DOI, SrcID:10.1158/1538-7445.AM2013-2050, URL:http://cancerres.aacrjournals.org/content/73/8_Supplement/2050",,CHEMBL2431,AKT2
2229,CHEMBL3545427,Cm-082,Small molecule,,,,,Vascular endothelial growth factor receptor 2 inhibitor,,,CHEMBL279,Vascular endothelial growth factor receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.tyrogenex.com/wordpress/wp-content/uploads/Oral-X-82-for-wet-AMD-ARVO-2013.pdf, URL:http://www.tyrogenex.com/wordpress/wp-content/uploads/Oral-X-82-for-wet-AMD-ARVO-2013.pdf",,CHEMBL279,KDR
2230,CHEMBL3545133,Jnj-26483327,Small molecule,,,,,Receptor protein-tyrosine kinase erbB-2 inhibitor,Multi-targeted tyrosine kinase inhibitor,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1016/S1359-6349(10)71870-X, URL:http://www.sciencedirect.com/science/article/pii/S135963491071870X|Name:PubMed, SrcID:20823884, URL:http://europepmc.org/abstract/MED/20823884",,CHEMBL1824,ERBB2
2231,CHEMBL2219421,Recilisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Other, SrcID:http://www.onconova.com/product-pipeline/recilisib.php, URL:http://www.onconova.com/product-pipeline/recilisib.php|Name:PubMed, SrcID:23505494, URL:http://europepmc.org/abstract/MED/23505494|Name:PubMed, SrcID:21341279, URL:http://europepmc.org/abstract/MED/21341279",OC(=O)c1ccc(\C=C\S(=O)(=O)Cc2ccc(Cl)cc2)cc1,CHEMBL3559703,PIK3R2
2232,CHEMBL2219421,Recilisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Other, SrcID:http://www.onconova.com/product-pipeline/recilisib.php, URL:http://www.onconova.com/product-pipeline/recilisib.php|Name:PubMed, SrcID:23505494, URL:http://europepmc.org/abstract/MED/23505494|Name:PubMed, SrcID:21341279, URL:http://europepmc.org/abstract/MED/21341279",OC(=O)c1ccc(\C=C\S(=O)(=O)Cc2ccc(Cl)cc2)cc1,CHEMBL3559703,PIK3R3
2233,CHEMBL2219421,Recilisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Other, SrcID:http://www.onconova.com/product-pipeline/recilisib.php, URL:http://www.onconova.com/product-pipeline/recilisib.php|Name:PubMed, SrcID:23505494, URL:http://europepmc.org/abstract/MED/23505494|Name:PubMed, SrcID:21341279, URL:http://europepmc.org/abstract/MED/21341279",OC(=O)c1ccc(\C=C\S(=O)(=O)Cc2ccc(Cl)cc2)cc1,CHEMBL3559703,PIK3R5
2234,CHEMBL3545139,Ps-516895,Small molecule,,,,,MAP kinase p38 alpha inhibitor,No references found,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.google.com/patents/US20120276064, URL:http://www.google.com/patents/US20120276064|Name:Other, SrcID:http://www.sec.gov/Archives/edgar/data/1273013/000110465905000914/a05-1273_1ex99d1.htm, URL:http://www.sec.gov/Archives/edgar/data/1273013/000110465905000914/a05-1273_1ex99d1.htm",,CHEMBL260,MAPK14
2235,CHEMBL3545111,Hemay-022,Small molecule,,,,,Receptor protein-tyrosine kinase erbB-2 inhibitor,,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:ClinicalTrials, SrcID:NCT02476539, URL:https://www.clinicaltrials.gov/ct2/show/NCT02476539",,CHEMBL1824,ERBB2
2236,CHEMBL1915540,Pf-03893787,Small molecule,,,,,Histamine H4 receptor antagonist,,,CHEMBL3759,Histamine H4 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16349977, URL:http://europepmc.org/abstract/MED/16349977",CN[C@@H]1CCN(C1)c2cc(NCC3CC3)nc(N)n2,CHEMBL3759,HRH4
2237,CHEMBL411907,Sonolisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:22693357, URL:http://europepmc.org/abstract/MED/22693357|Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718",COC[C@H]1OC(=O)\C(=C\N(CC=C)CC=C)\C2=C(O)C(=O)C3=C([C@@H](C[C@@]4(C)[C@H]3CCC4=O)OC(=O)C)[C@@]12C,CHEMBL3559703,PIK3R2
2238,CHEMBL411907,Sonolisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:22693357, URL:http://europepmc.org/abstract/MED/22693357|Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718",COC[C@H]1OC(=O)\C(=C\N(CC=C)CC=C)\C2=C(O)C(=O)C3=C([C@@H](C[C@@]4(C)[C@H]3CCC4=O)OC(=O)C)[C@@]12C,CHEMBL3559703,PIK3R3
2239,CHEMBL411907,Sonolisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:22693357, URL:http://europepmc.org/abstract/MED/22693357|Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718",COC[C@H]1OC(=O)\C(=C\N(CC=C)CC=C)\C2=C(O)C(=O)C3=C([C@@H](C[C@@]4(C)[C@H]3CCC4=O)OC(=O)C)[C@@]12C,CHEMBL3559703,PIK3R5
2240,CHEMBL3301604,Ralinepag,Small molecule,,,,-nepag,Prostanoid IP receptor agonist,,,CHEMBL1995,Prostanoid IP receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.arenapharm.com/ralinepag, URL:http://www.arenapharm.com/ralinepag",OC(=O)COC[C@@H]1CC[C@@H](COC(=O)N(c2ccccc2)c3ccc(Cl)cc3)CC1,CHEMBL1995,PTGIR
2241,CHEMBL3545343,Adc3680,Small molecule,,,,,G protein-coupled receptor 44 antagonist,,,CHEMBL5071,G protein-coupled receptor 44,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://erj.ersjournals.com/content/42/Suppl_57/P735.short, URL:http://erj.ersjournals.com/content/42/Suppl_57/P735.short|Name:PubMed, SrcID:24073896, URL:http://europepmc.org/abstract/MED/24073896|Name:Other, SrcID:http://www.pulmagen.com/adc3680.html, URL:http://www.pulmagen.com/adc3680.html",,CHEMBL5071,PTGDR2
2242,CHEMBL3545039,Azd1386,Small molecule,,,,,Vanilloid receptor antagonist,,,CHEMBL4794,Vanilloid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21410733, URL:http://europepmc.org/abstract/MED/21410733",Cc1cc(Cl)cc2c1N(Cc3cccc(c3)C(F)(F)F)C(=O)C24NC(=O)NC4=O,CHEMBL4794,TRPV1
2243,CHEMBL3707318,Grc-17536,Small molecule,,,,,Transient receptor potential cation channel subfamily A member 1 antagonist,,,CHEMBL6007,Transient receptor potential cation channel subfamily A member 1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.glenmarkpharma.com/common/images/Research-Pipeline-big.jpg, URL:http://www.glenmarkpharma.com/common/images/Research-Pipeline-big.jpg|Name:PubMed, SrcID:24819048, URL:http://europepmc.org/abstract/MED/24819048",,CHEMBL6007,TRPA1
2244,CHEMBL68055,Acolbifene,Small molecule,,,,-ifene,Estrogen receptor modulator,SERM,,CHEMBL2093866,Estrogen receptor,MODULATOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:22196312, URL:http://europepmc.org/abstract/MED/22196312|Name:Other, SrcID:http://www.endoceutics.com/our-products/acolbifene/, URL:http://www.endoceutics.com/our-products/acolbifene/|Name:PubMed, SrcID:11850228, URL:http://europepmc.org/abstract/MED/11850228|Name:Wikipedia, SrcID:Acolbifene, URL:http://en.wikipedia.org/wiki/Acolbifene",CC1=C([C@@H](Oc2cc(O)ccc12)c3ccc(OCCN4CCCCC4)cc3)c5ccc(O)cc5,,
2245,CHEMBL603469,Lestaurtinib,Small molecule,,,,-tinib,Nerve growth factor receptor Trk-A inhibitor,,,CHEMBL2815,Nerve growth factor receptor Trk-A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10473107, URL:http://europepmc.org/abstract/MED/10473107",C[C@]12O[C@H](C[C@]1(O)CO)n3c4ccccc4c5c6C(=O)NCc6c7c8ccccc8n2c7c35,CHEMBL2815,NTRK1
2246,CHEMBL2103840,Dinaciclib,Small molecule,,,,-ciclib,Cyclin-dependent kinase 1 inhibitor,,,CHEMBL308,Cyclin-dependent kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25215591, URL:http://europepmc.org/abstract/MED/25215591",CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(nc12)N4CCCC[C@H]4CCO,CHEMBL308,CDK1
2247,CHEMBL1287853,Fedratinib,Small molecule,,,,-tinib,Tyrosine-protein kinase JAK2 inhibitor,Potent inhibitor of BRD4 (PMID: 24584101).,,CHEMBL2971,Tyrosine-protein kinase JAK2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18394554, URL:http://europepmc.org/abstract/MED/18394554",Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc4cccc(c4)S(=O)(=O)NC(C)(C)C,CHEMBL2971,JAK2
2248,CHEMBL49429,Lixivaptan,Small molecule,,,,-vaptan,Vasopressin V2 receptor antagonist,FDA has denied approval.,,CHEMBL1790,Vasopressin V2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11012895, URL:http://europepmc.org/abstract/MED/11012895|Name:Wikipedia, SrcID:Lixivaptan, URL:http://en.wikipedia.org/wiki/Lixivaptan|Name:PubMed, SrcID:9651149, URL:http://europepmc.org/abstract/MED/9651149",Cc1ccc(F)cc1C(=O)Nc2ccc(C(=O)N3Cc4cccn4Cc5ccccc35)c(Cl)c2,CHEMBL1790,AVPR2
2249,CHEMBL2107771,Ralfinamide,Small molecule,,,,,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://www.newron.com/ENG/Default.aspx?SEZ=3&PAG=40, URL:http://www.newron.com/ENG/Default.aspx?SEZ=3&PAG=40|Name:PubMed, SrcID:23121096, URL:http://europepmc.org/abstract/MED/23121096",C[C@H](NCc1ccc(OCc2ccccc2F)cc1)C(=O)N,,
2250,CHEMBL2110585,Ezatiostat,Small molecule,,,,-stat,Glutathione S-transferase Pi inhibitor,Ezatiostat is metabolized to TLK117. TLK117 selectively binds to and disrupts the interaction of GST P1-1 with JNK.,,CHEMBL3902,Glutathione S-transferase Pi,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19398716, URL:http://europepmc.org/abstract/MED/19398716",CCOC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCc1ccccc1)C(=O)N[C@@H](C(=O)OCC)c2ccccc2,CHEMBL3902,GSTP1
2251,CHEMBL2103884,Oprozomib,Small molecule,,,,-zomib,26S proteosome inhibitor,Irreversible binding,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:21484190, URL:http://europepmc.org/abstract/MED/21484190|Name:PubMed, SrcID:26924128, URL:http://europepmc.org/abstract/MED/26924128|Name:PubMed, SrcID:27167000, URL:http://europepmc.org/abstract/MED/27167000",COC[C@H](NC(=O)[C@H](COC)NC(=O)c1cnc(C)s1)C(=O)N[C@@H](Cc2ccccc2)C(=O)[C@@]3(C)CO3,CHEMBL2364701,PSMC6
2252,CHEMBL2103884,Oprozomib,Small molecule,,,,-zomib,26S proteosome inhibitor,Irreversible binding,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:21484190, URL:http://europepmc.org/abstract/MED/21484190|Name:PubMed, SrcID:26924128, URL:http://europepmc.org/abstract/MED/26924128|Name:PubMed, SrcID:27167000, URL:http://europepmc.org/abstract/MED/27167000",COC[C@H](NC(=O)[C@H](COC)NC(=O)c1cnc(C)s1)C(=O)N[C@@H](Cc2ccccc2)C(=O)[C@@]3(C)CO3,CHEMBL2364701,PSMD13
2253,CHEMBL2103884,Oprozomib,Small molecule,,,,-zomib,26S proteosome inhibitor,Irreversible binding,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:21484190, URL:http://europepmc.org/abstract/MED/21484190|Name:PubMed, SrcID:26924128, URL:http://europepmc.org/abstract/MED/26924128|Name:PubMed, SrcID:27167000, URL:http://europepmc.org/abstract/MED/27167000",COC[C@H](NC(=O)[C@H](COC)NC(=O)c1cnc(C)s1)C(=O)N[C@@H](Cc2ccccc2)C(=O)[C@@]3(C)CO3,CHEMBL2364701,ADRM1
2254,CHEMBL2103884,Oprozomib,Small molecule,,,,-zomib,26S proteosome inhibitor,Irreversible binding,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:21484190, URL:http://europepmc.org/abstract/MED/21484190|Name:PubMed, SrcID:26924128, URL:http://europepmc.org/abstract/MED/26924128|Name:PubMed, SrcID:27167000, URL:http://europepmc.org/abstract/MED/27167000",COC[C@H](NC(=O)[C@H](COC)NC(=O)c1cnc(C)s1)C(=O)N[C@@H](Cc2ccccc2)C(=O)[C@@]3(C)CO3,CHEMBL2364701,PSMD12
2255,CHEMBL2103884,Oprozomib,Small molecule,,,,-zomib,26S proteosome inhibitor,Irreversible binding,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:21484190, URL:http://europepmc.org/abstract/MED/21484190|Name:PubMed, SrcID:26924128, URL:http://europepmc.org/abstract/MED/26924128|Name:PubMed, SrcID:27167000, URL:http://europepmc.org/abstract/MED/27167000",COC[C@H](NC(=O)[C@H](COC)NC(=O)c1cnc(C)s1)C(=O)N[C@@H](Cc2ccccc2)C(=O)[C@@]3(C)CO3,CHEMBL2364701,PSMC4
2256,CHEMBL2103884,Oprozomib,Small molecule,,,,-zomib,26S proteosome inhibitor,Irreversible binding,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:21484190, URL:http://europepmc.org/abstract/MED/21484190|Name:PubMed, SrcID:26924128, URL:http://europepmc.org/abstract/MED/26924128|Name:PubMed, SrcID:27167000, URL:http://europepmc.org/abstract/MED/27167000",COC[C@H](NC(=O)[C@H](COC)NC(=O)c1cnc(C)s1)C(=O)N[C@@H](Cc2ccccc2)C(=O)[C@@]3(C)CO3,CHEMBL2364701,PSMD11
2257,CHEMBL2103884,Oprozomib,Small molecule,,,,-zomib,26S proteosome inhibitor,Irreversible binding,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:21484190, URL:http://europepmc.org/abstract/MED/21484190|Name:PubMed, SrcID:26924128, URL:http://europepmc.org/abstract/MED/26924128|Name:PubMed, SrcID:27167000, URL:http://europepmc.org/abstract/MED/27167000",COC[C@H](NC(=O)[C@H](COC)NC(=O)c1cnc(C)s1)C(=O)N[C@@H](Cc2ccccc2)C(=O)[C@@]3(C)CO3,CHEMBL2364701,PSMC3
2258,CHEMBL2103884,Oprozomib,Small molecule,,,,-zomib,26S proteosome inhibitor,Irreversible binding,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:21484190, URL:http://europepmc.org/abstract/MED/21484190|Name:PubMed, SrcID:26924128, URL:http://europepmc.org/abstract/MED/26924128|Name:PubMed, SrcID:27167000, URL:http://europepmc.org/abstract/MED/27167000",COC[C@H](NC(=O)[C@H](COC)NC(=O)c1cnc(C)s1)C(=O)N[C@@H](Cc2ccccc2)C(=O)[C@@]3(C)CO3,CHEMBL2364701,PSMD8
2259,CHEMBL2103884,Oprozomib,Small molecule,,,,-zomib,26S proteosome inhibitor,Irreversible binding,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:21484190, URL:http://europepmc.org/abstract/MED/21484190|Name:PubMed, SrcID:26924128, URL:http://europepmc.org/abstract/MED/26924128|Name:PubMed, SrcID:27167000, URL:http://europepmc.org/abstract/MED/27167000",COC[C@H](NC(=O)[C@H](COC)NC(=O)c1cnc(C)s1)C(=O)N[C@@H](Cc2ccccc2)C(=O)[C@@]3(C)CO3,CHEMBL2364701,SEM1
2260,CHEMBL2103884,Oprozomib,Small molecule,,,,-zomib,26S proteosome inhibitor,Irreversible binding,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:21484190, URL:http://europepmc.org/abstract/MED/21484190|Name:PubMed, SrcID:26924128, URL:http://europepmc.org/abstract/MED/26924128|Name:PubMed, SrcID:27167000, URL:http://europepmc.org/abstract/MED/27167000",COC[C@H](NC(=O)[C@H](COC)NC(=O)c1cnc(C)s1)C(=O)N[C@@H](Cc2ccccc2)C(=O)[C@@]3(C)CO3,CHEMBL2364701,PSMD7
2261,CHEMBL2103884,Oprozomib,Small molecule,,,,-zomib,26S proteosome inhibitor,Irreversible binding,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:21484190, URL:http://europepmc.org/abstract/MED/21484190|Name:PubMed, SrcID:26924128, URL:http://europepmc.org/abstract/MED/26924128|Name:PubMed, SrcID:27167000, URL:http://europepmc.org/abstract/MED/27167000",COC[C@H](NC(=O)[C@H](COC)NC(=O)c1cnc(C)s1)C(=O)N[C@@H](Cc2ccccc2)C(=O)[C@@]3(C)CO3,CHEMBL2364701,PSMC5
2262,CHEMBL2103884,Oprozomib,Small molecule,,,,-zomib,26S proteosome inhibitor,Irreversible binding,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:21484190, URL:http://europepmc.org/abstract/MED/21484190|Name:PubMed, SrcID:26924128, URL:http://europepmc.org/abstract/MED/26924128|Name:PubMed, SrcID:27167000, URL:http://europepmc.org/abstract/MED/27167000",COC[C@H](NC(=O)[C@H](COC)NC(=O)c1cnc(C)s1)C(=O)N[C@@H](Cc2ccccc2)C(=O)[C@@]3(C)CO3,CHEMBL2364701,PSMC2
2263,CHEMBL2103884,Oprozomib,Small molecule,,,,-zomib,26S proteosome inhibitor,Irreversible binding,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:21484190, URL:http://europepmc.org/abstract/MED/21484190|Name:PubMed, SrcID:26924128, URL:http://europepmc.org/abstract/MED/26924128|Name:PubMed, SrcID:27167000, URL:http://europepmc.org/abstract/MED/27167000",COC[C@H](NC(=O)[C@H](COC)NC(=O)c1cnc(C)s1)C(=O)N[C@@H](Cc2ccccc2)C(=O)[C@@]3(C)CO3,CHEMBL2364701,PSMC1
2264,CHEMBL2103884,Oprozomib,Small molecule,,,,-zomib,26S proteosome inhibitor,Irreversible binding,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:21484190, URL:http://europepmc.org/abstract/MED/21484190|Name:PubMed, SrcID:26924128, URL:http://europepmc.org/abstract/MED/26924128|Name:PubMed, SrcID:27167000, URL:http://europepmc.org/abstract/MED/27167000",COC[C@H](NC(=O)[C@H](COC)NC(=O)c1cnc(C)s1)C(=O)N[C@@H](Cc2ccccc2)C(=O)[C@@]3(C)CO3,CHEMBL2364701,PSMD6
2265,CHEMBL2103884,Oprozomib,Small molecule,,,,-zomib,26S proteosome inhibitor,Irreversible binding,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:21484190, URL:http://europepmc.org/abstract/MED/21484190|Name:PubMed, SrcID:26924128, URL:http://europepmc.org/abstract/MED/26924128|Name:PubMed, SrcID:27167000, URL:http://europepmc.org/abstract/MED/27167000",COC[C@H](NC(=O)[C@H](COC)NC(=O)c1cnc(C)s1)C(=O)N[C@@H](Cc2ccccc2)C(=O)[C@@]3(C)CO3,CHEMBL2364701,PSMD3
2266,CHEMBL2103884,Oprozomib,Small molecule,,,,-zomib,26S proteosome inhibitor,Irreversible binding,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:21484190, URL:http://europepmc.org/abstract/MED/21484190|Name:PubMed, SrcID:26924128, URL:http://europepmc.org/abstract/MED/26924128|Name:PubMed, SrcID:27167000, URL:http://europepmc.org/abstract/MED/27167000",COC[C@H](NC(=O)[C@H](COC)NC(=O)c1cnc(C)s1)C(=O)N[C@@H](Cc2ccccc2)C(=O)[C@@]3(C)CO3,CHEMBL2364701,PSMD1
2267,CHEMBL2103884,Oprozomib,Small molecule,,,,-zomib,26S proteosome inhibitor,Irreversible binding,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:21484190, URL:http://europepmc.org/abstract/MED/21484190|Name:PubMed, SrcID:26924128, URL:http://europepmc.org/abstract/MED/26924128|Name:PubMed, SrcID:27167000, URL:http://europepmc.org/abstract/MED/27167000",COC[C@H](NC(=O)[C@H](COC)NC(=O)c1cnc(C)s1)C(=O)N[C@@H](Cc2ccccc2)C(=O)[C@@]3(C)CO3,CHEMBL2364701,PSMD4
2268,CHEMBL2103884,Oprozomib,Small molecule,,,,-zomib,26S proteosome inhibitor,Irreversible binding,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:21484190, URL:http://europepmc.org/abstract/MED/21484190|Name:PubMed, SrcID:26924128, URL:http://europepmc.org/abstract/MED/26924128|Name:PubMed, SrcID:27167000, URL:http://europepmc.org/abstract/MED/27167000",COC[C@H](NC(=O)[C@H](COC)NC(=O)c1cnc(C)s1)C(=O)N[C@@H](Cc2ccccc2)C(=O)[C@@]3(C)CO3,CHEMBL2364701,PSMD2
2269,CHEMBL2105661,Litronesib,Small molecule,,,,-nesib,Kinesin-like protein 1 inhibitor,"Allosteric inhibitor of Eg5. ALso inhibits Eg5 localization to the mitotic spindle,",,CHEMBL4581,Kinesin-like protein 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26304237, URL:http://europepmc.org/abstract/MED/26304237|Name:PubMed, SrcID:24752449, URL:http://europepmc.org/abstract/MED/24752449",CCNCCS(=O)(=O)NC[C@]1(SC(=NN1C(=O)C(C)(C)C)NC(=O)C(C)(C)C)c2ccccc2,CHEMBL4581,KIF11
2270,CHEMBL3039507,Sotagliflozin,Small molecule,,,,-gliflozin,Sodium/glucose cotransporter 2 inhibitor,,"Human SGLT1 IC50=36 nmol/l, human SGLT2 IC50=1.8 nmol/l",CHEMBL3884,Sodium/glucose cotransporter 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22739142, URL:http://europepmc.org/abstract/MED/22739142",CCOc1ccc(Cc2cc(ccc2Cl)[C@@H]3O[C@H](SC)[C@@H](O)[C@H](O)[C@H]3O)cc1,CHEMBL3884,SLC5A2
2271,CHEMBL1615835,Muparfostat,Oligosaccharide,,,,-fo-; -stat,Acidic fibroblast growth factor inhibitor,,,CHEMBL2120,Acidic fibroblast growth factor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:14521421, URL:http://europepmc.org/abstract/MED/14521421",OP(=O)(O)OC[C@H]1O[C@H](O[C@H]2[C@H](OS(=O)(=O)O)[C@@H](COS(=O)(=O)O)O[C@H](O[C@H]3[C@H](OS(=O)(=O)O)[C@@H](COS(=O)(=O)O)O[C@H](O[C@H]4[C@H](OS(=O)(=O)O)[C@@H](COS(=O)(=O)O)O[C@H](O[C@@H]5[C@@H](OS(=O)(=O)O)O[C@H](COS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@@H]5OS(=O)(=O)O)[C@H]4OS(=O)(=O)O)[C@H]3OS(=O)(=O)O)[C@H]2OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@@H]1OS(=O)(=O)O,CHEMBL2120,FGF1
2272,CHEMBL429876,Cilengitide,Protein,,,,-tide,Integrin alpha-V/beta-5 antagonist,,,CHEMBL2096675,Integrin alpha-V/beta-5,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:21269250, URL:http://europepmc.org/abstract/MED/21269250|Name:PubMed, SrcID:12706360, URL:http://europepmc.org/abstract/MED/12706360",CC(C)[C@@H]1N(C)C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC1=O,CHEMBL2096675,ITGB5
2273,CHEMBL2108475,Priliximab,Antibody,,,,-mab,T-cell surface antigen CD4 negative modulator,Blocks activation of T-cells. Causes depletion of CD4+ lymphocytes.,,CHEMBL2754,T-cell surface antigen CD4,NEGATIVE MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:8103714, URL:http://europepmc.org/abstract/MED/8103714|Name:Patent, SrcID:WO-1991010722-A2, URL:https://www.surechembl.org/document/WO-1991010722-A2/",,CHEMBL2754,CD4
2274,CHEMBL2108489,Keliximab,Antibody,,,,-mab,T-cell surface antigen CD4 negative modulator,,,CHEMBL2754,T-cell surface antigen CD4,NEGATIVE MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:9191886, URL:http://europepmc.org/abstract/MED/9191886",,CHEMBL2754,CD4
2275,CHEMBL2108621,Mapatumumab,Antibody,,,,-mab,TRAIL receptor-1 agonist,"Mapatumumab, like the native ligand TRAIL, mediates apoptosis by binding to TRAIL-R1, leading to activation of the caspase cascade, cleavage of key intracellular signalling components and DNA and subsequent cell death.",,CHEMBL3551,TRAIL receptor-1,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15846298, URL:http://europepmc.org/abstract/MED/15846298",,CHEMBL3551,TNFRSF10A
2276,CHEMBL361497,Artesunate,Small molecule,,P01BE03,"P01BE03 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: ANTIMALARIALS: Artemisinin and derivatives, plain]",arte-,Unknown,,,,,,,,,,,C[C@@H]1CC[C@H]2[C@@H](C)[C@H](OC(=O)CCC(=O)O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4,,
2277,CHEMBL1201232,Isopropamide,Small molecule,1957.0,A03AB09,"A03AB09 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: Synthetic anticholinergics, quaternary ammonium compounds]",-pamide,Muscarinic acetylcholine receptor M3 antagonist,"Role in regulating gastric secretion, M3 likely involved",,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15446040, URL:http://europepmc.org/abstract/MED/15446040|Name:PubMed, SrcID:13473394, URL:http://europepmc.org/abstract/MED/13473394|Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718",CC(C)[N+](C)(CCC(C(=O)N)(c1ccccc1)c2ccccc2)C(C)C,CHEMBL245,CHRM3
2278,CHEMBL1201825,Ranibizumab,Antibody,2006.0,S01LA04,S01LA04 [SENSORY ORGANS: OPHTHALMOLOGICALS: OCULAR VASCULAR DISORDER AGENTS: Antineovascularisation agents],-mab,Vascular endothelial growth factor A inhibitor,,,CHEMBL1783,Vascular endothelial growth factor A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=de4e66cc-ca05-4dc9-8262-e00e9b41c36d, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de4e66cc-ca05-4dc9-8262-e00e9b41c36d",,CHEMBL1783,VEGFA
2279,CHEMBL639,Azelastine,Small molecule,1996.0,R01AC03; R06AX19; S01GX07,"R01AC03 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Antiallergic agents, excl. corticosteroids]; R06AX19 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Other antihistamines for systemic use]; S01GX07 [SENSORY ORGANS: OPHTHALMOLOGICALS: DECONGESTANTS AND ANTIALLERGICS: Other antiallergics]",-astine,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=46b2ddff-d40a-43ac-b027-4fac9fc2f4b9, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=46b2ddff-d40a-43ac-b027-4fac9fc2f4b9|Name:FDA, SrcID:label/2015/022203s010s011lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022203s010s011lbl.pdf",CN1CCCC(CC1)N2N=C(Cc3ccc(Cl)cc3)c4ccccc4C2=O,CHEMBL231,HRH1
2280,CHEMBL1201353,Dexchlorpheniramine,Small molecule,1981.0,R06AB52; R06AB02,R06AB52 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Substituted alkylamines]; R06AB02 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Substituted alkylamines],,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Dexchlorpheniramine, URL:http://en.wikipedia.org/wiki/Dexchlorpheniramine|Name:PubMed, SrcID:26515, URL:http://europepmc.org/abstract/MED/26515",CN(C)CC[C@@H](c1ccc(Cl)cc1)c2ccccn2,CHEMBL231,HRH1
2281,CHEMBL1201758,Bepotastine,Small molecule,2009.0,,,-astine,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=adba6255-f2be-4958-9e95-93000aff74f6, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=adba6255-f2be-4958-9e95-93000aff74f6|Name:FDA, SrcID:label/2012/022288s003lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022288s003lbl.pdf",OC(=O)CCCN1CCC(CC1)O[C@@H](c2ccc(Cl)cc2)c3ccccn3,CHEMBL231,HRH1
2282,CHEMBL1201577,Cetuximab,Antibody,2004.0,L01XC06,L01XC06 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,Epidermal growth factor receptor erbB1 inhibitor,,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=8bc6397e-4bd8-4d37-a007-a327e4da34d9, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8bc6397e-4bd8-4d37-a007-a327e4da34d9",,CHEMBL203,EGFR
2283,CHEMBL939,Gefitinib,Small molecule,2003.0,L01XE02,L01XE02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Epidermal growth factor receptor erbB1 inhibitor,,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=827d60e8-7e07-41b7-c28b-49ef1c4a5a41, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=827d60e8-7e07-41b7-c28b-49ef1c4a5a41",COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN4CCOCC4,CHEMBL203,EGFR
2284,CHEMBL93,Zileuton,Small molecule,1996.0,,,-leuton,Arachidonate 5-lipoxygenase inhibitor,,,CHEMBL215,Arachidonate 5-lipoxygenase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=9bc08d7b-13da-444f-ac8a-3714a05176cc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9bc08d7b-13da-444f-ac8a-3714a05176cc",CC(N(O)C(=O)N)c1cc2ccccc2s1,CHEMBL215,ALOX5
2285,CHEMBL1186610,Anisotropine,Small molecule,1962.0,,,-trop-,Muscarinic acetylcholine receptor M1 antagonist,"Role in regulating gastric secretion, M1 likely involved",,CHEMBL216,Muscarinic acetylcholine receptor M1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:4555460, URL:http://europepmc.org/abstract/MED/4555460|Name:PubMed, SrcID:353090, URL:http://europepmc.org/abstract/MED/353090|Name:Wikipedia, SrcID:Anisotropine_Methylbromide, URL:http://en.wikipedia.org/wiki/Anisotropine_Methylbromide",CCCC(CCC)C(=O)O[C@H]1C[C@H]2CC[C@@H](C1)[N+]2(C)C,CHEMBL216,CHRM1
2286,CHEMBL461101,Eltrombopag,Small molecule,2008.0,B02BX05,B02BX05 [BLOOD AND BLOOD FORMING ORGANS: ANTIHEMORRHAGICS: VITAMIN K AND OTHER HEMOSTATICS: Other systemic hemostatics],-trombopag,Thrombopoietin receptor agonist,,,CHEMBL1864,Thrombopoietin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=616224ff-a925-4b38-9ca2-00fbf669380f#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=616224ff-a925-4b38-9ca2-00fbf669380f#nlm34090-1",CC1=NN(C(=O)/C/1=N\Nc2cccc(c2O)c3cccc(c3)C(=O)O)c4ccc(C)c(C)c4,CHEMBL1864,MPL
2287,CHEMBL1946170,Regorafenib,Small molecule,2012.0,L01XE21,L01XE21 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-rafenib,Serine/threonine-protein kinase RAF inhibitor,,,CHEMBL1906,Serine/threonine-protein kinase RAF,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Expert, SrcID:REGORAFENIB, URL:http://chembl.blogspot.co.uk/search?q=REGORAFENIB",CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,CHEMBL1906,RAF1
2288,CHEMBL1113,Amoxapine,Small molecule,1980.0,N06AA17,N06AA17 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Non-selective monoamine reuptake inhibitors],-pin(e),Serotonin transporter inhibitor,,,CHEMBL228,Serotonin transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=261006c8-3fd0-491b-b322-42beff6f9880#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=261006c8-3fd0-491b-b322-42beff6f9880#nlm34090-1",Clc1ccc2Oc3ccccc3N=C(N4CCNCC4)c2c1,CHEMBL228,SLC6A4
2289,CHEMBL1336,Sorafenib,Small molecule,2005.0,L01XE05,L01XE05 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-rafenib,Stem cell growth factor receptor inhibitor,,,CHEMBL1936,Stem cell growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2011/021923s012lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf",CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,CHEMBL1936,KIT
2290,CHEMBL185,Fluorouracil,Small molecule,1962.0,L01BC52; L01BC02,L01BC52 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Pyrimidine analogues]; L01BC02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Pyrimidine analogues],-uracil,Thymidylate synthase inhibitor,,,CHEMBL1952,Thymidylate synthase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=b90e0da7-f702-4f09-9488-74f2bb20e9ac, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b90e0da7-f702-4f09-9488-74f2bb20e9ac",FC1=CNC(=O)NC1=O,CHEMBL1952,TYMS
2291,CHEMBL473,Dofetilide,Small molecule,1999.0,C01BD04,"C01BD04 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III]",-ilide,HERG blocker,,,CHEMBL240,HERG,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Herg, URL:http://en.wikipedia.org/wiki/Herg|Name:DailyMed, SrcID:setid=02438044-d6a3-49e9-a1ac-3aad21ef2c8c, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=02438044-d6a3-49e9-a1ac-3aad21ef2c8c",CN(CCOc1ccc(NS(=O)(=O)C)cc1)CCc2ccc(NS(=O)(=O)C)cc2,CHEMBL240,KCNH2
2292,CHEMBL2104391,Insulin Detemir,Protein,2005.0,A10AE05,"A10AE05 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: INSULINS AND ANALOGUES: Insulins and analogues for injection, long-acting]",,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=2b8d9730-686b-444b-9941-7b5877255924, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2b8d9730-686b-444b-9941-7b5877255924",CCCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](Cc4ccccc4)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]5CSSC[C@H](NC(=O)[C@H](Cc6ccc(O)cc6)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc7ccc(O)cc7)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]8CSSC[C@H](NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc9c[nH]cn9)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc%10ccccc%10)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc%11c[nH]cn%11)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc%12ccc(O)cc%12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N5)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N8)C(=O)N[C@@H](CC(=O)N)C(=O)O)[C@@H](C)O)C(=O)O,CHEMBL1981,INSR
2293,CHEMBL511142,Buprenorphine,Small molecule,1981.0,N07BC51; N02AE01; N07BC01,N07BC51 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: DRUGS USED IN ADDICTIVE DISORDERS: Drugs used in opioid dependence]; N02AE01 [NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Oripavine derivatives]; N07BC01 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: DRUGS USED IN ADDICTIVE DISORDERS: Drugs used in opioid dependence],,Mu opioid receptor agonist,,,CHEMBL233,Mu opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=b086772e-d15a-4d13-b1a2-38bfbde1f18c#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b086772e-d15a-4d13-b1a2-38bfbde1f18c#nlm34090-1",CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]4Cc5ccc(O)c6O[C@@H]2[C@]3(CCN4CC7CC7)c56,CHEMBL233,OPRM1
2294,CHEMBL1200617,Rimexolone,Small molecule,1994.0,H02AB12; S01BA13,"H02AB12 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Glucocorticoids]; S01BA13 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Corticosteroids, plain]",-olone,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:2386110, URL:http://europepmc.org/abstract/MED/2386110",CCC(=O)[C@@]1(C)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C,CHEMBL2034,NR3C1
2295,CHEMBL2109065,Drotrecogin Alfa (Activated),Unknown,2001.0,B01AD10,B01AD10 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Enzymes],,Coagulation factor V inhibitor,Activated protein c cleaves clotting factors to inactivate,,CHEMBL3618,Coagulation factor V,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:archiveid=10210#section-12, URL:http://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=10210#section-12",,CHEMBL3618,F5
2296,CHEMBL897,Probenecid,Small molecule,1951.0,M04AB01,M04AB01 [MUSCULO-SKELETAL SYSTEM: ANTIGOUT PREPARATIONS: ANTIGOUT PREPARATIONS: Preparations increasing uric acid excretion],,Solute carrier family 22 member 8 inhibitor,,,CHEMBL1641348,Solute carrier family 22 member 8,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:2962517, URL:http://europepmc.org/abstract/MED/2962517|Name:PubMed, SrcID:15377641, URL:http://europepmc.org/abstract/MED/15377641|Name:Wikipedia, SrcID:Probenecid#Pharmacology, URL:http://en.wikipedia.org/wiki/Probenecid#Pharmacology|Name:PubMed, SrcID:11426832, URL:http://europepmc.org/abstract/MED/11426832|Name:PubMed, SrcID:12130730, URL:http://europepmc.org/abstract/MED/12130730",CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)O,CHEMBL1641348,SLC22A8
2297,CHEMBL535,Sunitinib,Small molecule,2006.0,L01XE04,L01XE04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Platelet-derived growth factor receptor inhibitor,,,CHEMBL2095189,Platelet-derived growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:DailyMed, SrcID:setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14",CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C\2/C(=O)Nc3ccc(F)cc23)c1C,,
2298,CHEMBL386630,Testosterone,Small molecule,1972.0,G03BA03,G03BA03 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ANDROGENS: 3-oxoandrosten (4) derivatives],-ster-,Androgen Receptor agonist,,,CHEMBL1871,Androgen Receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Testosterone, URL:http://en.wikipedia.org/wiki/Testosterone|Name:FDA, SrcID:label/2015/021015s040lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021015s040lbl.pdf|Name:DailyMed, SrcID:setid=3fa5b81e-81fd-4017-8e87-a4a4c08119fd#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3fa5b81e-81fd-4017-8e87-a4a4c08119fd#nlm34090-1",C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O,CHEMBL1871,AR
2299,CHEMBL1537,Azlocillin,Small molecule,1982.0,J01CA09,"J01CA09 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: BETA-LACTAM ANTIBACTERIALS, PENICILLINS: Penicillins with extended spectrum]",-cillin,Penicillin-binding protein inhibitor,,,CHEMBL2363020,Penicillin-binding protein,INHIBITOR,Pseudomonas aeruginosa,PROTEIN FAMILY,,,"Name:PubMed, SrcID:2515794, URL:http://europepmc.org/abstract/MED/2515794",CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c4ccccc4)C(=O)N2[C@H]1C(=O)O,,
2300,CHEMBL591,Ethchlorvynol,Small molecule,1961.0,N05CM08,N05CM08 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Other hypnotics and sedatives],,GABA-A receptor; anion channel positive modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Unknown binding site,"Name:PubMed, SrcID:1585214, URL:http://europepmc.org/abstract/MED/1585214|Name:ISBN, SrcID:9780702034718 PP. 533, URL:http://www.isbnsearch.org/isbn/9780702034718",CCC(O)(\C=C\Cl)C#C,CHEMBL2093872,GABRG3
2301,CHEMBL591,Ethchlorvynol,Small molecule,1961.0,N05CM08,N05CM08 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Other hypnotics and sedatives],,GABA-A receptor; anion channel positive modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Unknown binding site,"Name:PubMed, SrcID:1585214, URL:http://europepmc.org/abstract/MED/1585214|Name:ISBN, SrcID:9780702034718 PP. 533, URL:http://www.isbnsearch.org/isbn/9780702034718",CCC(O)(\C=C\Cl)C#C,CHEMBL2093872,GABRP
2302,CHEMBL591,Ethchlorvynol,Small molecule,1961.0,N05CM08,N05CM08 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Other hypnotics and sedatives],,GABA-A receptor; anion channel positive modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Unknown binding site,"Name:PubMed, SrcID:1585214, URL:http://europepmc.org/abstract/MED/1585214|Name:ISBN, SrcID:9780702034718 PP. 533, URL:http://www.isbnsearch.org/isbn/9780702034718",CCC(O)(\C=C\Cl)C#C,CHEMBL2093872,GABRE
2303,CHEMBL591,Ethchlorvynol,Small molecule,1961.0,N05CM08,N05CM08 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Other hypnotics and sedatives],,GABA-A receptor; anion channel positive modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Unknown binding site,"Name:PubMed, SrcID:1585214, URL:http://europepmc.org/abstract/MED/1585214|Name:ISBN, SrcID:9780702034718 PP. 533, URL:http://www.isbnsearch.org/isbn/9780702034718",CCC(O)(\C=C\Cl)C#C,CHEMBL2093872,GABRG1
2304,CHEMBL1506,Chloramphenicol Palmitate,Small molecule,1982.0,S02AA01; J01BA01; D10AF03; S01AA01; D06AX02; S03AA08; G01AA05,"S02AA01 [SENSORY ORGANS: OTOLOGICALS: ANTIINFECTIVES: Antiinfectives]; J01BA01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: AMPHENICOLS: Amphenicols]; D10AF03 [DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Antiinfectives for treatment of acne]; S01AA01 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Antibiotics]; D06AX02 [DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: ANTIBIOTICS FOR TOPICAL USE: Other antibiotics for topical use]; S03AA08 [SENSORY ORGANS: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS: ANTIINFECTIVES: Antiinfectives]; G01AA05 [GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Antibiotics]",,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,23S ribosomal RNA,23S RRNA,"Name:Wikipedia, SrcID:Chloramphenicol, URL:http://en.wikipedia.org/wiki/Chloramphenicol|Name:PubMed, SrcID:6375931, URL:http://europepmc.org/abstract/MED/6375931|Name:PubMed, SrcID:16091044, URL:http://europepmc.org/abstract/MED/16091044",CCCCCCCCCCCCCCCC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc(cc1)[N+](=O)[O-],,
2305,CHEMBL387675,Daptomycin,Small molecule,2003.0,J01XX09,J01XX09 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER ANTIBACTERIALS: Other antibacterials],-mycin,Cell membrane inhibitor,It binds to bacterial membranes and causes a rapid depolarization of membrane potential,,CHEMBL2364031,Cell membrane,INHIBITOR,Bacteria,SUBCELLULAR,,,"Name:DailyMed, SrcID:setid=a7975871-46a6-4e9b-a8b5-38bfcb465f0e#S12.4, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a7975871-46a6-4e9b-a8b5-38bfcb465f0e#S12.4|Name:Wikipedia, SrcID:Daptomycin#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Daptomycin#Mechanism_of_action",CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H]3[C@@H](C)OC(=O)[C@H](CC(=O)c4ccccc4N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCN)NC(=O)CNC3=O)[C@H](C)CC(=O)O,,
2306,CHEMBL459265,Crystal Violet,Small molecule,1982.0,,,,DNA inhibitor,Generates free radicals causing DNA damage.,,CHEMBL2364041,DNA,INHIBITOR,Bacteria,NUCLEIC-ACID,,,"Name:PubMed, SrcID:3150994, URL:http://europepmc.org/abstract/MED/3150994|Name:PubMed, SrcID:2272286, URL:http://europepmc.org/abstract/MED/2272286",CN(C)c1ccc(cc1)C(=C2C=CC(=[N+](C)C)C=C2)c3ccc(cc3)N(C)C,,
2307,CHEMBL1619,Cladribine,Small molecule,1993.0,L01BB04,L01BB04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Purine analogues],-ribine,DNA inhibitor,"Activated by the deoxycytidine kinase to a toxic compound, which then gets incorporated into DNA",,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=a2592a9b-bca6-4a5a-89c2-855a0634d5fe, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a2592a9b-bca6-4a5a-89c2-855a0634d5fe",Nc1nc(Cl)nc2c1ncn2[C@H]3C[C@H](O)[C@@H](CO)O3,,
2308,CHEMBL1201197,Alatrofloxacin,Small molecule,1997.0,,,-oxacin,Bacterial DNA gyrase inhibitor,,,CHEMBL2311224,Bacterial DNA gyrase,INHIBITOR,Bacteria,PROTEIN COMPLEX,,,"Name:DailyMed, SrcID:setid=da9b26bb-d2d7-4113-a0f9-c6c2280f4875#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=da9b26bb-d2d7-4113-a0f9-c6c2280f4875#nlm34090-1|Name:PubMed, SrcID:17803740, URL:http://europepmc.org/abstract/MED/17803740",C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H]1[C@@H]2CN(C[C@H]12)c3nc4N(C=C(C(=O)O)C(=O)c4cc3F)c5ccc(F)cc5F,,
2309,CHEMBL284348,Dalfampridine,Small molecule,2010.0,N07XX07,N07XX07 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs],,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2013/022250s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022250s006lbl.pdf|Name:PubMed, SrcID:21595605, URL:http://europepmc.org/abstract/MED/21595605",Nc1ccncc1,CHEMBL2362996,KCNH6
2310,CHEMBL284348,Dalfampridine,Small molecule,2010.0,N07XX07,N07XX07 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs],,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2013/022250s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022250s006lbl.pdf|Name:PubMed, SrcID:21595605, URL:http://europepmc.org/abstract/MED/21595605",Nc1ccncc1,CHEMBL2362996,KCNF1
2311,CHEMBL284348,Dalfampridine,Small molecule,2010.0,N07XX07,N07XX07 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs],,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2013/022250s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022250s006lbl.pdf|Name:PubMed, SrcID:21595605, URL:http://europepmc.org/abstract/MED/21595605",Nc1ccncc1,CHEMBL2362996,KCNA7
2312,CHEMBL284348,Dalfampridine,Small molecule,2010.0,N07XX07,N07XX07 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs],,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2013/022250s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022250s006lbl.pdf|Name:PubMed, SrcID:21595605, URL:http://europepmc.org/abstract/MED/21595605",Nc1ccncc1,CHEMBL2362996,KCND1
2313,CHEMBL284348,Dalfampridine,Small molecule,2010.0,N07XX07,N07XX07 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs],,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2013/022250s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022250s006lbl.pdf|Name:PubMed, SrcID:21595605, URL:http://europepmc.org/abstract/MED/21595605",Nc1ccncc1,CHEMBL2362996,KCNG1
2314,CHEMBL284348,Dalfampridine,Small molecule,2010.0,N07XX07,N07XX07 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs],,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2013/022250s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022250s006lbl.pdf|Name:PubMed, SrcID:21595605, URL:http://europepmc.org/abstract/MED/21595605",Nc1ccncc1,CHEMBL2362996,KCNH8
2315,CHEMBL284348,Dalfampridine,Small molecule,2010.0,N07XX07,N07XX07 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs],,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2013/022250s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022250s006lbl.pdf|Name:PubMed, SrcID:21595605, URL:http://europepmc.org/abstract/MED/21595605",Nc1ccncc1,CHEMBL2362996,KCNG4
2316,CHEMBL284348,Dalfampridine,Small molecule,2010.0,N07XX07,N07XX07 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs],,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2013/022250s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022250s006lbl.pdf|Name:PubMed, SrcID:21595605, URL:http://europepmc.org/abstract/MED/21595605",Nc1ccncc1,CHEMBL2362996,KCNH7
2317,CHEMBL284348,Dalfampridine,Small molecule,2010.0,N07XX07,N07XX07 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs],,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2013/022250s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022250s006lbl.pdf|Name:PubMed, SrcID:21595605, URL:http://europepmc.org/abstract/MED/21595605",Nc1ccncc1,CHEMBL2362996,KCNH5
2318,CHEMBL284348,Dalfampridine,Small molecule,2010.0,N07XX07,N07XX07 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs],,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2013/022250s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022250s006lbl.pdf|Name:PubMed, SrcID:21595605, URL:http://europepmc.org/abstract/MED/21595605",Nc1ccncc1,CHEMBL2362996,KCNC3
2319,CHEMBL284348,Dalfampridine,Small molecule,2010.0,N07XX07,N07XX07 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs],,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2013/022250s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022250s006lbl.pdf|Name:PubMed, SrcID:21595605, URL:http://europepmc.org/abstract/MED/21595605",Nc1ccncc1,CHEMBL2362996,KCNV1
2320,CHEMBL284348,Dalfampridine,Small molecule,2010.0,N07XX07,N07XX07 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs],,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2013/022250s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022250s006lbl.pdf|Name:PubMed, SrcID:21595605, URL:http://europepmc.org/abstract/MED/21595605",Nc1ccncc1,CHEMBL2362996,KCNG3
2321,CHEMBL284348,Dalfampridine,Small molecule,2010.0,N07XX07,N07XX07 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs],,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2013/022250s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022250s006lbl.pdf|Name:PubMed, SrcID:21595605, URL:http://europepmc.org/abstract/MED/21595605",Nc1ccncc1,CHEMBL2362996,KCNS3
2322,CHEMBL284348,Dalfampridine,Small molecule,2010.0,N07XX07,N07XX07 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs],,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2013/022250s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022250s006lbl.pdf|Name:PubMed, SrcID:21595605, URL:http://europepmc.org/abstract/MED/21595605",Nc1ccncc1,CHEMBL2362996,KCNV2
2323,CHEMBL284348,Dalfampridine,Small molecule,2010.0,N07XX07,N07XX07 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs],,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2013/022250s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022250s006lbl.pdf|Name:PubMed, SrcID:21595605, URL:http://europepmc.org/abstract/MED/21595605",Nc1ccncc1,CHEMBL2362996,KCNH3
2324,CHEMBL284348,Dalfampridine,Small molecule,2010.0,N07XX07,N07XX07 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs],,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2013/022250s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022250s006lbl.pdf|Name:PubMed, SrcID:21595605, URL:http://europepmc.org/abstract/MED/21595605",Nc1ccncc1,CHEMBL2362996,KCNS2
2325,CHEMBL284348,Dalfampridine,Small molecule,2010.0,N07XX07,N07XX07 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs],,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2013/022250s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022250s006lbl.pdf|Name:PubMed, SrcID:21595605, URL:http://europepmc.org/abstract/MED/21595605",Nc1ccncc1,CHEMBL2362996,KCNS1
2326,CHEMBL284348,Dalfampridine,Small molecule,2010.0,N07XX07,N07XX07 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs],,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2013/022250s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022250s006lbl.pdf|Name:PubMed, SrcID:21595605, URL:http://europepmc.org/abstract/MED/21595605",Nc1ccncc1,CHEMBL2362996,KCNC2
2327,CHEMBL284348,Dalfampridine,Small molecule,2010.0,N07XX07,N07XX07 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs],,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2013/022250s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022250s006lbl.pdf|Name:PubMed, SrcID:21595605, URL:http://europepmc.org/abstract/MED/21595605",Nc1ccncc1,CHEMBL2362996,KCNH4
2328,CHEMBL284348,Dalfampridine,Small molecule,2010.0,N07XX07,N07XX07 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs],,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2013/022250s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022250s006lbl.pdf|Name:PubMed, SrcID:21595605, URL:http://europepmc.org/abstract/MED/21595605",Nc1ccncc1,CHEMBL2362996,KCNC4
2329,CHEMBL284348,Dalfampridine,Small molecule,2010.0,N07XX07,N07XX07 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs],,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2013/022250s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022250s006lbl.pdf|Name:PubMed, SrcID:21595605, URL:http://europepmc.org/abstract/MED/21595605",Nc1ccncc1,CHEMBL2362996,KCNH1
2330,CHEMBL284348,Dalfampridine,Small molecule,2010.0,N07XX07,N07XX07 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs],,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2013/022250s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022250s006lbl.pdf|Name:PubMed, SrcID:21595605, URL:http://europepmc.org/abstract/MED/21595605",Nc1ccncc1,CHEMBL2362996,KCNA10
2331,CHEMBL284348,Dalfampridine,Small molecule,2010.0,N07XX07,N07XX07 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs],,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2013/022250s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022250s006lbl.pdf|Name:PubMed, SrcID:21595605, URL:http://europepmc.org/abstract/MED/21595605",Nc1ccncc1,CHEMBL2362996,KCNG2
2332,CHEMBL1096562,Methyl Aminolevulinate,Small molecule,2004.0,L01XD03,L01XD03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Sensitizers used in photodynamic/radiation therapy],,DNA inhibitor,Photodynamic therapy,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=d02af310-d097-4886-86e5-adcf6bca0533, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d02af310-d097-4886-86e5-adcf6bca0533",COC(=O)CCC(=O)CN,,
2333,CHEMBL574738,Ast-487,Small molecule,,,,,Tyrosine-protein kinase receptor FLT3 inhibitor,"Also potent against KDR, FLT4, KIT, and ABL1. Selective inhibitor of mutant FLT3.",,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18820131, URL:http://europepmc.org/abstract/MED/18820131",CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1,CHEMBL1974,FLT3
2334,CHEMBL3545427,Cm-082,Small molecule,,,,,Tyrosine-protein kinase receptor FLT3 inhibitor,,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.tyrogenex.com/wordpress/wp-content/uploads/Oral-X-82-for-wet-AMD-ARVO-2013.pdf, URL:http://www.tyrogenex.com/wordpress/wp-content/uploads/Oral-X-82-for-wet-AMD-ARVO-2013.pdf",,CHEMBL1974,FLT3
2335,CHEMBL1090479,Gsk-1070916,Small molecule,,,,,Serine/threonine-protein kinase Aurora-C inhibitor,,,CHEMBL3935,Serine/threonine-protein kinase Aurora-C,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24965505, URL:http://europepmc.org/abstract/MED/24965505|Name:PubMed, SrcID:20420387, URL:http://europepmc.org/abstract/MED/20420387",CCn1cc(c2ccnc3[nH]c(cc23)c4cccc(CN(C)C)c4)c(n1)c5ccc(NC(=O)N(C)C)cc5,CHEMBL3935,AURKC
2336,CHEMBL494089,Gsk-690693,Small molecule,,,,,Serine/threonine-protein kinase AKT inhibitor,,,CHEMBL2111353,Serine/threonine-protein kinase AKT,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:18800763, URL:http://europepmc.org/abstract/MED/18800763",CCn1c(nc2c(ncc(OC[C@H]3CCCNC3)c12)C#CC(C)(C)O)c4nonc4N,,
2337,CHEMBL494089,Gsk-690693,Small molecule,,,,,cAMP-dependent protein kinase (PKA) inhibitor,,,CHEMBL2094138,cAMP-dependent protein kinase (PKA),INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:18800763, URL:http://europepmc.org/abstract/MED/18800763",CCn1c(nc2c(ncc(OC[C@H]3CCCNC3)c12)C#CC(C)(C)O)c4nonc4N,,
2338,CHEMBL3544998,Ly-3007113,Small molecule,,,,,MAP kinase p38 alpha inhibitor,,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=716106, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=716106",,CHEMBL260,MAPK14
2339,CHEMBL2323775,Mk-8033,Small molecule,,,,,Hepatocyte growth factor receptor inhibitor,,,CHEMBL3717,Hepatocyte growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23379595, URL:http://europepmc.org/abstract/MED/23379595",Cn1cc(cn1)c2cnc3C=Cc4ccc(CS(=O)(=O)NCc5ccccn5)cc4C(=O)c3c2,CHEMBL3717,MET
2340,CHEMBL3545005,Plx-8394,Small molecule,,,,,Serine/threonine-protein kinase B-raf inhibitor,,,CHEMBL5145,Serine/threonine-protein kinase B-raf,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=756043, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=756043|Name:PubMed, SrcID:24422853, URL:http://europepmc.org/abstract/MED/24422853|Name:PubMed, SrcID:26466569, URL:http://europepmc.org/abstract/MED/26466569",,CHEMBL5145,BRAF
2341,CHEMBL3545144,Tas-115,Small molecule,,,,,Vascular endothelial growth factor receptor 2 inhibitor,,,CHEMBL279,Vascular endothelial growth factor receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://www.taihooncology.com/us/science/product-pipeline/, URL:https://www.taihooncology.com/us/science/product-pipeline/|Name:PubMed, SrcID:24140932, URL:http://europepmc.org/abstract/MED/24140932",,CHEMBL279,KDR
2342,CHEMBL3545085,Xl-228,Small molecule,,,,,Insulin-like growth factor I receptor inhibitor,"Also potent inhibitor of AURKA, AURKB, FGFR1-3, and ALK.",,CHEMBL1957,Insulin-like growth factor I receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1158/1535-7163.TARG-09-C192, URL:http://mct.aacrjournals.org/content/8/12_Supplement/C192|Name:Other, SrcID:http://www.exelixis.com/sites/default/files/pdf/XL228-002_ASCO-2009.pdf, URL:http://www.exelixis.com/sites/default/files/pdf/XL228-002_ASCO-2009.pdf|Name:PubMed, SrcID:20124450, URL:http://europepmc.org/abstract/MED/20124450",CC(C)c1cc(CNc2nc(Nc3cc([nH]n3)C4CC4)cc(n2)N5CCN(C)CC5)on1,CHEMBL1957,IGF1R
2343,CHEMBL1084617,Temanogrel,Small molecule,,,,-grel,Serotonin 2a (5-HT2a) receptor inverse agonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,INVERSE AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19628629, URL:http://europepmc.org/abstract/MED/19628629",COc1cccc(c1)C(=O)Nc2ccc(OCCN3CCOCC3)c(c2)c4ccnn4C,CHEMBL224,HTR2A
2344,CHEMBL3544939,Ly2979165,Small molecule,,,,,Metabotropic glutamate receptor 2 agonist,,,CHEMBL5137,Metabotropic glutamate receptor 2,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.medchemexpress.com/DataSheet/LY2979165.html, URL:http://www.medchemexpress.com/DataSheet/LY2979165.html",,CHEMBL5137,GRM2
2345,CHEMBL3707225,Gsk2798745,Small molecule,,,,,Transient receptor potential cation channel subfamily V member 4 antagonist,,,CHEMBL3119,Transient receptor potential cation channel subfamily V member 4,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.gsk.com/media/1017505/product-pipeline-march-2016.pdf, URL:http://www.gsk.com/media/1017505/product-pipeline-march-2016.pdf",,CHEMBL3119,TRPV4
2346,CHEMBL2181927,Finerenone,Small molecule,,,,-renone,Mineralocorticoid receptor antagonist,,,CHEMBL1994,Mineralocorticoid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24621652, URL:http://europepmc.org/abstract/MED/24621652",CCOc1ncc(C)c2NC(=C([C@@H](c3ccc(cc3OC)C#N)c12)C(=O)N)C,,
2347,CHEMBL3137308,Peficitinib,Small molecule,,,,-tinib,Janus Kinase (JAK) inhibitor,,,CHEMBL2363062,Janus Kinase (JAK),INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://www.blackwellpublishing.com/acrmeeting/abstract.asp?MeetingID=789&id=102813, URL:http://www.blackwellpublishing.com/acrmeeting/abstract.asp?MeetingID=789&id=102813|Name:PubMed, SrcID:24818516, URL:http://europepmc.org/abstract/MED/24818516",NC(=O)c1cnc2[nH]ccc2c1N[C@@H]3[C@@H]4CC5C[C@H]3C[C@@](O)(C5)C4,,
2348,CHEMBL482968,Enmd-2076,Small molecule,,,,,Serine/threonine-protein kinase Aurora-B inhibitor,Tartrate salt of ENMD-981693,,CHEMBL2185,Serine/threonine-protein kinase Aurora-B,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf, URL:http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf|Name:PubMed, SrcID:21177375, URL:http://europepmc.org/abstract/MED/21177375|Name:PubMed, SrcID:22397360, URL:http://europepmc.org/abstract/MED/22397360",CN1CCN(CC1)c2cc(Nc3cc(C)[nH]n3)nc(\C=C\c4ccccc4)n2,CHEMBL2185,AURKB
2349,CHEMBL1822792,Mk-2461,Small molecule,,,,,Hepatocyte growth factor receptor inhibitor,,,CHEMBL3717,Hepatocyte growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21608528, URL:http://europepmc.org/abstract/MED/21608528|Name:PubMed, SrcID:25806189, URL:http://europepmc.org/abstract/MED/25806189",CN(C[C@@H]1COCCO1)S(=O)(=O)Nc2ccc3C=Cc4ncc(cc4C(=O)c3c2)c5cnn(C)c5,CHEMBL3717,MET
2350,CHEMBL564829,Milciclib,Small molecule,,,,-ciclib,Cyclin-dependent kinase 4 inhibitor,,,CHEMBL331,Cyclin-dependent kinase 4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25215591, URL:http://europepmc.org/abstract/MED/25215591|Name:PubMed, SrcID:20682657, URL:http://europepmc.org/abstract/MED/20682657",CNC(=O)c1nn(C)c2c3nc(Nc4ccc(cc4)N5CCN(C)CC5)ncc3CC(C)(C)c12,CHEMBL331,CDK4
2351,CHEMBL1090089,Pamapimod,Small molecule,,,,-imod,MAP kinase p38 alpha inhibitor,,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18776065, URL:http://europepmc.org/abstract/MED/18776065",CN1C(=O)C(=Cc2cnc(NC(CCO)CCO)nc12)Oc3ccc(F)cc3F,CHEMBL260,MAPK14
2352,CHEMBL2103880,Cerlapirdine,Small molecule,,,,-pirdine,Serotonin 6 (5-HT6) receptor antagonist,,,CHEMBL3371,Serotonin 6 (5-HT6) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25217486, URL:http://europepmc.org/abstract/MED/25217486",CN(C)CCCOc1ccc2[nH]nc(c2c1)S(=O)(=O)c3cccc4ccccc34,CHEMBL3371,HTR6
2353,CHEMBL2107371,Selodenoson,Small molecule,,,,-denoson,Adenosine A1 receptor agonist,,,CHEMBL226,Adenosine A1 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16654164, URL:http://www.ncbi.nlm.nih.gov/pubmed/?term=16654164",CCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(NC4CCCC4)ncnc23,CHEMBL226,ADORA1
2354,CHEMBL2110727,Cenicriviroc,Small molecule,,,,-viroc,C-C chemokine receptor type 2 antagonist,,,CHEMBL4015,C-C chemokine receptor type 2,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21317794, URL:http://europepmc.org/abstract/MED/21317794|Name:PubMed, SrcID:16251299, URL:http://europepmc.org/abstract/MED/16251299|Name:PubMed, SrcID:21486960, URL:http://europepmc.org/abstract/MED/21486960",CCCCOCCOc1ccc(cc1)c2ccc3N(CC(C)C)CCC\C(=C/c3c2)\C(=O)Nc4ccc(cc4)[S+]([O-])Cc5cncn5CCC,CHEMBL4015,CCR2
2355,CHEMBL3545367,Lemborexant,Small molecule,,,,,Orexin receptor 2 antagonist,,,CHEMBL4792,Orexin receptor 2,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.eisai.com/pdf/eir/erepo/epipeline.pdf, URL:http://www.eisai.com/pdf/eir/erepo/epipeline.pdf",Cc1ncc(OC[C@]2(C[C@H]2C(=O)Nc3ccc(F)cn3)c4cccc(F)c4)c(C)n1,CHEMBL4792,HCRTR2
2356,CHEMBL3545164,Azd2066,Small molecule,,,,,Metabotropic glutamate receptor 5 modulator,Discontinuedfor safety reasons.,,CHEMBL3227,Metabotropic glutamate receptor 5,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22469098, URL:http://europepmc.org/abstract/MED/22469098|Name:PMC, SrcID:PMC172159, URL:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC172159/",C[C@@H](Oc1nnc(c2ccncc2)n1C)c3cc(on3)c4cccc(Cl)c4,CHEMBL3227,GRM5
2357,CHEMBL2104262,Fadolmidine,Small molecule,,,,-adol-,Adrenergic receptor alpha-2 agonist,,,CHEMBL2095158,Adrenergic receptor alpha-2,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:18930723, URL:http://europepmc.org/abstract/MED/18930723",Oc1ccc2CCC(Cc3c[nH]cn3)c2c1,,
2358,CHEMBL329123,Etalocib,Small molecule,,,,,Peroxisome proliferator-activated receptor gamma agonist,,,CHEMBL235,Peroxisome proliferator-activated receptor gamma,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1155/2008/827096, URL:http://www.hindawi.com/journals/ppar/2008/827096/|Name:Wikipedia, SrcID:Etalocib, URL:http://en.wikipedia.org/wiki/Etalocib",CCCc1c(OCCCOc2cc(O)c(cc2CC)c3ccc(F)cc3)cccc1Oc4ccccc4C(=O)O,CHEMBL235,PPARG
2359,CHEMBL3545227,Ngd-8243,Small molecule,,,,,Vanilloid receptor antagonist,,,CHEMBL4794,Vanilloid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21804597, URL:http://europepmc.org/abstract/MED/21804597",,CHEMBL4794,TRPV1
2360,CHEMBL2105759,Baricitinib,Small molecule,,L04AA37,L04AA37 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Selective immunosuppressants],-tinib,Tyrosine-protein kinase JAK2 inhibitor,,,CHEMBL2971,Tyrosine-protein kinase JAK2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20363976, URL:http://europepmc.org/abstract/MED/20363976",CCS(=O)(=O)N1CC(CC#N)(C1)n2cc(cn2)c3ncnc4[nH]ccc34,CHEMBL2971,JAK2
2361,CHEMBL1950554,Binodenoson,Small molecule,,,,-denoson,Adenosine A2a receptor agonist,,,CHEMBL251,Adenosine A2a receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19920048, URL:http://europepmc.org/abstract/MED/19920048",Nc1nc(N\N=C\C2CCCCC2)nc3c1ncn3[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O,CHEMBL251,ADORA2A
2362,CHEMBL3286580,Idalopirdine,Small molecule,,,,-pirdine,Serotonin 6 (5-HT6) receptor antagonist,,,CHEMBL3371,Serotonin 6 (5-HT6) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://investor.lundbeck.com/pipeline.cfm, URL:http://investor.lundbeck.com/pipeline.cfm|Name:PubMed, SrcID:25297016, URL:http://europepmc.org/abstract/MED/25297016",FC(F)C(F)(F)COc1cccc(CNCCc2c[nH]c3cc(F)ccc23)c1,CHEMBL3371,HTR6
2363,CHEMBL74355,Volinanserin,Small molecule,,,,-anserin,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Volinanserin, URL:http://en.wikipedia.org/wiki/Volinanserin|Name:PubMed, SrcID:19331461, URL:http://europepmc.org/abstract/MED/19331461",COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC,CHEMBL224,HTR2A
2364,CHEMBL2107754,Iferanserin,Small molecule,,,,-anserin,Serotonin 2a (5-HT2a) receptor antagonist,"Phase 3 study terminated, primary endpoint was not met on the double blind data (NCT01355874)",,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22244049, URL:http://europepmc.org/abstract/MED/22244049|Name:Wikipedia, SrcID:Iferanserin, URL:http://en.wikipedia.org/wiki/Iferanserin|Name:Other, SrcID:http://www.ukmi.nhs.uk/applications/ndo/record_view_open.asp?newDrugID=5633, URL:http://www.ukmi.nhs.uk/applications/ndo/record_view_open.asp?newDrugID=5633",CN1CCCCC1CCc2ccccc2NC(=O)\C=C\c3ccccc3,CHEMBL224,HTR2A
2365,CHEMBL3544954,Zoptarelin Doxorubicin,Protein,,,,-relin,Gonadotropin-releasing hormone receptor agonist,,,CHEMBL1855,Gonadotropin-releasing hormone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Zoptarelin_doxorubicin, URL:http://en.wikipedia.org/wiki/Zoptarelin_doxorubicin|Name:PubMed, SrcID:22577891, URL:http://europepmc.org/abstract/MED/22577891",COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)COC(=O)CCCC(=O)NCCCC[C@@H](NC(=O)[C@H](Cc6ccc(O)cc6)NC(=O)[C@H](CO)NC(=O)[C@H](Cc7c[nH]c8ccccc78)NC(=O)[C@H](Cc9cnc[nH]9)NC(=O)[C@@H]%10CCC(=O)N%10)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N%11CCC[C@H]%11C(=O)NCC(=O)N,CHEMBL1855,GNRHR
2366,CHEMBL1743043,Moxetumomab Pasudotox,Antibody,,,,-mab,CD22 other,"The Fv at the amino terminus binds to CD22 present on the B-cell malignancy being targeted, and the carboxyl terminal lysine residue at position 613 is rapidly removed by plasma carboxypeptidase, generating a protein ending in REDL. Very soon after binding, the recombinant immunotoxin-CD22 complex is internalized through clathrin-coated pits into the endocytic compartment, where 2 steps occur: (i) reduction of the disulfide bond in domain II, and (ii) a furin-catalyzed cleavage in the middle of",,CHEMBL3218,CD22,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22003067, URL:http://europepmc.org/abstract/MED/22003067",,CHEMBL3218,CD22
2367,CHEMBL2108683,Entolimod,Unknown,,,,-imod,Toll-like receptor 5 agonist,Binds to and activates TLR5 thereby stimulating tumor necrosis factor production and activating nuclear factor kappa B (NF-kB).,,CHEMBL2176839,Toll-like receptor 5,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26831100, URL:http://europepmc.org/abstract/MED/26831100",,,
2368,CHEMBL2103831,Naproxcinod,Small molecule,,M01AE18,"M01AE18 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Propionic acid derivatives]",,Cyclooxygenase inhibitor,,,CHEMBL2094253,Cyclooxygenase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:14570719, URL:http://europepmc.org/abstract/MED/14570719",COc1ccc2cc(ccc2c1)[C@H](C)C(=O)OCCCCO[N+](=O)[O-],,
2369,CHEMBL2110954,Neramexane,Small molecule,,,,,Glutamate [NMDA] receptor antagonist,,,CHEMBL2094124,Glutamate [NMDA] receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:21223542, URL:http://europepmc.org/abstract/MED/21223542",CC1(C)CC(C)(C)CC(C)(N)C1,CHEMBL2094124,GRIN3B
2370,CHEMBL2109662,Delantercept,Protein,,,,-cept,Bone morphogenetic protein 10 inhibitor,Ligand trap for BMP9 and BMP10,,CHEMBL3713453,Bone morphogenetic protein 10,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20124460, URL:http://europepmc.org/abstract/MED/20124460|Name:PubMed, SrcID:24173543, URL:http://europepmc.org/abstract/MED/24173543",,CHEMBL3713453,BMP10
2371,CHEMBL1743012,Enokizumab,Antibody,,,,-mab,Interleukin-9 inhibitor,Humanized immunoglobulin (Ig) G1 mAb that neutralizes the activity of human IL-9.,,CHEMBL3712932,Interleukin-9,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19446146, URL:http://europepmc.org/abstract/MED/19446146",,CHEMBL3712932,IL9
2372,CHEMBL1743058,Ponezumab,Antibody,,,,-mab,Beta amyloid A4 protein other,Amyloid clearing function.,,CHEMBL2487,Beta amyloid A4 protein,OTHER,Homo sapiens,SINGLE PROTEIN,,Binds free carboxy terminal amino acids 30-40 of the Abeta40 peptide (PMID:22197375).,"Name:PubMed, SrcID:22197375, URL:http://europepmc.org/abstract/MED/22197375",,CHEMBL2487,APP
2373,CHEMBL2109417,Emd-273063,Antibody,,,,,Disialoganglioside GD2 other,"APN301 is designed to localize GD2-positive tumor cells via the antibody component. The fused IL2 then stimulates the patient's immune system against the tumor by activation of both, NK and T cells, whereas the Fc portion of the antibody is designed to trigger tumor cell killing by antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC).",,CHEMBL3390823,Disialoganglioside GD2,OTHER,Homo sapiens,SMALL MOLECULE,,,"Name:PubMed, SrcID:19548853, URL:http://europepmc.org/abstract/MED/19548853",,,
2374,CHEMBL2109426,Biw-8962,Antibody,,,,,Disialoganglioside GD2 inhibitor,Induces antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC).,,CHEMBL3390823,Disialoganglioside GD2,INHIBITOR,Homo sapiens,SMALL MOLECULE,,,"Name:PubMed, SrcID:21895875, URL:http://europepmc.org/abstract/MED/21895875",,,
2375,CHEMBL2109455,Al-901,Antibody,,,,,Ig epsilon chain C region inhibitor,,,CHEMBL1834,Ig epsilon chain C region,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:9433396, URL:http://europepmc.org/abstract/MED/9433396",,CHEMBL1834,IGHE
2376,CHEMBL2109475,Pg-102,Antibody,,,,,Tumor necrosis factor receptor superfamily member 5 inhibitor,"Engagement of CD40 by PG102 induces formation of a dysfunctional CD40 signaling complex characterized by altered TNFR-associated factor (TRAF) recruitment and association, with resultant ineffective induction of kinase and transcription factor activation. Importantly for potential therapeutic applications, although PG102 did not inhibit CD154–CD40 binding, it inhibited and prevented CD154-induced CD40 activation. ( Do not confuse with PG102, a water soluble extract from Actinidia arguta).",,CHEMBL1250358,Tumor necrosis factor receptor superfamily member 5,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25795759, URL:http://europepmc.org/abstract/MED/25795759",,CHEMBL1250358,CD40
2377,CHEMBL2109478,Cdp-7657,Antibody,,,,,CD40 ligand inhibitor,"Inhibits, dose-dependently, antigen-specific immune responses to tetanus toxoid in Cynomolgus monkeys.",,CHEMBL3580491,CD40 ligand,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25784719, URL:http://europepmc.org/abstract/MED/25784719|Name:PubMed, SrcID:26335795, URL:http://europepmc.org/abstract/MED/26335795",,CHEMBL3580491,CD40LG
2378,CHEMBL2109498,Iph-2101,Antibody,,,,,Killer cell immunoglobulin-like receptor 2DL1 inhibitor,"Acts as a checkpoint inhibitor by blocking the interaction between KIR2DL-1,-2,-3 inhibitory receptors and their ligands",,CHEMBL3712912,Killer cell immunoglobulin-like receptor 2DL1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19553639, URL:http://europepmc.org/abstract/MED/19553639|Name:PubMed, SrcID:22031859, URL:http://europepmc.org/abstract/MED/22031859",,,
2379,CHEMBL1518,Propylthiouracil,Small molecule,1947.0,H03BA02,"H03BA02 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: THYROID THERAPY: ANTITHYROID PREPARATIONS: Thiouracils]",-uracil,Thyroid peroxidase inhibitor,,,CHEMBL1839,Thyroid peroxidase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=88765882-d76e-2464-8a8f-e51afb2b4633, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=88765882-d76e-2464-8a8f-e51afb2b4633|Name:Wikipedia, SrcID:Propylthiouracil, URL:http://en.wikipedia.org/wiki/Propylthiouracil|Name:FDA, SrcID:label/2015/006188s024lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/006188s024lbl.pdf|Name:PubMed, SrcID:21851752, URL:http://europepmc.org/abstract/MED/21851752",CCCC1=CC(=O)NC(=S)N1,CHEMBL1839,TPO
2380,CHEMBL1441,Ethionamide,Small molecule,1965.0,J04AD03,J04AD03 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOBACTERIALS: DRUGS FOR TREATMENT OF TUBERCULOSIS: Thiocarbamide derivatives],,Enoyl-[acyl-carrier-protein] reductase inhibitor,Prodrug enzyme: FAD-containing monooxygenase (EthA),,CHEMBL1849,Enoyl-[acyl-carrier-protein] reductase,INHIBITOR,Mycobacterium tuberculosis,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12406221, URL:http://europepmc.org/abstract/MED/12406221|Name:PubMed, SrcID:8284673, URL:http://europepmc.org/abstract/MED/8284673|Name:PubMed, SrcID:14638486, URL:http://europepmc.org/abstract/MED/14638486",CCc1cc(ccn1)C(=S)N,,
2381,CHEMBL1201346,Balsalazid,Small molecule,2000.0,A07EC04,"A07EC04 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Aminosalicylic acid and similar agents]",-sal-,Arachidonate 5-lipoxygenase inhibitor,,,CHEMBL215,Arachidonate 5-lipoxygenase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19743890, URL:http://europepmc.org/abstract/MED/19743890|Name:PubMed, SrcID:1359745, URL:http://europepmc.org/abstract/MED/1359745",OC(=O)CCNC(=O)c1ccc(cc1)N=Nc2ccc(O)c(c2)C(=O)O,CHEMBL215,ALOX5
2382,CHEMBL421,Sulfasalazine,Small molecule,1950.0,A07EC01,"A07EC01 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Aminosalicylic acid and similar agents]",-sal-; sulfa-,Arachidonate 5-lipoxygenase inhibitor,,,CHEMBL215,Arachidonate 5-lipoxygenase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:6428914, URL:http://europepmc.org/abstract/MED/6428914|Name:PubMed, SrcID:2882965, URL:http://europepmc.org/abstract/MED/2882965|Name:PubMed, SrcID:6131674, URL:http://europepmc.org/abstract/MED/6131674",OC(=O)c1cc(ccc1O)N=Nc2ccc(cc2)S(=O)(=O)Nc3ccccn3,CHEMBL215,ALOX5
2383,CHEMBL86715,Procyclidine,Small molecule,1955.0,N04AA04,N04AA04 [NERVOUS SYSTEM: ANTI-PARKINSON DRUGS: ANTICHOLINERGIC AGENTS: Tertiary amines],-clidine,Muscarinic acetylcholine receptor M1 antagonist,"Indicated for Parkinson's disease, M1 likely responsible",,CHEMBL216,Muscarinic acetylcholine receptor M1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:10952768, URL:http://europepmc.org/abstract/MED/10952768",OC(CCN1CCCC1)(C2CCCCC2)c3ccccc3,CHEMBL216,CHRM1
2384,CHEMBL471,Sotalol,Small molecule,1992.0,C07AA07,"C07AA07 [CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, non-selective]",-alol,Beta-1 adrenergic receptor antagonist,,,CHEMBL213,Beta-1 adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=c4caf469-f684-4f6d-98e8-b6a2fff1de98, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4caf469-f684-4f6d-98e8-b6a2fff1de98|Name:Wikipedia, SrcID:Sotalol, URL:http://en.wikipedia.org/wiki/Sotalol",CC(C)NCC(O)c1ccc(NS(=O)(=O)C)cc1,,
2385,CHEMBL809,Sertraline,Small molecule,1991.0,N06AB06,N06AB06 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Selective serotonin reuptake inhibitors],-traline,Serotonin transporter inhibitor,reuptake inhibitor,,CHEMBL228,Serotonin transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2014/019839s084,020990s043lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019839s084,020990s043lbl.pdf|Name:Wikipedia, SrcID:Sertraline#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Sertraline#Mechanism_of_action|Name:DailyMed, SrcID:setid=4a0afc61-f83d-4871-86eb-929c9428a1e3, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4a0afc61-f83d-4871-86eb-929c9428a1e3",CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c3ccccc13,CHEMBL228,SLC6A4
2386,CHEMBL1175,Duloxetine,Small molecule,2004.0,N06AX21,N06AX21 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants],-oxetine,Serotonin transporter inhibitor,,,CHEMBL228,Serotonin transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18416656, URL:http://europepmc.org/abstract/MED/18416656|Name:Wikipedia, SrcID:Duloxetine, URL:http://en.wikipedia.org/wiki/Duloxetine|Name:DailyMed, SrcID:setid=baaa3a1a-bada-082f-5e77-d9013c6fc109#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=baaa3a1a-bada-082f-5e77-d9013c6fc109#nlm34090-1",CNCC[C@H](Oc1cccc2ccccc12)c3cccs3,CHEMBL228,SLC6A4
2387,CHEMBL1201539,Insulin Pork,Protein,1966.0,,,,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/022472s006s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022472s006s008lbl.pdf|Name:DailyMed, SrcID:setid=457531f0-9331-47fe-90b5-b31f284044dc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=457531f0-9331-47fe-90b5-b31f284044dc",,CHEMBL1981,INSR
2388,CHEMBL1201655,Insulin Susp Isophane Purified Beef,Protein,1980.0,,,,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/022472s006s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022472s006s008lbl.pdf|Name:DailyMed, SrcID:setid=457531f0-9331-47fe-90b5-b31f284044dc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=457531f0-9331-47fe-90b5-b31f284044dc",,CHEMBL1981,INSR
2389,CHEMBL128,Sumatriptan,Small molecule,1992.0,N02CC01,N02CC01 [NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Selective serotonin (5HT1) agonists],-triptan,Serotonin 1d (5-HT1d) receptor agonist,,Selective,CHEMBL1983,Serotonin 1d (5-HT1d) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2012/020080s039s040s041s045lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020080s039s040s041s045lbl.pdf",CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1,CHEMBL1983,HTR1D
2390,CHEMBL1201520,Urofollitropin,Unknown,1986.0,G03GA04,G03GA04 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: GONADOTROPINS AND OTHER OVULATION STIMULANTS: Gonadotropins],,Follicle stimulating hormone receptor agonist,,,CHEMBL2024,Follicle stimulating hormone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=9bb87daf-d156-504e-adaf-4c21383f8d16, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9bb87daf-d156-504e-adaf-4c21383f8d16",,,
2391,CHEMBL131,Prednisolone,Small molecule,1955.0,S01CB02; C05AA04; S03BA02; R01AD52; S01BA04; A07EA01; S02BA03; D07AA03; H02AB06; D07XA02; R01AD02; A01AC54,"S01CB02 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION: Corticosteroids/antiinfectives/mydriatics in combination]; C05AA04 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Corticosteroids]; S03BA02 [SENSORY ORGANS: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS: CORTICOSTEROIDS: Corticosteroids]; R01AD52 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Corticosteroids]; S01BA04 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Corticosteroids, plain]; A07EA01 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Corticosteroids acting locally]; S02BA03 [SENSORY ORGANS: OTOLOGICALS: CORTICOSTEROIDS: Corticosteroids]; D07AA03 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, weak (group I)]; H02AB06 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Glucocorticoids]; D07XA02 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, OTHER COMBINATIONS: Corticosteroids, weak, other combinations]; R01AD02 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Corticosteroids]; A01AC54 [ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Corticosteroids for local oral treatment]",pred-,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19482847, URL:http://europepmc.org/abstract/MED/19482847|Name:PubMed, SrcID:2879901, URL:http://europepmc.org/abstract/MED/2879901",C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO,CHEMBL2034,NR3C1
2392,CHEMBL1098,Bupivacaine,Small molecule,1972.0,N01BB01; N01BB51,"N01BB01 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Amides]; N01BB51 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Amides]",-caine,Sodium channel protein type IV alpha subunit blocker,,,CHEMBL2072,Sodium channel protein type IV alpha subunit,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12761351, URL:http://europepmc.org/abstract/MED/12761351",CCCCN1CCCCC1C(=O)Nc2c(C)cccc2C,CHEMBL2072,SCN4A
2393,CHEMBL796,Methylphenidate,Small molecule,1955.0,N06BA04,"N06BA04 [NERVOUS SYSTEM: PSYCHOANALEPTICS: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS: Centrally acting sympathomimetics]",,Norepinephrine transporter inhibitor,,,CHEMBL222,Norepinephrine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23284812, URL:http://europepmc.org/abstract/MED/23284812|Name:DailyMed, SrcID:setid=1a88218c-5b18-4220-8f56-526de1a276cd#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a88218c-5b18-4220-8f56-526de1a276cd#nlm34090-1",COC(=O)C(C1CCCCN1)c2ccccc2,CHEMBL222,SLC6A2
2394,CHEMBL76,Chloroquine,Small molecule,1949.0,P01BA01,"P01BA01 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: ANTIMALARIALS: Aminoquinolines]",,Ferriprotoporphyrin IX inhibitor,prevents crystallisation,,CHEMBL613897,Ferriprotoporphyrin IX,INHIBITOR,Plasmodium falciparum,SMALL MOLECULE,,,"Name:PubMed, SrcID:14967191, URL:http://europepmc.org/abstract/MED/14967191",CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,,
2395,CHEMBL2220442,Fluvastatin,Small molecule,1993.0,C10AA04,"C10AA04 [CARDIOVASCULAR SYSTEM: LIPID MODIFYING AGENTS: LIPID MODIFYING AGENTS, PLAIN: HMG CoA reductase inhibitors]",-stat-,HMG-CoA reductase inhibitor,,,CHEMBL402,HMG-CoA reductase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=aad8b373-0aec-4efb-8e61-3d8114b31127, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aad8b373-0aec-4efb-8e61-3d8114b31127",CC(C)n1c(\C=C\C(O)CC(O)CC(=O)O)c(c2ccc(F)cc2)c3ccccc13,CHEMBL402,HMGCR
2396,CHEMBL19019,Naltrexone,Small molecule,1984.0,N07BB04,N07BB04 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: DRUGS USED IN ADDICTIVE DISORDERS: Drugs used in alcohol dependence],nal-,Opioid receptors; mu/kappa/delta antagonist,,,CHEMBL2095181,Opioid receptors; mu/kappa/delta,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=49aa3d6d-2270-4615-aafa-b440859ab870#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=49aa3d6d-2270-4615-aafa-b440859ab870#nlm34090-1",Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36O,,
2397,CHEMBL1201212,Midodrine,Small molecule,1996.0,C01CA17,C01CA17 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES: Adrenergic and dopaminergic agents],-drine,Adrenergic receptor alpha-1 agonist,,,CHEMBL2094251,Adrenergic receptor alpha-1,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=964e3631-bcd2-49dd-8dbf-9e1de42cebc4, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=964e3631-bcd2-49dd-8dbf-9e1de42cebc4",COc1ccc(OC)c(c1)C(O)CNC(=O)CN,,
2398,CHEMBL1071,Oxaprozin,Small molecule,1992.0,M01AE12,"M01AE12 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Propionic acid derivatives]",,Cyclooxygenase inhibitor,,,CHEMBL2094253,Cyclooxygenase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=ea1de47e-3101-4414-817c-0a098af8988c, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ea1de47e-3101-4414-817c-0a098af8988c|Name:PubMed, SrcID:12065695, URL:http://europepmc.org/abstract/MED/12065695|Name:PubMed, SrcID:15324530, URL:http://europepmc.org/abstract/MED/15324530|Name:PubMed, SrcID:19952416, URL:http://europepmc.org/abstract/MED/19952416|Name:PubMed, SrcID:9831331, URL:http://europepmc.org/abstract/MED/9831331|Name:PubMed, SrcID:19338579, URL:http://europepmc.org/abstract/MED/19338579",OC(=O)CCc1oc(c2ccccc2)c(n1)c3ccccc3,,
2399,CHEMBL467,Hydroxyurea,Small molecule,1967.0,L01XX05,L01XX05 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],,Ribonucleoside-diphosphate reductase RR1 inhibitor,,,CHEMBL2095215,Ribonucleoside-diphosphate reductase RR1,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Ribonucleoside-diphosphate reductase M2 subunit,M2 subunit is binding site,"Name:PubMed, SrcID:23115527, URL:http://europepmc.org/abstract/MED/23115527|Name:DailyMed, SrcID:setid=740e054b-faac-7c27-f06d-a56efb699355, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=740e054b-faac-7c27-f06d-a56efb699355",NC(=O)NO,,
2400,CHEMBL76370,Tegaserod,Small molecule,2002.0,A06AX06,A06AX06 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR CONSTIPATION: DRUGS FOR CONSTIPATION: Other drugs for constipation],-serod,Serotonin 4 (5-HT4) receptor partial agonist,,,CHEMBL1875,Serotonin 4 (5-HT4) receptor,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2007/021200s014lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021200s014lbl.pdf|Name:DailyMed, SrcID:setid=a274e3ea-bf67-4f81-aaa0-10475b20cd69, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a274e3ea-bf67-4f81-aaa0-10475b20cd69",CCCCCNC(=N)N\N=C\c1c[nH]c2ccc(OC)cc12,CHEMBL1875,HTR4
2401,CHEMBL1201823,Abatacept,Protein,2006.0,L04AA24,L04AA24 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Selective immunosuppressants],-cept,T-lymphocyte activation antigen CD80 inhibitor,,,CHEMBL2364157,T-lymphocyte activation antigen CD80,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=0836c6ac-ee37-5640-2fed-a3185a0b16eb, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0836c6ac-ee37-5640-2fed-a3185a0b16eb",,CHEMBL2364157,CD80
2402,CHEMBL517712,Atropine,Small molecule,1960.0,A03BA01; S01FA01,"A03BA01 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: BELLADONNA AND DERIVATIVES, PLAIN: Belladonna alkaloids, tertiary amines]; S01FA01 [SENSORY ORGANS: OPHTHALMOLOGICALS: MYDRIATICS AND CYCLOPLEGICS: Anticholinergics]",-trop-,Muscarinic acetylcholine receptor M2 antagonist,"Indicated for bradycardia, M2 likely responsible",,CHEMBL211,Muscarinic acetylcholine receptor M2,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 159, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:FDA, SrcID:label/2004/17106s032lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/17106s032lbl.pdf|Name:Wikipedia, SrcID:Atropine, URL:http://en.wikipedia.org/wiki/Atropine",CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(=O)C(CO)c3ccccc3,CHEMBL211,CHRM2
2403,CHEMBL285674,Estazolam,Small molecule,1990.0,N05CD04,N05CD04 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:639854, URL:http://europepmc.org/abstract/MED/639854|Name:ISBN, SrcID:9780702034718 PP. 533, URL:http://www.isbnsearch.org/isbn/9780702034718",Clc1ccc2c(c1)C(=NCc3nncn23)c4ccccc4,CHEMBL2093872,GABRG3
2404,CHEMBL285674,Estazolam,Small molecule,1990.0,N05CD04,N05CD04 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:639854, URL:http://europepmc.org/abstract/MED/639854|Name:ISBN, SrcID:9780702034718 PP. 533, URL:http://www.isbnsearch.org/isbn/9780702034718",Clc1ccc2c(c1)C(=NCc3nncn23)c4ccccc4,CHEMBL2093872,GABRP
2405,CHEMBL285674,Estazolam,Small molecule,1990.0,N05CD04,N05CD04 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:639854, URL:http://europepmc.org/abstract/MED/639854|Name:ISBN, SrcID:9780702034718 PP. 533, URL:http://www.isbnsearch.org/isbn/9780702034718",Clc1ccc2c(c1)C(=NCc3nncn23)c4ccccc4,CHEMBL2093872,GABRE
2406,CHEMBL285674,Estazolam,Small molecule,1990.0,N05CD04,N05CD04 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:639854, URL:http://europepmc.org/abstract/MED/639854|Name:ISBN, SrcID:9780702034718 PP. 533, URL:http://www.isbnsearch.org/isbn/9780702034718",Clc1ccc2c(c1)C(=NCc3nncn23)c4ccccc4,CHEMBL2093872,GABRG1
2407,CHEMBL1200472,Quazepam,Small molecule,1985.0,N05CD10,N05CD10 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:2551039, URL:http://europepmc.org/abstract/MED/2551039|Name:Wikipedia, SrcID:Quazepam, URL:http://en.wikipedia.org/wiki/Quazepam",Fc1ccccc1C2=NCC(=S)N(CC(F)(F)F)c3ccc(Cl)cc23,CHEMBL2093872,GABRG3
2408,CHEMBL1200472,Quazepam,Small molecule,1985.0,N05CD10,N05CD10 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:2551039, URL:http://europepmc.org/abstract/MED/2551039|Name:Wikipedia, SrcID:Quazepam, URL:http://en.wikipedia.org/wiki/Quazepam",Fc1ccccc1C2=NCC(=S)N(CC(F)(F)F)c3ccc(Cl)cc23,CHEMBL2093872,GABRP
2409,CHEMBL1200472,Quazepam,Small molecule,1985.0,N05CD10,N05CD10 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:2551039, URL:http://europepmc.org/abstract/MED/2551039|Name:Wikipedia, SrcID:Quazepam, URL:http://en.wikipedia.org/wiki/Quazepam",Fc1ccccc1C2=NCC(=S)N(CC(F)(F)F)c3ccc(Cl)cc23,CHEMBL2093872,GABRE
2410,CHEMBL1200472,Quazepam,Small molecule,1985.0,N05CD10,N05CD10 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:2551039, URL:http://europepmc.org/abstract/MED/2551039|Name:Wikipedia, SrcID:Quazepam, URL:http://en.wikipedia.org/wiki/Quazepam",Fc1ccccc1C2=NCC(=S)N(CC(F)(F)F)c3ccc(Cl)cc23,CHEMBL2093872,GABRG1
2411,CHEMBL893,Dicloxacillin,Small molecule,1968.0,J01CF01,"J01CF01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: BETA-LACTAM ANTIBACTERIALS, PENICILLINS: Beta-lactamase resistant penicillins]",-cillin,Penicillin-binding protein inhibitor,,,CHEMBL2362972,Penicillin-binding protein,INHIBITOR,Staphylococcus aureus,PROTEIN FAMILY,,,"Name:PubMed, SrcID:2115510, URL:http://europepmc.org/abstract/MED/2115510|Name:PubMed, SrcID:7447421, URL:http://europepmc.org/abstract/MED/7447421",Cc1onc(c1C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(=O)O)c4c(Cl)cccc4Cl,,
2412,CHEMBL1591,Demeclocycline,Small molecule,1960.0,D06AA01; J01AA01,D06AA01 [DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: ANTIBIOTICS FOR TOPICAL USE: Tetracycline and derivatives]; J01AA01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: TETRACYCLINES: Tetracyclines],-cycline,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,16S ribosomal RNA,16s RRNA,"Name:Wikipedia, SrcID:Demeclocycline#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Demeclocycline#Mechanism_of_action|Name:PubMed, SrcID:6423382, URL:http://europepmc.org/abstract/MED/6423382",CN(C)[C@H]1[C@@H]2C[C@@H]3[C@H](O)c4c(Cl)ccc(O)c4C(=O)C3=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N,,
2413,CHEMBL1201558,Interferon Alfa-2b,Protein,1986.0,L03AB05,L03AB05 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSTIMULANTS: IMMUNOSTIMULANTS: Interferons],,Interferon alpha/beta receptor agonist,,,CHEMBL2364170,Interferon alpha/beta receptor,AGONIST,Homo sapiens,PROTEIN COMPLEX,,Alpha subunit is binding site,"Name:PubMed, SrcID:10049744, URL:http://europepmc.org/abstract/MED/10049744|Name:DailyMed, SrcID:setid=fd653d74-48ab-49e4-a42d-ec1cbc59badb, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fd653d74-48ab-49e4-a42d-ec1cbc59badb",,CHEMBL2364170,IFNAR2
2414,CHEMBL583,Grepafloxacin,Small molecule,1997.0,J01MA11,J01MA11 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolones],-oxacin,Topoisomerase IV inhibitor,,,CHEMBL2363033,Topoisomerase IV,INHIBITOR,Streptococcus pneumoniae,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:15942701, URL:http://europepmc.org/abstract/MED/15942701|Name:PubMed, SrcID:9925527, URL:http://europepmc.org/abstract/MED/9925527|Name:PubMed, SrcID:11796384, URL:http://europepmc.org/abstract/MED/11796384",CC1CN(CCN1)c2cc3N(C=C(C(=O)O)C(=O)c3c(C)c2F)C4CC4,,
2415,CHEMBL1200733,Desflurane,Small molecule,1992.0,N01AB07,"N01AB07 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,Potassium channel subfamily K member 3 opener,,,CHEMBL2321613,Potassium channel subfamily K member 3,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:15562060, URL:http://europepmc.org/abstract/MED/15562060|Name:PubMed, SrcID:16192517, URL:http://europepmc.org/abstract/MED/16192517|Name:PubMed, SrcID:17227289, URL:http://europepmc.org/abstract/MED/17227289",FC(F)OC(F)C(F)(F)F,CHEMBL2321613,KCNK3
2416,CHEMBL1201867,Ferumoxytol,Unknown,2009.0,,,,Unknown,,,,,,,,,,"Name:DailyMed, SrcID:setid=32b0e320-a739-11dc-a704-0002a5d5c51b#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=32b0e320-a739-11dc-a704-0002a5d5c51b#nlm34090-1",,,
2417,CHEMBL61,Podofilox,Small molecule,1990.0,D06BB04,D06BB04 [DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: CHEMOTHERAPEUTICS FOR TOPICAL USE: Antivirals],,Unknown,"Microtubule inhibitor, but this is likely not the mode of action against HPV",,,,,,,,,"Name:PubMed, SrcID:9562603, URL:http://europepmc.org/abstract/MED/9562603",COc1cc(cc(OC)c1OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](O)c4cc5OCOc5cc24,,
2418,CHEMBL231068,Flibanserin,Small molecule,2015.0,G02CX02,G02CX02 [GENITO URINARY SYSTEM AND SEX HORMONES: OTHER GYNECOLOGICALS: OTHER GYNECOLOGICALS: Other gynecologicals],-anserin,Unknown,,,,,,,,,,"Name:DailyMed, SrcID:setid=3819daf3-e935-2c53-c527-e1d57922f394, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3819daf3-e935-2c53-c527-e1d57922f394",FC(F)(F)c1cccc(c1)N2CCN(CCN3C(=O)Nc4ccccc34)CC2,,
2419,CHEMBL3545428,Chiauranib,Small molecule,,,,-anib,Vascular endothelial growth factor receptor inhibitor,,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://www.chipscreen.com/En/ProductLine/index74.html, URL:http://www.chipscreen.com/En/ProductLine/index74.html",,,
2420,CHEMBL1236962,Omipalisib,Small molecule,,,,-lisib,Serine/threonine-protein kinase mTOR inhibitor,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL2842,Serine/threonine-protein kinase mTOR,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24900173, URL:http://europepmc.org/abstract/MED/24900173|Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718",COc1ncc(cc1NS(=O)(=O)c2ccc(F)cc2F)c3ccc4nccc(c5ccnnc5)c4c3,CHEMBL2842,MTOR
2421,CHEMBL3545001,Mk-8353,Small molecule,,,,,MAP kinase ERK2 inhibitor,,,CHEMBL4040,MAP kinase ERK2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.hra.nhs.uk/news/research-summaries/safey-tolerability-efficacy-of-mk-8353-in-subjects-with-solid-tumors/, URL:http://www.hra.nhs.uk/news/research-summaries/safey-tolerability-efficacy-of-mk-8353-in-subjects-with-solid-tumors/",,CHEMBL4040,MAPK1
2422,CHEMBL3545078,Pf-03814735,Small molecule,,,,,Serine/threonine-protein kinase Aurora-B inhibitor,,,CHEMBL2185,Serine/threonine-protein kinase Aurora-B,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19568282, URL:http://europepmc.org/abstract/MED/19568282|Name:PubMed, SrcID:20354118, URL:http://europepmc.org/abstract/MED/20354118",,CHEMBL2185,AURKB
2423,CHEMBL375611,Ly404039,Small molecule,,,,,Metabotropic glutamate receptor 3 agonist,Active metabolite of LY2140023,,CHEMBL2888,Metabotropic glutamate receptor 3,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17204749, URL:http://europepmc.org/abstract/MED/17204749",N[C@]1(CS(=O)(=O)[C@H]2[C@@H]([C@@H]12)C(=O)O)C(=O)O,CHEMBL2888,GRM3
2424,CHEMBL3544940,G1t28-1,Small molecule,,,,,Cyclin-dependent kinase 4 inhibitor,,,CHEMBL331,Cyclin-dependent kinase 4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.g1therapeutics.com/pages/science-technology/G1T28.htm, URL:http://www.g1therapeutics.com/pages/science-technology/G1T28.htm|Name:DOI, SrcID:10.1158/1538-7445.AM2015-1784, URL:http://cancerres.aacrjournals.org/content/75/15_Supplement/1784|Name:DOI, SrcID:10.1158/1538-7445.AM2015-941, URL:http://cancerres.aacrjournals.org/content/75/15_Supplement/941",,CHEMBL331,CDK4
2425,CHEMBL3545021,Anlotinib,Small molecule,,,,-tinib,Vascular endothelial growth factor receptor 2 inhibitor,Multi-targeted receptor tyrosine kinase inhibitor,,CHEMBL279,Vascular endothelial growth factor receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:ClinicalTrials, SrcID:NCT01924195, URL:https://www.clinicaltrials.gov/ct2/show/NCT01924195|Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=749736, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=749736",,CHEMBL279,KDR
2426,CHEMBL2396661,Alpelisib,Small molecule,,,,-lisib,PI3-kinase p110-alpha subunit inhibitor,,,CHEMBL4005,PI3-kinase p110-alpha subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718|Name:PubMed, SrcID:23726034, URL:http://europepmc.org/abstract/MED/23726034",Cc1nc(NC(=O)N2CCC[C@H]2C(=O)N)sc1c3ccnc(c3)C(C)(C)C(F)(F)F,CHEMBL4005,PIK3CA
2427,CHEMBL3545155,Ji-101,Small molecule,,,,,Vascular endothelial growth factor receptor 2 inhibitor,,,CHEMBL279,Vascular endothelial growth factor receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26365907, URL:http://europepmc.org/abstract/MED/26365907|Name:DOI, SrcID:10.1158/1538-7445.AM10-17, URL:http://cancerres.aacrjournals.org/content/70/8_Supplement/17",COc1ccc(Br)cc1NC(=O)Nc2cccc3c2ccn3Cc4ccnc(N)c4,CHEMBL279,KDR
2428,CHEMBL1287935,Verucerfont,Small molecule,,,,-cerfont,Corticotropin releasing factor receptor 1 antagonist,,,CHEMBL1800,Corticotropin releasing factor receptor 1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21074436, URL:http://europepmc.org/abstract/MED/21074436|Name:PubMed, SrcID:23294766, URL:http://europepmc.org/abstract/MED/23294766",CC[C@H](Nc1cc(C)nc2c(c(C)nn12)c3ccc(OC)cc3C)c4onc(C)n4,CHEMBL1800,CRHR1
2429,CHEMBL3545286,Ccx140,Small molecule,,,,,C-C chemokine receptor type 2 antagonist,,,CHEMBL4015,C-C chemokine receptor type 2,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23986513, URL:http://europepmc.org/abstract/MED/23986513",,CHEMBL4015,CCR2
2430,CHEMBL3545102,Sb-773812,Small molecule,,,,,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21421726, URL:http://europepmc.org/abstract/MED/21421726",,CHEMBL224,HTR2A
2431,CHEMBL1094785,Carmoterol,Small molecule,,,,-terol,Beta-2 adrenergic receptor agonist,Discontinued does not have competitive profile (http://www.chiesi.es/Assets/docs/Annual_report_2010.pdf),,CHEMBL210,Beta-2 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:9443940, URL:http://europepmc.org/abstract/MED/9443940|Name:PubMed, SrcID:1687479, URL:http://europepmc.org/abstract/MED/1687479",COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c3NC(=O)C=Cc23)cc1,CHEMBL210,ADRB2
2432,CHEMBL2107735,Becampanel,Small molecule,,,,-ampa,Glutamate receptor ionotropic AMPA antagonist,Competitive antagonist.,,CHEMBL2096670,Glutamate receptor ionotropic AMPA,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Wikipedia, SrcID:Becampanel, URL:https://en.wikipedia.org/wiki/Becampanel|Name:PubMed, SrcID:16892196, URL:http://europepmc.org/abstract/MED/16892196|Name:PubMed, SrcID:20356304, URL:http://europepmc.org/abstract/MED/20356304",CSCCCNC(=O)c1csc(n1)c2csc(CCNC(=O)CCC(=O)N3CC(CCl)c4c3cc(O)c5ccccc45)n2,,
2433,CHEMBL428690,Alvocidib,Small molecule,,,,,Cyclin-dependent kinase 6 inhibitor,,,CHEMBL2508,Cyclin-dependent kinase 6,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25215591, URL:http://europepmc.org/abstract/MED/25215591|Name:PubMed, SrcID:15217973, URL:http://europepmc.org/abstract/MED/15217973",CN1CC[C@@H]([C@H](O)C1)c2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccccc4Cl,CHEMBL2508,CDK6
2434,CHEMBL1742408,Osemozotan,Small molecule,,,,-zotan,Serotonin 1a (5-HT1a) receptor agonist,,,CHEMBL214,Serotonin 1a (5-HT1a) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Osemozotan, URL:http://en.wikipedia.org/wiki/Osemozotan|Name:PubMed, SrcID:8786639, URL:http://europepmc.org/abstract/MED/8786639",C(CNC[C@H]1COc2ccccc2O1)COc3ccc4OCOc4c3,CHEMBL214,HTR1A
2435,CHEMBL2107771,Ralfinamide,Small molecule,,,,,Monoamine oxidase B inhibitor,,,CHEMBL2039,Monoamine oxidase B,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22872464, URL:http://europepmc.org/abstract/MED/22872464",C[C@H](NCc1ccc(OCc2ccccc2F)cc1)C(=O)N,CHEMBL2039,MAOB
2436,CHEMBL2108611,Inotuzumab Ozogamicin,Antibody,,L01XC26,L01XC26 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,CD22 binding agent,"Whenit binds to the CD22 antigen on malignant B-cells, it is internalized into the cell, where the cytotoxic agent calicheamicin is released to destroy the cell.",,CHEMBL3218,CD22,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16397048, URL:http://europepmc.org/abstract/MED/16397048",,CHEMBL3218,CD22
2437,CHEMBL1169880,Bitopertin,Small molecule,,,,-pertin,Glycine transporter 1 inhibitor,Noncompetitive glycine reuptake inhibitor,Selective for GlyT1. No effect on GlyT2-mediated glycine uptake,CHEMBL2337,Glycine transporter 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22138164, URL:http://europepmc.org/abstract/MED/22138164|Name:PubMed, SrcID:23132267, URL:http://europepmc.org/abstract/MED/23132267",C[C@@H](Oc1ccc(cc1C(=O)N2CCN(CC2)c3ncc(cc3F)C(F)(F)F)S(=O)(=O)C)C(F)(F)F,CHEMBL2337,SLC6A9
2438,CHEMBL3137322,Dianhydrogalactitol,Small molecule,,,,,DNA cross-linking agent,,,CHEMBL2311221,DNA,CROSS-LINKING AGENT,Homo sapiens,NUCLEIC-ACID,,,"Name:Other, SrcID:https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=39215, URL:https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=39215|Name:PubMed, SrcID:7387628, URL:http://europepmc.org/abstract/MED/7387628",O[C@H]([C@H](O)[C@@H]1CO1)[C@H]2CO2,,
2439,CHEMBL443684,Navitoclax,Small molecule,,,,-toclax,Apoptosis regulator Bcl-X inhibitor,,"High affinity for Bcl-xL, Bcl-2, and Bcl-w (Ki =1 nmol/L).",CHEMBL4625,Apoptosis regulator Bcl-X,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,"Occupies the BH3 binding groove of Bcl-xL, Bcl-2, and Bcl-w.","Name:PubMed, SrcID:21094089, URL:http://europepmc.org/abstract/MED/21094089|Name:PubMed, SrcID:18451170, URL:http://europepmc.org/abstract/MED/18451170",CC1(C)CCC(=C(CN2CCN(CC2)c3ccc(cc3)C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc6ccccc6)c(c4)S(=O)(=O)C(F)(F)F)C1)c7ccc(Cl)cc7,CHEMBL4625,BCL2L1
2440,CHEMBL3707326,Burosumab,Antibody,,M05BX05,M05BX05 [MUSCULO-SKELETAL SYSTEM: DRUGS FOR TREATMENT OF BONE DISEASES: DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION: Other drugs affecting bone structure and mineralization],-mab,Fibroblast growth factor 23 inhibitor,,,CHEMBL3713913,Fibroblast growth factor 23,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26073451, URL:http://europepmc.org/abstract/MED/26073451|Name:PubMed, SrcID:24569459, URL:http://europepmc.org/abstract/MED/24569459",,CHEMBL3713913,FGF23
2441,CHEMBL1743013,Ensituximab,Antibody,,,,-mab,Mucin-5AC other,Antibody-dependent cell-mediated cytotoxicity.,,CHEMBL3713020,Mucin-5AC,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23591984, URL:http://europepmc.org/abstract/MED/23591984|Name:PubMed, SrcID:27449137, URL:http://europepmc.org/abstract/MED/27449137",,CHEMBL3713020,MUC5AC
2442,CHEMBL1743067,Samalizumab,Antibody,,,,-mab,OX-2 membrane glycoprotein inhibitor,Blocks binding of CD200 to the CD200 receptor. Induces Ab-dependent cellular cytotoxicity of activated T cells.,,CHEMBL3712870,OX-2 membrane glycoprotein,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18178807, URL:http://europepmc.org/abstract/MED/18178807",,,
2443,CHEMBL2108459,Fontolizumab,Antibody,,,,-mab,Interferon gamma inhibitor,,,CHEMBL3286073,Interferon gamma,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16507585, URL:http://europepmc.org/abstract/MED/16507585",,CHEMBL3286073,IFNG
2444,CHEMBL2108591,Elsilimomab,Antibody,,,,-mab,Interleukin-6 inhibitor,,,CHEMBL1795129,Interleukin-6,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:1715218, URL:http://europepmc.org/abstract/MED/1715218",,CHEMBL1795129,IL6
2445,CHEMBL2108720,Oxelumab,Antibody,,,,-mab,Tumor necrosis factor ligand superfamily member 4 inhibitor,,,CHEMBL3712900,Tumor necrosis factor ligand superfamily member 4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23334208, URL:http://europepmc.org/abstract/MED/23334208",,CHEMBL3712900,TNFSF4
2446,CHEMBL2109355,Dusigitumab,Antibody,,,,-mab,Insulin-like growth factor I inhibitor,"Selectively binds to human IGF-I and IGF-II, and inhibits their ability to trigger IGFIR (Insulin-like growth factor 1 receptor) and INSR (insulin receptor) signaling without affecting insulin activation of INSR.",,CHEMBL3217394,Insulin-like growth factor I,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25193511, URL:http://europepmc.org/abstract/MED/25193511",,CHEMBL3217394,IGF1
2447,CHEMBL2109355,Dusigitumab,Antibody,,,,-mab,Insulin-like growth factor II inhibitor,"Selectively binds to human IGF-I and IGF-II, and inhibits their ability to trigger IGFIR (Insulin-like growth factor 1 receptor) and INSR (insulin receptor) signaling without affecting insulin activation of INSR.",,CHEMBL3712957,Insulin-like growth factor II,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25193511, URL:http://europepmc.org/abstract/MED/25193511",,CHEMBL3712957,IGF2
2448,CHEMBL2109357,Ave-1642,Antibody,,,,,Insulin-like growth factor I receptor antagonist,Inhibits IGF-1 signalling but has no effect on insulin pathway . selectively inhibit the growth of CD45-negative human myeloma cell lines (HMCLs).,,CHEMBL1957,Insulin-like growth factor I receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21875414, URL:http://europepmc.org/abstract/MED/21875414|Name:PubMed, SrcID:19165200, URL:http://europepmc.org/abstract/MED/19165200",,CHEMBL1957,IGF1R
2449,CHEMBL2109393,Rg-7160,Antibody,,,,,Epidermal growth factor receptor erbB1 antagonist,Induces antibody-dependent cell-mediated cytotoxicity (ADCC).,,CHEMBL203,Epidermal growth factor receptor erbB1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23209031, URL:http://europepmc.org/abstract/MED/23209031",,CHEMBL203,EGFR
2450,CHEMBL567,Perphenazine,Small molecule,1957.0,N05AB03,N05AB03 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Phenothiazines with piperazine structure],,Dopamine D2 receptor antagonist,,,CHEMBL217,Dopamine D2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11873706, URL:http://europepmc.org/abstract/MED/11873706|Name:PubMed, SrcID:7508675, URL:http://europepmc.org/abstract/MED/7508675|Name:Wikipedia, SrcID:Antipsychotic#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Antipsychotic#Mechanism_of_action|Name:PubMed, SrcID:7828655, URL:http://europepmc.org/abstract/MED/7828655|Name:PubMed, SrcID:15007534, URL:http://europepmc.org/abstract/MED/15007534",OCCN1CCN(CCCN2c3ccccc3Sc4ccc(Cl)cc24)CC1,CHEMBL217,DRD2
2451,CHEMBL644,Trimipramine,Small molecule,1979.0,N06AA06,N06AA06 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Non-selective monoamine reuptake inhibitors],-pramine,Dopamine D2 receptor antagonist,,,CHEMBL217,Dopamine D2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:0443-059748 PP. 555, URL:http://www.isbnsearch.org/isbn/0443059748|Name:Wikipedia, SrcID:Trimipramine, URL:http://en.wikipedia.org/wiki/Trimipramine",CC(CN(C)C)CN1c2ccccc2CCc3ccccc13,CHEMBL217,DRD2
2452,CHEMBL2028661,Azilsartan Medoxomil,Small molecule,2011.0,C09CA09,"C09CA09 [CARDIOVASCULAR SYSTEM: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM: ANGIOTENSIN II ANTAGONISTS, PLAIN: Angiotensin II antagonists, plain]",-sartan,Type-1 angiotensin II receptor antagonist,,Selective,CHEMBL227,Type-1 angiotensin II receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=b2d6e17b-f14a-463b-a662-03c9387c63dd#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b2d6e17b-f14a-463b-a662-03c9387c63dd#nlm34090-1",CCOc1nc2cccc(C(=O)OCC3=C(C)OC(=O)O3)c2n1Cc4ccc(cc4)c5ccccc5C6=NOC(=O)N6,CHEMBL227,AGTR1
2453,CHEMBL509,Meclofenamic Acid,Small molecule,1980.0,M02AA18; M01AG04,"M02AA18 [MUSCULO-SKELETAL SYSTEM: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: Antiinflammatory preparations, non-steroids for topical use]; M01AG04 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Fenamates]",-fenamate,Arachidonate 5-lipoxygenase inhibitor,,,CHEMBL215,Arachidonate 5-lipoxygenase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=96f19af4-de8f-4fd7-90d8-55fe6ebdd81d, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=96f19af4-de8f-4fd7-90d8-55fe6ebdd81d|Name:PubMed, SrcID:3020588, URL:http://europepmc.org/abstract/MED/3020588",Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl,CHEMBL215,ALOX5
2454,CHEMBL668,Protriptyline,Small molecule,1967.0,N06AA11,N06AA11 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Non-selective monoamine reuptake inhibitors],-triptyline,Serotonin transporter inhibitor,,,CHEMBL228,Serotonin transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18923402, URL:http://europepmc.org/abstract/MED/18923402",CNCCCC1c2ccccc2C=Cc3ccccc13,CHEMBL228,SLC6A4
2455,CHEMBL425,Olsalazine,Small molecule,1990.0,A07EC03,"A07EC03 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Aminosalicylic acid and similar agents]",-sal-,Peroxisome proliferator-activated receptor gamma agonist,,,CHEMBL235,Peroxisome proliferator-activated receptor gamma,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=75a96561-6f52-4c11-a105-391fbbfe4827, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=75a96561-6f52-4c11-a105-391fbbfe4827|Name:PubMed, SrcID:15824083, URL:http://europepmc.org/abstract/MED/15824083|Name:PubMed, SrcID:18077625, URL:http://europepmc.org/abstract/MED/18077625|Name:PubMed, SrcID:18544567, URL:http://europepmc.org/abstract/MED/18544567",OC(=O)c1cc(ccc1O)N=Nc2ccc(O)c(c2)C(=O)O,CHEMBL235,PPARG
2456,CHEMBL1946170,Regorafenib,Small molecule,2012.0,L01XE21,L01XE21 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-rafenib,Stem cell growth factor receptor inhibitor,,,CHEMBL1936,Stem cell growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Expert, SrcID:REGORAFENIB, URL:http://chembl.blogspot.co.uk/search?q=REGORAFENIB",CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,CHEMBL1936,KIT
2457,CHEMBL160,Cyclosporine,Protein,1983.0,S01XA18; L04AD01,S01XA18 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals]; L04AD01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Calcineurin inhibitors],,Cyclophilin A modulator,,,CHEMBL1949,Cyclophilin A,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22642569, URL:http://europepmc.org/abstract/MED/22642569|Name:PubMed, SrcID:18385230, URL:http://europepmc.org/abstract/MED/18385230|Name:FDA, SrcID:label/2013/050573s039,050574s047,050625s053lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/050573s039,050574s047,050625s053lbl.pdf|Name:PubMed, SrcID:15879096, URL:http://europepmc.org/abstract/MED/15879096",CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,CHEMBL1949,PPIA
2458,CHEMBL2103784,Cosyntropin,Protein,1970.0,H01AA02,"H01AA02 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES: ACTH]",,Melanocortin receptor 2 agonist,,,CHEMBL1965,Melanocortin receptor 2,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=746856e9-3930-4f6a-b8e6-a03845d6dd0b, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=746856e9-3930-4f6a-b8e6-a03845d6dd0b|Name:IUPHAR, SrcID:3633, URL:http://www.iuphar-db.org/DATABASE/LigandDisplayForward?tab=biology&ligandId=3633",CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc4c[nH]c5ccccc45)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N6CCC[C@H]6C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N7CCC[C@H]7C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc8ccc(O)cc8)C(=O)N9CCC[C@H]9C(=O)O,CHEMBL1965,MC2R
2459,CHEMBL1201642,Insulin Zinc Susp Prompt Beef,Protein,1982.0,,,,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/022472s006s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022472s006s008lbl.pdf|Name:DailyMed, SrcID:setid=457531f0-9331-47fe-90b5-b31f284044dc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=457531f0-9331-47fe-90b5-b31f284044dc",,CHEMBL1981,INSR
2460,CHEMBL1278,Naratriptan,Small molecule,1998.0,N02CC02,N02CC02 [NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Selective serotonin (5HT1) agonists],-triptan,Serotonin 1d (5-HT1d) receptor agonist,,Selective,CHEMBL1983,Serotonin 1d (5-HT1d) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2012/020763s008s009lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020763s008s009lbl.pdf",CNS(=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1,CHEMBL1983,HTR1D
2461,CHEMBL651,Methadone,Small molecule,1947.0,N07BC02; N02AC52,N07BC02 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: DRUGS USED IN ADDICTIVE DISORDERS: Drugs used in opioid dependence]; N02AC52 [NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Diphenylpropylamine derivatives],,Mu opioid receptor agonist,,,CHEMBL233,Mu opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=e6af84de-cbfc-4a3b-bd73-6bcf77337168#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e6af84de-cbfc-4a3b-bd73-6bcf77337168#nlm34090-1",CCC(=O)C(CC(C)N(C)C)(c1ccccc1)c2ccccc2,CHEMBL233,OPRM1
2462,CHEMBL1201692,Human Fsh,Protein,1997.0,G03GA06; G03GA05,G03GA06 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: GONADOTROPINS AND OTHER OVULATION STIMULANTS: Gonadotropins]; G03GA05 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: GONADOTROPINS AND OTHER OVULATION STIMULANTS: Gonadotropins],,Follicle stimulating hormone receptor agonist,"It's FSH, for the stimulation of ovarian follicular growth",,CHEMBL2024,Follicle stimulating hormone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=6d0af958-e1bc-26ab-b600-b77459688db4#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d0af958-e1bc-26ab-b600-b77459688db4#nlm34090-1|Name:DailyMed, SrcID:setid=4e07acff-27c2-4f5a-9d12-c9598496e9a0, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4e07acff-27c2-4f5a-9d12-c9598496e9a0|Name:FDA, SrcID:label/2014/021663s014lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021663s014lbl.pdf|Name:FDA, SrcID:label/2007/021765s007lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021765s007lbl.pdf|Name:PubMed, SrcID:18606720, URL:http://europepmc.org/abstract/MED/18606720",,,
2463,CHEMBL141,Lamivudine,Small molecule,1995.0,J05AF05,J05AF05 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleoside and nucleotide reverse transcriptase inhibitors],-vudine,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,"When monophosporylated is incorporates into the DNA, when triphosporylated inhibits the enzymes",,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,INHIBITOR,Human immunodeficiency virus 1,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=bc62b38c-4cc9-4e64-8852-1a0be6d36d8e, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bc62b38c-4cc9-4e64-8852-1a0be6d36d8e",NC1=NC(=O)N(C=C1)[C@@H]2CS[C@H](CO)O2,,
2464,CHEMBL411,Diethylstilbestrol,Small molecule,1973.0,L02AA01; G03CC05; G03CB02,"L02AA01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONES AND RELATED AGENTS: Estrogens]; G03CC05 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ESTROGENS: Estrogens, combinations with other drugs]; G03CB02 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ESTROGENS: Synthetic estrogens, plain]",-estr-,Estrogen receptor alpha agonist,,,CHEMBL206,Estrogen receptor alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22682699, URL:http://europepmc.org/abstract/MED/22682699",CC\C(=C(\CC)/c1ccc(O)cc1)\c2ccc(O)cc2,CHEMBL206,ESR1
2465,CHEMBL21731,Maprotiline,Small molecule,1980.0,N06AA21,N06AA21 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Non-selective monoamine reuptake inhibitors],,Norepinephrine transporter inhibitor,reuptake inhibitor,,CHEMBL222,Norepinephrine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=c3ca69e6-1ea0-4c2c-abcb-7264b2e79a87#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c3ca69e6-1ea0-4c2c-abcb-7264b2e79a87#nlm34090-1",CNCCCC12CCC(c3ccccc13)c4ccccc24,CHEMBL222,SLC6A2
2466,CHEMBL17,Dichlorphenamide,Small molecule,1958.0,S01EC02,S01EC02 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Carbonic anhydrase inhibitors],,Carbonic anhydrase XII inhibitor,,,CHEMBL3242,Carbonic anhydrase XII,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18336310, URL:http://europepmc.org/abstract/MED/18336310",NS(=O)(=O)c1cc(Cl)c(Cl)c(c1)S(=O)(=O)N,CHEMBL3242,CA12
2467,CHEMBL895,Nalbuphine,Small molecule,1979.0,N02AF02,N02AF02 [NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Morphinan derivatives],nal-,Opioid receptors; mu/kappa/delta agonist,may actually be mixed mode of action,,CHEMBL2095181,Opioid receptors; mu/kappa/delta,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=87d32eb5-6806-4aa4-8976-e3ba0fe871df#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=87d32eb5-6806-4aa4-8976-e3ba0fe871df#nlm34090-1",O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC6CCC6)c45,,
2468,CHEMBL1171837,Ponatinib,Small molecule,2012.0,L01XE24,L01XE24 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Bcr/Abl fusion protein inhibitor,,,CHEMBL2096618,Bcr/Abl fusion protein,INHIBITOR,Homo sapiens,CHIMERIC PROTEIN,,,"Name:DailyMed, SrcID:setid=807f988e-117b-4497-934d-73aa78baac71, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=807f988e-117b-4497-934d-73aa78baac71|Name:PubMed, SrcID:19878872, URL:http://europepmc.org/abstract/MED/19878872",CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc4cnc5cccnn45)cc2C(F)(F)F)CC1,,
2469,CHEMBL563,Flurbiprofen,Small molecule,1986.0,S01BC04; M02AA19; M01AE09; R02AX01,"S01BC04 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Antiinflammatory agents, non-steroids]; M02AA19 [MUSCULO-SKELETAL SYSTEM: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: Antiinflammatory preparations, non-steroids for topical use]; M01AE09 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Propionic acid derivatives]; R02AX01 [RESPIRATORY SYSTEM: THROAT PREPARATIONS: THROAT PREPARATIONS: Other throat preparations]",-profen,Cyclooxygenase inhibitor,,,CHEMBL2094253,Cyclooxygenase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10773011, URL:http://europepmc.org/abstract/MED/10773011|Name:PubMed, SrcID:17562170, URL:http://europepmc.org/abstract/MED/17562170|Name:PubMed, SrcID:11006278, URL:http://europepmc.org/abstract/MED/11006278|Name:PubMed, SrcID:11405284, URL:http://europepmc.org/abstract/MED/11405284|Name:PubMed, SrcID:12392782, URL:http://europepmc.org/abstract/MED/12392782|Name:PubMed, SrcID:11811354, URL:http://europepmc.org/abstract/MED/11811354",CC(C(=O)O)c1ccc(c(F)c1)c2ccccc2,,
2470,CHEMBL730,Nitroglycerin,Small molecule,1981.0,C05AE01; C01DA52; C01DA02,C05AE01 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Muscle relaxants]; C01DA52 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: VASODILATORS USED IN CARDIAC DISEASES: Organic nitrates]; C01DA02 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: VASODILATORS USED IN CARDIAC DISEASES: Organic nitrates],,Soluble guanylate cyclase activator,,,CHEMBL2111348,Soluble guanylate cyclase,ACTIVATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Soluble guanylate cyclase beta subunit,"Heterodimer, beta (1 or 2) is binding site","Name:Wikipedia, SrcID:Soluble_guanylyl_cyclase, URL:http://en.wikipedia.org/wiki/Soluble_guanylyl_cyclase|Name:FDA, SrcID:label/2016/021780s007lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021780s007lbl.pdf|Name:Wikipedia, SrcID:Nitrovasodilator, URL:http://en.wikipedia.org/wiki/Nitrovasodilator|Name:DailyMed, SrcID:setid=2dcdd1c3-6728-45fb-97aa-de21f1f5ccad, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2dcdd1c3-6728-45fb-97aa-de21f1f5ccad|Name:Wikipedia, SrcID:Nitric_oxide, URL:http://en.wikipedia.org/wiki/Nitric_oxide|Name:Wikipedia, SrcID:Nitroglycerin, URL:http://en.wikipedia.org/wiki/Nitroglycerin",[O-][N+](=O)OCC(CO[N+](=O)[O-])O[N+](=O)[O-],CHEMBL2111348,GUCY1A2
2471,CHEMBL498,Chlorpropamide,Small molecule,1958.0,A10BB02,"A10BB02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Sulfonylureas]",-pamide,"Sulfonylurea receptor 1, Kir6.2 blocker",,,CHEMBL2096972,"Sulfonylurea receptor 1, Kir6.2",BLOCKER,Homo sapiens,PROTEIN COMPLEX,,,"Name:FDA, SrcID:label/2011/011641s066lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/011641s066lbl.pdf|Name:Wikipedia, SrcID:Chlorpropamide, URL:http://en.wikipedia.org/wiki/Chlorpropamide|Name:PubMed, SrcID:10194514, URL:http://europepmc.org/abstract/MED/10194514|Name:PubMed, SrcID:22260657, URL:http://europepmc.org/abstract/MED/22260657|Name:DailyMed, SrcID:setid=9621afb9-bc1e-41a0-91ac-59266491fe5f#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9621afb9-bc1e-41a0-91ac-59266491fe5f#nlm34090-1",CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1,,
2472,CHEMBL1201550,Denileukin Diftitox,Protein,1999.0,L01XX29,L01XX29 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-kin,Elongation factor 2 inhibitor,,,CHEMBL1795108,Elongation factor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=42dfffb1-d0f3-42d5-944c-64f092fc436e#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=42dfffb1-d0f3-42d5-944c-64f092fc436e#nlm34090-1|Name:FDA, SrcID:label/2011/103767s5119lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/103767s5119lbl.pdf|Name:PubMed, SrcID:17187516, URL:http://europepmc.org/abstract/MED/17187516",,CHEMBL1795108,EEF2
2473,CHEMBL1170,Testosterone Propionate,Small molecule,1974.0,G03BA03,G03BA03 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ANDROGENS: 3-oxoandrosten (4) derivatives],-ster-,Androgen Receptor agonist,,,CHEMBL1871,Androgen Receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12604714, URL:http://europepmc.org/abstract/MED/12604714|Name:PubMed, SrcID:17084172, URL:http://europepmc.org/abstract/MED/17084172|Name:PubMed, SrcID:17322500, URL:http://europepmc.org/abstract/MED/17322500|Name:PubMed, SrcID:17086931, URL:http://europepmc.org/abstract/MED/17086931|Name:PubMed, SrcID:17128417, URL:http://europepmc.org/abstract/MED/17128417|Name:PubMed, SrcID:17202804, URL:http://europepmc.org/abstract/MED/17202804",CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,CHEMBL1871,AR
2474,CHEMBL1201196,Sertaconazole,Small molecule,2003.0,G01AF19; D01AC14,"G01AF19 [GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Imidazole derivatives]; D01AC14 [DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Imidazole and triazole derivatives]",-conazole,Cytochrome P450 51 inhibitor,,,CHEMBL1780,Cytochrome P450 51,INHIBITOR,Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast),SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2014/021385s005lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021385s005lbl.pdf|Name:DailyMed, SrcID:setid=07d47bbe-4a4f-4042-8534-d48aa6ce1cd0, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=07d47bbe-4a4f-4042-8534-d48aa6ce1cd0",Clc1ccc(C(Cn2ccnc2)OCc3csc4c(Cl)cccc34)c(Cl)c1,,
2475,CHEMBL880,Famciclovir,Small molecule,1994.0,J05AB09; S01AD07,J05AB09 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleosides and nucleotides excl. reverse transcriptase inhibitors]; S01AD07 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Antivirals],-vir,Human herpesvirus 1 DNA polymerase inhibitor,,,CHEMBL1872,Human herpesvirus 1 DNA polymerase,INHIBITOR,Herpes simplex virus (type 1 / strain 17),SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=3cd2e7f1-cbdb-47f6-b37f-830aaaef2482, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3cd2e7f1-cbdb-47f6-b37f-830aaaef2482",CC(=O)OCC(CCn1cnc2cnc(N)nc12)COC(=O)C,,
2476,CHEMBL1349,Valacyclovir,Small molecule,1995.0,J05AB11,J05AB11 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleosides and nucleotides excl. reverse transcriptase inhibitors],-vir,Human herpesvirus 1 DNA polymerase inhibitor,,,CHEMBL1872,Human herpesvirus 1 DNA polymerase,INHIBITOR,Herpes simplex virus (type 1 / strain 17),SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2010/020487s016lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020487s016lbl.pdf",CC(C)[C@H](N)C(=O)OCCOCn1cnc2C(=O)N=C(N)Nc12,,
2477,CHEMBL141,Lamivudine,Small molecule,1995.0,J05AF05,J05AF05 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleoside and nucleotide reverse transcriptase inhibitors],-vudine,DNA inhibitor,"When monophosporylated is incorporates into the DNA, when triphosporylated inhibits the enzymes",,CHEMBL2363047,DNA,INHIBITOR,Human immunodeficiency virus 2,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=bc62b38c-4cc9-4e64-8852-1a0be6d36d8e, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bc62b38c-4cc9-4e64-8852-1a0be6d36d8e",NC1=NC(=O)N(C=C1)[C@@H]2CS[C@H](CO)O2,,
2478,CHEMBL1257,Enflurane,Small molecule,1972.0,N01AB04,"N01AB04 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,Glycine receptor (alpha-1/beta) positive modulator,alpha1/beta is main adult form,,CHEMBL2363052,Glycine receptor (alpha-1/beta),POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX,Glycine receptor alpha subunit,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:16973644, URL:http://europepmc.org/abstract/MED/16973644",FC(F)OC(F)(F)C(F)Cl,CHEMBL2363052,GLRB
2479,CHEMBL1597,Dimercaprol,Small molecule,1946.0,V03AB09,V03AB09 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Antidotes],,Heavy metals chelating agent,gold/arsenic/mercury,,CHEMBL2363053,Heavy metals,CHELATING AGENT,,METAL,,,"Name:DailyMed, SrcID:setid=bee9a137-160f-47e8-a551-ca461ae4f51e#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bee9a137-160f-47e8-a551-ca461ae4f51e#nlm34090-1",OCC(S)CS,,
2480,CHEMBL497,Clioquinol,Small molecule,1982.0,D08AH30; G01AC02; D09AA10; S02AA05; P01AA02; P01AA52,"D08AH30 [DERMATOLOGICALS: ANTISEPTICS AND DISINFECTANTS: ANTISEPTICS AND DISINFECTANTS: Quinoline derivatives]; G01AC02 [GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Quinoline derivatives]; D09AA10 [DERMATOLOGICALS: MEDICATED DRESSINGS: MEDICATED DRESSINGS: Medicated dressings with antiinfectives]; S02AA05 [SENSORY ORGANS: OTOLOGICALS: ANTIINFECTIVES: Antiinfectives]; P01AA02 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES: Hydroxyquinoline derivatives]; P01AA52 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES: Hydroxyquinoline derivatives]",,Copper chelating agent,"Used as antibiotic against diarrhea in the 70s, but nowadays considered in cancer treatments (off-label), for its chelator and ionophore properties with capacity to inhibit proteosome",,CHEMBL2363057,Copper,CHELATING AGENT,,METAL,,,"Name:PubMed, SrcID:21247386, URL:http://europepmc.org/abstract/MED/21247386|Name:PubMed, SrcID:15833873, URL:http://europepmc.org/abstract/MED/15833873",Oc1c(I)cc(Cl)c2cccnc12,,
2481,CHEMBL440,Thiamylal,Small molecule,1982.0,,,,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:11900777, URL:http://europepmc.org/abstract/MED/11900777|Name:PubMed, SrcID:10209232, URL:http://europepmc.org/abstract/MED/10209232|Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CCCC(C)C1(CC=C)C(=O)NC(=NC1=O)S,CHEMBL2093872,GABRG3
2482,CHEMBL440,Thiamylal,Small molecule,1982.0,,,,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:11900777, URL:http://europepmc.org/abstract/MED/11900777|Name:PubMed, SrcID:10209232, URL:http://europepmc.org/abstract/MED/10209232|Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CCCC(C)C1(CC=C)C(=O)NC(=NC1=O)S,CHEMBL2093872,GABRP
2483,CHEMBL440,Thiamylal,Small molecule,1982.0,,,,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:11900777, URL:http://europepmc.org/abstract/MED/11900777|Name:PubMed, SrcID:10209232, URL:http://europepmc.org/abstract/MED/10209232|Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CCCC(C)C1(CC=C)C(=O)NC(=NC1=O)S,CHEMBL2093872,GABRE
2484,CHEMBL440,Thiamylal,Small molecule,1982.0,,,,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:11900777, URL:http://europepmc.org/abstract/MED/11900777|Name:PubMed, SrcID:10209232, URL:http://europepmc.org/abstract/MED/10209232|Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CCCC(C)C1(CC=C)C(=O)NC(=NC1=O)S,CHEMBL2093872,GABRG1
2485,CHEMBL428,Trovafloxacin,Small molecule,1997.0,J01MA13,J01MA13 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolones],-oxacin,Topoisomerase IV inhibitor,,Broad spectrum,CHEMBL2363076,Topoisomerase IV,INHIBITOR,Bacteria,PROTEIN COMPLEX,,,"Name:DailyMed, SrcID:setid=da9b26bb-d2d7-4113-a0f9-c6c2280f4875, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=da9b26bb-d2d7-4113-a0f9-c6c2280f4875",N[C@@H]1[C@H]2CN(C[C@@H]12)c3nc4N(C=C(C(=O)O)C(=O)c4cc3F)c5ccc(F)cc5F,,
2486,CHEMBL443,Sulfamethoxazole,Small molecule,1973.0,J01EC01,J01EC01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: SULFONAMIDES AND TRIMETHOPRIM: Intermediate-acting sulfonamides],sulfa-,Bacterial dihydropteroate synthase inhibitor,,Broad spectrum,CHEMBL2364668,Bacterial dihydropteroate synthase,INHIBITOR,Bacteria,SINGLE PROTEIN,,,"Name:PubMed, SrcID:7486915, URL:http://europepmc.org/abstract/MED/7486915",Cc1onc(NS(=O)(=O)c2ccc(N)cc2)c1,,
2487,CHEMBL1436,Cefuroxime,Small molecule,1983.0,S01AA27; J01DC02,S01AA27 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Antibiotics]; J01DC02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Second-generation cephalosporins],cef-,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:PubMed, SrcID:7968655, URL:http://europepmc.org/abstract/MED/7968655",CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)COC(=O)N)\c3occc3,,
2488,CHEMBL1201204,Cefpiramide,Small molecule,1989.0,J01DD11,J01DD11 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Third-generation cephalosporins],cef-,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:PubMed, SrcID:6448021, URL:http://europepmc.org/abstract/MED/6448021|Name:PubMed, SrcID:3943292, URL:http://europepmc.org/abstract/MED/3943292|Name:PubMed, SrcID:6426381, URL:http://europepmc.org/abstract/MED/6426381",Cc1cc(O)c(cn1)C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SCC(=C(N3C2=O)C(=O)O)CSc4nnnn4C)c5ccc(O)cc5,,
2489,CHEMBL2220427,Erythromycin Estolate,Small molecule,1967.0,,,-mycin,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,23S ribosomal RNA,23S RRNA,"Name:PubMed, SrcID:20876130, URL:http://europepmc.org/abstract/MED/20876130|Name:DailyMed, SrcID:setid=9a63da11-01be-4c63-a260-e6bdbb4a7a69, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9a63da11-01be-4c63-a260-e6bdbb4a7a69",CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(=O)CC)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,
2490,CHEMBL11359,Cisplatin,Small molecule,1978.0,L01XA01,L01XA01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Platinum compounds],,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:ISBN, SrcID:9780702034718 PP. 679, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:FDA, SrcID:label/2011/018057s081lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018057s081lbl.pdf",,,
2491,CHEMBL1200733,Desflurane,Small molecule,1992.0,N01AB07,"N01AB07 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,Potassium channel subfamily K member 2 opener,,,CHEMBL2321615,Potassium channel subfamily K member 2,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:15562060, URL:http://europepmc.org/abstract/MED/15562060|Name:PubMed, SrcID:16192517, URL:http://europepmc.org/abstract/MED/16192517|Name:PubMed, SrcID:17227289, URL:http://europepmc.org/abstract/MED/17227289",FC(F)OC(F)C(F)(F)F,CHEMBL2321615,KCNK2
2492,CHEMBL126,Linezolid,Small molecule,2000.0,J01XX08,J01XX08 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER ANTIBACTERIALS: Other antibacterials],-zolid,Bacterial 70S ribosome inhibitor,"Indicated for Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus agalactiae, Enterococcus faecium",,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,23S ribosomal RNA,23S RRNA,"Name:PubMed, SrcID:15992144, URL:http://europepmc.org/abstract/MED/15992144|Name:DailyMed, SrcID:setid=6e70e63b-bfd5-478d-a8ee-8ba22c9efabd, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6e70e63b-bfd5-478d-a8ee-8ba22c9efabd",CC(=O)NC[C@H]1CN(C(=O)O1)c2ccc(N3CCOCC3)c(F)c2,,
2493,CHEMBL1201514,Pegademase Bovine,Enzyme,1990.0,,,-ase; peg-,2'-deoxyadenosine hydrolytic enzyme,"Replaces the ada enzyme in case of deficiency, and hydrolyses purine substrates",,CHEMBL2364177,2'-deoxyadenosine,HYDROLYTIC ENZYME,Homo sapiens,SMALL MOLECULE,,,"Name:DailyMed, SrcID:setid=9880b900-ea23-11dc-ad56-0002a5d5c51b, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9880b900-ea23-11dc-ad56-0002a5d5c51b",,,
2494,CHEMBL1201514,Pegademase Bovine,Enzyme,1990.0,,,-ase; peg-,Adenosine hydrolytic enzyme,"Replaces the ada enzyme in case of deficiency, and hydrolyses purine substrates",,CHEMBL2364178,Adenosine,HYDROLYTIC ENZYME,Homo sapiens,SMALL MOLECULE,,,"Name:DailyMed, SrcID:setid=9880b900-ea23-11dc-ad56-0002a5d5c51b, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9880b900-ea23-11dc-ad56-0002a5d5c51b",,,
2495,CHEMBL942,Bisacodyl,Small molecule,2004.0,A06AB02; A06AB52; A06AG02,A06AB02 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR CONSTIPATION: DRUGS FOR CONSTIPATION: Contact laxatives]; A06AB52 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR CONSTIPATION: DRUGS FOR CONSTIPATION: Contact laxatives]; A06AG02 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR CONSTIPATION: DRUGS FOR CONSTIPATION: Enemas],,Unknown,,,,,,,,,,"Name:FDA, SrcID:label/2010/021551s013lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021551s013lbl.pdf",CC(=O)Oc1ccc(cc1)C(c2ccc(OC(=O)C)cc2)c3ccccn3,,
2496,CHEMBL1366,Auranofin,Small molecule,1985.0,M01CB03,M01CB03 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: SPECIFIC ANTIRHEUMATIC AGENTS: Gold preparations],,Unknown,"Mode of action not fully understood; it seems to interact with IKKB, which may play a role in its anti-rheumatic effects",,,,,,,,,"Name:PubMed, SrcID:17034761, URL:http://europepmc.org/abstract/MED/17034761|Name:PubMed, SrcID:12754408, URL:http://europepmc.org/abstract/MED/12754408",,,
2497,CHEMBL2108427,Menotropins,Protein,1975.0,,,-trop-,Follicle stimulating hormone receptor agonist,,,CHEMBL2024,Follicle stimulating hormone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=6d0af958-e1bc-26ab-b600-b77459688db4#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d0af958-e1bc-26ab-b600-b77459688db4#nlm34090-1|Name:FDA, SrcID:label/2014/021663s014lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021663s014lbl.pdf|Name:PubMed, SrcID:18606720, URL:http://europepmc.org/abstract/MED/18606720",,,
2498,CHEMBL2403108,Ceritinib,Small molecule,2014.0,L01XE28,L01XE28 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,ALK tyrosine kinase receptor inhibitor,,,CHEMBL4247,ALK tyrosine kinase receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2014/205755s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205755s000lbl.pdf",CC(C)Oc1cc(C2CCNCC2)c(C)cc1Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3,CHEMBL4247,ALK
2499,CHEMBL3545113,Px-102,Small molecule,,,,,Bile acid receptor FXR agonist,,,CHEMBL2047,Bile acid receptor FXR,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.phenex-pharma.com/pdf/Poster_APASL_2013.pdf, URL:http://www.phenex-pharma.com/pdf/Poster_APASL_2013.pdf|Name:Other, SrcID:http://www.phenex-pharma.com/en/r-and-d-programs/fxr/, URL:http://www.phenex-pharma.com/en/r-and-d-programs/fxr/|Name:PubMed, SrcID:25388536, URL:http://europepmc.org/abstract/MED/25388536",,CHEMBL2047,NR1H4
2500,CHEMBL1908397,Kw-2449,Small molecule,,,,,Tyrosine-protein kinase receptor FLT3 inhibitor,,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19541823, URL:http://europepmc.org/abstract/MED/19541823|Name:PubMed, SrcID:21474579, URL:http://europepmc.org/abstract/MED/21474579",O=C(N1CCNCC1)c2ccc(\C=C\c3n[nH]c4ccccc34)cc2,CHEMBL1974,FLT3
2501,CHEMBL3545267,Tgr-1202,Small molecule,,,,,PI3-kinase p110-delta subunit inhibitor,,,CHEMBL3130,PI3-kinase p110-delta subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://ash.confex.com/ash/2012/webprogram/Paper49134.html, URL:https://ash.confex.com/ash/2012/webprogram/Paper49134.html",,CHEMBL3130,PIK3CD
2502,CHEMBL1320667,Vgx-1027,Small molecule,,,,,Unknown,"Anti-inflammatory drug, mechanism of action may involve the inhibition of NF-kB and the early transient inhibition of P38 MAP kinase signaling pathways.",,,,,,,,,"Name:PubMed, SrcID:17449326, URL:http://europepmc.org/abstract/MED/17449326|Name:Other, SrcID:http://www.reuters.com/article/idUS178419+14-Jan-2008+BW20080114, URL:http://www.reuters.com/article/idUS178419+14-Jan-2008+BW20080114",OC(=O)CC1CC(=NO1)c2ccccc2,,
2503,CHEMBL278703,Erteberel,Small molecule,,,,-berel,Estrogen receptor beta agonist,"Ph2 study for indication Benign Prostatic Hyperplasia was terminated, drug in Ph2 trial for Schizophrenia.",,CHEMBL242,Estrogen receptor beta,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25348255, URL:http://europepmc.org/abstract/MED/25348255|Name:Other, SrcID:https://clinicaltrials.gov/ct2/results?term=LY-500307&Search=Search, URL:https://clinicaltrials.gov/ct2/results?term=LY-500307&Search=Search",Oc1ccc(cc1)[C@@H]2Oc3ccc(O)cc3[C@@H]4CCC[C@H]24,CHEMBL242,ESR2
2504,CHEMBL3545278,Atx08-001,Small molecule,,,,,Peroxisome proliferator-activated receptor gamma modulator,Selective PPAR gamma modulator (SPPAR?M) properties. Discontinued no advantage was demonstrated in clinical trials compared existing peroxisome proliferator activated receptor (PPAR) agonists,,CHEMBL235,Peroxisome proliferator-activated receptor gamma,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16125538, URL:http://europepmc.org/abstract/MED/16125538|Name:PubMed, SrcID:16314690, URL:http://europepmc.org/abstract/MED/16314690",CCCCCS(=O)(=O)NC(=O)c1ccc2nc(C)n(Cc3ccc(Cl)cc3Cl)c2c1,CHEMBL235,PPARG
2505,CHEMBL587723,Aee-788,Small molecule,,,,,Vascular endothelial growth factor receptor 2 inhibitor,"Also potent inhibitor of SRC, ABL1 and CSF1R",,CHEMBL279,Vascular endothelial growth factor receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15256466, URL:http://europepmc.org/abstract/MED/15256466",CCN1CCN(Cc2ccc(cc2)c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)CC1,CHEMBL279,KDR
2506,CHEMBL495727,At-9283,Small molecule,,,,,Tyrosine-protein kinase JAK3 inhibitor,,,CHEMBL2148,Tyrosine-protein kinase JAK3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19143567, URL:http://europepmc.org/abstract/MED/19143567|Name:PubMed, SrcID:20507304, URL:http://europepmc.org/abstract/MED/20507304",O=C(NC1CC1)Nc2c[nH]nc2c3nc4cc(CN5CCOCC5)ccc4[nH]3,CHEMBL2148,JAK3
2507,CHEMBL2017974,Buparlisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:22188813, URL:http://europepmc.org/abstract/MED/22188813",Nc1cc(c(cn1)c2cc(nc(n2)N3CCOCC3)N4CCOCC4)C(F)(F)F,CHEMBL3559703,PIK3R2
2508,CHEMBL2017974,Buparlisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:22188813, URL:http://europepmc.org/abstract/MED/22188813",Nc1cc(c(cn1)c2cc(nc(n2)N3CCOCC3)N4CCOCC4)C(F)(F)F,CHEMBL3559703,PIK3R3
2509,CHEMBL2017974,Buparlisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:22188813, URL:http://europepmc.org/abstract/MED/22188813",Nc1cc(c(cn1)c2cc(nc(n2)N3CCOCC3)N4CCOCC4)C(F)(F)F,CHEMBL3559703,PIK3R5
2510,CHEMBL3545308,Rociletinib,Small molecule,,L01XE37,L01XE37 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Epidermal growth factor receptor erbB1 inhibitor,"Irreversible inhibitor, EGFR T790M mutant selective",,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24723450, URL:http://europepmc.org/abstract/MED/24723450",COc1cc(ccc1Nc2ncc(c(Nc3cccc(NC(=O)C=C)c3)n2)C(F)(F)F)N4CCN(CC4)C(=O)C,CHEMBL203,EGFR
2511,CHEMBL3545399,R-112,Small molecule,,,,,Tyrosine-protein kinase SYK inhibitor,,,CHEMBL2599,Tyrosine-protein kinase SYK,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16950297, URL:http://europepmc.org/abstract/MED/16950297",,CHEMBL2599,SYK
2512,CHEMBL3137331,Defactinib,Small molecule,,,,-tinib,Focal adhesion kinase 1 inhibitor,,,CHEMBL2695,Focal adhesion kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.ecmcnetwork.org.uk/sites/default/files/Verastem%20CRUK%20VS6063%2011_12_14.pdf, URL:http://www.ecmcnetwork.org.uk/sites/default/files/Verastem%20CRUK%20VS6063%2011_12_14.pdf|Name:PubMed, SrcID:25971297, URL:http://europepmc.org/abstract/MED/25971297|Name:PubMed, SrcID:26334219, URL:http://europepmc.org/abstract/MED/26334219",CNC(=O)c1ccc(Nc2ncc(c(NCc3nccnc3N(C)S(=O)(=O)C)n2)C(F)(F)F)cc1,CHEMBL2695,PTK2
2513,CHEMBL3545402,Xl-820,Small molecule,,,,,Stem cell growth factor receptor inhibitor,,,CHEMBL1936,Stem cell growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.exelixis.com/sites/default/files/pdf/XL820%20EORTC-NCI-AACRnov06.pdf, URL:http://www.exelixis.com/sites/default/files/pdf/XL820%20EORTC-NCI-AACRnov06.pdf|Name:Other, SrcID:http://www.exelixis.com/sites/default/files/pdf/AACR_NCI_EORTC2007_XL820_resist.pdf, URL:http://www.exelixis.com/sites/default/files/pdf/AACR_NCI_EORTC2007_XL820_resist.pdf",,CHEMBL1936,KIT
2514,CHEMBL3545285,Xl-999,Small molecule,,,,,Tyrosine-protein kinase receptor FLT3 inhibitor,Spectrum Selective Kinase Inhibitor (SSKI),,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.exelixis.com/sites/default/files/pdf/XL999_AACR-NCI-EORTCnov05.pdf, URL:http://www.exelixis.com/sites/default/files/pdf/XL999_AACR-NCI-EORTCnov05.pdf|Name:DOI, SrcID:10.1016/S1359-6349(04)80149-6, URL:http://www.sciencedirect.com/science/article/pii/S1359634904801496|Name:PubMed, SrcID:21613405, URL:http://europepmc.org/abstract/MED/21613405",,CHEMBL1974,FLT3
2515,CHEMBL3545342,Rg7314,Small molecule,,,,,Vasopressin V1a receptor antagonist,,,CHEMBL1889,Vasopressin V1a receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:RG7314, URL:http://en.wikipedia.org/wiki/RG7314|Name:Other, SrcID:http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm, URL:http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm",,CHEMBL1889,AVPR1A
2516,CHEMBL41194,Pratosartan,Small molecule,,,,-sartan,Solute carrier family 22 member 12 inhibitor,,,CHEMBL6120,Solute carrier family 22 member 12,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17043154, URL:http://europepmc.org/abstract/MED/17043154",CCCc1nc2CCCCC(=O)c2n1Cc3ccc(cc3)c4ccccc4c5nn[nH]n5,CHEMBL6120,SLC22A12
2517,CHEMBL3545225,Incb-047986,Small molecule,,,,,Tyrosine-protein kinase JAK1 inhibitor,The compound is thought to be JAK1 selective but no selectivity data available.,,CHEMBL2835,Tyrosine-protein kinase JAK1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24818516, URL:http://europepmc.org/abstract/MED/24818516",,CHEMBL2835,JAK1
2518,CHEMBL1951575,Vidupiprant,Small molecule,,,,-piprant,Prostanoid DP receptor antagonist,Indication: Asthma,,CHEMBL4427,Prostanoid DP receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24900313, URL:http://europepmc.org/abstract/MED/24900313",CC(C)(C)NC(=O)c1ccc(Oc2cc(F)c(CC(=O)O)cc2Cl)c(NS(=O)(=O)c3ccc(cc3Cl)C4CC4)c1,CHEMBL4427,PTGDR
2519,CHEMBL3707401,Mk-8777,Small molecule,,,,,Glutamate receptor ionotropic AMPA positive allosteric modulator,Ampakine molecule.,,CHEMBL2096670,Glutamate receptor ionotropic AMPA,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Wikipedia, SrcID:Org_26576, URL:https://en.wikipedia.org/wiki/Org_26576|Name:PubMed, SrcID:15993447, URL:http://europepmc.org/abstract/MED/15993447|Name:PubMed, SrcID:22068461, URL:http://europepmc.org/abstract/MED/22068461",,,
2520,CHEMBL186179,Muraglitazar,Small molecule,,,,-glitazar,Peroxisome proliferator-activated receptor alpha agonist,Discontinueddue to safety concerns,,CHEMBL239,Peroxisome proliferator-activated receptor alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23594962, URL:http://europepmc.org/abstract/MED/23594962|Name:PubMed, SrcID:23721199, URL:http://europepmc.org/abstract/MED/23721199|Name:Wikipedia, SrcID:Muraglitazar, URL:http://en.wikipedia.org/wiki/Muraglitazar",COc1ccc(OC(=O)N(CC(=O)O)Cc2ccc(OCCc3nc(oc3C)c4ccccc4)cc2)cc1,CHEMBL239,PPARA
2521,CHEMBL101253,Vatalanib,Small molecule,,,,-anib,Stem cell growth factor receptor inhibitor,,,CHEMBL1936,Stem cell growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10786682, URL:http://europepmc.org/abstract/MED/10786682|Name:PubMed, SrcID:16882767, URL:http://europepmc.org/abstract/MED/16882767",Clc1ccc(Nc2nnc(Cc3ccncc3)c4ccccc24)cc1,CHEMBL1936,KIT
2522,CHEMBL274654,Orantinib,Small molecule,,,,-tinib,Vascular endothelial growth factor receptor 2 inhibitor,"Ph 3 trial discontinued, compound on hold?",,CHEMBL279,Vascular endothelial growth factor receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10945623, URL:http://europepmc.org/abstract/MED/10945623",Cc1[nH]c(\C=C\2/C(=O)Nc3ccccc23)c(C)c1CCC(=O)O,CHEMBL279,KDR
2523,CHEMBL1366933,Esmirtazapine,Small molecule,,,,-pin(e),Adrenergic receptor alpha-2 antagonist,Discontinued(strategic reasons),,CHEMBL2095158,Adrenergic receptor alpha-2,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:21246188, URL:http://europepmc.org/abstract/MED/21246188|Name:PubMed, SrcID:26047892, URL:http://europepmc.org/abstract/MED/26047892",CN1CCN2[C@H](C1)c3ccccc3Cc4cccnc24,,
2524,CHEMBL61780,Tezosentan,Small molecule,,,,-entan,Endothelin receptor ET-A antagonist,Discontinueddue to lack of clinical benefit.,,CHEMBL252,Endothelin receptor ET-A,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16542201, URL:http://europepmc.org/abstract/MED/16542201|Name:PubMed, SrcID:11966665, URL:http://europepmc.org/abstract/MED/11966665|Name:PubMed, SrcID:10411600, URL:http://europepmc.org/abstract/MED/10411600",COc1ccccc1Oc2c(NS(=O)(=O)c3ccc(cn3)C(C)C)nc(nc2OCCO)c4ccnc(c4)c5nn[nH]n5,CHEMBL252,EDNRA
2525,CHEMBL90983,Terameprocol,Small molecule,,,,,DNA inhibitor,Competes with the transcription factor Sp1 for specific Sp1 DNA binding domains within gene promoter regions during DNA synthesis.,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,Binds to the DNA major groove of specific Sp1 DNA binding domains within gene promoter regions.,"Name:PubMed, SrcID:21107289, URL:http://europepmc.org/abstract/MED/21107289",COc1ccc(C[C@@H](C)[C@@H](C)Cc2ccc(OC)c(OC)c2)cc1OC,,
2526,CHEMBL166863,Polmacoxib,Small molecule,,,,-coxib,Carbonic anhydrase I inhibitor,,,CHEMBL261,Carbonic anhydrase I,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,Three polmacoxib molecule binds the active site of CA II,"Name:PubMed, SrcID:27475498, URL:http://europepmc.org/abstract/MED/27475498",CC1(C)OC(=C(C1=O)c2cccc(F)c2)c3ccc(cc3)S(=O)(=O)N,CHEMBL261,CA1
2527,CHEMBL2364649,Margetuximab,Antibody,,,,-mab,Receptor protein-tyrosine kinase erbB-2 inhibitor,Antibody-dependent cell-mediated cytotoxicity (ADCC).,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://meetinglibrary.asco.org/content/164475-176, URL:http://meetinglibrary.asco.org/content/164475-176",,CHEMBL1824,ERBB2
2528,CHEMBL119625,Zonampanel,Protein,,,,-ampa,Glutamate receptor ionotropic AMPA antagonist,Competitive antagonist.,,CHEMBL2096670,Glutamate receptor ionotropic AMPA,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Other, SrcID:https://en.wikipedia.org/wiki/Zonampanel, URL:https://en.wikipedia.org/wiki/Zonampanel|Name:PubMed, SrcID:12481190, URL:http://europepmc.org/abstract/MED/12481190|Name:PubMed, SrcID:9720630, URL:http://europepmc.org/abstract/MED/9720630",OC(=O)CN1C(=O)C(=O)Nc2cc(c(cc12)n3ccnc3)[N+](=O)[O-],,
2529,CHEMBL1743032,Intetumumab,Antibody,,,,-mab,Integrin alpha-V/beta-3 antagonist,,,CHEMBL1907598,Integrin alpha-V/beta-3,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:15095296, URL:http://europepmc.org/abstract/MED/15095296",,,
2530,CHEMBL2108431,Metelimumab,Antibody,,,,-mab,Transforming growth factor beta-1 inhibitor,,,CHEMBL1795178,Transforming growth factor beta-1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17010369, URL:http://europepmc.org/abstract/MED/17010369",,,
2531,CHEMBL2109500,Lirilumab,Antibody,,,,-mab,Killer cell immunoglobulin-like receptor 2DL2 inhibitor,"Blocks the interaction of the three main inhibitory KIR receptors (KIR2DL-1, -2, -3) with their ligands, the human leukocyte antigen-C (HLA-C) molecules.",,CHEMBL3833441,Killer cell immunoglobulin-like receptor 2DL2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PMC, SrcID:PMC4803142, URL:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803142|Name:PubMed, SrcID:24326534, URL:http://europepmc.org/abstract/MED/24326534",,CHEMBL3833441,KIR2DL2
2532,CHEMBL1743006,Dalotuzumab,Antibody,,,,-mab,Insulin-like growth factor I receptor antagonist,"Dalotuzumab binds to membrane-bound IGF1R, preventing binding of the ligand IGF1 and the subsequent triggering of the PI3K/Akt signaling pathway.",,CHEMBL1957,Insulin-like growth factor I receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,,,CHEMBL1957,IGF1R
2533,CHEMBL1201354,Tridihexethyl,Small molecule,1954.0,A03AB08,"A03AB08 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: Synthetic anticholinergics, quaternary ammonium compounds]",,Muscarinic acetylcholine receptor M3 antagonist,"Role in regulating gastric secretion, M3 likely involved",,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Tridihexethyl_chloride, URL:http://en.wikipedia.org/wiki/Tridihexethyl_chloride|Name:PubMed, SrcID:704660, URL:http://europepmc.org/abstract/MED/704660|Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718",CC[N+](CC)(CC)CCC(O)(C1CCCCC1)c2ccccc2,CHEMBL245,CHRM3
2534,CHEMBL603,Zafirlukast,Small molecule,1996.0,R03DC01,R03DC01 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: Leukotriene receptor antagonists],-ast,Cysteinyl leukotriene receptor 1 antagonist,,,CHEMBL1798,Cysteinyl leukotriene receptor 1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=4bf90772-58d5-456d-ad1c-fc448cc5a231, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4bf90772-58d5-456d-ad1c-fc448cc5a231",COc1cc(ccc1Cc2cn(C)c3ccc(NC(=O)OC4CCCC4)cc23)C(=O)NS(=O)(=O)c5ccccc5C,CHEMBL1798,CYSLTR1
2535,CHEMBL1201581,Infliximab,Antibody,1998.0,L04AB02,L04AB02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Tumor necrosis factor alpha (TNF-&alpha;) inhibitors],-mab,TNF-alpha inhibitor,,,CHEMBL1825,TNF-alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=a0a046c1-056d-45a9-bfd9-13b47c24f257, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a0a046c1-056d-45a9-bfd9-13b47c24f257",,CHEMBL1825,TNF
2536,CHEMBL1201334,Triptorelin,Protein,2000.0,L02AE04,L02AE04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONES AND RELATED AGENTS: Gonadotropin releasing hormone analogues],-relin,Gonadotropin-releasing hormone receptor agonist,,,CHEMBL1855,Gonadotropin-releasing hormone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=a2f71c34-4493-4d58-9c23-f8543babe95f#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a2f71c34-4493-4d58-9c23-f8543babe95f#section-13",CC(C)C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@H](CO)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](Cc6c[nH]cn6)NC(=O)[C@@H]7CCC(=O)N7)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N8CCC[C@H]8C(=O)NCC(=O)N,CHEMBL1855,GNRHR
2537,CHEMBL423,Betaxolol,Small molecule,1985.0,S01ED52; C07AB05; S01ED02,"S01ED52 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Beta blocking agents 1)]; C07AB05 [CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, selective]; S01ED02 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Beta blocking agents 1)]",-olol,Beta-1 adrenergic receptor antagonist,,Selective,CHEMBL213,Beta-1 adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f3b50bbb-df03-4ed7-9d8d-180edc2abd54, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f3b50bbb-df03-4ed7-9d8d-180edc2abd54",CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1,,
2538,CHEMBL1055,Chlorthalidone,Small molecule,1960.0,C03BA04,"C03BA04 [CARDIOVASCULAR SYSTEM: DIURETICS: LOW-CEILING DIURETICS, EXCL. THIAZIDES: Sulfonamides, plain]",,Thiazide-sensitive sodium-chloride cotransporter inhibitor,,,CHEMBL1876,Thiazide-sensitive sodium-chloride cotransporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1056/NEJMra0907219, URL:http://www.nejm.org/doi/full/10.1056/NEJMra0907219|Name:Wikipedia, SrcID:Chlorthalidone, URL:http://en.wikipedia.org/wiki/Chlorthalidone|Name:DailyMed, SrcID:setid=15dd224a-87ad-48dc-80b1-e8382a452c4c, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=15dd224a-87ad-48dc-80b1-e8382a452c4c",NS(=O)(=O)c1cc(ccc1Cl)C2(O)NC(=O)c3ccccc23,CHEMBL1876,SLC12A3
2539,CHEMBL488,Aminoglutethimide,Small molecule,1980.0,L02BG01,L02BG01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONE ANTAGONISTS AND RELATED AGENTS: Aromatase inhibitors],,Cytochrome P450 19A1 inhibitor,,,CHEMBL1978,Cytochrome P450 19A1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2003/018202s021lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/018202s021lbl.pdf",CCC1(CCC(=O)NC1=O)c2ccc(N)cc2,CHEMBL1978,CYP19A1
2540,CHEMBL815,Dinoprost,Small molecule,1982.0,G02AD01,G02AD01 [GENITO URINARY SYSTEM AND SEX HORMONES: OTHER GYNECOLOGICALS: UTEROTONICS: Prostaglandins],-prost,Prostanoid FP receptor agonist,,,CHEMBL1987,Prostanoid FP receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 429, URL:http://www.isbnsearch.org/isbn/9780702034718",CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(=O)O,CHEMBL1987,PTGFR
2541,CHEMBL1237122,Carboprost,Small molecule,1979.0,G02AD04,G02AD04 [GENITO URINARY SYSTEM AND SEX HORMONES: OTHER GYNECOLOGICALS: UTEROTONICS: Prostaglandins],-prost,Prostanoid FP receptor agonist,,,CHEMBL1987,Prostanoid FP receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Carboprost, URL:http://en.wikipedia.org/wiki/Carboprost|Name:KEGG, SrcID:D00682, URL:http://www.kegg.jp/dbget-bin/www_bget?dr:D00682|Name:PubMed, SrcID:2225598, URL:http://europepmc.org/abstract/MED/2225598",CCCCC[C@](C)(O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(=O)O,CHEMBL1987,PTGFR
2542,CHEMBL1420,Pralidoxime,Small molecule,1964.0,V03AB04,V03AB04 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Antidotes],,Acetylcholinesterase activator,reactivates acetylcholinesterase deactivated by organophosphates,,CHEMBL220,Acetylcholinesterase,ACTIVATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Pralidoxime#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Pralidoxime#Mechanism_of_action|Name:DailyMed, SrcID:setid=a16ac225-bb32-4b27-bb66-9e152cf065eb, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a16ac225-bb32-4b27-bb66-9e152cf065eb|Name:KEGG, SrcID:D00469, URL:http://www.kegg.jp/dbget-bin/www_bget?dr:D00469",C[n+]1ccccc1C=NO,CHEMBL220,ACHE
2543,CHEMBL103,Progesterone,Small molecule,1976.0,G03DA04,G03DA04 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: PROGESTOGENS: Pregnen (4) derivatives],-gest-,Progesterone receptor agonist,,,CHEMBL208,Progesterone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10997774, URL:http://europepmc.org/abstract/MED/10997774",CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,CHEMBL208,PGR
2544,CHEMBL1509,Drospirenone,Small molecule,2001.0,G03AC10,G03AC10 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE: Progestogens],-renone,Progesterone receptor agonist,,,CHEMBL208,Progesterone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=077bf6ff-afb8-4cb7-9faa-fbb6fd9f037f#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=077bf6ff-afb8-4cb7-9faa-fbb6fd9f037f#nlm34090-1|Name:PubMed, SrcID:11024226, URL:http://europepmc.org/abstract/MED/11024226",C[C@]12CCC(=O)C=C1[C@@H]3C[C@@H]3[C@@H]4[C@@H]2CC[C@@]5(C)[C@H]4[C@@H]6C[C@@H]6[C@@]57CCC(=O)O7,CHEMBL208,PGR
2545,CHEMBL18,Ethoxzolamide,Small molecule,1982.0,,,-zolamide,Carbonic anhydrase inhibitor,,,CHEMBL2095180,Carbonic anhydrase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:18359629, URL:http://europepmc.org/abstract/MED/18359629",CCOc1ccc2nc(sc2c1)S(=O)(=O)N,,
2546,CHEMBL1456,Mycophenolate Mofetil,Small molecule,1995.0,,,,Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor,,,CHEMBL2111369,Inosine-5'-monophosphate dehydrogenase (IMPDH),INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:17713475, URL:http://europepmc.org/abstract/MED/17713475|Name:PubMed, SrcID:15621150, URL:http://europepmc.org/abstract/MED/15621150|Name:DailyMed, SrcID:setid=37241e87-4af4-4dc3-a1aa-ea6f20d8dc40, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=37241e87-4af4-4dc3-a1aa-ea6f20d8dc40|Name:PubMed, SrcID:17463174, URL:http://europepmc.org/abstract/MED/17463174",COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)\CCC(=O)OCCN3CCOCC3,,
2547,CHEMBL1254682,Levallorphan,Small molecule,1982.0,,,-orphan,Kappa opioid receptor partial agonist,,,CHEMBL237,Kappa opioid receptor,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:4030925, URL:http://europepmc.org/abstract/MED/4030925|Name:Wikipedia, SrcID:Levallorphan, URL:http://en.wikipedia.org/wiki/Levallorphan",Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC=C)c2c1,CHEMBL237,OPRK1
2548,CHEMBL119,Trimetrexate,Small molecule,1993.0,P01AX07,"P01AX07 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES: Other agents against amoebiasis and other protozoal diseases]",-trexate,Dihydrofolate reductase inhibitor,,,CHEMBL1926,Dihydrofolate reductase,INHIBITOR,Pneumocystis carinii,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=ad0f8925-f817-4460-aa6b-172a043a440b, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ad0f8925-f817-4460-aa6b-172a043a440b",COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC,,
2549,CHEMBL1182833,Mivacurium,Small molecule,1992.0,,,-curium,Muscle-type nicotinic acetylcholine receptor antagonist,,,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=98ca2c17-43e2-49af-abbc-f870877e5786#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=98ca2c17-43e2-49af-abbc-f870877e5786#nlm34090-1|Name:Wikipedia, SrcID:Nicotinic_acetylcholine_receptor, URL:http://en.wikipedia.org/wiki/Nicotinic_acetylcholine_receptor|Name:PubMed, SrcID:1373287, URL:http://europepmc.org/abstract/MED/1373287|Name:PubMed, SrcID:16402115, URL:http://europepmc.org/abstract/MED/16402115",COc1cc2CC[N+](C)(CCCOC(=O)CC\C=C\CCC(=O)OCCC[N+]3(C)CCc4cc(OC)c(OC)cc4[C@H]3Cc5cc(OC)c(OC)c(OC)c5)[C@H](Cc6cc(OC)c(OC)c(OC)c6)c2cc1OC,,
2550,CHEMBL1430,Penicillamine,Small molecule,1970.0,M01CC01,M01CC01 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: SPECIFIC ANTIRHEUMATIC AGENTS: Penicillamine and similar agents],,Copper chelating agent,,,CHEMBL2363057,Copper,CHELATING AGENT,,METAL,,,"Name:DailyMed, SrcID:setid=80e736d3-2017-4d68-94b4-38255c3c59c6, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80e736d3-2017-4d68-94b4-38255c3c59c6",CC(C)(S)[C@@H](N)C(=O)O,,
2551,CHEMBL1200596,Chloroxine,Small molecule,1976.0,,,,DNA inhibitor,Generates free radicals causing DNA damage.,,CHEMBL2364041,DNA,INHIBITOR,Bacteria,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:archiveid=120040, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=120040|Name:DailyMed, SrcID:setid=aae9e7f2-c7b8-5431-8265-7af04c18fc20#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aae9e7f2-c7b8-5431-8265-7af04c18fc20#nlm34090-1|Name:PubMed, SrcID:7513790, URL:http://europepmc.org/abstract/MED/7513790",Oc1c(Cl)cc(Cl)c2cccnc12,,
2552,CHEMBL1455,Altretamine,Small molecule,1990.0,L01XX03,L01XX03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=8456a8db-a7f6-4bc0-86be-e9c8c374140b, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8456a8db-a7f6-4bc0-86be-e9c8c374140b",CN(C)c1nc(nc(n1)N(C)C)N(C)C,,
2553,CHEMBL810,Temozolomide,Small molecule,1999.0,L01AX03,L01AX03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ALKYLATING AGENTS: Other alkylating agents],,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=046a9011-3911-4d3f-a15f-fbb56d5aad56#section-12, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=046a9011-3911-4d3f-a15f-fbb56d5aad56#section-12",CN1N=Nc2c(ncn2C1=O)C(=O)N,,
2554,CHEMBL931,Halothane,Small molecule,1958.0,N01AB01,"N01AB01 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",,Potassium channel subfamily K member 18 opener,,,CHEMBL2331042,Potassium channel subfamily K member 18,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:11886861, URL:http://europepmc.org/abstract/MED/11886861|Name:PubMed, SrcID:11605899, URL:http://europepmc.org/abstract/MED/11605899|Name:PubMed, SrcID:20519544, URL:http://europepmc.org/abstract/MED/20519544|Name:PubMed, SrcID:17227289, URL:http://europepmc.org/abstract/MED/17227289|Name:PubMed, SrcID:20217349, URL:http://europepmc.org/abstract/MED/20217349",FC(F)(F)C(Cl)Br,CHEMBL2331042,KCNK18
2555,CHEMBL1201336,Fosphenytoin,Small molecule,1996.0,N03AB05,N03AB05 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Hydantoin derivatives],fos-; -toin,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:15208697, URL:http://europepmc.org/abstract/MED/15208697|Name:PubMed, SrcID:23205958, URL:http://europepmc.org/abstract/MED/23205958|Name:DailyMed, SrcID:setid=b60c9c82-e5c7-4e05-98c7-5bbba4af04b2#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b60c9c82-e5c7-4e05-98c7-5bbba4af04b2#nlm34090-1",OP(=O)(O)OCN1C(=O)NC(C1=O)(c2ccccc2)c3ccccc3,,
2556,CHEMBL1108,Droperidol,Small molecule,1970.0,N05AD08,N05AD08 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Butyrophenone derivatives],-peridol,D2-like dopamine receptor antagonist,,,CHEMBL2331075,D2-like dopamine receptor,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:Wikipedia, SrcID:Droperidol, URL:http://en.wikipedia.org/wiki/Droperidol|Name:PubMed, SrcID:20832967, URL:http://europepmc.org/abstract/MED/20832967",Fc1ccc(cc1)C(=O)CCCN2CCC(=CC2)N3C(=O)Nc4ccccc34,,
2557,CHEMBL1201786,Lapyrium,Small molecule,1982.0,,,-ium,Unknown,,,,,,,,,,"Name:PubMed, SrcID:6745010, URL:http://europepmc.org/abstract/MED/6745010",CCCCCCCCCCCC(=O)OCCNC(=O)C[n+]1ccccc1,,
2558,CHEMBL443052,Tavaborole,Small molecule,2014.0,,,,Leucine-tRNA ligase inhibitor,,,CHEMBL3307222,Leucine-tRNA ligase,INHIBITOR,Trichophyton rubrum (strain ATCC MYA-4607 / CBS 118892) (Athlete'sfoot fungus),SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2014/204427s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204427s000lbl.pdf",OB1OCc2cc(F)ccc12,,
2559,CHEMBL3127326,Ombitasvir,Small molecule,2014.0,,,-vir,Nonstructural protein 5A inhibitor,,,CHEMBL3307224,Nonstructural protein 5A,INHIBITOR,Hepatitis C virus,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/206619s003lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206619s003lbl.pdf",COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)Nc2ccc(cc2)[C@@H]3CC[C@H](N3c4ccc(cc4)C(C)(C)C)c5ccc(NC(=O)[C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C)cc5,,
2560,CHEMBL2219425,Aripiprazole Lauroxil,Unknown,2015.0,,,-prazole,Serotonin 1a (5-HT1a) receptor partial agonist,Prodrug of aripiprazole,,CHEMBL214,Serotonin 1a (5-HT1a) receptor,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=17a8d11b-73b0-4833-a0b4-cf1ef85edefb, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17a8d11b-73b0-4833-a0b4-cf1ef85edefb",CCCCCCCCCCCC(=O)OCN1C(=O)CCc2ccc(OCCCCN3CCN(CC3)c4cccc(Cl)c4Cl)cc12,CHEMBL214,HTR1A
2561,CHEMBL2107840,Patiromer Calcium,Small molecule,2015.0,V03AE09,V03AE09 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Drugs for treatment of hyperkalemia and hyperphosphatemia],-mer,Potassium chelating agent,,,CHEMBL3545434,Potassium,CHELATING AGENT,,METAL,,,"Name:FDA, SrcID:label/2015/205739s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205739s000lbl.pdf",,,
2562,CHEMBL3545297,Pexmetinib,Small molecule,,,,-tinib,MAP kinase p38 alpha inhibitor,,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.arraybiopharma.com/product-pipeline/other-compounds/arry-614/, URL:http://www.arraybiopharma.com/product-pipeline/other-compounds/arry-614/|Name:Other, SrcID:http://www.bloodjournal.org/content/124/21/4628.full.pdf, URL:http://www.bloodjournal.org/content/124/21/4628.full.pdf",,CHEMBL260,MAPK14
2563,CHEMBL3545117,Ave-9940,Small molecule,,,,,MAP kinase p38 alpha inhibitor,No assay data or further target information found,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://adisinsight.springer.com/drugs/800023206, URL:http://adisinsight.springer.com/drugs/800023206",,CHEMBL260,MAPK14
2564,CHEMBL2041933,Azd-7762,Small molecule,,,,,Serine/threonine-protein kinase Chk1 inhibitor,"Development discontinued, part of Astra Zeneca's Open Innovation program",,CHEMBL4630,Serine/threonine-protein kinase Chk1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://openinnovation.astrazeneca.com/what-we-offer/compound/azd7762/, URL:http://openinnovation.astrazeneca.com/what-we-offer/compound/azd7762/|Name:PubMed, SrcID:18790776, URL:http://europepmc.org/abstract/MED/18790776|Name:PubMed, SrcID:19568282, URL:http://europepmc.org/abstract/MED/19568282",NC(=O)Nc1cc(sc1C(=O)N[C@H]2CCCNC2)c3cccc(F)c3,CHEMBL4630,CHEK1
2565,CHEMBL3545248,Ds-7423,Small molecule,,,,,Serine/threonine-protein kinase mTOR inhibitor,"Dual MTOR/PI3K inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL2842,Serine/threonine-protein kinase mTOR,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24504419, URL:http://europepmc.org/abstract/MED/24504419",,CHEMBL2842,MTOR
2566,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,MT-ND1
2567,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,MT-ND2
2568,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,MT-ND3
2569,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,MT-ND4L
2570,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,MT-ND5
2571,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,MT-ND6
2572,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFS3
2573,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFAF4
2574,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFS1
2575,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFB10
2576,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFA10
2577,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFS7
2578,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFA3
2579,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFV2
2580,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFA13
2581,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFB6
2582,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFA9
2583,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFA11
2584,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFA6
2585,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFAF2
2586,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFS4
2587,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFV3
2588,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFAF3
2589,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFA1
2590,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFAB1
2591,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFA5
2592,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFA7
2593,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFAF1
2594,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFA2
2595,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFB7
2596,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFS6
2597,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFA4L2
2598,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFB2
2599,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFB8
2600,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFS2
2601,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFB1
2602,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFC1
2603,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFB4
2604,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFS5
2605,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFV1
2606,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFB9
2607,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFB3
2608,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFB5
2609,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFB11
2610,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFC2
2611,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFA12
2612,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFA8
2613,CHEMBL3545135,Nv-128,Small molecule,,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor,"Prodrug - active metabolite is ME-344. Mitochondrial inhibitor, specific molecular target for ME-344 has not been completely defined but has been shown to inhibit mitochondrial oxidative phosphorylation (OXPHOS) complex I (PMID:25973307), may also inhibit the mTORC1-and mTORC2-dependent pathways (PMID:25411085, http://mct.aacrjournals.org/content/12/11_Supplement/A17.short).",,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:25411085, URL:http://europepmc.org/abstract/MED/25411085|Name:Other, SrcID:http://www.meipharma.com/our-programs/me-344, URL:http://www.meipharma.com/our-programs/me-344|Name:PubMed, SrcID:25973307, URL:http://europepmc.org/abstract/MED/25973307",,CHEMBL2363065,NDUFS8
2614,CHEMBL2141712,Palomid-529,Small molecule,,,,,Serine/threonine-protein kinase mTOR inhibitor,ATP-competitive mTORC1/mTORC2 inhibitor,,CHEMBL2842,Serine/threonine-protein kinase mTOR,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22982188, URL:http://europepmc.org/abstract/MED/22982188|Name:PubMed, SrcID:19010932, URL:http://europepmc.org/abstract/MED/19010932|Name:PubMed, SrcID:21551258, URL:http://europepmc.org/abstract/MED/21551258",COc1ccc(COc2cc3OC(=O)c4cc(ccc4c3cc2OC)C(C)O)cc1,CHEMBL2842,MTOR
2615,CHEMBL2001019,Pf-04217903,Small molecule,,,,,Hepatocyte growth factor receptor inhibitor,,,CHEMBL3717,Hepatocyte growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22924734, URL:http://europepmc.org/abstract/MED/22924734",OCCn1cc(cn1)c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2,CHEMBL3717,MET
2616,CHEMBL1944698,Tg-02,Small molecule,,,,,Cyclin-dependent kinase 9 inhibitor,,,CHEMBL3116,Cyclin-dependent kinase 9,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21860433, URL:http://europepmc.org/abstract/MED/21860433",CN1C\C=C\CCOc2cccc(c2)c3ccnc(Nc4cccc(C1)c4)n3,CHEMBL3116,CDK9
2617,CHEMBL3544956,Pyrotinib,Small molecule,,,,-tinib,Receptor protein-tyrosine kinase erbB-2 inhibitor,,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://meetinglibrary.asco.org/content/146824-156, URL:http://meetinglibrary.asco.org/content/146824-156",,CHEMBL1824,ERBB2
2618,CHEMBL3707354,Abt-560,Small molecule,,,,,Neuronal acetylcholine receptor; alpha4/beta2 modulator,,,CHEMBL1907589,Neuronal acetylcholine receptor; alpha4/beta2,MODULATOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:Other, SrcID:http://phrma.org/sites/default/files/pdf/alzheimers2012.pdf, URL:http://phrma.org/sites/default/files/pdf/alzheimers2012.pdf",,,
2619,CHEMBL3707315,D-3263,Small molecule,,,,,Transient receptor potential cation channel subfamily M member 8 agonist,,,CHEMBL1075319,Transient receptor potential cation channel subfamily M member 8,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=636649, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=636649",,CHEMBL1075319,TRPM8
2620,CHEMBL3545065,Verosudil,Small molecule,,,,-dil,Rho-associated protein kinase inhibitor,,,CHEMBL2111459,Rho-associated protein kinase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:21794845, URL:http://europepmc.org/abstract/MED/21794845|Name:PubMed, SrcID:24872673, URL:http://europepmc.org/abstract/MED/24872673",CN(C)C(C(=O)Nc1ccc2C(=O)NC=Cc2c1)c3ccsc3,,
2621,CHEMBL1230065,Bms-582949,Small molecule,,,,,MAP kinase p38 alpha inhibitor,Active metabolite of prodrug BMS-751324,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26359680, URL:http://europepmc.org/abstract/MED/26359680|Name:PubMed, SrcID:20804198, URL:http://europepmc.org/abstract/MED/20804198",CCCNC(=O)c1cn2ncnc(Nc3cc(ccc3C)C(=O)NC4CC4)c2c1C,CHEMBL260,MAPK14
2622,CHEMBL514201,Talmapimod,Small molecule,,,,-imod,MAP kinase p38 alpha inhibitor,Also potent inhibitor of MAPK11,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21659629, URL:http://europepmc.org/abstract/MED/21659629|Name:PubMed, SrcID:19195885, URL:http://europepmc.org/abstract/MED/19195885|Name:PubMed, SrcID:19950901, URL:http://europepmc.org/abstract/MED/19950901",C[C@@H]1CN(Cc2ccc(F)cc2)[C@@H](C)CN1C(=O)c3cc4c(cn(C)c4cc3Cl)C(=O)C(=O)N(C)C,CHEMBL260,MAPK14
2623,CHEMBL1631540,Gsk163090,Small molecule,,,,,Serotonin 1a (5-HT1a) receptor antagonist,,,CHEMBL214,Serotonin 1a (5-HT1a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21053897, URL:http://europepmc.org/abstract/MED/21053897",Cc1ccc2c(cccc2n1)N3CCN(CCc4cccc(c4)N5CCNC5=O)CC3,CHEMBL214,HTR1A
2624,CHEMBL208427,Solabegron,Small molecule,,,,-begron,Beta-3 adrenergic receptor agonist,,,CHEMBL246,Beta-3 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23263450, URL:http://europepmc.org/abstract/MED/23263450|Name:PubMed, SrcID:17626794, URL:http://europepmc.org/abstract/MED/17626794",O[C@@H](CNCCNc1cccc(c1)c2cccc(c2)C(=O)O)c3cccc(Cl)c3,CHEMBL246,ADRB3
2625,CHEMBL2178422,Rimegepant,Small molecule,,,,-gepant,Calcitonin gene-related peptide type 1 receptor antagonist,,,CHEMBL3798,Calcitonin gene-related peptide type 1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23153230, URL:http://europepmc.org/abstract/MED/23153230",N[C@H]1[C@@H](CC[C@@H](OC(=O)N2CCC(CC2)N3C(=O)Nc4ncccc34)c5ncccc15)c6cccc(F)c6F,,
2626,CHEMBL3545032,Pf-04634817,Small molecule,,,,,C-C chemokine receptor type 5 antagonist,,,CHEMBL274,C-C chemokine receptor type 5,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.pfizer.com/research/science_and_technology/product_pipeline, URL:http://www.pfizer.com/research/science_and_technology/product_pipeline",,CHEMBL274,CCR5
2627,CHEMBL244243,Srx246,Small molecule,,,,,Vasopressin V1a receptor antagonist,,,CHEMBL1889,Vasopressin V1a receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22249122, URL:http://europepmc.org/abstract/MED/22249122|Name:PubMed, SrcID:23471831, URL:http://europepmc.org/abstract/MED/23471831",C[C@@H](NC(=O)[C@@H](CC(=O)N1CCC(CC1)N2CCCCC2)N3[C@H](\C=C\c4ccccc4)[C@H](N5[C@H](COC5=O)c6ccccc6)C3=O)c7cccc(c7)C(F)(F)F,CHEMBL1889,AVPR1A
2628,CHEMBL1800159,Relugolix,Small molecule,,,,-golix,Gonadotropin-releasing hormone receptor antagonist,,,CHEMBL1855,Gonadotropin-releasing hormone receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24333551, URL:http://europepmc.org/abstract/MED/24333551",CONC(=O)Nc1ccc(cc1)c2sc3N(Cc4c(F)cccc4F)C(=O)N(C(=O)c3c2CN(C)C)c5ccc(OC)nn5,CHEMBL1855,GNRHR
2629,CHEMBL3545041,Af-219,Small molecule,,,,,P2X purinoceptor 3 antagonist,P2RX3 and P2RX2/3 trimers allosteric antagonist,,CHEMBL2998,P2X purinoceptor 3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/887.5, URL:http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/887.5|Name:PubMed, SrcID:24391544, URL:http://europepmc.org/abstract/MED/24391544",,CHEMBL2998,P2RX3
2630,CHEMBL2179529,Azd1446,Small molecule,,,,,Neuronal acetylcholine receptor; alpha4/beta2 agonist,,,CHEMBL1907589,Neuronal acetylcholine receptor; alpha4/beta2,AGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:22793665, URL:http://europepmc.org/abstract/MED/22793665",Clc1oc(cc1)C(=O)N2CC3CNCC3C2,,
2631,CHEMBL1277001,Mibampator,Small molecule,,,,-ampa,Glutamate receptor ionotropic AMPA positive allosteric modulator,,,CHEMBL2096670,Glutamate receptor ionotropic AMPA,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:16554450, URL:http://europepmc.org/abstract/MED/16554450|Name:PubMed, SrcID:17851540, URL:http://europepmc.org/abstract/MED/17851540",CC(C)S(=O)(=O)NC[C@H](C)c1ccc(cc1)c2ccc(CCNS(=O)(=O)C)cc2,,
2632,CHEMBL428690,Alvocidib,Small molecule,,,,,Cyclin-dependent kinase 9 inhibitor,,,CHEMBL3116,Cyclin-dependent kinase 9,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25215591, URL:http://europepmc.org/abstract/MED/25215591|Name:PubMed, SrcID:15217973, URL:http://europepmc.org/abstract/MED/15217973",CN1CC[C@@H]([C@H](O)C1)c2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccccc4Cl,CHEMBL3116,CDK9
2633,CHEMBL2108061,Volociximab,Antibody,,,,-mab,Integrin alpha-5/beta-1 antagonist,,,CHEMBL2095226,Integrin alpha-5/beta-1,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:17786386, URL:http://europepmc.org/abstract/MED/17786386|Name:PubMed, SrcID:17024968, URL:http://europepmc.org/abstract/MED/17024968",,,
2634,CHEMBL2103883,Avatrombopag,Small molecule,,,,-trombopag,Thrombopoietin receptor agonist,,,CHEMBL1864,Thrombopoietin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19183407, URL:http://europepmc.org/abstract/MED/19183407",OC(=O)C1CCN(CC1)c2ncc(cc2Cl)C(=O)Nc3nc(c4cc(Cl)cs4)c(s3)N5CCN(CC5)C6CCCCC6,CHEMBL1864,MPL
2635,CHEMBL1206232,Fosbretabulin,Small molecule,,,,-bulin; fos-,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:27559241, URL:http://europepmc.org/abstract/MED/27559241|Name:PubMed, SrcID:2920809, URL:http://europepmc.org/abstract/MED/2920809",COc1ccc(\C=C/c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O,CHEMBL2095182,TUBB8
2636,CHEMBL1206232,Fosbretabulin,Small molecule,,,,-bulin; fos-,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:27559241, URL:http://europepmc.org/abstract/MED/27559241|Name:PubMed, SrcID:2920809, URL:http://europepmc.org/abstract/MED/2920809",COc1ccc(\C=C/c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O,CHEMBL2095182,TUBA3C
2637,CHEMBL1206232,Fosbretabulin,Small molecule,,,,-bulin; fos-,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:27559241, URL:http://europepmc.org/abstract/MED/27559241|Name:PubMed, SrcID:2920809, URL:http://europepmc.org/abstract/MED/2920809",COc1ccc(\C=C/c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O,CHEMBL2095182,TUBA4A
2638,CHEMBL1206232,Fosbretabulin,Small molecule,,,,-bulin; fos-,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:27559241, URL:http://europepmc.org/abstract/MED/27559241|Name:PubMed, SrcID:2920809, URL:http://europepmc.org/abstract/MED/2920809",COc1ccc(\C=C/c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O,CHEMBL2095182,TUBA3E
2639,CHEMBL1206232,Fosbretabulin,Small molecule,,,,-bulin; fos-,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:27559241, URL:http://europepmc.org/abstract/MED/27559241|Name:PubMed, SrcID:2920809, URL:http://europepmc.org/abstract/MED/2920809",COc1ccc(\C=C/c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O,CHEMBL2095182,TUBB6
2640,CHEMBL1206232,Fosbretabulin,Small molecule,,,,-bulin; fos-,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:27559241, URL:http://europepmc.org/abstract/MED/27559241|Name:PubMed, SrcID:2920809, URL:http://europepmc.org/abstract/MED/2920809",COc1ccc(\C=C/c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O,CHEMBL2095182,TUBB2B
2641,CHEMBL1206232,Fosbretabulin,Small molecule,,,,-bulin; fos-,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:27559241, URL:http://europepmc.org/abstract/MED/27559241|Name:PubMed, SrcID:2920809, URL:http://europepmc.org/abstract/MED/2920809",COc1ccc(\C=C/c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O,CHEMBL2095182,TUBA3D
2642,CHEMBL2105659,Varespladib Methyl,Small molecule,,,,-pladib,Phospholipase A2 group IIA inhibitor,,Pan-inhibitor of sPLA2 enzymes (groups: IIA IC50: 9–14 nM; V IC50: 77 nM; and X IC50: 15 nM).,CHEMBL3474,Phospholipase A2 group IIA,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21112895, URL:http://europepmc.org/abstract/MED/21112895",CCc1c(C(=O)C(=O)N)c2c(OCC(=O)OC)cccc2n1Cc3ccccc3,CHEMBL3474,PLA2G2A
2643,CHEMBL1800955,Omecamtiv Mecarbil,Small molecule,,,,,Cardiac myosin activator,Selectively activates the S1 domain of cardiac myosin.,,CHEMBL3831286,Cardiac myosin,ACTIVATOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:21415352, URL:http://europepmc.org/abstract/MED/21415352|Name:PubMed, SrcID:21856480, URL:http://europepmc.org/abstract/MED/21856480",COC(=O)N1CCN(Cc2cccc(NC(=O)Nc3ccc(C)nc3)c2F)CC1,CHEMBL3831286,MYL4
2644,CHEMBL1800955,Omecamtiv Mecarbil,Small molecule,,,,,Cardiac myosin activator,Selectively activates the S1 domain of cardiac myosin.,,CHEMBL3831286,Cardiac myosin,ACTIVATOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:21415352, URL:http://europepmc.org/abstract/MED/21415352|Name:PubMed, SrcID:21856480, URL:http://europepmc.org/abstract/MED/21856480",COC(=O)N1CCN(Cc2cccc(NC(=O)Nc3ccc(C)nc3)c2F)CC1,CHEMBL3831286,MYL7
2645,CHEMBL1800955,Omecamtiv Mecarbil,Small molecule,,,,,Cardiac myosin activator,Selectively activates the S1 domain of cardiac myosin.,,CHEMBL3831286,Cardiac myosin,ACTIVATOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:21415352, URL:http://europepmc.org/abstract/MED/21415352|Name:PubMed, SrcID:21856480, URL:http://europepmc.org/abstract/MED/21856480",COC(=O)N1CCN(Cc2cccc(NC(=O)Nc3ccc(C)nc3)c2F)CC1,CHEMBL3831286,MYH6
2646,CHEMBL1800955,Omecamtiv Mecarbil,Small molecule,,,,,Cardiac myosin activator,Selectively activates the S1 domain of cardiac myosin.,,CHEMBL3831286,Cardiac myosin,ACTIVATOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:21415352, URL:http://europepmc.org/abstract/MED/21415352|Name:PubMed, SrcID:21856480, URL:http://europepmc.org/abstract/MED/21856480",COC(=O)N1CCN(Cc2cccc(NC(=O)Nc3ccc(C)nc3)c2F)CC1,CHEMBL3831286,MYH7
2647,CHEMBL1800955,Omecamtiv Mecarbil,Small molecule,,,,,Cardiac myosin activator,Selectively activates the S1 domain of cardiac myosin.,,CHEMBL3831286,Cardiac myosin,ACTIVATOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:21415352, URL:http://europepmc.org/abstract/MED/21415352|Name:PubMed, SrcID:21856480, URL:http://europepmc.org/abstract/MED/21856480",COC(=O)N1CCN(Cc2cccc(NC(=O)Nc3ccc(C)nc3)c2F)CC1,CHEMBL3831286,MYL3
2648,CHEMBL1800955,Omecamtiv Mecarbil,Small molecule,,,,,Cardiac myosin activator,Selectively activates the S1 domain of cardiac myosin.,,CHEMBL3831286,Cardiac myosin,ACTIVATOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:21415352, URL:http://europepmc.org/abstract/MED/21415352|Name:PubMed, SrcID:21856480, URL:http://europepmc.org/abstract/MED/21856480",COC(=O)N1CCN(Cc2cccc(NC(=O)Nc3ccc(C)nc3)c2F)CC1,CHEMBL3831286,MYL2
2649,CHEMBL180101,Esreboxetine,Small molecule,,,,-oxetine,Norepinephrine transporter inhibitor,,,CHEMBL222,Norepinephrine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20974319, URL:http://europepmc.org/abstract/MED/20974319",CCOc1ccccc1O[C@H]([C@@H]2CNCCO2)c3ccccc3,CHEMBL222,SLC6A2
2650,CHEMBL1743040,Milatuzumab,Antibody,,,,-mab,HLA-DR antigens-associated invariant chain antagonist,,,CHEMBL4692,HLA-DR antigens-associated invariant chain,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22404985, URL:http://europepmc.org/abstract/MED/22404985",,CHEMBL4692,CD74
2651,CHEMBL2108747,Toralizumab,Antibody,,,,-mab,CD40 ligand inhibitor,"Binds to CD154, block CD154 binding to CD40 and inhibit T cell-dependent B cell differentiation, The latter activity is independent of FcR binding.",,CHEMBL3580491,CD40 ligand,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11360929, URL:http://europepmc.org/abstract/MED/11360929",,CHEMBL3580491,CD40LG
2652,CHEMBL1201891,Deflazacort,Small molecule,2017.0,H02AB13,"H02AB13 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Glucocorticoids]",,Glucocorticoid receptor agonist,"Prodrug - activity due to metabolite, 21-desDFZ",,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2017/208684s000,208685s000lbl.pdf, URL:https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208684s000,208685s000lbl.pdf",CC(=O)OCC(=O)[C@@]12N=C(C)O[C@@H]1C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]23C,CHEMBL2034,NR3C1
2653,CHEMBL20,Acetazolamide,Small molecule,1953.0,S01EC01,S01EC01 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Carbonic anhydrase inhibitors],-zolamide,Carbonic anhydrase I inhibitor,Expressed in eye,,CHEMBL261,Carbonic anhydrase I,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18336310, URL:http://europepmc.org/abstract/MED/18336310|Name:PubMed, SrcID:10713865, URL:http://europepmc.org/abstract/MED/10713865",CC(=O)Nc1nnc(s1)S(=O)(=O)N,CHEMBL261,CA1
2654,CHEMBL1194325,Aclidinium,Small molecule,2012.0,,,-clidinium; -ium,Muscarinic acetylcholine receptor M3 antagonist,"Indicated for COPD, M3 likely responsible",,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Expert, SrcID:ACLIDINIUM, URL:http://chembl.blogspot.co.uk/search?q=ACLIDINIUM",OC(C(=O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)(c4cccs4)c5cccs5,CHEMBL245,CHRM3
2655,CHEMBL1378,Thiethylperazine,Small molecule,1961.0,R06AD03,R06AD03 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Phenothiazine derivatives],,Dopamine D2 receptor antagonist,,,CHEMBL217,Dopamine D2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 367, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:239403, URL:http://europepmc.org/abstract/MED/239403",CCSc1ccc2Sc3ccccc3N(CCCN4CCN(C)CC4)c2c1,CHEMBL217,DRD2
2656,CHEMBL14376,Iloperidone,Small molecule,2009.0,N05AX14,N05AX14 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Other antipsychotics],-peridone,Dopamine D2 receptor antagonist,,,CHEMBL217,Dopamine D2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=43452bf8-76e7-47a9-a5d8-41fe84d061f0, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43452bf8-76e7-47a9-a5d8-41fe84d061f0",COc1cc(ccc1OCCCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)C,CHEMBL217,DRD2
2657,CHEMBL121,Rosiglitazone,Small molecule,1999.0,A10BG02,"A10BG02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Thiazolidinediones]",-glitazone,Peroxisome proliferator-activated receptor gamma agonist,,Selective,CHEMBL235,Peroxisome proliferator-activated receptor gamma,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=28c31e58-0b27-43e2-bae0-9bbb21420e9f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=28c31e58-0b27-43e2-bae0-9bbb21420e9f",CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c3ccccn3,CHEMBL235,PPARG
2658,CHEMBL1467,Allopurinol,Small molecule,1966.0,M04AA01; M04AA51,M04AA01 [MUSCULO-SKELETAL SYSTEM: ANTIGOUT PREPARATIONS: ANTIGOUT PREPARATIONS: Preparations inhibiting uric acid production]; M04AA51 [MUSCULO-SKELETAL SYSTEM: ANTIGOUT PREPARATIONS: ANTIGOUT PREPARATIONS: Preparations inhibiting uric acid production],,Xanthine dehydrogenase inhibitor,,,CHEMBL1929,Xanthine dehydrogenase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2000/020298Orig1s001.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2000/020298Orig1s001.pdf|Name:DailyMed, SrcID:setid=81167e87-b1d5-44df-99aa-a033825634dd, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=81167e87-b1d5-44df-99aa-a033825634dd",O=C1NC=Nc2[nH]ncc12,CHEMBL1929,XDH
2659,CHEMBL917,Floxuridine,Small molecule,1970.0,,,-uridine,Thymidylate synthase inhibitor,,,CHEMBL1952,Thymidylate synthase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10697523, URL:http://europepmc.org/abstract/MED/10697523|Name:PubMed, SrcID:10482907, URL:http://europepmc.org/abstract/MED/10482907|Name:PubMed, SrcID:10697524, URL:http://europepmc.org/abstract/MED/10697524|Name:PubMed, SrcID:10553409, URL:http://europepmc.org/abstract/MED/10553409",OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(F)C(=O)NC2=O,CHEMBL1952,TYMS
2660,CHEMBL71,Chlorpromazine,Small molecule,1957.0,N05AA01,N05AA01 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Phenothiazines with aliphatic side-chain],,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Chlorpromazine, URL:http://en.wikipedia.org/wiki/Chlorpromazine|Name:ISBN, SrcID:0443059748, URL:http://www.isbnsearch.org/isbn/0443059748|Name:PubMed, SrcID:17015232, URL:http://europepmc.org/abstract/MED/17015232",CN(C)CCCN1c2ccccc2Sc3ccc(Cl)cc13,CHEMBL224,HTR2A
2661,CHEMBL1186579,Methylnaltrexone,Small molecule,2008.0,,,,Mu opioid receptor antagonist,,,CHEMBL233,Mu opioid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=c488fb7c-0a5b-487c-b452-996809d1cb99, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c488fb7c-0a5b-487c-b452-996809d1cb99",C[N+]1(CC2CC2)CC[C@]34[C@H]5Oc6c(O)ccc(C[C@@H]1[C@]3(O)CCC5=O)c46,CHEMBL233,OPRM1
2662,CHEMBL1200774,Fluprednisolone,Small molecule,1982.0,,,-pred-,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:978-1-889788-85-2, URL:http://www.isbnsearch.org/isbn/9781889788852|Name:PubMed, SrcID:613316, URL:http://europepmc.org/abstract/MED/613316",C[C@]12C[C@H](O)[C@H]3[C@@H](C[C@H](F)C4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO,CHEMBL2034,NR3C1
2663,CHEMBL1175,Duloxetine,Small molecule,2004.0,N06AX21,N06AX21 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants],-oxetine,Norepinephrine transporter inhibitor,,,CHEMBL222,Norepinephrine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18416656, URL:http://europepmc.org/abstract/MED/18416656|Name:Wikipedia, SrcID:Duloxetine, URL:http://en.wikipedia.org/wiki/Duloxetine|Name:DailyMed, SrcID:setid=baaa3a1a-bada-082f-5e77-d9013c6fc109#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=baaa3a1a-bada-082f-5e77-d9013c6fc109#nlm34090-1",CNCC[C@H](Oc1cccc2ccccc12)c3cccs3,CHEMBL222,SLC6A2
2664,CHEMBL832,Sulfinpyrazone,Small molecule,1959.0,M04AB02,M04AB02 [MUSCULO-SKELETAL SYSTEM: ANTIGOUT PREPARATIONS: ANTIGOUT PREPARATIONS: Preparations increasing uric acid excretion],,Solute carrier family 22 member 12 inhibitor,,,CHEMBL6120,Solute carrier family 22 member 12,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18724382, URL:http://europepmc.org/abstract/MED/18724382|Name:Wikipedia, SrcID:Uricosuric, URL:http://en.wikipedia.org/wiki/Uricosuric|Name:PubMed, SrcID:16740561, URL:http://europepmc.org/abstract/MED/16740561",[O-][S+](CCC1C(=O)N(N(C1=O)c2ccccc2)c3ccccc3)c4ccccc4,CHEMBL6120,SLC22A12
2665,CHEMBL1946170,Regorafenib,Small molecule,2012.0,L01XE21,L01XE21 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-rafenib,Platelet-derived growth factor receptor inhibitor,,,CHEMBL2095189,Platelet-derived growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:Expert, SrcID:REGORAFENIB, URL:http://chembl.blogspot.co.uk/search?q=REGORAFENIB",CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,,
2666,CHEMBL112,Acetaminophen,Small molecule,1968.0,N02BE51; N02BE71; N02BE01,N02BE51 [NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Anilides]; N02BE71 [NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Anilides]; N02BE01 [NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Anilides],,Cyclooxygenase inhibitor,,,CHEMBL2094253,Cyclooxygenase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:15662292, URL:http://europepmc.org/abstract/MED/15662292|Name:PubMed, SrcID:17884974, URL:http://europepmc.org/abstract/MED/17884974|Name:Wikipedia, SrcID:Acetaminophen#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Acetaminophen#Mechanism_of_action|Name:PubMed, SrcID:15987694, URL:http://europepmc.org/abstract/MED/15987694|Name:PubMed, SrcID:12660052, URL:http://europepmc.org/abstract/MED/12660052|Name:PubMed, SrcID:20862299, URL:http://europepmc.org/abstract/MED/20862299",CC(=O)Nc1ccc(O)cc1,,
2667,CHEMBL101,Phenylbutazone,Small molecule,1980.0,M02AA01; M01AA01,"M02AA01 [MUSCULO-SKELETAL SYSTEM: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: Antiinflammatory preparations, non-steroids for topical use]; M01AA01 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Butylpyrazolidines]",-butazone,Cyclooxygenase inhibitor,,,CHEMBL2094253,Cyclooxygenase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Expert, SrcID:, URL:",CCCCC1C(=O)N(N(C1=O)c2ccccc2)c3ccccc3,,
2668,CHEMBL1289926,Axitinib,Small molecule,2012.0,L01XE17,L01XE17 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Vascular endothelial growth factor receptor inhibitor,,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=84137882-e000-47da-bd5b-fa76ab3c76f9#section-12, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=84137882-e000-47da-bd5b-fa76ab3c76f9#section-12",CNC(=O)c1ccccc1Sc2ccc3c(\C=C\c4ccccn4)n[nH]c3c2,,
2669,CHEMBL27,Propranolol,Small molecule,1967.0,C07AA05,"C07AA05 [CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, non-selective]",-olol,Beta-2 adrenergic receptor antagonist,,,CHEMBL210,Beta-2 adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=fce692df-1e68-465e-8dda-0cb01320608c, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fce692df-1e68-465e-8dda-0cb01320608c|Name:Wikipedia, SrcID:Propranolol, URL:http://en.wikipedia.org/wiki/Propranolol",CC(C)NCC(O)COc1cccc2ccccc12,CHEMBL210,ADRB2
2670,CHEMBL1201595,Laronidase,Enzyme,2003.0,A16AB05,A16AB05 [ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Enzymes],-ase,Heparan sulfate hydrolytic enzyme,Replacement of alpha-L-iduronidase enzyme,,CHEMBL2364677,Heparan sulfate,HYDROLYTIC ENZYME,Homo sapiens,OLIGOSACCHARIDE,,,"Name:DailyMed, SrcID:setid=a80ac249-cae4-41f3-88bb-344088b20e60#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a80ac249-cae4-41f3-88bb-344088b20e60#nlm34090-1",,,
2671,CHEMBL2108709,Collagenase Clostridium Histolyticum,Enzyme,2010.0,D03BA02; M09AB02; D03BA52,D03BA02 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes]; M09AB02 [MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: Enzymes]; D03BA52 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes],-ase,Collagen hydrolytic enzyme,,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1",,CHEMBL2364188,COL6A1
2672,CHEMBL2108709,Collagenase Clostridium Histolyticum,Enzyme,2010.0,D03BA02; M09AB02; D03BA52,D03BA02 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes]; M09AB02 [MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: Enzymes]; D03BA52 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes],-ase,Collagen hydrolytic enzyme,,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1",,CHEMBL2364188,COL6A2
2673,CHEMBL2108709,Collagenase Clostridium Histolyticum,Enzyme,2010.0,D03BA02; M09AB02; D03BA52,D03BA02 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes]; M09AB02 [MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: Enzymes]; D03BA52 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes],-ase,Collagen hydrolytic enzyme,,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1",,CHEMBL2364188,COL4A4
2674,CHEMBL2108709,Collagenase Clostridium Histolyticum,Enzyme,2010.0,D03BA02; M09AB02; D03BA52,D03BA02 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes]; M09AB02 [MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: Enzymes]; D03BA52 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes],-ase,Collagen hydrolytic enzyme,,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1",,CHEMBL2364188,COL4A3
2675,CHEMBL2108709,Collagenase Clostridium Histolyticum,Enzyme,2010.0,D03BA02; M09AB02; D03BA52,D03BA02 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes]; M09AB02 [MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: Enzymes]; D03BA52 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes],-ase,Collagen hydrolytic enzyme,,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1",,CHEMBL2364188,COL4A6
2676,CHEMBL2108709,Collagenase Clostridium Histolyticum,Enzyme,2010.0,D03BA02; M09AB02; D03BA52,D03BA02 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes]; M09AB02 [MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: Enzymes]; D03BA52 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes],-ase,Collagen hydrolytic enzyme,,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1",,CHEMBL2364188,COL11A2
2677,CHEMBL2108709,Collagenase Clostridium Histolyticum,Enzyme,2010.0,D03BA02; M09AB02; D03BA52,D03BA02 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes]; M09AB02 [MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: Enzymes]; D03BA52 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes],-ase,Collagen hydrolytic enzyme,,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1",,CHEMBL2364188,COL4A5
2678,CHEMBL2108709,Collagenase Clostridium Histolyticum,Enzyme,2010.0,D03BA02; M09AB02; D03BA52,D03BA02 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes]; M09AB02 [MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: Enzymes]; D03BA52 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes],-ase,Collagen hydrolytic enzyme,,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1",,CHEMBL2364188,COL3A1
2679,CHEMBL2108709,Collagenase Clostridium Histolyticum,Enzyme,2010.0,D03BA02; M09AB02; D03BA52,D03BA02 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes]; M09AB02 [MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: Enzymes]; D03BA52 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes],-ase,Collagen hydrolytic enzyme,,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1",,CHEMBL2364188,COL5A2
2680,CHEMBL2108709,Collagenase Clostridium Histolyticum,Enzyme,2010.0,D03BA02; M09AB02; D03BA52,D03BA02 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes]; M09AB02 [MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: Enzymes]; D03BA52 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes],-ase,Collagen hydrolytic enzyme,,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1",,CHEMBL2364188,COL27A1
2681,CHEMBL2108709,Collagenase Clostridium Histolyticum,Enzyme,2010.0,D03BA02; M09AB02; D03BA52,D03BA02 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes]; M09AB02 [MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: Enzymes]; D03BA52 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes],-ase,Collagen hydrolytic enzyme,,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1",,CHEMBL2364188,COL2A1
2682,CHEMBL2108709,Collagenase Clostridium Histolyticum,Enzyme,2010.0,D03BA02; M09AB02; D03BA52,D03BA02 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes]; M09AB02 [MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: Enzymes]; D03BA52 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes],-ase,Collagen hydrolytic enzyme,,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1",,CHEMBL2364188,COL15A1
2683,CHEMBL2108709,Collagenase Clostridium Histolyticum,Enzyme,2010.0,D03BA02; M09AB02; D03BA52,D03BA02 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes]; M09AB02 [MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: Enzymes]; D03BA52 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes],-ase,Collagen hydrolytic enzyme,,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1",,CHEMBL2364188,COL28A1
2684,CHEMBL2108709,Collagenase Clostridium Histolyticum,Enzyme,2010.0,D03BA02; M09AB02; D03BA52,D03BA02 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes]; M09AB02 [MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: Enzymes]; D03BA52 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes],-ase,Collagen hydrolytic enzyme,,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1",,CHEMBL2364188,COL5A1
2685,CHEMBL2108709,Collagenase Clostridium Histolyticum,Enzyme,2010.0,D03BA02; M09AB02; D03BA52,D03BA02 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes]; M09AB02 [MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: Enzymes]; D03BA52 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes],-ase,Collagen hydrolytic enzyme,,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1",,CHEMBL2364188,COL11A1
2686,CHEMBL2108709,Collagenase Clostridium Histolyticum,Enzyme,2010.0,D03BA02; M09AB02; D03BA52,D03BA02 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes]; M09AB02 [MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: Enzymes]; D03BA52 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes],-ase,Collagen hydrolytic enzyme,,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1",,CHEMBL2364188,COL6A5
2687,CHEMBL2108709,Collagenase Clostridium Histolyticum,Enzyme,2010.0,D03BA02; M09AB02; D03BA52,D03BA02 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes]; M09AB02 [MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: Enzymes]; D03BA52 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes],-ase,Collagen hydrolytic enzyme,,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1",,CHEMBL2364188,COL6A6
2688,CHEMBL2108709,Collagenase Clostridium Histolyticum,Enzyme,2010.0,D03BA02; M09AB02; D03BA52,D03BA02 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes]; M09AB02 [MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: Enzymes]; D03BA52 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes],-ase,Collagen hydrolytic enzyme,,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1",,CHEMBL2364188,COL24A1
2689,CHEMBL2108709,Collagenase Clostridium Histolyticum,Enzyme,2010.0,D03BA02; M09AB02; D03BA52,D03BA02 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes]; M09AB02 [MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: Enzymes]; D03BA52 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes],-ase,Collagen hydrolytic enzyme,,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1",,CHEMBL2364188,COL5A3
2690,CHEMBL2108709,Collagenase Clostridium Histolyticum,Enzyme,2010.0,D03BA02; M09AB02; D03BA52,D03BA02 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes]; M09AB02 [MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: Enzymes]; D03BA52 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes],-ase,Collagen hydrolytic enzyme,,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1",,CHEMBL2364188,COL18A1
2691,CHEMBL2108709,Collagenase Clostridium Histolyticum,Enzyme,2010.0,D03BA02; M09AB02; D03BA52,D03BA02 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes]; M09AB02 [MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: Enzymes]; D03BA52 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes],-ase,Collagen hydrolytic enzyme,,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1",,CHEMBL2364188,COL4A2
2692,CHEMBL2108709,Collagenase Clostridium Histolyticum,Enzyme,2010.0,D03BA02; M09AB02; D03BA52,D03BA02 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes]; M09AB02 [MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: Enzymes]; D03BA52 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: ENZYMES: Proteolytic enzymes],-ase,Collagen hydrolytic enzyme,,,CHEMBL2364188,Collagen,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=805cecd0-fd1f-11dd-87af-0800200c9a66#nlm34090-1",,CHEMBL2364188,COL6A3
2693,CHEMBL1070,Nabumetone,Small molecule,1991.0,M01AX01,"M01AX01 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Other antiinflammatory and antirheumatic agents, non-steroids]",nab-,Cyclooxygenase-2 inhibitor,,,CHEMBL230,Cyclooxygenase-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=e21f89cf-ec07-4b07-9c9b-796b0111df39, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e21f89cf-ec07-4b07-9c9b-796b0111df39|Name:Wikipedia, SrcID:Nabumetone#Introduction, URL:http://en.wikipedia.org/wiki/Nabumetone#Introduction",COc1ccc2cc(CCC(=O)C)ccc2c1,CHEMBL230,PTGS2
2694,CHEMBL1163,Atazanavir,Small molecule,2003.0,J05AE08,J05AE08 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Protease inhibitors],-vir,Human immunodeficiency virus type 1 protease inhibitor,,,CHEMBL243,Human immunodeficiency virus type 1 protease,INHIBITOR,Human immunodeficiency virus 1,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=165cff62-b284-4a27-a65d-9ec8a5bfcdd8, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=165cff62-b284-4a27-a65d-9ec8a5bfcdd8",COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc2ccc(cc2)c3ccccn3)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,,
2695,CHEMBL464,Etretinate,Small molecule,1986.0,D05BB01,D05BB01 [DERMATOLOGICALS: ANTIPSORIATICS: ANTIPSORIATICS FOR SYSTEMIC USE: Retinoids for treatment of psoriasis],-retin-,Retinoid receptor agonist,Precise mechanism uncertain. RARG/RXRA are predominant forms in skin,,CHEMBL2363071,Retinoid receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:9298126, URL:http://europepmc.org/abstract/MED/9298126|Name:PubMed, SrcID:9074840, URL:http://europepmc.org/abstract/MED/9074840",CCOC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\c1c(C)cc(OC)c(C)c1C,,
2696,CHEMBL1256,Isoflurane,Small molecule,1979.0,N01AB06,"N01AB06 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:Wikipedia, SrcID:Isoflurane#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Isoflurane#Mechanism_of_action|Name:PubMed, SrcID:20083606, URL:http://europepmc.org/abstract/MED/20083606|Name:PubMed, SrcID:23364597, URL:http://europepmc.org/abstract/MED/23364597|Name:PubMed, SrcID:21788314, URL:http://europepmc.org/abstract/MED/21788314",FC(F)OC(Cl)C(F)(F)F,CHEMBL2093872,GABRG3
2697,CHEMBL1256,Isoflurane,Small molecule,1979.0,N01AB06,"N01AB06 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:Wikipedia, SrcID:Isoflurane#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Isoflurane#Mechanism_of_action|Name:PubMed, SrcID:20083606, URL:http://europepmc.org/abstract/MED/20083606|Name:PubMed, SrcID:23364597, URL:http://europepmc.org/abstract/MED/23364597|Name:PubMed, SrcID:21788314, URL:http://europepmc.org/abstract/MED/21788314",FC(F)OC(Cl)C(F)(F)F,CHEMBL2093872,GABRP
2698,CHEMBL1256,Isoflurane,Small molecule,1979.0,N01AB06,"N01AB06 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:Wikipedia, SrcID:Isoflurane#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Isoflurane#Mechanism_of_action|Name:PubMed, SrcID:20083606, URL:http://europepmc.org/abstract/MED/20083606|Name:PubMed, SrcID:23364597, URL:http://europepmc.org/abstract/MED/23364597|Name:PubMed, SrcID:21788314, URL:http://europepmc.org/abstract/MED/21788314",FC(F)OC(Cl)C(F)(F)F,CHEMBL2093872,GABRE
2699,CHEMBL1256,Isoflurane,Small molecule,1979.0,N01AB06,"N01AB06 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:Wikipedia, SrcID:Isoflurane#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Isoflurane#Mechanism_of_action|Name:PubMed, SrcID:20083606, URL:http://europepmc.org/abstract/MED/20083606|Name:PubMed, SrcID:23364597, URL:http://europepmc.org/abstract/MED/23364597|Name:PubMed, SrcID:21788314, URL:http://europepmc.org/abstract/MED/21788314",FC(F)OC(Cl)C(F)(F)F,CHEMBL2093872,GABRG1
2700,CHEMBL1585,Pipobroman,Small molecule,1966.0,L01AX02,L01AX02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ALKYLATING AGENTS: Other alkylating agents],,DNA inhibitor,Alkylating agent,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:PubMed, SrcID:17352450, URL:http://europepmc.org/abstract/MED/17352450",BrCCC(=O)N1CCN(CC1)C(=O)CCBr,,
2701,CHEMBL803,Cytarabine,Small molecule,1969.0,L01BC01,L01BC01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Pyrimidine analogues],-arabine,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=1315f89d-f530-4dff-98e5-27d51617d4a1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1315f89d-f530-4dff-98e5-27d51617d4a1",NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O,,
2702,CHEMBL1447,Lincomycin,Small molecule,1964.0,J01FF02,"J01FF02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS: Lincosamides]",-mycin,70S ribosome inhibitor,"Indicated for Staphylococcus aureus, Streptococcus pneumoniae",,CHEMBL2363853,70S ribosome,INHIBITOR,Streptococcus pneumoniae,PROTEIN NUCLEIC-ACID COMPLEX,23S ribosomal RNA,23S RRNA,"Name:PubMed, SrcID:10856379, URL:http://europepmc.org/abstract/MED/10856379|Name:PubMed, SrcID:1527036, URL:http://europepmc.org/abstract/MED/1527036",CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@@H](C)O)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O,,
2703,CHEMBL52,Nordihydroguaiaretic Acid,Small molecule,1992.0,L01XX10,L01XX10 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],,Unknown,,,,,,,,,,"Name:PubMed, SrcID:23053656, URL:http://europepmc.org/abstract/MED/23053656",CC(Cc1ccc(O)c(O)c1)C(C)Cc2ccc(O)c(O)c2,,
2704,CHEMBL502835,Nintedanib,Small molecule,2014.0,L01XE31,L01XE31 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-anib,Fibroblast growth factor receptor inhibitor,,"FGFR 1, 2 + 3",CHEMBL2095217,Fibroblast growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2014/205832s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205832s000lbl.pdf",COC(=O)c1ccc2\C(=C(\Nc3ccc(cc3)N(C)C(=O)CN4CCN(C)CC4)/c5ccccc5)\C(=O)Nc2c1,,
2705,CHEMBL2103872,Ceftolozane,Small molecule,2014.0,,,cef-,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2015/206829s001lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206829s001lbl.pdf",Cn1c(N)c(NC(=O)NCCN)c[n+]1CC2=C(N3[C@H](SC2)[C@H](NC(=O)\C(=N/OC(C)(C)C(=O)[O-])\c4nsc(N)n4)C3=O)C(=O)O,,
2706,CHEMBL3545432,Ixazomib Citrate,Small molecule,2015.0,L01XX50,L01XX50 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,Prodrug of ixazomib,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,Beta-5 subunit,"Name:DailyMed, SrcID:setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b",CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B2OC(=O)C(CC(=O)O)(CC(=O)O)O2,CHEMBL2364701,PSMC6
2707,CHEMBL3545432,Ixazomib Citrate,Small molecule,2015.0,L01XX50,L01XX50 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,Prodrug of ixazomib,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,Beta-5 subunit,"Name:DailyMed, SrcID:setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b",CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B2OC(=O)C(CC(=O)O)(CC(=O)O)O2,CHEMBL2364701,PSMD13
2708,CHEMBL3545432,Ixazomib Citrate,Small molecule,2015.0,L01XX50,L01XX50 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,Prodrug of ixazomib,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,Beta-5 subunit,"Name:DailyMed, SrcID:setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b",CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B2OC(=O)C(CC(=O)O)(CC(=O)O)O2,CHEMBL2364701,ADRM1
2709,CHEMBL3545432,Ixazomib Citrate,Small molecule,2015.0,L01XX50,L01XX50 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,Prodrug of ixazomib,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,Beta-5 subunit,"Name:DailyMed, SrcID:setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b",CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B2OC(=O)C(CC(=O)O)(CC(=O)O)O2,CHEMBL2364701,PSMD12
2710,CHEMBL3545432,Ixazomib Citrate,Small molecule,2015.0,L01XX50,L01XX50 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,Prodrug of ixazomib,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,Beta-5 subunit,"Name:DailyMed, SrcID:setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b",CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B2OC(=O)C(CC(=O)O)(CC(=O)O)O2,CHEMBL2364701,PSMC4
2711,CHEMBL3545432,Ixazomib Citrate,Small molecule,2015.0,L01XX50,L01XX50 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,Prodrug of ixazomib,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,Beta-5 subunit,"Name:DailyMed, SrcID:setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b",CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B2OC(=O)C(CC(=O)O)(CC(=O)O)O2,CHEMBL2364701,PSMD11
2712,CHEMBL3545432,Ixazomib Citrate,Small molecule,2015.0,L01XX50,L01XX50 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,Prodrug of ixazomib,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,Beta-5 subunit,"Name:DailyMed, SrcID:setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b",CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B2OC(=O)C(CC(=O)O)(CC(=O)O)O2,CHEMBL2364701,PSMC3
2713,CHEMBL3545432,Ixazomib Citrate,Small molecule,2015.0,L01XX50,L01XX50 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,Prodrug of ixazomib,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,Beta-5 subunit,"Name:DailyMed, SrcID:setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b",CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B2OC(=O)C(CC(=O)O)(CC(=O)O)O2,CHEMBL2364701,PSMD8
2714,CHEMBL3545432,Ixazomib Citrate,Small molecule,2015.0,L01XX50,L01XX50 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,Prodrug of ixazomib,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,Beta-5 subunit,"Name:DailyMed, SrcID:setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b",CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B2OC(=O)C(CC(=O)O)(CC(=O)O)O2,CHEMBL2364701,SEM1
2715,CHEMBL3545432,Ixazomib Citrate,Small molecule,2015.0,L01XX50,L01XX50 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,Prodrug of ixazomib,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,Beta-5 subunit,"Name:DailyMed, SrcID:setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b",CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B2OC(=O)C(CC(=O)O)(CC(=O)O)O2,CHEMBL2364701,PSMD7
2716,CHEMBL3545432,Ixazomib Citrate,Small molecule,2015.0,L01XX50,L01XX50 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,Prodrug of ixazomib,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,Beta-5 subunit,"Name:DailyMed, SrcID:setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b",CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B2OC(=O)C(CC(=O)O)(CC(=O)O)O2,CHEMBL2364701,PSMC5
2717,CHEMBL3545432,Ixazomib Citrate,Small molecule,2015.0,L01XX50,L01XX50 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,Prodrug of ixazomib,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,Beta-5 subunit,"Name:DailyMed, SrcID:setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b",CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B2OC(=O)C(CC(=O)O)(CC(=O)O)O2,CHEMBL2364701,PSMC2
2718,CHEMBL3545432,Ixazomib Citrate,Small molecule,2015.0,L01XX50,L01XX50 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,Prodrug of ixazomib,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,Beta-5 subunit,"Name:DailyMed, SrcID:setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b",CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B2OC(=O)C(CC(=O)O)(CC(=O)O)O2,CHEMBL2364701,PSMC1
2719,CHEMBL3545432,Ixazomib Citrate,Small molecule,2015.0,L01XX50,L01XX50 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,Prodrug of ixazomib,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,Beta-5 subunit,"Name:DailyMed, SrcID:setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b",CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B2OC(=O)C(CC(=O)O)(CC(=O)O)O2,CHEMBL2364701,PSMD6
2720,CHEMBL3545432,Ixazomib Citrate,Small molecule,2015.0,L01XX50,L01XX50 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,Prodrug of ixazomib,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,Beta-5 subunit,"Name:DailyMed, SrcID:setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b",CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B2OC(=O)C(CC(=O)O)(CC(=O)O)O2,CHEMBL2364701,PSMD3
2721,CHEMBL3545432,Ixazomib Citrate,Small molecule,2015.0,L01XX50,L01XX50 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,Prodrug of ixazomib,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,Beta-5 subunit,"Name:DailyMed, SrcID:setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b",CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B2OC(=O)C(CC(=O)O)(CC(=O)O)O2,CHEMBL2364701,PSMD1
2722,CHEMBL3545432,Ixazomib Citrate,Small molecule,2015.0,L01XX50,L01XX50 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,Prodrug of ixazomib,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,Beta-5 subunit,"Name:DailyMed, SrcID:setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b",CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B2OC(=O)C(CC(=O)O)(CC(=O)O)O2,CHEMBL2364701,PSMD4
2723,CHEMBL3545432,Ixazomib Citrate,Small molecule,2015.0,L01XX50,L01XX50 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,Prodrug of ixazomib,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,Beta-5 subunit,"Name:DailyMed, SrcID:setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b",CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B2OC(=O)C(CC(=O)O)(CC(=O)O)O2,CHEMBL2364701,PSMD2
2724,CHEMBL2010872,Cep-11981,Small molecule,,,,,Tyrosine-protein kinase TIE-2 inhibitor,,,CHEMBL4128,Tyrosine-protein kinase TIE-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22148921, URL:http://europepmc.org/abstract/MED/22148921",CC(C)Cn1c2ccc(Nc3ncccn3)cc2c4c5CNC(=O)c5c6c(CCc7nn(C)cc67)c14,CHEMBL4128,TEK
2725,CHEMBL3182444,Mk-5108,Small molecule,,,,,Serine/threonine-protein kinase Aurora-A inhibitor,,,CHEMBL4722,Serine/threonine-protein kinase Aurora-A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20053775, URL:http://europepmc.org/abstract/MED/20053775",OC(=O)C1(Cc2cccc(Nc3nccs3)n2)CCC(CC1)Oc4cccc(Cl)c4F,,
2726,CHEMBL2106468,Tricetamide,Small molecule,,,,,Tyrosine-protein kinase JAK3 inhibitor,Prodrug of R-507,,CHEMBL2148,Tyrosine-protein kinase JAK3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22971540, URL:http://europepmc.org/abstract/MED/22971540|Name:PubMed, SrcID:24671708, URL:http://europepmc.org/abstract/MED/24671708",CCN(CC)C(=O)CNC(=O)c1cc(OC)c(OC)c(OC)c1,CHEMBL2148,JAK3
2727,CHEMBL3545007,Rg-7602,Small molecule,,,,,Serine/threonine-protein kinase Chk1 inhibitor,,,CHEMBL4630,Serine/threonine-protein kinase Chk1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1158/1538-7445.AM2015-CT139, URL:http://cancerres.aacrjournals.org/content/75/15_Supplement/CT139",,CHEMBL4630,CHEK1
2728,CHEMBL3545017,Gtx-758,Small molecule,,,,,Estrogen receptor alpha agonist,Capesaris is proposed INN,,CHEMBL206,Estrogen receptor alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22294742, URL:http://europepmc.org/abstract/MED/22294742|Name:Other, SrcID:http://www.gtxinc.com/Pipeline/GTx758.aspx?Sid=5, URL:http://www.gtxinc.com/Pipeline/GTx758.aspx?Sid=5|Name:PubMed, SrcID:25002202, URL:http://europepmc.org/abstract/MED/25002202|Name:PubMed, SrcID:24968970, URL:http://europepmc.org/abstract/MED/24968970",Oc1ccc(cc1)N(C(=O)c2ccc(O)c(F)c2)c3ccc(F)cc3,CHEMBL206,ESR1
2729,CHEMBL3544999,Ly-3023414,Small molecule,,,,,PI3-kinase class I inhibitor,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Other, SrcID:http://www.lillyoncologypipeline.com/pi3kmtor-dual-inhibitor.aspx, URL:http://www.lillyoncologypipeline.com/pi3kmtor-dual-inhibitor.aspx",,CHEMBL3559703,PIK3R2
2730,CHEMBL3544999,Ly-3023414,Small molecule,,,,,PI3-kinase class I inhibitor,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Other, SrcID:http://www.lillyoncologypipeline.com/pi3kmtor-dual-inhibitor.aspx, URL:http://www.lillyoncologypipeline.com/pi3kmtor-dual-inhibitor.aspx",,CHEMBL3559703,PIK3R3
2731,CHEMBL3544999,Ly-3023414,Small molecule,,,,,PI3-kinase class I inhibitor,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Other, SrcID:http://www.lillyoncologypipeline.com/pi3kmtor-dual-inhibitor.aspx, URL:http://www.lillyoncologypipeline.com/pi3kmtor-dual-inhibitor.aspx",,CHEMBL3559703,PIK3R5
2732,CHEMBL392149,Tecadenoson,Small molecule,,,,-denoson,Adenosine A1 receptor agonist,,,CHEMBL226,Adenosine A1 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17933541, URL:http://europepmc.org/abstract/MED/17933541|Name:PubMed, SrcID:11584330, URL:http://europepmc.org/abstract/MED/11584330|Name:PubMed, SrcID:21185259, URL:http://europepmc.org/abstract/MED/21185259",OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(N[C@@H]4CCOC4)ncnc23,CHEMBL226,ADORA1
2733,CHEMBL3545407,Trabodenoson,Small molecule,,,,-denoson,Adenosine A1 receptor agonist,,,CHEMBL226,Adenosine A1 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23055540, URL:http://europepmc.org/abstract/MED/23055540|Name:Other, SrcID:http://www.inotekpharma.com/content/trabodenoson.asp, URL:http://www.inotekpharma.com/content/trabodenoson.asp",O[C@@H]1[C@@H](CO[N+](=O)[O-])O[C@H]([C@@H]1O)n2cnc3c(NC4CCCC4)ncnc23,CHEMBL226,ADORA1
2734,CHEMBL22055,Sufugolix,Small molecule,,,,-golix,Gonadotropin-releasing hormone receptor antagonist,,,CHEMBL1855,Gonadotropin-releasing hormone receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12502365, URL:http://europepmc.org/abstract/MED/12502365",CONC(=O)Nc1ccc(cc1)c2sc3N(Cc4c(F)cccc4F)C(=O)N(C(=O)c3c2CN(C)Cc5ccccc5)c6ccccc6,CHEMBL1855,GNRHR
2735,CHEMBL1628569,Robalzotan,Small molecule,,,,-zotan,Serotonin 1a (5-HT1a) receptor antagonist,,,CHEMBL214,Serotonin 1a (5-HT1a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:9851589, URL:http://europepmc.org/abstract/MED/9851589|Name:Wikipedia, SrcID:Robalzotan, URL:http://en.wikipedia.org/wiki/Robalzotan|Name:PubMed, SrcID:9336327, URL:http://europepmc.org/abstract/MED/9336327",NC(=O)c1ccc(F)c2OC[C@@H](Cc12)N(C3CCC3)C4CCC4,CHEMBL214,HTR1A
2736,CHEMBL519504,Aleglitazar,Small molecule,,,,-glitazar,Peroxisome proliferator-activated receptor gamma agonist,Development stopped due to safety concerns and lack of efficacy (http://www.roche.com/media/media_releases/med-cor-2013-07-10.htm),,CHEMBL235,Peroxisome proliferator-activated receptor gamma,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Aleglitazar, URL:http://en.wikipedia.org/wiki/Aleglitazar|Name:PubMed, SrcID:1438286, URL:http://europepmc.org/abstract/MED/1438286",CO[C@@H](Cc1ccc(OCCc2nc(oc2C)c3ccccc3)c4ccsc14)C(=O)O,CHEMBL235,PPARG
2737,CHEMBL223360,Linifanib,Small molecule,,,,-anib,Macrophage colony stimulating factor receptor inhibitor,,,CHEMBL1844,Macrophage colony stimulating factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17343372, URL:http://europepmc.org/abstract/MED/17343372|Name:PubMed, SrcID:16648571, URL:http://europepmc.org/abstract/MED/16648571",Cc1ccc(F)c(NC(=O)Nc2ccc(cc2)c3cccc4[nH]nc(N)c34)c1,CHEMBL1844,CSF1R
2738,CHEMBL1233528,Volasertib,Small molecule,,,,-sertib,Serine/threonine-protein kinase PLK1 inhibitor,,,CHEMBL3024,Serine/threonine-protein kinase PLK1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19383823, URL:http://europepmc.org/abstract/MED/19383823",CC[C@H]1N(C(C)C)c2nc(Nc3ccc(cc3OC)C(=O)N[C@@H]4CC[C@H](CC4)N5CCN(CC6CC6)CC5)ncc2N(C)C1=O,CHEMBL3024,PLK1
2739,CHEMBL1078178,Momelotinib,Small molecule,,,,-tinib,Tyrosine-protein kinase JAK1 inhibitor,,,CHEMBL2835,Tyrosine-protein kinase JAK1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19295546, URL:http://europepmc.org/abstract/MED/19295546|Name:PubMed, SrcID:20385788, URL:http://europepmc.org/abstract/MED/20385788",O=C(NCC#N)c1ccc(cc1)c2ccnc(Nc3ccc(cc3)N4CCOCC4)n2,CHEMBL2835,JAK1
2740,CHEMBL2110732,Dacomitinib,Small molecule,,,,-tinib,Receptor protein-tyrosine kinase erbB-4 inhibitor,Dacomitinib is an irreversible pan-ERBB inhibitor.,,CHEMBL3009,Receptor protein-tyrosine kinase erbB-4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://www.pfizer.com/files/news/esmo/dacomitinib_fact_sheet.pdf, URL:https://www.pfizer.com/files/news/esmo/dacomitinib_fact_sheet.pdf|Name:PubMed, SrcID:18089823, URL:http://europepmc.org/abstract/MED/18089823",COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)\C=C\CN4CCCCC4,CHEMBL3009,ERBB4
2741,CHEMBL522892,Dovitinib,Small molecule,,,,-tinib,Fibroblast growth factor receptor 3 inhibitor,,,CHEMBL2742,Fibroblast growth factor receptor 3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15897558, URL:http://europepmc.org/abstract/MED/15897558",CN1CCN(CC1)c2ccc3nc([nH]c3c2)C4=C(N)c5c(F)cccc5NC4=O,CHEMBL2742,FGFR3
2742,CHEMBL2364612,Latanoprostene Bunod,Small molecule,,,,-prost-,Prostanoid FP receptor agonist,Prodrug of latanoprost acid and butanediol mononitrate. Nitric oxide (NO)-donating prostaglandin F2-alpha analog,,CHEMBL1987,Prostanoid FP receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25488946, URL:http://europepmc.org/abstract/MED/25488946|Name:Other, SrcID:http://www.nicox.com/rd/ophthalmic-pipeline/vesneo-latanoprostene-bunod-2/, URL:http://www.nicox.com/rd/ophthalmic-pipeline/vesneo-latanoprostene-bunod-2/|Name:PubMed, SrcID:21396362, URL:http://europepmc.org/abstract/MED/21396362",O[C@H](CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(=O)OCCCCON(=O)=O)CCc2ccccc2,CHEMBL1987,PTGFR
2743,CHEMBL2364605,Cebranopadol,Small molecule,,,,-adol,Opioid receptors; mu/kappa/delta agonist,,,CHEMBL2095181,Opioid receptors; mu/kappa/delta,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:25147603, URL:http://europepmc.org/abstract/MED/25147603|Name:Wikipedia, SrcID:¿-opioid_receptor, URL:http://en.wikipedia.org/wiki/¿-opioid_receptor|Name:PubMed, SrcID:24713140, URL:http://europepmc.org/abstract/MED/24713140",CN(C)[C@@]1(CC[C@]2(CC1)OCCc3c2[nH]c4ccc(F)cc34)c5ccccc5,,
2744,CHEMBL61780,Tezosentan,Small molecule,,,,-entan,Endothelin receptor ET-B antagonist,Discontinueddue to lack of clinical benefit.,,CHEMBL1785,Endothelin receptor ET-B,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16542201, URL:http://europepmc.org/abstract/MED/16542201|Name:PubMed, SrcID:11966665, URL:http://europepmc.org/abstract/MED/11966665|Name:PubMed, SrcID:10411600, URL:http://europepmc.org/abstract/MED/10411600",COc1ccccc1Oc2c(NS(=O)(=O)c3ccc(cn3)C(C)C)nc(nc2OCCO)c4ccnc(c4)c5nn[nH]n5,CHEMBL1785,EDNRB
2745,CHEMBL572881,Motesanib,Small molecule,,,,-anib,Vascular endothelial growth factor receptor inhibitor,Multi-kinase inhibitor,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:16951187, URL:http://europepmc.org/abstract/MED/16951187",CC1(C)CNc2cc(NC(=O)c3cccnc3NCc4ccncc4)ccc12,,
2746,CHEMBL2108967,Lerdelimumab,Antibody,,,,-mab,Transforming growth factor beta-2 inhibitor,,,CHEMBL3217393,Transforming growth factor beta-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12882787, URL:http://europepmc.org/abstract/MED/12882787",,CHEMBL3217393,TGFB2
2747,CHEMBL2108735,Drisapersen,Oligonucleotide,,M09AX04,M09AX04 [MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: Other drugs for disorders of the musculo-skeletal system],-rsen,Dystrophin pre-mRNA OTHER,Induces specific exon skipping during messenger RNA (mRNA) splicing correcting the open reading frame of the DMD gene and thus to restore dystrophin expression.,,CHEMBL3826826,Dystrophin pre-mRNA,OTHER,Homo sapiens,NUCLEIC-ACID,,,"Name:PubMed, SrcID:18160687, URL:http://europepmc.org/abstract/MED/18160687|Name:PubMed, SrcID:21428760, URL:http://europepmc.org/abstract/MED/21428760",,,
2748,CHEMBL2103855,Telotristat,Small molecule,,,,-stat,Tryptophan 5-hydroxylase inhibitor,,,CHEMBL3831287,Tryptophan 5-hydroxylase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:23749550, URL:http://europepmc.org/abstract/MED/23749550",Cc1ccn(n1)c2cc(Cl)ccc2[C@@H](Oc3cc(nc(N)n3)c4ccc(C[C@H](N)C(=O)O)cc4)C(F)(F)F,,
2749,CHEMBL2110954,Neramexane,Small molecule,,,,,Neuronal acetylcholine receptor; alpha9/alpha10 antagonist,,,CHEMBL2109238,Neuronal acetylcholine receptor; alpha9/alpha10,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:21223542, URL:http://europepmc.org/abstract/MED/21223542",CC1(C)CC(C)(C)CC(C)(N)C1,CHEMBL2109238,CHRNA10
2750,CHEMBL2109667,Simtuzumab,Antibody,,,,-mab,Lysyl oxidase homolog 2 inhibitor,,,CHEMBL3714029,Lysyl oxidase homolog 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:27232579, URL:http://europepmc.org/abstract/MED/27232579",,CHEMBL3714029,LOXL2
2751,CHEMBL2109616,Abx-Il8,Antibody,,,,,Interleukin-8 inhibitor,"Blocks the binding of IL-8 to IL-8 receptors and inhibits IL-8-dependent neutrophil activation, migration, and degranulation.",,CHEMBL2157,Interleukin-8,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12107097, URL:http://europepmc.org/abstract/MED/12107097",,CHEMBL2157,CXCL8
2752,CHEMBL2108336,Lixisenatide,Protein,2016.0,A10BJ03,"A10BJ03 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Glucagon-like peptide-1 (GLP-1) analogues]",-tide,Glucagon-like peptide 1 receptor agonist,,,CHEMBL1784,Glucagon-like peptide 1 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2016/208471Orig1s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208471Orig1s000lbl.pdf",,CHEMBL1784,GLP1R
2753,CHEMBL2109252,Ni-0401,Antibody,,,,,T cell surface glycoprotein CD3 inhibitor,,,CHEMBL2364168,T cell surface glycoprotein CD3,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,,,CHEMBL2364168,CD3D
2754,CHEMBL2109252,Ni-0401,Antibody,,,,,T cell surface glycoprotein CD3 inhibitor,,,CHEMBL2364168,T cell surface glycoprotein CD3,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,,,CHEMBL2364168,CD3G
2755,CHEMBL175247,Orlistat,Small molecule,1999.0,A08AB01,"A08AB01 [ALIMENTARY TRACT AND METABOLISM: ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS: ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS: Peripherally acting antiobesity products]",-stat,Gastric lipase inhibitor,,,CHEMBL1796,Gastric lipase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=5bbdc95b-82a1-4ba5-8185-6504ff68cc06#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5bbdc95b-82a1-4ba5-8185-6504ff68cc06#nlm34090-1",CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,CHEMBL1796,LIPF
2756,CHEMBL1201662,Desirudin,Protein,2003.0,B01AE01,B01AE01 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Direct thrombin inhibitors],-irudin,Thrombin inhibitor,,Selective,CHEMBL204,Thrombin,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2014/021271s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021271s006lbl.pdf|Name:DailyMed, SrcID:setid=a0e9980e-4bc8-4fa4-b9c1-c3703bf74c44#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a0e9980e-4bc8-4fa4-b9c1-c3703bf74c44#nlm34090-1",,CHEMBL204,F2
2757,CHEMBL1201572,Etanercept,Protein,1998.0,L04AB01,L04AB01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Tumor necrosis factor alpha (TNF-&alpha;) inhibitors],-cept,TNF-alpha inhibitor,,,CHEMBL1825,TNF-alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10090426, URL:http://europepmc.org/abstract/MED/10090426|Name:DailyMed, SrcID:setid=a002b40c-097d-47a5-957f-7a7b1807af7f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a002b40c-097d-47a5-957f-7a7b1807af7f",,CHEMBL1825,TNF
2758,CHEMBL1201286,Oxyphenonium,Small molecule,1982.0,A03AB03; A03AB53,"A03AB03 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: Synthetic anticholinergics, quaternary ammonium compounds]; A03AB53 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: Synthetic anticholinergics, quaternary ammonium compounds]",-ium,Muscarinic acetylcholine receptor M1 antagonist,"Role in regulating gastric secretion, M1 likely involved",,CHEMBL216,Muscarinic acetylcholine receptor M1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:1907331, URL:http://europepmc.org/abstract/MED/1907331|Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718",CC[N+](C)(CC)CCOC(=O)C(O)(C1CCCCC1)c2ccccc2,CHEMBL216,CHRM1
2759,CHEMBL1201570,Anakinra,Protein,2001.0,L04AC03,L04AC03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Interleukin inhibitors],-kinra,Interleukin-1 receptor antagonist,,,CHEMBL1959,Interleukin-1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=d9d74915-6606-4570-9c52-c4001d3177de, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d9d74915-6606-4570-9c52-c4001d3177de",,CHEMBL1959,IL1R1
2760,CHEMBL1185,Zolmitriptan,Small molecule,1997.0,N02CC03,N02CC03 [NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Selective serotonin (5HT1) agonists],-triptan,Serotonin 1d (5-HT1d) receptor agonist,,,CHEMBL1983,Serotonin 1d (5-HT1d) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2012/020768s019s021,021231s010s011lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020768s019s021,021231s010s011lbl.pdf",CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12,CHEMBL1983,HTR1D
2761,CHEMBL1757,Fosfomycin,Small molecule,1996.0,J01XX01,J01XX01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER ANTIBACTERIALS: Other antibacterials],fos-; -mycin,UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor,,,CHEMBL1984,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,INHIBITOR,Escherichia coli K-12,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=ad155d62-9b49-4a50-a2ae-d3aad8155936, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ad155d62-9b49-4a50-a2ae-d3aad8155936",C[C@@H]1O[C@@H]1P(=O)(O)O,,
2762,CHEMBL1639,Aliskiren,Small molecule,2007.0,C09XA02,C09XA02 [CARDIOVASCULAR SYSTEM: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM: OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM: Renin-inhibitors],-kiren,Renin inhibitor,,,CHEMBL286,Renin,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=833c7a0b-5f64-4363-94d5-9a179049113a, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=833c7a0b-5f64-4363-94d5-9a179049113a",COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(=O)N)C(C)C)ccc1OC,CHEMBL286,REN
2763,CHEMBL1200799,Travoprost,Small molecule,2001.0,S01EE04,S01EE04 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Prostaglandin analogues 1)],-prost,Prostanoid FP receptor agonist,,,CHEMBL1987,Prostanoid FP receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=5549684b-1724-45ca-b67b-590c62b7c149, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5549684b-1724-45ca-b67b-590c62b7c149",CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COc2cccc(c2)C(F)(F)F,CHEMBL1987,PTGFR
2764,CHEMBL1265,Adapalene,Small molecule,1996.0,D10AD03; D10AD53,D10AD03 [DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Retinoids for topical use in acne]; D10AD53 [DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Retinoids for topical use in acne],,Retinoic acid receptor agonist,RARG/RXRA are predominant forms in skin,Binds with higher affinity to RARB+RARG,CHEMBL2363069,Retinoic acid receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10651997, URL:http://europepmc.org/abstract/MED/10651997|Name:PubMed, SrcID:18848668, URL:http://europepmc.org/abstract/MED/18848668",COc1ccc(cc1C23CC4CC(CC(C4)C2)C3)c5ccc6cc(ccc6c5)C(=O)O,,
2765,CHEMBL1539,Sulfadoxine,Small molecule,1981.0,,,sulfa-,Dihydropteroate synthetase inhibitor,,,CHEMBL2013,Dihydropteroate synthetase,INHIBITOR,Plasmodium falciparum,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Sulfadoxine, URL:http://en.wikipedia.org/wiki/Sulfadoxine|Name:DailyMed, SrcID:archiveid=86578, URL:http://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=86578",COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC,,
2766,CHEMBL1194666,Diethylpropion,Small molecule,1959.0,A08AA03,"A08AA03 [ALIMENTARY TRACT AND METABOLISM: ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS: ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS: Centrally acting antiobesity products]",,Dopamine transporter inhibitor,,,CHEMBL238,Dopamine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16767304, URL:http://europepmc.org/abstract/MED/16767304|Name:DailyMed, SrcID:setid=ba26f274-f385-49be-aef1-7041d146b9f7#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ba26f274-f385-49be-aef1-7041d146b9f7#nlm34090-1|Name:PubMed, SrcID:21197148, URL:http://europepmc.org/abstract/MED/21197148|Name:ISBN, SrcID:0443-059748 PP. 406, URL:http://www.isbnsearch.org/isbn/0443059748",CCN(CC)C(C)C(=O)c1ccccc1,CHEMBL238,SLC6A3
2767,CHEMBL1200376,Betamethasone Benzoate,Small molecule,1982.0,S01CB04; S03BA03; R01AD06; S01BA06; S02BA07; C05AA05; A07EA04; D07XC01; D07AC01; H02AB01; R03BA04,"S01CB04 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION: Corticosteroids/antiinfectives/mydriatics in combination]; S03BA03 [SENSORY ORGANS: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS: CORTICOSTEROIDS: Corticosteroids]; R01AD06 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Corticosteroids]; S01BA06 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Corticosteroids, plain]; S02BA07 [SENSORY ORGANS: OTOLOGICALS: CORTICOSTEROIDS: Corticosteroids]; C05AA05 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Corticosteroids]; A07EA04 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Corticosteroids acting locally]; D07XC01 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, OTHER COMBINATIONS: Corticosteroids, potent, other combinations]; D07AC01 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, potent (group III)]; H02AB01 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Glucocorticoids]; R03BA04 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS: Glucocorticoids]",,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12188035, URL:http://europepmc.org/abstract/MED/12188035|Name:PubMed, SrcID:15866114, URL:http://europepmc.org/abstract/MED/15866114|Name:PubMed, SrcID:15336699, URL:http://europepmc.org/abstract/MED/15336699",C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c5ccccc5)C(=O)CO,CHEMBL2034,NR3C1
2768,CHEMBL34259,Methotrexate,Small molecule,1953.0,L04AX03; L01BA01,L04AX03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Other immunosuppressants]; L01BA01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Folic acid analogues],-trexate,Dihydrofolate reductase inhibitor,,,CHEMBL202,Dihydrofolate reductase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=ec476b11-0b3c-4139-b1eb-a3daa76bc271, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ec476b11-0b3c-4139-b1eb-a3daa76bc271|Name:DailyMed, SrcID:setid=9ab8ce16-f7de-41d4-a4c8-1c742621b6d5, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9ab8ce16-f7de-41d4-a4c8-1c742621b6d5",CN(Cc1cnc2nc(N)nc(N)c2n1)c3ccc(cc3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,CHEMBL202,DHFR
2769,CHEMBL513,Carmustine,Small molecule,1977.0,L01AD01,L01AD01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ALKYLATING AGENTS: Nitrosoureas],-mustine,Glutathione reductase inhibitor,,,CHEMBL2755,Glutathione reductase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15321730, URL:http://europepmc.org/abstract/MED/15321730",ClCCNC(=O)N(CCCl)N=O,CHEMBL2755,GSR
2770,CHEMBL2103875,Trametinib,Small molecule,2013.0,L01XE25,L01XE25 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,,,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/204114s004lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204114s004lbl.pdf|Name:DailyMed, SrcID:setid=aeaf0430-f8ad-4e72-9dbf-1954503c3410#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aeaf0430-f8ad-4e72-9dbf-1954503c3410#nlm34090-1",CN1C(=O)C(=C2N(C(=O)N(C3CC3)C(=O)C2=C1Nc4ccc(I)cc4F)c5cccc(NC(=O)C)c5)C,CHEMBL3587,MAP2K1
2771,CHEMBL17,Dichlorphenamide,Small molecule,1958.0,S01EC02,S01EC02 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Carbonic anhydrase inhibitors],,Carbonic anhydrase IV inhibitor,,,CHEMBL3729,Carbonic anhydrase IV,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18336310, URL:http://europepmc.org/abstract/MED/18336310",NS(=O)(=O)c1cc(Cl)c(Cl)c(c1)S(=O)(=O)N,CHEMBL3729,CA4
2772,CHEMBL20,Acetazolamide,Small molecule,1953.0,S01EC01,S01EC01 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Carbonic anhydrase inhibitors],-zolamide,Carbonic anhydrase IV inhibitor,Expressed in eye,,CHEMBL3729,Carbonic anhydrase IV,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18336310, URL:http://europepmc.org/abstract/MED/18336310",CC(=O)Nc1nnc(s1)S(=O)(=O)N,CHEMBL3729,CA4
2773,CHEMBL1946170,Regorafenib,Small molecule,2012.0,L01XE21,L01XE21 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-rafenib,Discoidin domain-containing receptor 2 inhibitor,,,CHEMBL5122,Discoidin domain-containing receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Expert, SrcID:REGORAFENIB, URL:http://chembl.blogspot.co.uk/search?q=REGORAFENIB",CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,CHEMBL5122,DDR2
2774,CHEMBL1336,Sorafenib,Small molecule,2005.0,L01XE05,L01XE05 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-rafenib,Serine/threonine-protein kinase B-raf inhibitor,,,CHEMBL5145,Serine/threonine-protein kinase B-raf,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2011/021923s012lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf",CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,CHEMBL5145,BRAF
2775,CHEMBL1064,Simvastatin,Small molecule,1991.0,C10AA01,"C10AA01 [CARDIOVASCULAR SYSTEM: LIPID MODIFYING AGENTS: LIPID MODIFYING AGENTS, PLAIN: HMG CoA reductase inhibitors]",-stat-,HMG-CoA reductase inhibitor,,,CHEMBL402,HMG-CoA reductase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=e9e50cdb-4cef-4d03-9fb6-973d0c2bf293, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e9e50cdb-4cef-4d03-9fb6-973d0c2bf293",CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12,CHEMBL402,HMGCR
2776,CHEMBL1201863,Dexlansoprazole,Small molecule,2009.0,A02BC06,A02BC06 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): Proton pump inhibitors],-prazole,Potassium-transporting ATPase inhibitor,,,CHEMBL2095173,Potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,K-ATPase alpha subunit,Alpha subunit is likely binding site,"Name:PubMed, SrcID:14699149, URL:http://europepmc.org/abstract/MED/14699149|Name:PubMed, SrcID:23350044, URL:http://europepmc.org/abstract/MED/23350044|Name:DailyMed, SrcID:setid=d62d754e-2310-4912-b022-603ae925710d#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d62d754e-2310-4912-b022-603ae925710d#nlm34090-1",Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c2nc3ccccc3[nH]2,CHEMBL2095173,ATP4A
2777,CHEMBL1201863,Dexlansoprazole,Small molecule,2009.0,A02BC06,A02BC06 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): Proton pump inhibitors],-prazole,Potassium-transporting ATPase inhibitor,,,CHEMBL2095173,Potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,K-ATPase alpha subunit,Alpha subunit is likely binding site,"Name:PubMed, SrcID:14699149, URL:http://europepmc.org/abstract/MED/14699149|Name:PubMed, SrcID:23350044, URL:http://europepmc.org/abstract/MED/23350044|Name:DailyMed, SrcID:setid=d62d754e-2310-4912-b022-603ae925710d#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d62d754e-2310-4912-b022-603ae925710d#nlm34090-1",Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c2nc3ccccc3[nH]2,CHEMBL2095173,ATP4B
2778,CHEMBL527,Piroxicam,Small molecule,1982.0,M01AC01; M02AA07; S01BC06,"M01AC01 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Oxicams]; M02AA07 [MUSCULO-SKELETAL SYSTEM: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: Antiinflammatory preparations, non-steroids for topical use]; S01BC06 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Antiinflammatory agents, non-steroids]",-icam,Cyclooxygenase inhibitor,,,CHEMBL2094253,Cyclooxygenase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10381057, URL:http://europepmc.org/abstract/MED/10381057|Name:PubMed, SrcID:11153163, URL:http://europepmc.org/abstract/MED/11153163|Name:PubMed, SrcID:11785774, URL:http://europepmc.org/abstract/MED/11785774",CN1C(=C(O)c2ccccc2S1(=O)=O)C(=O)Nc3ccccn3,,
2779,CHEMBL1493,Flavoxate,Small molecule,1970.0,G04BD02,G04BD02 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Drugs for urinary frequency and incontinence],,Phosphodiesterase 7 inhibitor,,,CHEMBL2111411,Phosphodiesterase 7,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:167667, URL:http://europepmc.org/abstract/MED/167667|Name:PubMed, SrcID:6329116, URL:http://europepmc.org/abstract/MED/6329116",CC1=C(Oc2c(cccc2C1=O)C(=O)OCCN3CCCCC3)c4ccccc4,,
2780,CHEMBL1073,Glipizide,Small molecule,1984.0,A10BB07,"A10BB07 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Sulfonylureas]",gli-,"Sulfonylurea receptor 1, Kir6.2 blocker",,,CHEMBL2096972,"Sulfonylurea receptor 1, Kir6.2",BLOCKER,Homo sapiens,PROTEIN COMPLEX,,,"Name:DailyMed, SrcID:setid=07374dc6-a912-45a1-a758-9d0cdca77d5e#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=07374dc6-a912-45a1-a758-9d0cdca77d5e#nlm34090-1|Name:PubMed, SrcID:22260657, URL:http://europepmc.org/abstract/MED/22260657",Cc1cnc(cn1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3,,
2781,CHEMBL1201823,Abatacept,Protein,2006.0,L04AA24,L04AA24 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Selective immunosuppressants],-cept,T-lymphocyte activation antigen CD86 inhibitor,,,CHEMBL2364156,T-lymphocyte activation antigen CD86,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=0836c6ac-ee37-5640-2fed-a3185a0b16eb, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0836c6ac-ee37-5640-2fed-a3185a0b16eb",,CHEMBL2364156,CD86
2782,CHEMBL1668,Rescinnamine,Small molecule,1956.0,C02AA01,"C02AA01 [CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ANTIADRENERGIC AGENTS, CENTRALLY ACTING: Rauwolfia alkaloids]",,Synaptic vesicular amine transporter inhibitor,,,CHEMBL1893,Synaptic vesicular amine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:13699407, URL:http://europepmc.org/abstract/MED/13699407|Name:Wikipedia, SrcID:Reserpine, URL:http://en.wikipedia.org/wiki/Reserpine",CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5cc(OC)ccc45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)\C=C\c6cc(OC)c(OC)c(OC)c6,CHEMBL1893,SLC18A2
2783,CHEMBL222559,Tipranavir,Small molecule,2005.0,J05AE09,J05AE09 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Protease inhibitors],-vir,Human immunodeficiency virus type 1 protease inhibitor,,,CHEMBL243,Human immunodeficiency virus type 1 protease,INHIBITOR,Human immunodeficiency virus 1,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=08982e49-d2eb-4b25-b01a-1be52fd669ef, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=08982e49-d2eb-4b25-b01a-1be52fd669ef",CCC[C@@]1(CCc2ccccc2)CC(=C([C@H](CC)c3cccc(NS(=O)(=O)c4ccc(cn4)C(F)(F)F)c3)C(=O)O1)O,,
2784,CHEMBL1180725,Propantheline,Small molecule,1953.0,A03AB05,"A03AB05 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: Synthetic anticholinergics, quaternary ammonium compounds]",,Muscarinic acetylcholine receptor M2 antagonist,"Indicated for overactive bladder, M2 likely responsible",,CHEMBL211,Muscarinic acetylcholine receptor M2,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:13263156, URL:http://europepmc.org/abstract/MED/13263156|Name:PubMed, SrcID:3762265, URL:http://europepmc.org/abstract/MED/3762265|Name:PubMed, SrcID:16080359, URL:http://europepmc.org/abstract/MED/16080359|Name:PubMed, SrcID:16465186, URL:http://europepmc.org/abstract/MED/16465186|Name:PubMed, SrcID:4381291, URL:http://europepmc.org/abstract/MED/4381291|Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718",CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc3ccccc13)C(C)C,CHEMBL211,CHRM2
2785,CHEMBL497,Clioquinol,Small molecule,1982.0,D08AH30; G01AC02; D09AA10; S02AA05; P01AA02; P01AA52,"D08AH30 [DERMATOLOGICALS: ANTISEPTICS AND DISINFECTANTS: ANTISEPTICS AND DISINFECTANTS: Quinoline derivatives]; G01AC02 [GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Quinoline derivatives]; D09AA10 [DERMATOLOGICALS: MEDICATED DRESSINGS: MEDICATED DRESSINGS: Medicated dressings with antiinfectives]; S02AA05 [SENSORY ORGANS: OTOLOGICALS: ANTIINFECTIVES: Antiinfectives]; P01AA02 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES: Hydroxyquinoline derivatives]; P01AA52 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES: Hydroxyquinoline derivatives]",,Zinc chelating agent,"Used as antibiotic against diarrhea in the 70s, but nowadays considered in cancer treatments (off-label), for its chelator and ionophore properties with capacity to inhibit proteosome",,CHEMBL2363056,Zinc,CHELATING AGENT,,METAL,,,"Name:PubMed, SrcID:21247386, URL:http://europepmc.org/abstract/MED/21247386|Name:PubMed, SrcID:15833873, URL:http://europepmc.org/abstract/MED/15833873",Oc1c(I)cc(Cl)c2cccnc12,,
2786,CHEMBL1191,Sulfamethizole,Small molecule,1953.0,D06BA04; B05CA04; J01EB02; S01AB01,D06BA04 [DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: CHEMOTHERAPEUTICS FOR TOPICAL USE: Sulfonamides]; B05CA04 [BLOOD AND BLOOD FORMING ORGANS: BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS: IRRIGATING SOLUTIONS: Antiinfectives]; J01EB02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: SULFONAMIDES AND TRIMETHOPRIM: Short-acting sulfonamides]; S01AB01 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Sulfonamides],sulfa-,Bacterial dihydropteroate synthase inhibitor,,Broad spectrum,CHEMBL2364668,Bacterial dihydropteroate synthase,INHIBITOR,Bacteria,SINGLE PROTEIN,,,"Name:KEGG, SrcID:D00870, URL:http://www.kegg.jp/dbget-bin/www_bget?dr:D00870|Name:PubMed, SrcID:2372557, URL:http://europepmc.org/abstract/MED/2372557",Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1,,
2787,CHEMBL491571,Doripenem,Small molecule,2007.0,J01DH04,J01DH04 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Carbapenems],-penem,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=ded65c55-db1c-4dab-a707-951e7cc87c79, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ded65c55-db1c-4dab-a707-951e7cc87c79|Name:FDA, SrcID:label/2015/022106s015lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022106s015lbl.pdf",C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(=C(N2C1=O)C(=O)O)S[C@@H]3CN[C@H](CNS(=O)(=O)N)C3,,
2788,CHEMBL1201438,Human Interleukin-2,Protein,1992.0,L03AC01,L03AC01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSTIMULANTS: IMMUNOSTIMULANTS: Interleukins],-kin,Interleukin-2 receptor agonist,,,CHEMBL2364167,Interleukin-2 receptor,AGONIST,Homo sapiens,PROTEIN COMPLEX,Interleukin-2 alpha/beta subunit,Binding site involves alpha and beta subunits,"Name:DailyMed, SrcID:setid=a588140c-f9ed-4a9b-a9a6-bf3daafd8a5a#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a588140c-f9ed-4a9b-a9a6-bf3daafd8a5a#nlm34090-1",,CHEMBL2364167,IL2RG
2789,CHEMBL1200558,Bacitracin,Protein,1948.0,R02AB04; D06AX05; J01XX10,R02AB04 [RESPIRATORY SYSTEM: THROAT PREPARATIONS: THROAT PREPARATIONS: Antibiotics]; D06AX05 [DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: ANTIBIOTICS FOR TOPICAL USE: Other antibiotics for topical use]; J01XX10 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER ANTIBACTERIALS: Other antibacterials],,C55-isoprenyl pyrophosphate inhibitor,,,CHEMBL2364036,C55-isoprenyl pyrophosphate,INHIBITOR,Bacteria,SMALL MOLECULE,,,"Name:PubMed, SrcID:4332017, URL:http://europepmc.org/abstract/MED/4332017",CC[C@H](C)[C@H](N)C1=N[C@@H](CS1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(=O)N)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc4ccccc4)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC,,
2790,CHEMBL1201506,Gemtuzumab Ozogamicin,Antibody,2000.0,L01XC05,L01XC05 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,DNA inhibitor,intercalates DNA and causes double strand breakage,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=32fd2bb2-1cfa-4250-feb8-d7956c794e05, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=32fd2bb2-1cfa-4250-feb8-d7956c794e05|Name:FDA, SrcID:label/2006/021174s020lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021174s020lbl.pdf",,,
2791,CHEMBL487253,Bendamustine,Small molecule,2008.0,L01AA09,L01AA09 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ALKYLATING AGENTS: Nitrogen mustard analogues],-mustine,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:FDA, SrcID:label/2012/022249s012lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022249s012lbl.pdf",Cn1c(CCCC(=O)O)nc2cc(ccc12)N(CCCl)CCCl,,
2792,CHEMBL888,Gemcitabine,Small molecule,1996.0,L01BC05,L01BC05 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Pyrimidine analogues],-citabine,DNA polymerase (alpha/delta/epsilon) inhibitor,,,CHEMBL2363042,DNA polymerase (alpha/delta/epsilon),INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=a625c92b-c569-4b98-8d2e-2b3f5e12b34f#section-12, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a625c92b-c569-4b98-8d2e-2b3f5e12b34f#section-12",NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)C2(F)F,CHEMBL2363042,POLE
2793,CHEMBL1201242,Indecainide,Small molecule,1989.0,,,,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:2688391, URL:http://europepmc.org/abstract/MED/2688391|Name:PubMed, SrcID:2225716, URL:http://europepmc.org/abstract/MED/2225716|Name:Wikipedia, SrcID:Sodium_channel, URL:http://en.wikipedia.org/wiki/Sodium_channel|Name:Wikipedia, SrcID:Sodium_channel_blocker, URL:http://en.wikipedia.org/wiki/Sodium_channel_blocker",CC(C)NCCCC1(C(=O)N)c2ccccc2c3ccccc13,,
2794,CHEMBL2219640,Strontium Chloride,Small molecule,1993.0,,,,Unknown,,,,,,,,,,"Name:DailyMed, SrcID:setid=7b74f590-e698-02da-9878-5dc80902dbb4, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7b74f590-e698-02da-9878-5dc80902dbb4",[Cl-].[Cl-].[Sr+2],,
2795,CHEMBL3039583,Pasireotide,Protein,2012.0,H01CB05,"H01CB05 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: HYPOTHALAMIC HORMONES: Somatostatin and analogues]",-tide,Somatostatin receptor 3 agonist,,,CHEMBL2028,Somatostatin receptor 3,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=5504116c-d531-4d47-b160-41c6671d52aa, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5504116c-d531-4d47-b160-41c6671d52aa|Name:PubMed, SrcID:22397653, URL:http://europepmc.org/abstract/MED/22397653|Name:DailyMed, SrcID:setid=442f0d9d-5c7d-4b81-b329-d71be8cf2be2, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=442f0d9d-5c7d-4b81-b329-d71be8cf2be2|Name:PubMed, SrcID:11980628, URL:http://europepmc.org/abstract/MED/11980628",NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](NC(=O)[C@@H]4C[C@@H](CN4C(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](Cc6ccc(OCc7ccccc7)cc6)NC1=O)OC(=O)NCCN)c8ccccc8,CHEMBL2028,SSTR3
2796,CHEMBL52885,Enmd-981693,Small molecule,,,,,Vascular endothelial growth factor receptor 2 inhibitor,,,CHEMBL279,Vascular endothelial growth factor receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf, URL:http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf",Cn1cc(C2=C(C(=O)NC2=O)c3cn(C)c4cc(ccc34)[N+](=O)[O-])c5ccccc15,CHEMBL279,KDR
2797,CHEMBL3545420,Ag-24322,Small molecule,,,,,Cyclin-dependent kinase 4 inhibitor,,,CHEMBL331,Cyclin-dependent kinase 4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://cancerres.aacrjournals.org/content/65/9_Supplement/1045.2, URL:http://cancerres.aacrjournals.org/content/65/9_Supplement/1045.2|Name:PubMed, SrcID:18509643, URL:http://europepmc.org/abstract/MED/18509643",CCNCc1cncc(c1C)c2ccc3NN\C(=C\4/N=C5C=C(F)C=C(F)C5=N4)\c3c2,CHEMBL331,CDK4
2798,CHEMBL3545421,Arq-087,Small molecule,,,,,Fibroblast growth factor receptor inhibitor,,,CHEMBL2095217,Fibroblast growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://meetinglibrary.asco.org/content/149025-156, URL:http://meetinglibrary.asco.org/content/149025-156|Name:Other, SrcID:http://www.arqule.com/res/pip/, URL:http://www.arqule.com/res/pip/",,,
2799,CHEMBL3545359,Arry-300,Small molecule,,,,,Hepatocyte growth factor receptor inhibitor,,,CHEMBL3717,Hepatocyte growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24434059, URL:http://europepmc.org/abstract/MED/24434059",,CHEMBL3717,MET
2800,CHEMBL1236962,Omipalisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:24900173, URL:http://europepmc.org/abstract/MED/24900173|Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718",COc1ncc(cc1NS(=O)(=O)c2ccc(F)cc2F)c3ccc4nccc(c5ccnnc5)c4c3,CHEMBL3559703,PIK3R2
2801,CHEMBL1236962,Omipalisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:24900173, URL:http://europepmc.org/abstract/MED/24900173|Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718",COc1ncc(cc1NS(=O)(=O)c2ccc(F)cc2F)c3ccc4nccc(c5ccnnc5)c4c3,CHEMBL3559703,PIK3R3
2802,CHEMBL1236962,Omipalisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:24900173, URL:http://europepmc.org/abstract/MED/24900173|Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718",COc1ncc(cc1NS(=O)(=O)c2ccc(F)cc2F)c3ccc4nccc(c5ccnnc5)c4c3,CHEMBL3559703,PIK3R5
2803,CHEMBL1614766,Ro-4987655,Small molecule,,,,,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,,,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19934286, URL:http://europepmc.org/abstract/MED/19934286|Name:PubMed, SrcID:23587417, URL:http://europepmc.org/abstract/MED/23587417|Name:Other, SrcID:http://cancerres.aacrjournals.org/content/69/9_Supplement/3701.abstract, URL:http://cancerres.aacrjournals.org/content/69/9_Supplement/3701.abstract",OCCONC(=O)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc3ccc(I)cc3F,CHEMBL2964,MAP2K2
2804,CHEMBL190333,Rwj-67657,Small molecule,,,,,MAP kinase p38 alpha inhibitor,,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10525088, URL:http://europepmc.org/abstract/MED/10525088",OCCC#Cc1nc(c2ccc(F)cc2)c(c3ccncc3)n1CCCc4ccccc4,CHEMBL260,MAPK14
2805,CHEMBL3545268,Mln3126,Small molecule,,,,,C-C chemokine receptor type 9 antagonist,,,CHEMBL5815,C-C chemokine receptor type 9,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://www.takeda.com/research/files/pipeline_20150205_en.pdf, URL:https://www.takeda.com/research/files/pipeline_20150205_en.pdf",,CHEMBL5815,CCR9
2806,CHEMBL3545270,Ly2969822,Small molecule,,,,,Metabotropic glutamate receptor 3 agonist,"From poster: orally bioavailable prodrug for a potent, selective mGlu2/3 receptor agonist, have no more information.",,CHEMBL2888,Metabotropic glutamate receptor 3,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.mglu.it/doc/poster-session-2014.pdf, URL:http://www.mglu.it/doc/poster-session-2014.pdf",,CHEMBL2888,GRM3
2807,CHEMBL3545277,Oms405,Small molecule,,,,,Peroxisome proliferator-activated receptor gamma agonist,,,CHEMBL235,Peroxisome proliferator-activated receptor gamma,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.omeros.com/pipeline/pipeline.htm, URL:http://www.omeros.com/pipeline/pipeline.htm",,CHEMBL235,PPARG
2808,CHEMBL2105107,Inecalcitol,Small molecule,,,,-calci-,Vitamin D receptor agonist,orphan designation by EU January 2014,,CHEMBL1977,Vitamin D receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.hybrigenics.com/contents/pharma-1/inecalcitol-1, URL:http://www.hybrigenics.com/contents/pharma-1/inecalcitol-1|Name:Other, SrcID:http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/orphans/2014/03/human_orphan_001303.jsp&mid=WC0b01ac058001d12b, URL:http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/orphans/2014/03/human_orphan_001303.jsp&mid=WC0b01ac058001d12b",C[C@H](CC#CC(C)(C)O)[C@H]1CC[C@@H]2\C(=C\C=C3C[C@@H](O)C[C@H](O)C3)\CCC[C@]12C,CHEMBL1977,VDR
2809,CHEMBL2138601,Refametinib,Small molecule,,,,-tinib,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,Allosteric inhibitor,,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19706763, URL:http://europepmc.org/abstract/MED/19706763",COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1N[S+](=O)([O-])C3(CC(O)CO)CC3,CHEMBL3587,MAP2K1
2810,CHEMBL3545396,Bms-690514,Small molecule,,,,,Vascular endothelial growth factor receptor inhibitor,,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:24130056, URL:http://europepmc.org/abstract/MED/24130056|Name:PubMed, SrcID:21531814, URL:http://europepmc.org/abstract/MED/21531814",COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1,,
2811,CHEMBL1230609,Foretinib,Small molecule,,,,-tinib,Vascular endothelial growth factor receptor inhibitor,,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://www.exelixis.com/pipeline/xl880, URL:http://www.exelixis.com/pipeline/xl880|Name:PubMed, SrcID:19808973, URL:http://europepmc.org/abstract/MED/19808973",COc1cc2c(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc5ccc(F)cc5)cc3F)ccnc2cc1OCCCN6CCOCC6,,
2812,CHEMBL1079175,Mk-2206,Small molecule,,,,,Serine/threonine-protein kinase AKT inhibitor,Allosteric AKT inhibitor.,,CHEMBL2111353,Serine/threonine-protein kinase AKT,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://cancerres.aacrjournals.org/content/69/9_Supplement/DDT01-1.abstract, URL:http://cancerres.aacrjournals.org/content/69/9_Supplement/DDT01-1.abstract|Name:PubMed, SrcID:20571069, URL:http://europepmc.org/abstract/MED/20571069",NC1(CCC1)c2ccc(cc2)c3nc4C=CN5C(=O)NN=C5c4cc3c6ccccc6,,
2813,CHEMBL3545158,Plx-3397,Small molecule,,,,,Tyrosine-protein kinase receptor FLT3 inhibitor,,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22039576, URL:http://europepmc.org/abstract/MED/22039576",,CHEMBL1974,FLT3
2814,CHEMBL3545026,Famitinib,Small molecule,,,,-tinib,Stem cell growth factor receptor inhibitor,Multi-targeted receptor tyrosine kinase inhibitor,,CHEMBL1936,Stem cell growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1158/1538-7445.AM2011-3604, URL:http://cancerres.aacrjournals.org/content/71/8_Supplement/3604|Name:ClinicalTrials, SrcID:NCT02390947, URL:https://www.clinicaltrials.gov/ct2/show/NCT02390947|Name:PubMed, SrcID:24043137, URL:http://europepmc.org/abstract/MED/24043137",,CHEMBL1936,KIT
2815,CHEMBL403989,Tg100-801,Small molecule,,,,,Ephrin type-B receptor 4 inhibitor,Prodrug - active metabolite is TG-100-572 (HY-10184),,CHEMBL5147,Ephrin type-B receptor 4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18483622, URL:http://europepmc.org/abstract/MED/18483622",Cc1cc(cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12)c5cc(OC(=O)c6ccccc6)ccc5Cl,CHEMBL5147,EPHB4
2816,CHEMBL1852688,Infigratinib,Small molecule,,,,-tinib,Fibroblast growth factor receptor inhibitor,,,CHEMBL2095217,Fibroblast growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://www.novartisoncology.com/ct/pipelineDetails?compound=BGJ398&diseaseAcr=GBM, URL:http://www.novartisoncology.com/ct/pipelineDetails?compound=BGJ398&diseaseAcr=GBM|Name:PubMed, SrcID:21936542, URL:http://europepmc.org/abstract/MED/21936542",CCN1CCN(CC1)c2ccc(Nc3cc(ncn3)N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)cc2,,
2817,CHEMBL2104986,Tedatioxetine,Small molecule,,,,-oxetine,Alpha-1a adrenergic receptor antagonist,,,CHEMBL229,Alpha-1a adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://www.google.com/patents/US20100144788, URL:https://www.google.com/patents/US20100144788|Name:Other, SrcID:http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false, URL:http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false|Name:Wikipedia, SrcID:Tedatioxetine, URL:http://en.wikipedia.org/wiki/Tedatioxetine",Cc1ccc(Sc2ccccc2C3CCNCC3)cc1,CHEMBL229,ADRA1A
2818,CHEMBL476323,Mk-0249,Small molecule,,,,,Histamine H3 receptor inverse agonist,,,CHEMBL264,Histamine H3 receptor,INVERSE AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20981000, URL:http://europepmc.org/abstract/MED/20981000|Name:PubMed, SrcID:24263088, URL:http://europepmc.org/abstract/MED/24263088",CC1=Nc2cccc(c2C(=O)N1c3ccc(OCCCN4CCCC4)cc3)C(F)(F)F,CHEMBL264,HRH3
2819,CHEMBL2178570,Azd4818,Small molecule,,,,,C-C chemokine receptor type 1 antagonist,,,CHEMBL2413,C-C chemokine receptor type 1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20466530, URL:http://europepmc.org/abstract/MED/20466530",CC(=O)Nc1ccc(O)cc1OC[C@@](C)(O)CNC2CCN(Cc3ccc(Cl)cc3)CC2,CHEMBL2413,CCR1
2820,CHEMBL3545108,Azd9056,Small molecule,,,,,P2X purinoceptor 7 antagonist,Compound is listed in AstaZeneca's clinical and/or preclinical compound bank and available for research projects (http://openinnovation.astrazeneca.com/what-we-offer/compound/azd9056/).,,CHEMBL4805,P2X purinoceptor 7,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.ncats.nih.gov/files/AZD9056.pdf, URL:http://www.ncats.nih.gov/files/AZD9056.pdf|Name:Other, SrcID:http://openinnovation.astrazeneca.com/what-we-offer/compound/azd9056/, URL:http://openinnovation.astrazeneca.com/what-we-offer/compound/azd9056/|Name:PubMed, SrcID:24859298, URL:http://europepmc.org/abstract/MED/24859298",OCCCNCCCc1ccc(Cl)c(c1)C(=O)NCC23CC4CC(CC(C4)C2)C3,CHEMBL4805,P2RX7
2821,CHEMBL127071,Pozanicline,Small molecule,,,,-nicline,Nicotinic acetylcholine receptor alpha4/beta2/alpha5 partial agonist,,,CHEMBL3038461,Nicotinic acetylcholine receptor alpha4/beta2/alpha5,PARTIAL AGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:19481067, URL:http://europepmc.org/abstract/MED/19481067|Name:PubMed, SrcID:9336329, URL:http://europepmc.org/abstract/MED/9336329|Name:Wikipedia, SrcID:Pozanicline, URL:https://en.wikipedia.org/wiki/Pozanicline",Cc1ncccc1OC[C@@H]2CCCN2,,
2822,CHEMBL41306,Cns-5161,Small molecule,,,,,Glutamate [NMDA] receptor blocker,Being developed as PET scan ligand.,,CHEMBL2094124,Glutamate [NMDA] receptor,BLOCKER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:12829411, URL:http://europepmc.org/abstract/MED/12829411",CSc1ccc(Cl)c(NC(=N)N(C)c2cccc(SC)c2)c1,CHEMBL2094124,GRIN3B
2823,CHEMBL2103991,Balaglitazone,Small molecule,,,,-glitazone,Peroxisome proliferator-activated receptor gamma partial agonist,Discontinueddue to safety concerns,,CHEMBL235,Peroxisome proliferator-activated receptor gamma,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22404217, URL:http://europepmc.org/abstract/MED/22404217",CN1C(=Nc2ccccc2C1=O)COc3ccc(CC4SC(=O)NC4=O)cc3,CHEMBL235,PPARG
2824,CHEMBL608533,Midostaurin,Small molecule,,L01XE39,L01XE39 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],,Tyrosine-protein kinase receptor FLT3 inhibitor,Multi-kinase inhibitor,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16969355, URL:http://europepmc.org/abstract/MED/16969355|Name:PubMed, SrcID:12124173, URL:http://europepmc.org/abstract/MED/12124173",CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)n3c4ccccc4c5c6CNC(=O)c6c7c8ccccc8n2c7c35)N(C)C(=O)c9ccccc9,CHEMBL1974,FLT3
2825,CHEMBL2111101,Pimavanserin,Small molecule,2016.0,N05AX17,N05AX17 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Other antipsychotics],-anserin,Serotonin 2a (5-HT2a) receptor inverse agonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,INVERSE AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.acadia-pharm.com/pipeline/nuplazid-pdp/, URL:http://www.acadia-pharm.com/pipeline/nuplazid-pdp/|Name:PubMed, SrcID:16469866, URL:http://europepmc.org/abstract/MED/16469866|Name:PubMed, SrcID:7806373, URL:http://europepmc.org/abstract/MED/7806373|Name:Wikipedia, SrcID:Pimavanserin, URL:http://en.wikipedia.org/wiki/Pimavanserin",CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C3CCN(C)CC3)cc1,CHEMBL224,HTR2A
2826,CHEMBL2107771,Ralfinamide,Small molecule,,,,,Glutamate [NMDA] receptor antagonist,,,CHEMBL2094124,Glutamate [NMDA] receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:18583049, URL:http://europepmc.org/abstract/MED/18583049|Name:Other, SrcID:http://www.newron.com/ENG/Default.aspx?SEZ=3&PAG=40, URL:http://www.newron.com/ENG/Default.aspx?SEZ=3&PAG=40",C[C@H](NCc1ccc(OCc2ccccc2F)cc1)C(=O)N,CHEMBL2094124,GRIN3B
2827,CHEMBL1743072,Solanezumab,Antibody,,,,-mab,Beta amyloid A4 protein other,Targets the mid-region of the neurotoxic Amyloid ß peptide after it is produced. Neutralises disease-relevant aggregated forms of amyloid-beta. Amyloid ß is an early biomarker of Alzheimer's disease pathology and the major component of plaques found in AD-affected brain.,,CHEMBL2487,Beta amyloid A4 protein,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25880481, URL:http://europepmc.org/abstract/MED/25880481",,CHEMBL2487,APP
2828,CHEMBL2108576,Bapineuzumab,Antibody,,,,-mab,Beta amyloid A4 protein other,Targets N-terminus of amyloid beta. Induces Fc receptor mediated fagocytosis of amyloid-beta peptide.,,CHEMBL2487,Beta amyloid A4 protein,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10932230, URL:http://europepmc.org/abstract/MED/10932230",,CHEMBL2487,APP
2829,CHEMBL2108811,Visilizumab,Antibody,,,,-mab,T-cell surface glycoprotein CD3 epsilon chain inhibitor,Non–FcR-binding anti-CD3 monoclonal antibody (mAb) directed against the invariant CD3e chain of the TCR.,,CHEMBL1975,T-cell surface glycoprotein CD3 epsilon chain,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11349730, URL:http://europepmc.org/abstract/MED/11349730",,CHEMBL1975,CD3E
2830,CHEMBL2107884,Reslizumab,Antibody,2016.0,R03DX08,R03DX08 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: Other systemic drugs for obstructive airway diseases],-mab,Interleukin-5 inhibitor,,,CHEMBL1169600,Interleukin-5,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2016/761033lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761033lbl.pdf",,CHEMBL1169600,IL5
2831,CHEMBL2107842,Albinterferon Alfa-2b,Protein,,L03AB12,L03AB12 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSTIMULANTS: IMMUNOSTIMULANTS: Interferons],,Interferon alpha/beta receptor agonist,,,CHEMBL2364170,Interferon alpha/beta receptor,AGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:17573950, URL:http://europepmc.org/abstract/MED/17573950|Name:PubMed, SrcID:18666223, URL:http://europepmc.org/abstract/MED/18666223",,CHEMBL2364170,IFNAR2
2832,CHEMBL2107870,Pegnivacogin,Oligonucleotide,,,,peg-,Coagulation factor IX inhibitor,"Blocks the factor VIIIa/IXa–catalyzed conversion of factor X to factor Xa. Itas antidote. B007, is an oligonucleotide complementary to a portion of RB006 that binds effectively to RB006, thereby neutralizing its anti–factor IXa activity.",,CHEMBL2016,Coagulation factor IX,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17101847, URL:http://europepmc.org/abstract/MED/17101847",,CHEMBL2016,F9
2833,CHEMBL1743022,Fresolimumab,Antibody,,,,-mab,Transforming growth factor beta-3 inhibitor,,,CHEMBL3712903,Transforming growth factor beta-3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21368745, URL:http://europepmc.org/abstract/MED/21368745",,CHEMBL3712903,TGFB3
2834,CHEMBL2109224,Rovelizumab,Antibody,,,,-mab,Integrin alpha-M/beta-2 antagonist,Inhibits the leukocyte’s ability to adhere to the endothelial cell and transmigrate across the endothelial cell layer.,,CHEMBL2111362,Integrin alpha-M/beta-2,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:9784282, URL:http://europepmc.org/abstract/MED/9784282|Name:PubMed, SrcID:16100700, URL:http://europepmc.org/abstract/MED/16100700",,,
2835,CHEMBL2109487,Rg-1512,Antibody,,,,,P-selectin inhibitor,,,CHEMBL5378,P-selectin,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25714598, URL:http://europepmc.org/abstract/MED/25714598",,,
2836,CHEMBL1743014,Etaracizumab,Antibody,,,,-mab,Integrin alpha-V/beta-3 antagonist,,,CHEMBL1907598,Integrin alpha-V/beta-3,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX,,,,,,
2837,CHEMBL3137327,Omega-3-Carboxylic Acids,Small molecule,2014.0,,,,Unknown,,,,,,,,,,,CCCCC\C=C/C\C=C/CCCCCCCC(=O)O.CCCCC\C=C/C\C=C/C\C=C/CCCCC(=O)O.CCCCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(=O)O.CC\C=C/C\C=C/C\C=C/CCCCCCCC(=O)O.CC\C=C/C\C=C/C\C=C/C\C=C/CCCCCCC(=O)O.CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(=O)O.CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCC(=O)O.CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)O.CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(=O)O,,
2838,CHEMBL3545084,Tcd-717,Small molecule,,,,,Choline kinase alpha inhibitor,,,CHEMBL3117,Choline kinase alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,,,CHEMBL3117,CHKA
2839,CHEMBL19,Methazolamide,Small molecule,1959.0,S01EC05,S01EC05 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Carbonic anhydrase inhibitors],-zolamide,Carbonic anhydrase VII inhibitor,,,CHEMBL2326,Carbonic anhydrase VII,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18336310, URL:http://europepmc.org/abstract/MED/18336310|Name:DailyMed, SrcID:setid=8e162b6d-8fa6-45f6-80d8-5132d94c1207, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e162b6d-8fa6-45f6-80d8-5132d94c1207",CN1N=C(S/C/1=N/C(=O)C)S(=O)(=O)N,CHEMBL2326,CA7
2840,CHEMBL175247,Orlistat,Small molecule,1999.0,A08AB01,"A08AB01 [ALIMENTARY TRACT AND METABOLISM: ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS: ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS: Peripherally acting antiobesity products]",-stat,Pancreatic lipase inhibitor,,,CHEMBL1812,Pancreatic lipase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=5bbdc95b-82a1-4ba5-8185-6504ff68cc06#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5bbdc95b-82a1-4ba5-8185-6504ff68cc06#nlm34090-1",CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,CHEMBL1812,PNLIP
2841,CHEMBL534,Ketotifen,Small molecule,1999.0,R06AX17; S01GX08,R06AX17 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Other antihistamines for systemic use]; S01GX08 [SENSORY ORGANS: OPHTHALMOLOGICALS: DECONGESTANTS AND ANTIALLERGICS: Other antiallergics],,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 332, URL:http://www.isbnsearch.org/isbn/9780702034718",CN1CCC(=C2c3ccccc3CC(=O)c4sccc24)CC1,CHEMBL231,HRH1
2842,CHEMBL1200406,Dimenhydrinate,Small molecule,1972.0,,,,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11835984, URL:http://europepmc.org/abstract/MED/11835984",CN(C)CCOC(c1ccccc1)c2ccccc2.CN3C(=O)N(C)c4nc(Cl)[nH]c4C3=O,CHEMBL231,HRH1
2843,CHEMBL1201831,Certolizumab Pegol,Antibody,2008.0,L04AB05,L04AB05 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Tumor necrosis factor alpha (TNF-&alpha;) inhibitors],-mab,TNF-alpha inhibitor,,,CHEMBL1825,TNF-alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=b4c2c9dc-a0bb-4d64-a667-a67ebe88392d, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b4c2c9dc-a0bb-4d64-a667-a67ebe88392d",,CHEMBL1825,TNF
2844,CHEMBL2364968,Ergoloid,Small molecule,1953.0,,,,Serotonin 1b (5-HT1b) receptor agonist,,,CHEMBL1898,Serotonin 1b (5-HT1b) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:2869188, URL:http://europepmc.org/abstract/MED/2869188|Name:ISBN, SrcID:0443-059748 PP.167, URL:http://www.isbnsearch.org/isbn/0443059748",CCC(C)[C@@H]1N2C(=O)[C@](NC(=O)[C@@H]3C[C@H]4[C@@H](Cc5c[nH]c6cccc4c56)N(C)C3)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C.CC(C)C[C@@H]8N9C(=O)[C@](NC(=O)[C@@H]%10C[C@H]%11[C@@H](Cc%12c[nH]c%13cccc%11c%12%13)N(C)C%10)(O[C@@]9(O)[C@@H]%14CCCN%14C8=O)C(C)C.CC(C)[C@@H]%15N%16C(=O)[C@](NC(=O)[C@@H]%17C[C@H]%18[C@@H](Cc%19c[nH]c%20cccc%18c%19%20)N(C)C%17)(O[C@@]%16(O)[C@@H]%21CCCN%21C%15=O)C(C)C.CC(C)[C@@]%22(NC(=O)[C@@H]%23C[C@H]%24[C@@H](Cc%25c[nH]c%26cccc%24c%25%26)N(C)C%23)O[C@@]%27(O)[C@@H]%28CCCN%28C(=O)[C@H](Cc%29ccccc%29)N%27C%22=O,CHEMBL1898,HTR1B
2845,CHEMBL814,Fluvoxamine,Small molecule,1994.0,N06AB08,N06AB08 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Selective serotonin reuptake inhibitors],,Serotonin transporter inhibitor,reuptake inhibitor,,CHEMBL228,Serotonin transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2012/021519s003lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021519s003lbl.pdf|Name:Wikipedia, SrcID:Fluvoxamine, URL:http://en.wikipedia.org/wiki/Fluvoxamine",COCCCC\C(=N/OCCN)\c1ccc(cc1)C(F)(F)F,CHEMBL228,SLC6A4
2846,CHEMBL747,Cycloguanil,Small molecule,,,,,Dihydrofolate reductase inhibitor,,,CHEMBL1939,Dihydrofolate reductase,INHIBITOR,Plasmodium falciparum K1,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10348748, URL:http://europepmc.org/abstract/MED/10348748|Name:Wikipedia, SrcID:Cycloguanil, URL:http://en.wikipedia.org/wiki/Cycloguanil",CC1(C)N=C(N)N=C(N)N1c2ccc(Cl)cc2,,
2847,CHEMBL1621,Paliperidone,Small molecule,2006.0,N05AX13,N05AX13 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Other antipsychotics],-peridone,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=7b8e5b26-b9e4-4704-921b-3c3c0d159916#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7b8e5b26-b9e4-4704-921b-3c3c0d159916#nlm34090-1|Name:FDA, SrcID:label/2011/022264s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022264s006lbl.pdf",CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCC(O)C5=N1,CHEMBL224,HTR2A
2848,CHEMBL398707,Hydromorphone,Small molecule,1984.0,N02AA03,N02AA03 [NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Natural opium alkaloids],,Mu opioid receptor agonist,,,CHEMBL233,Mu opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=c88f81ac-1643-4c08-ae2c-63cbe956db7e#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c88f81ac-1643-4c08-ae2c-63cbe956db7e#nlm34090-1",CN1CC[C@@]23[C@H]4CCC(=O)[C@@H]2Oc5c(O)ccc(C[C@@H]14)c35,CHEMBL233,OPRM1
2849,CHEMBL1200877,Flumethasone Pivalate,Small molecule,1982.0,D07AB03; D07XB01,"D07AB03 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, moderately potent (group II)]; D07XB01 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, OTHER COMBINATIONS: Corticosteroids, moderately potent, other combinations]",,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:3212030, URL:http://europepmc.org/abstract/MED/3212030|Name:ISBN, SrcID:9780702034718 PP. 402, URL:http://www.isbnsearch.org/isbn/9780702034718",C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C(C)(C)C,CHEMBL2034,NR3C1
2850,CHEMBL1200975,Clocortolone Pivalate,Small molecule,1977.0,D07AB21,"D07AB21 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, moderately potent (group II)]",-olone,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Topical_steroid, URL:http://en.wikipedia.org/wiki/Topical_steroid|Name:FDA, SrcID:label/2003/17765scp024_cloderm_lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/17765scp024_cloderm_lbl.pdf|Name:DailyMed, SrcID:setid=1b20b467-1b29-45de-b00e-4228812444f6#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1b20b467-1b29-45de-b00e-4228812444f6#nlm34090-1",C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C,CHEMBL2034,NR3C1
2851,CHEMBL223228,Efavirenz,Small molecule,1998.0,J05AG03,J05AG03 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Non-nucleoside reverse transcriptase inhibitors],-vir-,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,,,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,INHIBITOR,Human immunodeficiency virus 1,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=32d6371e-ba56-4294-b732-6d43627c5c47, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=32d6371e-ba56-4294-b732-6d43627c5c47",FC(F)(F)[C@]1(OC(=O)Nc2ccc(Cl)cc12)C#CC3CC3,,
2852,CHEMBL240597,Chenodiol,Small molecule,1983.0,A05AA01,A05AA01 [ALIMENTARY TRACT AND METABOLISM: BILE AND LIVER THERAPY: BILE THERAPY: Bile acid preparations],,Bile acid receptor FXR agonist,,,CHEMBL2047,Bile acid receptor FXR,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21596890, URL:http://europepmc.org/abstract/MED/21596890|Name:DailyMed, SrcID:setid=b8b4539b-31d1-40cb-b284-86cf8b16522a#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b8b4539b-31d1-40cb-b284-86cf8b16522a#nlm34090-1",C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,CHEMBL2047,NR1H4
2853,CHEMBL1194666,Diethylpropion,Small molecule,1959.0,A08AA03,"A08AA03 [ALIMENTARY TRACT AND METABOLISM: ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS: ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS: Centrally acting antiobesity products]",,Norepinephrine transporter inhibitor,,,CHEMBL222,Norepinephrine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16767304, URL:http://europepmc.org/abstract/MED/16767304|Name:DailyMed, SrcID:setid=ba26f274-f385-49be-aef1-7041d146b9f7#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ba26f274-f385-49be-aef1-7041d146b9f7#nlm34090-1|Name:PubMed, SrcID:21197148, URL:http://europepmc.org/abstract/MED/21197148|Name:ISBN, SrcID:0443-059748 PP. 406, URL:http://www.isbnsearch.org/isbn/0443059748",CCN(CC)C(C)C(=O)c1ccccc1,CHEMBL222,SLC6A2
2854,CHEMBL1789941,Ruxolitinib,Small molecule,2011.0,L01XE18,L01XE18 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Tyrosine-protein kinase JAK1 inhibitor,,,CHEMBL2835,Tyrosine-protein kinase JAK1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2012/202192s001lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202192s001lbl.pdf",N#CC[C@H](C1CCCC1)n2cc(cn2)c3ncnc4[nH]ccc34,CHEMBL2835,JAK1
2855,CHEMBL416956,Mefloquine,Small molecule,1989.0,P01BC02,"P01BC02 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: ANTIMALARIALS: Methanolquinolines]",,Ferriprotoporphyrin IX inhibitor,,,CHEMBL613897,Ferriprotoporphyrin IX,INHIBITOR,Plasmodium falciparum,SMALL MOLECULE,,,"Name:PubMed, SrcID:14967191, URL:http://europepmc.org/abstract/MED/14967191",OC(C1CCCCN1)c2cc(nc3c(cccc23)C(F)(F)F)C(F)(F)F,,
2856,CHEMBL723,Carvedilol,Small molecule,1995.0,C07AG02,C07AG02 [CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Alpha and beta blocking agents],-dil-,Adrenergic receptor beta antagonist,,,CHEMBL2094118,Adrenergic receptor beta,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2011/020297s036lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020297s036lbl.pdf|Name:DailyMed, SrcID:setid=0b802a9c-332f-4ea8-bb34-75c677264654, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0b802a9c-332f-4ea8-bb34-75c677264654",COc1ccccc1OCCNCC(O)COc2cccc3[nH]c4ccccc4c23,,
2857,CHEMBL220492,Topiramate,Small molecule,1996.0,N03AX11,N03AX11 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],,Glutamate receptor ionotropic kainate antagonist,,,CHEMBL2109241,Glutamate receptor ionotropic kainate,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=21628112-0c47-11df-95b3-498d55d89593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=21628112-0c47-11df-95b3-498d55d89593#nlm34090-1|Name:PubMed, SrcID:10768292, URL:http://europepmc.org/abstract/MED/10768292",CC1(C)O[C@@H]2CO[C@@]3(COS(=O)(=O)N)OC(C)(C)O[C@H]3[C@@H]2O1,CHEMBL2109241,GRIK4
2858,CHEMBL611,Terazosin,Small molecule,1987.0,G04CA03,G04CA03 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY: Alpha-adrenoreceptor antagonists],-azosin,Adrenergic receptor alpha-1 antagonist,,,CHEMBL2094251,Adrenergic receptor alpha-1,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=2795c42c-8aad-41bd-f386-f075505d4e8b#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2795c42c-8aad-41bd-f386-f075505d4e8b#nlm34090-1",COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4,,
2859,CHEMBL559,Dextrothyroxine,Small molecule,1967.0,C10AX01,"C10AX01 [CARDIOVASCULAR SYSTEM: LIPID MODIFYING AGENTS: LIPID MODIFYING AGENTS, PLAIN: Other lipid modifying agents]",,Thyroid hormone receptor agonist,,,CHEMBL2111462,Thyroid hormone receptor,AGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:9440092, URL:http://europepmc.org/abstract/MED/9440092|Name:ISBN, SrcID:9780702034718 PP. 412, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:20935564, URL:http://europepmc.org/abstract/MED/20935564",N[C@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O,,
2860,CHEMBL1624,Levothyroxine,Small molecule,2000.0,,,,Thyroid hormone receptor agonist,,,CHEMBL2111462,Thyroid hormone receptor,AGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:DailyMed, SrcID:setid=f8aba2df-9771-4f53-b7db-0a05d41f0012#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f8aba2df-9771-4f53-b7db-0a05d41f0012#nlm34090-1|Name:FDA, SrcID:label/2011/021402s020lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021402s020lbl.pdf|Name:Wikipedia, SrcID:Thyroid_hormone, URL:http://en.wikipedia.org/wiki/Thyroid_hormone|Name:Wikipedia, SrcID:Thyroid_hormone_receptor, URL:http://en.wikipedia.org/wiki/Thyroid_hormone_receptor",N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O,,
2861,CHEMBL1094966,Pirbuterol,Small molecule,1986.0,R03AC08; R03CC07,"R03AC08 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS, INHALANTS: Selective beta-2-adrenoreceptor agonists]; R03CC07 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS FOR SYSTEMIC USE: Selective beta-2-adrenoreceptor agonists]",-terol,Beta-2 adrenergic receptor agonist,,,CHEMBL210,Beta-2 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2001/19009s6lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/19009s6lbl.pdf|Name:DailyMed, SrcID:setid=fbe6d514-9d89-48f7-80a0-d1b41983f203#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fbe6d514-9d89-48f7-80a0-d1b41983f203#nlm34090-1",CC(C)(C)NCC(O)c1ccc(O)c(CO)n1,CHEMBL210,ADRB2
2862,CHEMBL785,Ritodrine,Small molecule,1991.0,G02CA01,"G02CA01 [GENITO URINARY SYSTEM AND SEX HORMONES: OTHER GYNECOLOGICALS: OTHER GYNECOLOGICALS: Sympathomimetics, labour repressants]",-drine,Beta-2 adrenergic receptor agonist,,,CHEMBL210,Beta-2 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:0443-059748 PP. 450, URL:http://www.isbnsearch.org/isbn/0443059748|Name:Wikipedia, SrcID:Ritodrine, URL:http://en.wikipedia.org/wiki/Ritodrine",C[C@H](NCCc1ccc(O)cc1)[C@H](O)c2ccc(O)cc2,CHEMBL210,ADRB2
2863,CHEMBL1290,Penbutolol,Small molecule,1987.0,C07AA23,"C07AA23 [CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, non-selective]",-olol,Beta-2 adrenergic receptor antagonist,,,CHEMBL210,Beta-2 adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=d241fc80-2c55-4dbb-bdb2-44f731afa137, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d241fc80-2c55-4dbb-bdb2-44f731afa137|Name:FDA, SrcID:label/2011/018976s012lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018976s012lbl.pdf",CC(C)(C)NC[C@H](O)COc1ccccc1C2CCCC2,CHEMBL210,ADRB2
2864,CHEMBL89598,Vigabatrin,Small molecule,2009.0,N03AG04,N03AG04 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Fatty acid derivatives],-gab-,Gamma-amino-N-butyrate transaminase inhibitor,Irreversible inhibitor,,CHEMBL2044,Gamma-amino-N-butyrate transaminase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15208697, URL:http://europepmc.org/abstract/MED/15208697|Name:FDA, SrcID:label/2012/020427s005lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020427s005lbl.pdf",NC(CCC(=O)O)C=C,CHEMBL2044,ABAT
2865,CHEMBL398435,Ticagrelor,Small molecule,2011.0,B01AC24,B01AC24 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Platelet aggregation inhibitors excl. heparin],-grel-,Purinergic receptor P2Y12 negative allosteric modulator,,,CHEMBL2001,Purinergic receptor P2Y12,NEGATIVE ALLOSTERIC MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2011/022433s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022433s000lbl.pdf",CCCSc1nc(N[C@@H]2C[C@H]2c3ccc(F)c(F)c3)c4nnn([C@@H]5C[C@H](OCCO)[C@@H](O)[C@H]5O)c4n1,CHEMBL2001,P2RY12
2866,CHEMBL1201836,Ofatumumab,Antibody,2009.0,L01XC10,L01XC10 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,B-lymphocyte antigen CD20 inhibitor,,,CHEMBL2058,B-lymphocyte antigen CD20,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=e6e738dc-9026-4cd3-8f85-7b10ac730e7d, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e6e738dc-9026-4cd3-8f85-7b10ac730e7d",,CHEMBL2058,MS4A1
2867,CHEMBL24828,Vandetanib,Small molecule,2011.0,L01XE12,L01XE12 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-anib,Epidermal growth factor receptor inhibitor,,,CHEMBL2363049,Epidermal growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13",COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC4CCN(C)CC4,,
2868,CHEMBL450,Metharbital,Small molecule,1982.0,N03AA30,N03AA30 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Barbiturates and derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:PubMed, SrcID:6266847, URL:http://europepmc.org/abstract/MED/6266847|Name:PubMed, SrcID:10209232, URL:http://europepmc.org/abstract/MED/10209232|Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CCC1(CC)C(=O)NC(=O)N(C)C1=O,CHEMBL2093872,GABRG3
2869,CHEMBL450,Metharbital,Small molecule,1982.0,N03AA30,N03AA30 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Barbiturates and derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:PubMed, SrcID:6266847, URL:http://europepmc.org/abstract/MED/6266847|Name:PubMed, SrcID:10209232, URL:http://europepmc.org/abstract/MED/10209232|Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CCC1(CC)C(=O)NC(=O)N(C)C1=O,CHEMBL2093872,GABRP
2870,CHEMBL450,Metharbital,Small molecule,1982.0,N03AA30,N03AA30 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Barbiturates and derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:PubMed, SrcID:6266847, URL:http://europepmc.org/abstract/MED/6266847|Name:PubMed, SrcID:10209232, URL:http://europepmc.org/abstract/MED/10209232|Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CCC1(CC)C(=O)NC(=O)N(C)C1=O,CHEMBL2093872,GABRE
2871,CHEMBL450,Metharbital,Small molecule,1982.0,N03AA30,N03AA30 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Barbiturates and derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:PubMed, SrcID:6266847, URL:http://europepmc.org/abstract/MED/6266847|Name:PubMed, SrcID:10209232, URL:http://europepmc.org/abstract/MED/10209232|Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CCC1(CC)C(=O)NC(=O)N(C)C1=O,CHEMBL2093872,GABRG1
2872,CHEMBL437,Sulfathiazole,Small molecule,1945.0,J01EB07; D06BA02,J01EB07 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: SULFONAMIDES AND TRIMETHOPRIM: Short-acting sulfonamides]; D06BA02 [DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: CHEMOTHERAPEUTICS FOR TOPICAL USE: Sulfonamides],sulfa-,Bacterial dihydropteroate synthase inhibitor,,,CHEMBL2364668,Bacterial dihydropteroate synthase,INHIBITOR,Bacteria,SINGLE PROTEIN,,,"Name:PubMed, SrcID:14700578, URL:http://europepmc.org/abstract/MED/14700578",Nc1ccc(cc1)S(=O)(=O)Nc2nccs2,,
2873,CHEMBL374731,Telbivudine,Small molecule,2006.0,J05AF11,J05AF11 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleoside and nucleotide reverse transcriptase inhibitors],-vudine,DNA polymerase/reverse transcriptase inhibitor,,,CHEMBL2362994,DNA polymerase/reverse transcriptase,INHIBITOR,Hepatitis B virus,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=0664309d-1342-4a63-ba5f-4b899cdf3bec, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0664309d-1342-4a63-ba5f-4b899cdf3bec",CC1=CN([C@@H]2C[C@@H](O)[C@H](CO)O2)C(=O)NC1=O,,
2874,CHEMBL1077896,Ropivacaine,Small molecule,1996.0,N01BB09,"N01BB09 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Amides]",-caine,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=c6613708-c1f7-4f5c-91a3-ebbc1d7905c6#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c6613708-c1f7-4f5c-91a3-ebbc1d7905c6#nlm34090-1|Name:PubMed, SrcID:8799190, URL:http://europepmc.org/abstract/MED/8799190|Name:PubMed, SrcID:15635807, URL:http://europepmc.org/abstract/MED/15635807",CCCN1CCCC[C@H]1C(=O)Nc2c(C)cccc2C,,
2875,CHEMBL1256,Isoflurane,Small molecule,1979.0,N01AB06,"N01AB06 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,Potassium channel subfamily K member 2 opener,,,CHEMBL2321615,Potassium channel subfamily K member 2,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:11605899, URL:http://europepmc.org/abstract/MED/11605899|Name:PubMed, SrcID:17227289, URL:http://europepmc.org/abstract/MED/17227289",FC(F)OC(Cl)C(F)(F)F,CHEMBL2321615,KCNK2
2876,CHEMBL1200714,Chlormezanone,Small molecule,1960.0,M03BB52; M03BB02; M03BB72,"M03BB52 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS: Oxazol, thiazine, and triazine derivatives]; M03BB02 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS: Oxazol, thiazine, and triazine derivatives]; M03BB72 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS: Oxazol, thiazine, and triazine derivatives]",,Unknown,"Mode of action not fully understood; it seems to act as a muscle relaxant by interfering with GABA A receptors, sodium channels and calcium channels",,,,,,,,,"Name:PubMed, SrcID:9502168, URL:http://europepmc.org/abstract/MED/9502168|Name:ISBN, SrcID:0471948470 PP. 191, URL:http://www.isbnsearch.org/isbn/0471948470",CN1C(c2ccc(Cl)cc2)S(=O)(=O)CCC1=O,,
2877,CHEMBL1743087,Vedolizumab,Antibody,2014.0,L04AA33,L04AA33 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Selective immunosuppressants],-mab,Integrin alpha-4/beta-7 inhibitor,,,CHEMBL2095184,Integrin alpha-4/beta-7,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:FDA, SrcID:label/2014/125476s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125476s000lbl.pdf",,,
2878,CHEMBL3545297,Pexmetinib,Small molecule,,,,-tinib,Tyrosine-protein kinase TIE-2 inhibitor,,,CHEMBL4128,Tyrosine-protein kinase TIE-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.arraybiopharma.com/product-pipeline/other-compounds/arry-614/, URL:http://www.arraybiopharma.com/product-pipeline/other-compounds/arry-614/|Name:Other, SrcID:http://www.bloodjournal.org/content/124/21/4628.full.pdf, URL:http://www.bloodjournal.org/content/124/21/4628.full.pdf",,CHEMBL4128,TEK
2879,CHEMBL129857,As-602868,Small molecule,,,,,Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor,,,CHEMBL1991,Inhibitor of nuclear factor kappa B kinase beta subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:14603259, URL:http://europepmc.org/abstract/MED/14603259|Name:PubMed, SrcID:17330097, URL:http://europepmc.org/abstract/MED/17330097",COc1cccc2nc(nc(NN3C(=O)C=C(C)C3=O)c12)c4cccs4,CHEMBL1991,IKBKB
2880,CHEMBL488436,Azd-5438,Small molecule,,,,,Cyclin-dependent kinase inhibitor,"Potent oral inhibitor of cyclin-dependent kinases 1, 2, and 9 (CDK1 CDK2 and CDK9)",,CHEMBL3559691,Cyclin-dependent kinase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19509270, URL:http://europepmc.org/abstract/MED/19509270",CC(C)n1c(C)ncc1c2ccnc(Nc3ccc(cc3)S(=O)(=O)C)n2,CHEMBL3559691,CDK12
2881,CHEMBL488436,Azd-5438,Small molecule,,,,,Cyclin-dependent kinase inhibitor,"Potent oral inhibitor of cyclin-dependent kinases 1, 2, and 9 (CDK1 CDK2 and CDK9)",,CHEMBL3559691,Cyclin-dependent kinase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19509270, URL:http://europepmc.org/abstract/MED/19509270",CC(C)n1c(C)ncc1c2ccnc(Nc3ccc(cc3)S(=O)(=O)C)n2,CHEMBL3559691,CDK20
2882,CHEMBL3545298,Azd-6918,Small molecule,,,,,Neurotrophic tyrosine kinase receptor inhibitor,,,CHEMBL3559684,Neurotrophic tyrosine kinase receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:25700942, URL:http://europepmc.org/abstract/MED/25700942",,,
2883,CHEMBL2029988,Cep-32496,Small molecule,,,,,Epidermal growth factor receptor erbB1 inhibitor,,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf, URL:http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf",COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(on4)C(C)(C)C(F)(F)F)c3)c2cc1OC,CHEMBL203,EGFR
2884,CHEMBL3545121,Epitinib,Small molecule,,,,-tinib,Epidermal growth factor receptor erbB1 inhibitor,,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:ClinicalTrials, SrcID:NCT02590952, URL:https://www.clinicaltrials.gov/ct2/show/NCT02590952|Name:Other, SrcID:http://www.hmplglobal.com/en/epitinib-hmpl-813/, URL:http://www.hmplglobal.com/en/epitinib-hmpl-813/",,CHEMBL203,EGFR
2885,CHEMBL3545133,Jnj-26483327,Small molecule,,,,,Tyrosine-protein kinase LCK inhibitor,Multi-targeted tyrosine kinase inhibitor,,CHEMBL258,Tyrosine-protein kinase LCK,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1016/S1359-6349(10)71870-X, URL:http://www.sciencedirect.com/science/article/pii/S135963491071870X|Name:PubMed, SrcID:20823884, URL:http://europepmc.org/abstract/MED/20823884",,CHEMBL258,LCK
2886,CHEMBL2364652,Vantictumab,Antibody,,,,-mab,Frizzled-2 antagonist,mAB,,CHEMBL3559686,Frizzled-2,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22753465, URL:http://europepmc.org/abstract/MED/22753465",,CHEMBL3559686,FZD2
2887,CHEMBL2103851,Amuvatinib,Small molecule,,,,-tinib,Tyrosine-protein kinase receptor FLT3 inhibitor,"Inhibits mutant forms of KIT, FLT3 and PDGFRA (http://www.google.com/patents/US20080226747).",,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25110867, URL:http://europepmc.org/abstract/MED/25110867|Name:Other, SrcID:http://www.google.com/patents/US20080226747, URL:http://www.google.com/patents/US20080226747|Name:PubMed, SrcID:24326130, URL:http://europepmc.org/abstract/MED/24326130",S=C(NCc1ccc2OCOc2c1)N3CCN(CC3)c4ncnc5c4oc6ccccc56,CHEMBL1974,FLT3
2888,CHEMBL2110584,Darotropium,Small molecule,,,,-ium; -trop-,Muscarinic acetylcholine receptor antagonist,,,CHEMBL2094109,Muscarinic acetylcholine receptor,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:22419863, URL:http://europepmc.org/abstract/MED/22419863",C[N+]1(C)[C@@H]2CC[C@H]1C[C@@H](CC(C#N)(c3ccccc3)c4ccccc4)C2,,
2889,CHEMBL2110659,Aplindore,Small molecule,,,,-dore,Dopamine D2 receptor partial agonist,,,CHEMBL217,Dopamine D2 receptor,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17056032, URL:http://europepmc.org/abstract/MED/17056032",O=C1Cc2c(N1)ccc3OC[C@H](CNCc4ccccc4)Oc23,CHEMBL217,DRD2
2890,CHEMBL3545404,Ccx354,Small molecule,,,,,C-C chemokine receptor type 1 antagonist,,,CHEMBL2413,C-C chemokine receptor type 1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22589376, URL:http://europepmc.org/abstract/MED/22589376",,CHEMBL2413,CCR1
2891,CHEMBL431733,Cf102,Small molecule,,,,,Adenosine A3 receptor agonist,,,CHEMBL256,Adenosine A3 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21660967, URL:http://europepmc.org/abstract/MED/21660967",CNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(NCc4cccc(I)c4)nc(Cl)nc23,CHEMBL256,ADORA3
2892,CHEMBL2016681,Velneperit,Small molecule,,,,-perit,Neuropeptide Y receptor type 5 antagonist,Not in current pipeline,,CHEMBL4561,Neuropeptide Y receptor type 5,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24064009, URL:http://europepmc.org/abstract/MED/24064009",CC(C)(C)S(=O)(=O)N[C@@H]1CC[C@H](CC1)C(=O)Nc2ccc(cn2)C(F)(F)F,CHEMBL4561,NPY5R
2893,CHEMBL2151437,Azd0328,Small molecule,,,,,Neuronal acetylcholine receptor protein alpha-7 subunit agonist,Compound is listed in AstaZeneca's clinical and/or preclinical compound bank and available for research projects (http://openinnovation.astrazeneca.com/what-we-offer/compound/azd0328-2/).,,CHEMBL2492,Neuronal acetylcholine receptor protein alpha-7 subunit,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21919481, URL:http://europepmc.org/abstract/MED/21919481|Name:PubMed, SrcID:19615981, URL:http://europepmc.org/abstract/MED/19615981",C1CN2CCC1[C@@]3(C2)Cc4cccnc4O3,CHEMBL2492,CHRNA7
2894,CHEMBL1950649,Apadenoson,Small molecule,,,,-denoson,Adenosine A2a receptor agonist,All registered studies Discontinued Developed as pharmacologic stress agent for myocardial perfusion imaging.,,CHEMBL251,Adenosine A2a receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21185259, URL:http://europepmc.org/abstract/MED/21185259|Name:PubMed, SrcID:16524538, URL:http://europepmc.org/abstract/MED/16524538",CCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(N)nc(nc23)C#CC[C@@H]4CC[C@H](CC4)C(=O)OC,CHEMBL251,ADORA2A
2895,CHEMBL2105747,Tozadenant,Small molecule,,,,-denant,Adenosine A2a receptor antagonist,,,CHEMBL251,Adenosine A2a receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25082853, URL:http://europepmc.org/abstract/MED/25082853|Name:Other, SrcID:http://www.biotie.com/product-portfolio/syn115.aspx?sc_lang=en, URL:http://www.biotie.com/product-portfolio/syn115.aspx?sc_lang=en|Name:PubMed, SrcID:21123574, URL:http://europepmc.org/abstract/MED/21123574",COc1ccc(N2CCOCC2)c3sc(NC(=O)N4CCC(C)(O)CC4)nc13,CHEMBL251,ADORA2A
2896,CHEMBL889,Palifosfamide,Small molecule,,,,-fosfamide,DNA cross-linking agent,,,CHEMBL2311221,DNA,CROSS-LINKING AGENT,Homo sapiens,NUCLEIC-ACID,,,"Name:PubMed, SrcID:22027537, URL:http://europepmc.org/abstract/MED/22027537|Name:PubMed, SrcID:6821629, URL:http://europepmc.org/abstract/MED/6821629",OP(=O)(NCCCl)NCCCl,,
2897,CHEMBL2103832,Pardoprunox,Small molecule,,,,,Dopamine receptors; D2 & D3 partial agonist,,,CHEMBL2095169,Dopamine receptors; D2 & D3,PARTIAL AGONIST,Homo sapiens,SELECTIVITY GROUP,,,"Name:PubMed, SrcID:20434890, URL:http://europepmc.org/abstract/MED/20434890",CN1CCN(CC1)c2cccc3NC(=O)Oc23,,
2898,CHEMBL2105659,Varespladib Methyl,Small molecule,,,,-pladib,Group X secretory phospholipase A2 inhibitor,,,CHEMBL4342,Group X secretory phospholipase A2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21112895, URL:http://europepmc.org/abstract/MED/21112895",CCc1c(C(=O)C(=O)N)c2c(OCC(=O)OC)cccc2n1Cc3ccccc3,CHEMBL4342,PLA2G10
2899,CHEMBL2109391,Mdx-447,Antibody,,,,,Epidermal growth factor receptor erbB1 other,Binds to the EGFR and to the high-affinity immunoglobulin G (IgG) receptor CD64 both separately and simultaneously. Mediates antibody-dependent cell-mediated cytotoxicity (ADCC) with lysis of EGFR overexpressing cell lines.,,CHEMBL203,Epidermal growth factor receptor erbB1,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17602224, URL:http://europepmc.org/abstract/MED/17602224",,CHEMBL203,EGFR
2900,CHEMBL2109431,Kb-003,Antibody,,,,,Granulocyte-macrophage colony-stimulating factor inhibitor,Neutralizes soluble granulocyte-macrophage colony-stimulating factor (GM-CSF).,,CHEMBL3712955,Granulocyte-macrophage colony-stimulating factor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23632888, URL:http://europepmc.org/abstract/MED/23632888",,CHEMBL3712955,CSF2
2901,CHEMBL2109530,Ask-8007,Antibody,,,,,Osteopontin inhibitor,,,CHEMBL1741309,Osteopontin,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21917822, URL:http://europepmc.org/abstract/MED/21917822",,CHEMBL1741309,SPP1
2902,CHEMBL2109585,Ly-2382770,Antibody,,,,,Transforming growth factor beta-1 inhibitor,,,CHEMBL1795178,Transforming growth factor beta-1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23000686, URL:http://europepmc.org/abstract/MED/23000686",,,
2903,CHEMBL3545230,Nrx-1074,Small molecule,,,,,Glutamate [NMDA] receptor partial agonist,"Partial agonist of the glycin-site on GRIN1-subunits, preferentially modulates NR2B-containing NMDAR receptor complexes.",,CHEMBL2094124,Glutamate [NMDA] receptor,PARTIAL AGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Wikipedia, SrcID:NRX-1074, URL:https://en.wikipedia.org/wiki/NRX-1074",,CHEMBL2094124,GRIN3B
2904,CHEMBL787,Montelukast,Small molecule,1998.0,R03DC53; R03DC03,R03DC53 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: Leukotriene receptor antagonists]; R03DC03 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: Leukotriene receptor antagonists],-ast,Cysteinyl leukotriene receptor 1 antagonist,,Selective,CHEMBL1798,Cysteinyl leukotriene receptor 1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=ed2caffa-a75c-1c27-ae30-2d8280eaea7d, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ed2caffa-a75c-1c27-ae30-2d8280eaea7d",CC(C)(O)c1ccccc1CC[C@@H](SCC2(CC(=O)O)CC2)c3cccc(\C=C\c4ccc5ccc(Cl)cc5n4)c3,CHEMBL1798,CYSLTR1
2905,CHEMBL1201565,Epoetin Alfa,Protein,1989.0,,,-poetin,Erythropoietin receptor agonist,,,CHEMBL1817,Erythropoietin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=37204b95-bd46-4b12-b5b7-2c4b128b7203, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=37204b95-bd46-4b12-b5b7-2c4b128b7203|Name:FDA, SrcID:label/2013/103234s5323lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/103234s5323lbl.pdf",,CHEMBL1817,EPOR
2906,CHEMBL728,Prochlorperazine,Small molecule,1956.0,N05AB04,N05AB04 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Phenothiazines with piperazine structure],,Dopamine D2 receptor antagonist,,,CHEMBL217,Dopamine D2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=daabf2ee-7f0e-4b45-a2be-8ab6d8c9d3e7, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=daabf2ee-7f0e-4b45-a2be-8ab6d8c9d3e7|Name:ISBN, SrcID:0443-059748 PP. 379, 489, URL:http://www.isbnsearch.org/isbn/0443059748|Name:FDA, SrcID:label/2010/089903s018lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/089903s018lbl.pdf|Name:DailyMed, SrcID:setid=ea381bc5-0957-4c91-826a-0ff680cebacc#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ea381bc5-0957-4c91-826a-0ff680cebacc#nlm34090-1",CN1CCN(CCCN2c3ccccc3Sc4ccc(Cl)cc24)CC1,CHEMBL217,DRD2
2907,CHEMBL1123,Dicyclomine,Small molecule,1950.0,A03AA07,"A03AA07 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: Synthetic anticholinergics, esters with tertiary amino group]",,Muscarinic acetylcholine receptor M1 antagonist,"Indicated in irritable bowel, M3 likely involved",,CHEMBL216,Muscarinic acetylcholine receptor M1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=c56598d5-9cd1-4cce-b172-ac338775aec7, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c56598d5-9cd1-4cce-b172-ac338775aec7|Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718",CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,CHEMBL216,CHRM1
2908,CHEMBL288441,Bosutinib,Small molecule,2010.0,L01XE14,L01XE14 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Tyrosine-protein kinase ABL inhibitor,,,CHEMBL1862,Tyrosine-protein kinase ABL,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Expert, SrcID:BOSUTINIB, URL:http://chembl.blogspot.co.uk/search?q=BOSUTINIB",COc1cc(Nc2c(cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl,CHEMBL1862,ABL1
2909,CHEMBL406,Indapamide,Small molecule,1983.0,C03BA11,"C03BA11 [CARDIOVASCULAR SYSTEM: DIURETICS: LOW-CEILING DIURETICS, EXCL. THIAZIDES: Sulfonamides, plain]",-pamide,Thiazide-sensitive sodium-chloride cotransporter inhibitor,,,CHEMBL1876,Thiazide-sensitive sodium-chloride cotransporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=8da31a19-855d-4511-8365-edf70ca37272, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8da31a19-855d-4511-8365-edf70ca37272|Name:ISBN, SrcID:9780702034718 PP. 354, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:FDA, SrcID:anda/98/75-105_Indapamide_prntlbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/anda/98/75-105_Indapamide_prntlbl.pdf|Name:Wikipedia, SrcID:Indapamide, URL:http://en.wikipedia.org/wiki/Indapamide|Name:Wikipedia, SrcID:Thiazide-Like, URL:http://en.wikipedia.org/wiki/Thiazide-Like",CC1Cc2ccccc2N1NC(=O)c3ccc(Cl)c(c3)S(=O)(=O)N,CHEMBL1876,SLC12A3
2910,CHEMBL109,Valproic Acid,Small molecule,1978.0,N03AG01,N03AG01 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Fatty acid derivatives],,Succinate semialdehyde dehydrogenase inhibitor,,,CHEMBL1911,Succinate semialdehyde dehydrogenase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10812195, URL:http://europepmc.org/abstract/MED/10812195",CCCC(CCC)C(=O)O,CHEMBL1911,ALDH5A1
2911,CHEMBL30,Cimetidine,Small molecule,1977.0,A02BA01; A02BA51,A02BA01 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): H2-receptor antagonists]; A02BA51 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): H2-receptor antagonists],-tidine,Histamine H2 receptor antagonist,,,CHEMBL1941,Histamine H2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 211, URL:http://www.isbnsearch.org/isbn/9780702034718",CN\C(=N/CCSCc1nc[nH]c1C)\NC#N,CHEMBL1941,HRH2
2912,CHEMBL1201542,Insulin Zinc Susp Extended Purified Beef,Protein,1982.0,,,,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/022472s006s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022472s006s008lbl.pdf|Name:DailyMed, SrcID:setid=457531f0-9331-47fe-90b5-b31f284044dc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=457531f0-9331-47fe-90b5-b31f284044dc",,CHEMBL1981,INSR
2913,CHEMBL1201664,Insulin Aspart Protamine Recombinant,Protein,2001.0,,,,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=3a1e73a2-3009-40d0-876c-b4cb2be56fc5, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3a1e73a2-3009-40d0-876c-b4cb2be56fc5",,CHEMBL1981,INSR
2914,CHEMBL422,Trifluoperazine,Small molecule,1959.0,N05AB06,N05AB06 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Phenothiazines with piperazine structure],,Serotonin 2c (5-HT2c) receptor antagonist,,,CHEMBL225,Serotonin 2c (5-HT2c) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Trifluoperazine, URL:http://en.wikipedia.org/wiki/Trifluoperazine|Name:ISBN, SrcID:0443-059748 PP. 544, URL:http://www.isbnsearch.org/isbn/0443059748",CN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1,,
2915,CHEMBL1104,Edrophonium,Small molecule,1951.0,,,-ium,Acetylcholinesterase inhibitor,,,CHEMBL220,Acetylcholinesterase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=98a5a2f6-3194-4202-963f-0fcd28ecadbc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=98a5a2f6-3194-4202-963f-0fcd28ecadbc",CC[N+](C)(C)c1cccc(O)c1,CHEMBL220,ACHE
2916,CHEMBL1380,Abacavir,Small molecule,1998.0,J05AF06,J05AF06 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleoside and nucleotide reverse transcriptase inhibitors],-vir,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,,,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,INHIBITOR,Human immunodeficiency virus 1,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=80c1702a-973c-436a-90f8-69b29674dca0, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80c1702a-973c-436a-90f8-69b29674dca0",Nc1nc(NC2CC2)c3ncn([C@@H]4C[C@H](CO)C=C4)c3n1,,
2917,CHEMBL485,Codeine,Small molecule,1952.0,N02AA79; R05DA04; N02AA59,"N02AA79 [NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Natural opium alkaloids]; R05DA04 [RESPIRATORY SYSTEM: COUGH AND COLD PREPARATIONS: COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS: Opium alkaloids and derivatives]; N02AA59 [NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Natural opium alkaloids]",,Opioid receptors; mu/kappa/delta agonist,,,CHEMBL2095181,Opioid receptors; mu/kappa/delta,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:15611852, URL:http://europepmc.org/abstract/MED/15611852|Name:PubMed, SrcID:17620111, URL:http://europepmc.org/abstract/MED/17620111|Name:Wikipedia, SrcID:Opioid_receptor, URL:http://en.wikipedia.org/wiki/Opioid_receptor|Name:Wikipedia, SrcID:Codeine, URL:http://en.wikipedia.org/wiki/Codeine",COc1ccc2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5Oc1c2[C@]45CCN3C,,
2918,CHEMBL1201556,Becaplermin,Protein,1997.0,D03AX06; A01AD08,D03AX06 [DERMATOLOGICALS: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS: CICATRIZANTS: Other cicatrizants]; A01AD08 [ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Other agents for local oral treatment],-ermin,Platelet-derived growth factor receptor agonist,,,CHEMBL2095189,Platelet-derived growth factor receptor,AGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:FDA, SrcID:label/2011/103691s5095lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/103691s5095lbl.pdf|Name:DailyMed, SrcID:setid=594e76e5-2833-4386-991d-234d4f937e1b, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=594e76e5-2833-4386-991d-234d4f937e1b",,,
2919,CHEMBL839,Carteolol,Small molecule,1988.0,C07AA15; S01ED55; S01ED05,"C07AA15 [CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, non-selective]; S01ED55 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Beta blocking agents 1)]; S01ED05 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Beta blocking agents 1)]",-olol,Adrenergic receptor beta antagonist,,,CHEMBL2094118,Adrenergic receptor beta,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10864881, URL:http://europepmc.org/abstract/MED/10864881|Name:PubMed, SrcID:15526107, URL:http://europepmc.org/abstract/MED/15526107|Name:PubMed, SrcID:1349493, URL:http://europepmc.org/abstract/MED/1349493|Name:PubMed, SrcID:16160085, URL:http://europepmc.org/abstract/MED/16160085",CC(C)(C)NCC(O)COc1cccc2NC(=O)CCc12,,
2920,CHEMBL647,Apraclonidine,Small molecule,1987.0,S01EA03,S01EA03 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Sympathomimetics in glaucoma therapy 1)],,Adrenergic receptor alpha-2 agonist,,,CHEMBL2095158,Adrenergic receptor alpha-2,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=dc7d3a9f-c0b9-411c-9c62-0a14f1718b00, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dc7d3a9f-c0b9-411c-9c62-0a14f1718b00",Nc1cc(Cl)c(N=C2NCCN2)c(Cl)c1,,
2921,CHEMBL2108035,Incobotulinumtoxina,Unknown,2010.0,,,,Synaptosomal-associated protein 25 inhibitor,"BOTOX blocks neuromuscular transmission by binding to acceptor sites on motor or sympathetic nerve terminals, entering the nerve terminals, and inhibiting the release of acetylcholine. This inhibition occurs as the neurotoxin cleaves SNAP-25, a protein integral to the successful docking and release of acetylcholine from vesicles situated within nerve endings.",,CHEMBL2364159,Synaptosomal-associated protein 25,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2013/125360s045lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125360s045lbl.pdf",,CHEMBL2364159,SNAP25
2922,CHEMBL808,Econazole,Small molecule,1982.0,G01AF05; D01AC03,"G01AF05 [GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Imidazole derivatives]; D01AC03 [DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Imidazole and triazole derivatives]",-conazole,Cytochrome P450 51 inhibitor,,,CHEMBL1780,Cytochrome P450 51,INHIBITOR,Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast),SINGLE PROTEIN,,,"Name:PubMed, SrcID:20149798, URL:http://europepmc.org/abstract/MED/20149798|Name:PubMed, SrcID:11064188, URL:http://europepmc.org/abstract/MED/11064188",Clc1ccc(COC(Cn2ccnc2)c3ccc(Cl)cc3Cl)cc1,,
2923,CHEMBL1482,Bethanechol,Small molecule,1948.0,N07AB02,N07AB02 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: PARASYMPATHOMIMETICS: Choline esters],,Muscarinic acetylcholine receptor M2 agonist,"Indicated for urinary retention, M2 likely responsible",,CHEMBL211,Muscarinic acetylcholine receptor M2,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:982732, URL:http://europepmc.org/abstract/MED/982732|Name:PubMed, SrcID:16465186, URL:http://europepmc.org/abstract/MED/16465186|Name:ISBN, SrcID:9780702034718 PP. 157, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:Wikipedia, SrcID:Bethanechol, URL:http://en.wikipedia.org/wiki/Bethanechol",CC(C[N+](C)(C)C)OC(=O)N,CHEMBL211,CHRM2
2924,CHEMBL1237123,Doxacurium,Small molecule,1991.0,,,-curium,Muscle-type nicotinic acetylcholine receptor antagonist,non-depolarizing,,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:archiveid=2131, URL:http://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=2131|Name:PubMed, SrcID:18633030, URL:http://europepmc.org/abstract/MED/18633030",COc1cc(CC2c3c(CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]4(C)CCc5cc(OC)c(OC)c(OC)c5C4Cc6cc(OC)c(OC)c(OC)c6)cc(OC)c(OC)c3OC)cc(OC)c1OC,,
2925,CHEMBL1522,Eszopiclone,Small molecule,2004.0,N05CF04,N05CF04 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine related drugs],-clone,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:18973287, URL:http://europepmc.org/abstract/MED/18973287|Name:FDA, SrcID:label/2012/021476s024s026lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021476s024s026lbl.pdf|Name:Wikipedia, SrcID:Eszopiclone, URL:http://en.wikipedia.org/wiki/Eszopiclone",CN1CCN(CC1)C(=O)O[C@@H]2N(C(=O)c3nccnc23)c4ccc(Cl)cn4,CHEMBL2093872,GABRG3
2926,CHEMBL1522,Eszopiclone,Small molecule,2004.0,N05CF04,N05CF04 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine related drugs],-clone,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:18973287, URL:http://europepmc.org/abstract/MED/18973287|Name:FDA, SrcID:label/2012/021476s024s026lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021476s024s026lbl.pdf|Name:Wikipedia, SrcID:Eszopiclone, URL:http://en.wikipedia.org/wiki/Eszopiclone",CN1CCN(CC1)C(=O)O[C@@H]2N(C(=O)c3nccnc23)c4ccc(Cl)cn4,CHEMBL2093872,GABRP
2927,CHEMBL1522,Eszopiclone,Small molecule,2004.0,N05CF04,N05CF04 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine related drugs],-clone,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:18973287, URL:http://europepmc.org/abstract/MED/18973287|Name:FDA, SrcID:label/2012/021476s024s026lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021476s024s026lbl.pdf|Name:Wikipedia, SrcID:Eszopiclone, URL:http://en.wikipedia.org/wiki/Eszopiclone",CN1CCN(CC1)C(=O)O[C@@H]2N(C(=O)c3nccnc23)c4ccc(Cl)cn4,CHEMBL2093872,GABRE
2928,CHEMBL1522,Eszopiclone,Small molecule,2004.0,N05CF04,N05CF04 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine related drugs],-clone,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:18973287, URL:http://europepmc.org/abstract/MED/18973287|Name:FDA, SrcID:label/2012/021476s024s026lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021476s024s026lbl.pdf|Name:Wikipedia, SrcID:Eszopiclone, URL:http://en.wikipedia.org/wiki/Eszopiclone",CN1CCN(CC1)C(=O)O[C@@H]2N(C(=O)c3nccnc23)c4ccc(Cl)cn4,CHEMBL2093872,GABRG1
2929,CHEMBL850,Sparfloxacin,Small molecule,1996.0,J01MA09,J01MA09 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolones],-oxacin,Topoisomerase IV inhibitor,,Broad spectrum,CHEMBL2363076,Topoisomerase IV,INHIBITOR,Bacteria,PROTEIN COMPLEX,,,"Name:FDA, SrcID:label/2003/020677s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/020677s006lbl.pdf",C[C@@H]1CN(C[C@H](C)N1)c2c(F)c(N)c3C(=O)C(=CN(C4CC4)c3c2F)C(=O)O,,
2930,CHEMBL826,Enoxacin,Small molecule,1991.0,J01MA04,J01MA04 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolones],-oxacin,Topoisomerase IV inhibitor,,,CHEMBL2363077,Topoisomerase IV,INHIBITOR,Neisseria gonorrhoeae,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:15143768, URL:http://europepmc.org/abstract/MED/15143768",CCN1C=C(C(=O)O)C(=O)c2cc(F)c(nc12)N3CCNCC3,,
2931,CHEMBL702,Piperacillin,Small molecule,1981.0,J01CA12,"J01CA12 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: BETA-LACTAM ANTIBACTERIALS, PENICILLINS: Penicillins with extended spectrum]",-cillin,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:PubMed, SrcID:7447421, URL:http://europepmc.org/abstract/MED/7447421",CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(=O)O)c4ccccc4)C(=O)C1=O,,
2932,CHEMBL976,Praziquantel,Small molecule,1982.0,P02BA01,"P02BA01 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTHELMINTICS: ANTITREMATODALS: Quinoline derivatives and related substances]",-antel,Voltage-activated calcium channel beta 1 subunit blocker,,,CHEMBL2363079,Voltage-activated calcium channel beta 1 subunit,BLOCKER,Schistosoma mansoni,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19554083, URL:http://europepmc.org/abstract/MED/19554083|Name:Wikipedia, SrcID:Praziquantel, URL:http://en.wikipedia.org/wiki/Praziquantel|Name:PubMed, SrcID:18978535, URL:http://europepmc.org/abstract/MED/18978535",O=C(C1CCCCC1)N2CC3N(CCc4ccccc34)C(=O)C2,,
2933,CHEMBL1542,Azathioprine,Small molecule,1968.0,L04AX01,L04AX01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Other immunosuppressants],,DNA inhibitor,Prodrug enzyme: hypoxanthine-guanine phosphoribosyl transferase (HGPRT; EC 2.4.2.8),,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:PubMed, SrcID:18506437, URL:http://europepmc.org/abstract/MED/18506437",Cn1cnc(c1Sc2ncnc3nc[nH]c23)[N+](=O)[O-],,
2934,CHEMBL803,Cytarabine,Small molecule,1969.0,L01BC01,L01BC01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Pyrimidine analogues],-arabine,RNA inhibitor,,,CHEMBL2311222,RNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=1315f89d-f530-4dff-98e5-27d51617d4a1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1315f89d-f530-4dff-98e5-27d51617d4a1",NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O,,
2935,CHEMBL1208,Cinoxacin,Small molecule,1980.0,J01MB06,J01MB06 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Other quinolones],-oxacin,Bacterial DNA gyrase inhibitor,,,CHEMBL2311224,Bacterial DNA gyrase,INHIBITOR,Bacteria,PROTEIN COMPLEX,,,"Name:FDA, SrcID:label/2002/18067s29lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/18067s29lbl.pdf|Name:ISBN, SrcID:9780702034718 PP. 613, URL:http://www.isbnsearch.org/isbn/9780702034718",CCN1N=C(C(=O)O)C(=O)c2cc3OCOc3cc12,,
2936,CHEMBL931,Halothane,Small molecule,1958.0,N01AB01,"N01AB01 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",,Potassium channel subfamily K member 2 opener,,,CHEMBL2321615,Potassium channel subfamily K member 2,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:11886861, URL:http://europepmc.org/abstract/MED/11886861|Name:PubMed, SrcID:11605899, URL:http://europepmc.org/abstract/MED/11605899|Name:PubMed, SrcID:20519544, URL:http://europepmc.org/abstract/MED/20519544|Name:PubMed, SrcID:17227289, URL:http://europepmc.org/abstract/MED/17227289|Name:PubMed, SrcID:20217349, URL:http://europepmc.org/abstract/MED/20217349",FC(F)(F)C(Cl)Br,CHEMBL2321615,KCNK2
2937,CHEMBL1006,Amifostine,Small molecule,1995.0,V03AF05,V03AF05 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Detoxifying agents for antineoplastic treatment],-fo-,Reactive metabolite scavenging agent,Prodrug. Scavenge of reactive oxygen species and reactive metabolites of cisplatin,,,,,,,,,"Name:DailyMed, SrcID:setid=0a47114c-569c-40be-afd8-a22d2e99bb5d#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0a47114c-569c-40be-afd8-a22d2e99bb5d#nlm34090-1",NCCCNCCSP(=O)(O)O,,
2938,CHEMBL3542265,Ly2452473,Small molecule,,,,,Androgen Receptor modulator,,,CHEMBL1871,Androgen Receptor,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22961682, URL:http://europepmc.org/abstract/MED/22961682",CC(C)OC(=O)N[C@H]1Cc2c(C1)n(Cc3ccccn3)c4ccc(cc24)C#N,CHEMBL1871,AR
2939,CHEMBL3545243,As-703988,Small molecule,,,,,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,Non-competitive MEK1/2 inhibitor.,,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=714900, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=714900|Name:PubMed, SrcID:24434059, URL:http://europepmc.org/abstract/MED/24434059",,CHEMBL2964,MAP2K2
2940,CHEMBL3545134,Ly-2780301,Small molecule,,,,,Ribosomal protein S6 kinase (P70S6K) inhibitor,,,CHEMBL2111330,Ribosomal protein S6 kinase (P70S6K),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:Other, SrcID:http://www.lillyoncologypipeline.com/p70s6-kinase-akt-dual-inhibitor.aspx, URL:http://www.lillyoncologypipeline.com/p70s6-kinase-akt-dual-inhibitor.aspx|Name:PubMed, SrcID:25902900, URL:http://europepmc.org/abstract/MED/25902900",,,
2941,CHEMBL49120,Pd-0166285,Small molecule,,,,,Tyrosine-protein kinase SRC inhibitor,Multi-targeted kinase irreversible inhibitor,,CHEMBL267,Tyrosine-protein kinase SRC,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10638483, URL:http://europepmc.org/abstract/MED/10638483",CCN(CC)CCOc1ccc(Nc2ncc3C=C(C(=O)N(C)c3n2)c4c(Cl)cccc4Cl)cc1,CHEMBL267,SRC
2942,CHEMBL1938400,Pf-03715455,Small molecule,,,,,MAP kinase p38 alpha inhibitor,,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://www.pfizer.com/sites/default/files/product-pipeline/July%2028%202015%20Pipeline%20Update.pdf, URL:https://www.pfizer.com/sites/default/files/product-pipeline/July%2028%202015%20Pipeline%20Update.pdf|Name:PubMed, SrcID:21888439, URL:http://europepmc.org/abstract/MED/21888439",CC(C)(C)c1cc(NC(=O)NCc2ccccc2Sc3ccc4nnc(c5ccccc5SCCO)n4c3)n(n1)c6ccc(O)c(Cl)c6,CHEMBL260,MAPK14
2943,CHEMBL1944698,Tg-02,Small molecule,,,,,Tyrosine-protein kinase receptor FLT3 inhibitor,,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21860433, URL:http://europepmc.org/abstract/MED/21860433",CN1C\C=C\CCOc2cccc(c2)c3ccnc(Nc4cccc(C1)c4)n3,CHEMBL1974,FLT3
2944,CHEMBL2104927,Figopitant,Small molecule,,,,-tant,Neurokinin 1 receptor antagonist,,,CHEMBL249,Neurokinin 1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22184457, URL:http://europepmc.org/abstract/MED/22184457|Name:PubMed, SrcID:15140636, URL:http://europepmc.org/abstract/MED/15140636",CN(CCc1cc(cc(c1)C(F)(F)F)C(F)(F)F)C(=O)[C@@H](N2CCN(CC3CC3)CC2)c4ccccc4,CHEMBL249,TACR1
2945,CHEMBL482968,Enmd-2076,Small molecule,,,,,Tyrosine-protein kinase receptor FLT3 inhibitor,Tartrate salt of ENMD-981693,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf, URL:http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf|Name:PubMed, SrcID:21177375, URL:http://europepmc.org/abstract/MED/21177375|Name:PubMed, SrcID:22397360, URL:http://europepmc.org/abstract/MED/22397360",CN1CCN(CC1)c2cc(Nc3cc(C)[nH]n3)nc(\C=C\c4ccccc4)n2,CHEMBL1974,FLT3
2946,CHEMBL403989,Tg100-801,Small molecule,,,,,Vascular endothelial growth factor receptor 1 inhibitor,Prodrug - active metabolite is TG-100-572 (HY-10184),,CHEMBL1868,Vascular endothelial growth factor receptor 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18311895, URL:http://europepmc.org/abstract/MED/18311895|Name:PubMed, SrcID:18483622, URL:http://europepmc.org/abstract/MED/18483622|Name:PubMed, SrcID:18330892, URL:http://europepmc.org/abstract/MED/18330892",Cc1cc(cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12)c5cc(OC(=O)c6ccccc6)ccc5Cl,CHEMBL1868,FLT1
2947,CHEMBL3402762,Tepotinib,Small molecule,,,,-tinib,Hepatocyte growth factor receptor inhibitor,,,CHEMBL3717,Hepatocyte growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25110867, URL:http://europepmc.org/abstract/MED/25110867|Name:PubMed, SrcID:23553846, URL:http://europepmc.org/abstract/MED/23553846",CN1CCC(COc2cnc(nc2)c3cccc(CN4N=C(C=CC4=O)c5cccc(c5)C#N)c3)CC1,CHEMBL3717,MET
2948,CHEMBL2104986,Tedatioxetine,Small molecule,,,,-oxetine,Dopamine transporter inhibitor,,,CHEMBL238,Dopamine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://www.google.com/patents/US20100144788, URL:https://www.google.com/patents/US20100144788|Name:Other, SrcID:http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false, URL:http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false|Name:Wikipedia, SrcID:Tedatioxetine, URL:http://en.wikipedia.org/wiki/Tedatioxetine",Cc1ccc(Sc2ccccc2C3CCNCC3)cc1,CHEMBL238,SLC6A3
2949,CHEMBL1096896,Uk432097,Small molecule,,,,,Adenosine A2a receptor agonist,"Phase 2 trial terminated, poor efficacy results",,CHEMBL251,Adenosine A2a receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16654164, URL:http://www.ncbi.nlm.nih.gov/pubmed/?term=16654164|Name:Wikipedia, SrcID:UK-432,097, URL:http://en.wikipedia.org/wiki/UK-432,097|Name:PubMed, SrcID:22824275, URL:http://europepmc.org/abstract/MED/22824275",CCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(NCC(c4ccccc4)c5ccccc5)nc(nc23)C(=O)NCCNC(=O)NC6CCN(CC6)c7ccccn7,CHEMBL251,ADORA2A
2950,CHEMBL3545038,S-237648,Small molecule,,,,,Neuropeptide Y receptor type 5 antagonist,,,CHEMBL4561,Neuropeptide Y receptor type 5,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.shionogi.co.jp/en/company/pmrltj0000000u4v-att/e_kaihatsu.pdf, URL:http://www.shionogi.co.jp/en/company/pmrltj0000000u4v-att/e_kaihatsu.pdf",,CHEMBL4561,NPY5R
2951,CHEMBL1742420,Amelubant,Small molecule,,,,-lubant,Leukotriene B4 receptor 1 antagonist,Active metabolites are BIIL 260 and BIIL 315,,CHEMBL3911,Leukotriene B4 receptor 1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11259574, URL:http://europepmc.org/abstract/MED/11259574",CCOC(=O)NC(=N)c1ccc(OCc2cccc(COc3ccc(cc3)C(C)(C)c4ccc(O)cc4)c2)cc1,CHEMBL3911,LTB4R
2952,CHEMBL2105864,Labradimil,Protein,,,,,Bradykinin B2 receptor agonist,,,CHEMBL3157,Bradykinin B2 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11286321, URL:http://europepmc.org/abstract/MED/11286321",COc1ccc(C[C@@H](CN[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CO)NC(=O)[C@H](Cc3cccs3)NC(=O)CNC(=O)[C@@H]4C[C@@H](O)CN4C(=O)[C@@H]5CCCN5C(=O)[C@@H](N)CCCN=C(N)N)cc1,CHEMBL3157,BDKRB2
2953,CHEMBL1783282,Azd7325,Small molecule,,,,,GABA receptor alpha-2 subunit positive allosteric modulator,Discontinued by AstraZeneca but in trials by other sponsors. Compound is listed in AstaZeneca's clinical and/or preclinical compound bank and available for research projects.,"Binding affinity is high at GABAAa1, a2 and a3 (Ki of 0.5, 0.3 and 1.3 nM, respectively), but not GA",CHEMBL4956,GABA receptor alpha-2 subunit,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://openinnovation.astrazeneca.com/what-we-offer/compound/azd7325/, URL:http://openinnovation.astrazeneca.com/what-we-offer/compound/azd7325/|Name:PubMed, SrcID:24802722, URL:http://europepmc.org/abstract/MED/24802722|Name:PubMed, SrcID:22122233, URL:http://europepmc.org/abstract/MED/22122233",CCCNC(=O)c1nnc2c(cccc2c1N)c3c(F)cccc3OC,CHEMBL4956,GABRA2
2954,CHEMBL430497,Tebanicline Tosylate,Small molecule,,,,-nicline,Neuronal acetylcholine receptor; alpha4/beta2 agonist,selectivity for the cytisine binding site on CHRNA4,Selectivity for the cytisine binding site on CHRNA4.,CHEMBL1907589,Neuronal acetylcholine receptor; alpha4/beta2,AGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:9580626, URL:http://europepmc.org/abstract/MED/9580626",Clc1ccc(OC[C@H]2CCN2)cn1,,
2955,CHEMBL491473,Cediranib,Small molecule,,L01XE32,L01XE32 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-anib,Vascular endothelial growth factor receptor inhibitor,,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:15899831, URL:http://europepmc.org/abstract/MED/15899831",COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN5CCCC5,,
2956,CHEMBL2103840,Dinaciclib,Small molecule,,,,-ciclib,Cyclin-dependent kinase 5 inhibitor,,,CHEMBL4036,Cyclin-dependent kinase 5,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25215591, URL:http://europepmc.org/abstract/MED/25215591",CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(nc12)N4CCCC[C@H]4CCO,CHEMBL4036,CDK5
2957,CHEMBL2105755,Naldemedine,Small molecule,2017.0,,,nal-,Mu opioid receptor antagonist,,,CHEMBL233,Mu opioid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23900996, URL:http://europepmc.org/abstract/MED/23900996|Name:Other, SrcID:http://www.mdsabstracts.org/abstract/human-derived-synuclein-antibody-biib054-binds-pathologic-forms-of-synuclein-and-attenuates-transmission-of-synuclein-in-vitro-and-in-vivo/, URL:http://www.mdsabstracts.org/abstract/human-derived-synuclein-antibody-biib054-binds-pathologic-forms-of-synuclein-and-attenuates-transmission-of-synuclein-in-vitro-and-in-vivo/|Name:Other, SrcID:http://www.shionogi.com/newsroom/article.html#122494, URL:http://www.shionogi.com/newsroom/article.html#122494|Name:FDA, SrcID:label/2017/208854s000lbl.pdf, URL:https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208854s000lbl.pdf",CC(C)(NC(=O)C1=C(O)[C@@H]2Oc3c(O)ccc4C[C@H]5N(CC6CC6)CC[C@@]2(c34)[C@@]5(O)C1)c7onc(n7)c8ccccc8,CHEMBL233,OPRM1
2958,CHEMBL2107861,Zalutumumab,Antibody,,,,-mab,Epidermal growth factor receptor erbB1 antagonist,"Effectively blocks EGF-R signaling, and can potently induce Ab-dependent cell-mediated cytotoxicity (ADCC).",,CHEMBL203,Epidermal growth factor receptor erbB1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15383606, URL:http://europepmc.org/abstract/MED/15383606",,CHEMBL203,EGFR
2959,CHEMBL3137309,Venetoclax,Small molecule,2016.0,L01XX52,L01XX52 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-toclax,Apoptosis regulator Bcl-2 inhibitor,,,CHEMBL4860,Apoptosis regulator Bcl-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2016/208573s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208573s000lbl.pdf",CC1(C)CCC(=C(C1)c2ccc(Cl)cc2)CN3CCN(CC3)c4ccc(C(=O)NS(=O)(=O)c5ccc(NCC6CCOCC6)c(c5)N(=O)=O)c(Oc7cnc8[nH]ccc8c7)c4,CHEMBL4860,BCL2
2960,CHEMBL3039522,Birinapant,Small molecule,,,,-napant,cIAP1/cIAP2 inhibitor,"Specifically target cIAP1 and cIAP2 for degradation, resulting in a switch in TNFR signaling that leads to activation of caspase-8 and induction of apoptosis",Specifically targets cIAP1 and cIAP2,CHEMBL3038465,cIAP1/cIAP2,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:23403634, URL:http://europepmc.org/abstract/MED/23403634",CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1Cc2c([nH]c3cc(F)ccc23)c4[nH]c5cc(F)ccc5c4C[C@@H]6C[C@H](O)CN6C(=O)[C@H](CC)NC(=O)[C@H](C)NC,,
2961,CHEMBL190461,Cannabidiol,Small molecule,,,,-nab-,Cannabinoid CB1 receptor Negative allosteric modulator,,,CHEMBL218,Cannabinoid CB1 receptor,NEGATIVE ALLOSTERIC MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26218440, URL:http://europepmc.org/abstract/MED/26218440",CCCCCc1cc(O)c([C@@H]2C=C(C)CC[C@H]2C(=C)C)c(O)c1,CHEMBL218,CNR1
2962,CHEMBL218166,Bifeprunox,Small molecule,,,,,Dopamine D2 receptor partial agonist,,"High affinity: D3 and D4 receptors. Low affinity: a1, 5HT2A, 5HT2C, H1 and muscarinic receptors",CHEMBL217,Dopamine D2 receptor,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18597078, URL:http://europepmc.org/abstract/MED/18597078",O=C1Nc2cccc(N3CCN(Cc4cccc(c4)c5ccccc5)CC3)c2O1,CHEMBL217,DRD2
2963,CHEMBL1743085,Urelumab,Antibody,,,,-mab,Tumor necrosis factor receptor superfamily member 9 agonist,,,CHEMBL3712857,Tumor necrosis factor receptor superfamily member 9,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26137403, URL:http://europepmc.org/abstract/MED/26137403|Name:Other, SrcID:http://meetinglibrary.asco.org/content/130145-144, URL:http://meetinglibrary.asco.org/content/130145-144",,CHEMBL3712857,TNFRSF9
2964,CHEMBL2109381,Bhq-880,Antibody,,,,,Dickkopf-related protein 1 inhibitor,Can neutralize both human DKK1 and murine DKK1.,,CHEMBL6024,Dickkopf-related protein 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19417213, URL:http://europepmc.org/abstract/MED/19417213",,CHEMBL6024,DKK1
2965,CHEMBL3833331,Biib061,Small molecule,,,,,Unknown,May lead to replacement of myelin on damaged nerve fibres,,,,,,,,,"Name:Other, SrcID:https://www.biogen.com/en_us/research-pipeline/biogen-pipeline.html, URL:https://www.biogen.com/en_us/research-pipeline/biogen-pipeline.html",,,
2966,CHEMBL481,Irinotecan,Small molecule,1996.0,L01XX19,L01XX19 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-tecan,DNA topoisomerase I inhibitor,,,CHEMBL1781,DNA topoisomerase I,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=80f3b79c-a399-45b3-b755-8535457719af, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80f3b79c-a399-45b3-b755-8535457719af",CCc1c2CN3C(=O)C4=C(C=C3c2nc5ccc(OC(=O)N6CCC(CC6)N7CCCCC7)cc15)[C@@](O)(CC)C(=O)OC4,CHEMBL1781,TOP1
2967,CHEMBL1505,Almotriptan,Small molecule,2001.0,N02CC05,N02CC05 [NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Selective serotonin (5HT1) agonists],-triptan,Serotonin 1f (5-HT1f) receptor agonist,,Selective,CHEMBL1805,Serotonin 1f (5-HT1f) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2009/021001s010s011lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021001s010s011lbl.pdf",CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12,CHEMBL1805,HTR1F
2968,CHEMBL24778,Silodosin,Small molecule,2008.0,G04CA04,G04CA04 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY: Alpha-adrenoreceptor antagonists],,Alpha-1a adrenergic receptor antagonist,,,CHEMBL229,Alpha-1a adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=96425d91-cfe1-477d-a130-b58c330ca8a3#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=96425d91-cfe1-477d-a130-b58c330ca8a3#nlm34090-1",C[C@H](Cc1cc2CCN(CCCO)c2c(c1)C(=O)N)NCCOc3ccccc3OCC(F)(F)F,CHEMBL229,ADRA1A
2969,CHEMBL500,Pindolol,Small molecule,1982.0,C07AA03,"C07AA03 [CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, non-selective]",-olol,Beta-1 adrenergic receptor partial agonist,,,CHEMBL213,Beta-1 adrenergic receptor,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=07fe9cc3-1ef2-420c-b45d-7f1e894b6ef9, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=07fe9cc3-1ef2-420c-b45d-7f1e894b6ef9",CC(C)NCC(O)COc1cccc2[nH]ccc12,,
2970,CHEMBL1110,Alosetron,Small molecule,2000.0,A03AE01,A03AE01 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: Serotonin receptor antagonists],-setron,Serotonin 3a (5-HT3a) receptor antagonist,,,CHEMBL1899,Serotonin 3a (5-HT3a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=526ba44c-a476-4675-a63c-4d0a72b723f5, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=526ba44c-a476-4675-a63c-4d0a72b723f5",Cc1[nH]cnc1CN2CCc3c(C2=O)c4ccccc4n3C,CHEMBL1899,HTR3A
2971,CHEMBL621,Trazodone,Small molecule,1981.0,N06AX05,N06AX05 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants],,Serotonin transporter inhibitor,,,CHEMBL228,Serotonin transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=88c45123-f475-4dd0-bbac-c261868924ef#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=88c45123-f475-4dd0-bbac-c261868924ef#nlm34090-1|Name:FDA, SrcID:label/2013/071258Orig1s040, 071196Orig1s063lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/071258Orig1s040, 071196Orig1s063lbl.pdf",Clc1cccc(c1)N2CCN(CCCN3N=C4C=CC=CN4C3=O)CC2,CHEMBL228,SLC6A4
2972,CHEMBL479,Thioridazine,Small molecule,1962.0,N05AC02,N05AC02 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Phenothiazines with piperidine structure],,Serotonin 2c (5-HT2c) receptor antagonist,,,CHEMBL225,Serotonin 2c (5-HT2c) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=b8d8c29a-414d-4622-bffd-b742725b20f0#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b8d8c29a-414d-4622-bffd-b742725b20f0#nlm34090-1|Name:DailyMed, SrcID:archiveid=143101, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=143101|Name:ISBN, SrcID:0443-059748 PP. 542, URL:http://www.isbnsearch.org/isbn/0443059748",CSc1ccc2Sc3ccccc3N(CCC4CCCCN4C)c2c1,,
2973,CHEMBL644,Trimipramine,Small molecule,1979.0,N06AA06,N06AA06 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Non-selective monoamine reuptake inhibitors],-pramine,Serotonin 2c (5-HT2c) receptor antagonist,,,CHEMBL225,Serotonin 2c (5-HT2c) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16229049, URL:http://europepmc.org/abstract/MED/16229049|Name:ISBN, SrcID:0443-059748 PP. 555, URL:http://www.isbnsearch.org/isbn/0443059748|Name:Wikipedia, SrcID:Trimipramine, URL:http://en.wikipedia.org/wiki/Trimipramine",CC(CN(C)C)CN1c2ccccc2CCc3ccccc13,,
2974,CHEMBL33986,Butorphanol,Small molecule,1978.0,N02AF01,N02AF01 [NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Morphinan derivatives],-orphan-,Mu opioid receptor partial agonist,May be mixed agonist/antagonist,,CHEMBL233,Mu opioid receptor,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=b8e48063-0b40-ee43-85c1-4ef2de80c404#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b8e48063-0b40-ee43-85c1-4ef2de80c404#nlm34090-1",Oc1ccc2C[C@H]3N(CC4CCC4)CC[C@@]5(CCCC[C@@]35O)c2c1,CHEMBL233,OPRM1
2975,CHEMBL765,Guanethidine,Small molecule,1960.0,C02CC02; S01EX01,"C02CC02 [CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING: Guanidine derivatives]; S01EX01 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Other antiglaucoma preparations]",guan-,Norepinephrine transporter substrate,Taken up by transporter and displaces NE from vesicles,,CHEMBL222,Norepinephrine transporter,SUBSTRATE,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11403930, URL:http://europepmc.org/abstract/MED/11403930|Name:Wikipedia, SrcID:Guanethidine, URL:http://en.wikipedia.org/wiki/Guanethidine",NC(=N)NCCN1CCCCCCC1,CHEMBL222,SLC6A2
2976,CHEMBL107,Colchicine,Small molecule,1961.0,M04AC01,M04AC01 [MUSCULO-SKELETAL SYSTEM: ANTIGOUT PREPARATIONS: ANTIGOUT PREPARATIONS: Preparations with no effect on uric acid metabolism],,Tubulin inhibitor,Inhibits microtubule assembly,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin colchine binding site,Binds to beta tubulin,"Name:PubMed, SrcID:15720245, URL:http://europepmc.org/abstract/MED/15720245|Name:DailyMed, SrcID:setid=5ecaa34e-1bed-49a5-b97c-a8f8c0d885a7, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ecaa34e-1bed-49a5-b97c-a8f8c0d885a7",COC1=CC=C2C(=CC1=O)[C@H](CCc3cc(OC)c(OC)c(OC)c23)NC(=O)C,CHEMBL2095182,TUBB8
2977,CHEMBL107,Colchicine,Small molecule,1961.0,M04AC01,M04AC01 [MUSCULO-SKELETAL SYSTEM: ANTIGOUT PREPARATIONS: ANTIGOUT PREPARATIONS: Preparations with no effect on uric acid metabolism],,Tubulin inhibitor,Inhibits microtubule assembly,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin colchine binding site,Binds to beta tubulin,"Name:PubMed, SrcID:15720245, URL:http://europepmc.org/abstract/MED/15720245|Name:DailyMed, SrcID:setid=5ecaa34e-1bed-49a5-b97c-a8f8c0d885a7, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ecaa34e-1bed-49a5-b97c-a8f8c0d885a7",COC1=CC=C2C(=CC1=O)[C@H](CCc3cc(OC)c(OC)c(OC)c23)NC(=O)C,CHEMBL2095182,TUBA3C
2978,CHEMBL107,Colchicine,Small molecule,1961.0,M04AC01,M04AC01 [MUSCULO-SKELETAL SYSTEM: ANTIGOUT PREPARATIONS: ANTIGOUT PREPARATIONS: Preparations with no effect on uric acid metabolism],,Tubulin inhibitor,Inhibits microtubule assembly,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin colchine binding site,Binds to beta tubulin,"Name:PubMed, SrcID:15720245, URL:http://europepmc.org/abstract/MED/15720245|Name:DailyMed, SrcID:setid=5ecaa34e-1bed-49a5-b97c-a8f8c0d885a7, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ecaa34e-1bed-49a5-b97c-a8f8c0d885a7",COC1=CC=C2C(=CC1=O)[C@H](CCc3cc(OC)c(OC)c(OC)c23)NC(=O)C,CHEMBL2095182,TUBA4A
2979,CHEMBL107,Colchicine,Small molecule,1961.0,M04AC01,M04AC01 [MUSCULO-SKELETAL SYSTEM: ANTIGOUT PREPARATIONS: ANTIGOUT PREPARATIONS: Preparations with no effect on uric acid metabolism],,Tubulin inhibitor,Inhibits microtubule assembly,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin colchine binding site,Binds to beta tubulin,"Name:PubMed, SrcID:15720245, URL:http://europepmc.org/abstract/MED/15720245|Name:DailyMed, SrcID:setid=5ecaa34e-1bed-49a5-b97c-a8f8c0d885a7, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ecaa34e-1bed-49a5-b97c-a8f8c0d885a7",COC1=CC=C2C(=CC1=O)[C@H](CCc3cc(OC)c(OC)c(OC)c23)NC(=O)C,CHEMBL2095182,TUBA3E
2980,CHEMBL107,Colchicine,Small molecule,1961.0,M04AC01,M04AC01 [MUSCULO-SKELETAL SYSTEM: ANTIGOUT PREPARATIONS: ANTIGOUT PREPARATIONS: Preparations with no effect on uric acid metabolism],,Tubulin inhibitor,Inhibits microtubule assembly,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin colchine binding site,Binds to beta tubulin,"Name:PubMed, SrcID:15720245, URL:http://europepmc.org/abstract/MED/15720245|Name:DailyMed, SrcID:setid=5ecaa34e-1bed-49a5-b97c-a8f8c0d885a7, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ecaa34e-1bed-49a5-b97c-a8f8c0d885a7",COC1=CC=C2C(=CC1=O)[C@H](CCc3cc(OC)c(OC)c(OC)c23)NC(=O)C,CHEMBL2095182,TUBB6
2981,CHEMBL107,Colchicine,Small molecule,1961.0,M04AC01,M04AC01 [MUSCULO-SKELETAL SYSTEM: ANTIGOUT PREPARATIONS: ANTIGOUT PREPARATIONS: Preparations with no effect on uric acid metabolism],,Tubulin inhibitor,Inhibits microtubule assembly,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin colchine binding site,Binds to beta tubulin,"Name:PubMed, SrcID:15720245, URL:http://europepmc.org/abstract/MED/15720245|Name:DailyMed, SrcID:setid=5ecaa34e-1bed-49a5-b97c-a8f8c0d885a7, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ecaa34e-1bed-49a5-b97c-a8f8c0d885a7",COC1=CC=C2C(=CC1=O)[C@H](CCc3cc(OC)c(OC)c(OC)c23)NC(=O)C,CHEMBL2095182,TUBB2B
2982,CHEMBL107,Colchicine,Small molecule,1961.0,M04AC01,M04AC01 [MUSCULO-SKELETAL SYSTEM: ANTIGOUT PREPARATIONS: ANTIGOUT PREPARATIONS: Preparations with no effect on uric acid metabolism],,Tubulin inhibitor,Inhibits microtubule assembly,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin colchine binding site,Binds to beta tubulin,"Name:PubMed, SrcID:15720245, URL:http://europepmc.org/abstract/MED/15720245|Name:DailyMed, SrcID:setid=5ecaa34e-1bed-49a5-b97c-a8f8c0d885a7, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ecaa34e-1bed-49a5-b97c-a8f8c0d885a7",COC1=CC=C2C(=CC1=O)[C@H](CCc3cc(OC)c(OC)c(OC)c23)NC(=O)C,CHEMBL2095182,TUBA3D
2983,CHEMBL1200826,Lithium Carbonate,Small molecule,1970.0,N05AN01,N05AN01 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Lithium],,Glycogen synthase kinase-3 inhibitor,,,CHEMBL2095188,Glycogen synthase kinase-3,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=84d579dd-f12b-b727-6380-fd217ec115db#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=84d579dd-f12b-b727-6380-fd217ec115db#nlm34090-1|Name:FDA, SrcID:label/2011/018027s056lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018027s056lbl.pdf|Name:PubMed, SrcID:22707923, URL:http://europepmc.org/abstract/MED/22707923|Name:Wikipedia, SrcID:Lithium_(medication), URL:http://en.wikipedia.org/wiki/Lithium_(medication)",[Li+].[Li+].[O-]C(=O)[O-],,
2984,CHEMBL900,Orphenadrine,Small molecule,1957.0,M03BC51,"M03BC51 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS: Ethers, chemically close to antihistamines]",-drine,Glutamate [NMDA] receptor antagonist,,,CHEMBL2094124,Glutamate [NMDA] receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:19217209, URL:http://europepmc.org/abstract/MED/19217209|Name:PubMed, SrcID:20716669, URL:http://europepmc.org/abstract/MED/20716669|Name:PubMed, SrcID:8788072, URL:http://europepmc.org/abstract/MED/8788072",CN(C)CCOC(c1ccccc1)c2ccccc2C,CHEMBL2094124,GRIN3B
2985,CHEMBL862,Guanfacine,Small molecule,1986.0,C02AC02,"C02AC02 [CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ANTIADRENERGIC AGENTS, CENTRALLY ACTING: Imidazoline receptor agonists]",guan-,Adrenergic receptor alpha-2 agonist,,,CHEMBL2095158,Adrenergic receptor alpha-2,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=e889f164-a92c-412d-960a-59391e4151fe, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e889f164-a92c-412d-960a-59391e4151fe",NC(=N)NC(=O)Cc1c(Cl)cccc1Cl,,
2986,CHEMBL459,Methyldopa,Small molecule,1962.0,C02AB01,"C02AB01 [CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ANTIADRENERGIC AGENTS, CENTRALLY ACTING: Methyldopa]",-dopa,Adrenergic receptor alpha-2 agonist,,,CHEMBL2095158,Adrenergic receptor alpha-2,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2004/13400s086lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/13400s086lbl.pdf|Name:PubMed, SrcID:2841084, URL:http://europepmc.org/abstract/MED/2841084",C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O,,
2987,CHEMBL686,Mefenamic Acid,Small molecule,1967.0,M01AG01,"M01AG01 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Fenamates]",,Cyclooxygenase inhibitor,,,CHEMBL2094253,Cyclooxygenase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10377455, URL:http://europepmc.org/abstract/MED/10377455|Name:PubMed, SrcID:9626023, URL:http://europepmc.org/abstract/MED/9626023",Cc1cccc(Nc2ccccc2C(=O)O)c1C,,
2988,CHEMBL673,Pargyline,Small molecule,1982.0,C02KC01,C02KC01 [CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: OTHER ANTIHYPERTENSIVES: MAO inhibitors],,Monoamine oxidase inhibitor,,,CHEMBL2095205,Monoamine oxidase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Wikipedia, SrcID:Pargyline, URL:http://en.wikipedia.org/wiki/Pargyline|Name:PubMed, SrcID:9564606, URL:http://europepmc.org/abstract/MED/9564606",CN(CC#C)Cc1ccccc1,,
2989,CHEMBL1750,Clofarabine,Small molecule,2004.0,L01BB06,L01BB06 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Purine analogues],-arabine,Ribonucleoside-diphosphate reductase RR1 inhibitor,,,CHEMBL2095215,Ribonucleoside-diphosphate reductase RR1,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Ribonucleoside-diphosphate reductase M1 subunit,M1 subunit is binding site,"Name:PubMed, SrcID:23115527, URL:http://europepmc.org/abstract/MED/23115527|Name:DailyMed, SrcID:setid=c35903cd-e9eb-4841-93d1-fc14249d1e9f#section-12, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c35903cd-e9eb-4841-93d1-fc14249d1e9f#section-12|Name:PubMed, SrcID:21628579, URL:http://europepmc.org/abstract/MED/21628579",Nc1nc(Cl)nc2c1ncn2[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3F,,
2990,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Laminin hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364187,Laminin,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364187,LAMA5
2991,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Laminin hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364187,Laminin,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364187,LAMC3
2992,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Laminin hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364187,Laminin,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364187,LAMA1
2993,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Laminin hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364187,Laminin,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364187,LAMA2
2994,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Laminin hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364187,Laminin,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364187,LAMC1
2995,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Laminin hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364187,Laminin,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364187,LAMC2
2996,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Laminin hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364187,Laminin,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364187,LAMB1
2997,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Laminin hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364187,Laminin,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364187,LAMB4
2998,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Laminin hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364187,Laminin,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364187,LAMB3
2999,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Laminin hydrolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL2364187,Laminin,HYDROLYTIC ENZYME,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL2364187,LAMB2
3000,CHEMBL729,Lopinavir,Small molecule,2000.0,,,-vir,Human immunodeficiency virus type 1 protease inhibitor,,,CHEMBL243,Human immunodeficiency virus type 1 protease,INHIBITOR,Human immunodeficiency virus 1,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/021906s042,021251s049lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021906s042,021251s049lbl.pdf|Name:DailyMed, SrcID:setid=68e860d7-4adc-418a-ba12-233ccdf85d0a, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=68e860d7-4adc-418a-ba12-233ccdf85d0a",CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](Cc2ccccc2)NC(=O)COc3c(C)cccc3C)Cc4ccccc4,,
3001,CHEMBL1213252,Clorazepic Acid,Small molecule,1972.0,,,,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:FDA, SrcID:label/2010/017105s076lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/017105s076lbl.pdf|Name:ISBN, SrcID:9780702034718 PP. 533, URL:http://www.isbnsearch.org/isbn/9780702034718",OC(=O)C1N=C(c2ccccc2)c3cc(Cl)ccc3NC1=O,CHEMBL2093872,GABRG3
3002,CHEMBL1213252,Clorazepic Acid,Small molecule,1972.0,,,,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:FDA, SrcID:label/2010/017105s076lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/017105s076lbl.pdf|Name:ISBN, SrcID:9780702034718 PP. 533, URL:http://www.isbnsearch.org/isbn/9780702034718",OC(=O)C1N=C(c2ccccc2)c3cc(Cl)ccc3NC1=O,CHEMBL2093872,GABRP
3003,CHEMBL1213252,Clorazepic Acid,Small molecule,1972.0,,,,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:FDA, SrcID:label/2010/017105s076lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/017105s076lbl.pdf|Name:ISBN, SrcID:9780702034718 PP. 533, URL:http://www.isbnsearch.org/isbn/9780702034718",OC(=O)C1N=C(c2ccccc2)c3cc(Cl)ccc3NC1=O,CHEMBL2093872,GABRE
3004,CHEMBL1213252,Clorazepic Acid,Small molecule,1972.0,,,,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:FDA, SrcID:label/2010/017105s076lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/017105s076lbl.pdf|Name:ISBN, SrcID:9780702034718 PP. 533, URL:http://www.isbnsearch.org/isbn/9780702034718",OC(=O)C1N=C(c2ccccc2)c3cc(Cl)ccc3NC1=O,CHEMBL2093872,GABRG1
3005,CHEMBL454,Butalbital,Small molecule,1983.0,,,,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:PubMed, SrcID:10209232, URL:http://europepmc.org/abstract/MED/10209232|Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL2093872,GABRG3
3006,CHEMBL454,Butalbital,Small molecule,1983.0,,,,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:PubMed, SrcID:10209232, URL:http://europepmc.org/abstract/MED/10209232|Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL2093872,GABRP
3007,CHEMBL454,Butalbital,Small molecule,1983.0,,,,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:PubMed, SrcID:10209232, URL:http://europepmc.org/abstract/MED/10209232|Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL2093872,GABRE
3008,CHEMBL454,Butalbital,Small molecule,1983.0,,,,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:PubMed, SrcID:10209232, URL:http://europepmc.org/abstract/MED/10209232|Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL2093872,GABRG1
3009,CHEMBL448,Pentobarbital,Small molecule,1973.0,N05CA01,"N05CA01 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Barbiturates, plain]",-barb-,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:PubMed, SrcID:8961191, URL:http://europepmc.org/abstract/MED/8961191|Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449|Name:PubMed, SrcID:23205959, URL:http://europepmc.org/abstract/MED/23205959",CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,CHEMBL2093872,GABRG3
3010,CHEMBL448,Pentobarbital,Small molecule,1973.0,N05CA01,"N05CA01 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Barbiturates, plain]",-barb-,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:PubMed, SrcID:8961191, URL:http://europepmc.org/abstract/MED/8961191|Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449|Name:PubMed, SrcID:23205959, URL:http://europepmc.org/abstract/MED/23205959",CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,CHEMBL2093872,GABRP
3011,CHEMBL448,Pentobarbital,Small molecule,1973.0,N05CA01,"N05CA01 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Barbiturates, plain]",-barb-,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:PubMed, SrcID:8961191, URL:http://europepmc.org/abstract/MED/8961191|Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449|Name:PubMed, SrcID:23205959, URL:http://europepmc.org/abstract/MED/23205959",CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,CHEMBL2093872,GABRE
3012,CHEMBL448,Pentobarbital,Small molecule,1973.0,N05CA01,"N05CA01 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Barbiturates, plain]",-barb-,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:PubMed, SrcID:8961191, URL:http://europepmc.org/abstract/MED/8961191|Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449|Name:PubMed, SrcID:23205959, URL:http://europepmc.org/abstract/MED/23205959",CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,CHEMBL2093872,GABRG1
3013,CHEMBL441,Thiopental,Small molecule,1982.0,N05CA19; N01AF03,"N05CA19 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Barbiturates, plain]; N01AF03 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Barbiturates, plain]",,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:ISBN, SrcID:0721603246 PP. 113, URL:http://www.isbnsearch.org/isbn/0721603246|Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,CHEMBL2093872,GABRG3
3014,CHEMBL441,Thiopental,Small molecule,1982.0,N05CA19; N01AF03,"N05CA19 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Barbiturates, plain]; N01AF03 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Barbiturates, plain]",,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:ISBN, SrcID:0721603246 PP. 113, URL:http://www.isbnsearch.org/isbn/0721603246|Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,CHEMBL2093872,GABRP
3015,CHEMBL441,Thiopental,Small molecule,1982.0,N05CA19; N01AF03,"N05CA19 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Barbiturates, plain]; N01AF03 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Barbiturates, plain]",,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:ISBN, SrcID:0721603246 PP. 113, URL:http://www.isbnsearch.org/isbn/0721603246|Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,CHEMBL2093872,GABRE
3016,CHEMBL441,Thiopental,Small molecule,1982.0,N05CA19; N01AF03,"N05CA19 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Barbiturates, plain]; N01AF03 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Barbiturates, plain]",,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:ISBN, SrcID:0721603246 PP. 113, URL:http://www.isbnsearch.org/isbn/0721603246|Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,CHEMBL2093872,GABRG1
3017,CHEMBL1200688,Erythromycin Ethylsuccinate,Small molecule,1965.0,,,-mycin,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,23S ribosomal RNA,23S RRNA,"Name:PubMed, SrcID:20876130, URL:http://europepmc.org/abstract/MED/20876130|Name:DailyMed, SrcID:setid=b455bbdb-a3f1-470f-aa5f-ed83ac2e228d#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b455bbdb-a3f1-470f-aa5f-ed83ac2e228d#nlm34090-1",CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,,
3018,CHEMBL1256,Isoflurane,Small molecule,1979.0,N01AB06,"N01AB06 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,Potassium channel subfamily K member 10 opener,,,CHEMBL2331041,Potassium channel subfamily K member 10,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:11605899, URL:http://europepmc.org/abstract/MED/11605899|Name:PubMed, SrcID:17227289, URL:http://europepmc.org/abstract/MED/17227289",FC(F)OC(Cl)C(F)(F)F,CHEMBL2331041,KCNK10
3019,CHEMBL1087,Mepivacaine,Small molecule,1960.0,N01BB03; N01BB53,"N01BB03 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Amides]; N01BB53 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Amides]",-caine,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:8799190, URL:http://europepmc.org/abstract/MED/8799190|Name:PubMed, SrcID:15635807, URL:http://europepmc.org/abstract/MED/15635807",CN1CCCCC1C(=O)Nc2c(C)cccc2C,,
3020,CHEMBL1200838,Simethicone,Small molecule,1996.0,,,,Antifoaming agent,Rupture of thick liquid films by surface tension disruption,,,,,,,,,"Name:PubMed, SrcID:8083482, URL:http://europepmc.org/abstract/MED/8083482|Name:Wikipedia, SrcID:Simethicone, URL:http://en.wikipedia.org/wiki/Simethicone",CC(C)(C)[SiH2]O[Si](C)(C)O[SiH2]C(C)(C)C,,
3021,CHEMBL1200375,Edetate Calcium Disodium,Small molecule,1953.0,,,,Unknown,,,,,,,,,,"Name:FDA, SrcID:label/2009/008922s016lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/008922s016lbl.pdf",[Na+].[Na+].[Ca+2].[O-]C(=O)CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-],,
3022,CHEMBL1413,Ciclopirox,Small molecule,1982.0,G01AX12; D01AE14,"G01AX12 [GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Other antiinfectives and antiseptics]; D01AE14 [DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Other antifungals for topical use]",-pirox,Aluminium chelating agent,Trivalent metal cations chelating agent; inhibition of the metal-dependent enzymes that are responsible for the degradation of peroxides within the fungal cell,,CHEMBL2366381,Aluminium,CHELATING AGENT,,METAL,,,"Name:PubMed, SrcID:23416050, URL:http://europepmc.org/abstract/MED/23416050|Name:PubMed, SrcID:20964457, URL:http://europepmc.org/abstract/MED/20964457|Name:Wikipedia, SrcID:Ciclopirox#cite_note-pmid12760852-4, URL:http://en.wikipedia.org/wiki/Ciclopirox#cite_note-pmid12760852-4",CC1=CC(=O)N(O)C(=C1)C2CCCCC2,,
3023,CHEMBL2108074,Pancrelipase,Enzyme,1996.0,A09AA02,"A09AA02 [ALIMENTARY TRACT AND METABOLISM: DIGESTIVES, INCL. ENZYMES: DIGESTIVES, INCL. ENZYMES: Enzyme preparations]",-ase,Polypeptides hydrolytic enzyme,,,CHEMBL2364181,Polypeptides,HYDROLYTIC ENZYME,Homo sapiens,MACROMOLECULE,,,"Name:DailyMed, SrcID:setid=073201aa-556d-4a70-918e-84e9616fd88d#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=073201aa-556d-4a70-918e-84e9616fd88d#nlm34090-1",,,
3024,CHEMBL2105760,Brexpiprazole,Small molecule,2015.0,N05AX16,N05AX16 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Other antipsychotics],-prazole,Dopamine D2 receptor partial agonist,,,CHEMBL217,Dopamine D2 receptor,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/205422s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205422s000lbl.pdf",O=C1Nc2cc(OCCCCN3CCN(CC3)c4cccc5sccc45)ccc2C=C1,CHEMBL217,DRD2
3025,CHEMBL2219425,Aripiprazole Lauroxil,Unknown,2015.0,,,-prazole,Serotonin 2a (5-HT2a) receptor antagonist,Prodrug of aripiprazole,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=17a8d11b-73b0-4833-a0b4-cf1ef85edefb, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17a8d11b-73b0-4833-a0b4-cf1ef85edefb",CCCCCCCCCCCC(=O)OCN1C(=O)CCc2ccc(OCCCCN3CCN(CC3)c4cccc(Cl)c4Cl)cc12,CHEMBL224,HTR2A
3026,CHEMBL3545046,Gsk2849466,Small molecule,,,,,Androgen Receptor modulator,"Selective androgen receptor modulator (SARM). Ph1 study completed, compound not in pipeline published in February 2014.",,CHEMBL1871,Androgen Receptor,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.glaxosmithkline.de/docs-pdf/forschung/GSK-product-pipeline-Feb-2013.pdf, URL:http://www.glaxosmithkline.de/docs-pdf/forschung/GSK-product-pipeline-Feb-2013.pdf",,CHEMBL1871,AR
3027,CHEMBL3545284,Cerdulatinib,Small molecule,,,,-tinib,Tyrosine-protein kinase JAK1 inhibitor,Dual spleen tyrosine kinase (Syk) and janus kinase (JAK) inhibitor,,CHEMBL2835,Tyrosine-protein kinase JAK1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://www.portola.com/clinical-development/cerdulatinib-dual-syk-jak-inhibitor/l-development/cerdulatinib-dual-syk-jak-inhibitor/, URL:https://www.portola.com/clinical-development/cerdulatinib-dual-syk-jak-inhibitor/l-development/cerdulatinib-dual-syk-jak-inhibitor/|Name:PubMed, SrcID:25253883, URL:http://europepmc.org/abstract/MED/25253883",,CHEMBL2835,JAK1
3028,CHEMBL3545241,Ac-430,Small molecule,,,,,Tyrosine-protein kinase JAK2 inhibitor,,,CHEMBL2971,Tyrosine-protein kinase JAK2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.blackwellpublishing.com/acrmeeting/abstract.asp?MeetingID=774&id=88924, URL:http://www.blackwellpublishing.com/acrmeeting/abstract.asp?MeetingID=774&id=88924",Cc1cc(Nc2nc(nc3ccccc23)C(O)c4ccc(F)cc4)n[nH]1,CHEMBL2971,JAK2
3029,CHEMBL3545424,Azd-8186,Small molecule,,,,,PI3-kinase p110-delta subunit inhibitor,,,CHEMBL3130,PI3-kinase p110-delta subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25514658, URL:http://europepmc.org/abstract/MED/25514658",,CHEMBL3130,PIK3CD
3030,CHEMBL3545080,Rg-7256,Small molecule,,,,,Serine/threonine-protein kinase B-raf inhibitor,Mutant BRAF (V600E) kinase inhibitor,,CHEMBL5145,Serine/threonine-protein kinase B-raf,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26310975, URL:http://europepmc.org/abstract/MED/26310975",,CHEMBL5145,BRAF
3031,CHEMBL3544931,Tak-659,Small molecule,,,,,Tyrosine-protein kinase SYK inhibitor,,,CHEMBL2599,Tyrosine-protein kinase SYK,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://meetinglibrary.asco.org/content/134551-144, URL:http://meetinglibrary.asco.org/content/134551-144|Name:Other, SrcID:https://ash.confex.com/ash/2014/webprogram/Paper67380.html, URL:https://ash.confex.com/ash/2014/webprogram/Paper67380.html",,CHEMBL2599,SYK
3032,CHEMBL1944698,Tg-02,Small molecule,,,,,Tyrosine-protein kinase JAK2 inhibitor,,,CHEMBL2971,Tyrosine-protein kinase JAK2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21860433, URL:http://europepmc.org/abstract/MED/21860433",CN1C\C=C\CCOc2cccc(c2)c3ccnc(Nc4cccc(C1)c4)n3,CHEMBL2971,JAK2
3033,CHEMBL3545385,Wx-037,Small molecule,,,,,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=750893, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=750893|Name:Other, SrcID:http://www.wilex.de/press-investors/announcements/press-releases/20130807-2/, URL:http://www.wilex.de/press-investors/announcements/press-releases/20130807-2/",,CHEMBL3559703,PIK3R2
3034,CHEMBL3545385,Wx-037,Small molecule,,,,,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=750893, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=750893|Name:Other, SrcID:http://www.wilex.de/press-investors/announcements/press-releases/20130807-2/, URL:http://www.wilex.de/press-investors/announcements/press-releases/20130807-2/",,CHEMBL3559703,PIK3R3
3035,CHEMBL3545385,Wx-037,Small molecule,,,,,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=750893, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=750893|Name:Other, SrcID:http://www.wilex.de/press-investors/announcements/press-releases/20130807-2/, URL:http://www.wilex.de/press-investors/announcements/press-releases/20130807-2/",,CHEMBL3559703,PIK3R5
3036,CHEMBL260933,Gs 6201,Small molecule,,,,,Adenosine A2b receptor antagonist,,,CHEMBL255,Adenosine A2b receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16654164, URL:http://www.ncbi.nlm.nih.gov/pubmed/?term=16654164|Name:PubMed, SrcID:18568423, URL:http://europepmc.org/abstract/MED/18568423",CCCN1C(=O)N(CC)c2nc([nH]c2C1=O)c3cnn(Cc4cccc(c4)C(F)(F)F)c3,CHEMBL255,ADORA2B
3037,CHEMBL2181753,Am-211,Small molecule,,,,,G protein-coupled receptor 44 antagonist,Indication: Allergic diseases,,CHEMBL5071,G protein-coupled receptor 44,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.panmira.com/pipeline.html, URL:http://www.panmira.com/pipeline.html",CCN(Cc1cc(ccc1c2cc(CC(=O)O)ccc2OC)C(F)(F)F)C(=O)NCc3ccccc3,CHEMBL5071,PTGDR2
3038,CHEMBL3545389,Ly2245461,Small molecule,,,,,Estrogen receptor modulator,SERM,,CHEMBL2093866,Estrogen receptor,MODULATOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://ncats.nih.gov/files/LY2245461.pdf, URL:http://ncats.nih.gov/files/LY2245461.pdf",,,
3039,CHEMBL3545092,Cr 1447,Small molecule,,,,,Androgen Receptor agonist,Main metabolite is ESR2 agonist (:http://www.curadis.eu/index.php?page=cr-1447),,CHEMBL1871,Androgen Receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.curadis.eu/index.php?page=cr-1447, URL:http://www.curadis.eu/index.php?page=cr-1447",,CHEMBL1871,AR
3040,CHEMBL3545153,De-104,Small molecule,,,,,Rho-associated protein kinase inhibitor,,,CHEMBL2111459,Rho-associated protein kinase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:24872673, URL:http://europepmc.org/abstract/MED/24872673",,,
3041,CHEMBL2110670,Vabicaserin,Small molecule,,,,-caserin,Serotonin 2c (5-HT2c) receptor agonist,,,CHEMBL225,Serotonin 2c (5-HT2c) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21402690, URL:http://europepmc.org/abstract/MED/21402690",C1C[C@H]2CN3CCNCc4cccc([C@H]2C1)c34,,
3042,CHEMBL3301626,Basimglurant,Small molecule,,,,-glurant,Metabotropic glutamate receptor 5 modulator,Negative allosteric modulator (NAM),,CHEMBL3227,Metabotropic glutamate receptor 5,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.roche.com/de/irp2q14e-annex.pdf, URL:http://www.roche.com/de/irp2q14e-annex.pdf|Name:Other, SrcID:http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm, URL:http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm",Cc1nc(C#Cc2ccnc(Cl)c2)c(C)n1c3ccc(F)cc3,CHEMBL3227,GRM5
3043,CHEMBL2103829,Faxeladol,Small molecule,,,,-adol,Serotonin transporter inhibitor,,,CHEMBL228,Serotonin transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22337471, URL:http://europepmc.org/abstract/MED/22337471",CN(C)C[C@@H]1CCCC[C@H]1c2cccc(O)c2,CHEMBL228,SLC6A4
3044,CHEMBL431651,Enrasentan,Small molecule,,,,-entan,Endothelin receptor ET-A antagonist,,,CHEMBL252,Endothelin receptor ET-A,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:8632328, URL:http://europepmc.org/abstract/MED/8632328",CCCOc1ccc2[C@@H]([C@H]([C@H](c3ccc(OC)cc3OCCO)c2c1)C(=O)O)c4ccc5OCOc5c4,CHEMBL252,EDNRA
3045,CHEMBL3545169,Azd1305,Small molecule,,,,,Sodium channel protein type V alpha subunit blocker,"L-type calcium channel (CACNA1C, CACNA1D, CACNA1S, CACNA1F)",,CHEMBL1980,Sodium channel protein type V alpha subunit,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20233758, URL:http://europepmc.org/abstract/MED/20233758|Name:PubMed, SrcID:19528812, URL:http://europepmc.org/abstract/MED/19528812|Name:Wikipedia, SrcID:AZD1305, URL:http://en.wikipedia.org/wiki/AZD1305",CC(C)(C)OC(=O)NCCN1CC2CN(CCOc3ccc(cc3F)C#N)CC(C1)O2,CHEMBL1980,SCN5A
3046,CHEMBL2104753,Rivoglitazone,Small molecule,,,,-glitazone,Peroxisome proliferator-activated receptor gamma agonist,"Development discontinued in 2009, not sufficiently differentiate from existing product",,CHEMBL235,Peroxisome proliferator-activated receptor gamma,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21492364, URL:http://europepmc.org/abstract/MED/21492364|Name:PubMed, SrcID:23686684, URL:http://europepmc.org/abstract/MED/23686684|Name:Wikipedia, SrcID:Rivoglitazone, URL:http://en.wikipedia.org/wiki/Rivoglitazone|Name:Other, SrcID:http://www.daiichisankyo.com/media_investors/investor_relations/ir_calendar/files/005139/imm2009_07_31_22_01.pdf, URL:http://www.daiichisankyo.com/media_investors/investor_relations/ir_calendar/files/005139/imm2009_07_31_22_01.pdf",COc1ccc2nc(COc3ccc(CC4SC(=O)NC4=O)cc3)n(C)c2c1,CHEMBL235,PPARG
3047,CHEMBL603469,Lestaurtinib,Small molecule,,,,-tinib,Tyrosine-protein kinase JAK2 inhibitor,,,CHEMBL2971,Tyrosine-protein kinase JAK2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17984313, URL:http://europepmc.org/abstract/MED/17984313",C[C@]12O[C@H](C[C@]1(O)CO)n3c4ccccc4c5c6C(=O)NCc6c7c8ccccc8n2c7c35,CHEMBL2971,JAK2
3048,CHEMBL483158,Alisertib,Small molecule,,,,-sertib,Serine/threonine-protein kinase Aurora-A inhibitor,,,CHEMBL4722,Serine/threonine-protein kinase Aurora-A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22016509, URL:http://europepmc.org/abstract/MED/22016509",COc1cccc(F)c1C2=NCc3cnc(Nc4ccc(C(=O)O)c(OC)c4)nc3c5ccc(Cl)cc25,,
3049,CHEMBL220808,Sarizotan,Small molecule,,,,-zotan,Dopamine D3 receptor agonist,"Development discontunued, failed to meet primary efficacy endpoints, no difference between drug and placebo. Newron developing drug for Rett syndrome and received EMA and FDA orphan designation in July 2015. Agonist/partial agonistic/antagonsitic effect depending on dopamine receptor isoform.",,CHEMBL234,Dopamine D3 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:14767715, URL:http://europepmc.org/abstract/MED/14767715|Name:PubMed, SrcID:16844149, URL:http://europepmc.org/abstract/MED/16844149",Fc1ccc(cc1)c2cncc(CNC[C@H]3CCc4ccccc4O3)c2,,
3050,CHEMBL1743025,Gantenerumab,Antibody,,,,-mab,Beta amyloid A4 protein other,Binds with sub-nanomolar affinity to a conformational epitope expressed on amyloid-ß fibrils. Neutralises disease-relevant aggregated forms of amyloid-beta.,,CHEMBL2487,Beta amyloid A4 protein,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21955818, URL:http://europepmc.org/abstract/MED/21955818",,CHEMBL2487,APP
3051,CHEMBL3544926,Obiltoxaximab,Antibody,2016.0,,,-mab,Protective antigen binding agent,,,CHEMBL5352,Protective antigen,BINDING AGENT,Bacillus anthracis,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2016/125509lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125509lbl.pdf",,,
3052,CHEMBL2103867,Plecanatide,Protein,2017.0,,,-tide,Heat-stable enterotoxin receptor agonist,,,CHEMBL1795197,Heat-stable enterotoxin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23625291, URL:http://europepmc.org/abstract/MED/23625291",CC(C)C[C@H](NC(=O)[C@@H]1CSSC[C@@H]2NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N)NC(=O)[C@@H](NC2=O)C(C)C)C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(=O)N)C(=O)O,CHEMBL1795197,GUCY2C
3053,CHEMBL117287,Prucalopride,Small molecule,,A06AX05,A06AX05 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR CONSTIPATION: DRUGS FOR CONSTIPATION: Other drugs for constipation],-pride,Serotonin 4 (5-HT4) receptor agonist,,,CHEMBL1875,Serotonin 4 (5-HT4) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10205205, URL:http://europepmc.org/abstract/MED/10205205",COCCCN1CCC(CC1)NC(=O)c2cc(Cl)c(N)c3CCOc23,CHEMBL1875,HTR4
3054,CHEMBL591118,Carmegliptin,Small molecule,,,,-gliptin,Dipeptidyl peptidase IV inhibitor,,,CHEMBL284,Dipeptidyl peptidase IV,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20031405, URL:http://europepmc.org/abstract/MED/20031405",COc1cc2CCN3C[C@@H]([C@@H](N)C[C@H]3c2cc1OC)N4C[C@@H](CF)CC4=O,CHEMBL284,DPP4
3055,CHEMBL3544907,Picoplatin,Small molecule,,,,-platin,DNA cross-linking agent,,,CHEMBL2311221,DNA,CROSS-LINKING AGENT,Homo sapiens,NUCLEIC-ACID,,,"Name:PubMed, SrcID:9472630, URL:http://europepmc.org/abstract/MED/9472630",,,
3056,CHEMBL272980,Mocetinostat,Small molecule,,,,-stat,Histone deacetylase 2 inhibitor,,"Isotype-selective Class I (HDAC1, -2, -3, and -8) and IV (HDAC11) HDAC inhibitor.",CHEMBL1937,Histone deacetylase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18413790, URL:http://europepmc.org/abstract/MED/18413790|Name:PubMed, SrcID:27551526, URL:http://europepmc.org/abstract/MED/27551526",Nc1ccccc1NC(=O)c2ccc(CNc3nccc(n3)c4cccnc4)cc2,CHEMBL1937,HDAC2
3057,CHEMBL2108313,Conbercept,Protein,,,,-cept,Placenta growth factor inhibitor,Soluble receptor decoy which has a high binding affinity to VEGF and a long half-life in vitreous.,"All isoforms of VEGF-A, VEGF-B, VEGF-C, and PlGF.",CHEMBL1697671,Placenta growth factor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25960634, URL:http://europepmc.org/abstract/MED/25960634|Name:PubMed, SrcID:22958404, URL:http://europepmc.org/abstract/MED/22958404|Name:PubMed, SrcID:23950958, URL:http://europepmc.org/abstract/MED/23950958",,CHEMBL1697671,PGF
3058,CHEMBL3833320,Eptinezumab,Antibody,,,,-mab,Calcitonin gene-related peptide_UNCURATED inhibitor,"Inhibits the calcitonin gene-related peptide, or CGRP, a small protein involved in the transmission of, and heightened sensitivity to, pain experienced in migraine.",Kd <20 pM towards CGRP,CHEMBL3832947,Calcitonin gene-related peptide,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:27338837, URL:http://europepmc.org/abstract/MED/27338837|Name:PubMed, SrcID:25297013, URL:http://europepmc.org/abstract/MED/25297013",,CHEMBL3832947,CALCB
3059,CHEMBL2108029,Ertumaxomab,Antibody,,,,-mab,T-cell surface glycoprotein CD3 epsilon chain other,"Immunomodulator. Trifunctional bispecific monoclonal antibody (mAb) has the capacity to enhance immunological effector functions such as antibody dependent cell-mediated cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP). Designed to induce the formation of tri-cell-complexes consisting of Her2-positive tumor cells, CD3+ T cells, and Fc?-receptor positive accessory cells.",,CHEMBL1975,T-cell surface glycoprotein CD3 epsilon chain,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16707606, URL:http://europepmc.org/abstract/MED/16707606",,CHEMBL1975,CD3E
3060,CHEMBL2108612,Iratumumab,Antibody,,,,-mab,Tumor necrosis factor receptor superfamily member 8 other,Antibody-dependent cell-mediated cytotoxicity (ADCC).,,CHEMBL2364161,Tumor necrosis factor receptor superfamily member 8,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12881320, URL:http://europepmc.org/abstract/MED/12881320|Name:PubMed, SrcID:17515574, URL:http://europepmc.org/abstract/MED/17515574",,CHEMBL2364161,TNFRSF8
3061,CHEMBL2109421,4b5,Antibody,,,,,Disialoganglioside GD2 other,Mimics the GD2 glycopeptide antigen eliciting both a humoral and cellular anti-GD2 immune response.,,CHEMBL3390823,Disialoganglioside GD2,OTHER,Homo sapiens,SMALL MOLECULE,,,"Name:PubMed, SrcID:8376782, URL:http://europepmc.org/abstract/MED/8376782|Name:Patent, SrcID:EP-1000082-A2, URL:https://www.surechembl.org/document/EP-1000082-A2/",,,
3062,CHEMBL3545062,Velpatasvir,Small molecule,2016.0,,,-vir,Nonstructural protein 5A inhibitor,,,CHEMBL3307224,Nonstructural protein 5A,INHIBITOR,Hepatitis C virus,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2016/208341s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208341s000lbl.pdf",COC[C@H]1C[C@H](N(C1)C(=O)[C@H](NC(=O)OC)c2ccccc2)c3nc(c[nH]3)c4ccc5c(COc6cc7c(ccc8nc([nH]c78)[C@@H]9CC[C@H](C)N9C(=O)[C@@H](NC(=O)OC)C(C)C)cc56)c4,,
3063,CHEMBL1743082,Trastuzumab Emtansine,Antibody,2013.0,L01XC14; L01XC03,L01XC14 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies]; L01XC03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,Receptor protein-tyrosine kinase erbB-2 inhibitor,,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e#nlm34090-1|Name:PubMed, SrcID:23798344, URL:http://europepmc.org/abstract/MED/23798344|Name:DailyMed, SrcID:setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e|Name:PubMed, SrcID:22044006, URL:http://europepmc.org/abstract/MED/22044006",,CHEMBL1824,ERBB2
3064,CHEMBL829,Methylpromazine,Small molecule,1982.0,R06AD01,R06AD01 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Phenothiazine derivatives],,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Trimeprazine, URL:http://en.wikipedia.org/wiki/Trimeprazine|Name:PubMed, SrcID:13470125, URL:http://europepmc.org/abstract/MED/13470125|Name:PubMed, SrcID:15926215, URL:http://europepmc.org/abstract/MED/15926215",CC(CN(C)C)CN1c2ccccc2Sc3ccccc13,CHEMBL231,HRH1
3065,CHEMBL86,Metoclopramide,Small molecule,1979.0,A03FA01,A03FA01 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: PROPULSIVES: Propulsives],,Dopamine D2 receptor antagonist,,,CHEMBL217,Dopamine D2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Metoclopramide, URL:http://en.wikipedia.org/wiki/Metoclopramide|Name:DailyMed, SrcID:setid=7e14591f-0062-4159-b9d3-095b4ad68f00, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7e14591f-0062-4159-b9d3-095b4ad68f00|Name:FDA, SrcID:label/2011/017854s058lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/017854s058lbl.pdf",CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC,CHEMBL217,DRD2
3066,CHEMBL842,Chlorothiazide,Small molecule,1958.0,C03AH01; C03AA04,"C03AH01 [CARDIOVASCULAR SYSTEM: DIURETICS: LOW-CEILING DIURETICS, THIAZIDES: Thiazides, combinations with psycholeptics and/or analgesics]; C03AA04 [CARDIOVASCULAR SYSTEM: DIURETICS: LOW-CEILING DIURETICS, THIAZIDES: Thiazides, plain]",-thiazide,Thiazide-sensitive sodium-chloride cotransporter inhibitor,,,CHEMBL1876,Thiazide-sensitive sodium-chloride cotransporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1056/NEJMra0907219, URL:http://www.nejm.org/doi/full/10.1056/NEJMra0907219",NS(=O)(=O)c1cc2c(cc1Cl)N=CNS2(=O)=O,CHEMBL1876,SLC12A3
3067,CHEMBL1377,Chloroguanide,Small molecule,2000.0,P01BB51; P01BB01,"P01BB51 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: ANTIMALARIALS: Biguanides]; P01BB01 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: ANTIMALARIALS: Biguanides]",,Dihydrofolate reductase inhibitor,,,CHEMBL1939,Dihydrofolate reductase,INHIBITOR,Plasmodium falciparum K1,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=fc22e8d8-3bfb-4f70-a599-dd81262a4887, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fc22e8d8-3bfb-4f70-a599-dd81262a4887",CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1,,
3068,CHEMBL846,Calcitriol,Small molecule,1978.0,D05AX03; A11CC04,"D05AX03 [DERMATOLOGICALS: ANTIPSORIATICS: ANTIPSORIATICS FOR TOPICAL USE: Other antipsoriatics for topical use]; A11CC04 [ALIMENTARY TRACT AND METABOLISM: VITAMINS: VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO: Vitamin D and analogues]",calci-,Vitamin D receptor agonist,,,CHEMBL1977,Vitamin D receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2012/018874s022lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/018874s022lbl.pdf|Name:ISBN, SrcID:9780702034718 PP. 435, URL:http://www.isbnsearch.org/isbn/9780702034718",C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2\C(=C\C=C/3\C[C@@H](O)C[C@H](O)C3=C)\CCC[C@]12C,CHEMBL1977,VDR
3069,CHEMBL85,Risperidone,Small molecule,1993.0,N05AX08,N05AX08 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Other antipsychotics],-peridone,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=b45ceaaa-1236-493a-98c1-43df2f4a08f5#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b45ceaaa-1236-493a-98c1-43df2f4a08f5#nlm34090-1|Name:FDA, SrcID:label/2014/021346s052lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021346s052lbl.pdf",CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1,CHEMBL224,HTR2A
3070,CHEMBL479,Thioridazine,Small molecule,1962.0,N05AC02,N05AC02 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Phenothiazines with piperidine structure],,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=b8d8c29a-414d-4622-bffd-b742725b20f0#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b8d8c29a-414d-4622-bffd-b742725b20f0#nlm34090-1|Name:DailyMed, SrcID:archiveid=143101, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=143101|Name:ISBN, SrcID:0443-059748 PP. 542, URL:http://www.isbnsearch.org/isbn/0443059748",CSc1ccc2Sc3ccccc3N(CCC4CCCCN4C)c2c1,CHEMBL224,HTR2A
3071,CHEMBL1201231,Prednisolone Phosphoric Acid,Small molecule,1973.0,,,pred-,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Glucocorticoid, URL:http://en.wikipedia.org/wiki/Glucocorticoid|Name:ISBN, SrcID:978-1-889788-85-2, URL:http://www.isbnsearch.org/isbn/9781889788852|Name:PubMed, SrcID:17132855, URL:http://europepmc.org/abstract/MED/17132855",C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COP(=O)(O)O,CHEMBL2034,NR3C1
3072,CHEMBL1037,Guanadrel,Small molecule,1982.0,,,guan-,Norepinephrine transporter substrate,Taken up by transporter and displaces NE from vesicles,,CHEMBL222,Norepinephrine transporter,SUBSTRATE,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:0443-059748 PP. 157, URL:http://www.isbnsearch.org/isbn/0443059748|Name:PubMed, SrcID:3896742, URL:http://europepmc.org/abstract/MED/3896742",NC(=N)NCC1COC2(CCCCC2)O1,CHEMBL222,SLC6A2
3073,CHEMBL641,Atomoxetine,Small molecule,2002.0,N06BA09,"N06BA09 [NERVOUS SYSTEM: PSYCHOANALEPTICS: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS: Centrally acting sympathomimetics]",-oxetine,Norepinephrine transporter inhibitor,reuptake inhibitor,,CHEMBL222,Norepinephrine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=6f6bea0c-297b-43ff-8960-ecc11243e06e#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6f6bea0c-297b-43ff-8960-ecc11243e06e#nlm34090-1|Name:FDA, SrcID:label/2015/021411s046lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021411s046lbl.pdf",CNCC[C@@H](Oc1ccccc1C)c2ccccc2,CHEMBL222,SLC6A2
3074,CHEMBL1795072,Ziconotide Acetate,Protein,2004.0,N02BG08,N02BG08 [NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Other analgesics and antipyretics],-tide,Voltage-gated N-type calcium channel alpha-1B subunit blocker,,,CHEMBL4478,Voltage-gated N-type calcium channel alpha-1B subunit,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2011/021060s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021060s006lbl.pdf|Name:DailyMed, SrcID:setid=db671a67-346d-4d55-bfe3-eeecf60da01f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=db671a67-346d-4d55-bfe3-eeecf60da01f|Name:PubMed, SrcID:19300539, URL:http://europepmc.org/abstract/MED/19300539",,CHEMBL4478,CACNA1B
3075,CHEMBL1201139,Megestrol Acetate,Small molecule,1971.0,L02AB01; G03AC05; G03DB02,L02AB01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONES AND RELATED AGENTS: Progestogens]; G03AC05 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE: Progestogens]; G03DB02 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: PROGESTOGENS: Pregnadien derivatives],-gest-,Progesterone receptor agonist,,,CHEMBL208,Progesterone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16291771, URL:http://europepmc.org/abstract/MED/16291771|Name:Wikipedia, SrcID:Megestrol_acetate, URL:http://en.wikipedia.org/wiki/Megestrol_acetate|Name:PubMed, SrcID:23395103, URL:http://europepmc.org/abstract/MED/23395103",CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(=O)C,CHEMBL208,PGR
3076,CHEMBL1729,Cisapride,Small molecule,1993.0,,,-pride,Serotonin 4 (5-HT4) receptor agonist,,,CHEMBL1875,Serotonin 4 (5-HT4) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:archiveid=13266, URL:http://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=13266|Name:Wikipedia, SrcID:Cisapride, URL:http://en.wikipedia.org/wiki/Cisapride",COC1CN(CCCOc2ccc(F)cc2)CCC1NC(=O)c3cc(Cl)c(N)cc3OC,CHEMBL1875,HTR4
3077,CHEMBL444633,Rifabutin,Small molecule,1992.0,J04AB04,J04AB04 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOBACTERIALS: DRUGS FOR TREATMENT OF TUBERCULOSIS: Antibiotics],rifa-,Bacterial DNA-directed RNA polymerase inhibitor,,,CHEMBL2364672,Bacterial DNA-directed RNA polymerase,INHIBITOR,Bacteria,PROTEIN COMPLEX,RNA polymerase beta/beta prime subunit,Beta subunit is binding site,"Name:PubMed, SrcID:7849340, URL:http://europepmc.org/abstract/MED/7849340",CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C)c(O)c4C(=O)C(=C5NC6(CCN(CC(C)C)CC6)N=C5c4c3C2=O)NC(=O)\C(=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(=O)C)[C@@H]1C)\C,,
3078,CHEMBL1742990,Belatacept,Protein,2011.0,L04AA28,L04AA28 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Selective immunosuppressants],-cept,T-lymphocyte activation antigen CD80 inhibitor,,,CHEMBL2364157,T-lymphocyte activation antigen CD80,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=c16ac648-d5d2-9f7d-8637-e2328572754e, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c16ac648-d5d2-9f7d-8637-e2328572754e",,CHEMBL2364157,CD80
3079,CHEMBL1734,Solifenacin,Small molecule,2004.0,G04BD08,G04BD08 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Drugs for urinary frequency and incontinence],-fenacin,Muscarinic acetylcholine receptor M2 antagonist,"Indicated for overactive bladder, M2 likely responsible",,CHEMBL211,Muscarinic acetylcholine receptor M2,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 160, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:19446545, URL:http://europepmc.org/abstract/MED/19446545|Name:Wikipedia, SrcID:Solifenacin#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Solifenacin#Mechanism_of_action|Name:PubMed, SrcID:16465186, URL:http://europepmc.org/abstract/MED/16465186",O=C(O[C@H]1CN2CCC1CC2)N3CCc4ccccc4[C@@H]3c5ccccc5,CHEMBL211,CHRM2
3080,CHEMBL477772,Pazopanib,Small molecule,2009.0,L01XE11,L01XE11 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-anib,Tyrosine-protein kinase ITK/TSK inhibitor,,,CHEMBL2959,Tyrosine-protein kinase ITK/TSK,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14",CN(c1ccc2c(C)n(C)nc2c1)c3ccnc(Nc4ccc(C)c(c4)S(=O)(=O)N)n3,CHEMBL2959,ITK
3081,CHEMBL1201244,Rocuronium,Small molecule,1994.0,,,-ium,Muscle-type nicotinic acetylcholine receptor antagonist,,,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:19417616, URL:http://europepmc.org/abstract/MED/19417616|Name:DailyMed, SrcID:setid=f1933332-1ae0-4dc1-be4c-694849e6c9f9#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f1933332-1ae0-4dc1-be4c-694849e6c9f9#nlm34090-1|Name:PubMed, SrcID:18842832, URL:http://europepmc.org/abstract/MED/18842832",CC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N5CCOCC5)[N+]6(CC=C)CCCC6,,
3082,CHEMBL1200633,Ivermectin,Unknown,1996.0,D11AX22; P02CF01,"D11AX22 [DERMATOLOGICALS: OTHER DERMATOLOGICAL PREPARATIONS: OTHER DERMATOLOGICAL PREPARATIONS: Other dermatologicals]; P02CF01 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTHELMINTICS: ANTINEMATODAL AGENTS: Avermectines]",-ectin,Glutamate-gated chloride channel modulator,,,CHEMBL2363051,Glutamate-gated chloride channel,MODULATOR,Onchocerca volvulus,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Ivermectin, URL:http://en.wikipedia.org/wiki/Ivermectin|Name:FDA, SrcID:label/2014/204154Orig1s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204154Orig1s000lbl.pdf|Name:ISBN, SrcID:9780702034718 PP. 671, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:13678839, URL:http://europepmc.org/abstract/MED/13678839",CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]3C[C@@H](C\C=C(/C)\[C@@H](O[C@H]4C[C@H](OC)[C@@H](O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)\C=C\C=C\6/CO[C@@H]7[C@H](O)C(=C[C@@H](C(=O)O3)[C@]67O)C)O2.CO[C@H]8C[C@H](O[C@H]9[C@H](C)O[C@H](C[C@@H]9OC)O[C@H]%10[C@@H](C)\C=C\C=C\%11/CO[C@@H]%12[C@H](O)C(=C[C@@H](C(=O)O[C@H]%13C[C@@H](C\C=C\%10/C)O[C@@]%14(CC[C@H](C)[C@H](O%14)C(C)C)C%13)[C@]%11%12O)C)O[C@@H](C)[C@@H]8O,,
3083,CHEMBL438,Sulfamerazine,Small molecule,1982.0,D06BA06; J01ED07,D06BA06 [DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: CHEMOTHERAPEUTICS FOR TOPICAL USE: Sulfonamides]; J01ED07 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: SULFONAMIDES AND TRIMETHOPRIM: Long-acting sulfonamides],sulfa-,Bacterial dihydropteroate synthase inhibitor,,Broad spectrum,CHEMBL2364668,Bacterial dihydropteroate synthase,INHIBITOR,Bacteria,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21084778, URL:http://europepmc.org/abstract/MED/21084778|Name:PubMed, SrcID:7486915, URL:http://europepmc.org/abstract/MED/7486915|Name:PubMed, SrcID:4577373, URL:http://europepmc.org/abstract/MED/4577373",Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1,,
3084,CHEMBL528,Ceftizoxime,Small molecule,1983.0,J01DD07,J01DD07 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Third-generation cephalosporins],cef-,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:PubMed, SrcID:15716453, URL:http://europepmc.org/abstract/MED/15716453|Name:PubMed, SrcID:7018389, URL:http://europepmc.org/abstract/MED/7018389",CO\N=C(/C(=O)N[C@H]1[C@H]2SCC=C(N2C1=O)C(=O)O)\c3csc(N)n3,,
3085,CHEMBL186,Cefepime,Small molecule,1996.0,J01DE01,J01DE01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Fourth-generation cephalosporins],cef-,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=de477f37-40f6-4295-ae72-a2ee36a8922e#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de477f37-40f6-4295-ae72-a2ee36a8922e#nlm34090-1|Name:PubMed, SrcID:8150771, URL:http://europepmc.org/abstract/MED/8150771",CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)[O-])C[N+]3(C)CCCC3)\c4csc(N)n4,,
3086,CHEMBL1525,Permethrin,Small molecule,1986.0,P03AC04; P03AC54,"P03AC04 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS: ECTOPARASITICIDES, INCL. SCABICIDES: Pyrethrines, incl. synthetic compounds]; P03AC54 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS: ECTOPARASITICIDES, INCL. SCABICIDES: Pyrethrines, incl. synthetic compounds]",,Voltage-sensitive sodium channel blocker,,,CHEMBL2362985,Voltage-sensitive sodium channel,BLOCKER,Sarcoptes scabiei type hominis,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Permethrin, URL:http://en.wikipedia.org/wiki/Permethrin|Name:Wikipedia, SrcID:Pediculicide, URL:http://en.wikipedia.org/wiki/Pediculicide|Name:Wikipedia, SrcID:Pyrethroid, URL:http://en.wikipedia.org/wiki/Pyrethroid|Name:DailyMed, SrcID:setid=4de55a80-67d6-42c0-a6fc-57b89400c5b3, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4de55a80-67d6-42c0-a6fc-57b89400c5b3",CC1(C)C(C=C(Cl)Cl)C1C(=O)OCc2cccc(Oc3ccccc3)c2,,
3087,CHEMBL84,Topotecan,Small molecule,1996.0,L01XX17,L01XX17 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-tecan,"DNA topoisomerase I, mitochondrial inhibitor",,,CHEMBL2362989,"DNA topoisomerase I, mitochondrial",INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=140399d0-4b28-4100-b792-3d1aa3c3e29c#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=140399d0-4b28-4100-b792-3d1aa3c3e29c#section-14",CC[C@@]1(O)C(=O)OCC2=C1C=C3N(Cc4cc5c(CN(C)C)c(O)ccc5nc34)C2=O,CHEMBL2362989,TOP1MT
3088,CHEMBL267345,Amphotericin B,Small molecule,1964.0,G01AA03; A07AA07; J02AA01; A01AB04,"G01AA03 [GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Antibiotics]; A07AA07 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFECTIVES: Antibiotics]; J02AA01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: Antibiotics]; A01AB04 [ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Antiinfectives and antiseptics for local oral treatment]",,Ergosterol sequestering agent,forms pore in membrane by binding ergosterol,,CHEMBL2364028,Ergosterol,SEQUESTERING AGENT,Candida albicans,SMALL MOLECULE,,,"Name:PubMed, SrcID:19689243, URL:http://europepmc.org/abstract/MED/19689243",C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@]2(O)C[C@H](O)[C@H]([C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\[C@H](C)[C@@H](O)[C@H]1C)O2)C(=O)O,,
3089,CHEMBL1201441,Colistimethate Sodium,Small molecule,1970.0,,,,Cell membrane inhibitor,Disrupts cell membrane,,CHEMBL2364031,Cell membrane,INHIBITOR,Bacteria,SUBCELLULAR,,,"Name:DailyMed, SrcID:setid=dddcd6e6-09dd-4523-802e-21765e7abb5d#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dddcd6e6-09dd-4523-802e-21765e7abb5d#nlm34090-1",,,
3090,CHEMBL36506,Novobiocin,Small molecule,1964.0,,,,DNA gyrase inhibitor,,,CHEMBL2331040,DNA gyrase,INHIBITOR,Staphylococcus epidermidis,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:10093705, URL:http://europepmc.org/abstract/MED/10093705|Name:Wikipedia, SrcID:Novobiocin, URL:http://en.wikipedia.org/wiki/Novobiocin",CO[C@@H]1[C@@H](OC(=O)N)[C@@H](O)[C@H](Oc2ccc3C(=C(NC(=O)c4ccc(O)c(CC=C(C)C)c4)C(=O)Oc3c2C)O)OC1(C)C,,
3091,CHEMBL301265,Pramipexole,Small molecule,1997.0,N04BC05,N04BC05 [NERVOUS SYSTEM: ANTI-PARKINSON DRUGS: DOPAMINERGIC AGENTS: Dopamine agonists],,D2-like dopamine receptor agonist,,,CHEMBL2331075,D2-like dopamine receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=688fa4d7-de12-4930-8bc5-0169297c1da6#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=688fa4d7-de12-4930-8bc5-0169297c1da6#nlm34090-1",CCCN[C@H]1CCc2nc(N)sc2C1,,
3092,CHEMBL1201345,Tetradecyl Sulfuric Acid,Small molecule,1946.0,,,,Unknown,,,,,,,,,,"Name:DailyMed, SrcID:archiveid=208106, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=208106|Name:DailyMed, SrcID:setid=4749ba52-52d4-431b-8e86-14dcbeec7220#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4749ba52-52d4-431b-8e86-14dcbeec7220#nlm34090-1|Name:PubMed, SrcID:19442540, URL:http://europepmc.org/abstract/MED/19442540",CCCCC(CC)CCC(CC(C)C)OS(=O)(=O)O,,
3093,CHEMBL2107067,Testosterone Undecanoate,Small molecule,2014.0,G03BA03,G03BA03 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ANDROGENS: 3-oxoandrosten (4) derivatives],-ster-,Androgen Receptor agonist,,,CHEMBL1871,Androgen Receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2014/022219s001lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022219s001lbl.pdf",CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,CHEMBL1871,AR
3094,CHEMBL52885,Enmd-981693,Small molecule,,,,,Fibroblast growth factor receptor inhibitor,,,CHEMBL2095217,Fibroblast growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf, URL:http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf",Cn1cc(C2=C(C(=O)NC2=O)c3cn(C)c4cc(ccc34)[N+](=O)[O-])c5ccccc15,,
3095,CHEMBL3545383,Rg-7167,Small molecule,,,,,Dual specificity mitogen-activated protein kinase kinase; MEK1/2 inhibitor,,,CHEMBL2111289,Dual specificity mitogen-activated protein kinase kinase; MEK1/2,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://www.roche.com/genentech_oncology_r_d.pdf, URL:http://www.roche.com/genentech_oncology_r_d.pdf",,,
3096,CHEMBL2110732,Dacomitinib,Small molecule,,,,-tinib,Epidermal growth factor receptor inhibitor,,,CHEMBL2363049,Epidermal growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:https://www.pfizer.com/files/news/esmo/dacomitinib_fact_sheet.pdf, URL:https://www.pfizer.com/files/news/esmo/dacomitinib_fact_sheet.pdf|Name:PubMed, SrcID:24501009, URL:http://europepmc.org/abstract/MED/24501009",COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)\C=C\CN4CCCCC4,,
3097,CHEMBL3544960,At-13148,Small molecule,,,,,MAP kinase-activated protein kinase 2 inhibitor,,,CHEMBL2208,MAP kinase-activated protein kinase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25840982, URL:http://europepmc.org/abstract/MED/25840982|Name:PubMed, SrcID:22781553, URL:http://europepmc.org/abstract/MED/22781553|Name:Other, SrcID:http://www.astx.com/pipeline/products/clinical, URL:http://www.astx.com/pipeline/products/clinical",NC[C@@](O)(c1ccc(Cl)cc1)c2ccc(cc2)c3cn[nH]c3,CHEMBL2208,MAPKAPK2
3098,CHEMBL422872,Azd-4769,Small molecule,,,,,Epidermal growth factor receptor erbB1 inhibitor,No further data/studies for the compound found.,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://adisinsight.springer.com/drugs/800024847, URL:http://adisinsight.springer.com/drugs/800024847",OC(=O)CSC(CCCc1ccccc1)c2ccc(OCc3ccc4ccccc4n3)cc2,CHEMBL203,EGFR
3099,CHEMBL482967,Cyc-116,Small molecule,,,,,Vascular endothelial growth factor receptor 2 inhibitor,Pan-Aurora kinase inhibitor,,CHEMBL279,Vascular endothelial growth factor receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26345296, URL:http://europepmc.org/abstract/MED/26345296|Name:PubMed, SrcID:20462263, URL:http://europepmc.org/abstract/MED/20462263",Cc1nc(N)sc1c2ccnc(Nc3ccc(cc3)N4CCOCC4)n2,CHEMBL279,KDR
3100,CHEMBL3545365,Altiratinib,Small molecule,,,,-tinib,Tyrosine-protein kinase TIE-2 inhibitor,,,CHEMBL4128,Tyrosine-protein kinase TIE-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.deciphera.com/pipeline, URL:http://www.deciphera.com/pipeline|Name:PubMed, SrcID:26285778, URL:http://europepmc.org/abstract/MED/26285778",Fc1ccc(NC(=O)C2(CC2)C(=O)Nc3cc(F)c(Oc4ccnc(NC(=O)C5CC5)c4)cc3F)cc1,CHEMBL4128,TEK
3101,CHEMBL3545365,Altiratinib,Small molecule,,,,-tinib,Neurotrophic tyrosine kinase receptor inhibitor,,,CHEMBL3559684,Neurotrophic tyrosine kinase receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://www.deciphera.com/pipeline, URL:http://www.deciphera.com/pipeline|Name:PubMed, SrcID:26285778, URL:http://europepmc.org/abstract/MED/26285778",Fc1ccc(NC(=O)C2(CC2)C(=O)Nc3cc(F)c(Oc4ccnc(NC(=O)C5CC5)c4)cc3F)cc1,,
3102,CHEMBL3301577,Ipafricept,Protein,,,,-cept,Frizzled-8 antagonist,mAB,,CHEMBL3559689,Frizzled-8,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25172549, URL:http://europepmc.org/abstract/MED/25172549",,CHEMBL3559689,FZD8
3103,CHEMBL2107872,Delcasertib,Protein,,,,-sertib,Protein kinase C delta inhibitor,,,CHEMBL2996,Protein kinase C delta,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24796339, URL:http://europepmc.org/abstract/MED/24796339|Name:PubMed, SrcID:21712433, URL:http://europepmc.org/abstract/MED/21712433",,CHEMBL2996,PRKCD
3104,CHEMBL3545159,R-333,Small molecule,,,,,Tyrosine-protein kinase SYK inhibitor,Active metabolite of R-348,,CHEMBL2599,Tyrosine-protein kinase SYK,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.rigel.com/index.php/pipeline/, URL:http://www.rigel.com/index.php/pipeline/",,CHEMBL2599,SYK
3105,CHEMBL3545026,Famitinib,Small molecule,,,,-tinib,Vascular endothelial growth factor receptor 3 inhibitor,Multi-targeted receptor tyrosine kinase inhibitor,,CHEMBL1955,Vascular endothelial growth factor receptor 3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1158/1538-7445.AM2011-3604, URL:http://cancerres.aacrjournals.org/content/71/8_Supplement/3604|Name:PubMed, SrcID:24043137, URL:http://europepmc.org/abstract/MED/24043137",,CHEMBL1955,FLT4
3106,CHEMBL1631540,Gsk163090,Small molecule,,,,,Serotonin 1d (5-HT1d) receptor antagonist,,,CHEMBL1983,Serotonin 1d (5-HT1d) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21053897, URL:http://europepmc.org/abstract/MED/21053897",Cc1ccc2c(cccc2n1)N3CCN(CCc4cccc(c4)N5CCNC5=O)CC3,CHEMBL1983,HTR1D
3107,CHEMBL3545222,Azd8683,Small molecule,,,,,Muscarinic acetylcholine receptor M3 antagonist,,,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24144851, URL:http://europepmc.org/abstract/MED/24144851",,CHEMBL245,CHRM3
3108,CHEMBL3545367,Lemborexant,Small molecule,,,,,Orexin receptor 1 antagonist,,,CHEMBL5113,Orexin receptor 1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.eisai.com/pdf/eir/erepo/epipeline.pdf, URL:http://www.eisai.com/pdf/eir/erepo/epipeline.pdf",Cc1ncc(OC[C@]2(C[C@H]2C(=O)Nc3ccc(F)cn3)c4cccc(F)c4)c(C)n1,CHEMBL5113,HCRTR1
3109,CHEMBL3545408,Naltalimide,Small molecule,,,,nal-,Mu opioid receptor partial agonist,"Centrally acting, selective for OPRM1 but also potent agonist at OPRD1 and OPRK1",,CHEMBL233,Mu opioid receptor,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24928951, URL:http://europepmc.org/abstract/MED/24928951",Oc1ccc2CC3N(CC4CC4)CC[C@@]56C(Oc1c25)[C@@H](CC[C@@]36O)N7C(=O)c8ccccc8C7=O,CHEMBL233,OPRM1
3110,CHEMBL3545037,Stx107,Small molecule,,,,,Metabotropic glutamate receptor 5 negative allosteric modulator,,,CHEMBL3227,Metabotropic glutamate receptor 5,NEGATIVE ALLOSTERIC MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PMC, SrcID:PMC172159, URL:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC172159/",,CHEMBL3227,GRM5
3111,CHEMBL3545107,Grc-6211,Small molecule,,,,,Vanilloid receptor antagonist,,,CHEMBL4794,Vanilloid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21804597, URL:http://europepmc.org/abstract/MED/21804597|Name:PubMed, SrcID:19010489, URL:http://europepmc.org/abstract/MED/19010489",,CHEMBL4794,TRPV1
3112,CHEMBL3707249,Asm-024,Small molecule,,,,,Neuronal acetylcholine receptor; alpha3/beta4 antagonist,"ASM-024 displays both antagonistic and agonistic activity on CHRNA7, is thought to be a so called ""a7 silent agonist"": produce little or no CHRNA7 channel activation on its own but effectively activate the ion channel when combined with the type II positive allosteric modulator (PAM) PNU-120596. (A minimal pharmacophore for a nicotinic alpha7 silent agonist, relevance for the therapeutic development of treatments for asthma Poster#: 224.06/C24. Neuroscience Meeting Planner. New Orleans, LA: Soci",,CHEMBL1907594,Neuronal acetylcholine receptor; alpha3/beta4,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:24465890, URL:http://europepmc.org/abstract/MED/24465890|Name:PubMed, SrcID:25799096, URL:http://europepmc.org/abstract/MED/25799096",,,
3113,CHEMBL3707249,Asm-024,Small molecule,,,,,Muscarinic acetylcholine receptor M2 antagonist,"ASM-024 displays both antagonistic and agonistic activity on CHRNA7, is thought to be a so called ""a7 silent agonist"": produce little or no CHRNA7 channel activation on its own but effectively activate the ion channel when combined with the type II positive allosteric modulator (PAM) PNU-120596. (A minimal pharmacophore for a nicotinic alpha7 silent agonist, relevance for the therapeutic development of treatments for asthma Poster#: 224.06/C24. Neuroscience Meeting Planner. New Orleans, LA: Soci",,CHEMBL211,Muscarinic acetylcholine receptor M2,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24465890, URL:http://europepmc.org/abstract/MED/24465890|Name:PubMed, SrcID:25799096, URL:http://europepmc.org/abstract/MED/25799096",,CHEMBL211,CHRM2
3114,CHEMBL290352,Cep-1347,Small molecule,,,,,Mitogen-activated protein kinase kinase kinase 10 inhibitor,"CEP-1347 inhibits c-Jun N-terminal kinase signaling pathway by inhibition of mixed lineage kinases (MLKs), upstreams and known activators of JNK signaling.",,CHEMBL2873,Mitogen-activated protein kinase kinase kinase 10,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15023353, URL:http://europepmc.org/abstract/MED/15023353|Name:PubMed, SrcID:11325962, URL:http://europepmc.org/abstract/MED/11325962|Name:PubMed, SrcID:18714982, URL:http://europepmc.org/abstract/MED/18714982",CCSCc1ccc2c(c1)c3c4CNC(=O)c4c5c6cc(CSCC)ccc6n7[C@H]8C[C@](O)(C(=O)OC)[C@](C)(O8)n2c3c57,CHEMBL2873,MAP3K10
3115,CHEMBL1241855,Rigosertib,Small molecule,,,,-sertib,Proteinase-activated receptor 1 inhibitor,"Allosteric inhibitor, does not interact with ATP binidng site. May act by binding to c-Raf and indirectly suppress PI3K and Plk1 pathways. PMID: 24493827 and http://www.onconova.com/product-pipeline/rigosertib.php.",,CHEMBL3974,Proteinase-activated receptor 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19198627, URL:http://europepmc.org/abstract/MED/19198627|Name:PubMed, SrcID:24493827, URL:http://europepmc.org/abstract/MED/24493827|Name:Other, SrcID:http://www.onconova.com/product-pipeline/rigosertib.php, URL:http://www.onconova.com/product-pipeline/rigosertib.php",COc1cc(OC)c(\C=C\S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1,CHEMBL3974,F2R
3116,CHEMBL2110732,Dacomitinib,Small molecule,,,,-tinib,Epidermal growth factor receptor erbB1 inhibitor,Dacomitinib is an irreversible pan-ERBB inhibitor.,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://www.pfizer.com/files/news/esmo/dacomitinib_fact_sheet.pdf, URL:https://www.pfizer.com/files/news/esmo/dacomitinib_fact_sheet.pdf|Name:PubMed, SrcID:18089823, URL:http://europepmc.org/abstract/MED/18089823",COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)\C=C\CN4CCCCC4,CHEMBL203,EGFR
3117,CHEMBL608533,Midostaurin,Small molecule,,L01XE39,L01XE39 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],,Platelet-derived growth factor receptor inhibitor,Multi-kinase inhibitor,,CHEMBL2095189,Platelet-derived growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:16969355, URL:http://europepmc.org/abstract/MED/16969355|Name:PubMed, SrcID:12124173, URL:http://europepmc.org/abstract/MED/12124173",CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)n3c4ccccc4c5c6CNC(=O)c6c7c8ccccc8n2c7c35)N(C)C(=O)c9ccccc9,,
3118,CHEMBL2108312,Ozarelix,Protein,,,,-relix,Gonadotropin-releasing hormone receptor antagonist,,,CHEMBL1855,Gonadotropin-releasing hormone receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:7915036, URL:http://www.ncbi.nlm.nih.gov/pubmed/?term=7915036|Name:PubMed, SrcID:20623634, URL:http://europepmc.org/abstract/MED/20623634",,CHEMBL1855,GNRHR
3119,CHEMBL1922660,Fiboflapon,Small molecule,,,,-flapon,5-lipoxygenase activating protein inhibitor,,,CHEMBL4550,5-lipoxygenase activating protein,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20519143, URL:http://europepmc.org/abstract/MED/20519143|Name:PubMed, SrcID:24333186, URL:http://europepmc.org/abstract/MED/24333186",CCOc1ccc(cn1)c2ccc(Cn3c(CC(C)(C)C(=O)O)c(SC(C)(C)C)c4cc(OCc5ccc(C)cn5)ccc34)cc2,CHEMBL4550,ALOX5AP
3120,CHEMBL435224,Lapaquistat Acetate,Small molecule,,,,-stat,Squalene synthetase inhibitor,,,CHEMBL3338,Squalene synthetase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21518985, URL:http://europepmc.org/abstract/MED/21518985",COc1cccc([C@H]2O[C@H](CC(=O)N3CCC(CC(=O)O)CC3)C(=O)N(CC(C)(C)COC(=O)C)c4ccc(Cl)cc24)c1OC,CHEMBL3338,FDFT1
3121,CHEMBL3301595,Dasotraline,Small molecule,,,,-traline,Monoamine transporter inhibitor,"Dopamine and norepinephrine reuptake inhibitor Dasotraline acts as a potent inhibitor of human DA transporters (DAT; dopamine uptake IC50 3¿nM) and NE transporters (NET; norepinephrine uptake IC50 4¿nM), and a weaker inhibitor of human serotonin transporters (SERT; serotonin uptake IC50 15¿nM)",,CHEMBL2363064,Monoamine transporter,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:25948101, URL:http://europepmc.org/abstract/MED/25948101",N[C@@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c3ccccc13,,
3122,CHEMBL2105721,Nivocasan,Small molecule,,,,-casan,Caspase-9 inhibitor,Irreversible inhibitor,,CHEMBL2273,Caspase-9,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21667042, URL:http://europepmc.org/abstract/MED/21667042",CC(C)[C@]1(CC(=NO1)c2nccc3ccccc23)C(=O)N[C@H]4CC(=O)O[C@]4(O)CF,CHEMBL2273,CASP9
3123,CHEMBL2108678,Nesvacumab,Antibody,,,,-mab,Angiopoietin-2 inhibitor,"It blocks the binding of Ang2 (an important regulator of tumor angiogenesis and growth) to Tie 2 (with an IC50 of approximately 60 pmol/L) decreasing its activity, which causes inhibition of tumor growth. Ang2 expression is upregulated in a range of human cancers, and high levels of circulating Ang2 are associated with a poor prognosis.",high-affinity binding (KD ~ 18 pmol/L for human Ang2),CHEMBL3580489,Angiopoietin-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23149917, URL:http://europepmc.org/abstract/MED/23149917|Name:PubMed, SrcID:26490310, URL:http://europepmc.org/abstract/MED/26490310",,CHEMBL3580489,ANGPT2
3124,CHEMBL2109308,Oncolysin B,Antibody,,,,,B-lymphocyte antigen CD19 binding agent,Immunotoxin,,CHEMBL3390821,B-lymphocyte antigen CD19,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:14692524, URL:http://europepmc.org/abstract/MED/14692524",,CHEMBL3390821,CD19
3125,CHEMBL1510,Eletriptan,Small molecule,2002.0,N02CC06,N02CC06 [NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Selective serotonin (5HT1) agonists],-triptan,Serotonin 1f (5-HT1f) receptor agonist,,Selective,CHEMBL1805,Serotonin 1f (5-HT1f) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2011/021016s018lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021016s018lbl.pdf",CN1CCC[C@@H]1Cc2c[nH]c3ccc(CCS(=O)(=O)c4ccccc4)cc23,CHEMBL1805,HTR1F
3126,CHEMBL811,Brompheniramine,Small molecule,1957.0,R06AB51; R06AB01,R06AB51 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Substituted alkylamines]; R06AB01 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Substituted alkylamines],,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:6128358, URL:http://europepmc.org/abstract/MED/6128358",CN(C)CCC(c1ccc(Br)cc1)c2ccccn2,CHEMBL231,HRH1
3127,CHEMBL1201335,Glycopyrrolate,Small molecule,1961.0,,,-ium,Muscarinic acetylcholine receptor M1 antagonist,"Role in regulating gastric secretion, M1 likely involved",,CHEMBL216,Muscarinic acetylcholine receptor M1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=d200bd44-9856-4104-a29e-a4cca3db6737, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d200bd44-9856-4104-a29e-a4cca3db6737|Name:PubMed, SrcID:10385241, URL:http://europepmc.org/abstract/MED/10385241|Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718",C[N+]1(C)CCC(C1)OC(=O)C(O)(C2CCCC2)c3ccccc3,CHEMBL216,CHRM1
3128,CHEMBL24,Atenolol,Small molecule,1981.0,C07AB03,"C07AB03 [CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, selective]",-olol,Beta-1 adrenergic receptor antagonist,,,CHEMBL213,Beta-1 adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f36d4ed3-dcbb-4465-9fa6-1da811f555e6, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f36d4ed3-dcbb-4465-9fa6-1da811f555e6",CC(C)NCC(O)COc1ccc(CC(=O)N)cc1,,
3129,CHEMBL1464,Warfarin,Small molecule,1954.0,B01AA03,B01AA03 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Vitamin K antagonists],-farin,Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor,,,CHEMBL1930,Vitamin k epoxide reductase complex subunit 1 isoform 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:14765195, URL:http://europepmc.org/abstract/MED/14765195|Name:DailyMed, SrcID:setid=ba41b963-ec4a-4421-ac93-26654876a6be#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ba41b963-ec4a-4421-ac93-26654876a6be#nlm34090-1",CC(=O)CC(C1=C(O)c2ccccc2OC1=O)c3ccccc3,CHEMBL1930,VKORC1
3130,CHEMBL1237021,Lurasidone,Small molecule,2010.0,N05AE05,N05AE05 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Indole derivatives],-sidone,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=88a244d1-eddb-499c-bee2-e1f49056e78f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=88a244d1-eddb-499c-bee2-e1f49056e78f",O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1C[C@@H]4CCCC[C@H]4CN5CCN(CC5)c6nsc7ccccc67,CHEMBL224,HTR2A
3131,CHEMBL1514,Levomethadyl Acetate,Small molecule,1993.0,N07BC03,N07BC03 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: DRUGS USED IN ADDICTIVE DISORDERS: Drugs used in opioid dependence],,Mu opioid receptor agonist,,,CHEMBL233,Mu opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:9707384, URL:http://europepmc.org/abstract/MED/9707384",CC[C@H](OC(=O)C)C(C[C@H](C)N(C)C)(c1ccccc1)c2ccccc2,CHEMBL233,OPRM1
3132,CHEMBL1025,Isoflurophate,Small molecule,1957.0,S01EB07,S01EB07 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Parasympathomimetics],,Acetylcholinesterase inhibitor,,,CHEMBL220,Acetylcholinesterase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:13016741, URL:http://europepmc.org/abstract/MED/13016741|Name:PubMed, SrcID:6007355, URL:http://europepmc.org/abstract/MED/6007355",CC(C)OP(=O)(F)OC(C)C,CHEMBL220,ACHE
3133,CHEMBL1683,Hydrocortisone Butyrate,Small molecule,1982.0,D07AB02,"D07AB02 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, moderately potent (group II)]",-cort-,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16980198, URL:http://europepmc.org/abstract/MED/16980198|Name:PubMed, SrcID:16895953, URL:http://europepmc.org/abstract/MED/16895953|Name:PubMed, SrcID:17038445, URL:http://europepmc.org/abstract/MED/17038445|Name:PubMed, SrcID:17086345, URL:http://europepmc.org/abstract/MED/17086345",CCCC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)CO,CHEMBL2034,NR3C1
3134,CHEMBL3545985,Benzphetamine,Small molecule,1960.0,,,,Norepinephrine transporter releasing agent,,,CHEMBL222,Norepinephrine transporter,RELEASING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10605627, URL:http://europepmc.org/abstract/MED/10605627|Name:PubMed, SrcID:7902561, URL:http://europepmc.org/abstract/MED/7902561|Name:DailyMed, SrcID:setid=e95dfb31-8365-498d-91ea-79738033f905#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e95dfb31-8365-498d-91ea-79738033f905#nlm34090-1",C[C@@H](Cc1ccccc1)N(C)Cc2ccccc2,CHEMBL222,SLC6A2
3135,CHEMBL1201258,Pemetrexed,Small molecule,2004.0,L01BA04,L01BA04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Folic acid analogues],-trexed,GAR transformylase inhibitor,,,CHEMBL3972,GAR transformylase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f5a860f3-37ec-429c-ae04-9c88d7c55c08#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5a860f3-37ec-429c-ae04-9c88d7c55c08#section-13",NC1=Nc2[nH]cc(CCc3ccc(cc3)C(=O)N[C@H](CCC(=O)O)C(=O)O)c2C(=O)N1,CHEMBL3972,GART
3136,CHEMBL1433,Doxycycline,Small molecule,1967.0,J01AA02; A01AB22,J01AA02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: TETRACYCLINES: Tetracyclines]; A01AB22 [ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Antiinfectives and antiseptics for local oral treatment],-cycline,Matrix metalloproteinase 13 inhibitor,"It is an antibiotic, however, its primary action, due to the concentration reached in the human body is via metalloproteinases inhibition, which is beneficial in many pathological conditions in which MMP-mediated proteolysis of the extracellular matrix (ECM) contributes to the pathogenesis, such as heart remodeling, tumor invasion, and inflammation",,CHEMBL280,Matrix metalloproteinase 13,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=3105a84b-655e-4940-9d11-4209cdb05d6b, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3105a84b-655e-4940-9d11-4209cdb05d6b|Name:PubMed, SrcID:20370419, URL:http://europepmc.org/abstract/MED/20370419|Name:PubMed, SrcID:20592239, URL:http://europepmc.org/abstract/MED/20592239|Name:PubMed, SrcID:17199549, URL:http://europepmc.org/abstract/MED/17199549",C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(=C(C(=O)N)C(=O)[C@@]3(O)C(=C2C(=O)c4c(O)cccc14)O)O,CHEMBL280,MMP13
3137,CHEMBL1200598,Diethylstilbestrol Diphosphate,Small molecule,1982.0,L02AA04,L02AA04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONES AND RELATED AGENTS: Estrogens],-estr-,Estrogen receptor agonist,,,CHEMBL2093866,Estrogen receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:ISBN, SrcID:9780702034718 PP. 683, URL:http://www.isbnsearch.org/isbn/9780702034718",CC\C(=C(\CC)/c1ccc(OP(=O)(O)O)cc1)\c2ccc(OP(=O)(O)O)cc2,,
3138,CHEMBL154,Naproxen,Small molecule,1976.0,M02AA12; G02CC02; M01AE02,"M02AA12 [MUSCULO-SKELETAL SYSTEM: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: Antiinflammatory preparations, non-steroids for topical use]; G02CC02 [GENITO URINARY SYSTEM AND SEX HORMONES: OTHER GYNECOLOGICALS: OTHER GYNECOLOGICALS: Antiinflammatory products for vaginal administration]; M01AE02 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Propionic acid derivatives]",,Cyclooxygenase inhibitor,,,CHEMBL2094253,Cyclooxygenase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:17604186, URL:http://europepmc.org/abstract/MED/17604186|Name:PubMed, SrcID:17607546, URL:http://europepmc.org/abstract/MED/17607546|Name:PubMed, SrcID:17612049, URL:http://europepmc.org/abstract/MED/17612049|Name:PubMed, SrcID:17521299, URL:http://europepmc.org/abstract/MED/17521299",COc1ccc2cc(ccc2c1)[C@H](C)C(=O)O,,
3139,CHEMBL783,Nateglinide,Small molecule,2000.0,A10BX03,"A10BX03 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Other blood glucose lowering drugs, excl. insulins]",-glinide,"Sulfonylurea receptor 1, Kir6.2 blocker",,Selective,CHEMBL2096972,"Sulfonylurea receptor 1, Kir6.2",BLOCKER,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:11716850, URL:http://europepmc.org/abstract/MED/11716850|Name:PubMed, SrcID:10773014, URL:http://europepmc.org/abstract/MED/10773014|Name:PubMed, SrcID:12604678, URL:http://europepmc.org/abstract/MED/12604678|Name:PubMed, SrcID:12196472, URL:http://europepmc.org/abstract/MED/12196472",CC(C)[C@@H]1CC[C@H](CC1)C(=O)N[C@H](Cc2ccccc2)C(=O)O,,
3140,CHEMBL33986,Butorphanol,Small molecule,1978.0,N02AF01,N02AF01 [NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Morphinan derivatives],-orphan-,Kappa opioid receptor partial agonist,,,CHEMBL237,Kappa opioid receptor,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=b8e48063-0b40-ee43-85c1-4ef2de80c404#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b8e48063-0b40-ee43-85c1-4ef2de80c404#nlm34090-1",Oc1ccc2C[C@H]3N(CC4CCC4)CC[C@@]5(CCCC[C@@]35O)c2c1,CHEMBL237,OPRK1
3141,CHEMBL1395,Methyltestosterone,Small molecule,1973.0,G03EK01; G03BA02,G03EK01 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION: Androgens and female sex hormones in combination with other drugs]; G03BA02 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ANDROGENS: 3-oxoandrosten (4) derivatives],-ster-,Androgen Receptor agonist,,,CHEMBL1871,Androgen Receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=a9758bea-b15b-42e5-938c-03e3f042b290, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a9758bea-b15b-42e5-938c-03e3f042b290",C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,CHEMBL1871,AR
3142,CHEMBL609,Trientine,Small molecule,1985.0,A16AX12,A16AX12 [ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Various alimentary tract and metabolism products],,Copper chelating agent,,,CHEMBL2363057,Copper,CHELATING AGENT,,METAL,,,"Name:DailyMed, SrcID:archiveid=10753#CP, URL:http://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=10753#CP|Name:ISBN, SrcID:1573317802 PP. 180, URL:http://www.isbnsearch.org/isbn/1573317802",NCCNCCNCCN,,
3143,CHEMBL1525826,Sulfalene,Small molecule,,J01ED02,J01ED02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: SULFONAMIDES AND TRIMETHOPRIM: Long-acting sulfonamides],sulfa-,Bacterial dihydropteroate synthase inhibitor,,Broad spectrum,CHEMBL2364668,Bacterial dihydropteroate synthase,INHIBITOR,Bacteria,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Sulfalene, URL:http://en.wikipedia.org/wiki/Sulfalene|Name:PubMed, SrcID:12125519, URL:http://europepmc.org/abstract/MED/12125519|Name:PubMed, SrcID:16997145, URL:http://europepmc.org/abstract/MED/16997145|Name:Wikipedia, SrcID:Sulfonamide_(medicine)#Antimicrobial, URL:http://en.wikipedia.org/wiki/Sulfonamide_(medicine)#Antimicrobial",COc1nccnc1NS(=O)(=O)c2ccc(N)cc2,,
3144,CHEMBL700,Sulfapyridine,Small molecule,1939.0,J01EB04,J01EB04 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: SULFONAMIDES AND TRIMETHOPRIM: Short-acting sulfonamides],sulfa-,Bacterial dihydropteroate synthase inhibitor,,Broad spectrum,CHEMBL2364668,Bacterial dihydropteroate synthase,INHIBITOR,Bacteria,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 625, URL:http://www.isbnsearch.org/isbn/9780702034718",Nc1ccc(cc1)S(=O)(=O)Nc2ccccn2,,
3145,CHEMBL2219546,Ytterbium Pentetate,Small molecule,1976.0,,,,Radioactive metals chelating agent,,,CHEMBL2366037,Radioactive metals,CHELATING AGENT,,METAL,,,"Name:DailyMed, SrcID:setid=6052c707-a8a3-43a7-80c2-7ad1ad9391a4#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6052c707-a8a3-43a7-80c2-7ad1ad9391a4#nlm34090-1",,,
3146,CHEMBL1570,Sulfoxone,Small molecule,1982.0,,,-fo-,Dihydropteroate synthase 1 inhibitor,,,CHEMBL2362993,Dihydropteroate synthase 1,INHIBITOR,Mycobacterium leprae (strain TN),SINGLE PROTEIN,,,"Name:ISBN, SrcID:0-86577-843-4 PP. 272, URL:http://www.isbnsearch.org/isbn/0865778434|Name:PubMed, SrcID:17134675, URL:http://europepmc.org/abstract/MED/17134675|Name:ISBN, SrcID:0-471-94847-0 PP. 605, URL:http://www.isbnsearch.org/isbn/0471948470|Name:PubMed, SrcID:6753759, URL:http://europepmc.org/abstract/MED/6753759|Name:Wikipedia, SrcID:Sulfone, URL:http://en.wikipedia.org/wiki/Sulfone",OS(=O)CNc1ccc(cc1)S(=O)(=O)c2ccc(NCS(=O)O)cc2,,
3147,CHEMBL32,Moxifloxacin,Small molecule,1999.0,J01MA14; S01AE07,J01MA14 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolones]; S01AE07 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Fluoroquinolones],-oxacin,Bacterial DNA gyrase inhibitor,,,CHEMBL2311224,Bacterial DNA gyrase,INHIBITOR,Bacteria,PROTEIN COMPLEX,,,"Name:DailyMed, SrcID:setid=56b4f979-bf20-4908-9d7c-5536221d77f8, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=56b4f979-bf20-4908-9d7c-5536221d77f8",COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc4C(=O)C(=CN(C5CC5)c14)C(=O)O,,
3148,CHEMBL220492,Topiramate,Small molecule,1996.0,N03AX11,N03AX11 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=21628112-0c47-11df-95b3-498d55d89593#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=21628112-0c47-11df-95b3-498d55d89593#nlm34090-1|Name:PubMed, SrcID:10768292, URL:http://europepmc.org/abstract/MED/10768292",CC1(C)O[C@@H]2CO[C@@]3(COS(=O)(=O)N)OC(C)(C)O[C@H]3[C@@H]2O1,,
3149,CHEMBL698,Tetracaine,Small molecule,2005.0,S01HA03; C05AD02; N01BA03; D04AB06,"S01HA03 [SENSORY ORGANS: OPHTHALMOLOGICALS: LOCAL ANESTHETICS: Local anesthetics]; C05AD02 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Local anesthetics]; N01BA03 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Esters of aminobenzoic acid]; D04AB06 [DERMATOLOGICALS: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: Anesthetics for topical use]",-caine,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:ISBN, SrcID:9780702034718 PP. 526-528, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:6319406, URL:http://europepmc.org/abstract/MED/6319406|Name:PubMed, SrcID:8391120, URL:http://europepmc.org/abstract/MED/8391120|Name:PubMed, SrcID:14975698, URL:http://europepmc.org/abstract/MED/14975698",CCCCNc1ccc(cc1)C(=O)OCCN(C)C,,
3150,CHEMBL1764,Levomepromazine,Small molecule,1982.0,N05AA02,N05AA02 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Phenothiazines with aliphatic side-chain],,D2-like dopamine receptor antagonist,,,CHEMBL2331075,D2-like dopamine receptor,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:Wikipedia, SrcID:Phenothiazine, URL:http://en.wikipedia.org/wiki/Phenothiazine|Name:Wikipedia, SrcID:Levomepromazine, URL:http://en.wikipedia.org/wiki/Levomepromazine|Name:ISBN, SrcID:0443-059748 PP. 542, URL:http://www.isbnsearch.org/isbn/0443059748",COc1ccc2Sc3ccccc3N(C[C@H](C)CN(C)C)c2c1,,
3151,CHEMBL2108074,Pancrelipase,Enzyme,1996.0,A09AA02,"A09AA02 [ALIMENTARY TRACT AND METABOLISM: DIGESTIVES, INCL. ENZYMES: DIGESTIVES, INCL. ENZYMES: Enzyme preparations]",-ase,Starch hydrolytic enzyme,,,CHEMBL2364180,Starch,HYDROLYTIC ENZYME,Homo sapiens,OLIGOSACCHARIDE,,,"Name:DailyMed, SrcID:setid=073201aa-556d-4a70-918e-84e9616fd88d#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=073201aa-556d-4a70-918e-84e9616fd88d#nlm34090-1",,,
3152,CHEMBL456237,Lxr-623,Small molecule,,,,,LXR-alpha agonist,"project terminated in 2007, reason quoted as ""unfavorable profile for further development"" (http://www.karobio.com/investormedia/pressreleaser/pressrelease?pid=3005162)",,CHEMBL2808,LXR-alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19398602, URL:http://europepmc.org/abstract/MED/19398602|Name:PubMed, SrcID:24833295, URL:http://europepmc.org/abstract/MED/24833295",Fc1ccc(cc1)c2c3cccc(c3nn2Cc4ccc(F)cc4Cl)C(F)(F)F,CHEMBL2808,NR1H3
3153,CHEMBL1980297,Ilorasertib,Small molecule,,,,-sertib,SRC inhibitor,Multitargeted kinase inhibitor,,CHEMBL2363074,SRC,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:22935731, URL:http://europepmc.org/abstract/MED/22935731",Nc1ncc(c2cnn(CCO)c2)c3scc(c4ccc(NC(=O)Nc5cccc(F)c5)cc4)c13,,
3154,CHEMBL3545420,Ag-24322,Small molecule,,,,,Cyclin-dependent kinase 1 inhibitor,,,CHEMBL308,Cyclin-dependent kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://cancerres.aacrjournals.org/content/65/9_Supplement/1045.2, URL:http://cancerres.aacrjournals.org/content/65/9_Supplement/1045.2|Name:PubMed, SrcID:18509643, URL:http://europepmc.org/abstract/MED/18509643",CCNCc1cncc(c1C)c2ccc3NN\C(=C\4/N=C5C=C(F)C=C(F)C5=N4)\c3c2,CHEMBL308,CDK1
3155,CHEMBL1969664,Azd-1080,Small molecule,,,,,Glycogen synthase kinase-3 inhibitor,,,CHEMBL2095188,Glycogen synthase kinase-3,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:23410232, URL:http://europepmc.org/abstract/MED/23410232",Oc1[nH]c2ccc(cc2c1c3ccc(CN4CCOCC4)cn3)C#N,,
3156,CHEMBL3545052,Cudc-907,Small molecule,,,,,Histone deacetylase inhibitor,Inhibits mainly class I and IIb HDACS (PMID:22693356),,CHEMBL2093865,Histone deacetylase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:22693356, URL:http://europepmc.org/abstract/MED/22693356|Name:Other, SrcID:http://www.curis.com/pipeline/cudc-907, URL:http://www.curis.com/pipeline/cudc-907",,,
3157,CHEMBL3545053,Emd-1204831,Small molecule,,,,,Hepatocyte growth factor receptor inhibitor,,,CHEMBL3717,Hepatocyte growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25110867, URL:http://europepmc.org/abstract/MED/25110867|Name:PubMed, SrcID:23553846, URL:http://europepmc.org/abstract/MED/23553846",,CHEMBL3717,MET
3158,CHEMBL2106468,Tricetamide,Small molecule,,,,,Tyrosine-protein kinase JAK1 inhibitor,Prodrug of R-507,,CHEMBL2835,Tyrosine-protein kinase JAK1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22971540, URL:http://europepmc.org/abstract/MED/22971540|Name:PubMed, SrcID:24671708, URL:http://europepmc.org/abstract/MED/24671708",CCN(CC)C(=O)CNC(=O)c1cc(OC)c(OC)c(OC)c1,CHEMBL2835,JAK1
3159,CHEMBL1090173,Sd-0006,Small molecule,,,,,MAP kinase p38 alpha inhibitor,,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19590255, URL:http://europepmc.org/abstract/MED/19590255|Name:PubMed, SrcID:20227876, URL:http://europepmc.org/abstract/MED/20227876",OCC(=O)N1CCC(CC1)c2n[nH]c(c3ccc(Cl)cc3)c2c4ccncn4,CHEMBL260,MAPK14
3160,CHEMBL482767,Sns-314,Small molecule,,,,,Serine/threonine-protein kinase Aurora inhibitor,Pan-Aurora kinase inhibitor,,CHEMBL3430911,Serine/threonine-protein kinase Aurora,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:26345296, URL:http://europepmc.org/abstract/MED/26345296|Name:PubMed, SrcID:19649632, URL:http://europepmc.org/abstract/MED/19649632",OC(=Nc1cccc(Cl)c1)Nc2ncc(CCN=C3NC=Nc4ccsc34)s2,,
3161,CHEMBL2180604,Tak-593,Small molecule,,,,,Vascular endothelial growth factor receptor inhibitor,,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:23498918, URL:http://europepmc.org/abstract/MED/23498918",Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1,,
3162,CHEMBL3545211,Sr16234,Small molecule,,,,,Estrogen receptor alpha antagonist,,,CHEMBL206,Estrogen receptor alpha,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.sri.com/newsroom/press-releases/sri-nobelpharma-partner-endometriosis-drug-development, URL:http://www.sri.com/newsroom/press-releases/sri-nobelpharma-partner-endometriosis-drug-development|Name:PubMed, SrcID:15671561, URL:http://europepmc.org/abstract/MED/15671561",CCN(CC)Cc1ccc(OCC[C@H]2CCC3C4[C@H](C)Cc5cc(O)ccc5C4CC[C@]23C)c(OC)c1,CHEMBL206,ESR1
3163,CHEMBL1950289,Tanzisertib,Small molecule,,,,-sertib,c-Jun N-terminal kinase 3 inhibitor,,,CHEMBL2637,c-Jun N-terminal kinase 3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22244937, URL:http://europepmc.org/abstract/MED/22244937",O[C@@H]1CC[C@H](CC1)Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]5CCOC5)c3n2,CHEMBL2637,MAPK10
3164,CHEMBL1230165,Silmitasertib,Small molecule,,,,-sertib,Casein kinase II alpha inhibitor,,,CHEMBL3629,Casein kinase II alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21159648, URL:http://europepmc.org/abstract/MED/21159648",OC(=O)c1ccc2c(c1)nc(Nc3cccc(Cl)c3)c4ccncc24,CHEMBL3629,CSNK2A1
3165,CHEMBL3545218,Voruciclib,Small molecule,,,,-ciclib,Cyclin-dependent kinase 4 inhibitor,"Also thought to inhibit CDK1, CDK6 and CDK9 (http://www.bloodjournal.org/content/122/21/1636?sso-checked=true)",,CHEMBL331,Cyclin-dependent kinase 4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=618682, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=618682|Name:DOI, SrcID:10.1158/1538-7445.AM2012-3054, URL:http://cancerres.aacrjournals.org/content/72/8_Supplement/3054|Name:Other, SrcID:http://meeting.ascopubs.org/cgi/content/short/33/15_suppl/9076?rss=1, URL:http://meeting.ascopubs.org/cgi/content/short/33/15_suppl/9076?rss=1",,CHEMBL331,CDK4
3166,CHEMBL3545026,Famitinib,Small molecule,,,,-tinib,Platelet-derived growth factor receptor inhibitor,Multi-targeted receptor tyrosine kinase inhibitor,,CHEMBL2095189,Platelet-derived growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:DOI, SrcID:10.1158/1538-7445.AM2011-3604, URL:http://cancerres.aacrjournals.org/content/71/8_Supplement/3604|Name:ClinicalTrials, SrcID:NCT02390947, URL:https://www.clinicaltrials.gov/ct2/show/NCT02390947|Name:PubMed, SrcID:24043137, URL:http://europepmc.org/abstract/MED/24043137",,,
3167,CHEMBL1215661,Pruvanserin,Small molecule,,,,-anserin,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12892843, URL:http://europepmc.org/abstract/MED/12892843",Fc1ccc(CCN2CCN(CC2)C(=O)c3cccc4c(c[nH]c34)C#N)cc1,CHEMBL224,HTR2A
3168,CHEMBL3545347,Txa127,Protein,,,,,Proto-oncogene Mas agonist,A pharmaceutical grade formulation of endogenous ligand,,CHEMBL3559701,Proto-oncogene Mas,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12829792, URL:http://europepmc.org/abstract/MED/12829792",CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N3CCC[C@H]3C(=O)O,CHEMBL3559701,MAS1
3169,CHEMBL2035874,Eprotirome,Small molecule,,,,-tirome,Thyroid hormone receptor beta-1 agonist,Development discontinued in 2012 due to cartilage damage seen in animal study (http://www.karobio.com/investormedia/pressreleaser/pressrelease?pid=6395352),,CHEMBL1947,Thyroid hormone receptor beta-1,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22784847, URL:http://europepmc.org/abstract/MED/22784847|Name:PubMed, SrcID:23776891, URL:http://europepmc.org/abstract/MED/23776891",CC(C)c1cc(Oc2c(Br)cc(NC(=O)CC(=O)O)cc2Br)ccc1O,CHEMBL1947,THRB
3170,CHEMBL290352,Cep-1347,Small molecule,,,,,Mitogen-activated protein kinase kinase kinase 9 inhibitor,"CEP-1347 inhibits c-Jun N-terminal kinase signaling pathway by inhibition of mixed lineage kinases (MLKs), upstreams and known activators of JNK signaling.",,CHEMBL2872,Mitogen-activated protein kinase kinase kinase 9,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15023353, URL:http://europepmc.org/abstract/MED/15023353|Name:PubMed, SrcID:11325962, URL:http://europepmc.org/abstract/MED/11325962|Name:PubMed, SrcID:18714982, URL:http://europepmc.org/abstract/MED/18714982",CCSCc1ccc2c(c1)c3c4CNC(=O)c4c5c6cc(CSCC)ccc6n7[C@H]8C[C@](O)(C(=O)OC)[C@](C)(O8)n2c3c57,CHEMBL2872,MAP3K9
3171,CHEMBL1366933,Esmirtazapine,Small molecule,,,,-pin(e),Serotonin 2a (5-HT2a) receptor antagonist,Discontinued(strategic reasons),,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21246188, URL:http://europepmc.org/abstract/MED/21246188|Name:PubMed, SrcID:26047892, URL:http://europepmc.org/abstract/MED/26047892",CN1CCN2[C@H](C1)c3ccccc3Cc4cccnc24,CHEMBL224,HTR2A
3172,CHEMBL462605,Tiprolisant,Small molecule,,N07XX11,N07XX11 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs],-isant,Histamine H3 receptor inverse agonist,,,CHEMBL264,Histamine H3 receptor,INVERSE AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21615387, URL:http://europepmc.org/abstract/MED/21615387|Name:PubMed, SrcID:17005916, URL:http://europepmc.org/abstract/MED/17005916",Clc1ccc(CCCOCCCN2CCCCC2)cc1,CHEMBL264,HRH3
3173,CHEMBL1743023,Fulranumab,Antibody,,,,-mab,Beta-nerve growth factor inhibitor,"Potent anti-IL-1ß neutralizing antibody, binds to a unique IL-1ß epitope that is proximal to, but does not overlap with the receptor/ligand interface.",,CHEMBL1649058,Beta-nerve growth factor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23748114, URL:http://europepmc.org/abstract/MED/23748114",,CHEMBL1649058,NGF
3174,CHEMBL2108442,Mitumomab,Antibody,,,,-mab,Ganglioside GD3 other,"Mitumomab is an anti-idiotypic antibody that mimics GD3, a ganglioside that is expressed on the surface of tumor cells and is of neuroectodermal origin. Induce antibodies against GD3 ganglioside.",,CHEMBL3580507,Ganglioside GD3,OTHER,Homo sapiens,LIPID,,,"Name:PubMed, SrcID:16192577, URL:http://europepmc.org/abstract/MED/16192577|Name:PubMed, SrcID:2056117, URL:http://europepmc.org/abstract/MED/2056117",,,
3175,CHEMBL325424,Aleplasinin,Small molecule,,,,-plasinin,Plasminogen activator inhibitor-1 inhibitor,,,CHEMBL3475,Plasminogen activator inhibitor-1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22110351, URL:http://europepmc.org/abstract/MED/22110351",Cc1cccc(c1)c2ccc3c(c2)c(cn3Cc4ccc(cc4)C(C)(C)C)C(=O)C(=O)O,CHEMBL3475,SERPINE1
3176,CHEMBL3544988,Daprodustat,Small molecule,,,,-stat,HIF-prolyl hydroxylase inhibitor,,,CHEMBL3831261,Hypoxia-inducible factor prolyl hydroxylase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:27978511, URL:http://europepmc.org/abstract/MED/27978511",OC(=O)CNC(=O)C1C(=O)N(C2CCCCC2)C(=O)N(C3CCCCC3)C1=O,,
3177,CHEMBL2108583,Cintredekin Besudotox,Protein,,,,-kin,Interleukin-13 receptor subunit alpha-2 binding agent,Cytotoxic. Targets and kills tumor cells that express the IL13 receptor (IL13R).,,CHEMBL3713941,Interleukin-13 receptor subunit alpha-2,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:8639793, URL:http://europepmc.org/abstract/MED/8639793",,CHEMBL3713941,IL13RA2
3178,CHEMBL2109410,Tb-402,Antibody,,,,,Coagulation factor VIII inhibitor,Partially inhibits Factor VIII activity (FVIII:C). Inhibits 40% to 70% of FVIII:C in in vitro in the presence of excess antibody.,,CHEMBL3143,Coagulation factor VIII,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20637972, URL:http://europepmc.org/abstract/MED/20637972",,CHEMBL3143,F8
3179,CHEMBL2109467,Amg-714,Antibody,,,,,Interleukin-15 inhibitor,Neutralizes IL-15 biologic activity.,,CHEMBL3712954,Interleukin-15,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:14617758, URL:http://europepmc.org/abstract/MED/14617758",,CHEMBL3712954,IL15
3180,CHEMBL3707280,Cg250 111in,Antibody,,,,,Carbonic anhydrase IX binding agent,cG250 can be internalized by G250 antigen-expressing renal cell carcinoma (RCC) cells.,,CHEMBL3594,Carbonic anhydrase IX,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,,,,CHEMBL3594,CA9
3181,CHEMBL17,Dichlorphenamide,Small molecule,1958.0,S01EC02,S01EC02 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Carbonic anhydrase inhibitors],,Carbonic anhydrase I inhibitor,,,CHEMBL261,Carbonic anhydrase I,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18336310, URL:http://europepmc.org/abstract/MED/18336310",NS(=O)(=O)c1cc(Cl)c(Cl)c(c1)S(=O)(=O)N,CHEMBL261,CA1
3182,CHEMBL1482,Bethanechol,Small molecule,1948.0,N07AB02,N07AB02 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: PARASYMPATHOMIMETICS: Choline esters],,Muscarinic acetylcholine receptor M3 agonist,"Indicated for urinary retention, M3 likely responsible",,CHEMBL245,Muscarinic acetylcholine receptor M3,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:982732, URL:http://europepmc.org/abstract/MED/982732|Name:PubMed, SrcID:16465186, URL:http://europepmc.org/abstract/MED/16465186|Name:ISBN, SrcID:9780702034718 PP. 157, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:Wikipedia, SrcID:Bethanechol, URL:http://en.wikipedia.org/wiki/Bethanechol",CC(C[N+](C)(C)C)OC(=O)N,CHEMBL245,CHRM3
3183,CHEMBL1200604,Tropicamide,Small molecule,1960.0,S01FA56; S01FA06,S01FA56 [SENSORY ORGANS: OPHTHALMOLOGICALS: MYDRIATICS AND CYCLOPLEGICS: Anticholinergics]; S01FA06 [SENSORY ORGANS: OPHTHALMOLOGICALS: MYDRIATICS AND CYCLOPLEGICS: Anticholinergics],trop-,Muscarinic acetylcholine receptor M3 antagonist,"Indicated for mydriasis, M3 likely involved (main form in iris)",,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 153, 160, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:1111414, URL:http://europepmc.org/abstract/MED/1111414|Name:PubMed, SrcID:17579880, URL:http://europepmc.org/abstract/MED/17579880",CCN(Cc1ccncc1)C(=O)C(CO)c2ccccc2,CHEMBL245,CHRM3
3184,CHEMBL550,Pilocarpine,Small molecule,1974.0,S01EB51; S01EB01; N07AX01,S01EB51 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Parasympathomimetics]; S01EB01 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Parasympathomimetics]; N07AX01 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: PARASYMPATHOMIMETICS: Other parasympathomimetics],-pin(e),Muscarinic acetylcholine receptor M3 agonist,"Indicated for miosis, M3 likely involved (main form in iris)",,CHEMBL245,Muscarinic acetylcholine receptor M3,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23662958, URL:http://europepmc.org/abstract/MED/23662958|Name:PubMed, SrcID:11726216, URL:http://europepmc.org/abstract/MED/11726216|Name:PubMed, SrcID:970853, URL:http://europepmc.org/abstract/MED/970853|Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:Wikipedia, SrcID:Pilocarpine, URL:http://en.wikipedia.org/wiki/Pilocarpine",CC[C@H]1[C@@H](Cc2cncn2C)COC1=O,CHEMBL245,CHRM3
3185,CHEMBL1165,Moexipril,Small molecule,1995.0,C09AA13,"C09AA13 [CARDIOVASCULAR SYSTEM: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM: ACE INHIBITORS, PLAIN: ACE inhibitors, plain]",-pril,Angiotensin-converting enzyme inhibitor,,,CHEMBL1808,Angiotensin-converting enzyme,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=d18108f5-98ca-1220-d145-bcf4e71ceaee, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d18108f5-98ca-1220-d145-bcf4e71ceaee",CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2Cc3cc(OC)c(OC)cc3C[C@H]2C(=O)O,CHEMBL1808,ACE
3186,CHEMBL460,Molindone,Small molecule,1974.0,N05AE02,N05AE02 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Indole derivatives],,Dopamine D2 receptor antagonist,,,CHEMBL217,Dopamine D2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Molindone, URL:http://en.wikipedia.org/wiki/Molindone|Name:PubMed, SrcID:9353417, URL:http://europepmc.org/abstract/MED/9353417|Name:Wikipedia, SrcID:Antipsychotic#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Antipsychotic#Mechanism_of_action|Name:PubMed, SrcID:9577836, URL:http://europepmc.org/abstract/MED/9577836|Name:PubMed, SrcID:9342550, URL:http://europepmc.org/abstract/MED/9342550",CCc1c(C)[nH]c2CCC(CN3CCOCC3)C(=O)c12,CHEMBL217,DRD2
3187,CHEMBL535,Sunitinib,Small molecule,2006.0,L01XE04,L01XE04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Macrophage colony stimulating factor receptor inhibitor,,,CHEMBL1844,Macrophage colony stimulating factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14",CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C\2/C(=O)Nc3ccc(F)cc23)c1C,CHEMBL1844,CSF1R
3188,CHEMBL1201354,Tridihexethyl,Small molecule,1954.0,A03AB08,"A03AB08 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: Synthetic anticholinergics, quaternary ammonium compounds]",,Muscarinic acetylcholine receptor M1 antagonist,"Role in regulating gastric secretion, M1 likely involved",,CHEMBL216,Muscarinic acetylcholine receptor M1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Tridihexethyl_chloride, URL:http://en.wikipedia.org/wiki/Tridihexethyl_chloride|Name:PubMed, SrcID:704660, URL:http://europepmc.org/abstract/MED/704660|Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718",CC[N+](CC)(CC)CCC(O)(C1CCCCC1)c2ccccc2,CHEMBL216,CHRM1
3189,CHEMBL1684,Bendroflumethiazide,Small molecule,1959.0,C03AA01,"C03AA01 [CARDIOVASCULAR SYSTEM: DIURETICS: LOW-CEILING DIURETICS, THIAZIDES: Thiazides, plain]",-thiazide,Thiazide-sensitive sodium-chloride cotransporter inhibitor,,,CHEMBL1876,Thiazide-sensitive sodium-chloride cotransporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1056/NEJMra0907219, URL:http://www.nejm.org/doi/full/10.1056/NEJMra0907219",NS(=O)(=O)c1cc2c(NC(Cc3ccccc3)NS2(=O)=O)cc1C(F)(F)F,CHEMBL1876,SLC12A3
3190,CHEMBL1164729,Febuxostat,Small molecule,2009.0,M04AA03,M04AA03 [MUSCULO-SKELETAL SYSTEM: ANTIGOUT PREPARATIONS: ANTIGOUT PREPARATIONS: Preparations inhibiting uric acid production],-stat,Xanthine dehydrogenase inhibitor,,,CHEMBL1929,Xanthine dehydrogenase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=ae1e0d8a-03fc-419b-9d44-afa68fbd5681, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ae1e0d8a-03fc-419b-9d44-afa68fbd5681",CC(C)COc1ccc(cc1C#N)c2nc(C)c(s2)C(=O)O,CHEMBL1929,XDH
3191,CHEMBL535,Sunitinib,Small molecule,2006.0,L01XE04,L01XE04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Stem cell growth factor receptor inhibitor,,,CHEMBL1936,Stem cell growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14",CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C\2/C(=O)Nc3ccc(F)cc23)c1C,CHEMBL1936,KIT
3192,CHEMBL36,Pyrimethamine,Small molecule,1953.0,P01BD01; P01BD51,"P01BD01 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: ANTIMALARIALS: Diaminopyrimidines]; P01BD51 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: ANTIMALARIALS: Diaminopyrimidines]",,Dihydrofolate reductase inhibitor,,,CHEMBL1939,Dihydrofolate reductase,INHIBITOR,Plasmodium falciparum K1,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=3e4d5027-7939-480f-ae19-82e764d9fa97, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3e4d5027-7939-480f-ae19-82e764d9fa97|Name:Wikipedia, SrcID:Pyrimethamine, URL:http://en.wikipedia.org/wiki/Pyrimethamine",CCc1nc(N)nc(N)c1c2ccc(Cl)cc2,,
3193,CHEMBL652,Flecainide,Small molecule,1985.0,C01BC04,"C01BC04 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class Ic]",,Sodium channel protein type V alpha subunit blocker,,,CHEMBL1980,Sodium channel protein type V alpha subunit,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15272045, URL:http://europepmc.org/abstract/MED/15272045|Name:Wikipedia, SrcID:Flecainide, URL:http://en.wikipedia.org/wiki/Flecainide",FC(F)(F)COc1ccc(OCC(F)(F)F)c(c1)C(=O)NCC2CCCCN2,CHEMBL1980,SCN5A
3194,CHEMBL1512,Flunisolide,Small molecule,1981.0,R01AD04; R03BA03,"R01AD04 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Corticosteroids]; R03BA03 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS: Glucocorticoids]",,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=7c72c954-3758-40c3-9977-d03b25d71e0a, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7c72c954-3758-40c3-9977-d03b25d71e0a|Name:ISBN, SrcID:978-1-889788-85-2, URL:http://www.isbnsearch.org/isbn/9781889788852",CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,CHEMBL2034,NR3C1
3195,CHEMBL1201208,Phenmetrazine,Small molecule,1982.0,,,,Norepinephrine transporter inhibitor,,,CHEMBL222,Norepinephrine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23211394, URL:http://europepmc.org/abstract/MED/23211394|Name:Wikipedia, SrcID:Phenmetrazine, URL:http://en.wikipedia.org/wiki/Phenmetrazine",CC1NCCOC1c2ccccc2,CHEMBL222,SLC6A2
3196,CHEMBL897,Probenecid,Small molecule,1951.0,M04AB01,M04AB01 [MUSCULO-SKELETAL SYSTEM: ANTIGOUT PREPARATIONS: ANTIGOUT PREPARATIONS: Preparations increasing uric acid excretion],,Solute carrier family 22 member 6 inhibitor,,,CHEMBL1641347,Solute carrier family 22 member 6,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:2962517, URL:http://europepmc.org/abstract/MED/2962517|Name:PubMed, SrcID:15377641, URL:http://europepmc.org/abstract/MED/15377641|Name:Wikipedia, SrcID:Probenecid#Pharmacology, URL:http://en.wikipedia.org/wiki/Probenecid#Pharmacology|Name:PubMed, SrcID:11426832, URL:http://europepmc.org/abstract/MED/11426832|Name:PubMed, SrcID:12130730, URL:http://europepmc.org/abstract/MED/12130730",CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)O,CHEMBL1641347,SLC22A6
3197,CHEMBL1219,Rabeprazole,Small molecule,1999.0,A02BC04; A02BC54,A02BC04 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): Proton pump inhibitors]; A02BC54 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): Proton pump inhibitors],-prazole,Potassium-transporting ATPase inhibitor,,,CHEMBL2095173,Potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,K-ATPase alpha subunit,Alpha subunit is likely binding site,"Name:PubMed, SrcID:14699149, URL:http://europepmc.org/abstract/MED/14699149|Name:PubMed, SrcID:23350044, URL:http://europepmc.org/abstract/MED/23350044|Name:DailyMed, SrcID:setid=c03c0f10-4bd6-4181-9c2a-99facaa0ab1c#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c03c0f10-4bd6-4181-9c2a-99facaa0ab1c#nlm34090-1",COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C,CHEMBL2095173,ATP4A
3198,CHEMBL1219,Rabeprazole,Small molecule,1999.0,A02BC04; A02BC54,A02BC04 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): Proton pump inhibitors]; A02BC54 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): Proton pump inhibitors],-prazole,Potassium-transporting ATPase inhibitor,,,CHEMBL2095173,Potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,K-ATPase alpha subunit,Alpha subunit is likely binding site,"Name:PubMed, SrcID:14699149, URL:http://europepmc.org/abstract/MED/14699149|Name:PubMed, SrcID:23350044, URL:http://europepmc.org/abstract/MED/23350044|Name:DailyMed, SrcID:setid=c03c0f10-4bd6-4181-9c2a-99facaa0ab1c#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c03c0f10-4bd6-4181-9c2a-99facaa0ab1c#nlm34090-1",COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C,CHEMBL2095173,ATP4B
3199,CHEMBL1201346,Balsalazid,Small molecule,2000.0,A07EC04,"A07EC04 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Aminosalicylic acid and similar agents]",-sal-,Cyclooxygenase inhibitor,,,CHEMBL2094253,Cyclooxygenase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:12950415, URL:http://europepmc.org/abstract/MED/12950415|Name:PubMed, SrcID:19743890, URL:http://europepmc.org/abstract/MED/19743890|Name:PubMed, SrcID:17981262, URL:http://europepmc.org/abstract/MED/17981262",OC(=O)CCNC(=O)c1ccc(cc1)N=Nc2ccc(O)c(c2)C(=O)O,,
3200,CHEMBL753,Phenoxybenzamine,Small molecule,1953.0,C04AX02,C04AX02 [CARDIOVASCULAR SYSTEM: PERIPHERAL VASODILATORS: PERIPHERAL VASODILATORS: Other peripheral vasodilators],,Adrenergic receptor alpha antagonist,,,CHEMBL2095203,Adrenergic receptor alpha,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=4fcdf9ca-78a8-4e4b-958e-2f795bbbf9ca, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4fcdf9ca-78a8-4e4b-958e-2f795bbbf9ca",CC(COc1ccccc1)N(CCCl)Cc2ccccc2,,
3201,CHEMBL267936,Mecamylamine,Small molecule,1956.0,C02BB01,"C02BB01 [CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ANTIADRENERGIC AGENTS, GANGLION-BLOCKING: Secondary and tertiary amines]",,Neuronal acetylcholine receptor; alpha3/beta4 negative allosteric modulator,,,CHEMBL1907594,Neuronal acetylcholine receptor; alpha3/beta4,NEGATIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:Wikipedia, SrcID:Nicotinic_acetylcholine_receptor, URL:http://en.wikipedia.org/wiki/Nicotinic_acetylcholine_receptor|Name:DailyMed, SrcID:setid=e1fc95fe-7816-47b6-b73d-b2f644f79872, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e1fc95fe-7816-47b6-b73d-b2f644f79872|Name:Wikipedia, SrcID:Mecamylamine, URL:http://en.wikipedia.org/wiki/Mecamylamine|Name:PubMed, SrcID:19874251, URL:http://europepmc.org/abstract/MED/19874251",CNC1(C)C2CCC(C2)C1(C)C,,
3202,CHEMBL1201607,Natalizumab,Antibody,2004.0,L04AA23,L04AA23 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Selective immunosuppressants],-mab,Integrin alpha-4/beta-1 inhibitor,,,CHEMBL1907599,Integrin alpha-4/beta-1,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,Integrin alpha-4 subunit,Alpha subunit is binding site,"Name:DailyMed, SrcID:setid=c5fdde91-1989-4dd2-9129-4f3323ea2962, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5fdde91-1989-4dd2-9129-4f3323ea2962",,,
3203,CHEMBL734,Acetohydroxamic Acid,Small molecule,1983.0,G04BX03,G04BX03 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Other urologicals],,Bacterial urease inhibitor,,,CHEMBL2364683,Bacterial urease,INHIBITOR,Bacteria,PROTEIN COMPLEX,,,"Name:DailyMed, SrcID:setid=6660b616-a82d-9109-19ce-2bdf9747acea#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6660b616-a82d-9109-19ce-2bdf9747acea#nlm34090-1",CC(=O)NO,,
3204,CHEMBL1201574,Botulinum Toxin Type A Purified Neurotoxin Complex,Unknown,1991.0,M03AX01,"M03AX01 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS: Other muscle relaxants, peripherally acting agents]",-nab-,Synaptosomal-associated protein 25 inhibitor,"BOTOX blocks neuromuscular transmission by binding to acceptor sites on motor or sympathetic nerve terminals, entering the nerve terminals, and inhibiting the release of acetylcholine. This inhibition occurs as the neurotoxin cleaves SNAP-25, a protein integral to the successful docking and release of acetylcholine from vesicles situated within nerve endings.",,CHEMBL2364159,Synaptosomal-associated protein 25,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=33d066a9-34ff-4a1a-b38b-d10983df3300#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=33d066a9-34ff-4a1a-b38b-d10983df3300#nlm34090-1",,CHEMBL2364159,SNAP25
3205,CHEMBL1540,Penciclovir,Small molecule,1996.0,D06BB06; J05AB13,D06BB06 [DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: CHEMOTHERAPEUTICS FOR TOPICAL USE: Antivirals]; J05AB13 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleosides and nucleotides excl. reverse transcriptase inhibitors],-vir,Human herpesvirus 1 DNA polymerase inhibitor,,,CHEMBL1872,Human herpesvirus 1 DNA polymerase,INHIBITOR,Herpes simplex virus (type 1 / strain 17),SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=8d119057-f299-43ea-b516-e84a09cab890, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8d119057-f299-43ea-b516-e84a09cab890",Nc1nc(O)c2ncn(CCC(CO)CO)c2n1,,
3206,CHEMBL1200515,Deserpidine,Small molecule,1957.0,C02AA05,"C02AA05 [CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ANTIADRENERGIC AGENTS, CENTRALLY ACTING: Rauwolfia alkaloids]",,Synaptic vesicular amine transporter inhibitor,,,CHEMBL1893,Synaptic vesicular amine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:archiveid=98261, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=98261|Name:Wikipedia, SrcID:Reserpine, URL:http://en.wikipedia.org/wiki/Reserpine|Name:DailyMed, SrcID:setid=9778afde-01ae-49df-e7ab-d25d89711602, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9778afde-01ae-49df-e7ab-d25d89711602",CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)c6cc(OC)c(OC)c(OC)c6,CHEMBL1893,SLC18A2
3207,CHEMBL1200633,Ivermectin,Unknown,1996.0,D11AX22; P02CF01,"D11AX22 [DERMATOLOGICALS: OTHER DERMATOLOGICAL PREPARATIONS: OTHER DERMATOLOGICAL PREPARATIONS: Other dermatologicals]; P02CF01 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTHELMINTICS: ANTINEMATODAL AGENTS: Avermectines]",-ectin,Glutamate-gated chloride channel modulator,,,CHEMBL2363050,Glutamate-gated chloride channel,MODULATOR,Strongyloides stercoralis,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Ivermectin, URL:http://en.wikipedia.org/wiki/Ivermectin|Name:FDA, SrcID:label/2014/204154Orig1s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204154Orig1s000lbl.pdf|Name:ISBN, SrcID:9780702034718 PP. 671, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:13678839, URL:http://europepmc.org/abstract/MED/13678839",CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]3C[C@@H](C\C=C(/C)\[C@@H](O[C@H]4C[C@H](OC)[C@@H](O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)\C=C\C=C\6/CO[C@@H]7[C@H](O)C(=C[C@@H](C(=O)O3)[C@]67O)C)O2.CO[C@H]8C[C@H](O[C@H]9[C@H](C)O[C@H](C[C@@H]9OC)O[C@H]%10[C@@H](C)\C=C\C=C\%11/CO[C@@H]%12[C@H](O)C(=C[C@@H](C(=O)O[C@H]%13C[C@@H](C\C=C\%10/C)O[C@@]%14(CC[C@H](C)[C@H](O%14)C(C)C)C%13)[C@]%11%12O)C)O[C@@H](C)[C@@H]8O,,
3208,CHEMBL556,Deferoxamine,Small molecule,1968.0,V03AC01,V03AC01 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Iron chelating agents],,Iron chelating agent,,,CHEMBL2363058,Iron,CHELATING AGENT,,METAL,,,"Name:DailyMed, SrcID:setid=d91e16df-8daa-4cd2-86a2-273eaa2446e0#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d91e16df-8daa-4cd2-86a2-273eaa2446e0#nlm34090-1",CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN,,
3209,CHEMBL3545057,Acetyldigitoxin,Small molecule,1982.0,C01AA01,C01AA01 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC GLYCOSIDES: Digitalis glycosides],-oxin,Sodium/potassium-transporting ATPase inhibitor,,,CHEMBL2095186,Sodium/potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,K/Na-ATPase alpha subunit,Alpha subunit is binding site,"Name:PubMed, SrcID:23537048, URL:http://europepmc.org/abstract/MED/23537048|Name:ISBN, SrcID:9780702034718 PP. 258, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:13345619, URL:http://europepmc.org/abstract/MED/13345619",C[C@H]1O[C@H](C[C@H](OC(=O)C)[C@@H]1O)O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4)O[C@@H]3C)O[C@@H]2C,CHEMBL2095186,FXYD2
3210,CHEMBL3545057,Acetyldigitoxin,Small molecule,1982.0,C01AA01,C01AA01 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC GLYCOSIDES: Digitalis glycosides],-oxin,Sodium/potassium-transporting ATPase inhibitor,,,CHEMBL2095186,Sodium/potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,K/Na-ATPase alpha subunit,Alpha subunit is binding site,"Name:PubMed, SrcID:23537048, URL:http://europepmc.org/abstract/MED/23537048|Name:ISBN, SrcID:9780702034718 PP. 258, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:13345619, URL:http://europepmc.org/abstract/MED/13345619",C[C@H]1O[C@H](C[C@H](OC(=O)C)[C@@H]1O)O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4)O[C@@H]3C)O[C@@H]2C,CHEMBL2095186,ATP1A3
3211,CHEMBL3545057,Acetyldigitoxin,Small molecule,1982.0,C01AA01,C01AA01 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC GLYCOSIDES: Digitalis glycosides],-oxin,Sodium/potassium-transporting ATPase inhibitor,,,CHEMBL2095186,Sodium/potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,K/Na-ATPase alpha subunit,Alpha subunit is binding site,"Name:PubMed, SrcID:23537048, URL:http://europepmc.org/abstract/MED/23537048|Name:ISBN, SrcID:9780702034718 PP. 258, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:13345619, URL:http://europepmc.org/abstract/MED/13345619",C[C@H]1O[C@H](C[C@H](OC(=O)C)[C@@H]1O)O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4)O[C@@H]3C)O[C@@H]2C,CHEMBL2095186,ATP1A2
3212,CHEMBL3545057,Acetyldigitoxin,Small molecule,1982.0,C01AA01,C01AA01 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC GLYCOSIDES: Digitalis glycosides],-oxin,Sodium/potassium-transporting ATPase inhibitor,,,CHEMBL2095186,Sodium/potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,K/Na-ATPase alpha subunit,Alpha subunit is binding site,"Name:PubMed, SrcID:23537048, URL:http://europepmc.org/abstract/MED/23537048|Name:ISBN, SrcID:9780702034718 PP. 258, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:13345619, URL:http://europepmc.org/abstract/MED/13345619",C[C@H]1O[C@H](C[C@H](OC(=O)C)[C@@H]1O)O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4)O[C@@H]3C)O[C@@H]2C,CHEMBL2095186,ATP1A4
3213,CHEMBL3545057,Acetyldigitoxin,Small molecule,1982.0,C01AA01,C01AA01 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC GLYCOSIDES: Digitalis glycosides],-oxin,Sodium/potassium-transporting ATPase inhibitor,,,CHEMBL2095186,Sodium/potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,K/Na-ATPase alpha subunit,Alpha subunit is binding site,"Name:PubMed, SrcID:23537048, URL:http://europepmc.org/abstract/MED/23537048|Name:ISBN, SrcID:9780702034718 PP. 258, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:13345619, URL:http://europepmc.org/abstract/MED/13345619",C[C@H]1O[C@H](C[C@H](OC(=O)C)[C@@H]1O)O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4)O[C@@H]3C)O[C@@H]2C,CHEMBL2095186,ATP1B2
3214,CHEMBL3545057,Acetyldigitoxin,Small molecule,1982.0,C01AA01,C01AA01 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC GLYCOSIDES: Digitalis glycosides],-oxin,Sodium/potassium-transporting ATPase inhibitor,,,CHEMBL2095186,Sodium/potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,K/Na-ATPase alpha subunit,Alpha subunit is binding site,"Name:PubMed, SrcID:23537048, URL:http://europepmc.org/abstract/MED/23537048|Name:ISBN, SrcID:9780702034718 PP. 258, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:13345619, URL:http://europepmc.org/abstract/MED/13345619",C[C@H]1O[C@H](C[C@H](OC(=O)C)[C@@H]1O)O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4)O[C@@H]3C)O[C@@H]2C,CHEMBL2095186,ATP1B1
3215,CHEMBL3545057,Acetyldigitoxin,Small molecule,1982.0,C01AA01,C01AA01 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC GLYCOSIDES: Digitalis glycosides],-oxin,Sodium/potassium-transporting ATPase inhibitor,,,CHEMBL2095186,Sodium/potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,K/Na-ATPase alpha subunit,Alpha subunit is binding site,"Name:PubMed, SrcID:23537048, URL:http://europepmc.org/abstract/MED/23537048|Name:ISBN, SrcID:9780702034718 PP. 258, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:13345619, URL:http://europepmc.org/abstract/MED/13345619",C[C@H]1O[C@H](C[C@H](OC(=O)C)[C@@H]1O)O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4)O[C@@H]3C)O[C@@H]2C,CHEMBL2095186,ATP1B3
3216,CHEMBL967,Temazepam,Small molecule,1981.0,N05CD07,N05CD07 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:FDA, SrcID:label/2010/018163s054lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018163s054lbl.pdf|Name:Wikipedia, SrcID:Benzodiazepine, URL:http://en.wikipedia.org/wiki/Benzodiazepine|Name:Wikipedia, SrcID:GABAA_receptor, URL:http://en.wikipedia.org/wiki/GABAA_receptor",CN1C(=O)C(O)N=C(c2ccccc2)c3cc(Cl)ccc13,CHEMBL2093872,GABRG3
3217,CHEMBL967,Temazepam,Small molecule,1981.0,N05CD07,N05CD07 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:FDA, SrcID:label/2010/018163s054lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018163s054lbl.pdf|Name:Wikipedia, SrcID:Benzodiazepine, URL:http://en.wikipedia.org/wiki/Benzodiazepine|Name:Wikipedia, SrcID:GABAA_receptor, URL:http://en.wikipedia.org/wiki/GABAA_receptor",CN1C(=O)C(O)N=C(c2ccccc2)c3cc(Cl)ccc13,CHEMBL2093872,GABRP
3218,CHEMBL967,Temazepam,Small molecule,1981.0,N05CD07,N05CD07 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:FDA, SrcID:label/2010/018163s054lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018163s054lbl.pdf|Name:Wikipedia, SrcID:Benzodiazepine, URL:http://en.wikipedia.org/wiki/Benzodiazepine|Name:Wikipedia, SrcID:GABAA_receptor, URL:http://en.wikipedia.org/wiki/GABAA_receptor",CN1C(=O)C(O)N=C(c2ccccc2)c3cc(Cl)ccc13,CHEMBL2093872,GABRE
3219,CHEMBL967,Temazepam,Small molecule,1981.0,N05CD07,N05CD07 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:FDA, SrcID:label/2010/018163s054lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018163s054lbl.pdf|Name:Wikipedia, SrcID:Benzodiazepine, URL:http://en.wikipedia.org/wiki/Benzodiazepine|Name:Wikipedia, SrcID:GABAA_receptor, URL:http://en.wikipedia.org/wiki/GABAA_receptor",CN1C(=O)C(O)N=C(c2ccccc2)c3cc(Cl)ccc13,CHEMBL2093872,GABRG1
3220,CHEMBL976,Praziquantel,Small molecule,1982.0,P02BA01,"P02BA01 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTHELMINTICS: ANTITREMATODALS: Quinoline derivatives and related substances]",-antel,Voltage-activated calcium channel beta 2 subunit blocker,,,CHEMBL2363080,Voltage-activated calcium channel beta 2 subunit,BLOCKER,Schistosoma mansoni,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19554083, URL:http://europepmc.org/abstract/MED/19554083|Name:Wikipedia, SrcID:Praziquantel, URL:http://en.wikipedia.org/wiki/Praziquantel|Name:PubMed, SrcID:18978535, URL:http://europepmc.org/abstract/MED/18978535",O=C(C1CCCCC1)N2CC3N(CCc4ccccc34)C(=O)C2,,
3221,CHEMBL1294,Quinidine,Small molecule,1950.0,C01BA71; C01BA51; C01BA01,"C01BA71 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class Ia]; C01BA51 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class Ia]; C01BA01 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class Ia]",,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=a10b6ded-4fe0-4059-bd77-c45acc3c876d, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a10b6ded-4fe0-4059-bd77-c45acc3c876d|Name:DailyMed, SrcID:setid=a08a0f0b-6cf5-4fa4-a861-0b054d6fddfc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a08a0f0b-6cf5-4fa4-a861-0b054d6fddfc",COc1ccc2nccc([C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C)c2c1,,
3222,CHEMBL695,Trimethadione,Small molecule,1946.0,N03AC02,N03AC02 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Oxazolidine derivatives],,Voltage-gated T-type calcium channel blocker,,,CHEMBL2362995,Voltage-gated T-type calcium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:ISBN, SrcID:1609133455 PP. 565, URL:http://www.isbnsearch.org/isbn/1609133455|Name:PubMed, SrcID:16171802, URL:http://europepmc.org/abstract/MED/16171802|Name:PubMed, SrcID:17291698, URL:http://europepmc.org/abstract/MED/17291698",CN1C(=O)OC(C)(C)C1=O,,
3223,CHEMBL601,Aminolevulinic Acid,Small molecule,1999.0,L01XD04,L01XD04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Sensitizers used in photodynamic/radiation therapy],,DNA inhibitor,Photodynamic therapy,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=e45cc371-9ebc-4904-12bc-65cb4e2817ad#section-12, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e45cc371-9ebc-4904-12bc-65cb4e2817ad#section-12",NCC(=O)CCC(=O)O,,
3224,CHEMBL2104993,Vortioxetine,Small molecule,2013.0,N06AX26,N06AX26 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants],-oxetine,Serotonin 1a (5-HT1a) receptor agonist,,,CHEMBL214,Serotonin 1a (5-HT1a) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21486038, URL:http://europepmc.org/abstract/MED/21486038|Name:DailyMed, SrcID:4b0700c9-b417-4c3a-b36f-de461e125bd3, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4b0700c9-b417-4c3a-b36f-de461e125bd3",Cc1ccc(Sc2ccccc2N3CCNCC3)c(C)c1,CHEMBL214,HTR1A
3225,CHEMBL3545175,Pf-03882845,Small molecule,,,,,Mineralocorticoid receptor antagonist,"Ph1 study terminated, development discontinued in 2012 (http://www.pfizer.com/sites/default/files/product-pipeline/pipeline_2012_1108.pdf)",,CHEMBL1994,Mineralocorticoid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24133446, URL:http://europepmc.org/abstract/MED/24133446",,,
3226,CHEMBL3545176,Db959,Small molecule,,,,,Peroxisome proliferator-activated receptor gamma agonist,Ph1b study completed in 2011 (no trial ID). Compound outlicensed to T3D Therapeutics Inc in 2013.,,CHEMBL235,Peroxisome proliferator-activated receptor gamma,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.t3dtherapeutics.com/product-portfolio/, URL:http://www.t3dtherapeutics.com/product-portfolio/|Name:Other, SrcID:http://www.darabio.com/media-center/press-releases?detail=134, URL:http://www.darabio.com/media-center/press-releases?detail=134",,CHEMBL235,PPARG
3227,CHEMBL3545244,Allitinib,Small molecule,,,,-tinib,Receptor protein-tyrosine kinase erbB-2 inhibitor,"Irreversible inhibitor, also potent at ERBB4.",,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21789172, URL:http://europepmc.org/abstract/MED/21789172",,CHEMBL1824,ERBB2
3228,CHEMBL2031465,Azd-6703,Small molecule,,,,,MAP kinase p38 alpha inhibitor,,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22608965, URL:http://europepmc.org/abstract/MED/22608965",CN1CCN(CC1)c2ccc3N=CN(C(=O)c3c2)c4cc(ccc4C)C(=O)NC5CC5,CHEMBL260,MAPK14
3229,CHEMBL1090479,Gsk-1070916,Small molecule,,,,,Serine/threonine-protein kinase Aurora-B inhibitor,,,CHEMBL2185,Serine/threonine-protein kinase Aurora-B,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24965505, URL:http://europepmc.org/abstract/MED/24965505|Name:PubMed, SrcID:20420387, URL:http://europepmc.org/abstract/MED/20420387",CCn1cc(c2ccnc3[nH]c(cc23)c4cccc(CN(C)C)c4)c(n1)c5ccc(NC(=O)N(C)C)cc5,CHEMBL2185,AURKB
3230,CHEMBL3545430,Hm-61713,Small molecule,,,,,Epidermal growth factor receptor erbB1 inhibitor,EGFR mutant selective including both activating mutations and T790M (PMID: 26508839),,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.hanmipharm.com/ehanmi/img/rnd/2013_WCLC_(HM61713).pdf, URL:http://www.hanmipharm.com/ehanmi/img/rnd/2013_WCLC_(HM61713).pdf|Name:PubMed, SrcID:26508839, URL:http://europepmc.org/abstract/MED/26508839",,CHEMBL203,EGFR
3231,CHEMBL3544929,Pf-04965842,Small molecule,,,,,Tyrosine-protein kinase JAK1 inhibitor,,,CHEMBL2835,Tyrosine-protein kinase JAK1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://www.pfizer.com/sites/default/files/product-pipeline/July%2028%202015%20Pipeline%20Update.pdf, URL:https://www.pfizer.com/sites/default/files/product-pipeline/July%2028%202015%20Pipeline%20Update.pdf|Name:PubMed, SrcID:9572949, URL:http://europepmc.org/abstract/MED/9572949",,CHEMBL2835,JAK1
3232,CHEMBL2104449,Sarakalim,Small molecule,,,,-kalim,Sulfonylurea receptors; K-ATP channels opener,,,CHEMBL2095152,Sulfonylurea receptors; K-ATP channels,OPENER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:9605570, URL:http://europepmc.org/abstract/MED/9605570",CC(=O)N(O)CC1=C(N2C=CC=CC2=O)c3cc(ccc3OC1(C)C)C(F)(F)F,,
3233,CHEMBL2105738,Galeterone,Small molecule,,,,,Cytochrome P450 17A1 inhibitor,,,CHEMBL3522,Cytochrome P450 17A1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23713567, URL:http://europepmc.org/abstract/MED/23713567|Name:Other, SrcID:http://tokaipharmaceuticals.com/our-programs/about-galeterone/, URL:http://tokaipharmaceuticals.com/our-programs/about-galeterone/|Name:PubMed, SrcID:25591066, URL:http://europepmc.org/abstract/MED/25591066",C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CC=C2n5cnc6ccccc56,CHEMBL3522,CYP17A1
3234,CHEMBL338604,C-1311,Small molecule,,,,,Tyrosine-protein kinase receptor FLT3 inhibitor,"Intercalates to DNA and following metabolic activation, covalently crosslinks DNA strands (PMID: 12007568, PMID:25896848)",,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25896848, URL:http://europepmc.org/abstract/MED/25896848|Name:PubMed, SrcID:23823138, URL:http://europepmc.org/abstract/MED/23823138",CCN(CC)CCNc1ccc2ncn3c4ccc(O)cc4C(=O)c1c23,CHEMBL1974,FLT3
3235,CHEMBL3545025,Insm-18,Small molecule,,,,,Insulin-like growth factor I receptor inhibitor,,,CHEMBL1957,Insulin-like growth factor I receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21875414, URL:http://europepmc.org/abstract/MED/21875414|Name:PubMed, SrcID:16142439, URL:http://europepmc.org/abstract/MED/16142439",,CHEMBL1957,IGF1R
3236,CHEMBL3545158,Plx-3397,Small molecule,,,,,Macrophage colony stimulating factor receptor inhibitor,,,CHEMBL1844,Macrophage colony stimulating factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22039576, URL:http://europepmc.org/abstract/MED/22039576|Name:PubMed, SrcID:25847190, URL:http://europepmc.org/abstract/MED/25847190",,CHEMBL1844,CSF1R
3237,CHEMBL3360203,Pilaralisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Other, SrcID:http://www.exelixis.com/pipeline/xl147, URL:http://www.exelixis.com/pipeline/xl147|Name:PubMed, SrcID:24166903, URL:http://europepmc.org/abstract/MED/24166903|Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718",COc1ccc(Cl)c(Nc2nc3ccccc3nc2NS(=O)(=O)c4cccc(NC(=O)C(C)(C)N)c4)c1,CHEMBL3559703,PIK3R2
3238,CHEMBL3360203,Pilaralisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Other, SrcID:http://www.exelixis.com/pipeline/xl147, URL:http://www.exelixis.com/pipeline/xl147|Name:PubMed, SrcID:24166903, URL:http://europepmc.org/abstract/MED/24166903|Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718",COc1ccc(Cl)c(Nc2nc3ccccc3nc2NS(=O)(=O)c4cccc(NC(=O)C(C)(C)N)c4)c1,CHEMBL3559703,PIK3R3
3239,CHEMBL3360203,Pilaralisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Other, SrcID:http://www.exelixis.com/pipeline/xl147, URL:http://www.exelixis.com/pipeline/xl147|Name:PubMed, SrcID:24166903, URL:http://europepmc.org/abstract/MED/24166903|Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718",COc1ccc(Cl)c(Nc2nc3ccccc3nc2NS(=O)(=O)c4cccc(NC(=O)C(C)(C)N)c4)c1,CHEMBL3559703,PIK3R5
3240,CHEMBL403989,Tg100-801,Small molecule,,,,,SRC inhibitor,Prodrug - active metabolite is TG-100-572 (HY-10184),,CHEMBL2363074,SRC,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:18311895, URL:http://europepmc.org/abstract/MED/18311895|Name:PubMed, SrcID:18483622, URL:http://europepmc.org/abstract/MED/18483622|Name:PubMed, SrcID:18330892, URL:http://europepmc.org/abstract/MED/18330892",Cc1cc(cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12)c5cc(OC(=O)c6ccccc6)ccc5Cl,,
3241,CHEMBL105060,Dnk333,Small molecule,,,,,Neurokinin 1 receptor antagonist,,,CHEMBL249,Neurokinin 1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17169559, URL:http://europepmc.org/abstract/MED/17169559|Name:PubMed, SrcID:12877589, URL:http://europepmc.org/abstract/MED/12877589",CN([C@H](Cc1ccc(Cl)c(Cl)c1)\C=C\C(=O)N[C@@H]2CCCCNC2=O)C(=O)c3cc(cc(c3)C(F)(F)F)C(F)(F)F,CHEMBL249,TACR1
3242,CHEMBL489095,Camicinal,Small molecule,,,,,Motilin receptor agonist,,,CHEMBL2203,Motilin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25341626, URL:http://europepmc.org/abstract/MED/25341626",C[C@H]1CN(Cc2ccc(CC(=O)N3CCC(CC3)Nc4cccc(F)c4)cc2)CCN1,CHEMBL2203,MLNR
3243,CHEMBL257978,Dabuzalgron,Small molecule,,,,-algron,Alpha-1a adrenergic receptor partial agonist,,,CHEMBL229,Alpha-1a adrenergic receptor,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:14678390, URL:http://europepmc.org/abstract/MED/14678390",Cc1c(NS(=O)(=O)C)c(Cl)ccc1OCC2=NCCN2,CHEMBL229,ADRA1A
3244,CHEMBL3544949,Ctce-9908,Protein,,,,,C-X-C chemokine receptor type 4 antagonist,,,CHEMBL2107,C-X-C chemokine receptor type 4,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19088012, URL:http://europepmc.org/abstract/MED/19088012|Name:Other, SrcID:http://mct.aacrjournals.org/content/6/11_Supplement/A153.short, URL:http://mct.aacrjournals.org/content/6/11_Supplement/A153.short",CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N,CHEMBL2107,CXCR4
3245,CHEMBL482950,Pexacerfont,Small molecule,,,,-cerfont,Corticotropin releasing factor receptor 1 antagonist,,,CHEMBL1800,Corticotropin releasing factor receptor 1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25409596, URL:http://europepmc.org/abstract/MED/25409596|Name:PubMed, SrcID:22381334, URL:http://europepmc.org/abstract/MED/22381334",CC[C@@H](C)Nc1nc(C)nc2c(c(C)nn12)c3ccc(OC)nc3C,CHEMBL1800,CRHR1
3246,CHEMBL266125,Ibodutant,Small molecule,,,,-tant,Neurokinin 2 receptor antagonist,,,CHEMBL2327,Neurokinin 2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16979621, URL:http://europepmc.org/abstract/MED/16979621",Cc1ccc2cc(sc2c1)C(=O)NC3(CCCC3)C(=O)N[C@H](Cc4ccccc4)C(=O)NCC5CCN(CC6CCOCC6)CC5,CHEMBL2327,TACR2
3247,CHEMBL1743063,Rilotumumab,Antibody,,,,-mab,Hepatocyte growth factor inhibitor,"In November 2014, Amgen halted all clinical studies of its compound rilotumumab (formerly AMG 102) in advanced gastric cancer.",,CHEMBL5479,Hepatocyte growth factor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19649990, URL:http://europepmc.org/abstract/MED/19649990",,CHEMBL5479,HGF
3248,CHEMBL2103879,Ganetespib,Small molecule,,,,-espib,Heat shock protein HSP90 inhibitor,"Resorcinolic triazolone inhibitor of Hsp90. Disrupts the association of HSP90 with its cochaperone, p23.",,CHEMBL2095165,Heat shock protein HSP90,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,Binds to the ATP-binding domain at the N-terminus of Hsp90,"Name:PubMed, SrcID:22806877, URL:http://europepmc.org/abstract/MED/22806877|Name:PubMed, SrcID:21154128, URL:http://europepmc.org/abstract/MED/21154128",CC(C)c1cc(C2=NNC(=O)N2c3ccc4c(ccn4C)c3)c(O)cc1O,,
3249,CHEMBL27759,Entinostat,Small molecule,,,,-stat,Histone deacetylase inhibitor,,,CHEMBL2093865,Histone deacetylase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10200307, URL:http://europepmc.org/abstract/MED/10200307",Nc1ccccc1NC(=O)c2ccc(CNC(=O)OCc3cccnc3)cc2,,
3250,CHEMBL197672,Emricasan,Small molecule,,,,-casan,Caspase inhibitor,,,CHEMBL3831289,Caspase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:16250635, URL:http://europepmc.org/abstract/MED/16250635",C[C@H](NC(=O)C(=O)Nc1ccccc1C(C)(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)COc2c(F)c(F)cc(F)c2F,,
3251,CHEMBL2109621,Di17e6,Antibody,,,,,Integrin alpha-V/beta-3 inhibitor,"Inhibits ligand binding to all alphav heterodimers (alphavbeta1, alphavbeta3, alphavbeta5, alphavbeta6, alphavbeta8).",Specifically directed against the alphaV subunit of human integrins.,CHEMBL1907598,Integrin alpha-V/beta-3,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23791392, URL:http://europepmc.org/abstract/MED/23791392",,,
3252,CHEMBL1743008,Drozitumab,Antibody,,,,-mab,Tumor necrosis factor receptor superfamily member 10B agonist,Induces TNFRSF10B clustering at the cell surface and stimulates a death-inducing signaling complex containing the adaptor molecule Fas-associated death domain and the apoptosis-initiating protease caspase-8. Fc crosslinking further augmented Drozitumab's proapoptotic activity.,"Binds to TNFRSF10B, but shows no detectable binding to any of the other Apo2L/TRAIL receptors.",CHEMBL1075153,Tumor necrosis factor receptor superfamily member 10B,AGONIST,Homo sapiens,SINGLE PROTEIN,,"Binds at the junction between CRD2 and CRD3, interacting with residues in both CRD2 and CRD3.","Name:PubMed, SrcID:18219321, URL:http://europepmc.org/abstract/MED/18219321",,CHEMBL1075153,TNFRSF10B
3253,CHEMBL2109300,Gsk-933776,Antibody,,,,,Beta amyloid A4 protein other,Neutralises disease-relevant aggregated forms of amyloid-beta.,,CHEMBL2487,Beta amyloid A4 protein,OTHER,Homo sapiens,SINGLE PROTEIN,,Binds with high affinity to the Abeta N terminus (aa1-5).,"Name:PubMed, SrcID:24716469, URL:http://europepmc.org/abstract/MED/24716469",,CHEMBL2487,APP
3254,CHEMBL2107979,Pexelizumab,Antibody,,,,-mab,Complement C5 inhibitor,,,CHEMBL2364163,Complement C5,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,,,CHEMBL2364163,C5
3255,CHEMBL3039583,Pasireotide,Protein,2012.0,H01CB05,"H01CB05 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: HYPOTHALAMIC HORMONES: Somatostatin and analogues]",-tide,Somatostatin receptor 2 agonist,,Non-selective but type 5 receptor is overexpressed in Cushing's disease,CHEMBL1804,Somatostatin receptor 2,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=5504116c-d531-4d47-b160-41c6671d52aa, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5504116c-d531-4d47-b160-41c6671d52aa|Name:DailyMed, SrcID:setid=442f0d9d-5c7d-4b81-b329-d71be8cf2be2, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=442f0d9d-5c7d-4b81-b329-d71be8cf2be2|Name:PubMed, SrcID:22397653, URL:http://europepmc.org/abstract/MED/22397653|Name:PubMed, SrcID:11980628, URL:http://europepmc.org/abstract/MED/11980628",NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](NC(=O)[C@@H]4C[C@@H](CN4C(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](Cc6ccc(OCc7ccccc7)cc6)NC1=O)OC(=O)NCCN)c8ccccc8,CHEMBL1804,SSTR2
3256,CHEMBL1201237,Levobunolol,Small molecule,1985.0,S01ED03,S01ED03 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Beta blocking agents 1)],-olol,Beta-1 adrenergic receptor antagonist,,,CHEMBL213,Beta-1 adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=1a32c0e8-7d10-447e-a7c4-252c98b629bd, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a32c0e8-7d10-447e-a7c4-252c98b629bd",CC(C)(C)NC[C@H](O)COc1cccc2C(=O)CCCc12,,
3257,CHEMBL1510,Eletriptan,Small molecule,2002.0,N02CC06,N02CC06 [NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Selective serotonin (5HT1) agonists],-triptan,Serotonin 1b (5-HT1b) receptor agonist,,Selective,CHEMBL1898,Serotonin 1b (5-HT1b) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2011/021016s018lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021016s018lbl.pdf",CN1CCC[C@@H]1Cc2c[nH]c3ccc(CCS(=O)(=O)c4ccccc4)cc23,CHEMBL1898,HTR1B
3258,CHEMBL1200686,Pimecrolimus,Small molecule,2001.0,D11AH02,"D11AH02 [DERMATOLOGICALS: OTHER DERMATOLOGICAL PREPARATIONS: OTHER DERMATOLOGICAL PREPARATIONS: Agents for dermatitis, excluding corticosteroids]",-imus,FK506-binding protein 1A inhibitor,,,CHEMBL1902,FK506-binding protein 1A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=d8b4ec77-5f93-4a4f-9a4c-ee0767ac6ac5, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d8b4ec77-5f93-4a4f-9a4c-ee0767ac6ac5|Name:FDA, SrcID:label/2014/021302s018lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021302s018lbl.pdf",CC[C@@H]1\C=C(/C)\C[C@H](C)C[C@H](OC)[C@H]2O[C@](O)([C@H](C)C[C@@H]2OC)C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@H](C)[C@@H](O)CC1=O)\C(=C\[C@@H]4CC[C@H](Cl)[C@@H](C4)OC)\C,CHEMBL1902,FKBP1A
3259,CHEMBL672,Fenofibrate,Small molecule,1993.0,C10AB05,"C10AB05 [CARDIOVASCULAR SYSTEM: LIPID MODIFYING AGENTS: LIPID MODIFYING AGENTS, PLAIN: Fibrates]",-fibrate,Peroxisome proliferator-activated receptor alpha agonist,,,CHEMBL239,Peroxisome proliferator-activated receptor alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=24790a18-0291-4b88-a724-acac43b616ce, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24790a18-0291-4b88-a724-acac43b616ce",CC(C)OC(=O)C(C)(C)Oc1ccc(cc1)C(=O)c2ccc(Cl)cc2,CHEMBL239,PPARA
3260,CHEMBL1201476,Enoxaparin Sodium,Oligosaccharide,1993.0,B01AB05,B01AB05 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Heparin group],-parin,Antithrombin-III activator,Inhibits coagulation by activating antithrombin III; ATIII then binds to F10; It's a low-molecular-weight heparin,,CHEMBL1950,Antithrombin-III,ACTIVATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=ab8118dc-aca8-478b-8290-a468cbe36ae1#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ab8118dc-aca8-478b-8290-a468cbe36ae1#nlm34090-1",,CHEMBL1950,SERPINC1
3261,CHEMBL1201545,Insulin Susp Isophane Beef,Protein,1982.0,,,,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/022472s006s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022472s006s008lbl.pdf|Name:DailyMed, SrcID:setid=457531f0-9331-47fe-90b5-b31f284044dc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=457531f0-9331-47fe-90b5-b31f284044dc",,CHEMBL1981,INSR
3262,CHEMBL1732,Dihydroergotamine,Small molecule,1946.0,N02CA51; N02CA01,N02CA51 [NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Ergot alkaloids]; N02CA01 [NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Ergot alkaloids],-erg-,Serotonin 1d (5-HT1d) receptor agonist,,,CHEMBL1983,Serotonin 1d (5-HT1d) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=aec0308f-f583-4e27-9bb8-21800bde7faa#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aec0308f-f583-4e27-9bb8-21800bde7faa#nlm34090-1",CN1C[C@@H](C[C@H]2[C@H]1Cc3c[nH]c4cccc2c34)C(=O)N[C@]5(C)O[C@@]6(O)[C@@H]7CCCN7C(=O)[C@H](Cc8ccccc8)N6C5=O,CHEMBL1983,HTR1D
3263,CHEMBL1200761,Chlorotrianisene,Small molecule,1982.0,G03CA06,"G03CA06 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ESTROGENS: Natural and semisynthetic estrogens, plain]",,Estrogen receptor beta modulator,Mixed agonist/antagonist,,CHEMBL242,Estrogen receptor beta,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:2307235, URL:http://europepmc.org/abstract/MED/2307235|Name:Wikipedia, SrcID:Chlorotrianisene, URL:http://en.wikipedia.org/wiki/Chlorotrianisene|Name:Wikipedia, SrcID:Estrogen_receptor, URL:http://en.wikipedia.org/wiki/Estrogen_receptor",COc1ccc(cc1)C(=C(c2ccc(OC)cc2)c3ccc(OC)cc3)Cl,CHEMBL242,ESR2
3264,CHEMBL1200592,Desoxycorticosterone Pivalate,Small molecule,1982.0,H02AA03,"H02AA03 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Mineralocorticoids]",-cort-; -ster-,Mineralocorticoid receptor agonist,,,CHEMBL1994,Mineralocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=5e9f71f1-09d4-4313-ad66-5cfffe428ba8#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e9f71f1-09d4-4313-ad66-5cfffe428ba8#nlm34090-1",CC(C)(C)C(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,,
3265,CHEMBL1254682,Levallorphan,Small molecule,1982.0,,,-orphan,Mu opioid receptor antagonist,,,CHEMBL233,Mu opioid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:4030925, URL:http://europepmc.org/abstract/MED/4030925|Name:Wikipedia, SrcID:Levallorphan, URL:http://en.wikipedia.org/wiki/Levallorphan",Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC=C)c2c1,CHEMBL233,OPRM1
3266,CHEMBL1201265,Methylprednisolone Hemisuccinate,Small molecule,1959.0,,,-pred-,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=532f0c6c-cd76-44d1-27b7-581cee86bc34#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=532f0c6c-cd76-44d1-27b7-581cee86bc34#nlm34090-1|Name:FDA, SrcID:label/2014/011856s123lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/011856s123lbl.pdf",C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)COC(=O)CCC(=O)O)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]4(C)C=CC(=O)C=C14,CHEMBL2034,NR3C1
3267,CHEMBL959,Rimantadine,Small molecule,1993.0,J05AC02,J05AC02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Cyclic amines],-mantadine,Influenza virus A matrix protein M2 inhibitor,,,CHEMBL2052,Influenza virus A matrix protein M2,INHIBITOR,Influenza A virus (A/Udorn/307/1972(H3N2)),SINGLE PROTEIN,,,"Name:PubMed, SrcID:19215710, URL:http://europepmc.org/abstract/MED/19215710|Name:PubMed, SrcID:19917240, URL:http://europepmc.org/abstract/MED/19917240|Name:PubMed, SrcID:18669647, URL:http://europepmc.org/abstract/MED/18669647|Name:PubMed, SrcID:18620883, URL:http://europepmc.org/abstract/MED/18620883",CC(N)C12CC3CC(CC(C3)C1)C2,,
3268,CHEMBL445,Nortriptyline,Small molecule,1964.0,N06AA10,N06AA10 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Non-selective monoamine reuptake inhibitors],-triptyline,Norepinephrine transporter inhibitor,,,CHEMBL222,Norepinephrine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2014/018013s063lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/018013s063lbl.pdf|Name:Wikipedia, SrcID:Nortriptyline, URL:http://en.wikipedia.org/wiki/Nortriptyline|Name:DailyMed, SrcID:setid=64e8907b-a0c7-4d7a-a8a7-cbfacab24a4a#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=64e8907b-a0c7-4d7a-a8a7-cbfacab24a4a#nlm34090-1",CNCCC=C1c2ccccc2CCc3ccccc13,CHEMBL222,SLC6A2
3269,CHEMBL606,Misoprostol,Small molecule,1988.0,A02BB01; G02AD06,A02BB01 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): Prostaglandins]; G02AD06 [GENITO URINARY SYSTEM AND SEX HORMONES: OTHER GYNECOLOGICALS: UTEROTONICS: Prostaglandins],-prost-,Prostanoid EP3 receptor agonist,,,CHEMBL3710,Prostanoid EP3 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=10644068-fa47-4e3b-9e93-f57ebac3dd17#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10644068-fa47-4e3b-9e93-f57ebac3dd17#nlm34090-1|Name:ISBN, SrcID:0443-059748 PP. 376, URL:http://www.isbnsearch.org/isbn/0443059748|Name:Wikipedia, SrcID:Prostaglandin_receptor, URL:http://en.wikipedia.org/wiki/Prostaglandin_receptor",CCCCC(C)(O)C\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC,CHEMBL3710,PTGER3
3270,CHEMBL601719,Crizotinib,Small molecule,2011.0,L01XE16,L01XE16 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Hepatocyte growth factor receptor inhibitor,,,CHEMBL3717,Hepatocyte growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2012/202570s003lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202570s003lbl.pdf",C[C@@H](Oc1cc(cnc1N)c2cnn(c2)C3CCNCC3)c4c(Cl)ccc(F)c4Cl,CHEMBL3717,MET
3271,CHEMBL717,Medroxyprogesterone Acetate,Small molecule,1959.0,L02AB02; G03DA02; G03AC06,L02AB02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONES AND RELATED AGENTS: Progestogens]; G03DA02 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: PROGESTOGENS: Pregnen (4) derivatives]; G03AC06 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE: Progestogens],-gest-,Progesterone receptor agonist,,,CHEMBL208,Progesterone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=199cf13e-0859-4a73-9b45-e700d0cd1049#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=199cf13e-0859-4a73-9b45-e700d0cd1049#nlm34090-1",C[C@H]1C[C@@H]2[C@H](CC[C@@]3(C)[C@H]2CC[C@]3(OC(=O)C)C(=O)C)[C@@]4(C)CCC(=O)C=C14,CHEMBL208,PGR
3272,CHEMBL3301675,Linaclotide,Protein,2012.0,A06AX04,A06AX04 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR CONSTIPATION: DRUGS FOR CONSTIPATION: Other drugs for constipation],-tide,Heat-stable enterotoxin receptor agonist,,,CHEMBL1795197,Heat-stable enterotoxin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Expert, SrcID:LINACLOTIDE, URL:http://chembl.blogspot.co.uk/search?q=LINACLOTIDE",C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CSSC[C@H](NC(=O)CNC1=O)C(=O)N[C@@H](Cc4ccc(O)cc4)C(=O)O)NC(=O)[C@H](Cc5ccc(O)cc5)NC(=O)[C@H](CCC(=O)O)NC3=O)C(=O)N[C@@H](CC(=O)N)C(=O)N6CCC[C@H]6C(=O)N[C@@H](C)C(=O)N2,CHEMBL1795197,GUCY2C
3273,CHEMBL80,Naloxone,Small molecule,1971.0,A06AH04; V03AB15,A06AH04 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR CONSTIPATION: DRUGS FOR CONSTIPATION: Peripheral opioid receptor antagonists]; V03AB15 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Antidotes],nal-,Opioid receptors; mu/kappa/delta antagonist,,,CHEMBL2095181,Opioid receptors; mu/kappa/delta,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19435929, URL:http://europepmc.org/abstract/MED/19435929|Name:DailyMed, SrcID:setid=76f7eee1-d524-43a4-a868-ffa9f29638a6#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=76f7eee1-d524-43a4-a868-ffa9f29638a6#nlm34090-1|Name:FDA, SrcID:label/2014/205787Orig1s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205787Orig1s000lbl.pdf",Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O,,
3274,CHEMBL1423,Pimozide,Small molecule,1984.0,N05AG02,N05AG02 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Diphenylbutylpiperidine derivatives],,Dopamine receptor antagonist,,,CHEMBL2096905,Dopamine receptor,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=fd9729c3-545f-4d34-9bc7-72b61e028fc4#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fd9729c3-545f-4d34-9bc7-72b61e028fc4#nlm34090-1|Name:Wikipedia, SrcID:Pimozide, URL:http://en.wikipedia.org/wiki/Pimozide|Name:ISBN, SrcID:0443-059748 PP. 542, URL:http://www.isbnsearch.org/isbn/0443059748",Fc1ccc(cc1)C(CCCN2CCC(CC2)N3C(=O)Nc4ccccc34)c5ccc(F)cc5,,
3275,CHEMBL1445,Fluoxymesterone,Small molecule,1956.0,G03BA01,G03BA01 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ANDROGENS: 3-oxoandrosten (4) derivatives],-ster-,Androgen Receptor agonist,,,CHEMBL1871,Androgen Receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=5328c194-5650-4d1f-9e28-8cea038cce81, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5328c194-5650-4d1f-9e28-8cea038cce81|Name:Wikipedia, SrcID:Fluoxymesterone, URL:http://en.wikipedia.org/wiki/Fluoxymesterone",C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C,CHEMBL1871,AR
3276,CHEMBL86,Metoclopramide,Small molecule,1979.0,A03FA01,A03FA01 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: PROPULSIVES: Propulsives],,Serotonin 4 (5-HT4) receptor agonist,,,CHEMBL1875,Serotonin 4 (5-HT4) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Metoclopramide, URL:http://en.wikipedia.org/wiki/Metoclopramide|Name:ISBN, SrcID:0443-059748 PP. 167, URL:http://www.isbnsearch.org/isbn/0443059748",CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC,CHEMBL1875,HTR4
3277,CHEMBL1002,Levosalbutamol,Small molecule,1999.0,,,-terol,Beta-2 adrenergic receptor agonist,,,CHEMBL210,Beta-2 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22144765, URL:http://europepmc.org/abstract/MED/22144765",CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1,CHEMBL210,ADRB2
3278,CHEMBL684,Diethylcarbamazine,Small molecule,1950.0,P02CB02,"P02CB02 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTHELMINTICS: ANTINEMATODAL AGENTS: Piperazine and derivatives]",,Nematode GABA-A receptor positive modulator,,,CHEMBL2364676,Nematode GABA-A receptor,POSITIVE MODULATOR,Onchocercidae,PROTEIN COMPLEX GROUP,,,"Name:Wikipedia, SrcID:Diethylcarbamazine, URL:http://en.wikipedia.org/wiki/Diethylcarbamazine|Name:ISBN, SrcID:9780702034718 PP. 670, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:Wikipedia, SrcID:Anthelmintic, URL:http://en.wikipedia.org/wiki/Anthelmintic|Name:Wikipedia, SrcID:Piperazine, URL:http://en.wikipedia.org/wiki/Piperazine|Name:PubMed, SrcID:12421359, URL:http://europepmc.org/abstract/MED/12421359",CCN(CC)C(=O)N1CCN(C)CC1,,
3279,CHEMBL1201826,Idursulfase,Enzyme,2006.0,A16AB09,A16AB09 [ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Enzymes],-ase,Heparan sulfate hydrolytic enzyme,,,CHEMBL2364677,Heparan sulfate,HYDROLYTIC ENZYME,Homo sapiens,OLIGOSACCHARIDE,,,"Name:DailyMed, SrcID:setid=60cba843-5aab-4dd7-96dc-66648d413be3#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=60cba843-5aab-4dd7-96dc-66648d413be3#nlm34090-1",,,
3280,CHEMBL496,Hexachlorophene,Small molecule,1949.0,D08AE01,D08AE01 [DERMATOLOGICALS: ANTISEPTICS AND DISINFECTANTS: ANTISEPTICS AND DISINFECTANTS: Phenol and derivatives],,Bacterial enoyl-[acyl-carrier-protein] reductase inhibitor,,Broad spectrum,CHEMBL2364678,Bacterial enoyl-[acyl-carrier-protein] reductase,INHIBITOR,Bacteria,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10671494, URL:http://europepmc.org/abstract/MED/10671494",Oc1c(Cl)cc(Cl)c(Cl)c1Cc2c(O)c(Cl)cc(Cl)c2Cl,,
3281,CHEMBL1742990,Belatacept,Protein,2011.0,L04AA28,L04AA28 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Selective immunosuppressants],-cept,T-lymphocyte activation antigen CD86 inhibitor,,,CHEMBL2364156,T-lymphocyte activation antigen CD86,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=c16ac648-d5d2-9f7d-8637-e2328572754e, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c16ac648-d5d2-9f7d-8637-e2328572754e",,CHEMBL2364156,CD86
3282,CHEMBL705,Alitretinoin,Small molecule,1999.0,D11AH04; L01XX22,"D11AH04 [DERMATOLOGICALS: OTHER DERMATOLOGICAL PREPARATIONS: OTHER DERMATOLOGICAL PREPARATIONS: Agents for dermatitis, excluding corticosteroids]; L01XX22 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents]",-retin-,Retinoid receptor agonist,,,CHEMBL2363071,Retinoid receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=13c5de6d-d266-4d83-99c4-072ef104e7ff, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=13c5de6d-d266-4d83-99c4-072ef104e7ff",C\C(=C\C=C\C(=C\C(=O)O)\C)\C=C\C1=C(C)CCCC1(C)C,,
3283,CHEMBL1751,Digoxin,Small molecule,1975.0,C01AA05,C01AA05 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC GLYCOSIDES: Digitalis glycosides],-oxin,Sodium/potassium-transporting ATPase inhibitor,,,CHEMBL2095186,Sodium/potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,K/Na-ATPase alpha subunit,Alpha subunit is binding site,"Name:Wikipedia, SrcID:Digoxin, URL:http://en.wikipedia.org/wiki/Digoxin|Name:DailyMed, SrcID:setid=8a919762-ede5-4aa9-8688-65010c9a5641, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8a919762-ede5-4aa9-8688-65010c9a5641",C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4)O[C@@H]3C)O[C@@H]2C,CHEMBL2095186,FXYD2
3284,CHEMBL1751,Digoxin,Small molecule,1975.0,C01AA05,C01AA05 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC GLYCOSIDES: Digitalis glycosides],-oxin,Sodium/potassium-transporting ATPase inhibitor,,,CHEMBL2095186,Sodium/potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,K/Na-ATPase alpha subunit,Alpha subunit is binding site,"Name:Wikipedia, SrcID:Digoxin, URL:http://en.wikipedia.org/wiki/Digoxin|Name:DailyMed, SrcID:setid=8a919762-ede5-4aa9-8688-65010c9a5641, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8a919762-ede5-4aa9-8688-65010c9a5641",C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4)O[C@@H]3C)O[C@@H]2C,CHEMBL2095186,ATP1A3
3285,CHEMBL1751,Digoxin,Small molecule,1975.0,C01AA05,C01AA05 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC GLYCOSIDES: Digitalis glycosides],-oxin,Sodium/potassium-transporting ATPase inhibitor,,,CHEMBL2095186,Sodium/potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,K/Na-ATPase alpha subunit,Alpha subunit is binding site,"Name:Wikipedia, SrcID:Digoxin, URL:http://en.wikipedia.org/wiki/Digoxin|Name:DailyMed, SrcID:setid=8a919762-ede5-4aa9-8688-65010c9a5641, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8a919762-ede5-4aa9-8688-65010c9a5641",C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4)O[C@@H]3C)O[C@@H]2C,CHEMBL2095186,ATP1A2
3286,CHEMBL1751,Digoxin,Small molecule,1975.0,C01AA05,C01AA05 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC GLYCOSIDES: Digitalis glycosides],-oxin,Sodium/potassium-transporting ATPase inhibitor,,,CHEMBL2095186,Sodium/potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,K/Na-ATPase alpha subunit,Alpha subunit is binding site,"Name:Wikipedia, SrcID:Digoxin, URL:http://en.wikipedia.org/wiki/Digoxin|Name:DailyMed, SrcID:setid=8a919762-ede5-4aa9-8688-65010c9a5641, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8a919762-ede5-4aa9-8688-65010c9a5641",C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4)O[C@@H]3C)O[C@@H]2C,CHEMBL2095186,ATP1A4
3287,CHEMBL1751,Digoxin,Small molecule,1975.0,C01AA05,C01AA05 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC GLYCOSIDES: Digitalis glycosides],-oxin,Sodium/potassium-transporting ATPase inhibitor,,,CHEMBL2095186,Sodium/potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,K/Na-ATPase alpha subunit,Alpha subunit is binding site,"Name:Wikipedia, SrcID:Digoxin, URL:http://en.wikipedia.org/wiki/Digoxin|Name:DailyMed, SrcID:setid=8a919762-ede5-4aa9-8688-65010c9a5641, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8a919762-ede5-4aa9-8688-65010c9a5641",C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4)O[C@@H]3C)O[C@@H]2C,CHEMBL2095186,ATP1B2
3288,CHEMBL1751,Digoxin,Small molecule,1975.0,C01AA05,C01AA05 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC GLYCOSIDES: Digitalis glycosides],-oxin,Sodium/potassium-transporting ATPase inhibitor,,,CHEMBL2095186,Sodium/potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,K/Na-ATPase alpha subunit,Alpha subunit is binding site,"Name:Wikipedia, SrcID:Digoxin, URL:http://en.wikipedia.org/wiki/Digoxin|Name:DailyMed, SrcID:setid=8a919762-ede5-4aa9-8688-65010c9a5641, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8a919762-ede5-4aa9-8688-65010c9a5641",C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4)O[C@@H]3C)O[C@@H]2C,CHEMBL2095186,ATP1B1
3289,CHEMBL1751,Digoxin,Small molecule,1975.0,C01AA05,C01AA05 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC GLYCOSIDES: Digitalis glycosides],-oxin,Sodium/potassium-transporting ATPase inhibitor,,,CHEMBL2095186,Sodium/potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,K/Na-ATPase alpha subunit,Alpha subunit is binding site,"Name:Wikipedia, SrcID:Digoxin, URL:http://en.wikipedia.org/wiki/Digoxin|Name:DailyMed, SrcID:setid=8a919762-ede5-4aa9-8688-65010c9a5641, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8a919762-ede5-4aa9-8688-65010c9a5641",C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4)O[C@@H]3C)O[C@@H]2C,CHEMBL2095186,ATP1B3
3290,CHEMBL1201195,Cefmetazole,Small molecule,1989.0,J01DC09,J01DC09 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Second-generation cephalosporins],cef-,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:PubMed, SrcID:3898066, URL:http://europepmc.org/abstract/MED/3898066",CO[C@]1(NC(=O)CSCC#N)[C@H]2SCC(=C(N2C1=O)C(=O)O)CSc3nnnn3C,,
3291,CHEMBL1541,Cefixime,Small molecule,1989.0,J01DD08,J01DD08 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Third-generation cephalosporins],cef-,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:PubMed, SrcID:16940068, URL:http://europepmc.org/abstract/MED/16940068|Name:Wikipedia, SrcID:Cefixime, URL:http://en.wikipedia.org/wiki/Cefixime|Name:PubMed, SrcID:19528266, URL:http://europepmc.org/abstract/MED/19528266|Name:DailyMed, SrcID:setid=7e2462b2-bfed-4da4-8c47-46838d6153f8, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7e2462b2-bfed-4da4-8c47-46838d6153f8|Name:Wikipedia, SrcID:Penicillin_binding_proteins#Function, URL:http://en.wikipedia.org/wiki/Penicillin_binding_proteins#Function",Nc1nc(cs1)\C(=N\OCC(=O)O)\C(=O)N[C@H]2[C@H]3SCC(=C(N3C2=O)C(=O)O)C=C,,
3292,CHEMBL514,Lomustine,Small molecule,1976.0,L01AD02,L01AD02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ALKYLATING AGENTS: Nitrosoureas],-mustine,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:FDA, SrcID:label/2016/017588s043lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/017588s043lbl.pdf|Name:DailyMed, SrcID:setid=17893de9-7d54-448c-9fca-d10642046d14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=17893de9-7d54-448c-9fca-d10642046d14",ClCCN(N=O)C(=O)NC1CCCCC1,,
3293,CHEMBL1292,Clofazimine,Small molecule,1986.0,J04BA01,J04BA01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOBACTERIALS: DRUGS FOR TREATMENT OF LEPRA: Drugs for treatment of lepra],,DNA inhibitor,Direct DNA binding,,CHEMBL2366041,DNA,INHIBITOR,Mycobacterium leprae,NUCLEIC-ACID,,,"Name:ISBN, SrcID:9780702034718 PP. 636, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:FDA, SrcID:label/2003/19500slr010_lamprene_lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/19500slr010_lamprene_lbl.pdf",CC(C)\N=C\1/C=C2N(c3ccc(Cl)cc3)c4ccccc4N=C2C=C1Nc5ccc(Cl)cc5,,
3294,CHEMBL831,Loxapine,Small molecule,1975.0,N05AH01,"N05AH01 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Diazepines, oxazepines, thiazepines and oxepines]",-pin(e),D2-like dopamine receptor antagonist,,,CHEMBL2331075,D2-like dopamine receptor,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=50e11732-7387-452d-b3e6-db3a431d5c4a#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=50e11732-7387-452d-b3e6-db3a431d5c4a#nlm34090-1|Name:FDA, SrcID:label/2012/022549s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022549s000lbl.pdf",CN1CCN(CC1)C2=Nc3ccccc3Oc4ccc(Cl)cc24,,
3295,CHEMBL1201633,Alglucerase,Enzyme,1991.0,A16AB01,A16AB01 [ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Enzymes],-ase,Glucocerebroside hydrolytic enzyme,,,CHEMBL2364176,Glucocerebroside,HYDROLYTIC ENZYME,Homo sapiens,SMALL MOLECULE,,,"Name:DailyMed, SrcID:archiveid=4959, URL:http://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=4959",,,
3296,CHEMBL1201481,Porfimer Sodium,Small molecule,1995.0,L01XD01,L01XD01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Sensitizers used in photodynamic/radiation therapy],-mer,DNA inhibitor,Photodynamic therapy,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=f5fdda24-da7d-4e61-936e-9d1a55056b82#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5fdda24-da7d-4e61-936e-9d1a55056b82#nlm34090-1",,,
3297,CHEMBL2108677,Peginterferon Beta-1a,Protein,2014.0,L03AB13,L03AB13 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSTIMULANTS: IMMUNOSTIMULANTS: Interferons],peg-,Interferon alpha/beta receptor agonist,,,CHEMBL2364170,Interferon alpha/beta receptor,AGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:FDA, SrcID:label/2014/125499lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125499lbl.pdf",,CHEMBL2364170,IFNAR2
3298,CHEMBL1689063,Avibactam,Small molecule,2015.0,,,-bactam,Bacterial beta-lactamase TEM inhibitor,,,CHEMBL2364670,Bacterial beta-lactamase TEM,INHIBITOR,Bacteria,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/206494s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206494s000lbl.pdf",NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)O,,
3299,CHEMBL95889,Betaine,Small molecule,1996.0,A16AA06,A16AA06 [ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Amino acids and derivatives],,Betaine-homocysteine S-methyltransferase substrate,,,CHEMBL3391661,Betaine-homocysteine S-methyltransferase,SUBSTRATE,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:24795654, URL:http://europepmc.org/abstract/MED/24795654|Name:DailyMed, SrcID:setid=84f7c21f-d0af-4ae6-9cd5-d5af96ade329, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=84f7c21f-d0af-4ae6-9cd5-d5af96ade329",C[N+](C)(C)CC(=O)O,,
3300,CHEMBL2107869,Insulin Degludec,Protein,2015.0,A10AE06,"A10AE06 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: INSULINS AND ANALOGUES: Insulins and analogues for injection, long-acting]",,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=456c5e87-3dfd-46fa-8ac0-c6128d4c97c6, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=456c5e87-3dfd-46fa-8ac0-c6128d4c97c6",,CHEMBL1981,INSR
3301,CHEMBL3545114,Kd3010,Small molecule,,,,,Peroxisome proliferator-activated receptor delta agonist,"Ph1 trial completed in 2006, no new trials reported. Development discontinued?",,CHEMBL3979,Peroxisome proliferator-activated receptor delta,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.nature.com/scibx/journal/v5/n19/full/scibx.2012.485.html, URL:http://www.nature.com/scibx/journal/v5/n19/full/scibx.2012.485.html|Name:PubMed, SrcID:22538808, URL:http://europepmc.org/abstract/MED/22538808",,CHEMBL3979,PPARD
3302,CHEMBL3545264,Ly-2874455,Small molecule,,,,,Fibroblast growth factor receptor inhibitor,,,CHEMBL2095217,Fibroblast growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:21900693, URL:http://europepmc.org/abstract/MED/21900693|Name:Other, SrcID:http://www.lillyoncologypipeline.com/fgfr-inhibitor.aspx, URL:http://www.lillyoncologypipeline.com/fgfr-inhibitor.aspx",CC(Oc1ccc2[nH]nc(\C=C\c3cnn(CCO)c3)c2c1)c4c(Cl)cncc4Cl,,
3303,CHEMBL3545081,Rg-7304,Small molecule,,,,,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,"Bind allosterically to MEK and prevents its phosphorylation by, and release from, RAF. This results in the formation of a stable Raf-MEK-RO5126766 complex and the inhibition of RAF kinase (PMID:23667175).",,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23587417, URL:http://europepmc.org/abstract/MED/23587417|Name:PubMed, SrcID:22761467, URL:http://europepmc.org/abstract/MED/22761467|Name:PubMed, SrcID:23667175, URL:http://europepmc.org/abstract/MED/23667175",,CHEMBL3587,MAP2K1
3304,CHEMBL3545088,Puquitinib,Small molecule,,,,-tinib,Epidermal growth factor receptor erbB1 inhibitor,"Compound is most potent against PIK3CD, low potency against EGFR, KDR and PDGFRB",,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26499488, URL:http://europepmc.org/abstract/MED/26499488|Name:DOI, SrcID:10.1158/1538-7445.AM2011-4245, URL:http://cancerres.aacrjournals.org/content/71/8_Supplement/4245|Name:PubMed, SrcID:26510909, URL:http://europepmc.org/abstract/MED/26510909",,CHEMBL203,EGFR
3305,CHEMBL2105694,Telapristone Acetate,Small molecule,,,,-pristone,Progesterone receptor modulator,"Mixed-profile progestagen, selective progesterone receptor modulator",,CHEMBL208,Progesterone receptor,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15120421, URL:http://europepmc.org/abstract/MED/15120421|Name:Wikipedia, SrcID:Telapristone, URL:http://en.wikipedia.org/wiki/Telapristone|Name:Other, SrcID:http://www.reprosrx.com/proellex.php, URL:http://www.reprosrx.com/proellex.php",COCC(=O)[C@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c5ccc(cc5)N(C)C)OC(=O)C,CHEMBL208,PGR
3306,CHEMBL3218578,Bgt-226,Small molecule,,,,,Serine/threonine-protein kinase mTOR inhibitor,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL2842,Serine/threonine-protein kinase mTOR,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22357447, URL:http://europepmc.org/abstract/MED/22357447|Name:PubMed, SrcID:24591840, URL:http://europepmc.org/abstract/MED/24591840",COc1ccc(cn1)c2ccc3ncc4N(C)C(=O)N(c5ccc(N6CCNCC6)c(c5)C(F)(F)F)c4c3c2,CHEMBL2842,MTOR
3307,CHEMBL3545396,Bms-690514,Small molecule,,,,,Receptor protein-tyrosine kinase erbB-2 inhibitor,,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24130056, URL:http://europepmc.org/abstract/MED/24130056|Name:PubMed, SrcID:21531814, URL:http://europepmc.org/abstract/MED/21531814",COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1,CHEMBL1824,ERBB2
3308,CHEMBL3039513,Decernotinib,Small molecule,,,,-tinib,Tyrosine-protein kinase JAK3 inhibitor,,,CHEMBL2148,Tyrosine-protein kinase JAK3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26230873, URL:http://europepmc.org/abstract/MED/26230873",CC[C@@](C)(Nc1ccnc(n1)c2c[nH]c3ncccc23)C(=O)NCC(F)(F)F,CHEMBL2148,JAK3
3309,CHEMBL3545285,Xl-999,Small molecule,,,,,Stem cell growth factor receptor inhibitor,Spectrum Selective Kinase Inhibitor (SSKI),,CHEMBL1936,Stem cell growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.exelixis.com/sites/default/files/pdf/XL999_AACR-NCI-EORTCnov05.pdf, URL:http://www.exelixis.com/sites/default/files/pdf/XL999_AACR-NCI-EORTCnov05.pdf|Name:DOI, SrcID:10.1016/S1359-6349(04)80149-6, URL:http://www.sciencedirect.com/science/article/pii/S1359634904801496|Name:PubMed, SrcID:21613405, URL:http://europepmc.org/abstract/MED/21613405",,CHEMBL1936,KIT
3310,CHEMBL2110670,Vabicaserin,Small molecule,,,,-caserin,Serotonin 2b (5-HT2b) receptor antagonist,,,CHEMBL1833,Serotonin 2b (5-HT2b) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21402690, URL:http://europepmc.org/abstract/MED/21402690",C1C[C@H]2CN3CCNCc4cccc([C@H]2C1)c34,CHEMBL1833,HTR2B
3311,CHEMBL2206292,Pf-03654764,Small molecule,,,,,Histamine H3 receptor antagonist,,,CHEMBL264,Histamine H3 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21928839, URL:http://europepmc.org/abstract/MED/21928839",CC(C)CNC(=O)[C@@H]1C[C@@](F)(C1)c2ccc(CN3CCCC3)c(F)c2,CHEMBL264,HRH3
3312,CHEMBL14935,Tezampanel,Small molecule,,,,-ampa,Glutamate receptor ionotropic kainate antagonist,"Active metabolite of oral prodrug NGX424. AMPA/Kainate receptor antagonist, selective for GRIK1 subunit containing receptors. Indication: Migraine, Postoperative pain",,CHEMBL2109241,Glutamate receptor ionotropic kainate,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:16470401, URL:http://europepmc.org/abstract/MED/16470401|Name:PubMed, SrcID:18793656, URL:http://europepmc.org/abstract/MED/18793656|Name:PubMed, SrcID:15033339, URL:http://europepmc.org/abstract/MED/15033339|Name:PubMed, SrcID:8609884, URL:http://europepmc.org/abstract/MED/8609884",OC(=O)[C@@H]1C[C@H]2C[C@@H](CCc3nnn[nH]3)CC[C@H]2CN1,CHEMBL2109241,GRIK4
3313,CHEMBL236593,Telcagepant,Small molecule,,,,-gepant,Calcitonin gene-related peptide type 1 receptor antagonist,,,CHEMBL3798,Calcitonin gene-related peptide type 1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17929795, URL:http://europepmc.org/abstract/MED/17929795|Name:Wikipedia, SrcID:Telcagepant, URL:http://en.wikipedia.org/wiki/Telcagepant",Oc1nc2ncccc2n1C3CCN(CC3)C(=O)N[C@@H]4CC[C@H](CN(CC(F)(F)F)C4=O)c5cccc(F)c5F,,
3314,CHEMBL9194,Atrasentan,Small molecule,,,,-entan,Endothelin receptor ET-A antagonist,,,CHEMBL252,Endothelin receptor ET-A,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Atrasentan, URL:http://en.wikipedia.org/wiki/Atrasentan|Name:PubMed, SrcID:12193066, URL:http://europepmc.org/abstract/MED/12193066",CCCCN(CCCC)C(=O)CN1C[C@@H]([C@H]([C@@H]1c2ccc(OC)cc2)C(=O)O)c3ccc4OCOc4c3,CHEMBL252,EDNRA
3315,CHEMBL2107803,Avosentan,Small molecule,,,,-entan,Endothelin receptor ET-A antagonist,Ph 3 trial Discontinueddue to adverse effects.,,CHEMBL252,Endothelin receptor ET-A,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://newdrugapprovals.org/2014/01/09/avosentan/, URL:http://newdrugapprovals.org/2014/01/09/avosentan/|Name:PubMed, SrcID:1679927, URL:http://europepmc.org/abstract/MED/1679927",COc1ccccc1Oc2c(CS(=O)(=O)c3ccc(C)cn3)nc(nc2OC)c4ccncc4,CHEMBL252,EDNRA
3316,CHEMBL2108208,Lenercept,Protein,,,,-cept,TNF-alpha inhibitor,Gene fusion of the extracellular portion of human type 1 TNFR with the constant domains of human IgG heavy chain (TNFR-IgG).,,CHEMBL1825,TNF-alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:1660140, URL:http://europepmc.org/abstract/MED/1660140",,CHEMBL1825,TNF
3317,CHEMBL262075,Indiplon,Small molecule,,,,-plon,GABA receptor alpha-1 subunit positive allosteric modulator,,,CHEMBL1962,GABA receptor alpha-1 subunit,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Indiplon, URL:https://en.wikipedia.org/wiki/Indiplon|Name:PubMed, SrcID:16399882, URL:http://europepmc.org/abstract/MED/16399882",CN(C(=O)C)c1cccc(c1)c2ccnc3c(cnn23)C(=O)c4cccs4,CHEMBL1962,GABRA1
3318,CHEMBL2107846,Dulanermin,Protein,,,,-ermin,TRAIL receptor-1 agonist,"Binds to and activates TRAIL receptors 1 and 2 (TRAIL-R1/R2), which may activate caspases and induce p53-independent apoptosis.",,CHEMBL3551,TRAIL receptor-1,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10411544, URL:http://europepmc.org/abstract/MED/10411544|Name:PubMed, SrcID:22914439, URL:http://europepmc.org/abstract/MED/22914439",,CHEMBL3551,TNFRSF10A
3319,CHEMBL2108583,Cintredekin Besudotox,Protein,,,,-kin,"Interleukin-13 receptor subunit alpha-1, Interleukin-4 receptor subunit alpha binding agent",Cytotoxic. Targets and kills tumor cells that express the IL13 receptor (IL13R).,,CHEMBL3831285,Interleukin 13 receptor,BINDING AGENT,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:8639793, URL:http://europepmc.org/abstract/MED/8639793",,CHEMBL3831285,IL13RA1
3320,CHEMBL257704,Eplivanserin,Small molecule,,,,-anserin,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20467592, URL:http://europepmc.org/abstract/MED/20467592|Name:PubMed, SrcID:26787771, URL:http://europepmc.org/abstract/MED/26787771",CN(C)CCO\N=C(\C=C\c1ccc(O)cc1)/c2ccccc2F,CHEMBL224,HTR2A
3321,CHEMBL2109474,Trx-1,Antibody,,,,,T-cell surface antigen CD4 inhibitor,Non-depleting.,,CHEMBL2754,T-cell surface antigen CD4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16308668, URL:http://europepmc.org/abstract/MED/16308668",,CHEMBL2754,CD4
3322,CHEMBL2109500,Lirilumab,Antibody,,,,-mab,Killer cell immunoglobulin-like receptor 2DL3 inhibitor,"Blocks the interaction of the three main inhibitory KIR receptors (KIR2DL-1, -2, -3) with their ligands, the human leukocyte antigen-C (HLA-C) molecules.",,CHEMBL3713026,Killer cell immunoglobulin-like receptor 2DL3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PMC, SrcID:PMC4803142, URL:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803142|Name:PubMed, SrcID:24326534, URL:http://europepmc.org/abstract/MED/24326534",,CHEMBL3713026,KIR2DL3
3323,CHEMBL2107731,Axomadol,Small molecule,,,,-adol,Mu opioid receptor agonist,Haven't found any references that mentioned activity at targets,,CHEMBL233,Mu opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Axomadol, URL:http://en.wikipedia.org/wiki/Axomadol",COc1cccc(c1)[C@]2(O)C[C@@H](O)CC[C@H]2CN(C)C,CHEMBL233,OPRM1
3324,CHEMBL1123,Dicyclomine,Small molecule,1950.0,A03AA07,"A03AA07 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: Synthetic anticholinergics, esters with tertiary amino group]",,Muscarinic acetylcholine receptor M3 antagonist,"Indicated in irritable bowel, M3 likely involved",,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=c56598d5-9cd1-4cce-b172-ac338775aec7, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c56598d5-9cd1-4cce-b172-ac338775aec7|Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718",CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,CHEMBL245,CHRM3
3325,CHEMBL1201338,Cyclopentolate,Small molecule,1974.0,S01FA54; S01FA04,S01FA54 [SENSORY ORGANS: OPHTHALMOLOGICALS: MYDRIATICS AND CYCLOPLEGICS: Anticholinergics]; S01FA04 [SENSORY ORGANS: OPHTHALMOLOGICALS: MYDRIATICS AND CYCLOPLEGICS: Anticholinergics],,Muscarinic acetylcholine receptor M3 antagonist,"Indicated for mydriasis, M3 likely involved (main form in iris)",,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:15506601, URL:http://europepmc.org/abstract/MED/15506601",CN(C)CCOC(=O)C(c1ccccc1)C2(O)CCCC2,CHEMBL245,CHRM3
3326,CHEMBL1888176,Trospium,Small molecule,2004.0,G04BD09,G04BD09 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Drugs for urinary frequency and incontinence],-ium,Muscarinic acetylcholine receptor M3 antagonist,"Indicated for overactive bladder, M3 likely responsible",,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19029429, URL:http://europepmc.org/abstract/MED/19029429|Name:PubMed, SrcID:15723094, URL:http://europepmc.org/abstract/MED/15723094",OC(C(=O)O[C@H]1C[C@H]2CC[C@@H](C1)[N+]23CCCC3)(c4ccccc4)c5ccccc5,CHEMBL245,CHRM3
3327,CHEMBL218490,Dorzolamide,Small molecule,1994.0,S01EC03,S01EC03 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Carbonic anhydrase inhibitors],-zolamide,Carbonic anhydrase II inhibitor,,,CHEMBL205,Carbonic anhydrase II,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=8417d162-65a1-4266-bca7-707af1193bf3, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8417d162-65a1-4266-bca7-707af1193bf3",CCN[C@H]1C[C@H](C)S(=O)(=O)c2sc(cc12)S(=O)(=O)N,CHEMBL205,CA2
3328,CHEMBL58,Mitoxantrone,Small molecule,1987.0,L01DB07,L01DB07 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES: Anthracyclines and related substances],-antrone,DNA topoisomerase II alpha inhibitor,,,CHEMBL1806,DNA topoisomerase II alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Type_II_topoisomerase, URL:http://en.wikipedia.org/wiki/Type_II_topoisomerase|Name:DailyMed, SrcID:setid=4d0f0f1a-31af-40fa-9c64-e90891fa6ce4, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4d0f0f1a-31af-40fa-9c64-e90891fa6ce4",OCCNCCNc1ccc(NCCNCCO)c2C(=O)c3c(O)ccc(O)c3C(=O)c12,CHEMBL1806,TOP2A
3329,CHEMBL1560,Captopril,Small molecule,1981.0,C09AA01,"C09AA01 [CARDIOVASCULAR SYSTEM: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM: ACE INHIBITORS, PLAIN: ACE inhibitors, plain]",-pril,Angiotensin-converting enzyme inhibitor,,,CHEMBL1808,Angiotensin-converting enzyme,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=810fa667-2d9f-4fd1-bdde-aa8ca4390df1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=810fa667-2d9f-4fd1-bdde-aa8ca4390df1|Name:FDA, SrcID:label/2015/018343s086lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018343s086lbl.pdf",C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O,CHEMBL1808,ACE
3330,CHEMBL1201661,Calcitonin Salmon Recombinant,Protein,2005.0,H05BA01,"H05BA01 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CALCIUM HOMEOSTASIS: ANTI-PARATHYROID AGENTS: Calcitonin preparations]",calci-,Calcitonin receptor agonist,,,CHEMBL1832,Calcitonin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/017808s036lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/017808s036lbl.pdf|Name:IUPHAR, SrcID:685, URL:http://www.iuphar-db.org/DATABASE/LigandDisplayForward?tab=biology&ligandId=685|Name:DailyMed, SrcID:setid=f9d5a587-e2bc-4001-987d-9b04731303cb, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f9d5a587-e2bc-4001-987d-9b04731303cb",,,
3331,CHEMBL1014,Candesartan Cilexetil,Small molecule,1998.0,C09CA06,"C09CA06 [CARDIOVASCULAR SYSTEM: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM: ANGIOTENSIN II ANTAGONISTS, PLAIN: Angiotensin II antagonists, plain]",-sartan,Type-1 angiotensin II receptor antagonist,,,CHEMBL227,Type-1 angiotensin II receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=a73e1339-9643-4eea-2cbe-e879c88fb50e#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a73e1339-9643-4eea-2cbe-e879c88fb50e#section-14",CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc4ccc(cc4)c5ccccc5c6nn[nH]n6,CHEMBL227,AGTR1
3332,CHEMBL1007,Gonadorelin,Protein,1982.0,V04CM01; H01CA01,"V04CM01 [VARIOUS: DIAGNOSTIC AGENTS: OTHER DIAGNOSTIC AGENTS: Tests for fertility disturbances]; H01CA01 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: HYPOTHALAMIC HORMONES: Gonadotropin-releasing hormones]",-relin,Gonadotropin-releasing hormone receptor agonist,,,CHEMBL1855,Gonadotropin-releasing hormone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:archiveid=206937, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=206937|Name:DailyMed, SrcID:setid=ecb5441e-aa91-4969-87aa-82e36a4f2d6d, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ecb5441e-aa91-4969-87aa-82e36a4f2d6d",CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4cnc[nH]4)NC(=O)[C@@H]5CCC(=O)N5)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N6CCC[C@H]6C(=O)NCC(=O)N,CHEMBL1855,GNRHR
3333,CHEMBL1201832,Romiplostim,Protein,2008.0,B02BX04,B02BX04 [BLOOD AND BLOOD FORMING ORGANS: ANTIHEMORRHAGICS: VITAMIN K AND OTHER HEMOSTATICS: Other systemic hemostatics],-stim,Thrombopoietin receptor agonist,,,CHEMBL1864,Thrombopoietin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=c45f9a58-37c1-4f76-8e36-97d38c577037, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c45f9a58-37c1-4f76-8e36-97d38c577037",,CHEMBL1864,MPL
3334,CHEMBL1201187,Maraviroc,Small molecule,2007.0,J05AX09,J05AX09 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Other antivirals],-viroc,C-C chemokine receptor type 5 antagonist,,,CHEMBL274,C-C chemokine receptor type 5,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=a94a9a2b-337b-4c13-8622-fc392194dc21, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a94a9a2b-337b-4c13-8622-fc392194dc21",CC(C)c1nnc(C)n1[C@@H]2C[C@H]3CC[C@@H](C2)N3CC[C@H](NC(=O)C4CCC(F)(F)CC4)c5ccccc5,CHEMBL274,CCR5
3335,CHEMBL1201533,Thyrotropin Alfa,Protein,1998.0,H01AB01,"H01AB01 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES: Thyrotropin]",,Thyroid stimulating hormone receptor agonist,"It's recombinant human thyroid stimulating hormone approved for diagnosis of serum thyroglobulin levels, but also is indicated as an adjunctive treatment for radioiodine ablation of thyroid tissue remnants in cancer patients",,CHEMBL1963,Thyroid stimulating hormone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=b52dfa36-f90b-4e19-9b5e-26db9d04df2b, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b52dfa36-f90b-4e19-9b5e-26db9d04df2b",,,
3336,CHEMBL1201609,Corticotropin Zinc Hydroxide,Protein,1955.0,,,,Melanocortin receptor 2 agonist,,,CHEMBL1965,Melanocortin receptor 2,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:IUPHAR, SrcID:3633, URL:http://www.iuphar-db.org/DATABASE/LigandDisplayForward?tab=biology&ligandId=3633|Name:FDA, SrcID:label/2015/008372s044lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/008372s044lbl.pdf|Name:DailyMed, SrcID:setid=ae97eb2b-587a-4705-8c55-de0f97ee1f1f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ae97eb2b-587a-4705-8c55-de0f97ee1f1f",,CHEMBL1965,MC2R
3337,CHEMBL654,Mirtazapine,Small molecule,1996.0,N06AX11,N06AX11 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants],-pin(e),Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f23631be-c7ae-46e9-b771-a70be17bc9f0#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f23631be-c7ae-46e9-b771-a70be17bc9f0#nlm34090-1",CN1CCN2C(C1)c3ccccc3Cc4cccnc24,CHEMBL224,HTR2A
3338,CHEMBL1201668,Nesiritide,Protein,2001.0,C01DX19,C01DX19 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: VASODILATORS USED IN CARDIAC DISEASES: Other vasodilators used in cardiac diseases],-tide,Atrial natriuretic peptide receptor A agonist,,,CHEMBL1988,Atrial natriuretic peptide receptor A,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22145138, URL:http://europepmc.org/abstract/MED/22145138|Name:DailyMed, SrcID:setid=44c45bfe-461f-4398-8f20-ea771b2403ee, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=44c45bfe-461f-4398-8f20-ea771b2403ee",,CHEMBL1988,NPR1
3339,CHEMBL317052,Regadenoson,Small molecule,2008.0,C01EB21,C01EB21 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: OTHER CARDIAC PREPARATIONS: Other cardiac preparations],-denoson,Adenosine A2a receptor agonist,,,CHEMBL251,Adenosine A2a receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=057289f4-2e18-4c1e-bed4-6c1858e2ef16#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=057289f4-2e18-4c1e-bed4-6c1858e2ef16#section-13",CNC(=O)c1cnn(c1)c2nc(N)c3ncn([C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2,CHEMBL251,ADORA2A
3340,CHEMBL288441,Bosutinib,Small molecule,2010.0,L01XE14,L01XE14 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Tyrosine-protein kinase SRC inhibitor,,,CHEMBL267,Tyrosine-protein kinase SRC,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Expert, SrcID:BOSUTINIB, URL:http://chembl.blogspot.co.uk/search?q=BOSUTINIB",COc1cc(Nc2c(cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl,CHEMBL267,SRC
3341,CHEMBL1237044,Tramadol,Small molecule,1995.0,N02AX02,N02AX02 [NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Other opioids],-adol,Mu opioid receptor agonist,,,CHEMBL233,Mu opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/204421Orig1s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204421Orig1s000lbl.pdf|Name:DailyMed, SrcID:setid=2347726f-7755-7026-426c-6f7741776179#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2347726f-7755-7026-426c-6f7741776179#nlm34090-1",COc1cccc(c1)C2(O)CCCCC2CN(C)C,CHEMBL233,OPRM1
3342,CHEMBL488,Aminoglutethimide,Small molecule,1980.0,L02BG01,L02BG01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONE ANTAGONISTS AND RELATED AGENTS: Aromatase inhibitors],,Cytochrome P450 11A1 inhibitor,,,CHEMBL2033,Cytochrome P450 11A1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2003/018202s021lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/018202s021lbl.pdf",CCC1(CCC(=O)NC1=O)c2ccc(N)cc2,CHEMBL2033,CYP11A1
3343,CHEMBL885,Emtricitabine,Small molecule,2003.0,J05AF09,J05AF09 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleoside and nucleotide reverse transcriptase inhibitors],-citabine,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,,,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,INHIBITOR,Human immunodeficiency virus 1,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=d6599395-3944-44f9-97f2-e0424c6b6a1f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d6599395-3944-44f9-97f2-e0424c6b6a1f",NC1=NC(=O)N(C=C1F)[C@@H]2CS[C@H](CO)O2,,
3344,CHEMBL1201165,Quinestrol,Small molecule,1982.0,,,-estr-,Estrogen receptor agonist,,,CHEMBL2093866,Estrogen receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:22284225, URL:http://europepmc.org/abstract/MED/22284225|Name:PubMed, SrcID:452871, URL:http://europepmc.org/abstract/MED/452871",C[C@]12CC[C@H]3[C@@H](CCc4cc(OC5CCCC5)ccc34)[C@@H]1CC[C@@]2(O)C#C,,
3345,CHEMBL24828,Vandetanib,Small molecule,2011.0,L01XE12,L01XE12 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-anib,Vascular endothelial growth factor receptor inhibitor,,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13",COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC4CCN(C)CC4,,
3346,CHEMBL1201830,Rilonacept,Protein,2008.0,L04AC04,L04AC04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Interleukin inhibitors],-cept,Interleukin-1 beta inhibitor,,,CHEMBL1909490,Interleukin-1 beta,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=282f4099-e848-432a-bac1-e041c192a5ba, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=282f4099-e848-432a-bac1-e041c192a5ba|Name:PubMed, SrcID:20140476, URL:http://europepmc.org/abstract/MED/20140476",,CHEMBL1909490,IL1B
3347,CHEMBL1544,Liothyronine,Small molecule,1956.0,,,,Thyroid hormone receptor agonist,,,CHEMBL2111462,Thyroid hormone receptor,AGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:DailyMed, SrcID:setid=51452b31-ff68-4e0c-b982-c15502ebf1d3#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=51452b31-ff68-4e0c-b982-c15502ebf1d3#nlm34090-1|Name:Wikipedia, SrcID:Thyroid_hormone, URL:http://en.wikipedia.org/wiki/Thyroid_hormone|Name:Wikipedia, SrcID:Thyroid_hormone_receptor, URL:http://en.wikipedia.org/wiki/Thyroid_hormone_receptor",N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O,,
3348,CHEMBL511142,Buprenorphine,Small molecule,1981.0,N07BC51; N02AE01; N07BC01,N07BC51 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: DRUGS USED IN ADDICTIVE DISORDERS: Drugs used in opioid dependence]; N02AE01 [NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Oripavine derivatives]; N07BC01 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: DRUGS USED IN ADDICTIVE DISORDERS: Drugs used in opioid dependence],,Kappa opioid receptor agonist,,,CHEMBL237,Kappa opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=b086772e-d15a-4d13-b1a2-38bfbde1f18c#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b086772e-d15a-4d13-b1a2-38bfbde1f18c#nlm34090-1|Name:PubMed, SrcID:18997874, URL:http://europepmc.org/abstract/MED/18997874",CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]4Cc5ccc(O)c6O[C@@H]2[C@]3(CCN4CC7CC7)c56,CHEMBL237,OPRK1
3349,CHEMBL1200412,Nandrolone Phenpropionate,Small molecule,1959.0,S01XA11; A14AB01,S01XA11 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals]; A14AB01 [ALIMENTARY TRACT AND METABOLISM: ANABOLIC AGENTS FOR SYSTEMIC USE: ANABOLIC STEROIDS: Estren derivatives],-olone,Androgen Receptor agonist,,,CHEMBL1871,Androgen Receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17405825, URL:http://europepmc.org/abstract/MED/17405825|Name:PubMed, SrcID:14663936, URL:http://europepmc.org/abstract/MED/14663936|Name:PubMed, SrcID:14619588, URL:http://europepmc.org/abstract/MED/14619588",C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@H]2OC(=O)CCc5ccccc5,CHEMBL1871,AR
3350,CHEMBL799,Cilostazol,Small molecule,1999.0,B01AC23,B01AC23 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Platelet aggregation inhibitors excl. heparin],,Phosphodiesterase 3A inhibitor,,,CHEMBL241,Phosphodiesterase 3A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=ada307f1-b6b1-4b64-a060-5c254b1948f2, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ada307f1-b6b1-4b64-a060-5c254b1948f2",O=C1CCc2cc(OCCCCc3nnnn3C4CCCCC4)ccc2N1,CHEMBL241,PDE3A
3351,CHEMBL1201314,Valganciclovir,Small molecule,2001.0,J05AB14,J05AB14 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleosides and nucleotides excl. reverse transcriptase inhibitors],-vir,Human herpesvirus 1 DNA polymerase inhibitor,,,CHEMBL1872,Human herpesvirus 1 DNA polymerase,INHIBITOR,Herpes simplex virus (type 1 / strain 17),SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=dc548ff9-e8ea-4d6e-b9b4-e31f53ac4078, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dc548ff9-e8ea-4d6e-b9b4-e31f53ac4078",CC(C)[C@H](N)C(=O)OCC(CO)OCn1cnc2C(=O)NC(=Nc12)N,,
3352,CHEMBL931,Halothane,Small molecule,1958.0,N01AB01,"N01AB01 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",,Glycine receptor (alpha-1/beta) positive modulator,alpha1/beta is main adult form,,CHEMBL2363052,Glycine receptor (alpha-1/beta),POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX,Glycine receptor alpha subunit,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:10443614, URL:http://europepmc.org/abstract/MED/10443614|Name:PubMed, SrcID:15271715, URL:http://europepmc.org/abstract/MED/15271715",FC(F)(F)C(Cl)Br,CHEMBL2363052,GLRB
3353,CHEMBL628,Pentoxifylline,Small molecule,1984.0,C04AD03,C04AD03 [CARDIOVASCULAR SYSTEM: PERIPHERAL VASODILATORS: PERIPHERAL VASODILATORS: Purine derivatives],-fylline,"3',5'-cyclic phosphodiesterase inhibitor",,,CHEMBL2363066,"3',5'-cyclic phosphodiesterase",INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:18568240, URL:http://europepmc.org/abstract/MED/18568240|Name:PubMed, SrcID:11692087, URL:http://europepmc.org/abstract/MED/11692087|Name:FDA, SrcID:label/2012/018631s039lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/018631s039lbl.pdf|Name:Wikipedia, SrcID:Pentoxifylline, URL:http://en.wikipedia.org/wiki/Pentoxifylline",CN1C(=O)N(CCCCC(=O)C)C(=O)c2c1ncn2C,CHEMBL2363066,PDE6H
3354,CHEMBL628,Pentoxifylline,Small molecule,1984.0,C04AD03,C04AD03 [CARDIOVASCULAR SYSTEM: PERIPHERAL VASODILATORS: PERIPHERAL VASODILATORS: Purine derivatives],-fylline,"3',5'-cyclic phosphodiesterase inhibitor",,,CHEMBL2363066,"3',5'-cyclic phosphodiesterase",INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:18568240, URL:http://europepmc.org/abstract/MED/18568240|Name:PubMed, SrcID:11692087, URL:http://europepmc.org/abstract/MED/11692087|Name:FDA, SrcID:label/2012/018631s039lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/018631s039lbl.pdf|Name:Wikipedia, SrcID:Pentoxifylline, URL:http://en.wikipedia.org/wiki/Pentoxifylline",CN1C(=O)N(CCCCC(=O)C)C(=O)c2c1ncn2C,CHEMBL2363066,PDE6G
3355,CHEMBL1535,Hydroxychloroquine,Small molecule,1955.0,P01BA02,"P01BA02 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: ANTIMALARIALS: Aminoquinolines]",,Toll-like receptor 9 antagonist,,,CHEMBL5804,Toll-like receptor 9,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2007/009768s041lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/009768s041lbl.pdf|Name:PubMed, SrcID:18220957, URL:http://europepmc.org/abstract/MED/18220957|Name:PubMed, SrcID:17970883, URL:http://europepmc.org/abstract/MED/17970883|Name:DailyMed, SrcID:setid=3279d780-0940-f462-9709-83c77f8ae241, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3279d780-0940-f462-9709-83c77f8ae241",CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,CHEMBL5804,TLR9
3356,CHEMBL1013,Loracarbef,Small molecule,1991.0,,,-carbef,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:archiveid=3181, URL:http://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=3181|Name:Wikipedia, SrcID:Penicillin_binding_proteins#Function, URL:http://en.wikipedia.org/wiki/Penicillin_binding_proteins#Function",N[C@@H](C(=O)N[C@H]1[C@H]2CCC(=C(N2C1=O)C(=O)O)Cl)c3ccccc3,,
3357,CHEMBL1384,Kanamycin,Small molecule,1973.0,A07AA08; S01AA24; J01GB04,"A07AA08 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFECTIVES: Antibiotics]; S01AA24 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Antibiotics]; J01GB04 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: AMINOGLYCOSIDE ANTIBACTERIALS: Other aminoglycosides]",-mycin,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,16S ribosomal RNA,16s RRNA,"Name:PubMed, SrcID:3054810, URL:http://europepmc.org/abstract/MED/3054810",NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,,
3358,CHEMBL404520,Chlortetracycline,Small molecule,1950.0,J01AA03; S01AA02; A01AB21; D06AA02,J01AA03 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: TETRACYCLINES: Tetracyclines]; S01AA02 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Antibiotics]; A01AB21 [ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Antiinfectives and antiseptics for local oral treatment]; D06AA02 [DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: ANTIBIOTICS FOR TOPICAL USE: Tetracycline and derivatives],-cycline,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,16S ribosomal RNA,16s RRNA,"Name:PubMed, SrcID:20592239, URL:http://europepmc.org/abstract/MED/20592239",CN(C)[C@H]1[C@@H]2C[C@H]3C(=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N)C(=O)c4c(O)ccc(Cl)c4[C@@]3(C)O,,
3359,CHEMBL1201624,Beractant,Unknown,1991.0,,,-tant,Surfactant agent,Replaces endogenous surfactant in case of deficiency; endogenous pulmonary surfactant lower surface tension at the air-liquid of the alveolar surfaces,,,,,,,,,"Name:DailyMed, SrcID:setid=7ef9e3a5-fc39-4ae1-0dad-6b47a1684635#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7ef9e3a5-fc39-4ae1-0dad-6b47a1684635#nlm34090-1",,,
3360,CHEMBL1200559,Lactic Acid,Small molecule,2006.0,G01AD01,"G01AD01 [GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Organic acids]",,pH lowering agent,Antimicrobial activity,,,,,,,,,"Name:PubMed, SrcID:21535613, URL:http://europepmc.org/abstract/MED/21535613|Name:DOI, SrcID:10.1111/j.1365-2621.2004.tb13375.x, URL:http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2621.2004.tb13375.x/abstract",CC(O)C(=O)O,,
3361,CHEMBL99946,Levomilnacipran,Small molecule,2013.0,,,,Serotonin transporter inhibitor,,,CHEMBL228,Serotonin transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f371258d-91b3-4b6a-ac99-434a1964c3af, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f371258d-91b3-4b6a-ac99-434a1964c3af",CCN(CC)C(=O)[C@]1(C[C@H]1CN)c2ccccc2,CHEMBL228,SLC6A4
3362,CHEMBL2107841,Albiglutide,Protein,2014.0,A10BJ04,"A10BJ04 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Glucagon-like peptide-1 (GLP-1) analogues]",-tide,Glucagon-like peptide 1 receptor agonist,,,CHEMBL1784,Glucagon-like peptide 1 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2014/125431s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125431s000lbl.pdf",,CHEMBL1784,GLP1R
3363,CHEMBL3137342,Dinutuximab,Antibody,2015.0,L01XC16,L01XC16 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,Disialoganglioside GD2 binding agent,,,CHEMBL3390823,Disialoganglioside GD2,BINDING AGENT,Homo sapiens,SMALL MOLECULE,,,"Name:FDA, SrcID:label/2015/125516s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125516s000lbl.pdf",,,
3364,CHEMBL238804,Selexipag,Small molecule,2015.0,B01AC27,B01AC27 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Platelet aggregation inhibitors excl. heparin],,Prostanoid IP receptor agonist,,,CHEMBL1995,Prostanoid IP receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/207947s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207947s000lbl.pdf",CC(C)N(CCCCOCC(=O)NS(=O)(=O)C)c1cnc(c2ccccc2)c(n1)c3ccccc3,CHEMBL1995,PTGIR
3365,CHEMBL1721885,Su-014813,Small molecule,,,,,Platelet-derived growth factor receptor inhibitor,,,CHEMBL2095189,Platelet-derived growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:16891463, URL:http://europepmc.org/abstract/MED/16891463",Cc1[nH]c(\C=C\2/C(=O)Nc3ccc(F)cc23)c(C)c1C(=O)NC[C@H](O)CN4CCOCC4,,
3366,CHEMBL3545284,Cerdulatinib,Small molecule,,,,-tinib,Tyrosine-protein kinase SYK inhibitor,Dual spleen tyrosine kinase (Syk) and janus kinase (JAK) inhibitor,,CHEMBL2599,Tyrosine-protein kinase SYK,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://www.portola.com/clinical-development/cerdulatinib-dual-syk-jak-inhibitor/l-development/cerdulatinib-dual-syk-jak-inhibitor/, URL:https://www.portola.com/clinical-development/cerdulatinib-dual-syk-jak-inhibitor/l-development/cerdulatinib-dual-syk-jak-inhibitor/|Name:PubMed, SrcID:25253883, URL:http://europepmc.org/abstract/MED/25253883",,CHEMBL2599,SYK
3367,CHEMBL2140408,Amg-900,Small molecule,,,,,Serine/threonine-protein kinase Aurora inhibitor,Pan-Aurora kinase inhibitor,,CHEMBL3430911,Serine/threonine-protein kinase Aurora,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:26345296, URL:http://europepmc.org/abstract/MED/26345296|Name:PubMed, SrcID:20935223, URL:http://europepmc.org/abstract/MED/20935223",Cc1csc(c1)c2nnc(Nc3ccc(Oc4ncccc4c5ccnc(N)n5)cc3)c6ccccc26,,
3368,CHEMBL3545361,Bay-1163877,Small molecule,,,,,Fibroblast growth factor receptor inhibitor,,,CHEMBL2095217,Fibroblast growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DOI, SrcID:10.1158/1538-7445.AM2014-1739, URL:http://cancerres.aacrjournals.org/content/74/19_Supplement/1739",,,
3369,CHEMBL3544964,Gdc-0994,Small molecule,,,,,MAP kinase ERK1 inhibitor,,,CHEMBL3385,MAP kinase ERK1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://cancerres.aacrjournals.org/content/74/19_Supplement/DDT02-03, URL:http://cancerres.aacrjournals.org/content/74/19_Supplement/DDT02-03",Cn1nccc1Nc2nccc(n2)C3=CC(=O)N(C=C3)[C@H](CO)c4ccc(Cl)c(F)c4,CHEMBL3385,MAPK3
3370,CHEMBL1684984,Pa-799,Small molecule,,,,,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:21316229, URL:http://europepmc.org/abstract/MED/21316229|Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718",CS(=O)(=O)N1CCc2c1nc(nc2c3cnc(N)nc3)N4CCOCC4,CHEMBL3559703,PIK3R2
3371,CHEMBL1684984,Pa-799,Small molecule,,,,,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:21316229, URL:http://europepmc.org/abstract/MED/21316229|Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718",CS(=O)(=O)N1CCc2c1nc(nc2c3cnc(N)nc3)N4CCOCC4,CHEMBL3559703,PIK3R3
3372,CHEMBL1684984,Pa-799,Small molecule,,,,,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:21316229, URL:http://europepmc.org/abstract/MED/21316229|Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718",CS(=O)(=O)N1CCc2c1nc(nc2c3cnc(N)nc3)N4CCOCC4,CHEMBL3559703,PIK3R5
3373,CHEMBL2062154,Ci-988,Small molecule,,,,,Cholecystokinin B receptor antagonist,,,CHEMBL298,Cholecystokinin B receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:1527584, URL:http://europepmc.org/abstract/MED/1527584",C[C@](Cc1c[nH]c2ccccc12)(NC(=O)OC3[C@@H]4C[C@H]5C[C@H](C[C@@H]3C5)C4)C(=O)NC[C@H](NC(=O)CCC(=O)O)c6ccccc6,CHEMBL298,CCKBR
3374,CHEMBL3545011,Gs-9667,Small molecule,,,,,Adenosine A1 receptor partial agonist,Compound not in current pipeline,,CHEMBL226,Adenosine A1 receptor,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23427000, URL:http://europepmc.org/abstract/MED/23427000|Name:PubMed, SrcID:16654164, URL:http://www.ncbi.nlm.nih.gov/pubmed/?term=16654164|Name:PubMed, SrcID:16410404, URL:http://europepmc.org/abstract/MED/16410404",O[C@@H]1CCC[C@H]1Nc2ncnc3c2ncn3[C@@H]4O[C@H](CSc5ccccc5F)[C@@H](O)[C@H]4O,CHEMBL226,ADORA1
3375,CHEMBL1980391,Rg-1530,Small molecule,,,,,Platelet-derived growth factor receptor beta inhibitor,Multi-targeted kinase inhibitor,,CHEMBL1913,Platelet-derived growth factor receptor beta,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21553286, URL:http://europepmc.org/abstract/MED/21553286|Name:PubMed, SrcID:24900658, URL:http://europepmc.org/abstract/MED/24900658",COc1cc2Nc3n[nH]c(C)c3N=C(c4ccccc4Cl)c2cc1F,CHEMBL1913,PDGFRB
3376,CHEMBL504652,Tc-2216,Small molecule,,,,,Neuronal acetylcholine receptor; alpha4/beta2 antagonist,Racemic compound.,,CHEMBL1907589,Neuronal acetylcholine receptor; alpha4/beta2,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:19040552, URL:http://europepmc.org/abstract/MED/19040552|Name:PubMed, SrcID:1459956, URL:http://europepmc.org/abstract/MED/1459956",C1CNC2(C1)CCN(C2)c3cccnc3,,
3377,CHEMBL3545015,Rad1901,Small molecule,,,,,Estrogen receptor alpha degrader,FDA accepted IND-application in December 2014. Is a SERM (selective estrogen receptor modulator) and SERD (selective estrogen receptor down-regulator/degrader),,CHEMBL206,Estrogen receptor alpha,DEGRADER,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.radiuspharm.com/index.php/r-d/pipeline.html, URL:http://www.radiuspharm.com/index.php/r-d/pipeline.html|Name:PubMed, SrcID:26164151, URL:http://europepmc.org/abstract/MED/26164151|Name:Other, SrcID:http://ir.radiuspharm.com/releasedetail.cfm?ReleaseID=888510, URL:http://ir.radiuspharm.com/releasedetail.cfm?ReleaseID=888510",,CHEMBL206,ESR1
3378,CHEMBL3137304,Dagrocorat,Small molecule,,,,-corat,Glucocorticoid receptor modulator,Active metbolite of PF-04171327,,CHEMBL2034,Glucocorticoid receptor,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.abstracts2view.com/eular/view.php?nu=EULAR10L_THU0216, URL:http://www.abstracts2view.com/eular/view.php?nu=EULAR10L_THU0216|Name:Wikipedia, SrcID:Selective_glucocorticoid_receptor_modulator, URL:https://en.wikipedia.org/wiki/Selective_glucocorticoid_receptor_modulator",Cc1ncccc1NC(=O)c2ccc3c(CC[C@@H]4C[C@](O)(CC[C@@]34Cc5ccccc5)C(F)(F)F)c2,CHEMBL2034,NR3C1
3379,CHEMBL3218578,Bgt-226,Small molecule,,,,,PI3-kinase class I inhibitor,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:22357447, URL:http://europepmc.org/abstract/MED/22357447|Name:PubMed, SrcID:24591840, URL:http://europepmc.org/abstract/MED/24591840",COc1ccc(cn1)c2ccc3ncc4N(C)C(=O)N(c5ccc(N6CCNCC6)c(c5)C(F)(F)F)c4c3c2,CHEMBL3559703,PIK3R2
3380,CHEMBL3218578,Bgt-226,Small molecule,,,,,PI3-kinase class I inhibitor,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:22357447, URL:http://europepmc.org/abstract/MED/22357447|Name:PubMed, SrcID:24591840, URL:http://europepmc.org/abstract/MED/24591840",COc1ccc(cn1)c2ccc3ncc4N(C)C(=O)N(c5ccc(N6CCNCC6)c(c5)C(F)(F)F)c4c3c2,CHEMBL3559703,PIK3R3
3381,CHEMBL3218578,Bgt-226,Small molecule,,,,,PI3-kinase class I inhibitor,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:22357447, URL:http://europepmc.org/abstract/MED/22357447|Name:PubMed, SrcID:24591840, URL:http://europepmc.org/abstract/MED/24591840",COc1ccc(cn1)c2ccc3ncc4N(C)C(=O)N(c5ccc(N6CCNCC6)c(c5)C(F)(F)F)c4c3c2,CHEMBL3559703,PIK3R5
3382,CHEMBL460702,Bms-777607,Small molecule,,,,,Hepatocyte growth factor receptor inhibitor,"Also potent inhibitor of MST1R, AXL and TYRO3.",,CHEMBL3717,Hepatocyte growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26555154, URL:http://europepmc.org/abstract/MED/26555154|Name:PubMed, SrcID:19260711, URL:http://europepmc.org/abstract/MED/19260711",CCOC1=C(C(=O)Nc2ccc(Oc3ccnc(N)c3Cl)c(F)c2)C(=O)N(C=C1)c4ccc(F)cc4,CHEMBL3717,MET
3383,CHEMBL254760,Mgcd-265,Small molecule,,,,,Macrophage-stimulating protein receptor inhibitor,,,CHEMBL2689,Macrophage-stimulating protein receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://meetinglibrary.asco.org/content/96526-114, URL:http://meetinglibrary.asco.org/content/96526-114|Name:PubMed, SrcID:25806189, URL:http://europepmc.org/abstract/MED/25806189",Cn1cnc(c1)c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2,,
3384,CHEMBL3545102,Sb-773812,Small molecule,,,,,Dopamine D2 receptor antagonist,,,CHEMBL217,Dopamine D2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21421726, URL:http://europepmc.org/abstract/MED/21421726",,CHEMBL217,DRD2
3385,CHEMBL3544952,Rg3487,Small molecule,,,,,Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist,,,CHEMBL2492,Neuronal acetylcholine receptor protein alpha-7 subunit,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22408449, URL:http://europepmc.org/abstract/MED/22408449|Name:PubMed, SrcID:21919481, URL:http://europepmc.org/abstract/MED/21919481|Name:PubMed, SrcID:20959364, URL:http://europepmc.org/abstract/MED/20959364",,CHEMBL2492,CHRNA7
3386,CHEMBL2105631,Budiodarone,Small molecule,,,,-arone,Unknown,,,,,,,,,,"Name:Wikipedia, SrcID:Budiodarone, URL:https://en.wikipedia.org/wiki/Budiodarone|Name:PubMed, SrcID:19174378, URL:http://europepmc.org/abstract/MED/19174378",CC[C@H](C)OC(=O)Cc1oc2ccccc2c1C(=O)c3cc(I)c(OCCN(CC)CC)c(I)c3,,
3387,CHEMBL267431,Asoprisnil,Small molecule,,,,-prisnil,Progesterone receptor modulator,"Development discontinued due to ""endometrial changes"" experienced by some patients. Is a selective progesterone receptor modulator.",,CHEMBL208,Progesterone receptor,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Asoprisnil, URL:http://en.wikipedia.org/wiki/Asoprisnil|Name:PubMed, SrcID:15714390, URL:http://europepmc.org/abstract/MED/15714390|Name:PubMed, SrcID:14667995, URL:http://europepmc.org/abstract/MED/14667995",COC[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c5ccc(\C=N\O)cc5)OC,CHEMBL208,PGR
3388,CHEMBL31965,Canertinib,Small molecule,,,,-tinib,Receptor protein-tyrosine kinase erbB-2 inhibitor,Canertinib is an irreversible pan-ErbB tyrosine kinase inhibitor.,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12648472, URL:http://europepmc.org/abstract/MED/12648472|Name:PubMed, SrcID:11706399, URL:http://europepmc.org/abstract/MED/11706399",Fc1ccc(Nc2ncnc3cc(OCCCN4CCOCC4)c(NC(=O)C=C)cc23)cc1Cl,CHEMBL1824,ERBB2
3389,CHEMBL1088752,Losmapimod,Small molecule,,,,-imod,MAP kinase p38 alpha inhibitor,,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19556450, URL:http://europepmc.org/abstract/MED/19556450|Name:PubMed, SrcID:21262998, URL:http://europepmc.org/abstract/MED/21262998",Cc1c(F)cc(cc1c2ccc(cn2)C(=O)NCC(C)(C)C)C(=O)NC3CC3,CHEMBL260,MAPK14
3390,CHEMBL3545110,Ribociclib,Small molecule,2017.0,,,-ciclib,Cyclin-dependent kinase 4 inhibitor,,,CHEMBL331,Cyclin-dependent kinase 4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://mct.aacrjournals.org/content/12/11_Supplement/PR02, URL:http://mct.aacrjournals.org/content/12/11_Supplement/PR02|Name:PubMed, SrcID:24045179, URL:http://europepmc.org/abstract/MED/24045179",CN(C)C(=O)c1cc2cnc(Nc3ccc(cn3)N4CCNCC4)nc2n1C5CCCC5,CHEMBL331,CDK4
3391,CHEMBL608533,Midostaurin,Small molecule,,L01XE39,L01XE39 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],,Vascular endothelial growth factor receptor 2 inhibitor,Multi-kinase inhibitor,,CHEMBL279,Vascular endothelial growth factor receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16969355, URL:http://europepmc.org/abstract/MED/16969355|Name:PubMed, SrcID:12124173, URL:http://europepmc.org/abstract/MED/12124173",CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)n3c4ccccc4c5c6CNC(=O)c6c7c8ccccc8n2c7c35)N(C)C(=O)c9ccccc9,CHEMBL279,KDR
3392,CHEMBL1743034,Ixekizumab,Antibody,2016.0,L04AC13,L04AC13 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Interleukin inhibitors],-mab,Interleukin 17A inhibitor,,,CHEMBL3390822,Interleukin 17A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2016/125521s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125521s000lbl.pdf",,CHEMBL3390822,IL17A
3393,CHEMBL2103826,Davunetide,Protein,,,,-tide,Tubulin stabiliser,,"Interacts with the Tubulin heterodimer, but shows preference to Tubulin beta III in neurons.",CHEMBL2095182,Tubulin,STABILISER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:16893427, URL:http://europepmc.org/abstract/MED/16893427|Name:PubMed, SrcID:24210139, URL:http://europepmc.org/abstract/MED/24210139",CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)CC(=O)N)C(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(=O)N)C(=O)O,CHEMBL2095182,TUBB8
3394,CHEMBL2103826,Davunetide,Protein,,,,-tide,Tubulin stabiliser,,"Interacts with the Tubulin heterodimer, but shows preference to Tubulin beta III in neurons.",CHEMBL2095182,Tubulin,STABILISER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:16893427, URL:http://europepmc.org/abstract/MED/16893427|Name:PubMed, SrcID:24210139, URL:http://europepmc.org/abstract/MED/24210139",CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)CC(=O)N)C(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(=O)N)C(=O)O,CHEMBL2095182,TUBA3C
3395,CHEMBL2103826,Davunetide,Protein,,,,-tide,Tubulin stabiliser,,"Interacts with the Tubulin heterodimer, but shows preference to Tubulin beta III in neurons.",CHEMBL2095182,Tubulin,STABILISER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:16893427, URL:http://europepmc.org/abstract/MED/16893427|Name:PubMed, SrcID:24210139, URL:http://europepmc.org/abstract/MED/24210139",CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)CC(=O)N)C(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(=O)N)C(=O)O,CHEMBL2095182,TUBA4A
3396,CHEMBL2103826,Davunetide,Protein,,,,-tide,Tubulin stabiliser,,"Interacts with the Tubulin heterodimer, but shows preference to Tubulin beta III in neurons.",CHEMBL2095182,Tubulin,STABILISER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:16893427, URL:http://europepmc.org/abstract/MED/16893427|Name:PubMed, SrcID:24210139, URL:http://europepmc.org/abstract/MED/24210139",CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)CC(=O)N)C(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(=O)N)C(=O)O,CHEMBL2095182,TUBA3E
3397,CHEMBL2103826,Davunetide,Protein,,,,-tide,Tubulin stabiliser,,"Interacts with the Tubulin heterodimer, but shows preference to Tubulin beta III in neurons.",CHEMBL2095182,Tubulin,STABILISER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:16893427, URL:http://europepmc.org/abstract/MED/16893427|Name:PubMed, SrcID:24210139, URL:http://europepmc.org/abstract/MED/24210139",CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)CC(=O)N)C(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(=O)N)C(=O)O,CHEMBL2095182,TUBB6
3398,CHEMBL2103826,Davunetide,Protein,,,,-tide,Tubulin stabiliser,,"Interacts with the Tubulin heterodimer, but shows preference to Tubulin beta III in neurons.",CHEMBL2095182,Tubulin,STABILISER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:16893427, URL:http://europepmc.org/abstract/MED/16893427|Name:PubMed, SrcID:24210139, URL:http://europepmc.org/abstract/MED/24210139",CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)CC(=O)N)C(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(=O)N)C(=O)O,CHEMBL2095182,TUBB2B
3399,CHEMBL2103826,Davunetide,Protein,,,,-tide,Tubulin stabiliser,,"Interacts with the Tubulin heterodimer, but shows preference to Tubulin beta III in neurons.",CHEMBL2095182,Tubulin,STABILISER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:16893427, URL:http://europepmc.org/abstract/MED/16893427|Name:PubMed, SrcID:24210139, URL:http://europepmc.org/abstract/MED/24210139",CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)CC(=O)N)C(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(=O)N)C(=O)O,CHEMBL2095182,TUBA3D
3400,CHEMBL272980,Mocetinostat,Small molecule,,,,-stat,Histone deacetylase 1 inhibitor,,"Isotype-selective Class I (HDAC1, -2, -3, and -8) and IV (HDAC11) HDAC inhibitor.",CHEMBL325,Histone deacetylase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18413790, URL:http://europepmc.org/abstract/MED/18413790|Name:PubMed, SrcID:27551526, URL:http://europepmc.org/abstract/MED/27551526",Nc1ccccc1NC(=O)c2ccc(CNc3nccc(n3)c4cccnc4)cc2,CHEMBL325,HDAC1
3401,CHEMBL1812161,Vatiquinone,Small molecule,,,,,Quinone reductase 1 modulator,,,CHEMBL3623,Quinone reductase 1),MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:27476756, URL:http://europepmc.org/abstract/MED/27476756",CC(=CCC\C(=C\CC\C(=C\CC[C@@](C)(O)CCC1=C(C)C(=O)C(=C(C)C1=O)C)\C)\C)C,CHEMBL3623,NQO1
3402,CHEMBL1615835,Muparfostat,Oligosaccharide,,,,-fo-; -stat,Vascular endothelial growth factor A inhibitor,,,CHEMBL1783,Vascular endothelial growth factor A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:14521421, URL:http://europepmc.org/abstract/MED/14521421",OP(=O)(O)OC[C@H]1O[C@H](O[C@H]2[C@H](OS(=O)(=O)O)[C@@H](COS(=O)(=O)O)O[C@H](O[C@H]3[C@H](OS(=O)(=O)O)[C@@H](COS(=O)(=O)O)O[C@H](O[C@H]4[C@H](OS(=O)(=O)O)[C@@H](COS(=O)(=O)O)O[C@H](O[C@@H]5[C@@H](OS(=O)(=O)O)O[C@H](COS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@@H]5OS(=O)(=O)O)[C@H]4OS(=O)(=O)O)[C@H]3OS(=O)(=O)O)[C@H]2OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@@H]1OS(=O)(=O)O,CHEMBL1783,VEGFA
3403,CHEMBL3707357,Brolucizumab,Antibody,,,,-mab,Vascular endothelial growth factor A inhibitor,,Binds to all isoforms of VEGF-A including VEGF165.,CHEMBL1783,Vascular endothelial growth factor A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://retinatoday.com/2016/06/a-novel-compound-for-treatment-of-wet-amd/, URL:http://retinatoday.com/2016/06/a-novel-compound-for-treatment-of-wet-amd/",,CHEMBL1783,VEGFA
3404,CHEMBL2108038,Matuzumab,Antibody,,,,-mab,Epidermal growth factor receptor erbB1 inhibitor,The binding of matuzumab to domain III sterically blocks the domain rearrangement that is required for high affinity ligand binding and receptor dimerization.,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18394559, URL:http://europepmc.org/abstract/MED/18394559",,CHEMBL203,EGFR
3405,CHEMBL2109057,Ecromeximab,Antibody,,,,-mab,Ganglioside GD3 other,"Immunostimulant. Binds to GD3-positive cells, thereby initiating antibody-dependent cytotoxicity against GD3-positive cells and complement-mediated cytotoxicity.",,CHEMBL3580507,Ganglioside GD3,OTHER,Homo sapiens,LIPID,,,"Name:PubMed, SrcID:8500110, URL:http://europepmc.org/abstract/MED/8500110",,,
3406,CHEMBL978,Methacholine,Small molecule,1986.0,,,,Muscarinic acetylcholine receptor M3 agonist,"Indicated for diagnosis of broncoconstriction, M3 likely responsible",,CHEMBL245,Muscarinic acetylcholine receptor M3,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:20347047, URL:http://europepmc.org/abstract/MED/20347047",CC(C[N+](C)(C)C)OC(=O)C,CHEMBL245,CHRM3
3407,CHEMBL2108791,Tenecteplase,Enzyme,2000.0,B01AD11,B01AD11 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Enzymes],-ase,Plasminogen activator,,,CHEMBL1801,Plasminogen,ACTIVATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=69e391bf-1250-4083-aa60-6aa41c33657f#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=69e391bf-1250-4083-aa60-6aa41c33657f#nlm34090-1|Name:Other, SrcID:http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/ucm093370.htm, URL:http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/ucm093370.htm",,CHEMBL1801,PLG
3408,CHEMBL269732,Tacrolimus,Small molecule,1994.0,L04AD02; D11AH01,"L04AD02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Calcineurin inhibitors]; D11AH01 [DERMATOLOGICALS: OTHER DERMATOLOGICAL PREPARATIONS: OTHER DERMATOLOGICAL PREPARATIONS: Agents for dermatitis, excluding corticosteroids]",-imus,FK506-binding protein 1A inhibitor,,,CHEMBL1902,FK506-binding protein 1A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=95b03516-34b0-4438-a05c-918d80f70091, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=95b03516-34b0-4438-a05c-918d80f70091",CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)\[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)C\C(=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)\C)OC)[C@H](C[C@H]4C)OC,CHEMBL1902,FKBP1A
3409,CHEMBL1580,Pentostatin,Small molecule,1991.0,L01XX08,L01XX08 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-stat-,Adenosine deaminase inhibitor,,,CHEMBL1910,Adenosine deaminase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=674e0e6d-46ed-4868-9196-04019d667716, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=674e0e6d-46ed-4868-9196-04019d667716",OC[C@H]1O[C@H](C[C@@H]1O)n2cnc3[C@H](O)CNC=Nc23,CHEMBL1910,ADA
3410,CHEMBL1336,Sorafenib,Small molecule,2005.0,L01XE05,L01XE05 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-rafenib,Platelet-derived growth factor receptor beta inhibitor,,,CHEMBL1913,Platelet-derived growth factor receptor beta,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2011/021923s012lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf",CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,CHEMBL1913,PDGFRB
3411,CHEMBL1790041,Ranitidine,Small molecule,1983.0,A02BA02,A02BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): H2-receptor antagonists],-tidine,Histamine H2 receptor antagonist,,,CHEMBL1941,Histamine H2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=187c2ad2-176e-497b-90bd-1ba4a6509062, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=187c2ad2-176e-497b-90bd-1ba4a6509062|Name:FDA, SrcID:label/2009/019090s053,019593s042lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019090s053,019593s042lbl.pdf",CNC(=C[N+](=O)[O-])NCCSCc1oc(CN(C)C)cc1,CHEMBL1941,HRH2
3412,CHEMBL1404,Ranolazine,Small molecule,2006.0,C01EB18,C01EB18 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: OTHER CARDIAC PREPARATIONS: Other cardiac preparations],,Sodium channel protein type IV alpha subunit blocker,Competitive reversible inhibitor,,CHEMBL2072,Sodium channel protein type IV alpha subunit,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18462746, URL:http://europepmc.org/abstract/MED/18462746",COc1ccccc1OCC(O)CN2CCN(CC(=O)Nc3c(C)cccc3C)CC2,CHEMBL2072,SCN4A
3413,CHEMBL1502,Pantoprazole,Small molecule,2000.0,A02BC02,A02BC02 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): Proton pump inhibitors],-prazole,Potassium-transporting ATPase inhibitor,,,CHEMBL2095173,Potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,K-ATPase alpha subunit,Alpha subunit is likely binding site,"Name:PubMed, SrcID:14699149, URL:http://europepmc.org/abstract/MED/14699149|Name:PubMed, SrcID:23350044, URL:http://europepmc.org/abstract/MED/23350044|Name:DailyMed, SrcID:setid=eda64039-771b-41d7-b9c4-970cfbf5fbb9#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eda64039-771b-41d7-b9c4-970cfbf5fbb9#nlm34090-1",COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[nH]2)c1OC,CHEMBL2095173,ATP4A
3414,CHEMBL1502,Pantoprazole,Small molecule,2000.0,A02BC02,A02BC02 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): Proton pump inhibitors],-prazole,Potassium-transporting ATPase inhibitor,,,CHEMBL2095173,Potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,K-ATPase alpha subunit,Alpha subunit is likely binding site,"Name:PubMed, SrcID:14699149, URL:http://europepmc.org/abstract/MED/14699149|Name:PubMed, SrcID:23350044, URL:http://europepmc.org/abstract/MED/23350044|Name:DailyMed, SrcID:setid=eda64039-771b-41d7-b9c4-970cfbf5fbb9#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eda64039-771b-41d7-b9c4-970cfbf5fbb9#nlm34090-1",COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[nH]2)c1OC,CHEMBL2095173,ATP4B
3415,CHEMBL524,Methoxamine,Small molecule,1982.0,C01CA10,C01CA10 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES: Adrenergic and dopaminergic agents],,Adrenergic receptor alpha-1 agonist,,,CHEMBL2094251,Adrenergic receptor alpha-1,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:ISBN, SrcID:9780702034718 PP. 176, URL:http://www.isbnsearch.org/isbn/9780702034718",COc1ccc(OC)c(c1)C(O)C(C)N,,
3416,CHEMBL113,Caffeine,Small molecule,1948.0,N06BC01,"N06BC01 [NERVOUS SYSTEM: PSYCHOANALEPTICS: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS: Xanthine derivatives]",,Adenosine receptor antagonist,,,CHEMBL2111329,Adenosine receptor,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:15095008, URL:http://europepmc.org/abstract/MED/15095008|Name:FDA, SrcID:label/2000/20793s1lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2000/20793s1lbl.pdf|Name:Wikipedia, SrcID:Adenosine_receptor, URL:http://en.wikipedia.org/wiki/Adenosine_receptor",CN1C(=O)N(C)c2ncn(C)c2C1=O,,
3417,CHEMBL499,Timolol,Small molecule,1978.0,S01ED51; C07AA06; S01ED01,"S01ED51 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Beta blocking agents 1)]; C07AA06 [CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, non-selective]; S01ED01 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Beta blocking agents 1)]",-olol,Beta-2 adrenergic receptor antagonist,,,CHEMBL210,Beta-2 adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=00f62dd1-dad2-4892-8a5d-21e5e54509ce, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=00f62dd1-dad2-4892-8a5d-21e5e54509ce",CC(C)(C)NC[C@H](O)COc1nsnc1N2CCOCC2,CHEMBL210,ADRB2
3418,CHEMBL106,Fluconazole,Small molecule,1990.0,D01AC15; J02AC01,D01AC15 [DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Imidazole and triazole derivatives]; J02AC01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: Triazole derivatives],-conazole,Cytochrome P450 51 inhibitor,,,CHEMBL1780,Cytochrome P450 51,INHIBITOR,Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast),SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f694c617-3383-416c-91b6-b94fda371204, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f694c617-3383-416c-91b6-b94fda371204",OC(Cn1cncn1)(Cn2cncn2)c3ccc(F)cc3F,,
3419,CHEMBL407,Flumazenil,Small molecule,1991.0,V03AB25,V03AB25 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Antidotes],-azenil,GABA-A receptor; anion channel allosteric antagonist,Antagonist at benzodiazepine site to treat overdose,,CHEMBL2093872,GABA-A receptor; anion channel,ALLOSTERIC ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:FDA, SrcID:label/2007/020073s016lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020073s016lbl.pdf",CCOC(=O)c1ncn2c1CN(C)C(=O)c3cc(F)ccc23,CHEMBL2093872,GABRG3
3420,CHEMBL407,Flumazenil,Small molecule,1991.0,V03AB25,V03AB25 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Antidotes],-azenil,GABA-A receptor; anion channel allosteric antagonist,Antagonist at benzodiazepine site to treat overdose,,CHEMBL2093872,GABA-A receptor; anion channel,ALLOSTERIC ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:FDA, SrcID:label/2007/020073s016lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020073s016lbl.pdf",CCOC(=O)c1ncn2c1CN(C)C(=O)c3cc(F)ccc23,CHEMBL2093872,GABRP
3421,CHEMBL407,Flumazenil,Small molecule,1991.0,V03AB25,V03AB25 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Antidotes],-azenil,GABA-A receptor; anion channel allosteric antagonist,Antagonist at benzodiazepine site to treat overdose,,CHEMBL2093872,GABA-A receptor; anion channel,ALLOSTERIC ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:FDA, SrcID:label/2007/020073s016lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020073s016lbl.pdf",CCOC(=O)c1ncn2c1CN(C)C(=O)c3cc(F)ccc23,CHEMBL2093872,GABRE
3422,CHEMBL407,Flumazenil,Small molecule,1991.0,V03AB25,V03AB25 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Antidotes],-azenil,GABA-A receptor; anion channel allosteric antagonist,Antagonist at benzodiazepine site to treat overdose,,CHEMBL2093872,GABA-A receptor; anion channel,ALLOSTERIC ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:FDA, SrcID:label/2007/020073s016lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020073s016lbl.pdf",CCOC(=O)c1ncn2c1CN(C)C(=O)c3cc(F)ccc23,CHEMBL2093872,GABRG1
3423,CHEMBL1201293,Acamprosate,Small molecule,2004.0,N07BB03,N07BB03 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: DRUGS USED IN ADDICTIVE DISORDERS: Drugs used in alcohol dependence],,GABA-A receptor; anion channel positive modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:PubMed, SrcID:22346357, URL:http://europepmc.org/abstract/MED/22346357|Name:FDA, SrcID:label/2012/021431s015lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021431s015lbl.pdf|Name:Wikipedia, SrcID:Acamprosate, URL:http://en.wikipedia.org/wiki/Acamprosate",CC(=O)NCCCS(=O)(=O)O,CHEMBL2093872,GABRG3
3424,CHEMBL1201293,Acamprosate,Small molecule,2004.0,N07BB03,N07BB03 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: DRUGS USED IN ADDICTIVE DISORDERS: Drugs used in alcohol dependence],,GABA-A receptor; anion channel positive modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:PubMed, SrcID:22346357, URL:http://europepmc.org/abstract/MED/22346357|Name:FDA, SrcID:label/2012/021431s015lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021431s015lbl.pdf|Name:Wikipedia, SrcID:Acamprosate, URL:http://en.wikipedia.org/wiki/Acamprosate",CC(=O)NCCCS(=O)(=O)O,CHEMBL2093872,GABRP
3425,CHEMBL1201293,Acamprosate,Small molecule,2004.0,N07BB03,N07BB03 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: DRUGS USED IN ADDICTIVE DISORDERS: Drugs used in alcohol dependence],,GABA-A receptor; anion channel positive modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:PubMed, SrcID:22346357, URL:http://europepmc.org/abstract/MED/22346357|Name:FDA, SrcID:label/2012/021431s015lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021431s015lbl.pdf|Name:Wikipedia, SrcID:Acamprosate, URL:http://en.wikipedia.org/wiki/Acamprosate",CC(=O)NCCCS(=O)(=O)O,CHEMBL2093872,GABRE
3426,CHEMBL1201293,Acamprosate,Small molecule,2004.0,N07BB03,N07BB03 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: DRUGS USED IN ADDICTIVE DISORDERS: Drugs used in alcohol dependence],,GABA-A receptor; anion channel positive modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:PubMed, SrcID:22346357, URL:http://europepmc.org/abstract/MED/22346357|Name:FDA, SrcID:label/2012/021431s015lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021431s015lbl.pdf|Name:Wikipedia, SrcID:Acamprosate, URL:http://en.wikipedia.org/wiki/Acamprosate",CC(=O)NCCCS(=O)(=O)O,CHEMBL2093872,GABRG1
3427,CHEMBL1059,Pregabalin,Small molecule,2004.0,N03AX16,N03AX16 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],-gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:FDA, SrcID:label/2012/021446s028lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021446s028lbl.pdf|Name:PubMed, SrcID:21651903, URL:http://europepmc.org/abstract/MED/21651903",CC(C)C[C@H](CN)CC(=O)O,CHEMBL2363032,CACNB3
3428,CHEMBL1059,Pregabalin,Small molecule,2004.0,N03AX16,N03AX16 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],-gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:FDA, SrcID:label/2012/021446s028lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021446s028lbl.pdf|Name:PubMed, SrcID:21651903, URL:http://europepmc.org/abstract/MED/21651903",CC(C)C[C@H](CN)CC(=O)O,CHEMBL2363032,CACNG3
3429,CHEMBL1059,Pregabalin,Small molecule,2004.0,N03AX16,N03AX16 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],-gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:FDA, SrcID:label/2012/021446s028lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021446s028lbl.pdf|Name:PubMed, SrcID:21651903, URL:http://europepmc.org/abstract/MED/21651903",CC(C)C[C@H](CN)CC(=O)O,CHEMBL2363032,CACNG5
3430,CHEMBL1059,Pregabalin,Small molecule,2004.0,N03AX16,N03AX16 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],-gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:FDA, SrcID:label/2012/021446s028lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021446s028lbl.pdf|Name:PubMed, SrcID:21651903, URL:http://europepmc.org/abstract/MED/21651903",CC(C)C[C@H](CN)CC(=O)O,CHEMBL2363032,CACNG4
3431,CHEMBL1059,Pregabalin,Small molecule,2004.0,N03AX16,N03AX16 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],-gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:FDA, SrcID:label/2012/021446s028lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021446s028lbl.pdf|Name:PubMed, SrcID:21651903, URL:http://europepmc.org/abstract/MED/21651903",CC(C)C[C@H](CN)CC(=O)O,CHEMBL2363032,CACNG1
3432,CHEMBL1059,Pregabalin,Small molecule,2004.0,N03AX16,N03AX16 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],-gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:FDA, SrcID:label/2012/021446s028lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021446s028lbl.pdf|Name:PubMed, SrcID:21651903, URL:http://europepmc.org/abstract/MED/21651903",CC(C)C[C@H](CN)CC(=O)O,CHEMBL2363032,CACNB4
3433,CHEMBL1059,Pregabalin,Small molecule,2004.0,N03AX16,N03AX16 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],-gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:FDA, SrcID:label/2012/021446s028lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021446s028lbl.pdf|Name:PubMed, SrcID:21651903, URL:http://europepmc.org/abstract/MED/21651903",CC(C)C[C@H](CN)CC(=O)O,CHEMBL2363032,CACNA2D4
3434,CHEMBL1059,Pregabalin,Small molecule,2004.0,N03AX16,N03AX16 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],-gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:FDA, SrcID:label/2012/021446s028lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021446s028lbl.pdf|Name:PubMed, SrcID:21651903, URL:http://europepmc.org/abstract/MED/21651903",CC(C)C[C@H](CN)CC(=O)O,CHEMBL2363032,CACNG2
3435,CHEMBL1059,Pregabalin,Small molecule,2004.0,N03AX16,N03AX16 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],-gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:FDA, SrcID:label/2012/021446s028lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021446s028lbl.pdf|Name:PubMed, SrcID:21651903, URL:http://europepmc.org/abstract/MED/21651903",CC(C)C[C@H](CN)CC(=O)O,CHEMBL2363032,CACNG7
3436,CHEMBL1059,Pregabalin,Small molecule,2004.0,N03AX16,N03AX16 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],-gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:FDA, SrcID:label/2012/021446s028lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021446s028lbl.pdf|Name:PubMed, SrcID:21651903, URL:http://europepmc.org/abstract/MED/21651903",CC(C)C[C@H](CN)CC(=O)O,CHEMBL2363032,CACNG8
3437,CHEMBL1059,Pregabalin,Small molecule,2004.0,N03AX16,N03AX16 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],-gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:FDA, SrcID:label/2012/021446s028lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021446s028lbl.pdf|Name:PubMed, SrcID:21651903, URL:http://europepmc.org/abstract/MED/21651903",CC(C)C[C@H](CN)CC(=O)O,CHEMBL2363032,CACNG6
3438,CHEMBL1059,Pregabalin,Small molecule,2004.0,N03AX16,N03AX16 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],-gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:FDA, SrcID:label/2012/021446s028lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021446s028lbl.pdf|Name:PubMed, SrcID:21651903, URL:http://europepmc.org/abstract/MED/21651903",CC(C)C[C@H](CN)CC(=O)O,CHEMBL2363032,CACNA1F
3439,CHEMBL1059,Pregabalin,Small molecule,2004.0,N03AX16,N03AX16 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],-gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:FDA, SrcID:label/2012/021446s028lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021446s028lbl.pdf|Name:PubMed, SrcID:21651903, URL:http://europepmc.org/abstract/MED/21651903",CC(C)C[C@H](CN)CC(=O)O,CHEMBL2363032,CACNB1
3440,CHEMBL1059,Pregabalin,Small molecule,2004.0,N03AX16,N03AX16 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],-gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:FDA, SrcID:label/2012/021446s028lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021446s028lbl.pdf|Name:PubMed, SrcID:21651903, URL:http://europepmc.org/abstract/MED/21651903",CC(C)C[C@H](CN)CC(=O)O,CHEMBL2363032,CACNA2D3
3441,CHEMBL1201648,Amylase,Enzyme,1996.0,A09AA02,"A09AA02 [ALIMENTARY TRACT AND METABOLISM: DIGESTIVES, INCL. ENZYMES: DIGESTIVES, INCL. ENZYMES: Enzyme preparations]",-ase,Starch hydrolytic enzyme,Replaces digestive enzymes when pancreas is not fully functional; hydrolyses starches to dextrins and short chain sugars such as maltose and maltriose,,CHEMBL2364180,Starch,HYDROLYTIC ENZYME,Homo sapiens,OLIGOSACCHARIDE,,,"Name:DailyMed, SrcID:setid=073201aa-556d-4a70-918e-84e9616fd88d#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=073201aa-556d-4a70-918e-84e9616fd88d#nlm34090-1",,,
3442,CHEMBL2103877,Efinaconazole,Small molecule,2014.0,D01AC19,D01AC19 [DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Imidazole and triazole derivatives],-conazole,Lanosterol 14-alpha demethylase inhibitor,,,CHEMBL3307221,Lanosterol 14-alpha demethylase,INHIBITOR,Trichophyton rubrum (strain ATCC MYA-4607 / CBS 118892) (Athlete'sfoot fungus),SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2014/203567s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203567s000lbl.pdf",C[C@@H](N1CCC(=C)CC1)[C@](O)(Cn2cncn2)c3ccc(F)cc3F,,
3443,CHEMBL2108738,Nivolumab,Antibody,2015.0,L01XC17,L01XC17 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,Programmed cell death protein 1 inhibitor,,,CHEMBL3307223,Programmed cell death protein 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/125527s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125527s000lbl.pdf",,CHEMBL3307223,PDCD1
3444,CHEMBL2028019,Cariprazine,Small molecule,2015.0,N05AX15,N05AX15 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Other antipsychotics],,Dopamine D3 receptor modulator,Mixed antagonist/partial agonist,,CHEMBL234,Dopamine D3 receptor,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20093397, URL:http://europepmc.org/abstract/MED/20093397",CN(C)C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc(Cl)c3Cl)CC1,,
3445,CHEMBL3707331,Rolapitant,Small molecule,2015.0,A04AD14,A04AD14 [ALIMENTARY TRACT AND METABOLISM: ANTIEMETICS AND ANTINAUSEANTS: ANTIEMETICS AND ANTINAUSEANTS: Other antiemetics],-tant,Neurokinin 1 receptor antagonist,,,CHEMBL249,Neurokinin 1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=ed3ef3f8-8cb7-40db-9d75-e728ee607760, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ed3ef3f8-8cb7-40db-9d75-e728ee607760",C[C@@H](OC[C@]1(CC[C@]2(CCC(=O)N2)CN1)c3ccccc3)c4cc(cc(c4)C(F)(F)F)C(F)(F)F,CHEMBL249,TACR1
3446,CHEMBL3545243,As-703988,Small molecule,,,,,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,Non-competitive MEK1/2 inhibitor.,,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=714900, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=714900|Name:PubMed, SrcID:24434059, URL:http://europepmc.org/abstract/MED/24434059",,CHEMBL3587,MAP2K1
3447,CHEMBL571948,Y-39983,Small molecule,,,,,Rho-associated protein kinase inhibitor,,,CHEMBL2111459,Rho-associated protein kinase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:24872673, URL:http://europepmc.org/abstract/MED/24872673|Name:PubMed, SrcID:17591891, URL:http://europepmc.org/abstract/MED/17591891",C[C@@H](N)c1ccc(cc1)C(=O)Nc2ccnc3[nH]ccc23,,
3448,CHEMBL3545236,Bpi-9016,Small molecule,,,,,Hepatocyte growth factor receptor inhibitor,,,CHEMBL3717,Hepatocyte growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:ClinicalTrials, SrcID:NCT02478866, URL:https://www.clinicaltrials.gov/ct2/show/NCT02478866",,CHEMBL3717,MET
3449,CHEMBL3545272,Las190792,Small molecule,,,,,Muscarinic acetylcholine receptor M3 antagonist,Dual acting MABA (beta 2 adrenergic receptor agonists; Muscarinic receptor antagonists),,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.almirall.com/en/about-almirall/research-and-development/pipeline, URL:http://www.almirall.com/en/about-almirall/research-and-development/pipeline|Name:Other, SrcID:http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A3767, URL:http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A3767",,CHEMBL245,CHRM3
3450,CHEMBL3545332,Cep-2563,Small molecule,,,,,Tyrosine-protein kinase receptor RET inhibitor,,,CHEMBL2041,Tyrosine-protein kinase receptor RET,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:14500395, URL:http://europepmc.org/abstract/MED/14500395",,CHEMBL2041,RET
3451,CHEMBL457748,Mb07811,Small molecule,,,,,Thyroid hormone receptor beta-1 agonist,Ph2 study withdrawn. Prodrug of MB07344.,,CHEMBL1947,Thyroid hormone receptor beta-1,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23776891, URL:http://europepmc.org/abstract/MED/23776891",CC(C)c1cc(Cc2c(C)cc(OC[P@@]3(=O)OCC[C@H](O3)c4cccc(Cl)c4)cc2C)ccc1O,CHEMBL1947,THRB
3452,CHEMBL2104955,Becocalcidiol,Small molecule,,,,-calci-,Vitamin D receptor agonist,,,CHEMBL1977,Vitamin D receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.deltanoid.com/portfolio.php, URL:http://www.deltanoid.com/portfolio.php",CC[C@H](C)[C@H]1CC[C@H]2\C(=C\C=C3C[C@@H](O)C(=C)[C@H](O)C3)\CCC[C@]12C,CHEMBL1977,VDR
3453,CHEMBL574737,(7s)-Hydroxyl-Staurosporine,Small molecule,,,,,Protein kinase C (PKC) inhibitor,,,CHEMBL2093867,Protein kinase C (PKC),INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7907, URL:http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7907|Name:PubMed, SrcID:12892559, URL:http://europepmc.org/abstract/MED/12892559|Name:PubMed, SrcID:19568282, URL:http://europepmc.org/abstract/MED/19568282",CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n3c4ccccc4c5c6[C@H](O)NC(=O)c6c7c8ccccc8n2c7c35,,
3454,CHEMBL3545027,Xl-281,Small molecule,,,,,Serine/threonine-protein kinase RAF inhibitor,"Selectively targets RAF kinases including BRAF, RAF1 and the BRAF mutant (V600E) (http://www.exelixis.com/sites/default/files/pdf/XL281-001_ASCO-2009.pdf)",,CHEMBL1906,Serine/threonine-protein kinase RAF,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.exelixis.com/sites/default/files/pdf/XL281-001_ASCO-2009.pdf, URL:http://www.exelixis.com/sites/default/files/pdf/XL281-001_ASCO-2009.pdf|Name:PubMed, SrcID:25476894, URL:http://europepmc.org/abstract/MED/25476894|Name:Other, SrcID:http://annonc.oxfordjournals.org/content/18/suppl_4/iv29.full.pdf, URL:http://annonc.oxfordjournals.org/content/18/suppl_4/iv29.full.pdf|Name:PubMed, SrcID:23617957, URL:http://europepmc.org/abstract/MED/23617957",COC(=O)Nc1nc2cc(ccc2[nH]1)C3(O)N(C(=O)c4ccccc34)c5cc(Cl)ccc5C,CHEMBL1906,RAF1
3455,CHEMBL2103799,Cobiprostone,Small molecule,,,,-prost-,Chloride channel protein 2 activator,,,CHEMBL1628478,Chloride channel protein 2,ACTIVATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.ukmi.nhs.uk/applications/ndo/record_view_open.asp?newDrugID=4819, URL:http://www.ukmi.nhs.uk/applications/ndo/record_view_open.asp?newDrugID=4819|Name:PubMed, SrcID:23002337, URL:http://europepmc.org/abstract/MED/23002337",CC[C@H](C)CC(F)(F)[C@@]1(O)CC[C@@H]2[C@@H](CCCCCCC(=O)O)C(=O)C[C@H]2O1,CHEMBL1628478,CLCN2
3456,CHEMBL3039531,Danirixin,Small molecule,,,,-rixin,Interleukin-8 receptor B antagonist,,,CHEMBL2434,Interleukin-8 receptor B,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24504700, URL:http://europepmc.org/abstract/MED/24504700",Cc1c(F)cccc1NC(=O)Nc2ccc(Cl)c(c2O)S(=O)(=O)[C@H]3CCCNC3,CHEMBL2434,CXCR2
3457,CHEMBL592054,Imiglitazar,Small molecule,,,,-glitazar,Peroxisome proliferator-activated receptor gamma agonist,Development discontinued after Ph3 in 2005 due to abnormalities in liver enzyme tests (http://www.firstwordpharma.com/node/218757#axzz3OLRFCbFS3).,,CHEMBL235,Peroxisome proliferator-activated receptor gamma,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15219816, URL:http://europepmc.org/abstract/MED/15219816|Name:PubMed, SrcID:17884441, URL:http://europepmc.org/abstract/MED/17884441|Name:PubMed, SrcID:23721199, URL:http://europepmc.org/abstract/MED/23721199",Cc1oc(nc1COc2ccc(CO\N=C(/CCC(=O)O)\c3ccccc3)cc2)c4ccccc4,CHEMBL235,PPARG
3458,CHEMBL491473,Cediranib,Small molecule,,L01XE32,L01XE32 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-anib,Platelet-derived growth factor receptor inhibitor,,,CHEMBL2095189,Platelet-derived growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:15899831, URL:http://europepmc.org/abstract/MED/15899831",COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN5CCCC5,,
3459,CHEMBL608533,Midostaurin,Small molecule,,L01XE39,L01XE39 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],,Stem cell growth factor receptor inhibitor,Multi-kinase inhibitor,,CHEMBL1936,Stem cell growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16969355, URL:http://europepmc.org/abstract/MED/16969355|Name:PubMed, SrcID:12124173, URL:http://europepmc.org/abstract/MED/12124173",CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)n3c4ccccc4c5c6CNC(=O)c6c7c8ccccc8n2c7c35)N(C)C(=O)c9ccccc9,CHEMBL1936,KIT
3460,CHEMBL1366933,Esmirtazapine,Small molecule,,,,-pin(e),Histamine H1 receptor antagonist,Discontinued(strategic reasons),,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21246188, URL:http://europepmc.org/abstract/MED/21246188|Name:PubMed, SrcID:26047892, URL:http://europepmc.org/abstract/MED/26047892",CN1CCN2[C@H](C1)c3ccccc3Cc4cccnc24,CHEMBL231,HRH1
3461,CHEMBL2108887,Afelimomab,Antibody,,L04AB03,L04AB03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Tumor necrosis factor alpha (TNF-&alpha;) inhibitors],-mab,TNF-alpha inhibitor,Reduces the concentration of interleukin-6 in serum.,,CHEMBL1825,TNF-alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11373466, URL:http://europepmc.org/abstract/MED/11373466",,CHEMBL1825,TNF
3462,CHEMBL431770,Istradefylline,Small molecule,,,,-fylline,Adenosine A2a receptor antagonist,,,CHEMBL251,Adenosine A2a receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26415982, URL:http://europepmc.org/abstract/MED/26415982",CCN1C(=O)N(CC)c2nc(\C=C\c3ccc(OC)c(OC)c3)n(C)c2C1=O,CHEMBL251,ADORA2A
3463,CHEMBL260046,Evofosfamide,Small molecule,,,,-fosfamide,DNA inhibitor,"Activated by a process that involves a 1-electron reduction mediated by ubiquitous cellular reductases to generate a radical anion prodrug (RP). When exposed to severe hypoxic conditions (<0.5% O2), the RP can either fragment directly or undergo further reduction at the nitroimidazole site of the prodrug, leading to fragmentation and the release of Bromo isophosphoramide mustard (Br-IPM), a potent DNA alkylating agent",,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:PubMed, SrcID:21415214, URL:http://europepmc.org/abstract/MED/21415214",Cn1c(COP(=O)(NCCBr)NCCBr)cnc1[N+](=O)[O-],,
3464,CHEMBL1200706,Aluminum Hydroxide,Small molecule,1983.0,A02AB01,A02AB01 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: ANTACIDS: Aluminium compounds],,Unknown,,,,,,,,,,,[OH-].[OH-].[OH-].[Al+3],,
3465,CHEMBL3545223,Gw493838,Small molecule,,,,,Adenosine A1 receptor agonist,,,CHEMBL226,Adenosine A1 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,,,CHEMBL226,ADORA1
3466,CHEMBL3544940,G1t28-1,Small molecule,,,,,Cyclin-dependent kinase 6 inhibitor,,,CHEMBL2508,Cyclin-dependent kinase 6,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,,,CHEMBL2508,CDK6
3467,CHEMBL3545300,Cp-459632,Small molecule,,,,,Tyrosine-protein kinase receptor Tie-1 inhibitor,No references found,,CHEMBL5274,Tyrosine-protein kinase receptor Tie-1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,,,CHEMBL5274,TIE1
3468,CHEMBL1200959,Methdilazine,Small molecule,1982.0,R06AD04,R06AD04 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Phenothiazine derivatives],-dil-,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Methdilazine, URL:http://en.wikipedia.org/wiki/Methdilazine|Name:PubMed, SrcID:19790517, URL:http://europepmc.org/abstract/MED/19790517",CN1CCC(CN2c3ccccc3Sc4ccccc24)C1,CHEMBL231,HRH1
3469,CHEMBL1085,Acetophenazine,Small molecule,1961.0,N05AB07,N05AB07 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Phenothiazines with piperazine structure],,Dopamine D2 receptor antagonist,,,CHEMBL217,Dopamine D2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11873706, URL:http://europepmc.org/abstract/MED/11873706|Name:PubMed, SrcID:6147851, URL:http://europepmc.org/abstract/MED/6147851|Name:Wikipedia, SrcID:Antipsychotic#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Antipsychotic#Mechanism_of_action",CC(=O)c1ccc2Sc3ccccc3N(CCCN4CCN(CCO)CC4)c2c1,CHEMBL217,DRD2
3470,CHEMBL1201589,Omalizumab,Antibody,2003.0,R03DX05,R03DX05 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: Other systemic drugs for obstructive airway diseases],-mab,Ig epsilon chain C region inhibitor,Should be protein complex but not trivial to define,,CHEMBL1834,Ig epsilon chain C region,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=7f6a2191-adfb-48b9-9bfa-0d9920479f0d, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7f6a2191-adfb-48b9-9bfa-0d9920479f0d|Name:PubMed, SrcID:11704611, URL:http://europepmc.org/abstract/MED/11704611",,CHEMBL1834,IGHE
3471,CHEMBL1290,Penbutolol,Small molecule,1987.0,C07AA23,"C07AA23 [CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, non-selective]",-olol,Beta-1 adrenergic receptor antagonist,,,CHEMBL213,Beta-1 adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=d241fc80-2c55-4dbb-bdb2-44f731afa137, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d241fc80-2c55-4dbb-bdb2-44f731afa137|Name:FDA, SrcID:label/2011/018976s012lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018976s012lbl.pdf",CC(C)(C)NC[C@H](O)COc1ccccc1C2CCCC2,,
3472,CHEMBL631,Propafenone,Small molecule,1989.0,C01BC03,"C01BC03 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class Ic]",-afenone,Beta-1 adrenergic receptor antagonist,,,CHEMBL213,Beta-1 adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=d4a552ce-f215-4ec7-b5dd-aee266ba9b08, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d4a552ce-f215-4ec7-b5dd-aee266ba9b08",CCCNCC(O)COc1ccccc1C(=O)CCc2ccccc2,,
3473,CHEMBL3039582,Secretin,Protein,2002.0,V04CK01,V04CK01 [VARIOUS: DIAGNOSTIC AGENTS: OTHER DIAGNOSTIC AGENTS: Tests for pancreatic function],-retin,Secretin receptor agonist,,,CHEMBL1925,Secretin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=b4dfe70f-0a86-4488-9ba1-dcd8f86cbfcd, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b4dfe70f-0a86-4488-9ba1-dcd8f86cbfcd",CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc2cnc[nH]2)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N,CHEMBL1925,SCTR
3474,CHEMBL1201621,Somatropin,Protein,1976.0,H01AC01,"H01AC01 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES: Somatropin and somatropin agonists]",som-,Growth hormone receptor agonist,It's a recombinant protein approved for the treatment of growth hormone deficiency,,CHEMBL1976,Growth hormone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=ffebf88b-d257-4542-9808-74d9b7167765, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ffebf88b-d257-4542-9808-74d9b7167765|Name:ISBN, SrcID:9780702034718 PP. 396, URL:http://www.isbnsearch.org/isbn/9780702034718",,CHEMBL1976,GHR
3475,CHEMBL719,Mupirocin,Small molecule,1987.0,R01AX06; D06AX09,R01AX06 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Other nasal preparations]; D06AX09 [DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: ANTIBIOTICS FOR TOPICAL USE: Other antibiotics for topical use],-rocin,Isoleucyl-tRNA synthetase inhibitor,,,CHEMBL1982,Isoleucyl-tRNA synthetase,INHIBITOR,Staphylococcus aureus,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=9257f9cd-abaf-4bb2-d9ac-4bc8f65ae558, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9257f9cd-abaf-4bb2-d9ac-4bc8f65ae558",C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]2CO[C@@H](C\C(=C\C(=O)OCCCCCCCCC(=O)O)\C)[C@H](O)[C@@H]2O,,
3476,CHEMBL1065,Methysergide,Small molecule,1962.0,N02CA04,N02CA04 [NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Ergot alkaloids],-erg-,Serotonin 2c (5-HT2c) receptor antagonist,,,CHEMBL225,Serotonin 2c (5-HT2c) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 199, URL:http://www.isbnsearch.org/isbn/9780702034718",CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2Cc3cn(C)c4cccc(C2=C1)c34,,
3477,CHEMBL1201129,Decitabine,Small molecule,2006.0,L01BC08,L01BC08 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Pyrimidine analogues],-citabine,DNA (cytosine-5)-methyltransferase 1 inhibitor,,,CHEMBL1993,DNA (cytosine-5)-methyltransferase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13|Name:Wikipedia, SrcID:DNA_methylation, URL:http://en.wikipedia.org/wiki/DNA_methylation",NC1=NC(=O)N(C=N1)[C@H]2C[C@H](O)[C@@H](CO)O2,CHEMBL1993,DNMT1
3478,CHEMBL1201010,Fludrocortisone Acetate,Small molecule,1955.0,H02AA02,"H02AA02 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Mineralocorticoids]",-cort-,Mineralocorticoid receptor agonist,,,CHEMBL1994,Mineralocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Glucocorticoid, URL:http://en.wikipedia.org/wiki/Glucocorticoid|Name:PubMed, SrcID:17132855, URL:http://europepmc.org/abstract/MED/17132855",CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C,,
3479,CHEMBL1200908,Halobetasol Propionate,Small molecule,1990.0,D07AC21,"D07AC21 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, potent (group III)]",,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:9891987, URL:http://europepmc.org/abstract/MED/9891987|Name:PubMed, SrcID:19293512, URL:http://europepmc.org/abstract/MED/19293512",CCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CCl,CHEMBL2034,NR3C1
3480,CHEMBL20,Acetazolamide,Small molecule,1953.0,S01EC01,S01EC01 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Carbonic anhydrase inhibitors],-zolamide,Carbonic anhydrase XII inhibitor,Expressed in eye,,CHEMBL3242,Carbonic anhydrase XII,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18336310, URL:http://europepmc.org/abstract/MED/18336310",CC(=O)Nc1nnc(s1)S(=O)(=O)N,CHEMBL3242,CA12
3481,CHEMBL707,Doxazosin,Small molecule,1990.0,C02CA04,"C02CA04 [CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING: Alpha-adrenoreceptor antagonists]",-azosin,Adrenergic receptor alpha-1 antagonist,,,CHEMBL2094251,Adrenergic receptor alpha-1,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:Wikipedia, SrcID:Doxazosin, URL:http://en.wikipedia.org/wiki/Doxazosin|Name:DailyMed, SrcID:setid=eefc47bc-c10f-49bb-8ef7-5999f798ab39, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eefc47bc-c10f-49bb-8ef7-5999f798ab39",COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4COc5ccccc5O4,,
3482,CHEMBL626,Naftifine,Small molecule,1988.0,D01AE22,D01AE22 [DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Other antifungals for topical use],,Squalene monooxygenase inhibitor,,,CHEMBL2364679,Squalene monooxygenase,INHIBITOR,Trichophyton,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f4b6c5d8-615c-47d6-8ad9-523c7ab146af, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f4b6c5d8-615c-47d6-8ad9-523c7ab146af",CN(C\C=C\c1ccccc1)Cc2cccc3ccccc23,,
3483,CHEMBL1237023,Denosumab,Antibody,2010.0,M05BX04,M05BX04 [MUSCULO-SKELETAL SYSTEM: DRUGS FOR TREATMENT OF BONE DISEASES: DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION: Other drugs affecting bone structure and mineralization],-mab,Tumor necrosis factor ligand superfamily member 11 inhibitor,,,CHEMBL2364162,Tumor necrosis factor ligand superfamily member 11,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=49e5afe9-a0c7-40c4-af9f-f287a80c5c88, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=49e5afe9-a0c7-40c4-af9f-f287a80c5c88",,CHEMBL2364162,TNFSF11
3484,CHEMBL1231,Oxybutynin,Small molecule,1975.0,G04BD04,G04BD04 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Drugs for urinary frequency and incontinence],,Muscarinic acetylcholine receptor M2 antagonist,"Indicated for overactive bladder, M2 likely responsible",,CHEMBL211,Muscarinic acetylcholine receptor M2,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 160, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:16188951, URL:http://europepmc.org/abstract/MED/16188951|Name:PubMed, SrcID:17222678, URL:http://europepmc.org/abstract/MED/17222678|Name:PubMed, SrcID:15963006, URL:http://europepmc.org/abstract/MED/15963006|Name:PubMed, SrcID:20590605, URL:http://europepmc.org/abstract/MED/20590605",CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c2ccccc2,CHEMBL211,CHRM2
3485,CHEMBL1201576,Rituximab,Antibody,1997.0,L01XC02,L01XC02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,B-lymphocyte antigen CD20 inhibitor,,,CHEMBL2058,B-lymphocyte antigen CD20,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=b172773b-3905-4a1c-ad95-bab4b6126563, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b172773b-3905-4a1c-ad95-bab4b6126563",,CHEMBL2058,MS4A1
3486,CHEMBL1200969,Dutasteride,Small molecule,2001.0,G04CB02,G04CB02 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY: Testosterone-5-alpha reductase inhibitors],-steride,Steroid 5-alpha-reductase inhibitor,,,CHEMBL2363075,Steroid 5-alpha-reductase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=dc330e70-a1d3-400b-3aaf-46067e3fd090, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dc330e70-a1d3-400b-3aaf-46067e3fd090",C[C@]12CC[C@H]3[C@@H](CC[C@H]4NC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2C(=O)Nc5cc(ccc5C(F)(F)F)C(F)(F)F,CHEMBL2363075,SRD5A3
3487,CHEMBL1200937,Dalfopristin,Small molecule,1999.0,,,-pristin,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,23S ribosomal RNA,23S RRNA,"Name:DailyMed, SrcID:setid=28f698df-b584-4455-2e94-6efc41313960, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=28f698df-b584-4455-2e94-6efc41313960|Name:PubMed, SrcID:15991995, URL:http://europepmc.org/abstract/MED/15991995",CCN(CC)CCS(=O)(=O)[C@@H]1CCN2[C@H]1C(=O)O[C@H](C(C)C)[C@H](C)\C=C\C(=O)NC\C=C\C(=C\[C@@H](O)CC(=O)Cc3occ(n3)C2=O)\C,,
3488,CHEMBL1103,Furazolidone,Small molecule,1958.0,G01AX06,"G01AX06 [GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Other antiinfectives and antiseptics]",,DNA inhibitor,Promotes inter-strand DNA cross-linking,,CHEMBL2364041,DNA,INHIBITOR,Bacteria,NUCLEIC-ACID,,,"Name:PubMed, SrcID:535918, URL:http://europepmc.org/abstract/MED/535918|Name:PubMed, SrcID:7870098, URL:http://europepmc.org/abstract/MED/7870098",[O-][N+](=O)c1oc(\C=N\N2CCOC2=O)cc1,,
3489,CHEMBL640,Procainamide,Small molecule,1950.0,C01BA02,"C01BA02 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class Ia]",,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:ISBN, SrcID:9780702034718 PP. 255, URL:http://www.isbnsearch.org/isbn/9780702034718",CCN(CC)CCNC(=O)c1ccc(N)cc1,,
3490,CHEMBL1738990,Levopropoxyphene,Small molecule,1962.0,,,,Unknown,Antitussive drug; probable action in the CNS cough centre,,,,,,,,,"Name:PubMed, SrcID:1530004, URL:http://europepmc.org/abstract/MED/1530004|Name:PubMed, SrcID:15491779, URL:http://europepmc.org/abstract/MED/15491779",CCC(=O)O[C@](Cc1ccccc1)([C@@H](C)CN(C)C)c2ccccc2,,
3491,CHEMBL1200747,Ammonium Lactate,Small molecule,1985.0,,,-ium,Unknown,,,,,,,,,,"Name:FDA, SrcID:label/2007/019155s022lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/019155s022lbl.pdf",[NH4+].CC(O)C(=O)[O-],,
3492,CHEMBL296306,Lactitol,Small molecule,1976.0,A06AD12,A06AD12 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR CONSTIPATION: DRUGS FOR CONSTIPATION: Osmotically acting laxatives],,Colonic bacteria substrate,Increases water content in the colon,,,,,,,,,"Name:DailyMed, SrcID:setid=461ec39f-eeb4-4460-9b5c-62367d47162b#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=461ec39f-eeb4-4460-9b5c-62367d47162b#nlm34090-1|Name:PubMed, SrcID:21856402, URL:http://europepmc.org/abstract/MED/21856402",OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,
3493,CHEMBL2096629,Prussian Blue Insoluble,Small molecule,2003.0,V03AB31,V03AB31 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Antidotes],,Radioactive metals chelating agent,Scavenge of radioactive and non-radioactive cesium and thalium,,CHEMBL2366037,Radioactive metals,CHELATING AGENT,,METAL,,,"Name:FDA, SrcID:label/2008/021626s007lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021626s007lbl.pdf",,,
3494,CHEMBL514800,Apremilast,Small molecule,2014.0,L04AA32,L04AA32 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Selective immunosuppressants],-ast,Phosphodiesterase 4 inhibitor,,Selective,CHEMBL2093863,Phosphodiesterase 4,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=3acf6751-827d-11e2-9e96-0800200c9a66#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3acf6751-827d-11e2-9e96-0800200c9a66#nlm34090-1",CCOc1cc(ccc1OC)[C@@H](CS(=O)(=O)C)N2C(=O)c3cccc(NC(=O)C)c3C2=O,,
3495,CHEMBL1183349,Isavuconazonium,Small molecule,2015.0,,,-ium,Lanosterol 14-alpha demethylase inhibitor,,,CHEMBL3390824,Lanosterol 14-alpha demethylase,INHIBITOR,Aspergillus,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/207500s001,207501s001lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207500s001,207501s001lbl.pdf",CNCC(=O)OCc1cccnc1N(C)C(=O)OC(C)[n+]2cnn(C[C@@](O)([C@@H](C)c3nc(cs3)c4ccc(cc4)C#N)c5cc(F)ccc5F)c2,,
3496,CHEMBL3039537,Sebelipase Alfa,Enzyme,2015.0,A16AB14,A16AB14 [ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Enzymes],-ase,Triglyceride hydrolytic enzyme,,,CHEMBL3559389,Triglyceride,HYDROLYTIC ENZYME,,LIPID,,,"Name:FDA, SrcID:label/2015/125561s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125561s000lbl.pdf",,,
3497,CHEMBL3545160,Su-14813,Small molecule,,,,,Vascular endothelial growth factor receptor inhibitor,,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:16891463, URL:http://europepmc.org/abstract/MED/16891463",,,
3498,CHEMBL456237,Lxr-623,Small molecule,,,,,LXR-beta agonist,"project terminated in 2007, reason quoted as ""unfavorable profile for further development"" (http://www.karobio.com/investormedia/pressreleaser/pressrelease?pid=3005162)",,CHEMBL4093,LXR-beta,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19398602, URL:http://europepmc.org/abstract/MED/19398602|Name:PubMed, SrcID:24833295, URL:http://europepmc.org/abstract/MED/24833295",Fc1ccc(cc1)c2c3cccc(c3nn2Cc4ccc(F)cc4Cl)C(F)(F)F,CHEMBL4093,NR1H2
3499,CHEMBL3545240,Clx-0921,Small molecule,,,,,Peroxisome proliferator-activated receptor gamma agonist,"According to reports, Ph1 trial was completed but can't find trial ID or any further planned trials. Discontinued",,CHEMBL235,Peroxisome proliferator-activated receptor gamma,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12898466, URL:http://europepmc.org/abstract/MED/12898466|Name:PubMed, SrcID:11569941, URL:http://europepmc.org/abstract/MED/11569941",,CHEMBL235,PPARG
3500,CHEMBL3545051,Cep-37440,Small molecule,,,,,ALK tyrosine kinase receptor inhibitor,,,CHEMBL4247,ALK tyrosine kinase receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1158/1538-7445.AM2015-3232, URL:http://cancerres.aacrjournals.org/content/75/15_Supplement/3232|Name:PubMed, SrcID:25888090, URL:http://europepmc.org/abstract/MED/25888090|Name:PubMed, SrcID:25322323, URL:http://europepmc.org/abstract/MED/25322323",,CHEMBL4247,ALK
3501,CHEMBL3545195,Ly-3009120,Small molecule,,,,,Serine/threonine-protein kinase A-Raf inhibitor,,,CHEMBL1169596,Serine/threonine-protein kinase A-Raf,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25965804, URL:http://europepmc.org/abstract/MED/25965804",,CHEMBL1169596,ARAF
3502,CHEMBL1230122,R-1487,Small molecule,,,,,MAP kinase p38 alpha inhibitor,,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21375264, URL:http://europepmc.org/abstract/MED/21375264",CN1C(=O)C(=Cc2cnc(NC3CCOCC3)nc12)Oc4ccc(F)cc4F,CHEMBL260,MAPK14
3503,CHEMBL3545083,Rgb-286638,Small molecule,,,,,Cyclin-dependent kinase 1 inhibitor,,,CHEMBL308,Cyclin-dependent kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23807770, URL:http://europepmc.org/abstract/MED/23807770",COCCN1CCN(Cc2ccc(cc2)c3n[nH]c4c5cccc(NC(=O)NN6CCOCC6)c5C(=O)c34)CC1,CHEMBL308,CDK1
3504,CHEMBL3544934,X-396,Small molecule,,,,,ALK tyrosine kinase receptor inhibitor,,,CHEMBL4247,ALK tyrosine kinase receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25322323, URL:http://europepmc.org/abstract/MED/25322323|Name:Other, SrcID:http://www.xcovery.com/our-science/alk-inhibitor/, URL:http://www.xcovery.com/our-science/alk-inhibitor/",,CHEMBL4247,ALK
3505,CHEMBL1206245,Briciclib,Small molecule,,,,-ciclib,G1/S-specific cyclin D1 inhibitor,Prodrug of ON-013100,,CHEMBL3610,G1/S-specific cyclin D1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23124440, URL:http://europepmc.org/abstract/MED/23124440|Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=664346, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=664346",COc1cc(OC)c(\C=C\S(=O)(=O)Cc2ccc(OC)c(OP(=O)(O)O)c2)c(OC)c1,CHEMBL3610,CCND1
3506,CHEMBL1980391,Rg-1530,Small molecule,,,,,Serine/threonine-protein kinase PLK4 inhibitor,Multi-targeted kinase inhibitor,,CHEMBL3788,Serine/threonine-protein kinase PLK4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21553286, URL:http://europepmc.org/abstract/MED/21553286|Name:PubMed, SrcID:24900658, URL:http://europepmc.org/abstract/MED/24900658",COc1cc2Nc3n[nH]c(C)c3N=C(c4ccccc4Cl)c2cc1F,CHEMBL3788,PLK4
3507,CHEMBL3545019,Mbx-8025,Small molecule,,,,,Peroxisome proliferator-activated receptor delta agonist,,,CHEMBL3979,Peroxisome proliferator-activated receptor delta,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:MBX-8025, URL:http://en.wikipedia.org/wiki/MBX-8025|Name:Other, SrcID:http://www.cymabay.com/pipeline_mbx8025.html, URL:http://www.cymabay.com/pipeline_mbx8025.html|Name:PubMed, SrcID:21752880, URL:http://europepmc.org/abstract/MED/21752880",Cc1cc(SCc2nn(nc2C)c3ccc(cc3)C(F)(F)F)ccc1OCC(=O)O,CHEMBL3979,PPARD
3508,CHEMBL605525,Dp001,Small molecule,,,,,Vitamin D receptor agonist,,,CHEMBL1977,Vitamin D receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12374862, URL:http://europepmc.org/abstract/MED/12374862|Name:Other, SrcID:http://www.deltanoid.com/portfolio.php, URL:http://www.deltanoid.com/portfolio.php",C[C@@H](CCCC(C)(C)O)[C@H]1CC[C@H]2\C(=C\C=C3C[C@@H](O)C(=C)[C@H](O)C3)\CCC[C@]12C,CHEMBL1977,VDR
3509,CHEMBL2103851,Amuvatinib,Small molecule,,,,-tinib,Platelet-derived growth factor receptor alpha inhibitor,"Inhibits mutant forms of KIT, FLT3 and PDGFRA (http://www.google.com/patents/US20080226747).",,CHEMBL2007,Platelet-derived growth factor receptor alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25110867, URL:http://europepmc.org/abstract/MED/25110867|Name:Other, SrcID:http://www.google.com/patents/US20080226747, URL:http://www.google.com/patents/US20080226747|Name:PubMed, SrcID:24326130, URL:http://europepmc.org/abstract/MED/24326130",S=C(NCc1ccc2OCOc2c1)N3CCN(CC3)c4ncnc5c4oc6ccccc56,CHEMBL2007,PDGFRA
3510,CHEMBL3545033,Ly2828360,Small molecule,,,,,Cannabinoid CB2 receptor agonist,"Phase 2 study in 2012 completed, no further studies recorded.",,CHEMBL253,Cannabinoid CB2 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.ncats.nih.gov/files/LY2828360.pdf, URL:http://www.ncats.nih.gov/files/LY2828360.pdf",,CHEMBL253,CNR2
3511,CHEMBL3183740,Trelanserin,Small molecule,,,,-anserin,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10996601, URL:http://europepmc.org/abstract/MED/10996601|Name:PubMed, SrcID:11504649, URL:http://europepmc.org/abstract/MED/11504649",NC(=O)CN1C(=O)C=C(CCN2CCN(CC2)c3nccc4sccc34)c5ccc(F)cc15,CHEMBL224,HTR2A
3512,CHEMBL41194,Pratosartan,Small molecule,,,,-sartan,Type-1 angiotensin II receptor antagonist,,,CHEMBL227,Type-1 angiotensin II receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1016/S0960-894X(00)80018-9, URL:http://www.sciencedirect.com/science/article/pii/S0960894X00800189",CCCc1nc2CCCCC(=O)c2n1Cc3ccc(cc3)c4ccccc4c5nn[nH]n5,CHEMBL227,AGTR1
3513,CHEMBL1258006,Bradanicline,Small molecule,,,,-nicline,Neuronal acetylcholine receptor protein alpha-7 subunit agonist,,,CHEMBL2492,Neuronal acetylcholine receptor protein alpha-7 subunit,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19482012, URL:http://europepmc.org/abstract/MED/19482012|Name:PubMed, SrcID:23126648, URL:http://europepmc.org/abstract/MED/23126648",O=C(N[C@@H]1C2CCN(CC2)[C@H]1Cc3cccnc3)c4oc5ccccc5c4,CHEMBL2492,CHRNA7
3514,CHEMBL3544913,Raxatrigine,Small molecule,,,,,Sodium channel protein type IX alpha subunit blocker,,,CHEMBL4296,Sodium channel protein type IX alpha subunit,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.convergencepharma.com/index.asp?page_id=14, URL:http://www.convergencepharma.com/index.asp?page_id=14|Name:PubMed, SrcID:25060923, URL:http://europepmc.org/abstract/MED/25060923",NC(=O)[C@@H]1CC[C@@H](N1)c2ccc(OCc3ccccc3F)cc2,CHEMBL4296,SCN9A
3515,CHEMBL3353410,Osimertinib,Small molecule,2015.0,L01XE35,L01XE35 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Epidermal growth factor receptor erbB1 inhibitor,"Irreversible inhibitor, selective for EGFR-TKI sensitizing and resistance T790M mutations",,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24893891, URL:http://europepmc.org/abstract/MED/24893891|Name:PubMed, SrcID:25271963, URL:http://europepmc.org/abstract/MED/25271963",COc1cc(N(C)CCN(C)C)c(NC(=O)C=C)cc1Nc2nccc(n2)c3cn(C)c4ccccc34,CHEMBL203,EGFR
3516,CHEMBL2146883,Cobimetinib,Small molecule,2015.0,L01XE38,L01XE38 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,Approved in Switzerland 2015 for use in combination with vemurafenib as a treatment for patients with advanced melanoma.,,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22496205, URL:http://europepmc.org/abstract/MED/22496205|Name:DailyMed, SrcID:setid=c387579e-cee0-4334-bd1e-73f93ac1bde6, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c387579e-cee0-4334-bd1e-73f93ac1bde6|Name:PubMed, SrcID:22084396, URL:http://europepmc.org/abstract/MED/22084396",OC1(CN(C1)C(=O)c2ccc(F)c(F)c2Nc3ccc(I)cc3F)[C@@H]4CCCCN4,CHEMBL2964,MAP2K2
3517,CHEMBL274654,Orantinib,Small molecule,,,,-tinib,Platelet-derived growth factor receptor inhibitor,"Ph 3 trial discontinued, compound on hold?",,CHEMBL2095189,Platelet-derived growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:10945623, URL:http://europepmc.org/abstract/MED/10945623",Cc1[nH]c(\C=C\2/C(=O)Nc3ccccc23)c(C)c1CCC(=O)O,,
3518,CHEMBL1743035,Lebrikizumab,Antibody,,,,-mab,Interleukin-13 inhibitor,,,CHEMBL3580486,Interleukin-13,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23357170, URL:http://europepmc.org/abstract/MED/23357170",,,
3519,CHEMBL2108041,Ocrelizumab,Antibody,2017.0,L04AA36,L04AA36 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Selective immunosuppressants],-mab,B-lymphocyte antigen CD20 other,"Humanized monoclonal antibody designed to target CD20-positive B cells, which are implicated in the inflammatory and neurodegenerative processes of multiple sclerosis. By targeting CD20-positive B cells, this molecule depletes (antibody-dependent cell-mediated cytotoxicity) pre-B cells and mature B cells without affecting plasma cells or progenitor cells in the bone marrow.",,CHEMBL2058,B-lymphocyte antigen CD20,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26788130, URL:http://europepmc.org/abstract/MED/26788130",,CHEMBL2058,MS4A1
3520,CHEMBL3137349,Bococizumab,Antibody,,,,-mab,Subtilisin/kexin type 9 inhibitor,"PCSK9 causes the degradation of LDLR, then inhibiting PCSK9 would mean prolonging the lifespan of LDLR, which would lead to drastic reductions in plasma LDL-C levels.",,CHEMBL2929,Subtilisin/kexin type 9,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25712137, URL:http://europepmc.org/abstract/MED/25712137|Name:PubMed, SrcID:25784512, URL:http://europepmc.org/abstract/MED/25784512",,CHEMBL2929,PCSK9
3521,CHEMBL1186894,Amrubicin,Small molecule,,L01DB10,L01DB10 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES: Anthracyclines and related substances],-rubicin,DNA topoisomerase II alpha inhibitor,"Intercalates into DNA and inhibits the activity of topoisomerase II, resulting in inhibition of DNA replication.",,CHEMBL1806,DNA topoisomerase II alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26750506, URL:http://europepmc.org/abstract/MED/26750506",CC(=O)[C@@]1(N)C[C@H](O[C@H]2C[C@H](O)[C@H](O)CO2)c3c(O)c4C(=O)c5ccccc5C(=O)c4c(O)c3C1,CHEMBL1806,TOP2A
3522,CHEMBL2108401,Enlimomab Pegol,Antibody,,,,-mab,Intercellular adhesion molecule-1 antagonist,It attenuates T cell and neutrophil emigration and tissue effector functions by blocking their adhesion to the vascular endothelium through ICAM1.,,CHEMBL3070,Intercellular adhesion molecule-1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:9973515, URL:http://europepmc.org/abstract/MED/9973515",,CHEMBL3070,ICAM1
3523,CHEMBL2109321,Trc-105,Antibody,,,,,Endoglin inhibitor,Induces antibody-dependent cellular cytotoxicity (ADCC) and apoptosis of CD105 (Endoglin)-positive tumour cells.,,CHEMBL3712885,Endoglin,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22767667, URL:http://europepmc.org/abstract/MED/22767667",,CHEMBL3712885,ENG
3524,CHEMBL2109457,Ligelizumab,Antibody,,,,-mab,Ig epsilon chain C region inhibitor,,,CHEMBL1834,Ig epsilon chain C region,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25200415, URL:http://europepmc.org/abstract/MED/25200415",,CHEMBL1834,IGHE
3525,CHEMBL168815,Cevimeline,Small molecule,2000.0,N07AX03,N07AX03 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: PARASYMPATHOMIMETICS: Other parasympathomimetics],-meline,Muscarinic acetylcholine receptor M3 agonist,"Role in regulating gastric secretion, M3 likely involved",,CHEMBL245,Muscarinic acetylcholine receptor M3,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:23629427, URL:http://europepmc.org/abstract/MED/23629427|Name:DailyMed, SrcID:setid=773a19e8-4c3e-4414-99a6-aea98c9790ee#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=773a19e8-4c3e-4414-99a6-aea98c9790ee#nlm34090-1",CC1OC2(CS1)CN3CCC2CC3,CHEMBL245,CHRM3
3526,CHEMBL2103749,Bivalirudin,Protein,2000.0,B01AE06,B01AE06 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Direct thrombin inhibitors],-irudin,Thrombin inhibitor,,,CHEMBL204,Thrombin,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=799d3b00-809b-4abc-989c-05faccec49f8, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=799d3b00-809b-4abc-989c-05faccec49f8",CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]3CCCN3C(=O)[C@H](N)Cc4ccccc4)C(=O)N5CCC[C@H]5C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc6ccc(O)cc6)C(=O)N[C@@H](CC(C)C)C(=O)O,CHEMBL204,F2
3527,CHEMBL1009,Levodopa,Small molecule,1970.0,N04BA01,N04BA01 [NERVOUS SYSTEM: ANTI-PARKINSON DRUGS: DOPAMINERGIC AGENTS: Dopa and dopa derivatives],-dopa,Dopamine D3 receptor agonist,,,CHEMBL234,Dopamine D3 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=3c768639-8a70-4d12-ad93-827bb42ec6b7, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3c768639-8a70-4d12-ad93-827bb42ec6b7|Name:PubMed, SrcID:9633680, URL:http://europepmc.org/abstract/MED/9633680|Name:Wikipedia, SrcID:Levodopa#Biological_role, URL:http://en.wikipedia.org/wiki/Levodopa#Biological_role|Name:PubMed, SrcID:11978145, URL:http://europepmc.org/abstract/MED/11978145|Name:PubMed, SrcID:18549347, URL:http://europepmc.org/abstract/MED/18549347",N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O,,
3528,CHEMBL1201255,Histrelin,Protein,1991.0,L02AE05,L02AE05 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONES AND RELATED AGENTS: Gonadotropin releasing hormone analogues],-relin,Gonadotropin-releasing hormone receptor agonist,,,CHEMBL1855,Gonadotropin-releasing hormone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=d8fb000e-3cc9-4803-b71d-2cc597661977, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d8fb000e-3cc9-4803-b71d-2cc597661977",CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2cn(Cc3ccccc3)cn2)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CO)NC(=O)[C@H](Cc5c[nH]c6ccccc56)NC(=O)[C@H](Cc7cnc[nH]7)NC(=O)[C@@H]8CCC(=O)N8,CHEMBL1855,GNRHR
3529,CHEMBL168815,Cevimeline,Small molecule,2000.0,N07AX03,N07AX03 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: PARASYMPATHOMIMETICS: Other parasympathomimetics],-meline,Muscarinic acetylcholine receptor M1 agonist,"Role in regulating gastric secretion, M1 likely involved",,CHEMBL216,Muscarinic acetylcholine receptor M1,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:23629427, URL:http://europepmc.org/abstract/MED/23629427|Name:DailyMed, SrcID:setid=773a19e8-4c3e-4414-99a6-aea98c9790ee#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=773a19e8-4c3e-4414-99a6-aea98c9790ee#nlm34090-1",CC1OC2(CS1)CN3CCC2CC3,CHEMBL216,CHRM1
3530,CHEMBL524004,Mepenzolate,Small molecule,1956.0,A03AB12,"A03AB12 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: Synthetic anticholinergics, quaternary ammonium compounds]",,Muscarinic acetylcholine receptor M1 antagonist,"Role in regulating gastric secretion, M1 likely involved",,CHEMBL216,Muscarinic acetylcholine receptor M1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:7122991, URL:http://europepmc.org/abstract/MED/7122991|Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:6345649, URL:http://europepmc.org/abstract/MED/6345649",C[N+]1(C)CCCC(C1)OC(=O)C(O)(c2ccccc2)c3ccccc3,CHEMBL216,CHRM1
3531,CHEMBL1201227,Cycrimine,Small molecule,1982.0,,,,Muscarinic acetylcholine receptor M1 antagonist,"Indicated for Parkinson's disease, M1 likely responsible",,CHEMBL216,Muscarinic acetylcholine receptor M1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:13477721, URL:http://europepmc.org/abstract/MED/13477721|Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:1267542, URL:http://europepmc.org/abstract/MED/1267542|Name:Wikipedia, SrcID:Cycrimine, URL:http://en.wikipedia.org/wiki/Cycrimine",OC(CCN1CCCCC1)(C2CCCC2)c3ccccc3,CHEMBL216,CHRM1
3532,CHEMBL941,Imatinib,Small molecule,2001.0,L01XE01,L01XE01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Platelet-derived growth factor receptor beta inhibitor,,,CHEMBL1913,Platelet-derived growth factor receptor beta,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13|Name:Wikipedia, SrcID:Bcr-Abl_tyrosine-kinase_inhibitor, URL:http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor",CN1CCN(Cc2ccc(cc2)C(=O)Nc3ccc(C)c(Nc4nccc(n4)c5cccnc5)c3)CC1,CHEMBL1913,PDGFRB
3533,CHEMBL544,Mequinol,Small molecule,1999.0,D11AX06,D11AX06 [DERMATOLOGICALS: OTHER DERMATOLOGICAL PREPARATIONS: OTHER DERMATOLOGICAL PREPARATIONS: Other dermatologicals],,Tyrosinase inhibitor,,,CHEMBL1973,Tyrosinase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2009/020922s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020922s006lbl.pdf",COc1ccc(O)cc1,CHEMBL1973,TYR
3534,CHEMBL1201540,Insulin Susp Isophane Recombinant Human,Protein,1982.0,,,,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/022472s006s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022472s006s008lbl.pdf|Name:DailyMed, SrcID:setid=457531f0-9331-47fe-90b5-b31f284044dc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=457531f0-9331-47fe-90b5-b31f284044dc",,CHEMBL1981,INSR
3535,CHEMBL1200986,Haloperidol Decanoate,Small molecule,1986.0,N05AD01,N05AD01 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Butyrophenone derivatives],-peridol,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:0443059748, URL:http://www.isbnsearch.org/isbn/0443059748|Name:Wikipedia, SrcID:Haloperidol, URL:http://en.wikipedia.org/wiki/Haloperidol|Name:PubMed, SrcID:17015232, URL:http://europepmc.org/abstract/MED/17015232",CCCCCCCCCC(=O)OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,CHEMBL224,HTR2A
3536,CHEMBL632,Betamethasone,Small molecule,1961.0,A07EA04; D07XC01; R01AD06; C05AA05; S03BA03; D07AC01; S01BA06; H02AB01; R03BA04; S01CB04; S02BA07,"A07EA04 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Corticosteroids acting locally]; D07XC01 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, OTHER COMBINATIONS: Corticosteroids, potent, other combinations]; R01AD06 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Corticosteroids]; C05AA05 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Corticosteroids]; S03BA03 [SENSORY ORGANS: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS: CORTICOSTEROIDS: Corticosteroids]; D07AC01 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, potent (group III)]; S01BA06 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Corticosteroids, plain]; H02AB01 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Glucocorticoids]; R03BA04 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS: Glucocorticoids]; S01CB04 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION: Corticosteroids/antiinfectives/mydriatics in combination]; S02BA07 [SENSORY ORGANS: OTOLOGICALS: CORTICOSTEROIDS: Corticosteroids]",,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12188035, URL:http://europepmc.org/abstract/MED/12188035|Name:PubMed, SrcID:15866114, URL:http://europepmc.org/abstract/MED/15866114|Name:PubMed, SrcID:15336699, URL:http://europepmc.org/abstract/MED/15336699",C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,CHEMBL2034,NR3C1
3537,CHEMBL477772,Pazopanib,Small molecule,2009.0,L01XE11,L01XE11 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-anib,Tyrosine-protein kinase LCK inhibitor,,,CHEMBL258,Tyrosine-protein kinase LCK,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14",CN(c1ccc2c(C)n(C)nc2c1)c3ccnc(Nc4ccc(C)c(c4)S(=O)(=O)N)n3,CHEMBL258,LCK
3538,CHEMBL1477,Cerivastatin,Small molecule,1997.0,C10AA06,"C10AA06 [CARDIOVASCULAR SYSTEM: LIPID MODIFYING AGENTS: LIPID MODIFYING AGENTS, PLAIN: HMG CoA reductase inhibitors]",-stat-,HMG-CoA reductase inhibitor,,,CHEMBL402,HMG-CoA reductase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 290, URL:http://www.isbnsearch.org/isbn/9780702034718",COCc1c(nc(C(C)C)c(\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)c1c2ccc(F)cc2)C(C)C,CHEMBL402,HMGCR
3539,CHEMBL521,Ibuprofen,Small molecule,1974.0,R02AX02; G02CC01; C01EB16; M02AA13; M01AE51; M01AE01,"R02AX02 [RESPIRATORY SYSTEM: THROAT PREPARATIONS: THROAT PREPARATIONS: Other throat preparations]; G02CC01 [GENITO URINARY SYSTEM AND SEX HORMONES: OTHER GYNECOLOGICALS: OTHER GYNECOLOGICALS: Antiinflammatory products for vaginal administration]; C01EB16 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: OTHER CARDIAC PREPARATIONS: Other cardiac preparations]; M02AA13 [MUSCULO-SKELETAL SYSTEM: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: Antiinflammatory preparations, non-steroids for topical use]; M01AE51 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Propionic acid derivatives]; M01AE01 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Propionic acid derivatives]",-profen,Cyclooxygenase inhibitor,,,CHEMBL2094253,Cyclooxygenase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2009/021903s004lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021903s004lbl.pdf|Name:Wikipedia, SrcID:Ibuprofen_lysine#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Ibuprofen_lysine#Mechanism_of_action|Name:ISBN, SrcID:0443-059748 PP. 229, URL:http://www.isbnsearch.org/isbn/0443059748|Name:Wikipedia, SrcID:Ibuprofen, URL:http://en.wikipedia.org/wiki/Ibuprofen",CC(C)Cc1ccc(cc1)C(C)C(=O)O,,
3540,CHEMBL830,Eflornithine,Small molecule,1990.0,D11AX16; P01CX03,"D11AX16 [DERMATOLOGICALS: OTHER DERMATOLOGICAL PREPARATIONS: OTHER DERMATOLOGICAL PREPARATIONS: Other dermatologicals]; P01CX03 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS: Other agents against leishmaniasis and trypanosomiasis]",,Ornithine decarboxylase inhibitor,,,CHEMBL1869,Ornithine decarboxylase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=a2c3d206-b893-4f65-a2f6-c11fa9a0e486, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a2c3d206-b893-4f65-a2f6-c11fa9a0e486",NCCCC(N)(C(F)F)C(=O)O,CHEMBL1869,ODC1
3541,CHEMBL1201573,Oprelvekin,Protein,1997.0,L03AC02,L03AC02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSTIMULANTS: IMMUNOSTIMULANTS: Interleukins],-kin,Interleukin 11 receptor alpha agonist,complex with beta but only associcates on ligand binding so excluded,,CHEMBL2050,Interleukin 11 receptor alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=6408f6b7-8794-4dd5-2db6-0b44660c586d, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6408f6b7-8794-4dd5-2db6-0b44660c586d",,CHEMBL2050,IL11RA
3542,CHEMBL1201116,Hetacillin,Small molecule,1982.0,J01CA18,"J01CA18 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: BETA-LACTAM ANTIBACTERIALS, PENICILLINS: Penicillins with extended spectrum]",-cillin,Penicillin-binding protein inhibitor,,,CHEMBL2362973,Penicillin-binding protein,INHIBITOR,Streptococcus pneumoniae,PROTEIN FAMILY,,,"Name:PubMed, SrcID:1095502, URL:http://europepmc.org/abstract/MED/1095502|Name:PubMed, SrcID:7447421, URL:http://europepmc.org/abstract/MED/7447421",CC1(C)S[C@@H]2[C@H](N3C(=O)[C@H](NC3(C)C)c4ccccc4)C(=O)N2[C@H]1C(=O)O,,
3543,CHEMBL1493,Flavoxate,Small molecule,1970.0,G04BD02,G04BD02 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Drugs for urinary frequency and incontinence],,Phosphodiesterase 8 inhibitor,,,CHEMBL2363067,Phosphodiesterase 8,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:167667, URL:http://europepmc.org/abstract/MED/167667|Name:PubMed, SrcID:6329116, URL:http://europepmc.org/abstract/MED/6329116",CC1=C(Oc2c(cccc2C1=O)C(=O)OCCN3CCCCC3)c4ccccc4,,
3544,CHEMBL1201197,Alatrofloxacin,Small molecule,1997.0,,,-oxacin,Topoisomerase IV inhibitor,,Broad spectrum,CHEMBL2363076,Topoisomerase IV,INHIBITOR,Bacteria,PROTEIN COMPLEX,,,"Name:DailyMed, SrcID:setid=da9b26bb-d2d7-4113-a0f9-c6c2280f4875#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=da9b26bb-d2d7-4113-a0f9-c6c2280f4875#nlm34090-1|Name:PubMed, SrcID:17803740, URL:http://europepmc.org/abstract/MED/17803740",C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H]1[C@@H]2CN(C[C@H]12)c3nc4N(C=C(C(=O)O)C(=O)c4cc3F)c5ccc(F)cc5F,,
3545,CHEMBL1296,Cefotiam,Small molecule,1988.0,J01DC07,J01DC07 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Second-generation cephalosporins],cef-,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:PubMed, SrcID:8592992, URL:http://europepmc.org/abstract/MED/8592992",CN(C)CCn1nnnc1SCC2=C(N3[C@H](SC2)[C@H](NC(=O)Cc4csc(N)n4)C3=O)C(=O)O,,
3546,CHEMBL174,Ampicillin,Small molecule,1965.0,S01AA19; J01CA51; J01CA01,"S01AA19 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Antibiotics]; J01CA51 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: BETA-LACTAM ANTIBACTERIALS, PENICILLINS: Penicillins with extended spectrum]; J01CA01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: BETA-LACTAM ANTIBACTERIALS, PENICILLINS: Penicillins with extended spectrum]",-cillin,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:PubMed, SrcID:7447421, URL:http://europepmc.org/abstract/MED/7447421|Name:Wikipedia, SrcID:Penicillin_binding_proteins#Function, URL:http://en.wikipedia.org/wiki/Penicillin_binding_proteins#Function",CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O,,
3547,CHEMBL1201760,Besifloxacin,Small molecule,2009.0,S01AE08,S01AE08 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Fluoroquinolones],-oxacin,Bacterial DNA gyrase inhibitor,,,CHEMBL2311224,Bacterial DNA gyrase,INHIBITOR,Bacteria,PROTEIN COMPLEX,,,"Name:FDA, SrcID:label/2012/022308s003lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022308s003lbl.pdf",N[C@@H]1CCCCN(C1)c2c(F)cc3C(=O)C(=CN(C4CC4)c3c2Cl)C(=O)O,,
3548,CHEMBL2108888,Agalsidase Beta,Enzyme,2003.0,A16AB04,A16AB04 [ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Enzymes],-ase,Globotriosylceramide hydrolytic enzyme,,,CHEMBL2366040,Globotriosylceramide,HYDROLYTIC ENZYME,Homo sapiens,SMALL MOLECULE,,,"Name:DailyMed, SrcID:setid=988513ab-b06f-4dd0-93f7-d2d4531dcce4#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=988513ab-b06f-4dd0-93f7-d2d4531dcce4#nlm34090-1",,,
3549,CHEMBL1194,Prilocaine,Small molecule,1965.0,N01BB54; N01BB04,"N01BB54 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Amides]; N01BB04 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Amides]",-caine,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:12761351, URL:http://europepmc.org/abstract/MED/12761351|Name:PubMed, SrcID:8799190, URL:http://europepmc.org/abstract/MED/8799190|Name:PubMed, SrcID:15635807, URL:http://europepmc.org/abstract/MED/15635807|Name:DailyMed, SrcID:setid=db23a56f-1e41-4843-9220-1b2e3059db41#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=db23a56f-1e41-4843-9220-1b2e3059db41#nlm34090-1",CCCNC(C)C(=O)Nc1ccccc1C,,
3550,CHEMBL708,Ziprasidone,Small molecule,2001.0,N05AE04,N05AE04 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Indole derivatives],-sidone,Dopamine D2 receptor antagonist,,,CHEMBL217,Dopamine D2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=5c03ca62-5dd5-4cf5-abc7-b0c2873503dd#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5c03ca62-5dd5-4cf5-abc7-b0c2873503dd#nlm34090-1",Clc1cc2NC(=O)Cc2cc1CCN3CCN(CC3)c4nsc5ccccc45,CHEMBL217,DRD2
3551,CHEMBL2108546,Pegaspargase,Enzyme,1994.0,L01XX24,L01XX24 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-ase; peg-,Asparagine hydrolytic enzyme,,,CHEMBL2364706,Asparagine,HYDROLYTIC ENZYME,Homo sapiens,SMALL MOLECULE,,,"Name:DailyMed, SrcID:setid=d046ec54-9ac8-4c9f-87a7-69e9900d8016#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d046ec54-9ac8-4c9f-87a7-69e9900d8016#nlm34090-1",,,
3552,CHEMBL1721885,Su-014813,Small molecule,,,,,Tyrosine-protein kinase receptor FLT3 inhibitor,,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16891463, URL:http://europepmc.org/abstract/MED/16891463",Cc1[nH]c(\C=C\2/C(=O)Nc3ccc(F)cc23)c(C)c1C(=O)NC[C@H](O)CN4CCOCC4,CHEMBL1974,FLT3
3553,CHEMBL1980297,Ilorasertib,Small molecule,,,,-sertib,Serine/threonine-protein kinase Aurora inhibitor,Multitargeted kinase inhibitor,,CHEMBL3430911,Serine/threonine-protein kinase Aurora,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:22935731, URL:http://europepmc.org/abstract/MED/22935731",Nc1ncc(c2cnn(CCO)c2)c3scc(c4ccc(NC(=O)Nc5cccc(F)c5)cc4)c13,,
3554,CHEMBL3545244,Allitinib,Small molecule,,,,-tinib,Epidermal growth factor receptor erbB1 inhibitor,"Irreversible inhibitor, also potent at ERBB4.",,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21789172, URL:http://europepmc.org/abstract/MED/21789172",,CHEMBL203,EGFR
3555,CHEMBL3545426,Cc-115,Small molecule,,,,,Serine/threonine-protein kinase mTOR inhibitor,ATP-competitive mTORC1/mTORC2 inhibitor,,CHEMBL2842,Serine/threonine-protein kinase mTOR,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26102506, URL:http://europepmc.org/abstract/MED/26102506",,CHEMBL2842,MTOR
3556,CHEMBL346631,Cep-7055,Small molecule,,,,,Vascular endothelial growth factor receptor inhibitor,Prodrug-active metabolite is CEP-5214,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:14522925, URL:http://europepmc.org/abstract/MED/14522925|Name:PubMed, SrcID:14640546, URL:http://europepmc.org/abstract/MED/14640546",CC(C)OCc1ccc2c(c1)c3c4CNC(=O)c4c5c(Cc6ccccc56)c3n2CCCOC(=O)CN(C)C,,
3557,CHEMBL1614710,Osi-930,Small molecule,,,,,Vascular endothelial growth factor receptor inhibitor,,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:16424037, URL:http://europepmc.org/abstract/MED/16424037|Name:PubMed, SrcID:23403628, URL:http://europepmc.org/abstract/MED/23403628",FC(F)(F)Oc1ccc(NC(=O)c2sccc2NCc3ccnc4ccccc34)cc1,,
3558,CHEMBL3545209,Nktr-171,Small molecule,,,,,Sodium channel alpha subunit blocker,Shows no specificity among human SCN channel family members (SCN1A-11A).,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://www.nektar.com/product_pipeline/cns_pain_nktr-171.html, URL:http://www.nektar.com/product_pipeline/cns_pain_nktr-171.html|Name:PubMed, SrcID:25060923, URL:http://europepmc.org/abstract/MED/25060923",,,
3559,CHEMBL3545335,Ag-13958,Small molecule,,,,,Vascular endothelial growth factor receptor inhibitor,,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:https://www.pfizer.com/files/annualreport/2006/annual/review2006.pdf, URL:https://www.pfizer.com/files/annualreport/2006/annual/review2006.pdf",Cc1cc(C(=O)Nc2cc(Nc3ccc4c(\C=C\c5ccccn5)n[nH]c4c3)ccc2F)n(C)n1,,
3560,CHEMBL1614713,Cc-401,Small molecule,,,,,c-Jun N-terminal kinase 1 inhibitor,,,CHEMBL2276,c-Jun N-terminal kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17202416, URL:http://europepmc.org/abstract/MED/17202416|Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=453550, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=453550",C(CN1CCCCC1)Oc2cccc(c2)c3n[nH]c4ccc(cc34)c5nnc[nH]5,CHEMBL2276,MAPK8
3561,CHEMBL124660,Tandutinib,Small molecule,,,,-tinib,Stem cell growth factor receptor inhibitor,,,CHEMBL1936,Stem cell growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12124172, URL:http://europepmc.org/abstract/MED/12124172|Name:PubMed, SrcID:12166950, URL:http://europepmc.org/abstract/MED/12166950|Name:Other, SrcID:http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804, URL:http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804",COc1cc2c(ncnc2cc1OCCCN3CCCCC3)N4CCN(CC4)C(=O)Nc5ccc(OC(C)C)cc5,CHEMBL1936,KIT
3562,CHEMBL564829,Milciclib,Small molecule,,,,-ciclib,Nerve growth factor receptor Trk-A inhibitor,,,CHEMBL2815,Nerve growth factor receptor Trk-A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25215591, URL:http://europepmc.org/abstract/MED/25215591|Name:PubMed, SrcID:20682657, URL:http://europepmc.org/abstract/MED/20682657",CNC(=O)c1nn(C)c2c3nc(Nc4ccc(cc4)N5CCN(C)CC5)ncc3CC(C)(C)c12,CHEMBL2815,NTRK1
3563,CHEMBL3545026,Famitinib,Small molecule,,,,-tinib,Vascular endothelial growth factor receptor 1 inhibitor,Multi-targeted receptor tyrosine kinase inhibitor,,CHEMBL1868,Vascular endothelial growth factor receptor 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1158/1538-7445.AM2011-3604, URL:http://cancerres.aacrjournals.org/content/71/8_Supplement/3604|Name:ClinicalTrials, SrcID:NCT02390947, URL:https://www.clinicaltrials.gov/ct2/show/NCT02390947|Name:PubMed, SrcID:24043137, URL:http://europepmc.org/abstract/MED/24043137",,CHEMBL1868,FLT1
3564,CHEMBL403989,Tg100-801,Small molecule,,,,,Platelet-derived growth factor receptor beta inhibitor,Prodrug - active metabolite is TG-100-572 (HY-10184),,CHEMBL1913,Platelet-derived growth factor receptor beta,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18311895, URL:http://europepmc.org/abstract/MED/18311895|Name:PubMed, SrcID:18483622, URL:http://europepmc.org/abstract/MED/18483622|Name:PubMed, SrcID:18330892, URL:http://europepmc.org/abstract/MED/18330892",Cc1cc(cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12)c5cc(OC(=O)c6ccccc6)ccc5Cl,CHEMBL1913,PDGFRB
3565,CHEMBL574737,(7s)-Hydroxyl-Staurosporine,Small molecule,,,,,Cyclin-dependent kinase 2 inhibitor,,,CHEMBL301,Cyclin-dependent kinase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7907, URL:http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7907|Name:PubMed, SrcID:12892559, URL:http://europepmc.org/abstract/MED/12892559|Name:PubMed, SrcID:19568282, URL:http://europepmc.org/abstract/MED/19568282",CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n3c4ccccc4c5c6[C@H](O)NC(=O)c6c7c8ccccc8n2c7c35,CHEMBL301,CDK2
3566,CHEMBL2178579,Elubrixin,Small molecule,,,,-rixin,Interleukin-8 receptor B antagonist,,,CHEMBL2434,Interleukin-8 receptor B,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21426372, URL:http://europepmc.org/abstract/MED/21426372",Oc1c(NC(=O)Nc2cccc(F)c2Cl)ccc(Cl)c1S(=O)(=O)N3CCNCC3,CHEMBL2434,CXCR2
3567,CHEMBL3544952,Rg3487,Small molecule,,,,,Serotonin 3 (5-HT3) receptor antagonist,,,CHEMBL2094132,Serotonin 3 (5-HT3) receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:24317442, URL:http://europepmc.org/abstract/MED/24317442",,CHEMBL2094132,HTR3D
3568,CHEMBL3544952,Rg3487,Small molecule,,,,,Serotonin 3 (5-HT3) receptor antagonist,,,CHEMBL2094132,Serotonin 3 (5-HT3) receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:24317442, URL:http://europepmc.org/abstract/MED/24317442",,CHEMBL2094132,HTR3C
3569,CHEMBL3544952,Rg3487,Small molecule,,,,,Serotonin 3 (5-HT3) receptor antagonist,,,CHEMBL2094132,Serotonin 3 (5-HT3) receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:24317442, URL:http://europepmc.org/abstract/MED/24317442",,CHEMBL2094132,HTR3E
3570,CHEMBL2103791,Adipiplon,Small molecule,,,,-plon,GABA-A receptor; benzodiazepine site partial agonist,,,CHEMBL2109243,GABA-A receptor; benzodiazepine site,PARTIAL AGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,Binds to benzodiazepine site.,"Name:Other, SrcID:http://www.springer.com/cda/content/document/cda_downloaddocument/9783034602259-c2.pdf?SGWID=0-0-45-1004847-p174009657., URL:http://www.springer.com/cda/content/document/cda_downloaddocument/9783034602259-c2.pdf?SGWID=0-0-45-1004847-p174009657.|Name:Wikipedia, SrcID:Adipiplon, URL:https://en.wikipedia.org/wiki/Adipiplon",CCCc1c(Cn2ccnc2c3ncccc3F)ncn4nc(C)nc14,,
3571,CHEMBL2110732,Dacomitinib,Small molecule,,,,-tinib,Receptor protein-tyrosine kinase erbB-2 inhibitor,Dacomitinib is an irreversible pan-ERBB inhibitor.,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://www.pfizer.com/files/news/esmo/dacomitinib_fact_sheet.pdf, URL:https://www.pfizer.com/files/news/esmo/dacomitinib_fact_sheet.pdf|Name:PubMed, SrcID:18089823, URL:http://europepmc.org/abstract/MED/18089823",COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)\C=C\CN4CCCCC4,CHEMBL1824,ERBB2
3572,CHEMBL1287853,Fedratinib,Small molecule,,,,-tinib,Tyrosine-protein kinase receptor FLT3 inhibitor,Potent inhibitor of BRD4 (PMID: 24584101).,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18394554, URL:http://europepmc.org/abstract/MED/18394554",Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc4cccc(c4)S(=O)(=O)NC(C)(C)C,CHEMBL1974,FLT3
3573,CHEMBL2109592,Medi-500,Antibody,,,,,T-cell receptor antagonist,"Targets aß heterodimer of the T cell receptor, resulting in modulation of the receptor of the surface of the targeted T cells and apoptosis, not mitogenic and has a reduced capacity to stimulate the production of inflammatory cytokines.",,CHEMBL3580506,T-cell receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:8996751, URL:http://europepmc.org/abstract/MED/8996751|Name:PubMed, SrcID:19920935, URL:http://europepmc.org/abstract/MED/19920935|Name:PubMed, SrcID:15570254, URL:http://europepmc.org/abstract/MED/15570254",,CHEMBL3580506,TRGV3
3574,CHEMBL3707227,Atezolizumab,Antibody,2016.0,,,-mab,Programmed cell death 1 ligand 1 inhibitor,,,CHEMBL3580522,Programmed cell death 1 ligand 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2016/761034Orig1s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761034Orig1s000lbl.pdf",,CHEMBL3580522,CD274
3575,CHEMBL2103792,Agatolimod,Oligonucleotide,,,,-imod,Toll-like receptor 9 agonist,"Targets TLR9, thereby activating dendritic and B cells and stimulating cytotoxic T cell and antibody responses against tumor cells bearing tumor antigens",,CHEMBL5804,Toll-like receptor 9,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=38660, URL:https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=38660|Name:PubMed, SrcID:18596994, URL:http://europepmc.org/abstract/MED/18596994",CC1=CN([C@H]2C[C@H](O)[C@@H](COP(=S)(O)O[C@H]3C[C@@H](O[C@@H]3COP(=S)(O)O[C@H]4C[C@@H](O[C@@H]4COP(=S)(O)O[C@H]5C[C@@H](O[C@@H]5COP(=S)(O)O[C@H]6C[C@@H](O[C@@H]6COP(=S)(O)O[C@H]7C[C@@H](O[C@@H]7COP(=S)(O)O[C@H]8C[C@@H](O[C@@H]8COP(=S)(O)O[C@H]9C[C@@H](O[C@@H]9COP(=S)(O)O[C@H]%10C[C@@H](O[C@@H]%10COP(=S)(O)O[C@H]%11C[C@@H](O[C@@H]%11COP(=S)(O)O[C@H]%12C[C@@H](O[C@@H]%12COP(=S)(O)O[C@H]%13C[C@@H](O[C@@H]%13COP(=S)(O)O[C@H]%14C[C@@H](O[C@@H]%14COP(=S)(O)O[C@H]%15C[C@@H](O[C@@H]%15COP(=S)(O)O[C@H]%16C[C@@H](O[C@@H]%16COP(=S)(O)O[C@H]%17C[C@@H](O[C@@H]%17COP(=S)(O)O[C@H]%18C[C@@H](O[C@@H]%18COP(=S)(O)O[C@H]%19C[C@@H](O[C@@H]%19COP(=S)(O)O[C@H]%20C[C@@H](O[C@@H]%20COP(=S)(O)O[C@H]%21C[C@@H](O[C@@H]%21COP(=S)(O)O[C@H]%22C[C@@H](O[C@@H]%22COP(=S)(O)O[C@H]%23C[C@@H](O[C@@H]%23COP(=S)(O)O[C@H]%24C[C@@H](O[C@@H]%24COP(=S)(O)O[C@H]%25C[C@@H](O[C@@H]%25CO)N%26C=C(C)C(=O)NC%26=O)N%27C=C(C)C(=O)NC%27=O)n%28cnc%29C(=O)NC(=Nc%28%29)N)N%30C=CC(=NC%30=O)N)N%31C=C(C)C(=O)NC%31=O)n%32cnc%33C(=O)NC(=Nc%32%33)N)N%34C=C(C)C(=O)NC%34=O)N%35C=C(C)C(=O)NC%35=O)N%36C=C(C)C(=O)NC%36=O)N%37C=C(C)C(=O)NC%37=O)n%38cnc%39C(=O)NC(=Nc%38%39)N)N%40C=CC(=NC%40=O)N)N%41C=C(C)C(=O)NC%41=O)n%42cnc%43C(=O)NC(=Nc%42%43)N)N%44C=C(C)C(=O)NC%44=O)N%45C=C(C)C(=O)NC%45=O)N%46C=C(C)C(=O)NC%46=O)N%47C=C(C)C(=O)NC%47=O)n%48cnc%49C(=O)NC(=Nc%48%49)N)N%50C=CC(=NC%50=O)N)N%51C=C(C)C(=O)NC%51=O)n%52cnc%53C(=O)NC(=Nc%52%53)N)N%54C=CC(=NC%54=O)N)O2)C(=O)NC1=O,CHEMBL5804,TLR9
3576,CHEMBL1921976,Orteronel,Small molecule,,,,,Cytochrome P450 17A1 inhibitor,,,CHEMBL3522,Cytochrome P450 17A1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26418412, URL:http://europepmc.org/abstract/MED/26418412",CNC(=O)c1ccc2cc(ccc2c1)[C@@]3(O)CCn4cncc34,CHEMBL3522,CYP17A1
3577,CHEMBL2107312,Arbaclofen Placarbil,Small molecule,,,,,GABA-B receptor agonist,,,CHEMBL2111463,GABA-B receptor,AGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:19502531, URL:http://europepmc.org/abstract/MED/19502531",CC(C)[C@H](OC(=O)NC[C@H](CC(=O)O)c1ccc(Cl)cc1)OC(=O)C(C)C,,
3578,CHEMBL109480,Tanespimycin,Small molecule,,,,-mycin,Heat shock protein HSP90 inhibitor,Disrupts the Hsp90 chaperone complex.,,CHEMBL2095165,Heat shock protein HSP90,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,"Binds to a highly conserved 25 kDa N-terminal domain of Hsp90, a binding site for ATP","Name:PubMed, SrcID:12881371, URL:http://europepmc.org/abstract/MED/12881371",CO[C@H]1C[C@H](C)CC2=C(NCC=C)C(=O)C=C(NC(=O)\C(=C\C=C/[C@H](OC)[C@@H](OC(=O)N)\C(=C\[C@H](C)[C@H]1O)\C)\C)C2=O,,
3579,CHEMBL2107818,Aldoxorubicin,Small molecule,,,,-rubicin,DNA topoisomerase II alpha inhibitor,,,CHEMBL1806,DNA topoisomerase II alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25312684, URL:http://europepmc.org/abstract/MED/25312684",COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)\C(=N\NC(=O)CCCCCN6C(=O)C=CC6=O)\CO,CHEMBL1806,TOP2A
3580,CHEMBL3833330,Biib054,Antibody,,,,,Alpha-synuclein inhibitor,"Recombinant human antibody that prevents alpha-synuclein cell-to-cell transmission, and thus propagation of Lewy body pathology",,CHEMBL6152,Alpha-synuclein,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,,,CHEMBL6152,SNCA
3581,CHEMBL1940832,Milveterol,Small molecule,,,,-terol,Beta-2 adrenergic receptor agonist,,,CHEMBL210,Beta-2 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,,O[C@@H](CNCCc1ccc(NC[C@H](O)c2ccccc2)cc1)c3ccc(O)c(NC=O)c3,CHEMBL210,ADRB2
3582,CHEMBL1186610,Anisotropine,Small molecule,1962.0,,,-trop-,Muscarinic acetylcholine receptor M3 antagonist,"Role in regulating gastric secretion, M3 likely involved",,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:4555460, URL:http://europepmc.org/abstract/MED/4555460|Name:PubMed, SrcID:353090, URL:http://europepmc.org/abstract/MED/353090|Name:Wikipedia, SrcID:Anisotropine_Methylbromide, URL:http://en.wikipedia.org/wiki/Anisotropine_Methylbromide",CCCC(CCC)C(=O)O[C@H]1C[C@H]2CC[C@@H](C1)[N+]2(C)C,CHEMBL245,CHRM3
3583,CHEMBL1623,Meclizine,Small molecule,1957.0,R06AE55; R06AE05,R06AE55 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Piperazine derivatives]; R06AE05 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Piperazine derivatives],,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:7513381, URL:http://europepmc.org/abstract/MED/7513381|Name:DailyMed, SrcID:setid=305a537b-db97-4c5b-824a-0b97dd4c6dc0, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=305a537b-db97-4c5b-824a-0b97dd4c6dc0",Cc1cccc(CN2CCN(CC2)C(c3ccccc3)c4ccc(Cl)cc4)c1,CHEMBL231,HRH1
3584,CHEMBL1201356,Methylergonovine,Small molecule,1946.0,G02AB01,G02AB01 [GENITO URINARY SYSTEM AND SEX HORMONES: OTHER GYNECOLOGICALS: UTEROTONICS: Ergot alkaloids],-erg-; -vin-,Serotonin 2b (5-HT2b) receptor partial agonist,,,CHEMBL1833,Serotonin 2b (5-HT2b) receptor,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11104741, URL:http://europepmc.org/abstract/MED/11104741|Name:Wikipedia, SrcID:Methylergonovine#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Methylergonovine#Mechanism_of_action",CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34,CHEMBL1833,HTR2B
3585,CHEMBL1201509,"Gonadotropin, Chorionic",Protein,1973.0,G03GA01,G03GA01 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: GONADOTROPINS AND OTHER OVULATION STIMULANTS: Gonadotropins],-trop-,Luteinizing hormone/Choriogonadotropin receptor agonist,,,CHEMBL1854,Luteinizing hormone/Choriogonadotropin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f93b2baa-03ac-4650-b35a-20b818d712d6, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f93b2baa-03ac-4650-b35a-20b818d712d6",,CHEMBL1854,LHCGR
3586,CHEMBL1278,Naratriptan,Small molecule,1998.0,N02CC02,N02CC02 [NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Selective serotonin (5HT1) agonists],-triptan,Serotonin 1b (5-HT1b) receptor agonist,,Selective,CHEMBL1898,Serotonin 1b (5-HT1b) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2012/020763s008s009lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020763s008s009lbl.pdf",CNS(=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1,CHEMBL1898,HTR1B
3587,CHEMBL1042,Cholecalciferol,Small molecule,1999.0,A11CC05,"A11CC05 [ALIMENTARY TRACT AND METABOLISM: VITAMINS: VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO: Vitamin D and analogues]",-calci-,Vitamin D receptor agonist,,,CHEMBL1977,Vitamin D receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15503649, URL:http://europepmc.org/abstract/MED/15503649|Name:PubMed, SrcID:20435140, URL:http://europepmc.org/abstract/MED/20435140",CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2\C(=C\C=C/3\C[C@@H](O)CCC3=C)\CCC[C@]12C,CHEMBL1977,VDR
3588,CHEMBL1201541,Insulin Susp Protamine Zinc Purified Beef,Protein,1980.0,,,,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/022472s006s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022472s006s008lbl.pdf|Name:DailyMed, SrcID:setid=457531f0-9331-47fe-90b5-b31f284044dc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=457531f0-9331-47fe-90b5-b31f284044dc",,CHEMBL1981,INSR
3589,CHEMBL1200963,Bimatoprost,Small molecule,2001.0,S01EE03,S01EE03 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Prostaglandin analogues 1)],-prost,Prostanoid FP receptor agonist,,,CHEMBL1987,Prostanoid FP receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:KEGG, SrcID:D02724, URL:http://www.kegg.jp/dbget-bin/www_bget?dr:D02724|Name:PubMed, SrcID:19627411, URL:http://europepmc.org/abstract/MED/19627411|Name:PubMed, SrcID:11740958, URL:http://europepmc.org/abstract/MED/11740958|Name:PubMed, SrcID:12222762, URL:http://europepmc.org/abstract/MED/12222762|Name:PubMed, SrcID:14733708, URL:http://europepmc.org/abstract/MED/14733708",CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCc2ccccc2,CHEMBL1987,PTGFR
3590,CHEMBL796,Methylphenidate,Small molecule,1955.0,N06BA04,"N06BA04 [NERVOUS SYSTEM: PSYCHOANALEPTICS: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS: Centrally acting sympathomimetics]",,Dopamine transporter inhibitor,,,CHEMBL238,Dopamine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23284812, URL:http://europepmc.org/abstract/MED/23284812|Name:DailyMed, SrcID:setid=1a88218c-5b18-4220-8f56-526de1a276cd#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a88218c-5b18-4220-8f56-526de1a276cd#nlm34090-1",COC(=O)C(C1CCCCN1)c2ccccc2,CHEMBL238,SLC6A3
3591,CHEMBL1201490,Sermorelin Acetate,Protein,1990.0,H01AC04; V04CD03,"H01AC04 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES: Somatropin and somatropin agonists]; V04CD03 [VARIOUS: DIAGNOSTIC AGENTS: OTHER DIAGNOSTIC AGENTS: Tests for pituitary function]",-relin,Growth hormone-releasing hormone receptor agonist,"It's an analogue of GHRH, which seems to be used as diagnostic of growth hormone deficiency, but also as a replacement therapy in children",,CHEMBL2032,Growth hormone-releasing hormone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18031173, URL:http://europepmc.org/abstract/MED/18031173",,CHEMBL2032,GHRHR
3592,CHEMBL977,Hydrocortisone Hemisuccinate,Small molecule,1955.0,,,-cort-,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=6d9bf1b0-599e-41da-7092-32f571ed79b1#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d9bf1b0-599e-41da-7092-32f571ed79b1#nlm34090-1|Name:ISBN, SrcID:0443-059748 PP. 421, URL:http://www.isbnsearch.org/isbn/0443059748",C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)COC(=O)CCC(=O)O)[C@@]4(C)C[C@H](O)[C@H]23,CHEMBL2034,NR3C1
3593,CHEMBL1200449,Triamcinolone Diacetate,Small molecule,1959.0,H02AB08; D07AB09; S01BA05; R03BA06; A01AC01; C05AA12; D07XB02; R01AD11,"H02AB08 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Glucocorticoids]; D07AB09 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, moderately potent (group II)]; S01BA05 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Corticosteroids, plain]; R03BA06 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS: Glucocorticoids]; A01AC01 [ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Corticosteroids for local oral treatment]; C05AA12 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Corticosteroids]; D07XB02 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, OTHER COMBINATIONS: Corticosteroids, moderately potent, other combinations]; R01AD11 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Corticosteroids]",-olone,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Glucocorticoid, URL:http://en.wikipedia.org/wiki/Glucocorticoid|Name:ISBN, SrcID:978-1-889788-85-2, URL:http://www.isbnsearch.org/isbn/9781889788852|Name:PubMed, SrcID:17132855, URL:http://europepmc.org/abstract/MED/17132855|Name:DailyMed, SrcID:setid=25fcc17b-da24-49cc-8e06-ac3ee22cbdbf#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=25fcc17b-da24-49cc-8e06-ac3ee22cbdbf#nlm34090-1|Name:FDA, SrcID:label/2014/012802s033lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/012802s033lbl.pdf",CC(=O)OCC(=O)[C@@]1(O)[C@@H](C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)OC(=O)C,CHEMBL2034,NR3C1
3594,CHEMBL989,Fluocinolone Acetonide,Small molecule,1963.0,C05AA10; D07AC04; S01BA15; S02BA08,"C05AA10 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Corticosteroids]; D07AC04 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, potent (group III)]; S01BA15 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Corticosteroids, plain]; S02BA08 [SENSORY ORGANS: OTOLOGICALS: CORTICOSTEROIDS: Corticosteroids]",-olone,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19744340, URL:http://europepmc.org/abstract/MED/19744340",CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,CHEMBL2034,NR3C1
3595,CHEMBL1372,Oxiglutatione,Small molecule,2008.0,,,,Glutathione reductase,,,CHEMBL2755,Glutathione reductase,,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=d93a8991-bf69-956a-21fc-dac24955ee42#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d93a8991-bf69-956a-21fc-dac24955ee42#nlm34090-1|Name:Wikipedia, SrcID:Glutathione_reductase, URL:http://en.wikipedia.org/wiki/Glutathione_reductase|Name:Wikipedia, SrcID:Glutathione_disulfide, URL:http://en.wikipedia.org/wiki/Glutathione_disulfide",N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)NCC(=O)O)C(=O)O,CHEMBL2755,GSR
3596,CHEMBL1201774,Sapropterin,Small molecule,2007.0,A16AX07,A16AX07 [ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Various alimentary tract and metabolism products],,Phenylalanine-4-hydroxylase activator,,,CHEMBL3076,Phenylalanine-4-hydroxylase,ACTIVATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=af38711e-8873-4790-a92d-4d583e23fb89#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=af38711e-8873-4790-a92d-4d583e23fb89#nlm34090-1",C[C@H](O)[C@H](O)[C@H]1CNc2nc(N)nc(O)c2N1,CHEMBL3076,PAH
3597,CHEMBL2095222,Ocriplasmin,Enzyme,2010.0,S01XA22,S01XA22 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],-plasmin,Fibronectin proteolytic enzyme,It's a recombinant truncated form of human plasmin with proteolytic activity against protein components of the vitreous body and the vitreoretinal interface,,CHEMBL3810,Fibronectin,PROTEOLYTIC ENZYME,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=390682b7-72c4-11e1-b0c4-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66",,CHEMBL3810,FN1
3598,CHEMBL1201753,Pitavastatin,Small molecule,2009.0,C10AA08,"C10AA08 [CARDIOVASCULAR SYSTEM: LIPID MODIFYING AGENTS: LIPID MODIFYING AGENTS, PLAIN: HMG CoA reductase inhibitors]",-stat-,HMG-CoA reductase inhibitor,,,CHEMBL402,HMG-CoA reductase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2013/022363s012lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022363s012lbl.pdf|Name:DailyMed, SrcID:setid=b3c41a2f-da77-4465-8af6-038006a7ea58, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b3c41a2f-da77-4465-8af6-038006a7ea58",O[C@H](C[C@H](O)\C=C\c1c(nc2ccccc2c1c3ccc(F)cc3)C4CC4)CC(=O)O,CHEMBL402,HMGCR
3599,CHEMBL1208646,Theophylline Glycinate,Small molecule,1982.0,,,,Phosphodiesterase 4 inhibitor,,,CHEMBL2093863,Phosphodiesterase 4,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=25b2fdbe-2f18-4153-835a-7a67bff83ef8, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=25b2fdbe-2f18-4153-835a-7a67bff83ef8|Name:Wikipedia, SrcID:Theophylline#Mechanisms_of_action, URL:http://en.wikipedia.org/wiki/Theophylline#Mechanisms_of_action",CN1C(=O)N(C)c2nc[nH]c2C1=O.NCC(=O)O,,
3600,CHEMBL778,Dexmedetomidine,Small molecule,1999.0,N05CM18,N05CM18 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Other hypnotics and sedatives],,Adrenergic receptor alpha-2 agonist,,Selective,CHEMBL2095158,Adrenergic receptor alpha-2,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=548a88c0-afda-427e-75ac-5af0cfa2224c#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=548a88c0-afda-427e-75ac-5af0cfa2224c#nlm34090-1",C[C@H](c1c[nH]cn1)c2cccc(C)c2C,,
3601,CHEMBL704,Mesalamine,Small molecule,1987.0,A07EC02,"A07EC02 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Aminosalicylic acid and similar agents]",-sal-,Cyclooxygenase inhibitor,,,CHEMBL2094253,Cyclooxygenase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:12950415, URL:http://europepmc.org/abstract/MED/12950415|Name:PubMed, SrcID:14742690, URL:http://europepmc.org/abstract/MED/14742690|Name:PubMed, SrcID:12463455, URL:http://europepmc.org/abstract/MED/12463455",Nc1ccc(O)c(c1)C(=O)O,,
3602,CHEMBL1096882,Fludarabine Phosphate,Small molecule,1991.0,L01BB05,L01BB05 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Purine analogues],-arabine,Ribonucleoside-diphosphate reductase RR1 inhibitor,,,CHEMBL2095215,Ribonucleoside-diphosphate reductase RR1,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Ribonucleoside-diphosphate reductase M1 subunit,M1 subunit is binding site,"Name:FDA, SrcID:label/2011/022137s003lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022137s003lbl.pdf|Name:PubMed, SrcID:23115527, URL:http://europepmc.org/abstract/MED/23115527|Name:DailyMed, SrcID:setid=af05203c-16fb-44de-8f42-802fbaa03578, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=af05203c-16fb-44de-8f42-802fbaa03578",Nc1nc(F)nc2c1ncn2[C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@@H]3O,,
3603,CHEMBL471,Sotalol,Small molecule,1992.0,C07AA07,"C07AA07 [CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, non-selective]",-alol,Beta-2 adrenergic receptor antagonist,,,CHEMBL210,Beta-2 adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=c4caf469-f684-4f6d-98e8-b6a2fff1de98, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4caf469-f684-4f6d-98e8-b6a2fff1de98|Name:Wikipedia, SrcID:Sotalol, URL:http://en.wikipedia.org/wiki/Sotalol",CC(C)NCC(O)c1ccc(NS(=O)(=O)C)cc1,CHEMBL210,ADRB2
3604,CHEMBL768,Esmolol,Small molecule,1986.0,C07AB09,"C07AB09 [CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, selective]",-olol,Beta-2 adrenergic receptor antagonist,,,CHEMBL210,Beta-2 adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=fdc9cea8-0eb4-4930-9e1c-d44bfa9346d2, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fdc9cea8-0eb4-4930-9e1c-d44bfa9346d2",COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1,CHEMBL210,ADRB2
3605,CHEMBL1542,Azathioprine,Small molecule,1968.0,L04AX01,L04AX01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Other immunosuppressants],,Amidophosphoribosyltransferase inhibitor,Prodrug enzyme: hypoxanthine-guanine phosphoribosyl transferase (HGPRT; EC 2.4.2.8),,CHEMBL2362992,Amidophosphoribosyltransferase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18506437, URL:http://europepmc.org/abstract/MED/18506437",Cn1cnc(c1Sc2ncnc3nc[nH]c23)[N+](=O)[O-],CHEMBL2362992,PPAT
3606,CHEMBL1201605,Daclizumab,Antibody,1997.0,L04AC01,L04AC01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Interleukin inhibitors],-mab,Interleukin-2 receptor inhibitor,,,CHEMBL2364167,Interleukin-2 receptor,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,Interleukin-2 alpha subunit,Alpha subunit is binding site,"Name:DailyMed, SrcID:archiveid=26085, URL:http://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=26085|Name:FDA, SrcID:label/2005/103749s5059lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/103749s5059lbl.pdf",,CHEMBL2364167,IL2RG
3607,CHEMBL1200656,Natamycin,Small molecule,1978.0,D01AA02; A01AB10; S01AA10; A07AA03; G01AA02,"D01AA02 [DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Antibiotics]; A01AB10 [ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Antiinfectives and antiseptics for local oral treatment]; S01AA10 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Antibiotics]; A07AA03 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFECTIVES: Antibiotics]; G01AA02 [GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Antibiotics]",-mycin,Ergosterol sequestering agent,,,CHEMBL2364028,Ergosterol,SEQUESTERING AGENT,Candida albicans,SMALL MOLECULE,,,"Name:PubMed, SrcID:20385867, URL:http://europepmc.org/abstract/MED/20385867|Name:PubMed, SrcID:18165687, URL:http://europepmc.org/abstract/MED/18165687",C[C@@H]1C\C=C\C=C\C=C\C=C\[C@@H](C[C@@H]2O[C@](O)(C[C@@H](O)C[C@H]3O[C@@H]3\C=C\C(=O)O1)C[C@H](O)[C@H]2C(=O)O)O[C@@H]4O[C@H](C)[C@@H](O)[C@H](N)[C@@H]4O,,
3608,CHEMBL1489,Azacitidine,Small molecule,2004.0,L01BC07,L01BC07 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Pyrimidine analogues],-tidine,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:Wikipedia, SrcID:Azacitidine, URL:http://en.wikipedia.org/wiki/Azacitidine|Name:DailyMed, SrcID:setid=3495a71a-cc04-4776-851f-f185956f32af#section-12, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3495a71a-cc04-4776-851f-f185956f32af#section-12|Name:Wikipedia, SrcID:DNA_methylation, URL:http://en.wikipedia.org/wiki/DNA_methylation",NC1=NC(=O)N(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O,,
3609,CHEMBL1750,Clofarabine,Small molecule,2004.0,L01BB06,L01BB06 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Purine analogues],-arabine,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=c35903cd-e9eb-4841-93d1-fc14249d1e9f#section-12, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c35903cd-e9eb-4841-93d1-fc14249d1e9f#section-12",Nc1nc(Cl)nc2c1ncn2[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3F,,
3610,CHEMBL1773,Capecitabine,Small molecule,1998.0,L01BC06,L01BC06 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Pyrimidine analogues],-citabine,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8#section-13|Name:PubMed, SrcID:12724731, URL:http://europepmc.org/abstract/MED/12724731",CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]2O[C@H](C)[C@@H](O)[C@H]2O,,
3611,CHEMBL4,Ofloxacin,Small molecule,1990.0,S02AA16; J01MA01; S01AE01,S02AA16 [SENSORY ORGANS: OTOLOGICALS: ANTIINFECTIVES: Antiinfectives]; J01MA01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolones]; S01AE01 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Fluoroquinolones],-oxacin,Bacterial DNA gyrase inhibitor,,,CHEMBL2311224,Bacterial DNA gyrase,INHIBITOR,Bacteria,PROTEIN COMPLEX,,,"Name:DailyMed, SrcID:setid=81e8ece1-ab0b-4deb-8f84-79f21419b328, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=81e8ece1-ab0b-4deb-8f84-79f21419b328",CC1COc2c(N3CCN(C)CC3)c(F)cc4C(=O)C(=CN1c24)C(=O)O,,
3612,CHEMBL55,Pentamidine,Small molecule,1984.0,,,-amidine,Kinetoplast DNA inhibitor,"Binds DNA, concentrated in kinetoplast",,CHEMBL2366047,Kinetoplast DNA,INHIBITOR,Trypanosoma brucei,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=e2ad9d3c-b6c3-4f70-87e0-722a8ff94ccb#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e2ad9d3c-b6c3-4f70-87e0-722a8ff94ccb#nlm34090-1|Name:PubMed, SrcID:23375541, URL:http://europepmc.org/abstract/MED/23375541",NC(=N)c1ccc(OCCCCCOc2ccc(cc2)C(=N)N)cc1,,
3613,CHEMBL1075,Moricizine,Small molecule,1990.0,C01BG01,"C01BG01 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Other antiarrhythmics, class I and III]",,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=c8fe88f7-b72d-406b-a883-d3419a5e065a, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c8fe88f7-b72d-406b-a883-d3419a5e065a|Name:Wikipedia, SrcID:Moracizine, URL:http://en.wikipedia.org/wiki/Moracizine|Name:Wikipedia, SrcID:Antiarrhythmic_agent, URL:http://en.wikipedia.org/wiki/Antiarrhythmic_agent|Name:DailyMed, SrcID:archiveid=132048, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=132048|Name:Wikipedia, SrcID:Sodium_channel, URL:http://en.wikipedia.org/wiki/Sodium_channel",CCOC(=O)Nc1ccc2Sc3ccccc3N(C(=O)CCN4CCOCC4)c2c1,,
3614,CHEMBL716,Quetiapine,Small molecule,1997.0,N05AH04,"N05AH04 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Diazepines, oxazepines, thiazepines and oxepines]",-tiapine,Dopamine D2 receptor antagonist,,,CHEMBL217,Dopamine D2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=a951cd63-d329-47c9-965a-582fa73a07c6#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a951cd63-d329-47c9-965a-582fa73a07c6#nlm34090-1",OCCOCCN1CCN(CC1)C2=Nc3ccccc3Sc4ccccc24,CHEMBL217,DRD2
3615,CHEMBL1201626,Chymopapain,Unknown,1982.0,M09AB01,M09AB01 [MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM: Enzymes],,Polypeptides proteolytic enzyme,"It's a proteolytic enzyme derived from papaya, which hydrolysis proteins in the nucleus pulposus, and helps to manage pain in disc herniations",,CHEMBL2364181,Polypeptides,PROTEOLYTIC ENZYME,Homo sapiens,MACROMOLECULE,,,"Name:PubMed, SrcID:18727771, URL:http://europepmc.org/abstract/MED/18727771",,,
3616,CHEMBL1201198,Pemirolast,Small molecule,1999.0,,,-ast,Unknown,"Mode of action not fully understood; it seems to inhibit calcium influx into mast cells, stabilizing them",,,,,,,,,"Name:PubMed, SrcID:22586429, URL:http://europepmc.org/abstract/MED/22586429|Name:DailyMed, SrcID:setid=18836374-7e66-45bd-8380-3f9714de0b40#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=18836374-7e66-45bd-8380-3f9714de0b40#nlm34090-1|Name:FDA, SrcID:label/2005/021079s006,008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021079s006,008lbl.pdf|Name:PubMed, SrcID:21150433, URL:http://europepmc.org/abstract/MED/21150433",CC1=CC=CN2C(=O)C(=CN=C12)c3nnn[nH]3,,
3617,CHEMBL334966,Cangrelor,Small molecule,2015.0,B01AC25,B01AC25 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Platelet aggregation inhibitors excl. heparin],-grel-,Purinergic receptor P2Y12 antagonist,,,CHEMBL2001,Purinergic receptor P2Y12,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/204958lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204958lbl.pdf",CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)C(Cl)(Cl)P(=O)(O)O)[C@@H](O)[C@H]3O,CHEMBL2001,P2RY12
3618,CHEMBL3545160,Su-14813,Small molecule,,,,,Stem cell growth factor receptor inhibitor,,,CHEMBL1936,Stem cell growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16891463, URL:http://europepmc.org/abstract/MED/16891463",,CHEMBL1936,KIT
3619,CHEMBL3545174,Gsk2881078,Small molecule,,,,,Androgen Receptor modulator,SARM,,CHEMBL1871,Androgen Receptor,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.gsk.com/en-gb/research/what-we-are-working-on/product-pipeline/, URL:http://www.gsk.com/en-gb/research/what-we-are-working-on/product-pipeline/",,CHEMBL1871,AR
3620,CHEMBL3545358,4sc-203,Small molecule,,,,,Tyrosine-protein kinase receptor FLT3 inhibitor,,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.4sc.de/sites/default/files/documents/4SC-203-Poster-ECCO-Stockholm-2011.pdf, URL:http://www.4sc.de/sites/default/files/documents/4SC-203-Poster-ECCO-Stockholm-2011.pdf|Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=666086, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=666086",,CHEMBL1974,FLT3
3621,CHEMBL3545177,Azd-0424,Small molecule,,,,,Tyrosine-protein kinase SRC inhibitor,,,CHEMBL267,Tyrosine-protein kinase SRC,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25662515, URL:http://europepmc.org/abstract/MED/25662515|Name:ClinicalTrials, SrcID:NCT01668550, URL:https://www.clinicaltrials.gov/ct2/show/NCT01668550",,CHEMBL267,SRC
3622,CHEMBL296468,Bms-387032,Small molecule,,,,,Cyclin-dependent kinase 9 inhibitor,,,CHEMBL3116,Cyclin-dependent kinase 9,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25215591, URL:http://europepmc.org/abstract/MED/25215591|Name:PubMed, SrcID:19169685, URL:http://europepmc.org/abstract/MED/19169685",CC(C)(C)c1oc(CSc2cnc(NC(=O)C3CCNCC3)s2)nc1,CHEMBL3116,CDK9
3623,CHEMBL1258517,Pki-179,Small molecule,,,,,PI3-kinase p110-alpha subunit inhibitor,ATP-competitive PI3K/mTOR inhibitor,,CHEMBL4005,PI3-kinase p110-alpha subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20797855, URL:http://europepmc.org/abstract/MED/20797855",O=C(Nc1ccncc1)Nc2ccc(cc2)c3nc(nc(n3)N4C5CCC4COC5)N6CCOCC6,CHEMBL4005,PIK3CA
3624,CHEMBL203567,Ro-3201195,Small molecule,,,,,MAP kinase p38 alpha inhibitor,Binds to both p38a (MAPK14) and p38ß (MAPK11) isoforms,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18539026, URL:http://europepmc.org/abstract/MED/18539026|Name:PubMed, SrcID:16509574, URL:http://europepmc.org/abstract/MED/16509574",Nc1c(cnn1c2ccc(F)cc2)C(=O)c3cccc(OC[C@@H](O)CO)c3,CHEMBL260,MAPK14
3625,CHEMBL3545327,Ttp-607,Small molecule,,,,,Serine/threonine-protein kinase Aurora inhibitor,,,CHEMBL3430911,Serine/threonine-protein kinase Aurora,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=650689, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=650689|Name:PubMed, SrcID:20124450, URL:http://europepmc.org/abstract/MED/20124450",,,
3626,CHEMBL3545203,Rg7342,Small molecule,,,,,Metabotropic glutamate receptor 5 modulator,Positive allosteric modulator (PAM),,CHEMBL3227,Metabotropic glutamate receptor 5,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.roche.com/de/irp2q14e-annex.pdf, URL:http://www.roche.com/de/irp2q14e-annex.pdf|Name:Other, SrcID:http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm, URL:http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm",,CHEMBL3227,GRM5
3627,CHEMBL3545270,Ly2969822,Small molecule,,,,,Metabotropic glutamate receptor 2 agonist,"From poster: orally bioavailable prodrug for a potent, selective mGlu2/3 receptor agonist, have no more information.",,CHEMBL5137,Metabotropic glutamate receptor 2,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.mglu.it/doc/poster-session-2014.pdf, URL:http://www.mglu.it/doc/poster-session-2014.pdf",,CHEMBL5137,GRM2
3628,CHEMBL3545088,Puquitinib,Small molecule,,,,-tinib,Platelet-derived growth factor receptor beta inhibitor,"Compound is most potent against PIK3CD, low potency against EGFR, KDR and PDGFRB",,CHEMBL1913,Platelet-derived growth factor receptor beta,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26499488, URL:http://europepmc.org/abstract/MED/26499488|Name:DOI, SrcID:10.1158/1538-7445.AM2011-4245, URL:http://cancerres.aacrjournals.org/content/71/8_Supplement/4245|Name:PubMed, SrcID:26510909, URL:http://europepmc.org/abstract/MED/26510909",,CHEMBL1913,PDGFRB
3629,CHEMBL3545392,Mt-3995,Small molecule,,,,,Mineralocorticoid receptor antagonist,,,CHEMBL1994,Mineralocorticoid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.mt-pharma.co.jp/e/develop/pipeline/e_pipeline1409.pdf, URL:http://www.mt-pharma.co.jp/e/develop/pipeline/e_pipeline1409.pdf",,,
3630,CHEMBL1908373,Onapristone,Small molecule,,,,-pristone,Progesterone receptor antagonist,,,CHEMBL208,Progesterone receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.arnothera.com/onapristone.html, URL:http://www.arnothera.com/onapristone.html|Name:PubMed, SrcID:15790602, URL:http://europepmc.org/abstract/MED/15790602",CN(C)c1ccc(cc1)[C@H]2C[C@]3(C)[C@@H](CC[C@]3(O)CCCO)[C@@H]4CCC5=CC(=O)CCC5=C24,CHEMBL208,PGR
3631,CHEMBL2105728,Crenolanib,Small molecule,,,,-anib,Tyrosine-protein kinase receptor FLT3 inhibitor,,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://arogpharma.com/crenolanib, URL:http://arogpharma.com/crenolanib|Name:PubMed, SrcID:24623852, URL:http://europepmc.org/abstract/MED/24623852",CC1(COc2ccc3c(c2)ncn3c4ccc5cccc(N6CCC(N)CC6)c5n4)COC1,CHEMBL1974,FLT3
3632,CHEMBL3120215,Osi-027,Small molecule,,,,,Serine/threonine-protein kinase mTOR inhibitor,ATP-competitive mTORC1/mTORC2 inhibitor,,CHEMBL2842,Serine/threonine-protein kinase mTOR,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21673091, URL:http://europepmc.org/abstract/MED/21673091",COc1cccc2cc([nH]c12)c3nc([C@@H]4CC[C@H](CC4)C(=O)O)n5ncnc(N)c35,CHEMBL2842,MTOR
3633,CHEMBL564829,Milciclib,Small molecule,,,,-ciclib,Cyclin-dependent kinase 2 inhibitor,,,CHEMBL301,Cyclin-dependent kinase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25215591, URL:http://europepmc.org/abstract/MED/25215591|Name:PubMed, SrcID:20682657, URL:http://europepmc.org/abstract/MED/20682657",CNC(=O)c1nn(C)c2c3nc(Nc4ccc(cc4)N5CCN(C)CC5)ncc3CC(C)(C)c12,CHEMBL301,CDK2
3634,CHEMBL3544983,Tesevatinib,Small molecule,,,,-tinib,Epidermal growth factor receptor erbB1 inhibitor,,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17575237, URL:http://europepmc.org/abstract/MED/17575237|Name:Other, SrcID:http://kadmon.com/press/kadmon-corporation-presents-encouraging-nonclinical-data-on-tesevatinib-kd019-at-aacr-annual-meeting/, URL:http://kadmon.com/press/kadmon-corporation-presents-encouraging-nonclinical-data-on-tesevatinib-kd019-at-aacr-annual-meeting/|Name:PubMed, SrcID:22173702, URL:http://europepmc.org/abstract/MED/22173702",COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]4C[C@@H]5CN(C)C[C@@H]5C4,CHEMBL203,EGFR
3635,CHEMBL2110932,Elzasonan,Small molecule,,,,-sonan,Serotonin 1b (5-HT1b) receptor antagonist,,,CHEMBL1898,Serotonin 1b (5-HT1b) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Elzasonan, URL:https://en.wikipedia.org/wiki/Elzasonan|Name:PubMed, SrcID:20668248, URL:http://europepmc.org/abstract/MED/20668248",CN1CCN(CC1)c2ccccc2\C=C/3\SCCN(C3=O)c4ccc(Cl)c(Cl)c4,CHEMBL1898,HTR1B
3636,CHEMBL593430,Atagabalin,Small molecule,,,,-gab-,Voltage-gated calcium channel modulator,Ligand for the voltage-gated calcium channel alpha-2-delta subunit.,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:19694735, URL:http://europepmc.org/abstract/MED/19694735|Name:Wikipedia, SrcID:Atagabalin, URL:https://en.wikipedia.org/wiki/Atagabalin",C[C@H]1CC(CN)(CC(=O)O)C[C@@H]1C,CHEMBL2363032,CACNB3
3637,CHEMBL593430,Atagabalin,Small molecule,,,,-gab-,Voltage-gated calcium channel modulator,Ligand for the voltage-gated calcium channel alpha-2-delta subunit.,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:19694735, URL:http://europepmc.org/abstract/MED/19694735|Name:Wikipedia, SrcID:Atagabalin, URL:https://en.wikipedia.org/wiki/Atagabalin",C[C@H]1CC(CN)(CC(=O)O)C[C@@H]1C,CHEMBL2363032,CACNG3
3638,CHEMBL593430,Atagabalin,Small molecule,,,,-gab-,Voltage-gated calcium channel modulator,Ligand for the voltage-gated calcium channel alpha-2-delta subunit.,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:19694735, URL:http://europepmc.org/abstract/MED/19694735|Name:Wikipedia, SrcID:Atagabalin, URL:https://en.wikipedia.org/wiki/Atagabalin",C[C@H]1CC(CN)(CC(=O)O)C[C@@H]1C,CHEMBL2363032,CACNG5
3639,CHEMBL593430,Atagabalin,Small molecule,,,,-gab-,Voltage-gated calcium channel modulator,Ligand for the voltage-gated calcium channel alpha-2-delta subunit.,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:19694735, URL:http://europepmc.org/abstract/MED/19694735|Name:Wikipedia, SrcID:Atagabalin, URL:https://en.wikipedia.org/wiki/Atagabalin",C[C@H]1CC(CN)(CC(=O)O)C[C@@H]1C,CHEMBL2363032,CACNG4
3640,CHEMBL593430,Atagabalin,Small molecule,,,,-gab-,Voltage-gated calcium channel modulator,Ligand for the voltage-gated calcium channel alpha-2-delta subunit.,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:19694735, URL:http://europepmc.org/abstract/MED/19694735|Name:Wikipedia, SrcID:Atagabalin, URL:https://en.wikipedia.org/wiki/Atagabalin",C[C@H]1CC(CN)(CC(=O)O)C[C@@H]1C,CHEMBL2363032,CACNG1
3641,CHEMBL593430,Atagabalin,Small molecule,,,,-gab-,Voltage-gated calcium channel modulator,Ligand for the voltage-gated calcium channel alpha-2-delta subunit.,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:19694735, URL:http://europepmc.org/abstract/MED/19694735|Name:Wikipedia, SrcID:Atagabalin, URL:https://en.wikipedia.org/wiki/Atagabalin",C[C@H]1CC(CN)(CC(=O)O)C[C@@H]1C,CHEMBL2363032,CACNB4
3642,CHEMBL593430,Atagabalin,Small molecule,,,,-gab-,Voltage-gated calcium channel modulator,Ligand for the voltage-gated calcium channel alpha-2-delta subunit.,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:19694735, URL:http://europepmc.org/abstract/MED/19694735|Name:Wikipedia, SrcID:Atagabalin, URL:https://en.wikipedia.org/wiki/Atagabalin",C[C@H]1CC(CN)(CC(=O)O)C[C@@H]1C,CHEMBL2363032,CACNA2D4
3643,CHEMBL593430,Atagabalin,Small molecule,,,,-gab-,Voltage-gated calcium channel modulator,Ligand for the voltage-gated calcium channel alpha-2-delta subunit.,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:19694735, URL:http://europepmc.org/abstract/MED/19694735|Name:Wikipedia, SrcID:Atagabalin, URL:https://en.wikipedia.org/wiki/Atagabalin",C[C@H]1CC(CN)(CC(=O)O)C[C@@H]1C,CHEMBL2363032,CACNG2
3644,CHEMBL593430,Atagabalin,Small molecule,,,,-gab-,Voltage-gated calcium channel modulator,Ligand for the voltage-gated calcium channel alpha-2-delta subunit.,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:19694735, URL:http://europepmc.org/abstract/MED/19694735|Name:Wikipedia, SrcID:Atagabalin, URL:https://en.wikipedia.org/wiki/Atagabalin",C[C@H]1CC(CN)(CC(=O)O)C[C@@H]1C,CHEMBL2363032,CACNG7
3645,CHEMBL593430,Atagabalin,Small molecule,,,,-gab-,Voltage-gated calcium channel modulator,Ligand for the voltage-gated calcium channel alpha-2-delta subunit.,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:19694735, URL:http://europepmc.org/abstract/MED/19694735|Name:Wikipedia, SrcID:Atagabalin, URL:https://en.wikipedia.org/wiki/Atagabalin",C[C@H]1CC(CN)(CC(=O)O)C[C@@H]1C,CHEMBL2363032,CACNG8
3646,CHEMBL593430,Atagabalin,Small molecule,,,,-gab-,Voltage-gated calcium channel modulator,Ligand for the voltage-gated calcium channel alpha-2-delta subunit.,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:19694735, URL:http://europepmc.org/abstract/MED/19694735|Name:Wikipedia, SrcID:Atagabalin, URL:https://en.wikipedia.org/wiki/Atagabalin",C[C@H]1CC(CN)(CC(=O)O)C[C@@H]1C,CHEMBL2363032,CACNG6
3647,CHEMBL593430,Atagabalin,Small molecule,,,,-gab-,Voltage-gated calcium channel modulator,Ligand for the voltage-gated calcium channel alpha-2-delta subunit.,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:19694735, URL:http://europepmc.org/abstract/MED/19694735|Name:Wikipedia, SrcID:Atagabalin, URL:https://en.wikipedia.org/wiki/Atagabalin",C[C@H]1CC(CN)(CC(=O)O)C[C@@H]1C,CHEMBL2363032,CACNA1F
3648,CHEMBL593430,Atagabalin,Small molecule,,,,-gab-,Voltage-gated calcium channel modulator,Ligand for the voltage-gated calcium channel alpha-2-delta subunit.,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:19694735, URL:http://europepmc.org/abstract/MED/19694735|Name:Wikipedia, SrcID:Atagabalin, URL:https://en.wikipedia.org/wiki/Atagabalin",C[C@H]1CC(CN)(CC(=O)O)C[C@@H]1C,CHEMBL2363032,CACNB1
3649,CHEMBL593430,Atagabalin,Small molecule,,,,-gab-,Voltage-gated calcium channel modulator,Ligand for the voltage-gated calcium channel alpha-2-delta subunit.,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:19694735, URL:http://europepmc.org/abstract/MED/19694735|Name:Wikipedia, SrcID:Atagabalin, URL:https://en.wikipedia.org/wiki/Atagabalin",C[C@H]1CC(CN)(CC(=O)O)C[C@@H]1C,CHEMBL2363032,CACNA2D3
3650,CHEMBL1743027,Girentuximab,Antibody,,,,-mab,Carbonic anhydrase IX other,"Binds to the CA9 (G250) antigen expressed on the tumour cells, thereby triggering an immune reaction called Antibody-Dependent Cellular Cytotoxicity (ADCC). Through this mechanism, effector cells, e.g. NK (natural killer) cells, of the immune system are activated to kill the tumour cells.",,CHEMBL3594,Carbonic anhydrase IX,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11941456, URL:http://europepmc.org/abstract/MED/11941456|Name:Other, SrcID:http://www.wilex.de/portfolio-english/rencarex/therapeutic-target/, URL:http://www.wilex.de/portfolio-english/rencarex/therapeutic-target/",,CHEMBL3594,CA9
3651,CHEMBL2109621,Di17e6,Antibody,,,,,Integrin alpha-V/beta-1 inhibitor,"Inhibits ligand binding to all alphav heterodimers (alphavbeta1, alphavbeta3, alphavbeta5, alphavbeta6, alphavbeta8).",Specifically directed against the alphaV subunit of human integrins.,CHEMBL2111407,Integrin alpha-V/beta-1,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23791392, URL:http://europepmc.org/abstract/MED/23791392",,,
3652,CHEMBL2109623,Stx-100,Antibody,,,,,Integrin alpha-V/beta-6 inhibitor,,,CHEMBL2111416,Integrin alpha-V/beta-6,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PMC, SrcID:PMC3944742, URL:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944742|Name:PubMed, SrcID:17916809, URL:http://europepmc.org/abstract/MED/17916809",,CHEMBL2111416,ITGB6
3653,CHEMBL1742998,Cantuzumab Ravtansine,Antibody,,,,-mab,Mucin-1 binding agent,"Cantuzumab ravtansine is generated based on MoAb C242, which is raised against a cell surface superantigen, CA242, found in a variety of human tumor cells. Upon binding and entry, the immunoconjugate releases the maytansinoid agent DM4, which binds to tubulin, thereby affecting microtubule assembly/disassembly dynamics.",,CHEMBL3580494,Mucin-1,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=492706, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=492706",,,
3654,CHEMBL1743032,Intetumumab,Antibody,,,,-mab,Integrin alpha-V/beta-6 antagonist,,,CHEMBL2111416,Integrin alpha-V/beta-6,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:15095296, URL:http://europepmc.org/abstract/MED/15095296",,CHEMBL2111416,ITGB6
3655,CHEMBL1743054,Ozoralizumab,Antibody,,,,-mab,TNF-alpha inhibitor,Trivalent albumin-binding nanobody that neutralizes the pro-inflammatory tumor necrosis factor alpha (TNF-alpha) as a causative agent for exacerbating rheumatoid arthritis. It binds to serum to increase its in vivo half-life.,,CHEMBL1825,TNF-alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22155554, URL:http://europepmc.org/abstract/MED/22155554",,CHEMBL1825,TNF
3656,CHEMBL1450,Atovaquone,Small molecule,1992.0,P01AX06,"P01AX06 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES: Other agents against amoebiasis and other protozoal diseases]",,Cytochrome b inhibitor,,,CHEMBL1777,Cytochrome b,INHIBITOR,Plasmodium falciparum,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=b426b6bf-f07e-4580-97ae-dfca1ddf5b8f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b426b6bf-f07e-4580-97ae-dfca1ddf5b8f#nlm34090-1|Name:PubMed, SrcID:20855748, URL:http://europepmc.org/abstract/MED/20855748",OC1=C([C@@H]2CC[C@H](CC2)c3ccc(Cl)cc3)C(=O)c4ccccc4C1=O,,
3657,CHEMBL1382,Tolterodine,Small molecule,1998.0,G04BD07,G04BD07 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Drugs for urinary frequency and incontinence],,Muscarinic acetylcholine receptor M3 antagonist,"Indicated for overactive bladder, M3 likely responsible",,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Tolterodine#Pharmacology, URL:http://en.wikipedia.org/wiki/Tolterodine#Pharmacology|Name:DailyMed, SrcID:setid=5e29f133-270c-4e5a-8493-e038c163a891, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e29f133-270c-4e5a-8493-e038c163a891|Name:PubMed, SrcID:16465186, URL:http://europepmc.org/abstract/MED/16465186",CC(C)N(CC[C@H](c1ccccc1)c2cc(C)ccc2O)C(C)C,CHEMBL245,CHRM3
3658,CHEMBL524004,Mepenzolate,Small molecule,1956.0,A03AB12,"A03AB12 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: Synthetic anticholinergics, quaternary ammonium compounds]",,Muscarinic acetylcholine receptor M3 antagonist,"Role in regulating gastric secretion, M3 likely involved",,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:7122991, URL:http://europepmc.org/abstract/MED/7122991|Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:6345649, URL:http://europepmc.org/abstract/MED/6345649",C[N+]1(C)CCCC(C1)OC(=O)C(O)(c2ccccc2)c3ccccc3,CHEMBL245,CHRM3
3659,CHEMBL1495,Oxyphencyclimine,Small molecule,1982.0,A03AA01,"A03AA01 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: Synthetic anticholinergics, esters with tertiary amino group]",,Muscarinic acetylcholine receptor M3 antagonist,"Role in regulating gastric secretion, M3 likely involved",,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:14492109, URL:http://europepmc.org/abstract/MED/14492109|Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:14168823, URL:http://europepmc.org/abstract/MED/14168823",CN1CCCN=C1COC(=O)C(O)(C2CCCCC2)c3ccccc3,CHEMBL245,CHRM3
3660,CHEMBL2108147,Streptokinase,Enzyme,1997.0,B06AA55; B01AD01,B06AA55 [BLOOD AND BLOOD FORMING ORGANS: OTHER HEMATOLOGICAL AGENTS: OTHER HEMATOLOGICAL AGENTS: Enzymes]; B01AD01 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Enzymes],-ase,Plasminogen activator,,,CHEMBL1801,Plasminogen,ACTIVATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:14367349, URL:http://europepmc.org/abstract/MED/14367349|Name:PubMed, SrcID:14927798, URL:http://europepmc.org/abstract/MED/14927798|Name:PubMed, SrcID:9733510, URL:http://europepmc.org/abstract/MED/9733510",,CHEMBL1801,PLG
3661,CHEMBL2107885,Reteplase,Enzyme,1996.0,B01AD07,B01AD07 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Enzymes],-ase,Plasminogen activator,,,CHEMBL1801,Plasminogen,ACTIVATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=e9ae6656-977c-4105-8528-bee664aab27a#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e9ae6656-977c-4105-8528-bee664aab27a#nlm34090-1",,CHEMBL1801,PLG
3662,CHEMBL1189432,Olopatadine,Small molecule,1996.0,R01AC08; S01GX09,"R01AC08 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Antiallergic agents, excl. corticosteroids]; S01GX09 [SENSORY ORGANS: OPHTHALMOLOGICALS: DECONGESTANTS AND ANTIALLERGICS: Other antiallergics]",-(a)tadine,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=6393e997-7080-4ce6-8a34-2f80b48f5a3a, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6393e997-7080-4ce6-8a34-2f80b48f5a3a",CN(C)CC\C=C/1\c2ccccc2COc3ccc(CC(=O)O)cc13,CHEMBL231,HRH1
3663,CHEMBL1515,Methimazole,Small molecule,1950.0,H03BB52; H03BB02,"H03BB52 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: THYROID THERAPY: ANTITHYROID PREPARATIONS: Sulfur-containing imidazole derivatives]; H03BB02 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: THYROID THERAPY: ANTITHYROID PREPARATIONS: Sulfur-containing imidazole derivatives]",,Thyroid peroxidase inhibitor,,,CHEMBL1839,Thyroid peroxidase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=2d70b747-314c-4baa-95c4-1734855a1556, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2d70b747-314c-4baa-95c4-1734855a1556",CN1C=CNC1=S,CHEMBL1839,TPO
3664,CHEMBL1251,Ganirelix Acetate,Protein,1999.0,H01CC01,"H01CC01 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: HYPOTHALAMIC HORMONES: Anti-gonadotropin-releasing hormones]",-relix,Gonadotropin-releasing hormone receptor antagonist,,,CHEMBL1855,Gonadotropin-releasing hormone receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=96118395-557e-4998-842d-424a59d574b6, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=96118395-557e-4998-842d-424a59d574b6",CCN\C(=N/CC)\NCCCC[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc2cccnc2)NC(=O)[C@@H](Cc3ccc(Cl)cc3)NC(=O)[C@@H](Cc4ccc5ccccc5c4)NC(=O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN\C(=N\CC)\NCC)C(=O)N6CCC[C@H]6C(=O)N[C@H](C)C(=O)N,CHEMBL1855,GNRHR
3665,CHEMBL1505,Almotriptan,Small molecule,2001.0,N02CC05,N02CC05 [NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Selective serotonin (5HT1) agonists],-triptan,Serotonin 1b (5-HT1b) receptor agonist,,Selective,CHEMBL1898,Serotonin 1b (5-HT1b) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2009/021001s010s011lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021001s010s011lbl.pdf",CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12,CHEMBL1898,HTR1B
3666,CHEMBL1466,Dicumarol,Small molecule,1944.0,B01AA01,B01AA01 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Vitamin K antagonists],-arol,Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor,,,CHEMBL1930,Vitamin k epoxide reductase complex subunit 1 isoform 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18374197, URL:http://europepmc.org/abstract/MED/18374197",OC1=C(CC2=C(O)c3ccccc3OC2=O)C(=O)Oc4ccccc14,CHEMBL1930,VKORC1
3667,CHEMBL653,Nizatidine,Small molecule,1988.0,A02BA04,A02BA04 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): H2-receptor antagonists],-tidine,Histamine H2 receptor antagonist,,,CHEMBL1941,Histamine H2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=66e33307-1191-40cc-8501-6fd5d10ab18f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=66e33307-1191-40cc-8501-6fd5d10ab18f",CN\C(=C/[N+](=O)[O-])\NCCSCc1csc(CN(C)C)n1,CHEMBL1941,HRH2
3668,CHEMBL1201496,Insulin Aspart,Protein,2000.0,A10AB05; A10AD05,"A10AB05 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: INSULINS AND ANALOGUES: Insulins and analogues for injection, fast-acting]; A10AD05 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: INSULINS AND ANALOGUES: Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting]",,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=3a1e73a2-3009-40d0-876c-b4cb2be56fc5, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3a1e73a2-3009-40d0-876c-b4cb2be56fc5",,CHEMBL1981,INSR
3669,CHEMBL612,Dextroamphetamine,Small molecule,1955.0,N06BA02,"N06BA02 [NERVOUS SYSTEM: PSYCHOANALEPTICS: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS: Centrally acting sympathomimetics]",,Dopamine transporter releasing agent,,,CHEMBL238,Dopamine transporter,RELEASING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16122767, URL:http://europepmc.org/abstract/MED/16122767|Name:PubMed, SrcID:7869099, URL:http://europepmc.org/abstract/MED/7869099|Name:PubMed, SrcID:19244097, URL:http://europepmc.org/abstract/MED/19244097",C[C@H](N)Cc1ccccc1,CHEMBL238,SLC6A3
3670,CHEMBL1200845,Halcinonide,Small molecule,1974.0,D07AD02,"D07AD02 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, very potent (group IV)]",-onide,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:3494458, URL:http://europepmc.org/abstract/MED/3494458|Name:PubMed, SrcID:22127244, URL:http://europepmc.org/abstract/MED/22127244",CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CCl,CHEMBL2034,NR3C1
3671,CHEMBL1201064,Fluorometholone Acetate,Small molecule,1986.0,D07XB04; S01CB05; S01BA07; D07AB06; D10AA01; C05AA06,"D07XB04 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, OTHER COMBINATIONS: Corticosteroids, moderately potent, other combinations]; S01CB05 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION: Corticosteroids/antiinfectives/mydriatics in combination]; S01BA07 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Corticosteroids, plain]; D07AB06 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, moderately potent (group II)]; D10AA01 [DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Corticosteroids, combinations for treatment of acne]; C05AA06 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Corticosteroids]",-olone,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Expert, SrcID:, URL:|Name:PubMed, SrcID:21482870, URL:http://europepmc.org/abstract/MED/21482870|Name:DailyMed, SrcID:setid=6ae122c0-eb4f-4124-96d7-ba5e9a350d35, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6ae122c0-eb4f-4124-96d7-ba5e9a350d35",C[C@H]1C[C@H]2[C@@H]3CC[C@](OC(=O)C)(C(=O)C)[C@@]3(C)C[C@H](O)[C@]2(F)[C@@]4(C)C=CC(=O)C=C14,CHEMBL2034,NR3C1
3672,CHEMBL1201148,Meprednisone,Small molecule,1982.0,H02AB15,"H02AB15 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Glucocorticoids]",-pred-,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Expert, SrcID:, URL:|Name:PubMed, SrcID:3772747, URL:http://europepmc.org/abstract/MED/3772747|Name:Wikipedia, SrcID:Meprednisone, URL:http://en.wikipedia.org/wiki/Meprednisone|Name:ISBN, SrcID:0471-948470 PP. 330-331, URL:http://www.isbnsearch.org/isbn/0471948470",C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3C(=O)C[C@]2(C)[C@@]1(O)C(=O)CO,CHEMBL2034,NR3C1
3673,CHEMBL2040682,Ciclesonide,Small molecule,2006.0,R01AD13; R03BA08,"R01AD13 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Corticosteroids]; R03BA08 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS: Glucocorticoids]",-onide,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21437141, URL:http://europepmc.org/abstract/MED/21437141|Name:DailyMed, SrcID:setid=e4d92dc8-9bde-45af-a79f-13d80a812768#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e4d92dc8-9bde-45af-a79f-13d80a812768#nlm34090-1",CC(C)C(=O)OCC(=O)[C@@]12O[C@@H](O[C@@H]1C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]23C)C6CCCCC6,CHEMBL2034,NR3C1
3674,CHEMBL72,Desipramine,Small molecule,1964.0,N06AA01,N06AA01 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Non-selective monoamine reuptake inhibitors],-pramine,Norepinephrine transporter inhibitor,reuptake inhibitor,,CHEMBL222,Norepinephrine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=3433c754-cc2e-4e72-bd82-16ed4af3144d#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3433c754-cc2e-4e72-bd82-16ed4af3144d#nlm34090-1",CNCCCN1c2ccccc2CCc3ccccc13,CHEMBL222,SLC6A2
3675,CHEMBL405,Amphetamine,Small molecule,1955.0,N06BA01,"N06BA01 [NERVOUS SYSTEM: PSYCHOANALEPTICS: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS: Centrally acting sympathomimetics]",,Norepinephrine transporter releasing agent,,,CHEMBL222,Norepinephrine transporter,RELEASING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:KEGG, SrcID:D07445, URL:http://www.kegg.jp/dbget-bin/www_bget?dr:D07445",CC(N)Cc1ccccc1,CHEMBL222,SLC6A2
3676,CHEMBL1086,Dibucaine,Small molecule,1982.0,C05AD04; N01BB06; S01HA06; S02DA04; D04AB02,"C05AD04 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Local anesthetics]; N01BB06 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Amides]; S01HA06 [SENSORY ORGANS: OPHTHALMOLOGICALS: LOCAL ANESTHETICS: Local anesthetics]; S02DA04 [SENSORY ORGANS: OTOLOGICALS: OTHER OTOLOGICALS: Analgesics and anesthetics]; D04AB02 [DERMATOLOGICALS: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: Anesthetics for topical use]",-caine,Sodium channel protein type X alpha subunit blocker,,,CHEMBL5451,Sodium channel protein type X alpha subunit,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:8798723, URL:http://europepmc.org/abstract/MED/8798723|Name:PubMed, SrcID:9742684, URL:http://europepmc.org/abstract/MED/9742684",CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1,CHEMBL5451,SCN10A
3677,CHEMBL870,Alendronic Acid,Small molecule,1995.0,M05BA04,M05BA04 [MUSCULO-SKELETAL SYSTEM: DRUGS FOR TREATMENT OF BONE DISEASES: DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION: Bisphosphonates],-dronate,Farnesyl diphosphate synthase inhibitor,"Binds to the bone matrix (hydroxyapatite), and when the bone starts to be reabsorbed the compound is released and taken up by osteoclasts, inhibiting protein prenylation of the GTPases involved in the formation of the ruffled border",,CHEMBL1782,Farnesyl diphosphate synthase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16835450, URL:http://europepmc.org/abstract/MED/16835450|Name:ISBN, SrcID:9780702034718 PP. 437-438, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:15028820, URL:http://europepmc.org/abstract/MED/15028820|Name:PubMed, SrcID:11160603, URL:http://europepmc.org/abstract/MED/11160603|Name:PubMed, SrcID:16006204, URL:http://europepmc.org/abstract/MED/16006204",NCCCC(O)(P(=O)(O)O)P(=O)(O)O,CHEMBL1782,FDPS
3678,CHEMBL1144,Pravastatin,Small molecule,1991.0,C10AA03,"C10AA03 [CARDIOVASCULAR SYSTEM: LIPID MODIFYING AGENTS: LIPID MODIFYING AGENTS, PLAIN: HMG CoA reductase inhibitors]",-stat-,HMG-CoA reductase inhibitor,,,CHEMBL402,HMG-CoA reductase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=897ad8b7-921d-eb02-a61c-3419e662a2da, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=897ad8b7-921d-eb02-a61c-3419e662a2da",CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@@H]12,CHEMBL402,HMGCR
3679,CHEMBL139,Diclofenac,Small molecule,1988.0,S01BC03; M02AA15; M01AB05; D11AX18; M01AB55,"S01BC03 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Antiinflammatory agents, non-steroids]; M02AA15 [MUSCULO-SKELETAL SYSTEM: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: Antiinflammatory preparations, non-steroids for topical use]; M01AB05 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Acetic acid derivatives and related substances]; D11AX18 [DERMATOLOGICALS: OTHER DERMATOLOGICAL PREPARATIONS: OTHER DERMATOLOGICAL PREPARATIONS: Other dermatologicals]; M01AB55 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Acetic acid derivatives and related substances]",-ac,Cyclooxygenase inhibitor,,,CHEMBL2094253,Cyclooxygenase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:12534640, URL:http://europepmc.org/abstract/MED/12534640|Name:PubMed, SrcID:12925531, URL:http://europepmc.org/abstract/MED/12925531|Name:FDA, SrcID:label/2013/204592s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204592s000lbl.pdf|Name:Wikipedia, SrcID:Diclofenac#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Diclofenac#Mechanism_of_action|Name:PubMed, SrcID:12713596, URL:http://europepmc.org/abstract/MED/12713596",OC(=O)Cc1ccccc1Nc2c(Cl)cccc2Cl,,
3680,CHEMBL1311,Isosorbide Mononitrate,Small molecule,1991.0,C01DA14,C01DA14 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: VASODILATORS USED IN CARDIAC DISEASES: Organic nitrates],,Soluble guanylate cyclase activator,,,CHEMBL2111348,Soluble guanylate cyclase,ACTIVATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Soluble guanylate cyclase beta subunit,"Heterodimer, beta (1 or 2) is binding site","Name:FDA, SrcID:nda/98/75041_Isosorbide%20Mononitrate_prntlbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/75041_Isosorbide%20Mononitrate_prntlbl.pdf|Name:ISBN, SrcID:9780702034718 PP. 260-261, URL:http://www.isbnsearch.org/isbn/9780702034718",O[C@H]1CO[C@@H]2[C@@H](CO[C@H]12)O[N+](=O)[O-],CHEMBL2111348,GUCY1A2
3681,CHEMBL535,Sunitinib,Small molecule,2006.0,L01XE04,L01XE04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Vascular endothelial growth factor receptor inhibitor,,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14",CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C\2/C(=O)Nc3ccc(F)cc23)c1C,,
3682,CHEMBL1946170,Regorafenib,Small molecule,2012.0,L01XE21,L01XE21 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-rafenib,Vascular endothelial growth factor receptor inhibitor,,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Expert, SrcID:REGORAFENIB, URL:http://chembl.blogspot.co.uk/search?q=REGORAFENIB",CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,,
3683,CHEMBL218394,Boceprevir,Small molecule,2011.0,J05AE12,J05AE12 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Protease inhibitors],-vir,"Hepatitis C virus serine protease, NS3/NS4A inhibitor",,,CHEMBL2095231,"Hepatitis C virus serine protease, NS3/NS4A",INHIBITOR,Hepatitis C virus,PROTEIN COMPLEX,,,"Name:DailyMed, SrcID:setid=ae879ebe-b620-4829-b6f8-74b58da1c771#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ae879ebe-b620-4829-b6f8-74b58da1c771#nlm34090-1|Name:Expert, SrcID:BOCEPREVIR, URL:http://chembl.blogspot.co.uk/search?q=BOCEPREVIR",CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC3CCC3)C(=O)C(=O)N)C2(C)C)C(C)(C)C,,
3684,CHEMBL806,Flutamide,Small molecule,1989.0,L02BB01,L02BB01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONE ANTAGONISTS AND RELATED AGENTS: Anti-androgens],-lutamide,Androgen Receptor antagonist,,,CHEMBL1871,Androgen Receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2001/18554s23lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/18554s23lbl.pdf|Name:DailyMed, SrcID:setid=68322b78-8b39-4d42-9889-6126cdd7d43a, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=68322b78-8b39-4d42-9889-6126cdd7d43a",CC(C)C(=O)Nc1ccc(c(c1)C(F)(F)F)[N+](=O)[O-],CHEMBL1871,AR
3685,CHEMBL1518,Propylthiouracil,Small molecule,1947.0,H03BA02,"H03BA02 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: THYROID THERAPY: ANTITHYROID PREPARATIONS: Thiouracils]",-uracil,Type I iodothyronine deiodinase (Type-I 5&apos;deiodinase) (DIOI) (Type 1 DI) (5DI) inhibitor,,,CHEMBL2019,Type I iodothyronine deiodinase (Type-I 5'-deiodinase) (DIOI) (Type 1 DI) (5DI),INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:8641212, URL:http://europepmc.org/abstract/MED/8641212|Name:Wikipedia, SrcID:Propylthiouracil, URL:http://en.wikipedia.org/wiki/Propylthiouracil|Name:Wikipedia, SrcID:Iodothyronine_deiodinase, URL:http://en.wikipedia.org/wiki/Iodothyronine_deiodinase",CCCC1=CC(=O)NC(=S)N1,CHEMBL2019,DIO1
3686,CHEMBL189,Milrinone,Small molecule,1987.0,C01CE02,C01CE02 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES: Phosphodiesterase inhibitors],-rinone,Phosphodiesterase 3A inhibitor,,,CHEMBL241,Phosphodiesterase 3A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=30c46443-aaff-4681-91a9-8293c11dd95c, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=30c46443-aaff-4681-91a9-8293c11dd95c|Name:FDA, SrcID:label/2002/75660_Milrinone%20Lactate_Prntlbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/75660_Milrinone%20Lactate_Prntlbl.pdf",CC1=C(C=C(C#N)C(=O)N1)c2ccncc2,CHEMBL241,PDE3A
3687,CHEMBL856,Primidone,Small molecule,1954.0,N03AA03,N03AA03 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Barbiturates and derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:Wikipedia, SrcID:Primidone, URL:http://en.wikipedia.org/wiki/Primidone|Name:Wikipedia, SrcID:Phenobarbital#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Phenobarbital#Mechanism_of_action|Name:ISBN, SrcID:9780702034718 PP. 546-548, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:2871724, URL:http://europepmc.org/abstract/MED/2871724",CCC1(C(=O)NCNC1=O)c2ccccc2,CHEMBL2093872,GABRG3
3688,CHEMBL856,Primidone,Small molecule,1954.0,N03AA03,N03AA03 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Barbiturates and derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:Wikipedia, SrcID:Primidone, URL:http://en.wikipedia.org/wiki/Primidone|Name:Wikipedia, SrcID:Phenobarbital#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Phenobarbital#Mechanism_of_action|Name:ISBN, SrcID:9780702034718 PP. 546-548, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:2871724, URL:http://europepmc.org/abstract/MED/2871724",CCC1(C(=O)NCNC1=O)c2ccccc2,CHEMBL2093872,GABRP
3689,CHEMBL856,Primidone,Small molecule,1954.0,N03AA03,N03AA03 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Barbiturates and derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:Wikipedia, SrcID:Primidone, URL:http://en.wikipedia.org/wiki/Primidone|Name:Wikipedia, SrcID:Phenobarbital#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Phenobarbital#Mechanism_of_action|Name:ISBN, SrcID:9780702034718 PP. 546-548, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:2871724, URL:http://europepmc.org/abstract/MED/2871724",CCC1(C(=O)NCNC1=O)c2ccccc2,CHEMBL2093872,GABRE
3690,CHEMBL856,Primidone,Small molecule,1954.0,N03AA03,N03AA03 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Barbiturates and derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:Wikipedia, SrcID:Primidone, URL:http://en.wikipedia.org/wiki/Primidone|Name:Wikipedia, SrcID:Phenobarbital#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Phenobarbital#Mechanism_of_action|Name:ISBN, SrcID:9780702034718 PP. 546-548, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:2871724, URL:http://europepmc.org/abstract/MED/2871724",CCC1(C(=O)NCNC1=O)c2ccccc2,CHEMBL2093872,GABRG1
3691,CHEMBL1201046,Ceforanide,Small molecule,1984.0,J01DC11,J01DC11 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Second-generation cephalosporins],cef-,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:PubMed, SrcID:3266730, URL:http://europepmc.org/abstract/MED/3266730|Name:PubMed, SrcID:6762529, URL:http://europepmc.org/abstract/MED/6762529|Name:Wikipedia, SrcID:Penicillin_binding_proteins#Function, URL:http://en.wikipedia.org/wiki/Penicillin_binding_proteins#Function",NCc1ccccc1CC(=O)N[C@H]2[C@H]3SCC(=C(N3C2=O)C(=O)O)CSc4nnnn4CC(=O)O,,
3692,CHEMBL1200649,Quinupristin,Small molecule,1999.0,,,-pristin,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,23S ribosomal RNA,23S RRNA,"Name:DailyMed, SrcID:setid=28f698df-b584-4455-2e94-6efc41313960, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=28f698df-b584-4455-2e94-6efc41313960|Name:Wikipedia, SrcID:Synercid#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Synercid#Mechanism_of_action|Name:PubMed, SrcID:15991995, URL:http://europepmc.org/abstract/MED/15991995",CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@@H]3CC(=O)[C@H](CS[C@@H]4CN5CCC4CC5)CN3C(=O)[C@H](Cc6ccc(cc6)N(C)C)N(C)C(=O)[C@@H]7CCCN7C1=O)c8ccccc8,,
3693,CHEMBL314854,Fingolimod,Small molecule,2010.0,L04AA27,L04AA27 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Selective immunosuppressants],-imod,Sphingosine 1-phosphate receptor agonist,,EDG5 less relevant,CHEMBL2363041,Sphingosine 1-phosphate receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=cc9e1c8c-0e2b-44e2-878b-27057f786be9#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cc9e1c8c-0e2b-44e2-878b-27057f786be9#section-13",CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1,,
3694,CHEMBL1242,Phenazopyridine,Small molecule,1987.0,G04BX06,G04BX06 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Other urologicals],,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:8799190, URL:http://europepmc.org/abstract/MED/8799190|Name:PubMed, SrcID:15635807, URL:http://europepmc.org/abstract/MED/15635807|Name:PubMed, SrcID:20976818, URL:http://europepmc.org/abstract/MED/20976818|Name:DailyMed, SrcID:setid=78506c63-8061-499c-a57e-bdd88f805591#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=78506c63-8061-499c-a57e-bdd88f805591#nlm34090-1",Nc1ccc(N=Nc2ccccc2)c(N)n1,,
3695,CHEMBL1762,Tocainide,Small molecule,1984.0,C01BB03,"C01BB03 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class Ib]",,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:Wikipedia, SrcID:Tocainide, URL:http://en.wikipedia.org/wiki/Tocainide|Name:Wikipedia, SrcID:Antiarrhythmic_agent, URL:http://en.wikipedia.org/wiki/Antiarrhythmic_agent|Name:ISBN, SrcID:9780702034718 PP. 521, 255, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:Wikipedia, SrcID:Sodium_channel, URL:http://en.wikipedia.org/wiki/Sodium_channel",CC(N)C(=O)Nc1c(C)cccc1C,,
3696,CHEMBL1256,Isoflurane,Small molecule,1979.0,N01AB06,"N01AB06 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,Potassium channel subfamily K member 3 opener,,,CHEMBL2321613,Potassium channel subfamily K member 3,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:11605899, URL:http://europepmc.org/abstract/MED/11605899|Name:PubMed, SrcID:17227289, URL:http://europepmc.org/abstract/MED/17227289",FC(F)OC(Cl)C(F)(F)F,CHEMBL2321613,KCNK3
3697,CHEMBL746,Nedocromil,Small molecule,1992.0,S01GX04; R03BC03; R01AC07,"S01GX04 [SENSORY ORGANS: OPHTHALMOLOGICALS: DECONGESTANTS AND ANTIALLERGICS: Other antiallergics]; R03BC03 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS: Antiallergic agents, excl. corticosteroids]; R01AC07 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Antiallergic agents, excl. corticosteroids]",-cromil,Unknown,"Mode of action not fully understood; it seems to inhibit calcium influx into mast cells, stabilizing them",,,,,,,,,"Name:PubMed, SrcID:16164449, URL:http://europepmc.org/abstract/MED/16164449|Name:ISBN, SrcID:9780702034718 PP. 343, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:20558817, URL:http://europepmc.org/abstract/MED/20558817|Name:FDA, SrcID:label/2008/021009s010lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021009s010lbl.pdf",CCCc1c2OC(=CC(=O)c2cc3C(=O)C=C(N(CC)c13)C(=O)O)C(=O)O,,
3698,CHEMBL604,Cupric Sulfate,Small molecule,1987.0,V03AB20,V03AB20 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Antidotes],,Unknown,,,,,,,,,,"Name:DailyMed, SrcID:setid=941ad1e2-6052-4df4-8cfe-5af4a99703e4, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=941ad1e2-6052-4df4-8cfe-5af4a99703e4|Name:DailyMed, SrcID:archiveid=161554, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=161554",,,
3699,CHEMBL1201766,Fospropofol,Small molecule,2008.0,,,fos-,Unknown,,,,,,,,,,"Name:FDA, SrcID:label/2011/022090s005lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022090s005lbl.pdf",CC(C)c1cccc(C(C)C)c1OCOP(=O)(O)O,,
3700,CHEMBL2105689,Luliconazole,Small molecule,2013.0,D01AC18,D01AC18 [DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Imidazole and triazole derivatives],-conazole,Cytochrome P450 51 inhibitor,,,CHEMBL1780,Cytochrome P450 51,INHIBITOR,Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast),SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2013/204153s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204153s000lbl.pdf",Clc1ccc([C@@H]2CS\C(=C(\C#N)/n3ccnc3)\S2)c(Cl)c1,,
3701,CHEMBL2103827,Droxidopa,Small molecule,2014.0,C01CA27,C01CA27 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES: Adrenergic and dopaminergic agents],-dopa,Adrenergic receptor agonist,,,CHEMBL2331074,Adrenergic receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:17214596, URL:http://europepmc.org/abstract/MED/17214596|Name:FDA, SrcID:label/2014/203202lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203202lbl.pdf|Name:DailyMed, SrcID:setid=6ea2f20d-09b9-4e09-999e-be84a01dc07e#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6ea2f20d-09b9-4e09-999e-be84a01dc07e#nlm34090-1",N[C@@H]([C@H](O)c1ccc(O)c(O)c1)C(=O)O,,
3702,CHEMBL2108676,Elosulfase Alfa,Enzyme,2014.0,A16AB12,A16AB12 [ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Enzymes],-ase,Chondroitin-6-sulfate hydrolytic enzyme,,,CHEMBL3140342,Chondroitin-6-sulfate,HYDROLYTIC ENZYME,Homo sapiens,OLIGOSACCHARIDE,,,"Name:FDA, SrcID:label/2014/125460s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125460s000lbl.pdf",,,
3703,CHEMBL1269025,Edoxaban,Small molecule,2015.0,B01AF03,B01AF03 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Direct factor Xa inhibitors],-xaban,Coagulation factor X inhibitor,,,CHEMBL244,Coagulation factor X,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/206316lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206316lbl.pdf",CN(C)C(=O)[C@H]1CC[C@H](NC(=O)C(=O)Nc2ccc(Cl)cn2)[C@@H](C1)NC(=O)c3nc4CCN(C)Cc4s3,CHEMBL244,F10
3704,CHEMBL1224207,Trabectedin,Small molecule,2015.0,L01CX01,L01CX01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Other plant alkaloids and natural products],-ectedin,DNA inhibitor,Alkylating agent,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=472bd78e-be17-4b9d-90f4-9482c3aec9ff, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=472bd78e-be17-4b9d-90f4-9482c3aec9ff",COc1cc2c(CCN[C@]23CS[C@@H]4[C@H]5[C@@H]6N(C)[C@@H](Cc7cc(C)c(OC)c(O)c67)[C@H](O)N5[C@H](COC3=O)c8c9OCOc9c(C)c(OC(=O)C)c48)cc1O,,
3705,CHEMBL2146883,Cobimetinib,Small molecule,2015.0,L01XE38,L01XE38 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,Reversible inhibitor of mitogen-activated protein kinase (MAPK)/extracellular signal regulated kinase 1 (MEK1) and MEK2,,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22496205, URL:http://europepmc.org/abstract/MED/22496205|Name:DailyMed, SrcID:setid=c387579e-cee0-4334-bd1e-73f93ac1bde6, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c387579e-cee0-4334-bd1e-73f93ac1bde6|Name:PubMed, SrcID:22084396, URL:http://europepmc.org/abstract/MED/22084396",OC1(CN(C1)C(=O)c2ccc(F)c(F)c2Nc3ccc(I)cc3F)[C@@H]4CCCCN4,CHEMBL2964,MAP2K2
3706,CHEMBL1645462,Ac-480,Small molecule,,,,,Receptor protein-tyrosine kinase erbB-4 inhibitor,,,CHEMBL3009,Receptor protein-tyrosine kinase erbB-4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19821562, URL:http://europepmc.org/abstract/MED/19821562|Name:PubMed, SrcID:17062696, URL:http://europepmc.org/abstract/MED/17062696",Cc1c(NC(=O)OC[C@@H]2COCCN2)cn3ncnc(Nc4ccc5c(cnn5Cc6cccc(F)c6)c4)c13,CHEMBL3009,ERBB4
3707,CHEMBL3545377,Ly-2606368,Small molecule,,,,,Serine/threonine-protein kinase Chk1 inhibitor,,,CHEMBL4630,Serine/threonine-protein kinase Chk1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.lillyoncologypipeline.com/chk1-inhibitor.aspx, URL:http://www.lillyoncologypipeline.com/chk1-inhibitor.aspx|Name:PubMed, SrcID:5828916, URL:http://europepmc.org/abstract/MED/5828916",,CHEMBL4630,CHEK1
3708,CHEMBL3545001,Mk-8353,Small molecule,,,,,MAP kinase ERK1 inhibitor,,,CHEMBL3385,MAP kinase ERK1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.hra.nhs.uk/news/research-summaries/safey-tolerability-efficacy-of-mk-8353-in-subjects-with-solid-tumors/, URL:http://www.hra.nhs.uk/news/research-summaries/safey-tolerability-efficacy-of-mk-8353-in-subjects-with-solid-tumors/",,CHEMBL3385,MAPK3
3709,CHEMBL3545136,Pf-00337210,Small molecule,,,,,Vascular endothelial growth factor receptor 2 inhibitor,,,CHEMBL279,Vascular endothelial growth factor receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://cancerres.aacrjournals.org/content/67/9_Supplement/3992, URL:http://cancerres.aacrjournals.org/content/67/9_Supplement/3992|Name:PubMed, SrcID:21312012, URL:http://europepmc.org/abstract/MED/21312012",,CHEMBL279,KDR
3710,CHEMBL2331680,Rg-7603,Small molecule,,,,,Serine/threonine-protein kinase mTOR inhibitor,ATP-competitive mTORC1/mTORC2 inhibitor,,CHEMBL2842,Serine/threonine-protein kinase mTOR,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24900569, URL:http://europepmc.org/abstract/MED/24900569",CCNC(=O)Nc1ccc(cc1)c2nc3CN(CCc3c(n2)N4CCOC[C@@H]4C)C5COC5,CHEMBL2842,MTOR
3711,CHEMBL1829335,Irdabisant,Small molecule,,,,-isant,Histamine H3 receptor antagonist,,,CHEMBL264,Histamine H3 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21634396, URL:http://europepmc.org/abstract/MED/21634396|Name:PubMed, SrcID:22001260, URL:http://europepmc.org/abstract/MED/22001260",C[C@@H]1CCCN1CCCOc2ccc(cc2)C3=NNC(=O)C=C3,CHEMBL264,HRH3
3712,CHEMBL3545088,Puquitinib,Small molecule,,,,-tinib,PI3-kinase class I inhibitor,"Compound is most potent against PIK3CD, low potency against EGFR, KDR and PDGFRB",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:26499488, URL:http://europepmc.org/abstract/MED/26499488|Name:DOI, SrcID:10.1158/1538-7445.AM2011-4245, URL:http://cancerres.aacrjournals.org/content/71/8_Supplement/4245|Name:PubMed, SrcID:26510909, URL:http://europepmc.org/abstract/MED/26510909",,CHEMBL3559703,PIK3R2
3713,CHEMBL3545088,Puquitinib,Small molecule,,,,-tinib,PI3-kinase class I inhibitor,"Compound is most potent against PIK3CD, low potency against EGFR, KDR and PDGFRB",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:26499488, URL:http://europepmc.org/abstract/MED/26499488|Name:DOI, SrcID:10.1158/1538-7445.AM2011-4245, URL:http://cancerres.aacrjournals.org/content/71/8_Supplement/4245|Name:PubMed, SrcID:26510909, URL:http://europepmc.org/abstract/MED/26510909",,CHEMBL3559703,PIK3R3
3714,CHEMBL3545088,Puquitinib,Small molecule,,,,-tinib,PI3-kinase class I inhibitor,"Compound is most potent against PIK3CD, low potency against EGFR, KDR and PDGFRB",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:26499488, URL:http://europepmc.org/abstract/MED/26499488|Name:DOI, SrcID:10.1158/1538-7445.AM2011-4245, URL:http://cancerres.aacrjournals.org/content/71/8_Supplement/4245|Name:PubMed, SrcID:26510909, URL:http://europepmc.org/abstract/MED/26510909",,CHEMBL3559703,PIK3R5
3715,CHEMBL3545208,Azd3161,Small molecule,,,,,Sodium channel protein type IX alpha subunit blocker,,,CHEMBL4296,Sodium channel protein type IX alpha subunit,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25060923, URL:http://europepmc.org/abstract/MED/25060923",,CHEMBL4296,SCN9A
3716,CHEMBL29919,Elpetrigine,Small molecule,,,,,Voltage-gated L-type calcium channel blocker,,,CHEMBL2095229,Voltage-gated L-type calcium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:18377968, URL:http://europepmc.org/abstract/MED/18377968|Name:PubMed, SrcID:19008076, URL:http://europepmc.org/abstract/MED/19008076",Nc1cnc(c(N)n1)c2cc(Cl)cc(Cl)c2Cl,,
3717,CHEMBL3707398,Pac-14028,Small molecule,,,,,Vanilloid receptor antagonist,,,CHEMBL4794,Vanilloid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22477184, URL:http://europepmc.org/abstract/MED/22477184",,CHEMBL4794,TRPV1
3718,CHEMBL490029,Mk-0533,Small molecule,,,,,Peroxisome proliferator-activated receptor gamma modulator,"Ph2 study terminated, compound development discontinued. Selective PPAR gamma modulator (SPPAR?M)",,CHEMBL235,Peroxisome proliferator-activated receptor gamma,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19507861, URL:http://europepmc.org/abstract/MED/19507861",CC[C@@H](Oc1cccc(c1)n2c(C)c(C(=O)c3ccc(OC)cc3)c4ccc(OC(F)(F)F)cc24)C(=O)O,CHEMBL235,PPARG
3719,CHEMBL587723,Aee-788,Small molecule,,,,,Receptor protein-tyrosine kinase erbB-2 inhibitor,"Also potent inhibitor of SRC, ABL1 and CSF1R",,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15256466, URL:http://europepmc.org/abstract/MED/15256466",CCN1CCN(Cc2ccc(cc2)c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)CC1,CHEMBL1824,ERBB2
3720,CHEMBL2079588,Telatinib,Small molecule,,,,-tinib,Platelet-derived growth factor receptor beta inhibitor,,,CHEMBL1913,Platelet-derived growth factor receptor beta,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19002179, URL:http://europepmc.org/abstract/MED/19002179|Name:PubMed, SrcID:19636022, URL:http://europepmc.org/abstract/MED/19636022",CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c4ccoc24)ccn1,CHEMBL1913,PDGFRB
3721,CHEMBL1097999,E-6201,Small molecule,,,,,Mitogen-activated protein kinase kinase kinase 1 inhibitor,,,CHEMBL3956,Mitogen-activated protein kinase kinase kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19684251, URL:http://europepmc.org/abstract/MED/19684251|Name:PubMed, SrcID:24448821, URL:http://europepmc.org/abstract/MED/24448821",CCNc1cc(O)c2C(=O)O[C@@H](C)[C@H](C)\C=C/C(=O)[C@@H](O)[C@@H](O)C\C=C\c2c1,CHEMBL3956,MAP3K1
3722,CHEMBL507361,Pd-0325901,Small molecule,,,,,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,,,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://cancerres.aacrjournals.org/content/64/7_Supplement/925.1, URL:http://cancerres.aacrjournals.org/content/64/7_Supplement/925.1|Name:PubMed, SrcID:15573115, URL:http://europepmc.org/abstract/MED/15573115",OC[C@@H](O)CONC(=O)c1ccc(F)c(F)c1Nc2ccc(I)cc2F,CHEMBL3587,MAP2K1
3723,CHEMBL558752,Chir-265,Small molecule,,,,,Serine/threonine-protein kinase B-raf inhibitor,,,CHEMBL5145,Serine/threonine-protein kinase B-raf,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26396681, URL:http://europepmc.org/abstract/MED/26396681|Name:PubMed, SrcID:23617957, URL:http://europepmc.org/abstract/MED/23617957",Cn1c(Nc2ccc(cc2)C(F)(F)F)nc3cc(Oc4ccnc(c4)c5ncc([nH]5)C(F)(F)F)ccc13,CHEMBL5145,BRAF
3724,CHEMBL1922094,Apitolisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:21981714, URL:http://europepmc.org/abstract/MED/21981714|Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718",C[C@H](O)C(=O)N1CCN(Cc2sc3c(nc(nc3c2C)c4cnc(N)nc4)N5CCOCC5)CC1,CHEMBL3559703,PIK3R2
3725,CHEMBL1922094,Apitolisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:21981714, URL:http://europepmc.org/abstract/MED/21981714|Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718",C[C@H](O)C(=O)N1CCN(Cc2sc3c(nc(nc3c2C)c4cnc(N)nc4)N5CCOCC5)CC1,CHEMBL3559703,PIK3R3
3726,CHEMBL1922094,Apitolisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:21981714, URL:http://europepmc.org/abstract/MED/21981714|Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718",C[C@H](O)C(=O)N1CCN(Cc2sc3c(nc(nc3c2C)c4cnc(N)nc4)N5CCOCC5)CC1,CHEMBL3559703,PIK3R5
3727,CHEMBL3545403,Bms-833923,Small molecule,,,,,Smoothened homolog antagonist,,,CHEMBL5971,Smoothened homolog,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25670876, URL:http://europepmc.org/abstract/MED/25670876",CNCc1ccc(C)c(NC(=O)c2ccc(Nc3nc(c4ccccc4)c5ccccc5n3)cc2)c1,CHEMBL5971,SMO
3728,CHEMBL3545345,Ur-63325,Small molecule,,,,,Histamine H4 receptor antagonist,,,CHEMBL3759,Histamine H4 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16349977, URL:http://europepmc.org/abstract/MED/16349977|Name:Other, SrcID:http://www.researchgate.net/profile/Caridad_Pontes/publication/231521944_First_into_Man_administration_of_UR-63325_a_first_in_class_H4_receptor_antagonist/links/0fcfd50ad1b857063d000000.pdf, URL:http://www.researchgate.net/profile/Caridad_Pontes/publication/231521944_First_into_Man_administration_of_UR-63325_a_first_in_class_H4_receptor_antagonist/links/0fcfd50ad1b857063d000000.pdf",,CHEMBL3759,HRH4
3729,CHEMBL3235279,Capadenoson,Small molecule,,,,-denoson,Adenosine A1 receptor partial agonist,,,CHEMBL226,Adenosine A1 receptor,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:8370736, URL:http://europepmc.org/abstract/MED/8370736|Name:PubMed, SrcID:16654164, URL:http://www.ncbi.nlm.nih.gov/pubmed/?term=16654164",Nc1nc(SCc2csc(n2)c3ccc(Cl)cc3)c(C#N)c(c4ccc(OCCO)cc4)c1C#N,CHEMBL226,ADORA1
3730,CHEMBL431651,Enrasentan,Small molecule,,,,-entan,Endothelin receptor ET-B antagonist,,,CHEMBL1785,Endothelin receptor ET-B,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:8632328, URL:http://europepmc.org/abstract/MED/8632328",CCCOc1ccc2[C@@H]([C@H]([C@H](c3ccc(OC)cc3OCCO)c2c1)C(=O)O)c4ccc5OCOc5c4,CHEMBL1785,EDNRB
3731,CHEMBL217092,Saracatinib,Small molecule,,,,-tinib,Tyrosine-protein kinase ABL inhibitor,,,CHEMBL1862,Tyrosine-protein kinase ABL,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17064066, URL:http://europepmc.org/abstract/MED/17064066",CN1CCN(CCOc2cc(OC3CCOCC3)c4c(Nc5c(Cl)ccc6OCOc56)ncnc4c2)CC1,CHEMBL1862,ABL1
3732,CHEMBL603469,Lestaurtinib,Small molecule,,,,-tinib,Tyrosine-protein kinase receptor FLT3 inhibitor,,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12010785, URL:http://europepmc.org/abstract/MED/12010785",C[C@]12O[C@H](C[C@]1(O)CO)n3c4ccccc4c5c6C(=O)NCc6c7c8ccccc8n2c7c35,CHEMBL1974,FLT3
3733,CHEMBL428690,Alvocidib,Small molecule,,,,,Cyclin-dependent kinase 7 inhibitor,,,CHEMBL3055,Cyclin-dependent kinase 7,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25215591, URL:http://europepmc.org/abstract/MED/25215591|Name:PubMed, SrcID:15217973, URL:http://europepmc.org/abstract/MED/15217973",CN1CC[C@@H]([C@H](O)C1)c2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccccc4Cl,CHEMBL3055,CDK7
3734,CHEMBL3187723,Binimetinib,Small molecule,,,,-tinib,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,Non-ATP-competitive allosteric inhibitor,,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://arraybiopharma.com/files/4813/9810/8023/PubAttachment490.pdf, URL:http://arraybiopharma.com/files/4813/9810/8023/PubAttachment490.pdf|Name:Other, SrcID:http://arraybiopharma.com/product-pipeline/binimetinib/, URL:http://arraybiopharma.com/product-pipeline/binimetinib/|Name:PubMed, SrcID:23414587, URL:http://europepmc.org/abstract/MED/23414587",Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(cc12)C(=O)NOCCO,CHEMBL3587,MAP2K1
3735,CHEMBL3137314,Esuberaprost,Small molecule,,,,-prost,Prostanoid IP receptor agonist,,,CHEMBL1995,Prostanoid IP receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.lungbiotechnology.com/content/clinical-trials, URL:http://www.lungbiotechnology.com/content/clinical-trials",CC#CC[C@H](C)[C@H](O)\C=C\[C@H]1[C@H](O)C[C@@H]2Oc3c(CCCC(=O)O)cccc3[C@H]12,CHEMBL1995,PTGIR
3736,CHEMBL2151572,Encenicline,Small molecule,,,,-nicline,Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist,Alpha-7 nicotinic receptor: consists entirely of a7 subunits (pentamere) CNS-type.,,CHEMBL2492,Neuronal acetylcholine receptor protein alpha-7 subunit,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26044974, URL:http://europepmc.org/abstract/MED/26044974|Name:PubMed, SrcID:22085888, URL:http://europepmc.org/abstract/MED/22085888",Clc1cccc2cc(sc12)C(=O)N[C@H]3CN4CCC3CC4,CHEMBL2492,CHRNA7
3737,CHEMBL1743019,Figitumumab,Antibody,,,,-mab,Insulin-like growth factor I receptor antagonist,Blocks binding of IGF-1 to its receptor (IGF1R) and specifically inhibits the IGF-1-induced receptor autophosphorylation.,,CHEMBL1957,Insulin-like growth factor I receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15756033, URL:http://europepmc.org/abstract/MED/15756033",,CHEMBL1957,IGF1R
3738,CHEMBL49642,Indibulin,Small molecule,,,,-bulin,Tubulin inhibitor,Destabilizes microtubules and blocks cell cycle transition specifically at G2-M phase.,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Binding site of D-24851 does not overlap with tubulin binding sites of vincristine or colchicine.,"Name:PubMed, SrcID:11196193, URL:http://europepmc.org/abstract/MED/11196193",Clc1ccc(Cn2cc(C(=O)C(=O)Nc3ccncc3)c4ccccc24)cc1,CHEMBL2095182,TUBB8
3739,CHEMBL49642,Indibulin,Small molecule,,,,-bulin,Tubulin inhibitor,Destabilizes microtubules and blocks cell cycle transition specifically at G2-M phase.,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Binding site of D-24851 does not overlap with tubulin binding sites of vincristine or colchicine.,"Name:PubMed, SrcID:11196193, URL:http://europepmc.org/abstract/MED/11196193",Clc1ccc(Cn2cc(C(=O)C(=O)Nc3ccncc3)c4ccccc24)cc1,CHEMBL2095182,TUBA3C
3740,CHEMBL49642,Indibulin,Small molecule,,,,-bulin,Tubulin inhibitor,Destabilizes microtubules and blocks cell cycle transition specifically at G2-M phase.,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Binding site of D-24851 does not overlap with tubulin binding sites of vincristine or colchicine.,"Name:PubMed, SrcID:11196193, URL:http://europepmc.org/abstract/MED/11196193",Clc1ccc(Cn2cc(C(=O)C(=O)Nc3ccncc3)c4ccccc24)cc1,CHEMBL2095182,TUBA4A
3741,CHEMBL49642,Indibulin,Small molecule,,,,-bulin,Tubulin inhibitor,Destabilizes microtubules and blocks cell cycle transition specifically at G2-M phase.,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Binding site of D-24851 does not overlap with tubulin binding sites of vincristine or colchicine.,"Name:PubMed, SrcID:11196193, URL:http://europepmc.org/abstract/MED/11196193",Clc1ccc(Cn2cc(C(=O)C(=O)Nc3ccncc3)c4ccccc24)cc1,CHEMBL2095182,TUBA3E
3742,CHEMBL49642,Indibulin,Small molecule,,,,-bulin,Tubulin inhibitor,Destabilizes microtubules and blocks cell cycle transition specifically at G2-M phase.,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Binding site of D-24851 does not overlap with tubulin binding sites of vincristine or colchicine.,"Name:PubMed, SrcID:11196193, URL:http://europepmc.org/abstract/MED/11196193",Clc1ccc(Cn2cc(C(=O)C(=O)Nc3ccncc3)c4ccccc24)cc1,CHEMBL2095182,TUBB6
3743,CHEMBL49642,Indibulin,Small molecule,,,,-bulin,Tubulin inhibitor,Destabilizes microtubules and blocks cell cycle transition specifically at G2-M phase.,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Binding site of D-24851 does not overlap with tubulin binding sites of vincristine or colchicine.,"Name:PubMed, SrcID:11196193, URL:http://europepmc.org/abstract/MED/11196193",Clc1ccc(Cn2cc(C(=O)C(=O)Nc3ccncc3)c4ccccc24)cc1,CHEMBL2095182,TUBB2B
3744,CHEMBL49642,Indibulin,Small molecule,,,,-bulin,Tubulin inhibitor,Destabilizes microtubules and blocks cell cycle transition specifically at G2-M phase.,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Binding site of D-24851 does not overlap with tubulin binding sites of vincristine or colchicine.,"Name:PubMed, SrcID:11196193, URL:http://europepmc.org/abstract/MED/11196193",Clc1ccc(Cn2cc(C(=O)C(=O)Nc3ccncc3)c4ccccc24)cc1,CHEMBL2095182,TUBA3D
3745,CHEMBL2443262,Oliceridine,Small molecule,,,,-eridine,Mu opioid receptor agonist,,,CHEMBL233,Mu opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:27778501, URL:http://europepmc.org/abstract/MED/27778501",COc1ccsc1CNCC[C@]2(CCOC3(CCCC3)C2)c4ccccn4,CHEMBL233,OPRM1
3746,CHEMBL2108313,Conbercept,Protein,,,,-cept,Vascular endothelial growth factor C inhibitor,Soluble receptor decoy which has a high binding affinity to VEGF and a long half-life in vitreous.,"All isoforms of VEGF-A, VEGF-B, VEGF-C, and PlGF.",CHEMBL3714157,Vascular endothelial growth factor C,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25960634, URL:http://europepmc.org/abstract/MED/25960634",,CHEMBL3714157,VEGFC
3747,CHEMBL3833344,Mm-302,Antibody,,,,,DNA topoisomerase II alpha inhibitor,"Upon binding of the antibody to the receptor protein-tyrosine kinase ERBB2, the immunoliposome allows for specific delivery of doxorubicin to tumors overexpressing the ERBB2 receptor. Once inside the HER2-expressing tumor cells, doxorubicin intercalates into DNA and interferes with DNA topoisomerase II activity, thereby inhibiting DNA replication and RNA synthesis.",,CHEMBL1806,DNA topoisomerase II alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21048526, URL:http://europepmc.org/abstract/MED/21048526|Name:PubMed, SrcID:26162690, URL:http://europepmc.org/abstract/MED/26162690|Name:PubMed, SrcID:27259714, URL:http://europepmc.org/abstract/MED/27259714",,CHEMBL1806,TOP2A
3748,CHEMBL1743073,Sotatercept,Protein,,,,-cept,Inhibin beta A chain inhibitor,"By binding activin, Sotatercept prevents activin from binding endogenous receptors and thus acts as a decoy.",,CHEMBL3588735,Inhibin beta A chain,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19049340, URL:http://europepmc.org/abstract/MED/19049340",,CHEMBL3588735,INHBA
3749,CHEMBL2109286,Sar-3419,Antibody,,,,,B-lymphocyte antigen CD19 binding agent,"The mechanism of action of SAR3419 involves binding to the cell-surface antigen, followed by internalization via endocytosis and subsequent intracellular routing to lysosomes where the huB4 antibody moiety of the ADC is degraded to yield the lysine-SPDB-DM4 metabolite. Induces antibody-dependent cell-mediated cytotoxicity (ADCC) but not complement-dependent cytotoxicity (CDC). Induces cell-cycle arrest at the G2/M phase followed by an increase in apoptotic cells.",,CHEMBL3390821,B-lymphocyte antigen CD19,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22003072, URL:http://europepmc.org/abstract/MED/22003072",,CHEMBL3390821,CD19
3750,CHEMBL2109377,Fg-3019,Antibody,,,,,Connective tissue growth factor inhibitor,,,CHEMBL3712901,Connective tissue growth factor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16740721, URL:http://europepmc.org/abstract/MED/16740721",,CHEMBL3712901,CTGF
3751,CHEMBL3301593,Decoglurant,Small molecule,,,,-glurant,Metabotropic glutamate receptor 3 modulator,Negative allosteric modulator (NAM). Removed from development pipeline January 2015 (http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm),,CHEMBL2888,Metabotropic glutamate receptor 3,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Decoglurant, URL:http://en.wikipedia.org/wiki/Decoglurant",Nc1ccc(cn1)C#Cc2cnn3c(cc(nc23)c4ccc(cc4)C(F)(F)F)C(F)(F)F,CHEMBL2888,GRM3
3752,CHEMBL1201421,Pegaptanib Sodium,Unknown,2004.0,S01LA03,S01LA03 [SENSORY ORGANS: OPHTHALMOLOGICALS: OCULAR VASCULAR DISORDER AGENTS: Antineovascularisation agents],-anib; peg-,Vascular endothelial growth factor A antagonist,"It's an aptamer, a pegylated modified oligonucleotide",Selective,CHEMBL1783,Vascular endothelial growth factor A,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=45d03177-5d52-492c-b2e0-01afc7c8d2e0, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=45d03177-5d52-492c-b2e0-01afc7c8d2e0",,CHEMBL1783,VEGFA
3753,CHEMBL1592,Quinapril,Small molecule,1991.0,C09AA06,"C09AA06 [CARDIOVASCULAR SYSTEM: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM: ACE INHIBITORS, PLAIN: ACE inhibitors, plain]",-pril,Angiotensin-converting enzyme inhibitor,,,CHEMBL1808,Angiotensin-converting enzyme,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=26614f0c-7187-4acf-805f-9e5c2bdfff7a, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=26614f0c-7187-4acf-805f-9e5c2bdfff7a",CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2Cc3ccccc3C[C@H]2C(=O)O,CHEMBL1808,ACE
3754,CHEMBL914,Fexofenadine,Small molecule,1996.0,R06AX26,R06AX26 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Other antihistamines for systemic use],,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=ac0c0247-3b20-445a-84c0-cb7f3939c823, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ac0c0247-3b20-445a-84c0-cb7f3939c823",CC(C)(C(=O)O)c1ccc(cc1)C(O)CCCN2CCC(CC2)C(O)(c3ccccc3)c4ccccc4,CHEMBL231,HRH1
3755,CHEMBL1201287,Dexbrompheniramine,Small molecule,1963.0,R06AB56; R06AB06,R06AB56 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Substituted alkylamines]; R06AB06 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Substituted alkylamines],,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19085565, URL:http://europepmc.org/abstract/MED/19085565",CN(C)CC[C@@H](c1ccc(Br)cc1)c2ccccn2,CHEMBL231,HRH1
3756,CHEMBL908,Chlorprothixene,Small molecule,1967.0,N05AF03,N05AF03 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Thioxanthene derivatives],,Dopamine D3 receptor antagonist,,,CHEMBL234,Dopamine D3 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Antipsychotic#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Antipsychotic#Mechanism_of_action|Name:Wikipedia, SrcID:Chlorprothixene#Pharmacology, URL:http://en.wikipedia.org/wiki/Chlorprothixene#Pharmacology|Name:PubMed, SrcID:1830565, URL:http://europepmc.org/abstract/MED/1830565",CN(C)CC\C=C/1\c2ccccc2Sc3ccc(Cl)cc13,,
3757,CHEMBL1201627,Insulin Susp Isophane Semisynthetic Purified Human,Protein,1985.0,,,,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/022472s006s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022472s006s008lbl.pdf|Name:DailyMed, SrcID:setid=457531f0-9331-47fe-90b5-b31f284044dc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=457531f0-9331-47fe-90b5-b31f284044dc",,CHEMBL1981,INSR
3758,CHEMBL1460,Didanosine,Small molecule,1991.0,J05AF02,J05AF02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleoside and nucleotide reverse transcriptase inhibitors],,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,,,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,INHIBITOR,Human immunodeficiency virus 1,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=22e2ca82-c7b5-4f03-9a81-81e130237565, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=22e2ca82-c7b5-4f03-9a81-81e130237565",OC[C@@H]1CC[C@@H](O1)n2cnc3C(=O)NC=Nc23,,
3759,CHEMBL1590,Pseudoephedrine,Small molecule,1963.0,R01BA52; R01BA02,R01BA52 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: NASAL DECONGESTANTS FOR SYSTEMIC USE: Sympathomimetics]; R01BA02 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: NASAL DECONGESTANTS FOR SYSTEMIC USE: Sympathomimetics],-drine,Norepinephrine transporter releasing agent,,,CHEMBL222,Norepinephrine transporter,RELEASING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Adrenergic_receptor, URL:http://en.wikipedia.org/wiki/Adrenergic_receptor|Name:Wikipedia, SrcID:Pseudoephedrine, URL:http://en.wikipedia.org/wiki/Pseudoephedrine|Name:Wikipedia, SrcID:Adrenergic_agonist, URL:http://en.wikipedia.org/wiki/Adrenergic_agonist|Name:ISBN, SrcID:9780702034718 PP. 191, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:19948186, URL:http://europepmc.org/abstract/MED/19948186|Name:PubMed, SrcID:12373557, URL:http://europepmc.org/abstract/MED/12373557|Name:Wikipedia, SrcID:Decongestant, URL:http://en.wikipedia.org/wiki/Decongestant",CN[C@@H](C)[C@@H](O)c1ccccc1,CHEMBL222,SLC6A2
3760,CHEMBL900,Orphenadrine,Small molecule,1957.0,M03BC51,"M03BC51 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS: Ethers, chemically close to antihistamines]",-drine,Norepinephrine transporter inhibitor,,,CHEMBL222,Norepinephrine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10344632, URL:http://europepmc.org/abstract/MED/10344632|Name:PubMed, SrcID:19217209, URL:http://europepmc.org/abstract/MED/19217209",CN(C)CCOC(c1ccccc1)c2ccccc2C,CHEMBL222,SLC6A2
3761,CHEMBL1201222,Lisdexamfetamine,Small molecule,2007.0,N06BA12,"N06BA12 [NERVOUS SYSTEM: PSYCHOANALEPTICS: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS: Centrally acting sympathomimetics]",-fetamin(e),Norepinephrine transporter releasing agent,,,CHEMBL222,Norepinephrine transporter,RELEASING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=c9eaca3d-cca7-4627-bb3e-75b1c2aec9d4#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c9eaca3d-cca7-4627-bb3e-75b1c2aec9d4#nlm34090-1",C[C@@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN,CHEMBL222,SLC6A2
3762,CHEMBL1535,Hydroxychloroquine,Small molecule,1955.0,P01BA02,"P01BA02 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: ANTIMALARIALS: Aminoquinolines]",,Ferriprotoporphyrin IX inhibitor,inhibits polymerisation,,CHEMBL613897,Ferriprotoporphyrin IX,INHIBITOR,Plasmodium falciparum,SMALL MOLECULE,,,"Name:PubMed, SrcID:14967191, URL:http://europepmc.org/abstract/MED/14967191|Name:Wikipedia, SrcID:Hemozoin, URL:http://en.wikipedia.org/wiki/Hemozoin",CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,,
3763,CHEMBL1201146,Norethindrone Acetate,Small molecule,1973.0,,,,Progesterone receptor agonist,,,CHEMBL208,Progesterone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10494488, URL:http://europepmc.org/abstract/MED/10494488|Name:PubMed, SrcID:7711211, URL:http://europepmc.org/abstract/MED/7711211|Name:PubMed, SrcID:15261304, URL:http://europepmc.org/abstract/MED/15261304|Name:PubMed, SrcID:15189034, URL:http://europepmc.org/abstract/MED/15189034",CC(=O)O[C@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C)C#C,CHEMBL208,PGR
3764,CHEMBL1200624,Ethynodiol Diacetate,Small molecule,1966.0,G03DC06,G03DC06 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: PROGESTOGENS: Estren derivatives],,Progesterone receptor agonist,,,CHEMBL208,Progesterone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:858280, URL:http://europepmc.org/abstract/MED/858280|Name:PubMed, SrcID:166800, URL:http://europepmc.org/abstract/MED/166800|Name:KEGG, SrcID:D07939, URL:http://www.kegg.jp/dbget-bin/www_bget?dr:D07939|Name:PubMed, SrcID:5428836, URL:http://europepmc.org/abstract/MED/5428836",CC(=O)O[C@H]1CC[C@@H]2[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(OC(=O)C)C#C)[C@@H]3CCC2=C1,CHEMBL208,PGR
3765,CHEMBL434394,Nebivolol,Small molecule,2007.0,C07AB12,"C07AB12 [CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, selective]",-olol,Beta-2 adrenergic receptor antagonist,,,CHEMBL210,Beta-2 adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=8b8ad213-1dc8-454e-a524-075685c0e1a8#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8b8ad213-1dc8-454e-a524-075685c0e1a8#section-13",OC(CNCC(O)C1CCc2cc(F)ccc2O1)C3CCc4cc(F)ccc4O3,CHEMBL210,ADRB2
3766,CHEMBL532,Erythromycin,Small molecule,1964.0,D10AF02; D10AF52; S01AA17; J01FA01,"D10AF02 [DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Antiinfectives for treatment of acne]; D10AF52 [DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Antiinfectives for treatment of acne]; S01AA17 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Antibiotics]; J01FA01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS: Macrolides]",-mycin,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,23S ribosomal RNA,23S RRNA,"Name:DailyMed, SrcID:setid=a96c405f-bd70-4bb4-719e-ac6a79dcc213#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a96c405f-bd70-4bb4-719e-ac6a79dcc213#nlm34090-1|Name:PubMed, SrcID:20876130, URL:http://europepmc.org/abstract/MED/20876130|Name:DailyMed, SrcID:setid=e3f03b3c-b06f-42e3-a6f9-2ccf0e102b1f#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e3f03b3c-b06f-42e3-a6f9-2ccf0e102b1f#nlm34090-1|Name:DailyMed, SrcID:setid=9a63da11-01be-4c63-a260-e6bdbb4a7a69, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9a63da11-01be-4c63-a260-e6bdbb4a7a69|Name:FDA, SrcID:label/2013/060359s028lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/060359s028lbl.pdf",CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,
3767,CHEMBL1237054,Plicamycin,Small molecule,1970.0,L01DC02,L01DC02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES: Other cytotoxic antibiotics],-mycin,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:PubMed, SrcID:10796068, URL:http://europepmc.org/abstract/MED/10796068",CO[C@@H]([C@@H]1Cc2cc3cc(O[C@H]4C[C@@H](O[C@@H]5C[C@@H](O)[C@H](O)[C@@H](C)O5)[C@H](O)[C@@H](C)O4)c(C)c(O)c3c(O)c2C(=O)[C@H]1O[C@H]6C[C@@H](O[C@@H]7C[C@@H](O)[C@@H](O[C@@H]8C[C@](C)(O)[C@H](O)[C@@H](C)O8)[C@@H](C)O7)[C@H](O)[C@@H](C)O6)C(=O)[C@@H](O)[C@@H](C)O,,
3768,CHEMBL513,Carmustine,Small molecule,1977.0,L01AD01,L01AD01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ALKYLATING AGENTS: Nitrosoureas],-mustine,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=be6776fe-7f24-417d-ef08-8830c4eca959, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=be6776fe-7f24-417d-ef08-8830c4eca959|Name:FDA, SrcID:label/2013/017422s046lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/017422s046lbl.pdf",ClCCNC(=O)N(CCCl)N=O,,
3769,CHEMBL1201798,Sevelamer,Small molecule,2007.0,V03AE02,V03AE02 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Drugs for treatment of hyperkalemia and hyperphosphatemia],-mer,Unknown,,,,,,,,,,"Name:FDA, SrcID:label/2011/022318s003,022127s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022318s003,022127s008lbl.pdf",NCC=C.ClCC1CO1,,
3770,CHEMBL504,Dimethyl Sulfoxide,Small molecule,1978.0,G04BX13; M02AX03,G04BX13 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Other urologicals]; M02AX03 [MUSCULO-SKELETAL SYSTEM: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: Other topical products for joint and muscular pain],,Unknown,,,,,,,,,,"Name:PubMed, SrcID:17661513, URL:http://europepmc.org/abstract/MED/17661513|Name:PubMed, SrcID:3510103, URL:http://europepmc.org/abstract/MED/3510103",C[S+](C)[O-],,
3771,CHEMBL1200800,Calcium Acetate,Small molecule,1982.0,V03AE07,V03AE07 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Drugs for treatment of hyperkalemia and hyperphosphatemia],,Phosphate sequestering agent,,,CHEMBL2364184,Phosphate,SEQUESTERING AGENT,Homo sapiens,SMALL MOLECULE,,,"Name:DailyMed, SrcID:setid=5bbed4df-5883-49fc-adae-1af4073bb860, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5bbed4df-5883-49fc-adae-1af4073bb860",[Ca+2].CC(=O)[O-].CC(=O)[O-],,
3772,CHEMBL2108184,Crofelemer,Small molecule,2012.0,,,-mer,Anoctamin-1 blocker,,,CHEMBL2046267,Anoctamin-1,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=684ca8ce-2583-4c2d-a283-8a16fc63f8f8#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=684ca8ce-2583-4c2d-a283-8a16fc63f8f8#nlm34090-1|Name:PubMed, SrcID:19808995, URL:http://europepmc.org/abstract/MED/19808995",,CHEMBL2046267,ANO1
3773,CHEMBL3545048,Amg-319,Small molecule,,,,,PI3-kinase p110-delta subunit inhibitor,,,CHEMBL3130,PI3-kinase p110-delta subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.amgenoncology-international.com/#/our-products/our-pipeline/, URL:http://www.amgenoncology-international.com/#/our-products/our-pipeline/|Name:PubMed, SrcID:24591840, URL:http://europepmc.org/abstract/MED/24591840",,CHEMBL3130,PIK3CD
3774,CHEMBL3182621,Azd-8330,Small molecule,,,,,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,,,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://cancerres.aacrjournals.org/content/69/9_Supplement/3696, URL:http://cancerres.aacrjournals.org/content/69/9_Supplement/3696|Name:PubMed, SrcID:24434059, URL:http://europepmc.org/abstract/MED/24434059",CN1C(=O)C(=CC(=C1Nc2ccc(I)cc2F)C(=O)NOCCO)C,CHEMBL2964,MAP2K2
3775,CHEMBL3545273,Cr-3465,Small molecule,,,,,Cysteinyl leukotriene receptor 1 antagonist,Inhibits PDE3 and PDE4 IC50 2.01uM and 4.7uM respectively (PMID:15541426),,CHEMBL1798,Cysteinyl leukotriene receptor 1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.rottapharm.fr/rph-fr/media/pdf/RD_pipeline_May_2013_clean.pdf, URL:http://www.rottapharm.fr/rph-fr/media/pdf/RD_pipeline_May_2013_clean.pdf|Name:PubMed, SrcID:15541426, URL:http://europepmc.org/abstract/MED/15541426",,CHEMBL1798,CYSLTR1
3776,CHEMBL3330650,Rg-7420,Small molecule,,,,,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,,,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23934108, URL:http://europepmc.org/abstract/MED/23934108",OCCONC(=O)c1ccc2cncn2c1Nc3ccc(I)cc3F,CHEMBL3587,MAP2K1
3777,CHEMBL29919,Elpetrigine,Small molecule,,,,,Sodium channel protein type II alpha subunit blocker,,,CHEMBL4187,Sodium channel protein type II alpha subunit,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18377968, URL:http://europepmc.org/abstract/MED/18377968|Name:PubMed, SrcID:19008076, URL:http://europepmc.org/abstract/MED/19008076",Nc1cnc(c(N)n1)c2cc(Cl)cc(Cl)c2Cl,CHEMBL4187,SCN2A
3778,CHEMBL424133,Ly-518674,Small molecule,,,,,Peroxisome proliferator-activated receptor alpha agonist,Compound failed to show an advantage over marketed fenofibrate in Ph2 trial. Also potential adverse effects on kidney function (http://www.firstwordpharma.com/node/110221#axzz3Oj1URprS). Developement on hold or discontinued?,,CHEMBL239,Peroxisome proliferator-activated receptor alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15933217, URL:http://europepmc.org/abstract/MED/15933217",Cc1ccc(Cn2nc(CCCc3ccc(OC(C)(C)C(=O)O)cc3)nc2O)cc1,CHEMBL239,PPARA
3779,CHEMBL3545281,Akn-028,Small molecule,,,,,Tyrosine-protein kinase receptor FLT3 inhibitor,,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22864397, URL:http://europepmc.org/abstract/MED/22864397",,CHEMBL1974,FLT3
3780,CHEMBL3218576,Copanlisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:24170767, URL:http://europepmc.org/abstract/MED/24170767|Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718",COc1c(OCCCN2CCOCC2)ccc3C4=NCCN4C(=Nc13)NC(=O)c5cnc(N)nc5,CHEMBL3559703,PIK3R2
3781,CHEMBL3218576,Copanlisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:24170767, URL:http://europepmc.org/abstract/MED/24170767|Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718",COc1c(OCCCN2CCOCC2)ccc3C4=NCCN4C(=Nc13)NC(=O)c5cnc(N)nc5,CHEMBL3559703,PIK3R3
3782,CHEMBL3218576,Copanlisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:24170767, URL:http://europepmc.org/abstract/MED/24170767|Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718",COc1c(OCCCN2CCOCC2)ccc3C4=NCCN4C(=Nc13)NC(=O)c5cnc(N)nc5,CHEMBL3559703,PIK3R5
3783,CHEMBL2103851,Amuvatinib,Small molecule,,,,-tinib,Stem cell growth factor receptor inhibitor,"Inhibits mutant forms of KIT, FLT3 and PDGFRA (http://www.google.com/patents/US20080226747).",,CHEMBL1936,Stem cell growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25110867, URL:http://europepmc.org/abstract/MED/25110867|Name:Other, SrcID:http://www.google.com/patents/US20080226747, URL:http://www.google.com/patents/US20080226747|Name:PubMed, SrcID:24326130, URL:http://europepmc.org/abstract/MED/24326130",S=C(NCc1ccc2OCOc2c1)N3CCN(CC3)c4ncnc5c4oc6ccccc56,CHEMBL1936,KIT
3784,CHEMBL3545366,Voxtalisib,Small molecule,,,,-lisib,Serine/threonine-protein kinase mTOR inhibitor,,,CHEMBL2842,Serine/threonine-protein kinase mTOR,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24634413, URL:http://europepmc.org/abstract/MED/24634413|Name:Other, SrcID:http://www.exelixis.com/pipeline/xl765, URL:http://www.exelixis.com/pipeline/xl765|Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718",CCN1C(=O)C(=Cc2c(C)nc(N)nc12)c3cc[nH]n3,CHEMBL2842,MTOR
3785,CHEMBL3545054,Incb-40093,Small molecule,,,,,PI3-kinase p110-delta subunit inhibitor,,,CHEMBL3130,PI3-kinase p110-delta subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://cancerres.aacrjournals.org/content/74/19_Supplement/4531.short, URL:http://cancerres.aacrjournals.org/content/74/19_Supplement/4531.short",,CHEMBL3130,PIK3CD
3786,CHEMBL429736,Retosiban,Small molecule,,,,-siban,Oxytocin receptor antagonist,,,CHEMBL2049,Oxytocin receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20027670, URL:http://europepmc.org/abstract/MED/20027670",CC[C@H](C)[C@H]1N([C@@H](C(=O)N2CCOCC2)c3coc(C)n3)C(=O)[C@H](NC1=O)C4Cc5ccccc5C4,CHEMBL2049,OXTR
3787,CHEMBL3545030,Jnj-17216498,Small molecule,,,,,Histamine H3 receptor antagonist,,,CHEMBL264,Histamine H3 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22931528, URL:http://europepmc.org/abstract/MED/22931528",,CHEMBL264,HRH3
3788,CHEMBL1096146,Ponesimod,Small molecule,,,,-imod,Sphingosine 1-phosphate receptor Edg-1 agonist,,,CHEMBL4333,Sphingosine 1-phosphate receptor Edg-1,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20446681, URL:http://europepmc.org/abstract/MED/20446681|Name:PubMed, SrcID:21345969, URL:http://europepmc.org/abstract/MED/21345969",CCC\N=C\1/S\C(=C/c2ccc(OC[C@H](O)CO)c(Cl)c2)\C(=O)N1c3ccccc3C,CHEMBL4333,S1PR1
3789,CHEMBL189475,Ladarixin,Small molecule,,,,-rixin,Interleukin-8 receptor B modulator,"Ph 2 study terminated, being developed for new indication (http://www.dompe.com/Diabetology/).",,CHEMBL2434,Interleukin-8 receptor B,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21718305, URL:http://europepmc.org/abstract/MED/21718305",C[C@@H](C(=O)NS(=O)(=O)C)c1ccc(OS(=O)(=O)C(F)(F)F)cc1,CHEMBL2434,CXCR2
3790,CHEMBL1823817,Ce-224535,Small molecule,,,,,P2X purinoceptor 7 antagonist,,,CHEMBL4805,P2X purinoceptor 7,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.mrc.ac.uk/funding/browse/mrc-industry-asset-sharing-initiative/compounds-list/purinergic-receptor-2-p2x7-antagonist/, URL:http://www.mrc.ac.uk/funding/browse/mrc-industry-asset-sharing-initiative/compounds-list/purinergic-receptor-2-p2x7-antagonist/|Name:PubMed, SrcID:21565499, URL:http://europepmc.org/abstract/MED/21565499",COC[C@H](O)CN1C(=O)C=NN(C1=O)c2ccc(Cl)c(c2)C(=O)NCC3(O)CCCCCC3,CHEMBL4805,P2RX7
3791,CHEMBL3545353,Tc-6499,Small molecule,,,,,Neuronal acetylcholine receptor; alpha4/beta2 agonist,,,CHEMBL1907589,Neuronal acetylcholine receptor; alpha4/beta2,AGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:18511441, URL:http://europepmc.org/abstract/MED/18511441|Name:Other, SrcID:http://www.jefferies.com/CMSFiles/Jefferies.com/files/Conferences/060214/Presentations/Targacept.pdf, URL:http://www.jefferies.com/CMSFiles/Jefferies.com/files/Conferences/060214/Presentations/Targacept.pdf",,,
3792,CHEMBL3707400,Indantadol,Small molecule,,,,-adol,Glutamate [NMDA] receptor antagonist,,,CHEMBL2094124,Glutamate [NMDA] receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:15671203, URL:http://europepmc.org/abstract/MED/15671203|Name:PubMed, SrcID:11378157, URL:http://europepmc.org/abstract/MED/11378157|Name:PubMed, SrcID:12890713, URL:http://europepmc.org/abstract/MED/12890713",,CHEMBL2094124,GRIN3B
3793,CHEMBL2107762,Nerispirdine,Small molecule,,,,-pirdine,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19413590, URL:http://europepmc.org/abstract/MED/19413590|Name:Other, SrcID:http://www.google.com/patents/US20090209595, URL:http://www.google.com/patents/US20090209595",CCCN(c1ccncc1F)n2cc(C)c3ccccc23,CHEMBL2362996,KCNH6
3794,CHEMBL2107762,Nerispirdine,Small molecule,,,,-pirdine,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19413590, URL:http://europepmc.org/abstract/MED/19413590|Name:Other, SrcID:http://www.google.com/patents/US20090209595, URL:http://www.google.com/patents/US20090209595",CCCN(c1ccncc1F)n2cc(C)c3ccccc23,CHEMBL2362996,KCNF1
3795,CHEMBL2107762,Nerispirdine,Small molecule,,,,-pirdine,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19413590, URL:http://europepmc.org/abstract/MED/19413590|Name:Other, SrcID:http://www.google.com/patents/US20090209595, URL:http://www.google.com/patents/US20090209595",CCCN(c1ccncc1F)n2cc(C)c3ccccc23,CHEMBL2362996,KCNA7
3796,CHEMBL2107762,Nerispirdine,Small molecule,,,,-pirdine,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19413590, URL:http://europepmc.org/abstract/MED/19413590|Name:Other, SrcID:http://www.google.com/patents/US20090209595, URL:http://www.google.com/patents/US20090209595",CCCN(c1ccncc1F)n2cc(C)c3ccccc23,CHEMBL2362996,KCND1
3797,CHEMBL2107762,Nerispirdine,Small molecule,,,,-pirdine,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19413590, URL:http://europepmc.org/abstract/MED/19413590|Name:Other, SrcID:http://www.google.com/patents/US20090209595, URL:http://www.google.com/patents/US20090209595",CCCN(c1ccncc1F)n2cc(C)c3ccccc23,CHEMBL2362996,KCNG1
3798,CHEMBL2107762,Nerispirdine,Small molecule,,,,-pirdine,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19413590, URL:http://europepmc.org/abstract/MED/19413590|Name:Other, SrcID:http://www.google.com/patents/US20090209595, URL:http://www.google.com/patents/US20090209595",CCCN(c1ccncc1F)n2cc(C)c3ccccc23,CHEMBL2362996,KCNH8
3799,CHEMBL2107762,Nerispirdine,Small molecule,,,,-pirdine,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19413590, URL:http://europepmc.org/abstract/MED/19413590|Name:Other, SrcID:http://www.google.com/patents/US20090209595, URL:http://www.google.com/patents/US20090209595",CCCN(c1ccncc1F)n2cc(C)c3ccccc23,CHEMBL2362996,KCNG4
3800,CHEMBL2107762,Nerispirdine,Small molecule,,,,-pirdine,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19413590, URL:http://europepmc.org/abstract/MED/19413590|Name:Other, SrcID:http://www.google.com/patents/US20090209595, URL:http://www.google.com/patents/US20090209595",CCCN(c1ccncc1F)n2cc(C)c3ccccc23,CHEMBL2362996,KCNH7
3801,CHEMBL2107762,Nerispirdine,Small molecule,,,,-pirdine,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19413590, URL:http://europepmc.org/abstract/MED/19413590|Name:Other, SrcID:http://www.google.com/patents/US20090209595, URL:http://www.google.com/patents/US20090209595",CCCN(c1ccncc1F)n2cc(C)c3ccccc23,CHEMBL2362996,KCNH5
3802,CHEMBL2107762,Nerispirdine,Small molecule,,,,-pirdine,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19413590, URL:http://europepmc.org/abstract/MED/19413590|Name:Other, SrcID:http://www.google.com/patents/US20090209595, URL:http://www.google.com/patents/US20090209595",CCCN(c1ccncc1F)n2cc(C)c3ccccc23,CHEMBL2362996,KCNC3
3803,CHEMBL2107762,Nerispirdine,Small molecule,,,,-pirdine,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19413590, URL:http://europepmc.org/abstract/MED/19413590|Name:Other, SrcID:http://www.google.com/patents/US20090209595, URL:http://www.google.com/patents/US20090209595",CCCN(c1ccncc1F)n2cc(C)c3ccccc23,CHEMBL2362996,KCNV1
3804,CHEMBL2107762,Nerispirdine,Small molecule,,,,-pirdine,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19413590, URL:http://europepmc.org/abstract/MED/19413590|Name:Other, SrcID:http://www.google.com/patents/US20090209595, URL:http://www.google.com/patents/US20090209595",CCCN(c1ccncc1F)n2cc(C)c3ccccc23,CHEMBL2362996,KCNG3
3805,CHEMBL2107762,Nerispirdine,Small molecule,,,,-pirdine,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19413590, URL:http://europepmc.org/abstract/MED/19413590|Name:Other, SrcID:http://www.google.com/patents/US20090209595, URL:http://www.google.com/patents/US20090209595",CCCN(c1ccncc1F)n2cc(C)c3ccccc23,CHEMBL2362996,KCNS3
3806,CHEMBL2107762,Nerispirdine,Small molecule,,,,-pirdine,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19413590, URL:http://europepmc.org/abstract/MED/19413590|Name:Other, SrcID:http://www.google.com/patents/US20090209595, URL:http://www.google.com/patents/US20090209595",CCCN(c1ccncc1F)n2cc(C)c3ccccc23,CHEMBL2362996,KCNV2
3807,CHEMBL2107762,Nerispirdine,Small molecule,,,,-pirdine,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19413590, URL:http://europepmc.org/abstract/MED/19413590|Name:Other, SrcID:http://www.google.com/patents/US20090209595, URL:http://www.google.com/patents/US20090209595",CCCN(c1ccncc1F)n2cc(C)c3ccccc23,CHEMBL2362996,KCNH3
3808,CHEMBL2107762,Nerispirdine,Small molecule,,,,-pirdine,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19413590, URL:http://europepmc.org/abstract/MED/19413590|Name:Other, SrcID:http://www.google.com/patents/US20090209595, URL:http://www.google.com/patents/US20090209595",CCCN(c1ccncc1F)n2cc(C)c3ccccc23,CHEMBL2362996,KCNS2
3809,CHEMBL2107762,Nerispirdine,Small molecule,,,,-pirdine,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19413590, URL:http://europepmc.org/abstract/MED/19413590|Name:Other, SrcID:http://www.google.com/patents/US20090209595, URL:http://www.google.com/patents/US20090209595",CCCN(c1ccncc1F)n2cc(C)c3ccccc23,CHEMBL2362996,KCNS1
3810,CHEMBL2107762,Nerispirdine,Small molecule,,,,-pirdine,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19413590, URL:http://europepmc.org/abstract/MED/19413590|Name:Other, SrcID:http://www.google.com/patents/US20090209595, URL:http://www.google.com/patents/US20090209595",CCCN(c1ccncc1F)n2cc(C)c3ccccc23,CHEMBL2362996,KCNC2
3811,CHEMBL2107762,Nerispirdine,Small molecule,,,,-pirdine,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19413590, URL:http://europepmc.org/abstract/MED/19413590|Name:Other, SrcID:http://www.google.com/patents/US20090209595, URL:http://www.google.com/patents/US20090209595",CCCN(c1ccncc1F)n2cc(C)c3ccccc23,CHEMBL2362996,KCNH4
3812,CHEMBL2107762,Nerispirdine,Small molecule,,,,-pirdine,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19413590, URL:http://europepmc.org/abstract/MED/19413590|Name:Other, SrcID:http://www.google.com/patents/US20090209595, URL:http://www.google.com/patents/US20090209595",CCCN(c1ccncc1F)n2cc(C)c3ccccc23,CHEMBL2362996,KCNC4
3813,CHEMBL2107762,Nerispirdine,Small molecule,,,,-pirdine,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19413590, URL:http://europepmc.org/abstract/MED/19413590|Name:Other, SrcID:http://www.google.com/patents/US20090209595, URL:http://www.google.com/patents/US20090209595",CCCN(c1ccncc1F)n2cc(C)c3ccccc23,CHEMBL2362996,KCNH1
3814,CHEMBL2107762,Nerispirdine,Small molecule,,,,-pirdine,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19413590, URL:http://europepmc.org/abstract/MED/19413590|Name:Other, SrcID:http://www.google.com/patents/US20090209595, URL:http://www.google.com/patents/US20090209595",CCCN(c1ccncc1F)n2cc(C)c3ccccc23,CHEMBL2362996,KCNA10
3815,CHEMBL2107762,Nerispirdine,Small molecule,,,,-pirdine,Voltage-gated potassium channel blocker,,,CHEMBL2362996,Voltage-gated potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19413590, URL:http://europepmc.org/abstract/MED/19413590|Name:Other, SrcID:http://www.google.com/patents/US20090209595, URL:http://www.google.com/patents/US20090209595",CCCN(c1ccncc1F)n2cc(C)c3ccccc23,CHEMBL2362996,KCNG2
3816,CHEMBL491473,Cediranib,Small molecule,,L01XE32,L01XE32 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-anib,Stem cell growth factor receptor inhibitor,,,CHEMBL1936,Stem cell growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15899831, URL:http://europepmc.org/abstract/MED/15899831",COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN5CCCC5,CHEMBL1936,KIT
3817,CHEMBL180022,Neratinib,Small molecule,,,,-tinib,Epidermal growth factor receptor erbB1 inhibitor,Neratinib is an irreversible pan-HER tyrosine kinase inhibitor.,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26089701, URL:http://europepmc.org/abstract/MED/26089701|Name:PubMed, SrcID:15715478, URL:http://europepmc.org/abstract/MED/15715478",CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)\C=C\CN(C)C,CHEMBL203,EGFR
3818,CHEMBL608533,Midostaurin,Small molecule,,L01XE39,L01XE39 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],,Protein kinase C (PKC) inhibitor,Multi-kinase inhibitor,,CHEMBL2093867,Protein kinase C (PKC),INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:16969355, URL:http://europepmc.org/abstract/MED/16969355|Name:PubMed, SrcID:12124173, URL:http://europepmc.org/abstract/MED/12124173",CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)n3c4ccccc4c5c6CNC(=O)c6c7c8ccccc8n2c7c35)N(C)C(=O)c9ccccc9,,
3819,CHEMBL1255794,Aplaviroc,Small molecule,,,,-viroc,C-C chemokine receptor type 5 antagonist,Discontinueddue to liver toxicity concerns.,,CHEMBL274,C-C chemokine receptor type 5,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15280474, URL:http://europepmc.org/abstract/MED/15280474|Name:PubMed, SrcID:18378711, URL:http://europepmc.org/abstract/MED/18378711",CCCCN1C(=O)[C@H](NC(=O)C12CCN(Cc3ccc(Oc4ccc(cc4)C(=O)O)cc3)CC2)[C@H](O)C5CCCCC5,CHEMBL274,CCR5
3820,CHEMBL301742,Arbaclofen,Small molecule,,,,,GABA-B receptor agonist,,,CHEMBL2111463,GABA-B receptor,AGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:24272415, URL:http://europepmc.org/abstract/MED/24272415",NC[C@H](CC(=O)O)c1ccc(Cl)cc1,,
3821,CHEMBL408194,Obatoclax,Small molecule,,,,-toclax,Apoptosis regulator Bcl-2 inhibitor,,,CHEMBL4860,Apoptosis regulator Bcl-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,BH3 binding groove,"Name:PubMed, SrcID:18931344, URL:http://europepmc.org/abstract/MED/18931344|Name:PubMed, SrcID:16645636, URL:http://europepmc.org/abstract/MED/16645636|Name:PubMed, SrcID:18040043, URL:http://europepmc.org/abstract/MED/18040043",COC1=CC(=N/C/1=C\c2[nH]c(C)cc2C)c3cc4ccccc4[nH]3,CHEMBL4860,BCL2
3822,CHEMBL3137320,Talazoparib,Small molecule,,,,-parib,Poly [ADP-ribose] polymerase-1 inhibitor,,Potent PARP1/2 inhibitor (PARP1 IC50 = 0.57 nmol/L). PARP1 Ki=1.2 nmol/L. PARP2 Ki= 0.85 nmol/L.,CHEMBL3105,Poly [ADP-ribose] polymerase-1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23881923, URL:http://europepmc.org/abstract/MED/23881923",Cn1ncnc1[C@@H]2[C@H](Nc3cc(F)cc4C(=O)NN=C2c34)c5ccc(F)cc5,CHEMBL3105,PARP1
3823,CHEMBL1201340,Diphemanil,Small molecule,1982.0,A03AB15,"A03AB15 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: Synthetic anticholinergics, quaternary ammonium compounds]",,Muscarinic acetylcholine receptor M3 antagonist,"Role in regulating gastric secretion, M3 likely involved",,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:13478170, URL:http://europepmc.org/abstract/MED/13478170|Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718",C[N+]1(C)CCC(=C(c2ccccc2)c3ccccc3)CC1,CHEMBL245,CHRM3
3824,CHEMBL667,Acetylcholine,Small molecule,1973.0,S01EB09,S01EB09 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Parasympathomimetics],,Muscarinic acetylcholine receptor M3 agonist,"Indicated for miosis, M3 likely involved (main form in iris)",,CHEMBL245,Muscarinic acetylcholine receptor M3,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:2912119, URL:http://europepmc.org/abstract/MED/2912119|Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718",CC(=O)OCC[N+](C)(C)C,CHEMBL245,CHRM3
3825,CHEMBL620,Clidinium,Small molecule,1982.0,,,-ium,Muscarinic acetylcholine receptor M3 antagonist,"Role in regulating gastric secretion, M3 likely involved",,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Muscarinic_acetylcholine_receptor, URL:http://en.wikipedia.org/wiki/Muscarinic_acetylcholine_receptor|Name:DailyMed, SrcID:setid=a3e521be-bdd7-406d-9791-749f75399c38#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a3e521be-bdd7-406d-9791-749f75399c38#nlm34090-1|Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:DailyMed, SrcID:archiveid=44903, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=44903",C[N+]12CCC(CC1)C(C2)OC(=O)C(O)(c3ccccc3)c4ccccc4,CHEMBL245,CHRM3
3826,CHEMBL19,Methazolamide,Small molecule,1959.0,S01EC05,S01EC05 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Carbonic anhydrase inhibitors],-zolamide,Carbonic anhydrase II inhibitor,,,CHEMBL205,Carbonic anhydrase II,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18336310, URL:http://europepmc.org/abstract/MED/18336310|Name:DailyMed, SrcID:setid=8e162b6d-8fa6-45f6-80d8-5132d94c1207, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e162b6d-8fa6-45f6-80d8-5132d94c1207",CN1N=C(S/C/1=N/C(=O)C)S(=O)(=O)N,CHEMBL205,CA2
3827,CHEMBL1201185,Lanreotide,Protein,2007.0,H01CB03,"H01CB03 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: HYPOTHALAMIC HORMONES: Somatostatin and analogues]",-tide,Somatostatin receptor 2 agonist,,,CHEMBL1804,Somatostatin receptor 2,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f11b1d88-74ca-4a6d-89fb-40d0f51bca95#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f11b1d88-74ca-4a6d-89fb-40d0f51bca95#nlm34090-1",CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N)NC(=O)[C@H](N)Cc5ccc6ccccc6c5,CHEMBL1804,SSTR2
3828,CHEMBL1963684,Peginesatide Acetate,Protein,2012.0,B03XA04,B03XA04 [BLOOD AND BLOOD FORMING ORGANS: ANTIANEMIC PREPARATIONS: OTHER ANTIANEMIC PREPARATIONS: Other antianemic preparations],peg-; -tide,Erythropoietin receptor agonist,,,CHEMBL1817,Erythropoietin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2012/202799s001lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202799s001lbl.pdf",,CHEMBL1817,EPOR
3829,CHEMBL643,Promethazine,Small molecule,1951.0,R06AD02; R06AD52; D04AA10,"R06AD02 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Phenothiazine derivatives]; R06AD52 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Phenothiazine derivatives]; D04AA10 [DERMATOLOGICALS: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: Antihistamines for topical use]",,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=6f7e47cc-f823-4336-8107-f980e3049617, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6f7e47cc-f823-4336-8107-f980e3049617",CC(CN1c2ccccc2Sc3ccccc13)N(C)C,CHEMBL231,HRH1
3830,CHEMBL1201210,Propiomazine,Small molecule,1960.0,N05CM06,N05CM06 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Other hypnotics and sedatives],,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Promethazine, URL:http://en.wikipedia.org/wiki/Promethazine|Name:ISBN, SrcID:0443-059748 PP. 240, 529, URL:http://www.isbnsearch.org/isbn/0443059748|Name:Wikipedia, SrcID:Propiomazine, URL:http://en.wikipedia.org/wiki/Propiomazine",CCC(=O)c1ccc2Sc3ccccc3N(CC(C)N(C)C)c2c1,CHEMBL231,HRH1
3831,CHEMBL1241,Tripelennamine,Small molecule,1948.0,R06AC04; D04AA04,"R06AC04 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Substituted ethylene diamines]; D04AA04 [DERMATOLOGICALS: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: Antihistamines for topical use]",,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:7513381, URL:http://europepmc.org/abstract/MED/7513381",CN(C)CCN(Cc1ccccc1)c2ccccn2,CHEMBL231,HRH1
3832,CHEMBL1069,Valsartan,Small molecule,1996.0,C09CA03,"C09CA03 [CARDIOVASCULAR SYSTEM: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM: ANGIOTENSIN II ANTAGONISTS, PLAIN: Angiotensin II antagonists, plain]",-sartan,Type-1 angiotensin II receptor antagonist,,,CHEMBL227,Type-1 angiotensin II receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/021283s046lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021283s046lbl.pdf|Name:DailyMed, SrcID:setid=0dd5fd1c-ab03-4860-87d6-4a95df6e7b7a, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0dd5fd1c-ab03-4860-87d6-4a95df6e7b7a",CCCCC(=O)N(Cc1ccc(cc1)c2ccccc2c3nnn[nH]3)[C@@H](C(C)C)C(=O)O,CHEMBL227,AGTR1
3833,CHEMBL61593,Cyclothiazide,Small molecule,1982.0,C03AA09,"C03AA09 [CARDIOVASCULAR SYSTEM: DIURETICS: LOW-CEILING DIURETICS, THIAZIDES: Thiazides, plain]",-thiazide,Thiazide-sensitive sodium-chloride cotransporter inhibitor,,,CHEMBL1876,Thiazide-sensitive sodium-chloride cotransporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1056/NEJMra0907219, URL:http://www.nejm.org/doi/full/10.1056/NEJMra0907219",NS(=O)(=O)c1cc2c(NC(NS2(=O)=O)C3CC4CC3C=C4)cc1Cl,CHEMBL1876,SLC12A3
3834,CHEMBL1201039,Benzthiazide,Small molecule,1960.0,,,-thiazide,Thiazide-sensitive sodium-chloride cotransporter inhibitor,,,CHEMBL1876,Thiazide-sensitive sodium-chloride cotransporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1056/NEJMra0907219, URL:http://www.nejm.org/doi/full/10.1056/NEJMra0907219",NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc3ccccc3)NS2(=O)=O,CHEMBL1876,SLC12A3
3835,CHEMBL1508,Escitalopram,Small molecule,2002.0,N06AB10,N06AB10 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Selective serotonin reuptake inhibitors],,Serotonin transporter inhibitor,reuptake inhibitor,,CHEMBL228,Serotonin transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Escitalopram, URL:http://en.wikipedia.org/wiki/Escitalopram|Name:DailyMed, SrcID:setid=2db02476-325f-ee47-a7e5-b5aed56c364c#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2db02476-325f-ee47-a7e5-b5aed56c364c#nlm34090-1",CN(C)CCC[C@]1(OCc2cc(ccc12)C#N)c3ccc(F)cc3,CHEMBL228,SLC6A4
3836,CHEMBL477772,Pazopanib,Small molecule,2009.0,L01XE11,L01XE11 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-anib,Stem cell growth factor receptor inhibitor,,,CHEMBL1936,Stem cell growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14",CN(c1ccc2c(C)n(C)nc2c1)c3ccnc(Nc4ccc(C)c(c4)S(=O)(=O)N)n3,CHEMBL1936,KIT
3837,CHEMBL1422,Sitagliptin,Small molecule,2006.0,A10BH01,"A10BH01 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Dipeptidyl peptidase 4 (DPP-4) inhibitors]",-gliptin,Dipeptidyl peptidase IV inhibitor,,,CHEMBL284,Dipeptidyl peptidase IV,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f85a48d0-0407-4c50-b0fa-7673a160bf01, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f85a48d0-0407-4c50-b0fa-7673a160bf01",N[C@@H](CC(=O)N1CCn2c(C1)nnc2C(F)(F)F)Cc3cc(F)c(F)cc3F,CHEMBL284,DPP4
3838,CHEMBL237500,Linagliptin,Small molecule,2011.0,A10BH05,"A10BH05 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Dipeptidyl peptidase 4 (DPP-4) inhibitors]",-gliptin,Dipeptidyl peptidase IV inhibitor,,,CHEMBL284,Dipeptidyl peptidase IV,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f6dd9b86-0d18-95d4-2bc7-05591bfdd597, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f6dd9b86-0d18-95d4-2bc7-05591bfdd597",CC#CCn1c(nc2N(C)C(=O)N(Cc3nc(C)c4ccccc4n3)C(=O)c12)N5CCC[C@@H](N)C5,CHEMBL284,DPP4
3839,CHEMBL1201489,Seractide Acetate,Protein,1978.0,,,-tide,Melanocortin receptor 2 agonist,Is corticotropin,,CHEMBL1965,Melanocortin receptor 2,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:IUPHAR, SrcID:3633, URL:http://www.iuphar-db.org/DATABASE/LigandDisplayForward?tab=biology&ligandId=3633|Name:FDA, SrcID:label/2015/008372s044lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/008372s044lbl.pdf|Name:DailyMed, SrcID:setid=ae97eb2b-587a-4705-8c55-de0f97ee1f1f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ae97eb2b-587a-4705-8c55-de0f97ee1f1f",,CHEMBL1965,MC2R
3840,CHEMBL1237119,Treprostinil,Small molecule,2002.0,B01AC21,B01AC21 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Platelet aggregation inhibitors excl. heparin],-prost-,Prostanoid IP receptor agonist,,,CHEMBL1995,Prostanoid IP receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11897647, URL:¿http://europepmc.org/abstract/MED/11897647|Name:PubMed, SrcID:11897647, URL:http://europepmc.org/abstract/MED/11897647",CCCCC[C@H](O)CC[C@H]1[C@H](O)C[C@@H]2Cc3c(C[C@H]12)cccc3OCC(=O)O,CHEMBL1995,PTGIR
3841,CHEMBL853,Zalcitabine,Small molecule,1992.0,J05AF03,J05AF03 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleoside and nucleotide reverse transcriptase inhibitors],-citabine,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,,,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,INHIBITOR,Human immunodeficiency virus 1,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=a6ca918f-d031-4601-31a4-1848b580f2f0, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6ca918f-d031-4601-31a4-1848b580f2f0|Name:FDA, SrcID:label/2002/20199s16lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20199s16lbl.pdf",NC1=NC(=O)N(C=C1)[C@H]2CC[C@@H](CO)O2,,
3842,CHEMBL1561,Miglitol,Small molecule,1996.0,A10BF02,"A10BF02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Alpha glucosidase inhibitors]",,Maltase-glucoamylase inhibitor,,,CHEMBL2074,Maltase-glucoamylase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=75711d16-2d27-476e-a312-d5af448a0e25#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=75711d16-2d27-476e-a312-d5af448a0e25#nlm34090-1|Name:PubMed, SrcID:23185202, URL:http://europepmc.org/abstract/MED/23185202",OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,CHEMBL2074,MGAM
3843,CHEMBL1683590,Eribulin,Small molecule,2010.0,L01XX41,L01XX41 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-bulin,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,Binds to beta tubulin,"Name:PubMed, SrcID:22619477, URL:http://europepmc.org/abstract/MED/22619477|Name:DailyMed, SrcID:setid=31ce4750-ded5-4a0b-95e9-f229fa6bc822#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=31ce4750-ded5-4a0b-95e9-f229fa6bc822#nlm34090-1",CO[C@H]1[C@@H](C[C@H](O)CN)O[C@H]2C[C@H]3O[C@@H](CC[C@@H]4O[C@@H](CC[C@@]56C[C@H]7O[C@@H]8[C@@H](O[C@H]9CC[C@H](CC(=O)C[C@H]12)O[C@@H]9[C@@H]8O5)[C@H]7O6)CC4=C)C[C@@H](C)C3=C,CHEMBL2095182,TUBB8
3844,CHEMBL1683590,Eribulin,Small molecule,2010.0,L01XX41,L01XX41 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-bulin,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,Binds to beta tubulin,"Name:PubMed, SrcID:22619477, URL:http://europepmc.org/abstract/MED/22619477|Name:DailyMed, SrcID:setid=31ce4750-ded5-4a0b-95e9-f229fa6bc822#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=31ce4750-ded5-4a0b-95e9-f229fa6bc822#nlm34090-1",CO[C@H]1[C@@H](C[C@H](O)CN)O[C@H]2C[C@H]3O[C@@H](CC[C@@H]4O[C@@H](CC[C@@]56C[C@H]7O[C@@H]8[C@@H](O[C@H]9CC[C@H](CC(=O)C[C@H]12)O[C@@H]9[C@@H]8O5)[C@H]7O6)CC4=C)C[C@@H](C)C3=C,CHEMBL2095182,TUBA3C
3845,CHEMBL1683590,Eribulin,Small molecule,2010.0,L01XX41,L01XX41 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-bulin,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,Binds to beta tubulin,"Name:PubMed, SrcID:22619477, URL:http://europepmc.org/abstract/MED/22619477|Name:DailyMed, SrcID:setid=31ce4750-ded5-4a0b-95e9-f229fa6bc822#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=31ce4750-ded5-4a0b-95e9-f229fa6bc822#nlm34090-1",CO[C@H]1[C@@H](C[C@H](O)CN)O[C@H]2C[C@H]3O[C@@H](CC[C@@H]4O[C@@H](CC[C@@]56C[C@H]7O[C@@H]8[C@@H](O[C@H]9CC[C@H](CC(=O)C[C@H]12)O[C@@H]9[C@@H]8O5)[C@H]7O6)CC4=C)C[C@@H](C)C3=C,CHEMBL2095182,TUBA4A
3846,CHEMBL1683590,Eribulin,Small molecule,2010.0,L01XX41,L01XX41 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-bulin,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,Binds to beta tubulin,"Name:PubMed, SrcID:22619477, URL:http://europepmc.org/abstract/MED/22619477|Name:DailyMed, SrcID:setid=31ce4750-ded5-4a0b-95e9-f229fa6bc822#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=31ce4750-ded5-4a0b-95e9-f229fa6bc822#nlm34090-1",CO[C@H]1[C@@H](C[C@H](O)CN)O[C@H]2C[C@H]3O[C@@H](CC[C@@H]4O[C@@H](CC[C@@]56C[C@H]7O[C@@H]8[C@@H](O[C@H]9CC[C@H](CC(=O)C[C@H]12)O[C@@H]9[C@@H]8O5)[C@H]7O6)CC4=C)C[C@@H](C)C3=C,CHEMBL2095182,TUBA3E
3847,CHEMBL1683590,Eribulin,Small molecule,2010.0,L01XX41,L01XX41 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-bulin,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,Binds to beta tubulin,"Name:PubMed, SrcID:22619477, URL:http://europepmc.org/abstract/MED/22619477|Name:DailyMed, SrcID:setid=31ce4750-ded5-4a0b-95e9-f229fa6bc822#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=31ce4750-ded5-4a0b-95e9-f229fa6bc822#nlm34090-1",CO[C@H]1[C@@H](C[C@H](O)CN)O[C@H]2C[C@H]3O[C@@H](CC[C@@H]4O[C@@H](CC[C@@]56C[C@H]7O[C@@H]8[C@@H](O[C@H]9CC[C@H](CC(=O)C[C@H]12)O[C@@H]9[C@@H]8O5)[C@H]7O6)CC4=C)C[C@@H](C)C3=C,CHEMBL2095182,TUBB6
3848,CHEMBL1683590,Eribulin,Small molecule,2010.0,L01XX41,L01XX41 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-bulin,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,Binds to beta tubulin,"Name:PubMed, SrcID:22619477, URL:http://europepmc.org/abstract/MED/22619477|Name:DailyMed, SrcID:setid=31ce4750-ded5-4a0b-95e9-f229fa6bc822#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=31ce4750-ded5-4a0b-95e9-f229fa6bc822#nlm34090-1",CO[C@H]1[C@@H](C[C@H](O)CN)O[C@H]2C[C@H]3O[C@@H](CC[C@@H]4O[C@@H](CC[C@@]56C[C@H]7O[C@@H]8[C@@H](O[C@H]9CC[C@H](CC(=O)C[C@H]12)O[C@@H]9[C@@H]8O5)[C@H]7O6)CC4=C)C[C@@H](C)C3=C,CHEMBL2095182,TUBB2B
3849,CHEMBL1683590,Eribulin,Small molecule,2010.0,L01XX41,L01XX41 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-bulin,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,Binds to beta tubulin,"Name:PubMed, SrcID:22619477, URL:http://europepmc.org/abstract/MED/22619477|Name:DailyMed, SrcID:setid=31ce4750-ded5-4a0b-95e9-f229fa6bc822#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=31ce4750-ded5-4a0b-95e9-f229fa6bc822#nlm34090-1",CO[C@H]1[C@@H](C[C@H](O)CN)O[C@H]2C[C@H]3O[C@@H](CC[C@@H]4O[C@@H](CC[C@@]56C[C@H]7O[C@@H]8[C@@H](O[C@H]9CC[C@H](CC(=O)C[C@H]12)O[C@@H]9[C@@H]8O5)[C@H]7O6)CC4=C)C[C@@H](C)C3=C,CHEMBL2095182,TUBA3D
3850,CHEMBL723,Carvedilol,Small molecule,1995.0,C07AG02,C07AG02 [CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Alpha and beta blocking agents],-dil-,Adrenergic receptor alpha-1 antagonist,,,CHEMBL2094251,Adrenergic receptor alpha-1,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2011/020297s036lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020297s036lbl.pdf|Name:DailyMed, SrcID:setid=0b802a9c-332f-4ea8-bb34-75c677264654, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0b802a9c-332f-4ea8-bb34-75c677264654",COc1ccccc1OCCNCC(O)COc2cccc3[nH]c4ccccc4c23,,
3851,CHEMBL727,Thioguanine,Small molecule,1966.0,L01BB03,L01BB03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Purine analogues],,Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor,,,CHEMBL2111369,Inosine-5'-monophosphate dehydrogenase (IMPDH),INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2004/12429s022lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/12429s022lbl.pdf|Name:DailyMed, SrcID:setid=dfda4177-3c9d-44ab-3ca6-e4db8e9fc603, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dfda4177-3c9d-44ab-3ca6-e4db8e9fc603",NC1=Nc2[nH]cnc2C(=S)N1,,
3852,CHEMBL1089,Phenelzine,Small molecule,1961.0,N06AF03,"N06AF03 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Monoamine oxidase inhibitors, non-selective]",,Monoamine oxidase inhibitor,,,CHEMBL2095205,Monoamine oxidase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2007/011909s038lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/011909s038lbl.pdf|Name:Wikipedia, SrcID:Monoamine_oxidase_inhibitor, URL:http://en.wikipedia.org/wiki/Monoamine_oxidase_inhibitor",NNCCc1ccccc1,,
3853,CHEMBL1200623,Ethylestrenol,Small molecule,1964.0,A14AB02,A14AB02 [ALIMENTARY TRACT AND METABOLISM: ANABOLIC AGENTS FOR SYSTEMIC USE: ANABOLIC STEROIDS: Estren derivatives],-estr-,Androgen Receptor agonist,,,CHEMBL1871,Androgen Receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:4057776, URL:http://europepmc.org/abstract/MED/4057776|Name:ISBN, SrcID:9780702034718 PP. 423, URL:http://www.isbnsearch.org/isbn/9780702034718",CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@]12C,CHEMBL1871,AR
3854,CHEMBL1200946,Nandrolone Decanoate,Small molecule,1983.0,S01XA11; A14AB01,S01XA11 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals]; A14AB01 [ALIMENTARY TRACT AND METABOLISM: ANABOLIC AGENTS FOR SYSTEMIC USE: ANABOLIC STEROIDS: Estren derivatives],-olone,Androgen Receptor agonist,,,CHEMBL1871,Androgen Receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18809391, URL:http://europepmc.org/abstract/MED/18809391",CCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C,CHEMBL1871,AR
3855,CHEMBL1201101,Testosterone Cypionate,Small molecule,1978.0,G03BA03,G03BA03 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ANDROGENS: 3-oxoandrosten (4) derivatives],-ster-,Androgen Receptor agonist,,,CHEMBL1871,Androgen Receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Testosterone, URL:http://en.wikipedia.org/wiki/Testosterone|Name:DailyMed, SrcID:setid=cfbb53d4-b868-4a28-8436-f9112eb01c39#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cfbb53d4-b868-4a28-8436-f9112eb01c39#nlm34090-1",C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2OC(=O)CCC5CCCC5,CHEMBL1871,AR
3856,CHEMBL1201206,Pipecuronium,Small molecule,1990.0,,,-ium,Muscle-type nicotinic acetylcholine receptor antagonist,non-depolarizing,,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:12426786, URL:http://europepmc.org/abstract/MED/12426786|Name:PubMed, SrcID:1748153, URL:http://europepmc.org/abstract/MED/1748153|Name:PubMed, SrcID:9227834, URL:http://europepmc.org/abstract/MED/9227834",CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@@H]([C@@H]4OC(=O)C)N5CC[N+](C)(C)CC5)[C@@]2(C)C[C@@H]1N6CC[N+](C)(C)CC6,,
3857,CHEMBL1259,Metocurine,Small molecule,1982.0,,,-ium,Muscle-type nicotinic acetylcholine receptor antagonist,,,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Wikipedia, SrcID:Dimethyltubocurarine, URL:http://en.wikipedia.org/wiki/Dimethyltubocurarine|Name:PubMed, SrcID:18633030, URL:http://europepmc.org/abstract/MED/18633030",COc1ccc2C[C@@H]3c4c(CC[N+]3(C)C)cc(OC)c(OC)c4Oc5ccc(C[C@H]6c7cc(Oc1c2)c(OC)cc7CC[N+]6(C)C)cc5,,
3858,CHEMBL970,Halazepam,Small molecule,1981.0,N05BA13,N05BA13 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:18384456, URL:http://europepmc.org/abstract/MED/18384456",FC(F)(F)CN1C(=O)CN=C(c2ccccc2)c3cc(Cl)ccc13,CHEMBL2093872,GABRG3
3859,CHEMBL970,Halazepam,Small molecule,1981.0,N05BA13,N05BA13 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:18384456, URL:http://europepmc.org/abstract/MED/18384456",FC(F)(F)CN1C(=O)CN=C(c2ccccc2)c3cc(Cl)ccc13,CHEMBL2093872,GABRP
3860,CHEMBL970,Halazepam,Small molecule,1981.0,N05BA13,N05BA13 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:18384456, URL:http://europepmc.org/abstract/MED/18384456",FC(F)(F)CN1C(=O)CN=C(c2ccccc2)c3cc(Cl)ccc13,CHEMBL2093872,GABRE
3861,CHEMBL970,Halazepam,Small molecule,1981.0,N05BA13,N05BA13 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],-azepam,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:18384456, URL:http://europepmc.org/abstract/MED/18384456",FC(F)(F)CN1C(=O)CN=C(c2ccccc2)c3cc(Cl)ccc13,CHEMBL2093872,GABRG1
3862,CHEMBL1201564,Interferon Gama-1b,Protein,1999.0,L03AB03,L03AB03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSTIMULANTS: IMMUNOSTIMULANTS: Interferons],,Interferon gamma receptor agonist,,,CHEMBL2364171,Interferon gamma receptor,AGONIST,Homo sapiens,PROTEIN COMPLEX,,Alpha subunit is binding site,"Name:FDA, SrcID:label/2015/103836s5182lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103836s5182lbl.pdf|Name:DailyMed, SrcID:setid=1145af19-824f-4701-9620-ee1c76a892b5, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1145af19-824f-4701-9620-ee1c76a892b5|Name:PubMed, SrcID:7617032, URL:http://europepmc.org/abstract/MED/7617032",,CHEMBL2364171,IFNGR2
3863,CHEMBL1201564,Interferon Gama-1b,Protein,1999.0,L03AB03,L03AB03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSTIMULANTS: IMMUNOSTIMULANTS: Interferons],,Interferon gamma receptor agonist,,,CHEMBL2364171,Interferon gamma receptor,AGONIST,Homo sapiens,PROTEIN COMPLEX,,Alpha subunit is binding site,"Name:FDA, SrcID:label/2015/103836s5182lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103836s5182lbl.pdf|Name:DailyMed, SrcID:setid=1145af19-824f-4701-9620-ee1c76a892b5, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1145af19-824f-4701-9620-ee1c76a892b5|Name:PubMed, SrcID:7617032, URL:http://europepmc.org/abstract/MED/7617032",,CHEMBL2364171,IFNGR1
3864,CHEMBL1220,Tinidazole,Small molecule,2004.0,P01AB02; J01XD02,"P01AB02 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES: Nitroimidazole derivatives]; J01XD02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER ANTIBACTERIALS: Imidazole derivatives]",-nidazole,DNA inhibitor,,,CHEMBL2366045,DNA,INHIBITOR,Trichomonas,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=a0d01539-8413-4703-94cc-d221918630a1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a0d01539-8413-4703-94cc-d221918630a1",CCS(=O)(=O)CCn1c(C)ncc1[N+](=O)[O-],,
3865,CHEMBL1093,Articaine,Small molecule,2000.0,N01BB08; N01BB58,"N01BB08 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Amides]; N01BB58 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Amides]",-caine,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:8799190, URL:http://europepmc.org/abstract/MED/8799190|Name:PubMed, SrcID:15635807, URL:http://europepmc.org/abstract/MED/15635807|Name:DailyMed, SrcID:setid=d18424f0-a691-11dd-ad8b-0800200c9a66#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d18424f0-a691-11dd-ad8b-0800200c9a66#nlm34090-1",CCCNC(C)C(=O)Nc1c(C)csc1C(=O)OC,,
3866,CHEMBL696,Ethosuximide,Small molecule,1960.0,N03AD01; N03AD51,N03AD01 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Succinimide derivatives]; N03AD51 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Succinimide derivatives],,Voltage-gated T-type calcium channel blocker,,,CHEMBL2362995,Voltage-gated T-type calcium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:11641441, URL:http://europepmc.org/abstract/MED/11641441|Name:Wikipedia, SrcID:Ethosuximide#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Ethosuximide#Mechanism_of_action|Name:PubMed, SrcID:17291698, URL:http://europepmc.org/abstract/MED/17291698",CCC1(C)CC(=O)NC1=O,,
3867,CHEMBL1201622,Poractant Alfa,Unknown,1999.0,,,-tant,Surfactant agent,Replaces endogenous surfactant in case of deficiency; endogenous pulmonary surfactant lower surface tension at the air-liquid of the alveolar surfaces,,,,,,,,,"Name:DailyMed, SrcID:setid=99bef307-00bd-4379-9f45-ede1380e74d4, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=99bef307-00bd-4379-9f45-ede1380e74d4",,,
3868,CHEMBL1200680,Selenium Sulfide,Small molecule,1951.0,D01AE13,D01AE13 [DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Other antifungals for topical use],,Unknown,,,,,,,,,,"Name:DailyMed, SrcID:setid=7498ba49-9ec8-4057-845b-94e2320870b2, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7498ba49-9ec8-4057-845b-94e2320870b2",S=[Se]=S,,
3869,CHEMBL3039566,Sucroferric Oxyhydroxide,Unknown,2013.0,V03AE05,V03AE05 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Drugs for treatment of hyperkalemia and hyperphosphatemia],,Phosphate sequestering agent,It is a phosphate binder indicated for the control of serum phosphorus levels in patients with chronic kidney disease on dialysis,,CHEMBL2364184,Phosphate,SEQUESTERING AGENT,Homo sapiens,SMALL MOLECULE,,,"Name:DailyMed, SrcID:setid=237da26c-f38c-4faa-93ad-735e71c9d0c1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=237da26c-f38c-4faa-93ad-735e71c9d0c1",,,
3870,CHEMBL605846,Olodaterol,Small molecule,2014.0,R03AC19,"R03AC19 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS, INHALANTS: Selective beta-2-adrenoreceptor agonists]",-terol,Beta-2 adrenergic receptor agonist,Long-acting,,CHEMBL210,Beta-2 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2014/203108s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203108s000lbl.pdf",COc1ccc(CC(C)(C)NC[C@H](O)c2cc(O)cc3NC(=O)COc23)cc1,CHEMBL210,ADRB2
3871,CHEMBL1908370,Finafloxacin,Small molecule,2014.0,,,-oxacin,DNA gyrase inhibitor,,,CHEMBL3038482,DNA gyrase,INHIBITOR,Staphylococcus aureus,PROTEIN COMPLEX,,,"Name:FDA, SrcID:label/2014/206307s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206307s000lbl.pdf",OC(=O)C1=CN(C2CC2)c3c(C#N)c(N4C[C@@H]5NCCO[C@H]5C4)c(F)cc3C1=O,,
3872,CHEMBL184412,Dronedarone,Small molecule,2009.0,C01BD07,"C01BD07 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III]",-arone,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 blocker,,HCN4 is predominant form in sinoatrial node and atrioventricular node,CHEMBL1250417,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19394343, URL:http://europepmc.org/abstract/MED/19394343|Name:PubMed, SrcID:23647933, URL:http://europepmc.org/abstract/MED/23647933|Name:PubMed, SrcID:23933296, URL:http://europepmc.org/abstract/MED/23933296|Name:PubMed, SrcID:21279331, URL:http://europepmc.org/abstract/MED/21279331|Name:PubMed, SrcID:14563715, URL:http://europepmc.org/abstract/MED/14563715",CCCCN(CCCC)CCCOc1ccc(cc1)C(=O)c2c(CCCC)oc3ccc(NS(=O)(=O)C)cc23,CHEMBL1250417,HCN4
3873,CHEMBL3545176,Db959,Small molecule,,,,,Peroxisome proliferator-activated receptor delta agonist,Ph1b study completed in 2011 (no trial ID). Compound outlicensed to T3D Therapeutics Inc in 2013.,,CHEMBL3979,Peroxisome proliferator-activated receptor delta,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.t3dtherapeutics.com/product-portfolio/, URL:http://www.t3dtherapeutics.com/product-portfolio/|Name:Other, SrcID:http://www.darabio.com/media-center/press-releases?detail=134, URL:http://www.darabio.com/media-center/press-releases?detail=134",,CHEMBL3979,PPARD
3874,CHEMBL3545358,4sc-203,Small molecule,,,,,Vascular endothelial growth factor receptor inhibitor,,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://www.4sc.de/sites/default/files/documents/4SC-203-Poster-ECCO-Stockholm-2011.pdf, URL:http://www.4sc.de/sites/default/files/documents/4SC-203-Poster-ECCO-Stockholm-2011.pdf|Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=666086, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=666086",,,
3875,CHEMBL3545365,Altiratinib,Small molecule,,,,-tinib,Vascular endothelial growth factor receptor 2 inhibitor,,,CHEMBL279,Vascular endothelial growth factor receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.deciphera.com/pipeline, URL:http://www.deciphera.com/pipeline|Name:PubMed, SrcID:26285778, URL:http://europepmc.org/abstract/MED/26285778",Fc1ccc(NC(=O)C2(CC2)C(=O)Nc3cc(F)c(Oc4ccnc(NC(=O)C5CC5)c4)cc3F)cc1,CHEMBL279,KDR
3876,CHEMBL1908397,Kw-2449,Small molecule,,,,,Tyrosine-protein kinase ABL inhibitor,,,CHEMBL1862,Tyrosine-protein kinase ABL,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19541823, URL:http://europepmc.org/abstract/MED/19541823|Name:PubMed, SrcID:21474579, URL:http://europepmc.org/abstract/MED/21474579",O=C(N1CCNCC1)c2ccc(\C=C\c3n[nH]c4ccccc34)cc2,CHEMBL1862,ABL1
3877,CHEMBL3545004,Pl-225b,Small molecule,,,,,Insulin-like growth factor I receptor inhibitor,,,CHEMBL1957,Insulin-like growth factor I receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=746194, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=746194|Name:ClinicalTrials, SrcID:NCT01779336, URL:https://www.clinicaltrials.gov/ct2/show/NCT01779336",,CHEMBL1957,IGF1R
3878,CHEMBL3545199,Rg-7741,Small molecule,,,,,Serine/threonine-protein kinase Chk1 inhibitor,,,CHEMBL4630,Serine/threonine-protein kinase Chk1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.gene.com/medical-professionals/pipeline, URL:http://www.gene.com/medical-professionals/pipeline",,CHEMBL4630,CHEK1
3879,CHEMBL3545384,Sb-85635,Small molecule,,,,,MAP kinase p38 alpha inhibitor,No references found,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.google.com/patents/US20120276064, URL:http://www.google.com/patents/US20120276064",,CHEMBL260,MAPK14
3880,CHEMBL1944698,Tg-02,Small molecule,,,,,Cyclin-dependent kinase 2 inhibitor,,,CHEMBL301,Cyclin-dependent kinase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21860433, URL:http://europepmc.org/abstract/MED/21860433",CN1C\C=C\CCOc2cccc(c2)c3ccnc(Nc4cccc(C1)c4)n3,CHEMBL301,CDK2
3881,CHEMBL1944698,Tg-02,Small molecule,,,,,Cyclin-dependent kinase 7 inhibitor,,,CHEMBL3055,Cyclin-dependent kinase 7,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21860433, URL:http://europepmc.org/abstract/MED/21860433",CN1C\C=C\CCOc2cccc(c2)c3ccnc(Nc4cccc(C1)c4)n3,CHEMBL3055,CDK7
3882,CHEMBL3133037,Leq506,Small molecule,,,,,Smoothened homolog antagonist,,,CHEMBL5971,Smoothened homolog,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23821351, URL:http://europepmc.org/abstract/MED/23821351",C[C@@H]1CN(CCN1c2cnc(cn2)C(C)(C)O)c3nnc(Cc4ccccc4)c(C)c3C,CHEMBL5971,SMO
3883,CHEMBL3545193,Msc-2364447,Small molecule,,,,,Tyrosine-protein kinase BTK inhibitor,"Ph1b trial planned, not yet recruiting (NCT02537028)",,CHEMBL5251,Tyrosine-protein kinase BTK,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://biopharma.merckgroup.com/en/research_development/pipeline/pipeline.html, URL:http://biopharma.merckgroup.com/en/research_development/pipeline/pipeline.html",,CHEMBL5251,BTK
3884,CHEMBL3545016,Cb-03-01,Small molecule,,,,,Androgen Receptor antagonist,,,CHEMBL1871,Androgen Receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15646372, URL:http://europepmc.org/abstract/MED/15646372|Name:Other, SrcID:http://intrepidthera.com/development-pipeline/cb-03-01-for-acne/, URL:http://intrepidthera.com/development-pipeline/cb-03-01-for-acne/|Name:Other, SrcID:http://www.cosmopharmaceuticals.com/activities/pipeline/cb.aspx, URL:http://www.cosmopharmaceuticals.com/activities/pipeline/cb.aspx",CCC(=O)O[C@@]1(CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C)C(=O)CO,CHEMBL1871,AR
3885,CHEMBL3301610,Abemaciclib,Small molecule,,,,-ciclib,Cyclin-dependent kinase 6 inhibitor,,,CHEMBL2508,Cyclin-dependent kinase 6,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24919854, URL:http://europepmc.org/abstract/MED/24919854",CCN1CCN(Cc2ccc(Nc3ncc(F)c(n3)c4cc(F)c5nc(C)n(C(C)C)c5c4)nc2)CC1,CHEMBL2508,CDK6
3886,CHEMBL564829,Milciclib,Small molecule,,,,-ciclib,Cyclin-dependent kinase 1 inhibitor,,,CHEMBL308,Cyclin-dependent kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25215591, URL:http://europepmc.org/abstract/MED/25215591|Name:PubMed, SrcID:20682657, URL:http://europepmc.org/abstract/MED/20682657",CNC(=O)c1nn(C)c2c3nc(Nc4ccc(cc4)N5CCN(C)CC5)ncc3CC(C)(C)c12,CHEMBL308,CDK1
3887,CHEMBL2110727,Cenicriviroc,Small molecule,,,,-viroc,C-C chemokine receptor type 5 antagonist,,,CHEMBL274,C-C chemokine receptor type 5,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21317794, URL:http://europepmc.org/abstract/MED/21317794|Name:PubMed, SrcID:16251299, URL:http://europepmc.org/abstract/MED/16251299|Name:PubMed, SrcID:21486960, URL:http://europepmc.org/abstract/MED/21486960",CCCCOCCOc1ccc(cc1)c2ccc3N(CC(C)C)CCC\C(=C/c3c2)\C(=O)Nc4ccc(cc4)[S+]([O-])Cc5cncn5CCC,CHEMBL274,CCR5
3888,CHEMBL3301623,Patidegib,Small molecule,,,,-degib,Smoothened homolog antagonist,,,CHEMBL5971,Smoothened homolog,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19522463, URL:http://europepmc.org/abstract/MED/19522463|Name:Wikipedia, SrcID:Saridegib, URL:http://en.wikipedia.org/wiki/Saridegib",C[C@@H]1CN[C@H]2[C@H](C1)O[C@]3(CC[C@H]4[C@@H]5CC[C@@H]6C[C@@H](CC[C@]6(C)[C@H]5CC4=C(C)C3)NS(=O)(=O)C)[C@@H]2C,CHEMBL5971,SMO
3889,CHEMBL3545104,Modimelanotide,Protein,,,,-tide,Melanocortin receptor 3 agonist,,,CHEMBL4644,Melanocortin receptor 3,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Modimelanotide, URL:https://en.wikipedia.org/wiki/Modimelanotide|Name:PubMed, SrcID:21703408, URL:http://europepmc.org/abstract/MED/21703408",,CHEMBL4644,MC3R
3890,CHEMBL3187723,Binimetinib,Small molecule,,,,-tinib,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,Non-ATP-competitive allosteric inhibitor,,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://arraybiopharma.com/files/4813/9810/8023/PubAttachment490.pdf, URL:http://arraybiopharma.com/files/4813/9810/8023/PubAttachment490.pdf|Name:Other, SrcID:http://arraybiopharma.com/product-pipeline/binimetinib/, URL:http://arraybiopharma.com/product-pipeline/binimetinib/|Name:PubMed, SrcID:23414587, URL:http://europepmc.org/abstract/MED/23414587",Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(cc12)C(=O)NOCCO,CHEMBL2964,MAP2K2
3891,CHEMBL2070241,Bremelanotide,Protein,,,,-tide,Melanocortin receptor 4 agonist,"Peptide, alpha-MSH analogue.",,CHEMBL259,Melanocortin receptor 4,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Bremelanotide, URL:http://en.wikipedia.org/wiki/Bremelanotide|Name:PubMed, SrcID:12851303, URL:http://europepmc.org/abstract/MED/12851303|Name:PubMed, SrcID:17584130, URL:http://europepmc.org/abstract/MED/17584130",CCCC[C@H](NC(=O)C)C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc4ccccc4)NC(=O)[C@H](Cc5cnc[nH]5)NC1=O)C(=O)O,CHEMBL259,MC4R
3892,CHEMBL2103975,Vapreotide,Protein,,H01CB04,"H01CB04 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: HYPOTHALAMIC HORMONES: Somatostatin and analogues]",-tide,Somatostatin receptor 2 agonist,"Somatostatin analogue. Not apporved by FDA, rejected by advisory panel. Not in current company pipeline and no further development reported.",,CHEMBL1804,Somatostatin receptor 2,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:7907795, URL:http://europepmc.org/abstract/MED/7907795|Name:PubMed, SrcID:7878022, URL:http://europepmc.org/abstract/MED/7878022|Name:Other, SrcID:http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2054, URL:http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2054",CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc4ccc(O)cc4)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N[C@@H](Cc5c[nH]c6ccccc56)C(=O)N)NC(=O)[C@H](N)Cc7ccccc7,CHEMBL1804,SSTR2
3893,CHEMBL607400,Brivaracetam,Small molecule,2016.0,N03AX23,N03AX23 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],-racetam,Synaptic vesicle glycoprotein 2A modulator,,,CHEMBL1998,Synaptic vesicle glycoprotein 2A,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2016/205836s001,205837s001,205838s001lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205836s001,205837s001,205838s001lbl.pdf|Name:PubMed, SrcID:17199019, URL:http://europepmc.org/abstract/MED/17199019",CCC[C@H]1CN([C@@H](CC)C(=O)N)C(=O)C1,CHEMBL1998,SV2A
3894,CHEMBL2107313,Becatecarin,Small molecule,,,,-tecarin,DNA topoisomerase I inhibitor,,,CHEMBL1781,DNA topoisomerase I,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19132374, URL:http://europepmc.org/abstract/MED/19132374|Name:PubMed, SrcID:22425925, URL:http://europepmc.org/abstract/MED/22425925",CCN(CC)CCN1C(=O)c2c(C1=O)c3c4cccc(Cl)c4n([C@@H]5O[C@H](CO)[C@@H](OC)[C@H](O)[C@H]5O)c3c6[nH]c7c(Cl)cccc7c26,CHEMBL1781,TOP1
3895,CHEMBL2338329,Roxadustat,Small molecule,,,,-stat,HIF-prolyl hydroxylase inhibitor,,,CHEMBL3831261,Hypoxia-inducible factor prolyl hydroxylase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:26238121, URL:http://europepmc.org/abstract/MED/26238121",Cc1nc(C(=O)NCC(=O)O)c(O)c2ccc(Oc3ccccc3)cc12,,
3896,CHEMBL408194,Obatoclax,Small molecule,,,,-toclax,Bcl-2-like protein 10,,,CHEMBL5988,Bcl-2-like protein 10,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18931344, URL:http://europepmc.org/abstract/MED/18931344|Name:PubMed, SrcID:16645636, URL:http://europepmc.org/abstract/MED/16645636|Name:PubMed, SrcID:18040043, URL:http://europepmc.org/abstract/MED/18040043",COC1=CC(=N/C/1=C\c2[nH]c(C)cc2C)c3cc4ccccc4[nH]3,,
3897,CHEMBL3707446,Rivipansel,Small molecule,,,,-pansel,Leukocyte adhesion molecule-1 antagonist,,"E-selectin IC50 = 4.3uM, P-selectin IC50 = 423uM and L-selectin IC50 = 337uM",CHEMBL3161,Leukocyte adhesion molecule-1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26117840, URL:http://europepmc.org/abstract/MED/26117840",C[C@@H]1O[C@@H](O[C@@H]2[C@H](C[C@H](C[C@H]2O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H](CC4CCCCC4)C(=O)O)[C@H]3OC(=O)c5ccccc5)C(=O)NCCNC(=O)COCCOCC(=O)Nc6cc(cc7cc(cc(c67)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)NC(=O)C8=CC(=O)NC(=O)N8)[C@@H](O)[C@H](O)[C@@H]1O,,
3898,CHEMBL2109621,Di17e6,Antibody,,,,,Vitronectin receptor alpha inhibitor,"Inhibits ligand binding to all alphav heterodimers (alphavbeta1, alphavbeta3, alphavbeta5, alphavbeta6, alphavbeta8).",Specifically directed against the alphav subunit of human integrins.,CHEMBL3660,Vitronectin receptor alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23791392, URL:http://europepmc.org/abstract/MED/23791392",,CHEMBL3660,ITGAV
3899,CHEMBL1743052,Oportuzumab Monatox,Antibody,,,,-mab,Epithelial cell adhesion molecule binding agent,"Single chain anti-EpCAM fragment fused with Pseudomonas exotoxin. Designed to target cancer cells expressing EpCAM, which internalize the recombinant fusion protein once it is bound. Within the cell, the payload dissociates from the single chain fragment and is then able to exert its cell-killing activity.",,CHEMBL3580493,Epithelial cell adhesion molecule,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.viventia.com/products/vb4-845-vinicium/, URL:http://www.viventia.com/products/vb4-845-vinicium/",,CHEMBL3580493,EPCAM
3900,CHEMBL2109267,M195,Antibody,,,,,Myeloid cell surface antigen CD33 other,M195 is rapidly internalized after binding to target cells. No antibody-dependent cell-mediated cytotoxicity (ADCC).,,CHEMBL1842,Myeloid cell surface antigen CD33,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:2716349, URL:http://europepmc.org/abstract/MED/2716349",,CHEMBL1842,CD33
3901,CHEMBL2109444,Ad-159,Antibody,,,,,Envelope glycoprotein gp160 inhibitor,,,CHEMBL1293311,Envelope glycoprotein gp160,INHIBITOR,Human immunodeficiency virus 1,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19252861, URL:http://europepmc.org/abstract/MED/19252861",,,
3902,CHEMBL2109562,Cal,Antibody,,,,,Parathyroid hormone-related protein inhibitor,,,CHEMBL3712869,Parathyroid hormone-related protein,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=38505, URL:https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=38505",,CHEMBL3712869,PTHLH
3903,CHEMBL1000,Cetirizine,Small molecule,1995.0,R06AE07,R06AE07 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Piperazine derivatives],,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2004/19835slr016,21150slr005,30346slr011_zyrtec_lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19835slr016,21150slr005,30346slr011_zyrtec_lbl.pdf",OC(=O)COCCN1CCN(CC1)C(c2ccccc2)c3ccc(Cl)cc3,CHEMBL231,HRH1
3904,CHEMBL64,Isoniazid,Small molecule,1952.0,J04AC51; J04AC01,J04AC51 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOBACTERIALS: DRUGS FOR TREATMENT OF TUBERCULOSIS: Hydrazides]; J04AC01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOBACTERIALS: DRUGS FOR TREATMENT OF TUBERCULOSIS: Hydrazides],,Enoyl-[acyl-carrier-protein] reductase inhibitor,,,CHEMBL1849,Enoyl-[acyl-carrier-protein] reductase,INHIBITOR,Mycobacterium tuberculosis,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15273113, URL:http://europepmc.org/abstract/MED/15273113",NNC(=O)c1ccncc1,,
3905,CHEMBL710,Finasteride,Small molecule,1992.0,D11AX10; G04CB01,D11AX10 [DERMATOLOGICALS: OTHER DERMATOLOGICAL PREPARATIONS: OTHER DERMATOLOGICAL PREPARATIONS: Other dermatologicals]; G04CB01 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY: Testosterone-5-alpha reductase inhibitors],-steride,Steroid 5-alpha-reductase 2 inhibitor,,,CHEMBL1856,Steroid 5-alpha-reductase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=c8ed59a3-c5b2-3156-b781-5e514b79011b, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c8ed59a3-c5b2-3156-b781-5e514b79011b",CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C,,
3906,CHEMBL1336,Sorafenib,Small molecule,2005.0,L01XE05,L01XE05 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-rafenib,Serine/threonine-protein kinase RAF inhibitor,,,CHEMBL1906,Serine/threonine-protein kinase RAF,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2011/021923s012lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf",CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,CHEMBL1906,RAF1
3907,CHEMBL1065,Methysergide,Small molecule,1962.0,N02CA04,N02CA04 [NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Ergot alkaloids],-erg-,Serotonin 1a (5-HT1a) receptor partial agonist,,,CHEMBL214,Serotonin 1a (5-HT1a) receptor,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 199, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:11049861, URL:http://europepmc.org/abstract/MED/11049861",CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2Cc3cn(C)c4cccc(C2=C1)c34,CHEMBL214,HTR1A
3908,CHEMBL52440,Dextromethorphan,Small molecule,1982.0,N07XX59; R05DA09,"N07XX59 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs]; R05DA09 [RESPIRATORY SYSTEM: COUGH AND COLD PREPARATIONS: COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS: Opium alkaloids and derivatives]",-orphan,Glutamate [NMDA] receptor subunit epsilon 1 antagonist,,,CHEMBL1972,Glutamate [NMDA] receptor subunit epsilon 1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:2897648, URL:http://europepmc.org/abstract/MED/2897648|Name:Wikipedia, SrcID:Nmda_receptor_antagonist, URL:http://en.wikipedia.org/wiki/Nmda_receptor_antagonist|Name:Wikipedia, SrcID:Dextromethorphan, URL:http://en.wikipedia.org/wiki/Dextromethorphan",COc1ccc2C[C@H]3[C@H]4CCCC[C@@]4(CCN3C)c2c1,CHEMBL1972,GRIN2A
3909,CHEMBL1201567,Filgrastim,Protein,1991.0,L03AA02,L03AA02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSTIMULANTS: IMMUNOSTIMULANTS: Colony stimulating factors],-stim,Granulocyte colony stimulating factor receptor agonist,,,CHEMBL1996,Granulocyte colony stimulating factor receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=fdfe5d72-6b80-435a-afa4-c5d74dd852ce, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fdfe5d72-6b80-435a-afa4-c5d74dd852ce|Name:PubMed, SrcID:9679526, URL:http://europepmc.org/abstract/MED/9679526|Name:PubMed, SrcID:7504384, URL:http://europepmc.org/abstract/MED/7504384",,CHEMBL1996,CSF3R
3910,CHEMBL1201192,Armodafinil,Small molecule,2007.0,N06BA13,"N06BA13 [NERVOUS SYSTEM: PSYCHOANALEPTICS: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS: Centrally acting sympathomimetics]",,Dopamine transporter inhibitor,,,CHEMBL238,Dopamine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=2c824d4c-2309-4e2a-bc74-aa8d80a5c454, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c824d4c-2309-4e2a-bc74-aa8d80a5c454|Name:PubMed, SrcID:11222668, URL:http://europepmc.org/abstract/MED/11222668",NC(=O)C[S+]([O-])C(c1ccccc1)c2ccccc2,CHEMBL238,SLC6A3
3911,CHEMBL1201263,Hydrocortamate,Small molecule,1956.0,,,-cort-,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 400-401, URL:http://www.isbnsearch.org/isbn/9780702034718",CCN(CC)CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C,CHEMBL2034,NR3C1
3912,CHEMBL1200430,Estradiol Acetate,Small molecule,2003.0,G03CA03; G03CA53,"G03CA03 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ESTROGENS: Natural and semisynthetic estrogens, plain]; G03CA53 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ESTROGENS: Natural and semisynthetic estrogens, plain]",estr-,Estrogen receptor alpha agonist,,,CHEMBL206,Estrogen receptor alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=86b90d68-bfb6-47f6-aa5b-a6642391ff13#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=86b90d68-bfb6-47f6-aa5b-a6642391ff13#nlm34090-1|Name:Wikipedia, SrcID:Estrogen_receptor, URL:http://en.wikipedia.org/wiki/Estrogen_receptor",CC(=O)Oc1ccc2[C@H]3CC[C@]4(C)[C@@H](O)CC[C@H]4[C@@H]3CCc2c1,CHEMBL206,ESR1
3913,CHEMBL256087,Menthol,Small molecule,2008.0,,,,Transient receptor potential cation channel subfamily A member 1 opener,,,CHEMBL6007,Transient receptor potential cation channel subfamily A member 1,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23061635, URL:http://europepmc.org/abstract/MED/23061635",CC(C)C1CCC(C)CC1O,CHEMBL6007,TRPA1
3914,CHEMBL1096,Amlexanox,Small molecule,1996.0,R03DX01; A01AD07,R03DX01 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: Other systemic drugs for obstructive airway diseases]; A01AD07 [ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Other agents for local oral treatment],-xanox,Phosphodiesterase 4 inhibitor,,,CHEMBL2093863,Phosphodiesterase 4,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:ISBN, SrcID:978-4-431-99361-2 PP. 188, URL:http://www.isbnsearch.org/isbn/9784431993612|Name:PubMed, SrcID:22668622, URL:http://europepmc.org/abstract/MED/22668622|Name:PubMed, SrcID:2433225, URL:http://europepmc.org/abstract/MED/2433225",CC(C)c1ccc2Oc3nc(N)c(cc3C(=O)c2c1)C(=O)O,,
3915,CHEMBL1201466,"Estrogens, Conjugated Synthetic A",Small molecule,1999.0,,,estr-,Estrogen receptor agonist,,,CHEMBL2093866,Estrogen receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=1cd07b54-f66f-4040-9058-462324267196#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1cd07b54-f66f-4040-9058-462324267196#nlm34090-1|Name:ISBN, SrcID:9780702034718 PP. 420, URL:http://www.isbnsearch.org/isbn/9780702034718",,,
3916,CHEMBL469,Ketorolac,Small molecule,1989.0,S01BC05; M01AB15,"S01BC05 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Antiinflammatory agents, non-steroids]; M01AB15 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Acetic acid derivatives and related substances]",-ac,Cyclooxygenase inhibitor,,,CHEMBL2094253,Cyclooxygenase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10422661, URL:http://europepmc.org/abstract/MED/10422661|Name:PubMed, SrcID:12446609, URL:http://europepmc.org/abstract/MED/12446609|Name:PubMed, SrcID:14568028, URL:http://europepmc.org/abstract/MED/14568028|Name:PubMed, SrcID:10220509, URL:http://europepmc.org/abstract/MED/10220509|Name:PubMed, SrcID:14568029, URL:http://europepmc.org/abstract/MED/14568029|Name:PubMed, SrcID:11695255, URL:http://europepmc.org/abstract/MED/11695255",OC(=O)C1CCn2c1ccc2C(=O)c3ccccc3,,
3917,CHEMBL1342,Oxybate,Small molecule,2002.0,,,,GABA-B receptor agonist,,,CHEMBL2111463,GABA-B receptor,AGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23065655, URL:http://europepmc.org/abstract/MED/23065655|Name:DailyMed, SrcID:setid=926eb076-a4a8-45e4-91ef-411f0aa4f3ca#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=926eb076-a4a8-45e4-91ef-411f0aa4f3ca#nlm34090-1",OCCCC(=O)O,,
3918,CHEMBL1614,Deslanoside,Small molecule,1982.0,C01AA07,C01AA07 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC GLYCOSIDES: Digitalis glycosides],,Sodium/potassium-transporting ATPase inhibitor,,,CHEMBL2095186,Sodium/potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,K/Na-ATPase alpha subunit,Alpha subunit is binding site,"Name:PubMed, SrcID:23537048, URL:http://europepmc.org/abstract/MED/23537048|Name:ISBN, SrcID:9780702034718 PP. 258, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:16319518, URL:http://europepmc.org/abstract/MED/16319518",C[C@H]1O[C@H](C[C@H](O)[C@@H]1O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](C)O3)[C@@H](C)O2)O[C@H]5CC[C@@]6(C)[C@H](CC[C@@H]7[C@@H]6C[C@@H](O)[C@]8(C)[C@H](CC[C@]78O)C9=CC(=O)OC9)C5,CHEMBL2095186,FXYD2
3919,CHEMBL1614,Deslanoside,Small molecule,1982.0,C01AA07,C01AA07 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC GLYCOSIDES: Digitalis glycosides],,Sodium/potassium-transporting ATPase inhibitor,,,CHEMBL2095186,Sodium/potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,K/Na-ATPase alpha subunit,Alpha subunit is binding site,"Name:PubMed, SrcID:23537048, URL:http://europepmc.org/abstract/MED/23537048|Name:ISBN, SrcID:9780702034718 PP. 258, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:16319518, URL:http://europepmc.org/abstract/MED/16319518",C[C@H]1O[C@H](C[C@H](O)[C@@H]1O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](C)O3)[C@@H](C)O2)O[C@H]5CC[C@@]6(C)[C@H](CC[C@@H]7[C@@H]6C[C@@H](O)[C@]8(C)[C@H](CC[C@]78O)C9=CC(=O)OC9)C5,CHEMBL2095186,ATP1A3
3920,CHEMBL1614,Deslanoside,Small molecule,1982.0,C01AA07,C01AA07 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC GLYCOSIDES: Digitalis glycosides],,Sodium/potassium-transporting ATPase inhibitor,,,CHEMBL2095186,Sodium/potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,K/Na-ATPase alpha subunit,Alpha subunit is binding site,"Name:PubMed, SrcID:23537048, URL:http://europepmc.org/abstract/MED/23537048|Name:ISBN, SrcID:9780702034718 PP. 258, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:16319518, URL:http://europepmc.org/abstract/MED/16319518",C[C@H]1O[C@H](C[C@H](O)[C@@H]1O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](C)O3)[C@@H](C)O2)O[C@H]5CC[C@@]6(C)[C@H](CC[C@@H]7[C@@H]6C[C@@H](O)[C@]8(C)[C@H](CC[C@]78O)C9=CC(=O)OC9)C5,CHEMBL2095186,ATP1A2
3921,CHEMBL1614,Deslanoside,Small molecule,1982.0,C01AA07,C01AA07 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC GLYCOSIDES: Digitalis glycosides],,Sodium/potassium-transporting ATPase inhibitor,,,CHEMBL2095186,Sodium/potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,K/Na-ATPase alpha subunit,Alpha subunit is binding site,"Name:PubMed, SrcID:23537048, URL:http://europepmc.org/abstract/MED/23537048|Name:ISBN, SrcID:9780702034718 PP. 258, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:16319518, URL:http://europepmc.org/abstract/MED/16319518",C[C@H]1O[C@H](C[C@H](O)[C@@H]1O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](C)O3)[C@@H](C)O2)O[C@H]5CC[C@@]6(C)[C@H](CC[C@@H]7[C@@H]6C[C@@H](O)[C@]8(C)[C@H](CC[C@]78O)C9=CC(=O)OC9)C5,CHEMBL2095186,ATP1A4
3922,CHEMBL1614,Deslanoside,Small molecule,1982.0,C01AA07,C01AA07 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC GLYCOSIDES: Digitalis glycosides],,Sodium/potassium-transporting ATPase inhibitor,,,CHEMBL2095186,Sodium/potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,K/Na-ATPase alpha subunit,Alpha subunit is binding site,"Name:PubMed, SrcID:23537048, URL:http://europepmc.org/abstract/MED/23537048|Name:ISBN, SrcID:9780702034718 PP. 258, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:16319518, URL:http://europepmc.org/abstract/MED/16319518",C[C@H]1O[C@H](C[C@H](O)[C@@H]1O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](C)O3)[C@@H](C)O2)O[C@H]5CC[C@@]6(C)[C@H](CC[C@@H]7[C@@H]6C[C@@H](O)[C@]8(C)[C@H](CC[C@]78O)C9=CC(=O)OC9)C5,CHEMBL2095186,ATP1B2
3923,CHEMBL1614,Deslanoside,Small molecule,1982.0,C01AA07,C01AA07 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC GLYCOSIDES: Digitalis glycosides],,Sodium/potassium-transporting ATPase inhibitor,,,CHEMBL2095186,Sodium/potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,K/Na-ATPase alpha subunit,Alpha subunit is binding site,"Name:PubMed, SrcID:23537048, URL:http://europepmc.org/abstract/MED/23537048|Name:ISBN, SrcID:9780702034718 PP. 258, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:16319518, URL:http://europepmc.org/abstract/MED/16319518",C[C@H]1O[C@H](C[C@H](O)[C@@H]1O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](C)O3)[C@@H](C)O2)O[C@H]5CC[C@@]6(C)[C@H](CC[C@@H]7[C@@H]6C[C@@H](O)[C@]8(C)[C@H](CC[C@]78O)C9=CC(=O)OC9)C5,CHEMBL2095186,ATP1B1
3924,CHEMBL1614,Deslanoside,Small molecule,1982.0,C01AA07,C01AA07 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC GLYCOSIDES: Digitalis glycosides],,Sodium/potassium-transporting ATPase inhibitor,,,CHEMBL2095186,Sodium/potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,K/Na-ATPase alpha subunit,Alpha subunit is binding site,"Name:PubMed, SrcID:23537048, URL:http://europepmc.org/abstract/MED/23537048|Name:ISBN, SrcID:9780702034718 PP. 258, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:16319518, URL:http://europepmc.org/abstract/MED/16319518",C[C@H]1O[C@H](C[C@H](O)[C@@H]1O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](C)O3)[C@@H](C)O2)O[C@H]5CC[C@@]6(C)[C@H](CC[C@@H]7[C@@H]6C[C@@H](O)[C@]8(C)[C@H](CC[C@]78O)C9=CC(=O)OC9)C5,CHEMBL2095186,ATP1B3
3925,CHEMBL254219,Digitoxin,Small molecule,1982.0,C01AA04,C01AA04 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC GLYCOSIDES: Digitalis glycosides],-oxin,Sodium/potassium-transporting ATPase inhibitor,,,CHEMBL2095186,Sodium/potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,K/Na-ATPase alpha subunit,Alpha subunit is binding site,"Name:ISBN, SrcID:9780702034718 PP. 258, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:23210930, URL:http://europepmc.org/abstract/MED/23210930",C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4)O[C@@H]3C)O[C@@H]2C,CHEMBL2095186,FXYD2
3926,CHEMBL254219,Digitoxin,Small molecule,1982.0,C01AA04,C01AA04 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC GLYCOSIDES: Digitalis glycosides],-oxin,Sodium/potassium-transporting ATPase inhibitor,,,CHEMBL2095186,Sodium/potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,K/Na-ATPase alpha subunit,Alpha subunit is binding site,"Name:ISBN, SrcID:9780702034718 PP. 258, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:23210930, URL:http://europepmc.org/abstract/MED/23210930",C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4)O[C@@H]3C)O[C@@H]2C,CHEMBL2095186,ATP1A3
3927,CHEMBL254219,Digitoxin,Small molecule,1982.0,C01AA04,C01AA04 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC GLYCOSIDES: Digitalis glycosides],-oxin,Sodium/potassium-transporting ATPase inhibitor,,,CHEMBL2095186,Sodium/potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,K/Na-ATPase alpha subunit,Alpha subunit is binding site,"Name:ISBN, SrcID:9780702034718 PP. 258, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:23210930, URL:http://europepmc.org/abstract/MED/23210930",C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4)O[C@@H]3C)O[C@@H]2C,CHEMBL2095186,ATP1A2
3928,CHEMBL254219,Digitoxin,Small molecule,1982.0,C01AA04,C01AA04 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC GLYCOSIDES: Digitalis glycosides],-oxin,Sodium/potassium-transporting ATPase inhibitor,,,CHEMBL2095186,Sodium/potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,K/Na-ATPase alpha subunit,Alpha subunit is binding site,"Name:ISBN, SrcID:9780702034718 PP. 258, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:23210930, URL:http://europepmc.org/abstract/MED/23210930",C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4)O[C@@H]3C)O[C@@H]2C,CHEMBL2095186,ATP1A4
3929,CHEMBL254219,Digitoxin,Small molecule,1982.0,C01AA04,C01AA04 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC GLYCOSIDES: Digitalis glycosides],-oxin,Sodium/potassium-transporting ATPase inhibitor,,,CHEMBL2095186,Sodium/potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,K/Na-ATPase alpha subunit,Alpha subunit is binding site,"Name:ISBN, SrcID:9780702034718 PP. 258, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:23210930, URL:http://europepmc.org/abstract/MED/23210930",C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4)O[C@@H]3C)O[C@@H]2C,CHEMBL2095186,ATP1B2
3930,CHEMBL254219,Digitoxin,Small molecule,1982.0,C01AA04,C01AA04 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC GLYCOSIDES: Digitalis glycosides],-oxin,Sodium/potassium-transporting ATPase inhibitor,,,CHEMBL2095186,Sodium/potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,K/Na-ATPase alpha subunit,Alpha subunit is binding site,"Name:ISBN, SrcID:9780702034718 PP. 258, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:23210930, URL:http://europepmc.org/abstract/MED/23210930",C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4)O[C@@H]3C)O[C@@H]2C,CHEMBL2095186,ATP1B1
3931,CHEMBL254219,Digitoxin,Small molecule,1982.0,C01AA04,C01AA04 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC GLYCOSIDES: Digitalis glycosides],-oxin,Sodium/potassium-transporting ATPase inhibitor,,,CHEMBL2095186,Sodium/potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,K/Na-ATPase alpha subunit,Alpha subunit is binding site,"Name:ISBN, SrcID:9780702034718 PP. 258, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:23210930, URL:http://europepmc.org/abstract/MED/23210930",C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4)O[C@@H]3C)O[C@@H]2C,CHEMBL2095186,ATP1B3
3932,CHEMBL1425,Mercaptopurine,Small molecule,1953.0,,,,Amidophosphoribosyltransferase inhibitor,Prodrug enzyme: hypoxanthine-guanine phosphoribosyl transferase (HGPRT; ec 2.4.2.8),,CHEMBL2362992,Amidophosphoribosyltransferase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=15904472-4c32-4224-95d3-eb131a7ff9c8, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=15904472-4c32-4224-95d3-eb131a7ff9c8|Name:PubMed, SrcID:18506437, URL:http://europepmc.org/abstract/MED/18506437",Sc1ncnc2nc[nH]c12,CHEMBL2362992,PPAT
3933,CHEMBL370143,Paromomycin,Small molecule,1969.0,A07AA06,"A07AA06 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFECTIVES: Antibiotics]",-mycin,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,16S ribosomal RNA,16s RRNA,"Name:DailyMed, SrcID:setid=ad56c3a5-8461-473d-9b04-57621302c9c4#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ad56c3a5-8461-473d-9b04-57621302c9c4#nlm34090-1|Name:PubMed, SrcID:11587639, URL:http://europepmc.org/abstract/MED/11587639|Name:DailyMed, SrcID:archiveid=103824, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=103824",NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,,
3934,CHEMBL1201562,Interferon Beta-1a,Protein,1996.0,L03AB07,L03AB07 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSTIMULANTS: IMMUNOSTIMULANTS: Interferons],,Interferon alpha/beta receptor agonist,,,CHEMBL2364170,Interferon alpha/beta receptor,AGONIST,Homo sapiens,PROTEIN COMPLEX,,Alpha subunit is binding site,"Name:PubMed, SrcID:10049744, URL:http://europepmc.org/abstract/MED/10049744|Name:FDA, SrcID:label/2015/103780s5194lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103780s5194lbl.pdf|Name:DailyMed, SrcID:setid=84d42ba4-6eef-41a7-a1d1-2cc887ef118d, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=84d42ba4-6eef-41a7-a1d1-2cc887ef118d",,CHEMBL2364170,IFNAR2
3935,CHEMBL1201835,Ustekinumab,Antibody,2009.0,L04AC05,L04AC05 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Interleukin inhibitors],-mab,Interleukin-12 inhibitor,,,CHEMBL2364153,Interleukin-12,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,Interleukin-12 beta subunit,Beta subunit is binding site,"Name:DailyMed, SrcID:setid=c77a9664-e3bb-4023-b400-127aa53bca2b, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c77a9664-e3bb-4023-b400-127aa53bca2b",,,
3936,CHEMBL561,Lomefloxacin,Small molecule,1992.0,S01AE04; J01MA07,S01AE04 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Fluoroquinolones]; J01MA07 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolones],-oxacin,Bacterial DNA gyrase inhibitor,,,CHEMBL2311224,Bacterial DNA gyrase,INHIBITOR,Bacteria,PROTEIN COMPLEX,,,"Name:DailyMed, SrcID:setid=173018f5-fd76-4480-90f8-4b7efe328444, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=173018f5-fd76-4480-90f8-4b7efe328444",CCN1C=C(C(=O)O)C(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c12,,
3937,CHEMBL1448,Niclosamide,Small molecule,1982.0,P02DA01,"P02DA01 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTHELMINTICS: ANTICESTODALS: Salicylic acid derivatives]",,DNA inhibitor,,,CHEMBL2366043,DNA,INHIBITOR,Schistosoma mansoni,NUCLEIC-ACID,,,"Name:PubMed, SrcID:12392939, URL:http://europepmc.org/abstract/MED/12392939|Name:Wikipedia, SrcID:Niclosamide, URL:http://en.wikipedia.org/wiki/Niclosamide",Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-],,
3938,CHEMBL1257,Enflurane,Small molecule,1972.0,N01AB04,"N01AB04 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,Potassium channel subfamily K member 3 opener,,,CHEMBL2321613,Potassium channel subfamily K member 3,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:16973644, URL:http://europepmc.org/abstract/MED/16973644|Name:PubMed, SrcID:17227289, URL:http://europepmc.org/abstract/MED/17227289",FC(F)OC(F)(F)C(F)Cl,CHEMBL2321613,KCNK3
3939,CHEMBL797,Phensuximide,Small molecule,1982.0,N03AD02,N03AD02 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Succinimide derivatives],,Voltage-gated T-type calcium channel blocker,,,CHEMBL2362995,Voltage-gated T-type calcium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:11641441, URL:http://europepmc.org/abstract/MED/11641441",CN1C(=O)CC(C1=O)c2ccccc2,,
3940,CHEMBL1201447,Calfactant,Unknown,1998.0,,,-tant,Surfactant agent,Replaces endogenous surfactant in case of deficiency; endogenous pulmonary surfactant lower surface tension at the air-liquid of the alveolar surfaces,,,,,,,,,"Name:DailyMed, SrcID:setid=315c128a-272d-4c57-bfbe-1a8b3402af08#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=315c128a-272d-4c57-bfbe-1a8b3402af08#nlm34090-1",,,
3941,CHEMBL2021424,Potassium Sulfate,Small molecule,2010.0,,,,Unknown,,,,,,,,,,"Name:FDA, SrcID:label/2012/022372s004lbledt.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022372s004lbledt.pdf",[K+].[K+].[O-]S(=O)(=O)[O-],,
3942,CHEMBL1079604,Metaxalone,Small molecule,1962.0,,,,Unknown,,,,,,,,,,"Name:FDA, SrcID:label/2006/013217s046lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/013217s046lbl.pdf",Cc1cc(C)cc(OCC2CNC(=O)O2)c1,,
3943,CHEMBL1743048,Obinutuzumab,Antibody,2013.0,L01XC15,L01XC15 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,B-lymphocyte antigen CD20 inhibitor,,,CHEMBL2058,B-lymphocyte antigen CD20,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2013/125486s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125486s000lbl.pdf",,CHEMBL2058,MS4A1
3944,CHEMBL3137343,Pembrolizumab,Antibody,2014.0,L01XC18,L01XC18 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,Programmed cell death protein 1 inhibitor,,,CHEMBL3307223,Programmed cell death protein 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2014/125514lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125514lbl.pdf",,CHEMBL3307223,PDCD1
3945,CHEMBL3545160,Su-14813,Small molecule,,,,,Platelet-derived growth factor receptor inhibitor,,,CHEMBL2095189,Platelet-derived growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:16891463, URL:http://europepmc.org/abstract/MED/16891463",,,
3946,CHEMBL3545119,Bms-794833,Small molecule,,,,,Hepatocyte growth factor receptor inhibitor,,,CHEMBL3717,Hepatocyte growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.ejcancersupplements.com/article/S1359-6349(10)71811-5/abstract, URL:http://www.ejcancersupplements.com/article/S1359-6349(10)71811-5/abstract",,CHEMBL3717,MET
3947,CHEMBL146506,Mofarotene,Small molecule,,,,-arotene,Retinoid receptor modulator,,,CHEMBL2363071,Retinoid receptor,MODULATOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DOI, SrcID:10.1038/nrd2397, URL:http://www.nature.com/nrd/journal/v6/n10/full/nrd2397.html",C\C(=C/c1ccc(OCCN2CCOCC2)cc1)\c3ccc4c(c3)C(C)(C)CCC4(C)C,,
3948,CHEMBL3545427,Cm-082,Small molecule,,,,,Stem cell growth factor receptor inhibitor,,,CHEMBL1936,Stem cell growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.tyrogenex.com/wordpress/wp-content/uploads/Oral-X-82-for-wet-AMD-ARVO-2013.pdf, URL:http://www.tyrogenex.com/wordpress/wp-content/uploads/Oral-X-82-for-wet-AMD-ARVO-2013.pdf",,CHEMBL1936,KIT
3949,CHEMBL494089,Gsk-690693,Small molecule,,,,,Protein kinase C (PKC) inhibitor,,,CHEMBL2093867,Protein kinase C (PKC),INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:18800763, URL:http://europepmc.org/abstract/MED/18800763",CCn1c(nc2c(ncc(OC[C@H]3CCCNC3)c12)C#CC(C)(C)O)c4nonc4N,,
3950,CHEMBL2104954,Balamapimod,Small molecule,,,,-imod,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,No references found,,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://books.google.co.uk/books?id=prtObCihET4C&pg=PA7&lpg=PA7&dq=MKI-833&source=bl&ots=7p9-#v=onepage&q=MKI-833&f=false, URL:https://books.google.co.uk/books?id=prtObCihET4C&pg=PA7&lpg=PA7&dq=MKI-833&source=bl&ots=7p9-#v=onepage&q=MKI-833&f=false",COc1cc2c(Nc3ccc(Sc4nccn4C)c(Cl)c3)c(cnc2cc1N5CCC(CC5)N6CCCC6)C#N,CHEMBL2964,MAP2K2
3951,CHEMBL1230607,Pha-793887,Small molecule,,,,,Cyclin-dependent kinase inhibitor,,,CHEMBL3559691,Cyclin-dependent kinase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:20153204, URL:http://europepmc.org/abstract/MED/20153204",CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C3CCN(C)CC3)C2(C)C,CHEMBL3559691,CDK12
3952,CHEMBL1230607,Pha-793887,Small molecule,,,,,Cyclin-dependent kinase inhibitor,,,CHEMBL3559691,Cyclin-dependent kinase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:20153204, URL:http://europepmc.org/abstract/MED/20153204",CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C3CCN(C)CC3)C2(C)C,CHEMBL3559691,CDK20
3953,CHEMBL3545006,Pwt-33587,Small molecule,,,,,PI3-kinase class I inhibitor,"Also studied in veterinary cancers. Dual MTOR/PI3K inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DOI, SrcID:10.1158/1538-7445.AM2014-1644, URL:http://cancerres.aacrjournals.org/content/74/19_Supplement/1644|Name:Other, SrcID:http://www.mosaiclabs.com/pdf/AACR2012_PWT33597_RCC.pdf, URL:http://www.mosaiclabs.com/pdf/AACR2012_PWT33597_RCC.pdf",,CHEMBL3559703,PIK3R2
3954,CHEMBL3545006,Pwt-33587,Small molecule,,,,,PI3-kinase class I inhibitor,"Also studied in veterinary cancers. Dual MTOR/PI3K inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DOI, SrcID:10.1158/1538-7445.AM2014-1644, URL:http://cancerres.aacrjournals.org/content/74/19_Supplement/1644|Name:Other, SrcID:http://www.mosaiclabs.com/pdf/AACR2012_PWT33597_RCC.pdf, URL:http://www.mosaiclabs.com/pdf/AACR2012_PWT33597_RCC.pdf",,CHEMBL3559703,PIK3R3
3955,CHEMBL3545006,Pwt-33587,Small molecule,,,,,PI3-kinase class I inhibitor,"Also studied in veterinary cancers. Dual MTOR/PI3K inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DOI, SrcID:10.1158/1538-7445.AM2014-1644, URL:http://cancerres.aacrjournals.org/content/74/19_Supplement/1644|Name:Other, SrcID:http://www.mosaiclabs.com/pdf/AACR2012_PWT33597_RCC.pdf, URL:http://www.mosaiclabs.com/pdf/AACR2012_PWT33597_RCC.pdf",,CHEMBL3559703,PIK3R5
3956,CHEMBL3545332,Cep-2563,Small molecule,,,,,Neurotrophic tyrosine kinase receptor inhibitor,,,CHEMBL3559684,Neurotrophic tyrosine kinase receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:9259409, URL:http://europepmc.org/abstract/MED/9259409|Name:PubMed, SrcID:15292715, URL:http://europepmc.org/abstract/MED/15292715",,,
3957,CHEMBL3545147,Imd-2560,Small molecule,,,,,Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor,Prodrug - active metabolite is IMD-0560,,CHEMBL1991,Inhibitor of nuclear factor kappa B kinase beta subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25373602, URL:http://europepmc.org/abstract/MED/25373602|Name:Other, SrcID:http://www.immd.co.jp/en/development.html, URL:http://www.immd.co.jp/en/development.html",,CHEMBL1991,IKBKB
3958,CHEMBL1088750,Arry-797,Small molecule,,,,,MAP kinase p38 alpha inhibitor,,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.arraybiopharma.com/product-pipeline/other-compounds/arry-797/, URL:http://www.arraybiopharma.com/product-pipeline/other-compounds/arry-797/|Name:PubMed, SrcID:22773734, URL:http://europepmc.org/abstract/MED/22773734",CC(C)Cn1ncc2cc(Oc3ccc(F)cc3F)c(cc12)C(=O)NCCN(C)C,CHEMBL260,MAPK14
3959,CHEMBL3545336,Savolitinib,Small molecule,,,,-tinib,Hepatocyte growth factor receptor inhibitor,,,CHEMBL3717,Hepatocyte growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25779944, URL:http://europepmc.org/abstract/MED/25779944|Name:PubMed, SrcID:25148209, URL:http://europepmc.org/abstract/MED/25148209",,CHEMBL3717,MET
3960,CHEMBL1614701,Selumetinib,Small molecule,,,,-tinib,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,Non-adenosine-5'-triphosphate (ATP) competitive inhibitor,,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17332304, URL:http://europepmc.org/abstract/MED/17332304|Name:PubMed, SrcID:17699718, URL:http://europepmc.org/abstract/MED/17699718",Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(cc12)C(=O)NOCCO,CHEMBL3587,MAP2K1
3961,CHEMBL2104986,Tedatioxetine,Small molecule,,,,-oxetine,Serotonin transporter inhibitor,,,CHEMBL228,Serotonin transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://www.google.com/patents/US20100144788, URL:https://www.google.com/patents/US20100144788|Name:Other, SrcID:http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false, URL:http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false|Name:Wikipedia, SrcID:Tedatioxetine, URL:http://en.wikipedia.org/wiki/Tedatioxetine",Cc1ccc(Sc2ccccc2C3CCNCC3)cc1,CHEMBL228,SLC6A4
3962,CHEMBL2104986,Tedatioxetine,Small molecule,,,,-oxetine,Serotonin 3 (5-HT3) receptor antagonist,,,CHEMBL2094132,Serotonin 3 (5-HT3) receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Other, SrcID:https://www.google.com/patents/US20100144788, URL:https://www.google.com/patents/US20100144788|Name:Other, SrcID:http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false, URL:http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false|Name:Wikipedia, SrcID:Tedatioxetine, URL:http://en.wikipedia.org/wiki/Tedatioxetine",Cc1ccc(Sc2ccccc2C3CCNCC3)cc1,CHEMBL2094132,HTR3D
3963,CHEMBL2104986,Tedatioxetine,Small molecule,,,,-oxetine,Serotonin 3 (5-HT3) receptor antagonist,,,CHEMBL2094132,Serotonin 3 (5-HT3) receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Other, SrcID:https://www.google.com/patents/US20100144788, URL:https://www.google.com/patents/US20100144788|Name:Other, SrcID:http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false, URL:http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false|Name:Wikipedia, SrcID:Tedatioxetine, URL:http://en.wikipedia.org/wiki/Tedatioxetine",Cc1ccc(Sc2ccccc2C3CCNCC3)cc1,CHEMBL2094132,HTR3C
3964,CHEMBL2104986,Tedatioxetine,Small molecule,,,,-oxetine,Serotonin 3 (5-HT3) receptor antagonist,,,CHEMBL2094132,Serotonin 3 (5-HT3) receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Other, SrcID:https://www.google.com/patents/US20100144788, URL:https://www.google.com/patents/US20100144788|Name:Other, SrcID:http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false, URL:http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false|Name:Wikipedia, SrcID:Tedatioxetine, URL:http://en.wikipedia.org/wiki/Tedatioxetine",Cc1ccc(Sc2ccccc2C3CCNCC3)cc1,CHEMBL2094132,HTR3E
3965,CHEMBL522987,Vestipitant,Small molecule,,,,-tant,Neurokinin 1 receptor antagonist,,,CHEMBL249,Neurokinin 1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18657401, URL:http://europepmc.org/abstract/MED/18657401",C[C@@H](N(C)C(=O)N1CCNC[C@@H]1c2ccc(F)cc2C)c3cc(cc(c3)C(F)(F)F)C(F)(F)F,CHEMBL249,TACR1
3966,CHEMBL2142592,Taladegib,Small molecule,,,,-degib,Smoothened homolog antagonist,,,CHEMBL5971,Smoothened homolog,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25646180, URL:http://europepmc.org/abstract/MED/25646180|Name:PubMed, SrcID:24637074, URL:http://europepmc.org/abstract/MED/24637074",CN(C1CCN(CC1)c2nnc(c3ccnn3C)c4ccccc24)C(=O)c5ccc(F)cc5C(F)(F)F,CHEMBL5971,SMO
3967,CHEMBL560993,Oc000459,Small molecule,,,,,G protein-coupled receptor 44 antagonist,,,CHEMBL5071,G protein-coupled receptor 44,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22106101, URL:http://europepmc.org/abstract/MED/22106101",Cc1c(Cc2ccc3ccccc3n2)c4cc(F)ccc4n1CC(=O)O,CHEMBL5071,PTGDR2
3968,CHEMBL2105635,Davalintide,Protein,,,,-tide,"Amylin receptor AMY1, CALCR/RAMP1 agonist","Peptide, active fragment of ADNP",,CHEMBL2111189,"Amylin receptor AMY1, CALCR/RAMP1",AGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:19935749, URL:http://europepmc.org/abstract/MED/19935749",CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](C)O)C(=O)N1)C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)N)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc5ccc(O)cc5)C(=O)N,,
3969,CHEMBL3545412,K-877,Small molecule,,,,,Peroxisome proliferator-activated receptor alpha agonist,Selective PPAR alpha modulator (SPPAR?M) properties. Ph3 in Japan,,CHEMBL239,Peroxisome proliferator-activated receptor alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.kowa.co.jp/eng/company/division/pharmaceutic/labo.htm, URL:http://www.kowa.co.jp/eng/company/division/pharmaceutic/labo.htm|Name:Other, SrcID:http://kenesforms.kenes.com/eas2012/abstracts/pdf/787.pdf, URL:http://kenesforms.kenes.com/eas2012/abstracts/pdf/787.pdf|Name:PubMed, SrcID:23721199, URL:http://europepmc.org/abstract/MED/23721199",,CHEMBL239,PPARA
3970,CHEMBL1762621,Bardoxolone Methyl,Small molecule,,,,-olone,Keap1/Nrf2 inhibitor,"Ph3 study terminated, safety and efficacy to be re-evaluated in new Ph2 study in 2014/2015. Activates KEAP1-Nrf2 pathway (http://en.wikipedia.org/wiki/Bardoxolone_methyl, http://www.kyowa-kirin.com/news_releases/2014/e20140702_01.html)",,CHEMBL3038498,Keap1/Nrf2,INHIBITOR,Homo sapiens,PROTEIN-PROTEIN INTERACTION,,,"Name:PubMed, SrcID:3542979, URL:http://europepmc.org/abstract/MED/3542979",COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]3C(=O)C=C4[C@@](C)(CC[C@H]5C(C)(C)C(=O)C(=C[C@]45C)C#N)[C@]3(C)CC2,,
3971,CHEMBL223360,Linifanib,Small molecule,,,,-anib,Tyrosine-protein kinase receptor FLT3 inhibitor,,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17343372, URL:http://europepmc.org/abstract/MED/17343372|Name:PubMed, SrcID:16648571, URL:http://europepmc.org/abstract/MED/16648571",Cc1ccc(F)c(NC(=O)Nc2ccc(cc2)c3cccc4[nH]nc(N)c34)c1,CHEMBL1974,FLT3
3972,CHEMBL1289494,Tivozanib,Small molecule,,L01XE34,L01XE34 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-anib,Vascular endothelial growth factor receptor inhibitor,,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:16982756, URL:http://europepmc.org/abstract/MED/16982756|Name:PubMed, SrcID:23818763, URL:http://europepmc.org/abstract/MED/23818763",COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC,,
3973,CHEMBL1963249,Ulimorelin,Small molecule,,,,-relin,Ghrelin receptor agonist,,,CHEMBL4616,Ghrelin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18719021, URL:http://europepmc.org/abstract/MED/18719021",C[C@@H]1CN[C@@H](C2CC2)C(=O)N(C)[C@H](C)C(=O)N[C@H](Cc3ccc(F)cc3)C(=O)NCCCc4ccccc4O1,CHEMBL4616,GHSR
3974,CHEMBL506981,Reminertant,Small molecule,,,,-tant,Neurotensin receptor 1 antagonist,,,CHEMBL4123,Neurotensin receptor 1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:8380498, URL:http://europepmc.org/abstract/MED/8380498|Name:PubMed, SrcID:11179604, URL:http://europepmc.org/abstract/MED/11179604",COc1cccc(OC)c1c2cc(nn2c3ccnc4cc(Cl)ccc34)C(=O)NC5(C6CC7CC(CC5C7)C6)C(=O)O,CHEMBL4123,NTSR1
3975,CHEMBL2107771,Ralfinamide,Small molecule,,,,,Voltage-gated N-type calcium channel alpha-1B subunit blocker,,,CHEMBL4478,Voltage-gated N-type calcium channel alpha-1B subunit,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.newron.com/ENG/Default.aspx?SEZ=3&PAG=40, URL:http://www.newron.com/ENG/Default.aspx?SEZ=3&PAG=40|Name:PubMed, SrcID:23121096, URL:http://europepmc.org/abstract/MED/23121096",C[C@H](NCc1ccc(OCc2ccccc2F)cc1)C(=O)N,CHEMBL4478,CACNA1B
3976,CHEMBL2107917,Oregovomab,Antibody,,,,-mab,Mucin-16 other,"Oregovomab targets the circulating tumour-associated antigen CA125. The complex formation of MAb-B43.13 with CA125 appears to facilitate activation of immune specific B and T Cell responses to CA125, otherwise not recognised by the immune system.",,CHEMBL3580482,Mucin-16,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11471484, URL:http://europepmc.org/abstract/MED/11471484|Name:PubMed, SrcID:15337799, URL:http://europepmc.org/abstract/MED/15337799",,CHEMBL3580482,MUC16
3977,CHEMBL2107875,Patiromer,Small molecule,,,,-mer,Potassium chelating agent,,,CHEMBL3545434,Potassium,CHELATING AGENT,,METAL,,,"Name:PubMed, SrcID:27784004, URL:http://europepmc.org/abstract/MED/27784004",,,
3978,CHEMBL148674,Varespladib,Small molecule,,,,-pladib,Phospholipase A2 group IIA inhibitor,,Inhibits sPLA2 activity with an IC50=9 +/- 1 nM,CHEMBL3474,Phospholipase A2 group IIA,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10027849, URL:http://europepmc.org/abstract/MED/10027849",CCc1c(C(=O)C(=O)N)c2c(OCC(=O)O)cccc2n1Cc3ccccc3,CHEMBL3474,PLA2G2A
3979,CHEMBL408194,Obatoclax,Small molecule,,,,-toclax,Induced myeloid leukemia cell differentiation protein Mcl-1 inhibitor,,,CHEMBL4361,Induced myeloid leukemia cell differentiation protein Mcl-1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18931344, URL:http://europepmc.org/abstract/MED/18931344|Name:PubMed, SrcID:16645636, URL:http://europepmc.org/abstract/MED/16645636|Name:PubMed, SrcID:18040043, URL:http://europepmc.org/abstract/MED/18040043",COC1=CC(=N/C/1=C\c2[nH]c(C)cc2C)c3cc4ccccc4[nH]3,CHEMBL4361,MCL1
3980,CHEMBL1169,Aminosalicylic Acid,Small molecule,1950.0,J04AA01,J04AA01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOBACTERIALS: DRUGS FOR TREATMENT OF TUBERCULOSIS: Aminosalicylic acid and derivatives],-sal-,Dihydrofolate reductase inhibitor,"PAS is incorporated into the folate pathway by dihydropteroate synthase (DHPS) and dihydrofolate synthase (DHFS) to generate a hydroxyl dihydrofolate antimetabolite, which in turn inhibits DHFR enzymatic activity.",,CHEMBL6065,Dihydrofolate reductase,INHIBITOR,Mycobacterium tuberculosis,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23779105, URL:http://europepmc.org/abstract/MED/23779105",Nc1ccc(C(=O)O)c(O)c1,,
3981,CHEMBL2108734,Flanvotumab,Antibody,,,,-mab,"5,6-dihydroxyindole-2-carboxylic acid oxidase other",Tumor-specific T-cell response via antibody-dependent cell-mediated phagocytosis (ADCP),,CHEMBL3712886,"5,6-dihydroxyindole-2-carboxylic acid oxidase",OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:27797971, URL:http://europepmc.org/abstract/MED/27797971",,CHEMBL3712886,TYRP1
3982,CHEMBL1742988,Baminercept,Protein,,,,-cept,Tumor necrosis factor ligand superfamily member 14 inhibitor,"Baminercept binds to both LTBR ligands, namely, a membrane bound heterotrimeric lymphotoxin (LT) form LTalpha1beta2 and the ligand called LIGHT (TNFSF14). It is a dual pathway inhibitor blocking signaling triggered by both membrane LT and LIGHT ligands.",,CHEMBL3712914,Tumor necrosis factor ligand superfamily member 14,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25405351, URL:http://europepmc.org/abstract/MED/25405351|Name:PubMed, SrcID:7995952, URL:http://europepmc.org/abstract/MED/7995952",,CHEMBL3712914,TNFSF14
3983,CHEMBL2107888,Talizumab,Antibody,,,,-mab,Ig epsilon chain C region inhibitor,Humanized IgG1 monoclonal antibody against IgE that recognizes and masks an epitope in the CH3 region of IgE responsible for binding to the high-affinity Fc(epsilon) receptor on mast cells and basophils.,,CHEMBL1834,Ig epsilon chain C region,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12637608, URL:http://europepmc.org/abstract/MED/12637608",,CHEMBL1834,IGHE
3984,CHEMBL2109429,Rg-7686,Antibody,,,,,Ganglioside GD3 other,Interacts with CD16/Fc?RIIIa and triggers antibody-dependent cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP).,,CHEMBL3580507,Ganglioside GD3,OTHER,Homo sapiens,LIPID,,,"Name:PubMed, SrcID:27085251, URL:http://europepmc.org/abstract/MED/27085251",,,
3985,CHEMBL3545323,Pwt-33579,Small molecule,,,,,Serine/threonine-protein kinase mTOR inhibitor,No references found,,CHEMBL2842,Serine/threonine-protein kinase mTOR,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,,,CHEMBL2842,MTOR
3986,CHEMBL2108767,Ruplizumab,Antibody,,,,-mab,CD40 ligand inhibitor,Discontinued early due to thromboses in some recipients.,,CHEMBL3580491,CD40 ligand,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,,,CHEMBL3580491,CD40LG
3987,CHEMBL1201309,Nafarelin,Protein,1990.0,H01CA02,"H01CA02 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: HYPOTHALAMIC HORMONES: Gonadotropin-releasing hormones]",-relin,Gonadotropin-releasing hormone receptor agonist,,,CHEMBL1855,Gonadotropin-releasing hormone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=d0aa57cb-d2f4-46d7-af43-7c8b06aa81a6#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d0aa57cb-d2f4-46d7-af43-7c8b06aa81a6#nlm34090-1",CC(C)C[C@H](NC(=O)[C@@H](Cc1cccc2ccccc12)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@H](CO)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](Cc6cnc[nH]6)NC(=O)[C@@H]7CCC(=O)N7)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N8CCC[C@H]8C(=O)NCC(=O)N,CHEMBL1855,GNRHR
3988,CHEMBL645,Bisoprolol,Small molecule,1992.0,C07AB07,"C07AB07 [CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, selective]",-olol,Beta-1 adrenergic receptor antagonist,,,CHEMBL213,Beta-1 adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=621d9058-804a-4f46-a047-ea6e432eee49, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=621d9058-804a-4f46-a047-ea6e432eee49",CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1,,
3989,CHEMBL1201448,Ardeparin Sodium,Oligosaccharide,1997.0,,,-parin,Antithrombin-III activator,Inhibits coagulation by activating antithrombin III; ATIII then binds to F10; It's a low-molecular-weight heparin,,CHEMBL1950,Antithrombin-III,ACTIVATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=cbc26e3c-aee9-4c0d-bdb1-bf350308fbce#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cbc26e3c-aee9-4c0d-bdb1-bf350308fbce#nlm34090-1|Name:PubMed, SrcID:9031445, URL:http://europepmc.org/abstract/MED/9031445|Name:ISBN, SrcID:9780702034718 PP. 299, URL:http://www.isbnsearch.org/isbn/9780702034718",,CHEMBL1950,SERPINC1
3990,CHEMBL1201258,Pemetrexed,Small molecule,2004.0,L01BA04,L01BA04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Folic acid analogues],-trexed,Thymidylate synthase inhibitor,,,CHEMBL1952,Thymidylate synthase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f5a860f3-37ec-429c-ae04-9c88d7c55c08#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5a860f3-37ec-429c-ae04-9c88d7c55c08#section-13",NC1=Nc2[nH]cc(CCc3ccc(cc3)C(=O)N[C@H](CCC(=O)O)C(=O)O)c2C(=O)N1,CHEMBL1952,TYMS
3991,CHEMBL1399,Anastrozole,Small molecule,1995.0,L02BG03,L02BG03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONE ANTAGONISTS AND RELATED AGENTS: Aromatase inhibitors],-rozole,Cytochrome P450 19A1 inhibitor,,,CHEMBL1978,Cytochrome P450 19A1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=03586c40-eb32-45c5-beb7-6762a6b78790#section-12, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=03586c40-eb32-45c5-beb7-6762a6b78790#section-12",CC(C)(C#N)c1cc(Cn2cncn2)cc(c1)C(C)(C)C#N,CHEMBL1978,CYP19A1
3992,CHEMBL1201543,Insulin Zinc Susp Semisynthetic Purified Human,Protein,1983.0,,,,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/022472s006s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022472s006s008lbl.pdf|Name:DailyMed, SrcID:setid=457531f0-9331-47fe-90b5-b31f284044dc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=457531f0-9331-47fe-90b5-b31f284044dc",,CHEMBL1981,INSR
3993,CHEMBL564,Promazine,Small molecule,1956.0,N05AA03,N05AA03 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Phenothiazines with aliphatic side-chain],,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Chlorpromazine, URL:http://en.wikipedia.org/wiki/Chlorpromazine|Name:Wikipedia, SrcID:Promazine, URL:http://en.wikipedia.org/wiki/Promazine|Name:ISBN, SrcID:0471-948470 PP. 663, URL:http://www.isbnsearch.org/isbn/0471948470|Name:ISBN, SrcID:0443-059748 PP. 542, URL:http://www.isbnsearch.org/isbn/0443059748",CN(C)CCCN1c2ccccc2Sc3ccccc13,CHEMBL224,HTR2A
3994,CHEMBL85,Risperidone,Small molecule,1993.0,N05AX08,N05AX08 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Other antipsychotics],-peridone,Serotonin 2c (5-HT2c) receptor antagonist,,,CHEMBL225,Serotonin 2c (5-HT2c) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=b45ceaaa-1236-493a-98c1-43df2f4a08f5#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b45ceaaa-1236-493a-98c1-43df2f4a08f5#nlm34090-1|Name:FDA, SrcID:label/2014/021346s052lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021346s052lbl.pdf",CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1,,
3995,CHEMBL1201618,Glucagon Hydrochloride,Protein,1960.0,H04AA01,"H04AA01 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PANCREATIC HORMONES: GLYCOGENOLYTIC HORMONES: Glycogenolytic hormones]",,Glucagon receptor agonist,,,CHEMBL1985,Glucagon receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12529935, URL:http://europepmc.org/abstract/MED/12529935",,CHEMBL1985,GCGR
3996,CHEMBL1095097,Eplerenone,Small molecule,2002.0,C03DA04,C03DA04 [CARDIOVASCULAR SYSTEM: DIURETICS: POTASSIUM-SPARING AGENTS: Aldosterone antagonists],-renone,Mineralocorticoid receptor antagonist,,,CHEMBL1994,Mineralocorticoid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=cd6cbf0b-34b8-43aa-8037-360480a19cf8#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd6cbf0b-34b8-43aa-8037-360480a19cf8#section-13",COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]34O[C@@H]3C[C@@]5(C)[C@@H](CC[C@@]56CCC(=O)O6)[C@H]14,,
3997,CHEMBL494,Iloprost,Small molecule,2004.0,B01AC11,B01AC11 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Platelet aggregation inhibitors excl. heparin],-prost,Prostanoid IP receptor agonist,,,CHEMBL1995,Prostanoid IP receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=d3bebc1c-f032-402a-bbc9-aff024276ed1#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d3bebc1c-f032-402a-bbc9-aff024276ed1#nlm34090-1|Name:ISBN, SrcID:0443-059748 PP. 216, URL:http://www.isbnsearch.org/isbn/0443059748",CC#CCC(C)[C@H](O)\C=C\[C@H]1[C@H](O)C[C@@H]2C\C(=C/CCCC(=O)O)\C[C@H]12,CHEMBL1995,PTGIR
3998,CHEMBL1744,Phendimetrazine,Small molecule,1976.0,,,,Dopamine transporter inhibitor,,,CHEMBL238,Dopamine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23211394, URL:http://europepmc.org/abstract/MED/23211394|Name:FDA, SrcID:label/2012/018074s034lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/018074s034lbl.pdf|Name:DailyMed, SrcID:setid=c4adaaef-cb23-4e29-8645-347578beb60a#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4adaaef-cb23-4e29-8645-347578beb60a#nlm34090-1",CC1C(OCCN1C)c2ccccc2,CHEMBL238,SLC6A3
3999,CHEMBL1159650,Clobetasol Propionate,Small molecule,1985.0,D07AD01,"D07AD01 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, very potent (group IV)]",,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:9891987, URL:http://europepmc.org/abstract/MED/9891987",CCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CCl,CHEMBL2034,NR3C1
4000,CHEMBL1473,Fluticasone Propionate,Small molecule,1990.0,D07AC17; R01AD08; R01AD58; R03BA05,"D07AC17 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, potent (group III)]; R01AD08 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Corticosteroids]; R01AD58 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Corticosteroids]; R03BA05 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS: Glucocorticoids]",,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11730731, URL:http://europepmc.org/abstract/MED/11730731|Name:PubMed, SrcID:7878687, URL:http://europepmc.org/abstract/MED/7878687|Name:PubMed, SrcID:8646863, URL:http://europepmc.org/abstract/MED/8646863|Name:PubMed, SrcID:10518812, URL:http://europepmc.org/abstract/MED/10518812",CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF,CHEMBL2034,NR3C1
4001,CHEMBL1201571,Alefacept,Protein,2003.0,L04AA15,L04AA15 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Selective immunosuppressants],-cept,T-cell surface antigen CD2 inhibitor,,,CHEMBL2040,T-cell surface antigen CD2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2012/125036s0144lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/125036s0144lbl.pdf|Name:DailyMed, SrcID:archiveid=20297, URL:http://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=20297",,CHEMBL2040,CD2
4002,CHEMBL1229,Oseltamivir,Small molecule,1999.0,J05AH02,J05AH02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Neuraminidase inhibitors],-vir,Neuraminidase inhibitor,,,CHEMBL2051,Neuraminidase,INHIBITOR,Influenza A virus (A/Puerto Rico/8/1934(H1N1)),SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=644ddc43-b2fa-44bd-aeb7-2547defb85e0, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=644ddc43-b2fa-44bd-aeb7-2547defb85e0",CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(=O)C)[C@@H](N)C1,,
4003,CHEMBL668,Protriptyline,Small molecule,1967.0,N06AA11,N06AA11 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Non-selective monoamine reuptake inhibitors],-triptyline,Norepinephrine transporter inhibitor,,,CHEMBL222,Norepinephrine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18923402, URL:http://europepmc.org/abstract/MED/18923402",CNCCCC1c2ccccc2C=Cc3ccccc13,CHEMBL222,SLC6A2
4004,CHEMBL2105717,Cabozantinib,Small molecule,2012.0,L01XE26,L01XE26 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Hepatocyte growth factor receptor inhibitor,"Multi-kinase inhibitor; Cabozantinib (XL184) is a potent inhibitor of MET and VEGFR2 that also inhibits RET, KIT, AXL, and FLT3, all of which have been implicated in tumor pathogenesis (PMID: 21926191)",,CHEMBL3717,Hepatocyte growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=1a0c3bea-c87b-4d25-bb44-5f0174da6b34, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a0c3bea-c87b-4d25-bb44-5f0174da6b34|Name:PubMed, SrcID:23104465, URL:http://europepmc.org/abstract/MED/23104465|Name:PubMed, SrcID:21926191, URL:http://europepmc.org/abstract/MED/21926191",COc1cc2nccc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc5ccc(F)cc5)cc3)c2cc1OC,CHEMBL3717,MET
4005,CHEMBL1433,Doxycycline,Small molecule,1967.0,J01AA02; A01AB22,J01AA02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: TETRACYCLINES: Tetracyclines]; A01AB22 [ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Antiinfectives and antiseptics for local oral treatment],-cycline,Matrix metalloproteinase 7 inhibitor,"It is an antibiotic, however, its primary action, due to the concentration reached in the human body is via metalloproteinases inhibition, which is beneficial in many pathological conditions in which MMP-mediated proteolysis of the extracellular matrix (ECM) contributes to the pathogenesis, such as heart remodeling, tumor invasion, and inflammation",,CHEMBL4073,Matrix metalloproteinase 7,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=3105a84b-655e-4940-9d11-4209cdb05d6b, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3105a84b-655e-4940-9d11-4209cdb05d6b|Name:PubMed, SrcID:20370419, URL:http://europepmc.org/abstract/MED/20370419|Name:PubMed, SrcID:20592239, URL:http://europepmc.org/abstract/MED/20592239|Name:PubMed, SrcID:17199549, URL:http://europepmc.org/abstract/MED/17199549",C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(=C(C(=O)N)C(=O)[C@@]3(O)C(=C2C(=O)c4c(O)cccc14)O)O,CHEMBL4073,MMP7
4006,CHEMBL503,Lovastatin,Small molecule,1987.0,C10AA02,"C10AA02 [CARDIOVASCULAR SYSTEM: LIPID MODIFYING AGENTS: LIPID MODIFYING AGENTS, PLAIN: HMG CoA reductase inhibitors]",-stat-,HMG-CoA reductase inhibitor,,,CHEMBL402,HMG-CoA reductase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=10a557fe-6620-4b15-862a-d3ff5dece612, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10a557fe-6620-4b15-862a-d3ff5dece612",CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12,CHEMBL402,HMGCR
4007,CHEMBL1201584,Abciximab,Antibody,1993.0,B01AC13,B01AC13 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Platelet aggregation inhibitors excl. heparin],-mab,Integrin alpha-IIb/beta-3 inhibitor,,,CHEMBL2093869,Integrin alpha-IIb/beta-3,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,Integrin beta-3 subunit,Beta subunit is binding site,"Name:DailyMed, SrcID:setid=033d4c3b-4630-4256-b8f7-9ed5f15de9a3, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=033d4c3b-4630-4256-b8f7-9ed5f15de9a3",,,
4008,CHEMBL428647,Paclitaxel,Small molecule,1992.0,L01CD01,L01CD01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Taxanes],-taxel,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin paclitaxel binding site,Binds to beta tubulin,"Name:Wikipedia, SrcID:Microtubule, URL:http://en.wikipedia.org/wiki/Microtubule|Name:DailyMed, SrcID:setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15",CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(=O)C)[C@H]2[C@H](OC(=O)c4ccccc4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c6ccccc6)c7ccccc7)C(=C1C5(C)C)C,CHEMBL2095182,TUBB8
4009,CHEMBL428647,Paclitaxel,Small molecule,1992.0,L01CD01,L01CD01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Taxanes],-taxel,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin paclitaxel binding site,Binds to beta tubulin,"Name:Wikipedia, SrcID:Microtubule, URL:http://en.wikipedia.org/wiki/Microtubule|Name:DailyMed, SrcID:setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15",CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(=O)C)[C@H]2[C@H](OC(=O)c4ccccc4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c6ccccc6)c7ccccc7)C(=C1C5(C)C)C,CHEMBL2095182,TUBA3C
4010,CHEMBL428647,Paclitaxel,Small molecule,1992.0,L01CD01,L01CD01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Taxanes],-taxel,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin paclitaxel binding site,Binds to beta tubulin,"Name:Wikipedia, SrcID:Microtubule, URL:http://en.wikipedia.org/wiki/Microtubule|Name:DailyMed, SrcID:setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15",CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(=O)C)[C@H]2[C@H](OC(=O)c4ccccc4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c6ccccc6)c7ccccc7)C(=C1C5(C)C)C,CHEMBL2095182,TUBA4A
4011,CHEMBL428647,Paclitaxel,Small molecule,1992.0,L01CD01,L01CD01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Taxanes],-taxel,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin paclitaxel binding site,Binds to beta tubulin,"Name:Wikipedia, SrcID:Microtubule, URL:http://en.wikipedia.org/wiki/Microtubule|Name:DailyMed, SrcID:setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15",CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(=O)C)[C@H]2[C@H](OC(=O)c4ccccc4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c6ccccc6)c7ccccc7)C(=C1C5(C)C)C,CHEMBL2095182,TUBA3E
4012,CHEMBL428647,Paclitaxel,Small molecule,1992.0,L01CD01,L01CD01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Taxanes],-taxel,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin paclitaxel binding site,Binds to beta tubulin,"Name:Wikipedia, SrcID:Microtubule, URL:http://en.wikipedia.org/wiki/Microtubule|Name:DailyMed, SrcID:setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15",CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(=O)C)[C@H]2[C@H](OC(=O)c4ccccc4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c6ccccc6)c7ccccc7)C(=C1C5(C)C)C,CHEMBL2095182,TUBB6
4013,CHEMBL428647,Paclitaxel,Small molecule,1992.0,L01CD01,L01CD01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Taxanes],-taxel,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin paclitaxel binding site,Binds to beta tubulin,"Name:Wikipedia, SrcID:Microtubule, URL:http://en.wikipedia.org/wiki/Microtubule|Name:DailyMed, SrcID:setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15",CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(=O)C)[C@H]2[C@H](OC(=O)c4ccccc4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c6ccccc6)c7ccccc7)C(=C1C5(C)C)C,CHEMBL2095182,TUBB2B
4014,CHEMBL428647,Paclitaxel,Small molecule,1992.0,L01CD01,L01CD01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Taxanes],-taxel,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin paclitaxel binding site,Binds to beta tubulin,"Name:Wikipedia, SrcID:Microtubule, URL:http://en.wikipedia.org/wiki/Microtubule|Name:DailyMed, SrcID:setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15",CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(=O)C)[C@H]2[C@H](OC(=O)c4ccccc4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c6ccccc6)c7ccccc7)C(=C1C5(C)C)C,CHEMBL2095182,TUBA3D
4015,CHEMBL1201748,Cabazitaxel,Small molecule,2010.0,L01CD04,L01CD04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Taxanes],-taxel,Tubulin inhibitor,Stabilises microtubule assembly,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin paclitaxel binding site,Binds to beta tubulin,"Name:DailyMed, SrcID:setid=de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa#nlm34090-1|Name:Wikipedia, SrcID:Taxane, URL:http://en.wikipedia.org/wiki/Taxane",CO[C@H]1C[C@H]2OC[C@@]2(OC(=O)C)[C@H]3[C@H](OC(=O)c4ccccc4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c6ccccc6)C(=C([C@@H](OC)C(=O)[C@]13C)C5(C)C)C,CHEMBL2095182,TUBB8
4016,CHEMBL1201748,Cabazitaxel,Small molecule,2010.0,L01CD04,L01CD04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Taxanes],-taxel,Tubulin inhibitor,Stabilises microtubule assembly,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin paclitaxel binding site,Binds to beta tubulin,"Name:DailyMed, SrcID:setid=de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa#nlm34090-1|Name:Wikipedia, SrcID:Taxane, URL:http://en.wikipedia.org/wiki/Taxane",CO[C@H]1C[C@H]2OC[C@@]2(OC(=O)C)[C@H]3[C@H](OC(=O)c4ccccc4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c6ccccc6)C(=C([C@@H](OC)C(=O)[C@]13C)C5(C)C)C,CHEMBL2095182,TUBA3C
4017,CHEMBL1201748,Cabazitaxel,Small molecule,2010.0,L01CD04,L01CD04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Taxanes],-taxel,Tubulin inhibitor,Stabilises microtubule assembly,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin paclitaxel binding site,Binds to beta tubulin,"Name:DailyMed, SrcID:setid=de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa#nlm34090-1|Name:Wikipedia, SrcID:Taxane, URL:http://en.wikipedia.org/wiki/Taxane",CO[C@H]1C[C@H]2OC[C@@]2(OC(=O)C)[C@H]3[C@H](OC(=O)c4ccccc4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c6ccccc6)C(=C([C@@H](OC)C(=O)[C@]13C)C5(C)C)C,CHEMBL2095182,TUBA4A
4018,CHEMBL1201748,Cabazitaxel,Small molecule,2010.0,L01CD04,L01CD04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Taxanes],-taxel,Tubulin inhibitor,Stabilises microtubule assembly,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin paclitaxel binding site,Binds to beta tubulin,"Name:DailyMed, SrcID:setid=de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa#nlm34090-1|Name:Wikipedia, SrcID:Taxane, URL:http://en.wikipedia.org/wiki/Taxane",CO[C@H]1C[C@H]2OC[C@@]2(OC(=O)C)[C@H]3[C@H](OC(=O)c4ccccc4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c6ccccc6)C(=C([C@@H](OC)C(=O)[C@]13C)C5(C)C)C,CHEMBL2095182,TUBA3E
4019,CHEMBL1201748,Cabazitaxel,Small molecule,2010.0,L01CD04,L01CD04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Taxanes],-taxel,Tubulin inhibitor,Stabilises microtubule assembly,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin paclitaxel binding site,Binds to beta tubulin,"Name:DailyMed, SrcID:setid=de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa#nlm34090-1|Name:Wikipedia, SrcID:Taxane, URL:http://en.wikipedia.org/wiki/Taxane",CO[C@H]1C[C@H]2OC[C@@]2(OC(=O)C)[C@H]3[C@H](OC(=O)c4ccccc4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c6ccccc6)C(=C([C@@H](OC)C(=O)[C@]13C)C5(C)C)C,CHEMBL2095182,TUBB6
4020,CHEMBL1201748,Cabazitaxel,Small molecule,2010.0,L01CD04,L01CD04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Taxanes],-taxel,Tubulin inhibitor,Stabilises microtubule assembly,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin paclitaxel binding site,Binds to beta tubulin,"Name:DailyMed, SrcID:setid=de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa#nlm34090-1|Name:Wikipedia, SrcID:Taxane, URL:http://en.wikipedia.org/wiki/Taxane",CO[C@H]1C[C@H]2OC[C@@]2(OC(=O)C)[C@H]3[C@H](OC(=O)c4ccccc4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c6ccccc6)C(=C([C@@H](OC)C(=O)[C@]13C)C5(C)C)C,CHEMBL2095182,TUBB2B
4021,CHEMBL1201748,Cabazitaxel,Small molecule,2010.0,L01CD04,L01CD04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Taxanes],-taxel,Tubulin inhibitor,Stabilises microtubule assembly,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin paclitaxel binding site,Binds to beta tubulin,"Name:DailyMed, SrcID:setid=de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa#nlm34090-1|Name:Wikipedia, SrcID:Taxane, URL:http://en.wikipedia.org/wiki/Taxane",CO[C@H]1C[C@H]2OC[C@@]2(OC(=O)C)[C@H]3[C@H](OC(=O)c4ccccc4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c6ccccc6)C(=C([C@@H](OC)C(=O)[C@]13C)C5(C)C)C,CHEMBL2095182,TUBA3D
4022,CHEMBL1021,Nepafenac,Small molecule,2005.0,S01BC10,"S01BC10 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Antiinflammatory agents, non-steroids]",-ac,Cyclooxygenase inhibitor,,,CHEMBL2094253,Cyclooxygenase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=6c212466-ff8d-ecfc-ede2-ef8bdcaaf114, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6c212466-ff8d-ecfc-ede2-ef8bdcaaf114",NC(=O)Cc1cccc(C(=O)c2ccccc2)c1N,,
4023,CHEMBL1228,Oxyphenbutazone,Small molecule,1960.0,M02AA04; S01BC02; M01AA03,"M02AA04 [MUSCULO-SKELETAL SYSTEM: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: Antiinflammatory preparations, non-steroids for topical use]; S01BC02 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Antiinflammatory agents, non-steroids]; M01AA03 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Butylpyrazolidines]",-butazone,Cyclooxygenase inhibitor,,,CHEMBL2094253,Cyclooxygenase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:3108222, URL:http://europepmc.org/abstract/MED/3108222|Name:PubMed, SrcID:11048646, URL:http://europepmc.org/abstract/MED/11048646|Name:KEGG, SrcID:D08324, URL:http://www.kegg.jp/dbget-bin/www_bget?dr:D08324",CCCCC1C(=O)N(N(C1=O)c2ccc(O)cc2)c3ccccc3,,
4024,CHEMBL1200983,Gallium Nitrate,Small molecule,1991.0,,,,Ribonucleoside-diphosphate reductase RR1 inhibitor,,,CHEMBL2095215,Ribonucleoside-diphosphate reductase RR1,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Ribonucleoside-diphosphate reductase M2 subunit,M2 subunit is binding site,"Name:PubMed, SrcID:15651176, URL:http://europepmc.org/abstract/MED/15651176|Name:PubMed, SrcID:22800370, URL:http://europepmc.org/abstract/MED/22800370|Name:PubMed, SrcID:1335254, URL:http://europepmc.org/abstract/MED/1335254|Name:PubMed, SrcID:12776257, URL:http://europepmc.org/abstract/MED/12776257",,,
4025,CHEMBL1201048,Dromostanolone Propionate,Small molecule,1982.0,,,-olone,Androgen Receptor agonist,,,CHEMBL1871,Androgen Receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15351799, URL:http://europepmc.org/abstract/MED/15351799|Name:PubMed, SrcID:3758193, URL:http://europepmc.org/abstract/MED/3758193",CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CC[C@H]4CC(=O)[C@H](C)C[C@]4(C)[C@H]3CC[C@]12C,CHEMBL1871,AR
4026,CHEMBL198362,Rivaroxaban,Small molecule,2011.0,B01AF01,B01AF01 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Direct factor Xa inhibitors],-xaban,Coagulation factor X inhibitor,,,CHEMBL244,Coagulation factor X,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=10db92f9-2300-4a80-836b-673e1ae91610#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10db92f9-2300-4a80-836b-673e1ae91610#nlm34090-1",Clc1ccc(s1)C(=O)NC[C@H]2CN(C(=O)O2)c3ccc(cc3)N4CCOCC4=O,CHEMBL244,F10
4027,CHEMBL451887,Carfilzomib,Protein,2009.0,L01XX45,L01XX45 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:FDA, SrcID:label/2012/202714lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202714lbl.pdf|Name:PubMed, SrcID:20116451, URL:http://europepmc.org/abstract/MED/20116451",CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN2CCOCC2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]4(C)CO4,CHEMBL2364701,PSMC6
4028,CHEMBL451887,Carfilzomib,Protein,2009.0,L01XX45,L01XX45 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:FDA, SrcID:label/2012/202714lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202714lbl.pdf|Name:PubMed, SrcID:20116451, URL:http://europepmc.org/abstract/MED/20116451",CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN2CCOCC2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]4(C)CO4,CHEMBL2364701,PSMD13
4029,CHEMBL451887,Carfilzomib,Protein,2009.0,L01XX45,L01XX45 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:FDA, SrcID:label/2012/202714lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202714lbl.pdf|Name:PubMed, SrcID:20116451, URL:http://europepmc.org/abstract/MED/20116451",CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN2CCOCC2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]4(C)CO4,CHEMBL2364701,ADRM1
4030,CHEMBL451887,Carfilzomib,Protein,2009.0,L01XX45,L01XX45 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:FDA, SrcID:label/2012/202714lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202714lbl.pdf|Name:PubMed, SrcID:20116451, URL:http://europepmc.org/abstract/MED/20116451",CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN2CCOCC2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]4(C)CO4,CHEMBL2364701,PSMD12
4031,CHEMBL451887,Carfilzomib,Protein,2009.0,L01XX45,L01XX45 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:FDA, SrcID:label/2012/202714lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202714lbl.pdf|Name:PubMed, SrcID:20116451, URL:http://europepmc.org/abstract/MED/20116451",CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN2CCOCC2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]4(C)CO4,CHEMBL2364701,PSMC4
4032,CHEMBL451887,Carfilzomib,Protein,2009.0,L01XX45,L01XX45 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:FDA, SrcID:label/2012/202714lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202714lbl.pdf|Name:PubMed, SrcID:20116451, URL:http://europepmc.org/abstract/MED/20116451",CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN2CCOCC2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]4(C)CO4,CHEMBL2364701,PSMD11
4033,CHEMBL451887,Carfilzomib,Protein,2009.0,L01XX45,L01XX45 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:FDA, SrcID:label/2012/202714lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202714lbl.pdf|Name:PubMed, SrcID:20116451, URL:http://europepmc.org/abstract/MED/20116451",CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN2CCOCC2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]4(C)CO4,CHEMBL2364701,PSMC3
4034,CHEMBL451887,Carfilzomib,Protein,2009.0,L01XX45,L01XX45 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:FDA, SrcID:label/2012/202714lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202714lbl.pdf|Name:PubMed, SrcID:20116451, URL:http://europepmc.org/abstract/MED/20116451",CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN2CCOCC2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]4(C)CO4,CHEMBL2364701,PSMD8
4035,CHEMBL451887,Carfilzomib,Protein,2009.0,L01XX45,L01XX45 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:FDA, SrcID:label/2012/202714lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202714lbl.pdf|Name:PubMed, SrcID:20116451, URL:http://europepmc.org/abstract/MED/20116451",CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN2CCOCC2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]4(C)CO4,CHEMBL2364701,SEM1
4036,CHEMBL451887,Carfilzomib,Protein,2009.0,L01XX45,L01XX45 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:FDA, SrcID:label/2012/202714lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202714lbl.pdf|Name:PubMed, SrcID:20116451, URL:http://europepmc.org/abstract/MED/20116451",CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN2CCOCC2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]4(C)CO4,CHEMBL2364701,PSMD7
4037,CHEMBL451887,Carfilzomib,Protein,2009.0,L01XX45,L01XX45 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:FDA, SrcID:label/2012/202714lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202714lbl.pdf|Name:PubMed, SrcID:20116451, URL:http://europepmc.org/abstract/MED/20116451",CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN2CCOCC2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]4(C)CO4,CHEMBL2364701,PSMC5
4038,CHEMBL451887,Carfilzomib,Protein,2009.0,L01XX45,L01XX45 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:FDA, SrcID:label/2012/202714lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202714lbl.pdf|Name:PubMed, SrcID:20116451, URL:http://europepmc.org/abstract/MED/20116451",CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN2CCOCC2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]4(C)CO4,CHEMBL2364701,PSMC2
4039,CHEMBL451887,Carfilzomib,Protein,2009.0,L01XX45,L01XX45 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:FDA, SrcID:label/2012/202714lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202714lbl.pdf|Name:PubMed, SrcID:20116451, URL:http://europepmc.org/abstract/MED/20116451",CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN2CCOCC2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]4(C)CO4,CHEMBL2364701,PSMC1
4040,CHEMBL451887,Carfilzomib,Protein,2009.0,L01XX45,L01XX45 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:FDA, SrcID:label/2012/202714lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202714lbl.pdf|Name:PubMed, SrcID:20116451, URL:http://europepmc.org/abstract/MED/20116451",CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN2CCOCC2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]4(C)CO4,CHEMBL2364701,PSMD6
4041,CHEMBL451887,Carfilzomib,Protein,2009.0,L01XX45,L01XX45 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:FDA, SrcID:label/2012/202714lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202714lbl.pdf|Name:PubMed, SrcID:20116451, URL:http://europepmc.org/abstract/MED/20116451",CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN2CCOCC2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]4(C)CO4,CHEMBL2364701,PSMD3
4042,CHEMBL451887,Carfilzomib,Protein,2009.0,L01XX45,L01XX45 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:FDA, SrcID:label/2012/202714lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202714lbl.pdf|Name:PubMed, SrcID:20116451, URL:http://europepmc.org/abstract/MED/20116451",CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN2CCOCC2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]4(C)CO4,CHEMBL2364701,PSMD1
4043,CHEMBL451887,Carfilzomib,Protein,2009.0,L01XX45,L01XX45 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:FDA, SrcID:label/2012/202714lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202714lbl.pdf|Name:PubMed, SrcID:20116451, URL:http://europepmc.org/abstract/MED/20116451",CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN2CCOCC2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]4(C)CO4,CHEMBL2364701,PSMD4
4044,CHEMBL451887,Carfilzomib,Protein,2009.0,L01XX45,L01XX45 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:FDA, SrcID:label/2012/202714lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202714lbl.pdf|Name:PubMed, SrcID:20116451, URL:http://europepmc.org/abstract/MED/20116451",CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN2CCOCC2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]4(C)CO4,CHEMBL2364701,PSMD2
4045,CHEMBL325041,Bortezomib,Small molecule,2003.0,L01XX32,L01XX32 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:DailyMed, SrcID:setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13|Name:PubMed, SrcID:21606441, URL:http://europepmc.org/abstract/MED/21606441",CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)B(O)O,CHEMBL2364701,PSMC6
4046,CHEMBL325041,Bortezomib,Small molecule,2003.0,L01XX32,L01XX32 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:DailyMed, SrcID:setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13|Name:PubMed, SrcID:21606441, URL:http://europepmc.org/abstract/MED/21606441",CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)B(O)O,CHEMBL2364701,PSMD13
4047,CHEMBL325041,Bortezomib,Small molecule,2003.0,L01XX32,L01XX32 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:DailyMed, SrcID:setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13|Name:PubMed, SrcID:21606441, URL:http://europepmc.org/abstract/MED/21606441",CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)B(O)O,CHEMBL2364701,ADRM1
4048,CHEMBL325041,Bortezomib,Small molecule,2003.0,L01XX32,L01XX32 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:DailyMed, SrcID:setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13|Name:PubMed, SrcID:21606441, URL:http://europepmc.org/abstract/MED/21606441",CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)B(O)O,CHEMBL2364701,PSMD12
4049,CHEMBL325041,Bortezomib,Small molecule,2003.0,L01XX32,L01XX32 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:DailyMed, SrcID:setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13|Name:PubMed, SrcID:21606441, URL:http://europepmc.org/abstract/MED/21606441",CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)B(O)O,CHEMBL2364701,PSMC4
4050,CHEMBL325041,Bortezomib,Small molecule,2003.0,L01XX32,L01XX32 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:DailyMed, SrcID:setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13|Name:PubMed, SrcID:21606441, URL:http://europepmc.org/abstract/MED/21606441",CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)B(O)O,CHEMBL2364701,PSMD11
4051,CHEMBL325041,Bortezomib,Small molecule,2003.0,L01XX32,L01XX32 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:DailyMed, SrcID:setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13|Name:PubMed, SrcID:21606441, URL:http://europepmc.org/abstract/MED/21606441",CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)B(O)O,CHEMBL2364701,PSMC3
4052,CHEMBL325041,Bortezomib,Small molecule,2003.0,L01XX32,L01XX32 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:DailyMed, SrcID:setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13|Name:PubMed, SrcID:21606441, URL:http://europepmc.org/abstract/MED/21606441",CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)B(O)O,CHEMBL2364701,PSMD8
4053,CHEMBL325041,Bortezomib,Small molecule,2003.0,L01XX32,L01XX32 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:DailyMed, SrcID:setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13|Name:PubMed, SrcID:21606441, URL:http://europepmc.org/abstract/MED/21606441",CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)B(O)O,CHEMBL2364701,SEM1
4054,CHEMBL325041,Bortezomib,Small molecule,2003.0,L01XX32,L01XX32 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:DailyMed, SrcID:setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13|Name:PubMed, SrcID:21606441, URL:http://europepmc.org/abstract/MED/21606441",CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)B(O)O,CHEMBL2364701,PSMD7
4055,CHEMBL325041,Bortezomib,Small molecule,2003.0,L01XX32,L01XX32 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:DailyMed, SrcID:setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13|Name:PubMed, SrcID:21606441, URL:http://europepmc.org/abstract/MED/21606441",CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)B(O)O,CHEMBL2364701,PSMC5
4056,CHEMBL325041,Bortezomib,Small molecule,2003.0,L01XX32,L01XX32 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:DailyMed, SrcID:setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13|Name:PubMed, SrcID:21606441, URL:http://europepmc.org/abstract/MED/21606441",CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)B(O)O,CHEMBL2364701,PSMC2
4057,CHEMBL325041,Bortezomib,Small molecule,2003.0,L01XX32,L01XX32 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:DailyMed, SrcID:setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13|Name:PubMed, SrcID:21606441, URL:http://europepmc.org/abstract/MED/21606441",CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)B(O)O,CHEMBL2364701,PSMC1
4058,CHEMBL325041,Bortezomib,Small molecule,2003.0,L01XX32,L01XX32 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:DailyMed, SrcID:setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13|Name:PubMed, SrcID:21606441, URL:http://europepmc.org/abstract/MED/21606441",CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)B(O)O,CHEMBL2364701,PSMD6
4059,CHEMBL325041,Bortezomib,Small molecule,2003.0,L01XX32,L01XX32 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:DailyMed, SrcID:setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13|Name:PubMed, SrcID:21606441, URL:http://europepmc.org/abstract/MED/21606441",CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)B(O)O,CHEMBL2364701,PSMD3
4060,CHEMBL325041,Bortezomib,Small molecule,2003.0,L01XX32,L01XX32 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:DailyMed, SrcID:setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13|Name:PubMed, SrcID:21606441, URL:http://europepmc.org/abstract/MED/21606441",CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)B(O)O,CHEMBL2364701,PSMD1
4061,CHEMBL325041,Bortezomib,Small molecule,2003.0,L01XX32,L01XX32 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:DailyMed, SrcID:setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13|Name:PubMed, SrcID:21606441, URL:http://europepmc.org/abstract/MED/21606441",CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)B(O)O,CHEMBL2364701,PSMD4
4062,CHEMBL325041,Bortezomib,Small molecule,2003.0,L01XX32,L01XX32 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-zomib,26S proteosome inhibitor,,,CHEMBL2364701,26S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,26S proteosome beta-5 subunit,MB1 (P28074) is binding site,"Name:DailyMed, SrcID:setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13|Name:PubMed, SrcID:21606441, URL:http://europepmc.org/abstract/MED/21606441",CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)B(O)O,CHEMBL2364701,PSMD2
4063,CHEMBL2040681,Spinosad,Small molecule,2011.0,,,,Nicotinic acetylcholine receptor agonist,,,CHEMBL2364023,Nicotinic acetylcholine receptor,AGONIST,Pediculus humanus capitis,PROTEIN COMPLEX GROUP,,,"Name:Expert, SrcID:2011/01/new-drug-approvals-2011-pt-i-spinosad.html, URL:http://chembl.blogspot.co.uk/2011/01/new-drug-approvals-2011-pt-i-spinosad.html",CC[C@H]1CCC[C@H](O[C@H]2CC[C@@H]([C@@H](C)O2)N(C)C)[C@@H](C)C(=O)C3=C[C@H]4[C@@H]5C[C@@H](C[C@H]5C=C[C@H]4[C@@H]3CC(=O)O1)O[C@@H]6O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]6OC.CC[C@H]7CCC[C@H](O[C@H]8CC[C@@H]([C@@H](C)O8)N(C)C)[C@@H](C)C(=O)C9=C[C@H]%10[C@@H]%11C[C@@H](C[C@H]%11C(=C[C@H]%10[C@@H]9CC(=O)O7)C)O[C@@H]%12O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]%12OC,,
4064,CHEMBL1201594,Rasburicase,Enzyme,2002.0,V03AF07,V03AF07 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Detoxifying agents for antineoplastic treatment],-ase,Uric acid oxidative enzyme,,,CHEMBL2364183,Uric acid,OXIDATIVE ENZYME,Homo sapiens,SMALL MOLECULE,,,"Name:DailyMed, SrcID:setid=0ae10bc4-6b65-402f-9db5-2d7753054922#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0ae10bc4-6b65-402f-9db5-2d7753054922#nlm34090-1",,,
4065,CHEMBL474579,Cefotetan,Small molecule,1985.0,J01DC05,J01DC05 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Second-generation cephalosporins],cef-,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=56912a83-4cba-4461-d983-3a0656515458, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=56912a83-4cba-4461-d983-3a0656515458|Name:FDA, SrcID:label/2004/50588slr030_cefotan_lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/50588slr030_cefotan_lbl.pdf|Name:PubMed, SrcID:6573313, URL:http://europepmc.org/abstract/MED/6573313|Name:Wikipedia, SrcID:Penicillin_binding_proteins#Function, URL:http://en.wikipedia.org/wiki/Penicillin_binding_proteins#Function",CO[C@]1(NC(=O)C2SC(=C(C(=O)N)C(=O)O)S2)[C@H]3SCC(=C(N3C1=O)C(=O)O)CSc4nnnn4C,,
4066,CHEMBL1434,Minocycline,Small molecule,1971.0,J01AA08; A01AB23,J01AA08 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: TETRACYCLINES: Tetracyclines]; A01AB23 [ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Antiinfectives and antiseptics for local oral treatment],-cycline,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,16S ribosomal RNA,16s RRNA,"Name:KEGG, SrcID:D00850, URL:http://www.kegg.jp/dbget-bin/www_bget?dr:D00850|Name:PubMed, SrcID:14723559, URL:http://europepmc.org/abstract/MED/14723559",CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(ccc(O)c4C(=O)C3=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N)N(C)C,,
4067,CHEMBL229383,Nystatin,Small molecule,1964.0,D01AA01; G01AA51; A07AA02; G01AA01,"D01AA01 [DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Antibiotics]; G01AA51 [GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Antibiotics]; A07AA02 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFECTIVES: Antibiotics]; G01AA01 [GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Antibiotics]",-stat-,Ergosterol sequestering agent,,,CHEMBL2364028,Ergosterol,SEQUESTERING AGENT,Candida albicans,SMALL MOLECULE,,,"Name:FDA, SrcID:anda/98/64142ap_appltr_prntlbl_chemr.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/anda/98/64142ap_appltr_prntlbl_chemr.pdf",C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@]2(O)C[C@H](O)[C@H]([C@H](C[C@@H](O[C@H]3O[C@@H](C)[C@H](O)[C@@H](N)[C@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@H]1C)O2)C(=O)O,,
4068,CHEMBL727,Thioguanine,Small molecule,1966.0,L01BB03,L01BB03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Purine analogues],,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:FDA, SrcID:label/2004/12429s022lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/12429s022lbl.pdf|Name:DailyMed, SrcID:setid=dfda4177-3c9d-44ab-3ca6-e4db8e9fc603, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dfda4177-3c9d-44ab-3ca6-e4db8e9fc603",NC1=Nc2[nH]cnc2C(=S)N1,,
4069,CHEMBL1750,Clofarabine,Small molecule,2004.0,L01BB06,L01BB06 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Purine analogues],-arabine,DNA polymerase (alpha/delta/epsilon) inhibitor,,,CHEMBL2363042,DNA polymerase (alpha/delta/epsilon),INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=c35903cd-e9eb-4841-93d1-fc14249d1e9f#section-12, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c35903cd-e9eb-4841-93d1-fc14249d1e9f#section-12",Nc1nc(Cl)nc2c1ncn2[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3F,CHEMBL2363042,POLE
4070,CHEMBL1201637,Lipase,Enzyme,1996.0,A09AA02,"A09AA02 [ALIMENTARY TRACT AND METABOLISM: DIGESTIVES, INCL. ENZYMES: DIGESTIVES, INCL. ENZYMES: Enzyme preparations]",-ase,Fatty acids hydrolytic enzyme,,,CHEMBL2364711,Fatty acids,HYDROLYTIC ENZYME,Homo sapiens,SMALL MOLECULE,,,"Name:DailyMed, SrcID:setid=073201aa-556d-4a70-918e-84e9616fd88d#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=073201aa-556d-4a70-918e-84e9616fd88d#nlm34090-1",,,
4071,CHEMBL1743068,Secukinumab,Antibody,2015.0,L04AC10,L04AC10 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Interleukin inhibitors],-mab,Interleukin 17A inhibitor,,,CHEMBL3390822,Interleukin 17A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/125504s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125504s000lbl.pdf",,CHEMBL3390822,IL17A
4072,CHEMBL3545357,Jte-151,Small molecule,,,,,Nuclear receptor ROR-gamma antagonist,,,CHEMBL1741186,Nuclear receptor ROR-gamma,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.jt.com/investors/results/S_information/pharmaceuticals/pdf/20141030_9.pdf, URL:http://www.jt.com/investors/results/S_information/pharmaceuticals/pdf/20141030_9.pdf",,CHEMBL1741186,RORC
4073,CHEMBL3545178,Azd-6738,Small molecule,,,,,Serine-protein kinase ATR inhibitor,,,CHEMBL5024,Serine-protein kinase ATR,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26517239, URL:http://europepmc.org/abstract/MED/26517239",,CHEMBL5024,ATR
4074,CHEMBL482967,Cyc-116,Small molecule,,,,,Serine/threonine-protein kinase Aurora inhibitor,Pan-Aurora kinase inhibitor,,CHEMBL3430911,Serine/threonine-protein kinase Aurora,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:26345296, URL:http://europepmc.org/abstract/MED/26345296|Name:PubMed, SrcID:20462263, URL:http://europepmc.org/abstract/MED/20462263",Cc1nc(N)sc1c2ccnc(Nc3ccc(cc3)N4CCOCC4)n2,,
4075,CHEMBL3545249,Glpg-0555,Small molecule,,,,,Tyrosine-protein kinase JAK1 inhibitor,Backup to GSK-2586184 (GLPG-0778),,CHEMBL2835,Tyrosine-protein kinase JAK1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.glpg.com/glpg-0778-555, URL:http://www.glpg.com/glpg-0778-555",,CHEMBL2835,JAK1
4076,CHEMBL2326966,Sf-1126,Small molecule,,,,,Serine/threonine-protein kinase mTOR inhibitor,"Prodrug - active metabolite is LY-294002. Dual MTOR/PI3K inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor.",,CHEMBL2842,Serine/threonine-protein kinase mTOR,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22261336, URL:http://europepmc.org/abstract/MED/22261336|Name:ClinicalTrials, SrcID:NCT02337309, URL:https://www.clinicaltrials.gov/ct2/show/NCT02337309",NC(=N)NCCC[C@H](NC(=O)CCC(=O)OC[N+]1(CCOCC1)C2=CC(=O)c3cccc(c3O2)c4ccccc4)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)[O-],CHEMBL2842,MTOR
4077,CHEMBL29919,Elpetrigine,Small molecule,,,,,Sodium channel protein type III alpha subunit blocker,,,CHEMBL5163,Sodium channel protein type III alpha subunit,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18377968, URL:http://europepmc.org/abstract/MED/18377968|Name:PubMed, SrcID:19008076, URL:http://europepmc.org/abstract/MED/19008076",Nc1cnc(c(N)n1)c2cc(Cl)cc(Cl)c2Cl,CHEMBL5163,SCN3A
4078,CHEMBL3707379,Pf-04958242,Small molecule,,,,,Glutamate receptor ionotropic AMPA positive allosteric modulator,,,CHEMBL2096670,Glutamate receptor ionotropic AMPA,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Binds to LBD (ligand binding domain) of GRIA2.,"Name:PubMed, SrcID:25905800, URL:http://europepmc.org/abstract/MED/25905800",,,
4079,CHEMBL75133,Irx-4204,Small molecule,,,,,Retinoid X receptor agonist,,,CHEMBL2363070,Retinoid X receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://io-therapeutics.com/programs/4204-2/, URL:http://io-therapeutics.com/programs/4204-2/|Name:Other, SrcID:http://www.neurology.org/content/82/10_Supplement/S14.005, URL:http://www.neurology.org/content/82/10_Supplement/S14.005|Name:PubMed, SrcID:17947492, URL:http://europepmc.org/abstract/MED/17947492",C\C(=C/C(=O)O)\C=C\[C@@H]1C[C@]1(C)c2ccc3c(c2)C(C)(C)CCC3(C)C,,
4080,CHEMBL450940,Prinaberel,Small molecule,,,,-berel,Estrogen receptor beta agonist,Development discontinued after Ph2 trial,,CHEMBL242,Estrogen receptor beta,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20556817, URL:http://europepmc.org/abstract/MED/20556817|Name:PubMed, SrcID:17824176, URL:http://europepmc.org/abstract/MED/17824176|Name:PubMed, SrcID:24217507, URL:http://europepmc.org/abstract/MED/24217507|Name:Wikipedia, SrcID:Prinaberel, URL:http://en.wikipedia.org/wiki/Prinaberel",Oc1cc(C=C)c2oc(nc2c1)c3ccc(O)c(F)c3,CHEMBL242,ESR2
4081,CHEMBL283120,Picropodophyllotoxin,Small molecule,,,,-oxin,Insulin-like growth factor I receptor inhibitor,"Allosteric inhibitor, thought to inhibit IGFR1 by interfering with phosphorylation of the kinase domain A-loop at a site distinct form ATP-binidng site.",,CHEMBL1957,Insulin-like growth factor I receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15334055, URL:http://europepmc.org/abstract/MED/15334055|Name:PubMed, SrcID:20698809, URL:http://europepmc.org/abstract/MED/20698809",COc1cc(cc(OC)c1OC)[C@H]2[C@H]3[C@H](COC3=O)[C@@H](O)c4cc5OCOc5cc24,CHEMBL1957,IGF1R
4082,CHEMBL1976040,Azd-1775,Small molecule,,,,,Serine/threonine-protein kinase WEE1 inhibitor,,,CHEMBL5491,Serine/threonine-protein kinase WEE1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19887545, URL:http://europepmc.org/abstract/MED/19887545|Name:PubMed, SrcID:23699655, URL:http://europepmc.org/abstract/MED/23699655",CN1CCN(CC1)c2ccc(Nc3ncc4C(=O)N(CC=C)N(c5cccc(n5)C(C)(C)O)c4n3)cc2,CHEMBL5491,WEE1
4083,CHEMBL2408045,Sapitinib,Small molecule,,,,-tinib,Receptor protein-tyrosine kinase erbB-2 inhibitor,,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24900741, URL:http://europepmc.org/abstract/MED/24900741|Name:PubMed, SrcID:20145185, URL:http://europepmc.org/abstract/MED/20145185",CNC(=O)CN1CCC(CC1)Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC,CHEMBL1824,ERBB2
4084,CHEMBL1230609,Foretinib,Small molecule,,,,-tinib,Tyrosine-protein kinase TIE-2 inhibitor,,,CHEMBL4128,Tyrosine-protein kinase TIE-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.exelixis.com/pipeline/xl880, URL:http://www.exelixis.com/pipeline/xl880|Name:PubMed, SrcID:19808973, URL:http://europepmc.org/abstract/MED/19808973",COc1cc2c(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc5ccc(F)cc5)cc3F)ccnc2cc1OCCCN6CCOCC6,CHEMBL4128,TEK
4085,CHEMBL3039517,Rabusertib,Small molecule,,,,-sertib,Serine/threonine-protein kinase Chk1 inhibitor,,,CHEMBL4630,Serine/threonine-protein kinase Chk1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24114124, URL:http://europepmc.org/abstract/MED/24114124",Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]3CNCCO3)cn1,CHEMBL4630,CHEK1
4086,CHEMBL1234354,Pf-04691502,Small molecule,,,,,PI3-kinase class I inhibitor,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:21750219, URL:http://europepmc.org/abstract/MED/21750219|Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718",COc1ccc(cn1)C2=Cc3c(C)nc(N)nc3N([C@@H]4CC[C@H](CC4)OCCO)C2=O,CHEMBL3559703,PIK3R2
4087,CHEMBL1234354,Pf-04691502,Small molecule,,,,,PI3-kinase class I inhibitor,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:21750219, URL:http://europepmc.org/abstract/MED/21750219|Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718",COc1ccc(cn1)C2=Cc3c(C)nc(N)nc3N([C@@H]4CC[C@H](CC4)OCCO)C2=O,CHEMBL3559703,PIK3R3
4088,CHEMBL1234354,Pf-04691502,Small molecule,,,,,PI3-kinase class I inhibitor,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:21750219, URL:http://europepmc.org/abstract/MED/21750219|Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718",COc1ccc(cn1)C2=Cc3c(C)nc(N)nc3N([C@@H]4CC[C@H](CC4)OCCO)C2=O,CHEMBL3559703,PIK3R5
4089,CHEMBL592445,Gedatolisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718|Name:PubMed, SrcID:21325073, URL:http://europepmc.org/abstract/MED/21325073",CN(C)C1CCN(CC1)C(=O)c2ccc(NC(=O)Nc3ccc(cc3)c4nc(nc(n4)N5CCOCC5)N6CCOCC6)cc2,CHEMBL3559703,PIK3R2
4090,CHEMBL592445,Gedatolisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718|Name:PubMed, SrcID:21325073, URL:http://europepmc.org/abstract/MED/21325073",CN(C)C1CCN(CC1)C(=O)c2ccc(NC(=O)Nc3ccc(cc3)c4nc(nc(n4)N5CCOCC5)N6CCOCC6)cc2,CHEMBL3559703,PIK3R3
4091,CHEMBL592445,Gedatolisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718|Name:PubMed, SrcID:21325073, URL:http://europepmc.org/abstract/MED/21325073",CN(C)C1CCN(CC1)C(=O)c2ccc(NC(=O)Nc3ccc(cc3)c4nc(nc(n4)N5CCOCC5)N6CCOCC6)cc2,CHEMBL3559703,PIK3R5
4092,CHEMBL1198855,Ronacaleret,Small molecule,,,,-calaret,Calcium sensing receptor antagonist,,,CHEMBL1878,Calcium sensing receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21593114, URL:http://europepmc.org/abstract/MED/21593114",CC(C)(CC1Cc2ccccc2C1)NC[C@@H](O)COc3cc(CCC(=O)O)cc(F)c3F,CHEMBL1878,CASR
4093,CHEMBL1162175,Regrelor,Small molecule,,,,-grel-,Purinergic receptor P2Y12 antagonist,"Phase 2 study terminated, possibly due to adverse effects.",,CHEMBL2001,Purinergic receptor P2Y12,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:234946, URL:http://europepmc.org/abstract/MED/234946",CCNC(=O)Nc1ncnc2c1ncn2[C@@H]3O[C@H](COP(=O)(O)O)[C@H]4O[C@@H](O[C@@H]34)\C=C\c5ccccc5,CHEMBL2001,P2RY12
4094,CHEMBL2111083,Bedoradrine,Small molecule,,,,-drine,Beta-2 adrenergic receptor agonist,,,CHEMBL210,Beta-2 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19527375, URL:http://europepmc.org/abstract/MED/19527375|Name:Other, SrcID:http://medicinova.com/wp-content/uploads/2013/09/MediciNova-PosterPresentationMN-004.pdf, URL:http://medicinova.com/wp-content/uploads/2013/09/MediciNova-PosterPresentationMN-004.pdf",CN(C)C(=O)COc1ccc2CC[C@@H](Cc2c1)NC[C@H](O)c3ccc(O)c(CCO)c3,CHEMBL210,ADRB2
4095,CHEMBL2105081,Frakefamide,Small molecule,,,,-kef-,Mu opioid receptor agonist,,,CHEMBL233,Mu opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15728057, URL:http://europepmc.org/abstract/MED/15728057|Name:Wikipedia, SrcID:Frakefamide, URL:http://en.wikipedia.org/wiki/Frakefamide",C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)Cc3ccc(F)cc3,CHEMBL233,OPRM1
4096,CHEMBL127071,Pozanicline,Small molecule,,,,-nicline,Neuronal acetylcholine receptor; alpha6/beta2 partial agonist,,,CHEMBL2109237,Neuronal acetylcholine receptor; alpha6/beta2,PARTIAL AGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:19481067, URL:http://europepmc.org/abstract/MED/19481067|Name:Wikipedia, SrcID:Pozanicline, URL:https://en.wikipedia.org/wiki/Pozanicline",Cc1ncccc1OC[C@@H]2CCCN2,,
4097,CHEMBL223360,Linifanib,Small molecule,,,,-anib,Platelet-derived growth factor receptor inhibitor,,,CHEMBL2095189,Platelet-derived growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:17343372, URL:http://europepmc.org/abstract/MED/17343372|Name:PubMed, SrcID:16648571, URL:http://europepmc.org/abstract/MED/16648571",Cc1ccc(F)c(NC(=O)Nc2ccc(cc2)c3cccc4[nH]nc(N)c34)c1,,
4098,CHEMBL1743015,Etrolizumab,Antibody,,,,-mab,Integrin beta-7 antagonist,"Binds the ß7 subunit of the integrins a4ß7 and aEß7, blocking interaction with their ligands.",,CHEMBL2979,Integrin beta-7,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21232034, URL:http://europepmc.org/abstract/MED/21232034",,CHEMBL2979,ITGB7
4099,CHEMBL2109361,Pemtumomab,Antibody,,,,-mab,Mucin-1 binding agent,"The antibody is attached to the radioisotope Yttrium-90, which irradiates and destroys the cells bound by the antibody and those in close proximity. Targets MUC1 that expressed by several types of secretory epithelial-derived cancers.",,CHEMBL3580494,Mucin-1,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,Directed against the specific antigenic epitope PDTR sequence in the MUC1 tandem repeat.,"Name:PubMed, SrcID:25961915, URL:http://europepmc.org/abstract/MED/25961915|Name:PubMed, SrcID:8306249, URL:http://europepmc.org/abstract/MED/8306249|Name:PubMed, SrcID:8347497, URL:http://europepmc.org/abstract/MED/8347497",,,
4100,CHEMBL2109653,Ra-18c3,Antibody,,,,,Interleukin-1 alpha inhibitor,Prevents binding of IL1A to interleukin-1 receptor type 1.,,CHEMBL3580496,Interleukin-1 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24746841, URL:http://europepmc.org/abstract/MED/24746841",,CHEMBL3580496,IL1A
4101,CHEMBL2108278,Eteplirsen,Oligonucleotide,2016.0,,,-rsen,Dystrophin pre-mRNA modulator,"Phosphorodiamidate morpholino oligomer (PMO) that selectively binds to exon 51 of dystrophin pre-mRNA, restoring the open reading frame and ena- bling production of functional truncated in-frame dystrophin protein.",,CHEMBL3826826,Dystrophin pre-mRNA,MODULATOR,Homo sapiens,NUCLEIC-ACID,,Binds to exon 51 of dystrophin pre-mRNA.,"Name:PubMed, SrcID:23907995, URL:http://europepmc.org/abstract/MED/23907995|Name:Other, SrcID:http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206488lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206488lbl.pdf",,,
4102,CHEMBL57242,Azilsartan,Small molecule,,,,-sartan,Type-1 angiotensin II receptor antagonist,,,CHEMBL227,Type-1 angiotensin II receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17485025, URL:http://europepmc.org/abstract/MED/17485025|Name:PubMed, SrcID:21123673, URL:http://europepmc.org/abstract/MED/21123673",CCOc1nc2cccc(C(=O)O)c2n1Cc3ccc(cc3)c4ccccc4c5noc(O)n5,CHEMBL227,AGTR1
4103,CHEMBL2103849,Udenafil,Small molecule,,G04BE11,G04BE11 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Drugs used in erectile dysfunction],-afil,Phosphodiesterase 5A inhibitor,,,CHEMBL1827,Phosphodiesterase 5A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20412426, URL:http://europepmc.org/abstract/MED/20412426",CCCOc1ccc(cc1C2=Nc3c(CCC)nn(C)c3C(=O)N2)S(=O)(=O)NCCC4CCCN4C,CHEMBL1827,PDE5A
4104,CHEMBL2103837,Tafamidis,Small molecule,,N07XX08,N07XX08 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs],-amidis,Transthyretin stabiliser,,,CHEMBL3194,Transthyretin,STABILISER,Homo sapiens,SINGLE PROTEIN,,Binds with high affinity to TTR at its Thyroxine (T4)-binding sites,"Name:PubMed, SrcID:22645360, URL:http://europepmc.org/abstract/MED/22645360",OC(=O)c1ccc2nc(oc2c1)c3cc(Cl)cc(Cl)c3,CHEMBL3194,TTR
4105,CHEMBL73822,Apaziquone,Small molecule,,,,,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:PubMed, SrcID:22509926, URL:http://europepmc.org/abstract/MED/22509926",Cn1c(\C=C\CO)c(CO)c2C(=O)C(=CC(=O)c12)N3CC3,,
4106,CHEMBL1808388,Bexagliflozin,Small molecule,,,,-gliflozin,Sodium/glucose cotransporter 2 inhibitor,,,CHEMBL3884,Sodium/glucose cotransporter 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.theracos.com/sglt2-inhibitors/, URL:http://www.theracos.com/sglt2-inhibitors/|Name:Other, SrcID:http://adisinsight.springer.com/drugs/800035524, URL:http://adisinsight.springer.com/drugs/800035524",OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)c2ccc(Cl)c(Cc3ccc(OCCOC4CC4)cc3)c2,CHEMBL3884,SLC5A2
4107,CHEMBL272980,Mocetinostat,Small molecule,,,,-stat,Histone deacetylase 3,,"Isotype-selective Class I (HDAC1, -2, -3, and -8) and IV (HDAC11) HDAC inhibitor.",CHEMBL1829,Histone deacetylase 3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18413790, URL:http://europepmc.org/abstract/MED/18413790|Name:PubMed, SrcID:27551526, URL:http://europepmc.org/abstract/MED/27551526",Nc1ccccc1NC(=O)c2ccc(CNc3nccc(n3)c4cccnc4)cc2,CHEMBL1829,HDAC3
4108,CHEMBL2109528,Fasinumab,Antibody,,,,-mab,Beta-nerve growth factor inhibitor,,,CHEMBL1649058,Beta-nerve growth factor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24686255, URL:http://europepmc.org/abstract/MED/24686255",,CHEMBL1649058,NGF
4109,CHEMBL3833309,Elenbecestat,Small molecule,,,,-stat,Beta-secretase 1 inhibitor,"Orally bioavailable small molecule BACE1 inhibitor, has shown robust lowering of cerebral amyloid-beta in preclinical and clinical studies",,CHEMBL4822,Beta-secretase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25621019, URL:http://europepmc.org/abstract/MED/25621019",,CHEMBL4822,BACE1
4110,CHEMBL19,Methazolamide,Small molecule,1959.0,S01EC05,S01EC05 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Carbonic anhydrase inhibitors],-zolamide,Carbonic anhydrase I inhibitor,,,CHEMBL261,Carbonic anhydrase I,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18336310, URL:http://europepmc.org/abstract/MED/18336310|Name:DailyMed, SrcID:setid=8e162b6d-8fa6-45f6-80d8-5132d94c1207, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e162b6d-8fa6-45f6-80d8-5132d94c1207",CN1N=C(S/C/1=N/C(=O)C)S(=O)(=O)N,CHEMBL261,CA1
4111,CHEMBL1201268,Methscopolamine,Small molecule,1953.0,S01FA03; A03BB03,"S01FA03 [SENSORY ORGANS: OPHTHALMOLOGICALS: MYDRIATICS AND CYCLOPLEGICS: Anticholinergics]; A03BB03 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: BELLADONNA AND DERIVATIVES, PLAIN: Belladonna alkaloids, semisynthetic, quaternary ammonium compounds]",,Muscarinic acetylcholine receptor M3 antagonist,"Role in regulating gastric secretion, M3 likely involved",,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:DailyMed, SrcID:setid=46e661aa-b1bd-465e-a800-03bd3455d7d1#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=46e661aa-b1bd-465e-a800-03bd3455d7d1#nlm34090-1",C[N+]1(C)[C@H]2C[C@@H](C[C@H]1[C@H]3O[C@@H]23)OC(=O)[C@H](CO)c4ccccc4,CHEMBL245,CHRM3
4112,CHEMBL1168,Ramipril,Small molecule,1991.0,C09AA05,"C09AA05 [CARDIOVASCULAR SYSTEM: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM: ACE INHIBITORS, PLAIN: ACE inhibitors, plain]",-pril,Angiotensin-converting enzyme inhibitor,,,CHEMBL1808,Angiotensin-converting enzyme,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=c9536030-cd6c-4cd0-8598-aa9ac9336492, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c9536030-cd6c-4cd0-8598-aa9ac9336492|Name:FDA, SrcID:label/2015/019901s065lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/019901s065lbl.pdf",CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)O,CHEMBL1808,ACE
4113,CHEMBL620,Clidinium,Small molecule,1982.0,,,-ium,Muscarinic acetylcholine receptor M1 antagonist,"Role in regulating gastric secretion, M1 likely involved",,CHEMBL216,Muscarinic acetylcholine receptor M1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Muscarinic_acetylcholine_receptor, URL:http://en.wikipedia.org/wiki/Muscarinic_acetylcholine_receptor|Name:DailyMed, SrcID:setid=a3e521be-bdd7-406d-9791-749f75399c38#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a3e521be-bdd7-406d-9791-749f75399c38#nlm34090-1|Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:DailyMed, SrcID:archiveid=44903, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=44903",C[N+]12CCC(CC1)C(C2)OC(=O)C(O)(c3ccccc3)c4ccccc4,CHEMBL216,CHRM1
4114,CHEMBL1200666,Calcipotriene,Small molecule,1993.0,D05AX52; D05AX02,D05AX52 [DERMATOLOGICALS: ANTIPSORIATICS: ANTIPSORIATICS FOR TOPICAL USE: Other antipsoriatics for topical use]; D05AX02 [DERMATOLOGICALS: ANTIPSORIATICS: ANTIPSORIATICS FOR TOPICAL USE: Other antipsoriatics for topical use],calci-,Vitamin D receptor agonist,,,CHEMBL1977,Vitamin D receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Calcipotriene, URL:http://en.wikipedia.org/wiki/Calcipotriene|Name:PubMed, SrcID:18393827, URL:http://europepmc.org/abstract/MED/18393827",C[C@H](\C=C\[C@@H](O)C1CC1)[C@H]2CC[C@H]3\C(=C\C=C/4\C[C@@H](O)C[C@H](O)C4=C)\CCC[C@]23C,CHEMBL1977,VDR
4115,CHEMBL1404,Ranolazine,Small molecule,2006.0,C01EB18,C01EB18 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: OTHER CARDIAC PREPARATIONS: Other cardiac preparations],,Sodium channel protein type V alpha subunit blocker,,,CHEMBL1980,Sodium channel protein type V alpha subunit,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18462746, URL:http://europepmc.org/abstract/MED/18462746",COc1ccccc1OCC(O)CN2CCN(CC(=O)Nc3c(C)cccc3C)CC2,CHEMBL1980,SCN5A
4116,CHEMBL1201644,Insulin Zinc Susp Recombinant Human,Protein,1985.0,,,,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/022472s006s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022472s006s008lbl.pdf|Name:DailyMed, SrcID:setid=457531f0-9331-47fe-90b5-b31f284044dc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=457531f0-9331-47fe-90b5-b31f284044dc",,CHEMBL1981,INSR
4117,CHEMBL1201302,Dexamethasone Phosphoric Acid,Small molecule,1959.0,,,,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=5564ee46-7bd7-4b2a-ad51-d01f7fda0461#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5564ee46-7bd7-4b2a-ad51-d01f7fda0461#nlm34090-1",C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O,CHEMBL2034,NR3C1
4118,CHEMBL1766,Desoximetasone,Small molecule,1977.0,D07XC02; D07AC03,"D07XC02 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, OTHER COMBINATIONS: Corticosteroids, potent, other combinations]; D07AC03 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, potent (group III)]",,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16980198, URL:http://europepmc.org/abstract/MED/16980198|Name:PubMed, SrcID:16895953, URL:http://europepmc.org/abstract/MED/16895953|Name:PubMed, SrcID:17038445, URL:http://europepmc.org/abstract/MED/17038445",C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO,CHEMBL2034,NR3C1
4119,CHEMBL1946170,Regorafenib,Small molecule,2012.0,L01XE21,L01XE21 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-rafenib,MAP kinase p38 beta inhibitor,,,CHEMBL3961,MAP kinase p38 beta,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Expert, SrcID:REGORAFENIB, URL:http://chembl.blogspot.co.uk/search?q=REGORAFENIB",CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,CHEMBL3961,MAPK11
4120,CHEMBL1201821,Palifermin,Protein,2005.0,V03AF08,V03AF08 [VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Detoxifying agents for antineoplastic treatment],-ermin,Fibroblast growth factor receptor 2 agonist,,,CHEMBL4142,Fibroblast growth factor receptor 2,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16597617, URL:http://europepmc.org/abstract/MED/16597617|Name:DailyMed, SrcID:setid=007b604f-9776-4f64-95db-c0aac776fa5d, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=007b604f-9776-4f64-95db-c0aac776fa5d|Name:FDA, SrcID:label/2013/125103s146lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125103s146lbl.pdf",,CHEMBL4142,FGFR2
4121,CHEMBL1371,Chlorzoxazone,Small molecule,1958.0,M03BB73; M03BB03; M03BB53,"M03BB73 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS: Oxazol, thiazine, and triazine derivatives]; M03BB03 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS: Oxazol, thiazine, and triazine derivatives]; M03BB53 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS: Oxazol, thiazine, and triazine derivatives]",,Intermediate conductance calcium-activated potassium channel protein 4 opener,,,CHEMBL4305,Intermediate conductance calcium-activated potassium channel protein 4,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10712246, URL:http://europepmc.org/abstract/MED/10712246|Name:PubMed, SrcID:20505091, URL:http://europepmc.org/abstract/MED/20505091|Name:PubMed, SrcID:16859676, URL:http://europepmc.org/abstract/MED/16859676",Clc1ccc2OC(=O)Nc2c1,CHEMBL4305,KCNN4
4122,CHEMBL682,Amodiaquine,Small molecule,1982.0,P01BA06,"P01BA06 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: ANTIMALARIALS: Aminoquinolines]",,Ferriprotoporphyrin IX inhibitor,prevents crystallisation,,CHEMBL613897,Ferriprotoporphyrin IX,INHIBITOR,Plasmodium falciparum,SMALL MOLECULE,,,"Name:PubMed, SrcID:8885219, URL:http://europepmc.org/abstract/MED/8885219|Name:PubMed, SrcID:14967191, URL:http://europepmc.org/abstract/MED/14967191|Name:Wikipedia, SrcID:Amodiaquine, URL:http://en.wikipedia.org/wiki/Amodiaquine",CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,,
4123,CHEMBL1201170,Lithium Citrate,Small molecule,1980.0,,,,Glycogen synthase kinase-3 inhibitor,,,CHEMBL2095188,Glycogen synthase kinase-3,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=1dadbe49-93e6-467a-a12b-2b80b811fcbb#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1dadbe49-93e6-467a-a12b-2b80b811fcbb#nlm34090-1|Name:FDA, SrcID:label/2011/017812s028,018421s027lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/017812s028,018421s027lbl.pdf|Name:PubMed, SrcID:22707923, URL:http://europepmc.org/abstract/MED/22707923|Name:Wikipedia, SrcID:Lithium_(medication), URL:http://en.wikipedia.org/wiki/Lithium_(medication)",[Li+].[Li+].[Li+].OC(CC(=O)[O-])(CC(=O)[O-])C(=O)[O-],,
4124,CHEMBL1218,Ramelteon,Small molecule,2005.0,N05CH02,N05CH02 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Melatonin receptor agonists],-melteon,Melatonin receptor agonist,,,CHEMBL2094268,Melatonin receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2010/021782s011lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021782s011lbl.pdf",CCC(=O)NCC[C@@H]1CCc2ccc3OCCc3c12,,
4125,CHEMBL1077,Bromfenac,Small molecule,1997.0,S01BC11,"S01BC11 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Antiinflammatory agents, non-steroids]",-ac,Cyclooxygenase inhibitor,,,CHEMBL2094253,Cyclooxygenase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=aa4dd955-f3d5-489d-b649-656b2784b0e2, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aa4dd955-f3d5-489d-b649-656b2784b0e2",Nc1c(CC(=O)O)cccc1C(=O)c2ccc(Br)cc2,,
4126,CHEMBL1789844,Ipilimumab,Antibody,2011.0,L01XC11,L01XC11 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,Cytotoxic T-lymphocyte protein 4 inhibitor,,,CHEMBL2364164,Cytotoxic T-lymphocyte protein 4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=2265ef30-253e-11df-8a39-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2265ef30-253e-11df-8a39-0800200c9a66",,CHEMBL2364164,CTLA4
4127,CHEMBL1535,Hydroxychloroquine,Small molecule,1955.0,P01BA02,"P01BA02 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: ANTIMALARIALS: Aminoquinolines]",,Toll-like receptor 7 antagonist,,,CHEMBL5936,Toll-like receptor 7,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2007/009768s041lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/009768s041lbl.pdf|Name:PubMed, SrcID:18220957, URL:http://europepmc.org/abstract/MED/18220957|Name:PubMed, SrcID:17970883, URL:http://europepmc.org/abstract/MED/17970883|Name:DailyMed, SrcID:setid=3279d780-0940-f462-9709-83c77f8ae241, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3279d780-0940-f462-9709-83c77f8ae241",CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,CHEMBL5936,TLR7
4128,CHEMBL584,Nelfinavir,Small molecule,1997.0,J05AE04,J05AE04 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Protease inhibitors],-vir,Human immunodeficiency virus type 1 protease inhibitor,,,CHEMBL243,Human immunodeficiency virus type 1 protease,INHIBITOR,Human immunodeficiency virus 1,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=e72c2bc6-9462-4a2e-8e1d-b97592376cbd, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e72c2bc6-9462-4a2e-8e1d-b97592376cbd",Cc1c(O)cccc1C(=O)N[C@@H](CSc2ccccc2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C,,
4129,CHEMBL1201764,Fesoterodine,Small molecule,2008.0,G04BD11,G04BD11 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Drugs for urinary frequency and incontinence],,Muscarinic acetylcholine receptor M2 antagonist,"Indicated for overactive bladder, M2 likely responsible",,CHEMBL211,Muscarinic acetylcholine receptor M2,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 160, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:16465186, URL:http://europepmc.org/abstract/MED/16465186|Name:DailyMed, SrcID:setid=5be745f0-8ae7-4c3c-9962-37d6263326f1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5be745f0-8ae7-4c3c-9962-37d6263326f1|Name:PubMed, SrcID:12076307, URL:http://europepmc.org/abstract/MED/12076307",CC(C)N(CC[C@H](c1ccccc1)c2cc(CO)ccc2OC(=O)C(C)C)C(C)C,CHEMBL211,CHRM2
4130,CHEMBL403,Sulbactam,Small molecule,1986.0,J01CG01,"J01CG01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: BETA-LACTAM ANTIBACTERIALS, PENICILLINS: Beta-lactamase inhibitors]",-bactam,Bacterial beta-lactamase TEM inhibitor,,Broad spectrum,CHEMBL2364670,Bacterial beta-lactamase TEM,INHIBITOR,Bacteria,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2012/050608s040lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050608s040lbl.pdf",CC1(C)[C@@H](N2[C@@H](CC2=O)S1(=O)=O)C(=O)O,,
4131,CHEMBL790,Chlorhexidine,Small molecule,1976.0,R02AA05; D08AC52; S01AX09; S02AA09; A01AB03; S03AA04; D09AA12; D08AC02; B05CA02,R02AA05 [RESPIRATORY SYSTEM: THROAT PREPARATIONS: THROAT PREPARATIONS: Antiseptics]; D08AC52 [DERMATOLOGICALS: ANTISEPTICS AND DISINFECTANTS: ANTISEPTICS AND DISINFECTANTS: Biguanides and amidines]; S01AX09 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Other antiinfectives]; S02AA09 [SENSORY ORGANS: OTOLOGICALS: ANTIINFECTIVES: Antiinfectives]; A01AB03 [ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Antiinfectives and antiseptics for local oral treatment]; S03AA04 [SENSORY ORGANS: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS: ANTIINFECTIVES: Antiinfectives]; D09AA12 [DERMATOLOGICALS: MEDICATED DRESSINGS: MEDICATED DRESSINGS: Medicated dressings with antiinfectives]; D08AC02 [DERMATOLOGICALS: ANTISEPTICS AND DISINFECTANTS: ANTISEPTICS AND DISINFECTANTS: Biguanides and amidines]; B05CA02 [BLOOD AND BLOOD FORMING ORGANS: BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS: IRRIGATING SOLUTIONS: Antiinfectives],,Cell membrane inhibitor,Disrupts cell membrane,,CHEMBL2364031,Cell membrane,INHIBITOR,Bacteria,SUBCELLULAR,,,"Name:Wikipedia, SrcID:Chlorhexidine_gluconate, URL:http://en.wikipedia.org/wiki/Chlorhexidine_gluconate|Name:PubMed, SrcID:1335944, URL:http://europepmc.org/abstract/MED/1335944",Clc1ccc(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)Nc2ccc(Cl)cc2)cc1,,
4132,CHEMBL583,Grepafloxacin,Small molecule,1997.0,J01MA11,J01MA11 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolones],-oxacin,DNA gyrase inhibitor,,,CHEMBL2311225,DNA gyrase,INHIBITOR,Streptococcus pneumoniae,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:15942701, URL:http://europepmc.org/abstract/MED/15942701|Name:PubMed, SrcID:9925527, URL:http://europepmc.org/abstract/MED/9925527|Name:PubMed, SrcID:11796384, URL:http://europepmc.org/abstract/MED/11796384",CC1CN(CCN1)c2cc3N(C=C(C(=O)O)C(=O)c3c(C)c2F)C4CC4,,
4133,CHEMBL1008,Bepridil,Small molecule,1990.0,C08EA02,C08EA02 [CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: NON-SELECTIVE CALCIUM CHANNEL BLOCKERS: Phenylalkylamine derivatives],-dil,Voltage-gated calcium channel blocker,,,CHEMBL2363032,Voltage-gated calcium channel,BLOCKER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:ISBN, SrcID:9780702034718 PP. 256, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:10792039, URL:http://europepmc.org/abstract/MED/10792039",CC(C)COCC(CN(Cc1ccccc1)c2ccccc2)N3CCCC3,CHEMBL2363032,CACNB3
4134,CHEMBL1008,Bepridil,Small molecule,1990.0,C08EA02,C08EA02 [CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: NON-SELECTIVE CALCIUM CHANNEL BLOCKERS: Phenylalkylamine derivatives],-dil,Voltage-gated calcium channel blocker,,,CHEMBL2363032,Voltage-gated calcium channel,BLOCKER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:ISBN, SrcID:9780702034718 PP. 256, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:10792039, URL:http://europepmc.org/abstract/MED/10792039",CC(C)COCC(CN(Cc1ccccc1)c2ccccc2)N3CCCC3,CHEMBL2363032,CACNG3
4135,CHEMBL1008,Bepridil,Small molecule,1990.0,C08EA02,C08EA02 [CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: NON-SELECTIVE CALCIUM CHANNEL BLOCKERS: Phenylalkylamine derivatives],-dil,Voltage-gated calcium channel blocker,,,CHEMBL2363032,Voltage-gated calcium channel,BLOCKER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:ISBN, SrcID:9780702034718 PP. 256, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:10792039, URL:http://europepmc.org/abstract/MED/10792039",CC(C)COCC(CN(Cc1ccccc1)c2ccccc2)N3CCCC3,CHEMBL2363032,CACNG5
4136,CHEMBL1008,Bepridil,Small molecule,1990.0,C08EA02,C08EA02 [CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: NON-SELECTIVE CALCIUM CHANNEL BLOCKERS: Phenylalkylamine derivatives],-dil,Voltage-gated calcium channel blocker,,,CHEMBL2363032,Voltage-gated calcium channel,BLOCKER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:ISBN, SrcID:9780702034718 PP. 256, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:10792039, URL:http://europepmc.org/abstract/MED/10792039",CC(C)COCC(CN(Cc1ccccc1)c2ccccc2)N3CCCC3,CHEMBL2363032,CACNG4
4137,CHEMBL1008,Bepridil,Small molecule,1990.0,C08EA02,C08EA02 [CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: NON-SELECTIVE CALCIUM CHANNEL BLOCKERS: Phenylalkylamine derivatives],-dil,Voltage-gated calcium channel blocker,,,CHEMBL2363032,Voltage-gated calcium channel,BLOCKER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:ISBN, SrcID:9780702034718 PP. 256, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:10792039, URL:http://europepmc.org/abstract/MED/10792039",CC(C)COCC(CN(Cc1ccccc1)c2ccccc2)N3CCCC3,CHEMBL2363032,CACNG1
4138,CHEMBL1008,Bepridil,Small molecule,1990.0,C08EA02,C08EA02 [CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: NON-SELECTIVE CALCIUM CHANNEL BLOCKERS: Phenylalkylamine derivatives],-dil,Voltage-gated calcium channel blocker,,,CHEMBL2363032,Voltage-gated calcium channel,BLOCKER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:ISBN, SrcID:9780702034718 PP. 256, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:10792039, URL:http://europepmc.org/abstract/MED/10792039",CC(C)COCC(CN(Cc1ccccc1)c2ccccc2)N3CCCC3,CHEMBL2363032,CACNB4
4139,CHEMBL1008,Bepridil,Small molecule,1990.0,C08EA02,C08EA02 [CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: NON-SELECTIVE CALCIUM CHANNEL BLOCKERS: Phenylalkylamine derivatives],-dil,Voltage-gated calcium channel blocker,,,CHEMBL2363032,Voltage-gated calcium channel,BLOCKER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:ISBN, SrcID:9780702034718 PP. 256, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:10792039, URL:http://europepmc.org/abstract/MED/10792039",CC(C)COCC(CN(Cc1ccccc1)c2ccccc2)N3CCCC3,CHEMBL2363032,CACNA2D4
4140,CHEMBL1008,Bepridil,Small molecule,1990.0,C08EA02,C08EA02 [CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: NON-SELECTIVE CALCIUM CHANNEL BLOCKERS: Phenylalkylamine derivatives],-dil,Voltage-gated calcium channel blocker,,,CHEMBL2363032,Voltage-gated calcium channel,BLOCKER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:ISBN, SrcID:9780702034718 PP. 256, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:10792039, URL:http://europepmc.org/abstract/MED/10792039",CC(C)COCC(CN(Cc1ccccc1)c2ccccc2)N3CCCC3,CHEMBL2363032,CACNG2
4141,CHEMBL1008,Bepridil,Small molecule,1990.0,C08EA02,C08EA02 [CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: NON-SELECTIVE CALCIUM CHANNEL BLOCKERS: Phenylalkylamine derivatives],-dil,Voltage-gated calcium channel blocker,,,CHEMBL2363032,Voltage-gated calcium channel,BLOCKER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:ISBN, SrcID:9780702034718 PP. 256, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:10792039, URL:http://europepmc.org/abstract/MED/10792039",CC(C)COCC(CN(Cc1ccccc1)c2ccccc2)N3CCCC3,CHEMBL2363032,CACNG7
4142,CHEMBL1008,Bepridil,Small molecule,1990.0,C08EA02,C08EA02 [CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: NON-SELECTIVE CALCIUM CHANNEL BLOCKERS: Phenylalkylamine derivatives],-dil,Voltage-gated calcium channel blocker,,,CHEMBL2363032,Voltage-gated calcium channel,BLOCKER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:ISBN, SrcID:9780702034718 PP. 256, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:10792039, URL:http://europepmc.org/abstract/MED/10792039",CC(C)COCC(CN(Cc1ccccc1)c2ccccc2)N3CCCC3,CHEMBL2363032,CACNG8
4143,CHEMBL1008,Bepridil,Small molecule,1990.0,C08EA02,C08EA02 [CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: NON-SELECTIVE CALCIUM CHANNEL BLOCKERS: Phenylalkylamine derivatives],-dil,Voltage-gated calcium channel blocker,,,CHEMBL2363032,Voltage-gated calcium channel,BLOCKER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:ISBN, SrcID:9780702034718 PP. 256, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:10792039, URL:http://europepmc.org/abstract/MED/10792039",CC(C)COCC(CN(Cc1ccccc1)c2ccccc2)N3CCCC3,CHEMBL2363032,CACNG6
4144,CHEMBL1008,Bepridil,Small molecule,1990.0,C08EA02,C08EA02 [CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: NON-SELECTIVE CALCIUM CHANNEL BLOCKERS: Phenylalkylamine derivatives],-dil,Voltage-gated calcium channel blocker,,,CHEMBL2363032,Voltage-gated calcium channel,BLOCKER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:ISBN, SrcID:9780702034718 PP. 256, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:10792039, URL:http://europepmc.org/abstract/MED/10792039",CC(C)COCC(CN(Cc1ccccc1)c2ccccc2)N3CCCC3,CHEMBL2363032,CACNA1F
4145,CHEMBL1008,Bepridil,Small molecule,1990.0,C08EA02,C08EA02 [CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: NON-SELECTIVE CALCIUM CHANNEL BLOCKERS: Phenylalkylamine derivatives],-dil,Voltage-gated calcium channel blocker,,,CHEMBL2363032,Voltage-gated calcium channel,BLOCKER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:ISBN, SrcID:9780702034718 PP. 256, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:10792039, URL:http://europepmc.org/abstract/MED/10792039",CC(C)COCC(CN(Cc1ccccc1)c2ccccc2)N3CCCC3,CHEMBL2363032,CACNB1
4146,CHEMBL1008,Bepridil,Small molecule,1990.0,C08EA02,C08EA02 [CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: NON-SELECTIVE CALCIUM CHANNEL BLOCKERS: Phenylalkylamine derivatives],-dil,Voltage-gated calcium channel blocker,,,CHEMBL2363032,Voltage-gated calcium channel,BLOCKER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:ISBN, SrcID:9780702034718 PP. 256, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:10792039, URL:http://europepmc.org/abstract/MED/10792039",CC(C)COCC(CN(Cc1ccccc1)c2ccccc2)N3CCCC3,CHEMBL2363032,CACNA2D3
4147,CHEMBL2111187,Radium Dichloride,Small molecule,2013.0,,,,Radiotherapy agent,"Radiotherapy agent, binds to hydroxyapatite in bone, where alpha radiation results in double strand DNA breaks.",,,,,,,,,"Name:DailyMed, SrcID:setid=a398400e-bd31-41a9-9696-4f7c06569ede#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a398400e-bd31-41a9-9696-4f7c06569ede#nlm34090-1",[Cl-].[Cl-].[Ra+2],,
4148,CHEMBL2095209,Icosapent Ethyl,Small molecule,2012.0,,,,Unknown,"Mode of action not fully understood; it seems to increase beta-oxidation, inhibit acyl-CoA:1,2-diacylglycerol acyltransferase (EC 2.3.1.20), decreas lipogenesis in the liver, and increase plasma lipoprotein lipase activity",,,,,,,,,"Name:DailyMed, SrcID:setid=9c1a2828-1583-4414-ab22-a60480e8e508, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9c1a2828-1583-4414-ab22-a60480e8e508",CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,,
4149,CHEMBL1576,Ethinamate,Small molecule,1982.0,,,,Unknown,Mode of action not fully understood; it seems to interact with GABA A receptors as other carbinol hypnotic drugs,,,,,,,,,"Name:ISBN, SrcID:0471948470 PP. 325, URL:http://www.isbnsearch.org/isbn/0471948470",NC(=O)OC1(CCCCC1)C#C,,
4150,CHEMBL2105669,Tedizolid Phosphate,Small molecule,2014.0,,,-zolid,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,23S ribosomal RNA,23S RRNA,"Name:PubMed, SrcID:25673021, URL:http://europepmc.org/abstract/MED/25673021|Name:PubMed, SrcID:18838596, URL:http://europepmc.org/abstract/MED/18838596|Name:FDA, SrcID:label/2014/205435s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205435s000lbl.pdf",Cn1nnc(n1)c2ccc(cn2)c3ccc(cc3F)N4C[C@H](COP(=O)(O)O)OC4=O,,
4151,CHEMBL2110588,Eliglustat,Small molecule,2014.0,A16AX10,A16AX10 [ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Various alimentary tract and metabolism products],-stat,Ceramide glucosyltransferase inhibitor,,,CHEMBL2063,Ceramide glucosyltransferase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2014/205494Orig1s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205494Orig1s000lbl.pdf",CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)c2ccc3OCCOc3c2,CHEMBL2063,UGCG
4152,CHEMBL1738797,Alectinib,Small molecule,2015.0,L01XE36,L01XE36 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,ALK tyrosine kinase receptor inhibitor,,,CHEMBL4247,ALK tyrosine kinase receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/208434s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/208434s000lbl.pdf",CCc1cc2C(=O)c3c([nH]c4cc(ccc34)C#N)C(C)(C)c2cc1N5CCC(CC5)N6CCOCC6,CHEMBL4247,ALK
4153,CHEMBL3545355,Chf4227,Small molecule,,,,,Estrogen receptor modulator,SERM,,CHEMBL2093866,Estrogen receptor,MODULATOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:17367495, URL:http://europepmc.org/abstract/MED/17367495|Name:PubMed, SrcID:12235251, URL:http://europepmc.org/abstract/MED/12235251",COc1ccc(cc1)C2=C(Cc3ccc(OCCN4CCCCC4)cc3)c5ccc(O)cc5OC2,,
4154,CHEMBL496102,Amg-208,Small molecule,,,,,Hepatocyte growth factor receptor inhibitor,,,CHEMBL3717,Hepatocyte growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.amgenoncology-international.com/#/our-products/our-pipeline/, URL:http://www.amgenoncology-international.com/#/our-products/our-pipeline/|Name:PubMed, SrcID:26155941, URL:http://europepmc.org/abstract/MED/26155941",COc1ccc2c(OCc3nnc4ccc(nn34)c5ccccc5)ccnc2c1,CHEMBL3717,MET
4155,CHEMBL3545177,Azd-0424,Small molecule,,,,,Tyrosine-protein kinase ABL inhibitor,,,CHEMBL1862,Tyrosine-protein kinase ABL,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25662515, URL:http://europepmc.org/abstract/MED/25662515|Name:ClinicalTrials, SrcID:NCT01668550, URL:https://www.clinicaltrials.gov/ct2/show/NCT01668550",,CHEMBL1862,ABL1
4156,CHEMBL483321,Cp-724714,Small molecule,,,,,Receptor protein-tyrosine kinase erbB-2 inhibitor,,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17317835, URL:http://europepmc.org/abstract/MED/17317835|Name:PubMed, SrcID:17942920, URL:http://europepmc.org/abstract/MED/17942920",COCC(=O)NC\C=C\c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1,CHEMBL1824,ERBB2
4157,CHEMBL3545265,Mln-0415,Small molecule,,,,,Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor,,,CHEMBL1991,Inhibitor of nuclear factor kappa B kinase beta subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25449604, URL:http://europepmc.org/abstract/MED/25449604|Name:Other, SrcID:http://investor.millennium.com/phoenix.zhtml?c=80159&p=irol-newsArticle&ID=900341, URL:http://investor.millennium.com/phoenix.zhtml?c=80159&p=irol-newsArticle&ID=900341|Name:Other, SrcID:https://www.takeda.com/investor-information/results/pdf/2009/qr2009_full_d10_en.pdf, URL:https://www.takeda.com/investor-information/results/pdf/2009/qr2009_full_d10_en.pdf",,CHEMBL1991,IKBKB
4158,CHEMBL3545379,Mln-1117,Small molecule,,,,,PI3-kinase p110-alpha subunit inhibitor,,,CHEMBL4005,PI3-kinase p110-alpha subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23275335, URL:http://europepmc.org/abstract/MED/23275335|Name:PubMed, SrcID:24915189, URL:http://europepmc.org/abstract/MED/24915189",,CHEMBL4005,PIK3CA
4159,CHEMBL3545003,Msc-2363318a,Small molecule,,,,,Serine/threonine-protein kinase AKT inhibitor,,,CHEMBL4282,Serine/threonine-protein kinase AKT,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://biopharma.merckgroup.com/en/research_development/pipeline/pipeline.html, URL:http://biopharma.merckgroup.com/en/research_development/pipeline/pipeline.html",,CHEMBL4282,AKT1
4160,CHEMBL3545381,Plx-7486,Small molecule,,,,,Nerve growth factor receptor Trk-A inhibitor,,,CHEMBL2815,Nerve growth factor receptor Trk-A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.ecmcnetwork.org.uk/sites/default/files/PLX7486%20Background%20for%20CRUK%20Combinations%20Alliance%20(Non-CI)%202015-10-08%20final.pdf, URL:http://www.ecmcnetwork.org.uk/sites/default/files/PLX7486%20Background%20for%20CRUK%20Combinations%20Alliance%20(Non-CI)%202015-10-08%20final.pdf",,CHEMBL2815,NTRK1
4161,CHEMBL3545143,Sr-13668,Small molecule,,,,,Serine/threonine-protein kinase AKT inhibitor,Compound is thought to be an Akt pathway inhibitor and inhibits Akt phosphorylation but does not bind to ATP-binding site (or any site?) on Akt kinases (PMID:17602463),,CHEMBL4282,Serine/threonine-protein kinase AKT,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17602463, URL:http://europepmc.org/abstract/MED/17602463|Name:PubMed, SrcID:19756605, URL:http://europepmc.org/abstract/MED/19756605",,CHEMBL4282,AKT1
4162,CHEMBL3545085,Xl-228,Small molecule,,,,,Tyrosine-protein kinase ABL inhibitor,"Also potent inhibitor of AURKA, AURKB, FGFR1-3, and ALK.",,CHEMBL1862,Tyrosine-protein kinase ABL,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1158/1535-7163.TARG-09-C192, URL:http://mct.aacrjournals.org/content/8/12_Supplement/C192|Name:Other, SrcID:http://www.exelixis.com/sites/default/files/pdf/XL228-002_ASCO-2009.pdf, URL:http://www.exelixis.com/sites/default/files/pdf/XL228-002_ASCO-2009.pdf|Name:PubMed, SrcID:20124450, URL:http://europepmc.org/abstract/MED/20124450",CC(C)c1cc(CNc2nc(Nc3cc([nH]n3)C4CC4)cc(n2)N5CCN(C)CC5)on1,CHEMBL1862,ABL1
4163,CHEMBL219586,Gw590735,Small molecule,,,,,Peroxisome proliferator-activated receptor alpha agonist,"Not in pipeline, development discontinued?",,CHEMBL239,Peroxisome proliferator-activated receptor alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17243659, URL:http://europepmc.org/abstract/MED/17243659",Cc1nc(sc1C(=O)NCc2ccc(OC(C)(C)C(=O)O)cc2)c3ccc(cc3)C(F)(F)F,CHEMBL239,PPARA
4164,CHEMBL3545021,Anlotinib,Small molecule,,,,-tinib,Platelet-derived growth factor receptor beta inhibitor,Multi-targeted receptor tyrosine kinase inhibitor,,CHEMBL1913,Platelet-derived growth factor receptor beta,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:ClinicalTrials, SrcID:NCT01924195, URL:https://www.clinicaltrials.gov/ct2/show/NCT01924195|Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=749736, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=749736",,CHEMBL1913,PDGFRB
4165,CHEMBL495727,At-9283,Small molecule,,,,,Tyrosine-protein kinase JAK2 inhibitor,,,CHEMBL2971,Tyrosine-protein kinase JAK2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19143567, URL:http://europepmc.org/abstract/MED/19143567|Name:PubMed, SrcID:20507304, URL:http://europepmc.org/abstract/MED/20507304",O=C(NC1CC1)Nc2c[nH]nc2c3nc4cc(CN5CCOCC5)ccc4[nH]3,CHEMBL2971,JAK2
4166,CHEMBL575448,Bms-754807,Small molecule,,,,,Insulin-like growth factor I receptor inhibitor,,,CHEMBL1957,Insulin-like growth factor I receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21875414, URL:http://europepmc.org/abstract/MED/21875414|Name:PubMed, SrcID:19996272, URL:http://europepmc.org/abstract/MED/19996272",C[C@]1(CCCN1c2nc(Nc3cc([nH]n3)C4CC4)c5cccn5n2)C(=O)Nc6ccc(F)nc6,CHEMBL1957,IGF1R
4167,CHEMBL1950289,Tanzisertib,Small molecule,,,,-sertib,c-Jun N-terminal kinase 1 inhibitor,,,CHEMBL2276,c-Jun N-terminal kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22244937, URL:http://europepmc.org/abstract/MED/22244937",O[C@@H]1CC[C@H](CC1)Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]5CCOC5)c3n2,CHEMBL2276,MAPK8
4168,CHEMBL105442,Ci-1040,Small molecule,,,,,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,Allosteric inhibitor,,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10395327, URL:http://europepmc.org/abstract/MED/10395327|Name:PubMed, SrcID:16009947, URL:http://europepmc.org/abstract/MED/16009947",Fc1ccc(C(=O)NOCC2CC2)c(Nc3ccc(I)cc3Cl)c1F,CHEMBL3587,MAP2K1
4169,CHEMBL482968,Enmd-2076,Small molecule,,,,,Vascular endothelial growth factor receptor 2 inhibitor,Tartrate salt of ENMD-981693,,CHEMBL279,Vascular endothelial growth factor receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf, URL:http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf|Name:PubMed, SrcID:21177375, URL:http://europepmc.org/abstract/MED/21177375|Name:PubMed, SrcID:22397360, URL:http://europepmc.org/abstract/MED/22397360",CN1CCN(CC1)c2cc(Nc3cc(C)[nH]n3)nc(\C=C\c4ccccc4)n2,CHEMBL279,KDR
4170,CHEMBL2012520,Ly377604,Small molecule,,,,,Beta-3 adrenergic receptor agonist,Phase 2 study in 2011 terminated.,,CHEMBL246,Beta-3 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24900353, URL:http://europepmc.org/abstract/MED/24900353",CC(C)(Cc1ccc(Oc2ccc(cn2)C(=O)N)cc1)NC[C@H](O)COc3cccc4[nH]c5ccccc5c34,CHEMBL246,ADRB3
4171,CHEMBL3545031,Mk-1029,Small molecule,,,,,G protein-coupled receptor 44 antagonist,,,CHEMBL5071,G protein-coupled receptor 44,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24073896, URL:http://europepmc.org/abstract/MED/24073896",,CHEMBL5071,PTGDR2
4172,CHEMBL3545221,Azd2423,Small molecule,,,,,C-C chemokine receptor type 2 antagonist,,,CHEMBL4015,C-C chemokine receptor type 2,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23523116, URL:http://europepmc.org/abstract/MED/23523116",,CHEMBL4015,CCR2
4173,CHEMBL207433,Sb-705498,Small molecule,,,,,Vanilloid receptor antagonist,,,CHEMBL4794,Vanilloid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16580202, URL:http://europepmc.org/abstract/MED/16580202",FC(F)(F)c1ccc(nc1)N2CC[C@H](C2)NC(=O)Nc3ccccc3Br,CHEMBL4794,TRPV1
4174,CHEMBL3183409,Arn-509,Small molecule,,,,,Androgen Receptor antagonist,,,CHEMBL1871,Androgen Receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24002508, URL:http://europepmc.org/abstract/MED/24002508|Name:Other, SrcID:http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Genitourinary-Tumours-Prostate/Novel-antiandrogen-ARN-509-in-high-risk-non-metastatic-M0-castration-resistant-prostate-cancer-CRPC, URL:http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Genitourinary-Tumours-Prostate/Novel-antiandrogen-ARN-509-in-high-risk-non-metastatic-M0-castration-resistant-prostate-cancer-CRPC",CNC(=O)c1ccc(cc1F)N2C(=S)N(C(=O)C23CCC3)c4cnc(C#N)c(c4)C(F)(F)F,CHEMBL1871,AR
4175,CHEMBL428690,Alvocidib,Small molecule,,,,,Cyclin-dependent kinase 2 inhibitor,,,CHEMBL301,Cyclin-dependent kinase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25215591, URL:http://europepmc.org/abstract/MED/25215591|Name:PubMed, SrcID:15217973, URL:http://europepmc.org/abstract/MED/15217973",CN1CC[C@@H]([C@H](O)C1)c2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccccc4Cl,CHEMBL301,CDK2
4176,CHEMBL82301,Vicriviroc,Small molecule,,,,-viroc,C-C chemokine receptor type 5 antagonist,Discontinueddue to disappointing results in Ph2 and Ph3 studies.,,CHEMBL274,C-C chemokine receptor type 5,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16304152, URL:http://europepmc.org/abstract/MED/16304152",COC[C@H](N1CCN(C[C@@H]1C)C2(C)CCN(CC2)C(=O)c3c(C)ncnc3C)c4ccc(cc4)C(F)(F)F,CHEMBL274,CCR5
4177,CHEMBL2178578,Verecimon,Small molecule,,,,-cirnon,C-C chemokine receptor type 9 antagonist,"Phase 3 trials terminated, compound development discontinued due to lack of efficacy and adverse events. Still in ChemoCentryx pipeline, compound on hold. Indication: Crohn’s disease",,CHEMBL5815,C-C chemokine receptor type 9,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20582872, URL:http://europepmc.org/abstract/MED/20582872",CC(C)(C)c1ccc(cc1)S(=O)(=O)Nc2ccc(Cl)cc2C(=O)c3ccn(=O)cc3,CHEMBL5815,CCR9
4178,CHEMBL2108358,Serelaxin,Protein,,C01DX21,C01DX21 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: VASODILATORS USED IN CARDIAC DISEASES: Other vasodilators used in cardiac diseases],,Relaxin receptor 1 activator,"Peptide, recombinant human relaxin-2. EMA and FDA regulators have rejected marketing authorisation.",,CHEMBL1293316,Relaxin receptor 1,ACTIVATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23141816, URL:http://europepmc.org/abstract/MED/23141816|Name:Other, SrcID:http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002817/WC500171911.pdf, URL:http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002817/WC500171911.pdf|Name:Other, SrcID:http://assets.escardio.org/assets/Presentations/OTHER2013/Davos/Day%203/17-Serelaxin.pdf, URL:http://assets.escardio.org/assets/Presentations/OTHER2013/Davos/Day%203/17-Serelaxin.pdf",,CHEMBL1293316,RXFP1
4179,CHEMBL2108712,Plovamer Acetate,Small molecule,,,,-mer,"HLA class II histocompatibility antigen, DRB1-15 beta chain modulator","Immunomodulator. Binds to antigenic peptide-presenting MHC Class II molecules, HLA-DR2 (DRB1*1501) haplotype.",,CHEMBL3831291,"HLA class II histocompatibility antigen, DRB1-15 beta chain",MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20940336, URL:http://europepmc.org/abstract/MED/20940336|Name:PubMed, SrcID:12070311, URL:http://europepmc.org/abstract/MED/12070311",,CHEMBL3831291,HLA-DRB1
4180,CHEMBL286738,Irosustat,Small molecule,,,,-stat,Steryl-sulfatase inhibitor,,,CHEMBL3559,Steryl-sulfatase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10910045, URL:http://europepmc.org/abstract/MED/10910045",NS(=O)(=O)Oc1ccc2C3=C(CCCCC3)C(=O)Oc2c1,CHEMBL3559,STS
4181,CHEMBL552212,Lexibulin,Small molecule,,,,-bulin,Tubulin inhibitor,Microtubule polymerization inhibitor,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,"Lexibulin forms H-bonds with the main chain of betaV236 on H7, betaD249 on T7 and aT179 on T5","Name:PubMed, SrcID:26462166, URL:http://europepmc.org/abstract/MED/26462166",CCC[C@H](Nc1nc(ncc1C)c2ccc(NC(=O)NCC)c(OC)c2)c3cccnc3,CHEMBL2095182,TUBB8
4182,CHEMBL552212,Lexibulin,Small molecule,,,,-bulin,Tubulin inhibitor,Microtubule polymerization inhibitor,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,"Lexibulin forms H-bonds with the main chain of betaV236 on H7, betaD249 on T7 and aT179 on T5","Name:PubMed, SrcID:26462166, URL:http://europepmc.org/abstract/MED/26462166",CCC[C@H](Nc1nc(ncc1C)c2ccc(NC(=O)NCC)c(OC)c2)c3cccnc3,CHEMBL2095182,TUBA3C
4183,CHEMBL552212,Lexibulin,Small molecule,,,,-bulin,Tubulin inhibitor,Microtubule polymerization inhibitor,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,"Lexibulin forms H-bonds with the main chain of betaV236 on H7, betaD249 on T7 and aT179 on T5","Name:PubMed, SrcID:26462166, URL:http://europepmc.org/abstract/MED/26462166",CCC[C@H](Nc1nc(ncc1C)c2ccc(NC(=O)NCC)c(OC)c2)c3cccnc3,CHEMBL2095182,TUBA4A
4184,CHEMBL552212,Lexibulin,Small molecule,,,,-bulin,Tubulin inhibitor,Microtubule polymerization inhibitor,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,"Lexibulin forms H-bonds with the main chain of betaV236 on H7, betaD249 on T7 and aT179 on T5","Name:PubMed, SrcID:26462166, URL:http://europepmc.org/abstract/MED/26462166",CCC[C@H](Nc1nc(ncc1C)c2ccc(NC(=O)NCC)c(OC)c2)c3cccnc3,CHEMBL2095182,TUBA3E
4185,CHEMBL552212,Lexibulin,Small molecule,,,,-bulin,Tubulin inhibitor,Microtubule polymerization inhibitor,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,"Lexibulin forms H-bonds with the main chain of betaV236 on H7, betaD249 on T7 and aT179 on T5","Name:PubMed, SrcID:26462166, URL:http://europepmc.org/abstract/MED/26462166",CCC[C@H](Nc1nc(ncc1C)c2ccc(NC(=O)NCC)c(OC)c2)c3cccnc3,CHEMBL2095182,TUBB6
4186,CHEMBL552212,Lexibulin,Small molecule,,,,-bulin,Tubulin inhibitor,Microtubule polymerization inhibitor,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,"Lexibulin forms H-bonds with the main chain of betaV236 on H7, betaD249 on T7 and aT179 on T5","Name:PubMed, SrcID:26462166, URL:http://europepmc.org/abstract/MED/26462166",CCC[C@H](Nc1nc(ncc1C)c2ccc(NC(=O)NCC)c(OC)c2)c3cccnc3,CHEMBL2095182,TUBB2B
4187,CHEMBL552212,Lexibulin,Small molecule,,,,-bulin,Tubulin inhibitor,Microtubule polymerization inhibitor,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,"Lexibulin forms H-bonds with the main chain of betaV236 on H7, betaD249 on T7 and aT179 on T5","Name:PubMed, SrcID:26462166, URL:http://europepmc.org/abstract/MED/26462166",CCC[C@H](Nc1nc(ncc1C)c2ccc(NC(=O)NCC)c(OC)c2)c3cccnc3,CHEMBL2095182,TUBA3D
4188,CHEMBL235191,Tacedinaline,Small molecule,,,,,Histone deacetylase inhibitor,,,CHEMBL2093865,Histone deacetylase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:25827403, URL:http://europepmc.org/abstract/MED/25827403",CC(=O)Nc1ccc(cc1)C(=O)Nc2ccccc2N,,
4189,CHEMBL371405,Marizomib,Small molecule,,,,-zomib,20S Proteasome inhibitor,"Irreversible proteasome inhibitor. Inhibits all three proteolytic chymotrypsin-like (CT-L, b5), trypsin-like (T-L, b2) and caspase-like (C-L, b1) activities.",,CHEMBL3831201,20S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:27161872, URL:http://europepmc.org/abstract/MED/27161872",C[C@@]12OC(=O)[C@@]1(NC(=O)[C@@H]2CCCl)[C@@H](O)[C@H]3CCCC=C3,CHEMBL3831201,PSMA7
4190,CHEMBL371405,Marizomib,Small molecule,,,,-zomib,20S Proteasome inhibitor,"Irreversible proteasome inhibitor. Inhibits all three proteolytic chymotrypsin-like (CT-L, b5), trypsin-like (T-L, b2) and caspase-like (C-L, b1) activities.",,CHEMBL3831201,20S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:27161872, URL:http://europepmc.org/abstract/MED/27161872",C[C@@]12OC(=O)[C@@]1(NC(=O)[C@@H]2CCCl)[C@@H](O)[C@H]3CCCC=C3,CHEMBL3831201,PSMA8
4191,CHEMBL371405,Marizomib,Small molecule,,,,-zomib,20S Proteasome inhibitor,"Irreversible proteasome inhibitor. Inhibits all three proteolytic chymotrypsin-like (CT-L, b5), trypsin-like (T-L, b2) and caspase-like (C-L, b1) activities.",,CHEMBL3831201,20S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:27161872, URL:http://europepmc.org/abstract/MED/27161872",C[C@@]12OC(=O)[C@@]1(NC(=O)[C@@H]2CCCl)[C@@H](O)[C@H]3CCCC=C3,CHEMBL3831201,PSMB11
4192,CHEMBL371405,Marizomib,Small molecule,,,,-zomib,20S Proteasome inhibitor,"Irreversible proteasome inhibitor. Inhibits all three proteolytic chymotrypsin-like (CT-L, b5), trypsin-like (T-L, b2) and caspase-like (C-L, b1) activities.",,CHEMBL3831201,20S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:27161872, URL:http://europepmc.org/abstract/MED/27161872",C[C@@]12OC(=O)[C@@]1(NC(=O)[C@@H]2CCCl)[C@@H](O)[C@H]3CCCC=C3,CHEMBL3831201,PSMA1
4193,CHEMBL371405,Marizomib,Small molecule,,,,-zomib,20S Proteasome inhibitor,"Irreversible proteasome inhibitor. Inhibits all three proteolytic chymotrypsin-like (CT-L, b5), trypsin-like (T-L, b2) and caspase-like (C-L, b1) activities.",,CHEMBL3831201,20S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:27161872, URL:http://europepmc.org/abstract/MED/27161872",C[C@@]12OC(=O)[C@@]1(NC(=O)[C@@H]2CCCl)[C@@H](O)[C@H]3CCCC=C3,CHEMBL3831201,PSMA6
4194,CHEMBL371405,Marizomib,Small molecule,,,,-zomib,20S Proteasome inhibitor,"Irreversible proteasome inhibitor. Inhibits all three proteolytic chymotrypsin-like (CT-L, b5), trypsin-like (T-L, b2) and caspase-like (C-L, b1) activities.",,CHEMBL3831201,20S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:27161872, URL:http://europepmc.org/abstract/MED/27161872",C[C@@]12OC(=O)[C@@]1(NC(=O)[C@@H]2CCCl)[C@@H](O)[C@H]3CCCC=C3,CHEMBL3831201,PSMA2
4195,CHEMBL371405,Marizomib,Small molecule,,,,-zomib,20S Proteasome inhibitor,"Irreversible proteasome inhibitor. Inhibits all three proteolytic chymotrypsin-like (CT-L, b5), trypsin-like (T-L, b2) and caspase-like (C-L, b1) activities.",,CHEMBL3831201,20S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:27161872, URL:http://europepmc.org/abstract/MED/27161872",C[C@@]12OC(=O)[C@@]1(NC(=O)[C@@H]2CCCl)[C@@H](O)[C@H]3CCCC=C3,CHEMBL3831201,PSMB3
4196,CHEMBL371405,Marizomib,Small molecule,,,,-zomib,20S Proteasome inhibitor,"Irreversible proteasome inhibitor. Inhibits all three proteolytic chymotrypsin-like (CT-L, b5), trypsin-like (T-L, b2) and caspase-like (C-L, b1) activities.",,CHEMBL3831201,20S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:27161872, URL:http://europepmc.org/abstract/MED/27161872",C[C@@]12OC(=O)[C@@]1(NC(=O)[C@@H]2CCCl)[C@@H](O)[C@H]3CCCC=C3,CHEMBL3831201,PSMA5
4197,CHEMBL371405,Marizomib,Small molecule,,,,-zomib,20S Proteasome inhibitor,"Irreversible proteasome inhibitor. Inhibits all three proteolytic chymotrypsin-like (CT-L, b5), trypsin-like (T-L, b2) and caspase-like (C-L, b1) activities.",,CHEMBL3831201,20S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:27161872, URL:http://europepmc.org/abstract/MED/27161872",C[C@@]12OC(=O)[C@@]1(NC(=O)[C@@H]2CCCl)[C@@H](O)[C@H]3CCCC=C3,CHEMBL3831201,PSMA4
4198,CHEMBL371405,Marizomib,Small molecule,,,,-zomib,20S Proteasome inhibitor,"Irreversible proteasome inhibitor. Inhibits all three proteolytic chymotrypsin-like (CT-L, b5), trypsin-like (T-L, b2) and caspase-like (C-L, b1) activities.",,CHEMBL3831201,20S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:27161872, URL:http://europepmc.org/abstract/MED/27161872",C[C@@]12OC(=O)[C@@]1(NC(=O)[C@@H]2CCCl)[C@@H](O)[C@H]3CCCC=C3,CHEMBL3831201,PSMB4
4199,CHEMBL371405,Marizomib,Small molecule,,,,-zomib,20S Proteasome inhibitor,"Irreversible proteasome inhibitor. Inhibits all three proteolytic chymotrypsin-like (CT-L, b5), trypsin-like (T-L, b2) and caspase-like (C-L, b1) activities.",,CHEMBL3831201,20S proteosome,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:27161872, URL:http://europepmc.org/abstract/MED/27161872",C[C@@]12OC(=O)[C@@]1(NC(=O)[C@@H]2CCCl)[C@@H](O)[C@H]3CCCC=C3,CHEMBL3831201,PSMA3
4200,CHEMBL218291,Forodesine,Small molecule,,,,,Purine nucleoside phosphorylase inhibitor,Highly specific and potent transition state analog inhibitor of PNP that inhibits T-cell proliferation.,,CHEMBL4338,Purine nucleoside phosphorylase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19541822, URL:http://europepmc.org/abstract/MED/19541822",OC[C@H]1N[C@H]([C@H](O)[C@@H]1O)c2c[nH]c3C(=O)NC=Nc23,CHEMBL4338,PNP
4201,CHEMBL3545070,Vonapanitase,Enzyme,,,,-ase,Elastin proteolytic enzyme,Recombinant human chymotrypsin-like elastase family member 1 (CELA1) shown to cleave the elastin component of elastic fibers.,,CHEMBL3713712,Elastin,PROTEOLYTIC ENZYME,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26745001, URL:http://europepmc.org/abstract/MED/26745001|Name:PubMed, SrcID:27433340, URL:http://europepmc.org/abstract/MED/27433340",,,
4202,CHEMBL2107846,Dulanermin,Protein,,,,-ermin,Tumor necrosis factor receptor superfamily member 10B agonist,"Binds to and activates TRAIL receptors 1 and 2 (TRAIL-R1/R2), which may activate caspases and induce p53-independent apoptosis.",,CHEMBL1075153,Tumor necrosis factor receptor superfamily member 10B,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10411544, URL:http://europepmc.org/abstract/MED/10411544|Name:PubMed, SrcID:22914439, URL:http://europepmc.org/abstract/MED/22914439",,CHEMBL1075153,TNFRSF10B
4203,CHEMBL468,Thalidomide,Small molecule,1998.0,L04AX02,L04AX02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Other immunosuppressants],-domide,CRL4(CRBN) E3 ubiquitin ligase inhibitor,,,CHEMBL3833061,CRL4(CRBN) E3 ubiquitin ligase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,Cereblon,"Name:PubMed, SrcID:22552008, URL:http://europepmc.org/abstract/MED/22552008|Name:PubMed, SrcID:25043012, URL:http://europepmc.org/abstract/MED/25043012",O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,CHEMBL3833061,DDB1
4204,CHEMBL468,Thalidomide,Small molecule,1998.0,L04AX02,L04AX02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Other immunosuppressants],-domide,CRL4(CRBN) E3 ubiquitin ligase inhibitor,,,CHEMBL3833061,CRL4(CRBN) E3 ubiquitin ligase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,Cereblon,"Name:PubMed, SrcID:22552008, URL:http://europepmc.org/abstract/MED/22552008|Name:PubMed, SrcID:25043012, URL:http://europepmc.org/abstract/MED/25043012",O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,CHEMBL3833061,CUL4A
4205,CHEMBL468,Thalidomide,Small molecule,1998.0,L04AX02,L04AX02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Other immunosuppressants],-domide,CRL4(CRBN) E3 ubiquitin ligase inhibitor,,,CHEMBL3833061,CRL4(CRBN) E3 ubiquitin ligase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,Cereblon,"Name:PubMed, SrcID:22552008, URL:http://europepmc.org/abstract/MED/22552008|Name:PubMed, SrcID:25043012, URL:http://europepmc.org/abstract/MED/25043012",O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,CHEMBL3833061,RBX1
4206,CHEMBL1743011,Enavatuzumab,Antibody,,,,-mab,Tumor necrosis factor receptor superfamily member 12A agonist,"Activates the NF?B pathway, and that its growth inhibitory activity is dependent on NF?B.",,CHEMBL3712850,Tumor necrosis factor receptor superfamily member 12A,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23073510, URL:http://europepmc.org/abstract/MED/23073510|Name:PubMed, SrcID:24409185, URL:http://europepmc.org/abstract/MED/24409185",,CHEMBL3712850,TNFRSF12A
4207,CHEMBL1743022,Fresolimumab,Antibody,,,,-mab,Transforming growth factor beta-2 inhibitor,,,CHEMBL3217393,Transforming growth factor beta-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21368745, URL:http://europepmc.org/abstract/MED/21368745",,CHEMBL3217393,TGFB2
4208,CHEMBL1743088,Veltuzumab,Antibody,,,,-mab,B-lymphocyte antigen CD20 inhibitor,"Induces apoptosis, Antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC).",,CHEMBL2058,B-lymphocyte antigen CD20,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18941114, URL:http://europepmc.org/abstract/MED/18941114|Name:PubMed, SrcID:15102696, URL:http://europepmc.org/abstract/MED/15102696",,CHEMBL2058,MS4A1
4209,CHEMBL2109390,Mab-425,Antibody,,,,,Epidermal growth factor receptor erbB1 inhibitor,,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:9191875, URL:http://europepmc.org/abstract/MED/9191875",,CHEMBL203,EGFR
4210,CHEMBL2109584,F16sip,Antibody,,,,,Tenascin binding agent,To be used radiolabelled for radioimaging or radioimmunotherapeutic applications.,,CHEMBL3712856,Tenascin,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,A1 domain of tenascin-C.,"Name:PubMed, SrcID:23334725, URL:http://europepmc.org/abstract/MED/23334725|Name:Other, SrcID:https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=689747, URL:https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=689747",,CHEMBL3712856,TNC
4211,CHEMBL3301593,Decoglurant,Small molecule,,,,-glurant,Metabotropic glutamate receptor 2 modulator,Negative allosteric modulator (NAM). Removed from development pipeline January 2015 (http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm),,CHEMBL5137,Metabotropic glutamate receptor 2,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Decoglurant, URL:http://en.wikipedia.org/wiki/Decoglurant",Nc1ccc(cn1)C#Cc2cnn3c(cc(nc23)c4ccc(cc4)C(F)(F)F)C(F)(F)F,CHEMBL5137,GRM2
4212,CHEMBL384304,Rg-547,Small molecule,,,,,Cyclin-dependent kinase 4 inhibitor,,,CHEMBL331,Cyclin-dependent kinase 4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,,COc1ccc(F)c(F)c1C(=O)c2cnc(NC3CCN(CC3)S(=O)(=O)C)nc2N,CHEMBL331,CDK4
4213,CHEMBL1200490,Cetrorelix,Protein,2000.0,H01CC02,"H01CC02 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: HYPOTHALAMIC HORMONES: Anti-gonadotropin-releasing hormones]",-relix,Gonadotropin-releasing hormone receptor antagonist,,,CHEMBL1855,Gonadotropin-releasing hormone receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=aca7768e-28a7-4027-b1d8-e66247665f79#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aca7768e-28a7-4027-b1d8-e66247665f79#nlm34090-1",CC(C)C[C@H](NC(=O)[C@@H](CCCNC(=O)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc2cccnc2)NC(=O)[C@@H](Cc3ccc(Cl)cc3)NC(=O)[C@@H](Cc4ccc5ccccc5c4)NC(=O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N6CCC[C@H]6C(=O)N[C@H](C)C(=O)N,CHEMBL1855,GNRHR
4214,CHEMBL642,Acebutolol,Small molecule,1984.0,C07AB04,"C07AB04 [CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, selective]",-olol,Beta-1 adrenergic receptor antagonist,,,CHEMBL213,Beta-1 adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=6bfb00a0-c057-4dfb-9ae3-e5b7d782cd24, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6bfb00a0-c057-4dfb-9ae3-e5b7d782cd24",CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(c1)C(=O)C,,
4215,CHEMBL289469,Granisetron,Small molecule,1993.0,A04AA02,A04AA02 [ALIMENTARY TRACT AND METABOLISM: ANTIEMETICS AND ANTINAUSEANTS: ANTIEMETICS AND ANTINAUSEANTS: Serotonin (5HT3) antagonists],-setron,Serotonin 3a (5-HT3a) receptor antagonist,,,CHEMBL1899,Serotonin 3a (5-HT3a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=dddc8714-383f-4bc5-a468-ae89dbc802b4, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dddc8714-383f-4bc5-a468-ae89dbc802b4",CN1C2CCCC1CC(C2)NC(=O)c3nn(C)c4ccccc34,CHEMBL1899,HTR3A
4216,CHEMBL11,Imipramine,Small molecule,1959.0,N06AA02,N06AA02 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Non-selective monoamine reuptake inhibitors],-pramine,Serotonin transporter inhibitor,,,CHEMBL228,Serotonin transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11357798, URL:http://europepmc.org/abstract/MED/11357798",CN(C)CCCN1c2ccccc2CCc3ccccc13,CHEMBL228,SLC6A4
4217,CHEMBL1201173,Medrysone,Small molecule,1969.0,S01BA08,"S01BA08 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Corticosteroids, plain]",,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:6336597, URL:http://europepmc.org/abstract/MED/6336597",C[C@H]1C[C@H]2[C@@H]3CC[C@H](C(=O)C)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]4(C)CCC(=O)C=C14,CHEMBL2034,NR3C1
4218,CHEMBL1451,Triamcinolone,Small molecule,1957.0,D07AB09; R01AD11; H02AB08; A01AC01; C05AA12; D07XB02; S01BA05; R03BA06,"D07AB09 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, moderately potent (group II)]; R01AD11 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Corticosteroids]; H02AB08 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Glucocorticoids]; A01AC01 [ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Corticosteroids for local oral treatment]; C05AA12 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Corticosteroids]; D07XB02 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, OTHER COMBINATIONS: Corticosteroids, moderately potent, other combinations]; S01BA05 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Corticosteroids, plain]; R03BA06 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS: Glucocorticoids]",-olone,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15976447, URL:http://europepmc.org/abstract/MED/15976447|Name:PubMed, SrcID:16507850, URL:http://europepmc.org/abstract/MED/16507850|Name:PubMed, SrcID:19744340, URL:http://europepmc.org/abstract/MED/19744340",C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO,CHEMBL2034,NR3C1
4219,CHEMBL1152,Prednisolone Acetate,Small molecule,1955.0,D07XA02; S01BA04; A07EA01; D07AA03; S01CB02; S02BA03; C05AA04; H02AB06; S03BA02; R01AD02,"D07XA02 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, OTHER COMBINATIONS: Corticosteroids, weak, other combinations]; S01BA04 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Corticosteroids, plain]; A07EA01 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Corticosteroids acting locally]; D07AA03 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, weak (group I)]; S01CB02 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION: Corticosteroids/antiinfectives/mydriatics in combination]; S02BA03 [SENSORY ORGANS: OTOLOGICALS: CORTICOSTEROIDS: Corticosteroids]; C05AA04 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Corticosteroids]; H02AB06 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Glucocorticoids]; S03BA02 [SENSORY ORGANS: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS: CORTICOSTEROIDS: Corticosteroids]; R01AD02 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Corticosteroids]",pred-,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=92ae1de4-6b27-4f03-acb5-7170664f67cb#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=92ae1de4-6b27-4f03-acb5-7170664f67cb#nlm34090-1|Name:FDA, SrcID:label/2007/017469s040lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/017469s040lbl.pdf",CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C,CHEMBL2034,NR3C1
4220,CHEMBL308954,Etravirine,Small molecule,2008.0,J05AG04,J05AG04 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Non-nucleoside reverse transcriptase inhibitors],-virine,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,,,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,INHIBITOR,Human immunodeficiency virus 1,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=6a9cbc29-9f15-4b24-8d86-206b82887f3d, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6a9cbc29-9f15-4b24-8d86-206b82887f3d",Cc1cc(cc(C)c1Oc2nc(Nc3ccc(cc3)C#N)nc(N)c2Br)C#N,,
4221,CHEMBL294199,Capsaicin,Small molecule,2009.0,N01BX04; M02AB01,"N01BX04 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Other local anesthetics]; M02AB01 [MUSCULO-SKELETAL SYSTEM: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: Capsaicin and similar agents]",,Vanilloid receptor opener,,,CHEMBL4794,Vanilloid receptor,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Capsaicin#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Capsaicin#Mechanism_of_action|Name:FDA, SrcID:label/2009/022395lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022395lbl.pdf",COc1cc(CNC(=O)CCCC\C=C\C(C)C)ccc1O,CHEMBL4794,TRPV1
4222,CHEMBL1200934,Norgestimate,Small molecule,1989.0,,,-gest-,Progesterone receptor agonist,,,CHEMBL208,Progesterone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=222f0530-c4b7-47ec-99c9-4ff81eabf485#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=222f0530-c4b7-47ec-99c9-4ff81eabf485#nlm34090-1",CC[C@]12CC[C@H]3[C@@H](CCC4=C\C(=N\O)\CC[C@H]34)[C@@H]1CC[C@@]2(OC(=O)C)C#C,CHEMBL208,PGR
4223,CHEMBL1496,Rosuvastatin,Small molecule,2003.0,C10AA07,"C10AA07 [CARDIOVASCULAR SYSTEM: LIPID MODIFYING AGENTS: LIPID MODIFYING AGENTS, PLAIN: HMG CoA reductase inhibitors]",-stat-,HMG-CoA reductase inhibitor,,,CHEMBL402,HMG-CoA reductase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=e498b80d-7177-4f9d-8471-2e8f913196af, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e498b80d-7177-4f9d-8471-2e8f913196af",CC(C)c1nc(nc(c2ccc(F)cc2)c1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(=O)(=O)C,CHEMBL402,HMGCR
4224,CHEMBL982,Nalmefene,Small molecule,1995.0,N07BB05,N07BB05 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: DRUGS USED IN ADDICTIVE DISORDERS: Drugs used in alcohol dependence],nal-,Opioid receptors; mu/kappa/delta antagonist,,,CHEMBL2095181,Opioid receptors; mu/kappa/delta,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2006/020459s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020459s006lbl.pdf",Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=C)CC[C@@]36O,,
4225,CHEMBL866,Mycophenolic Acid,Small molecule,2004.0,L04AA06,L04AA06 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Selective immunosuppressants],,Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor,,,CHEMBL2111369,Inosine-5'-monophosphate dehydrogenase (IMPDH),INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=eed26501-890d-4ff6-88e7-6dbea4726e53, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eed26501-890d-4ff6-88e7-6dbea4726e53",COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)\CCC(=O)O,,
4226,CHEMBL1201550,Denileukin Diftitox,Protein,1999.0,L01XX29,L01XX29 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-kin,Interleukin-2 receptor binding agent,targets toxin to cell,,CHEMBL2364167,Interleukin-2 receptor,BINDING AGENT,Homo sapiens,PROTEIN COMPLEX,Interleukin-2 alpha/beta subunit,Binding site involves alpha and beta subunits,"Name:DailyMed, SrcID:setid=42dfffb1-d0f3-42d5-944c-64f092fc436e#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=42dfffb1-d0f3-42d5-944c-64f092fc436e#nlm34090-1|Name:FDA, SrcID:label/2011/103767s5119lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/103767s5119lbl.pdf|Name:PubMed, SrcID:17187516, URL:http://europepmc.org/abstract/MED/17187516",,CHEMBL2364167,IL2RG
4227,CHEMBL1201563,Interferon Beta-1b,Protein,1993.0,L03AB08,L03AB08 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSTIMULANTS: IMMUNOSTIMULANTS: Interferons],,Interferon alpha/beta receptor agonist,,,CHEMBL2364170,Interferon alpha/beta receptor,AGONIST,Homo sapiens,PROTEIN COMPLEX,,Alpha subunit is binding site,"Name:PubMed, SrcID:10049744, URL:http://europepmc.org/abstract/MED/10049744|Name:DailyMed, SrcID:setid=4cfdb571-ec4c-478f-bedc-e0669eeea504, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4cfdb571-ec4c-478f-bedc-e0669eeea504",,CHEMBL2364170,IFNAR2
4228,CHEMBL1488,Uracil Mustard,Small molecule,1962.0,,,-racil,DNA inhibitor,Alkylating agent,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:ISBN, SrcID:9780702034718 PP. 615, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:FDA, SrcID:label/1999/012892Orig1s015s016lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/1999/012892Orig1s015s016lbl.pdf",ClCCN(CCCl)C1=CNC(=O)NC1=O,,
4229,CHEMBL1096885,Valrubicin,Small molecule,1998.0,L01DB09,L01DB09 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES: Anthracyclines and related substances],-rubicin,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:Wikipedia, SrcID:Type_II_topoisomerase, URL:http://en.wikipedia.org/wiki/Type_II_topoisomerase|Name:DailyMed, SrcID:setid=e96f30a0-6662-11de-8f80-0002a5d5c51b, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e96f30a0-6662-11de-8f80-0002a5d5c51b",CCCCC(=O)OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)c3c(O)c4C(=O)c5c(OC)cccc5C(=O)c4c(O)c3C1,,
4230,CHEMBL850,Sparfloxacin,Small molecule,1996.0,J01MA09,J01MA09 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolones],-oxacin,Bacterial DNA gyrase inhibitor,,,CHEMBL2311224,Bacterial DNA gyrase,INHIBITOR,Bacteria,PROTEIN COMPLEX,,,"Name:FDA, SrcID:label/2003/020677s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/020677s006lbl.pdf",C[C@@H]1CN(C[C@H](C)N1)c2c(F)c(N)c3C(=O)C(=CN(C4CC4)c3c2F)C(=O)O,,
4231,CHEMBL1256,Isoflurane,Small molecule,1979.0,N01AB06,"N01AB06 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,Potassium channel subfamily K member 18 opener,,,CHEMBL2331042,Potassium channel subfamily K member 18,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:11605899, URL:http://europepmc.org/abstract/MED/11605899|Name:PubMed, SrcID:17227289, URL:http://europepmc.org/abstract/MED/17227289",FC(F)OC(Cl)C(F)(F)F,CHEMBL2331042,KCNK18
4232,CHEMBL1303,Rotigotine,Small molecule,2007.0,N04BC09,N04BC09 [NERVOUS SYSTEM: ANTI-PARKINSON DRUGS: DOPAMINERGIC AGENTS: Dopamine agonists],,D2-like dopamine receptor agonist,,,CHEMBL2331075,D2-like dopamine receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2012/021829s001lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021829s001lbl.pdf",CCCN(CCc1cccs1)[C@H]2CCc3c(O)cccc3C2,,
4233,CHEMBL422,Trifluoperazine,Small molecule,1959.0,N05AB06,N05AB06 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Phenothiazines with piperazine structure],,D2-like dopamine receptor antagonist,,,CHEMBL2331075,D2-like dopamine receptor,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:Wikipedia, SrcID:Trifluoperazine, URL:http://en.wikipedia.org/wiki/Trifluoperazine|Name:ISBN, SrcID:0443-059748 PP. 544, URL:http://www.isbnsearch.org/isbn/0443059748",CN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1,,
4234,CHEMBL1201482,Protease,Enzyme,1996.0,A09AA02,"A09AA02 [ALIMENTARY TRACT AND METABOLISM: DIGESTIVES, INCL. ENZYMES: DIGESTIVES, INCL. ENZYMES: Enzyme preparations]",-ase,Polypeptides hydrolytic enzyme,,,CHEMBL2364181,Polypeptides,HYDROLYTIC ENZYME,Homo sapiens,MACROMOLECULE,,,"Name:DailyMed, SrcID:setid=073201aa-556d-4a70-918e-84e9616fd88d#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=073201aa-556d-4a70-918e-84e9616fd88d#nlm34090-1",,,
4235,CHEMBL1201256,Trimethobenzamide,Small molecule,1974.0,R06AA10,R06AA10 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Aminoalkyl ethers],,Unknown,,,,,,,,,,"Name:FDA, SrcID:label/2008/017530s024lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/017530s024lbl.pdf",COc1cc(cc(OC)c1OC)C(=O)NCc2ccc(OCCN(C)C)cc2,,
4236,CHEMBL1259059,Sofosbuvir,Small molecule,2013.0,J05AX15,J05AX15 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Other antivirals],-vir,Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor,,,CHEMBL5375,Hepatitis C virus NS5B RNA-dependent RNA polymerase,INHIBITOR,Hepatitis C virus,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2013/204671s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204671s000lbl.pdf",CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(F)[C@@H]1O)Oc3ccccc3,,
4237,CHEMBL46740,Bazedoxifene,Small molecule,2009.0,G03XC02,G03XC02 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: Selective estrogen receptor modulators],-ifene,Estrogen receptor modulator,"Bazedoxifene profile is antagonistic in breast and endometrial tissue, while an estrogen agonist in bone tissue; Bazedoxifene in combination with conjugated estrogens is the first approved tissue-selective estrogen receptor complex (TSEC)",,CHEMBL2093866,Estrogen receptor,MODULATOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:24373794, URL:http://europepmc.org/abstract/MED/24373794|Name:FDA, SrcID:label/2013/022247Orig1s001lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022247Orig1s001lbl.pdf",Cc1c(c2ccc(O)cc2)n(Cc3ccc(OCCN4CCCCCC4)cc3)c5ccc(O)cc15,,
4238,CHEMBL262777,Vancomycin,Small molecule,1964.0,A07AA09; J01XA01,"A07AA09 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFECTIVES: Antibiotics]; J01XA01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER ANTIBACTERIALS: Glycopeptide antibacterials]",-mycin,Peptidoglycan inhibitor,,,CHEMBL3041361,Peptidoglycan,INHIBITOR,Bacteria,MACROMOLECULE,,,"Name:ISBN, SrcID:9780702034718 PP. 612, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:FDA, SrcID:label/2011/050606s028lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/050606s028lbl.pdf|Name:PubMed, SrcID:14982757, URL:http://europepmc.org/abstract/MED/14982757",CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)c2ccc(Oc3cc4cc(Oc5ccc(cc5Cl)[C@@H](O)[C@@H]6NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H](CC(=O)N)NC1=O)c7ccc(O)c(c7)c8c(O)cc(O)cc8[C@H](NC6=O)C(=O)O)c3O[C@@H]9O[C@H](CO)[C@@H](O)[C@H](O)[C@H]9O[C@H]%10C[C@](C)(N)[C@H](O)[C@H](C)O%10)c(Cl)c2,,
4239,CHEMBL3301669,Dalbavancin,Unknown,2014.0,J01XA04,J01XA04 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER ANTIBACTERIALS: Glycopeptide antibacterials],,Peptidoglycan inhibitor,,,CHEMBL3041361,Peptidoglycan,INHIBITOR,Bacteria,MACROMOLECULE,,,"Name:FDA, SrcID:label/2014/021883s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021883s000lbl.pdf",CN[C@H]1C(=O)N[C@@H]2Cc3ccc(Oc4cc5cc(Oc6ccc(cc6Cl)[C@@H](O)[C@@H]7NC(=O)[C@H](NC(=O)[C@@H]5NC(=O)[C@@H](NC2=O)c8cc(Oc9cc1ccc9O)cc(O)c8Cl)c%10ccc(O)c(c%10)c%11c(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]%12O)cc(O)cc%11[C@H](NC7=O)C(=O)NCCCN(C)C)c4O[C@@H]%13O[C@@H]([C@@H](O)[C@H](O)[C@H]%13NC(=O)CCCCCCCCC(C)C)C(=O)O)cc3,,
4240,CHEMBL206253,Netupitant,Small molecule,2014.0,,,-tant,Neurokinin 1 receptor antagonist,,,CHEMBL249,Neurokinin 1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2014/205718s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205718s000lbl.pdf",CN(C(=O)C(C)(C)c1cc(cc(c1)C(F)(F)F)C(F)(F)F)c2cnc(cc2c3ccccc3C)N4CCN(C)CC4,CHEMBL249,TACR1
4241,CHEMBL1289601,Lenvatinib,Small molecule,2015.0,L01XE29,L01XE29 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Vascular endothelial growth factor receptor inhibitor,,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=f4bedd21-efde-44c6-9d9c-b48b78d7ed1e, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f4bedd21-efde-44c6-9d9c-b48b78d7ed1e",COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(=O)N,,
4242,CHEMBL1743047,Necitumumab,Antibody,2015.0,L01XC22,L01XC22 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,Epidermal growth factor receptor erbB1 inhibitor,,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=89bcf553-669a-40b0-a9d7-67a5c1d2f591, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89bcf553-669a-40b0-a9d7-67a5c1d2f591",,CHEMBL203,EGFR
4243,CHEMBL52885,Enmd-981693,Small molecule,,,,,Platelet-derived growth factor receptor inhibitor,,,CHEMBL2095189,Platelet-derived growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:Other, SrcID:http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf, URL:http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf",Cn1cc(C2=C(C(=O)NC2=O)c3cn(C)c4cc(ccc34)[N+](=O)[O-])c5ccccc15,,
4244,CHEMBL3545245,Bay-1082439,Small molecule,,,,,PI3-kinase p110-alpha subunit inhibitor,,,CHEMBL4005,PI3-kinase p110-alpha subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.pharmatest.com/files/5613/9844/3444/Suominen_BAY_1082439.pdf, URL:http://www.pharmatest.com/files/5613/9844/3444/Suominen_BAY_1082439.pdf",,CHEMBL4005,PIK3CA
4245,CHEMBL150894,Cep-5214,Small molecule,,,,,Vascular endothelial growth factor receptor inhibitor,Its Prodrug Clinical Candidate is CEP-7055,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:14640546, URL:http://europepmc.org/abstract/MED/14640546",CC(C)OCc1ccc2c(c1)c3c4CNC(=O)c4c5c(Cc6ccccc56)c3n2CCCO,,
4246,CHEMBL3545052,Cudc-907,Small molecule,,,,,PI3-kinase p110-delta subunit inhibitor,Inhibits mainly class I and IIb HDACS (PMID:22693356),,CHEMBL3130,PI3-kinase p110-delta subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22693356, URL:http://europepmc.org/abstract/MED/22693356|Name:Other, SrcID:http://www.curis.com/pipeline/cudc-907, URL:http://www.curis.com/pipeline/cudc-907",,CHEMBL3130,PIK3CD
4247,CHEMBL3545079,Plx-5622,Small molecule,,,,,Macrophage colony stimulating factor receptor inhibitor,,,CHEMBL1844,Macrophage colony stimulating factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26232154, URL:http://europepmc.org/abstract/MED/26232154|Name:PubMed, SrcID:22294205, URL:http://europepmc.org/abstract/MED/22294205",,CHEMBL1844,CSF1R
4248,CHEMBL3707353,Rg7893,Small molecule,,,,,Sodium channel protein type IX alpha subunit blocker,"Reversible sodium channel blocker that is selective for Nav1.7, which is expressed primarily on peripheral nociceptor C-fiber neurons and is required for pain sensing in humans.",,CHEMBL4296,Sodium channel protein type IX alpha subunit,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.xenon-pharma.com/product-candidates/pain/pain-genentech/, URL:http://www.xenon-pharma.com/product-candidates/pain/pain-genentech/|Name:Other, SrcID:http://www.roche.com/de/research_and_development/who_we_are_how_we_work/pipeline.htm, URL:http://www.roche.com/de/research_and_development/who_we_are_how_we_work/pipeline.htm",,CHEMBL4296,SCN9A
4249,CHEMBL3545394,Drf-10945,Small molecule,,,,,Peroxisome proliferator-activated receptor alpha agonist,"Report about Ph2 trial in Canada 2007, no trial ID or references found. Compound may have been discontinued.",,CHEMBL239,Peroxisome proliferator-activated receptor alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://adisinsight.springer.com/drugs/800020522, URL:http://adisinsight.springer.com/drugs/800020522",,CHEMBL239,PPARA
4250,CHEMBL2103824,Arhalofenate,Small molecule,,,,,Solute carrier family 22 member 12 inhibitor,"Selective PPAR gamma modulator (SPPAR?M), SLC22A12 inhibitor",,CHEMBL6120,Solute carrier family 22 member 12,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.cymabay.com/pipeline_arhalofenate.html, URL:http://www.cymabay.com/pipeline_arhalofenate.html|Name:PubMed, SrcID:15588299, URL:http://europepmc.org/abstract/MED/15588299",CC(=O)NCCOC(=O)[C@H](Oc1cccc(c1)C(F)(F)F)c2ccc(Cl)cc2,CHEMBL6120,SLC22A12
4251,CHEMBL2103842,Varlitinib,Small molecule,,,,-tinib,Epidermal growth factor receptor erbB1 inhibitor,Also ERBB4 inhibitor,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://arraybiopharma.com/files/8813/9810/8032/PubAttachment460.pdf, URL:http://arraybiopharma.com/files/8813/9810/8032/PubAttachment460.pdf|Name:Other, SrcID:http://www.arraybiopharma.com/product-pipeline/other-compounds/aslan001-arry-543/, URL:http://www.arraybiopharma.com/product-pipeline/other-compounds/aslan001-arry-543/",C[C@@H]1COC(=N1)Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2,CHEMBL203,EGFR
4252,CHEMBL2079588,Telatinib,Small molecule,,,,-tinib,Stem cell growth factor receptor inhibitor,,,CHEMBL1936,Stem cell growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19002179, URL:http://europepmc.org/abstract/MED/19002179|Name:PubMed, SrcID:19636022, URL:http://europepmc.org/abstract/MED/19636022",CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c4ccoc24)ccn1,CHEMBL1936,KIT
4253,CHEMBL3544944,Bms-863233,Small molecule,,,,,Cell division cycle 7-related protein kinase inhibitor,,,CHEMBL5443,Cell division cycle 7-related protein kinase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22560567, URL:http://europepmc.org/abstract/MED/22560567",Clc1ccc2oc3C(=O)NC(=Nc3c2c1)C4CCCN4,CHEMBL5443,CDC7
4254,CHEMBL3137331,Defactinib,Small molecule,,,,-tinib,Protein tyrosine kinase 2 beta inhibitor,,,CHEMBL5469,Protein tyrosine kinase 2 beta,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.ecmcnetwork.org.uk/sites/default/files/Verastem%20CRUK%20VS6063%2011_12_14.pdf, URL:http://www.ecmcnetwork.org.uk/sites/default/files/Verastem%20CRUK%20VS6063%2011_12_14.pdf|Name:PubMed, SrcID:25971297, URL:http://europepmc.org/abstract/MED/25971297|Name:PubMed, SrcID:26334219, URL:http://europepmc.org/abstract/MED/26334219",CNC(=O)c1ccc(Nc2ncc(c(NCc3nccnc3N(C)S(=O)(=O)C)n2)C(F)(F)F)cc1,CHEMBL5469,PTK2B
4255,CHEMBL2364619,Methylsamidorphan,Small molecule,,,,-orphan,Mu opioid receptor antagonist,"Peripherally-restricted opioid receptor antagonist, affinity for OPRM1, OPRK1, OPRD1. Efficasy target OPRM1, no selectivity infomration found.",,CHEMBL233,Mu opioid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22056608, URL:http://europepmc.org/abstract/MED/22056608|Name:Other, SrcID:http://investor.alkermes.com/phoenix.zhtml?c=92211&p=irol-newsArticle&ID=1227200, URL:http://investor.alkermes.com/phoenix.zhtml?c=92211&p=irol-newsArticle&ID=1227200",C[N@+]1(CC2CC2)CC[C@]34CC(=O)CC[C@@]3(O)[C@H]1Cc5ccc(C(=O)N)c(O)c45,CHEMBL233,OPRM1
4256,CHEMBL1950553,Sonedenoson,Small molecule,,,,-denoson,Adenosine A2a receptor agonist,,,CHEMBL251,Adenosine A2a receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16654164, URL:http://www.ncbi.nlm.nih.gov/pubmed/?term=16654164",Nc1nc(OCCc2ccc(Cl)cc2)nc3c1ncn3[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O,CHEMBL251,ADORA2A
4257,CHEMBL3137316,Fosdagrocorat,Small molecule,,,,-corat; fos-,Glucocorticoid receptor modulator,pro-drug of PF-00251802. Indication: Rheumatoid Arthritis,,CHEMBL2034,Glucocorticoid receptor,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://ard.bmj.com/content/74/Suppl_2/737.3, URL:http://ard.bmj.com/content/74/Suppl_2/737.3|Name:Other, SrcID:http://www.abstracts2view.com/eular/view.php?nu=EULAR10L_THU0216, URL:http://www.abstracts2view.com/eular/view.php?nu=EULAR10L_THU0216",Cc1ncccc1NC(=O)c2ccc3c(CC[C@@H]4C[C@@](CC[C@@]34Cc5ccccc5)(OP(=O)(O)O)C(F)(F)F)c2,CHEMBL2034,NR3C1
4258,CHEMBL3137307,Pefcalcitol,Small molecule,,,,-calci-,Vitamin D receptor agonist,vitamin D3 analogue,,CHEMBL1977,Vitamin D receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://clinicaltrials.gov/ct2/show/NCT01989429, URL:http://clinicaltrials.gov/ct2/show/NCT01989429|Name:Other, SrcID:http://www.maruho.co.jp/english/aboutmaruho/activities/randd/pipeline.html, URL:http://www.maruho.co.jp/english/aboutmaruho/activities/randd/pipeline.html",C[C@H](OCC(=O)NCC(F)(F)C(F)(F)F)C1=CC[C@H]2\C(=C\C=C\3/C[C@@H](O)C[C@H](O)C3=C)\CCC[C@]12C,CHEMBL1977,VDR
4259,CHEMBL2103840,Dinaciclib,Small molecule,,,,-ciclib,Cyclin-dependent kinase 2 inhibitor,,,CHEMBL301,Cyclin-dependent kinase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25215591, URL:http://europepmc.org/abstract/MED/25215591",CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(nc12)N4CCCC[C@H]4CCO,CHEMBL301,CDK2
4260,CHEMBL191413,Reparixin,Small molecule,,,,-rixin,Interleukin-8 receptor B modulator,,,CHEMBL2434,Interleukin-8 receptor B,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15302676, URL:http://europepmc.org/abstract/MED/15302676|Name:PubMed, SrcID:15282370, URL:http://europepmc.org/abstract/MED/15282370",CC(C)Cc1ccc(cc1)[C@@H](C)C(=O)NS(=O)(=O)C,CHEMBL2434,CXCR2
4261,CHEMBL240624,Preladenant,Small molecule,,,,-denant,Adenosine A2a receptor antagonist,Discontinued no more effective than placebo.,,CHEMBL251,Adenosine A2a receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Preladenant, URL:http://en.wikipedia.org/wiki/Preladenant|Name:PubMed, SrcID:17236762, URL:http://europepmc.org/abstract/MED/17236762|Name:PubMed, SrcID:19332567, URL:http://europepmc.org/abstract/MED/19332567",COCCOc1ccc(cc1)N2CCN(CCn3ncc4c3nc(N)n5nc(nc45)c6occc6)CC2,CHEMBL251,ADORA2A
4262,CHEMBL2108358,Serelaxin,Protein,,C01DX21,C01DX21 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: VASODILATORS USED IN CARDIAC DISEASES: Other vasodilators used in cardiac diseases],,Relaxin receptor 2 activator,"Peptide, recombinant human relaxin-2. EMA and FDA regulators have rejected marketing authorisation.",,CHEMBL1628482,Relaxin receptor 2,ACTIVATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23141816, URL:http://europepmc.org/abstract/MED/23141816|Name:Other, SrcID:http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002817/WC500171911.pdf, URL:http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002817/WC500171911.pdf|Name:Other, SrcID:http://assets.escardio.org/assets/Presentations/OTHER2013/Davos/Day%203/17-Serelaxin.pdf, URL:http://assets.escardio.org/assets/Presentations/OTHER2013/Davos/Day%203/17-Serelaxin.pdf",,CHEMBL1628482,RXFP2
4263,CHEMBL2107874,Romosozumab,Antibody,,,,-mab,Sclerostin inhibitor,"Inhibits the protein sclerostin, and has a dual effect on bone, both increasing bone formation and decreasing bone breakdown.",,CHEMBL3580487,Sclerostin,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22031665, URL:http://europepmc.org/abstract/MED/22031665",,CHEMBL3580487,SOST
4264,CHEMBL2108718,Semuloparin Sodium,Oligosaccharide,,,,-parin,Antithrombin-III inhibitor,Indireclyt inhibits factor Xa (FXa) via binding to Antithrombin III.,,CHEMBL1950,Antithrombin-III,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21045018, URL:http://europepmc.org/abstract/MED/21045018",,CHEMBL1950,SERPINC1
4265,CHEMBL3304485,Tenapanor,Small molecule,,,,-napanor,Sodium/hydrogen exchanger 3 inhibitor,"Acts locally in the gut, where it reduces absorption of sodium and phosphate.",,CHEMBL3273,Sodium/hydrogen exchanger 3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:27654985, URL:http://europepmc.org/abstract/MED/27654985",CN1C[C@@H](c2cccc(c2)S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)c3cccc(c3)[C@@H]4CN(C)Cc5c(Cl)cc(Cl)cc45)c6cc(Cl)cc(Cl)c6C1,CHEMBL3273,SLC9A3
4266,CHEMBL3545369,Epacadostat,Small molecule,,,,-stat,"Indoleamine 2,3-dioxygenase inhibitor",,,CHEMBL4685,"Indoleamine 2,3-dioxygenase",INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:27192116, URL:http://europepmc.org/abstract/MED/27192116",NS(=O)(=O)NCCNc1nonc1\C(=N\O)\Nc2ccc(F)c(Br)c2,CHEMBL4685,IDO1
4267,CHEMBL68117,Vosaroxin,Small molecule,,L01XX53,L01XX53 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-oxin,DNA inhibitor,"First-in-class topoisomerase II poison and inhibitor that intercalates DNA and induces site-selective DNA DSB, G2 arrest, and apoptosis",,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:PubMed, SrcID:20419121, URL:http://europepmc.org/abstract/MED/20419121",CN[C@H]1CN(C[C@@H]1OC)c2ccc3C(=O)C(=CN(c4nccs4)c3n2)C(=O)O,,
4268,CHEMBL2107313,Becatecarin,Small molecule,,,,-tecarin,DNA topoisomerase II inhibitor,,,CHEMBL2094255,DNA topoisomerase II,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19132374, URL:http://europepmc.org/abstract/MED/19132374|Name:PubMed, SrcID:22425925, URL:http://europepmc.org/abstract/MED/22425925",CCN(CC)CCN1C(=O)c2c(C1=O)c3c4cccc(Cl)c4n([C@@H]5O[C@H](CO)[C@@H](OC)[C@H](O)[C@H]5O)c3c6[nH]c7c(Cl)cccc7c26,,
4269,CHEMBL1743022,Fresolimumab,Antibody,,,,-mab,Transforming growth factor beta-1 inhibitor,,,CHEMBL1795178,Transforming growth factor beta-1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21368745, URL:http://europepmc.org/abstract/MED/21368745",,,
4270,CHEMBL2108051,Stamulumab,Antibody,,,,-mab,Growth/differentiation factor 8 inhibitor,,,CHEMBL3407325,Growth/differentiation factor 8,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18335515, URL:http://europepmc.org/abstract/MED/18335515",,CHEMBL3407325,MSTN
4271,CHEMBL2109343,Pro-140,Antibody,,,,,C-C chemokine receptor type 5 antagonist,Viral-entry inhibitor.,,CHEMBL274,C-C chemokine receptor type 5,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18771406, URL:http://europepmc.org/abstract/MED/18771406",,CHEMBL274,CCR5
4272,CHEMBL384304,Rg-547,Small molecule,,,,,Cyclin-dependent kinase 2 inhibitor,,,CHEMBL301,Cyclin-dependent kinase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,,COc1ccc(F)c(F)c1C(=O)c2cnc(NC3CCN(CC3)S(=O)(=O)C)nc2N,CHEMBL301,CDK2
4273,CHEMBL1743064,Robatumumab,Antibody,,,,-mab,Insulin-like growth factor I receptor antagonist,,,CHEMBL1957,Insulin-like growth factor I receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,,,CHEMBL1957,IGF1R
4274,CHEMBL1046,Aminocaproic Acid,Small molecule,1964.0,B02AA01,B02AA01 [BLOOD AND BLOOD FORMING ORGANS: ANTIHEMORRHAGICS: ANTIFIBRINOLYTICS: Amino acids],,Plasminogen inhibitor,,,CHEMBL1801,Plasminogen,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=2238c70f-b0b5-4755-896b-45b28777b217#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2238c70f-b0b5-4755-896b-45b28777b217#nlm34090-1",NCCCCCC(=O)O,CHEMBL1801,PLG
4275,CHEMBL1643,Ribavirin,Small molecule,1985.0,J05AB04,J05AB04 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleosides and nucleotides excl. reverse transcriptase inhibitors],-vir-,Inosine-5'-monophosphate dehydrogenase 1 inhibitor,,,CHEMBL1822,Inosine-5'-monophosphate dehydrogenase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Ribavirin#Mechanisms_of_action, URL:http://en.wikipedia.org/wiki/Ribavirin#Mechanisms_of_action|Name:PubMed, SrcID:16107837, URL:http://europepmc.org/abstract/MED/16107837",NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O,,
4276,CHEMBL770,Tolazoline,Small molecule,1985.0,C04AB02; M02AX02,C04AB02 [CARDIOVASCULAR SYSTEM: PERIPHERAL VASODILATORS: PERIPHERAL VASODILATORS: Imidazoline derivatives]; M02AX02 [MUSCULO-SKELETAL SYSTEM: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: Other topical products for joint and muscular pain],-azoline,Histamine H1 receptor agonist,,,CHEMBL231,Histamine H1 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=0b94baa5-5af2-46e9-8111-519225206a28, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0b94baa5-5af2-46e9-8111-519225206a28|Name:PubMed, SrcID:6386273, URL:http://europepmc.org/abstract/MED/6386273|Name:DailyMed, SrcID:archiveid=232939, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=232939|Name:PubMed, SrcID:8487790, URL:http://europepmc.org/abstract/MED/8487790|Name:ISBN, SrcID:9780702034718 PP. 12, URL:http://www.isbnsearch.org/isbn/9780702034718",C(C1=NCCN1)c2ccccc2,CHEMBL231,HRH1
4277,CHEMBL191,Losartan,Small molecule,1995.0,C09CA01,"C09CA01 [CARDIOVASCULAR SYSTEM: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM: ANGIOTENSIN II ANTAGONISTS, PLAIN: Angiotensin II antagonists, plain]",-sartan,Type-1 angiotensin II receptor antagonist,,,CHEMBL227,Type-1 angiotensin II receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=5ac32c20-169d-475a-fc8a-934f758d6ab0, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ac32c20-169d-475a-fc8a-934f758d6ab0",CCCCc1nc(Cl)c(CO)n1Cc2ccc(cc2)c3ccccc3c4nnn[nH]4,CHEMBL227,AGTR1
4278,CHEMBL1513,Irbesartan,Small molecule,1997.0,C09CA04,"C09CA04 [CARDIOVASCULAR SYSTEM: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM: ANGIOTENSIN II ANTAGONISTS, PLAIN: Angiotensin II antagonists, plain]",-sartan,Type-1 angiotensin II receptor antagonist,,,CHEMBL227,Type-1 angiotensin II receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2016/020757s059s067lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020757s059s067lbl.pdf|Name:DailyMed, SrcID:setid=b7f1a9ef-c7bb-465c-e4d7-a41395205cad, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b7f1a9ef-c7bb-465c-e4d7-a41395205cad",CCCCC1=NC2(CCCC2)C(=O)N1Cc3ccc(cc3)c4ccccc4c5nn[nH]n5,CHEMBL227,AGTR1
4279,CHEMBL408,Troglitazone,Small molecule,1997.0,A10BG01,"A10BG01 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Thiazolidinediones]",-glitazone,Peroxisome proliferator-activated receptor gamma agonist,,,CHEMBL235,Peroxisome proliferator-activated receptor gamma,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Troglitazone, URL:http://en.wikipedia.org/wiki/Troglitazone|Name:PubMed, SrcID:23388479, URL:http://europepmc.org/abstract/MED/23388479",Cc1c(C)c2OC(C)(COc3ccc(CC4SC(=O)NC4=O)cc3)CCc2c(C)c1O,CHEMBL235,PPARG
4280,CHEMBL711,Phenindione,Small molecule,1982.0,B01AA02,B01AA02 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Vitamin K antagonists],,Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor,,,CHEMBL1930,Vitamin k epoxide reductase complex subunit 1 isoform 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22472992, URL:http://europepmc.org/abstract/MED/22472992|Name:PubMed, SrcID:3781349, URL:http://europepmc.org/abstract/MED/3781349",O=C1C(C(=O)c2ccccc12)c3ccccc3,CHEMBL1930,VKORC1
4281,CHEMBL1201610,Corticotropin,Protein,1950.0,H01AA01; H01AA01,"H01AA01 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES: ACTH]; H01AA01 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES: ACTH]",-trop-,Melanocortin receptor 2 agonist,,,CHEMBL1965,Melanocortin receptor 2,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:IUPHAR, SrcID:3633, URL:http://www.iuphar-db.org/DATABASE/LigandDisplayForward?tab=biology&ligandId=3633|Name:FDA, SrcID:label/2015/008372s044lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/008372s044lbl.pdf|Name:DailyMed, SrcID:setid=ae97eb2b-587a-4705-8c55-de0f97ee1f1f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ae97eb2b-587a-4705-8c55-de0f97ee1f1f",,CHEMBL1965,MC2R
4282,CHEMBL1201656,Insulin Susp Isophane Purified Pork,Protein,1979.0,,,,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/022472s006s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022472s006s008lbl.pdf|Name:DailyMed, SrcID:setid=457531f0-9331-47fe-90b5-b31f284044dc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=457531f0-9331-47fe-90b5-b31f284044dc",,CHEMBL1981,INSR
4283,CHEMBL1201837,Ecallantide,Protein,2009.0,B06AC03,B06AC03 [BLOOD AND BLOOD FORMING ORGANS: OTHER HEMATOLOGICAL AGENTS: OTHER HEMATOLOGICAL AGENTS: Drugs used in hereditary angioedema],-tide,Plasma kallikrein inhibitor,,,CHEMBL2000,Plasma kallikrein,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f56aec67-c662-477c-b866-bfc23e8809cf, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f56aec67-c662-477c-b866-bfc23e8809cf",,,
4284,CHEMBL894,Bupropion,Small molecule,1985.0,N06AX12,N06AX12 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants],,Dopamine transporter inhibitor,,,CHEMBL238,Dopamine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=5cb7fd36-ae36-409b-af79-9c432e1cf5d9#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5cb7fd36-ae36-409b-af79-9c432e1cf5d9#nlm34090-1|Name:PubMed, SrcID:19497387, URL:http://europepmc.org/abstract/MED/19497387",CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,CHEMBL238,SLC6A3
4285,CHEMBL1201776,Tapentadol,Small molecule,2008.0,N02AX06,N02AX06 [NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Other opioids],-adol,Mu opioid receptor agonist,,,CHEMBL233,Mu opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=e921054f-b3f1-4624-8edd-f6628c6f0fd9#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e921054f-b3f1-4624-8edd-f6628c6f0fd9#nlm34090-1",CC[C@H]([C@@H](C)CN(C)C)c1cccc(O)c1,CHEMBL233,OPRM1
4286,CHEMBL1200732,Amcinonide,Small molecule,1979.0,D07AC11,"D07AC11 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, potent (group III)]",-onide,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16895953, URL:http://europepmc.org/abstract/MED/16895953",CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]4[C@@H]5CCC6=CC(=O)C=C[C@]6(C)[C@@]5(F)[C@@H](O)C[C@]24C,CHEMBL2034,NR3C1
4287,CHEMBL83,Tamoxifen,Small molecule,1977.0,L02BA01,L02BA01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONE ANTAGONISTS AND RELATED AGENTS: Anti-estrogens],,Estrogen receptor alpha modulator,Mixed agonist/antagonist,,CHEMBL206,Estrogen receptor alpha,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Tamoxifen, URL:http://en.wikipedia.org/wiki/Tamoxifen|Name:PubMed, SrcID:18819158, URL:http://europepmc.org/abstract/MED/18819158|Name:DailyMed, SrcID:setid=407a372d-4448-4d53-afd4-eb0e74bbc336, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=407a372d-4448-4d53-afd4-eb0e74bbc336",CC\C(=C(/c1ccccc1)\c2ccc(OCCN(C)C)cc2)\c3ccccc3,CHEMBL206,ESR1
4288,CHEMBL1201233,Methyldopate,Small molecule,1962.0,,,,Adrenergic receptor alpha-2 agonist,,,CHEMBL2095158,Adrenergic receptor alpha-2,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=f5f25053-a9f3-48b9-a412-078f5ee942fd#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5f25053-a9f3-48b9-a412-078f5ee942fd#nlm34090-1|Name:Wikipedia, SrcID:Methyldopa, URL:http://en.wikipedia.org/wiki/Methyldopa",CCOC(=O)[C@@](C)(N)Cc1ccc(O)c(O)c1,,
4289,CHEMBL571,Ketoprofen,Small molecule,1986.0,M02AA10; M01AE53; M01AE03,"M02AA10 [MUSCULO-SKELETAL SYSTEM: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: Antiinflammatory preparations, non-steroids for topical use]; M01AE53 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Propionic acid derivatives]; M01AE03 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Propionic acid derivatives]",-profen,Cyclooxygenase inhibitor,,,CHEMBL2094253,Cyclooxygenase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Wikipedia, SrcID:Ketoprofen, URL:http://en.wikipedia.org/wiki/Ketoprofen|Name:Wikipedia, SrcID:Nsaid, URL:http://en.wikipedia.org/wiki/Nsaid|Name:PubMed, SrcID:10377455, URL:http://europepmc.org/abstract/MED/10377455",CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2,,
4290,CHEMBL3559672,Rauwolfia Serpentina,Small molecule,1954.0,C02AA03; C02AA04; C02AA53,"C02AA03 [CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ANTIADRENERGIC AGENTS, CENTRALLY ACTING: Rauwolfia alkaloids]; C02AA04 [CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ANTIADRENERGIC AGENTS, CENTRALLY ACTING: Rauwolfia alkaloids]; C02AA53 [CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ANTIADRENERGIC AGENTS, CENTRALLY ACTING: Rauwolfia alkaloids]",,Adrenergic receptor alpha antagonist,,,CHEMBL2095203,Adrenergic receptor alpha,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:7562902, URL:http://europepmc.org/abstract/MED/7562902|Name:ISBN, SrcID:0471-948470 PP. 174, URL:http://www.isbnsearch.org/isbn/0471948470|Name:Wikipedia, SrcID:Ajmalicine, URL:http://en.wikipedia.org/wiki/Ajmalicine",,,
4291,CHEMBL1946170,Regorafenib,Small molecule,2012.0,L01XE21,L01XE21 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-rafenib,Tyrosine-protein kinase receptor RET inhibitor,,,CHEMBL2041,Tyrosine-protein kinase receptor RET,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Expert, SrcID:REGORAFENIB, URL:http://chembl.blogspot.co.uk/search?q=REGORAFENIB",CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,CHEMBL2041,RET
4292,CHEMBL24828,Vandetanib,Small molecule,2011.0,L01XE12,L01XE12 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-anib,Ephrin receptor inhibitor,,,CHEMBL2363043,Ephrin receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13",COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC4CCN(C)CC4,CHEMBL2363043,EPHA10
4293,CHEMBL1200694,Sevoflurane,Small molecule,1995.0,N01AB08,"N01AB08 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,Glycine receptor (alpha-1/beta) positive modulator,alpha1/beta is main adult form,,CHEMBL2363052,Glycine receptor (alpha-1/beta),POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX,Glycine receptor alpha subunit,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:22226507, URL:http://europepmc.org/abstract/MED/22226507|Name:PubMed, SrcID:21788314, URL:http://europepmc.org/abstract/MED/21788314",FCOC(C(F)(F)F)C(F)(F)F,CHEMBL2363052,GLRB
4294,CHEMBL911,Zolpidem,Small molecule,1992.0,N05CF02,N05CF02 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine related drugs],-pidem,GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator,,,CHEMBL2111392,GABA A receptor alpha-1/beta-1/gamma-2,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX,Benzodiazepine binding site,"Not clear if allosteric, but looks like benzodiazepine","Name:FDA, SrcID:label/2010/019908s029lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/019908s029lbl.pdf",CN(C)C(=O)Cc1c(nc2ccc(C)cn12)c3ccc(C)cc3,CHEMBL2111392,GABRG2
4295,CHEMBL911,Zolpidem,Small molecule,1992.0,N05CF02,N05CF02 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine related drugs],-pidem,GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator,,,CHEMBL2111392,GABA A receptor alpha-1/beta-1/gamma-2,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX,Benzodiazepine binding site,"Not clear if allosteric, but looks like benzodiazepine","Name:FDA, SrcID:label/2010/019908s029lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/019908s029lbl.pdf",CN(C)C(=O)Cc1c(nc2ccc(C)cn12)c3ccc(C)cc3,CHEMBL2111392,GABRB1
4296,CHEMBL1443,Nafcillin,Small molecule,1965.0,J01CF06,"J01CF06 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: BETA-LACTAM ANTIBACTERIALS, PENICILLINS: Beta-lactamase resistant penicillins]",-cillin,Penicillin-binding protein inhibitor,,,CHEMBL2362972,Penicillin-binding protein,INHIBITOR,Staphylococcus aureus,PROTEIN FAMILY,,,"Name:PubMed, SrcID:7447421, URL:http://europepmc.org/abstract/MED/7447421",CCOc1ccc2ccccc2c1C(=O)N[C@H]3[C@H]4SC(C)(C)[C@@H](N4C3=O)C(=O)O,,
4297,CHEMBL1572,Netilmicin,Small molecule,1983.0,J01GB07; S01AA23,J01GB07 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: AMINOGLYCOSIDE ANTIBACTERIALS: Other aminoglycosides]; S01AA23 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Antibiotics],-micin,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,16S ribosomal RNA,16s RRNA,"Name:PubMed, SrcID:16891542, URL:http://europepmc.org/abstract/MED/16891542|Name:PubMed, SrcID:6927285, URL:http://europepmc.org/abstract/MED/6927285",CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(=CC[C@H]2N)CN)[C@H](O)[C@H]1O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O,,
4298,CHEMBL1201270,Methenamine,Small molecule,1967.0,J01XX05,J01XX05 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER ANTIBACTERIALS: Other antibacterials],,DNA inhibitor,Causes cross-linking of proteins and nucleic acids (PMID: 9880479).,,CHEMBL2364041,DNA,INHIBITOR,Bacteria,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=7488ad5c-376d-47a2-8c23-47eff94547fb, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7488ad5c-376d-47a2-8c23-47eff94547fb|Name:PubMed, SrcID:10986255, URL:http://europepmc.org/abstract/MED/10986255|Name:PubMed, SrcID:10432583, URL:http://europepmc.org/abstract/MED/10432583",C1N2CN3CN(CN1C3)C2,,
4299,CHEMBL713,Entecavir,Small molecule,2005.0,J05AF10,J05AF10 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleoside and nucleotide reverse transcriptase inhibitors],-vir,DNA polymerase/reverse transcriptase inhibitor,,,CHEMBL2362994,DNA polymerase/reverse transcriptase,INHIBITOR,Hepatitis B virus,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=046e61c9-9298-4b2e-b76e-b26b81fecd20, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=046e61c9-9298-4b2e-b76e-b26b81fecd20",NC1=Nc2c(ncn2[C@H]3C[C@H](O)[C@@H](CO)C3=C)C(=O)N1,,
4300,CHEMBL715,Olanzapine,Small molecule,1996.0,N05AH03,"N05AH03 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Diazepines, oxazepines, thiazepines and oxepines]",-pin(e),D2-like dopamine receptor antagonist,,,CHEMBL2331075,D2-like dopamine receptor,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=4464f13c-b9b9-4464-a05e-5b2cdc091fb2#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4464f13c-b9b9-4464-a05e-5b2cdc091fb2#nlm34090-1|Name:FDA, SrcID:label/2015/020592s064,021086s042,021253s049lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020592s064,021086s042,021253s049lbl.pdf|Name:FDA, SrcID:label/2012/022173s008s010s014lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022173s008s010s014lbl.pdf",CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24,,
4301,CHEMBL931,Halothane,Small molecule,1958.0,N01AB01,"N01AB01 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",,Potassium channel subfamily K member 3 opener,,,CHEMBL2321613,Potassium channel subfamily K member 3,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:11886861, URL:http://europepmc.org/abstract/MED/11886861|Name:PubMed, SrcID:11605899, URL:http://europepmc.org/abstract/MED/11605899|Name:PubMed, SrcID:20519544, URL:http://europepmc.org/abstract/MED/20519544|Name:PubMed, SrcID:17227289, URL:http://europepmc.org/abstract/MED/17227289|Name:PubMed, SrcID:20217349, URL:http://europepmc.org/abstract/MED/20217349",FC(F)(F)C(Cl)Br,CHEMBL2321613,KCNK3
4302,CHEMBL1201822,Galsulfase,Enzyme,2005.0,A16AB08,A16AB08 [ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Enzymes],-ase,Dermatan sulfate hydrolytic enzyme,To replace endogenous lysosomal enzymes required for the catabollism of GAG in case of mucopolysaccharide storage disorders,,CHEMBL2364179,Dermatan sulfate,HYDROLYTIC ENZYME,Homo sapiens,OLIGOSACCHARIDE,,,"Name:DailyMed, SrcID:setid=59341250-deac-ed71-3823-a4f5d64dbd77, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=59341250-deac-ed71-3823-a4f5d64dbd77",,,
4303,CHEMBL1231574,Levomefolic Acid,Small molecule,2010.0,,,-fo-; -fol-,Unknown,,,,,,,,,,"Name:FDA, SrcID:label/2012/022574s004lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022574s004lbl.pdf",CN1[C@@H](CNc2ccc(cc2)C(=O)N[C@@H](CCC(=O)O)C(=O)O)CNC3=C1C(=O)N=C(N)N3,,
4304,CHEMBL46286,Omacetaxine Mepesuccinate,Small molecule,2009.0,L01XX40,L01XX40 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],,Protein synthesis inhibitor,Inhibition of protein synthesis independent of direct BCR-ABL binding,,,,,,,,,"Name:FDA, SrcID:label/2012/203585lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203585lbl.pdf|Name:Expert, SrcID:BOSUTINIB, URL:http://chembl.blogspot.co.uk/search?q=BOSUTINIB|Name:PubMed, SrcID:22289991, URL:http://europepmc.org/abstract/MED/22289991",COC(=O)C[C@](O)(CCCC(C)(C)O)C(=O)O[C@H]1[C@H]2c3cc4OCOc4cc3CCN5CCC[C@]25C=C1OC,,
4305,CHEMBL2103873,Macitentan,Small molecule,2010.0,C02KX04,C02KX04 [CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: OTHER ANTIHYPERTENSIVES: Antihypertensives for pulmonary arterial hypertension],-entan,"Endothelin receptor, ET-A/ET-B antagonist",,,CHEMBL2096678,"Endothelin receptor, ET-A/ET-B",ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2013/204410s000lbl.pdf, URL:https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204410s000lbl.pdf",CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1c3ccc(Br)cc3,,
4306,CHEMBL99946,Levomilnacipran,Small molecule,2013.0,,,,Norepinephrine transporter inhibitor,,,CHEMBL222,Norepinephrine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f371258d-91b3-4b6a-ac99-434a1964c3af, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f371258d-91b3-4b6a-ac99-434a1964c3af",CCN(CC)C(=O)[C@]1(C[C@H]1CN)c2ccccc2,CHEMBL222,SLC6A2
4307,CHEMBL3137301,Sacubitril,Small molecule,2015.0,,,-tril,Neprilysin inhibitor,,,CHEMBL1944,Neprilysin,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/207620Orig1s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207620Orig1s000lbl.pdf",CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(cc1)c2ccccc2)NC(=O)CCC(=O)O,CHEMBL1944,MME
4308,CHEMBL52885,Enmd-981693,Small molecule,,,,,Serine/threonine-protein kinase Aurora-A inhibitor,,,CHEMBL4722,Serine/threonine-protein kinase Aurora-A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf, URL:http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf",Cn1cc(C2=C(C(=O)NC2=O)c3cn(C)c4cc(ccc34)[N+](=O)[O-])c5ccccc15,,
4309,CHEMBL3545179,Azd-7451,Small molecule,,,,,NT-3 growth factor receptor inhibitor,,,CHEMBL5608,NT-3 growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25054037, URL:http://europepmc.org/abstract/MED/25054037|Name:PubMed, SrcID:23027130, URL:http://europepmc.org/abstract/MED/23027130",,CHEMBL5608,NTRK3
4310,CHEMBL3545050,Bms-817378,Small molecule,,,,,Vascular endothelial growth factor receptor 2 inhibitor,,,CHEMBL279,Vascular endothelial growth factor receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1016/S1359-6349(10)71801-2, URL:http://www.sciencedirect.com/science/article/pii/S1359634910718012",,CHEMBL279,KDR
4311,CHEMBL3544936,Xl-844,Small molecule,,,,,Serine/threonine-protein kinase Chk2 inhibitor,,,CHEMBL2527,Serine/threonine-protein kinase Chk2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=469731, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=469731|Name:PubMed, SrcID:17245119, URL:http://europepmc.org/abstract/MED/17245119|Name:PubMed, SrcID:19568282, URL:http://europepmc.org/abstract/MED/19568282",,CHEMBL2527,CHEK2
4312,CHEMBL3234681,Tedalinab,Small molecule,,,,,Cannabinoid CB2 receptor agonist,,,CHEMBL253,Cannabinoid CB2 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.glenmarkpharma.com/gln_nws/pdf/glenmark_molecule_GRC_10693.pdf, URL:http://www.glenmarkpharma.com/gln_nws/pdf/glenmark_molecule_GRC_10693.pdf|Name:PubMed, SrcID:14638775, URL:http://europepmc.org/abstract/MED/14638775",CC(C)(C)NC(=O)c1nn(c2[C@@H]3CC[C@@H](C3)c12)c4ccc(F)cc4F,CHEMBL253,CNR2
4313,CHEMBL93747,Netoglitazone,Small molecule,,,,-glitazone,Peroxisome proliferator-activated receptor gamma modulator,Drug in Ph1 or 2? Development status unknown.,,CHEMBL235,Peroxisome proliferator-activated receptor gamma,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:9830009, URL:http://europepmc.org/abstract/MED/9830009",Fc1ccccc1COc2ccc3cc(CC4SC(=O)NC4=O)ccc3c2,CHEMBL235,PPARG
4314,CHEMBL3544984,Tradipitant,Small molecule,,,,-tant,Neurokinin 1 receptor antagonist,,,CHEMBL249,Neurokinin 1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20018493, URL:http://europepmc.org/abstract/MED/20018493",FC(F)(F)c1cc(Cn2nnc(c3ncccc3C(=O)c4ccccc4Cl)c2c5ccncc5)cc(c1)C(F)(F)F,CHEMBL249,TACR1
4315,CHEMBL2103829,Faxeladol,Small molecule,,,,-adol,Mu opioid receptor agonist,,,CHEMBL233,Mu opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22337471, URL:http://europepmc.org/abstract/MED/22337471",CN(C)C[C@@H]1CCCC[C@H]1c2cccc(O)c2,CHEMBL233,OPRM1
4316,CHEMBL2103829,Faxeladol,Small molecule,,,,-adol,Norepinephrine transporter inhibitor,,,CHEMBL222,Norepinephrine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22337471, URL:http://europepmc.org/abstract/MED/22337471",CN(C)C[C@@H]1CCCC[C@H]1c2cccc(O)c2,CHEMBL222,SLC6A2
4317,CHEMBL232943,Mk0686,Small molecule,,,,,Bradykinin B1 receptor antagonist,,,CHEMBL4308,Bradykinin B1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17228869, URL:http://europepmc.org/abstract/MED/17228869|Name:PubMed, SrcID:24333733, URL:http://europepmc.org/abstract/MED/24333733",COC(=O)c1c(Cl)cccc1c2ccc([C@@H](C)NC(=O)C3(CC3)NC(=O)C(F)(F)F)c(F)c2,CHEMBL4308,BDKRB1
4318,CHEMBL222460,Bms-223131,Small molecule,,,,,Calcium-activated potassium channel subunit alpha-1 activator,Indication: Erectile dysfunction,,CHEMBL4304,Calcium-activated potassium channel subunit alpha-1,ACTIVATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15701710, URL:http://europepmc.org/abstract/MED/15701710|Name:PubMed, SrcID:12825925, URL:http://europepmc.org/abstract/MED/12825925",OCCC1=C(c2cc(Cl)ccc2O)c3cc(ccc3NC1=O)C(F)(F)F,CHEMBL4304,KCNMA1
4319,CHEMBL3545234,Egf816,Small molecule,,,,,Epidermal growth factor receptor erbB1 inhibitor,EGF816 is an irreversible TKI that demonstrates selectivity for mutant EGFRs compared with WT EGFR and targets activating and resistance mutations with equal potency (doi: 10.1158/1538-7445.AM2014-1734).,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.novartisoncology.com/ct/pipelineDetails?compound=EGF816&diseaseAcr=NSCLC, URL:http://www.novartisoncology.com/ct/pipelineDetails?compound=EGF816&diseaseAcr=NSCLC|Name:ClinicalTrials, SrcID:NCT02108964, URL:https://www.clinicaltrials.gov/ct2/show/NCT02108964|Name:DOI, SrcID:10.1158/1538-7445.AM2014-1734, URL:http://cancerres.aacrjournals.org/content/74/19_Supplement/1734",,CHEMBL203,EGFR
4320,CHEMBL2103881,Dexmecamylamine,Small molecule,,,,,Neuronal acetylcholine receptor; alpha4/beta2 antagonist,TC-5214 [S-(+)-mecamylamine] was more effective than TC-5213 [R-(-)-mecamylamine] in inhibiting the LS a4ß2 NNRs. TC-5214 potentiated and TC-5213 inhibited agonist-induced activation of HS a4ß2 NNRs.,,CHEMBL1907589,Neuronal acetylcholine receptor; alpha4/beta2,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:19040552, URL:http://europepmc.org/abstract/MED/19040552|Name:PubMed, SrcID:18957576, URL:http://europepmc.org/abstract/MED/18957576",CN[C@@]1(C)[C@@H]2CC[C@@H](C2)C1(C)C,,
4321,CHEMBL2107866,Peginesatide,Protein,,B03XA04,B03XA04 [BLOOD AND BLOOD FORMING ORGANS: ANTIANEMIC PREPARATIONS: OTHER ANTIANEMIC PREPARATIONS: Other antianemic preparations],peg-; -tide,Erythropoietin receptor agonist,,,CHEMBL1817,Erythropoietin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21940838, URL:http://europepmc.org/abstract/MED/21940838",,CHEMBL1817,EPOR
4322,CHEMBL2105659,Varespladib Methyl,Small molecule,,,,-pladib,Phospholipase A2 group V inhibitor,,,CHEMBL4323,Phospholipase A2 group V,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21112895, URL:http://europepmc.org/abstract/MED/21112895",CCc1c(C(=O)C(=O)N)c2c(OCC(=O)OC)cccc2n1Cc3ccccc3,CHEMBL4323,PLA2G5
4323,CHEMBL2107911,Onercept,Protein,,,,-cept,TNF-alpha inhibitor,,,CHEMBL1825,TNF-alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20718590, URL:http://europepmc.org/abstract/MED/20718590",,CHEMBL1825,TNF
4324,CHEMBL2109442,Pro-542,Antibody,,,,,Envelope glycoprotein gp160 inhibitor,Blocking its attachment to CD4 cells. Immunoprophyaxis HIV1 infection.,,CHEMBL1293311,Envelope glycoprotein gp160,INHIBITOR,Human immunodeficiency virus 1,SINGLE PROTEIN,,,"Name:PubMed, SrcID:7576908, URL:http://europepmc.org/abstract/MED/7576908",,,
4325,CHEMBL1173055,Rucaparib,Small molecule,2016.0,,,-parib,"PARP 1, 2 and 3 inhibitor",In patients with BRCA mutation,,CHEMBL3390820,"PARP 1, 2 and 3",INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2016/209115s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/209115s000lbl.pdf|Name:PubMed, SrcID:19047122 , URL:http://europepmc.org/abstract/MED/19047122",CNCc1ccc(cc1)c2[nH]c3cc(F)cc4C(=O)NCCc2c34,,
4326,CHEMBL3707375,Amiselimod,Small molecule,,,,-imod,Sphingosine 1-phosphate receptor modulator,"Amiselimod (also known as MT-1303) is another oral S1P receptor modulator, and is converted to its active metabolite amiselimod phosphate in vivo. Amiselimod showed greater affinity for S1P1 than for S1P2–5 receptors in human cells and, unlike fingolimod phosphate, had little agonistic activity at human S1P3 receptors",,CHEMBL2363041,Sphingosine 1-phosphate receptor,MODULATOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:27543447, URL:http://europepmc.org/abstract/MED/27543447",CCCCCCCOc1ccc(CCC(N)(CO)CO)cc1C(F)(F)F,,
4327,CHEMBL2109406,Patritumab,Antibody,,,,-mab,Receptor tyrosine-protein kinase erbB-3 inhibitor,,,CHEMBL5838,Receptor tyrosine-protein kinase erbB-3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,,,CHEMBL5838,ERBB3
4328,CHEMBL3544968,Gsk-610677,Small molecule,,,,,MAP kinase p38 alpha inhibitor,,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,,,CHEMBL260,MAPK14
4329,CHEMBL1584,Piperacetazine,Small molecule,1969.0,,,,Unknown,,,,,,,,,,,CC(=O)c1ccc2Sc3ccccc3N(CCCN4CCC(CCO)CC4)c2c1,,
4330,CHEMBL1201185,Lanreotide,Protein,2007.0,H01CB03,"H01CB03 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: HYPOTHALAMIC HORMONES: Somatostatin and analogues]",-tide,Somatostatin receptor 5 agonist,,,CHEMBL1792,Somatostatin receptor 5,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=f11b1d88-74ca-4a6d-89fb-40d0f51bca95#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f11b1d88-74ca-4a6d-89fb-40d0f51bca95#nlm34090-1",CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N)NC(=O)[C@H](N)Cc5ccc6ccccc6c5,CHEMBL1792,SSTR5
4331,CHEMBL539697,Dabigatran Etexilate,Small molecule,2010.0,B01AE07,B01AE07 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Direct thrombin inhibitors],-gatran,Thrombin inhibitor,,,CHEMBL204,Thrombin,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=ba74e3cd-b06f-4145-b284-5fd6b84ff3c9, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ba74e3cd-b06f-4145-b284-5fd6b84ff3c9",CCCCCCOC(=O)\N=C(/N)\c1ccc(NCc2nc3cc(ccc3n2C)C(=O)N(CCC(=O)OCC)c4ccccn4)cc1,CHEMBL204,F2
4332,CHEMBL516,Cyproheptadine,Small molecule,1961.0,R06AX02,R06AX02 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Other antihistamines for systemic use],-(a)tadine,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 333, URL:http://www.isbnsearch.org/isbn/9780702034718",CN1CCC(=C2c3ccccc3C=Cc4ccccc24)CC1,CHEMBL231,HRH1
4333,CHEMBL3187365,Asenapine,Small molecule,2009.0,N05AH05,"N05AH05 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Diazepines, oxazepines, thiazepines and oxepines]",-pin(e),Dopamine D2 receptor antagonist,,,CHEMBL217,Dopamine D2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=17209c32-56eb-4f84-954d-aed7b7a1b18d, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=17209c32-56eb-4f84-954d-aed7b7a1b18d",CN1CC2C(C1)c3cc(Cl)ccc3Oc4ccccc24,CHEMBL217,DRD2
4334,CHEMBL1201342,Methixene,Small molecule,1982.0,N04AA03,N04AA03 [NERVOUS SYSTEM: ANTI-PARKINSON DRUGS: ANTICHOLINERGIC AGENTS: Tertiary amines],,Muscarinic acetylcholine receptor M1 antagonist,"Indicated for Parkinson's disease, M1 likely responsible",,CHEMBL216,Muscarinic acetylcholine receptor M1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 153, 162, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:3353357, URL:http://europepmc.org/abstract/MED/3353357",CN1CCCC(CC2c3ccccc3Sc4ccccc24)C1,CHEMBL216,CHRM1
4335,CHEMBL1454,Levamisole,Small molecule,1990.0,P02CE01,"P02CE01 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTHELMINTICS: ANTINEMATODAL AGENTS: Imidazothiazole derivatives]",,Nicotinic acetylcholine receptor alpha subunit agonist,,,CHEMBL1884,Nicotinic acetylcholine receptor alpha subunit,AGONIST,Ascaris suum,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19668355, URL:http://europepmc.org/abstract/MED/19668355|Name:PubMed, SrcID:15280391, URL:http://europepmc.org/abstract/MED/15280391",C1CN2C[C@@H](N=C2S1)c3ccccc3,,
4336,CHEMBL471,Sotalol,Small molecule,1992.0,C07AA07,"C07AA07 [CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, non-selective]",-alol,HERG blocker,,,CHEMBL240,HERG,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=c4caf469-f684-4f6d-98e8-b6a2fff1de98, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4caf469-f684-4f6d-98e8-b6a2fff1de98|Name:Wikipedia, SrcID:Sotalol, URL:http://en.wikipedia.org/wiki/Sotalol",CC(C)NCC(O)c1ccc(NS(=O)(=O)C)cc1,CHEMBL240,KCNH2
4337,CHEMBL1201628,Insulin Susp Protamine Zinc Beef/Pork,Protein,1966.0,,,,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/022472s006s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022472s006s008lbl.pdf|Name:DailyMed, SrcID:setid=457531f0-9331-47fe-90b5-b31f284044dc, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=457531f0-9331-47fe-90b5-b31f284044dc",,CHEMBL1981,INSR
4338,CHEMBL623,Nefazodone,Small molecule,1994.0,N06AX06,N06AX06 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants],,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=b1d149db-ad43-4f3f-aef1-fb0395ba4191#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b1d149db-ad43-4f3f-aef1-fb0395ba4191#nlm34090-1",CCC1=NN(CCCN2CCN(CC2)c3cccc(Cl)c3)C(=O)N1CCOc4ccccc4,CHEMBL224,HTR2A
4339,CHEMBL1115,Pyridostigmine,Small molecule,1955.0,N07AA02,N07AA02 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: PARASYMPATHOMIMETICS: Anticholinesterases],-stigmine,Acetylcholinesterase inhibitor,,,CHEMBL220,Acetylcholinesterase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=30cb0b9f-e308-4501-90c2-b17349c048b7, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=30cb0b9f-e308-4501-90c2-b17349c048b7|Name:Wikipedia, SrcID:Pyridostigmine#Mode_of_action, URL:http://en.wikipedia.org/wiki/Pyridostigmine#Mode_of_action",CN(C)C(=O)Oc1ccc[n+](C)c1,CHEMBL220,ACHE
4340,CHEMBL1670,Mitotane,Small molecule,1970.0,L01XX23,L01XX23 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],,Cytochrome P450 11A1 inhibitor,,,CHEMBL2033,Cytochrome P450 11A1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19667279, URL:http://europepmc.org/abstract/MED/19667279",ClC(Cl)C(c1ccc(Cl)cc1)c2ccccc2Cl,CHEMBL2033,CYP11A1
4341,CHEMBL1201749,Difluprednate,Small molecule,2008.0,D07AC19,"D07AC19 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, potent (group III)]",-pred-,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15764038, URL:http://europepmc.org/abstract/MED/15764038",CCCC(=O)O[C@@]1(CC[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)COC(=O)C,CHEMBL2034,NR3C1
4342,CHEMBL1200909,Prednisolone Tebutate,Small molecule,1956.0,H02AB06; S03BA02; S01CB02; S02BA03; D07XA02; S01BA04; D07AA03; R01AD02; C05AA04; A07EA01,"H02AB06 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Glucocorticoids]; S03BA02 [SENSORY ORGANS: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS: CORTICOSTEROIDS: Corticosteroids]; S01CB02 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION: Corticosteroids/antiinfectives/mydriatics in combination]; S02BA03 [SENSORY ORGANS: OTOLOGICALS: CORTICOSTEROIDS: Corticosteroids]; D07XA02 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, OTHER COMBINATIONS: Corticosteroids, weak, other combinations]; S01BA04 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Corticosteroids, plain]; D07AA03 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, weak (group I)]; R01AD02 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Corticosteroids]; C05AA04 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Corticosteroids]; A07EA01 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Corticosteroids acting locally]",pred-,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 340, URL:http://www.isbnsearch.org/isbn/9780702034718",CC(C)(C)CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C,CHEMBL2034,NR3C1
4343,CHEMBL129,Zidovudine,Small molecule,1987.0,J05AF01,J05AF01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleoside and nucleotide reverse transcriptase inhibitors],-vudine,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,,,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,INHIBITOR,Human immunodeficiency virus 1,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=6df09f15-b102-431c-adde-d7aeef6f5d84, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6df09f15-b102-431c-adde-d7aeef6f5d84",CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O,,
4344,CHEMBL1628227,Doxepin,Small molecule,1969.0,N06AA12,N06AA12 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Non-selective monoamine reuptake inhibitors],-pin(e),Norepinephrine transporter inhibitor,reuptake inhibitor,,CHEMBL222,Norepinephrine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=912d8d23-1c69-fc0e-1d2d-49dafd3c3746#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=912d8d23-1c69-fc0e-1d2d-49dafd3c3746#nlm34090-1",CN(C)CCC=C1c2ccccc2COc3ccccc13,CHEMBL222,SLC6A2
4345,CHEMBL2103758,Pramlintide,Protein,2005.0,A10BX05,"A10BX05 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Other blood glucose lowering drugs, excl. insulins]",-tide,"Amylin receptor AMY1, CALCR/RAMP1 agonist","Is amylin analogue, calcitonin receptor is binding site",,CHEMBL2111189,"Amylin receptor AMY1, CALCR/RAMP1",AGONIST,Homo sapiens,PROTEIN COMPLEX,Calcitonin receptor,Calcitonin receptor is binding site,"Name:DailyMed, SrcID:setid=d2262f20-bedb-43d9-b274-6ce275b0a69e, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d2262f20-bedb-43d9-b274-6ce275b0a69e|Name:IUPHAR, SrcID:687, URL:http://www.iuphar-db.org/DATABASE/LigandDisplayForward?tab=biology&ligandId=687",CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc3c[nH]cn3)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]5CSSC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N5)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N6CCC[C@H]6C(=O)N7CCC[C@H]7C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc8ccc(O)cc8)C(=O)N,,
4346,CHEMBL442,Ergotamine,Small molecule,1948.0,N02CA52; N02CA02; N02CA72,N02CA52 [NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Ergot alkaloids]; N02CA02 [NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Ergot alkaloids]; N02CA72 [NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Ergot alkaloids],,Adrenergic receptor alpha agonist,,,CHEMBL2095203,Adrenergic receptor alpha,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=1c066197-dea6-4705-9b4a-8703dd564a2a#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1c066197-dea6-4705-9b4a-8703dd564a2a#nlm34090-1|Name:ISBN, SrcID:0443-059748 PP. 169, URL:http://www.isbnsearch.org/isbn/0443059748|Name:PubMed, SrcID:10611116, URL:http://europepmc.org/abstract/MED/10611116",CN1C[C@@H](C=C2[C@H]1Cc3c[nH]c4cccc2c34)C(=O)N[C@]5(C)O[C@@]6(O)[C@@H]7CCCN7C(=O)[C@H](Cc8ccccc8)N6C5=O,,
4347,CHEMBL585,Triamterene,Small molecule,1964.0,C03DB02,C03DB02 [CARDIOVASCULAR SYSTEM: DIURETICS: POTASSIUM-SPARING AGENTS: Other potassium-sparing agents],,"Amiloride-sensitive sodium channel, ENaC blocker",,,CHEMBL2107836,"Amiloride-sensitive sodium channel, ENaC",BLOCKER,Homo sapiens,PROTEIN COMPLEX,Amiloride-sensitive sodium channel alpha subunit,Alpha subunit is binding site,"Name:Wikipedia, SrcID:Triamtere, URL:http://en.wikipedia.org/wiki/Triamtere|Name:PubMed, SrcID:8772124, URL:http://europepmc.org/abstract/MED/8772124|Name:DailyMed, SrcID:setid=5012f997-9fb2-4c3d-99fd-4f7efd7c39af, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5012f997-9fb2-4c3d-99fd-4f7efd7c39af",Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3,CHEMBL2107836,SCNN1G
4348,CHEMBL585,Triamterene,Small molecule,1964.0,C03DB02,C03DB02 [CARDIOVASCULAR SYSTEM: DIURETICS: POTASSIUM-SPARING AGENTS: Other potassium-sparing agents],,"Amiloride-sensitive sodium channel, ENaC blocker",,,CHEMBL2107836,"Amiloride-sensitive sodium channel, ENaC",BLOCKER,Homo sapiens,PROTEIN COMPLEX,Amiloride-sensitive sodium channel alpha subunit,Alpha subunit is binding site,"Name:Wikipedia, SrcID:Triamtere, URL:http://en.wikipedia.org/wiki/Triamtere|Name:PubMed, SrcID:8772124, URL:http://europepmc.org/abstract/MED/8772124|Name:DailyMed, SrcID:setid=5012f997-9fb2-4c3d-99fd-4f7efd7c39af, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5012f997-9fb2-4c3d-99fd-4f7efd7c39af",Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3,CHEMBL2107836,SCNN1B
4349,CHEMBL193,Nifedipine,Small molecule,1981.0,C08CA05; C08CA55,C08CA05 [CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS: Dihydropyridine derivatives]; C08CA55 [CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS: Dihydropyridine derivatives],-dipine,Voltage-gated L-type calcium channel blocker,,,CHEMBL2095229,Voltage-gated L-type calcium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2011/020198s023lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020198s023lbl.pdf|Name:Wikipedia, SrcID:Nifedipine, URL:http://en.wikipedia.org/wiki/Nifedipine|Name:DailyMed, SrcID:setid=b8fdcb32-b571-43b4-91e9-b4e9f75d86ae, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b8fdcb32-b571-43b4-91e9-b4e9f75d86ae|Name:Wikipedia, SrcID:Calcium_channel_blocker, URL:http://en.wikipedia.org/wiki/Calcium_channel_blocker|Name:Wikipedia, SrcID:L-type_calcium_channel, URL:http://en.wikipedia.org/wiki/L-type_calcium_channel|Name:Wikipedia, SrcID:Voltage-dependent_calcium_channel, URL:http://en.wikipedia.org/wiki/Voltage-dependent_calcium_channel",COC(=O)C1=C(C)NC(=C(C1c2ccccc2[N+](=O)[O-])C(=O)OC)C,,
4350,CHEMBL1480,Felodipine,Small molecule,1991.0,C08CA02,C08CA02 [CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS: Dihydropyridine derivatives],-dipine,Voltage-gated L-type calcium channel blocker,,,CHEMBL2095229,Voltage-gated L-type calcium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:Wikipedia, SrcID:Calcium_channel_blocker, URL:http://en.wikipedia.org/wiki/Calcium_channel_blocker|Name:Wikipedia, SrcID:L-type_calcium_channel, URL:http://en.wikipedia.org/wiki/L-type_calcium_channel|Name:Wikipedia, SrcID:Voltage-dependent_calcium_channel, URL:http://en.wikipedia.org/wiki/Voltage-dependent_calcium_channel|Name:Wikipedia, SrcID:Felodipine, URL:http://en.wikipedia.org/wiki/Felodipine|Name:DailyMed, SrcID:setid=55637724-8757-11de-8a39-0800200c9a66, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=55637724-8757-11de-8a39-0800200c9a66",CCOC(=O)C1=C(C)NC(=C(C1c2cccc(Cl)c2Cl)C(=O)OC)C,,
4351,CHEMBL685,Mebendazole,Small molecule,1974.0,P02CA51; P02CA01,"P02CA51 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTHELMINTICS: ANTINEMATODAL AGENTS: Benzimidazole derivatives]; P02CA01 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTHELMINTICS: ANTINEMATODAL AGENTS: Benzimidazole derivatives]",-bendazole,Tubulin inhibitor,,,CHEMBL2364704,Tubulin,INHIBITOR,Taeniidae,PROTEIN COMPLEX GROUP,Beta tubulin,Binds to beta tubulin,"Name:ISBN, SrcID:9780702034718 PP. 669, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:13678839, URL:http://europepmc.org/abstract/MED/13678839|Name:DailyMed, SrcID:setid=c338415f-41e0-071d-8c51-a80a02ebf2cd, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c338415f-41e0-071d-8c51-a80a02ebf2cd|Name:Wikipedia, SrcID:Mebendazole, URL:http://en.wikipedia.org/wiki/Mebendazole",COC(=O)Nc1nc2ccc(cc2[nH]1)C(=O)c3ccccc3,,
4352,CHEMBL1316,Carprofen,Small molecule,1987.0,,,-profen,Cyclooxygenase-2 inhibitor,,Selective,CHEMBL230,Cyclooxygenase-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=8257d939-ad54-415f-91ce-21ec7f874a68, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8257d939-ad54-415f-91ce-21ec7f874a68|Name:DailyMed, SrcID:archiveid=147266, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=147266",CC(C(=O)O)c1ccc2c(c1)[nH]c3ccc(Cl)cc23,CHEMBL230,PTGS2
4353,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,MT-ND1
4354,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,MT-ND2
4355,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,MT-ND3
4356,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,MT-ND4L
4357,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,MT-ND5
4358,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,MT-ND6
4359,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFS3
4360,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFAF4
4361,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFS1
4362,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFB10
4363,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFA10
4364,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFS7
4365,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFA3
4366,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFV2
4367,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFA13
4368,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFB6
4369,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFA9
4370,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFA11
4371,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFA6
4372,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFAF2
4373,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFS4
4374,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFV3
4375,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFAF3
4376,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFA1
4377,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFAB1
4378,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFA5
4379,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFA7
4380,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFAF1
4381,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFA2
4382,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFB7
4383,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFS6
4384,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFA4L2
4385,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFB2
4386,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFB8
4387,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFS2
4388,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFB1
4389,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFC1
4390,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFB4
4391,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFS5
4392,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFV1
4393,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFB9
4394,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFB3
4395,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFB5
4396,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFB11
4397,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFC2
4398,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFA12
4399,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFA8
4400,CHEMBL1431,Metformin,Small molecule,1995.0,A10BA02,"A10BA02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides]",-formin,Mitochondrial complex I (NADH dehydrogenase) inhibitor,May not be direct target,,CHEMBL2363065,Mitochondrial complex I (NADH dehydrogenase),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:23277337, URL:http://europepmc.org/abstract/MED/23277337|Name:PubMed, SrcID:25017630, URL:http://europepmc.org/abstract/MED/25017630|Name:PubMed, SrcID:23358356, URL:http://europepmc.org/abstract/MED/23358356",CN(C)C(=N)NC(=N)N,CHEMBL2363065,NDUFS8
4401,CHEMBL1521,Zaleplon,Small molecule,1999.0,N05CF03,N05CF03 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine related drugs],-plon,GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator,,"Selective for the brain omega-1 receptor (i.e. BZ1-type, i.e. alpha1/beta1/gamma2-GABA receptor)",CHEMBL2111392,GABA A receptor alpha-1/beta-1/gamma-2,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX,Benzodiazepine binding site,,"Name:PubMed, SrcID:12404558, URL:http://europepmc.org/abstract/MED/12404558|Name:Wikipedia, SrcID:Zaleplon, URL:http://en.wikipedia.org/wiki/Zaleplon|Name:FDA, SrcID:label/2013/020859s013lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020859s013lbl.pdf",CCN(C(=O)C)c1cccc(c1)c2ccnc3c(cnn23)C#N,CHEMBL2111392,GABRG2
4402,CHEMBL1521,Zaleplon,Small molecule,1999.0,N05CF03,N05CF03 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine related drugs],-plon,GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator,,"Selective for the brain omega-1 receptor (i.e. BZ1-type, i.e. alpha1/beta1/gamma2-GABA receptor)",CHEMBL2111392,GABA A receptor alpha-1/beta-1/gamma-2,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX,Benzodiazepine binding site,,"Name:PubMed, SrcID:12404558, URL:http://europepmc.org/abstract/MED/12404558|Name:Wikipedia, SrcID:Zaleplon, URL:http://en.wikipedia.org/wiki/Zaleplon|Name:FDA, SrcID:label/2013/020859s013lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020859s013lbl.pdf",CCN(C(=O)C)c1cccc(c1)c2ccnc3c(cnn23)C#N,CHEMBL2111392,GABRB1
4403,CHEMBL1421,Dasatinib,Small molecule,2006.0,L01XE06,L01XE06 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,SRC inhibitor,,,CHEMBL2363074,SRC,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13",Cc1nc(Nc2ncc(s2)C(=O)Nc3c(C)cccc3Cl)cc(n1)N4CCN(CCO)CC4,,
4404,CHEMBL1200356,Cyclacillin,Small molecule,1979.0,,,-cillin,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:PubMed, SrcID:7447421, URL:http://europepmc.org/abstract/MED/7447421|Name:Wikipedia, SrcID:Penicillin_binding_proteins#Function, URL:http://en.wikipedia.org/wiki/Penicillin_binding_proteins#Function",CC1(C)S[C@@H]2[C@H](NC(=O)C3(N)CCCCC3)C(=O)N2[C@H]1C(=O)O,,
4405,CHEMBL3039597,Gentamicin,Small molecule,1970.0,S01AA11; S03AA06; J01GB03; D06AX07; S02AA14,S01AA11 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Antibiotics]; S03AA06 [SENSORY ORGANS: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS: ANTIINFECTIVES: Antiinfectives]; J01GB03 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: AMINOGLYCOSIDE ANTIBACTERIALS: Other aminoglycosides]; D06AX07 [DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: ANTIBIOTICS FOR TOPICAL USE: Other antibiotics for topical use]; S02AA14 [SENSORY ORGANS: OTOLOGICALS: ANTIINFECTIVES: Antiinfectives],-micin,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,16S ribosomal RNA,16s RRNA,"Name:ISBN, SrcID:9780702034718 PP. 614, URL:http://www.isbnsearch.org/isbn/9780702034718",CNC(C)[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.CN[C@@H]4[C@@H](O)[C@@H](O[C@H]5[C@H](N)C[C@H](N)[C@@H](O[C@H]6O[C@H](CN)CC[C@H]6N)[C@@H]5O)OC[C@]4(C)O.CN[C@@H]7[C@@H](O)[C@@H](O[C@H]8[C@H](N)C[C@H](N)[C@@H](O[C@H]9O[C@@H](CC[C@H]9N)C(C)N)[C@@H]8O)OC[C@]7(C)O,,
4406,CHEMBL184618,Neomycin,Small molecule,1957.0,J01GB05; B05CA09; D06AX04; A07AA01; S01AA03; S03AA01; A01AB08; S02AA07; A07AA51; R02AB01,"J01GB05 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: AMINOGLYCOSIDE ANTIBACTERIALS: Other aminoglycosides]; B05CA09 [BLOOD AND BLOOD FORMING ORGANS: BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS: IRRIGATING SOLUTIONS: Antiinfectives]; D06AX04 [DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: ANTIBIOTICS FOR TOPICAL USE: Other antibiotics for topical use]; A07AA01 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFECTIVES: Antibiotics]; S01AA03 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Antibiotics]; S03AA01 [SENSORY ORGANS: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS: ANTIINFECTIVES: Antiinfectives]; A01AB08 [ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Antiinfectives and antiseptics for local oral treatment]; S02AA07 [SENSORY ORGANS: OTOLOGICALS: ANTIINFECTIVES: Antiinfectives]; A07AA51 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFECTIVES: Antibiotics]; R02AB01 [RESPIRATORY SYSTEM: THROAT PREPARATIONS: THROAT PREPARATIONS: Antibiotics]",-mycin,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,16S ribosomal RNA,16s RRNA,"Name:Wikipedia, SrcID:Neomycin#Neomycin_as_a_DNA_binder, URL:http://en.wikipedia.org/wiki/Neomycin#Neomycin_as_a_DNA_binder|Name:PubMed, SrcID:17553640, URL:http://europepmc.org/abstract/MED/17553640|Name:PubMed, SrcID:18060665, URL:http://europepmc.org/abstract/MED/18060665|Name:PubMed, SrcID:17875999, URL:http://europepmc.org/abstract/MED/17875999|Name:PubMed, SrcID:17131180, URL:http://europepmc.org/abstract/MED/17131180",NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]4O[C@H](CN)[C@@H](O)[C@H](O)[C@H]4N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,,
4407,CHEMBL376488,Bedaquiline,Small molecule,2012.0,J04AK05,J04AK05 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOBACTERIALS: DRUGS FOR TREATMENT OF TUBERCULOSIS: Other drugs for treatment of tuberculosis],-quiline,ATP synthase inhibitor,"It has been shown that mutation in the atpE gene, which encodes the c subunit, of the mycobacterial ATP synthase, confers resistant to Bedaquiline, suggesting that Bedaquiline binds crucially to this target, inhibiting the proton pump of M. tuberculosis and therefore interfering with the rotation properties of the transmembrane disk, leading to ATP depletion (PMID: 15591164)",,CHEMBL2364166,ATP synthase,INHIBITOR,Mycobacterium tuberculosis,PROTEIN COMPLEX,,,"Name:DailyMed, SrcID:setid=1534c9ae-4948-4cf4-9f66-222a99db6d0e, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1534c9ae-4948-4cf4-9f66-222a99db6d0e|Name:PubMed, SrcID:15591164, URL:http://europepmc.org/abstract/MED/15591164",COc1nc2ccc(Br)cc2cc1[C@@H](c3ccccc3)[C@@](O)(CCN(C)C)c4cccc5ccccc45,,
4408,CHEMBL1651906,Streptozotocin,Small molecule,1982.0,L01AD04,L01AD04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ALKYLATING AGENTS: Nitrosoureas],-tocin,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=15d161ed-9e7b-4c92-ba45-0556d2423e67, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=15d161ed-9e7b-4c92-ba45-0556d2423e67|Name:Wikipedia, SrcID:Streptozocin, URL:http://en.wikipedia.org/wiki/Streptozocin",CN(N=O)C(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O,,
4409,CHEMBL1773,Capecitabine,Small molecule,1998.0,L01BC06,L01BC06 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Pyrimidine analogues],-citabine,RNA inhibitor,,,CHEMBL2311222,RNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8#section-13|Name:PubMed, SrcID:12724731, URL:http://europepmc.org/abstract/MED/12724731",CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]2O[C@H](C)[C@@H](O)[C@H]2O,,
4410,CHEMBL428,Trovafloxacin,Small molecule,1997.0,J01MA13,J01MA13 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolones],-oxacin,Bacterial DNA gyrase inhibitor,,,CHEMBL2311224,Bacterial DNA gyrase,INHIBITOR,Bacteria,PROTEIN COMPLEX,,,"Name:DailyMed, SrcID:setid=da9b26bb-d2d7-4113-a0f9-c6c2280f4875, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=da9b26bb-d2d7-4113-a0f9-c6c2280f4875",N[C@@H]1[C@H]2CN(C[C@@H]12)c3nc4N(C=C(C(=O)O)C(=O)c4cc3F)c5ccc(F)cc5F,,
4411,CHEMBL1237025,Pegloticase,Enzyme,2010.0,M04AX02,M04AX02 [MUSCULO-SKELETAL SYSTEM: ANTIGOUT PREPARATIONS: ANTIGOUT PREPARATIONS: Other antigout preparations],-ase; peg-,Uric acid oxidative enzyme,"It's a recombinant uricase, which catalysis the oxidation of uric acid to allantoin, approved for the treatment of chronic gout",,CHEMBL2364183,Uric acid,OXIDATIVE ENZYME,Homo sapiens,SMALL MOLECULE,,,"Name:DailyMed, SrcID:setid=5f4574d1-401f-4647-83e5-28c0f4a122a7#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5f4574d1-401f-4647-83e5-28c0f4a122a7#nlm34090-1",,,
4412,CHEMBL1100,Paramethadione,Small molecule,1949.0,N03AC01,N03AC01 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Oxazolidine derivatives],,Voltage-gated T-type calcium channel blocker,,,CHEMBL2362995,Voltage-gated T-type calcium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:11641441, URL:http://europepmc.org/abstract/MED/11641441|Name:PubMed, SrcID:17291698, URL:http://europepmc.org/abstract/MED/17291698",CCC1(C)OC(=O)N(C)C1=O,,
4413,CHEMBL1201650,Thyroglobulin,Unknown,1982.0,,,-bulin,Iodine storage agent,"It is a synthetic thyroglobulin, hence it works as an iodine storage, and when necessary it is degraded in lysossomes into T4 and T3 hormones",,,,,,,,,"Name:PubMed, SrcID:7121261, URL:http://europepmc.org/abstract/MED/7121261",,,
4414,CHEMBL720,Benzyl Alcohol,Small molecule,2009.0,P03AX06,"P03AX06 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS: ECTOPARASITICIDES, INCL. SCABICIDES: Other ectoparasiticides, incl. scabicides]",,Unknown,,,,,,,,,,"Name:Wikipedia, SrcID:Benzyl_alcohol, URL:http://en.wikipedia.org/wiki/Benzyl_alcohol|Name:Expert, SrcID:2009/07/new-drug-approvals-part-x-benzyl.html, URL:http://chembl.blogspot.co.uk/2009/07/new-drug-approvals-part-x-benzyl.html|Name:PubMed, SrcID:20199404, URL:http://europepmc.org/abstract/MED/20199404",OCc1ccccc1,,
4415,CHEMBL1356,Sodium Benzoate,Small molecule,1987.0,A16AX11,A16AX11 [ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Various alimentary tract and metabolism products],,Unknown,,,,,,,,,,"Name:FDA, SrcID:label/2011/020645s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020645s008lbl.pdf",[Na+].[O-]C(=O)c1ccccc1,,
4416,CHEMBL607710,Chlorphenesin Carbamate,Small molecule,1965.0,D01AE07,D01AE07 [DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Other antifungals for topical use],,Unknown,,,,,,,,,,"Name:PubMed, SrcID:6503049, URL:http://europepmc.org/abstract/MED/6503049",NC(=O)OCC(O)COc1ccc(Cl)cc1,,
4417,CHEMBL1200709,Crotamiton,Small molecule,1949.0,,,,Unknown,,,,,,,,,,"Name:FDA, SrcID:label/2003/06927slr030,09112slr021_eurax_lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/06927slr030,09112slr021_eurax_lbl.pdf",CCN(C(=O)\C=C\C)c1ccccc1C,,
4418,CHEMBL1239,Benzyl Benzoate,Small molecule,1976.0,P03AX01,"P03AX01 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS: ECTOPARASITICIDES, INCL. SCABICIDES: Other ectoparasiticides, incl. scabicides]",,Unknown,,,,,,,,,,"Name:Wikipedia, SrcID:Benzyl_alcohol, URL:http://en.wikipedia.org/wiki/Benzyl_alcohol|Name:Expert, SrcID:2009/07/new-drug-approvals-part-x-benzyl.html, URL:http://chembl.blogspot.co.uk/2009/07/new-drug-approvals-part-x-benzyl.html|Name:Wikipedia, SrcID:Benzyl_benzoate, URL:http://en.wikipedia.org/wiki/Benzyl_benzoate",O=C(OCc1ccccc1)c2ccccc2,,
4419,CHEMBL112,Acetaminophen,Small molecule,1968.0,N02BE51; N02BE71; N02BE01,N02BE51 [NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Anilides]; N02BE71 [NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Anilides]; N02BE01 [NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Anilides],,Vanilloid receptor opener,"Active metabolite, AM404, activates vanilloid receptor (TRPV1)",,CHEMBL4794,Vanilloid receptor,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Acetaminophen#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Acetaminophen#Mechanism_of_action|Name:PubMed, SrcID:15987694, URL:http://europepmc.org/abstract/MED/15987694|Name:PubMed, SrcID:20862299, URL:http://europepmc.org/abstract/MED/20862299",CC(=O)Nc1ccc(O)cc1,CHEMBL4794,TRPV1
4420,CHEMBL2108427,Menotropins,Protein,1975.0,,,-trop-,Luteinizing hormone/Choriogonadotropin receptor agonist,,,CHEMBL1854,Luteinizing hormone/Choriogonadotropin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:IUPHAR, SrcID:1159, URL:http://www.iuphar-db.org/DATABASE/LigandDisplayForward?tab=biology&ligandId=1159|Name:FDA, SrcID:label/2004/21322lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21322lbl.pdf|Name:DailyMed, SrcID:setid=ae1977ed-32ea-4cbf-b51d-ce4a438215b8, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ae1977ed-32ea-4cbf-b51d-ce4a438215b8",,CHEMBL1854,LHCGR
4421,CHEMBL1173655,Afatinib,Small molecule,2013.0,L01XE13,L01XE13 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Receptor protein-tyrosine kinase erbB-4 inhibitor,"Afatinib covalently binds to the kinase domains of EGFR (ErbB1), HER2 (ErbB2), and HER4 (ErbB4) and irreversibly inhibits tyrosine kinase autophosphorylation, resulting in downregulation of ErbB signaling",,CHEMBL3009,Receptor protein-tyrosine kinase erbB-4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:fd638e5e-8032-e7ca-0179-95e96ab5d387, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fd638e5e-8032-e7ca-0179-95e96ab5d387",CN(C)C\C=C\C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]4CCOC4,CHEMBL3009,ERBB4
4422,CHEMBL2105760,Brexpiprazole,Small molecule,2015.0,N05AX16,N05AX16 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Other antipsychotics],-prazole,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2015/205422s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205422s000lbl.pdf",O=C1Nc2cc(OCCCCN3CCN(CC3)c4cccc5sccc45)ccc2C=C1,CHEMBL224,HTR2A
4423,CHEMBL3545238,Cs-8080,Small molecule,,,,,LXR-alpha agonist,"discontinued in 2008, did not meet criteria in clinical trials (http://www.daiichisankyo.com/media_investors/investor_relations/ir_calendar/files/005144/imm2009_01_30_26_01.pdf)",,CHEMBL2808,LXR-alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24833295, URL:http://europepmc.org/abstract/MED/24833295",,CHEMBL2808,NR1H3
4424,CHEMBL272621,Hyodeoxycholic_Acid,Small molecule,,,,,LXR-alpha agonist,,,CHEMBL2808,LXR-alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10936612, URL:http://europepmc.org/abstract/MED/10936612|Name:PubMed, SrcID:24833295, URL:http://europepmc.org/abstract/MED/24833295",C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3C[C@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,CHEMBL2808,NR1H3
4425,CHEMBL1614707,Mubritinib,Small molecule,,,,-tinib,Receptor protein-tyrosine kinase erbB-2 inhibitor,,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15138566, URL:http://europepmc.org/abstract/MED/15138566|Name:PubMed, SrcID:17486079, URL:http://europepmc.org/abstract/MED/17486079|Name:PubMed, SrcID:16771730, URL:http://europepmc.org/abstract/MED/16771730",FC(F)(F)c1ccc(\C=C\c2occ(COc3ccc(CCCCn4ccnn4)cc3)n2)cc1,CHEMBL1824,ERBB2
4426,CHEMBL1615025,Tak-733,Small molecule,,,,,Dual specificity mitogen-activated protein kinase kinase 1 inhibitor,,,CHEMBL3587,Dual specificity mitogen-activated protein kinase kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23587417, URL:http://europepmc.org/abstract/MED/23587417|Name:PubMed, SrcID:21310613, URL:http://europepmc.org/abstract/MED/21310613",CN1C(=O)C(=C(Nc2ccc(I)cc2F)C3=C1N=CN(C[C@@H](O)CO)C3=O)F,CHEMBL3587,MAP2K1
4427,CHEMBL1783256,Azd6280,Small molecule,,,,,GABA receptor alpha-2 subunit positive allosteric modulator,,,CHEMBL4956,GABA receptor alpha-2 subunit,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25493397, URL:http://europepmc.org/abstract/MED/25493397",CCCNC(=O)c1nnc2c(cccc2c1N)c3cc(OC)ccc3OC,CHEMBL4956,GABRA2
4428,CHEMBL3707396,Evt401,Small molecule,,,,,P2X purinoceptor 7 antagonist,,,CHEMBL4805,P2X purinoceptor 7,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11036028, URL:http://europepmc.org/abstract/MED/11036028|Name:PubMed, SrcID:9502771, URL:http://europepmc.org/abstract/MED/9502771|Name:Other, SrcID:https://www.evotec.com/uploads/cms_article/1511/Evotec_Announces_Successful_Completion.pdf, URL:https://www.evotec.com/uploads/cms_article/1511/Evotec_Announces_Successful_Completion.pdf",,CHEMBL4805,P2RX7
4429,CHEMBL10041,Afimoxifene,Small molecule,,,,-ifene,Estrogen receptor modulator,Active metabolite of tamoxifen,,CHEMBL2093866,Estrogen receptor,MODULATOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Wikipedia, SrcID:Afimoxifene, URL:http://en.wikipedia.org/wiki/Afimoxifene|Name:KEGG, SrcID:D06551, URL:",CC\C(=C(/c1ccccc1)\c2ccc(OCCN(C)C)cc2)\c3ccc(O)cc3,,
4430,CHEMBL2220486,Lucitanib,Small molecule,,,,-anib,Vascular endothelial growth factor receptor inhibitor,"E-3810 is an ambiguous research code for this compouynd, also research code for rabeprazole, a proton pump inhibitor.",,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://bit.ly/1ZGqyT3, URL:http://bit.ly/1ZGqyT3|Name:PubMed, SrcID:21212416, URL:http://europepmc.org/abstract/MED/21212416|Name:PubMed, SrcID:22304225, URL:http://europepmc.org/abstract/MED/22304225",CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12,,
4431,CHEMBL3265032,Entospletinib,Small molecule,,,,-tinib,Tyrosine-protein kinase SYK inhibitor,,,CHEMBL2599,Tyrosine-protein kinase SYK,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24779514, URL:http://europepmc.org/abstract/MED/24779514",C1CN(CCO1)c2ccc(Nc3nc(cn4ccnc34)c5ccc6cn[nH]c6c5)cc2,CHEMBL2599,SYK
4432,CHEMBL3545156,Kw-2450,Small molecule,,,,,Insulin-like growth factor I receptor inhibitor,,,CHEMBL1957,Insulin-like growth factor I receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1158/1538-7445.AM2013-920, URL:http://cancerres.aacrjournals.org/content/73/8_Supplement/920",,CHEMBL1957,IGF1R
4433,CHEMBL2103851,Amuvatinib,Small molecule,,,,-tinib,Hepatocyte growth factor receptor inhibitor,"Inhibits mutant forms of KIT, FLT3 and PDGFRA (http://www.google.com/patents/US20080226747).",,CHEMBL3717,Hepatocyte growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25110867, URL:http://europepmc.org/abstract/MED/25110867|Name:Other, SrcID:http://www.google.com/patents/US20080226747, URL:http://www.google.com/patents/US20080226747|Name:PubMed, SrcID:24326130, URL:http://europepmc.org/abstract/MED/24326130",S=C(NCc1ccc2OCOc2c1)N3CCN(CC3)c4ncnc5c4oc6ccccc56,CHEMBL3717,MET
4434,CHEMBL2104986,Tedatioxetine,Small molecule,,,,-oxetine,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://www.google.com/patents/US20100144788, URL:https://www.google.com/patents/US20100144788|Name:Other, SrcID:http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false, URL:http://books.google.co.uk/books?id=qoyYobgX0uwC&pg=PA105&redir_esc=y#v=onepage&q&f=false|Name:Wikipedia, SrcID:Tedatioxetine, URL:http://en.wikipedia.org/wiki/Tedatioxetine",Cc1ccc(Sc2ccccc2C3CCNCC3)cc1,CHEMBL224,HTR2A
4435,CHEMBL2110670,Vabicaserin,Small molecule,,,,-caserin,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21402690, URL:http://europepmc.org/abstract/MED/21402690",C1C[C@H]2CN3CCNCc4cccc([C@H]2C1)c34,CHEMBL224,HTR2A
4436,CHEMBL3039518,Batefenterol,Small molecule,,,,-terol,Beta-2 adrenergic receptor agonist,,,CHEMBL210,Beta-2 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25629394, URL:http://europepmc.org/abstract/MED/25629394|Name:PubMed, SrcID:25100753, URL:http://europepmc.org/abstract/MED/25100753",COc1cc(NC(=O)CCN2CCC(CC2)OC(=O)Nc3ccccc3c4ccccc4)c(Cl)cc1CNC[C@H](O)c5ccc(O)c6NC(=O)C=Cc56,CHEMBL210,ADRB2
4437,CHEMBL2027925,Capeserod,Small molecule,,,,-serod,Serotonin 4 (5-HT4) receptor partial agonist,"Binds to other 5-HT receptors with micromolar affinity. Can't find any clinical trial IDs, only mentions that the compound has been through phase 2 trials (OTHER:http://en.wikipedia.org/wiki/SL65.0155).",,CHEMBL1875,Serotonin 4 (5-HT4) receptor,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12130738, URL:http://europepmc.org/abstract/MED/12130738|Name:Wikipedia, SrcID:SL65.0155, URL:http://en.wikipedia.org/wiki/SL65.0155",Nc1c(Cl)cc(C2=NN(C3CCN(CCc4ccccc4)CC3)C(=O)O2)c5OCCOc15,CHEMBL1875,HTR4
4438,CHEMBL522302,Vofopitant,Small molecule,,,,-tant,Neurokinin 1 receptor antagonist,Discontinueddue to lack of efficacy.,,CHEMBL249,Neurokinin 1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:8876035, URL:http://europepmc.org/abstract/MED/8876035",COc1ccc(cc1CN[C@H]2CCCN[C@H]2c3ccccc3)n4nnnc4C(F)(F)F,CHEMBL249,TACR1
4439,CHEMBL515966,Ezlopitant,Small molecule,,,,-tant,Neurokinin 1 receptor antagonist,,,CHEMBL249,Neurokinin 1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Ezlopitant, URL:http://en.wikipedia.org/wiki/Ezlopitant|Name:PubMed, SrcID:12372904, URL:http://europepmc.org/abstract/MED/12372904",COc1ccc(cc1CN[C@H]2C3CCN(CC3)[C@H]2C(c4ccccc4)c5ccccc5)C(C)C,CHEMBL249,TACR1
4440,CHEMBL2068839,Cerc-301,Small molecule,,,,,Glutamate NMDA receptor; GRIN1/GRIN2B antagonist,"Non-competitive antagonist, negative modulator.",GRIN2B selective.,CHEMBL1907603,Glutamate NMDA receptor; GRIN1/GRIN2B,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX,,Binds to ifenprodil site on N-terminal domain.,"Name:PubMed, SrcID:23455590, URL:http://europepmc.org/abstract/MED/23455590|Name:PubMed, SrcID:22722512, URL:http://europepmc.org/abstract/MED/22722512|Name:Other, SrcID:http://www.cerecor.com/pipeline/overview.php, URL:http://www.cerecor.com/pipeline/overview.php",Cc1ccc(COC(=O)N2CC[C@H](CNc3ncccn3)[C@H](F)C2)cc1,,
4441,CHEMBL3545292,Qbw251,Small molecule,,,,,Cystic fibrosis transmembrane conductance regulator activator,"Indication: Cystic Fibrosis, COPD",,CHEMBL4051,Cystic fibrosis transmembrane conductance regulator,ACTIVATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.rbht.nhs.uk/research/our-research/active-research-studies/cystic-fibrosis/, URL:http://www.rbht.nhs.uk/research/our-research/active-research-studies/cystic-fibrosis/|Name:Other, SrcID:https://tools.cff.org/research/drugdevelopmentpipeline/, URL:https://tools.cff.org/research/drugdevelopmentpipeline/",,CHEMBL4051,CFTR
4442,CHEMBL3707250,Cp-601927,Small molecule,,,,,Neuronal acetylcholine receptor; alpha4/beta2 partial agonist,,,CHEMBL1907589,Neuronal acetylcholine receptor; alpha4/beta2,PARTIAL AGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:Other, SrcID:https://ncats.nih.gov/files/CP-601927.pdf, URL:https://ncats.nih.gov/files/CP-601927.pdf",,,
4443,CHEMBL2105160,Naminidil,Small molecule,,,,-dil,Sulfonylurea receptors; K-ATP channels opener,,,CHEMBL2095152,Sulfonylurea receptors; K-ATP channels,OPENER,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Other, SrcID:http://www.kegg.jp/dbget-bin/www_bget?dr:D05114, URL:http://www.kegg.jp/dbget-bin/www_bget?dr:D05114",C[C@@H](N\C(=N/C#N)\Nc1ccc(cc1)C#N)C(C)(C)C,,
4444,CHEMBL1908391,Masitinib,Small molecule,,L01XE22,L01XE22 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Fibroblast growth factor receptor 3 inhibitor,"Approved veterinary - 2012. Not recommended for approval (Negative opinion) in EU, phase 3 trials in US.",,CHEMBL2742,Fibroblast growth factor receptor 3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19789626, URL:http://europepmc.org/abstract/MED/19789626|Name:PubMed, SrcID:19541476, URL:http://europepmc.org/abstract/MED/19541476|Name:Other, SrcID:http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/veterinary/000128/WC500064717.pdf, URL:http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/veterinary/000128/WC500064717.pdf",CN1CCN(Cc2ccc(cc2)C(=O)Nc3ccc(C)c(Nc4nc(cs4)c5cccnc5)c3)CC1,CHEMBL2742,FGFR3
4445,CHEMBL1088752,Losmapimod,Small molecule,,,,-imod,MAP kinase p38 beta inhibitor,,,CHEMBL3961,MAP kinase p38 beta,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19556450, URL:http://europepmc.org/abstract/MED/19556450|Name:PubMed, SrcID:21262998, URL:http://europepmc.org/abstract/MED/21262998",Cc1c(F)cc(cc1c2ccc(cn2)C(=O)NCC(C)(C)C)C(=O)NC3CC3,CHEMBL3961,MAPK11
4446,CHEMBL101253,Vatalanib,Small molecule,,,,-anib,Platelet-derived growth factor receptor inhibitor,,,CHEMBL2095189,Platelet-derived growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:10786682, URL:http://europepmc.org/abstract/MED/10786682|Name:PubMed, SrcID:16882767, URL:http://europepmc.org/abstract/MED/16882767",Clc1ccc(Nc2nnc(Cc3ccncc3)c4ccccc24)cc1,,
4447,CHEMBL2108723,Peginterferon Lambda-1a,Protein,,,,peg-,Interferon lambda receptor agonist,,,CHEMBL3831284,Interferon lambda receptor,AGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:26357610, URL:http://europepmc.org/abstract/MED/26357610",,CHEMBL3831284,IFNLR1
4448,CHEMBL2108723,Peginterferon Lambda-1a,Protein,,,,peg-,Interferon lambda receptor agonist,,,CHEMBL3831284,Interferon lambda receptor,AGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:26357610, URL:http://europepmc.org/abstract/MED/26357610",,CHEMBL3831284,IL10RB
4449,CHEMBL515387,Gosogliptin,Small molecule,,,,-gliptin,Dipeptidyl peptidase IV inhibitor,,,CHEMBL284,Dipeptidyl peptidase IV,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21366665, URL:http://europepmc.org/abstract/MED/21366665",FC1(F)CCN(C1)C(=O)[C@@H]2C[C@@H](CN2)N3CCN(CC3)c4ncccn4,CHEMBL284,DPP4
4450,CHEMBL1650443,Trelagliptin,Small molecule,,,,-gliptin,Dipeptidyl peptidase IV inhibitor,,,CHEMBL284,Dipeptidyl peptidase IV,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24622716, URL:http://europepmc.org/abstract/MED/24622716",CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(Cc3cc(F)ccc3C#N)C1=O,CHEMBL284,DPP4
4451,CHEMBL3137320,Talazoparib,Small molecule,,,,-parib,Poly [ADP-ribose] polymerase-1 inhibitor,,,CHEMBL3105,Poly [ADP-ribose] polymerase-1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23881923, URL:http://europepmc.org/abstract/MED/23881923",Cn1ncnc1[C@@H]2[C@H](Nc3cc(F)cc4C(=O)NN=C2c34)c5ccc(F)cc5,CHEMBL3105,PARP1
4452,CHEMBL1742986,Atacicept,Protein,,,,-cept,Tumor necrosis factor ligand superfamily member 13 inhibitor,Soluble receptor. Acts as a decoy receptor for TNFSF13 (APRIL) and TNFSF13B (BAFF).,,CHEMBL3713436,Tumor necrosis factor ligand superfamily member 13,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21179612, URL:http://europepmc.org/abstract/MED/21179612|Name:PubMed, SrcID:18046446, URL:http://europepmc.org/abstract/MED/18046446",,CHEMBL3713436,TNFSF13
4453,CHEMBL1743077,Tenatumomab,Antibody,,,,-mab,Tenascin other,Intended use as tumour pretargeting agent.,,CHEMBL3712856,Tenascin,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12671694, URL:http://europepmc.org/abstract/MED/12671694",,CHEMBL3712856,TNC
4454,CHEMBL2109397,Morab-004,Antibody,,,,,Endosialin inhibitor,,,CHEMBL3712975,Endosialin,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25398449, URL:http://europepmc.org/abstract/MED/25398449",,CHEMBL3712975,CD248
4455,CHEMBL2108670,Bezlotoxumab,Antibody,2016.0,J06BB21,J06BB21 [ANTIINFECTIVES FOR SYSTEMIC USE: IMMUNE SERA AND IMMUNOGLOBULINS: IMMUNOGLOBULINS: Specific immunoglobulins],-mab,Toxin B inhibitor,,,CHEMBL3580505,Toxin B,INHIBITOR,Peptoclostridium difficile,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2016/761046s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761046s000lbl.pdf",,,
4456,CHEMBL1201325,Hexocyclium,Small molecule,1982.0,A03AB10,"A03AB10 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: Synthetic anticholinergics, quaternary ammonium compounds]",-ium,Muscarinic acetylcholine receptor M3 antagonist,"Role in regulating gastric secretion, M3 likely involved",,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:8075869, URL:http://europepmc.org/abstract/MED/8075869|Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:9183081, URL:http://europepmc.org/abstract/MED/9183081",C[N+]1(C)CCN(CC(O)(C2CCCCC2)c3ccccc3)CC1,CHEMBL245,CHRM3
4457,CHEMBL1305,Antazoline,Small molecule,1994.0,R01AC04; R06AX05,"R01AC04 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Antiallergic agents, excl. corticosteroids]; R06AX05 [RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Other antihistamines for systemic use]",-azoline,Histamine H1 receptor antagonist,,,CHEMBL231,Histamine H1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Antazoline, URL:http://en.wikipedia.org/wiki/Antazoline|Name:PubMed, SrcID:6113566, URL:http://europepmc.org/abstract/MED/6113566",C(N(Cc1ccccc1)c2ccccc2)C3=NCCN3,CHEMBL231,HRH1
4458,CHEMBL1201268,Methscopolamine,Small molecule,1953.0,S01FA03; A03BB03,"S01FA03 [SENSORY ORGANS: OPHTHALMOLOGICALS: MYDRIATICS AND CYCLOPLEGICS: Anticholinergics]; A03BB03 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: BELLADONNA AND DERIVATIVES, PLAIN: Belladonna alkaloids, semisynthetic, quaternary ammonium compounds]",,Muscarinic acetylcholine receptor M1 antagonist,"Role in regulating gastric secretion, M1 likely involved",,CHEMBL216,Muscarinic acetylcholine receptor M1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 153, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:DailyMed, SrcID:setid=46e661aa-b1bd-465e-a800-03bd3455d7d1#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=46e661aa-b1bd-465e-a800-03bd3455d7d1#nlm34090-1",C[N+]1(C)[C@H]2C[C@@H](C[C@H]1[C@H]3O[C@@H]23)OC(=O)[C@H](CO)c4ccccc4,CHEMBL216,CHRM1
4459,CHEMBL1118,Desvenlafaxine,Small molecule,2008.0,N06AX23,N06AX23 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants],-faxine,Serotonin transporter inhibitor,,,CHEMBL228,Serotonin transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=d52d4043-9795-41d0-91f1-d558fe18d680#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d52d4043-9795-41d0-91f1-d558fe18d680#nlm34090-1|Name:DailyMed, SrcID:setid=91cf39c9-4d26-480a-a3a3-a3d8d4c4d222#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=91cf39c9-4d26-480a-a3a3-a3d8d4c4d222#nlm34090-1|Name:FDA, SrcID:label/2013/205208s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/205208s000lbl.pdf",CN(C)CC(c1ccc(O)cc1)C2(O)CCCCC2,CHEMBL228,SLC6A4
4460,CHEMBL1201269,Chlorphentermine,Small molecule,1982.0,,,,Serotonin transporter substrate,,,CHEMBL228,Serotonin transporter,SUBSTRATE,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10458725, URL:http://europepmc.org/abstract/MED/10458725|Name:PubMed, SrcID:11888573, URL:http://europepmc.org/abstract/MED/11888573",CC(C)(N)Cc1ccc(Cl)cc1,CHEMBL228,SLC6A4
4461,CHEMBL457,Gemfibrozil,Small molecule,1981.0,C10AB04,"C10AB04 [CARDIOVASCULAR SYSTEM: LIPID MODIFYING AGENTS: LIPID MODIFYING AGENTS, PLAIN: Fibrates]",,Peroxisome proliferator-activated receptor alpha agonist,,,CHEMBL239,Peroxisome proliferator-activated receptor alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Gemfibrozil, URL:http://en.wikipedia.org/wiki/Gemfibrozil|Name:Wikipedia, SrcID:Fibrates, URL:http://en.wikipedia.org/wiki/Fibrates|Name:DailyMed, SrcID:setid=16a775ec-47e7-491f-8c48-319ce43dcd3b, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=16a775ec-47e7-491f-8c48-319ce43dcd3b",Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1,CHEMBL239,PPARA
4462,CHEMBL1201657,Heparin Sodium,Oligosaccharide,1939.0,B01AB51; C05BA03; S01XA14; C05BA53; B01AB01,B01AB51 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Heparin group]; C05BA03 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: ANTIVARICOSE THERAPY: Heparins or heparinoids for topical use]; S01XA14 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals]; C05BA53 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: ANTIVARICOSE THERAPY: Heparins or heparinoids for topical use]; B01AB01 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Heparin group],-parin,Antithrombin-III activator,Inhibits coagulation by activating antithrombin III; ATIII then binds to F10;,,CHEMBL1950,Antithrombin-III,ACTIVATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=cbc26e3c-aee9-4c0d-bdb1-bf350308fbce#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cbc26e3c-aee9-4c0d-bdb1-bf350308fbce#nlm34090-1|Name:ISBN, SrcID:9780702034718 PP. 299, URL:http://www.isbnsearch.org/isbn/9780702034718",,CHEMBL1950,SERPINC1
4463,CHEMBL442,Ergotamine,Small molecule,1948.0,N02CA52; N02CA02; N02CA72,N02CA52 [NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Ergot alkaloids]; N02CA02 [NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Ergot alkaloids]; N02CA72 [NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Ergot alkaloids],,Serotonin 1d (5-HT1d) receptor agonist,,,CHEMBL1983,Serotonin 1d (5-HT1d) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=1c066197-dea6-4705-9b4a-8703dd564a2a#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1c066197-dea6-4705-9b4a-8703dd564a2a#nlm34090-1|Name:ISBN, SrcID:0443-059748 PP. 167, URL:http://www.isbnsearch.org/isbn/0443059748|Name:PubMed, SrcID:10611116, URL:http://europepmc.org/abstract/MED/10611116",CN1C[C@@H](C=C2[C@H]1Cc3c[nH]c4cccc2c34)C(=O)N[C@]5(C)O[C@@]6(O)[C@@H]7CCCN7C(=O)[C@H](Cc8ccccc8)N6C5=O,CHEMBL1983,HTR1D
4464,CHEMBL716,Quetiapine,Small molecule,1997.0,N05AH04,"N05AH04 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Diazepines, oxazepines, thiazepines and oxepines]",-tiapine,Serotonin 2c (5-HT2c) receptor antagonist,,,CHEMBL225,Serotonin 2c (5-HT2c) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=a951cd63-d329-47c9-965a-582fa73a07c6#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a951cd63-d329-47c9-965a-582fa73a07c6#nlm34090-1",OCCOCCN1CCN(CC1)C2=Nc3ccccc3Sc4ccccc24,,
4465,CHEMBL766,Cilastatin,Small molecule,1985.0,,,-stat-,Renal dipeptidase inhibitor,,,CHEMBL1989,Renal dipeptidase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:3480361, URL:http://europepmc.org/abstract/MED/3480361|Name:Wikipedia, SrcID:Cilastatin, URL:http://en.wikipedia.org/wiki/Cilastatin|Name:PubMed, SrcID:3038022, URL:http://europepmc.org/abstract/MED/3038022|Name:PubMed, SrcID:3474745, URL:http://europepmc.org/abstract/MED/3474745",CC1(C)C[C@@H]1C(=O)N\C(=C/CCCCSC[C@H](N)C(=O)O)\C(=O)O,CHEMBL1989,DPEP1
4466,CHEMBL422330,Lumefantrine,Small molecule,2009.0,,,,Ferriprotoporphyrin IX inhibitor,,,CHEMBL613897,Ferriprotoporphyrin IX,INHIBITOR,Plasmodium falciparum,SMALL MOLECULE,,,"Name:Wikipedia, SrcID:Hemin, URL:http://en.wikipedia.org/wiki/Hemin|Name:DailyMed, SrcID:setid=7866ec19-dfac-47d4-a53f-511a12643cbf#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7866ec19-dfac-47d4-a53f-511a12643cbf#nlm34090-1",CCCCN(CCCC)CC(O)c1cc(Cl)cc2\C(=C\c3ccc(Cl)cc3)\c4cc(Cl)ccc4c12,,
4467,CHEMBL90555,Vincristine,Small molecule,1963.0,L01CA02,L01CA02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Vinca alkaloids and analogues],vin-,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,"Binds to beta tubulin, vinca site (PMID: 15057285)","Name:DailyMed, SrcID:setid=01cee93f-3ab9-44fa-8c9a-dd5958fd2db9, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=01cee93f-3ab9-44fa-8c9a-dd5958fd2db9|Name:PubMed, SrcID:22044006, URL:http://europepmc.org/abstract/MED/22044006",CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(=O)C)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1,CHEMBL2095182,TUBB8
4468,CHEMBL90555,Vincristine,Small molecule,1963.0,L01CA02,L01CA02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Vinca alkaloids and analogues],vin-,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,"Binds to beta tubulin, vinca site (PMID: 15057285)","Name:DailyMed, SrcID:setid=01cee93f-3ab9-44fa-8c9a-dd5958fd2db9, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=01cee93f-3ab9-44fa-8c9a-dd5958fd2db9|Name:PubMed, SrcID:22044006, URL:http://europepmc.org/abstract/MED/22044006",CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(=O)C)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1,CHEMBL2095182,TUBA3C
4469,CHEMBL90555,Vincristine,Small molecule,1963.0,L01CA02,L01CA02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Vinca alkaloids and analogues],vin-,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,"Binds to beta tubulin, vinca site (PMID: 15057285)","Name:DailyMed, SrcID:setid=01cee93f-3ab9-44fa-8c9a-dd5958fd2db9, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=01cee93f-3ab9-44fa-8c9a-dd5958fd2db9|Name:PubMed, SrcID:22044006, URL:http://europepmc.org/abstract/MED/22044006",CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(=O)C)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1,CHEMBL2095182,TUBA4A
4470,CHEMBL90555,Vincristine,Small molecule,1963.0,L01CA02,L01CA02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Vinca alkaloids and analogues],vin-,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,"Binds to beta tubulin, vinca site (PMID: 15057285)","Name:DailyMed, SrcID:setid=01cee93f-3ab9-44fa-8c9a-dd5958fd2db9, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=01cee93f-3ab9-44fa-8c9a-dd5958fd2db9|Name:PubMed, SrcID:22044006, URL:http://europepmc.org/abstract/MED/22044006",CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(=O)C)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1,CHEMBL2095182,TUBA3E
4471,CHEMBL90555,Vincristine,Small molecule,1963.0,L01CA02,L01CA02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Vinca alkaloids and analogues],vin-,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,"Binds to beta tubulin, vinca site (PMID: 15057285)","Name:DailyMed, SrcID:setid=01cee93f-3ab9-44fa-8c9a-dd5958fd2db9, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=01cee93f-3ab9-44fa-8c9a-dd5958fd2db9|Name:PubMed, SrcID:22044006, URL:http://europepmc.org/abstract/MED/22044006",CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(=O)C)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1,CHEMBL2095182,TUBB6
4472,CHEMBL90555,Vincristine,Small molecule,1963.0,L01CA02,L01CA02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Vinca alkaloids and analogues],vin-,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,"Binds to beta tubulin, vinca site (PMID: 15057285)","Name:DailyMed, SrcID:setid=01cee93f-3ab9-44fa-8c9a-dd5958fd2db9, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=01cee93f-3ab9-44fa-8c9a-dd5958fd2db9|Name:PubMed, SrcID:22044006, URL:http://europepmc.org/abstract/MED/22044006",CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(=O)C)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1,CHEMBL2095182,TUBB2B
4473,CHEMBL90555,Vincristine,Small molecule,1963.0,L01CA02,L01CA02 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Vinca alkaloids and analogues],vin-,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,"Binds to beta tubulin, vinca site (PMID: 15057285)","Name:DailyMed, SrcID:setid=01cee93f-3ab9-44fa-8c9a-dd5958fd2db9, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=01cee93f-3ab9-44fa-8c9a-dd5958fd2db9|Name:PubMed, SrcID:22044006, URL:http://europepmc.org/abstract/MED/22044006",CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(=O)C)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1,CHEMBL2095182,TUBA3D
4474,CHEMBL644,Trimipramine,Small molecule,1979.0,N06AA06,N06AA06 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Non-selective monoamine reuptake inhibitors],-pramine,Adrenergic receptor alpha-1 antagonist,,,CHEMBL2094251,Adrenergic receptor alpha-1,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:16229049, URL:http://europepmc.org/abstract/MED/16229049|Name:ISBN, SrcID:0443-059748 PP. 555, URL:http://www.isbnsearch.org/isbn/0443059748|Name:Wikipedia, SrcID:Trimipramine, URL:http://en.wikipedia.org/wiki/Trimipramine",CC(CN(C)C)CN1c2ccccc2CCc3ccccc13,,
4475,CHEMBL1020,Tolmetin,Small molecule,1976.0,M01AB03; M02AA21,"M01AB03 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Acetic acid derivatives and related substances]; M02AA21 [MUSCULO-SKELETAL SYSTEM: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: Antiinflammatory preparations, non-steroids for topical use]",,Cyclooxygenase inhibitor,,,CHEMBL2094253,Cyclooxygenase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:15458776, URL:http://europepmc.org/abstract/MED/15458776|Name:PubMed, SrcID:10377455, URL:http://europepmc.org/abstract/MED/10377455",Cc1ccc(cc1)C(=O)c2ccc(CC(=O)O)n2C,,
4476,CHEMBL15770,Sulindac,Small molecule,1978.0,M01AB02,"M01AB02 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Acetic acid derivatives and related substances]",-ac,Cyclooxygenase inhibitor,,,CHEMBL2094253,Cyclooxygenase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:10372826, URL:http://europepmc.org/abstract/MED/10372826",C[S+]([O-])c1ccc(\C=C/2\C(=C(CC(=O)O)c3cc(F)ccc23)C)cc1,,
4477,CHEMBL1159,Pinacidil,Small molecule,1989.0,,,-dil,"Sulfonylurea receptor 2, Kir6.2 opener",,,CHEMBL2095198,"Sulfonylurea receptor 2, Kir6.2",OPENER,Homo sapiens,PROTEIN COMPLEX,Sulfonylurea receptor 2,SUR2 is binding site,"Name:PubMed, SrcID:10825398, URL:http://europepmc.org/abstract/MED/10825398|Name:PubMed, SrcID:11118199, URL:http://europepmc.org/abstract/MED/11118199",CC(N\C(=N/C#N)\Nc1ccncc1)C(C)(C)C,,
4478,CHEMBL23,Diltiazem,Small molecule,1982.0,C05AE03; C08DB01,C05AE03 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Muscle relaxants]; C08DB01 [CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS: Benzothiazepine derivatives],-tiazem,Voltage-gated L-type calcium channel blocker,,,CHEMBL2095229,Voltage-gated L-type calcium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=a91f6d42-e74e-461b-af00-44a118ecc502, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a91f6d42-e74e-461b-af00-44a118ecc502|Name:Wikipedia, SrcID:Calcium_channel_blocker, URL:http://en.wikipedia.org/wiki/Calcium_channel_blocker|Name:Wikipedia, SrcID:L-type_calcium_channel, URL:http://en.wikipedia.org/wiki/L-type_calcium_channel|Name:Wikipedia, SrcID:Voltage-dependent_calcium_channel, URL:http://en.wikipedia.org/wiki/Voltage-dependent_calcium_channel|Name:Wikipedia, SrcID:Diltiazem, URL:http://en.wikipedia.org/wiki/Diltiazem",COc1ccc(cc1)[C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(=O)C,,
4479,CHEMBL776,Metaproterenol,Small molecule,1973.0,R03AB03; R03CB03,"R03AB03 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS, INHALANTS: Non-selective beta-adrenoreceptor agonists]; R03CB03 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS FOR SYSTEMIC USE: Non-selective beta-adrenoreceptor agonists]",,Beta-2 adrenergic receptor agonist,,,CHEMBL210,Beta-2 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:archiveid=170791, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=170791|Name:DailyMed, SrcID:setid=66eb4b4d-2388-49d3-8ffa-0b9bca75a28e#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=66eb4b4d-2388-49d3-8ffa-0b9bca75a28e#nlm34090-1",CC(C)NCC(O)c1cc(O)cc(O)c1,CHEMBL210,ADRB2
4480,CHEMBL1670,Mitotane,Small molecule,1970.0,L01XX23,L01XX23 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],,Cytochrome P450 11B1 inhibitor,,,CHEMBL1908,Cytochrome P450 11B1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19667279, URL:http://europepmc.org/abstract/MED/19667279",ClC(Cl)C(c1ccc(Cl)cc1)c2ccccc2Cl,CHEMBL1908,CYP11B1
4481,CHEMBL184,Acyclovir,Small molecule,1982.0,D06BB53; J05AB01; S01AD03; D06BB03,D06BB53 [DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: CHEMOTHERAPEUTICS FOR TOPICAL USE: Antivirals]; J05AB01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleosides and nucleotides excl. reverse transcriptase inhibitors]; S01AD03 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Antivirals]; D06BB03 [DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: CHEMOTHERAPEUTICS FOR TOPICAL USE: Antivirals],-vir,Human herpesvirus 1 DNA polymerase inhibitor,Prodrug enzyme: Thymidine kinase,,CHEMBL1872,Human herpesvirus 1 DNA polymerase,INHIBITOR,Herpes simplex virus (type 1 / strain 17),SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=12ea5042-8ea6-4ee9-a734-684a73edb373, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=12ea5042-8ea6-4ee9-a734-684a73edb373|Name:FDA, SrcID:label/2014/022436s004lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022436s004lbl.pdf",Nc1nc(O)c2ncn(COCCO)c2n1,,
4482,CHEMBL221959,Tofacitinib,Small molecule,2012.0,L04AA29,L04AA29 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Selective immunosuppressants],-tinib,Janus Kinase (JAK) inhibitor,,,CHEMBL2363062,Janus Kinase (JAK),INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Expert, SrcID:TOFACITINIB, URL:http://chembl.blogspot.co.uk/search?q=TOFACITINIB",C[C@@H]1CCN(C[C@@H]1N(C)c2ncnc3[nH]ccc23)C(=O)CC#N,,
4483,CHEMBL1341,Methoxyflurane,Small molecule,,N02BG09,N02BG09 [NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Other analgesics and antipyretics],-flurane,GABA-A receptor; anion channel positive modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:18175089, URL:http://europepmc.org/abstract/MED/18175089",COC(F)(F)C(Cl)Cl,CHEMBL2093872,GABRG3
4484,CHEMBL1341,Methoxyflurane,Small molecule,,N02BG09,N02BG09 [NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Other analgesics and antipyretics],-flurane,GABA-A receptor; anion channel positive modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:18175089, URL:http://europepmc.org/abstract/MED/18175089",COC(F)(F)C(Cl)Cl,CHEMBL2093872,GABRP
4485,CHEMBL1341,Methoxyflurane,Small molecule,,N02BG09,N02BG09 [NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Other analgesics and antipyretics],-flurane,GABA-A receptor; anion channel positive modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:18175089, URL:http://europepmc.org/abstract/MED/18175089",COC(F)(F)C(Cl)Cl,CHEMBL2093872,GABRE
4486,CHEMBL1341,Methoxyflurane,Small molecule,,N02BG09,N02BG09 [NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Other analgesics and antipyretics],-flurane,GABA-A receptor; anion channel positive modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:18175089, URL:http://europepmc.org/abstract/MED/18175089",COC(F)(F)C(Cl)Cl,CHEMBL2093872,GABRG1
4487,CHEMBL9,Norfloxacin,Small molecule,1986.0,S01AE02; J01MA06,S01AE02 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Fluoroquinolones]; J01MA06 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolones],-oxacin,Topoisomerase IV inhibitor,,Broad spectrum,CHEMBL2363076,Topoisomerase IV,INHIBITOR,Bacteria,PROTEIN COMPLEX,,,"Name:FDA, SrcID:label/2013/019384s066lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019384s066lbl.pdf|Name:DailyMed, SrcID:setid=36087c76-5da9-4fab-e88f-da1d5a579d8e, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=36087c76-5da9-4fab-e88f-da1d5a579d8e",CCN1C=C(C(=O)O)C(=O)c2cc(F)c(cc12)N3CCNCC3,,
4488,CHEMBL608,Probucol,Small molecule,1977.0,C10AX02,"C10AX02 [CARDIOVASCULAR SYSTEM: LIPID MODIFYING AGENTS: LIPID MODIFYING AGENTS, PLAIN: Other lipid modifying agents]",,ATP-binding cassette sub-family A member 1 inhibitor,,,CHEMBL2362986,ATP-binding cassette sub-family A member 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15514211, URL:http://europepmc.org/abstract/MED/15514211",CC(C)(C)c1cc(SC(C)(C)Sc2cc(c(O)c(c2)C(C)(C)C)C(C)(C)C)cc(c1O)C(C)(C)C,CHEMBL2362986,ABCA1
4489,CHEMBL2221249,Colistin,Unknown,1962.0,J01XB01; A07AA10,"J01XB01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER ANTIBACTERIALS: Polymyxins]; A07AA10 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFECTIVES: Antibiotics]",,Cell outer membrane inhibitor,Disrupts cell membrane,,CHEMBL2364032,Cell outer membrane,INHIBITOR,Bacteria,SUBCELLULAR,,,"Name:FDA, SrcID:label/2009/050356s050lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/050356s050lbl.pdf",CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O)[C@@H](C)O.CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]2CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC2=O)[C@@H](C)O)[C@@H](C)O,,
4490,CHEMBL1201486,Quinidine Polygalacturonate,Small molecule,1982.0,C01BA01,"C01BA01 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class Ia]",,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:nda/99/11-642S012_Cardioquin_prntlbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/11-642S012_Cardioquin_prntlbl.pdf",,,
4491,CHEMBL1068,Oxcarbazepine,Small molecule,2000.0,N03AF02,N03AF02 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Carboxamide derivatives],-pin(e),Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=ca6bfbbb-fcca-4c15-a160-ee5791ed2f6e#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ca6bfbbb-fcca-4c15-a160-ee5791ed2f6e#nlm34090-1|Name:PubMed, SrcID:15208697, URL:http://europepmc.org/abstract/MED/15208697|Name:PubMed, SrcID:23205958, URL:http://europepmc.org/abstract/MED/23205958",NC(=O)N1c2ccccc2CC(=O)c3ccccc13,,
4492,CHEMBL1200694,Sevoflurane,Small molecule,1995.0,N01AB08,"N01AB08 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,Potassium channel subfamily K member 3 opener,,,CHEMBL2321613,Potassium channel subfamily K member 3,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:22226507, URL:http://europepmc.org/abstract/MED/22226507|Name:PubMed, SrcID:21788314, URL:http://europepmc.org/abstract/MED/21788314",FCOC(C(F)(F)F)C(F)(F)F,CHEMBL2321613,KCNK3
4493,CHEMBL2219536,Mipomersen,Oligonucleotide,2013.0,C10AX11,"C10AX11 [CARDIOVASCULAR SYSTEM: LIPID MODIFYING AGENTS: LIPID MODIFYING AGENTS, PLAIN: Other lipid modifying agents]",-rsen,Apo-B 100 mRNA antisense inhibitor,"It's an antisense oligonucleotide against apo b-100, the principal apoliprotein of LDL and its metabolic precursor VLDL",,CHEMBL2364185,Apo-B 100 mRNA,ANTISENSE INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=34de65be-f110-4000-a0f1-cb00ec98658f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=34de65be-f110-4000-a0f1-cb00ec98658f",COCCO[C@H]1[C@@H](O)[C@H](COP(=O)(O)S[C@H]2[C@H](COP(=O)(O)S[C@H]3[C@H](COP(=O)(O)S[C@H]4[C@H](COP(=O)(O)S[C@@H]5[C@@H](COP(=O)(O)S[C@H]6C[C@@H](O[C@@H]6COP(=O)(O)S[C@H]7C[C@@H](O[C@@H]7COP(=O)(O)S[C@H]8C[C@@H](O[C@@H]8COP(=O)(O)S[C@H]9C[C@@H](O[C@@H]9COP(=O)(O)S[C@H]%10C[C@@H](O[C@@H]%10COP(=O)(O)S[C@H]%11C[C@@H](O[C@@H]%11COP(=O)(O)S[C@H]%12C[C@@H](O[C@@H]%12COP(=O)(O)S[C@H]%13C[C@@H](O[C@@H]%13COP(=O)(O)S[C@H]%14C[C@@H](O[C@@H]%14COP(=O)(O)S[C@H]%15C[C@@H](O[C@@H]%15COP(=O)(O)S[C@@H]%16[C@@H](COP(=O)(O)S[C@@H]%17[C@@H](COP(=O)(O)S[C@@H]%18[C@@H](COP(=O)(O)S[C@@H]%19[C@@H](COP(=O)(O)S[C@@H]%20[C@@H](CO)O[C@H]([C@@H]%20OCCOC)n%21cnc%22C(=O)NC(=Nc%21%22)N)O[C@H]([C@@H]%19OCCOC)N%23C=C(C)C(=NC%23=O)N)O[C@H]([C@@H]%18OCCOC)N%24C=C(C)C(=NC%24=O)N)O[C@H]([C@@H]%17OCCOC)N%25C=C(C)C(=O)NC%25=O)O[C@H]([C@@H]%16OCCOC)N%26C=C(C)C(=NC%26=O)N)n%27cnc%28c(N)ncnc%27%28)n%29cnc%30C(=O)NC(=Nc%29%30)N)N%31C=C(C)C(=O)NC%31=O)N%32C=C(C)C(=NC%32=O)N)N%33C=C(C)C(=O)NC%33=O)n%34cnc%35C(=O)NC(=Nc%34%35)N)N%36C=C(C)C(=NC%36=O)N)N%37C=C(C)C(=O)NC%37=O)N%38C=C(C)C(=O)NC%38=O)N%39C=C(C)C(=NC%39=O)N)O[C@H]([C@@H]5OCCOC)n%40cnc%41C(=O)NC(=Nc%40%41)N)O[C@@H]([C@H]4OCCOC)N%42C=C(C)C(=NC%42=O)N)O[C@@H]([C@H]3OCCOC)n%43cnc%44c(N)ncnc%43%44)O[C@@H]([C@H]2OCCOC)N%45C=C(C)C(=NC%45=O)N)O[C@@H]1N%46C=C(C)C(=NC%46=O)N,,
4494,CHEMBL1198,Pramoxine,Small molecule,1976.0,D04AB07; C05AD07,"D04AB07 [DERMATOLOGICALS: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: Anesthetics for topical use]; C05AD07 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Local anesthetics]",,Unknown,,,,,,,,,,"Name:PubMed, SrcID:13107298, URL:http://europepmc.org/abstract/MED/13107298",CCCCOc1ccc(OCCCN2CCOCC2)cc1,,
4495,CHEMBL3039583,Pasireotide,Protein,2012.0,H01CB05,"H01CB05 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: HYPOTHALAMIC HORMONES: Somatostatin and analogues]",-tide,Somatostatin receptor 2 agonist,,,CHEMBL1804,Somatostatin receptor 2,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=5504116c-d531-4d47-b160-41c6671d52aa, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5504116c-d531-4d47-b160-41c6671d52aa|Name:DailyMed, SrcID:setid=442f0d9d-5c7d-4b81-b329-d71be8cf2be2, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=442f0d9d-5c7d-4b81-b329-d71be8cf2be2|Name:PubMed, SrcID:22397653, URL:http://europepmc.org/abstract/MED/22397653|Name:PubMed, SrcID:11980628, URL:http://europepmc.org/abstract/MED/11980628",NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](NC(=O)[C@@H]4C[C@@H](CN4C(=O)[C@H](Cc5ccccc5)NC(=O)[C@H](Cc6ccc(OCc7ccccc7)cc6)NC1=O)OC(=O)NCCN)c8ccccc8,CHEMBL1804,SSTR2
4496,CHEMBL3301625,Spebrutinib,Small molecule,,,,-tinib,Tyrosine-protein kinase BTK inhibitor,Irreversible inhibitor,,CHEMBL5251,Tyrosine-protein kinase BTK,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23709115, URL:http://europepmc.org/abstract/MED/23709115",COCCOc1ccc(Nc2ncc(F)c(Nc3cccc(NC(=O)C=C)c3)n2)cc1,CHEMBL5251,BTK
4497,CHEMBL1908397,Kw-2449,Small molecule,,,,,Serine/threonine-protein kinase Aurora-B inhibitor,,,CHEMBL2185,Serine/threonine-protein kinase Aurora-B,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19541823, URL:http://europepmc.org/abstract/MED/19541823|Name:PubMed, SrcID:21474579, URL:http://europepmc.org/abstract/MED/21474579",O=C(N1CCNCC1)c2ccc(\C=C\c3n[nH]c4ccccc34)cc2,CHEMBL2185,AURKB
4498,CHEMBL3545378,Mk-6592,Small molecule,,,,,Serine/threonine-protein kinase Aurora inhibitor,,,CHEMBL3430911,Serine/threonine-protein kinase Aurora,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19684075, URL:http://europepmc.org/abstract/MED/19684075|Name:Other, SrcID:http://investors.vrtx.com/releasedetail.cfm?ReleaseID=276543, URL:http://investors.vrtx.com/releasedetail.cfm?ReleaseID=276543",Cc1cc(Nc2cc(nc(O[C@H]3CCN(C3)C(=O)c4cc(Cl)ccc4F)n2)N5CC(F)(C5)C6CC6)n[nH]1,,
4499,CHEMBL3545002,Mp-412,Small molecule,,,,,Receptor protein-tyrosine kinase erbB-2 inhibitor,,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17888033, URL:http://europepmc.org/abstract/MED/17888033|Name:PubMed, SrcID:19459856, URL:http://europepmc.org/abstract/MED/19459856",,CHEMBL1824,ERBB2
4500,CHEMBL49120,Pd-0166285,Small molecule,,,,,Platelet-derived growth factor receptor beta inhibitor,Multi-targeted kinase irreversible inhibitor,,CHEMBL1913,Platelet-derived growth factor receptor beta,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10638483, URL:http://europepmc.org/abstract/MED/10638483",CCN(CC)CCOc1ccc(Nc2ncc3C=C(C(=O)N(C)c3n2)c4c(Cl)cccc4Cl)cc1,CHEMBL1913,PDGFRB
4501,CHEMBL1963502,Pki-166,Small molecule,,,,,Epidermal growth factor receptor erbB1 inhibitor,Also potent against ABL1,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10850439, URL:http://europepmc.org/abstract/MED/10850439",C[C@@H](Nc1ncnc2[nH]c(cc12)c3ccc(O)cc3)c4ccccc4,CHEMBL203,EGFR
4502,CHEMBL3545006,Pwt-33587,Small molecule,,,,,Serine/threonine-protein kinase mTOR inhibitor,"Also studied in veterinary cancers. Dual MTOR/PI3K inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL2842,Serine/threonine-protein kinase mTOR,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1158/1538-7445.AM2014-1644, URL:http://cancerres.aacrjournals.org/content/74/19_Supplement/1644|Name:Other, SrcID:http://www.mosaiclabs.com/pdf/AACR2012_PWT33597_RCC.pdf, URL:http://www.mosaiclabs.com/pdf/AACR2012_PWT33597_RCC.pdf",,CHEMBL2842,MTOR
4503,CHEMBL1952329,Sgi-1776,Small molecule,,,,,Serine/threonine-protein kinase PIM inhibitor,,,CHEMBL3559682,Serine/threonine-protein kinase PIM,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:19825806, URL:http://europepmc.org/abstract/MED/19825806|Name:PubMed, SrcID:21628411, URL:http://europepmc.org/abstract/MED/21628411",CN1CCC(CNc2ccc3ncc(c4cccc(OC(F)(F)F)c4)n3n2)CC1,,
4504,CHEMBL3545085,Xl-228,Small molecule,,,,,SRC inhibitor,"Also potent inhibitor of AURKA, AURKB, FGFR1-3, and ALK.",,CHEMBL2363074,SRC,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DOI, SrcID:10.1158/1535-7163.TARG-09-C192, URL:http://mct.aacrjournals.org/content/8/12_Supplement/C192|Name:Other, SrcID:http://www.exelixis.com/sites/default/files/pdf/XL228-002_ASCO-2009.pdf, URL:http://www.exelixis.com/sites/default/files/pdf/XL228-002_ASCO-2009.pdf|Name:PubMed, SrcID:20124450, URL:http://europepmc.org/abstract/MED/20124450",CC(C)c1cc(CNc2nc(Nc3cc([nH]n3)C4CC4)cc(n2)N5CCN(C)CC5)on1,,
4505,CHEMBL3545329,Apd371,Small molecule,,,,,Cannabinoid CB2 receptor agonist,,,CHEMBL253,Cannabinoid CB2 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.arenapharm.com/apd371, URL:http://www.arenapharm.com/apd371",,CHEMBL253,CNR2
4506,CHEMBL2103824,Arhalofenate,Small molecule,,,,,Peroxisome proliferator-activated receptor gamma modulator,"Selective PPAR gamma modulator (SPPAR?M), SLC22A12 inhibitor",,CHEMBL235,Peroxisome proliferator-activated receptor gamma,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22404217, URL:http://europepmc.org/abstract/MED/22404217",CC(=O)NCCOC(=O)[C@H](Oc1cccc(c1)C(F)(F)F)c2ccc(Cl)cc2,CHEMBL235,PPARG
4507,CHEMBL2408045,Sapitinib,Small molecule,,,,-tinib,Epidermal growth factor receptor erbB1 inhibitor,,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24900741, URL:http://europepmc.org/abstract/MED/24900741|Name:PubMed, SrcID:20145185, URL:http://europepmc.org/abstract/MED/20145185",CNC(=O)CN1CCC(CC1)Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC,CHEMBL203,EGFR
4508,CHEMBL3039525,Golvatinib,Small molecule,,,,-tinib,Vascular endothelial growth factor receptor 2 inhibitor,,,CHEMBL279,Vascular endothelial growth factor receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25110867, URL:http://europepmc.org/abstract/MED/25110867|Name:PubMed, SrcID:19832844, URL:http://europepmc.org/abstract/MED/19832844",CN1CCN(CC1)C2CCN(CC2)C(=O)Nc3cc(Oc4ccc(NC(=O)C5(CC5)C(=O)Nc6ccc(F)cc6)c(F)c4)ccn3,CHEMBL279,KDR
4509,CHEMBL3545158,Plx-3397,Small molecule,,,,,Stem cell growth factor receptor inhibitor,,,CHEMBL1936,Stem cell growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22039576, URL:http://europepmc.org/abstract/MED/22039576|Name:PubMed, SrcID:25847190, URL:http://europepmc.org/abstract/MED/25847190",,CHEMBL1936,KIT
4510,CHEMBL3545159,R-333,Small molecule,,,,,Tyrosine-protein kinase JAK3 inhibitor,Active metabolite of R-348,,CHEMBL2148,Tyrosine-protein kinase JAK3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.rigel.com/index.php/pipeline/, URL:http://www.rigel.com/index.php/pipeline/",,CHEMBL2148,JAK3
4511,CHEMBL1922094,Apitolisib,Small molecule,,,,-lisib,Serine/threonine-protein kinase mTOR inhibitor,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL2842,Serine/threonine-protein kinase mTOR,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21981714, URL:http://europepmc.org/abstract/MED/21981714|Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718",C[C@H](O)C(=O)N1CCN(Cc2sc3c(nc(nc3c2C)c4cnc(N)nc4)N5CCOCC5)CC1,CHEMBL2842,MTOR
4512,CHEMBL119385,Vx-745,Small molecule,,,,,MAP kinase p38 alpha inhibitor,,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24900264, URL:http://europepmc.org/abstract/MED/24900264",Fc1ccc(SC2=NN3C=NC(=O)C(=C3C=C2)c4c(Cl)cccc4Cl)c(F)c1,CHEMBL260,MAPK14
4513,CHEMBL3544946,Pf-06291874,Small molecule,,,,,Glucagon receptor antagonist,,,CHEMBL1985,Glucagon receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.pfizer.com/research/science_and_technology/product_pipeline, URL:http://www.pfizer.com/research/science_and_technology/product_pipeline",,CHEMBL1985,GCGR
4514,CHEMBL189475,Ladarixin,Small molecule,,,,-rixin,Interleukin-8 receptor A modulator,"Ph 2 study terminated, being developed for new indication (http://www.dompe.com/Diabetology/).",,CHEMBL4029,Interleukin-8 receptor A,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21718305, URL:http://europepmc.org/abstract/MED/21718305",C[C@@H](C(=O)NS(=O)(=O)C)c1ccc(OS(=O)(=O)C(F)(F)F)cc1,CHEMBL4029,CXCR1
4515,CHEMBL10188,Talnetant,Small molecule,,,,-tant,Neurokinin 3 receptor antagonist,,,CHEMBL4429,Neurokinin 3 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:9190866, URL:http://europepmc.org/abstract/MED/9190866",CC[C@H](NC(=O)c1c(O)c(nc2ccccc12)c3ccccc3)c4ccccc4,CHEMBL4429,TACR3
4516,CHEMBL2070241,Bremelanotide,Protein,,,,-tide,Melanocortin receptor 3 agonist,"Peptide, alpha-MSH analogue.",,CHEMBL4644,Melanocortin receptor 3,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Bremelanotide, URL:http://en.wikipedia.org/wiki/Bremelanotide|Name:PubMed, SrcID:12851303, URL:http://europepmc.org/abstract/MED/12851303|Name:PubMed, SrcID:17584130, URL:http://europepmc.org/abstract/MED/17584130",CCCC[C@H](NC(=O)C)C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc4ccccc4)NC(=O)[C@H](Cc5cnc[nH]5)NC1=O)C(=O)O,CHEMBL4644,MC3R
4517,CHEMBL2109191,Galiximab,Antibody,,,,-mab,T-lymphocyte activation antigen CD80 inhibitor,Antibody-dependent cell-mediated cytotoxicity (ADCC).,,CHEMBL2364157,T-lymphocyte activation antigen CD80,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22267549, URL:http://europepmc.org/abstract/MED/22267549",,CHEMBL2364157,CD80
4518,CHEMBL2107856,Imetelstat,Oligonucleotide,,,,-stat,Telomerase reverse transcriptase inhibitor,Competes with telomere binding leading to dose-dependent nihibition of telomerase (IC50 0.45µM) and progressively telomere shortening.,,CHEMBL2916,Telomerase reverse transcriptase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,Binds the template region of the RNA component of telomerase (hTR or hTERC),"Name:PubMed, SrcID:27192120, URL:http://europepmc.org/abstract/MED/27192120|Name:PubMed, SrcID:20048334, URL:http://europepmc.org/abstract/MED/20048334",,CHEMBL2916,TERT
4519,CHEMBL2107862,Rintatolimod,Oligonucleotide,,,,-imod,Toll-like receptor 3 agonist,,,CHEMBL1075113,Toll-like receptor 3,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11607032, URL:http://europepmc.org/abstract/MED/11607032",,CHEMBL1075113,TLR3
4520,CHEMBL2104967,Firategrast,Small molecule,,,,-ast,Integrin alpha-4/beta-1 antagonist,,,CHEMBL1907599,Integrin alpha-4/beta-1,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:22226929, URL:http://europepmc.org/abstract/MED/22226929",CCOCc1cc(OC)c(c(OC)c1)c2ccc(C[C@H](NC(=O)c3c(F)cccc3F)C(=O)O)cc2,,
4521,CHEMBL2104981,Rilapladib,Small molecule,,,,-pladib,LDL-associated phospholipase A2 inhibitor,,,CHEMBL3514,LDL-associated phospholipase A2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24475026, URL:http://europepmc.org/abstract/MED/24475026|Name:PubMed, SrcID:23973698, URL:http://europepmc.org/abstract/MED/23973698",COCCN1CCC(CC1)N(Cc2ccc(cc2)c3ccc(cc3)C(F)(F)F)C(=O)CN4C(=CC(=O)c5ccccc45)SCc6cccc(F)c6F,CHEMBL3514,PLA2G7
4522,CHEMBL429876,Cilengitide,Protein,,,,-tide,Integrin alpha-V/beta-3 antagonist,,,CHEMBL1907598,Integrin alpha-V/beta-3,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:21269250, URL:http://europepmc.org/abstract/MED/21269250|Name:PubMed, SrcID:12706360, URL:http://europepmc.org/abstract/MED/12706360",CC(C)[C@@H]1N(C)C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC1=O,,
4523,CHEMBL18901,Efaproxiral,Small molecule,,L01XD06,L01XD06 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Sensitizers used in photodynamic/radiation therapy],,Hemoglobin HbA negative modulator,"Reduces hemoglobin-oxygen binding affinity facilitating oxygen release from hemoglobin, resulting in increases in tissue partial pressure of oxygen",,CHEMBL2095168,Hemoglobin HbA,NEGATIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:11316875, URL:http://europepmc.org/abstract/MED/11316875|Name:PubMed, SrcID:8770102, URL:http://europepmc.org/abstract/MED/8770102",Cc1cc(C)cc(NC(=O)Cc2ccc(OC(C)(C)C(=O)O)cc2)c1,,
4524,CHEMBL3833329,Erenumab,Antibody,,,,-mab,Calcitonin gene-related peptide type 1 receptor antagonist,Binds to the CGRP receptor and inhibits the function of CGRP.,,CHEMBL3798,Calcitonin gene-related peptide type 1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:28129635, URL:http://europepmc.org/abstract/MED/28129635",,,
4525,CHEMBL1742984,Amatuximab,Antibody,,,,-mab,Mesothelin inhibitor,MORAb-009 can internalize after binding mesothelin on the cell surface. MORAb-009 can exert antibody-dependent cellular cytotoxicity. MORAb-009 blocks CA125/MUC16-mesothelin interaction.,,CHEMBL3712878,Mesothelin,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18088084, URL:http://europepmc.org/abstract/MED/18088084|Name:Other, SrcID:http://www.morphotek.com/pipeline/Amatuximab.aspx, URL:http://www.morphotek.com/pipeline/Amatuximab.aspx",,CHEMBL3712878,MSLN
4526,CHEMBL3545350,Evt-101,Small molecule,,,,,Glutamate NMDA receptor; GRIN1/GRIN2B antagonist,"Non-competitive antagonist, negative modulator.",GRIN2B selective.,CHEMBL1907603,Glutamate NMDA receptor; GRIN1/GRIN2B,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX,,Binds to ifenprodil site on N-terminal domain.,,Cc1nccn1Cc2cc(cnn2)c3ccc(F)c(c3)C(F)F,,
4527,CHEMBL98,Vorinostat,Small molecule,2006.0,L01XX38,L01XX38 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-stat,Histone deacetylase 3 inhibitor,,,CHEMBL1829,Histone deacetylase 3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13",ONC(=O)CCCCCCC(=O)Nc1ccccc1,CHEMBL1829,HDAC3
4528,CHEMBL59,Dopamine,Small molecule,1974.0,C01CA04,C01CA04 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES: Adrenergic and dopaminergic agents],-pamine,Beta-1 adrenergic receptor agonist,,,CHEMBL213,Beta-1 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Dopamine, URL:http://en.wikipedia.org/wiki/Dopamine|Name:DailyMed, SrcID:setid=e061fb3e-afd7-4188-b5fb-617ac1d3e38d, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e061fb3e-afd7-4188-b5fb-617ac1d3e38d",NCCc1ccc(O)c(O)c1,,
4529,CHEMBL1200978,Arsenic Trioxide,Small molecule,2000.0,L01XX27,L01XX27 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],,Thioredoxin reductase 1 inhibitor,,,CHEMBL1927,Thioredoxin reductase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17640917, URL:http://europepmc.org/abstract/MED/17640917",O=[As]O[As]=O,CHEMBL1927,TXNRD1
4530,CHEMBL770,Tolazoline,Small molecule,1985.0,C04AB02; M02AX02,C04AB02 [CARDIOVASCULAR SYSTEM: PERIPHERAL VASODILATORS: PERIPHERAL VASODILATORS: Imidazoline derivatives]; M02AX02 [MUSCULO-SKELETAL SYSTEM: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: Other topical products for joint and muscular pain],-azoline,Histamine H2 receptor agonist,,,CHEMBL1941,Histamine H2 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=0b94baa5-5af2-46e9-8111-519225206a28, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0b94baa5-5af2-46e9-8111-519225206a28|Name:PubMed, SrcID:6386273, URL:http://europepmc.org/abstract/MED/6386273|Name:DailyMed, SrcID:archiveid=232939, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=232939|Name:PubMed, SrcID:8487790, URL:http://europepmc.org/abstract/MED/8487790|Name:ISBN, SrcID:9780702034718 PP. 12, URL:http://www.isbnsearch.org/isbn/9780702034718",C(C1=NCCN1)c2ccccc2,CHEMBL1941,HRH2
4531,CHEMBL439849,Vilazodone,Small molecule,2011.0,N06AX24,N06AX24 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants],,Serotonin 1a (5-HT1a) receptor partial agonist,,,CHEMBL214,Serotonin 1a (5-HT1a) receptor,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15740724, URL:http://europepmc.org/abstract/MED/15740724|Name:FDA, SrcID:label/2012/022567s005lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022567s005lbl.pdf",NC(=O)c1oc2ccc(cc2c1)N3CCN(CCCCc4c[nH]c5ccc(cc45)C#N)CC3,CHEMBL214,HTR1A
4532,CHEMBL1201534,Danaparoid Sodium,Unknown,1996.0,B01AB09,B01AB09 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Heparin group],-paroid,Antithrombin-III activator,Inhibits coagulation by activating antithrombin III; ATIII then binds to F10;,,CHEMBL1950,Antithrombin-III,ACTIVATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 299, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:FDA, SrcID:nda/2001/20-430S003_Orgaran_prntlbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/20-430S003_Orgaran_prntlbl.pdf",,CHEMBL1950,SERPINC1
4533,CHEMBL1201716,Mecasermin,Protein,2005.0,H01AC03,"H01AC03 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES: ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES: Somatropin and somatropin agonists]",-ermin,Insulin-like growth factor I receptor agonist,,,CHEMBL1957,Insulin-like growth factor I receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=a8b27a1b-a611-4f91-ad22-76d4b390c3ae, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a8b27a1b-a611-4f91-ad22-76d4b390c3ae",,CHEMBL1957,IGF1R
4534,CHEMBL644,Trimipramine,Small molecule,1979.0,N06AA06,N06AA06 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Non-selective monoamine reuptake inhibitors],-pramine,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16229049, URL:http://europepmc.org/abstract/MED/16229049|Name:ISBN, SrcID:0443-059748 PP. 555, URL:http://www.isbnsearch.org/isbn/0443059748|Name:Wikipedia, SrcID:Trimipramine, URL:http://en.wikipedia.org/wiki/Trimipramine",CC(CN(C)C)CN1c2ccccc2CCc3ccccc13,CHEMBL224,HTR2A
4535,CHEMBL715,Olanzapine,Small molecule,1996.0,N05AH03,"N05AH03 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Diazepines, oxazepines, thiazepines and oxepines]",-pin(e),Serotonin 2c (5-HT2c) receptor antagonist,,,CHEMBL225,Serotonin 2c (5-HT2c) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=4464f13c-b9b9-4464-a05e-5b2cdc091fb2#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4464f13c-b9b9-4464-a05e-5b2cdc091fb2#nlm34090-1|Name:FDA, SrcID:label/2015/020592s064,021086s042,021253s049lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020592s064,021086s042,021253s049lbl.pdf|Name:FDA, SrcID:label/2012/022173s008s010s014lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022173s008s010s014lbl.pdf",CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24,,
4536,CHEMBL1201508,Glucagon Hydrochloride Recombinant,Protein,1998.0,H04AA01,"H04AA01 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PANCREATIC HORMONES: GLYCOGENOLYTIC HORMONES: Glycogenolytic hormones]",,Glucagon receptor agonist,,,CHEMBL1985,Glucagon receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12529935, URL:http://europepmc.org/abstract/MED/12529935",,CHEMBL1985,GCGR
4537,CHEMBL1574,Phentermine,Small molecule,1959.0,A08AA01,"A08AA01 [ALIMENTARY TRACT AND METABOLISM: ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS: ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS: Centrally acting antiobesity products]",,Norepinephrine transporter releasing agent,,,CHEMBL222,Norepinephrine transporter,RELEASING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Phentermine, URL:http://en.wikipedia.org/wiki/Phentermine|Name:PubMed, SrcID:21197148, URL:http://europepmc.org/abstract/MED/21197148",CC(C)(N)Cc1ccccc1,CHEMBL222,SLC6A2
4538,CHEMBL1433,Doxycycline,Small molecule,1967.0,J01AA02; A01AB22,J01AA02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: TETRACYCLINES: Tetracyclines]; A01AB22 [ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Antiinfectives and antiseptics for local oral treatment],-cycline,Matrix metalloproteinase 8 inhibitor,"It is an antibiotic, however, its primary action, due to the concentration reached in the human body is via metalloproteinases inhibition, which is beneficial in many pathological conditions in which MMP-mediated proteolysis of the extracellular matrix (ECM) contributes to the pathogenesis, such as heart remodeling, tumor invasion, and inflammation",,CHEMBL4588,Matrix metalloproteinase 8,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=3105a84b-655e-4940-9d11-4209cdb05d6b, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3105a84b-655e-4940-9d11-4209cdb05d6b|Name:PubMed, SrcID:20370419, URL:http://europepmc.org/abstract/MED/20370419|Name:PubMed, SrcID:20592239, URL:http://europepmc.org/abstract/MED/20592239|Name:PubMed, SrcID:17199549, URL:http://europepmc.org/abstract/MED/17199549",C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(=C(C(=O)N)C(=O)[C@@]3(O)C(=C2C(=O)c4c(O)cccc14)O)O,CHEMBL4588,MMP8
4539,CHEMBL2104987,Teduglutide,Protein,2012.0,A16AX08,A16AX08 [ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Various alimentary tract and metabolism products],-tide,Glucagon-like peptide 2 receptor agonist,,,CHEMBL5844,Glucagon-like peptide 2 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=66b69c1e-b25c-44d3-b5ff-1c1de9a516fa, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=66b69c1e-b25c-44d3-b5ff-1c1de9a516fa",CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)N)NC(=O)[C@@H](NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc5c[nH]cn5)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)O,CHEMBL5844,GLP2R
4540,CHEMBL1213490,Romidepsin,Small molecule,2009.0,L01XX39,L01XX39 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents],-depsin,Histone deacetylase inhibitor,,,CHEMBL2093865,Histone deacetylase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=03b39d40-90fe-11df-9de6-0002a5d5c51b#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=03b39d40-90fe-11df-9de6-0002a5d5c51b#section-13|Name:Wikipedia, SrcID:Histone_deacetylase_inhibitor, URL:http://en.wikipedia.org/wiki/Histone_deacetylase_inhibitor|Name:Wikipedia, SrcID:Romidepsin, URL:http://en.wikipedia.org/wiki/Romidepsin",C\C=C\1/NC(=O)[C@@H](CS)NC(=O)[C@H](CC(=O)C[C@H](OC(=O)[C@@H](NC1=O)C(C)C)\C=C\CCS)C(C)C,,
4541,CHEMBL1272,Repaglinide,Small molecule,1997.0,A10BX02,"A10BX02 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Other blood glucose lowering drugs, excl. insulins]",-glinide,"Sulfonylurea receptor 1, Kir6.2 blocker",,,CHEMBL2096972,"Sulfonylurea receptor 1, Kir6.2",BLOCKER,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:15219283, URL:http://europepmc.org/abstract/MED/15219283|Name:PubMed, SrcID:11716850, URL:http://europepmc.org/abstract/MED/11716850|Name:PubMed, SrcID:10773014, URL:http://europepmc.org/abstract/MED/10773014|Name:PubMed, SrcID:12196472, URL:http://europepmc.org/abstract/MED/12196472",CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3)ccc1C(=O)O,,
4542,CHEMBL546,Oxprenolol,Small molecule,1983.0,C07AA02,"C07AA02 [CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, non-selective]",-olol,Beta-2 adrenergic receptor antagonist,,,CHEMBL210,Beta-2 adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:2897304, URL:http://europepmc.org/abstract/MED/2897304|Name:ISBN, SrcID:9780702034718 PP. 189, URL:http://www.isbnsearch.org/isbn/9780702034718",CC(C)NCC(O)COc1ccccc1OCC=C,CHEMBL210,ADRB2
4543,CHEMBL685,Mebendazole,Small molecule,1974.0,P02CA51; P02CA01,"P02CA51 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTHELMINTICS: ANTINEMATODAL AGENTS: Benzimidazole derivatives]; P02CA01 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTHELMINTICS: ANTINEMATODAL AGENTS: Benzimidazole derivatives]",-bendazole,Tubulin inhibitor,,,CHEMBL2364705,Tubulin,INHIBITOR,Nematoda,PROTEIN COMPLEX GROUP,Beta tubulin,Binds to beta tubulin,"Name:ISBN, SrcID:9780702034718 PP. 669, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:13678839, URL:http://europepmc.org/abstract/MED/13678839|Name:DailyMed, SrcID:setid=c338415f-41e0-071d-8c51-a80a02ebf2cd, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c338415f-41e0-071d-8c51-a80a02ebf2cd|Name:Wikipedia, SrcID:Mebendazole, URL:http://en.wikipedia.org/wiki/Mebendazole",COC(=O)Nc1nc2ccc(cc2[nH]1)C(=O)c3ccccc3,,
4544,CHEMBL622,Etodolac,Small molecule,1991.0,M01AB08,"M01AB08 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Acetic acid derivatives and related substances]",-ac,Cyclooxygenase-2 inhibitor,,,CHEMBL230,Cyclooxygenase-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10377455, URL:http://europepmc.org/abstract/MED/10377455",CCc1cccc2c3CCOC(CC)(CC(=O)O)c3[nH]c12,CHEMBL230,PTGS2
4545,CHEMBL24828,Vandetanib,Small molecule,2011.0,L01XE12,L01XE12 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-anib,Tyrosine-protein kinase receptor RET inhibitor,,,CHEMBL2041,Tyrosine-protein kinase receptor RET,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13",COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC4CCN(C)CC4,CHEMBL2041,RET
4546,CHEMBL41355,Ezogabine,Small molecule,2011.0,N03AX21,N03AX21 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],-gab-,KCNQ (Kv7) potassium channel blocker,,,CHEMBL2363063,KCNQ (Kv7) potassium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2012/022345s001lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022345s001lbl.pdf|Name:PubMed, SrcID:18590620, URL:http://europepmc.org/abstract/MED/18590620",CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N,,
4547,CHEMBL1102,Glutethimide,Small molecule,1976.0,N05CE01,N05CE01 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Piperidinedione derivatives],,GABA-A receptor; anion channel positive modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:ISBN, SrcID:9780702034718 PP. 457, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:1585214, URL:http://europepmc.org/abstract/MED/1585214",CCC1(CCC(=O)NC1=O)c2ccccc2,CHEMBL2093872,GABRG3
4548,CHEMBL1102,Glutethimide,Small molecule,1976.0,N05CE01,N05CE01 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Piperidinedione derivatives],,GABA-A receptor; anion channel positive modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:ISBN, SrcID:9780702034718 PP. 457, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:1585214, URL:http://europepmc.org/abstract/MED/1585214",CCC1(CCC(=O)NC1=O)c2ccccc2,CHEMBL2093872,GABRP
4549,CHEMBL1102,Glutethimide,Small molecule,1976.0,N05CE01,N05CE01 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Piperidinedione derivatives],,GABA-A receptor; anion channel positive modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:ISBN, SrcID:9780702034718 PP. 457, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:1585214, URL:http://europepmc.org/abstract/MED/1585214",CCC1(CCC(=O)NC1=O)c2ccccc2,CHEMBL2093872,GABRE
4550,CHEMBL1102,Glutethimide,Small molecule,1976.0,N05CE01,N05CE01 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Piperidinedione derivatives],,GABA-A receptor; anion channel positive modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:ISBN, SrcID:9780702034718 PP. 457, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:1585214, URL:http://europepmc.org/abstract/MED/1585214",CCC1(CCC(=O)NC1=O)c2ccccc2,CHEMBL2093872,GABRG1
4551,CHEMBL447,Secobarbital,Small molecule,1950.0,N05CA06,"N05CA06 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Barbiturates, plain]",-barb-,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL2093872,GABRG3
4552,CHEMBL447,Secobarbital,Small molecule,1950.0,N05CA06,"N05CA06 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Barbiturates, plain]",-barb-,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL2093872,GABRP
4553,CHEMBL447,Secobarbital,Small molecule,1950.0,N05CA06,"N05CA06 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Barbiturates, plain]",-barb-,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL2093872,GABRE
4554,CHEMBL447,Secobarbital,Small molecule,1950.0,N05CA06,"N05CA06 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Barbiturates, plain]",-barb-,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL2093872,GABRG1
4555,CHEMBL1200359,Sulfameter,Small molecule,1966.0,J01ED04,J01ED04 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: SULFONAMIDES AND TRIMETHOPRIM: Long-acting sulfonamides],sulfa-,Bacterial dihydropteroate synthase inhibitor,,Broad spectrum,CHEMBL2364668,Bacterial dihydropteroate synthase,INHIBITOR,Bacteria,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 622, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:23118736, URL:http://europepmc.org/abstract/MED/23118736",COc1cnc(NS(=O)(=O)c2ccc(N)cc2)nc1,,
4556,CHEMBL1753,Clindamycin,Small molecule,1970.0,D10AF51; D10AF01; J01FF01; G01AA10,"D10AF51 [DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Antiinfectives for treatment of acne]; D10AF01 [DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Antiinfectives for treatment of acne]; J01FF01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS: Lincosamides]; G01AA10 [GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Antibiotics]",-mycin,Bacterial 70S ribosome inhibitor,,,CHEMBL2363135,Bacterial 70S ribosome,INHIBITOR,Bacteria,PROTEIN NUCLEIC-ACID COMPLEX,23S ribosomal RNA,23S RRNA,"Name:DailyMed, SrcID:setid=b225ab20-bc7c-43af-ae93-0f07d5948e1c#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b225ab20-bc7c-43af-ae93-0f07d5948e1c#nlm34090-1|Name:Wikipedia, SrcID:Lincosamides, URL:http://en.wikipedia.org/wiki/Lincosamides|Name:Wikipedia, SrcID:Clindamycin, URL:http://en.wikipedia.org/wiki/Clindamycin|Name:PubMed, SrcID:12860123, URL:http://europepmc.org/abstract/MED/12860123",CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O,,
4557,CHEMBL1237022,Tocilizumab,Antibody,2005.0,L04AC07,L04AC07 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Interleukin inhibitors],-mab,Interleukin-6 receptor alpha subunit inhibitor,"Complex with beta subunit in membrane bound form, but binds to soluble (alpha only) form too",,CHEMBL2364155,Interleukin-6 receptor alpha subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,Alpha subunit is binding site,"Name:DailyMed, SrcID:setid=2e5365ff-cb2a-4b16-b2c7-e35c6bf2de13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2e5365ff-cb2a-4b16-b2c7-e35c6bf2de13",,CHEMBL2364155,IL6R
4558,CHEMBL820,Busulfan,Small molecule,1954.0,L01AB01,L01AB01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ALKYLATING AGENTS: Alkyl sulfonates],-sulfan,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=03dc50f9-c7bd-4c0c-8bbb-c1216ec90c95, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=03dc50f9-c7bd-4c0c-8bbb-c1216ec90c95",CS(=O)(=O)OCCCCOS(=O)(=O)C,,
4559,CHEMBL105,Mitomycin,Small molecule,1981.0,L01DC03,L01DC03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES: Other cytotoxic antibiotics],-mycin,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=1a13d7a3-c625-4925-84c2-685323a1f8ec, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a13d7a3-c625-4925-84c2-685323a1f8ec|Name:FDA, SrcID:label/2014/022572s003lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022572s003lbl.pdf|Name:Wikipedia, SrcID:Mitomycin, URL:http://en.wikipedia.org/wiki/Mitomycin",CO[C@]12[C@H]3N[C@H]3CN1C4=C([C@H]2COC(=O)N)C(=O)C(=C(C)C4=O)N,,
4560,CHEMBL1301,Hydroxystilbamidine,Small molecule,1953.0,,,-amidine,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:PubMed, SrcID:6897222, URL:http://europepmc.org/abstract/MED/6897222",NC(=N)c1ccc(\C=C\c2ccc(cc2O)C(=N)N)cc1,,
4561,CHEMBL513,Carmustine,Small molecule,1977.0,L01AD01,L01AD01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ALKYLATING AGENTS: Nitrosoureas],-mustine,RNA inhibitor,,,CHEMBL2311222,RNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=be6776fe-7f24-417d-ef08-8830c4eca959, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=be6776fe-7f24-417d-ef08-8830c4eca959|Name:FDA, SrcID:label/2013/017422s046lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/017422s046lbl.pdf",ClCCNC(=O)N(CCCl)N=O,,
4562,CHEMBL1200,Benoxinate,Small molecule,1982.0,S01HA02; D04AB03,"S01HA02 [SENSORY ORGANS: OPHTHALMOLOGICALS: LOCAL ANESTHETICS: Local anesthetics]; D04AB03 [DERMATOLOGICALS: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: Anesthetics for topical use]",,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:Wikipedia, SrcID:Oxybuprocaine, URL:http://en.wikipedia.org/wiki/Oxybuprocaine|Name:PubMed, SrcID:15635807, URL:http://europepmc.org/abstract/MED/15635807",CCCCOc1cc(ccc1N)C(=O)OCCN(CC)CC,,
4563,CHEMBL15891,Lindane,Small molecule,1974.0,P03AB02,"P03AB02 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS: ECTOPARASITICIDES, INCL. SCABICIDES: Chlorine containing products]",,GABA-A receptor negative allosteric modulator,"mode not clear, but seems negative and likely allosteric, binds at picrotoxin site?",,CHEMBL2364025,GABA-A receptor,NEGATIVE ALLOSTERIC MODULATOR,Pediculus humanus,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:14635176, URL:http://europepmc.org/abstract/MED/14635176|Name:Wikipedia, SrcID:Lindane, URL:http://en.wikipedia.org/wiki/Lindane",Cl[C@@H]1[C@@H](Cl)[C@H](Cl)[C@H](Cl)[C@@H](Cl)[C@@H]1Cl,,
4564,CHEMBL1401,Nitazoxanide,Small molecule,2002.0,P01AX11,"P01AX11 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES: Other agents against amoebiasis and other protozoal diseases]",-oxanide,Pyruvate:ferredoxin oxidoreductase inhibitor,,,CHEMBL2364027,Pyruvate:ferredoxin oxidoreductase,INHIBITOR,Giardia intestinalis,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=56b1575a-dff4-4c5a-a159-2f858e7a0cb8, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=56b1575a-dff4-4c5a-a159-2f858e7a0cb8",CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-],,
4565,CHEMBL1754,Doxapram,Small molecule,1965.0,R07AB01,R07AB01 [RESPIRATORY SYSTEM: OTHER RESPIRATORY SYSTEM PRODUCTS: OTHER RESPIRATORY SYSTEM PRODUCTS: Respiratory stimulants],,Potassium channel subfamily K member 9 blocker,,,CHEMBL2321614,Potassium channel subfamily K member 9,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=a6bebe92-c96b-4022-a78b-652f03f32ca5#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6bebe92-c96b-4022-a78b-652f03f32ca5#nlm34090-1|Name:FDA, SrcID:label/2005/14879s044lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/14879s044lbl.pdf|Name:PubMed, SrcID:17227289, URL:http://europepmc.org/abstract/MED/17227289",CCN1CC(CCN2CCOCC2)C(C1=O)(c3ccccc3)c4ccccc4,CHEMBL2321614,KCNK9
4566,CHEMBL1201723,Sinecatechins,Unknown,2006.0,D06BB12,D06BB12 [DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: CHEMOTHERAPEUTICS FOR TOPICAL USE: Antivirals],,Unknown,"Mode of action not fully understood; it seems to inhibit some HPV enzymes, and it has some antioxidant properties",,,,,,,,,"Name:DailyMed, SrcID:setid=2c1cd745-79ab-487d-b759-995794cedb92, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c1cd745-79ab-487d-b759-995794cedb92|Name:PubMed, SrcID:22328955, URL:http://europepmc.org/abstract/MED/22328955|Name:PubMed, SrcID:23067286, URL:http://europepmc.org/abstract/MED/23067286",,,
4567,CHEMBL2108074,Pancrelipase,Enzyme,1996.0,A09AA02,"A09AA02 [ALIMENTARY TRACT AND METABOLISM: DIGESTIVES, INCL. ENZYMES: DIGESTIVES, INCL. ENZYMES: Enzyme preparations]",-ase,Fatty acids hydrolytic enzyme,,,CHEMBL2364711,Fatty acids,HYDROLYTIC ENZYME,Homo sapiens,SMALL MOLECULE,,,"Name:DailyMed, SrcID:setid=073201aa-556d-4a70-918e-84e9616fd88d#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=073201aa-556d-4a70-918e-84e9616fd88d#nlm34090-1",,,
4568,CHEMBL1721885,Su-014813,Small molecule,,,,,Stem cell growth factor receptor inhibitor,,,CHEMBL1936,Stem cell growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16891463, URL:http://europepmc.org/abstract/MED/16891463",Cc1[nH]c(\C=C\2/C(=O)Nc3ccc(F)cc23)c(C)c1C(=O)NC[C@H](O)CN4CCOCC4,CHEMBL1936,KIT
4569,CHEMBL3545322,Panulisib,Small molecule,,,,-lisib,Serine/threonine-protein kinase mTOR inhibitor,ATP-competitive mTORC1/mTORC2 inhibitor,,CHEMBL2842,Serine/threonine-protein kinase mTOR,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25700704, URL:http://europepmc.org/abstract/MED/25700704",,CHEMBL2842,MTOR
4570,CHEMBL1614725,Tak-285,Small molecule,,,,,Receptor protein-tyrosine kinase erbB-2 inhibitor,,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1016/S1359-6349(08)72245-6, URL:http://www.sciencedirect.com/science/article/pii/S1359634908722456|Name:PubMed, SrcID:22003817, URL:http://europepmc.org/abstract/MED/22003817",CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(c4)C(F)(F)F)c(Cl)c3)c12,CHEMBL1824,ERBB2
4571,CHEMBL3544933,Vs-4718,Small molecule,,,,,Focal adhesion kinase 1 inhibitor,,,CHEMBL2695,Focal adhesion kinase 1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20234193, URL:http://europepmc.org/abstract/MED/20234193|Name:PubMed, SrcID:20234191, URL:http://europepmc.org/abstract/MED/20234191",,CHEMBL2695,PTK2
4572,CHEMBL375611,Ly404039,Small molecule,,,,,Metabotropic glutamate receptor 2 agonist,Active metabolite of LY2140023,,CHEMBL5137,Metabotropic glutamate receptor 2,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17204749, URL:http://europepmc.org/abstract/MED/17204749",N[C@]1(CS(=O)(=O)[C@H]2[C@@H]([C@@H]12)C(=O)O)C(=O)O,CHEMBL5137,GRM2
4573,CHEMBL3545205,Incb-040093,Small molecule,,,,,PI3-kinase p110-delta subunit inhibitor,,,CHEMBL3130,PI3-kinase p110-delta subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://meetinglibrary.asco.org/content/146209-156, URL:http://meetinglibrary.asco.org/content/146209-156|Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=751623, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=751623",,CHEMBL3130,PIK3CD
4574,CHEMBL1783256,Azd6280,Small molecule,,,,,GABA receptor alpha-3 subunit positive allosteric modulator,,,CHEMBL3026,GABA receptor alpha-3 subunit,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25493397, URL:http://europepmc.org/abstract/MED/25493397",CCCNC(=O)c1nnc2c(cccc2c1N)c3cc(OC)ccc3OC,CHEMBL3026,GABRA3
4575,CHEMBL107367,Farglitazar,Small molecule,,,,-glitazar,Peroxisome proliferator-activated receptor gamma agonist,"1000-fold less potent at PPARA. Last updated November 2009, discontinued?",,CHEMBL235,Peroxisome proliferator-activated receptor gamma,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11698662, URL:http://europepmc.org/abstract/MED/11698662",Cc1oc(nc1CCOc2ccc(C[C@H](Nc3ccccc3C(=O)c4ccccc4)C(=O)O)cc2)c5ccccc5,CHEMBL235,PPARG
4576,CHEMBL445813,At-7519,Small molecule,,,,,Cyclin-dependent kinase inhibitor,,,CHEMBL3559691,Cyclin-dependent kinase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:25914884, URL:http://europepmc.org/abstract/MED/25914884|Name:PubMed, SrcID:19174555, URL:http://europepmc.org/abstract/MED/19174555",Clc1cccc(Cl)c1C(=O)Nc2c[nH]nc2C(=O)NC3CCNCC3,CHEMBL3559691,CDK12
4577,CHEMBL445813,At-7519,Small molecule,,,,,Cyclin-dependent kinase inhibitor,,,CHEMBL3559691,Cyclin-dependent kinase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:25914884, URL:http://europepmc.org/abstract/MED/25914884|Name:PubMed, SrcID:19174555, URL:http://europepmc.org/abstract/MED/19174555",Clc1cccc(Cl)c1C(=O)Nc2c[nH]nc2C(=O)NC3CCNCC3,CHEMBL3559691,CDK20
4578,CHEMBL1078983,Azd-2014,Small molecule,,,,,Serine/threonine-protein kinase mTOR inhibitor,ATP-competitive mTORC1/mTORC2 inhibitor,,CHEMBL2842,Serine/threonine-protein kinase mTOR,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://ncats.nih.gov/files/AZD2014.pdf, URL:https://ncats.nih.gov/files/AZD2014.pdf|Name:PubMed, SrcID:23375793, URL:http://europepmc.org/abstract/MED/23375793",COc1ccc(cc1CO)c2ccc3c(nc(nc3n2)N4C[C@@H](C)O[C@@H](C)C4)N5CCOCC5,CHEMBL2842,MTOR
4579,CHEMBL3184679,Azd-4547,Small molecule,,,,,Fibroblast growth factor receptor inhibitor,Compound can be found in AstraZeneca's clinical compound bank for OpenInnovation opportunities.,,CHEMBL2095217,Fibroblast growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:22369928, URL:http://europepmc.org/abstract/MED/22369928|Name:Other, SrcID:http://openinnovation.astrazeneca.com/what-we-offer/compound/azd4547/, URL:http://openinnovation.astrazeneca.com/what-we-offer/compound/azd4547/",COc1cc(CCc2cc(NC(=O)c3ccc(cc3)N4CC(C)NC(C)C4)n[nH]2)cc(OC)c1,,
4580,CHEMBL3545022,Ulixertinib,Small molecule,,,,-tinib,MAP kinase ERK2 inhibitor,,,CHEMBL4040,MAP kinase ERK2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://biomed-valley.com/portfolio/bvd-523, URL:https://biomed-valley.com/portfolio/bvd-523|Name:DOI, SrcID:10.1158/1538-7445.AM2015-4693, URL:http://cancerres.aacrjournals.org/content/75/15_Supplement/4693",,CHEMBL4040,MAPK1
4581,CHEMBL14762,Seliciclib,Small molecule,,,,-ciclib,Cyclin-dependent kinase 7 inhibitor,,,CHEMBL3055,Cyclin-dependent kinase 7,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26207228, URL:http://europepmc.org/abstract/MED/26207228|Name:PubMed, SrcID:25747275, URL:http://europepmc.org/abstract/MED/25747275|Name:PubMed, SrcID:9030781, URL:http://europepmc.org/abstract/MED/9030781",CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1,CHEMBL3055,CDK7
4582,CHEMBL3545154,Poziotinib,Small molecule,,,,-tinib,Epidermal growth factor receptor inhibitor,Irreversible inhibitor,,CHEMBL2363049,Epidermal growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:21306821, URL:http://europepmc.org/abstract/MED/21306821",COc1cc2ncnc(Nc3ccc(Cl)c(Cl)c3F)c2cc1OC4CCN(CC4)C(=O)C=C,,
4583,CHEMBL1234354,Pf-04691502,Small molecule,,,,,Serine/threonine-protein kinase mTOR inhibitor,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL2842,Serine/threonine-protein kinase mTOR,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21750219, URL:http://europepmc.org/abstract/MED/21750219|Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718",COc1ccc(cn1)C2=Cc3c(C)nc(N)nc3N([C@@H]4CC[C@H](CC4)OCCO)C2=O,CHEMBL2842,MTOR
4584,CHEMBL403989,Tg100-801,Small molecule,,,,,Fibroblast growth factor receptor 2 inhibitor,Prodrug - active metabolite is TG-100-572 (HY-10184),,CHEMBL4142,Fibroblast growth factor receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18311895, URL:http://europepmc.org/abstract/MED/18311895|Name:PubMed, SrcID:18483622, URL:http://europepmc.org/abstract/MED/18483622|Name:PubMed, SrcID:18330892, URL:http://europepmc.org/abstract/MED/18330892",Cc1cc(cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12)c5cc(OC(=O)c6ccccc6)ccc5Cl,CHEMBL4142,FGFR2
4585,CHEMBL3137313,Axelopran,Small molecule,,,,-opran,Mu opioid receptor antagonist,"Peripherally-restricted opioid receptor antagonist, affinity for OPRM1, OPRK1, OPRD1. Efficasy target OPRM1.",,CHEMBL233,Mu opioid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23549670, URL:http://europepmc.org/abstract/MED/23549670|Name:Other, SrcID:http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM401679.pdf, URL:http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM401679.pdf|Name:Other, SrcID:http://www.theravance.com/cns_pain, URL:http://www.theravance.com/cns_pain",NC(=O)c1cccc(c1)[C@H]2C[C@H]3CC[C@@H](C2)N3CCN(CC4CCCCC4)C(=O)[C@@H](O)CO,CHEMBL233,OPRM1
4586,CHEMBL426084,Samidorphan,Small molecule,,,,-orphan,Mu opioid receptor antagonist,"Compound is art of the combination product ALKS-5461, where samidorphan is combined with buprenorphine ALKS-5461 is being developed as an as antidepressant drug.",,CHEMBL233,Mu opioid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23381803, URL:http://europepmc.org/abstract/MED/23381803",NC(=O)c1ccc2C[C@H]3N(CC4CC4)CC[C@@]5(CC(=O)CC[C@@]35O)c2c1O,CHEMBL233,OPRM1
4587,CHEMBL539423,Sparsentan,Small molecule,,,,-entan,Type-1 angiotensin II receptor antagonist,,,CHEMBL227,Type-1 angiotensin II receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:6384196, URL:http://europepmc.org/abstract/MED/6384196|Name:Other, SrcID:http://www.drugs.com/clinical_trials/pharmacopeia-announces-positive-results-initial-dara-clinical-trial-523.html, URL:http://www.drugs.com/clinical_trials/pharmacopeia-announces-positive-results-initial-dara-clinical-trial-523.html|Name:Other, SrcID:http://www.retrophin.com/content/pipeline/re021.php, URL:http://www.retrophin.com/content/pipeline/re021.php",CCCCC1=NC2(CCCC2)C(=O)N1Cc3ccc(c(COCC)c3)c4ccccc4S(=O)(=O)Nc5noc(C)c5C,CHEMBL227,AGTR1
4588,CHEMBL3545036,Raseglurant,Small molecule,,,,-glurant,Metabotropic glutamate receptor 5 modulator,,,CHEMBL3227,Metabotropic glutamate receptor 5,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Raseglurant, URL:http://en.wikipedia.org/wiki/Raseglurant|Name:PMC, SrcID:PMC172159, URL:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC172159/|Name:PubMed, SrcID:19460767, URL:http://europepmc.org/abstract/MED/19460767",Cc1cc(C)c(N)c(n1)C#Cc2cccc(F)c2,CHEMBL3227,GRM5
4589,CHEMBL2106841,Nonabine,Small molecule,,,,-nab-,Cannabinoid CB1 receptor agonist,,,CHEMBL218,Cannabinoid CB1 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:6402096, URL:http://europepmc.org/abstract/MED/6402096|Name:Wikipedia, SrcID:Nonabine, URL:http://en.wikipedia.org/wiki/Nonabine",CCCCCC(C)C(C)c1cc(O)c2C(=CC(C)(C)Oc2c1)c3ccncc3,CHEMBL218,CNR1
4590,CHEMBL14935,Tezampanel,Small molecule,,,,-ampa,Glutamate receptor ionotropic AMPA antagonist,"Active metabolite of oral prodrug NGX424. AMPA/Kainate receptor antagonist, selective for GRIK1 subunit containing receptors. Indication: Migraine, Postoperative pain",,CHEMBL2096670,Glutamate receptor ionotropic AMPA,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:16470401, URL:http://europepmc.org/abstract/MED/16470401|Name:PubMed, SrcID:18793656, URL:http://europepmc.org/abstract/MED/18793656|Name:PubMed, SrcID:15033339, URL:http://europepmc.org/abstract/MED/15033339|Name:PubMed, SrcID:8609884, URL:http://europepmc.org/abstract/MED/8609884",OC(=O)[C@@H]1C[C@H]2C[C@@H](CCc3nnn[nH]3)CC[C@H]2CN1,,
4591,CHEMBL1276138,Farampator,Small molecule,,,,-ampa,Glutamate receptor ionotropic AMPA positive allosteric modulator,Ampakine molecule.,,CHEMBL2096670,Glutamate receptor ionotropic AMPA,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:Wikipedia, SrcID:Farampator, URL:https://en.wikipedia.org/wiki/Farampator|Name:PubMed, SrcID:17119538, URL:http://europepmc.org/abstract/MED/17119538",O=C(N1CCCCC1)c2ccc3nonc3c2,,
4592,CHEMBL220360,Taranabant,Small molecule,,,,-nab-,Cannabinoid CB1 receptor inverse agonist,"Merck has Discontinueddevelopment of the drug, potential serious side effects linked to targetting of CNR1 (http://en.wikipedia.org/wiki/Taranabant)",,CHEMBL218,Cannabinoid CB1 receptor,INVERSE AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18574849, URL:http://europepmc.org/abstract/MED/18574849",C[C@H](NC(=O)C(C)(C)Oc1ccc(cn1)C(F)(F)F)[C@@H](Cc2ccc(Cl)cc2)c3cccc(c3)C#N,CHEMBL218,CNR1
4593,CHEMBL2107860,Taspoglutide,Protein,,,,-tide,Glucagon-like peptide 1 receptor agonist,"Peptide, GLP-1 analogue. Development stopped due to adverse events.",,CHEMBL1784,Glucagon-like peptide 1 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23139373, URL:http://europepmc.org/abstract/MED/23139373|Name:PubMed, SrcID:21114599, URL:http://europepmc.org/abstract/MED/21114599",,CHEMBL1784,GLP1R
4594,CHEMBL2109177,Odulimomab,Antibody,,,,-mab,Leukocyte adhesion glycoprotein LFA-1 alpha inhibitor,,,CHEMBL1803,Leukocyte adhesion glycoprotein LFA-1 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21466654, URL:http://europepmc.org/abstract/MED/21466654",,CHEMBL1803,ITGAL
4595,CHEMBL289228,Tipifarnib,Small molecule,,,,-farnib,Protein farnesyltransferase inhibitor,"Inhibits isolated human FPT with IC50s of 0.86 nm and 7.9 nm observed for a lamin B peptide and for the K-RasB peptide, respectively. Competitive inhibitor for both the K-ras and lamin B1 peptide substrates (Ki = 0.5 nm) and noncompetitive for the farnesylpyrophosphate substrate.",,CHEMBL2094108,Protein farnesyltransferase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:11196150, URL:http://europepmc.org/abstract/MED/11196150",CN1C(=O)C=C(c2cccc(Cl)c2)c3cc(ccc13)[C@](N)(c4ccc(Cl)cc4)c5cncn5C,,
4596,CHEMBL1800807,Anacetrapib,Small molecule,,,,-cetrapib,Cholesteryl ester transfer protein inhibitor,,,CHEMBL3572,Cholesteryl ester transfer protein,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18068514, URL:http://europepmc.org/abstract/MED/18068514",COc1cc(F)c(cc1c2ccc(cc2CN3[C@@H](C)[C@H](OC3=O)c4cc(cc(c4)C(F)(F)F)C(F)(F)F)C(F)(F)F)C(C)C,CHEMBL3572,CETP
4597,CHEMBL1095032,Letaxaban,Small molecule,,,,-xaban,Coagulation factor X inhibitor,,,CHEMBL244,Coagulation factor X,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26861270, URL:http://europepmc.org/abstract/MED/26861270",O[C@H](CS(=O)(=O)c1ccc2cc(Cl)ccc2c1)C(=O)N3CCC(CC3)N4CCCNC4=O,CHEMBL244,F10
4598,CHEMBL3039521,Vintafolide,Small molecule,,L01CA06,L01CA06 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Vinca alkaloids and analogues],-fol-; vin-,Folate receptor alpha binding agent,"The folate moiety of vintafolide binds to folic acid receptors on the tumor cell surface and the agent is internalized via folate receptor-mediated endocytosis, delivering the tubulin-binding DAVLBH moiety directly into the tumor cell; DAVLBH binding to tubulin results in the disruption of microtubule assembly-disassembly dynamics, cell cycle arrest, and tumor cell apoptosis",,CHEMBL2121,Folate receptor alpha,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23863359, URL:http://europepmc.org/abstract/MED/23863359",CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[C@H]7[C@](O)([C@H](O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)NNC(=O)OCCSSC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)CC[C@H](NC(=O)c%10ccc(NCc%11cnc%12NC(=NC(=O)c%12n%11)N)cc%10)C(=O)O)C(=O)O)C1,CHEMBL2121,FOLR1
4599,CHEMBL3301576,Pegpleranib Sodium,Unknown,,,,-anib; peg-,Platelet-derived growth factor subunit B inhibitor,"Specifically supresses PDGF-B, thereby limiting the recruitment and maturation of pericytes, which in turn induces neovascular regression.",,CHEMBL3108633,Platelet-derived growth factor subunit B,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:https://www.euroscan.org/technologies/pegpleranib-fovista-for-neovascular-age-related-macular-degeneration/download, URL:https://www.euroscan.org/technologies/pegpleranib-fovista-for-neovascular-age-related-macular-degeneration/download",,CHEMBL3108633,PDGFB
4600,CHEMBL3039540,Aducanumab,Antibody,,,,-mab,Beta amyloid A4 protein other,Reduces brain disease-relevant aggregated forms of amyloid-beta (Abeta) in a dose- and time-dependent manner.,"Shows >10,000-fold selectivity for aggregated Abeta over monomer",CHEMBL2487,Beta amyloid A4 protein,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:27582220, URL:http://europepmc.org/abstract/MED/27582220",,CHEMBL2487,APP
4601,CHEMBL2109573,Gsk-249320,Antibody,,,,,Myelin-associated glycoprotein inhibitor,,,CHEMBL5807,Myelin-associated glycoprotein,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23267856, URL:http://europepmc.org/abstract/MED/23267856",,CHEMBL5807,MAG
4602,CHEMBL2107731,Axomadol,Small molecule,,,,-adol,Delta opioid receptor agonist,Haven't found any references that mentioned activity at targets,,CHEMBL236,Delta opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Axomadol, URL:http://en.wikipedia.org/wiki/Axomadol",COc1cccc(c1)[C@]2(O)C[C@@H](O)CC[C@H]2CN(C)C,CHEMBL236,OPRD1
4603,CHEMBL1200660,Isosorbide,Small molecule,1974.0,,,,Unknown,,,,,,,,,,,O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@H]12,,
4604,CHEMBL301267,Artemotil,Small molecule,,P01BE04,"P01BE04 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: ANTIMALARIALS: Artemisinin and derivatives, plain]",arte-,Unknown,,,,,,,,,,,CCO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3,,
4605,CHEMBL1017,Telmisartan,Small molecule,1998.0,C09CA07,"C09CA07 [CARDIOVASCULAR SYSTEM: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM: ANGIOTENSIN II ANTAGONISTS, PLAIN: Angiotensin II antagonists, plain]",-sartan,Type-1 angiotensin II receptor antagonist,,,CHEMBL227,Type-1 angiotensin II receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=cfb9309f-e0df-4a55-9542-0e869fce05fb#section-14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cfb9309f-e0df-4a55-9542-0e869fce05fb#section-14|Name:PubMed, SrcID:18580862, URL:http://europepmc.org/abstract/MED/18580862|Name:PubMed, SrcID:16938288, URL:http://europepmc.org/abstract/MED/16938288|Name:Wikipedia, SrcID:Telmisartan, URL:http://en.wikipedia.org/wiki/Telmisartan",CCCc1nc2c(C)cc(cc2n1Cc3ccc(cc3)c4ccccc4C(=O)O)c5nc6ccccc6n5C,CHEMBL227,AGTR1
4606,CHEMBL553,Erlotinib,Small molecule,2004.0,L01XE03,L01XE03 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Epidermal growth factor receptor erbB1 inhibitor,,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=57bccb29-1c47-4c64-ab6a-77960a91cc20#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=57bccb29-1c47-4c64-ab6a-77960a91cc20#section-13",COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCOC,CHEMBL203,EGFR
4607,CHEMBL434394,Nebivolol,Small molecule,2007.0,C07AB12,"C07AB12 [CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, selective]",-olol,Beta-1 adrenergic receptor antagonist,,,CHEMBL213,Beta-1 adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=8b8ad213-1dc8-454e-a524-075685c0e1a8#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8b8ad213-1dc8-454e-a524-075685c0e1a8#section-13",OC(CNCC(O)C1CCc2cc(F)ccc2O1)C3CCc4cc(F)ccc4O3,,
4608,CHEMBL1046,Aminocaproic Acid,Small molecule,1964.0,B02AA01,B02AA01 [BLOOD AND BLOOD FORMING ORGANS: ANTIHEMORRHAGICS: ANTIFIBRINOLYTICS: Amino acids],,Tissue-type plasminogen activator inhibitor,,,CHEMBL1873,Tissue-type plasminogen activator,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22918041, URL:http://europepmc.org/abstract/MED/22918041|Name:DailyMed, SrcID:setid=2238c70f-b0b5-4755-896b-45b28777b217#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2238c70f-b0b5-4755-896b-45b28777b217#nlm34090-1",NCCCCCC(=O)O,CHEMBL1873,PLAT
4609,CHEMBL44884,Ethambutol,Small molecule,1967.0,J04AK02,J04AK02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOBACTERIALS: DRUGS FOR TREATMENT OF TUBERCULOSIS: Other drugs for treatment of tuberculosis],,Arabinosyltransferase A inhibitor,,,CHEMBL1877,Arabinosyltransferase A,INHIBITOR,Mycobacterium tuberculosis,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17630736, URL:http://europepmc.org/abstract/MED/17630736|Name:PubMed, SrcID:11854934, URL:http://europepmc.org/abstract/MED/11854934|Name:PubMed, SrcID:19596878, URL:http://europepmc.org/abstract/MED/19596878|Name:PubMed, SrcID:16595677, URL:http://europepmc.org/abstract/MED/16595677|Name:PubMed, SrcID:16641474, URL:http://europepmc.org/abstract/MED/16641474|Name:Wikipedia, SrcID:Ethambutol_hydrochloride#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Ethambutol_hydrochloride#Mechanism_of_action|Name:PubMed, SrcID:16127055, URL:http://europepmc.org/abstract/MED/16127055",CC[C@@H](CO)NCCN[C@@H](CC)CO,,
4610,CHEMBL981,Fenofibric Acid,Small molecule,2008.0,,,,Peroxisome proliferator-activated receptor alpha agonist,,,CHEMBL239,Peroxisome proliferator-activated receptor alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=86c49aff-0a4a-46b5-ac6e-26789bf17c9b, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=86c49aff-0a4a-46b5-ac6e-26789bf17c9b",CC(C)(Oc1ccc(cc1)C(=O)c2ccc(Cl)cc2)C(=O)O,CHEMBL239,PPARA
4611,CHEMBL533,Ibutilide,Small molecule,1995.0,C01BD05,"C01BD05 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III]",-ilide,HERG blocker,,,CHEMBL240,HERG,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15926871, URL:http://europepmc.org/abstract/MED/15926871|Name:Wikipedia, SrcID:Potassium_channel_blocker, URL:http://en.wikipedia.org/wiki/Potassium_channel_blocker|Name:DailyMed, SrcID:setid=b7d717ed-022d-4459-b5e6-098c2a8b7427, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b7d717ed-022d-4459-b5e6-098c2a8b7427",CCCCCCCN(CC)CCCC(O)c1ccc(NS(=O)(=O)C)cc1,CHEMBL240,KCNH2
4612,CHEMBL1086,Dibucaine,Small molecule,1982.0,C05AD04; N01BB06; S01HA06; S02DA04; D04AB02,"C05AD04 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Local anesthetics]; N01BB06 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Amides]; S01HA06 [SENSORY ORGANS: OPHTHALMOLOGICALS: LOCAL ANESTHETICS: Local anesthetics]; S02DA04 [SENSORY ORGANS: OTOLOGICALS: OTHER OTOLOGICALS: Analgesics and anesthetics]; D04AB02 [DERMATOLOGICALS: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: Anesthetics for topical use]",-caine,Sodium channel protein type V alpha subunit blocker,,,CHEMBL1980,Sodium channel protein type V alpha subunit,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:8798723, URL:http://europepmc.org/abstract/MED/8798723|Name:PubMed, SrcID:9742684, URL:http://europepmc.org/abstract/MED/9742684",CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1,CHEMBL1980,SCN5A
4613,CHEMBL42,Clozapine,Small molecule,1989.0,N05AH02,"N05AH02 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Diazepines, oxazepines, thiazepines and oxepines]",-pin(e),Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:0443059748, URL:http://www.isbnsearch.org/isbn/0443059748|Name:Wikipedia, SrcID:Clozapine, URL:http://en.wikipedia.org/wiki/Clozapine|Name:DailyMed, SrcID:setid=53bdb79c-c4cf-4818-b1f0-225e67a14536#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=53bdb79c-c4cf-4818-b1f0-225e67a14536#nlm34090-1|Name:PubMed, SrcID:17015232, URL:http://europepmc.org/abstract/MED/17015232",CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,CHEMBL224,HTR2A
4614,CHEMBL1509,Drospirenone,Small molecule,2001.0,G03AC10,G03AC10 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE: Progestogens],-renone,Mineralocorticoid receptor antagonist,,,CHEMBL1994,Mineralocorticoid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=077bf6ff-afb8-4cb7-9faa-fbb6fd9f037f#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=077bf6ff-afb8-4cb7-9faa-fbb6fd9f037f#nlm34090-1|Name:PubMed, SrcID:11024226, URL:http://europepmc.org/abstract/MED/11024226",C[C@]12CCC(=O)C=C1[C@@H]3C[C@@H]3[C@@H]4[C@@H]2CC[C@@]5(C)[C@H]4[C@@H]6C[C@@H]6[C@@]57CCC(=O)O7,,
4615,CHEMBL634,Alfentanil,Small molecule,1986.0,N01AH02,"N01AH02 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Opioid anesthetics]",-fentanil,Mu opioid receptor agonist,,,CHEMBL233,Mu opioid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21215785, URL:http://europepmc.org/abstract/MED/21215785|Name:DailyMed, SrcID:setid=098af6c6-7400-4b2b-bae6-03d5913ad712#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=098af6c6-7400-4b2b-bae6-03d5913ad712#nlm34090-1",CCN1N=NN(CCN2CCC(COC)(CC2)N(C(=O)CC)c3ccccc3)C1=O,CHEMBL233,OPRM1
4616,CHEMBL1018,Dienestrol,Small molecule,1947.0,G03CC02; G03CB01,"G03CC02 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ESTROGENS: Estrogens, combinations with other drugs]; G03CB01 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ESTROGENS: Synthetic estrogens, plain]",-estr-,Estrogen receptor alpha agonist,,,CHEMBL206,Estrogen receptor alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 420, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:4882972, URL:http://europepmc.org/abstract/MED/4882972",C\C=C(\C(=C\C)\c1ccc(O)cc1)/c2ccc(O)cc2,CHEMBL206,ESR1
4617,CHEMBL2048484,Canagliflozin,Small molecule,2011.0,,,-gliflozin,Sodium/glucose cotransporter 2 inhibitor,,,CHEMBL3884,Sodium/glucose cotransporter 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=b9057d3b-b104-4f09-8a61-c61ef9d4a3f3#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b9057d3b-b104-4f09-8a61-c61ef9d4a3f3#nlm34090-1",Cc1ccc(cc1Cc2ccc(s2)c3ccc(F)cc3)[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O,CHEMBL3884,SLC5A2
4618,CHEMBL288441,Bosutinib,Small molecule,2010.0,L01XE14,L01XE14 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Tyrosine-protein kinase Lyn inhibitor,,,CHEMBL3905,Tyrosine-protein kinase Lyn,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Expert, SrcID:BOSUTINIB, URL:http://chembl.blogspot.co.uk/search?q=BOSUTINIB",COc1cc(Nc2c(cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl,CHEMBL3905,LYN
4619,CHEMBL1229517,Vemurafenib,Small molecule,2011.0,L01XE15,L01XE15 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-rafenib,Serine/threonine-protein kinase B-raf inhibitor,Indicated for mutated form - V600E,,CHEMBL5145,Serine/threonine-protein kinase B-raf,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2011/202429s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202429s000lbl.pdf",CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(cc23)c4ccc(Cl)cc4)c1F,CHEMBL5145,BRAF
4620,CHEMBL1387,Norethynodrel,Small molecule,1961.0,,,,Progesterone receptor agonist,,,CHEMBL208,Progesterone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:1833399, URL:http://europepmc.org/abstract/MED/1833399|Name:PubMed, SrcID:22960752, URL:http://europepmc.org/abstract/MED/22960752|Name:PubMed, SrcID:166800, URL:http://europepmc.org/abstract/MED/166800",C[C@]12CC[C@H]3[C@@H](CCC4=C3CCC(=O)C4)[C@@H]1CC[C@@]2(O)C#C,CHEMBL208,PGR
4621,CHEMBL1531,Etonogestrel,Small molecule,2001.0,G03AC08,G03AC08 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE: Progestogens],-gest-,Progesterone receptor agonist,,,CHEMBL208,Progesterone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:0443-059748 PP. 447, URL:http://www.isbnsearch.org/isbn/0443059748|Name:Wikipedia, SrcID:Etonogestrel, URL:http://en.wikipedia.org/wiki/Etonogestrel",CC[C@]12CC(=C)[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C,CHEMBL208,PGR
4622,CHEMBL1493,Flavoxate,Small molecule,1970.0,G04BD02,G04BD02 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Drugs for urinary frequency and incontinence],,Phosphodiesterase 4 inhibitor,,,CHEMBL2093863,Phosphodiesterase 4,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:167667, URL:http://europepmc.org/abstract/MED/167667|Name:PubMed, SrcID:6329116, URL:http://europepmc.org/abstract/MED/6329116",CC1=C(Oc2c(cccc2C1=O)C(=O)OCCN3CCCCC3)c4ccccc4,,
4623,CHEMBL1201293,Acamprosate,Small molecule,2004.0,N07BB03,N07BB03 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: DRUGS USED IN ADDICTIVE DISORDERS: Drugs used in alcohol dependence],,Glutamate [NMDA] receptor antagonist,,,CHEMBL2094124,Glutamate [NMDA] receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:22346357, URL:http://europepmc.org/abstract/MED/22346357|Name:ISBN, SrcID:9780702034718 PP. 596, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:FDA, SrcID:label/2012/021431s015lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021431s015lbl.pdf|Name:PubMed, SrcID:15963001, URL:http://europepmc.org/abstract/MED/15963001|Name:Wikipedia, SrcID:Acamprosate, URL:http://en.wikipedia.org/wiki/Acamprosate|Name:PubMed, SrcID:18540918, URL:http://europepmc.org/abstract/MED/18540918",CC(=O)NCCCS(=O)(=O)O,CHEMBL2094124,GRIN3B
4624,CHEMBL1201319,Metaraminol,Small molecule,1954.0,C01CA09,C01CA09 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES: Adrenergic and dopaminergic agents],,Adrenergic receptor alpha-1 agonist,,,CHEMBL2094251,Adrenergic receptor alpha-1,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:15703094, URL:http://europepmc.org/abstract/MED/15703094",C[C@H](N)[C@H](O)c1cccc(O)c1,,
4625,CHEMBL1648,Isradipine,Small molecule,1990.0,C08CA03,C08CA03 [CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS: Dihydropyridine derivatives],-dipine,Voltage-gated L-type calcium channel blocker,,,CHEMBL2095229,Voltage-gated L-type calcium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=c5745462-fab9-4916-acee-1bc6f9e63560, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5745462-fab9-4916-acee-1bc6f9e63560|Name:Wikipedia, SrcID:Dihydropyridine, URL:http://en.wikipedia.org/wiki/Dihydropyridine|Name:Wikipedia, SrcID:L-type_calcium_channel, URL:http://en.wikipedia.org/wiki/L-type_calcium_channel|Name:Wikipedia, SrcID:Voltage-dependent_calcium_channel, URL:http://en.wikipedia.org/wiki/Voltage-dependent_calcium_channel|Name:DailyMed, SrcID:archiveid=27627, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=27627|Name:Wikipedia, SrcID:Clevidipine, URL:http://en.wikipedia.org/wiki/Clevidipine",COC(=O)C1=C(C)NC(=C(C1c2cccc3nonc23)C(=O)OC(C)C)C,,
4626,CHEMBL22587,Itraconazole,Small molecule,1992.0,J02AC02,J02AC02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: Triazole derivatives],-conazole,Cytochrome P450 51 inhibitor,,,CHEMBL1780,Cytochrome P450 51,INHIBITOR,Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast),SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=599dcdd0-df9b-41e2-a767-b1f44f466fbd, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=599dcdd0-df9b-41e2-a767-b1f44f466fbd",CCC(C)N1N=CN(C1=O)c2ccc(cc2)N3CCN(CC3)c4ccc(OC[C@H]5CO[C@@](Cn6cncn6)(O5)c7ccc(Cl)cc7Cl)cc4,,
4627,CHEMBL141,Lamivudine,Small molecule,1995.0,J05AF05,J05AF05 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleoside and nucleotide reverse transcriptase inhibitors],-vudine,DNA inhibitor,"When monophosporylated is incorporates into the DNA, when triphosporylated inhibits the enzymes",,CHEMBL2363046,DNA,INHIBITOR,Human immunodeficiency virus 1,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=bc62b38c-4cc9-4e64-8852-1a0be6d36d8e, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bc62b38c-4cc9-4e64-8852-1a0be6d36d8e",NC1=NC(=O)N(C=C1)[C@@H]2CS[C@H](CO)O2,,
4628,CHEMBL1657,Tazarotene,Small molecule,1997.0,D05AX05,D05AX05 [DERMATOLOGICALS: ANTIPSORIATICS: ANTIPSORIATICS FOR TOPICAL USE: Other antipsoriatics for topical use],-arotene,Retinoic acid receptor agonist,,,CHEMBL2363069,Retinoic acid receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=cd8a3be3-8f83-42cf-8752-6fd16da65150, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd8a3be3-8f83-42cf-8752-6fd16da65150",CCOC(=O)c1ccc(nc1)C#Cc2ccc3SCCC(C)(C)c3c2,,
4629,CHEMBL451,Chlordiazepoxide,Small molecule,1960.0,N05BA02,N05BA02 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:Wikipedia, SrcID:Chlordiazepoxide, URL:http://en.wikipedia.org/wiki/Chlordiazepoxide|Name:PubMed, SrcID:6135616, URL:http://europepmc.org/abstract/MED/6135616",CNC1=Nc2ccc(Cl)cc2C(=[N+]([O-])C1)c3ccccc3,CHEMBL2093872,GABRG3
4630,CHEMBL451,Chlordiazepoxide,Small molecule,1960.0,N05BA02,N05BA02 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:Wikipedia, SrcID:Chlordiazepoxide, URL:http://en.wikipedia.org/wiki/Chlordiazepoxide|Name:PubMed, SrcID:6135616, URL:http://europepmc.org/abstract/MED/6135616",CNC1=Nc2ccc(Cl)cc2C(=[N+]([O-])C1)c3ccccc3,CHEMBL2093872,GABRP
4631,CHEMBL451,Chlordiazepoxide,Small molecule,1960.0,N05BA02,N05BA02 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:Wikipedia, SrcID:Chlordiazepoxide, URL:http://en.wikipedia.org/wiki/Chlordiazepoxide|Name:PubMed, SrcID:6135616, URL:http://europepmc.org/abstract/MED/6135616",CNC1=Nc2ccc(Cl)cc2C(=[N+]([O-])C1)c3ccccc3,CHEMBL2093872,GABRE
4632,CHEMBL451,Chlordiazepoxide,Small molecule,1960.0,N05BA02,N05BA02 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:Wikipedia, SrcID:Chlordiazepoxide, URL:http://en.wikipedia.org/wiki/Chlordiazepoxide|Name:PubMed, SrcID:6135616, URL:http://europepmc.org/abstract/MED/6135616",CNC1=Nc2ccc(Cl)cc2C(=[N+]([O-])C1)c3ccccc3,CHEMBL2093872,GABRG1
4633,CHEMBL70418,Clobazam,Small molecule,2005.0,N05BA09,N05BA09 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:11530681, URL:http://europepmc.org/abstract/MED/11530681|Name:Wikipedia, SrcID:Clobazam, URL:http://en.wikipedia.org/wiki/Clobazam",CN1C(=O)CC(=O)N(c2ccccc2)c3cc(Cl)ccc13,CHEMBL2093872,GABRG3
4634,CHEMBL70418,Clobazam,Small molecule,2005.0,N05BA09,N05BA09 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:11530681, URL:http://europepmc.org/abstract/MED/11530681|Name:Wikipedia, SrcID:Clobazam, URL:http://en.wikipedia.org/wiki/Clobazam",CN1C(=O)CC(=O)N(c2ccccc2)c3cc(Cl)ccc13,CHEMBL2093872,GABRP
4635,CHEMBL70418,Clobazam,Small molecule,2005.0,N05BA09,N05BA09 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:11530681, URL:http://europepmc.org/abstract/MED/11530681|Name:Wikipedia, SrcID:Clobazam, URL:http://en.wikipedia.org/wiki/Clobazam",CN1C(=O)CC(=O)N(c2ccccc2)c3cc(Cl)ccc13,CHEMBL2093872,GABRE
4636,CHEMBL70418,Clobazam,Small molecule,2005.0,N05BA09,N05BA09 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives],,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Benzodiazepine binding site,Benzodiazepine site,"Name:PubMed, SrcID:11530681, URL:http://europepmc.org/abstract/MED/11530681|Name:Wikipedia, SrcID:Clobazam, URL:http://en.wikipedia.org/wiki/Clobazam",CN1C(=O)CC(=O)N(c2ccccc2)c3cc(Cl)ccc13,CHEMBL2093872,GABRG1
4637,CHEMBL1200802,Talbutal,Small molecule,1982.0,N05CA07,"N05CA07 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Barbiturates, plain]",,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL2093872,GABRG3
4638,CHEMBL1200802,Talbutal,Small molecule,1982.0,N05CA07,"N05CA07 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Barbiturates, plain]",,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL2093872,GABRP
4639,CHEMBL1200802,Talbutal,Small molecule,1982.0,N05CA07,"N05CA07 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Barbiturates, plain]",,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL2093872,GABRE
4640,CHEMBL1200802,Talbutal,Small molecule,1982.0,N05CA07,"N05CA07 [NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Barbiturates, plain]",,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Barbiturate binding site,Barbiturate site,"Name:PubMed, SrcID:11264449, URL:http://europepmc.org/abstract/MED/11264449",CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL2093872,GABRG1
4641,CHEMBL1200694,Sevoflurane,Small molecule,1995.0,N01AB08,"N01AB08 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:22226507, URL:http://europepmc.org/abstract/MED/22226507|Name:PubMed, SrcID:21788314, URL:http://europepmc.org/abstract/MED/21788314",FCOC(C(F)(F)F)C(F)(F)F,CHEMBL2093872,GABRG3
4642,CHEMBL1200694,Sevoflurane,Small molecule,1995.0,N01AB08,"N01AB08 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:22226507, URL:http://europepmc.org/abstract/MED/22226507|Name:PubMed, SrcID:21788314, URL:http://europepmc.org/abstract/MED/21788314",FCOC(C(F)(F)F)C(F)(F)F,CHEMBL2093872,GABRP
4643,CHEMBL1200694,Sevoflurane,Small molecule,1995.0,N01AB08,"N01AB08 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:22226507, URL:http://europepmc.org/abstract/MED/22226507|Name:PubMed, SrcID:21788314, URL:http://europepmc.org/abstract/MED/21788314",FCOC(C(F)(F)F)C(F)(F)F,CHEMBL2093872,GABRE
4644,CHEMBL1200694,Sevoflurane,Small molecule,1995.0,N01AB08,"N01AB08 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,GABA-A receptor; anion channel positive allosteric modulator,,,CHEMBL2093872,GABA-A receptor; anion channel,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,,Likely allosteric but unclear whether benzodiazepine or barbiturate site involved,"Name:PubMed, SrcID:16402123, URL:http://europepmc.org/abstract/MED/16402123|Name:PubMed, SrcID:22226507, URL:http://europepmc.org/abstract/MED/22226507|Name:PubMed, SrcID:21788314, URL:http://europepmc.org/abstract/MED/21788314",FCOC(C(F)(F)F)C(F)(F)F,CHEMBL2093872,GABRG1
4645,CHEMBL501122,Ceftaroline Fosamil,Small molecule,2010.0,J01DI02,J01DI02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Other cephalosporins and penems],cef-,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2012/200327s007lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/200327s007lbl.pdf",CCO\N=C(/C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)[O-])Sc3nc(cs3)c4cc[n+](C)cc4)\c5nsc(NP(=O)(O)O)n5,,
4646,CHEMBL31,Gatifloxacin,Small molecule,1999.0,S01AE06; J01MA16,S01AE06 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Fluoroquinolones]; J01MA16 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolones],-oxacin,DNA gyrase inhibitor,,,CHEMBL2311225,DNA gyrase,INHIBITOR,Streptococcus pneumoniae,PROTEIN COMPLEX,,,"Name:DailyMed, SrcID:setid=a5b0725e-9b7e-426b-ab1c-fcca3b1972fd, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a5b0725e-9b7e-426b-ab1c-fcca3b1972fd|Name:FDA, SrcID:label/2015/021493s010lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021493s010lbl.pdf",COc1c(N2CCNC(C)C2)c(F)cc3C(=O)C(=CN(C4CC4)c13)C(=O)O,,
4647,CHEMBL1628502,Gabapentin Enacarbil,Small molecule,2011.0,N03AX12,N03AX12 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:DailyMed, SrcID:setid=05506250-1641-4b64-ac0c-69f96c46a773#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=05506250-1641-4b64-ac0c-69f96c46a773#nlm34090-1|Name:FDA, SrcID:label/2013/022399s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022399s008lbl.pdf|Name:PubMed, SrcID:18299583, URL:http://europepmc.org/abstract/MED/18299583",CC(C)C(=O)OC(C)OC(=O)NCC1(CC(=O)O)CCCCC1,CHEMBL2363032,CACNB3
4648,CHEMBL1628502,Gabapentin Enacarbil,Small molecule,2011.0,N03AX12,N03AX12 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:DailyMed, SrcID:setid=05506250-1641-4b64-ac0c-69f96c46a773#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=05506250-1641-4b64-ac0c-69f96c46a773#nlm34090-1|Name:FDA, SrcID:label/2013/022399s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022399s008lbl.pdf|Name:PubMed, SrcID:18299583, URL:http://europepmc.org/abstract/MED/18299583",CC(C)C(=O)OC(C)OC(=O)NCC1(CC(=O)O)CCCCC1,CHEMBL2363032,CACNG3
4649,CHEMBL1628502,Gabapentin Enacarbil,Small molecule,2011.0,N03AX12,N03AX12 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:DailyMed, SrcID:setid=05506250-1641-4b64-ac0c-69f96c46a773#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=05506250-1641-4b64-ac0c-69f96c46a773#nlm34090-1|Name:FDA, SrcID:label/2013/022399s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022399s008lbl.pdf|Name:PubMed, SrcID:18299583, URL:http://europepmc.org/abstract/MED/18299583",CC(C)C(=O)OC(C)OC(=O)NCC1(CC(=O)O)CCCCC1,CHEMBL2363032,CACNG5
4650,CHEMBL1628502,Gabapentin Enacarbil,Small molecule,2011.0,N03AX12,N03AX12 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:DailyMed, SrcID:setid=05506250-1641-4b64-ac0c-69f96c46a773#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=05506250-1641-4b64-ac0c-69f96c46a773#nlm34090-1|Name:FDA, SrcID:label/2013/022399s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022399s008lbl.pdf|Name:PubMed, SrcID:18299583, URL:http://europepmc.org/abstract/MED/18299583",CC(C)C(=O)OC(C)OC(=O)NCC1(CC(=O)O)CCCCC1,CHEMBL2363032,CACNG4
4651,CHEMBL1628502,Gabapentin Enacarbil,Small molecule,2011.0,N03AX12,N03AX12 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:DailyMed, SrcID:setid=05506250-1641-4b64-ac0c-69f96c46a773#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=05506250-1641-4b64-ac0c-69f96c46a773#nlm34090-1|Name:FDA, SrcID:label/2013/022399s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022399s008lbl.pdf|Name:PubMed, SrcID:18299583, URL:http://europepmc.org/abstract/MED/18299583",CC(C)C(=O)OC(C)OC(=O)NCC1(CC(=O)O)CCCCC1,CHEMBL2363032,CACNG1
4652,CHEMBL1628502,Gabapentin Enacarbil,Small molecule,2011.0,N03AX12,N03AX12 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:DailyMed, SrcID:setid=05506250-1641-4b64-ac0c-69f96c46a773#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=05506250-1641-4b64-ac0c-69f96c46a773#nlm34090-1|Name:FDA, SrcID:label/2013/022399s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022399s008lbl.pdf|Name:PubMed, SrcID:18299583, URL:http://europepmc.org/abstract/MED/18299583",CC(C)C(=O)OC(C)OC(=O)NCC1(CC(=O)O)CCCCC1,CHEMBL2363032,CACNB4
4653,CHEMBL1628502,Gabapentin Enacarbil,Small molecule,2011.0,N03AX12,N03AX12 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:DailyMed, SrcID:setid=05506250-1641-4b64-ac0c-69f96c46a773#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=05506250-1641-4b64-ac0c-69f96c46a773#nlm34090-1|Name:FDA, SrcID:label/2013/022399s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022399s008lbl.pdf|Name:PubMed, SrcID:18299583, URL:http://europepmc.org/abstract/MED/18299583",CC(C)C(=O)OC(C)OC(=O)NCC1(CC(=O)O)CCCCC1,CHEMBL2363032,CACNA2D4
4654,CHEMBL1628502,Gabapentin Enacarbil,Small molecule,2011.0,N03AX12,N03AX12 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:DailyMed, SrcID:setid=05506250-1641-4b64-ac0c-69f96c46a773#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=05506250-1641-4b64-ac0c-69f96c46a773#nlm34090-1|Name:FDA, SrcID:label/2013/022399s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022399s008lbl.pdf|Name:PubMed, SrcID:18299583, URL:http://europepmc.org/abstract/MED/18299583",CC(C)C(=O)OC(C)OC(=O)NCC1(CC(=O)O)CCCCC1,CHEMBL2363032,CACNG2
4655,CHEMBL1628502,Gabapentin Enacarbil,Small molecule,2011.0,N03AX12,N03AX12 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:DailyMed, SrcID:setid=05506250-1641-4b64-ac0c-69f96c46a773#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=05506250-1641-4b64-ac0c-69f96c46a773#nlm34090-1|Name:FDA, SrcID:label/2013/022399s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022399s008lbl.pdf|Name:PubMed, SrcID:18299583, URL:http://europepmc.org/abstract/MED/18299583",CC(C)C(=O)OC(C)OC(=O)NCC1(CC(=O)O)CCCCC1,CHEMBL2363032,CACNG7
4656,CHEMBL1628502,Gabapentin Enacarbil,Small molecule,2011.0,N03AX12,N03AX12 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:DailyMed, SrcID:setid=05506250-1641-4b64-ac0c-69f96c46a773#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=05506250-1641-4b64-ac0c-69f96c46a773#nlm34090-1|Name:FDA, SrcID:label/2013/022399s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022399s008lbl.pdf|Name:PubMed, SrcID:18299583, URL:http://europepmc.org/abstract/MED/18299583",CC(C)C(=O)OC(C)OC(=O)NCC1(CC(=O)O)CCCCC1,CHEMBL2363032,CACNG8
4657,CHEMBL1628502,Gabapentin Enacarbil,Small molecule,2011.0,N03AX12,N03AX12 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:DailyMed, SrcID:setid=05506250-1641-4b64-ac0c-69f96c46a773#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=05506250-1641-4b64-ac0c-69f96c46a773#nlm34090-1|Name:FDA, SrcID:label/2013/022399s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022399s008lbl.pdf|Name:PubMed, SrcID:18299583, URL:http://europepmc.org/abstract/MED/18299583",CC(C)C(=O)OC(C)OC(=O)NCC1(CC(=O)O)CCCCC1,CHEMBL2363032,CACNG6
4658,CHEMBL1628502,Gabapentin Enacarbil,Small molecule,2011.0,N03AX12,N03AX12 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:DailyMed, SrcID:setid=05506250-1641-4b64-ac0c-69f96c46a773#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=05506250-1641-4b64-ac0c-69f96c46a773#nlm34090-1|Name:FDA, SrcID:label/2013/022399s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022399s008lbl.pdf|Name:PubMed, SrcID:18299583, URL:http://europepmc.org/abstract/MED/18299583",CC(C)C(=O)OC(C)OC(=O)NCC1(CC(=O)O)CCCCC1,CHEMBL2363032,CACNA1F
4659,CHEMBL1628502,Gabapentin Enacarbil,Small molecule,2011.0,N03AX12,N03AX12 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:DailyMed, SrcID:setid=05506250-1641-4b64-ac0c-69f96c46a773#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=05506250-1641-4b64-ac0c-69f96c46a773#nlm34090-1|Name:FDA, SrcID:label/2013/022399s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022399s008lbl.pdf|Name:PubMed, SrcID:18299583, URL:http://europepmc.org/abstract/MED/18299583",CC(C)C(=O)OC(C)OC(=O)NCC1(CC(=O)O)CCCCC1,CHEMBL2363032,CACNB1
4660,CHEMBL1628502,Gabapentin Enacarbil,Small molecule,2011.0,N03AX12,N03AX12 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics],gab-,Voltage-gated calcium channel modulator,,,CHEMBL2363032,Voltage-gated calcium channel,MODULATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Calcium channel alpha-2/delta-1 subunit,"alpha2delta-1 is binding site: 23836974, 23642658","Name:DailyMed, SrcID:setid=05506250-1641-4b64-ac0c-69f96c46a773#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=05506250-1641-4b64-ac0c-69f96c46a773#nlm34090-1|Name:FDA, SrcID:label/2013/022399s008lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022399s008lbl.pdf|Name:PubMed, SrcID:18299583, URL:http://europepmc.org/abstract/MED/18299583",CC(C)C(=O)OC(C)OC(=O)NCC1(CC(=O)O)CCCCC1,CHEMBL2363032,CACNA2D3
4661,CHEMBL1201754,Rufinamide,Small molecule,2008.0,N03AF03,N03AF03 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Carboxamide derivatives],,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:Wikipedia, SrcID:Rufinamide, URL:http://en.wikipedia.org/wiki/Rufinamide|Name:DailyMed, SrcID:setid=0a3fa925-1abd-458a-bd57-4ae780a1ef2d, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0a3fa925-1abd-458a-bd57-4ae780a1ef2d",NC(=O)c1cn(Cc2c(F)cccc2F)nn1,,
4662,CHEMBL2221250,Capreomycine,Protein,1971.0,J04AB30,J04AB30 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOBACTERIALS: DRUGS FOR TREATMENT OF TUBERCULOSIS: Antibiotics],-mycin,70S ribosome inhibitor,,,CHEMBL2363965,70S ribosome,INHIBITOR,Mycobacterium tuberculosis,PROTEIN NUCLEIC-ACID COMPLEX,16S/23S ribosomal RNA interface,Binding site 23S and 16S RNA (interface),"Name:PubMed, SrcID:20154709, URL:http://europepmc.org/abstract/MED/20154709|Name:PubMed, SrcID:16857584, URL:http://europepmc.org/abstract/MED/16857584",C[C@@H]1NC(=O)[C@@H](N)CNC(=O)[C@@H](NC(=O)\C(=C\NC(=O)N)\NC(=O)[C@H](CNC(=O)CC(N)CCCN)NC1=O)C2CCNC(=N)N2.NCCCC(N)CC(=O)NC[C@@H]3NC(=O)[C@H](CO)NC(=O)[C@@H](N)CNC(=O)[C@@H](NC(=O)\C(=C\NC(=O)N)\NC3=O)C4CCNC(=N)N4,,
4663,CHEMBL1749,Edetate Disodium,Small molecule,1982.0,S01XA05,S01XA05 [SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals],,Calcium chelating agent,Divalent and Trivalent metal chelating agent. Removes Ca2+ in case of hypercalciemia,,CHEMBL2364030,Calcium,CHELATING AGENT,null,METAL,,,"Name:FDA, SrcID:label/2009/008922s016lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/008922s016lbl.pdf",[Na+].[Na+].OC(=O)CN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)[O-],,
4664,CHEMBL3545119,Bms-794833,Small molecule,,,,,Vascular endothelial growth factor receptor 2 inhibitor,,,CHEMBL279,Vascular endothelial growth factor receptor 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.ejcancersupplements.com/article/S1359-6349(10)71811-5/abstract, URL:http://www.ejcancersupplements.com/article/S1359-6349(10)71811-5/abstract",,CHEMBL279,KDR
4665,CHEMBL3545238,Cs-8080,Small molecule,,,,,LXR-beta agonist,"discontinued in 2008, did not meet criteria in clinical trials (http://www.daiichisankyo.com/media_investors/investor_relations/ir_calendar/files/005144/imm2009_01_30_26_01.pdf)",,CHEMBL4093,LXR-beta,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24833295, URL:http://europepmc.org/abstract/MED/24833295",,CHEMBL4093,NR1H2
4666,CHEMBL3545115,Abl-001,Small molecule,,,,,Tyrosine-protein kinase ABL inhibitor,"ABL001 binds to a pocket on the BCR-ABL kinase domain that is normally occupied by the myristoylated N-terminus of ABL1 (""ABL001, a potent allosteric inhibitor of BCR-ABL, prevents emergence of resistant disease when administered in combination with nilotinib in an in vivo murine model of chronic myeloid leukemia"". Blood. 2014;124(21) [abstract 398])",,CHEMBL1862,Tyrosine-protein kinase ABL,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.bloodjournal.org/content/124/21/398?sso-checked=true, URL:http://www.bloodjournal.org/content/124/21/398?sso-checked=true|Name:Other, SrcID:http://www.novartisoncology.com/ct/pipelineDetails?compound=ABL001&diseaseAcr=CML, URL:http://www.novartisoncology.com/ct/pipelineDetails?compound=ABL001&diseaseAcr=CML",,CHEMBL1862,ABL1
4667,CHEMBL3545365,Altiratinib,Small molecule,,,,-tinib,Hepatocyte growth factor receptor inhibitor,,,CHEMBL3717,Hepatocyte growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.deciphera.com/pipeline, URL:http://www.deciphera.com/pipeline|Name:PubMed, SrcID:26285778, URL:http://europepmc.org/abstract/MED/26285778",Fc1ccc(NC(=O)C2(CC2)C(=O)Nc3cc(F)c(Oc4ccnc(NC(=O)C5CC5)c4)cc3F)cc1,CHEMBL3717,MET
4668,CHEMBL3545251,Sulfatinib,Small molecule,,,,sulfa-; -tinib,Vascular endothelial growth factor receptor inhibitor,,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:Other, SrcID:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=760894, URL:http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=760894|Name:Other, SrcID:http://www.hmplglobal.com/en/sulfatinib/, URL:http://www.hmplglobal.com/en/sulfatinib/|Name:ClinicalTrials, SrcID:NCT02133157, URL:https://www.clinicaltrials.gov/ct2/show/NCT02133157",,,
4669,CHEMBL3545133,Jnj-26483327,Small molecule,,,,,Tyrosine-protein kinase YES inhibitor,Multi-targeted tyrosine kinase inhibitor,,CHEMBL2073,Tyrosine-protein kinase YES,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1016/S1359-6349(10)71870-X, URL:http://www.sciencedirect.com/science/article/pii/S135963491071870X|Name:PubMed, SrcID:20823884, URL:http://europepmc.org/abstract/MED/20823884",,CHEMBL2073,YES1
4670,CHEMBL3545319,Jnj-40346527,Small molecule,,,,,Macrophage colony stimulating factor receptor inhibitor,,,CHEMBL1844,Macrophage colony stimulating factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26233509, URL:http://europepmc.org/abstract/MED/26233509",,CHEMBL1844,CSF1R
4671,CHEMBL3545194,Lgh-447,Small molecule,,,,,Serine/threonine-protein kinase PIM inhibitor,,,CHEMBL3559682,Serine/threonine-protein kinase PIM,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:26505898, URL:http://europepmc.org/abstract/MED/26505898|Name:Other, SrcID:http://www.novartisoncology.com/ct/pipelineDetails?compound=PIM447&diseaseAcr=AML, URL:http://www.novartisoncology.com/ct/pipelineDetails?compound=PIM447&diseaseAcr=AML",,,
4672,CHEMBL3545380,Irbinitinib,Small molecule,,,,-tinib,Receptor protein-tyrosine kinase erbB-2 inhibitor,,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.oncothyreon.com/product_pipeline/ont-380.html, URL:http://www.oncothyreon.com/product_pipeline/ont-380.html|Name:Other, SrcID:http://www.arraybiopharma.com/product-pipeline/other-compounds/arry-380-ont-380/, URL:http://www.arraybiopharma.com/product-pipeline/other-compounds/arry-380-ont-380/",,CHEMBL1824,ERBB2
4673,CHEMBL1614725,Tak-285,Small molecule,,,,,Epidermal growth factor receptor erbB1 inhibitor,,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1016/S1359-6349(08)72245-6, URL:http://www.sciencedirect.com/science/article/pii/S1359634908722456|Name:PubMed, SrcID:22003817, URL:http://europepmc.org/abstract/MED/22003817",CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(c4)C(F)(F)F)c(Cl)c3)c12,CHEMBL203,EGFR
4674,CHEMBL3544935,Xl-418,Small molecule,,,,,Ribosomal protein S6 kinase (P70S6K) inhibitor,,,CHEMBL2111330,Ribosomal protein S6 kinase (P70S6K),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:13891463, URL:http://europepmc.org/abstract/MED/13891463|Name:ClinicalTrials, SrcID:NCT00460278, URL:https://www.clinicaltrials.gov/ct2/show/NCT00460278",,,
4675,CHEMBL254760,Mgcd-265,Small molecule,,,,,Tyrosine-protein kinase TIE-2 inhibitor,,,CHEMBL4128,Tyrosine-protein kinase TIE-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://meetinglibrary.asco.org/content/96526-114, URL:http://meetinglibrary.asco.org/content/96526-114|Name:PubMed, SrcID:25806189, URL:http://europepmc.org/abstract/MED/25806189",Cn1cnc(c1)c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2,CHEMBL4128,TEK
4676,CHEMBL574737,(7s)-Hydroxyl-Staurosporine,Small molecule,,,,,Serine/threonine-protein kinase Chk1 inhibitor,,,CHEMBL4630,Serine/threonine-protein kinase Chk1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7907, URL:http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7907|Name:PubMed, SrcID:12892559, URL:http://europepmc.org/abstract/MED/12892559|Name:PubMed, SrcID:19568282, URL:http://europepmc.org/abstract/MED/19568282",CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n3c4ccccc4c5c6[C@H](O)NC(=O)c6c7c8ccccc8n2c7c35,CHEMBL4630,CHEK1
4677,CHEMBL345237,Piclozotan,Small molecule,,,,-zotan,Serotonin 1a (5-HT1a) receptor agonist,Not in current pipelines.,,CHEMBL214,Serotonin 1a (5-HT1a) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16290165, URL:http://europepmc.org/abstract/MED/16290165|Name:PubMed, SrcID:11229779, URL:http://europepmc.org/abstract/MED/11229779",ClC1=COc2ccccc2C(=O)N1CCCCN3CCC(=CC3)c4ccccn4,CHEMBL214,HTR1A
4678,CHEMBL279260,Rafabegron,Small molecule,,,,-begron,Beta-3 adrenergic receptor agonist,Discontinueddue to lack of efficacy (http://business.highbeam.com/436989/article-1G1-108457473/rafabegron-dainippon-takeda-Discontinuedeurope-usa),,CHEMBL246,Beta-3 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15684518, URL:http://europepmc.org/abstract/MED/15684518",C[C@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c3cccc(Cl)c3,CHEMBL246,ADRB3
4679,CHEMBL3301622,Gilteritinib,Small molecule,,,,-tinib,Tyrosine-protein kinase receptor FLT3 inhibitor,,,CHEMBL1974,Tyrosine-protein kinase receptor FLT3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:2073104, URL:http://europepmc.org/abstract/MED/2073104|Name:PubMed, SrcID:26555154, URL:http://europepmc.org/abstract/MED/26555154|Name:Other, SrcID:http://meetinglibrary.asco.org/content/131170-144, URL:http://meetinglibrary.asco.org/content/131170-144",CCc1nc(C(=O)N)c(Nc2ccc(N3CCC(CC3)N4CCN(C)CC4)c(OC)c2)nc1NC5CCOCC5,CHEMBL1974,FLT3
4680,CHEMBL592054,Imiglitazar,Small molecule,,,,-glitazar,Peroxisome proliferator-activated receptor alpha agonist,Development discontinued after Ph3 in 2005 due to abnormalities in liver enzyme tests (http://www.firstwordpharma.com/node/218757#axzz3OLRFCbFS3).,,CHEMBL239,Peroxisome proliferator-activated receptor alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15219816, URL:http://europepmc.org/abstract/MED/15219816|Name:PubMed, SrcID:17884441, URL:http://europepmc.org/abstract/MED/17884441|Name:PubMed, SrcID:23721199, URL:http://europepmc.org/abstract/MED/23721199",Cc1oc(nc1COc2ccc(CO\N=C(/CCC(=O)O)\c3ccccc3)cc2)c4ccccc4,CHEMBL239,PPARA
4681,CHEMBL1762621,Bardoxolone Methyl,Small molecule,,,,-olone,Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor,"Ph3 study terminated, safety and efficacy to be re-evaluated in new Ph2 study in 2014/2015. Activates KEAP1-Nrf2 pathway (http://en.wikipedia.org/wiki/Bardoxolone_methyl, http://www.kyowa-kirin.com/news_releases/2014/e20140702_01.html)",,CHEMBL1991,Inhibitor of nuclear factor kappa B kinase beta subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16998237, URL:http://europepmc.org/abstract/MED/16998237|Name:PubMed, SrcID:3542979, URL:http://europepmc.org/abstract/MED/3542979",COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]3C(=O)C=C4[C@@](C)(CC[C@H]5C(C)(C)C(=O)C(=C[C@]45C)C#N)[C@]3(C)CC2,CHEMBL1991,IKBKB
4682,CHEMBL266510,Flindokalner,Small molecule,,,,-kalner,Calcium-activated potassium channel subunit alpha-1 opener,Indication: Stroke,,CHEMBL4304,Calcium-activated potassium channel subunit alpha-1,OPENER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11323525, URL:http://europepmc.org/abstract/MED/11323525|Name:PubMed, SrcID:12481191, URL:http://europepmc.org/abstract/MED/12481191",COc1ccc(Cl)cc1[C@]2(F)C(=O)Nc3cc(ccc23)C(F)(F)F,CHEMBL4304,KCNMA1
4683,CHEMBL2108658,Tremelimumab,Antibody,,,,-mab,Cytotoxic T-lymphocyte protein 4 inhibitor,"Blocks the binding of the antigen-presenting cell ligands B7.1 and B7.2 to CTLA-4, resulting in inhibition of B7-CTLA-4-mediated downregulation of T-cell activation.",,CHEMBL2364164,Cytotoxic T-lymphocyte protein 4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:27042127, URL:http://europepmc.org/abstract/MED/27042127|Name:PubMed, SrcID:22437870, URL:http://europepmc.org/abstract/MED/22437870",,CHEMBL2364164,CTLA4
4684,CHEMBL1908845,Idraparinux,Oligosaccharide,,,,-parinux,Coagulation factor X inhibitor,,,CHEMBL244,Coagulation factor X,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:14717965, URL:http://europepmc.org/abstract/MED/14717965",CO[C@H]1O[C@H](COS(=O)(=O)O)[C@@H](O[C@H]2O[C@H]([C@@H](O[C@H]3O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]4O[C@@H]([C@@H](O[C@H]5O[C@H](COS(=O)(=O)O)[C@@H](OC)[C@H](OC)[C@H]5OC)[C@H](OC)[C@H]4OC)C(=O)O)[C@H](OS(=O)(=O)O)[C@H]3OS(=O)(=O)O)[C@H](OC)[C@H]2OC)C(=O)O)[C@H](OS(=O)(=O)O)[C@H]1OS(=O)(=O)O,CHEMBL244,F10
4685,CHEMBL315985,Eslicarbazepine,Small molecule,,N03AF04,N03AF04 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Carboxamide derivatives],-pin(e),Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:24225327, URL:http://europepmc.org/abstract/MED/24225327|Name:PubMed, SrcID:12952496, URL:http://europepmc.org/abstract/MED/12952496",NC(=O)N1c2ccccc2C[C@H](O)c3ccccc13,,
4686,CHEMBL444929,Squalamine,Small molecule,,,,,Sodium/hydrogen exchanger 3 inhibitor,Anti-angiogenic amino sterol,,CHEMBL3273,Sodium/hydrogen exchanger 3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:9886929, URL:http://europepmc.org/abstract/MED/9886929|Name:PubMed, SrcID:19668729, URL:http://europepmc.org/abstract/MED/19668729",CC(C)[C@@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@H]4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)NCCCNCCCCN)OS(=O)(=O)O,CHEMBL3273,SLC9A3
4687,CHEMBL3707446,Rivipansel,Small molecule,,,,-pansel,Selectin E antagonist,,"E-selectin IC50 = 4.3uM, P-selectin IC50 = 423uM and L-selectin IC50 = 337uM",CHEMBL3890,Selectin E,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26117840, URL:http://europepmc.org/abstract/MED/26117840",C[C@@H]1O[C@@H](O[C@@H]2[C@H](C[C@H](C[C@H]2O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H](CC4CCCCC4)C(=O)O)[C@H]3OC(=O)c5ccccc5)C(=O)NCCNC(=O)COCCOCC(=O)Nc6cc(cc7cc(cc(c67)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)NC(=O)C8=CC(=O)NC(=O)N8)[C@@H](O)[C@H](O)[C@@H]1O,CHEMBL3890,SELE
4688,CHEMBL3833344,Mm-302,Antibody,,,,,Receptor protein-tyrosine kinase erbB-2 binding agent,"Upon binding of the antibody to receptor protein-tyrosine kinase ERBB2, the immunoliposome allows for specific delivery of doxorubicin to tumors overexpressing the ERBB2 receptor.",,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26162690, URL:http://europepmc.org/abstract/MED/26162690|Name:PubMed, SrcID:27259714, URL:http://europepmc.org/abstract/MED/27259714",,CHEMBL1824,ERBB2
4689,CHEMBL2108266,Cedelizumab,Antibody,,,,-mab,T-cell surface antigen CD4 inhibitor,It causes consistent blockade of cell-surface CD4 molecules on T lymphocytes blocking the activation of T lymphocytes (no depletion of T cells). Regulation of the immune response.,,CHEMBL2754,T-cell surface antigen CD4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1159/isbn.978-3-318-00490-8, URL:https://www.karger.com/Book/Home/223663|Name:ISBN, SrcID:978-3-662-22195-2, URL:http://www.springer.com/gb/book/9783662221976|Name:PubMed, SrcID:9489810, URL:http://europepmc.org/abstract/MED/9489810|Name:PubMed, SrcID:11004613, URL:http://europepmc.org/abstract/MED/11004613",,CHEMBL2754,CD4
4690,CHEMBL3833373,Avelumab,Antibody,2017.0,,,-mab,Programmed cell death 1 ligand 1 other,"Avelumab binds to PD-L1 and prevents the interaction of PD-L1 with its receptor programmed cell death protein 1 (PD-1). This inhibits the activation of PD-1 and its downstream signalling pathways. This results in the activation of cytotoxic T-lymphocytes (CTLs) targeted to PD-L1-overexpressing tumor cells. In addition, avelumab induces an antibody-dependent cellular cytotoxic (ADCC) response against PD-L1-expressing tumor cells.",,CHEMBL3580522,Programmed cell death 1 ligand 1,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:28214087, URL:http://europepmc.org/abstract/MED/28214087|Name:PubMed, SrcID:28239472, URL:http://europepmc.org/abstract/MED/28239472",,CHEMBL3580522,CD274
4691,CHEMBL2109271,Mdx-210,Antibody,,,,,Receptor protein-tyrosine kinase erbB-2 other,Immunostimulant. Induces antibody dependent cellular phagocytosis (ADCP) and antibody-dependent cell-mediated cytotoxicity (ADCC).,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,OTHER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10369066, URL:http://europepmc.org/abstract/MED/10369066",,CHEMBL1824,ERBB2
4692,CHEMBL1201528,Vasopressin Tannate,Protein,1982.0,,,-pressin,Vasopressin V2 receptor agonist,,,CHEMBL1790,Vasopressin V2 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:IUPHAR, SrcID:2168, URL:http://www.iuphar-db.org/DATABASE/LigandDisplayForward?tab=biology&ligandId=2168|Name:DailyMed, SrcID:archiveid=190251, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=190251|Name:DailyMed, SrcID:setid=1b316ff5-b7f8-4509-acc4-fd263d0a1703, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1b316ff5-b7f8-4509-acc4-fd263d0a1703",,CHEMBL1790,AVPR2
4693,CHEMBL525610,Teriparatide,Protein,2002.0,H05AA02,"H05AA02 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CALCIUM HOMEOSTASIS: PARATHYROID HORMONES AND ANALOGUES: Parathyroid hormones and analogues]",-tide,Parathyroid hormone receptor agonist,It's a recombinant protein of the parathyroid hormone for the treatment of postmenopausal women with osteoporosis,,CHEMBL1793,Parathyroid hormone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=aae667c5-381f-4f92-93df-2ed6158d07b0, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aae667c5-381f-4f92-93df-2ed6158d07b0",CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc5cnc[nH]5)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc6ccccc6)C(=O)O,CHEMBL1793,PTH1R
4694,CHEMBL838,Benazepril,Small molecule,1991.0,C09AA07,"C09AA07 [CARDIOVASCULAR SYSTEM: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM: ACE INHIBITORS, PLAIN: ACE inhibitors, plain]",-pril,Angiotensin-converting enzyme inhibitor,,,CHEMBL1808,Angiotensin-converting enzyme,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=2abb091b-a53e-46b0-9b84-e5ee8f2bdd8e, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2abb091b-a53e-46b0-9b84-e5ee8f2bdd8e",CCOC(=O)[C@H](CCc1ccccc1)N[C@H]2CCc3ccccc3N(CC(=O)O)C2=O,CHEMBL1808,ACE
4695,CHEMBL554,Lapatinib,Small molecule,2007.0,L01XE07,L01XE07 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Receptor protein-tyrosine kinase erbB-2 inhibitor,,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=63319b01-cad6-4d0a-c39b-938fa951a808#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=63319b01-cad6-4d0a-c39b-938fa951a808#section-13",CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2,CHEMBL1824,ERBB2
4696,CHEMBL1532,Quinethazone,Small molecule,1963.0,C03BA02,"C03BA02 [CARDIOVASCULAR SYSTEM: DIURETICS: LOW-CEILING DIURETICS, EXCL. THIAZIDES: Sulfonamides, plain]",,Thiazide-sensitive sodium-chloride cotransporter inhibitor,,,CHEMBL1876,Thiazide-sensitive sodium-chloride cotransporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1056/NEJMra0907219, URL:http://www.nejm.org/doi/full/10.1056/NEJMra0907219",CCC1NC(=O)c2cc(c(Cl)cc2N1)S(=O)(=O)N,CHEMBL1876,SLC12A3
4697,CHEMBL46,Ondansetron,Small molecule,1991.0,A04AA01,A04AA01 [ALIMENTARY TRACT AND METABOLISM: ANTIEMETICS AND ANTINAUSEANTS: ANTIEMETICS AND ANTINAUSEANTS: Serotonin (5HT3) antagonists],-setron,Serotonin 3a (5-HT3a) receptor antagonist,,Selective,CHEMBL1899,Serotonin 3a (5-HT3a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=bb4bc810-db26-471b-9ce7-6e2fb3018af0, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bb4bc810-db26-471b-9ce7-6e2fb3018af0",Cc1nccn1CC2CCc3c(C2=O)c4ccccc4n3C,CHEMBL1899,HTR3A
4698,CHEMBL2364968,Ergoloid,Small molecule,1953.0,,,,Serotonin 1a (5-HT1a) receptor agonist,,,CHEMBL214,Serotonin 1a (5-HT1a) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:2869188, URL:http://europepmc.org/abstract/MED/2869188|Name:ISBN, SrcID:0443-059748 PP.167, URL:http://www.isbnsearch.org/isbn/0443059748",CCC(C)[C@@H]1N2C(=O)[C@](NC(=O)[C@@H]3C[C@H]4[C@@H](Cc5c[nH]c6cccc4c56)N(C)C3)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C.CC(C)C[C@@H]8N9C(=O)[C@](NC(=O)[C@@H]%10C[C@H]%11[C@@H](Cc%12c[nH]c%13cccc%11c%12%13)N(C)C%10)(O[C@@]9(O)[C@@H]%14CCCN%14C8=O)C(C)C.CC(C)[C@@H]%15N%16C(=O)[C@](NC(=O)[C@@H]%17C[C@H]%18[C@@H](Cc%19c[nH]c%20cccc%18c%19%20)N(C)C%17)(O[C@@]%16(O)[C@@H]%21CCCN%21C%15=O)C(C)C.CC(C)[C@@]%22(NC(=O)[C@@H]%23C[C@H]%24[C@@H](Cc%25c[nH]c%26cccc%24c%25%26)N(C)C%23)O[C@@]%27(O)[C@@H]%28CCCN%28C(=O)[C@H](Cc%29ccccc%29)N%27C%22=O,CHEMBL214,HTR1A
4699,CHEMBL1201611,Insulin Lispro Protamine Recombinant,Protein,1999.0,,,,Insulin receptor agonist,,,CHEMBL1981,Insulin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=c8ecbd7a-0e22-4fc7-a503-faa58c1b6f3f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c8ecbd7a-0e22-4fc7-a503-faa58c1b6f3f",,CHEMBL1981,INSR
4700,CHEMBL1423,Pimozide,Small molecule,1984.0,N05AG02,N05AG02 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Diphenylbutylpiperidine derivatives],,Serotonin 2a (5-HT2a) receptor antagonist,,,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=fd9729c3-545f-4d34-9bc7-72b61e028fc4#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fd9729c3-545f-4d34-9bc7-72b61e028fc4#nlm34090-1|Name:Wikipedia, SrcID:Pimozide, URL:http://en.wikipedia.org/wiki/Pimozide|Name:ISBN, SrcID:0443-059748 PP. 542, URL:http://www.isbnsearch.org/isbn/0443059748",Fc1ccc(cc1)C(CCCN2CCC(CC2)N3C(=O)Nc4ccccc34)c5ccc(F)cc5,CHEMBL224,HTR2A
4701,CHEMBL1756,Estramustine Phosphate,Small molecule,1981.0,,,estr-; -mustine,Estrogen receptor beta,Estrogen replacement therapy for prostate cancer,,CHEMBL242,Estrogen receptor beta,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=a9b01bc6-95ac-46f9-befa-d845a74d53c1#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a9b01bc6-95ac-46f9-befa-d845a74d53c1#nlm34090-1|Name:PubMed, SrcID:14755680, URL:http://europepmc.org/abstract/MED/14755680|Name:Wikipedia, SrcID:Estrogen_receptor, URL:http://en.wikipedia.org/wiki/Estrogen_receptor",C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)[C@@H]1CC[C@@H]2OP(=O)(O)O,CHEMBL242,ESR2
4702,CHEMBL1201056,Sulfacytine,Small molecule,1975.0,,,sulfa-,Dihydropteroate synthetase inhibitor,,,CHEMBL2013,Dihydropteroate synthetase,INHIBITOR,Plasmodium falciparum,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Sulfacytine, URL:http://en.wikipedia.org/wiki/Sulfacytine|Name:PubMed, SrcID:1195474, URL:http://europepmc.org/abstract/MED/1195474",CCN1C=CC(=NC1=O)NS(=O)(=O)c2ccc(N)cc2,,
4703,CHEMBL1201109,Desonide,Small molecule,1972.0,D07AB08; S01BA11,"D07AB08 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, moderately potent (group II)]; S01BA11 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Corticosteroids, plain]",-onide,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17038445, URL:http://europepmc.org/abstract/MED/17038445|Name:PubMed, SrcID:20371666, URL:http://europepmc.org/abstract/MED/20371666|Name:PubMed, SrcID:20427668, URL:http://europepmc.org/abstract/MED/20427668",CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,CHEMBL2034,NR3C1
4704,CHEMBL1497,Betamethasone Valerate,Small molecule,1967.0,C05AA05; D07XC01; A07EA04; S03BA03; S02BA07; R01AD06; R03BA04; H02AB01; S01CB04; D07AC01; S01BA06,"C05AA05 [CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Corticosteroids]; D07XC01 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, OTHER COMBINATIONS: Corticosteroids, potent, other combinations]; A07EA04 [ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Corticosteroids acting locally]; S03BA03 [SENSORY ORGANS: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS: CORTICOSTEROIDS: Corticosteroids]; S02BA07 [SENSORY ORGANS: OTOLOGICALS: CORTICOSTEROIDS: Corticosteroids]; R01AD06 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Corticosteroids]; R03BA04 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS: Glucocorticoids]; H02AB01 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Glucocorticoids]; S01CB04 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION: Corticosteroids/antiinfectives/mydriatics in combination]; D07AC01 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, potent (group III)]; S01BA06 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Corticosteroids, plain]",,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12188035, URL:http://europepmc.org/abstract/MED/12188035|Name:Wikipedia, SrcID:Betamethasone, URL:http://en.wikipedia.org/wiki/Betamethasone",CCCCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CO,CHEMBL2034,NR3C1
4705,CHEMBL991,Stavudine,Small molecule,1994.0,J05AF04,J05AF04 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleoside and nucleotide reverse transcriptase inhibitors],-vudine,Human immunodeficiency virus type 1 reverse transcriptase inhibitor,,,CHEMBL247,Human immunodeficiency virus type 1 reverse transcriptase,INHIBITOR,Human immunodeficiency virus 1,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=e29485f8-df97-47b2-b5f9-62e99adcf4af, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e29485f8-df97-47b2-b5f9-62e99adcf4af|Name:FDA, SrcID:label/2011/020412s038,020413s030lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020412s038,020413s030lbl.pdf",CC1=CN([C@@H]2O[C@H](CO)C=C2)C(=O)NC1=O,,
4706,CHEMBL2107797,Norgestrel,Small molecule,1968.0,,,-gest-,Progesterone receptor agonist,,,CHEMBL208,Progesterone receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Expert, SrcID:NORGESTREL, URL:http://chembl.blogspot.co.uk/search?q=NORGESTREL",CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CCC2(O)C#C,CHEMBL208,PGR
4707,CHEMBL480,Lansoprazole,Small molecule,1995.0,A02BC03; A02BC53,A02BC03 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): Proton pump inhibitors]; A02BC53 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): Proton pump inhibitors],-prazole,Potassium-transporting ATPase inhibitor,,,CHEMBL2095173,Potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,K-ATPase alpha subunit,Alpha subunit is likely binding site,"Name:PubMed, SrcID:14699149, URL:http://europepmc.org/abstract/MED/14699149|Name:PubMed, SrcID:23350044, URL:http://europepmc.org/abstract/MED/23350044|Name:DailyMed, SrcID:setid=82174fcc-1b0f-2068-7fc4-db335b43b5e2#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=82174fcc-1b0f-2068-7fc4-db335b43b5e2#nlm34090-1",Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c2nc3ccccc3[nH]2,CHEMBL2095173,ATP4A
4708,CHEMBL480,Lansoprazole,Small molecule,1995.0,A02BC03; A02BC53,A02BC03 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): Proton pump inhibitors]; A02BC53 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): Proton pump inhibitors],-prazole,Potassium-transporting ATPase inhibitor,,,CHEMBL2095173,Potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,K-ATPase alpha subunit,Alpha subunit is likely binding site,"Name:PubMed, SrcID:14699149, URL:http://europepmc.org/abstract/MED/14699149|Name:PubMed, SrcID:23350044, URL:http://europepmc.org/abstract/MED/23350044|Name:DailyMed, SrcID:setid=82174fcc-1b0f-2068-7fc4-db335b43b5e2#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=82174fcc-1b0f-2068-7fc4-db335b43b5e2#nlm34090-1",Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c2nc3ccccc3[nH]2,CHEMBL2095173,ATP4B
4709,CHEMBL1201320,Esomeprazole,Small molecule,2001.0,A02BC05,A02BC05 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): Proton pump inhibitors],-prazole,Potassium-transporting ATPase inhibitor,,,CHEMBL2095173,Potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,K-ATPase alpha subunit,Alpha subunit is likely binding site,"Name:DailyMed, SrcID:setid=f4853677-1622-4037-688b-fdf533a11d96, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f4853677-1622-4037-688b-fdf533a11d96|Name:DailyMed, SrcID:setid=61a5a84e-0194-4f11-91f8-83d7ac404932, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=61a5a84e-0194-4f11-91f8-83d7ac404932",COc1ccc2[nH]c(nc2c1)[S+]([O-])Cc3ncc(C)c(OC)c3C,CHEMBL2095173,ATP4A
4710,CHEMBL1201320,Esomeprazole,Small molecule,2001.0,A02BC05,A02BC05 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): Proton pump inhibitors],-prazole,Potassium-transporting ATPase inhibitor,,,CHEMBL2095173,Potassium-transporting ATPase,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,K-ATPase alpha subunit,Alpha subunit is likely binding site,"Name:DailyMed, SrcID:setid=f4853677-1622-4037-688b-fdf533a11d96, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f4853677-1622-4037-688b-fdf533a11d96|Name:DailyMed, SrcID:setid=61a5a84e-0194-4f11-91f8-83d7ac404932, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=61a5a84e-0194-4f11-91f8-83d7ac404932",COc1ccc2[nH]c(nc2c1)[S+]([O-])Cc3ncc(C)c(OC)c3C,CHEMBL2095173,ATP4B
4711,CHEMBL761,Naphazoline,Small molecule,1971.0,S01GA01; R01AA08; R01AB02; S01GA51,"S01GA01 [SENSORY ORGANS: OPHTHALMOLOGICALS: DECONGESTANTS AND ANTIALLERGICS: Sympathomimetics used as decongestants]; R01AA08 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Sympathomimetics, plain]; R01AB02 [RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Sympathomimetics, combinations excl. corticosteroids]; S01GA51 [SENSORY ORGANS: OPHTHALMOLOGICALS: DECONGESTANTS AND ANTIALLERGICS: Sympathomimetics used as decongestants]",-azoline,Adrenergic receptor alpha agonist,,,CHEMBL2095203,Adrenergic receptor alpha,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:8930173, URL:http://europepmc.org/abstract/MED/8930173|Name:PubMed, SrcID:17852165, URL:http://europepmc.org/abstract/MED/17852165|Name:PubMed, SrcID:11180982, URL:http://europepmc.org/abstract/MED/11180982",C(C1=NCCN1)c2cccc3ccccc23,,
4712,CHEMBL945,Amiloride,Small molecule,1981.0,C03DB01,C03DB01 [CARDIOVASCULAR SYSTEM: DIURETICS: POTASSIUM-SPARING AGENTS: Other potassium-sparing agents],,"Amiloride-sensitive sodium channel, ENaC blocker",,,CHEMBL2107836,"Amiloride-sensitive sodium channel, ENaC",BLOCKER,Homo sapiens,PROTEIN COMPLEX,Amiloride-sensitive sodium channel alpha subunit,Alpha subunit is binding site,"Name:PubMed, SrcID:12928313, URL:http://europepmc.org/abstract/MED/12928313|Name:PubMed, SrcID:17198922, URL:http://europepmc.org/abstract/MED/17198922",NC(=N)NC(=O)c1nc(Cl)c(N)nc1N,CHEMBL2107836,SCNN1G
4713,CHEMBL945,Amiloride,Small molecule,1981.0,C03DB01,C03DB01 [CARDIOVASCULAR SYSTEM: DIURETICS: POTASSIUM-SPARING AGENTS: Other potassium-sparing agents],,"Amiloride-sensitive sodium channel, ENaC blocker",,,CHEMBL2107836,"Amiloride-sensitive sodium channel, ENaC",BLOCKER,Homo sapiens,PROTEIN COMPLEX,Amiloride-sensitive sodium channel alpha subunit,Alpha subunit is binding site,"Name:PubMed, SrcID:12928313, URL:http://europepmc.org/abstract/MED/12928313|Name:PubMed, SrcID:17198922, URL:http://europepmc.org/abstract/MED/17198922",NC(=N)NC(=O)c1nc(Cl)c(N)nc1N,CHEMBL2107836,SCNN1B
4714,CHEMBL1491,Amlodipine,Small molecule,1992.0,C08CA01,C08CA01 [CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS: Dihydropyridine derivatives],-dipine,Voltage-gated L-type calcium channel blocker,,,CHEMBL2095229,Voltage-gated L-type calcium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:Wikipedia, SrcID:Dihydropyridine, URL:http://en.wikipedia.org/wiki/Dihydropyridine|Name:Wikipedia, SrcID:L-type_calcium_channel, URL:http://en.wikipedia.org/wiki/L-type_calcium_channel|Name:Wikipedia, SrcID:Voltage-dependent_calcium_channel, URL:http://en.wikipedia.org/wiki/Voltage-dependent_calcium_channel|Name:Wikipedia, SrcID:Amlodipine, URL:http://en.wikipedia.org/wiki/Amlodipine|Name:DailyMed, SrcID:setid=15416229-d7d3-5bfb-a373-71575c36d5cf#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=15416229-d7d3-5bfb-a373-71575c36d5cf#section-13",CCOC(=O)C1=C(COCCN)NC(=C(C1c2ccccc2Cl)C(=O)OC)C,,
4715,CHEMBL1726,Nisoldipine,Small molecule,1995.0,C08CA07,C08CA07 [CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS: Dihydropyridine derivatives],-dipine,Voltage-gated L-type calcium channel blocker,,,CHEMBL2095229,Voltage-gated L-type calcium channel,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:Wikipedia, SrcID:Dihydropyridine, URL:http://en.wikipedia.org/wiki/Dihydropyridine|Name:Wikipedia, SrcID:L-type_calcium_channel, URL:http://en.wikipedia.org/wiki/L-type_calcium_channel|Name:Wikipedia, SrcID:Voltage-dependent_calcium_channel, URL:http://en.wikipedia.org/wiki/Voltage-dependent_calcium_channel|Name:Wikipedia, SrcID:Nisoldipine, URL:http://en.wikipedia.org/wiki/Nisoldipine|Name:DailyMed, SrcID:setid=00d506a4-74d6-4838-b008-3f9e7c017e08, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=00d506a4-74d6-4838-b008-3f9e7c017e08",COC(=O)C1=C(C)NC(=C(C1c2ccccc2[N+](=O)[O-])C(=O)OCC(C)C)C,,
4716,CHEMBL1685,Dezocine,Small molecule,1989.0,N02AX03,N02AX03 [NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Other opioids],,Kappa opioid receptor antagonist,,,CHEMBL237,Kappa opioid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:0443-059748 PP. 592, URL:http://www.isbnsearch.org/isbn/0443059748|Name:PubMed, SrcID:1348168, URL:http://europepmc.org/abstract/MED/1348168",C[C@@]12CCCCC[C@@H](Cc3ccc(O)cc13)[C@@H]2N,CHEMBL237,OPRK1
4717,CHEMBL1256786,Formoterol,Small molecule,2001.0,R03AC13,"R03AC13 [RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS, INHALANTS: Selective beta-2-adrenoreceptor agonists]",-terol,Beta-2 adrenergic receptor agonist,Long acting,,CHEMBL210,Beta-2 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2016/022518s019,205641s005lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022518s019,205641s005lbl.pdf|Name:DailyMed, SrcID:setid=7b9da867-04ad-4ace-a889-9f4ff8bec47b#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7b9da867-04ad-4ace-a889-9f4ff8bec47b#nlm34090-1",COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1,CHEMBL210,ADRB2
4718,CHEMBL1291,Metipranolol,Small molecule,1989.0,S01ED04; S01ED54,S01ED04 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Beta blocking agents 1)]; S01ED54 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Beta blocking agents 1)],-olol,Beta-2 adrenergic receptor antagonist,,,CHEMBL210,Beta-2 adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=209a4cc3-8453-4e4c-8af5-ad059bebf046, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=209a4cc3-8453-4e4c-8af5-ad059bebf046|Name:DailyMed, SrcID:archiveid=129928, URL:http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=129928",CC(C)NCC(O)COc1cc(C)c(OC(=O)C)c(C)c1C,CHEMBL210,ADRB2
4719,CHEMBL354541,Lomitapide,Small molecule,2012.0,C10AX12,"C10AX12 [CARDIOVASCULAR SYSTEM: LIPID MODIFYING AGENTS: LIPID MODIFYING AGENTS, PLAIN: Other lipid modifying agents]",-tapide,Microsomal triglyceride transfer protein inhibitor,,,CHEMBL2364681,Microsomal triglyceride transfer protein,INHIBITOR,Homo sapiens,PROTEIN COMPLEX,Microsomal triglyceride transfer protein large subunit,Large subunit (P55157) is binding site,"Name:DailyMed, SrcID:setid=e4c45bb5-15f4-437e-ab98-a649b3676d14, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e4c45bb5-15f4-437e-ab98-a649b3676d14",FC(F)(F)CNC(=O)C1(CCCCN2CCC(CC2)NC(=O)c3ccccc3c4ccc(cc4)C(F)(F)F)c5ccccc5c6ccccc16,,
4720,CHEMBL865,Valdecoxib,Small molecule,2001.0,M01AH03,"M01AH03 [MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Coxibs]",-coxib,Cyclooxygenase-2 inhibitor,,,CHEMBL230,Cyclooxygenase-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=caf64301-262c-45ca-acd1-a9d6696c584e, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=caf64301-262c-45ca-acd1-a9d6696c584e",Cc1onc(c2ccccc2)c1c3ccc(cc3)S(=O)(=O)N,CHEMBL230,PTGS2
4721,CHEMBL465,Dronabinol,Small molecule,1985.0,A04AD10,A04AD10 [ALIMENTARY TRACT AND METABOLISM: ANTIEMETICS AND ANTINAUSEANTS: ANTIEMETICS AND ANTINAUSEANTS: Other antiemetics],-nab-,Cannabinoid CB1 receptor agonist,,,CHEMBL218,Cannabinoid CB1 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=68b4168b-5782-4e68-a25a-5b4e4408dbce#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=68b4168b-5782-4e68-a25a-5b4e4408dbce#nlm34090-1|Name:PubMed, SrcID:16570099, URL:http://europepmc.org/abstract/MED/16570099",CCCCCc1cc(O)c2[C@@H]3C=C(C)CC[C@H]3C(C)(C)Oc2c1,CHEMBL218,CNR1
4722,CHEMBL1201248,Cisatracurium,Small molecule,1995.0,M03AC11,"M03AC11 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS: Other quaternary ammonium compounds]",-curium,Muscle-type nicotinic acetylcholine receptor antagonist,non-depolarizing,,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:DailyMed, SrcID:setid=291a55dd-ab45-4660-b513-4ecb729eb051, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=291a55dd-ab45-4660-b513-4ecb729eb051|Name:PubMed, SrcID:12171561, URL:http://europepmc.org/abstract/MED/12171561|Name:ISBN, SrcID:9780702034718 PP. 164, URL:http://www.isbnsearch.org/isbn/9780702034718",COc1ccc(C[C@@H]2c3cc(OC)c(OC)cc3CC[N@+]2(C)CCC(=O)OCCCCCOC(=O)CC[N@@+]4(C)CCc5cc(OC)c(OC)cc5[C@H]4Cc6ccc(OC)c(OC)c6)cc1OC,,
4723,CHEMBL703,Suxamethonium,Small molecule,1952.0,M03AB01,"M03AB01 [MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS: Choline derivatives]",-ium,Muscle-type nicotinic acetylcholine receptor agonist,,,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,AGONIST,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:ISBN, SrcID:9780702034718 PP. 164, URL:http://www.isbnsearch.org/isbn/9780702034718",C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,,
4724,CHEMBL1256,Isoflurane,Small molecule,1979.0,N01AB06,"N01AB06 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons]",-flurane,Glycine receptor (alpha-1/beta) positive modulator,alpha1/beta is main adult form,,CHEMBL2363052,Glycine receptor (alpha-1/beta),POSITIVE MODULATOR,Homo sapiens,PROTEIN COMPLEX,Glycine receptor alpha subunit,,"Name:Wikipedia, SrcID:Isoflurane#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Isoflurane#Mechanism_of_action|Name:PubMed, SrcID:21788314, URL:http://europepmc.org/abstract/MED/21788314",FC(F)OC(Cl)C(F)(F)F,CHEMBL2363052,GLRB
4725,CHEMBL1731,Mezlocillin,Small molecule,1981.0,J01CA10,"J01CA10 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: BETA-LACTAM ANTIBACTERIALS, PENICILLINS: Penicillins with extended spectrum]",-cillin,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:PubMed, SrcID:6220263, URL:http://europepmc.org/abstract/MED/6220263|Name:PubMed, SrcID:2683579, URL:http://europepmc.org/abstract/MED/2683579",CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCN(C3=O)S(=O)(=O)C)c4ccccc4)C(=O)N2[C@H]1C(=O)O,,
4726,CHEMBL1201431,Human Dnase-1,Enzyme,1993.0,R05CB13,"R05CB13 [RESPIRATORY SYSTEM: COUGH AND COLD PREPARATIONS: EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS: Mucolytics]",-ase,DNA hydrolytic enzyme,,,CHEMBL2311221,DNA,HYDROLYTIC ENZYME,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=d8c78a7e-ff99-48f3-8952-643ec2ea0f86#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d8c78a7e-ff99-48f3-8952-643ec2ea0f86#nlm34090-1",,,
4727,CHEMBL416,Methoxsalen,Small molecule,1954.0,D05BA02; D05AD02,D05BA02 [DERMATOLOGICALS: ANTIPSORIATICS: ANTIPSORIATICS FOR SYSTEMIC USE: Psoralens for systemic use]; D05AD02 [DERMATOLOGICALS: ANTIPSORIATICS: ANTIPSORIATICS FOR TOPICAL USE: Psoralens for topical use],-sal-,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=a4c61db9-b72d-4b67-b69b-a97257b614ad, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a4c61db9-b72d-4b67-b69b-a97257b614ad",COc1c2OC(=O)C=Cc2cc3ccoc13,,
4728,CHEMBL1195,Propoxycaine,Small molecule,1982.0,,,-caine,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:18407836, URL:http://europepmc.org/abstract/MED/18407836|Name:PubMed, SrcID:23142844, URL:http://europepmc.org/abstract/MED/23142844",CCCOc1cc(N)ccc1C(=O)OCCN(CC)CC,,
4729,CHEMBL1200986,Haloperidol Decanoate,Small molecule,1986.0,N05AD01,N05AD01 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Butyrophenone derivatives],-peridol,D2-like dopamine receptor inverse agonist,,,CHEMBL2331075,D2-like dopamine receptor,INVERSE AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:ISBN, SrcID:0443059748, URL:http://www.isbnsearch.org/isbn/0443059748|Name:Wikipedia, SrcID:Haloperidol, URL:http://en.wikipedia.org/wiki/Haloperidol|Name:DailyMed, SrcID:setid=af0159a8-dff5-449a-aa2b-a0c430081e21, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=af0159a8-dff5-449a-aa2b-a0c430081e21|Name:PubMed, SrcID:17015232, URL:http://europepmc.org/abstract/MED/17015232",CCCCCCCCCC(=O)OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,,
4730,CHEMBL1201865,Velaglucerase Alfa,Enzyme,2010.0,A16AB10,A16AB10 [ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Enzymes],-ase,Glucocerebroside hydrolytic enzyme,Given in cases of gaucher disease to overcome a deficiency of beta-glucocerebrosidase activity. Imiglucerase catalyses the hydrolysis of glucocerebroside to glucose and ceramide,,CHEMBL2364176,Glucocerebroside,HYDROLYTIC ENZYME,Homo sapiens,SMALL MOLECULE,,,"Name:DailyMed, SrcID:setid=ca02f7a4-ae4f-43c1-a06a-259fe4fcf9cf, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ca02f7a4-ae4f-43c1-a06a-259fe4fcf9cf",,,
4731,CHEMBL1200922,Mebutamate,Small molecule,1982.0,N05BC04,N05BC04 [NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Carbamates],,Unknown,,,,,,,,,,"Name:PubMed, SrcID:6037393, URL:http://europepmc.org/abstract/MED/6037393",CCC(C)C(C)(COC(=O)N)COC(=O)N,,
4732,CHEMBL1645462,Ac-480,Small molecule,,,,,Receptor protein-tyrosine kinase erbB-2 inhibitor,,,CHEMBL1824,Receptor protein-tyrosine kinase erbB-2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19821562, URL:http://europepmc.org/abstract/MED/19821562|Name:PubMed, SrcID:17062696, URL:http://europepmc.org/abstract/MED/17062696",Cc1c(NC(=O)OC[C@@H]2COCCN2)cn3ncnc(Nc4ccc5c(cnn5Cc6cccc(F)c6)c4)c13,CHEMBL1824,ERBB2
4733,CHEMBL3545422,Arq-092,Small molecule,,,,,Serine/threonine-protein kinase AKT inhibitor,Allosteric inhibitor,,CHEMBL2111353,Serine/threonine-protein kinase AKT,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:26469692, URL:http://europepmc.org/abstract/MED/26469692|Name:Other, SrcID:http://files.shareholder.com/downloads/ARQL/0x0x520085/a3db887d-f50a-4736-919c-650d355b5d16/ARQ_092_AACR_poster_FINAL.PDF, URL:http://files.shareholder.com/downloads/ARQL/0x0x520085/a3db887d-f50a-4736-919c-650d355b5d16/ARQ_092_AACR_poster_FINAL.PDF",,,
4734,CHEMBL259084,Mln-8054,Small molecule,,,,,Serine/threonine-protein kinase Aurora-A inhibitor,,,CHEMBL4722,Serine/threonine-protein kinase Aurora-A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26101564, URL:http://europepmc.org/abstract/MED/26101564|Name:PubMed, SrcID:26345296, URL:http://europepmc.org/abstract/MED/26345296|Name:PubMed, SrcID:17360485, URL:http://europepmc.org/abstract/MED/17360485",OC(=O)c1ccc(Nc2ncc3CN=C(c4cc(Cl)ccc4c3n2)c5c(F)cccc5F)cc1,,
4735,CHEMBL3545321,Nms-1116354,Small molecule,,,,,Cell division cycle 7-related protein kinase inhibitor,,,CHEMBL5443,Cell division cycle 7-related protein kinase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25312588, URL:http://europepmc.org/abstract/MED/25312588|Name:DOI, SrcID:10.1016/S1359-6349(10)71841-3, URL:http://www.sciencedirect.com/science/article/pii/S1359634910718413",,CHEMBL5443,CDC7
4736,CHEMBL3545083,Rgb-286638,Small molecule,,,,,Cyclin-dependent kinase 4 inhibitor,,,CHEMBL331,Cyclin-dependent kinase 4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23807770, URL:http://europepmc.org/abstract/MED/23807770",COCCN1CCN(Cc2ccc(cc2)c3n[nH]c4c5cccc(NC(=O)NN6CCOCC6)c5C(=O)c34)CC1,CHEMBL331,CDK4
4737,CHEMBL1980391,Rg-1530,Small molecule,,,,,Serine/threonine-protein kinase Aurora-A inhibitor,Multi-targeted kinase inhibitor,,CHEMBL4722,Serine/threonine-protein kinase Aurora-A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21553286, URL:http://europepmc.org/abstract/MED/21553286|Name:PubMed, SrcID:24900658, URL:http://europepmc.org/abstract/MED/24900658",COc1cc2Nc3n[nH]c(C)c3N=C(c4ccccc4Cl)c2cc1F,,
4738,CHEMBL3545151,Cc-223,Small molecule,,,,,Serine/threonine-protein kinase mTOR inhibitor,ATP-competitive mTORC1/mTORC2 inhibitor,,CHEMBL2842,Serine/threonine-protein kinase mTOR,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25855786, URL:http://europepmc.org/abstract/MED/25855786",,CHEMBL2842,MTOR
4739,CHEMBL3545152,Ct-327,Small molecule,,,,,Nerve growth factor receptor Trk-A inhibitor,,,CHEMBL2815,Nerve growth factor receptor Trk-A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25594427, URL:http://europepmc.org/abstract/MED/25594427|Name:Other, SrcID:http://www.creabilis-sa.com/ct-327/, URL:http://www.creabilis-sa.com/ct-327/",,CHEMBL2815,NTRK1
4740,CHEMBL206834,Bafetinib,Small molecule,,,,-tinib,Tyrosine-protein kinase Lyn inhibitor,,,CHEMBL3905,Tyrosine-protein kinase Lyn,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16105974, URL:http://europepmc.org/abstract/MED/16105974",CN(C)[C@H]1CCN(Cc2ccc(cc2C(F)(F)F)C(=O)Nc3ccc(C)c(Nc4nccc(n4)c5cncnc5)c3)C1,CHEMBL3905,LYN
4741,CHEMBL3545155,Ji-101,Small molecule,,,,,Ephrin type-B receptor 4 inhibitor,,,CHEMBL5147,Ephrin type-B receptor 4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26365907, URL:http://europepmc.org/abstract/MED/26365907|Name:DOI, SrcID:10.1158/1538-7445.AM10-17, URL:http://cancerres.aacrjournals.org/content/70/8_Supplement/17",COc1ccc(Br)cc1NC(=O)Nc2cccc3c2ccn3Cc4ccnc(N)c4,CHEMBL5147,EPHB4
4742,CHEMBL507361,Pd-0325901,Small molecule,,,,,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,,,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://cancerres.aacrjournals.org/content/64/7_Supplement/925.1, URL:http://cancerres.aacrjournals.org/content/64/7_Supplement/925.1|Name:PubMed, SrcID:15573115, URL:http://europepmc.org/abstract/MED/15573115",OC[C@@H](O)CONC(=O)c1ccc(F)c(F)c1Nc2ccc(I)cc2F,CHEMBL2964,MAP2K2
4743,CHEMBL592445,Gedatolisib,Small molecule,,,,-lisib,Serine/threonine-protein kinase mTOR inhibitor,"Dual MTOR/PIK3 inhibitor, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL2842,Serine/threonine-protein kinase mTOR,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718|Name:PubMed, SrcID:21325073, URL:http://europepmc.org/abstract/MED/21325073",CN(C)C1CCN(CC1)C(=O)c2ccc(NC(=O)Nc3ccc(cc3)c4nc(nc(n4)N5CCOCC5)N6CCOCC6)cc2,CHEMBL2842,MTOR
4744,CHEMBL3545366,Voxtalisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:24634413, URL:http://europepmc.org/abstract/MED/24634413|Name:Other, SrcID:http://www.exelixis.com/pipeline/xl765, URL:http://www.exelixis.com/pipeline/xl765|Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718",CCN1C(=O)C(=Cc2c(C)nc(N)nc12)c3cc[nH]n3,CHEMBL3559703,PIK3R2
4745,CHEMBL3545366,Voxtalisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:24634413, URL:http://europepmc.org/abstract/MED/24634413|Name:Other, SrcID:http://www.exelixis.com/pipeline/xl765, URL:http://www.exelixis.com/pipeline/xl765|Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718",CCN1C(=O)C(=Cc2c(C)nc(N)nc12)c3cc[nH]n3,CHEMBL3559703,PIK3R3
4746,CHEMBL3545366,Voxtalisib,Small molecule,,,,-lisib,PI3-kinase class I inhibitor,,,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:24634413, URL:http://europepmc.org/abstract/MED/24634413|Name:Other, SrcID:http://www.exelixis.com/pipeline/xl765, URL:http://www.exelixis.com/pipeline/xl765|Name:PubMed, SrcID:15705718, URL:http://europepmc.org/abstract/MED/15705718",CCN1C(=O)C(=Cc2c(C)nc(N)nc12)c3cc[nH]n3,CHEMBL3559703,PIK3R5
4747,CHEMBL3545103,Azd3199,Small molecule,,,,,Beta-2 adrenergic receptor agonist,,,CHEMBL210,Beta-2 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24900851, URL:http://europepmc.org/abstract/MED/24900851",,CHEMBL210,ADRB2
4748,CHEMBL3545165,Afacifenacin,Small molecule,,,,-fenacin,Sodium channel protein type X alpha subunit blocker,Non-selective muscarinic receptor antagonist and sodium channel blocker.,,CHEMBL5451,Sodium channel protein type X alpha subunit,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.jurology.com/article/S0022-5347(08)60371-7/pdf, URL:http://www.jurology.com/article/S0022-5347(08)60371-7/pdf|Name:Other, SrcID:http://www.ds-pharma.com/ir/library/financial_results_summary/pdf/ebr20130131_2.pdf, URL:http://www.ds-pharma.com/ir/library/financial_results_summary/pdf/ebr20130131_2.pdf|Name:PubMed, SrcID:21206614, URL:http://europepmc.org/abstract/MED/21206614",FC(F)(F)Oc1cccc(CN2CCC(CC2)N3C(c4ccccc4)c5ccccc5NC3=O)c1,CHEMBL5451,SCN10A
4749,CHEMBL582857,Nelivaptan,Small molecule,,,,-vaptan,Vasopressin V1b receptor antagonist,,,CHEMBL1921,Vasopressin V1b receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11861823, URL:http://europepmc.org/abstract/MED/11861823",COc1ccc(c(OC)c1)S(=O)(=O)N2C(=O)[C@](N3C[C@H](O)C[C@H]3C(=O)N(C)C)(c4ccccc4OC)c5cc(Cl)ccc25,CHEMBL1921,AVPR1B
4750,CHEMBL1256717,Itriglumide,Small molecule,,,,-glumide,Cholecystokinin B receptor antagonist,,,CHEMBL298,Cholecystokinin B receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.rottapharm.fr/rph-fr/media/pdf/RD_pipeline_May_2013_clean.pdf, URL:http://www.rottapharm.fr/rph-fr/media/pdf/RD_pipeline_May_2013_clean.pdf|Name:PubMed, SrcID:10204685, URL:http://europepmc.org/abstract/MED/10204685",Cc1cc(C)c(NC(=O)C[C@H](CC(=O)O)c2cccc3ccccc23)c(c1)C(=O)N4CCC5(CCCC5)CC4,CHEMBL298,CCKBR
4751,CHEMBL1090488,Pf-00446687,Small molecule,,,,,Melanocortin receptor 4 agonist,,,CHEMBL259,Melanocortin receptor 4,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:PF-00446687, URL:http://en.wikipedia.org/wiki/PF-00446687|Name:PubMed, SrcID:20329799, URL:http://europepmc.org/abstract/MED/20329799",C[C@@H]1CN(C[C@H](C)[C@@]1(O)c2ccccc2)C(=O)[C@@H]3CN(C[C@H]3c4ccc(F)cc4F)C(C)(C)C,CHEMBL259,MC4R
4752,CHEMBL448343,Lesogaberan,Small molecule,,,,-gab-,GABA-B receptor 2 agonist,,,CHEMBL5034,GABA-B receptor 2,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.ncats.nih.gov/files/AZD3355.pdf, URL:http://www.ncats.nih.gov/files/AZD3355.pdf|Name:PubMed, SrcID:20655487, URL:http://europepmc.org/abstract/MED/20655487",NC[C@@H](F)CP(=O)O,CHEMBL5034,GABBR2
4753,CHEMBL3545110,Ribociclib,Small molecule,2017.0,,,-ciclib,Cyclin-dependent kinase 6 inhibitor,,,CHEMBL2508,Cyclin-dependent kinase 6,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://mct.aacrjournals.org/content/12/11_Supplement/PR02, URL:http://mct.aacrjournals.org/content/12/11_Supplement/PR02|Name:PubMed, SrcID:24045179, URL:http://europepmc.org/abstract/MED/24045179",CN(C)C(=O)c1cc2cnc(Nc3ccc(cn3)N4CCNCC4)nc2n1C5CCCC5,CHEMBL2508,CDK6
4754,CHEMBL414157,Tonapofylline,Small molecule,,,,-fylline,Adenosine A1 receptor antagonist,,,CHEMBL226,Adenosine A1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17125264, URL:http://europepmc.org/abstract/MED/17125264|Name:PubMed, SrcID:20926754, URL:http://europepmc.org/abstract/MED/20926754",CCCN1C(=O)N(CCC)c2[nH]c(nc2C1=O)C34CCC(CCC(=O)O)(CC3)CC4,CHEMBL226,ADORA1
4755,CHEMBL3545415,Smc021,Protein,,,,,Calcitonin receptor agonist,"peptide drug, oral salmon calcitonin",,CHEMBL1832,Calcitonin receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18782439, URL:http://europepmc.org/abstract/MED/18782439",,,
4756,CHEMBL2108566,Nerelimomab,Antibody,,,,-mab,TNF-alpha inhibitor,,,CHEMBL1825,TNF-alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:15361500, URL:http://europepmc.org/abstract/MED/15361500",,CHEMBL1825,TNF
4757,CHEMBL2108730,Sarilumab,Antibody,,L04AC14,L04AC14 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Interleukin inhibitors],-mab,Interleukin-6 receptor alpha subunit antagonist,,,CHEMBL2364155,Interleukin-6 receptor alpha subunit,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24297381, URL:http://europepmc.org/abstract/MED/24297381",,CHEMBL2364155,IL6R
4758,CHEMBL492399,Verubulin,Small molecule,,,,-bulin,Tubulin disrupting agent,,,CHEMBL2095182,Tubulin,DISRUPTING AGENT,Homo sapiens,PROTEIN COMPLEX GROUP,,Binds to the same (or nearby) sites on ß-tubulin as colchicine,"Name:PubMed, SrcID:21159616, URL:http://europepmc.org/abstract/MED/21159616",COc1ccc(cc1)N(C)c2nc(C)nc3ccccc23,CHEMBL2095182,TUBB8
4759,CHEMBL492399,Verubulin,Small molecule,,,,-bulin,Tubulin disrupting agent,,,CHEMBL2095182,Tubulin,DISRUPTING AGENT,Homo sapiens,PROTEIN COMPLEX GROUP,,Binds to the same (or nearby) sites on ß-tubulin as colchicine,"Name:PubMed, SrcID:21159616, URL:http://europepmc.org/abstract/MED/21159616",COc1ccc(cc1)N(C)c2nc(C)nc3ccccc23,CHEMBL2095182,TUBA3C
4760,CHEMBL492399,Verubulin,Small molecule,,,,-bulin,Tubulin disrupting agent,,,CHEMBL2095182,Tubulin,DISRUPTING AGENT,Homo sapiens,PROTEIN COMPLEX GROUP,,Binds to the same (or nearby) sites on ß-tubulin as colchicine,"Name:PubMed, SrcID:21159616, URL:http://europepmc.org/abstract/MED/21159616",COc1ccc(cc1)N(C)c2nc(C)nc3ccccc23,CHEMBL2095182,TUBA4A
4761,CHEMBL492399,Verubulin,Small molecule,,,,-bulin,Tubulin disrupting agent,,,CHEMBL2095182,Tubulin,DISRUPTING AGENT,Homo sapiens,PROTEIN COMPLEX GROUP,,Binds to the same (or nearby) sites on ß-tubulin as colchicine,"Name:PubMed, SrcID:21159616, URL:http://europepmc.org/abstract/MED/21159616",COc1ccc(cc1)N(C)c2nc(C)nc3ccccc23,CHEMBL2095182,TUBA3E
4762,CHEMBL492399,Verubulin,Small molecule,,,,-bulin,Tubulin disrupting agent,,,CHEMBL2095182,Tubulin,DISRUPTING AGENT,Homo sapiens,PROTEIN COMPLEX GROUP,,Binds to the same (or nearby) sites on ß-tubulin as colchicine,"Name:PubMed, SrcID:21159616, URL:http://europepmc.org/abstract/MED/21159616",COc1ccc(cc1)N(C)c2nc(C)nc3ccccc23,CHEMBL2095182,TUBB6
4763,CHEMBL492399,Verubulin,Small molecule,,,,-bulin,Tubulin disrupting agent,,,CHEMBL2095182,Tubulin,DISRUPTING AGENT,Homo sapiens,PROTEIN COMPLEX GROUP,,Binds to the same (or nearby) sites on ß-tubulin as colchicine,"Name:PubMed, SrcID:21159616, URL:http://europepmc.org/abstract/MED/21159616",COc1ccc(cc1)N(C)c2nc(C)nc3ccccc23,CHEMBL2095182,TUBB2B
4764,CHEMBL492399,Verubulin,Small molecule,,,,-bulin,Tubulin disrupting agent,,,CHEMBL2095182,Tubulin,DISRUPTING AGENT,Homo sapiens,PROTEIN COMPLEX GROUP,,Binds to the same (or nearby) sites on ß-tubulin as colchicine,"Name:PubMed, SrcID:21159616, URL:http://europepmc.org/abstract/MED/21159616",COc1ccc(cc1)N(C)c2nc(C)nc3ccccc23,CHEMBL2095182,TUBA3D
4765,CHEMBL2364639,Valbenazine,Small molecule,,,,,Synaptic vesicular amine transporter inhibitor,,,CHEMBL1893,Synaptic vesicular amine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26346941, URL:http://europepmc.org/abstract/MED/26346941",COc1cc2CCN3C[C@@H](CC(C)C)[C@@H](C[C@@H]3c2cc1OC)OC(=O)[C@@H](N)C(C)C,CHEMBL1893,SLC18A2
4766,CHEMBL408194,Obatoclax,Small molecule,,,,-toclax,Apoptosis regulator Bcl-X inhibitor,,,CHEMBL4625,Apoptosis regulator Bcl-X,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18931344, URL:http://europepmc.org/abstract/MED/18931344|Name:PubMed, SrcID:16645636, URL:http://europepmc.org/abstract/MED/16645636|Name:PubMed, SrcID:18040043, URL:http://europepmc.org/abstract/MED/18040043",COC1=CC(=N/C/1=C\c2[nH]c(C)cc2C)c3cc4ccccc4[nH]3,CHEMBL4625,BCL2L1
4767,CHEMBL2104967,Firategrast,Small molecule,,,,-ast,Integrin alpha-4/beta-7 antagonist,,,CHEMBL2095184,Integrin alpha-4/beta-7,ANTAGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:PubMed, SrcID:22226929, URL:http://europepmc.org/abstract/MED/22226929",CCOCc1cc(OC)c(c(OC)c1)c2ccc(C[C@H](NC(=O)c3c(F)cccc3F)C(=O)O)cc2,,
4768,CHEMBL2108703,Liprotamase,Enzyme,,,,-ase,Starch hydrolytic enzyme,Amylases catalyse the hydrolysis of polyssacharides into sugars.,,CHEMBL2364180,Starch,HYDROLYTIC ENZYME,Homo sapiens,OLIGOSACCHARIDE,,,"Name:PubMed, SrcID:21831726, URL:http://europepmc.org/abstract/MED/21831726",,,
4769,CHEMBL3833342,Nusinersen Sodium,Oligonucleotide,2016.0,,,-rsen,SMN2 pre-mRNA modulator,SPINRAZA was shown to increase exon 7 inclusion in SMN2 messenger ribonucleic acid (mRNA) transcripts and production of full-length SMN protein,,CHEMBL3826841,SMN2 pre-mRNA,MODULATOR,Homo sapiens,NUCLEIC-ACID,,,"Name:FDA, SrcID:label/2016/209531lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/209531lbl.pdf",,,
4770,CHEMBL3545300,Cp-459632,Small molecule,,,,,Fibroblast growth factor receptor inhibitor,No references found,,CHEMBL2095217,Fibroblast growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,,,,
4771,CHEMBL1231,Oxybutynin,Small molecule,1975.0,G04BD04,G04BD04 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Drugs for urinary frequency and incontinence],,Muscarinic acetylcholine receptor M3 antagonist,"Indicated for overactive bladder, M3 likely responsible",,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ISBN, SrcID:9780702034718 PP. 160, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:19446545, URL:http://europepmc.org/abstract/MED/19446545|Name:PubMed, SrcID:17222678, URL:http://europepmc.org/abstract/MED/17222678|Name:PubMed, SrcID:19275276, URL:http://europepmc.org/abstract/MED/19275276|Name:PubMed, SrcID:20590605, URL:http://europepmc.org/abstract/MED/20590605",CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c2ccccc2,CHEMBL245,CHRM3
4772,CHEMBL1755,Conivaptan,Small molecule,2005.0,C03XA02,C03XA02 [CARDIOVASCULAR SYSTEM: DIURETICS: OTHER DIURETICS: Vasopressin antagonists],-vaptan,Vasopressin V2 receptor antagonist,,,CHEMBL1790,Vasopressin V2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2012/021697s003lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021697s003lbl.pdf|Name:DailyMed, SrcID:setid=87713d73-5dcc-4158-8890-60efdbd28c05#section-12, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=87713d73-5dcc-4158-8890-60efdbd28c05#section-12",Cc1nc2c(CCN(C(=O)c3ccc(NC(=O)c4ccccc4c5ccccc5)cc3)c6ccccc26)[nH]1,CHEMBL1790,AVPR2
4773,CHEMBL936,Diphenidol,Small molecule,1967.0,,,,Muscarinic acetylcholine receptor M1 antagonist,antiemetic,,CHEMBL216,Muscarinic acetylcholine receptor M1,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:4869300, URL:http://europepmc.org/abstract/MED/4869300|Name:PubMed, SrcID:2432979, URL:http://europepmc.org/abstract/MED/2432979|Name:ISBN, SrcID:9780702034718 PP. 162, 153, URL:http://www.isbnsearch.org/isbn/9780702034718|Name:PubMed, SrcID:562092, URL:http://europepmc.org/abstract/MED/562092",OC(CCCN1CCCCC1)(c2ccccc2)c3ccccc3,CHEMBL216,CHRM1
4774,CHEMBL941,Imatinib,Small molecule,2001.0,L01XE01,L01XE01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors],-tinib,Tyrosine-protein kinase ABL inhibitor,,,CHEMBL1862,Tyrosine-protein kinase ABL,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13|Name:Wikipedia, SrcID:Bcr-Abl_tyrosine-kinase_inhibitor, URL:http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor",CN1CCN(Cc2ccc(cc2)C(=O)Nc3ccc(C)c(Nc4nccc(n4)c5cccnc5)c3)CC1,CHEMBL1862,ABL1
4775,CHEMBL546,Oxprenolol,Small molecule,1983.0,C07AA02,"C07AA02 [CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, non-selective]",-olol,Beta-1 adrenergic receptor antagonist,,,CHEMBL213,Beta-1 adrenergic receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:2897304, URL:http://europepmc.org/abstract/MED/2897304|Name:ISBN, SrcID:9780702034718 PP. 189, URL:http://www.isbnsearch.org/isbn/9780702034718",CC(C)NCC(O)COc1ccccc1OCC=C,,
4776,CHEMBL1763,Hydroflumethiazide,Small molecule,1959.0,C03AA02; C03AH02,"C03AA02 [CARDIOVASCULAR SYSTEM: DIURETICS: LOW-CEILING DIURETICS, THIAZIDES: Thiazides, plain]; C03AH02 [CARDIOVASCULAR SYSTEM: DIURETICS: LOW-CEILING DIURETICS, THIAZIDES: Thiazides, combinations with psycholeptics and/or analgesics]",-thiazide,Thiazide-sensitive sodium-chloride cotransporter inhibitor,,,CHEMBL1876,Thiazide-sensitive sodium-chloride cotransporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1056/NEJMra0907219, URL:http://www.nejm.org/doi/full/10.1056/NEJMra0907219",NS(=O)(=O)c1cc2c(NCNS2(=O)=O)cc1C(F)(F)F,CHEMBL1876,SLC12A3
4777,CHEMBL1054,Trichlormethiazide,Small molecule,1960.0,C03AA06,"C03AA06 [CARDIOVASCULAR SYSTEM: DIURETICS: LOW-CEILING DIURETICS, THIAZIDES: Thiazides, plain]",-thiazide,Thiazide-sensitive sodium-chloride cotransporter inhibitor,,,CHEMBL1876,Thiazide-sensitive sodium-chloride cotransporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1056/NEJMra0907219, URL:http://www.nejm.org/doi/full/10.1056/NEJMra0907219",NS(=O)(=O)c1cc2c(NC(NS2(=O)=O)C(Cl)Cl)cc1Cl,CHEMBL1876,SLC12A3
4778,CHEMBL259209,Milnacipran,Small molecule,2009.0,N06AX17,N06AX17 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants],,Serotonin transporter inhibitor,,,CHEMBL228,Serotonin transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=16a4a314-f97e-4e91-95e9-576a3773d284#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=16a4a314-f97e-4e91-95e9-576a3773d284#nlm34090-1",CCN(CC)C(=O)C1(CC1CN)c2ccccc2,CHEMBL228,SLC6A4
4779,CHEMBL633,Amiodarone,Small molecule,1985.0,C01BD01,"C01BD01 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III]",-arone,HERG blocker,,,CHEMBL240,HERG,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=d8d04647-8e25-4127-8ecf-360ce1991c2f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d8d04647-8e25-4127-8ecf-360ce1991c2f|Name:Wikipedia, SrcID:Amiodarone, URL:http://en.wikipedia.org/wiki/Amiodarone|Name:Wikipedia, SrcID:Antiarrhythmic_agent, URL:http://en.wikipedia.org/wiki/Antiarrhythmic_agent|Name:Wikipedia, SrcID:Potassium_channel_blocker, URL:http://en.wikipedia.org/wiki/Potassium_channel_blocker|Name:Wikipedia, SrcID:Herg, URL:http://en.wikipedia.org/wiki/Herg",CCCCc1oc2ccccc2c1C(=O)c3cc(I)c(OCCN(CC)CC)c(I)c3,CHEMBL240,KCNH2
4780,CHEMBL650,Methylprednisolone,Small molecule,1957.0,H02BX01; D07AA01; H02AB04; D10AA02,"H02BX01 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS: Corticosteroids for systemic use, combinations]; D07AA01 [DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, weak (group I)]; H02AB04 [SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Glucocorticoids]; D10AA02 [DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Corticosteroids, combinations for treatment of acne]",-pred-,Glucocorticoid receptor agonist,,,CHEMBL2034,Glucocorticoid receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17068119, URL:http://europepmc.org/abstract/MED/17068119|Name:PubMed, SrcID:17016711, URL:http://europepmc.org/abstract/MED/17016711|Name:PubMed, SrcID:17251323, URL:http://europepmc.org/abstract/MED/17251323",C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]4(C)C=CC(=O)C=C14,CHEMBL2034,NR3C1
4781,CHEMBL972,Selegiline,Small molecule,1989.0,N04BD01,N04BD01 [NERVOUS SYSTEM: ANTI-PARKINSON DRUGS: DOPAMINERGIC AGENTS: Monoamine oxidase B inhibitors],-giline,Monoamine oxidase B inhibitor,Irreversible inhibitor,,CHEMBL2039,Monoamine oxidase B,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2008/021479s003s004lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021479s003s004lbl.pdf",C[C@H](Cc1ccccc1)N(C)CC#C,CHEMBL2039,MAOB
4782,CHEMBL1511,Estradiol Valerate,Small molecule,2010.0,G03CA53; G03CA03,"G03CA53 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ESTROGENS: Natural and semisynthetic estrogens, plain]; G03CA03 [GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ESTROGENS: Natural and semisynthetic estrogens, plain]",estr-,Estrogen receptor alpha agonist,,,CHEMBL206,Estrogen receptor alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=5d29dc3b-e19a-4924-8ad4-85018f0ab395, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d29dc3b-e19a-4924-8ad4-85018f0ab395",CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C,CHEMBL206,ESR1
4783,CHEMBL494753,Estrone Sulfuric Acid,Small molecule,1977.0,,,estr-,Estrogen receptor alpha agonist,,,CHEMBL206,Estrogen receptor alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2005/083220s041lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/083220s041lbl.pdf",C[C@]12CC[C@H]3[C@@H](CCc4cc(OS(=O)(=O)O)ccc34)[C@@H]1CCC2=O,CHEMBL206,ESR1
4784,CHEMBL1201151,Mestranol,Small molecule,1961.0,,,-estr-,Estrogen receptor alpha agonist,,,CHEMBL206,Estrogen receptor alpha,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21072303, URL:http://europepmc.org/abstract/MED/21072303|Name:Wikipedia, SrcID:Mestranol, URL:http://en.wikipedia.org/wiki/Mestranol|Name:ISBN, SrcID:0443-059748 PP. 438, URL:http://www.isbnsearch.org/isbn/0443059748",COc1ccc2[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@@H]3CCc2c1,CHEMBL206,ESR1
4785,CHEMBL1201193,Levobupivacaine,Small molecule,1999.0,N01BB10,"N01BB10 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Amides]",-caine,Sodium channel protein type IV alpha subunit blocker,,,CHEMBL2072,Sodium channel protein type IV alpha subunit,BLOCKER,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12761351, URL:http://europepmc.org/abstract/MED/12761351",CCCCN1CCCC[C@H]1C(=O)Nc2c(C)cccc2C,CHEMBL2072,SCN4A
4786,CHEMBL11,Imipramine,Small molecule,1959.0,N06AA02,N06AA02 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Non-selective monoamine reuptake inhibitors],-pramine,Norepinephrine transporter inhibitor,,,CHEMBL222,Norepinephrine transporter,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=d1dde497-1889-4424-af18-da7ca6459cf3#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d1dde497-1889-4424-af18-da7ca6459cf3#nlm34090-1|Name:DailyMed, SrcID:setid=55311747-710c-43c4-821d-76323ff2520e#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=55311747-710c-43c4-821d-76323ff2520e#nlm34090-1",CN(C)CCCN1c2ccccc2CCc3ccccc13,CHEMBL222,SLC6A2
4787,CHEMBL1396,Varenicline,Small molecule,2006.0,N07BA03,N07BA03 [NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: DRUGS USED IN ADDICTIVE DISORDERS: Drugs used in nicotine dependence],-nicline,Neuronal acetylcholine receptor; alpha4/beta2 agonist,,,CHEMBL1907589,Neuronal acetylcholine receptor; alpha4/beta2,AGONIST,Homo sapiens,PROTEIN COMPLEX,,,"Name:DailyMed, SrcID:setid=27c6abf0-6551-4333-980d-309b9c1eeba3#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=27c6abf0-6551-4333-980d-309b9c1eeba3#nlm34090-1",C1NCC2CC1c3cc4nccnc4cc23,,
4788,CHEMBL1200689,Nitric Oxide,Small molecule,1999.0,R07AX01,R07AX01 [RESPIRATORY SYSTEM: OTHER RESPIRATORY SYSTEM PRODUCTS: OTHER RESPIRATORY SYSTEM PRODUCTS: Other respiratory system products],,Soluble guanylate cyclase activator,,,CHEMBL2111348,Soluble guanylate cyclase,ACTIVATOR,Homo sapiens,PROTEIN COMPLEX GROUP,Soluble guanylate cyclase beta subunit,"Heterodimer, beta (1 or 2) is binding site","Name:Wikipedia, SrcID:Soluble_guanylyl_cyclase, URL:http://en.wikipedia.org/wiki/Soluble_guanylyl_cyclase|Name:DailyMed, SrcID:setid=762b51be-1893-4cd1-9511-e645fc420d3a#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=762b51be-1893-4cd1-9511-e645fc420d3a#nlm34090-1",O=[N],CHEMBL2111348,GUCY1A2
4789,CHEMBL1363,Arformoterol,Small molecule,2006.0,,,-terol,Beta-2 adrenergic receptor agonist,Long acting,,CHEMBL210,Beta-2 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=7134ae7c-6c64-470d-ab4e-81e35413b839#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7134ae7c-6c64-470d-ab4e-81e35413b839#nlm34090-1",COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1,CHEMBL210,ADRB2
4790,CHEMBL990,Butenafine,Small molecule,1996.0,D01AE23,D01AE23 [DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Other antifungals for topical use],,Squalene monooxygenase inhibitor,,,CHEMBL2364679,Squalene monooxygenase,INHIBITOR,Trichophyton,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12499173, URL:http://europepmc.org/abstract/MED/12499173|Name:Wikipedia, SrcID:Butenafine, URL:http://en.wikipedia.org/wiki/Butenafine|Name:PubMed, SrcID:16079485, URL:http://europepmc.org/abstract/MED/16079485",CN(Cc1ccc(cc1)C(C)(C)C)Cc2cccc3ccccc23,,
4791,CHEMBL1295,Butoconazole,Small molecule,1985.0,G01AF15,"G01AF15 [GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Imidazole derivatives]",-conazole,Cytochrome P450 51 inhibitor,,,CHEMBL1780,Cytochrome P450 51,INHIBITOR,Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast),SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2003/19881slr009_gynazole_lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/19881slr009_gynazole_lbl.pdf|Name:DailyMed, SrcID:setid=5eebfdbb-4800-4f59-9eaa-93e1c02b7b5f, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5eebfdbb-4800-4f59-9eaa-93e1c02b7b5f|Name:KEGG, SrcID:D00880, URL:http://www.kegg.jp/dbget-bin/www_bget?dr:D00880|Name:PubMed, SrcID:2184984, URL:http://europepmc.org/abstract/MED/2184984",Clc1ccc(CCC(Cn2ccnc2)Sc3c(Cl)cccc3Cl)cc1,,
4792,CHEMBL1109,Sulfaphenazole,Small molecule,1982.0,S01AB05; J01ED08,S01AB05 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Sulfonamides]; J01ED08 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: SULFONAMIDES AND TRIMETHOPRIM: Long-acting sulfonamides],sulfa-,Bacterial dihydropteroate synthase inhibitor,,Broad spectrum,CHEMBL2364668,Bacterial dihydropteroate synthase,INHIBITOR,Bacteria,SINGLE PROTEIN,,,"Name:PubMed, SrcID:7486915, URL:http://europepmc.org/abstract/MED/7486915",Nc1ccc(cc1)S(=O)(=O)Nc2ccnn2c3ccccc3,,
4793,CHEMBL127,Meropenem,Small molecule,1996.0,J01DH02,J01DH02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Carbapenems],-penem,Bacterial penicillin-binding protein inhibitor,,,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=185181e3-c004-4d61-b992-5df94fe57a90, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=185181e3-c004-4d61-b992-5df94fe57a90",C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(=C(N2C1=O)C(=O)O)S[C@@H]3CN[C@@H](C3)C(=O)N(C)C,,
4794,CHEMBL493,Bromocriptine,Small molecule,1978.0,N04BC01; G02CB01,N04BC01 [NERVOUS SYSTEM: ANTI-PARKINSON DRUGS: DOPAMINERGIC AGENTS: Dopamine agonists]; G02CB01 [GENITO URINARY SYSTEM AND SEX HORMONES: OTHER GYNECOLOGICALS: OTHER GYNECOLOGICALS: Prolactine inhibitors],,D2-like dopamine receptor agonist,,,CHEMBL2331075,D2-like dopamine receptor,AGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:17016425, URL:http://europepmc.org/abstract/MED/17016425|Name:DailyMed, SrcID:setid=93a0696b-b261-4262-9e06-f3180b419f8f#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=93a0696b-b261-4262-9e06-f3180b419f8f#nlm34090-1",CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C,,
4795,CHEMBL1201658,Alkavervir,Small molecule,1982.0,,,-vir,Unknown,,,,,,,,,,"Name:PubMed, SrcID:13316538, URL:http://europepmc.org/abstract/MED/13316538",,,
4796,CHEMBL2218885,Verteporfin,Small molecule,2000.0,S01LA01,S01LA01 [SENSORY ORGANS: OPHTHALMOLOGICALS: OCULAR VASCULAR DISORDER AGENTS: Antineovascularisation agents],-porfin,DNA inhibitor,Photodynamic therapy,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:DailyMed, SrcID:setid=ac57f330-244d-48f8-a224-459c2bd2a970, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ac57f330-244d-48f8-a224-459c2bd2a970",COC(=O)CCC1=C(C)c2cc3nc(cc4[nH]c(cc5nc(cc1[nH]2)c(CCC(=O)O)c5C)c(C=C)c4C)C6=CC=C(C(C(=O)OC)C36C)C(=O)OC.COC(=O)CCc7c(C)c8cc9[nH]c(cc%10nc(cc%11[nH]c(cc7n8)C(=C%11C)CCC(=O)O)C%12(C)C(C(=O)OC)C(=CC=C%10%12)C(=O)OC)c(C)c9C=C,,
4797,CHEMBL1413,Ciclopirox,Small molecule,1982.0,G01AX12; D01AE14,"G01AX12 [GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Other antiinfectives and antiseptics]; D01AE14 [DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Other antifungals for topical use]",-pirox,Iron chelating agent,Trivalent metal cations chelating agent; inhibition of the metal-dependent enzymes that are responsible for the degradation of peroxides within the fungal cell,,CHEMBL2363058,Iron,CHELATING AGENT,,METAL,,,"Name:PubMed, SrcID:23416050, URL:http://europepmc.org/abstract/MED/23416050|Name:PubMed, SrcID:20964457, URL:http://europepmc.org/abstract/MED/20964457|Name:Wikipedia, SrcID:Ciclopirox#cite_note-pmid12760852-4, URL:http://en.wikipedia.org/wiki/Ciclopirox#cite_note-pmid12760852-4",CC1=CC(=O)N(O)C(=C1)C2CCCCC2,,
4798,CHEMBL2108027,Dulaglutide,Protein,2014.0,A10BJ05,"A10BJ05 [ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Glucagon-like peptide-1 (GLP-1) analogues]",-tide,Glucagon-like peptide 1 receptor agonist,,,CHEMBL1784,Glucagon-like peptide 1 receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=463050bd-2b1c-40f5-b3c3-0a04bb433309, URL:http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=463050bd-2b1c-40f5-b3c3-0a04bb433309",,CHEMBL1784,GLP1R
4799,CHEMBL205596,Cholic Acid,Small molecule,2015.0,A05AA03,A05AA03 [ALIMENTARY TRACT AND METABOLISM: BILE AND LIVER THERAPY: BILE THERAPY: Bile acid preparations],,Unknown,,,,,,,,,,"Name:FDA, SrcID:label/2015/205750lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205750lbl.pdf",C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,,
4800,CHEMBL3545109,Arry-502,Small molecule,,,,,G protein-coupled receptor 44 antagonist,,,CHEMBL5071,G protein-coupled receptor 44,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.arraybiopharma.com/product-pipeline/other-compounds/arry-502/, URL:http://www.arraybiopharma.com/product-pipeline/other-compounds/arry-502/",,CHEMBL5071,PTGDR2
4801,CHEMBL37676,Apc-100,Small molecule,,,,,Androgen Receptor antagonist,Vitamin E derivate,,CHEMBL1871,Androgen Receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:12939470, URL:http://europepmc.org/abstract/MED/12939470|Name:Other, SrcID:http://www.adamispharmaceuticals.com/products-APC-100.php, URL:http://www.adamispharmaceuticals.com/products-APC-100.php",Cc1c(C)c2OC(C)(C)CCc2c(C)c1O,CHEMBL1871,AR
4802,CHEMBL3544997,Ls-104,Small molecule,,,,,Tyrosine-protein kinase JAK2 inhibitor,,,CHEMBL2971,Tyrosine-protein kinase JAK2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18483305, URL:http://europepmc.org/abstract/MED/18483305",,CHEMBL2971,JAK2
4803,CHEMBL3545083,Rgb-286638,Small molecule,,,,,Cyclin-dependent kinase 7 inhibitor,,,CHEMBL3055,Cyclin-dependent kinase 7,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23807770, URL:http://europepmc.org/abstract/MED/23807770",COCCN1CCN(Cc2ccc(cc2)c3n[nH]c4c5cccc(NC(=O)NN6CCOCC6)c5C(=O)c34)CC1,CHEMBL3055,CDK7
4804,CHEMBL1079593,Vs-5584,Small molecule,,,,,PI3-kinase class I inhibitor,"Inhibitor of class I phosphoinositide 3-kinase (PI3K) isoforms, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:23270925, URL:http://europepmc.org/abstract/MED/23270925",Fc1ccc2ncn(c3ncc4NC(=O)N([C@@H]5CCOc6c(F)cccc56)c4n3)c2c1,CHEMBL3559703,PIK3R2
4805,CHEMBL1079593,Vs-5584,Small molecule,,,,,PI3-kinase class I inhibitor,"Inhibitor of class I phosphoinositide 3-kinase (PI3K) isoforms, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:23270925, URL:http://europepmc.org/abstract/MED/23270925",Fc1ccc2ncn(c3ncc4NC(=O)N([C@@H]5CCOc6c(F)cccc56)c4n3)c2c1,CHEMBL3559703,PIK3R3
4806,CHEMBL1079593,Vs-5584,Small molecule,,,,,PI3-kinase class I inhibitor,"Inhibitor of class I phosphoinositide 3-kinase (PI3K) isoforms, ATP-competitive mTORC1/mTORC2 inhibitor",,CHEMBL3559703,PI3-kinase class I,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:23270925, URL:http://europepmc.org/abstract/MED/23270925",Fc1ccc2ncn(c3ncc4NC(=O)N([C@@H]5CCOc6c(F)cccc56)c4n3)c2c1,CHEMBL3559703,PIK3R5
4807,CHEMBL2364618,Mavatrep,Small molecule,,,,-vatrep,Vanilloid receptor antagonist,,,CHEMBL4794,Vanilloid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:ClinicalTrials, SrcID:NCT01006304, URL:https://www.clinicaltrials.gov/ct2/show/NCT01006304",CC(C)(O)c1ccccc1c2ccc3[nH]c(\C=C\c4ccc(cc4)C(F)(F)F)nc3c2,CHEMBL4794,TRPV1
4808,CHEMBL3544942,Roniciclib,Small molecule,,,,-ciclib,Cyclin-dependent kinase inhibitor,,,CHEMBL3559691,Cyclin-dependent kinase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:22821149, URL:http://europepmc.org/abstract/MED/22821149",,CHEMBL3559691,CDK12
4809,CHEMBL3544942,Roniciclib,Small molecule,,,,-ciclib,Cyclin-dependent kinase inhibitor,,,CHEMBL3559691,Cyclin-dependent kinase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:22821149, URL:http://europepmc.org/abstract/MED/22821149",,CHEMBL3559691,CDK20
4810,CHEMBL3039502,Duvelisib,Small molecule,,,,-lisib,PI3-kinase p110-gamma subunit inhibitor,,,CHEMBL3267,PI3-kinase p110-gamma subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24211136, URL:http://europepmc.org/abstract/MED/24211136",C[C@H](Nc1ncnc2nc[nH]c12)C3=Cc4cccc(Cl)c4C(=O)N3c5ccccc5,CHEMBL3267,PIK3CG
4811,CHEMBL3039502,Duvelisib,Small molecule,,,,-lisib,PI3-kinase p110-delta subunit inhibitor,,,CHEMBL3130,PI3-kinase p110-delta subunit,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24211136, URL:http://europepmc.org/abstract/MED/24211136",C[C@H](Nc1ncnc2nc[nH]c12)C3=Cc4cccc(Cl)c4C(=O)N3c5ccccc5,CHEMBL3130,PIK3CD
4812,CHEMBL3039530,Abediterol,Small molecule,,,,-terol,Beta-2 adrenergic receptor agonist,,,CHEMBL210,Beta-2 adrenergic receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25256258, URL:http://europepmc.org/abstract/MED/25256258",O[C@@H](CNCCCCCCOCC(F)(F)c1ccccc1)c2ccc(O)c3NC(=O)C=Cc23,CHEMBL210,ADRB2
4813,CHEMBL412262,Ibipinabant,Small molecule,,,,-nab-,Cannabinoid CB1 receptor antagonist,"Ph 2 study terminated and Ph2/3 study withdrawn, development Discontinuedbecause of potential serious side effects linked to targetting of CNR1 (http://en.wikipedia.org/wiki/Ibipinabant).",,CHEMBL218,Cannabinoid CB1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:14736243, URL:http://europepmc.org/abstract/MED/14736243",CN\C(=N/S(=O)(=O)c1ccc(Cl)cc1)\N2C[C@@H](C(=N2)c3ccc(Cl)cc3)c4ccccc4,CHEMBL218,CNR1
4814,CHEMBL1742428,Donitriptan,Small molecule,,,,-triptan,Serotonin 1d (5-HT1d) receptor agonist,,,CHEMBL1983,Serotonin 1d (5-HT1d) receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10381763, URL:http://europepmc.org/abstract/MED/10381763",NCCc1c[nH]c2ccc(OCC(=O)N3CCN(CC3)c4ccc(cc4)C#N)cc12,CHEMBL1983,HTR1D
4815,CHEMBL3544914,Tezacaftor,Small molecule,,,,-caftor,Cystic fibrosis transmembrane conductance regulator positive modulator,"CF-drug in development for people with one or two copies of the F508del mutation. A CFTR corrector that modulates the folding and trafficking of CFTR protein. In Ph3 in combination with CFTR potentiator Ivacaftor. Indication: Cystic Fibrosis, COPD",,CHEMBL4051,Cystic fibrosis transmembrane conductance regulator,POSITIVE MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25083129, URL:http://europepmc.org/abstract/MED/25083129|Name:PubMed, SrcID:24392786, URL:http://europepmc.org/abstract/MED/24392786",CC(C)(CO)c1cc2cc(NC(=O)C3(CC3)c4ccc5OC(F)(F)Oc5c4)c(F)cc2n1C[C@@H](O)CO,CHEMBL4051,CFTR
4816,CHEMBL3707249,Asm-024,Small molecule,,,,,Neuronal acetylcholine receptor protein alpha-7 subunit modulator,"ASM-024 displays both antagonistic and agonistic activity on CHRNA7, is thought to be a so called ""a7 silent agonist"": produce little or no CHRNA7 channel activation on its own but effectively activate the ion channel when combined with the type II positive allosteric modulator (PAM) PNU-120596.",,CHEMBL2492,Neuronal acetylcholine receptor protein alpha-7 subunit,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.sfn.org/~/media/SfN/Documents/Annual%20Meeting/FinalProgram/NS2013/FullAbstractPDFs_2013/AbstractPDFs_Poster_Sun_PM.ashx, URL:http://www.sfn.org/~/media/SfN/Documents/Annual%20Meeting/FinalProgram/NS2013/FullAbstractPDFs_2013/AbstractPDFs_Poster_Sun_PM.ashx|Name:PubMed, SrcID:24465890, URL:http://europepmc.org/abstract/MED/24465890|Name:PubMed, SrcID:25799096, URL:http://europepmc.org/abstract/MED/25799096",,CHEMBL2492,CHRNA7
4817,CHEMBL3301612,Encorafenib,Small molecule,,,,-rafenib,Serine/threonine-protein kinase B-raf inhibitor,Selective for mutation containing BRAF (V600E mutation) with little or no activity against wild-type BRAF.,,CHEMBL5145,Serine/threonine-protein kinase B-raf,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DOI, SrcID:10.1158/1538-7445.AM2012-3790, URL:http://cancerres.aacrjournals.org/content/72/8_Supplement/3790|Name:PubMed, SrcID:23617957, URL:http://europepmc.org/abstract/MED/23617957",COC(=O)N[C@@H](C)CNc1nccc(n1)c2cn(nc2c3cc(Cl)cc(NS(=O)(=O)C)c3F)C(C)C,CHEMBL5145,BRAF
4818,CHEMBL276711,Semaxanib,Small molecule,,,,-anib,Stem cell growth factor receptor inhibitor,,,CHEMBL1936,Stem cell growth factor receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:11222388, URL:http://europepmc.org/abstract/MED/11222388|Name:PubMed, SrcID:9892193, URL:http://europepmc.org/abstract/MED/9892193",Cc1cc(C)c(\C=C\2/C(=O)Nc3ccccc23)[nH]1,CHEMBL1936,KIT
4819,CHEMBL2107777,Satavaptan,Small molecule,,,,-vaptan,Vasopressin V2 receptor antagonist,"Application for marketing approval in the EU withdrawn, compound Discontinueddue to safety concerns.",,CHEMBL1790,Vasopressin V2 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10991964, URL:http://europepmc.org/abstract/MED/10991964|Name:Wikipedia, SrcID:Satavaptan, URL:http://en.wikipedia.org/wiki/Satavaptan|Name:PubMed, SrcID:11607038, URL:http://europepmc.org/abstract/MED/11607038|Name:PubMed, SrcID:8981918, URL:http://europepmc.org/abstract/MED/8981918",CCOc1ccc2N(C(=O)[C@@]3(CC[C@H](CCN4CCOCC4)CC3)c2c1)S(=O)(=O)c5ccc(cc5OC)C(=O)NC(C)(C)C,CHEMBL1790,AVPR2
4820,CHEMBL2386081,Setipiprant,Small molecule,,,,-piprant,G protein-coupled receptor 44 antagonist,"Indication: Seasonal allergic rhinitis, asthma",,CHEMBL5071,G protein-coupled receptor 44,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:23721423, URL:http://europepmc.org/abstract/MED/23721423|Name:Other, SrcID:http://www.kythera.com/products/kyth-105-setipiprant/, URL:http://www.kythera.com/products/kyth-105-setipiprant/",OC(=O)Cn1c2CCN(Cc2c3cc(F)ccc13)C(=O)c4cccc5ccccc45,CHEMBL5071,PTGDR2
4821,CHEMBL1743016,Farletuzumab,Antibody,,,,-mab,Folate receptor alpha inhibitor,,,CHEMBL2121,Folate receptor alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17346028, URL:http://europepmc.org/abstract/MED/17346028",,CHEMBL2121,FOLR1
4822,CHEMBL1206232,Fosbretabulin,Small molecule,,,,-bulin; fos-,Tubulin disrupting agent,Reversible tubulin depolymerizing agent.,,CHEMBL2095182,Tubulin,DISRUPTING AGENT,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:27942221, URL:http://europepmc.org/abstract/MED/27942221",COc1ccc(\C=C/c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O,CHEMBL2095182,TUBB8
4823,CHEMBL1206232,Fosbretabulin,Small molecule,,,,-bulin; fos-,Tubulin disrupting agent,Reversible tubulin depolymerizing agent.,,CHEMBL2095182,Tubulin,DISRUPTING AGENT,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:27942221, URL:http://europepmc.org/abstract/MED/27942221",COc1ccc(\C=C/c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O,CHEMBL2095182,TUBA3C
4824,CHEMBL1206232,Fosbretabulin,Small molecule,,,,-bulin; fos-,Tubulin disrupting agent,Reversible tubulin depolymerizing agent.,,CHEMBL2095182,Tubulin,DISRUPTING AGENT,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:27942221, URL:http://europepmc.org/abstract/MED/27942221",COc1ccc(\C=C/c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O,CHEMBL2095182,TUBA4A
4825,CHEMBL1206232,Fosbretabulin,Small molecule,,,,-bulin; fos-,Tubulin disrupting agent,Reversible tubulin depolymerizing agent.,,CHEMBL2095182,Tubulin,DISRUPTING AGENT,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:27942221, URL:http://europepmc.org/abstract/MED/27942221",COc1ccc(\C=C/c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O,CHEMBL2095182,TUBA3E
4826,CHEMBL1206232,Fosbretabulin,Small molecule,,,,-bulin; fos-,Tubulin disrupting agent,Reversible tubulin depolymerizing agent.,,CHEMBL2095182,Tubulin,DISRUPTING AGENT,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:27942221, URL:http://europepmc.org/abstract/MED/27942221",COc1ccc(\C=C/c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O,CHEMBL2095182,TUBB6
4827,CHEMBL1206232,Fosbretabulin,Small molecule,,,,-bulin; fos-,Tubulin disrupting agent,Reversible tubulin depolymerizing agent.,,CHEMBL2095182,Tubulin,DISRUPTING AGENT,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:27942221, URL:http://europepmc.org/abstract/MED/27942221",COc1ccc(\C=C/c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O,CHEMBL2095182,TUBB2B
4828,CHEMBL1206232,Fosbretabulin,Small molecule,,,,-bulin; fos-,Tubulin disrupting agent,Reversible tubulin depolymerizing agent.,,CHEMBL2095182,Tubulin,DISRUPTING AGENT,Homo sapiens,PROTEIN COMPLEX GROUP,,,"Name:PubMed, SrcID:27942221, URL:http://europepmc.org/abstract/MED/27942221",COc1ccc(\C=C/c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O,CHEMBL2095182,TUBA3D
4829,CHEMBL3707446,Rivipansel,Small molecule,,,,-pansel,P-selectin antagonist,,"E-selectin IC50 = 4.3uM, P-selectin IC50 = 423uM and L-selectin IC50 = 337uM",CHEMBL5378,P-selectin,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:26117840, URL:http://europepmc.org/abstract/MED/26117840",C[C@@H]1O[C@@H](O[C@@H]2[C@H](C[C@H](C[C@H]2O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H](CC4CCCCC4)C(=O)O)[C@H]3OC(=O)c5ccccc5)C(=O)NCCNC(=O)COCCOCC(=O)Nc6cc(cc7cc(cc(c67)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)NC(=O)C8=CC(=O)NC(=O)N8)[C@@H](O)[C@H](O)[C@@H]1O,,
4830,CHEMBL3544911,Prexasertib,Small molecule,,,,-sertib,Serine/threonine-protein kinase Chk2 inhibitor,Selective ATP competitor inhibitor of Chk1 and Chk2 proteins,,CHEMBL2527,Serine/threonine-protein kinase Chk2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:27438145, URL:http://europepmc.org/abstract/MED/27438145",COc1cccc(OCCCN)c1c2cc(Nc3cnc(cn3)C#N)n[nH]2,CHEMBL2527,CHEK2
4831,CHEMBL1743000,Citatuzumab Bogatox,Antibody,,,,-mab,Epithelial cell adhesion molecule binding agent,Immunotoxin,,CHEMBL3580493,Epithelial cell adhesion molecule,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22856424, URL:http://europepmc.org/abstract/MED/22856424|Name:PubMed, SrcID:19483652, URL:http://europepmc.org/abstract/MED/19483652",,CHEMBL3580493,EPCAM
4832,CHEMBL1743017,Fezakinumab,Antibody,,,,-mab,Interleukin-22 inhibitor,,,CHEMBL3712915,Interleukin-22,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21747375, URL:http://europepmc.org/abstract/MED/21747375",,CHEMBL3712915,IL22
4833,CHEMBL2108187,Clenoliximab,Antibody,,,,-mab,T-cell surface antigen CD4 inhibitor,,,CHEMBL2754,T-cell surface antigen CD4,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10384148, URL:http://europepmc.org/abstract/MED/10384148",,CHEMBL2754,CD4
4834,CHEMBL2108501,Labetuzumab,Antibody,,,,-mab,Carcinoembryonic antigen-related cell adhesion molecule 5 other,IgG1 MAb that induces antibody-dependent cell-mediated cytotoxicity (ADCC) in vitro.,,CHEMBL3712881,Carcinoembryonic antigen-related cell adhesion molecule 5,OTHER,Homo sapiens,SINGLE PROTEIN,,Binds with high affinity to the restricted A3B3 domain (Gold group 3) found on CEACAM5.,"Name:PubMed, SrcID:18728675, URL:http://europepmc.org/abstract/MED/18728675|Name:PubMed, SrcID:15634649, URL:http://europepmc.org/abstract/MED/15634649|Name:PubMed, SrcID:15592930, URL:http://europepmc.org/abstract/MED/15592930",,,
4835,CHEMBL2109498,Iph-2101,Antibody,,,,,Killer cell immunoglobulin-like receptor 2DL3 inhibitor,"Acts as a checkpoint inhibitor by blocking the interaction between KIR2DL-1,-2,-3 inhibitory receptors and their ligands.",,CHEMBL3713026,Killer cell immunoglobulin-like receptor 2DL3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19553639, URL:http://europepmc.org/abstract/MED/19553639|Name:PubMed, SrcID:22031859, URL:http://europepmc.org/abstract/MED/22031859",,CHEMBL3713026,KIR2DL3
4836,CHEMBL1201506,Gemtuzumab Ozogamicin,Antibody,2000.0,L01XC05,L01XC05 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Monoclonal antibodies],-mab,Myeloid cell surface antigen CD33 binding agent,targets ozogamicin to cell,,CHEMBL1842,Myeloid cell surface antigen CD33,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=32fd2bb2-1cfa-4250-feb8-d7956c794e05, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=32fd2bb2-1cfa-4250-feb8-d7956c794e05|Name:FDA, SrcID:label/2006/021174s020lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021174s020lbl.pdf",,CHEMBL1842,CD33
4837,CHEMBL86,Metoclopramide,Small molecule,1979.0,A03FA01,A03FA01 [ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: PROPULSIVES: Propulsives],,Serotonin 3a (5-HT3a) receptor antagonist,,,CHEMBL1899,Serotonin 3a (5-HT3a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Wikipedia, SrcID:Metoclopramide, URL:http://en.wikipedia.org/wiki/Metoclopramide|Name:ISBN, SrcID:0443-059748 PP. 379, URL:http://www.isbnsearch.org/isbn/0443059748",CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC,CHEMBL1899,HTR3A
4838,CHEMBL1773,Capecitabine,Small molecule,1998.0,L01BC06,L01BC06 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Pyrimidine analogues],-citabine,Thymidylate synthase inhibitor,,,CHEMBL1952,Thymidylate synthase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8#section-13",CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]2O[C@H](C)[C@@H](O)[C@H]2O,CHEMBL1952,TYMS
4839,CHEMBL1200374,Exemestane,Small molecule,1999.0,L02BG06,L02BG06 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONE ANTAGONISTS AND RELATED AGENTS: Aromatase inhibitors],-mestane,Cytochrome P450 19A1 inhibitor,,,CHEMBL1978,Cytochrome P450 19A1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=cf066b7a-032a-416c-8d40-15ba581423e3#section-13, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cf066b7a-032a-416c-8d40-15ba581423e3#section-13",C[C@]12CC[C@H]3[C@@H](CC(=C)C4=CC(=O)C=C[C@]34C)[C@@H]1CCC2=O,CHEMBL1978,CYP19A1
4840,CHEMBL1139,Epoprostenol,Small molecule,1995.0,B01AC09,B01AC09 [BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Platelet aggregation inhibitors excl. heparin],-prost-,Prostanoid IP receptor agonist,,,CHEMBL1995,Prostanoid IP receptor,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2012/022260s005lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022260s005lbl.pdf|Name:ISBN, SrcID:9780702034718 PP. 305, URL:http://www.isbnsearch.org/isbn/9780702034718",CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@@H]2O\C(=C/CCCC(=O)O)\C[C@H]12,CHEMBL1995,PTGIR
4841,CHEMBL502,Donepezil,Small molecule,1996.0,N06DA02,N06DA02 [NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTI-DEMENTIA DRUGS: Anticholinesterases],-pezil,Acetylcholinesterase inhibitor,,,CHEMBL220,Acetylcholinesterase,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=2b1b7b5f-2f20-418c-b1ac-794c2ef1ce5e, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2b1b7b5f-2f20-418c-b1ac-794c2ef1ce5e",COc1cc2CC(CC3CCN(Cc4ccccc4)CC3)C(=O)c2cc1OC,CHEMBL220,ACHE
4842,CHEMBL2355051,Clomiphene,Small molecule,1967.0,,,,Estrogen receptor alpha modulator,,,CHEMBL206,Estrogen receptor alpha,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=df518802-0efd-4da4-816d-65a7e92cecd2#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=df518802-0efd-4da4-816d-65a7e92cecd2#nlm34090-1|Name:FDA, SrcID:label/2012/016131s026lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/016131s026lbl.pdf|Name:Wikipedia, SrcID:Estrogen_receptor, URL:http://en.wikipedia.org/wiki/Estrogen_receptor",CCN(CC)CCOc1ccc(cc1)C(=C(Cl)c2ccccc2)c3ccccc3,CHEMBL206,ESR1
4843,CHEMBL19,Methazolamide,Small molecule,1959.0,S01EC05,S01EC05 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Carbonic anhydrase inhibitors],-zolamide,Carbonic anhydrase IV inhibitor,,,CHEMBL3729,Carbonic anhydrase IV,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18336310, URL:http://europepmc.org/abstract/MED/18336310|Name:DailyMed, SrcID:setid=8e162b6d-8fa6-45f6-80d8-5132d94c1207, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e162b6d-8fa6-45f6-80d8-5132d94c1207",CN1N=C(S/C/1=N/C(=O)C)S(=O)(=O)N,CHEMBL3729,CA4
4844,CHEMBL553025,Vinorelbine Base,Small molecule,1994.0,L01CA04,L01CA04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Vinca alkaloids and analogues],vin-,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,"Binds to beta tubulin, vinca site (PMID: 15057285)","Name:PubMed, SrcID:22594474, URL:http://europepmc.org/abstract/MED/22594474|Name:DailyMed, SrcID:setid=6d47c96a-7fdc-48ac-9250-41c5d3ecf8db, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d47c96a-7fdc-48ac-9250-41c5d3ecf8db|Name:PubMed, SrcID:22044006, URL:http://europepmc.org/abstract/MED/22044006",CCC1=C[C@@H]2CN(C1)Cc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[C@H]7[C@](O)([C@H](OC(=O)C)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC,CHEMBL2095182,TUBB8
4845,CHEMBL553025,Vinorelbine Base,Small molecule,1994.0,L01CA04,L01CA04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Vinca alkaloids and analogues],vin-,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,"Binds to beta tubulin, vinca site (PMID: 15057285)","Name:PubMed, SrcID:22594474, URL:http://europepmc.org/abstract/MED/22594474|Name:DailyMed, SrcID:setid=6d47c96a-7fdc-48ac-9250-41c5d3ecf8db, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d47c96a-7fdc-48ac-9250-41c5d3ecf8db|Name:PubMed, SrcID:22044006, URL:http://europepmc.org/abstract/MED/22044006",CCC1=C[C@@H]2CN(C1)Cc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[C@H]7[C@](O)([C@H](OC(=O)C)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC,CHEMBL2095182,TUBA3C
4846,CHEMBL553025,Vinorelbine Base,Small molecule,1994.0,L01CA04,L01CA04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Vinca alkaloids and analogues],vin-,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,"Binds to beta tubulin, vinca site (PMID: 15057285)","Name:PubMed, SrcID:22594474, URL:http://europepmc.org/abstract/MED/22594474|Name:DailyMed, SrcID:setid=6d47c96a-7fdc-48ac-9250-41c5d3ecf8db, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d47c96a-7fdc-48ac-9250-41c5d3ecf8db|Name:PubMed, SrcID:22044006, URL:http://europepmc.org/abstract/MED/22044006",CCC1=C[C@@H]2CN(C1)Cc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[C@H]7[C@](O)([C@H](OC(=O)C)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC,CHEMBL2095182,TUBA4A
4847,CHEMBL553025,Vinorelbine Base,Small molecule,1994.0,L01CA04,L01CA04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Vinca alkaloids and analogues],vin-,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,"Binds to beta tubulin, vinca site (PMID: 15057285)","Name:PubMed, SrcID:22594474, URL:http://europepmc.org/abstract/MED/22594474|Name:DailyMed, SrcID:setid=6d47c96a-7fdc-48ac-9250-41c5d3ecf8db, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d47c96a-7fdc-48ac-9250-41c5d3ecf8db|Name:PubMed, SrcID:22044006, URL:http://europepmc.org/abstract/MED/22044006",CCC1=C[C@@H]2CN(C1)Cc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[C@H]7[C@](O)([C@H](OC(=O)C)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC,CHEMBL2095182,TUBA3E
4848,CHEMBL553025,Vinorelbine Base,Small molecule,1994.0,L01CA04,L01CA04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Vinca alkaloids and analogues],vin-,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,"Binds to beta tubulin, vinca site (PMID: 15057285)","Name:PubMed, SrcID:22594474, URL:http://europepmc.org/abstract/MED/22594474|Name:DailyMed, SrcID:setid=6d47c96a-7fdc-48ac-9250-41c5d3ecf8db, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d47c96a-7fdc-48ac-9250-41c5d3ecf8db|Name:PubMed, SrcID:22044006, URL:http://europepmc.org/abstract/MED/22044006",CCC1=C[C@@H]2CN(C1)Cc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[C@H]7[C@](O)([C@H](OC(=O)C)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC,CHEMBL2095182,TUBB6
4849,CHEMBL553025,Vinorelbine Base,Small molecule,1994.0,L01CA04,L01CA04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Vinca alkaloids and analogues],vin-,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,"Binds to beta tubulin, vinca site (PMID: 15057285)","Name:PubMed, SrcID:22594474, URL:http://europepmc.org/abstract/MED/22594474|Name:DailyMed, SrcID:setid=6d47c96a-7fdc-48ac-9250-41c5d3ecf8db, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d47c96a-7fdc-48ac-9250-41c5d3ecf8db|Name:PubMed, SrcID:22044006, URL:http://europepmc.org/abstract/MED/22044006",CCC1=C[C@@H]2CN(C1)Cc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[C@H]7[C@](O)([C@H](OC(=O)C)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC,CHEMBL2095182,TUBB2B
4850,CHEMBL553025,Vinorelbine Base,Small molecule,1994.0,L01CA04,L01CA04 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Vinca alkaloids and analogues],vin-,Tubulin inhibitor,,,CHEMBL2095182,Tubulin,INHIBITOR,Homo sapiens,PROTEIN COMPLEX GROUP,Beta tubulin vinca binding domain,"Binds to beta tubulin, vinca site (PMID: 15057285)","Name:PubMed, SrcID:22594474, URL:http://europepmc.org/abstract/MED/22594474|Name:DailyMed, SrcID:setid=6d47c96a-7fdc-48ac-9250-41c5d3ecf8db, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d47c96a-7fdc-48ac-9250-41c5d3ecf8db|Name:PubMed, SrcID:22044006, URL:http://europepmc.org/abstract/MED/22044006",CCC1=C[C@@H]2CN(C1)Cc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[C@H]7[C@](O)([C@H](OC(=O)C)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC,CHEMBL2095182,TUBA3D
4851,CHEMBL1201454,Alseroxylon,Small molecule,1982.0,,,,Adrenergic receptor alpha antagonist,,,CHEMBL2095203,Adrenergic receptor alpha,ANTAGONIST,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:7562902, URL:http://europepmc.org/abstract/MED/7562902|Name:PubMed, SrcID:13167106, URL:http://europepmc.org/abstract/MED/13167106|Name:ISBN, SrcID:0471-948470 PP. 174, URL:http://www.isbnsearch.org/isbn/0471948470",,,
4852,CHEMBL1201834,Canakinumab,Antibody,2009.0,L04AC08,L04AC08 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Interleukin inhibitors],-mab,Interleukin-1 beta inhibitor,,,CHEMBL1909490,Interleukin-1 beta,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=7d271f3b-e4f9-4d80-8dcf-28d49123f80e, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7d271f3b-e4f9-4d80-8dcf-28d49123f80e",,CHEMBL1909490,IL1B
4853,CHEMBL1471,Aprepitant,Small molecule,2003.0,A04AD12,A04AD12 [ALIMENTARY TRACT AND METABOLISM: ANTIEMETICS AND ANTINAUSEANTS: ANTIEMETICS AND ANTINAUSEANTS: Other antiemetics],-tant,Neurokinin 1 receptor antagonist,,,CHEMBL249,Neurokinin 1 receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=696f9e80-9cae-403b-de9e-078343ce4713, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=696f9e80-9cae-403b-de9e-078343ce4713",C[C@@H](O[C@H]1OCCN(CC2=NNC(=O)N2)[C@H]1c3ccc(F)cc3)c4cc(cc(c4)C(F)(F)F)C(F)(F)F,CHEMBL249,TACR1
4854,CHEMBL12856,Inamrinone,Small molecule,1984.0,C01CE01,C01CE01 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES: Phosphodiesterase inhibitors],-rinone,Phosphodiesterase 3A inhibitor,,,CHEMBL241,Phosphodiesterase 3A,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:10478810, URL:http://europepmc.org/abstract/MED/10478810|Name:Wikipedia, SrcID:Amrinone, URL:http://en.wikipedia.org/wiki/Amrinone",NC1=CC(=CNC1=O)c2ccncc2,CHEMBL241,PDE3A
4855,CHEMBL1306,Terconazole,Small molecule,1987.0,G01AG02,"G01AG02 [GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Triazole derivatives]",-conazole,Cytochrome P450 51 inhibitor,,,CHEMBL1780,Cytochrome P450 51,INHIBITOR,Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast),SINGLE PROTEIN,,,"Name:DailyMed, SrcID:setid=6f2626b3-6053-4f7a-bc5d-78e30d983f90, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6f2626b3-6053-4f7a-bc5d-78e30d983f90|Name:PubMed, SrcID:2677363, URL:http://europepmc.org/abstract/MED/2677363|Name:PubMed, SrcID:1951574, URL:http://europepmc.org/abstract/MED/1951574",CC(C)N1CCN(CC1)c2ccc(OC[C@H]3CO[C@@](Cn4cncn4)(O3)c5ccc(Cl)cc5Cl)cc2,,
4856,CHEMBL1262,Oxiconazole,Small molecule,1988.0,G01AF17; D01AC11,"G01AF17 [GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Imidazole derivatives]; D01AC11 [DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Imidazole and triazole derivatives]",-conazole,Cytochrome P450 51 inhibitor,,,CHEMBL1780,Cytochrome P450 51,INHIBITOR,Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast),SINGLE PROTEIN,,,"Name:PubMed, SrcID:12383016, URL:http://europepmc.org/abstract/MED/12383016|Name:PubMed, SrcID:16964330, URL:http://europepmc.org/abstract/MED/16964330",Clc1ccc(CO\N=C(/Cn2ccnc2)\c3ccc(Cl)cc3Cl)c(Cl)c1,,
4857,CHEMBL1201760,Besifloxacin,Small molecule,2009.0,S01AE08,S01AE08 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Fluoroquinolones],-oxacin,Topoisomerase IV inhibitor,,Broad spectrum,CHEMBL2363076,Topoisomerase IV,INHIBITOR,Bacteria,PROTEIN COMPLEX,,,"Name:FDA, SrcID:label/2012/022308s003lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022308s003lbl.pdf",N[C@@H]1CCCCN(C1)c2c(F)cc3C(=O)C(=CN(C4CC4)c3c2Cl)C(=O)O,,
4858,CHEMBL453,Sulfisoxazole,Small molecule,1971.0,J01EB05; S01AB02,J01EB05 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: SULFONAMIDES AND TRIMETHOPRIM: Short-acting sulfonamides]; S01AB02 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Sulfonamides],,Bacterial dihydropteroate synthase inhibitor,,Broad spectrum,CHEMBL2364668,Bacterial dihydropteroate synthase,INHIBITOR,Bacteria,SINGLE PROTEIN,,,"Name:PubMed, SrcID:7486915, URL:http://europepmc.org/abstract/MED/7486915",Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C,,
4859,CHEMBL615,Penicillin V,Small molecule,1958.0,J01CE02,"J01CE02 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: BETA-LACTAM ANTIBACTERIALS, PENICILLINS: Beta-lactamase sensitive penicillins]",-cillin,Bacterial penicillin-binding protein inhibitor,"Indicated for streptococcal, pneumococcal and staphylococcal infections",,CHEMBL2354204,Bacterial penicillin-binding protein,INHIBITOR,Bacteria,PROTEIN FAMILY,,,"Name:DailyMed, SrcID:setid=2bfee83c-4f38-440e-9061-58036490d009, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2bfee83c-4f38-440e-9061-58036490d009|Name:Wikipedia, SrcID:Penicillin_binding_proteins#Function, URL:http://en.wikipedia.org/wiki/Penicillin_binding_proteins#Function",CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(=O)O,,
4860,CHEMBL869,Nitrofurazone,Small molecule,1945.0,B05CA03; P01CC02; D08AF01; S01AX04; S02AA02; D09AA03,"B05CA03 [BLOOD AND BLOOD FORMING ORGANS: BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS: IRRIGATING SOLUTIONS: Antiinfectives]; P01CC02 [ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS: Nitrofuran derivatives]; D08AF01 [DERMATOLOGICALS: ANTISEPTICS AND DISINFECTANTS: ANTISEPTICS AND DISINFECTANTS: Nitrofuran derivatives]; S01AX04 [SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Other antiinfectives]; S02AA02 [SENSORY ORGANS: OTOLOGICALS: ANTIINFECTIVES: Antiinfectives]; D09AA03 [DERMATOLOGICALS: MEDICATED DRESSINGS: MEDICATED DRESSINGS: Medicated dressings with antiinfectives]",,DNA inhibitor,"Prodrug; its activated by the type I nitroreductase (NTR), who produces reactive species, leading to an increase in oxidative stress",,CHEMBL2364041,DNA,INHIBITOR,Bacteria,NUCLEIC-ACID,,,"Name:PubMed, SrcID:22355582, URL:http://europepmc.org/abstract/MED/22355582|Name:Wikipedia, SrcID:Nitrofuran, URL:http://en.wikipedia.org/wiki/Nitrofuran|Name:PubMed, SrcID:23335745, URL:http://europepmc.org/abstract/MED/23335745",OC(=N)N\N=C\c1oc(cc1)[N+](=O)[O-],,
4861,CHEMBL572,Nitrofurantoin,Small molecule,1953.0,J01XE51; J01XE01,J01XE51 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER ANTIBACTERIALS: Nitrofuran derivatives]; J01XE01 [ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER ANTIBACTERIALS: Nitrofuran derivatives],-toin,DNA inhibitor,Generates free radicals causing DNA damage.,,CHEMBL2364041,DNA,INHIBITOR,Bacteria,NUCLEIC-ACID,,,"Name:FDA, SrcID:label/2009/009175s037lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/009175s037lbl.pdf",[O-][N+](=O)c1oc(\C=N\N2CC(=O)NC2=O)cc1,,
4862,CHEMBL1554,Dactinomycin,Protein,1964.0,L01DA01,L01DA01 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES: Actinomycines],-mycin,DNA inhibitor,,,CHEMBL2311221,DNA,INHIBITOR,Homo sapiens,NUCLEIC-ACID,,,"Name:FDA, SrcID:label/2012/050682s029s030lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050682s029s030lbl.pdf|Name:DailyMed, SrcID:setid=3d92b8b3-3a5d-44be-92ac-b5dab5d933ba, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3d92b8b3-3a5d-44be-92ac-b5dab5d933ba|Name:PubMed, SrcID:23144800, URL:http://europepmc.org/abstract/MED/23144800",CC(C)[C@H]1NC(=O)[C@@H](NC(=O)C2=C(N)C(=O)C(=C3Oc4c(C)ccc(C(=O)N[C@H]5[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]6CCCN6C(=O)[C@H](NC5=O)C(C)C)c4N=C23)C)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]7CCCN7C1=O,,
4863,CHEMBL1350,Tiludronic Acid,Small molecule,1997.0,M05BA05,M05BA05 [MUSCULO-SKELETAL SYSTEM: DRUGS FOR TREATMENT OF BONE DISEASES: DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION: Bisphosphonates],-dronate,ATP inhibitor,"Non N-containing biphosphonates, moa: its incorporated in ATP anologues, which accumulate in osteoclasts leading to its early apoptosis (specific to osteoclast, because it binds to hydropatite, and is then slowly released when the bone is reabsorded)",,CHEMBL2366048,ATP,INHIBITOR,Homo sapiens,SMALL MOLECULE,,,"Name:PubMed, SrcID:8889850, URL:http://europepmc.org/abstract/MED/8889850|Name:DailyMed, SrcID:setid=25369752-9d6c-4802-823c-c4205339a525, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=25369752-9d6c-4802-823c-c4205339a525|Name:FDA, SrcID:label/2010/020707s006lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020707s006lbl.pdf|Name:PubMed, SrcID:20722616, URL:http://europepmc.org/abstract/MED/20722616",OP(=O)(O)C(Sc1ccc(Cl)cc1)P(=O)(O)O,,
4864,CHEMBL184412,Dronedarone,Small molecule,2009.0,C01BD07,"C01BD07 [CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III]",-arone,Sodium channel alpha subunit blocker,Dronedarone reported to have antiarrhythmic properties belonging to all four Vaughan-Williams classes,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2013/022425s021lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022425s021lbl.pdf|Name:Wikipedia, SrcID:Dronedarone, URL:http://en.wikipedia.org/wiki/Dronedarone|Name:Expert, SrcID:DRONEDARONE, URL:http://chembl.blogspot.co.uk/search?q=DRONEDARONE|Name:PubMed, SrcID:21279331, URL:http://europepmc.org/abstract/MED/21279331",CCCCN(CCCC)CCCOc1ccc(cc1)C(=O)c2c(CCCC)oc3ccc(NS(=O)(=O)C)cc23,,
4865,CHEMBL492,Etidocaine,Small molecule,1976.0,N01BB07; N01BB57,"N01BB07 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Amides]; N01BB57 [NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Amides]",-caine,Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:8799190, URL:http://europepmc.org/abstract/MED/8799190|Name:PubMed, SrcID:15635807, URL:http://europepmc.org/abstract/MED/15635807",CCCN(CC)C(CC)C(=O)Nc1c(C)cccc1C,,
4866,CHEMBL1201575,Efalizumab,Antibody,2003.0,L04AA21,L04AA21 [ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Selective immunosuppressants],-mab,Integrin alpha-L/beta-2 (LFA-1) inhibitor,,,CHEMBL2364172,Integrin alpha-L/beta-2 (LFA-1),INHIBITOR,Homo sapiens,PROTEIN COMPLEX,Integrin alpha-L subunit,Alpha subunit is binding site,"Name:FDA, SrcID:label/2009/125075s130lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/125075s130lbl.pdf",,,
4867,CHEMBL1314,Tiopronin,Small molecule,1988.0,G04BX16,G04BX16 [GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Other urologicals],,Reducing agent,Prevents cysteine excretion,,,,,,,,,"Name:DailyMed, SrcID:setid=494a714e-923c-cd57-df6c-12886afb265a#nlm34090-1, URL:http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=494a714e-923c-cd57-df6c-12886afb265a#nlm34090-1",CC(S)C(=O)NCC(=O)O,,
4868,CHEMBL1356238,Pyrithione,Small molecule,1986.0,,,,Unknown,Disruption of membrane transport (direct or indirect effect on the primary proton pump which energizes transport),,,,,,,,,"Name:PubMed, SrcID:28693, URL:http://europepmc.org/abstract/MED/28693|Name:PubMed, SrcID:7574648, URL:http://europepmc.org/abstract/MED/7574648|Name:Wikipedia, SrcID:Pyrithione_zinc#Mechanism_of_action, URL:http://en.wikipedia.org/wiki/Pyrithione_zinc#Mechanism_of_action",[O-][n+]1ccccc1S,,
4869,CHEMBL1098319,2-Mercaptoethane,Small molecule,1988.0,,,,Unknown,,,,,,,,,,"Name:FDA, SrcID:nda/2002/20-855_Mesnex_Prntlbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/20-855_Mesnex_Prntlbl.pdf",OS(=O)(=O)CCS,,
4870,CHEMBL87992,Eslicarbazepine Acetate,Small molecule,2009.0,N03AF04,N03AF04 [NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Carboxamide derivatives],-pin(e),Sodium channel alpha subunit blocker,,,CHEMBL2331043,Sodium channel alpha subunit,BLOCKER,Homo sapiens,PROTEIN FAMILY,,,"Name:FDA, SrcID:label/2013/022416s000lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022416s000lbl.pdf|Name:PubMed, SrcID:24225327, URL:http://europepmc.org/abstract/MED/24225327",CC(=O)O[C@H]1Cc2ccccc2N(C(=O)N)c3ccccc13,,
4871,CHEMBL139367,Peramivir,Small molecule,2014.0,,,-vir,Neuraminidase inhibitor,,,CHEMBL3377,Neuraminidase,INHIBITOR,Influenza B virus (strain B/Lee/1940),SINGLE PROTEIN,,,"Name:FDA, SrcID:label/2014/206426lbl.pdf, URL:http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206426lbl.pdf",CCC(CC)[C@H](NC(=O)C)[C@@H]1[C@H](O)[C@H](C[C@H]1NC(=N)N)C(=O)O,,
4872,CHEMBL3545237,He3235,Small molecule,,,,,Androgen Receptor modulator,,,CHEMBL1871,Androgen Receptor,MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19881957, URL:http://europepmc.org/abstract/MED/19881957",C[C@]12CCC(O)CC1CCC3C2CC[C@@]4(C)C3CC[C@@]4(O)C#C,CHEMBL1871,AR
4873,CHEMBL271220,Cort 108297,Small molecule,,,,,Glucocorticoid receptor antagonist,Company reports initiation of No Ph1 trial in 2010 but no ID found and no further trials planned. Discontinuedcompound?,,CHEMBL2034,Glucocorticoid receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.corcept.com/news_events/view/pr_1269906075, URL:http://www.corcept.com/news_events/view/pr_1269906075|Name:PubMed, SrcID:24530653, URL:http://europepmc.org/abstract/MED/24530653",CCOC[C@@]12CN(CCC1=Cc3c(C2)cnn3c4ccc(F)cc4)S(=O)(=O)c5ccc(cc5)C(F)(F)F,CHEMBL2034,NR3C1
4874,CHEMBL1980297,Ilorasertib,Small molecule,,,,-sertib,Vascular endothelial growth factor receptor inhibitor,Multitargeted kinase inhibitor,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:22935731, URL:http://europepmc.org/abstract/MED/22935731",Nc1ncc(c2cnn(CCO)c2)c3scc(c4ccc(NC(=O)Nc5cccc(F)c5)cc4)c13,,
4875,CHEMBL3545360,Asp-3026,Small molecule,,,,,ALK tyrosine kinase receptor inhibitor,,,CHEMBL4247,ALK tyrosine kinase receptor,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24419060, URL:http://europepmc.org/abstract/MED/24419060",COc1cc(ccc1Nc2ncnc(Nc3ccccc3S(=O)(=O)C(C)C)n2)N4CCC(CC4)N5CCN(C)CC5,CHEMBL4247,ALK
4876,CHEMBL1672627,Las101057,Small molecule,,,,,Adenosine A2b receptor antagonist,,,CHEMBL255,Adenosine A2b receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16654164, URL:http://www.ncbi.nlm.nih.gov/pubmed/?term=16654164|Name:PubMed, SrcID:24900298, URL:http://europepmc.org/abstract/MED/24900298",Fc1cnccc1c2ncc(NC(=O)C3CC3)nc2c4cccnc4,CHEMBL255,ADORA2B
4877,CHEMBL2364652,Vantictumab,Antibody,,,,-mab,Frizzled-5 antagonist,mAB,,CHEMBL3559687,Frizzled-5,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22753465, URL:http://europepmc.org/abstract/MED/22753465",,CHEMBL3559687,FZD5
4878,CHEMBL2151570,Abt-107,Small molecule,,,,,Neuronal acetylcholine receptor protein alpha-7 subunit agonist,,,CHEMBL2492,Neuronal acetylcholine receptor protein alpha-7 subunit,AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:21919481, URL:http://europepmc.org/abstract/MED/21919481|Name:PubMed, SrcID:20504915, URL:http://europepmc.org/abstract/MED/20504915",C1CN2CCC1[C@H](C2)Oc3ccc(nn3)c4ccc5[nH]ccc5c4,CHEMBL2492,CHRNA7
4879,CHEMBL3544956,Pyrotinib,Small molecule,,,,-tinib,Epidermal growth factor receptor erbB1 inhibitor,,,CHEMBL203,Epidermal growth factor receptor erbB1,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://meetinglibrary.asco.org/content/146824-156, URL:http://meetinglibrary.asco.org/content/146824-156",,CHEMBL203,EGFR
4880,CHEMBL146032,Lonaprisan,Small molecule,,,,,Progesterone receptor antagonist,,,CHEMBL208,Progesterone receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:20043998, URL:http://europepmc.org/abstract/MED/20043998",CC(=O)c1ccc(cc1)[C@H]2C[C@@]3(C)[C@@H](CC[C@@]3(O)C(F)(F)C(F)(F)F)[C@@H]4CCC5=CC(=O)CCC5=C24,CHEMBL208,PGR
4881,CHEMBL1614701,Selumetinib,Small molecule,,,,-tinib,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,Non-adenosine-5'-triphosphate (ATP) competitive inhibitor,,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17332304, URL:http://europepmc.org/abstract/MED/17332304|Name:PubMed, SrcID:17699718, URL:http://europepmc.org/abstract/MED/17699718",Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(cc12)C(=O)NOCCO,CHEMBL2964,MAP2K2
4882,CHEMBL2138601,Refametinib,Small molecule,,,,-tinib,Dual specificity mitogen-activated protein kinase kinase 2 inhibitor,Allosteric inhibitor,,CHEMBL2964,Dual specificity mitogen-activated protein kinase kinase 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19706763, URL:http://europepmc.org/abstract/MED/19706763",COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1N[S+](=O)([O-])C3(CC(O)CO)CC3,CHEMBL2964,MAP2K2
4883,CHEMBL3545215,Bms-911543,Small molecule,,,,,Tyrosine-protein kinase JAK2 inhibitor,,,CHEMBL2971,Tyrosine-protein kinase JAK2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24766055, URL:http://europepmc.org/abstract/MED/24766055|Name:PubMed, SrcID:22015772, URL:http://europepmc.org/abstract/MED/22015772",CCn1c(cc2c1nc(Nc3cc(C)n(C)n3)c4ncn(C)c24)C(=O)N(C5CC5)C6CC6,CHEMBL2971,JAK2
4884,CHEMBL482968,Enmd-2076,Small molecule,,,,,Fibroblast growth factor receptor 3 inhibitor,Tartrate salt of ENMD-981693,,CHEMBL2742,Fibroblast growth factor receptor 3,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf, URL:http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf|Name:PubMed, SrcID:21177375, URL:http://europepmc.org/abstract/MED/21177375|Name:PubMed, SrcID:22397360, URL:http://europepmc.org/abstract/MED/22397360",CN1CCN(CC1)c2cc(Nc3cc(C)[nH]n3)nc(\C=C\c4ccccc4)n2,CHEMBL2742,FGFR3
4885,CHEMBL3545283,Riviciclib,Small molecule,,,,-ciclib,Cyclin-dependent kinase 9 inhibitor,,,CHEMBL3116,Cyclin-dependent kinase 9,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25215591, URL:http://europepmc.org/abstract/MED/25215591|Name:PubMed, SrcID:17363486, URL:http://europepmc.org/abstract/MED/17363486",CN1CCC(C1CO)c2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccccc4Cl,CHEMBL3116,CDK9
4886,CHEMBL475251,Tamatinib,Small molecule,,,,-tinib,Tyrosine-protein kinase SYK inhibitor,Active metabolite of prodrug R-788 (Fostamatinib),,CHEMBL2599,Tyrosine-protein kinase SYK,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16946104, URL:http://europepmc.org/abstract/MED/16946104",COc1cc(Nc2ncc(F)c(Nc3ccc4OC(C)(C)C(=O)Nc4n3)n2)cc(OC)c1OC,CHEMBL2599,SYK
4887,CHEMBL1090090,Vx-702,Small molecule,,,,,MAP kinase p38 alpha inhibitor,Also potent inhibitor of MAPK11,,CHEMBL260,MAP kinase p38 alpha,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19950901, URL:http://europepmc.org/abstract/MED/19950901",NC(=O)N(c1ccc(C(=O)N)c(n1)c2ccc(F)cc2F)c3c(F)cccc3F,CHEMBL260,MAPK14
4888,CHEMBL1933349,Mk-0893,Small molecule,,,,,Glucagon receptor antagonist,,,CHEMBL1985,Glucagon receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22708876, URL:http://europepmc.org/abstract/MED/22708876|Name:PubMed, SrcID:27111510, URL:http://europepmc.org/abstract/MED/27111510",COc1ccc2cc(ccc2c1)c3cc(nn3[C@@H](C)c4ccc(cc4)C(=O)NCCC(=O)O)c5cc(Cl)cc(Cl)c5,CHEMBL1985,GCGR
4889,CHEMBL1951575,Vidupiprant,Small molecule,,,,-piprant,G protein-coupled receptor 44 antagonist,Indication: Asthma,,CHEMBL5071,G protein-coupled receptor 44,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24900313, URL:http://europepmc.org/abstract/MED/24900313",CC(C)(C)NC(=O)c1ccc(Oc2cc(F)c(CC(=O)O)cc2Cl)c(NS(=O)(=O)c3ccc(cc3Cl)C4CC4)c1,CHEMBL5071,PTGDR2
4890,CHEMBL3707249,Asm-024,Small molecule,,,,,Muscarinic acetylcholine receptor M3 antagonist,"ASM-024 displays both antagonistic and agonistic activity on CHRNA7, is thought to be a so called ""a7 silent agonist"": produce little or no CHRNA7 channel activation on its own but effectively activate the ion channel when combined with the type II positive allosteric modulator (PAM) PNU-120596. (A minimal pharmacophore for a nicotinic alpha7 silent agonist, relevance for the therapeutic development of treatments for asthma Poster#: 224.06/C24. Neuroscience Meeting Planner. New Orleans, LA: Soci",,CHEMBL245,Muscarinic acetylcholine receptor M3,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24465890, URL:http://europepmc.org/abstract/MED/24465890|Name:PubMed, SrcID:25799096, URL:http://europepmc.org/abstract/MED/25799096",,CHEMBL245,CHRM3
4891,CHEMBL356388,Etazolate,Small molecule,,,,,GABA receptor beta-3 subunit positive allosteric modulator,,,CHEMBL1847,GABA receptor beta-3 subunit,POSITIVE ALLOSTERIC MODULATOR,Homo sapiens,SINGLE PROTEIN,,,"Name:Other, SrcID:http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7336, URL:http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7336|Name:Wikipedia, SrcID:Etazolate, URL:https://en.wikipedia.org/wiki/Etazolate",CCOC(=O)c1cnc2c(cnn2CC)c1NN=C(C)C,CHEMBL1847,GABRB3
4892,CHEMBL487,Droloxifene,Small molecule,,,,-ifene,Estrogen receptor modulator,"SERM, development stopped as ineffective compared to tamoxifen.",,CHEMBL2093866,Estrogen receptor,MODULATOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:25210448, URL:http://europepmc.org/abstract/MED/25210448|Name:PubMed, SrcID:1962598, URL:http://europepmc.org/abstract/MED/1962598",CC\C(=C(\c1ccc(OCCN(C)C)cc1)/c2cccc(O)c2)\c3ccccc3,,
4893,CHEMBL217092,Saracatinib,Small molecule,,,,-tinib,Tyrosine-protein kinase SRC inhibitor,,,CHEMBL267,Tyrosine-protein kinase SRC,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:17064066, URL:http://europepmc.org/abstract/MED/17064066",CN1CCN(CCOc2cc(OC3CCOCC3)c4c(Nc5c(Cl)ccc6OCOc56)ncnc4c2)CC1,CHEMBL267,SRC
4894,CHEMBL270995,Brivanib Alaninate,Small molecule,,,,-anib,Fibroblast growth factor receptor inhibitor,Prodrug - active metabolite is BMS-540215,,CHEMBL2095217,Fibroblast growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:18829493, URL:http://europepmc.org/abstract/MED/18829493|Name:PubMed, SrcID:18288793, URL:http://europepmc.org/abstract/MED/18288793",C[C@H](COc1cn2ncnc(Oc3ccc4[nH]c(C)cc4c3F)c2c1C)OC(=O)[C@H](C)N,,
4895,CHEMBL522892,Dovitinib,Small molecule,,,,-tinib,Vascular endothelial growth factor receptor inhibitor,,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:15897558, URL:http://europepmc.org/abstract/MED/15897558",CN1CCN(CC1)c2ccc3nc([nH]c3c2)C4=C(N)c5c(F)cccc5NC4=O,,
4896,CHEMBL220808,Sarizotan,Small molecule,,,,-zotan,Dopamine D2 receptor partial agonist,"Development discontunued, failed to meet primary efficacy endpoints, no difference between drug and placebo. Newron developing drug for Rett syndrome and received EMA and FDA orphan designation in July 2015. Agonist/partial agonistic/antagonsitic effect depending on dopamine receptor isoform.",,CHEMBL217,Dopamine D2 receptor,PARTIAL AGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:14767715, URL:http://europepmc.org/abstract/MED/14767715|Name:PubMed, SrcID:16844149, URL:http://europepmc.org/abstract/MED/16844149",Fc1ccc(cc1)c2cncc(CNC[C@H]3CCc4ccccc4O3)c2,CHEMBL217,DRD2
4897,CHEMBL3545045,Iti-007,Small molecule,,,,,Serotonin 2a (5-HT2a) receptor antagonist,"Atypical antipsychotic, shows partial agonism at the presynaptic D2 receptors and acts as an antagonist at postsynaptic D2 receptors (PMID: 25120104).",,CHEMBL224,Serotonin 2a (5-HT2a) receptor,ANTAGONIST,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:24559051, URL:http://europepmc.org/abstract/MED/24559051|Name:Other, SrcID:http://www.intracellulartherapies.com/products-technology/iti-007.html, URL:http://www.intracellulartherapies.com/products-technology/iti-007.html|Name:PubMed, SrcID:25120104, URL:http://europepmc.org/abstract/MED/25120104",CN1CCN2C3CCN(CCCC(=O)c4ccc(F)cc4)CC3c5cccc1c25,CHEMBL224,HTR2A
4898,CHEMBL3707253,Bevacizumab 111in,Antibody,,,,-mab,Vascular endothelial growth factor A binding agent,"Binds to VEGFA, allowing the detection of VEGFA distribution using gamma scintigraphy.",,CHEMBL1783,Vascular endothelial growth factor A,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:18240146, URL:http://europepmc.org/abstract/MED/18240146|Name:PubMed, SrcID:21429739, URL:http://europepmc.org/abstract/MED/21429739",,CHEMBL1783,VEGFA
4899,CHEMBL2103847,Tosedostat,Small molecule,,,,-stat,Aminopeptidases inhibitor,"Inhibition of the aminopeptidases disrupts normal protein turnover leading to peptide accumulation and decrease in free amino acids which leads to a stress response, amino acid depravation response, including activation of stress-related pathways such NF-¿B and pro-apoptotic regulators.",,CHEMBL3831223,Aminopeptidase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:26972558, URL:http://europepmc.org/abstract/MED/26972558",CC(C)C[C@H]([C@H](O)C(=O)NO)C(=O)N[C@H](C(=O)OC1CCCC1)c2ccccc2,CHEMBL3831223,METAP1D
4900,CHEMBL2103847,Tosedostat,Small molecule,,,,-stat,Aminopeptidases inhibitor,"Inhibition of the aminopeptidases disrupts normal protein turnover leading to peptide accumulation and decrease in free amino acids which leads to a stress response, amino acid depravation response, including activation of stress-related pathways such NF-¿B and pro-apoptotic regulators.",,CHEMBL3831223,Aminopeptidase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:26972558, URL:http://europepmc.org/abstract/MED/26972558",CC(C)C[C@H]([C@H](O)C(=O)NO)C(=O)N[C@H](C(=O)OC1CCCC1)c2ccccc2,CHEMBL3831223,RNPEPL1
4901,CHEMBL2103847,Tosedostat,Small molecule,,,,-stat,Aminopeptidases inhibitor,"Inhibition of the aminopeptidases disrupts normal protein turnover leading to peptide accumulation and decrease in free amino acids which leads to a stress response, amino acid depravation response, including activation of stress-related pathways such NF-¿B and pro-apoptotic regulators.",,CHEMBL3831223,Aminopeptidase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:26972558, URL:http://europepmc.org/abstract/MED/26972558",CC(C)C[C@H]([C@H](O)C(=O)NO)C(=O)N[C@H](C(=O)OC1CCCC1)c2ccccc2,CHEMBL3831223,LVRN
4902,CHEMBL2103847,Tosedostat,Small molecule,,,,-stat,Aminopeptidases inhibitor,"Inhibition of the aminopeptidases disrupts normal protein turnover leading to peptide accumulation and decrease in free amino acids which leads to a stress response, amino acid depravation response, including activation of stress-related pathways such NF-¿B and pro-apoptotic regulators.",,CHEMBL3831223,Aminopeptidase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:26972558, URL:http://europepmc.org/abstract/MED/26972558",CC(C)C[C@H]([C@H](O)C(=O)NO)C(=O)N[C@H](C(=O)OC1CCCC1)c2ccccc2,CHEMBL3831223,C9orf3
4903,CHEMBL2103847,Tosedostat,Small molecule,,,,-stat,Aminopeptidases inhibitor,"Inhibition of the aminopeptidases disrupts normal protein turnover leading to peptide accumulation and decrease in free amino acids which leads to a stress response, amino acid depravation response, including activation of stress-related pathways such NF-¿B and pro-apoptotic regulators.",,CHEMBL3831223,Aminopeptidase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:26972558, URL:http://europepmc.org/abstract/MED/26972558",CC(C)C[C@H]([C@H](O)C(=O)NO)C(=O)N[C@H](C(=O)OC1CCCC1)c2ccccc2,CHEMBL3831223,NPEPL1
4904,CHEMBL2103847,Tosedostat,Small molecule,,,,-stat,Aminopeptidases inhibitor,"Inhibition of the aminopeptidases disrupts normal protein turnover leading to peptide accumulation and decrease in free amino acids which leads to a stress response, amino acid depravation response, including activation of stress-related pathways such NF-¿B and pro-apoptotic regulators.",,CHEMBL3831223,Aminopeptidase,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,"Name:PubMed, SrcID:26972558, URL:http://europepmc.org/abstract/MED/26972558",CC(C)C[C@H]([C@H](O)C(=O)NO)C(=O)N[C@H](C(=O)OC1CCCC1)c2ccccc2,CHEMBL3831223,XPNPEP3
4905,CHEMBL2110731,Tofogliflozin,Small molecule,,,,-gliflozin,Sodium/glucose cotransporter 2 inhibitor,,"SGLT2 selective. IC50 rSGLT2= 14.5nM; mSGLT2= 5.0 nM vs IC50 rSGLT1=8200 nM; IC50 mSGLT1, 1800 nM.",CHEMBL3884,Sodium/glucose cotransporter 2,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:22410641, URL:http://europepmc.org/abstract/MED/22410641",CCc1ccc(Cc2ccc3CO[C@]4(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)c3c2)cc1,CHEMBL3884,SLC5A2
4906,CHEMBL2108313,Conbercept,Protein,,,,-cept,Vascular endothelial growth factor B inhibitor,Soluble receptor decoy which has a high binding affinity to VEGF and a long half-life in vitreous.,"All isoforms of VEGF-A, VEGF-B, VEGF-C, and PlGF.",CHEMBL3580488,Vascular endothelial growth factor B,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:25960634, URL:http://europepmc.org/abstract/MED/25960634|Name:PubMed, SrcID:18246030, URL:http://europepmc.org/abstract/MED/18246030|Name:PubMed, SrcID:23950958, URL:http://europepmc.org/abstract/MED/23950958",,CHEMBL3580488,VEGFB
4907,CHEMBL1743028,Glembatumumab Vedotin,Antibody,,,,-mab,Transmembrane glycoprotein NMB binding agent,"Glembatumumab vedotin is designed to be stable in the bloodstream, but to release MMAE upon internalization into gpNMB-expressing tumor cells, resulting in a targeted cell-killing effect. Antimitotic agent monomethyl auristatin E (MMAE), which blocks tubulin polymerization.",,CHEMBL3712919,Transmembrane glycoprotein NMB,BINDING AGENT,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:16489096, URL:http://europepmc.org/abstract/MED/16489096|Name:PubMed, SrcID:20215530, URL:http://europepmc.org/abstract/MED/20215530",,CHEMBL3712919,GPNMB
4908,CHEMBL1743056,Pateclizumab,Antibody,,,,-mab,TNF-beta inhibitor,"Binds LT-alpha in both the secreted LT-alpha3 and the surface-expressed LT-alpha1beta2, blocking TNFR and LTBR signalling. Depletes LT-alpha–expressing cells by antibody-dependent cellular cytotoxicity (ADCC).",,CHEMBL2059,TNF-beta,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:19561618, URL:http://europepmc.org/abstract/MED/19561618|Name:PubMed, SrcID:25359150, URL:http://europepmc.org/abstract/MED/25359150",,CHEMBL2059,LTA
4909,CHEMBL2109613,Pf-04236921,Antibody,,,,,Interleukin-6 inhibitor,,,CHEMBL1795129,Interleukin-6,INHIBITOR,Homo sapiens,SINGLE PROTEIN,,,"Name:PubMed, SrcID:27672124, URL:http://europepmc.org/abstract/MED/27672124",,CHEMBL1795129,IL6
4910,CHEMBL706,Cetyl Alcohol,Small molecule,1990.0,,,,Unknown,,,,,,,,,,,CCCCCCCCCCCCCCCCO,,
4911,CHEMBL3545300,Cp-459632,Small molecule,,,,,Vascular endothelial growth factor receptor inhibitor,No references found,,CHEMBL2095227,Vascular endothelial growth factor receptor,INHIBITOR,Homo sapiens,PROTEIN FAMILY,,,,,,
